Citrus Sinensis ID: 008707
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 557 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGI2 | 929 | Probable LRR receptor-lik | yes | no | 0.987 | 0.592 | 0.719 | 0.0 | |
| Q8LKZ1 | 924 | Nodulation receptor kinas | N/A | no | 0.903 | 0.544 | 0.406 | 4e-97 | |
| Q8L4H4 | 925 | Nodulation receptor kinas | N/A | no | 0.910 | 0.548 | 0.397 | 1e-95 | |
| Q9ZQQ7 | 886 | Putative leucine-rich rep | no | no | 0.863 | 0.542 | 0.382 | 4e-89 | |
| C0LGV0 | 895 | Probable LRR receptor-lik | no | no | 0.838 | 0.521 | 0.377 | 1e-86 | |
| O64556 | 877 | Putative leucine-rich rep | no | no | 0.795 | 0.505 | 0.374 | 2e-85 | |
| Q9FZB8 | 871 | Probable LRR receptor-lik | no | no | 0.820 | 0.524 | 0.365 | 4e-85 | |
| O65924 | 881 | Putative leucine-rich rep | no | no | 0.816 | 0.516 | 0.370 | 2e-84 | |
| C0LGQ7 | 898 | Probable LRR receptor-lik | no | no | 0.852 | 0.528 | 0.361 | 2e-84 | |
| Q9SI06 | 892 | Putative leucine-rich rep | no | no | 0.894 | 0.558 | 0.363 | 4e-84 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 789 bits (2038), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/559 (71%), Positives = 466/559 (83%), Gaps = 9/559 (1%)
Query: 2 VLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKN 61
VL+A+RS+S +S+ ++ GDPC+PV W WV CS+T+PPR+TKIALS KNL+GEIPP +
Sbjct: 377 VLDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLRGEIPPGINY 436
Query: 62 MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 121
MEALTELWLD N LTG LPDMS+L++L+I+HLENN+L+GSLP Y+ LPNLQEL IENNS
Sbjct: 437 MEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNLQELSIENNS 496
Query: 122 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 181
F G+IP ALL GKV+FKY+NNP+L E++R+ F ILG SI +AILL+L SL++L
Sbjct: 497 FKGKIPSALLKGKVLFKYNNNPELQNEAQRK-HFWQILGISIAAVAILLLLVGGSLVLLC 555
Query: 182 KLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCK 241
LR+ K +K DS T K AYS RGGH +DEGVAYFI LP LEEAT+NF K
Sbjct: 556 ALRK----TKRADKGDSTETKKK-GLVAYSAVRGGHLLDEGVAYFISLPVLEEATDNFSK 610
Query: 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 301
K+G+GSFGSVYYG+MKDGKEVAVKI AD SH +QFVTEVALLSRIHHRNLVPLIGYCE
Sbjct: 611 KVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIGYCE 670
Query: 302 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 361
E +RILVYEYMHNG+L D LHGS + KPLDWLTRLQIA DAAKGLEYLHTGCNP IIHR
Sbjct: 671 EADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLHTGCNPSIIHR 730
Query: 362 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 421
DVKSSNILLDINMRAKVSDFGLSRQ EEDLTH+SSVA+GTVGYLDPEYY +QQLTEKSDV
Sbjct: 731 DVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEKSDV 790
Query: 422 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 481
YSFGVVL EL+SGKKPVS EDFG ELNIVHWARS+I+KGDV I+DP + NVKIES+WR
Sbjct: 791 YSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDPCIASNVKIESVWR 850
Query: 482 IAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF---SSSSSKGQSSRKTLLTS 538
+AEVA QCVEQRG +RP+MQE+++AIQD+I+IE+G + SSSSSK QSSRKTLLTS
Sbjct: 851 VAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSKAQSSRKTLLTS 910
Query: 539 FLEIESPDLSNECLAPAAR 557
FLE+ESPD+S LAPAAR
Sbjct: 911 FLELESPDISRNSLAPAAR 929
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8LKZ1|NORK_PEA Nodulation receptor kinase OS=Pisum sativum GN=NORK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 355 bits (912), Expect = 4e-97, Method: Compositional matrix adjust.
Identities = 214/526 (40%), Positives = 305/526 (57%), Gaps = 23/526 (4%)
Query: 20 GDPCVPVPWEWVTCSTTTPPR-ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP 78
GDPC+ PW+ V C + ITK+ LS NLKG IP + M L L L N G
Sbjct: 385 GDPCMLFPWKGVACDGSNGSSVITKLDLSSSNLKGTIPSSVTEMTKLQILNLSHNHFDGY 444
Query: 79 LPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFK 138
+P L V L N+LTG LP + SLP+L L+ N + + A L +I
Sbjct: 445 IPSFPPSSLLISVDLSYNDLTGQLPESIISLPHLNSLYFGCNQHMRDDDEAKLNSSLI-- 502
Query: 139 YDNNPKLHKESRRRMRF-KLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQ----KSY 193
N + + ++ +F ++ + +I +IL+ L + L R + I+ + K+Y
Sbjct: 503 ---NTDYGRCNAKKPKFGQVFMIGAITSGSILITLAVVILFFCRYRHKSITLEGFGGKTY 559
Query: 194 EKADSLRTSTKPSNTAYSIARGGHFMDEGVAYF-IPLPELEEATNNFCKKIGKGSFGSVY 252
A +N +S+ F + V+ L +E AT + IG+G FGSVY
Sbjct: 560 PMA---------TNIIFSLPSKDDFFIKSVSVKPFTLEYIELATEKYKTLIGEGGFGSVY 610
Query: 253 YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312
G + DG+EVAVK+ + + + T++F E+ LLS I H NLVPL+GYC E Q+ILVY +
Sbjct: 611 RGTLDDGQEVAVKVRSATSTQGTREFDNELNLLSAIQHENLVPLLGYCNEYDQQILVYPF 670
Query: 313 MHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 371
M NG+L DRL+G +K LDW TRL IA AA+GL YLHT +IHRDVKSSNILLD
Sbjct: 671 MSNGSLLDRLYGEPAKRKILDWPTRLSIALGAARGLAYLHTFPGRSVIHRDVKSSNILLD 730
Query: 372 INMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLE 430
+M AKV+DFG S+ A +E +++S RGT GYLDPEYY QQL+EKSDV+SFGVVLLE
Sbjct: 731 HSMCAKVADFGFSKYAPQEGDSYVSLEVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLE 790
Query: 431 LISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV 490
++SG++P++++ E ++V WA+ I+ V IVDP + G E++WR+ EVA+QC+
Sbjct: 791 IVSGREPLNIKRPRVEWSLVEWAKPYIRASKVDEIVDPGIKGGYHAEALWRVVEVALQCL 850
Query: 491 EQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSSKGQSSRKTLL 536
E RP M +IV ++D++ IE + S S G S+R +++
Sbjct: 851 EPYSTYRPCMVDIVRELEDALIIENNASEYMKSIDSLGGSNRYSIV 896
|
Involved in the perception of symbiotic fungi and bacteria and required for the calcium spiking. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Pisum sativum (taxid: 3888) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 350 bits (899), Expect = 1e-95, Method: Compositional matrix adjust.
Identities = 207/521 (39%), Positives = 298/521 (57%), Gaps = 14/521 (2%)
Query: 20 GDPCVPVPWEWVTCSTTTPPRI-TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP 78
GDPC+ PW+ +TC +T I TK+ LS NLKG IP + M L L L N
Sbjct: 387 GDPCMIFPWKGITCDDSTGSSIITKLDLSSNNLKGAIPSIVTKMTNLQILNLSHNQFDML 446
Query: 79 LPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFK 138
P L + L N+L+G LP + SLP+L+ L+ N + + L +I
Sbjct: 447 FPSFPPSSLLISLDLSYNDLSGWLPESIISLPHLKSLYFGCNPSMSDEDTTKLNSSLI-- 504
Query: 139 YDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADS 198
N + ++ +F + LL+ ++ + R K + + K
Sbjct: 505 ---NTDYGRCKAKKPKFGQVFVIGAITSGSLLITLAVGILFFCRYRHKSITLEGFGKTYP 561
Query: 199 LRTSTKPSNTAYSIARGGHFMDEGVAYF-IPLPELEEATNNFCKKIGKGSFGSVYYGKMK 257
+ T N +S+ F + V+ L +E+AT + IG+G FGSVY G +
Sbjct: 562 MAT-----NIIFSLPSKDDFFIKSVSVKPFTLEYIEQATEQYKTLIGEGGFGSVYRGTLD 616
Query: 258 DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 317
DG+EVAVK+ + + + T++F E+ LLS I H NLVPL+GYC E Q+ILVY +M NG+
Sbjct: 617 DGQEVAVKVRSSTSTQGTREFDNELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGS 676
Query: 318 LRDRLHGSVNQ-KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 376
L DRL+G ++ K LDW TRL IA AA+GL YLHT +IHRDVKSSNILLD +M A
Sbjct: 677 LLDRLYGEASKRKILDWPTRLSIALGAARGLAYLHTFPGRSVIHRDVKSSNILLDQSMCA 736
Query: 377 KVSDFGLSRQA-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 435
KV+DFG S+ A +E +++S RGT GYLDPEYY QQL+EKSDV+SFGVVLLE++SG+
Sbjct: 737 KVADFGFSKYAPQEGDSYVSLEVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGR 796
Query: 436 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGF 495
+P++++ E ++V WA+ I+ V IVDP + G E++WR+ EVA+QC+E
Sbjct: 797 EPLNIKRPRIEWSLVEWAKPYIRASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYST 856
Query: 496 SRPKMQEIVLAIQDSIKIEKGGDQKFSSSSSKGQSSRKTLL 536
RP M +IV ++D++ IE + S S G S+R +++
Sbjct: 857 YRPCMVDIVRELEDALIIENNASEYMKSIDSLGGSNRYSIV 897
|
Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Medicago truncatula (taxid: 3880) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZQQ7|Y2144_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g14440 OS=Arabidopsis thaliana GN=At2g14440 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (843), Expect = 4e-89, Method: Compositional matrix adjust.
Identities = 202/528 (38%), Positives = 302/528 (57%), Gaps = 47/528 (8%)
Query: 15 RTNDRGDPCVPVPWEW--VTCST---TTPPRITKIALSGKNLKGEIPPELKNMEALTELW 69
R + +GDPCVP+ + W V+C+ +TPPRI + LS L G I P ++N+ L EL
Sbjct: 383 RISWQGDPCVPIQFSWMGVSCNVIDISTPPRIISLDLSSSGLTGVITPSIQNLTMLRELD 442
Query: 70 LDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 128
L N LTG +P + L LR + L NN LTG +P ++ ++ L +H+ N+ G +P
Sbjct: 443 LSNNNLTGVIPPSLQNLTMLRELDLSNNNLTGEVPEFLATIKPLLVIHLRGNNLRGSVPQ 502
Query: 129 ALLTGKVIFKYDNNP--KLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRK 186
AL +NN KL + + + + + SI +A+ +++ L + + R RRK
Sbjct: 503 ALQ------DRENNDGLKLLRGKHQPKSWLVAIVASISCVAVTIIV-LVLIFIFR--RRK 553
Query: 187 ISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKG 246
S +K +R S + N + + E++E TNNF +GKG
Sbjct: 554 SSTRKV------IRPSLEMKNRRFKYS-----------------EVKEMTNNFEVVLGKG 590
Query: 247 SFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 306
FG VY+G + + ++VAVK+++ S + ++F TEV LL R+HH NLV L+GYC++ +
Sbjct: 591 GFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHHVNLVSLVGYCDKGNDL 649
Query: 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 366
L+YE+M NG L++ L G L+W RL+IA ++A G+EYLH GC P ++HRDVKS+
Sbjct: 650 ALIYEFMENGNLKEHLSGKRGGPVLNWPGRLKIAIESALGIEYLHIGCKPPMVHRDVKST 709
Query: 367 NILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFG 425
NILL + AK++DFGLSR TH+S+ GT+GYLDPEYY LTEKSDVYSFG
Sbjct: 710 NILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGYLDPEYYQKNWLTEKSDVYSFG 769
Query: 426 VVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEV 485
+VLLE+I+G +PV +E + IV WA+SM+ GD+ SI+D L + S W+ E+
Sbjct: 770 IVLLEIITG-QPV-IEQSRDKSYIVEWAKSMLANGDIESIMDRNLHQDYDTSSSWKALEL 827
Query: 486 AIQCVEQRGFSRPKMQEIVLAIQDSIKI---EKGGDQKFSSSSSKGQS 530
A+ C+ RP M + + + ++I K Q +SS S G +
Sbjct: 828 AMLCINPSSTLRPNMTRVAHELNECLEIYNLTKRRSQDQNSSKSSGHT 875
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV0|Y5487_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g48740 OS=Arabidopsis thaliana GN=At5g48740 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 321 bits (822), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 205/543 (37%), Positives = 295/543 (54%), Gaps = 76/543 (13%)
Query: 21 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP 80
DPC P+PW + C R+T + LS NL+ I P ++ L L L LTG +
Sbjct: 369 DPCTPLPWNHIECEGN---RVTSLFLSKINLR-SISPTFGDLLDLKTLDLHNTSLTGAIQ 424
Query: 81 DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF------------------ 122
++ L DL+ ++L N+L S S + L NL+ L ++NNS
Sbjct: 425 NVGSLKDLQKLNLSFNQLE-SFGSELEDLVNLEVLDLQNNSLQGSVPETLGKLKKLRLLN 483
Query: 123 ------VGEIPPALLTGKVIFKYDNNPKL-----------------------HKESRRRM 153
VG +P +L + + NP L +K+ R++
Sbjct: 484 LENNNLVGPLPQSLNITGLEVRITGNPCLSFSSISCNNVSSTIDTPQVTIPINKKQRKQN 543
Query: 154 RFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIA 213
R ++LG S G L ++F+ I R+ R K + D R K N ++ +
Sbjct: 544 RIAILLGVSGGALFATFLVFVFMSIFTRRQRNK--------ERDITRAQLKMQN--WNAS 593
Query: 214 RGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH 273
R E++ AT NF + IG+GSFG+VY GK+ DGK+VAVK+ D
Sbjct: 594 R-----------IFSHKEIKSATRNFKEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQL 642
Query: 274 RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLD 332
F+ EV LLS+I H+NLV G+C E ++ILVYEY+ G+L D L+G +++ L+
Sbjct: 643 GADSFINEVHLLSQIRHQNLVSFEGFCYEPKRQILVYEYLSGGSLADHLYGPRSKRHSLN 702
Query: 333 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDL 391
W++RL++A DAAKGL+YLH G P IIHRDVKSSNILLD +M AKVSDFGLS+Q + D
Sbjct: 703 WVSRLKVAVDAAKGLDYLHNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSKQFTKADA 762
Query: 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 451
+HI++V +GT GYLDPEYY QLTEKSDVYSFGVVLLELI G++P+S N+V
Sbjct: 763 SHITTVVKGTAGYLDPEYYSTLQLTEKSDVYSFGVVLLELICGREPLSHSGSPDSFNLVL 822
Query: 452 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511
WAR ++ G IVD +L S+ + A +AI+CV + RP + E++ ++++
Sbjct: 823 WARPNLQAG-AFEIVDDILKETFDPASMKKAASIAIRCVGRDASGRPSIAEVLTKLKEAY 881
Query: 512 KIE 514
++
Sbjct: 882 SLQ 884
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64556|Y2923_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g19230 OS=Arabidopsis thaliana GN=At2g19230 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 317 bits (812), Expect = 2e-85, Method: Compositional matrix adjust.
Identities = 193/516 (37%), Positives = 280/516 (54%), Gaps = 73/516 (14%)
Query: 20 GDPCVPV--PWEWVTCSTTT--PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFL 75
GDPC P PW+ + CS T PPRI + LS L G+I P F+
Sbjct: 391 GDPCAPFGYPWQGINCSYTANNPPRIISVNLSFSGLTGQIDPV---------------FI 435
Query: 76 TGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL---- 131
T L L+ + L NN LTG++P ++ +LP+L EL++E N G +P LL
Sbjct: 436 T--------LTPLQKLDLSNNRLTGTVPDFLANLPDLTELNLEENKLTGILPEKLLERSK 487
Query: 132 TGKVIFKYDNNPKL-------HKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLR 184
G + + NP L +K++ R+ + + G+ +LL L
Sbjct: 488 DGSLSLRVGGNPDLCVSDSCRNKKTERKEYIIPSVASVTGLFFLLLAL------------ 535
Query: 185 RKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIG 244
IS + ++ S++T + Y + E+ E TNNF + +G
Sbjct: 536 --ISFWQFKKRQQSVKTGPLDTKRYYKYS-----------------EIVEITNNFERVLG 576
Query: 245 KGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 304
+G FG VYYG ++ G++VA+K+++ S + ++F EV LL R+HH+NL+ LIGYC E
Sbjct: 577 QGGFGKVYYGVLR-GEQVAIKMLSKSSAQGYKEFRAEVELLLRVHHKNLIALIGYCHEGD 635
Query: 305 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK 364
Q L+YEY+ NGTL D L G N L W RLQI+ DAA+GLEYLH GC P I+HRDVK
Sbjct: 636 QMALIYEYIGNGTLGDYLSGK-NSSILSWEERLQISLDAAQGLEYLHNGCKPPIVHRDVK 694
Query: 365 SSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYS 423
+NIL++ ++AK++DFGLSR E + +S+ GT+GYLDPE+Y QQ +EKSDVYS
Sbjct: 695 PTNILINEKLQAKIADFGLSRSFTLEGDSQVSTEVAGTIGYLDPEHYSMQQFSEKSDVYS 754
Query: 424 FGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIA 483
FGVVLLE+I+G+ +S +I M+ KGD+ SIVDP L W+I
Sbjct: 755 FGVVLLEVITGQPVISRSRTEENRHISDRVSLMLSKGDIKSIVDPKLGERFNAGLAWKIT 814
Query: 484 EVAIQCVEQRGFSRPKMQEIVLAIQDSI-KIEKGGD 518
EVA+ C + +R M ++V +++S+ + GD
Sbjct: 815 EVALACASESTKTRLTMSQVVAELKESLCRARTSGD 850
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZB8|Y5181_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g51810 OS=Arabidopsis thaliana GN=At1g51810 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 315 bits (808), Expect = 4e-85, Method: Compositional matrix adjust.
Identities = 191/522 (36%), Positives = 292/522 (55%), Gaps = 65/522 (12%)
Query: 15 RTNDRGDPCVP--VPWEWVTCSTT---TPPRITKIALSGKNLKGEIPPELKNMEALTELW 69
+T +GDPCVP W+ + C+ + TPP IT + LS L G I ++N+ L EL
Sbjct: 375 KTTWQGDPCVPKKFLWDGLNCNNSDDSTPPIITSLNLSSSGLTGIIVLTIQNLANLQEL- 433
Query: 70 LDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA 129
L NN L+G +P ++ + +L +++ N+ G +P
Sbjct: 434 ----------------------DLSNNNLSGGVPEFLADMKSLLVINLSGNNLSGVVPQK 471
Query: 130 LLTGKVI-FKYDNNPKLH----------KESRRRMRFKLI-LGTSIGVLAILLVLFLCSL 177
L+ K++ + NPKL+ +E R+++ I + SIG + V F +L
Sbjct: 472 LIEKKMLKLNIEGNPKLNCTVESCVNKDEEGGRQIKSMTIPIVASIGSV----VAFTVAL 527
Query: 178 IVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYS----IARGGHFMDEGVAYFIPLPELE 233
++ +R+ N S ++A + + P+++ S + + F E+
Sbjct: 528 MIFCVVRK---NNPSNDEAPT--SCMLPADSRSSEPTIVTKNKKFT---------YAEVL 573
Query: 234 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL 293
TNNF K +GKG FG VYYG + ++VAVK+++ S + +QF EV LL R+HH+NL
Sbjct: 574 TMTNNFQKILGKGGFGIVYYGSVNGTEQVAVKMLSHSSAQGYKQFKAEVELLLRVHHKNL 633
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
V L+GYCEE + L+YEYM NG L + + G L+W TRL+IA +AA+GLEYLH G
Sbjct: 634 VGLVGYCEEGDKLALIYEYMANGDLDEHMSGKRGGSILNWGTRLKIALEAAQGLEYLHNG 693
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGN 412
C P ++HRDVK++NILL+ + K++DFGLSR E TH+S+V GT+GYLDPEYY
Sbjct: 694 CKPLMVHRDVKTTNILLNEHFDTKLADFGLSRSFPIEGETHVSTVVAGTIGYLDPEYYRT 753
Query: 413 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472
LTEKSDVYSFGVVLL +I+ +PV ++ + +I W M+ KGD+ SI DP L+G
Sbjct: 754 NWLTEKSDVYSFGVVLLVMIT-NQPV-IDQNREKRHIAEWVGGMLTKGDIKSITDPNLLG 811
Query: 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514
+ S+W+ E+A+ C+ +RP M ++V +++ + E
Sbjct: 812 DYNSGSVWKAVELAMSCMNPSSMTRPTMSQVVFELKECLASE 853
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65924|Y2921_ARATH Putative leucine-rich repeat receptor-like protein kinase At2g19210 OS=Arabidopsis thaliana GN=At2g19210 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 313 bits (803), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 194/524 (37%), Positives = 282/524 (53%), Gaps = 69/524 (13%)
Query: 20 GDPCVPV--PWEWVTCS--TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFL 75
GDPC PV PW+ + CS PRI + LS L GEI D F
Sbjct: 390 GDPCAPVKYPWKDINCSYVDNESPRIISVNLSSSGLTGEI---------------DAAF- 433
Query: 76 TGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGK- 134
S L L I+ L NN LTG +P ++G+L NL EL++E N G IP LL
Sbjct: 434 -------SNLTLLHILDLSNNSLTGKIPDFLGNLHNLTELNLEGNKLSGAIPVKLLERSN 486
Query: 135 ---VIFKYDNNPKL---------HKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRK 182
++ + D NP L +++++ + ++ + +GVL ++L + +L +L K
Sbjct: 487 KKLILLRIDGNPDLCVSASCQISDEKTKKNVYIIPLVASVVGVLGLVLAI---ALFLLYK 543
Query: 183 LRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKK 242
R + +A L T+ + + E+ + TNNF +
Sbjct: 544 KRHRRGGSGGV-RAGPLDTTKR---------------------YYKYSEVVKVTNNFERV 581
Query: 243 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 302
+G+G FG VY+G + D +VAVKI+++S + ++F EV LL R+HH+NL LIGYC E
Sbjct: 582 LGQGGFGKVYHGVLND-DQVAVKILSESSAQGYKEFRAEVELLLRVHHKNLTALIGYCHE 640
Query: 303 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 362
+ L+YE+M NGTL D L G L W RLQI+ DAA+GLEYLH GC P I+ RD
Sbjct: 641 GKKMALIYEFMANGTLGDYLSGE-KSYVLSWEERLQISLDAAQGLEYLHNGCKPPIVQRD 699
Query: 363 VKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-RGTVGYLDPEYYGNQQLTEKSDV 421
VK +NIL++ ++AK++DFGLSR D + + A GT+GYLDPEY+ Q+L+EKSD+
Sbjct: 700 VKPANILINEKLQAKIADFGLSRSVALDGNNQDTTAVAGTIGYLDPEYHLTQKLSEKSDI 759
Query: 422 YSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIW 480
YSFGVVLLE++SG+ ++ AE ++I M+ GD+ IVDP L S W
Sbjct: 760 YSFGVVLLEVVSGQPVIARSRTTAENIHITDRVDLMLSTGDIRGIVDPKLGERFDAGSAW 819
Query: 481 RIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSS 524
+I EVA+ C +RP M +V +++S+ + G +SS
Sbjct: 820 KITEVAMACASSSSKNRPTMSHVVAELKESVSRARAGGGSGASS 863
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ7|Y4245_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g20450 OS=Arabidopsis thaliana GN=At4g20450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 313 bits (802), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 192/531 (36%), Positives = 291/531 (54%), Gaps = 56/531 (10%)
Query: 14 ERTNDRGDPCVPVPWEW--VTCST---TTPPRITKIALSGKNLKGEIPPELKNMEALTEL 68
++TN +GDPCVP+ + W + CS + PPRIT I S L G I +++ + L +L
Sbjct: 400 QKTNWQGDPCVPIQFIWTGLNCSNMFPSIPPRITSIDFSNFGLNGTITSDIQYLNQLQKL 459
Query: 69 WLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 127
L N LTG +P+ ++++ L ++L N L+GS+P + L++E N +
Sbjct: 460 DLSNNNLTGKVPEFLAKMKLLTFINLSGNNLSGSIPQSL--------LNMEKNGLI---- 507
Query: 128 PALLTGKVIFKYDN---NPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLR 184
+++ +N +P E+ K +L + IL +I+ L
Sbjct: 508 ------TLLYNGNNLCLDPSCESETGPGNNKKKLL------VPILASAASVGIIIAVLLL 555
Query: 185 RKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIG 244
I + + + + R+S + +Y+ E+ TNNF + +G
Sbjct: 556 VNILLLRKKKPSKASRSSMVANKRSYTYE-----------------EVAVITNNFERPLG 598
Query: 245 KGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 304
+G FG VY+G + D ++VAVK++++S + +QF EV LL R+HH NLV L+GYC+E
Sbjct: 599 EGGFGVVYHGNVNDNEQVAVKVLSESSAQGYKQFKAEVDLLLRVHHINLVTLVGYCDEGQ 658
Query: 305 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK 364
+L+YEYM NG L+ L G ++ PL W RL+IA + A+GLEYLH GC P +IHRD+K
Sbjct: 659 HLVLIYEYMSNGNLKQHLSGENSRSPLSWENRLRIAAETAQGLEYLHIGCKPPMIHRDIK 718
Query: 365 SSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYS 423
S NILLD N +AK+ DFGLSR TH+S+ G+ GYLDPEYY LTEKSDV+S
Sbjct: 719 SMNILLDNNFQAKLGDFGLSRSFPVGSETHVSTNVAGSPGYLDPEYYRTNWLTEKSDVFS 778
Query: 424 FGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIA 483
FGVVLLE+I+ +PV ++ + +I W + GD+ +IVDP + G+ S+W+
Sbjct: 779 FGVVLLEIIT-SQPV-IDQTREKSHIGEWVGFKLTNGDIKNIVDPSMNGDYDSSSLWKAL 836
Query: 484 EVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE---KGGDQKFSSSSSKGQSS 531
E+A+ CV RP M ++ +Q+ + E KGG S SS QS+
Sbjct: 837 ELAMSCVSPSSSGRPNMSQVANELQECLLTENSRKGGRHDVDSKSSLEQST 887
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SI06|Y5573_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g04300 OS=Arabidopsis thaliana GN=At2g04300 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 312 bits (800), Expect = 4e-84, Method: Compositional matrix adjust.
Identities = 196/539 (36%), Positives = 294/539 (54%), Gaps = 41/539 (7%)
Query: 15 RTNDRGDPCVP--VPWEWVTCSTT---TPPRITKIALSGKNLKGEIPPELKNMEALTELW 69
+T+ +GDPCVP W+ + C+ + TPP IT + LS +L G I ++N+ L L
Sbjct: 386 KTSWQGDPCVPKRFMWDGLNCNNSYISTPPTITFLNLSSSHLTGIIASAIQNLTHLQNLD 445
Query: 70 LDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 128
L N LTG +P+ ++ L L +++L N L+GS+P + L+ L++E N ++ P
Sbjct: 446 LSNNNLTGGVPEFLAGLKSLLVINLSGNNLSGSVPQTLLQKKGLK-LNLEGNIYL-NCP- 502
Query: 129 ALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKIS 188
G + K N K + + L +G L LFL V RK RK
Sbjct: 503 ---DGSCVSKDGNGGAKKKNVVVLVVVSIALVVVLGSA---LALFL----VFRK--RKTP 550
Query: 189 NQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSF 248
+ + SL + N ++ + E+ + TNNF K +GKG F
Sbjct: 551 RNEVSRTSRSLDPTITTKNRRFTYS-----------------EVVKMTNNFEKILGKGGF 593
Query: 249 GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308
G VY+G + D ++VAVK+++ S S ++F EV LL R+HH+NLV L+GYC+E L
Sbjct: 594 GMVYHGTVNDAEQVAVKMLSPSSSQGYKEFKAEVELLLRVHHKNLVGLVGYCDEGENLSL 653
Query: 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 368
+YEYM G L++ + G+ LDW TRL+I ++A+GLEYLH GC P ++HRDVK++NI
Sbjct: 654 IYEYMAKGDLKEHMLGNQGVSILDWKTRLKIVAESAQGLEYLHNGCKPPMVHRDVKTTNI 713
Query: 369 LLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVV 427
LLD + +AK++DFGLSR E T + +V GT GYLDPEYY L EKSDVYSFG+V
Sbjct: 714 LLDEHFQAKLADFGLSRSFPLEGETRVDTVVAGTPGYLDPEYYRTNWLNEKSDVYSFGIV 773
Query: 428 LLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAI 487
LLE+I+ + ++ + +I W M+ KGD+ SI+DP G+ S+WR E+A+
Sbjct: 774 LLEIITNQHVINQSR--EKPHIAEWVGVMLTKGDIKSIIDPKFSGDYDAGSVWRAVELAM 831
Query: 488 QCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSSKGQSSRKTLLTSFLEIESPD 546
CV RP M ++V+ + + + E + SKG + T+F +P+
Sbjct: 832 SCVNPSSTGRPTMSQVVIELNECLASENSRRGMSQNMESKGSIQYTEVSTNFGTEYTPE 890
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 557 | ||||||
| 224107699 | 934 | predicted protein [Populus trichocarpa] | 0.996 | 0.594 | 0.778 | 0.0 | |
| 224100089 | 932 | predicted protein [Populus trichocarpa] | 0.996 | 0.595 | 0.793 | 0.0 | |
| 225425928 | 930 | PREDICTED: probable LRR receptor-like se | 0.994 | 0.595 | 0.768 | 0.0 | |
| 297738322 | 926 | unnamed protein product [Vitis vinifera] | 0.987 | 0.593 | 0.765 | 0.0 | |
| 255547926 | 911 | protein with unknown function [Ricinus c | 0.955 | 0.583 | 0.760 | 0.0 | |
| 356567402 | 929 | PREDICTED: probable LRR receptor-like se | 0.987 | 0.592 | 0.740 | 0.0 | |
| 357463139 | 930 | Leucine-rich repeat family protein / pro | 0.987 | 0.591 | 0.732 | 0.0 | |
| 356538111 | 930 | PREDICTED: probable LRR receptor-like se | 0.987 | 0.591 | 0.731 | 0.0 | |
| 18408845 | 929 | putative LRR receptor-like serine/threon | 0.987 | 0.592 | 0.719 | 0.0 | |
| 449512995 | 956 | PREDICTED: probable LRR receptor-like se | 0.978 | 0.570 | 0.736 | 0.0 |
| >gi|224107699|ref|XP_002314568.1| predicted protein [Populus trichocarpa] gi|222863608|gb|EEF00739.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 908 bits (2346), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/560 (77%), Positives = 492/560 (87%), Gaps = 5/560 (0%)
Query: 2 VLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKN 61
VL ALRS+S ES TN++GDPCVP W+WV C++TTPPRITKIALSGKNLKGEIPPE+ N
Sbjct: 376 VLNALRSLSAESAWTNEQGDPCVPAHWDWVNCTSTTPPRITKIALSGKNLKGEIPPEINN 435
Query: 62 MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 121
ME LTELWLDGNFLTGP+P +S L++L+IVHLENN+L+G LP Y+GSLP+LQEL+I+NN
Sbjct: 436 METLTELWLDGNFLTGPIPSISNLVNLKIVHLENNKLSGQLPKYLGSLPDLQELYIQNNY 495
Query: 122 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 181
F GEIP LLTGKVI Y++NP LHKE+ ++ KLILG SIG+LA LLV+ + SL+ LR
Sbjct: 496 FSGEIPSGLLTGKVIINYEHNPGLHKEAGKKKHSKLILGVSIGILAALLVVLIGSLLFLR 555
Query: 182 KLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCK 241
L+RK S+QK+ + SLR S KPS TAYS++RG H MDEGV+Y+IPL E+EEAT NF K
Sbjct: 556 NLQRKTSHQKTAVQGSSLRVSAKPS-TAYSVSRGWHMMDEGVSYYIPLSEIEEATKNFSK 614
Query: 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 301
KIG+GSFG+VYYG+MK+GKEVAVKIM DS +H TQQFVTEVALLSRIHHRNLVPLIGYCE
Sbjct: 615 KIGRGSFGTVYYGQMKEGKEVAVKIMGDSTTHMTQQFVTEVALLSRIHHRNLVPLIGYCE 674
Query: 302 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 361
EE+QRILVYEYMHNGTLRD +HGSVNQK LDWL RLQIA D+AKGLEYLHTGCNP IIHR
Sbjct: 675 EENQRILVYEYMHNGTLRDHIHGSVNQKRLDWLARLQIAEDSAKGLEYLHTGCNPSIIHR 734
Query: 362 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 421
DVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY NQQLTEKSDV
Sbjct: 735 DVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYANQQLTEKSDV 794
Query: 422 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 481
YSFGVVLLEL+SGKKPVS EDFGAE+NIVHWAR++I+KGD +SIVDPVLIGNVKIESIWR
Sbjct: 795 YSFGVVLLELLSGKKPVSTEDFGAEMNIVHWARALIRKGDAMSIVDPVLIGNVKIESIWR 854
Query: 482 IAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSSRKTLLTSF 539
IAEVAIQCVEQR SRP+MQEI+LAIQ++ KIEKG G QK S SSK QSSRKTLLTSF
Sbjct: 855 IAEVAIQCVEQRAVSRPRMQEIILAIQEANKIEKGTYGSQKLPSGSSKAQSSRKTLLTSF 914
Query: 540 LEIE--SPDLSNECLAPAAR 557
LEIE SPDLSN CL PAAR
Sbjct: 915 LEIESQSPDLSNGCLVPAAR 934
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224100089|ref|XP_002311739.1| predicted protein [Populus trichocarpa] gi|222851559|gb|EEE89106.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 904 bits (2336), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/558 (79%), Positives = 493/558 (88%), Gaps = 3/558 (0%)
Query: 2 VLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKN 61
VL ALR +S ES N++GDPCVP WEWV CS+TTPPRITKIALSGKNLKGEIPPE+ N
Sbjct: 376 VLNALRFLSAESAWANEQGDPCVPAHWEWVNCSSTTPPRITKIALSGKNLKGEIPPEINN 435
Query: 62 MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 121
ME LTELWLDGNFLTGP+P +S L++L+IVHLENN+L G LP Y+GSLP LQ L+I+NNS
Sbjct: 436 MEQLTELWLDGNFLTGPIPGISNLVNLKIVHLENNKLNGPLPKYLGSLPKLQALYIQNNS 495
Query: 122 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 181
F GEIP LTGKVIF Y++NP LHKE+R++M KLI+G SIG+LA LLV+ + SL+ LR
Sbjct: 496 FSGEIPSEFLTGKVIFNYEHNPGLHKEARKKMHLKLIVGISIGILAGLLVVVIGSLLFLR 555
Query: 182 KLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCK 241
L+RK S++KS + +SLR STKPS TAYS+ARG H MDEGV+Y+IPLPELEEAT NF K
Sbjct: 556 NLQRKTSHKKSEVQGNSLRASTKPS-TAYSVARGWHMMDEGVSYYIPLPELEEATKNFSK 614
Query: 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 301
KIG+GSFG+VYYG+MKDGKEVAVKIMADS +H T QFVTEVALLSRIHHRNLVPL+GYCE
Sbjct: 615 KIGRGSFGTVYYGQMKDGKEVAVKIMADSSTHLTLQFVTEVALLSRIHHRNLVPLLGYCE 674
Query: 302 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 361
EEHQRILVYEYMHNGTLRD +HG VNQK LDWL RLQIA DAAKGLEYLHTGCNP IIHR
Sbjct: 675 EEHQRILVYEYMHNGTLRDHIHGPVNQKRLDWLARLQIAEDAAKGLEYLHTGCNPSIIHR 734
Query: 362 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 421
DVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY NQQLTEKSDV
Sbjct: 735 DVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYANQQLTEKSDV 794
Query: 422 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 481
YSFGVVLLEL+SGKKPVS EDFG+ELNIVHWARS+I+KGDV+SIVDPVLIGN KIESIWR
Sbjct: 795 YSFGVVLLELVSGKKPVSTEDFGSELNIVHWARSLIRKGDVMSIVDPVLIGNAKIESIWR 854
Query: 482 IAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSSRKTLLTSF 539
IAEVAIQCVEQR FSRP+M EI+LAIQ++ KIEKG G QK S+SSK QSSRKTLLTSF
Sbjct: 855 IAEVAIQCVEQRAFSRPRMHEIILAIQEANKIEKGTDGSQKQQSASSKAQSSRKTLLTSF 914
Query: 540 LEIESPDLSNECLAPAAR 557
LEIESPDLSN CL PAAR
Sbjct: 915 LEIESPDLSNGCLVPAAR 932
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425928|ref|XP_002267668.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 860 bits (2221), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/558 (76%), Positives = 476/558 (85%), Gaps = 4/558 (0%)
Query: 2 VLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKN 61
VL AL ++S ES +N+ DPCVP W WV CS TT PRITKI LSGKNL G IP ELKN
Sbjct: 375 VLNALCAMSTESAWSNEGRDPCVPAHWSWVACSPTTTPRITKITLSGKNLNGVIPSELKN 434
Query: 62 MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 121
ME LTELWLDGN+LTGP+PDMS LI L+IVHLENN LTG LPSY+GSLP+LQELH++NN
Sbjct: 435 MEGLTELWLDGNYLTGPIPDMSNLISLKIVHLENNRLTGPLPSYLGSLPSLQELHVQNNL 494
Query: 122 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 181
GEIPPALLTGKVIF Y+ N KLHKE+ + FKLILG S+G+LA+LLVL + SL +L
Sbjct: 495 LSGEIPPALLTGKVIFNYEGNSKLHKEAHK-THFKLILGASVGLLALLLVLCIGSLFLLC 553
Query: 182 KLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCK 241
RRK S KS +K SLRTSTK S T+YSIARGG+ MDEGVA +I L +LEEAT NF K
Sbjct: 554 NTRRKESQSKSNDKGSSLRTSTKAS-TSYSIARGGNLMDEGVACYISLSDLEEATKNFAK 612
Query: 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 301
+IG+GSFG VYYGKM DGKE+AVKIMADS SH TQQFVTEVALLSRIHHRNLVPLIGYCE
Sbjct: 613 QIGRGSFGPVYYGKMPDGKEIAVKIMADSSSHGTQQFVTEVALLSRIHHRNLVPLIGYCE 672
Query: 302 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 361
+EHQ +LVYEYMHNGTLR+ +H S NQK LDWL RL +A DAAKGLEYLHTGCNP IIHR
Sbjct: 673 DEHQHLLVYEYMHNGTLRNHIHDSTNQKCLDWLGRLYVAEDAAKGLEYLHTGCNPSIIHR 732
Query: 362 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 421
DVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY NQQLTEKSDV
Sbjct: 733 DVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYANQQLTEKSDV 792
Query: 422 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 481
YSFG+VLLELISG+KPVS ED+GAE NIVHWARS+I GDVISIVDP L+GNVKIESIWR
Sbjct: 793 YSFGIVLLELISGRKPVSPEDYGAEWNIVHWARSLICNGDVISIVDPFLLGNVKIESIWR 852
Query: 482 IAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSSRKTLLTSF 539
IAE+AI CVEQ G SRPKMQEI+LAIQD+IKIE+G GD K S SSKGQSSRKTLLT+F
Sbjct: 853 IAEIAILCVEQHGTSRPKMQEIILAIQDAIKIERGNEGDHKACSGSSKGQSSRKTLLTNF 912
Query: 540 LEIESPDLSNECLAPAAR 557
L+IESPDLSN+CL P+AR
Sbjct: 913 LDIESPDLSNDCLVPSAR 930
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297738322|emb|CBI27523.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 850 bits (2197), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/558 (76%), Positives = 474/558 (84%), Gaps = 8/558 (1%)
Query: 2 VLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKN 61
VL AL ++S ES +N+ DPCVP W WV CS TT PRITKI LSGKNL G IP ELKN
Sbjct: 375 VLNALCAMSTESAWSNEGRDPCVPAHWSWVACSPTTTPRITKITLSGKNLNGVIPSELKN 434
Query: 62 MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 121
ME LTELWLDGN+LTGP+PDMS LI L+IVHLENN LTG LPSY+GSLP+LQELH++NN
Sbjct: 435 MEGLTELWLDGNYLTGPIPDMSNLISLKIVHLENNRLTGPLPSYLGSLPSLQELHVQNNL 494
Query: 122 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 181
GEIPPALLTGKVIF Y+ N KLHKE+ + FKLILG S+G+LA+LLVL + SL +L
Sbjct: 495 LSGEIPPALLTGKVIFNYEGNSKLHKEAHK-THFKLILGASVGLLALLLVLCIGSLFLLC 553
Query: 182 KLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCK 241
RRK +S K SLRTSTK S T+YSIARGG+ MDEGVA +I L +LEEAT NF K
Sbjct: 554 NTRRK----ESQSKRSSLRTSTKAS-TSYSIARGGNLMDEGVACYISLSDLEEATKNFAK 608
Query: 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 301
+IG+GSFG VYYGKM DGKE+AVKIMADS SH TQQFVTEVALLSRIHHRNLVPLIGYCE
Sbjct: 609 QIGRGSFGPVYYGKMPDGKEIAVKIMADSSSHGTQQFVTEVALLSRIHHRNLVPLIGYCE 668
Query: 302 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 361
+EHQ +LVYEYMHNGTLR+ +H S NQK LDWL RL +A DAAKGLEYLHTGCNP IIHR
Sbjct: 669 DEHQHLLVYEYMHNGTLRNHIHDSTNQKCLDWLGRLYVAEDAAKGLEYLHTGCNPSIIHR 728
Query: 362 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 421
DVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY NQQLTEKSDV
Sbjct: 729 DVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYANQQLTEKSDV 788
Query: 422 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 481
YSFG+VLLELISG+KPVS ED+GAE NIVHWARS+I GDVISIVDP L+GNVKIESIWR
Sbjct: 789 YSFGIVLLELISGRKPVSPEDYGAEWNIVHWARSLICNGDVISIVDPFLLGNVKIESIWR 848
Query: 482 IAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSSRKTLLTSF 539
IAE+AI CVEQ G SRPKMQEI+LAIQD+IKIE+G GD K S SSKGQSSRKTLLT+F
Sbjct: 849 IAEIAILCVEQHGTSRPKMQEIILAIQDAIKIERGNEGDHKACSGSSKGQSSRKTLLTNF 908
Query: 540 LEIESPDLSNECLAPAAR 557
L+IESPDLSN+CL P+AR
Sbjct: 909 LDIESPDLSNDCLVPSAR 926
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255547926|ref|XP_002515020.1| protein with unknown function [Ricinus communis] gi|223546071|gb|EEF47574.1| protein with unknown function [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 841 bits (2172), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/559 (76%), Positives = 473/559 (84%), Gaps = 27/559 (4%)
Query: 2 VLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKN 61
VL A RSIS S T + GDPCVP WEWV CS+T+PPRITKIALSGKNLKGE+PPE+ N
Sbjct: 377 VLNAFRSISAGSYWTTEGGDPCVPAQWEWVNCSSTSPPRITKIALSGKNLKGEVPPEINN 436
Query: 62 MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 121
M L+EL HLENN+L+GSLP Y+GSLPNL+EL+I+NNS
Sbjct: 437 MVELSEL-----------------------HLENNKLSGSLPKYLGSLPNLRELYIQNNS 473
Query: 122 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 181
FVG++P ALLTGKV Y++NP LHKE ++M FKL LG SIGVLAILLVL L +LI LR
Sbjct: 474 FVGKVPAALLTGKVNLNYEDNPGLHKEVAKKMHFKLTLGISIGVLAILLVLLLGTLIYLR 533
Query: 182 KLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCK 241
+L+RK S+QK+ +S+R STKPS TAYSI RG H MDEG +Y+I ELEEAT NF K
Sbjct: 534 RLQRKTSHQKTDNPGNSMRASTKPS-TAYSITRGWHLMDEGGSYYISFAELEEATKNFFK 592
Query: 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 301
KIGKGSFGSVYYG+MKDGKEVAVKIMADSCSH TQQFVTEVALLSRIHHRNLVPLIG+CE
Sbjct: 593 KIGKGSFGSVYYGQMKDGKEVAVKIMADSCSHLTQQFVTEVALLSRIHHRNLVPLIGFCE 652
Query: 302 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 361
EEHQRILVYEYMHNGTLRD +HG N+K LDWLTRLQIA DAAKGLEYLHTGC+P IIHR
Sbjct: 653 EEHQRILVYEYMHNGTLRDHIHGIDNRKSLDWLTRLQIAEDAAKGLEYLHTGCSPSIIHR 712
Query: 362 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 421
DVK+SNILLDINMRAKVSDFGLSRQAE+DLTHISSVARGTVGYLDPEYY NQQLTEKSDV
Sbjct: 713 DVKTSNILLDINMRAKVSDFGLSRQAEDDLTHISSVARGTVGYLDPEYYANQQLTEKSDV 772
Query: 422 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 481
YSFGVVLLELISGKKPVS EDFGAE+NIVHWAR++I+KGDV+SIVDPVLIGNVKIESIWR
Sbjct: 773 YSFGVVLLELISGKKPVSTEDFGAEMNIVHWARALIRKGDVVSIVDPVLIGNVKIESIWR 832
Query: 482 IAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSS-SSKGQSSRKTLLTS 538
+AEVAIQCV+QR SRP+MQE++L+IQ++IKIEKG G QK S+S SSK QSSRKTLLTS
Sbjct: 833 VAEVAIQCVQQRAVSRPRMQEVILSIQEAIKIEKGTDGSQKLSNSGSSKAQSSRKTLLTS 892
Query: 539 FLEIESPDLSNECLAPAAR 557
FLEIESPDLSN CL PAAR
Sbjct: 893 FLEIESPDLSNGCLVPAAR 911
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567402|ref|XP_003551909.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 820 bits (2117), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/558 (74%), Positives = 466/558 (83%), Gaps = 8/558 (1%)
Query: 3 LEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNM 62
+ A R +S ES N+ GDPCVP PWEWV CSTTTPPRITKI LS +N+KGEIP EL NM
Sbjct: 377 VNAFRFLSAESVLKNE-GDPCVPTPWEWVNCSTTTPPRITKINLSRRNMKGEIPRELNNM 435
Query: 63 EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 122
EALTELWLDGN LTG LPDM LI+L+IVHLENN+L+G LPSY+GSLP+LQ L I+NNSF
Sbjct: 436 EALTELWLDGNMLTGQLPDMRNLINLKIVHLENNKLSGPLPSYLGSLPSLQALFIQNNSF 495
Query: 123 VGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRK 182
G IP LL+GK+IF +D+NP+LHK +++ F+L+LG SIGVLAILL+LFL SL++L
Sbjct: 496 SGVIPSGLLSGKIIFNFDDNPELHKGNKKH--FQLMLGISIGVLAILLILFLTSLVLLLN 553
Query: 183 LRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKK 242
LRRK S QK EK S R+STKP T YS R G+ MDEG AY+I L EL+EATNNF K
Sbjct: 554 LRRKTSRQKCDEKGISGRSSTKPL-TGYSFGRNGNIMDEGTAYYITLSELKEATNNFSKN 612
Query: 243 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 302
IGKGSFGSVYYGKMKDGKEVAVK M D S+ QQFV EVALLSRIHHRNLVPLIGYCEE
Sbjct: 613 IGKGSFGSVYYGKMKDGKEVAVKTMTDPSSYGNQQFVNEVALLSRIHHRNLVPLIGYCEE 672
Query: 303 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 362
E+Q ILVYEYMHNGTLR+ +H +QK LDWL RL+IA DA+KGLEYLHTGCNP IIHRD
Sbjct: 673 EYQHILVYEYMHNGTLREYIHECSSQKQLDWLARLRIAEDASKGLEYLHTGCNPSIIHRD 732
Query: 363 VKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVY 422
VK+SNILLDINMRAKVSDFGLSR AEEDLTHISSVARGTVGYLDPEYY NQQLTEKSDVY
Sbjct: 733 VKTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVARGTVGYLDPEYYANQQLTEKSDVY 792
Query: 423 SFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRI 482
SFGVVLLELISGKKPVS ED+G E+NIVHWARS+I+KGDVISI+DP L+GNVK ES+WR+
Sbjct: 793 SFGVVLLELISGKKPVSSEDYGPEMNIVHWARSLIRKGDVISIMDPSLVGNVKTESVWRV 852
Query: 483 AEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF---SSSSSKGQSSRKTLLTSF 539
AE+AIQCVEQ G RP+MQE++LAIQD+ IEKG + + SS SK QSSRKTLL SF
Sbjct: 853 AEIAIQCVEQHGACRPRMQEVILAIQDASNIEKGSEIQLKLSSSGGSKPQSSRKTLLASF 912
Query: 540 LEIESPDLSNECLAPAAR 557
LEIESPDLSN CL P+AR
Sbjct: 913 LEIESPDLSNSCL-PSAR 929
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357463139|ref|XP_003601851.1| Leucine-rich repeat family protein / protein kinase family protein [Medicago truncatula] gi|355490899|gb|AES72102.1| Leucine-rich repeat family protein / protein kinase family protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 816 bits (2109), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/558 (73%), Positives = 463/558 (82%), Gaps = 8/558 (1%)
Query: 3 LEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNM 62
+ A S+SDE N+ GDPCVP PWEWV CST TP RIT I LSG+NL GEIP EL NM
Sbjct: 378 VNAFSSLSDEIIPKNE-GDPCVPTPWEWVNCSTATPARITNINLSGRNLTGEIPRELNNM 436
Query: 63 EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 122
EALTELWLD N LTG LPDMS LI+L+I+HLENN+LTG LP+Y+GSLP LQ L+I+NNSF
Sbjct: 437 EALTELWLDRNLLTGQLPDMSNLINLKIMHLENNKLTGPLPTYLGSLPGLQALYIQNNSF 496
Query: 123 VGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRK 182
G+IP LL+ K+ F YD+NP LHK S++ F L++G SIGVL IL+V+FL SL++LR
Sbjct: 497 TGDIPAGLLSTKITFIYDDNPGLHKRSKKH--FPLMIGISIGVLVILMVMFLASLVLLRY 554
Query: 183 LRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKK 242
LRRK S QKS E+A S RT TK T YS R G+ MDEG AY+I L +L+ ATNNF KK
Sbjct: 555 LRRKASQQKSDERAISGRTGTK-HLTGYSFGRDGNLMDEGTAYYITLSDLKVATNNFSKK 613
Query: 243 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 302
IGKGSFGSVYYGKMKDGKE+AVK M D SH QFVTEVALLSRIHHRNLVPLIGYCEE
Sbjct: 614 IGKGSFGSVYYGKMKDGKEIAVKTMTDPSSHGNHQFVTEVALLSRIHHRNLVPLIGYCEE 673
Query: 303 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 362
E+Q ILVYEYMHNGTLRD +H ++K LDWLTRL+IA DAAKGLEYLHTGCNP IIHRD
Sbjct: 674 EYQHILVYEYMHNGTLRDHIHECSSEKRLDWLTRLRIAEDAAKGLEYLHTGCNPSIIHRD 733
Query: 363 VKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVY 422
VK+SNILLDINMRAKVSDFGLSR AEEDLTHISSVA+GTVGYLDPEYY NQQLTEKSDVY
Sbjct: 734 VKTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVAKGTVGYLDPEYYANQQLTEKSDVY 793
Query: 423 SFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRI 482
SFGVVLLELI GKKPVS ED+G E+NIVHWARS+I+KGD+ISI+DP+LIGNVK ESIWR+
Sbjct: 794 SFGVVLLELICGKKPVSPEDYGPEMNIVHWARSLIRKGDIISIMDPLLIGNVKTESIWRV 853
Query: 483 AEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFS---SSSSKGQSSRKTLLTSF 539
AE+A+QCVE G SRP+MQE++LAIQD+ KIEKG + + SSSS QSSRKTLLTSF
Sbjct: 854 AEIAMQCVEPHGASRPRMQEVILAIQDASKIEKGTESQLKVSSSSSSIPQSSRKTLLTSF 913
Query: 540 LEIESPDLSNECLAPAAR 557
LEIESPDLSN CL P+AR
Sbjct: 914 LEIESPDLSNGCL-PSAR 930
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356538111|ref|XP_003537548.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 801 bits (2068), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/559 (73%), Positives = 465/559 (83%), Gaps = 9/559 (1%)
Query: 3 LEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNM 62
+ A R +S ES N+ GDPCVP PWEWV CSTTTPPRITKI LS +NLKGEIP +L NM
Sbjct: 377 VNAFRFLSAESVLKNE-GDPCVPTPWEWVNCSTTTPPRITKINLSRRNLKGEIPGKLNNM 435
Query: 63 EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 122
EALTELWLDGN LTG LPDMS LI+++I+HLENN+LTG LPSY+GSLP+LQ L I+NNSF
Sbjct: 436 EALTELWLDGNMLTGQLPDMSNLINVKIMHLENNKLTGPLPSYLGSLPSLQALFIQNNSF 495
Query: 123 VGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRK 182
G IP LL+GK+IF +D+NP+LHK +++ F+L+LG SIGVL ILL+LFL SL++L
Sbjct: 496 SGVIPSGLLSGKIIFNFDDNPELHKGNKKH--FQLMLGISIGVLVILLILFLTSLVLLLI 553
Query: 183 LRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKK 242
LRRK S QK EK S R+STKP T YS R G+ MDEG AY+I L EL+EATNNF K
Sbjct: 554 LRRKTSQQKRDEKGVSGRSSTKPL-TGYSFGRDGNIMDEGTAYYITLSELKEATNNFSKN 612
Query: 243 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 302
IGKGSFGSVYYGKMKDGKEVAVK M D S+ QQFV EVALLSRIHHRNLVPLIGYCEE
Sbjct: 613 IGKGSFGSVYYGKMKDGKEVAVKTMTDPSSYGNQQFVNEVALLSRIHHRNLVPLIGYCEE 672
Query: 303 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 362
E+Q ILVYEYMHNGTLR+ +H +QK LDWL RL+IA DAAKGLEYLHTGCNP IIHRD
Sbjct: 673 EYQHILVYEYMHNGTLREYIHECSSQKQLDWLARLRIAEDAAKGLEYLHTGCNPSIIHRD 732
Query: 363 VKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVY 422
VK+SNILLDINMRAKVSDFGLSR AEEDLTHISSVARGTVGYLDPEYY NQQLTEKSDVY
Sbjct: 733 VKTSNILLDINMRAKVSDFGLSRLAEEDLTHISSVARGTVGYLDPEYYANQQLTEKSDVY 792
Query: 423 SFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRI 482
SFGVVLLEL+SGKK VS ED+G E+NIVHWARS+I+KGDVISI+DP L+GN+K ES+WR+
Sbjct: 793 SFGVVLLELLSGKKAVSSEDYGPEMNIVHWARSLIRKGDVISIMDPSLVGNLKTESVWRV 852
Query: 483 AEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSSKG----QSSRKTLLTS 538
AE+A+QCVEQ G RP+MQE++LAIQD+ IEKG + + SSS G QSSRKTLL S
Sbjct: 853 AEIAMQCVEQHGACRPRMQEVILAIQDASNIEKGTESQLKLSSSGGNSKPQSSRKTLLAS 912
Query: 539 FLEIESPDLSNECLAPAAR 557
FLEIESPDLSN CL P+AR
Sbjct: 913 FLEIESPDLSNSCL-PSAR 930
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|18408845|ref|NP_564904.1| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana] gi|263430191|sp|C0LGI2.1|Y1677_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase At1g67720; Flags: Precursor gi|224589467|gb|ACN59267.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332196566|gb|AEE34687.1| putative LRR receptor-like serine/threonine-protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 789 bits (2038), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/559 (71%), Positives = 466/559 (83%), Gaps = 9/559 (1%)
Query: 2 VLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKN 61
VL+A+RS+S +S+ ++ GDPC+PV W WV CS+T+PPR+TKIALS KNL+GEIPP +
Sbjct: 377 VLDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLRGEIPPGINY 436
Query: 62 MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 121
MEALTELWLD N LTG LPDMS+L++L+I+HLENN+L+GSLP Y+ LPNLQEL IENNS
Sbjct: 437 MEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNLQELSIENNS 496
Query: 122 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 181
F G+IP ALL GKV+FKY+NNP+L E++R+ F ILG SI +AILL+L SL++L
Sbjct: 497 FKGKIPSALLKGKVLFKYNNNPELQNEAQRK-HFWQILGISIAAVAILLLLVGGSLVLLC 555
Query: 182 KLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCK 241
LR+ K +K DS T K AYS RGGH +DEGVAYFI LP LEEAT+NF K
Sbjct: 556 ALRK----TKRADKGDSTETKKK-GLVAYSAVRGGHLLDEGVAYFISLPVLEEATDNFSK 610
Query: 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 301
K+G+GSFGSVYYG+MKDGKEVAVKI AD SH +QFVTEVALLSRIHHRNLVPLIGYCE
Sbjct: 611 KVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIGYCE 670
Query: 302 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 361
E +RILVYEYMHNG+L D LHGS + KPLDWLTRLQIA DAAKGLEYLHTGCNP IIHR
Sbjct: 671 EADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLHTGCNPSIIHR 730
Query: 362 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 421
DVKSSNILLDINMRAKVSDFGLSRQ EEDLTH+SSVA+GTVGYLDPEYY +QQLTEKSDV
Sbjct: 731 DVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEKSDV 790
Query: 422 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 481
YSFGVVL EL+SGKKPVS EDFG ELNIVHWARS+I+KGDV I+DP + NVKIES+WR
Sbjct: 791 YSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDPCIASNVKIESVWR 850
Query: 482 IAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKF---SSSSSKGQSSRKTLLTS 538
+AEVA QCVEQRG +RP+MQE+++AIQD+I+IE+G + SSSSSK QSSRKTLLTS
Sbjct: 851 VAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSKAQSSRKTLLTS 910
Query: 539 FLEIESPDLSNECLAPAAR 557
FLE+ESPD+S LAPAAR
Sbjct: 911 FLELESPDISRNSLAPAAR 929
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449512995|ref|XP_004164199.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g67720-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 788 bits (2036), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 411/558 (73%), Positives = 464/558 (83%), Gaps = 13/558 (2%)
Query: 2 VLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKN 61
V R++S E+ +N GDPCVP WEWVTCS T PPRITKI LS KNLKGEIPPE+
Sbjct: 410 VANIFRNVSAENVWSN-IGDPCVPTSWEWVTCSATQPPRITKIELSRKNLKGEIPPEINT 468
Query: 62 MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 121
M+ L ELWLDGN L GPLPDMS LI+L+I+HLENN+LTG+LPSY+ SLPNLQEL+I+NN+
Sbjct: 469 MDGLVELWLDGNSLAGPLPDMSNLINLKILHLENNKLTGTLPSYLCSLPNLQELYIQNNT 528
Query: 122 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 181
F GEIP LL K+IFKYD N LHK R ++ KLILG S+GVL +L++L L SL++LR
Sbjct: 529 FSGEIPSELLAKKLIFKYDGNVGLHKTERYKVHSKLILGVSLGVLVLLVILLLGSLLLLR 588
Query: 182 KLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCK 241
KLRRK + + +K SL STK S +AYSI +G DEG+AY++ L ELEEATNNF K
Sbjct: 589 KLRRKTAPYQ--KKGGSLNISTKRS-SAYSIGKG----DEGMAYYLSLSELEEATNNFSK 641
Query: 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 301
KIGKGSFGSV+YGKM DGKEVAVKIMA+S +H QQF+TEVALLSRIHHRNLVPLIGYCE
Sbjct: 642 KIGKGSFGSVFYGKMIDGKEVAVKIMAESSTHGNQQFMTEVALLSRIHHRNLVPLIGYCE 701
Query: 302 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 361
EEHQRILVYEYMHNGTLRD L+GS QK LDWL RL IA DAAKGLEYLHTGC+P IIHR
Sbjct: 702 EEHQRILVYEYMHNGTLRDHLYGSTTQKHLDWLARLHIAEDAAKGLEYLHTGCSPSIIHR 761
Query: 362 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 421
DVK+SNILLDINMRAKVSDFGLSRQAEEDLTH+SSVARGTVGYLDPEYY QQLTEKSDV
Sbjct: 762 DVKTSNILLDINMRAKVSDFGLSRQAEEDLTHVSSVARGTVGYLDPEYYACQQLTEKSDV 821
Query: 422 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 481
YSFGVVLLELISGKKPVS ED+G ELNIVHWARS++ KGDV SIVDP L G VKIES+WR
Sbjct: 822 YSFGVVLLELISGKKPVSPEDYGNELNIVHWARSLVHKGDVTSIVDPFLEGKVKIESVWR 881
Query: 482 IAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG--GDQKFSSSSSKGQSSRKTLLTSF 539
IAEVAIQCV+Q G SRP+MQE++LAIQD+IKIE G G+QK SS + K QSSRKTLLT+F
Sbjct: 882 IAEVAIQCVQQHGVSRPRMQEVILAIQDAIKIEHGTEGNQKLSSENLKAQSSRKTLLTTF 941
Query: 540 LEIESPDLSNECLAPAAR 557
LEIESPD S L P+AR
Sbjct: 942 LEIESPDGS---LLPSAR 956
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 557 | ||||||
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.987 | 0.592 | 0.685 | 2.1e-203 | |
| TAIR|locus:2057991 | 934 | AT2G37050 [Arabidopsis thalian | 0.906 | 0.540 | 0.478 | 7e-125 | |
| TAIR|locus:2028446 | 888 | AT1G49100 [Arabidopsis thalian | 0.506 | 0.317 | 0.491 | 1.2e-87 | |
| TAIR|locus:2055160 | 886 | AT2G14440 [Arabidopsis thalian | 0.502 | 0.316 | 0.461 | 2.7e-86 | |
| TAIR|locus:2156549 | 895 | AT5G48740 [Arabidopsis thalian | 0.508 | 0.316 | 0.503 | 3.1e-85 | |
| TAIR|locus:2078171 | 883 | AT3G46400 [Arabidopsis thalian | 0.506 | 0.319 | 0.470 | 1.5e-83 | |
| TAIR|locus:2078191 | 838 | AT3G46420 [Arabidopsis thalian | 0.500 | 0.332 | 0.471 | 3.1e-83 | |
| TAIR|locus:2126540 | 876 | AT4G29990 [Arabidopsis thalian | 0.518 | 0.329 | 0.472 | 5.1e-83 | |
| TAIR|locus:2078176 | 878 | MEE39 "maternal effect embryo | 0.506 | 0.321 | 0.468 | 1.1e-82 | |
| TAIR|locus:2059804 | 892 | AT2G04300 [Arabidopsis thalian | 0.506 | 0.316 | 0.459 | 1.3e-82 |
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1968 (697.8 bits), Expect = 2.1e-203, P = 2.1e-203
Identities = 383/559 (68%), Positives = 441/559 (78%)
Query: 2 VLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKN 61
VL+A+RS+S +S+ ++ GDPC+PV W WV CS+T+PPR+TKIALS KNL+GEIPP +
Sbjct: 377 VLDAIRSMSPDSDWASEGGDPCIPVLWSWVNCSSTSPPRVTKIALSRKNLRGEIPPGINY 436
Query: 62 MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 121
MEALTELWLD N LTG LPDMS+L++L+I+HLENN+L+GSLP Y+ LPNLQEL IENNS
Sbjct: 437 MEALTELWLDDNELTGTLPDMSKLVNLKIMHLENNQLSGSLPPYLAHLPNLQELSIENNS 496
Query: 122 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSXXXXXXXXXXXXXXXXXXR 181
F G+IP ALL GKV+FKY+NNP+L E++R+ F ILG S
Sbjct: 497 FKGKIPSALLKGKVLFKYNNNPELQNEAQRK-HFWQILGISIAAVAILLLLVGGSLVLLC 555
Query: 182 KLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCK 241
LR+ K +K DS T K AYS RGGH +DEGVAYFI LP LEEAT+NF K
Sbjct: 556 ALRKT----KRADKGDSTETKKK-GLVAYSAVRGGHLLDEGVAYFISLPVLEEATDNFSK 610
Query: 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 301
K+G+GSFGSVYYG+MKDGKEVAVKI AD SH +QFVTEVALLSRIHHRNLVPLIGYCE
Sbjct: 611 KVGRGSFGSVYYGRMKDGKEVAVKITADPSSHLNRQFVTEVALLSRIHHRNLVPLIGYCE 670
Query: 302 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 361
E +RILVYEYMHNG+L D LHGS + KPLDWLTRLQIA DAAKGLEYLHTGCNP IIHR
Sbjct: 671 EADRRILVYEYMHNGSLGDHLHGSSDYKPLDWLTRLQIAQDAAKGLEYLHTGCNPSIIHR 730
Query: 362 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 421
DVKSSNILLDINMRAKVSDFGLSRQ EEDLTH+SSVA+GTVGYLDPEYY +QQLTEKSDV
Sbjct: 731 DVKSSNILLDINMRAKVSDFGLSRQTEEDLTHVSSVAKGTVGYLDPEYYASQQLTEKSDV 790
Query: 422 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 481
YSFGVVL EL+SGKKPVS EDFG ELNIVHWARS+I+KGDV I+DP + NVKIES+WR
Sbjct: 791 YSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGIIDPCIASNVKIESVWR 850
Query: 482 IAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEXXXXX---XXXXXXXXXXXXRKTLLTS 538
+AEVA QCVEQRG +RP+MQE+++AIQD+I+IE RKTLLTS
Sbjct: 851 VAEVANQCVEQRGHNRPRMQEVIVAIQDAIRIERGNENGLKSSSSSSSKAQSSRKTLLTS 910
Query: 539 FLEIESPDLSNECLAPAAR 557
FLE+ESPD+S LAPAAR
Sbjct: 911 FLELESPDISRNSLAPAAR 929
|
|
| TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1227 (437.0 bits), Expect = 7.0e-125, P = 7.0e-125
Identities = 247/516 (47%), Positives = 330/516 (63%)
Query: 2 VLEALRSISDESERTNDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKN 61
V+ + S+ +E + GDPC P PW WV C++ PR+ I LS NL G IP +L
Sbjct: 377 VMANVASLYSSTEWAQEGGDPCSPSPWSWVQCNSDPQPRVVAIKLSSMNLTGNIPSDLVK 436
Query: 62 MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 121
+ L ELWLDGN TGP+PD SR +L I+HLENN LTG +PS + LPNL+EL+++NN
Sbjct: 437 LTGLVELWLDGNSFTGPIPDFSRCPNLEIIHLENNRLTGKIPSSLTKLPNLKELYLQNNV 496
Query: 122 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSXXXXXXXXXXXXXXXXXXR 181
G IP L VI + N L K + + +I+G S +
Sbjct: 497 LTGTIPSDLAKD-VISNFSGNLNLEKSGDKGKKLGVIIGASVGAFVLLIATIISCIVMCK 555
Query: 182 KLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCK 241
+ + S E + + S+T S A G A+ L E+EEAT F K
Sbjct: 556 SKKNNKLGKTSAELTNRPLPIQRVSSTL-SEAHGD------AAHCFTLYEIEEATKKFEK 608
Query: 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 301
+IG G FG VYYGK ++GKE+AVK++A++ ++F EV LLSRIHHRNLV +GYC+
Sbjct: 609 RIGSGGFGIVYYGKTREGKEIAVKVLANNSYQGKREFANEVTLLSRIHHRNLVQFLGYCQ 668
Query: 302 EEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 360
EE + +LVYE+MHNGTL++ L+G V + + W+ RL+IA DAA+G+EYLHTGC P IIH
Sbjct: 669 EEGKNMLVYEFMHNGTLKEHLYGVVPRDRRISWIKRLEIAEDAARGIEYLHTGCVPAIIH 728
Query: 361 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 420
RD+K+SNILLD +MRAKVSDFGLS+ A + +H+SS+ RGTVGYLDPEYY +QQLTEKSD
Sbjct: 729 RDLKTSNILLDKHMRAKVSDFGLSKFAVDGTSHVSSIVRGTVGYLDPEYYISQQLTEKSD 788
Query: 421 VYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKGDVISIVDPVLI-GNVKIES 478
VYSFGV+LLEL+SG++ +S E FG NIV WA+ I GD+ I+DP L + ++S
Sbjct: 789 VYSFGVILLELMSGQEAISNESFGVNCRNIVQWAKMHIDNGDIRGIIDPALAEDDYSLQS 848
Query: 479 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514
+W+IAE A+ CV+ G RP M E+ IQD+I+IE
Sbjct: 849 MWKIAEKALLCVKPHGNMRPSMSEVQKDIQDAIRIE 884
|
|
| TAIR|locus:2028446 AT1G49100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 720 (258.5 bits), Expect = 1.2e-87, Sum P(2) = 1.2e-87
Identities = 140/285 (49%), Positives = 192/285 (67%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 290
E+ E TNNF +GKG FG VY+G + ++VAVK+++ + H +QF EV LL R+HH
Sbjct: 575 EVTEMTNNFRSVLGKGGFGMVYHGYVNGREQVAVKVLSHASKHGHKQFKAEVELLLRVHH 634
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
+NLV L+GYCE+ + LVYEYM NG L++ G L W TRLQIA +AA+GLEYL
Sbjct: 635 KNLVSLVGYCEKGKELALVYEYMANGDLKEFFSGKRGDDVLRWETRLQIAVEAAQGLEYL 694
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 409
H GC P I+HRDVK++NILLD + +AK++DFGLSR E +H+S+V GT+GYLDPEY
Sbjct: 695 HKGCRPPIVHRDVKTANILLDEHFQAKLADFGLSRSFLNEGESHVSTVVAGTIGYLDPEY 754
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469
Y LTEKSDVYSFGVVLLE+I+ ++ + E + +I W MI KGD+ IVDP
Sbjct: 755 YRTNWLTEKSDVYSFGVVLLEIITNQRVI--ERTREKPHIAEWVNLMITKGDIRKIVDPN 812
Query: 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514
L G+ +S+W+ E+A+ CV +RP M ++V + + + +E
Sbjct: 813 LKGDYHSDSVWKFVELAMTCVNDSSATRPTMTQVVTELTECVTLE 857
|
|
| TAIR|locus:2055160 AT2G14440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 654 (235.3 bits), Expect = 2.7e-86, Sum P(2) = 2.7e-86
Identities = 131/284 (46%), Positives = 188/284 (66%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 290
E++E TNNF +GKG FG VY+G + + ++VAVK+++ S + ++F TEV LL R+HH
Sbjct: 575 EVKEMTNNFEVVLGKGGFGVVYHGFLNN-EQVAVKVLSQSSTQGYKEFKTEVELLLRVHH 633
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
NLV L+GYC++ + L+YE+M NG L++ L G L+W RL+IA ++A G+EYL
Sbjct: 634 VNLVSLVGYCDKGNDLALIYEFMENGNLKEHLSGKRGGPVLNWPGRLKIAIESALGIEYL 693
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEY 409
H GC P ++HRDVKS+NILL + AK++DFGLSR TH+S+ GT+GYLDPEY
Sbjct: 694 HIGCKPPMVHRDVKSTNILLGLRFEAKLADFGLSRSFLVGSQTHVSTNVAGTLGYLDPEY 753
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469
Y LTEKSDVYSFG+VLLE+I+G+ PV +E + IV WA+SM+ GD+ SI+D
Sbjct: 754 YQKNWLTEKSDVYSFGIVLLEIITGQ-PV-IEQSRDKSYIVEWAKSMLANGDIESIMDRN 811
Query: 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513
L + S W+ E+A+ C+ RP M + + + ++I
Sbjct: 812 LHQDYDTSSSWKALELAMLCINPSSTLRPNMTRVAHELNECLEI 855
|
|
| TAIR|locus:2156549 AT5G48740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 716 (257.1 bits), Expect = 3.1e-85, Sum P(2) = 3.1e-85
Identities = 144/286 (50%), Positives = 198/286 (69%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 290
E++ AT NF + IG+GSFG+VY GK+ DGK+VAVK+ D F+ EV LLS+I H
Sbjct: 600 EIKSATRNFKEVIGRGSFGAVYRGKLPDGKQVAVKVRFDRTQLGADSFINEVHLLSQIRH 659
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEY 349
+NLV G+C E ++ILVYEY+ G+L D L+G +++ L+W++RL++A DAAKGL+Y
Sbjct: 660 QNLVSFEGFCYEPKRQILVYEYLSGGSLADHLYGPRSKRHSLNWVSRLKVAVDAAKGLDY 719
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPE 408
LH G P IIHRDVKSSNILLD +M AKVSDFGLS+Q + D +HI++V +GT GYLDPE
Sbjct: 720 LHNGSEPRIIHRDVKSSNILLDKDMNAKVSDFGLSKQFTKADASHITTVVKGTAGYLDPE 779
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468
YY QLTEKSDVYSFGVVLLELI G++P+S N+V WAR ++ G IVD
Sbjct: 780 YYSTLQLTEKSDVYSFGVVLLELICGREPLSHSGSPDSFNLVLWARPNLQAG-AFEIVDD 838
Query: 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514
+L S+ + A +AI+CV + RP + E++ ++++ ++
Sbjct: 839 ILKETFDPASMKKAASIAIRCVGRDASGRPSIAEVLTKLKEAYSLQ 884
|
|
| TAIR|locus:2078171 AT3G46400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 692 (248.7 bits), Expect = 1.5e-83, Sum P(2) = 1.5e-83
Identities = 134/285 (47%), Positives = 184/285 (64%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 290
E+ E T F K +G+G FG VY+G +K+ ++VAVK+++ S S + F EV LL R+HH
Sbjct: 570 EVVEMTKKFEKALGEGGFGIVYHGYLKNVEQVAVKVLSQSSSQGYKHFKAEVELLLRVHH 629
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
NLV L+GYC+E+ L+YEYM NG L+D L G L+W TRLQIA D A GLEYL
Sbjct: 630 INLVSLVGYCDEKDHLALIYEYMPNGDLKDHLSGKQGDSVLEWTTRLQIAVDVALGLEYL 689
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEY 409
H GC P ++HRDVKS+NILLD AK++DFGLSR + D + IS+V GT GYLDPEY
Sbjct: 690 HYGCRPSMVHRDVKSTNILLDDQFMAKIADFGLSRSFKVGDESEISTVVAGTPGYLDPEY 749
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469
Y +L E SDVYSFG+VLLE+I+ ++ + +++I W M+ +GD+ IVDP
Sbjct: 750 YRTSRLAEMSDVYSFGIVLLEIITNQRVF--DQARGKIHITEWVAFMLNRGDITRIVDPN 807
Query: 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514
L G S+WR E+A+ C RP M ++V+ +++ + E
Sbjct: 808 LHGEYNSRSVWRAVELAMSCANPSSEYRPNMSQVVIELKECLTTE 852
|
|
| TAIR|locus:2078191 AT3G46420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 688 (247.2 bits), Expect = 3.1e-83, Sum P(2) = 3.1e-83
Identities = 133/282 (47%), Positives = 184/282 (65%)
Query: 234 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL 293
+ TNNF + +G+G FG VY+G + ++VAVK+++ S ++F EV LL R+HH NL
Sbjct: 528 DMTNNFQRALGEGGFGVVYHGYLNGSEQVAVKLLSQSSVQGYKEFKAEVELLLRVHHINL 587
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
V L+GYC++ + LVYEYM NG L+ L G N L W TRLQIA DAA GLEYLH G
Sbjct: 588 VSLVGYCDDRNHLALVYEYMSNGDLKHHLSGRNNGFVLSWSTRLQIAVDAALGLEYLHIG 647
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGN 412
C P ++HRDVKS+NILL AK++DFGLSR + D HIS+V GT GYLDPEYY
Sbjct: 648 CRPSMVHRDVKSTNILLGEQFTAKMADFGLSRSFQIGDENHISTVVAGTPGYLDPEYYRT 707
Query: 413 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472
+L EKSD+YSFG+VLLE+I+ + +++ + +I W S+I +GD+ I+DP L G
Sbjct: 708 SRLAEKSDIYSFGIVLLEMITSQH--AIDRTRVKHHITDWVVSLISRGDITRIIDPNLQG 765
Query: 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514
N S+WR E+A+ C RP M ++V+ +++ + E
Sbjct: 766 NYNSRSVWRALELAMSCANPTSEKRPNMSQVVIDLKECLATE 807
|
|
| TAIR|locus:2126540 AT4G29990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 681 (244.8 bits), Expect = 5.1e-83, Sum P(2) = 5.1e-83
Identities = 139/294 (47%), Positives = 191/294 (64%)
Query: 219 MDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQF 278
+D YFI E+ TNNF + +GKG FG VY+G + +G +VAVKI+++ + ++F
Sbjct: 557 LDTAKRYFI-YSEVVNITNNFERVLGKGGFGKVYHGFL-NGDQVAVKILSEESTQGYKEF 614
Query: 279 VTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ 338
EV LL R+HH NL LIGYC E++ L+YEYM NG L D L G + L W RLQ
Sbjct: 615 RAEVELLMRVHHTNLTSLIGYCNEDNHMALIYEYMANGNLGDYLSGK-SSLILSWEERLQ 673
Query: 339 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSV 397
I+ DAA+GLEYLH GC P I+HRDVK +NILL+ N++AK++DFGLSR E + +S+V
Sbjct: 674 ISLDAAQGLEYLHYGCKPPIVHRDVKPANILLNENLQAKIADFGLSRSFPVEGSSQVSTV 733
Query: 398 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 457
GT+GYLDPEYY +Q+ EKSDVYSFGVVLLE+I+GK P +++ SM+
Sbjct: 734 VAGTIGYLDPEYYATRQMNEKSDVYSFGVVLLEVITGK-PAIWHSRTESVHLSDQVGSML 792
Query: 458 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511
GD+ IVD L ++ S W+I E+A+ C + RP M ++V+ ++ SI
Sbjct: 793 ANGDIKGIVDQRLGDRFEVGSAWKITELALACASESSEQRPTMSQVVMELKQSI 846
|
|
| TAIR|locus:2078176 MEE39 "maternal effect embryo arrest 39" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 700 (251.5 bits), Expect = 1.1e-82, Sum P(2) = 1.1e-82
Identities = 134/286 (46%), Positives = 187/286 (65%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 290
E+ E T N + +G+G FG VY+G + ++VAVK+++ + + ++F EV LL R+HH
Sbjct: 560 EVMEMTKNLQRPLGEGGFGVVYHGDLNGSEQVAVKLLSQTSAQGYKEFKAEVELLLRVHH 619
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
NLV L+GYC+E+ L+YEYM NG L L G L+W TRLQIA +AA GLEYL
Sbjct: 620 INLVNLVGYCDEQDHFALIYEYMSNGDLHQHLSGKHGGSVLNWGTRLQIAIEAALGLEYL 679
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE 408
HTGC P ++HRDVKS+NILLD +AK++DFGLSR Q D + +S+V GT+GYLDPE
Sbjct: 680 HTGCKPAMVHRDVKSTNILLDEEFKAKIADFGLSRSFQVGGDQSQVSTVVAGTLGYLDPE 739
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468
YY +L+EKSDVYSFG++LLE+I+ ++ + + NI W +IKKGD IVDP
Sbjct: 740 YYLTSELSEKSDVYSFGILLLEIITNQRVI--DQTRENPNIAEWVTFVIKKGDTSQIVDP 797
Query: 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514
L GN S+WR EVA+ C RP M ++++ +++ + E
Sbjct: 798 KLHGNYDTHSVWRALEVAMSCANPSSVKRPNMSQVIINLKECLASE 843
|
|
| TAIR|locus:2059804 AT2G04300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 682 (245.1 bits), Expect = 1.3e-82, Sum P(2) = 1.3e-82
Identities = 131/285 (45%), Positives = 187/285 (65%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 290
E+ + TNNF K +GKG FG VY+G + D ++VAVK+++ S S ++F EV LL R+HH
Sbjct: 576 EVVKMTNNFEKILGKGGFGMVYHGTVNDAEQVAVKMLSPSSSQGYKEFKAEVELLLRVHH 635
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
+NLV L+GYC+E L+YEYM G L++ + G+ LDW TRL+I ++A+GLEYL
Sbjct: 636 KNLVGLVGYCDEGENLSLIYEYMAKGDLKEHMLGNQGVSILDWKTRLKIVAESAQGLEYL 695
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEY 409
H GC P ++HRDVK++NILLD + +AK++DFGLSR E T + +V GT GYLDPEY
Sbjct: 696 HNGCKPPMVHRDVKTTNILLDEHFQAKLADFGLSRSFPLEGETRVDTVVAGTPGYLDPEY 755
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469
Y L EKSDVYSFG+VLLE+I+ + ++ + +I W M+ KGD+ SI+DP
Sbjct: 756 YRTNWLNEKSDVYSFGIVLLEIITNQHVINQSR--EKPHIAEWVGVMLTKGDIKSIIDPK 813
Query: 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514
G+ S+WR E+A+ CV RP M ++V+ + + + E
Sbjct: 814 FSGDYDAGSVWRAVELAMSCVNPSSTGRPTMSQVVIELNECLASE 858
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGI2 | Y1677_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7191 | 0.9874 | 0.5920 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 557 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-54 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-53 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-53 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-48 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-43 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-41 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-40 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-36 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-34 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-32 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-31 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-30 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-30 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-29 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-28 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-28 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-27 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-27 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-26 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-26 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-26 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-24 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-24 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-24 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-23 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-23 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-22 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-21 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-20 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-19 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-19 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-18 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-18 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-17 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-17 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-16 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-15 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-15 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-15 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 7e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-13 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-13 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-13 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-12 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-12 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-11 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-11 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-09 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 6e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-08 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 7e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-07 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-06 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.003 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 3e-54
Identities = 73/207 (35%), Positives = 115/207 (55%), Gaps = 13/207 (6%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 292
KK+G+G+FG VY G +K E VAVK + + S ++ F+ E +++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 293 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
+V L+G C + +V EYM G L D L + + L LQ+A AKG+EYL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEKLTLKDLLQMALQIAKGMEYLE- 119
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV-ARGTVGYLDPEYYG 411
+ +HRD+ + N L+ N+ K+SDFGLSR ED + + + ++ PE
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLK 177
Query: 412 NQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ + T KSDV+SFGV+L E+ + G++P
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 2e-53
Identities = 74/206 (35%), Positives = 113/206 (54%), Gaps = 11/206 (5%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGK-----EVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 292
KK+G+G+FG VY G +K EVAVK + + S + + F+ E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 293 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
+V L+G C EE ++V EYM G L D L + K L L A A+G+EYL +
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLES 121
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
IHRD+ + N L+ N+ K+SDFGLSR +D + + + ++ PE
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 413 QQLTEKSDVYSFGVVLLELIS-GKKP 437
+ T KSDV+SFGV+L E+ + G++P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 4e-53
Identities = 77/193 (39%), Positives = 113/193 (58%), Gaps = 10/193 (5%)
Query: 243 IGKGSFGSVYYGK-MKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 300
+G+G FG+VY + K GK+VA+KI+ + S ++ + E+ +L +++H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 301 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 360
E+E+ LV EY G+L+D L N+ L L+I +GLEYLH + GIIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK--ENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 361 RDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQLTEK 418
RD+K NILLD N + K++DFGLS+ D + GT Y+ PE G +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 419 SDVYSFGVVLLEL 431
SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 5e-53
Identities = 74/206 (35%), Positives = 113/206 (54%), Gaps = 12/206 (5%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGK-----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRN 292
KK+G+G+FG VY GK+K EVAVK + + S + ++F+ E ++ ++ H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 293 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
+V L+G C EE +V EYM G L L N+ L L A A+G+EYL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLES 120
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
IHRD+ + N L+ N+ K+SDFGLSR +D + + + ++ PE
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 413 QQLTEKSDVYSFGVVLLELIS-GKKP 437
+ T KSDV+SFGV+L E+ + G++P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 8e-49
Identities = 75/210 (35%), Positives = 109/210 (51%), Gaps = 16/210 (7%)
Query: 241 KKIGKGSFGSVYYGKMKDGK----EVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVP 295
KK+G+G+FG VY GK+K EVAVK + + S + F+ E ++ ++ H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRL------HGSVNQKPLDWLTRLQIAHDAAKGLEY 349
L+G C EE LV EYM G L D L S + L L A AKG+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT-VGYLDPE 408
L + +HRD+ + N L+ ++ K+SDFGLSR +D + + ++ PE
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 409 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ T KSDV+SFGV+L E+ + G P
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 1e-48
Identities = 70/199 (35%), Positives = 105/199 (52%), Gaps = 10/199 (5%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+K+G+GSFG VY + K GK VA+K++ ++ + E+ +L ++ H N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
E+E + LV EY G L D L + L LEYLH + GI
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK---KRGRLSEDEARFYLRQILSALEYLH---SKGI 118
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
+HRD+K NILLD + K++DFGL+RQ + + V GT Y+ PE + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKGYGKA 176
Query: 419 SDVYSFGVVLLELISGKKP 437
D++S GV+L EL++GK P
Sbjct: 177 VDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 1e-43
Identities = 82/203 (40%), Positives = 112/203 (55%), Gaps = 15/203 (7%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIM----ADSCSHRTQQFVTEVALLSRIHHRNLVP 295
+K+G GSFG+VY K K GK VAVKI+ S + Q E+ +L R+ H N+V
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSK--KDQTARREIRILRRLSHPNIVR 62
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
LI E++ LV EY G L D L PL +IA +GLEYLH +
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---S 116
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQ 414
GIIHRD+K NILLD N K++DFGL+++ + + +++ GT Y+ PE G
Sbjct: 117 NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNG 175
Query: 415 LTEKSDVYSFGVVLLELISGKKP 437
K DV+S GV+L EL++GK P
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 5e-41
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 16/205 (7%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 297
+ +G+GSFGSVY KD G+ +AVK + S + E+ +LS + H N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 298 G-YCEEEHQRILVY-EYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
G +EE + ++ EY+ G+L L G + + + TR QI GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR-QILE----GLAYLH-- 118
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGN 412
+ GI+HRD+K +NIL+D + K++DFG +++ + + + RGT ++ PE
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 413 QQLTEKSDVYSFGVVLLELISGKKP 437
++ +D++S G ++E+ +GK P
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 8e-40
Identities = 74/201 (36%), Positives = 112/201 (55%), Gaps = 14/201 (6%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+KIGKG FG VY + K GKEVA+K++ + ++ + E+ +L + H N+V G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 356
++ + +V E+ G+L+D L + NQ LT QIA + KGLEYLH +
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLLKST-NQT----LTESQIAYVCKELLKGLEYLH---SN 117
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 416
GIIHRD+K++NILL + K+ DFGLS Q + + V GT ++ PE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYD 175
Query: 417 EKSDVYSFGVVLLELISGKKP 437
K+D++S G+ +EL GK P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 8e-36
Identities = 125/487 (25%), Positives = 210/487 (43%), Gaps = 45/487 (9%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 97
+ ++ LS L GEIP EL + + L L L N L+G +P S + L + L N+
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQ 558
Query: 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP--ALL-------TGKVIFKYDNNPKLHKE 148
L+G +P +G++ +L +++I +N G +P A L G + +
Sbjct: 559 LSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPP 618
Query: 149 SRRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNT 208
+R + L LVL L + + R K E D
Sbjct: 619 CKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWEL------ 672
Query: 209 AYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIM 267
F D V+ I + ++ + I +G G+ Y GK +K+G + VK +
Sbjct: 673 --------QFFDSKVSKSITINDILSSLKEE-NVISRGKKGASYKGKSIKNGMQFVVKEI 723
Query: 268 ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN 327
D S + +E+A + ++ H N+V LIG C E L++EY+ L + L
Sbjct: 724 NDVNSIPS----SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--- 776
Query: 328 QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387
L W R +IA AK L +LH C+P ++ ++ I++D + L
Sbjct: 777 ---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832
Query: 388 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 447
D S A Y+ PE + +TEKSD+Y FG++L+EL++GK P E FG
Sbjct: 833 CTDTKCFISSA-----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE-FGVHG 886
Query: 448 NIVHWARSMIKKGDVISIVDPVLIGNVKIES--IWRIAEVAIQCVEQRGFSRPKMQEIVL 505
+IV WAR + +DP + G+V + I + +A+ C +RP +++
Sbjct: 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946
Query: 506 AIQDSIK 512
++ + +
Sbjct: 947 TLESASR 953
|
Length = 968 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 69/196 (35%), Positives = 110/196 (56%), Gaps = 11/196 (5%)
Query: 243 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 302
IGKG FG V G + G++VAVK + D S Q F+ E ++++ + H NLV L+G +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 303 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRD 362
+ +V EYM G+L D L S + + +L A D +G+EYL +HRD
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLR-SRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRD 127
Query: 363 VKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVY 422
+ + N+L+ ++ AKVSDFGL+++A + + V + PE ++ + KSDV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQD----SGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 423 SFGVVLLELIS-GKKP 437
SFG++L E+ S G+ P
Sbjct: 184 SFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 6e-34
Identities = 75/216 (34%), Positives = 105/216 (48%), Gaps = 38/216 (17%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLI 297
K+IGKGSFG VY + K DGK +K + S + + EV +L +++H N+ I
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI---I 62
Query: 298 GYCE--EEHQRIL-VYEYMHNGTLRDRLHGSVNQKP----------LDWLTRLQIAHDAA 344
Y E EE ++ V EY G L ++ QK LDW Q+
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIK---KQKKEGKPFPEEQILDWFV--QLC---- 113
Query: 345 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG- 403
L+YLH+ I+HRD+K NI L N K+ DFG+S+ L+ +A+ VG
Sbjct: 114 LALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKV----LSSTVDLAKTVVGT 166
Query: 404 --YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
YL PE N+ KSD++S G VL EL + K P
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-32
Identities = 71/201 (35%), Positives = 107/201 (53%), Gaps = 17/201 (8%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVP 295
+KIGKG+FG VY G +K EVAVK +C ++F+ E +L + H N+V
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVK----TCRSTLPPDLKRKFLQEAEILKQYDHPNIVK 56
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
LIG C ++ +V E + G+L L N+ + L LQ++ DAA G+EYL +
Sbjct: 57 LIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL--LQMSLDAAAGMEYLESKN- 113
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDPEYYGNQ 413
IHRD+ + N L+ N K+SDFG+SR+ EE + S + + PE
Sbjct: 114 --CIHRDLAARNCLVGENNVLKISDFGMSRE-EEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 414 QLTEKSDVYSFGVVLLELISG 434
+ T +SDV+S+G++L E S
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 2e-32
Identities = 71/202 (35%), Positives = 105/202 (51%), Gaps = 14/202 (6%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
K +G+GS G VY + K GK A+K I D +Q + E+ L +V G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 299 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+E + +V EYM G+L D L G + + L ++ R QI GL+YLHT +
Sbjct: 67 AFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIAR-QILK----GLDYLHTKRH- 120
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQL 415
IIHRD+K SN+L++ K++DFG+S+ E L + V GTV Y+ PE +
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPERIQGESY 177
Query: 416 TEKSDVYSFGVVLLELISGKKP 437
+ +D++S G+ LLE GK P
Sbjct: 178 SYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 5e-32
Identities = 67/206 (32%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 239 FCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHR 291
F K++G+G FG V + G++VAVK + S HR+ F E+ +L + H
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRTLDHE 66
Query: 292 NLVPLIGYCEEEHQRI--LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 349
N+V G CE+ R L+ EY+ +G+LRD L +Q ++ L + KG++Y
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDY 124
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDP 407
L + IHRD+ + NIL++ K+SDFGL++ ED + G + + P
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 408 EYYGNQQLTEKSDVYSFGVVLLELIS 433
E + + SDV+SFGV L EL +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (316), Expect = 1e-31
Identities = 75/218 (34%), Positives = 114/218 (52%), Gaps = 18/218 (8%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRI-HHRNL 293
+K+G+GSFG VY + D K VA+K++A +S S ++F+ E+ +L+ + H N+
Sbjct: 3 RILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
V L + ++E LV EY+ G+L D L + PL L I LEYLH+
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 354 CNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTH-----ISSVARGTVGYLDP 407
GIIHRD+K NILLD + K+ DFGL++ + + + S + GT GY+ P
Sbjct: 121 ---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 408 EYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
E + SD++S G+ L EL++G P E
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-31
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 242 KIGKGSFGSVYYG-KMKDGKEVAVK--IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
IG+G+FG VY G ++ G VA+K + + + E+ LL + H N+V IG
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCN 355
E ++ EY NG+LR + K +A + +GL YLH
Sbjct: 67 SIETSDSLYIILEYAENGSLRQII------KKFGPFPESLVAVYVYQVLQGLAYLH---E 117
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 415
G+IHRD+K++NIL + K++DFG++ + + +SV GT ++ PE
Sbjct: 118 QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV-GTPYWMAPEVIEMSGA 176
Query: 416 TEKSDVYSFGVVLLELISGKKP 437
+ SD++S G ++EL++G P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 7e-30
Identities = 68/200 (34%), Positives = 108/200 (54%), Gaps = 7/200 (3%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
F K++G G FG V+ GK + +VA+K++ + + F+ E ++ ++ H NLV L G
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
C ++ +V EYM NG L + L + +WL L + D + +EYL +
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNG---F 121
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
IHRD+ + N L+ + KVSDFGL+R +D S + V + PE + + + K
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 419 SDVYSFGVVLLELIS-GKKP 437
SDV+SFGV++ E+ S GK P
Sbjct: 182 SDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 9e-30
Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 6/202 (2%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIH 289
E+E K+G G +G VY G K VAVK + + + ++F+ E A++ I
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIK 60
Query: 290 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 349
H NLV L+G C E ++ E+M G L D L N++ ++ + L +A + +EY
Sbjct: 61 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVNAVVLLYMATQISSAMEY 119
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
L IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE
Sbjct: 120 LEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 176
Query: 410 YGNQQLTEKSDVYSFGVVLLEL 431
+ + KSDV++FGV+L E+
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 9e-30
Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 296
+KIG+G+ G VY + GKEVA+K M + + E+ ++ H N+V
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 297 IG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 352
Y + +V EYM G+L D + Q + + QIA + +GLEYLH+
Sbjct: 81 YDSYLVGDEL-WVVMEYMDGGSLTD----IITQNFVR-MNEPQIAYVCREVLQGLEYLHS 134
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
+IHRD+KS NILL + K++DFG + Q ++ + +SV GT ++ PE
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190
Query: 413 QQLTEKSDVYSFGVVLLELISGKKP 437
+ K D++S G++ +E+ G+ P
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 72/225 (32%), Positives = 110/225 (48%), Gaps = 34/225 (15%)
Query: 239 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVT-EVALLSRI-HHRNL 293
F K IG+GSF +V K K KE A+KI+ + ++V E +L+R+ H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
+ L ++E V EY NG L R +GS+++K TR A + LEYLH
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK----CTRF-YAAEILLALEYLH 119
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFG---------LSRQAEEDLTHISSVAR--- 399
+ GIIHRD+K NILLD +M K++DFG + D T+I S
Sbjct: 120 ---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 400 -------GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
GT Y+ PE + + SD+++ G ++ ++++GK P
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-29
Identities = 71/201 (35%), Positives = 109/201 (54%), Gaps = 9/201 (4%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
F K++G G FG V YGK + +VA+K++ + S +F+ E ++ ++ H LV L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
C ++ +V EYM NG L + L K L++ D +G+ YL +
Sbjct: 67 VCTKQRPIYIVTEYMSNGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQF 121
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV-ARGTVGYLDPEYYGNQQLTE 417
IHRD+ + N L+D KVSDFGLSR +D + SSV ++ V + PE + +
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 418 KSDVYSFGVVLLELIS-GKKP 437
KSDV++FGV++ E+ S GK P
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 3e-29
Identities = 65/199 (32%), Positives = 106/199 (53%), Gaps = 6/199 (3%)
Query: 240 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+K+G G FG V+ G K+ VA+KI+ + Q F EV L R+ H++L+ L
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
C ++ E M G+L L S + L + + +A A+G+ YL I
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSI 126
Query: 360 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 419
HRD+ + NIL+ ++ KV+DFGL+R +ED+ ++SS + + PE + + KS
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTFSTKS 185
Query: 420 DVYSFGVVLLELIS-GKKP 437
DV+SFG++L E+ + G+ P
Sbjct: 186 DVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 15/206 (7%)
Query: 243 IGKGSFGSVYYGKMKD-GKEVAVKIM--ADSCSHRTQQFV-TEVALLSRIHHRNLVPLIG 298
+GKGSFG V + KD GK A+K++ + + TE +LSRI+H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 299 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+ E + LV EY G L L G +++ R A + LEYLH +
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE----RARFYAA-EIVLALEYLH---SL 112
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 416
GII+RD+K NILLD + K++DFGL+++ + + ++ GT YL PE +
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYG 171
Query: 417 EKSDVYSFGVVLLELISGKKPVSVED 442
+ D +S GV+L E+++GK P ED
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAED 197
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 69/201 (34%), Positives = 107/201 (53%), Gaps = 12/201 (5%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 300
+K+G G FG V+ G +VAVK + + + F+ E ++ ++ H LV L C
Sbjct: 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 301 EEEHQRILVYEYMHNGTLRDRLH-GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
EE +V EYM G+L D L G + L L + +A A+G+ YL + I
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL--VDMAAQIAEGMAYLES---RNYI 125
Query: 360 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--YYGNQQLTE 417
HRD+ + NIL+ N+ K++DFGL+R E+D A+ + + PE YG T
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR--FTI 183
Query: 418 KSDVYSFGVVLLELIS-GKKP 437
KSDV+SFG++L E+++ G+ P
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 64/204 (31%), Positives = 110/204 (53%), Gaps = 12/204 (5%)
Query: 241 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVP 295
K IG G FG V G++ K +VA+K + S + + F+TE +++ + H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
L G + +++ EYM NG+L L N + + A G++YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLR--ENDGKFTVGQLVGMLRGIASGMKYL---SE 124
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQ 414
+HRD+ + NIL++ N+ KVSDFGLSR+ E+ + T+ + + + + PE ++
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184
Query: 415 LTEKSDVYSFGVVLLELIS-GKKP 437
T SDV+SFG+V+ E++S G++P
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 70/218 (32%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVK-----IMADSCSHRTQQFVTEVALLSRIHHRNLV 294
+ IGKGSFG+V + K DGK + K M QQ V+EV +L + H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT---EKEKQQLVSEVNILRELKHPNIV 62
Query: 295 PLIGYCEEEH----QRI-LVYEYMHNGTLRDRL-HGSVNQKPLD----WLTRLQIAHDAA 344
Y + Q + +V EY G L + +K ++ W Q+
Sbjct: 63 ---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL--- 116
Query: 345 KGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 402
L H +PG ++HRD+K +NI LD N K+ DFGL++ L H SS A+ V
Sbjct: 117 -ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK----ILGHDSSFAKTYV 171
Query: 403 G---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
G Y+ PE + EKSD++S G ++ EL + P
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 70/219 (31%), Positives = 111/219 (50%), Gaps = 23/219 (10%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 291
+++G+G+FG V+ G+ + VAVK + ++ S+ ++ F E LL+ H
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG------SVNQKPLDWLTR---LQIA 340
N+V G C E I+V+EYM +G L R HG P+ LT LQIA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 341 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVAR 399
A G+ YL + +HRD+ + N L+ ++ K+ DFG+SR D +
Sbjct: 129 VQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTM 185
Query: 400 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ ++ PE ++ T +SDV+SFGVVL E+ + GK+P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 9e-28
Identities = 67/203 (33%), Positives = 109/203 (53%), Gaps = 13/203 (6%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
++IG G FG V+ G + ++VA+K + + + + F+ E ++ ++ H LV L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLH---GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
C E LV+E+M +G L D L G +Q+ L L + D +G+ YL +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSN- 120
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 415
+IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + +
Sbjct: 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY 178
Query: 416 TEKSDVYSFGVVLLELIS-GKKP 437
+ KSDV+SFGV++ E+ S GK P
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 23/270 (8%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
F K++G G FG V+ GK + +VA+K + + + + F+ E ++ ++ H LV L G
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
C ++ +V E+M NG L + L + D L L + D +G+EYL
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLERN---SF 121
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
IHRD+ + N L+ KVSDFG++R +D SS A+ V + PE + + + K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 419 SDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 477
SDV+SFGV++ E+ + GK P + + +V MI +G + P L
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEKK---SNYEVV----EMISRGF--RLYRPKLASMT--- 229
Query: 478 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 507
+ EV C ++ RP E++ AI
Sbjct: 230 ----VYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 72/203 (35%), Positives = 115/203 (56%), Gaps = 23/203 (11%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 300
+ IG+G FG+V G+ G++VAVK + C Q F+ E A+++++HH+NLV L+G
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 301 EEEHQRI-LVYEYMHNGTL----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
H + +V E M G L R R V+ L LQ + D A+G+EYL +
Sbjct: 69 L--HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQL-----LQFSLDVAEGMEYLES--- 118
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 415
++HRD+ + NIL+ + AKVSDFGL+R + + ++ V + PE +++
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN----SKLPVKWTAPEALKHKKF 174
Query: 416 TEKSDVYSFGVVLLELIS-GKKP 437
+ KSDV+S+GV+L E+ S G+ P
Sbjct: 175 SSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 3e-27
Identities = 75/233 (32%), Positives = 117/233 (50%), Gaps = 30/233 (12%)
Query: 227 IPLPELEEATNNFCKKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQ-FV 279
IPL + F +++G+G+FG VY G+ VA+K + ++ + QQ F
Sbjct: 2 IPLSAVR-----FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR 56
Query: 280 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVN------- 327
E L+S + H N+V L+G C +E +++EY+ +G L + L H V
Sbjct: 57 QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 328 -QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386
+ LD L IA A G+EYL + +HRD+ + N L+ + K+SDFGLSR
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRD 173
Query: 387 A-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
D + S + V ++ PE + T +SD++SFGVVL E+ S G +P
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 68/197 (34%), Positives = 109/197 (55%), Gaps = 13/197 (6%)
Query: 243 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 302
IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G E
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 303 EHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 361
E + +V EYM G+L D L S + L L+ + D + +EYL +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHR 126
Query: 362 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 421
D+ + N+L+ + AKVSDFGL+++A + + V + PE ++ + KSDV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 422 YSFGVVLLELIS-GKKP 437
+SFG++L E+ S G+ P
Sbjct: 183 WSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 64/220 (29%), Positives = 119/220 (54%), Gaps = 25/220 (11%)
Query: 243 IGKGSFGSVYY------GKMKDGKEVAV-KIMADSCSHRTQQFV----TEVALLSRIHHR 291
IGKG++G VY G+M K+V + +A R + V +E+ L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEY 349
N+V +G+ E + EY+ G++ R +G ++ + + T Q+ +GL Y
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-QVL----EGLAY 123
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-RGTVGYLDPE 408
LH + GI+HRD+K+ N+L+D + K+SDFG+S+++++ + +++ +G+V ++ PE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 409 YYGNQQ--LTEKSDVYSFGVVLLELISGKKPVS-VEDFGA 445
+ + K D++S G V+LE+ +G++P S E A
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 17/207 (8%)
Query: 241 KKIGKGSFGSVYYG-KMKDGKEVAVKIMA--DSCSHRTQQFVTEVALLSRIHHRNLVPLI 297
KIG G+FG VY + G+ +AVK + D+ ++ E+ +L + H NLV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 298 GYCEEEHQRILVY-EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
G E +++ ++ EY GTL + L + LD +GL YLH+
Sbjct: 66 G-VEVHREKVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGNQ 413
GI+HRD+K +NI LD N K+ DFG + + + + T + + G Y+ PE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178
Query: 414 QLTEK---SDVYSFGVVLLELISGKKP 437
+ +D++S G V+LE+ +GK+P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-26
Identities = 73/209 (34%), Positives = 109/209 (52%), Gaps = 23/209 (11%)
Query: 241 KKIGKGSFGSVYYG--KMKDGKE--VAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 295
K++G G+FGSV G MK GKE VAVK + ++F+ E ++++++ H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
LIG C+ E +LV E G L L + L ++AH A G+ YL
Sbjct: 61 LIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDL-----KELAHQVAMGMAYLE-S 113
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE--Y 409
+ +HRD+ + N+LL +AK+SDFG+SR A D ++ R + + PE
Sbjct: 114 KH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171
Query: 410 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
YG + + KSDV+S+GV L E S G KP
Sbjct: 172 YG--KFSSKSDVWSYGVTLWEAFSYGAKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 71/216 (32%), Positives = 113/216 (52%), Gaps = 24/216 (11%)
Query: 241 KKIGKGSFGSVYYGKMK--DGK--EVAVKIM-ADSCSHR-TQQFVTEVALLSRIHHRNLV 294
K +G+G FGSV G++ DG +VAVK M D ++ ++F++E A + H N++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 295 PLIGYC--EEEHQRI----LVYEYMHNGTLRD-----RLHGSVNQKPLDWLTRLQIAHDA 343
LIG C Q+I ++ +M +G L RL G + PL L + + D
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV--DI 122
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 402
A G+EYL N IHRD+ + N +L +M V+DFGLS++ D +A+ V
Sbjct: 123 ALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179
Query: 403 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
++ E ++ T KSDV++FGV + E+ + G+ P
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 70/219 (31%), Positives = 108/219 (49%), Gaps = 18/219 (8%)
Query: 230 PELEEATNNFCKKIGKGSFGSVYYGKM--KDGK----EVAVKIMADSCSHRTQQ-FVTEV 282
PE+ + + +G G+FG VY G +DG +VAVK + +SCS + + F+ E
Sbjct: 1 PEVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA 60
Query: 283 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----VNQKPLDWLTRLQ 338
++S+ +H+N+V LIG E R ++ E M G L+ L + L L
Sbjct: 61 LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 339 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA-EEDLTHI 394
A D AKG +YL IHRD+ + N LL AK++DFG++R
Sbjct: 121 CARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRK 177
Query: 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 433
A + ++ PE + + T K+DV+SFGV+L E+ S
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 9e-26
Identities = 75/218 (34%), Positives = 112/218 (51%), Gaps = 20/218 (9%)
Query: 243 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLVPL 296
+G GSFGSVY G + DG AVK + Q+ V E+ALLS++ H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
+G EE + E + G+L L +GS + + TR QI GLEYLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QIL----LGLEYLH--- 119
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 414
+ +HRD+K +NIL+D N K++DFG+++Q E + S +G+ ++ PE Q
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKSF-KGSPYWMAPEVIAQQG 177
Query: 415 L-TEKSDVYSFGVVLLELISGKKPVS-VEDFGAELNIV 450
+D++S G +LE+ +GK P S +E A I
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG 215
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 19/213 (8%)
Query: 241 KKIGKGSFGSVYYGKMK---DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPL 296
++G G+ G V K+ GK +AVK + + +Q + E+ +L + + +V
Sbjct: 7 GELGAGNSGVVS--KVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
G + EYM G+L L + P L ++ +A KGL YLH
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA--VLKGLTYLHE--KH 120
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQ 413
IIHRDVK SNIL++ + K+ DFG+S Q ++S+A+ GT Y+ PE
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL------VNSLAKTFVGTSSYMAPERIQGN 174
Query: 414 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 446
+ KSD++S G+ L+EL +G+ P E+ +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 6/208 (2%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 290
E++ + +K+G G FG V+ G + VAVK + + + F+ E ++ ++ H
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRH 60
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
L+ L C E +V E M G+L + L G + L + +A A G+ YL
Sbjct: 61 PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA-LKLPQLIDMAAQVASGMAYL 119
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410
IHRD+ + N+L+ N KV+DFGL+R +ED+ A+ + + PE
Sbjct: 120 EA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAA 176
Query: 411 GNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ + KSDV+SFG++L E+++ G+ P
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 71/210 (33%), Positives = 110/210 (52%), Gaps = 14/210 (6%)
Query: 233 EEATNNFCKKIGKGSFGSV---YYGKMKD--GKEVAVKIMADSCSHRTQQFVTEVALLSR 287
EE F +++GKG+FGSV Y ++D G+ VAVK + S + + F E+ +L
Sbjct: 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61
Query: 288 IHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 345
+ H N+V G C +R LV EY+ G+LRD L +++ LD L A K
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICK 119
Query: 346 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVG 403
G+EYL + +HRD+ + NIL++ R K+ DFGL++ +D + + +
Sbjct: 120 GMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF 176
Query: 404 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS 433
+ PE + + SDV+SFGVVL EL +
Sbjct: 177 WYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 1e-24
Identities = 78/272 (28%), Positives = 133/272 (48%), Gaps = 29/272 (10%)
Query: 241 KKIGKGSFGSVYYG--KMKDGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVP 295
K IG G FG V+ G KM KEVAV I + Q F++E +++ + H N++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
L G + +++ EYM NG L L + + + A G++YL +
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYYGNQ 413
+HRD+ + NIL++ N+ KVSDFGLSR E+D T+ +S + + + PE +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185
Query: 414 QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472
+ T SDV+SFG+V+ E++S G++P +W S +V+ ++
Sbjct: 186 KFTSASDVWSFGIVMWEVMSFGERP-------------YWDMS---NHEVMKAINDGFRL 229
Query: 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 504
++ + ++ +QC +Q RP+ +IV
Sbjct: 230 PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIV 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 70/209 (33%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 241 KKIGKGSFGSVYYGKMKDG------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 294
KKIG+GSFG +Y K K KE+ + M +++ EV LL+++ H N+V
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPNIV 62
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRL---HGSV--NQKPLDWLTRLQIAHDAAKGLEY 349
+E + +V EY G L R+ G + + L W ++ + GL++
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKH 116
Query: 350 LHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 408
+H + I+HRD+KS NI L N M AK+ DFG++RQ D ++ GT YL PE
Sbjct: 117 IH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYLSPE 172
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
N+ K+D++S G VL EL + K P
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 11/209 (5%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKE-VAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVP 295
+ IG G+ VY E VA+K + + C + EV +S+ +H N+V
Sbjct: 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
+ LV Y+ G+L D + S + LD + + KGLEYLH+
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-- 121
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYG 411
G IHRD+K+ NILL + K++DFG+S + + R GT ++ PE
Sbjct: 122 -GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG-GDRTRKVRKTFVGTPCWMAPEVME 179
Query: 412 NQQ-LTEKSDVYSFGVVLLELISGKKPVS 439
K+D++SFG+ +EL +G P S
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 72/213 (33%), Positives = 112/213 (52%), Gaps = 27/213 (12%)
Query: 243 IGKGSFGSVYYG-KMKDGKEVAVK------IMADSCSHRT---QQFVTEVALLSRIHHRN 292
IG GSFGSVY G G+ +AVK + A S + E+ALL + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 293 LVPLIG-YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 349
+V +G + +H I + EY+ G++ L +G+ + + R QI KGL Y
Sbjct: 68 IVQYLGSSLDADHLNIFL-EYVPGGSVAALLNNYGAFEETLVRNFVR-QIL----KGLNY 121
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-----RGTVGY 404
LH N GIIHRD+K +NIL+D K+SDFG+S++ E + + +G+V +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 405 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ PE T K+D++S G +++E+++GK P
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-24
Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 12/203 (5%)
Query: 241 KKIGKGSFGSVYYGKMKDGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVP 295
+ IG+G FG VY G + VAVK + S ++F+ E ++ + H ++V
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
LIG E I V E G LR L VN+ LD + + ++ + L YL +
Sbjct: 72 LIGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES--- 125
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 415
+HRD+ + N+L+ K+ DFGLSR E++ + +S + + ++ PE ++
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF 185
Query: 416 TEKSDVYSFGVVLLELIS-GKKP 437
T SDV+ FGV + E++ G KP
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 64/198 (32%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIG 298
++IG+G+FG V+ G+++ D VAVK ++ + +F+ E +L + H N+V LIG
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPG 357
C ++ +V E + G L + P L +Q+ +AA G+EYL +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLESKH--- 114
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVGYLDPEYYGNQQL 415
IHRD+ + N L+ K+SDFG+SR+ EED + S+ + + V + PE +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 416 TEKSDVYSFGVVLLELIS 433
+ +SDV+SFG++L E S
Sbjct: 174 SSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 72/262 (27%), Positives = 128/262 (48%), Gaps = 21/262 (8%)
Query: 243 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIGYCE 301
+GKG+FG V+ G +KD VAVK + + +F++E +L + H N+V LIG C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 302 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 361
+ +V E + G L ++ L + + DAA G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLES---KNCIHR 117
Query: 362 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 421
D+ + N L+ N K+SDFG+SRQ ++ + S + + + + PE + + +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177
Query: 422 YSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWR 481
+S+G++L E S + V + N AR ++KG +S + +++
Sbjct: 178 WSYGILLWETFS----LGVCPYPGMTN--QQAREQVEKGYRMSCPQKC------PDDVYK 225
Query: 482 IAEVAIQCVEQRGFSRPKMQEI 503
+ + +C + + +RPK E+
Sbjct: 226 VMQ---RCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 77/275 (28%), Positives = 135/275 (49%), Gaps = 35/275 (12%)
Query: 241 KKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVP 295
K IG G FG V G++K +E+ V I + +Q F++E +++ + H N++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 352
L G + ++V EYM NG+L L Q T +Q+ A G++YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-----FTVIQLVGMLRGIASGMKYL-- 122
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYY 410
+ G +HRD+ + NIL++ N+ KVSDFGLSR E+D + + + + + PE
Sbjct: 123 -SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181
Query: 411 GNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469
++ T SDV+S+G+V+ E++S G++P +W S DVI ++
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP-------------YWEMS---NQDVIKAIEEG 225
Query: 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 504
++ + ++ + C ++ RPK ++IV
Sbjct: 226 YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIV 260
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 67/206 (32%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 241 KKIGKGSFGSVYYGKMKD--GK--EVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVP 295
KK+G GSFG V G+ GK VAVK + +D S F+ E A++ + H NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL-QIAHDAAKGLEYLHTGC 354
L G H ++V E G+L DRL + ++ L A A G+ YL +
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRK--DALGHFLISTLCDYAVQIANGMRYLES-- 115
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV--GYLDPEYYGN 412
IHRD+ + NILL + + K+ DFGL R ++ H V + PE
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 413 QQLTEKSDVYSFGVVLLELIS-GKKP 437
+ + SDV+ FGV L E+ + G++P
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 29/210 (13%)
Query: 242 KIGKGSFGSVYYGKMKDGKEV-AVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
++G+G+ GSV ++K+ + A+K I D +Q + E+ + +V G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 300 CEEEHQRIL--VYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYL 350
+E + EY G+L D ++ V +K L +IA KGL YL
Sbjct: 68 FLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVL-----GKIAESVLKGLSYL 121
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDP 407
H+ IIHRD+K SNILL + K+ DFG+S + ++S+A GT Y+ P
Sbjct: 122 HS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL------VNSLAGTFTGTSFYMAP 172
Query: 408 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
E + + SDV+S G+ LLE+ + P
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 15/202 (7%)
Query: 242 KIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 300
K+G+GS+GSVY + G+ VA+K++ Q+ + E+++L + +V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 301 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNPG 357
+ +V EY G++ D + + K L T +IA + KGLEYLH +
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIM--KITNKTL---TEEEIAAILYQTLKGLEYLH---SNK 119
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
IHRD+K+ NILL+ +AK++DFG+S Q + + ++V GT ++ PE
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNN 178
Query: 418 KSDVYSFGVVLLELISGKKPVS 439
K+D++S G+ +E+ GK P S
Sbjct: 179 KADIWSLGITAIEMAEGKPPYS 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-23
Identities = 64/209 (30%), Positives = 107/209 (51%), Gaps = 22/209 (10%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNLV 294
K +G+G+FG VY D G+E+AVK + + E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 295 PLIGYCEEEHQRILVY-EYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
G C + + + ++ EYM G+++D + +G++ + TR QI G+EYLH
Sbjct: 68 QYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR-QILE----GVEYLH 121
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDPE 408
+ I+HRD+K +NIL D K+ DFG S++ + T + SV GT ++ PE
Sbjct: 122 SN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT-GTPYWMSPE 177
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ K+DV+S G ++E+++ K P
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-23
Identities = 68/208 (32%), Positives = 105/208 (50%), Gaps = 10/208 (4%)
Query: 242 KIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ--FVTEVALLSRIHHRNLVPLIG 298
KIGKGSFG V+ K K V A+K + S +R ++ + E +L+++ ++
Sbjct: 7 KIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
++ + +V EY NG L L + P D + R I GL +LH+
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI--QILLGLAHLHSK---K 121
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
I+HRD+KS N+ LD K+ D G+++ D T+ ++ GT YL PE ++ E
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNE 180
Query: 418 KSDVYSFGVVLLELISGKKPVSVEDFGA 445
KSDV++ GVVL E +GK P + GA
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGA 208
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 2e-23
Identities = 66/199 (33%), Positives = 98/199 (49%), Gaps = 12/199 (6%)
Query: 243 IGKGSFGSVYYGKMKDGKEV-AVKIMADS-C--SHRTQQFVTEVALLSRIHHRNLVPLIG 298
IGKG+FG V + +D K++ A+K M C + + E +L ++H LV L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
++E LV + + G LR H S K + + I + LEYLH + GI
Sbjct: 68 SFQDEENMYLVVDLLLGGDLR--YHLSQKVKFSEEQVKFWIC-EIVLALEYLH---SKGI 121
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
IHRD+K NILLD ++DF ++ + D T +S + GT GY+ PE Q +
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPD-TLTTSTS-GTPGYMAPEVLCRQGYSVA 179
Query: 419 SDVYSFGVVLLELISGKKP 437
D +S GV E + GK+P
Sbjct: 180 VDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 59/217 (27%), Positives = 107/217 (49%), Gaps = 14/217 (6%)
Query: 229 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEV 282
L L+E K +G G+FG+VY G E VA+K++ + S + + + E
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEA 60
Query: 283 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 342
+++ + H ++V L+G C Q L+ + M G L D + ++ + L
Sbjct: 61 YVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQ 117
Query: 343 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGT 401
AKG+ YL ++HRD+ + N+L+ K++DFGL++ + D + +
Sbjct: 118 IAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 402 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ ++ E ++ T KSDV+S+GV + EL++ G KP
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 3e-23
Identities = 66/214 (30%), Positives = 104/214 (48%), Gaps = 38/214 (17%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQF-VT---EVALLSRIHHRNLVP 295
+IG+G++G VY + K G+ VA+K + + + F +T E+ LL ++ H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 296 LIGYCEEEHQR--ILVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEY 349
L + + +V+EYM H+ T L S K T QI +GL+Y
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLT---GLLDSPEVK----FTESQIKCYMKQLLEGLQY 115
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG-------TV 402
LH + GI+HRD+K SNIL++ + K++DFGL+R + T+
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLAR-------PYTKRNSADYTNRVITL 165
Query: 403 GYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 435
Y PE G + + D++S G +L EL GK
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-23
Identities = 71/235 (30%), Positives = 107/235 (45%), Gaps = 47/235 (20%)
Query: 239 FCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHR 291
+ + IG+G+FG V+ + + VAVK++ + S Q F E AL++ H
Sbjct: 9 YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHP 68
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL------------HGSV-------NQKPLD 332
N+V L+G C L++EYM G L + L H + N PL
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 333 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ------ 386
+L IA A G+ YL +HRD+ + N L+ NM K++DFGLSR
Sbjct: 129 CTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 387 ---AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+E D I ++ PE + T +SDV+++GVVL E+ S G +P
Sbjct: 186 YKASENDAIPIR--------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 5e-23
Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 18/206 (8%)
Query: 243 IGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-----QQFVTEVALLSRIHHRNLVPLI 297
IGKG FG VY+G + D + S + T +QF+ E ++ H N++ L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 298 GYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR--LQIAHDAAKGLEYLHTGC 354
G C E ++V YM +G LR+ + + + L LQ+A KG+EYL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVA----KGMEYL---A 115
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPEYYG 411
+ +HRD+ + N +LD + KV+DFGL+R E H + A+ V ++ E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKP 437
Q+ T KSDV+SFGV+L EL++ P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 6e-23
Identities = 65/209 (31%), Positives = 107/209 (51%), Gaps = 8/209 (3%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 290
E+ + KK+G G FG V+ G + +VAVK + + Q F+ E L+ + H
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQH 60
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL-QIAHDAAKGLEY 349
LV L +E ++ EYM G+L D L K L L +L + A+G+ Y
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL--LPKLIDFSAQIAEGMAY 118
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
+ IHRD++++N+L+ ++ K++DFGL+R E++ A+ + + PE
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 175
Query: 410 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
T KSDV+SFG++L E+++ GK P
Sbjct: 176 INFGSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 7e-23
Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 21/215 (9%)
Query: 241 KKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 294
+++G+G+FG V+ + +D VAVK + D+ + + F E LL+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS-----VNQKPLDWLTR---LQIAHDAA 344
G C E I+V+EYM +G L R HG LT+ L IA A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 345 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVG 403
G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D + +
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 404 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
++ PE ++ T +SDV+S GVVL E+ + GK+P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 8e-23
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 26/211 (12%)
Query: 241 KKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
++IG G++G VY + G+ VA+K++ + E+++L H N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 356
+ +V EY G+L+D V + PL + LQIA+ + KGL YLH
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQ--VTRGPL---SELQIAYVCRETLKGLAYLH---ET 120
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLDPEYYG 411
G IHRD+K +NILL + K++DFG+S Q LT ++A+ GT ++ PE
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQ----LTA--TIAKRKSFIGTPYWMAPEVAA 174
Query: 412 NQQL---TEKSDVYSFGVVLLELISGKKPVS 439
++ K D+++ G+ +EL + P+
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMF 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 70/216 (32%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 243 IGKGSFGSVYYGKMK-DGKEVAVKIM--AD-SCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
I KG++G V+ K K G A+K++ AD ++ Q +TE +LS+ +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
+ + LV EY+ G L L +V D R+ IA + LEYLH + GI
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDV-ARIYIA-EIVLALEYLH---SNGI 114
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQ--------AEEDLTHISSVARGTVGYLDPEYY 410
IHRD+K NIL+D N K++DFGLS+ +D + GT Y+ PE
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPDYIAPEVI 173
Query: 411 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 446
Q ++ D +S G +L E + G P F E
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP-----FHGE 204
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-22
Identities = 65/208 (31%), Positives = 106/208 (50%), Gaps = 7/208 (3%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 290
E+ T KK+G G FG V+ G +VA+K + S + F+ E L+ ++ H
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQG-SMSPEAFLAEANLMKQLQH 60
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
LV L +E I + EYM NG+L D L K L + +A A+G+ ++
Sbjct: 61 PRLVRLYAVVTQEPIYI-ITEYMENGSLVDFLKTPEGIK-LTINKLIDMAAQIAEGMAFI 118
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE
Sbjct: 119 ER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 175
Query: 411 GNQQLTEKSDVYSFGVVLLELIS-GKKP 437
T KSDV+SFG++L E+++ G+ P
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 17/209 (8%)
Query: 243 IGKGSFGSVYYGKMK----DGKE--VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVP 295
+G+G FG V+ K K +G E V VK + + Q F E+ + ++ H+N+V
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGS------VNQKPLDWLTRLQIAHDAAKGLEY 349
L+G C E ++ EY G L+ L + + PL ++ + A G+++
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
L +HRD+ + N L+ KVS LS+ + A + +L PE
Sbjct: 133 LSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEA 189
Query: 410 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ KSDV+SFGV++ E+ + G+ P
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 68/204 (33%), Positives = 100/204 (49%), Gaps = 18/204 (8%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 296
++IG GSFG+VY+ + ++ + VA+K M+ S Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
G EH LV EY G+ D L V++KPL + I H A +GL YLH+
Sbjct: 81 KGCYLREHTAWLVMEYCL-GSASDIL--EVHKKPLQEVEIAAICHGALQGLAYLHSHER- 136
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY---YGNQ 413
IHRD+K+ NILL K++DFG + + + GT ++ PE
Sbjct: 137 --IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 414 QLTEKSDVYSFGVVLLELISGKKP 437
Q K DV+S G+ +EL K P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 5e-22
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 24/218 (11%)
Query: 241 KKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 294
+++G+G+FG V+ + KD VAVK + D + F E LL+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS-----VNQKP------LDWLTRLQIAH 341
G C + I+V+EYM +G L R HG V+ +P L L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 342 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARG 400
A G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 401 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ ++ PE ++ T +SDV+SFGV+L E+ + GK+P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 5e-22
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 243 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG-- 298
IG+G++G VY + K G+ VA+KIM D ++ E +L + +H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 299 ----YCEEEHQRILVYEYMHNGTLRD---RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
+ Q LV E G++ D L + +W+ I + +GL YLH
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA--YILRETLRGLAYLH 130
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLD 406
+IHRD+K NILL N K+ DFG+S Q + S++ R GT ++
Sbjct: 131 ---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD------STLGRRNTFIGTPYWMA 181
Query: 407 PE-----YYGNQQLTEKSDVYSFGVVLLELISGKKPVS 439
PE + +SDV+S G+ +EL GK P+
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 7e-22
Identities = 65/205 (31%), Positives = 114/205 (55%), Gaps = 15/205 (7%)
Query: 243 IGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLI 297
IG G FG V G++K GK VA+K + + + ++ F++E +++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
G + +++ E+M NG L L + Q + L + + A G++YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL--VGMLRGIAAGMKYL---SEMN 126
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVA-RGTVGYLDPEYYGNQ 413
+HRD+ + NIL++ N+ KVSDFGLSR E+ D T+ SS+ + + + PE +
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186
Query: 414 QLTEKSDVYSFGVVLLELIS-GKKP 437
+ T SDV+S+G+V+ E++S G++P
Sbjct: 187 KFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 242 KIGKGSFGSVYYGKM------KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 295
++G+G+FG V+ + +D VAVK + ++ Q F E LL+ + H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKPLDWLTRLQIAHDA 343
G C E ++V+EYM +G L R HG V L L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 402
A G+ YL + +HRD+ + N L+ + K+ DFG+SR D + +
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 403 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
++ PE ++ T +SD++SFGVVL E+ + GK+P
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 238 NFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 296
NF KIG+GS G V G++VAVK M R + EV ++ H N+V +
Sbjct: 23 NF-VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEM 81
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 352
+ +V E++ G L D + H +N++ QIA K L +LH
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE--------QIATVCLAVLKALSFLHA 133
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
G+IHRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE
Sbjct: 134 ---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISR 189
Query: 413 QQLTEKSDVYSFGVVLLELISGKKP 437
+ D++S G++++E++ G+ P
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 77/235 (32%), Positives = 115/235 (48%), Gaps = 19/235 (8%)
Query: 211 SIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMAD 269
S +R G D +A + E+ + ++IG GSFG+VY+ + ++ + VA+K M+
Sbjct: 2 STSRAGSLKDPEIAELFFKEDPEKLFTDL-REIGHGSFGAVYFARDVRTNEVVAIKKMSY 60
Query: 270 SCSHRT---QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV 326
S Q + EV L RI H N + G EH LV EY G+ D L V
Sbjct: 61 SGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLE--V 117
Query: 327 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386
++KPL + I H A +GL YLH+ +IHRD+K+ NILL + K++DFG +
Sbjct: 118 HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI 174
Query: 387 AEEDLTHISSVARGTVGYLDPEY---YGNQQLTEKSDVYSFGVVLLELISGKKPV 438
A + + GT ++ PE Q K DV+S G+ +EL K P+
Sbjct: 175 ASPANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 1e-21
Identities = 67/229 (29%), Positives = 115/229 (50%), Gaps = 25/229 (10%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGK-----MKDGKEVAVKIMAD-SCSHRTQQFVTEVAL 284
EL + F +++G+ +FG +Y G M + VA+K + D + + +F E +L
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 285 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVN---------QKP 330
++ +HH N+V L+G +E +++EY++ G L + L H V +
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 331 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EE 389
LD L IA A G+EYL + +H+D+ + NIL+ + K+SD GLSR+
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 390 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
D + + + ++ PE + + SD++SFGVVL E+ S G +P
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 240 CKKIGKGSFGSVYYGKMKD-GKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 297
+ IGKGSFG VY K + VA+K++ + + E+ LS+ +
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
G + + ++ EY G+ D L LD I + GLEYLH G
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLH---EEG 118
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGNQQ 414
IHRD+K++NILL K++DFG+S Q LT S VG ++ PE
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSGQ----LTSTMSKRNTFVGTPFWMAPEVIKQSG 174
Query: 415 LTEKSDVYSFGVVLLELISGKKPVS 439
EK+D++S G+ +EL G+ P+S
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLS 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 2e-21
Identities = 66/223 (29%), Positives = 111/223 (49%), Gaps = 33/223 (14%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ----FVTEVALLSRIHHRNLVP 295
KK+GKGS+GSVY K + D + A+K + +Q+ V E+ +L+ ++H N+
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEV--DLGSMSQKEREDAVNEIRILASVNHPNI-- 61
Query: 296 LIGYCE---EEHQRILVYEYMHNGTLRDRLHGSVNQKPL-----DWLTRLQIAHDAAKGL 347
I Y E + ++ +V EY G L + ++ L W +Q+ +GL
Sbjct: 62 -ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL----RGL 116
Query: 348 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL--THISSVARGTVGYL 405
+ LH I+HRD+KS+NILL N K+ D G+S+ ++++ T I GT Y+
Sbjct: 117 QALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYM 168
Query: 406 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 448
PE + + + KSD++S G +L E+ + P +L
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-QDLR 210
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 243 IGKGSFGS-VYYGKMKDGKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLIGY 299
+GKG+FG Y + +D V K + S + ++ E+ +LS + H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH--DAAKGLEYLHTGCNPG 357
+++ ++ EY + GTL D++ V QK + + + + + Y+H G
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKI---VRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---G 121
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
I+HRD+K+ NI L K+ DFG+S+ + + +V GT Y+ PE +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYNF 180
Query: 418 KSDVYSFGVVLLELISGKK 436
KSD+++ G VL EL++ K+
Sbjct: 181 KSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 7/198 (3%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 300
KK+G G FG V+ G +VAVK + + + F+ E ++ ++ H LV L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPG-TMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 301 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 360
EE I V EYM G+L D L + L + +A A G+ Y+ IH
Sbjct: 71 SEEPIYI-VTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125
Query: 361 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 420
RD++S+NIL+ + K++DFGL+R E++ A+ + + PE + T KSD
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 421 VYSFGVVLLELIS-GKKP 437
V+SFG++L EL++ G+ P
Sbjct: 186 VWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 2e-21
Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 301
K+G+G FG V+ G VA+K + + + F+ E ++ ++ H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 302 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 361
EE I V EYM G+L D L G + K L + +A A G+ Y+ +HR
Sbjct: 72 EEPIYI-VTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 362 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 421
D++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T KSDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 422 YSFGVVLLELIS-GKKP 437
+SFG++L EL + G+ P
Sbjct: 187 WSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 75/224 (33%), Positives = 111/224 (49%), Gaps = 27/224 (12%)
Query: 230 PELEEATNNFCKKIGKGSFGSVYYGKM-KDG--KEVAVKIMADSCS---HRTQQFVTEVA 283
P LE F IG+G+FG V ++ KDG + A+K M + S HR F E+
Sbjct: 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELE 59
Query: 284 LLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS----------VNQKPLD 332
+L ++ HH N++ L+G CE L EY +G L D L S +
Sbjct: 60 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119
Query: 333 WLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389
L+ Q+ H D A+G++YL IHRD+ + NIL+ N AK++DFGLSR E
Sbjct: 120 TLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176
Query: 390 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 433
+ ++ R V ++ E T SDV+S+GV+L E++S
Sbjct: 177 YVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-21
Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 301
K+G+G FG V+ G +VA+K + + + F+ E ++ ++ H LVPL
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 302 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 361
EE I V E+M G+L D L + K L + +A A G+ Y+ IHR
Sbjct: 72 EEPIYI-VTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 362 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDV 421
D++++NIL+ N+ K++DFGL+R E++ A+ + + PE + T KSDV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 422 YSFGVVLLELIS-GKKP 437
+SFG++L EL++ G+ P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 22/219 (10%)
Query: 242 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ-----QFVTEVALLSRIHHRNLVP 295
+IG+G+ G V+ K + G+ VA+K + R + Q + E+ L H +V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKV---ALRRLEGGIPNQALREIKALQACQHPYVVK 63
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEYLHT 352
L+ +LV EYM L + L ++PL Q+ KG+ Y+H
Sbjct: 64 LLDVFPHGSGFVLVMEYM-PSDLSEVLRDE--ERPL---PEAQVKSYMRMLLKGVAYMH- 116
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 411
GI+HRD+K +N+L+ + K++DFGL+R E+ + S T Y PE YG
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 450
++ D+++ G + EL++G E+ +L IV
Sbjct: 175 ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIV 213
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 27/211 (12%)
Query: 243 IGKGSFGSVYYGKMK-DGKEV--AVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLI 297
IG+G+FG V +K DG ++ A+K++ + S + F E+ +L ++ HH N++ L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 298 GYCEEEHQRILVYEYMHNGTLRD---------------RLHGSVNQKPLDWLTRLQIAHD 342
G CE + EY G L D + HG+ + L LQ A D
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST--LTSQQLLQFASD 127
Query: 343 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 402
A G++YL IHRD+ + N+L+ N+ +K++DFGLSR E++ ++ R V
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG--EEVYVKKTMGRLPV 182
Query: 403 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 433
++ E T KSDV+SFGV+L E++S
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 69/232 (29%), Positives = 113/232 (48%), Gaps = 33/232 (14%)
Query: 228 PLPELEEATNNFCKKIGKGSFGSVYYG------KMKDGKEVAVKIM-ADSCSHRTQQFVT 280
P EL K +G+G+FG V + VAVK++ D+ V+
Sbjct: 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVS 64
Query: 281 EVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQK-------- 329
E+ ++ I H+N++ L+G C +E +V EY +G LRD R +
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 330 PLDWLTR---LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386
P + LT+ + A+ A+G+E+L + IHRD+ + N+L+ + K++DFGL+R
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR- 180
Query: 387 AEEDLTHISSVARGTVGYLD-----PEYYGNQQLTEKSDVYSFGVVLLELIS 433
D+ HI + T G L PE ++ T +SDV+SFGV+L E+ +
Sbjct: 181 ---DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 7e-21
Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 19/213 (8%)
Query: 241 KKIGKGSFGSVYYGKMKDGK---EVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVP 295
K +G+G FGSV G++ +VAVK M + R++ F++E + H N++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 296 LIGYCEEEHQR------ILVYEYMHNGTLRD-RLHGSVNQKPLDWLTRL--QIAHDAAKG 346
LIG C + + +++ +M +G L L+ + P T++ + D A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYL 405
+EYL + IHRD+ + N +L+ NM V+DFGLS++ D +A+ V ++
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 406 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
E ++ T KSDV+SFGV + E+ + G+ P
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 1e-20
Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 243 IGKGSFGSVYYGKMK-DGKEV--AVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLI 297
IG+G+FG V ++K DG + A+K M + S + F E+ +L ++ HH N++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 298 GYCEEEHQRILVYEYMHNGTLRD---------------RLHGSVNQKPLDWLTRLQIAHD 342
G CE L EY +G L D + + + L L A D
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST--LSSQQLLHFAAD 120
Query: 343 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 402
A+G++YL IHRD+ + NIL+ N AK++DFGLSR +++ ++ R V
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLPV 175
Query: 403 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 433
++ E T SDV+S+GV+L E++S
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 60/213 (28%), Positives = 105/213 (49%), Gaps = 21/213 (9%)
Query: 243 IGKGSFGSVYYGKMKDGKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHHRNLVPL 296
+GKG++G+VY G G+ +AVK + + ++ EV LL + H N+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
+G C +++ + E++ G++ L+ G + + T+ QI G+ YLH C
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QIL----DGVAYLHNNC 122
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTH--ISSVARGTVGYLDPEY 409
++HRD+K +N++L N K+ DFG +R+ TH + GT ++ PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
KSD++S G + E+ +GK P++ D
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 70/208 (33%), Positives = 105/208 (50%), Gaps = 24/208 (11%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 296
++IG GSFG+VY+ + +++ + VA+K M+ S + + Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
G EH LV EY G+ D L V++KPL + + H A +GL YLH +
Sbjct: 81 RGCYLREHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEY---Y 410
+IHRDVK+ NILL K+ DFG + I + A VG ++ PE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSAS--------IMAPANXFVGTPYWMAPEVILAM 186
Query: 411 GNQQLTEKSDVYSFGVVLLELISGKKPV 438
Q K DV+S G+ +EL K P+
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 60/197 (30%), Positives = 102/197 (51%), Gaps = 9/197 (4%)
Query: 242 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 300
KIG+GS G V + K G++VAVK+M R + EV ++ H+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 301 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 360
+ ++ E++ G L D V+Q L+ + + L YLH+ G+IH
Sbjct: 88 LVGEELWVLMEFLQGGALTD----IVSQTRLNEEQIATVCESVLQALCYLHS---QGVIH 140
Query: 361 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 420
RD+KS +ILL ++ R K+SDFG Q +D+ S+ GT ++ PE + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVD 199
Query: 421 VYSFGVVLLELISGKKP 437
++S G++++E++ G+ P
Sbjct: 200 IWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 70/204 (34%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 242 KIGKGSFGSVYYGKMKDGKE-VAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLI 297
+IG GSFG+VY+ E VAVK M+ S + + Q + EV L ++ H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
G +EH LV EY G+ D L V++KPL + I H A +GL YLH+
Sbjct: 88 GCYLKEHTAWLVMEYCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY---YGNQQ 414
+IHRD+K+ NILL + K++DFG + ++ + + GT ++ PE Q
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196
Query: 415 LTEKSDVYSFGVVLLELISGKKPV 438
K DV+S G+ +EL K P+
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 65/206 (31%), Positives = 105/206 (50%), Gaps = 17/206 (8%)
Query: 239 FCKKIGKGSFGSVY----YGKMKDGK--EVAVKIMADSCSHRT--QQFVTEVALLSRI-H 289
F K +G G+FG V YG K +VAVK M +H + + ++E+ ++S + +
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVK-MLKPTAHSSEREALMSELKIMSHLGN 97
Query: 290 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 349
H N+V L+G C +++ EY G L + L + L L ++ AKG+ +
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLR-RKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 350 LHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDP 407
L + C IHRD+ + N+LL K+ DFGL+R D ++ AR V ++ P
Sbjct: 157 LASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212
Query: 408 EYYGNQQLTEKSDVYSFGVVLLELIS 433
E N T +SDV+S+G++L E+ S
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-20
Identities = 68/276 (24%), Positives = 126/276 (45%), Gaps = 31/276 (11%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQ------FVTEVALLSRIHHRNL 293
+++G G+F S Y + +K G +AVK + + ++Q E+ L++R++H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 294 VPLIG-YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
+ ++G CE+ H + V E+M G++ L + +GL YLH
Sbjct: 66 IRMLGATCEDSHFNLFV-EWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLH- 120
Query: 353 GCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLT---HISSVARGTVGYLDPE 408
IIHRDVK +N+L+D R +++DFG + + T GT+ ++ PE
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468
+Q DV+S G V++E+ + K P + E L ++ S + + P
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238
Query: 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 504
L +V ++C+E + RP +E++
Sbjct: 239 GL------------RDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 66/214 (30%), Positives = 110/214 (51%), Gaps = 20/214 (9%)
Query: 241 KKIGKGSFGSVYYGKMK----DGKEVAVKIM-AD-SCSHRTQQFVTEVALLSRIHHRNLV 294
+ +GKG FGSV ++K ++VAVK++ AD S ++F+ E A + H N++
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 295 PLIGYC--EEEHQRI----LVYEYMHNGTLRDRLHGS-VNQKP--LDWLTRLQIAHDAAK 345
LIG R+ ++ +M +G L L S + ++P L T ++ D A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 346 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVARGTVGY 404
G+EYL + IHRD+ + N +L+ NM V+DFGLS++ D ++ V +
Sbjct: 125 GMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 405 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
L E + T SDV++FGV + E+++ G+ P
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 9/209 (4%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH 290
E+ + KK+G G FG V+ +VAVK M S + F+ E ++ + H
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQH 60
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEY 349
LV L +E I+ E+M G+L D L +++PL L + + A+G+ +
Sbjct: 61 DKLVKLHAVVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAEGMAF 117
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
+ IHRD++++NIL+ ++ K++DFGL+R E++ A+ + + PE
Sbjct: 118 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 174
Query: 410 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
T KSDV+SFG++L+E+++ G+ P
Sbjct: 175 INFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 242 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 300
KIG+GS G V K GK+VAVK M R + EV ++ HH N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 301 EEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
+ +V E++ G L D + H +N++ + + + L YLH N G+I
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLH---NQGVI 140
Query: 360 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 419
HRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 420 DVYSFGVVLLELISGKKP 437
D++S G++++E+I G+ P
Sbjct: 200 DIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 18/208 (8%)
Query: 241 KKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNL 293
+++G+GSFG VY G K VA+K + ++ S R + +F+ E +++ + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----SVNQKPLDWLTR---LQIAHDAAKG 346
V L+G ++V E M G L+ L + N L T +Q+A + A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYL 405
+ YL +HRD+ + N ++ ++ K+ DFG++R E D V ++
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 406 DPEYYGNQQLTEKSDVYSFGVVLLELIS 433
PE + T KSDV+SFGVVL E+ +
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 67/211 (31%), Positives = 92/211 (43%), Gaps = 26/211 (12%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR-----NLV 294
K I KG+FGSVY K + G A+K++ S Q VT V I +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVA 60
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYL 350
L + + LV EY++ G S+ + P DW Q + G+E L
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDC-----ASLIKTLGGLPEDWAK--QYIAEVVLGVEDL 113
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410
H GIIHRD+K N+L+D K++DFGLSR E+ + GT YL PE
Sbjct: 114 H---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-----GTPDYLAPETI 165
Query: 411 GNQQLTEKSDVYSFGVVLLELISGKKPVSVE 441
+ SD +S G V+ E + G P E
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 240 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMA---------DSCSHRTQQFVTEVALLSRIH 289
+K+G+G++G VY + K G+ VA+K + + + E++LL +
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA-------LREISLLKELK 56
Query: 290 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 349
H N+V L+ E + LV+EY L+ L PL I + +GL Y
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLD--KRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 408
H+ I+HRD+K NIL++ + K++DFGL+R L T+ V T+ Y PE
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPE 168
Query: 409 -YYGNQQLTEKSDVYSFGVVLLELISGK 435
G++ + D++S G + E+I+GK
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-19
Identities = 67/209 (32%), Positives = 102/209 (48%), Gaps = 22/209 (10%)
Query: 239 FCKKI---GKGSFGSVY---YGKMKD--GKEVAVKIMADSCSHR-TQQFVTEVALLSRIH 289
+ KKI G+G FG V Y D G+ VAVK + C + T + E+ +L ++
Sbjct: 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64
Query: 290 HRNLVPLIGYCEEEHQRI--LVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKG 346
H N+V G C E+ + L+ EY+ G+LRD L +N L L A +G
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEG 119
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGY 404
+ YLH+ IHRD+ + N+LLD + K+ DFGL++ E + + V +
Sbjct: 120 MAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 176
Query: 405 LDPEYYGNQQLTEKSDVYSFGVVLLELIS 433
E + + SDV+SFGV L EL++
Sbjct: 177 YAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 62/222 (27%), Positives = 109/222 (49%), Gaps = 28/222 (12%)
Query: 241 KKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRT-QQFVTEVALLSRI-HH 290
K +G+G FG V K K+ VAVK++ D + + V+E+ ++ I H
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRL 337
+N++ L+G C ++ ++ EY G LR+ L V + + + +
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 338 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISS 396
+ A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D ++
Sbjct: 141 SCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTT 197
Query: 397 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
R V ++ PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 198 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 21/204 (10%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQF----VTEVALLSRIHHRNLVP 295
KIG+G++G VY + K E VA+K + ++ + E+ LL ++H N++
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKI--KLRFESEGIPKTALREIKLLKELNHPNIIK 62
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
L+ + LV+E+M L + Q+ L + +GL + H+
Sbjct: 63 LLDVFRHKGDLYLVFEFMDT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSH-- 117
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHISSVARGTVGYLDPE-YYG 411
GI+HRD+K N+L++ K++DFGL+R TH T Y PE G
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV----TRWYRAPELLLG 172
Query: 412 NQQLTEKSDVYSFGVVLLELISGK 435
++ + D++S G + EL+S +
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 63/227 (27%), Positives = 112/227 (49%), Gaps = 33/227 (14%)
Query: 241 KKIGKGSFGSVYYGKMKDGK------EVAVKIMAD-SCSHRTQQFVTEVALLSRIHHRNL 293
K +G+G FG V K VAVK++ + + S + ++E LL +++H ++
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------------GSVN--------QKPLD 332
+ L G C ++ +L+ EY G+LR L G+ N ++ L
Sbjct: 66 IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125
Query: 333 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392
+ A ++G++YL ++HRD+ + N+L+ + K+SDFGLSR E+ +
Sbjct: 126 MGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 393 HIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
++ S R V ++ E + T +SDV+SFGV+L E+++ G P
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 66/254 (25%), Positives = 105/254 (41%), Gaps = 41/254 (16%)
Query: 237 NNFC--KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHH 290
++F K IG+G+FG V+ + KD +V A+K++ S + Q E +L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
+V L ++E LV EYM G L L + P + R IA + L+ +
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEET-ARFYIA-ELVLALDSV 117
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS-------------------------- 384
H G IHRD+K NIL+D + K++DFGL
Sbjct: 118 H---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 385 --RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
R+ + ++ GT Y+ PE + D +S GV+L E++ G P +
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234
Query: 443 -FGAELNIVHWARS 455
I++W S
Sbjct: 235 LQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 240 CKKIGKGSFGSVY----YGKMKDGKE--VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRN 292
+++G+GSFG VY G +KD E VA+K + ++ S R + +F+ E +++ + +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 293 LVPLIGYCEEEHQRILVYEYMHNG-------TLRDRLHGSVNQKPLDWLTRLQIAHDAAK 345
+V L+G + +++ E M G +LR + + Q P +Q+A + A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 346 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGY 404
G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 405 LDPEYYGNQQLTEKSDVYSFGVVLLEL 431
+ PE + T SDV+SFGVVL E+
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 64/218 (29%), Positives = 113/218 (51%), Gaps = 29/218 (13%)
Query: 241 KKIGKGSFGSVY----YGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRI-HH 290
K +G+G FG V YG K + VAVK++ D+ + + ++E+ L+ I H
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTRL 337
+N++ L+G C +E ++ EY G LR+ L V ++ L + +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 338 QIAHDAAKGLEYLHTG-CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHIS 395
A+ A+G+EYL + C IHRD+ + N+L+ + K++DFGL+R + D +
Sbjct: 138 SCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 433
S R V ++ PE ++ T +SDV+SFG+++ E+ +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 68/223 (30%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 238 NFCKKIGKGSFGSVYYGKM--------KDGKE---------VAVKIM-ADSCSHRTQQFV 279
NF +K+G+G FG V+ + K E VAVK++ D+ + + F+
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL 67
Query: 280 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPL 331
EV +LSR+ N+ L+G C + ++ EYM NG L L V N K L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 332 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EED 390
+ T L +A A G+ YL + +HRD+ + N L+ N K++DFG+SR D
Sbjct: 128 SFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184
Query: 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 433
+ A + ++ E + T KSDV++FGV L E+++
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 7e-19
Identities = 67/210 (31%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 294
K +G+G+FG VY D G+E+AVK + D S T + V E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 295 PLIGYCEEEHQRIL--VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
G + +R L E+M G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-QIL----EGVSYL 122
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 407
H+ I+HRD+K +NIL D K+ DFG S++ + T + SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT-GTPYWMSP 178
Query: 408 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
E + K+D++S G ++E+++ K P
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 7e-19
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 15/205 (7%)
Query: 241 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 295
++G G+FG+V Y K K VAVKI+ + + + + E ++ ++ + +V
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
+IG CE E +LV E G L L + + + +T L H + G++YL
Sbjct: 61 MIGICEAESW-MLVMELAELGPLNKFLQKNKHVTEKN-ITEL--VHQVSMGMKYLE---E 113
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT--VGYLDPEYYGNQ 413
+HRD+ + N+LL AK+SDFGLS+ D + + G V + PE
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 414 QLTEKSDVYSFGVVLLELIS-GKKP 437
+ + KSDV+SFGV++ E S G+KP
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 21/208 (10%)
Query: 246 GSFGSVYYGKMKDGK-----EVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGY 299
G+FG ++YG + D K EV VK + D S + + E LL + H+N++P++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 300 CEEEHQRILV-YEYMHNGTLRDRL----HGSVNQKPLDWLTRLQIAHDA---AKGLEYLH 351
C E+ + V Y YM+ G L+ L G N L+ Q+ H A A G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA--LSTQQLVHMAIQIACGMSYLH 134
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYY 410
G+IH+D+ + N ++D ++ K++D LSR H + V ++ E
Sbjct: 135 ---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191
Query: 411 GNQQLTEKSDVYSFGVVLLELIS-GKKP 437
N++ + SDV+SFGV+L EL++ G+ P
Sbjct: 192 VNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 9e-19
Identities = 68/210 (32%), Positives = 109/210 (51%), Gaps = 22/210 (10%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 294
K +G+G+FG VY D G+E+AVK + D S T + V E+ LL + H +V
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 295 PLIGYCEEEHQRIL--VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
G + ++ L EYM G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR-QIL----QGVSYL 122
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 407
H+ I+HRD+K +NIL D K+ DFG S++ + T I SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT-GTPYWMSP 178
Query: 408 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
E + K+DV+S ++E+++ K P
Sbjct: 179 EVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 241 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+KIG+G+ G+VY + G+EVA+K M + + + E+ ++ H N+V +
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
+ +V EY+ G+L D V + +D + + + LE+LH+ +I
Sbjct: 85 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 360 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 419
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 420 DVYSFGVVLLELISGKKP 437
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 242 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 300
KIG+GS G V +K GK VAVK M R + EV ++ H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 301 EEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
+ +V E++ G L D + H +N++ + + K L LH G+I
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA---QGVI 138
Query: 360 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 419
HRD+KS +ILL + R K+SDFG Q +++ S+ GT ++ PE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEV 197
Query: 420 DVYSFGVVLLELISGKKP 437
D++S G++++E++ G+ P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-18
Identities = 68/210 (32%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVT----EVALLSRIHHRNLV 294
K +G+G+FG VY D G+E+A K + D S T + V+ E+ LL + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 295 PLIGYCEEEHQRILV--YEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
G + ++ L EYM G+++D+L +G++ + TR QI +G+ YL
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR-QIL----EGMSYL 122
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE---DLTHISSVARGTVGYLDP 407
H+ I+HRD+K +NIL D K+ DFG S++ + T I SV GT ++ P
Sbjct: 123 HSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT-GTPYWMSP 178
Query: 408 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
E + K+DV+S G ++E+++ K P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-18
Identities = 67/214 (31%), Positives = 105/214 (49%), Gaps = 22/214 (10%)
Query: 243 IGKGSFGSVYYGKMKD----GKE---VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLV 294
+G G+FG VY G D G VAVK + + + + +F+ E L+S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK---PLDWLTRL-QIAHDAAKGLEYL 350
L+G C + ++ E M G L L + ++ PL L L I D AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 351 HTGCNPGIIHRDVKSSNILL-----DINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGY 404
IHRD+ + N L+ D + K+ DFGL+R + D V +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 405 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ PE + + T +SDV+SFGV++ E+++ G++P
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 67/206 (32%), Positives = 102/206 (49%), Gaps = 24/206 (11%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLI 297
KKIG+GSFG K K DGK+ +K + S ++ EVA+LS + H N+V
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGS-----VNQKPLDWLTRLQIAHDAAKGLEYLHT 352
EE +V +Y G L +++ + LDW ++ +A L+++H
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVH- 118
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEY 409
+ I+HRD+KS NI L + K+ DFG++R L +AR GT YL PE
Sbjct: 119 --DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV----LNSTVELARTCIGTPYYLSPEI 172
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGK 435
N+ KSD+++ G VL E+ + K
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 243 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 301
+GKG++G VY + + +A+K + + S Q E+AL S + HRN+V +G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 302 EEHQRILVYEYMHNGTLRDRLHG-----SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
E + E + G+L L N++ + + T+ QI +GL+YLH +
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-QI----LEGLKYLH---DN 127
Query: 357 GIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY--YGNQ 413
I+HRD+K N+L++ + K+SDFG S++ + + GT+ Y+ PE G +
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 414 QLTEKSDVYSFGVVLLELISGKKP 437
+D++S G ++E+ +GK P
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 243 IGKGSFGSVYYGK-MKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY- 299
IG+G++G+VY GK + G+ VA+KI+ D+ EVALLS++ + Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 300 -CEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
+ R+ ++ EY G++R + P+ I + L+Y+H G
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---G 121
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQQLT 416
+IHRD+K++NIL+ K+ DFG++ ++ + S+ GT ++ PE +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYD 180
Query: 417 EKSDVYSFGVVLLELISGKKPVSVED 442
K+D++S G+ + E+ +G P S D
Sbjct: 181 TKADIWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-18
Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 21/194 (10%)
Query: 259 GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL-VYEYMH 314
G EVA+K++ H+ +F E AL +R++H N+V L+ E + V+EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---D 371
TLR+ L L ++ L H N GI+HRD+K NI++
Sbjct: 63 GRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116
Query: 372 INMRAKVSDFGLS-------RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF 424
+ AKV DFG+ LT + V GT Y PE + +T SD+Y++
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL-GTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 425 GVVLLELISGKKPV 438
G++ LE ++G++ V
Sbjct: 176 GLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 238 NFCKKIGKGSFGS--VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP 295
N + +G+GSFG + D K +I S + E LL+++ H N+V
Sbjct: 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVA 62
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRL---HGSV--NQKPLDWLTRLQIAHDAAKGLEYL 350
E + +V EY G L ++ G + L W ++ + G++++
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHI 116
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDP 407
H ++HRD+KS NI L N + K+ DFG +R LT + A VG Y+ P
Sbjct: 117 H---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL----LTSPGAYACTYVGTPYYVPP 169
Query: 408 EYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
E + N KSD++S G +L EL + K P
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-17
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLI 297
+ +G+G+FG V+ + K D K V +K I + + + E +L + H N+ I
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI---I 62
Query: 298 GYCE---EEHQRILVYEYMHNGTLRDRLHGSVN-----QKPLDWLTRLQIAHDAAKGLEY 349
Y E E+ ++V EY GTL + + N L + ++ +A L +
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------LHH 116
Query: 350 LHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 408
+HT I+HRD+K+ NILLD + M K+ DFG+S+ + V GT Y+ PE
Sbjct: 117 VHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--GTPCYISPE 171
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 445
+ +KSD+++ G VL EL S K+ + A
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 67/235 (28%), Positives = 114/235 (48%), Gaps = 28/235 (11%)
Query: 228 PLPELEEATNNFCKKIGKGSFGSVYYG------KMKDGK--EVAVKIMADSCSHRT-QQF 278
P EL K +G+G FG V K K K VAVK++ D + +
Sbjct: 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL 64
Query: 279 VTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG------------- 324
V+E+ ++ I H+N++ L+G C ++ ++ EY G LR+ L
Sbjct: 65 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 325 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 384
+ ++ L + + A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 385 RQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
R D ++ R V ++ PE ++ T +SDV+SFGV+L E+ + G P
Sbjct: 182 RDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 64/220 (29%), Positives = 114/220 (51%), Gaps = 13/220 (5%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEV----AVKIMADSCSHRTQQFVT--EVALLSRIHHRNLV 294
K +G+GSFG V+ + G + A+K++ + + T E +L+ ++H +V
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
L + E + L+ +++ G L RL V D + +A + A L++LH+
Sbjct: 62 KLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED--VKFYLA-ELALALDHLHS-- 116
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 414
GII+RD+K NILLD K++DFGLS+++ + S GTV Y+ PE +
Sbjct: 117 -LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNRRG 174
Query: 415 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 454
T+ +D +SFGV++ E+++G P +D + ++ A+
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK 214
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 31/230 (13%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKE---------------VAVKIM-ADSCSHRTQQFVTEV 282
+K+G+G FG V+ + + E VAVK++ AD F+ E+
Sbjct: 9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEI 68
Query: 283 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL---------RDRLHGSVNQKPLDW 333
++SR+ + N++ L+G C + ++ EYM NG L + N +
Sbjct: 69 KIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 334 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLT 392
L +A A G++YL + +HRD+ + N L+ + K++DFG+SR D
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY 185
Query: 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSV 440
I A + ++ E + T SDV++FGV L E+ + ++P S+
Sbjct: 186 RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 70/210 (33%), Positives = 112/210 (53%), Gaps = 27/210 (12%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRT--QQFVTEVALLSRI-HHRNLVPL 296
+K+GKG++G V+ + KE VA+K + D+ + T Q+ E+ L + H N+V L
Sbjct: 13 QKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 297 IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
+ + E+ + LV+EYM D LH + L+ + + I + K L+Y+H+G
Sbjct: 73 LNVIKAENDKDIYLVFEYMET----D-LHAVIRANILEDVHKRYIMYQLLKALKYIHSG- 126
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR--------QAEEDLTHISSVARGTVGYLD 406
+IHRD+K SNILL+ + R K++DFGL+R LT VA T Y
Sbjct: 127 --NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDY--VA--TRWYRA 180
Query: 407 PE-YYGNQQLTEKSDVYSFGVVLLELISGK 435
PE G+ + T+ D++S G +L E++ GK
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 69/235 (29%), Positives = 119/235 (50%), Gaps = 39/235 (16%)
Query: 241 KKIGKGSFGSVYYG------KMKDGK--EVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 290
K +G+G FG V K K + +VAVK++ +D+ ++E+ ++ I H
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 83
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----------SVNQKPLDWLTR---L 337
+N++ L+G C ++ ++ EY G LR+ L + Q P + L+ +
Sbjct: 84 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143
Query: 338 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 397
A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R D+ HI
Sbjct: 144 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 196
Query: 398 ARGTVG-----YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP---VSVEDF 443
+ T G ++ PE ++ T +SDV+SFGV+L E+ + G P V VE+
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 2e-17
Identities = 58/203 (28%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 242 KIGKGSFGSVYYG--KMKDGK-EVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLI 297
++G G+FG V G KM+ + +VA+K++ + + + E ++ ++ + +V +I
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
G CE E +LV E G L L G ++ + + L H + G++YL
Sbjct: 62 GVCEAE-ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELM--HQVSMGMKYLE---GKN 115
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQQL 415
+HRD+ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 416 TEKSDVYSFGVVLLELIS-GKKP 437
+ +SDV+S+G+ + E S G+KP
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 60/218 (27%), Positives = 100/218 (45%), Gaps = 46/218 (21%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVK-I------MADSCSHRTQQFVTEVALLSRIHHRN 292
KK+G+G++ VY + K G+ VA+K I A + T + E+ LL + H N
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTA--LREIKLLQELKHPN 63
Query: 293 LVPLIG-YCEEEHQRI-LVYEYMHN---GTLRDRLHGSVNQKPLDWLTRLQIAHDAA--- 344
++ L+ + + I LV+E+M ++D+ L A +
Sbjct: 64 IIGLLDVFGHK--SNINLVFEFMETDLEKVIKDKS------------IVLTPADIKSYML 109
Query: 345 ---KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVA 398
+GLEYLH + I+HRD+K +N+L+ + K++DFGL+R +TH V
Sbjct: 110 MTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH--QVV 164
Query: 399 RGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 435
T Y PE +G + D++S G + EL+
Sbjct: 165 --TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.1 bits (202), Expect = 4e-17
Identities = 55/198 (27%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 241 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+KIG+G+ G+VY + G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
+ +V EY+ G+L D V + +D + + + LE+LH+ +I
Sbjct: 86 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 360 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 419
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 420 DVYSFGVVLLELISGKKP 437
D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 242 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS----HRTQQFVTEVALLSRIHHRNLVPL 296
+G+G++G V + K G+ VA+K +S +T + EV +L ++ H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA--LREVKVLRQLRHENIVNL 65
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+ + LV+EY+ TL + L S P D R I + + Y H+
Sbjct: 66 KEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPD-AVRSYI-WQLLQAIAYCHSH--- 119
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQ----AEEDLTHISSVARGTVGYLDPEYY-G 411
IIHRD+K NIL+ + K+ DFG +R LT VA T Y PE G
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT--DYVA--TRWYRAPELLVG 175
Query: 412 NQQLTEKSDVYSFGVVLLELISG 434
+ + DV++ G ++ EL+ G
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 62/213 (29%), Positives = 95/213 (44%), Gaps = 19/213 (8%)
Query: 236 TNNFC--KKIGKGSFGSVYYGKMK-DGKEVA---VKIMADSCSHRTQQFVTEVALLSRIH 289
NF KKIGKG F VY DG+ VA V+I + Q + E+ LL ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 290 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL-----DWLTRLQIAHDAA 344
H N++ + E ++ +V E G L + QK L W +Q+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116
Query: 345 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 404
LE++H+ I+HRD+K +N+ + K+ D GL R T S+ GT Y
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172
Query: 405 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ PE KSD++S G +L E+ + + P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 4e-17
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+G G+ GSV K + G +A K + + S +Q + E+ ++ +V G
Sbjct: 11 SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
E+ + E+M G+L DR++ P++ L + IA +GL YL+ I
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--I 125
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQL 415
+HRD+K SNIL++ + K+ DFG+S + I+S+A GT Y+ PE +
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGEL------INSIADTFVGTSTYMSPERIQGGKY 179
Query: 416 TEKSDVYSFGVVLLELISGKKPVS 439
T KSDV+S G+ ++EL GK P +
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 4e-17
Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 12/202 (5%)
Query: 241 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+KIGKGSFG V+ G + K VA+KI+ + + E+ +LS+ + G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
++ + ++ EY+ G+ D L PLD I + KGL+YLH+
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEKK--- 122
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVARGTVGYLDPEYYGNQQLTE 417
IHRD+K++N+LL + K++DFG++ Q + T I + GT ++ PE
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 418 KSDVYSFGVVLLELISGKKPVS 439
K+D++S G+ +EL G+ P S
Sbjct: 181 KADIWSLGITAIELAKGEPPHS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 5e-17
Identities = 54/198 (27%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 241 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+KIG+G+ G+VY + G+EVA+K M + + + E+ ++ + N+V +
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
+ +V EY+ G+L D V + +D + + + L++LH+ +I
Sbjct: 85 YLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVCRECLQALDFLHSN---QVI 137
Query: 360 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 419
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 420 DVYSFGVVLLELISGKKP 437
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 6e-17
Identities = 52/198 (26%), Positives = 103/198 (52%), Gaps = 9/198 (4%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+KIG+G+ G+V+ + G+EVA+K + + + + E+ ++ + + N+V +
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
+ +V EY+ G+L D V + +D + + + LE+LH +I
Sbjct: 85 FLVGDELFVVMEYLAGGSLTD----VVTETCMDEAQIAAVCRECLQALEFLHAN---QVI 137
Query: 360 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 419
HRD+KS N+LL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 196
Query: 420 DVYSFGVVLLELISGKKP 437
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 54/199 (27%), Positives = 91/199 (45%), Gaps = 10/199 (5%)
Query: 243 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVPLIG 298
+GKG FG V ++K GK A K + + + + E +L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
E + LV M+ G L+ ++ +V + + A GLE+LH I
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIY-NVGEPGFPEARAIFYAAQIICGLEHLH---QRRI 116
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
++RD+K N+LLD + ++SD GL+ + + GT GY+ PE +
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA--GTPGYMAPEVLQGEVYDFS 174
Query: 419 SDVYSFGVVLLELISGKKP 437
D ++ G L E+I+G+ P
Sbjct: 175 VDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 7e-17
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 32/213 (15%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 297
K IG G++G V K G++VA+K +++ ++ + E+ LL + H N++ L+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 298 -----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEY 349
E+ + +V E M D LH V + P LT I + +GL+Y
Sbjct: 66 DILRPPSPEDFNDVYIVTELMET----D-LH-KVIKSPQP-LTDDHIQYFLYQILRGLKY 118
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
LH+ +IHRD+K SNIL++ N K+ DFGL+R + D Y+ +
Sbjct: 119 LHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE----KGFLTEYVVTRW 171
Query: 410 Y-------GNQQLTEKSDVYSFGVVLLELISGK 435
Y + + T+ D++S G + EL++ K
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 38/230 (16%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKE-----------------VAVKIM-ADSCSHRTQQFVT 280
F +K+G+G FG V+ ++ + ++ VAVKI+ D+ + F+
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 281 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL------RDRLHGSVNQKPLD-- 332
EV +LSR+ N++ L+G C +E ++ EYM NG L N
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 333 --------WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 384
+ + L +A A G++YL + +HRD+ + N L+ N+ K++DFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 385 RQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 433
R D I A + ++ E + T SDV++FGV L E++
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-16
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKE---VAVKIMADSCSHRTQQ-FVTEVALL 285
EL+ + + +G G FG + G +K K VA+ + CS + ++ F+ E L
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 286 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 345
+ H N+V L G + ++V EYM NG L L Q L + + A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ--LVAGQLMGMLPGLAS 118
Query: 346 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG--TVG 403
G++YL G +H+ + + +L++ ++ K+S F R E+ I + G V
Sbjct: 119 GMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVL 173
Query: 404 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ PE + SDV+SFG+V+ E++S G++P
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 59/206 (28%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVA---VKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 296
+IG G FG V G+ G A VK + S + Q F+ EV ++H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
+G C E +LV E+ G L++ L G V Q ++A + A GL +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMA-QKDVLQRMACEVASGLLWLHQA 119
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEYYGN 412
IH D+ N L ++ K+ D+GL+ Q ED + +L PE
Sbjct: 120 ---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 413 QQ-------LTEKSDVYSFGVVLLEL 431
+ T+KS+++S GV + EL
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 61/211 (28%), Positives = 104/211 (49%), Gaps = 18/211 (8%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHH 290
+++G+GSFG VY G +D VAVK + +S S R + +F+ E +++
Sbjct: 9 TLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC 68
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG----SVNQ--KPLDWLTRL-QIAHDA 343
++V L+G + ++V E M +G L+ L + N +P L + Q+A +
Sbjct: 69 HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTV 402
A G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 403 GYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 433
++ PE + T SD++SFGVVL E+ S
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 60/201 (29%), Positives = 99/201 (49%), Gaps = 10/201 (4%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEV-AVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
++IGKGSFG VY G KEV A+KI+ + + E+ +LS+ + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
+ + ++ EY+ G+ D L PL+ I + KGL+YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERK--- 122
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
IHRD+K++N+LL K++DFG++ Q + ++ GT ++ PE K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFK 181
Query: 419 SDVYSFGVVLLELISGKKPVS 439
+D++S G+ +EL G+ P S
Sbjct: 182 ADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 62/208 (29%), Positives = 106/208 (50%), Gaps = 18/208 (8%)
Query: 239 FCKKI---GKGSFGSV---YYGKMKD--GKEVAVK-IMADSCSHRTQQFVTEVALLSRIH 289
F K+I G+G FG V Y D G++VAVK + +S + E+ +L ++
Sbjct: 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64
Query: 290 HRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 347
H N+V G C E+ L+ E++ +G+L++ L + N+ L +L+ A KG+
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--QQLKYAVQICKGM 122
Query: 348 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYL 405
+YL + +HRD+ + N+L++ + K+ DFGL++ E D + + V +
Sbjct: 123 DYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY 179
Query: 406 DPEYYGNQQLTEKSDVYSFGVVLLELIS 433
PE + SDV+SFGV L EL++
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 21/210 (10%)
Query: 243 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY- 299
+G G++G VY G+ +K G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 300 -----CEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTG 353
+ Q LV E+ G++ D + + N DW+ I + +GL +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHLHAH 140
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 413
+IHRD+K N+LL N K+ DFG+S Q + + ++ GT ++ PE
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 196
Query: 414 QLTE-----KSDVYSFGVVLLELISGKKPV 438
+ + +SD++S G+ +E+ G P+
Sbjct: 197 ENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 4e-16
Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 243 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYC 300
+G G++G VY G+ +K G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 301 EEEH------QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTG 353
+++ Q LV E+ G++ D + + N +W+ I + +GL +LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH-- 128
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 413
+IHRD+K N+LL N K+ DFG+S Q + + ++ GT ++ PE
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 186
Query: 414 QLTE-----KSDVYSFGVVLLELISGKKPV 438
+ + KSD++S G+ +E+ G P+
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 5e-16
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 39/228 (17%)
Query: 228 PLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM----ADSCSHRTQQFVTEV 282
L ELE +IG G+ G+VY + G+ A+K++ D+ +Q E+
Sbjct: 72 SLSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR---RQICREI 123
Query: 283 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 342
+L ++H N+V + + ++ E+M G+L + + +A
Sbjct: 124 EILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT---HIADEQ-------FLADV 173
Query: 343 AAK---GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVA 398
A + G+ YLH I+HRD+K SN+L++ K++DFG+SR + + SSV
Sbjct: 174 ARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV- 229
Query: 399 RGTVGYLDPEYYGNQQLTE------KSDVYSFGVVLLELISGKKPVSV 440
GT+ Y+ PE N L D++S GV +LE G+ P V
Sbjct: 230 -GTIAYMSPERI-NTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
|
Length = 353 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 21/200 (10%)
Query: 243 IGKGSFGSVYYG-KMKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 300
+G G+ G+VY + + +AVK I D +Q ++E+ +L + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 301 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 360
E++ + E+M G+L ++ + P L R+ +A KGL YL + I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKI---PEHVLGRIAVA--VVKGLTYLWS---LKILH 118
Query: 361 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQLTE 417
RDVK SN+L++ + K+ DFG+S Q ++S+A+ GT Y+ PE +Q
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL------VNSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 418 KSDVYSFGVVLLELISGKKP 437
SDV+S G+ +EL G+ P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 6e-16
Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 243 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-GYC 300
+G G+FG VY + K+ G A KI+ + F+ E+ +LS H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 301 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNPG 357
E IL+ E+ G L S+ + LT QI + L +LH +
Sbjct: 73 YENKLWILI-EFCDGGAL-----DSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHK 123
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEY-----YG 411
+IHRD+K+ NILL ++ K++DFG+S + + + GT ++ PE +
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI--GTPYWMAPEVVACETFK 181
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKP 437
+ K+D++S G+ L+EL + P
Sbjct: 182 DNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-16
Identities = 74/228 (32%), Positives = 113/228 (49%), Gaps = 22/228 (9%)
Query: 227 IPLPELEEATNNF--CKKIGKGSFGSVY-YGKMKDGKEVAVKIMADSCSHRTQQFVTEVA 283
+ L L + T+ + + IGKG++G VY KDG AVKI+ D S ++ E
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-DPISDVDEEIEAEYN 70
Query: 284 LLSRI-HHRNLVPLIG-YCEEEH----QRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTR 336
+L + +H N+V G + + + Q LV E + G++ + + G + + LD
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 337 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHIS 395
I + A GL++LH N IIHRDVK +NILL K+ DFG+S Q L +
Sbjct: 131 SYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187
Query: 396 SVARGTVGYLDPEYYGNQQLTEKS-----DVYSFGVVLLELISGKKPV 438
SV GT ++ PE +Q + S DV+S G+ +EL G P+
Sbjct: 188 SV--GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 54/198 (27%), Positives = 104/198 (52%), Gaps = 8/198 (4%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+K+G+G++ +VY G+ + E VA+K I D+ + E++L+ + H N+V L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
E++ +LV+EYM + L+ + + LD T + KG+ + H +
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTE 417
+HRD+K N+L++ K++DFGL+R + S+ T+ Y P+ G++ +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYST 180
Query: 418 KSDVYSFGVVLLELISGK 435
D++S G ++ E+I+G+
Sbjct: 181 SIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 243 IGKGSFGSVYYGKMKDGKE-VAVKIMA---DSCSH--RTQQFVTEVALLSRIHHRNLVPL 296
+G G++G V VA+K ++ S H RT + E+ LL + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR---ELRLLKHMDHENVIGL 79
Query: 297 IG-YCEEEHQRIL--VYEYMHNGTLRDR-LHGSVNQKPL--DWLTRL--QIAHDAAKGLE 348
+ + VY H L L+ V + L D + L QI +GL+
Sbjct: 80 LDVFTPASSLEDFQDVYLVTH---LMGADLNNIVKCQKLSDDHIQFLVYQIL----RGLK 132
Query: 349 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 408
Y+H+ GIIHRD+K SNI ++ + K+ DFGL+R ++++T VA T Y PE
Sbjct: 133 YIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPE 185
Query: 409 YYGN-QQLTEKSDVYSFGVVLLELISGK 435
N + D++S G ++ EL++GK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 64/218 (29%), Positives = 116/218 (53%), Gaps = 22/218 (10%)
Query: 232 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEV----AVKIMADSCSHRTQ-QFVTEVALL 285
L+E K +G G+FG+VY G + +G+ V A+KI+ ++ + +F+ E ++
Sbjct: 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIM 63
Query: 286 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAH 341
+ + H +LV L+G C + LV + M +G L D +H + Q L+W ++
Sbjct: 64 ASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI---- 118
Query: 342 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS-VARG 400
AKG+ YL ++HRD+ + N+L+ K++DFGL+R E D ++ +
Sbjct: 119 --AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173
Query: 401 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 242 KIGKGSFGSVYYGKMKD-GKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+G+GS+G V K K+ G+ VA+K +S + + E+ +L ++ H NLV LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
+ + LV+E++ + T+ D L N LD + +G+E+ H + I
Sbjct: 68 VFRRKKRLYLVFEFVDH-TVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH---SHNI 121
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYY-GNQQLT 416
IHRD+K NIL+ + K+ DFG +R A + VA T Y PE G+ +
Sbjct: 122 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA--TRWYRAPELLVGDTKYG 179
Query: 417 EKSDVYSFGVVLLELISG 434
D+++ G ++ E+++G
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 241 KKIGKGSFGSVYYG-KMKDGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
++IGKGSFG V+ G + + VA+KI+ + + E+ +LS+ + G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
+ + ++ EY+ G+ D L P D + + KGL+YLH+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHS---EKK 122
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
IHRD+K++N+LL K++DFG++ Q + ++ GT ++ PE K
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSK 181
Query: 419 SDVYSFGVVLLELISGKKPVS 439
+D++S G+ +EL G+ P S
Sbjct: 182 ADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 250 SVYYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLIGY----CEE 302
S+Y G + KEV ++ E+ L RI N++ + G+ ++
Sbjct: 35 SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93
Query: 303 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN-PGIIHR 361
+ L+ EY G LR+ L +K L + T+L +A D KGL L+ N P ++
Sbjct: 94 LPRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147
Query: 362 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKS 419
++ S + L+ N + K+ GL E+ L+ + Y + + + T K
Sbjct: 148 NLTSVSFLVTENYKLKIICHGL----EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKD 203
Query: 420 DVYSFGVVLLELISGKKP 437
D+YS GVVL E+ +GK P
Sbjct: 204 DIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 58/216 (26%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 239 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVP 295
F + +GKGS+G V + + DGK+ +K + ++ + E LLS++ H N+V
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 296 LIGYCE-EEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEY 349
E E+ +V + G L +L + + ++W ++ +A L+Y
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQY 117
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
LH I+HRD+K+ N+ L KV D G++R E+ ++S GT Y+ PE
Sbjct: 118 LH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSPEL 173
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 445
+ N+ KSDV++ G + E+ + K + +D +
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 53/220 (24%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQF--------VTEVALLSRI-HH 290
K++G G+FGSVY + K+ E VA+K M ++F + EV L ++ H
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEH 57
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHN---GTLRDRLHGSVNQKPL------DWLTRLQIAH 341
N+V L E + V+EYM ++DR KP + QI
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDR-----KGKPFSESVIRSII--YQIL- 109
Query: 342 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 401
+GL ++H G HRD+K N+L+ K++DFGL+R+ + V T
Sbjct: 110 ---QGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV--ST 161
Query: 402 VGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGK 435
Y PE Y + + D+++ G ++ EL + +
Sbjct: 162 RWYRAPEILLRSTSY-SSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 243 IGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV 294
+G+G+F ++ G ++ EV +K++ S + ++ F +++S++ H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
G C + I+V EY+ G+L L + N + W +L++A A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE--- 117
Query: 355 NPGIIHRDVKSSNILLDINMRA--------KVSDFGLS--RQAEEDLTHISSVARGTVGY 404
+ G+ H +V + N+LL K+SD G+S +E L + +
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLE-------RIPW 170
Query: 405 LDPEYYGN-QQLTEKSDVYSFGVVLLELISG-KKPVSVED 442
+ PE N Q L+ +D +SFG L E+ SG KP+S D
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 15/144 (10%)
Query: 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 370
E+M G+L D++ + P + L ++ IA +GL YL I+HRDVK SNIL+
Sbjct: 79 EHMDGGSL-DQVLKKAGRIPENILGKISIA--VLRGLTYLRE--KHKIMHRDVKPSNILV 133
Query: 371 DINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVV 427
+ K+ DFG+S Q I S+A GT Y+ PE T +SD++S G+
Sbjct: 134 NSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLS 187
Query: 428 LLELISGKKPVSVEDFGAELNIVH 451
L+E+ G+ P+ D EL +
Sbjct: 188 LVEMAIGRYPIPPPD-AKELEAMF 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 4e-15
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 40/216 (18%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMAD------SCSHRTQQFVTEVALLSRIHHRNL 293
+ IG G+FG V+ +DGK VA+K M + SC ++ E+ +L H N+
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSC----KRVFRELKMLCFFKHDNV 61
Query: 294 V--------PLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-VNQKPLD----WLTRLQIA 340
+ P I EE + +V E M + LH V+ +PL + QI
Sbjct: 62 LSALDILQPPHIDPFEEIY---VVTELMQSD-----LHKIIVSPQPLSSDHVKVFLYQIL 113
Query: 341 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 400
+GL+YLH+ GI+HRD+K N+L++ N K+ DFGL+R E D + +
Sbjct: 114 ----RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV 166
Query: 401 TVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 435
T Y PE G++ T D++S G + EL+ +
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 4e-15
Identities = 69/225 (30%), Positives = 107/225 (47%), Gaps = 26/225 (11%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD---SCSHRTQQFVTEVALLSRIHHRNLVPL 296
K IG+G+FG V K+K+ +V A+KI+ T F E +L ++ + L
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAAKGLEYLHT 352
++E+ LV +Y G L L ++ P D +L + IA D+ L Y
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-- 410
+HRD+K NIL+D+N +++DFG + ED T SSVA GT Y+ PE
Sbjct: 124 ------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 411 ---GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 448
G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 4e-15
Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
++IG G++G VY + + G+ A+K++ E+ ++ H N+V G
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
+ + E+ G+L+D H + PL ++ + +GL YLH + G +
Sbjct: 75 YLRRDKLWICMEFCGGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLH---SKGKM 128
Query: 360 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ---LT 416
HRD+K +NILL N K++DFG+S Q + S GT ++ PE ++
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYN 187
Query: 417 EKSDVYSFGVVLLELISGKKPV 438
+ D+++ G+ +EL + P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 243 IGKGSFGSVYYGKMKDG-------KEVAVKIMADSCSHRTQ-----QFVTEVALL-SRIH 289
+G G+FG VY + K+ KE+ V A R + V+EV ++ ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 290 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL------HGSVNQKPLDWLTRLQIAHDA 343
H N+V E + +V + + L + ++ + W +Q+
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI-WNIFVQMV--- 123
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 403
L YLH I+HRD+ +NI+L + + ++DFGL++Q + + + ++SV GT+
Sbjct: 124 -LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTSVV-GTIL 178
Query: 404 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
Y PE N+ EK+DV++FG +L ++ + + P
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 28/209 (13%)
Query: 242 KIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLI 297
++G+G +G V+ K KD E VA+K M S + + +TE +L+ LV L+
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 298 GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD------WLTRLQIAHDAAKGLEYL 350
Y ++ + + L EY+ G R L N L ++ + A DA L
Sbjct: 68 -YAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFEAVDA------L 117
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410
H G IHRD+K N L+D + K++DFGLS+ +T+ +SV G+ Y+ PE
Sbjct: 118 H---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANSVV-GSPDYMAPEVL 170
Query: 411 GNQQLTEKSDVYSFGVVLLELISGKKPVS 439
+ D +S G +L E + G P S
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 243 IGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQ--FVTEVALLSRIHHRNLVPLIG 298
+G G FG V K+K + A+K + QQ +E +L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+++ ++ EY G L L G + ++ R IA EYLH N
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFD----EYTARFYIAC-VVLAFEYLH---NR 112
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----GTVGYLDPEYYG 411
GII+RD+K N+LLD N K+ DFG +++ + S + GT Y+ PE
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKK-------LKSGQKTWTFCGTPEYVAPEIIL 165
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
N+ D +S G++L EL++G+ P +D
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 243 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNLVPLIG 298
+GKG FG V +M+ GK A K + + + + + E +L+++H R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPG 357
+ + LV M+ G LR ++ + P GLE+LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
II+RD+K N+LLD + ++SD GL+ + ++ + A GT G++ PE ++
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYDF 176
Query: 418 KSDVYSFGVVLLELISGKKP 437
D ++ GV L E+I+ + P
Sbjct: 177 SVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 37/217 (17%)
Query: 242 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVP 295
IG+G++G VY K K DGKE A+K T Q E+ALL + H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 296 LIGYCEEEHQRI--LVYEY----------MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 343
L+ E + L+++Y H R + S+ K L W QI +
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM-VKSLLW----QILN-- 119
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILL--DINMRA--KVSDFGLSRQAEEDLTHISSVAR 399
G+ YLH+ ++HRD+K +NIL+ + R K+ D GL+R L ++ +
Sbjct: 120 --GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 400 G--TVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELIS 433
T+ Y PE G + T+ D+++ G + EL++
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 10/199 (5%)
Query: 243 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 298
+GKG FG V +++ GK A K + + + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
E + LV M+ G L+ ++ + + + + A + GLE LH I
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDLH---QERI 123
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
++RD+K NILLD + ++SD GL+ E T V GTVGY+ PE N++ T
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERYTFS 181
Query: 419 SDVYSFGVVLLELISGKKP 437
D ++ G +L E+I+G+ P
Sbjct: 182 PDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 58/229 (25%), Positives = 108/229 (47%), Gaps = 25/229 (10%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVA 283
E+ +T F +++G+ FG VY G + + + VA+K + D ++F E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 284 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-----HGSVNQKPLDWLTR-- 336
+ SR+ H N+V L+G +E +++ Y + L + L H V D +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 337 ------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EE 389
+ I A G+E+L + ++H+D+ + N+L+ + K+SD GL R+
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 390 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
D + + + ++ PE + + SD++S+GVVL E+ S G +P
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRIHHRNL 293
K +GKGSFG V ++K E A+K ++ D T V L H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECT--MVERRVLALAWEHPFL 58
Query: 294 VPLIGYC--EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
L +C + + V EY++ G D + + D A + GL++LH
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 411
GII+RD+K N+LLD + K++DFG+ ++ + +S GT Y+ PE
Sbjct: 114 KK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEILK 169
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
Q+ E D +SFGV+L E++ G+ P ED
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 48/228 (21%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA--------DSCSHRTQQFVTEVALLSRI 288
NF +GKGSFG V + K E+ A+KI+ D ++ V +AL +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRV--LALPGKP 60
Query: 289 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI--------- 339
L L + + V EY++ G D + +Q
Sbjct: 61 PF--LTQLHSCFQTMDRLYFVMEYVNGG---------------DLMYHIQQVGKFKEPHA 103
Query: 340 ---AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHI 394
A + A GL +LH+ GII+RD+K N++LD K++DFG+ ++ T
Sbjct: 104 VFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160
Query: 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
GT Y+ PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 161 FC---GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 31/215 (14%)
Query: 234 EATNNFC--KKIGKGSFGSVYYGK-MKDGKEVAVK-IMAD-SCSHRTQQFVTEVALLSRI 288
E TN + + +G G+FG V + G+ VA+K IM S ++ E+ LL +
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 289 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 347
H N++ L + I V E + GT LH + +PL+ + +GL
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELL--GT---DLHRLLTSRPLEKQFIQYFLYQILRGL 121
Query: 348 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 407
+Y+H+ G++HRD+K SNIL++ N K+ DFGL+R + +T GY+
Sbjct: 122 KYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMT----------GYVST 168
Query: 408 EYYGN-------QQLTEKSDVYSFGVVLLELISGK 435
YY Q+ + D++S G + E++ GK
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 243 IGKGSFGSVY-YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIG-Y 299
IGKG++G V+ K+G + AVKI+ D ++ E +L + H N+V G Y
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 300 CEEE----HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHT 352
+++ Q LV E + G++ D + G + + + + IA H+A GL++LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG--ERMEEPIIAYILHEALMGLQHLH- 141
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG- 411
IHRDVK +NILL K+ DFG+S Q + + GT ++ PE
Sbjct: 142 --VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TSTRLRRNTSVGTPFWMAPEVIAC 198
Query: 412 NQQL----TEKSDVYSFGVVLLELISGKKPVS 439
QQL + DV+S G+ +EL G P++
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 22/205 (10%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE-VAVKIMA--DSCSHRTQQFV-TEVALLSRIHHRNLVPL 296
K +G G+FG V+ + + + A+K+MA + + +Q V E +L + H ++ L
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 297 IGYCEEEHQRIL--VYEYMHNGTLRD--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
+ E QR L + EY+ G L R G + T L A + LEYLH+
Sbjct: 67 --FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS-----TGLFYASEIVCALEYLHS 119
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
I++RD+K NILLD K++DFG +++ + + GT YL PE +
Sbjct: 120 ---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC----GTPEYLAPEVIQS 172
Query: 413 QQLTEKSDVYSFGVVLLELISGKKP 437
+ + D ++ G+++ E++ G P
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 58/222 (26%), Positives = 104/222 (46%), Gaps = 30/222 (13%)
Query: 239 FCKKIGKGSFGSVYYGK---MKDGKE--------------VAVKIM-ADSCSHRTQQFVT 280
F +K+G+G FG V+ + M+ + VAVK++ D+ + F+
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 281 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL-----RDRLHGSV---NQKPLD 332
E+ ++SR+ N++ L+ C ++ EYM NG L R + + +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 333 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DL 391
+ T + +A A G++YL + +HRD+ + N L+ N K++DFG+SR D
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 433
I A + ++ E + T SDV++FGV L E+++
Sbjct: 186 YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 14/204 (6%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHHRNL 293
F K +G GSFG V + K + A+KI++ + + +Q + E +L I H L
Sbjct: 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
V L G +++ LV EY+ G L L + P R A LEYLH
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEPV-ARFYAA-QVVLALEYLH-- 118
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 413
+ I++RD+K N+LLD + K++DFG +++ + + GT YL PE ++
Sbjct: 119 -SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAPEIILSK 173
Query: 414 QLTEKSDVYSFGVVLLELISGKKP 437
+ D ++ G+++ E+++G P
Sbjct: 174 GYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 25/213 (11%)
Query: 239 FCKKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 296
++GKG++GSVY + G +A+K I + + Q + E+ +L + +V
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
G E + EYM G+L D+L+ + P D L R I + KGL++L
Sbjct: 65 YGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLKFLKEE 121
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEY- 409
N IIHRDVK +N+L++ N + K+ DFG+S +S+A+ +G Y+ PE
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV------ASLAKTNIGCQSYMAPERI 173
Query: 410 -----YGNQQLTEKSDVYSFGVVLLELISGKKP 437
N T +SDV+S G+ +LE+ G+ P
Sbjct: 174 KSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 11/206 (5%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 296
K +GKG+FG V + K GK A+KI+ +TE +L H L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+ + + V EY++ G L H S + + TR A + L+YLH+G
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELF--FHLSRERVFSEDRTRFYGA-EIVSALDYLHSG--- 114
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 416
I++RD+K N++LD + K++DFGL ++ D + + GT YL PE +
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 417 EKSDVYSFGVVLLELISGKKPVSVED 442
D + GVV+ E++ G+ P +D
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 44/214 (20%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVA---VKIM-----ADSCSHRTQQFVTEVALLSRIHHRN 292
+++GKGSFG+VY +KD K VA +K++ + + T Q E LLS++ H
Sbjct: 6 QRLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 293 LVP-------------LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI 339
+V + YCE + E H G S NQ +W +L +
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL-----SENQV-CEWFIQLLL 117
Query: 340 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSV 397
G+ Y+H I+HRD+K+ NI L N+ K+ DFG+SR DL ++
Sbjct: 118 ------GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDL---ATT 164
Query: 398 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLEL 431
GT Y+ PE +Q KSD++S G +L E+
Sbjct: 165 FTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 58/211 (27%), Positives = 109/211 (51%), Gaps = 22/211 (10%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRTQQFVTEVAL-LSRIHHRNLV 294
K +G G FG+V+ G + +G VA+K + D +T Q +T+ L + + H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLH---GSVN-QKPLDWLTRLQIAHDAAKGLEYL 350
L+G C + LV + G+L D + S++ Q+ L+W ++ AKG+ YL
Sbjct: 73 RLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYL 125
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVGYLDPEY 409
++HR++ + NILL + +++DFG++ +D + S + + ++ E
Sbjct: 126 EEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182
Query: 410 YGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 439
+ T +SDV+S+GV + E++S G +P +
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 67/217 (30%), Positives = 111/217 (51%), Gaps = 35/217 (16%)
Query: 243 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF----VTEVALLSRIHHRNLVPL- 296
IG+G++G VY + KD G+ VA+K + + + F + E+ +L +++HRN+V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKV--RLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72
Query: 297 ---------IGYCEEEHQRILVYEYM-HN--GTLRDRLHGSVNQKPLDWLTRLQIAHDAA 344
+ + +++ LV+EYM H+ G L L ++ +L
Sbjct: 73 EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL------L 126
Query: 345 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTV 402
+GL Y H +HRD+K SNILL+ + K++DFGL+R +EE + + V T+
Sbjct: 127 EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI--TL 181
Query: 403 GYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPV 438
Y PE G ++ DV+S G +L EL + KKP+
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIHHRN 292
K +GKG+FG V + K GK A+KI+ D +H +TE +L H
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT----LTESRVLQNTRHPF 56
Query: 293 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
L L Y + H R+ V EY + G L H S + + R A + L YLH
Sbjct: 57 LTAL-KYSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALGYLH 112
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEY 409
+ +++RD+K N++LD + K++DFGL + E ++ +++ GT YL PE
Sbjct: 113 SC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEV 166
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
+ D + GVV+ E++ G+ P +D
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 16/215 (7%)
Query: 243 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIG 298
+GKGSFG V ++K G+ AVK++ + +TE +LS + + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 299 YCEEEHQRIL-VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
C + R+ V E+++ G L + S + D A + L +LH + G
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEITSALMFLH---DKG 116
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
II+RD+K N+LLD K++DFG+ ++ + S+ GT Y+ PE
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEMLYGP 175
Query: 418 KSDVYSFGVVLLELISGKKPVSVED----FGAELN 448
D ++ GV+L E++ G P E+ F A LN
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 26/208 (12%)
Query: 243 IGKGSFGSVYYGKM---KDGKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHR--NLV 294
IG G+ G VY KM K G +AVK M + + + + +V L S H +V
Sbjct: 23 IGSGTCGQVY--KMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS---HDCPYIV 77
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTG 353
GY + + E M T D+L + P D L ++ +A K L YL
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVA--IVKALHYLKE- 132
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 413
G+IHRDVK SNILLD + K+ DFG+S + + S G Y+ PE
Sbjct: 133 -KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMAPERIDPP 189
Query: 414 QLTEK----SDVYSFGVVLLELISGKKP 437
K +DV+S G+ L+EL +G+ P
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 6e-14
Identities = 40/102 (39%), Positives = 61/102 (59%), Gaps = 6/102 (5%)
Query: 28 WEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRL 85
W+ +TC+ ++ R+ I LSGKN+ G+I + + + + L N L+GP+PD +
Sbjct: 60 WQGITCNNSS--RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTS 117
Query: 86 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 127
LR ++L NN TGS+P GS+PNL+ L + NN GEIP
Sbjct: 118 SSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIP 157
|
Length = 968 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 67/217 (30%), Positives = 95/217 (43%), Gaps = 13/217 (5%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ----FVTEVALLSRIHHRNLVP 295
K IGKGSFG V K K DG AVK++ + ++ LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
L + + V +Y++ G L H + L+ R A + A + YLH+
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELF--FHLQRERCFLEPRARFYAA-EVASAIGYLHS--- 114
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 415
II+RD+K NILLD ++DFGL ++ E S+ GT YL PE +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEPY 173
Query: 416 TEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVH 451
D + G VL E++ G P D NI+H
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 7e-14
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 240 CKKIGKGSFGSVYYGKM---KDGKEVAVK-IMADSCSHRTQQFVTEV-ALLSRIHHRNLV 294
+IG+G+FG+V KM G +AVK I + ++ + ++ ++ +V
Sbjct: 9 LGEIGRGAFGTVN--KMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIV 66
Query: 295 PLIGYCEEEHQRILVYEYMHNG--TLRDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLH 351
G E + E M ++ + P + L + IA K L YL
Sbjct: 67 KFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGK--IAVATVKALNYLK 124
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 407
IIHRDVK SNILLD N K+ DFG+S Q + S+A+ G Y+ P
Sbjct: 125 EELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD------SIAKTRDAGCRPYMAP 176
Query: 408 EY---YGNQQLTEKSDVYSFGVVLLELISGKKP 437
E +SDV+S G+ L E+ +GK P
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 8e-14
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 242 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIG 298
KIG+GS+G V+ + ++ G+ VA+K +S + + E+ +L ++ H NLV LI
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT-GCNPG 357
+ + LV+EY + T+ + L N + + +I + + + H C
Sbjct: 68 VFRRKRKLHLVFEYCDH-TVLNELEK--NPRGVPEHLIKKIIWQTLQAVNFCHKHNC--- 121
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPEYY-GNQ 413
IHRDVK NIL+ + K+ DFG +R +D T VA T Y PE G+
Sbjct: 122 -IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT--DYVA--TRWYRAPELLVGDT 176
Query: 414 QLTEKSDVYSFGVVLLELISG 434
Q DV++ G V EL++G
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 64/229 (27%), Positives = 104/229 (45%), Gaps = 46/229 (20%)
Query: 238 NFCKKIGKGSFGSVYYG-KMKDGKEVAVK--IMADSCSHRTQQF-VT---EVALLSRIHH 290
K+G+G+FG VY ++K G+ VA+K +M + F +T E+ +L ++ H
Sbjct: 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILM----HNEKDGFPITALREIKILKKLKH 66
Query: 291 RNLVPLIGYCEEEHQRI--------LVYEYM-H--NGTLRD-RLHGSVNQ-KPLDWLTRL 337
N+VPLI E + +V YM H +G L + + + +Q K L
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK----CYML 122
Query: 338 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHI 394
Q+ G+ YLH N I+HRD+K++NIL+D K++DFGL+R +
Sbjct: 123 QLLE----GINYLH--EN-HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175
Query: 395 SSVARG-------TVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 435
T Y PE G ++ T D++ G V E+ + +
Sbjct: 176 GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 241 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+++G G++G VY + G+ AVKI+ E+ ++ H N+V G
Sbjct: 15 QRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 356
+ + EY G+L+D H + PL + LQIA+ + +GL YLH+
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVT---GPL---SELQIAYVCRETLQGLAYLHS---K 125
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG---NQ 413
G +HRD+K +NILL N K++DFG++ + + S GT ++ PE N
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNG 184
Query: 414 QLTEKSDVYSFGVVLLELISGKKPV 438
+ D+++ G+ +EL + P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 61/201 (30%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 243 IGKGSFGSV------YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 296
+GKG FG V GKM K++ K + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR--KGEAMALNEKQILEKVNSRFVVSL 65
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
E + LV M+ G L+ ++ ++ D + A + GLE LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIY-NMGNPGFDEERAVFYAAEITCGLEDLHR---E 121
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 416
I++RD+K NILLD ++SD GL+ + E T V GTVGY+ PE N++ T
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKNERYT 179
Query: 417 EKSDVYSFGVVLLELISGKKP 437
D + G ++ E+I GK P
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 38/231 (16%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEV-AVKIM---------ADSCSHRTQQFVTEVALLSRIHH 290
K IG+G+FG V KMK+ +V A+KI+ +C F E +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC------FREERDVLVNGDR 60
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAAKG 346
R + L ++E+ LV +Y G L L ++ P D +L + +A D+
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 406
L Y +HRD+K N+LLD N +++DFG + D T S+VA GT Y+
Sbjct: 121 LGY---------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171
Query: 407 PEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPV----SVEDFGAELN 448
PE G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 64/220 (29%), Positives = 92/220 (41%), Gaps = 29/220 (13%)
Query: 239 FCKKIGKGSFG--SVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNL 293
IGK V+ K K VAVK + DSCS + + E+ ++ H N+
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYL 350
+P + + + +V M G+ D L + L L IA D L+Y+
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP----EGLPELAIAFILKDVLNALDYI 117
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS--------RQAEEDLTHISSVARGTV 402
H + G IHR VK+S+ILL + + +S S RQ SSV +
Sbjct: 118 H---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK--NL 172
Query: 403 GYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVS 439
+L PE Q L EKSD+YS G+ EL +G P
Sbjct: 173 PWLSPEVL-QQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 24/203 (11%)
Query: 243 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRI---HHRNLVPL 296
IG+G++G+VY + + G+ VA+K + S + E+ALL ++ H N+V L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 297 IGYC-----EEEHQRILVYEYMHNGTLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLE 348
+ C + E + LV+E++ +D L + L T + +G++
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVD----QD-LATYLSKCPKPGLPPETIKDLMRQLLRGVD 121
Query: 349 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 408
+LH+ I+HRD+K NIL+ + + K++DFGL+R ++ S V T+ Y PE
Sbjct: 122 FLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRAPE 176
Query: 409 YYGNQQLTEKSDVYSFGVVLLEL 431
D++S G + EL
Sbjct: 177 VLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 64/233 (27%), Positives = 109/233 (46%), Gaps = 42/233 (18%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEV-AVKIM--------ADSCSHRTQQFVT---EVALLSRI 288
K IG+G+FG V KMK + + A+KI+ A++ R ++ V + ++ +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66
Query: 289 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD----WLTRLQIAHDAA 344
H+ ++E+ LV +Y G L L ++ P D ++ + +A +
Sbjct: 67 HYA--------FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 345 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 404
L Y +HRD+K N+LLD+N +++DFG + +D T SSVA GT Y
Sbjct: 119 HQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169
Query: 405 LDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVS----VEDFGAELN 448
+ PE G + + D +S GV + E++ G+ P VE +G +N
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 222
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPLIG 298
+K+G+GS+ +VY GK K +GK VA+K++ T + E +LL + H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70
Query: 299 YCEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+ LV+EY+H + D+ G ++ + + L Q+ +GL Y+H
Sbjct: 71 IIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVK-LFLFQLL----RGLSYIH---QR 122
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 415
I+HRD+K N+L+ K++DFGL+R A+ +H S T+ Y P+ G+ +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 416 TEKSDVYSFGVVLLELISG 434
+ D++ G + +E+I G
Sbjct: 182 STCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 15/208 (7%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQ--FVTEVALLSRIHHRNL 293
+ K IG+G+FG V + K K+V A+K+++ R+ F E +++ + +
Sbjct: 46 DVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWI 105
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
V L +++ +V EYM G L + + S P W R A + L+ +H
Sbjct: 106 VQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKW-ARFYTA-EVVLALDAIH-- 159
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 413
+ G IHRDVK N+LLD + K++DFG + + + A GT Y+ PE +Q
Sbjct: 160 -SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 414 ----QLTEKSDVYSFGVVLLELISGKKP 437
+ D +S GV L E++ G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 51/219 (23%)
Query: 242 KIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQ--------FVTEVALLSRIHHRN 292
+IG+G++G VY + E VA+K + R + E+ LL + H N
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKV------RMDNERDGIPISSLREITLLLNLRHPN 67
Query: 293 LVPL---------------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL 337
+V L + YCE++ +L D + ++ + L L
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLL-----------DNMPTPFSESQVKCLM-L 115
Query: 338 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 397
Q+ +GL+YLH IIHRD+K SN+LL K++DFGL+R ++
Sbjct: 116 QLL----RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168
Query: 398 ARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 435
T+ Y PE G T D+++ G +L EL++ K
Sbjct: 169 VV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 61/257 (23%), Positives = 98/257 (38%), Gaps = 68/257 (26%)
Query: 219 MDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVY-YGKMKDGKEVAVKIM------ADSC 271
+I +G+G++G V GK VA+K + D
Sbjct: 3 SFSISERYIQKG----------AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVT 52
Query: 272 SHRTQ------QFVT--EVALLSRIHHRNLVPLIG-YCEEEHQRILVYEYMHNGTLRDRL 322
R F T E+ +++ I H N++ L+ Y E + LV + M L+
Sbjct: 53 KDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFIN-LVMDIMA-SDLK--- 107
Query: 323 HGSVNQKPLDWLTRLQIAH------DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 376
K +D RL + GL LH +HRD+ +NI ++
Sbjct: 108 ------KVVDRKIRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC 158
Query: 377 KVSDFGLSR-----------------QAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEK 418
K++DFGL+R Q E++T S V T+ Y PE G ++
Sbjct: 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMT--SKVV--TLWYRAPELLMGAEKYHFA 214
Query: 419 SDVYSFGVVLLELISGK 435
D++S G + EL++GK
Sbjct: 215 VDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 241 KKIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 296
K+IG G FG V G++ G +V VK + S S + Q +F+ E + H NL+
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL--DWLTRLQIAHDAAKGLEYLHTGC 354
+G C E +LV E+ G L+ L + + D T ++A + A GL +LH
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS-----VARGTVGYLDPEY 409
IH D+ N LL ++ K+ D+GLS ++ +++ R L E
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 410 YGNQQL---TEKSDVYSFGVVLLELIS-GKKP 437
+GN + T++S+V+S GV + EL G +P
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 27/218 (12%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA--------DSCSHRTQQFVTEVALLSRI 288
+G+G FG V + K E+ A+K + + S ++ + E A +
Sbjct: 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETA--NSE 59
Query: 289 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKG 346
H LV L C + + V EY G L +H V +P R A G
Sbjct: 60 RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACVVLG 113
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGY 404
L+YLH I++RD+K N+LLD K++DFGL + E + + GT +
Sbjct: 114 LQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEF 167
Query: 405 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
L PE T D + GV++ E++ G+ P +D
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 3e-13
Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 31/212 (14%)
Query: 243 IGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQ-QFVTEVALLSR-IHHRNLVPLI 297
+G+G++G V KM+ G +AVK + + + + Q + + ++ + R + V
Sbjct: 9 LGRGAYGVVD--KMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL----DWLTRLQIAHDAAKGLEYLHTG 353
G E + E M T D+ + V K L D L + IA K LEYLH+
Sbjct: 67 GALFREGDVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLHSK 122
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEY 409
+ +IHRDVK SN+L++ N + K+ DFG+S + SVA+ G Y+ PE
Sbjct: 123 LS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL------VDSVAKTIDAGCKPYMAPER 174
Query: 410 Y---GNQQLTE-KSDVYSFGVVLLELISGKKP 437
NQ+ + KSDV+S G+ ++EL +G+ P
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 12/207 (5%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVP 295
K +GKGSFG V+ ++K + A+K + + + E +LS H L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
L + + V EY++ G L H K D A + GL++LH+
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLM--FHIQSCHK-FDLPRATFYAAEIICGLQFLHS--- 114
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 415
GI++RD+K NILLD + K++DFG+ ++ + GT Y+ PE Q+
Sbjct: 115 KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKY 173
Query: 416 TEKSDVYSFGVVLLELISGKKPVSVED 442
D +SFGV+L E++ G+ P D
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 71/220 (32%), Positives = 102/220 (46%), Gaps = 19/220 (8%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVT--EVALLSRIHHRNLVP 295
K IGKGSFG V K K DGK AVK++ + + Q+ + LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
L + + V ++++ G L H + + R A + A L YLH+
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELF--FHLQRERSFPEPRARFYAA-EIASALGYLHS--- 114
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQ 413
I++RD+K NILLD ++DFGL ++ A+ D T + GT YL PE Q
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVIRKQ 171
Query: 414 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVH 451
D + G VL E++ G P D AE+ NI+H
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-AEMYDNILH 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 62/225 (27%), Positives = 102/225 (45%), Gaps = 42/225 (18%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMAD---------SCS---HRTQQFVTEVAL 284
NF +GKGSFG V + K E+ A+KI+ C+ R +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPF 62
Query: 285 LSRIHHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH-- 341
L+++H C + R+ V EY++ G L ++ + R + H
Sbjct: 63 LTQLHS---------CFQTMDRLYFVMEYVNGGDLMYQIQQ---------VGRFKEPHAV 104
Query: 342 ----DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 397
+ A GL +LH+ GII+RD+K N++LD K++DFG+ ++ D +
Sbjct: 105 FYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTF 161
Query: 398 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
GT Y+ PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 162 C-GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-13
Identities = 71/225 (31%), Positives = 99/225 (44%), Gaps = 29/225 (12%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVA----LLSRIHHRNLVP 295
K IGKGSFG V K K DGK AVK++ + ++ +A LL + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 296 LIGYCEEEHQRILVYEYMHNGTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
L + + V +Y++ G L R+R + A + A L YL
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR--------FYAAEIASALGYL 112
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPE 408
H+ II+RD+K NILLD ++DFGL ++ T S GT YL PE
Sbjct: 113 HS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT---STFCGTPEYLAPE 166
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVH 451
Q D + G VL E++ G P D AE+ NI++
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-AEMYDNILN 210
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 6e-13
Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 20/208 (9%)
Query: 238 NFCK--KIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRN 292
NF K KIG+G++G VY + K G+ VA+K I D+ + + E++LL ++H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 293 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 349
+V L+ E++ LV+E++H L ++ PL + I +GL +
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQD-----LKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPE 408
H+ ++HRD+K N+L++ K++DFGL+R + T+ V T+ Y PE
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPE 170
Query: 409 -YYGNQQLTEKSDVYSFGVVLLELISGK 435
G + + D++S G + E+++ +
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 243 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 298
+GKG FG V +++ GK A K + + + + E +L +++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
E + LV M+ G L+ ++ N + L A + GLE LH
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FEEERALFYAAEILCGLEDLH---RENT 123
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
++RD+K NILLD ++SD GL+ + E + V GTVGY+ PE NQ+ T
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNNQRYTLS 181
Query: 419 SDVYSFGVVLLELISGKKP 437
D + G ++ E+I G+ P
Sbjct: 182 PDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 7e-13
Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIHHRN 292
K +GKG+FG V + K G+ A+KI+ D +H VTE +L H
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT----VTESRVLQNTRHPF 56
Query: 293 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
L L Y + H R+ V EY + G L H S + + R A + LEYLH
Sbjct: 57 LTAL-KYAFQTHDRLCFVMEYANGGELF--FHLSRERVFTEERARFYGA-EIVSALEYLH 112
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 411
+ +++RD+K N++LD + K++DFGL ++ D + + GT YL PE
Sbjct: 113 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLE 168
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
+ D + GVV+ E++ G+ P +D
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 58/210 (27%), Positives = 112/210 (53%), Gaps = 24/210 (11%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLV 294
K +G G+FG+VY G + +G++ VA+K + ++ S + ++ + E +++ + + ++
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRD--RLHGS--VNQKPLDWLTRLQIAHDAAKGLEYL 350
L+G C + L+ + M G L D R H +Q L+W ++ AKG+ YL
Sbjct: 73 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 125
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE 408
++HRD+ + N+L+ K++DFGL++ A+E H + + ++ E
Sbjct: 126 E---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG-GKVPIKWMALE 181
Query: 409 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
++ T +SDV+S+GV + EL++ G KP
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 8e-13
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVK---IMADSCSHRTQQFVTEVALLSRIHHRNLVPL 296
KKIG+G F VY + DG VA+K I + + E+ LL +++H N++
Sbjct: 8 KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEYLH 351
E+++ +V E G L + QK L W +Q+ LE++H
Sbjct: 68 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SALEHMH 123
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 411
+ ++HRD+K +N+ + K+ D GL R T S+ GT Y+ PE
Sbjct: 124 S---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIH 179
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 449
KSD++S G +L E+ + + P +G ++N+
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 21/231 (9%)
Query: 241 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRN 292
K +G G++G V+ + GK A+K++ + + T+ TE +L I
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 293 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKGLEYL 350
+ + Y + ++ L+ +Y++ G L L K +QI + + LE+L
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE----QEVQIYSGEIVLALEHL 121
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410
H GII+RD+K NILLD N ++DFGLS++ ED + GT+ Y+ P+
Sbjct: 122 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 411 --GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 459
G+ + D +S GV++ EL++G P +V+ G + + +R ++K
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASPFTVD--GEKNSQAEISRRILKS 227
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 56/211 (26%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 242 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQF-VTEVALLSRIHHRNLVPLIG 298
KIG+G++G+V+ K ++ E VA+K + D + E+ LL + H+N+V L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 299 YCEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+ + LV+EY + D +G ++ + + Q+ KGL + H+
Sbjct: 67 VLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFM-FQLL----KGLAFCHS---H 118
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 415
++HRD+K N+L++ N K++DFGL+R + S+ T+ Y P+ +G +
Sbjct: 119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLY 177
Query: 416 TEKSDVYSFGVVLLELISGKKPV----SVED 442
+ D++S G + EL + +P+ V+D
Sbjct: 178 STSIDMWSAGCIFAELANAGRPLFPGNDVDD 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRNLV 294
KKIG+G F VY + D K VA+K M D+ + Q V E+ LL +++H N++
Sbjct: 8 KKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR--QDCVKEIDLLKQLNHPNVI 65
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEY 349
+ E+++ +V E G L + QK L W +Q+ +E+
Sbjct: 66 KYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SAVEH 121
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
+H+ ++HRD+K +N+ + K+ D GL R T S+ GT Y+ PE
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 449
KSD++S G +L E+ + + P +G ++N+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-------DSCSHRTQQFVTEVALLSRIHHRN 292
K +GKG+FG V K K G+ A+KI+ D +H +TE +L H
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT----LTENRVLQNSRHPF 56
Query: 293 LVPLIGYCEEEHQRI-LVYEYMHNGTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKG 346
L L Y + H R+ V EY + G L R+R+ + +
Sbjct: 57 LTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--------FYGAEIVSA 107
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 406
L+YLH+ N +++RD+K N++LD + K++DFGL ++ +D + + GT YL
Sbjct: 108 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLA 164
Query: 407 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
PE + D + GVV+ E++ G+ P +D
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 81/324 (25%), Positives = 145/324 (44%), Gaps = 48/324 (14%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVK-------IMAD--SCS---HRTQQFVTEVALLSR 287
K +GKGSFG V ++K G+ AVK ++ D C+ R E L+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 288 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 347
++ + +EH V E+++ G L + ++ D A + GL
Sbjct: 61 LY-------CTFQTKEHL-FFVMEFLNGGDLMFHIQ---DKGRFDLYRATFYAAEIVCGL 109
Query: 348 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 407
++LH+ GII+RD+K N++LD + K++DFG+ ++ S+ GT Y+ P
Sbjct: 110 QFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAP 165
Query: 408 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED----FGA-ELNIVHWARSMIKKG-D 461
E + T D +SFGV+L E++ G+ P +D F + ++ H+ R + K+ D
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKD 225
Query: 462 VISIV---DPV----LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514
++ + DP ++GN++ ++ +E+R P + V + D
Sbjct: 226 ILEKLFERDPTRRLGVVGNIRGHPFFKTINWTA--LEKRELD-PPFKPKVKSPSDYSNF- 281
Query: 515 KGGDQKFSSSSSKGQSSRKTLLTS 538
D++F S + S K L+ S
Sbjct: 282 ---DREFLSEKPRLSYSDKNLIDS 302
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 54/202 (26%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 242 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 300
++G G+FG VY K K+ G A K++ + ++ E+ +L+ +H +V L+G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 301 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 360
+ + ++ E+ G + D + +++ LT QI + LE L + IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAV-DAIMLELDRG----LTEPQIQVICRQMLEALQYLHSMKIIH 133
Query: 361 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE--- 417
RD+K+ N+LL ++ K++DFG+S + + L S GT ++ PE + + +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTPY 192
Query: 418 --KSDVYSFGVVLLELISGKKP 437
K+D++S G+ L+E+ + P
Sbjct: 193 DYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 10/199 (5%)
Query: 243 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPLIG 298
+GKG FG V +++ GK A K + + + + E +L +++ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
E + LV M+ G L+ ++ N D + A + GLE L I
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPG-FDEQRAIFYAAELCCGLEDLQ---RERI 123
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
++RD+K NILLD ++SD GL+ Q E T V GTVGY+ PE N++ T
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVINNEKYTFS 181
Query: 419 SDVYSFGVVLLELISGKKP 437
D + G ++ E+I G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 28/217 (12%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE--VAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVPL 296
K I G++G+VY + K+ ++ KI + R Q Q E +L+ + +V +
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 297 IGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
+C E +R L V EY+ G L ++ P+D + R+ A + LEYLH
Sbjct: 67 --FCSFETKRHLCMVMEYVEGGDCATLLK-NIGALPVD-MARMYFA-ETVLALEYLH--- 118
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT------HISSVAR--------G 400
N GI+HRD+K N+L+ K++DFGLS+ LT HI R G
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 401 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
T Y+ PE Q + D ++ G++L E + G P
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 58/213 (27%), Positives = 92/213 (43%), Gaps = 45/213 (21%)
Query: 242 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT---EVALLSRI-HHRNLVPL 296
KIG+G+F V + K GK A+K M Q V E+ L R+ H N++ L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ--VNNLREIQALRRLSPHPNILRL 63
Query: 297 IGYC-EEEHQRI-LV--------YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 346
I + + R+ LV YE + + R ++ ++ +L K
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELI-----KGRKRPLPEKRVKSYMYQL------LKS 112
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 406
L+++H GI HRD+K NIL+ + K++DFG R + ++ T Y
Sbjct: 113 LDHMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS--TRWYRA 166
Query: 407 PE------YYGNQQLTEKSDVYSFGVVLLELIS 433
PE YYG K D+++ G V E++S
Sbjct: 167 PECLLTDGYYG-----PKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 63/221 (28%), Positives = 116/221 (52%), Gaps = 28/221 (12%)
Query: 232 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKE----VAVKIMADSCSHRT-QQFVTEVALL 285
L+E K +G G+FG+VY G + DG+ VA+K++ ++ S + ++ + E ++
Sbjct: 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVM 63
Query: 286 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL-------RDRLHGSVNQKPLDWLTRLQ 338
+ + + L+G C + LV + M G L +DR+ GS Q L+W ++
Sbjct: 64 AGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRI-GS--QDLLNWCVQI- 118
Query: 339 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 397
AKG+ YL ++HRD+ + N+L+ K++DFGL+R + D T +
Sbjct: 119 -----AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADG 170
Query: 398 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ + ++ E +++ T +SDV+S+GV + EL++ G KP
Sbjct: 171 GKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 61/212 (28%), Positives = 107/212 (50%), Gaps = 35/212 (16%)
Query: 242 KIGKGSFGSVYYGKMK-DGKEVAVK-IMAD-------SCSHRTQQFVTEVALLSRIHHRN 292
KIG+G++G VY + K G+ VA+K I + S + R E++LL ++H N
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR------EISLLKELNHPN 59
Query: 293 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 349
+V L+ E++ LV+E++ L ++ PL L I + +G+ Y
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLD-----LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL---THISSVARGTVGYLD 406
H+ ++HRD+K N+L+D K++DFGL+R + TH V T+ Y
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH--EVV--TLWYRA 167
Query: 407 PE-YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
PE G++Q + D++S G + E+++ ++P
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 30/207 (14%)
Query: 243 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPLIG 298
+G GSFG V K K G+ A+K + + +Q E ++L + H +V ++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK--------GLEYL 350
++E++ + E++ G L L + P +D AK EYL
Sbjct: 86 SFQDENRVYFLLEFVVGGELFTHLR-KAGRFP----------NDVAKFYHAELVLAFEYL 134
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410
H + II+RD+K N+LLD KV+DFG +++ + + GT YL PE
Sbjct: 135 H---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC----GTPEYLAPEVI 187
Query: 411 GNQQLTEKSDVYSFGVVLLELISGKKP 437
++ + D ++ GV+L E I+G P
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 236 TNNFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHR 291
NF +GKGSFG V + K E+ A+KI+ + + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 292 NLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLE 348
+ + C + R+ V EY++ G L + G + + A + + GL
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP-----QAVFYAAEISVGLF 115
Query: 349 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 408
+LH GII+RD+K N++LD K++DFG+ ++ D + GT Y+ PE
Sbjct: 116 FLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPE 171
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
Q + D +++GV+L E+++G+ P ED
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 5e-12
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 31/214 (14%)
Query: 242 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQ--------QFVTEVALLSRIH--- 289
+IG G++G+VY + G VA+K S R Q V EVALL R+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALK------SVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 290 HRNLVPLIGYC-----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 344
H N+V L+ C + E + LV+E++ + LR L V L T +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLD-KVPPPGLPAETIKDLMRQFL 118
Query: 345 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 404
+GL++LH C I+HRD+K NIL+ + K++DFGL+R + V T+ Y
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWY 173
Query: 405 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 438
PE D++S G + E+ +KP+
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 67/233 (28%), Positives = 104/233 (44%), Gaps = 25/233 (10%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRIHHRNL 293
K +GKGSFG V ++K E+ AVK I+ D T +AL + H L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFL 58
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
L + + + V EY++ G L + D A + GL++LH
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLH-- 113
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDPEYYG 411
GII+RD+K N+LLD K++DFG+ ++ T S GT Y+ PE
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILS 169
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKPVSVED----FGAELNI-VHWARSMIKK 459
Q D ++ GV+L E+++G+ P +D F + L V + R + K+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKE 222
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYC 300
++G G+FG VY + K+ +A + D+ S + ++ E+ +L+ H N+V L+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 301 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIH 360
E+ ++ E+ G + D + + ++PL + + L YLH IIH
Sbjct: 72 YYENNLWILIEFCAGGAV-DAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH---ENKIIH 126
Query: 361 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-----GNQQL 415
RD+K+ NIL ++ K++DFG+S + + S GT ++ PE ++
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPY 185
Query: 416 TEKSDVYSFGVVLLELISGKKP 437
K+DV+S G+ L+E+ + P
Sbjct: 186 DYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 16/205 (7%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 297
+KIG+G++G VY G+ K G+ VA+K I +S + E++LL + H N+V L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
+E + L++E++ + L+ L + +D + +G+ + H+
Sbjct: 66 DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RR 121
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE-YYGNQ 413
++HRD+K N+L+D K++DFGL+R TH V T+ Y PE G+
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTH--EVV--TLWYRAPEVLLGSP 177
Query: 414 QLTEKSDVYSFGVVLLELISGKKPV 438
+ + D++S G + E+ + KKP+
Sbjct: 178 RYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 41/111 (36%), Positives = 63/111 (56%), Gaps = 7/111 (6%)
Query: 330 PLDWLTRLQIAHDAAKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388
PLD L+ + A+G+++L + C IHRDV + N+LL AK+ DFGL+R
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIM 263
Query: 389 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
D + + AR V ++ PE + T +SDV+S+G++L E+ S GK P
Sbjct: 264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 14/169 (8%)
Query: 277 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 336
Q + E+ +L + +V G + + + E+M G+L D++ + P + L +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGK 107
Query: 337 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 396
+ IA +GL YL I+HRDVK SNIL++ K+ DFG+S Q I S
Sbjct: 108 VSIA--VLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDS 157
Query: 397 VAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
+A GT Y+ PE + +SD++S G+ L+EL G+ P+ D
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 65/216 (30%), Positives = 106/216 (49%), Gaps = 36/216 (16%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLI 297
K IG+G++G V K + ++VA+K +A++ +R T E+ LL + H N++ +
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 298 GYCEEEHQRI-----LVYEYMHNGTLRDRLHGSV--NQKPLD-----WLTRLQIAHDAAK 345
H+ +VYE M LH + +Q D +L +L +
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQL------LR 119
Query: 346 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVG 403
GL+Y+H+ ++HRD+K SN+LL+ N K+ DFGL+R E ++ V R
Sbjct: 120 GLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR---W 173
Query: 404 YLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPV 438
Y PE N + T DV+S G + EL+ G+KP+
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 32/210 (15%)
Query: 241 KKIGKGSFGSVYYG-KMKDGKEVAVK-----IMADSCSHRTQQFVTEVALLSRIHHRNLV 294
K++G G++G+V + G +VA+K ++ + R + E+ LL + H N++
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR---ELRLLKHMKHENVI 77
Query: 295 PLIGY------CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKG 346
L+ + H LV +M GT +L H +++ + +L + KG
Sbjct: 78 GLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLV-----YQMLKG 130
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 406
L+Y+H GIIHRD+K N+ ++ + K+ DFGL+RQ + ++T T Y
Sbjct: 131 LKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVV----TRWYRA 183
Query: 407 PEYYGN-QQLTEKSDVYSFGVVLLELISGK 435
PE N T+ D++S G ++ E+++GK
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 36/213 (16%)
Query: 242 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI- 297
IG+G++G V K G +VA+K ++ H+T Q+ + E+ +L R H N++ ++
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKIS-PFEHQTFCQRTLREIKILRRFKHENIIGILD 70
Query: 298 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPL--DWLTRL--QIAHDAAKGLEY 349
E + +V E M L+ + + L D + QI +GL+Y
Sbjct: 71 IIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQIL----RGLKY 121
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS------VARGTVG 403
+H N ++HRD+K SN+LL+ N K+ DFGL+R A D H + VA T
Sbjct: 122 IH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIA--DPEHDHTGFLTEYVA--TRW 174
Query: 404 YLDPEYYGNQQLTEKS-DVYSFGVVLLELISGK 435
Y PE N + K+ D++S G +L E++S +
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 34/81 (41%), Positives = 50/81 (61%), Gaps = 1/81 (1%)
Query: 51 LKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSL 109
L G IPP + +++ L L L N L+G +P++ +L +L I+HL +N TG +P + SL
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSL 331
Query: 110 PNLQELHIENNSFVGEIPPAL 130
P LQ L + +N F GEIP L
Sbjct: 332 PRLQVLQLWSNKFSGEIPKNL 352
|
Length = 968 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLS-RIHHRNLVP 295
K +GKGSFG V ++K EV A+K++ + +TE +L+ H L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
L + + + V EY++ G L ++ S + D A + L +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH-- 115
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYGNQ 413
G+I+RD+K NILLD K++DFG+ ++ T + GT Y+ PE
Sbjct: 116 -GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQEL 171
Query: 414 QLTEKSDVYSFGVVLLELISGKKPVSVED 442
+ D ++ GV++ E+++G+ P ++
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADN 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 67/218 (30%), Positives = 108/218 (49%), Gaps = 33/218 (15%)
Query: 243 IGKGSFGSVYYGKMKD---------GKEVAVKI-MADSCSHRTQQFVTEVALLSRIHHRN 292
+G+G+F ++Y G ++ G+EV+V + + S + F +L+S++ H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 293 LVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
LV L G C +E+ I+V EY+ G L LH N L W L +A A L YL
Sbjct: 63 LVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLE 118
Query: 352 TGCNPGIIHRDVKSSNILL---DINMR----AKVSDFGLSRQAEEDLTHISSVARGTVGY 404
+ ++H +V NIL+ +N K+SD G+ L+ V R + +
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV---LSREERVER--IPW 170
Query: 405 LDPEYYGNQQ--LTEKSDVYSFGVVLLELIS-GKKPVS 439
+ PE N Q LT +D +SFG LLE+ S G++P+S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 65/244 (26%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQFVT----EVALLSRIHHRN 292
K +GKG +G V+ + G + A+K++ + R Q+ E +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 293 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS---VNQKPLDWLTRLQIAHDAAKGLEY 349
+V LI + + L+ EY+ G L L + +L+ + +A LE+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA------LEH 115
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDP 407
LH GII+RD+K NILLD K++DFGL +++ E +TH GT+ Y+ P
Sbjct: 116 LHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAP 169
Query: 408 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED--------FGAELNI----VHWARS 455
E + D +S G ++ ++++G P + E+ +LN+ AR
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARD 229
Query: 456 MIKK 459
++KK
Sbjct: 230 LLKK 233
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 52/169 (30%), Positives = 83/169 (49%), Gaps = 14/169 (8%)
Query: 277 QFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR 336
Q + E+ +L + +V G + + + E+M G+L D++ + P L +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGK 107
Query: 337 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 396
+ IA KGL YL I+HRDVK SNIL++ K+ DFG+S Q I S
Sbjct: 108 VSIA--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDS 157
Query: 397 VAR---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
+A GT Y+ PE + +SD++S G+ L+E+ G+ P+ D
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 27/208 (12%)
Query: 243 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV-----PL 296
IG+G FG VY + D GK A+K + D + +Q T +AL RI +LV P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGET-LALNERIM-LSLVSTGDCPF 58
Query: 297 I---GYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
I Y ++ + + M+ G L L HG ++ + + A + GLE++
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY-----AAEIILGLEHM 113
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410
H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ PE
Sbjct: 114 H---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVL 167
Query: 411 GNQQLTEKS-DVYSFGVVLLELISGKKP 437
+ S D +S G +L +L+ G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 52/201 (25%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 243 IGKGSFGSV------YYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 296
+GKG FG V GKM K++ K + + + E +L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMA--LLEKEILEKVNSPFIVNL 58
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
E + LV M+ G L+ ++ +V ++ L+ + + G+ +LH+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIY-NVGERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 416
I++RD+K N+LLD ++SD GL+ + ++ T I+ A GT GY+ PE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-ITQRA-GTNGYMAPEILKEEPYS 172
Query: 417 EKSDVYSFGVVLLELISGKKP 437
D ++ G + E+++G+ P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 241 KKIGKGSFGSVYY----GKMKDGKEVAVKIMADSC---SHRTQQFV-TEVALLSRIHHRN 292
+ +G G++G V+ G GK A+K++ + +T + TE +L +
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 293 -LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
LV L + + + L+ +Y++ G L L+ + + R+ IA + L++LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE--VRVYIA-EIVLALDHLH 122
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 408
GII+RD+K NILLD ++DFGLS++ EE+ + GT+ Y+ PE
Sbjct: 123 ---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC---GTIEYMAPE 176
Query: 409 YY--GNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
G+ + D +S GV+ EL++G P +V+
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 3e-11
Identities = 68/237 (28%), Positives = 107/237 (45%), Gaps = 53/237 (22%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR------TQQFVTEVALLSRIHHRNLV 294
KKIG G FG V+ K K +E + S+R Q V EV ++ + H+N+V
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEF---FCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIV 75
Query: 295 PLIG-YCEEEHQRI-LVYEYMHNGTLRD------RLHGSVNQKPLDWLTRLQIAHDAAKG 346
I + + +Q++ ++ E+ G L ++ G + + + +TR Q+ H
Sbjct: 76 RYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR-QLLH----A 130
Query: 347 LEYLHT---GCN-PGIIHRDVKSSNILLDINMR-----------------AKVSDFGLSR 385
L Y H G N ++HRD+K NI L +R AK+ DFGLS+
Sbjct: 131 LAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
Query: 386 QAEEDLTHISSVARGTVG---YLDPEY--YGNQQLTEKSDVYSFGVVLLELISGKKP 437
I S+A VG Y PE + + +KSD+++ G ++ EL SGK P
Sbjct: 191 N-----IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 241 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 296
+ IGKG G VY + VA+K + + S ++F+ E + + + H +VP+
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTR----LQIAHDAAKGL 347
C + Y+ TL+ L SV Q K L T L I H +
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLK-SVWQKESLSKELAEKTSVGAFLSIFHKICATI 126
Query: 348 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG--LSRQAEEDLTHISSVAR------ 399
EY+H+ G++HRD+K NILL + + D+G + ++ EE+ V
Sbjct: 127 EYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183
Query: 400 ---------GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 443
GT Y+ PE +E +D+Y+ GV+L ++++ P +
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236
|
Length = 932 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 3e-11
Identities = 58/232 (25%), Positives = 96/232 (41%), Gaps = 42/232 (18%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEV-AVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 296
K +GKG G V+ ++K ++ A+K++ ++ ++ +TE +L+ + H L L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK---GLEYLHTG 353
+ E LV +Y G L + ++P L+ AA+ LEYLH
Sbjct: 67 YASFQTETYLCLVMDYCPGG----ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH-- 120
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA----------------------EEDL 391
GI++RD+K NILL + +SDF LS+Q+
Sbjct: 121 -LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179
Query: 392 THI-SSVAR-----GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
T R GT Y+ PE D ++ G++L E++ G P
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 241 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 297
K IG G+ G V G VAVK ++ ++T ++ E+ LL ++H+N++ L+
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 86
Query: 298 GY------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
EE LV E M + L +H ++ + + +L + G+++LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYLLYQMLC-----GIKHLH 140
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 411
+ GIIHRD+K SNI++ + K+ DFGL+R A + V T Y PE
Sbjct: 141 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVIL 195
Query: 412 NQQLTEKSDVYSFGVVLLELISG 434
E D++S G ++ EL+ G
Sbjct: 196 GMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 69/268 (25%), Positives = 112/268 (41%), Gaps = 75/268 (27%)
Query: 241 KKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRN 292
K +G G+FG V K VAVK++ + + + ++E+ +L I +H N
Sbjct: 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72
Query: 293 LVPLIGYCEEEHQRILV-YEYMHNGTL---------------------RDRLHGSVNQKP 330
+V L+G C + + ++V E+ G L R R V Q
Sbjct: 73 VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132
Query: 331 LD--------------------------------WLTRLQI------AHDAAKGLEYLHT 352
+D W + L + + A+G+E+L +
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192
Query: 353 -GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYY 410
C IHRD+ + NILL N K+ DFGL+R +D ++ AR + ++ PE
Sbjct: 193 RKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESI 248
Query: 411 GNQQLTEKSDVYSFGVVLLELIS-GKKP 437
++ T +SDV+SFGV+L E+ S G P
Sbjct: 249 FDKVYTTQSDVWSFGVLLWEIFSLGASP 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 56/207 (27%), Positives = 105/207 (50%), Gaps = 22/207 (10%)
Query: 242 KIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVT---EVALLSRIHHRNLVPL 296
+I +G++G VY + K G+ VA+K + + + +T E+ +L ++ H N+V +
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEK--EKEGFPITSLREINILLKLQHPNIVTV 69
Query: 297 --IGYCEEEHQRILVYEYMHNG--TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
+ + +V EY+ + +L + + Q + L LQ+ G+ +LH
Sbjct: 70 KEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM-LQLL----SGVAHLHD 124
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 411
I+HRD+K+SN+LL+ K+ DFGL+R+ L + + T+ Y PE G
Sbjct: 125 NW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELLLG 180
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKPV 438
++ + D++S G + EL++ KKP+
Sbjct: 181 AKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 30/207 (14%)
Query: 243 IGKGSFGSV---YYGKMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPL 296
+G G++GSV Y +++ ++VAVK ++ S H + + E+ LL + H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGL 79
Query: 297 IGY------CEEEHQRILVYEYMHNGTLRDRLHGSVN-QKPLDWLTRLQIAHDAAKGLEY 349
+ E ++ LV M L+ V QK D + I + +GL+Y
Sbjct: 80 LDVFTPATSIENFNEVYLVTNLMGAD-----LNNIVKCQKLSDEHVQFLI-YQLLRGLKY 133
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
+H+ GIIHRD+K SN+ ++ + ++ DFGL+RQA++++T VA T Y PE
Sbjct: 134 IHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT--GYVA--TRWYRAPEI 186
Query: 410 YGN-QQLTEKSDVYSFGVVLLELISGK 435
N + D++S G ++ EL+ GK
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 25/210 (11%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 296
K IG+G+FG V + K ++V A+K+++ R+ F E +++ + +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+++ +V EYM G L + + S P W + A + L+ +H+
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKW-AKFYTA-EVVLALDAIHS---M 161
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-------- 408
G+IHRDVK N+LLD + K++DFG + +E A GT Y+ PE
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 409 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
YYG + D +S GV L E++ G P
Sbjct: 222 GYYGRE-----CDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEV-ALLSRIHHRNLVP 295
K IGKGSFG V + K + K AVK++ + ++E LL + H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
L + + V +Y++ G L H + L+ R A + A L YLH+
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELF--YHLQRERCFLEPRARFYAA-EIASALGYLHS--- 114
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 415
I++RD+K NILLD ++DFGL ++ E S+ GT YL PE Q
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPY 173
Query: 416 TEKSDVYSFGVVLLELISGKKP 437
D + G VL E++ G P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 243 IGKGSFGSVYYG-KMKDGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNLVPLI- 297
+G G++GSV K G VAVK ++ S H + + E+ LL + H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83
Query: 298 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
EE + + ++ L + + QK D + I + +GL+Y+H+
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLI-YQILRGLKYIHSA 139
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN- 412
IIHRD+K SN+ ++ + K+ DFGL+R ++++T VA T Y PE N
Sbjct: 140 ---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVA--TRWYRAPEIMLNW 192
Query: 413 QQLTEKSDVYSFGVVLLELISGK 435
+ D++S G ++ EL++G+
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 243 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRN---LVP 295
IGKG+FG VY + KD + + A+K+++ ++ + E +L R +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
L + + LV +YM G L L G ++ + IA + LE+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDR----AKFYIA-ELVLALEHLHKY 115
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLDPEYYG 411
I++RD+K NILLD + DFGLS+ + T+ GT YL PE
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPEVLL 169
Query: 412 NQQ-LTEKSDVYSFGVVLLELISGKKPVSVED 442
+++ T+ D +S GV++ E+ G P ED
Sbjct: 170 DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 36/223 (16%)
Query: 243 IGKGSFGSVYYGK-MKDGKEVAVKI-----MADSCSHRTQQFVTEVALLSRIH------- 289
+G G+ G+V K + DG+ AVK+ M+++ +R Q EV L
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQ---AEVCCLLNCDFFSIVKC 96
Query: 290 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 348
H + E I LV +Y + G LR + K R H+A GL
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEI------KSRAKTNRTFREHEA--GLL 148
Query: 349 YL------HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--- 399
++ H + +IHRD+KS+NILL N K+ DFG S+ ++ V R
Sbjct: 149 FIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVS--DDVGRTFC 206
Query: 400 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
GT Y+ PE + + ++K+D++S GV+L EL++ K+P E+
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 56/207 (27%), Positives = 102/207 (49%), Gaps = 27/207 (13%)
Query: 241 KKIGKGSFGSVYYG-KMKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 295
K++G G++GSV + G++VA+K + S +++ F E+ LL + H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHMQHENVIG 78
Query: 296 LIGY------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 349
L+ +E LV YM + H +++ + +L + GL+Y
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH-PLSEDKVQYLV-----YQMLCGLKY 132
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
+H+ GIIHRD+K N+ ++ + K+ DFGL+R A+ ++T T Y PE
Sbjct: 133 IHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV----TRWYRAPEV 185
Query: 410 YGN-QQLTEKSDVYSFGVVLLELISGK 435
N + D++S G ++ E+++GK
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 243 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 293
IG+GS+ V ++K ++ A+K++ H +T++ V E A + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF----L 58
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
V L + + LV EY++ G L H +K + R A + L +LH
Sbjct: 59 VGLHSCFQTTSRLFLVIEYVNGGDLM--FHMQRQRKLPEEHARFYAA-EICIALNFLH-- 113
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 413
GII+RD+K N+LLD + K++D+G+ ++ S+ GT Y+ PE +
Sbjct: 114 -ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRGE 171
Query: 414 QLTEKSDVYSFGVVLLELISGKKPVSV 440
+ D ++ GV++ E+++G+ P +
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 9e-11
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 33/211 (15%)
Query: 243 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI--GY 299
IG+G FG VY + D GK A+K + D + +Q T +AL RI ++ L+ G
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCL-DKKRIKMKQGET-LALNERI----MLSLVSTGD 55
Query: 300 C----------EEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 347
C + + + M+ G L L HG ++K + + A + GL
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY-----ATEIILGL 110
Query: 348 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 407
E++H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ P
Sbjct: 111 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164
Query: 408 EYYGNQQLTEKS-DVYSFGVVLLELISGKKP 437
E + S D +S G +L +L+ G P
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 68/272 (25%), Positives = 108/272 (39%), Gaps = 64/272 (23%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 296
K IG+G+FG V + KD G A+K + S +Q E +L+ + +V L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 297 IGYC--EEEHQRILVYEYMHNG---TL---RDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 348
Y ++E+ L+ EY+ G TL +D TR IA + ++
Sbjct: 67 --YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE--------TRFYIA-ETILAID 115
Query: 349 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL--------SRQAEEDLTHISS---- 396
+H G IHRD+K N+LLD K+SDFGL + L+H
Sbjct: 116 SIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 397 ----------------------VARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLEL 431
+A TVG Y+ PE + ++ D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 432 ISGKKP-VSVEDFGAELNIVHWARSMIKKGDV 462
+ G P S I++W ++ +V
Sbjct: 233 LVGYPPFCSDNPQETYRKIINWKETLQFPDEV 264
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 243 IGKGSFGSVYYGKMKDGKEV-AVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIG 298
IGKGSFG V + +D + + A+K + + + E +L++++ +VPL
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+ + LV +++ G L L G + R A + LE LH
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDL----SRARFYTA-ELLCALENLHKF--- 112
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQ 414
+I+RD+K NILLD + DFGL + ++D T+ GT YL PE
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC---GTPEYLAPELLLGHG 169
Query: 415 LTEKSDVYSFGVVLLELISGKKPVSVED 442
T+ D ++ GV+L E+++G P E+
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFYDEN 197
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 30/232 (12%)
Query: 243 IGKGSFGSVYYGKMKDGKEV-AVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+G+G FG V + K ++ A+K+M S F E +LS + + L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD------WLTRLQIAHDAAKGLEYLHT 352
+++ LV EY G L L + + D +L L +A +H+
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLA---------IHS 117
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY--- 409
G +HRD+K N+L+D K++DFG + + + S + GT Y+ PE
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 410 ---YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVHWARSM 456
G + D +S GV+ E+I G+ P E A+ NI+++ R +
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH-EGTSAKTYNNIMNFQRFL 228
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 24/205 (11%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVT-----EVALLSRIHHRNLV 294
+K+G+GS+ +VY G + +G+ VA+K++ S +T++ V E +LL + H N+V
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALKVI----SMKTEEGVPFTAIREASLLKGLKHANIV 66
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP--LDWLTRLQIAHDAAKGLEYLHT 352
L + V+EYMH L + Q P L +GL Y+H
Sbjct: 67 LLHDIIHTKETLTFVFEYMHTD-----LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH- 120
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPE-YY 410
I+HRD+K N+L+ K++DFGL+R ++ T+ S V T+ Y P+
Sbjct: 121 --GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLL 176
Query: 411 GNQQLTEKSDVYSFGVVLLELISGK 435
G + D++ G + +E++ G+
Sbjct: 177 GATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEV-AVKIMAD-SCSHRTQQ--FVTEVALLSRIHHRNLVPL 296
K IG+G+FG V + K ++V A+K+++ R+ F E +++ + +V L
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+++ +V EYM G L + + S P W R A + L+ +H+
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKW-ARFYTA-EVVLALDAIHS---M 161
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-------- 408
G IHRDVK N+LLD + K++DFG + ++ A GT Y+ PE
Sbjct: 162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 409 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
YYG + D +S GV L E++ G P
Sbjct: 222 GYYGRE-----CDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 36/100 (36%), Positives = 55/100 (55%), Gaps = 7/100 (7%)
Query: 38 PPRITKIA------LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 90
P +T + L+ L G+IP EL M++L ++L N L+G +P ++ L L
Sbjct: 181 PNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH 240
Query: 91 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+ L N LTG +PS +G+L NLQ L + N G IPP++
Sbjct: 241 LDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSI 280
|
Length = 968 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 36/212 (16%)
Query: 241 KKIGKGSFGSV---YYGKMKDGKEVAVKIMADSCSHRTQQFVT-------EVALLSRIHH 290
K IG G+ G V Y G+ VA+K ++ R Q VT E+ L+ ++H
Sbjct: 22 KPIGSGAQGIVCAAYD--TVTGQNVAIKKLS-----RPFQNVTHAKRAYRELVLMKLVNH 74
Query: 291 RNLVPLIGYCE-----EEHQRI-LVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 343
+N++ L+ EE Q + LV E M N L V Q LD + +
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN------LC-QVIQMDLDHERMSYLLYQM 127
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 403
G+++LH + GIIHRD+K SNI++ + K+ DFGL+R A V T
Sbjct: 128 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRY 182
Query: 404 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 435
Y PE E D++S G ++ E+I G
Sbjct: 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 42/160 (26%), Positives = 83/160 (51%), Gaps = 5/160 (3%)
Query: 280 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQ 338
+E+ L+ H +V + + + +L+ EY G L ++ + + P
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173
Query: 339 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSV 397
+ + L+ +H+ ++HRD+KS+NI L K+ DFG S+Q + ++ ++S
Sbjct: 174 LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 398 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
GT YL PE + ++ ++K+D++S GV+L EL++ +P
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 38/97 (39%), Positives = 58/97 (59%), Gaps = 7/97 (7%)
Query: 344 AKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGT 401
A+G+E+L + C IHRD+ + NILL N K+ DFGL+R +D ++ AR
Sbjct: 183 ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 402 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ ++ PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP 275
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-10
Identities = 49/162 (30%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 230 PELEEATNNFCKKIGKGSFGSVYYG-KMKDGKEVAVKIMADS---CSHRTQQFVTEVALL 285
P +EE K I +G+FG VY G K + K AVK++ + + Q E L
Sbjct: 1 PSIEEFV--IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL 58
Query: 286 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDA 343
+ +V L + + LV EY+ G ++ LH G +++ ++ +
Sbjct: 59 ALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEE-----MAVKYISEV 113
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385
A L+YLH GIIHRD+K N+L+ K++DFGLS+
Sbjct: 114 ALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 24/204 (11%)
Query: 242 KIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
K+G+G++ +V+ G+ K VA+K I + + EV+LL + H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA-------KGLEYLHT 352
E LV+EY+ + ++ LD L H+ +GL Y H
Sbjct: 72 IHTERCLTLVFEYLDSDL----------KQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH- 120
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYG 411
I+HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G
Sbjct: 121 --KRKILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLG 177
Query: 412 NQQLTEKSDVYSFGVVLLELISGK 435
+ + + D++ G +L E+ +G+
Sbjct: 178 STEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 39/109 (35%), Positives = 58/109 (53%), Gaps = 5/109 (4%)
Query: 331 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390
LD L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 391 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ + AR V ++ PE N T +SDV+S+G++L E+ S G P
Sbjct: 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 48/196 (24%), Positives = 76/196 (38%), Gaps = 60/196 (30%)
Query: 20 GDPCVPV--PWEWVTC---STTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF 74
GDPCVP PW C ST I + L + L+G IP
Sbjct: 394 GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN----------------- 436
Query: 75 LTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL---- 130
D+S+L L+ ++L N + G++P +GS+ +L+ L + NSF G IP +L
Sbjct: 437 ------DISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490
Query: 131 -----------LTGKV------------IFKYDNNPKL-----HKESRRRMRFKLILGTS 162
L+G+V F + +N L + + +G +
Sbjct: 491 SLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLSVGAKIGIA 550
Query: 163 IGVLAILLVLFLCSLI 178
GV L L +C++
Sbjct: 551 FGVSVAFLFLVICAMC 566
|
Length = 623 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 243 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 293
IG+GS+ V ++K + + A+K++ + +T++ V E A +H L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA----SNHPFL 58
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
V L + E + V EY++ G L H +K + R A + + L YLH
Sbjct: 59 VGLHSCFQTESRLFFVIEYVNGGDLM--FHMQRQRKLPEEHARFYSA-EISLALNYLH-- 113
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 413
GII+RD+K N+LLD K++D+G+ ++ +S GT Y+ PE +
Sbjct: 114 -ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEILRGE 171
Query: 414 QLTEKSDVYSFGVVLLELISGKKPVSV 440
D ++ GV++ E+++G+ P +
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 6e-10
Identities = 58/236 (24%), Positives = 103/236 (43%), Gaps = 45/236 (19%)
Query: 239 FCKKIGKGSFG---SVYYGKMKDGKEVAVKIMADSCSHR--TQQFVTEVALLSRIH-HRN 292
K++G+G++G S + + + VA+K + + S + ++ + E+ LL H+N
Sbjct: 4 LIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKN 63
Query: 293 LVPLI--------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH--- 341
+ L + E + +YE + L + L AH
Sbjct: 64 ITCLYDMDIVFPGNFNE-----LYLYEELMEADLHQIIRSGQ---------PLTDAHFQS 109
Query: 342 ---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR----QAEEDLTHI 394
GL+Y+H+ ++HRD+K N+L++ + K+ DFGL+R E+ +
Sbjct: 110 FIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166
Query: 395 SS-VARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 448
+ VA T Y PE Q T+ DV+S G +L EL+ K +D+ +LN
Sbjct: 167 TEYVA--TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN 220
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 243 IGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQ--QFVTEVALLSRIHHRNLVP---- 295
IGKGS+G V G++VA+K + D H + + + E+ LL + H ++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 296 LIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 351
++ E + I +V+E M + LH + K D LT + + L+Y+H
Sbjct: 68 MLPPSRREFKDIYVVFELMESD-----LHQVI--KANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THI---SSVARGTVGYLDP 407
T + HRD+K NIL + + + K+ DFGL+R A D T I VA T Y P
Sbjct: 121 TA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVA--TRWYRAP 175
Query: 408 EYYGN--QQLTEKSDVYSFGVVLLELISGK 435
E G+ + T D++S G + E+++GK
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 39/97 (40%), Positives = 58/97 (59%), Gaps = 7/97 (7%)
Query: 344 AKGLEYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGT 401
AKG+E+L + C IHRD+ + NILL N K+ DFGL+R +D ++ AR
Sbjct: 189 AKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 402 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ ++ PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 241 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 296
K IG G+ G V Y + D + VA+K ++ ++T ++ E+ L+ ++H+N++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 297 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
+ EE Q + + + + L + ++ + + +L + G+++LH
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 136
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 411
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 137 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 191
Query: 412 NQQLTEKSDVYSFGVVLLELISGK 435
E D++S G ++ E++ K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 9e-10
Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 242 KIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 296
K+G+G++G VY K KDG KE A+K + + + E+ALL + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQK 65
Query: 297 IGYCEEEHQRILVYEYMHNG---TLRDRLHGSVNQKPLDWLTRL--QIAHDAAKGLEYLH 351
+ + + L+++Y + ++ N+KP+ + + + G+ YLH
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 352 TGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSV--ARGTVGYL 405
++HRD+K +NIL+ R K++D G +R L ++ + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 406 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 435
PE G + T+ D+++ G + EL++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 53/204 (25%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 241 KKIGKGSFGSV--YYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPL 296
K IG G+ G V Y + + + VA+K ++ ++T ++ E+ L+ ++H+N++ L
Sbjct: 30 KPIGSGAQGIVCAAYDAILE-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGL 88
Query: 297 IGYCE-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
+ EE Q + + + + L + ++ + + +L + G+++LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLC-----GIKHLH 143
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 411
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 144 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 198
Query: 412 NQQLTEKSDVYSFGVVLLELISGK 435
E D++S G ++ E+I G
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 60/241 (24%), Positives = 111/241 (46%), Gaps = 53/241 (21%)
Query: 242 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQF----VTEVALLSRIHHRNLVP 295
KIG+G+FG V+ + K K+ VA+K ++ + + + F + E+ +L + H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLME---NEKEGFPITALREIKILQLLKHENVVN 75
Query: 296 LIGYCEEEHQR--------ILVYEYM-HNGTLRDRLHGSVNQKPLDW-LTRLQ-IAHDAA 344
LI C + LV+E+ H+ L G ++ K + + L+ ++ +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEHD------LAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 345 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGT 401
GL Y+H I+HRD+K++NIL+ + K++DFGL+R ++ + + T
Sbjct: 130 NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186
Query: 402 VGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 460
+ Y PE G + D++ G ++ E+ W RS I +G
Sbjct: 187 LWYRPPELLLGERDYGPPIDMWGAGCIMAEM--------------------WTRSPIMQG 226
Query: 461 D 461
+
Sbjct: 227 N 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 37/213 (17%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQ--------FVTEVALLSRIHHR 291
+KIG+G++G VY + + E +A+K + R +Q + E++LL + H
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKI------RLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA----HDAAKGL 347
N+V L E + LV+EY L L ++ P D+ ++ + +G+
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSP-DFAKNPRLIKTYLYQILRGI 115
Query: 348 EYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGTVG 403
Y H+ ++HRD+K N+L+D A K++DFGL+R TH V T+
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH--EVV--TLW 168
Query: 404 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISGK 435
Y PE G++ + D++S G + E+++ K
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 53/219 (24%), Positives = 99/219 (45%), Gaps = 32/219 (14%)
Query: 241 KKIGKGSFGSVYY----GKMKDGKEVAVKIMADSC---SHRTQQFV-TEVALLSRIHHRN 292
K +G G++G V+ GK A+K++ + +T + TE +L +
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 293 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK------ 345
+ + Y + ++ L+ +Y+ G + L+ R + D +
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-----------QRDNFSEDEVRFYSGEI 114
Query: 346 --GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 403
LE+LH GI++RD+K NILLD ++DFGLS++ + + GT+
Sbjct: 115 ILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 404 YLDPEYYGNQQLTEKS-DVYSFGVVLLELISGKKPVSVE 441
Y+ PE + K+ D +S G+++ EL++G P ++E
Sbjct: 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 37/219 (16%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-- 297
+ +G GS G V+ D K VAVK + + + + E+ ++ R+ H N+V +
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 298 ----GYCEEEHQRIL--------VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 345
G E L V EYM L + Q PL + +
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLSEEHARLFMYQLLR 125
Query: 346 GLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVG- 403
GL+Y+H+ ++HRD+K +N+ ++ ++ K+ DFGL+R + +H ++ G V
Sbjct: 126 GLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 404 -------YLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 435
L P Y T+ D+++ G + E+++GK
Sbjct: 183 WYRSPRLLLSPNNY-----TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 35/85 (41%), Positives = 49/85 (57%), Gaps = 1/85 (1%)
Query: 44 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSL 102
I L NL GEIP E+ + +L L L N LTGP+P + L +L+ + L N+L+G +
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 103 PSYMGSLPNLQELHIENNSFVGEIP 127
P + SL L L + +NS GEIP
Sbjct: 277 PPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 51/211 (24%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 242 KIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 296
K+G+G++G VY K KDG ++ A+K + + + E+ALL + H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQK 65
Query: 297 IGYCEEEHQRILVYEYMHNG---TLRDRLHGSVNQKPLDWLTRL--QIAHDAAKGLEYLH 351
+ + + L+++Y + ++ N+KP+ + + + G+ YLH
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 352 TGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSV--ARGTVGYL 405
++HRD+K +NIL+ R K++D G +R L ++ + T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 406 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 435
PE G + T+ D+++ G + EL++ +
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 242 KIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
K+G+G++ +VY G+ K VA+K I + + EV+LL + H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 300 CEEEHQRILVYEYMHNGTLR--DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
E LV+EY+ + D S+N + L Q+ +GL Y H
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVK-LFLFQLL----RGLNYCH---RRK 124
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLT 416
++HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G+ +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183
Query: 417 EKSDVYSFGVVLLELISGK 435
+ D++ G + E+ +G+
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 53/209 (25%), Positives = 94/209 (44%), Gaps = 36/209 (17%)
Query: 242 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ-------FVTEVALLSRIHHRNL 293
K+G+GS+ +VY G+ K G+ VA+K + R + + E +LL + H N+
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEI------RLEHEEGAPFTAIREASLLKDLKHANI 65
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA-------KG 346
V L + LV+EY+ D ++ +D H+ +G
Sbjct: 66 VTLHDIIHTKKTLTLVFEYLD----TDL------KQYMDDCGGGLSMHNVRLFLFQLLRG 115
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 406
L Y H ++HRD+K N+L+ K++DFGL+R A+ + S T+ Y
Sbjct: 116 LAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVVTLWYRP 171
Query: 407 PE-YYGNQQLTEKSDVYSFGVVLLELISG 434
P+ G+ + + D++ G + E+ +G
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGK--EVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRN 292
NF + +G GSFG V K+ VA+K S + +Q +E +L+ I+H
Sbjct: 33 NFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 293 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
V L G ++E LV E++ G L + + P D A EYL +
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPND--VGCFYAAQIVLIFEYLQS 149
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
I++RD+K N+LLD + K++DFG ++ + T ++ GT Y+ PE N
Sbjct: 150 ---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD---TRTYTLC-GTPEYIAPEILLN 202
Query: 413 QQLTEKSDVYSFGVVLLELISGKKP 437
+ +D ++ G+ + E++ G P
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 243 IGKGSFGSVYYGKMKDGKEV-AVKIMADSCSH--------RTQQFVTEVALLSRIHHRNL 293
IG+GS+ V ++K + + A+K++ + +T++ V E A +H L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETA----SNHPFL 58
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
V L + E + V E++ G L H +K + R A + + L +LH
Sbjct: 59 VGLHSCFQTESRLFFVIEFVSGGDLM--FHMQRQRKLPEEHARFYSA-EISLALNFLHER 115
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHISSVARGTVGYLDPEYYG 411
GII+RD+K N+LLD K++D+G+ ++ D T S GT Y+ PE
Sbjct: 116 ---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILR 169
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKP 437
+ D ++ GV++ E+++G+ P
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 243 IGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLIGY 299
+G+G++G V + K+ KE VA+K DS + + T E+ +L + N+V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 300 CEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+ LV+EY+ L + +G +K ++ +L K + + H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL------IKAIHWCHKN--- 119
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEYYGNQQ 414
I+HRD+K N+L+ N K+ DFG +R E + + VA T Y PE
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA--TRWYRSPELLLGAP 177
Query: 415 LTEKSDVYSFGVVLLELISGK 435
+ D++S G +L EL G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 54/200 (27%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE-VAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+K+G+G++ +V+ G+ K + VA+K I + + EV+LL + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+ LV+EY+ + L+ + G++ + QI +GL Y H
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQIL----RGLAYCH---RR 123
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQL 415
++HRD+K N+L++ K++DFGL+R A+ T S T+ Y P+ G+ +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 416 TEKSDVYSFGVVLLELISGK 435
+ + D++ G + E+ SG+
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 50/194 (25%), Positives = 85/194 (43%), Gaps = 24/194 (12%)
Query: 250 SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV--------PLIGYCE 301
S GK K + +A ++ A S Q E+ L R++H N++ Y
Sbjct: 184 STNQGKPKCERLIAKRVKAGS--RAAIQLENEILALGRLNHENILKIEEILRSEANTYMI 241
Query: 302 EEHQRILVYEYMHNGTL--RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
+ +Y +M++ +DR PL TR I +EY+H + +I
Sbjct: 242 TQKYDFDLYSFMYDEAFDWKDR--------PLLKQTR-AIMKQLLCAVEYIH---DKKLI 289
Query: 360 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 419
HRD+K NI L+ + + + DFG + E++ GTV PE E +
Sbjct: 290 HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEIT 349
Query: 420 DVYSFGVVLLELIS 433
D++S G++LL+++S
Sbjct: 350 DIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 17/213 (7%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVA---VKIMADSCSHRTQ-QFVTEVALLSRIHHRNLVPL 296
++IG G FG V ++ VA VK + + S + Q +F+ + + H N++
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKGLEYLHTGCN 355
+G C E +LV+EY G L+ L + L LQ +A + A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---K 117
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLS-RQAEEDLTHISSVARGTVGYLDPEYYGNQQ 414
+H D+ N L ++ KV D+G+ + +ED + +L PE G
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFH 177
Query: 415 -------LTEKSDVYSFGVVLLELI-SGKKPVS 439
T+ S+V++ GV L EL + +P S
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYS 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 35/216 (16%)
Query: 242 KIGKGSFGSVYYG-KMKDGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVP 295
IG G++G V + GK+VA+K + + + RT + E+ +L H N++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT---LRELKILRHFKHDNIIA 68
Query: 296 L--IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL---QIAHDAAKGLE 348
+ I + +V + M + L +H +Q + R Q+ +GL+
Sbjct: 69 IRDILRPPGADFKDVYVVMDLMES-DLHHIIHS--DQPLTEEHIRYFLYQLL----RGLK 121
Query: 349 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA----EEDLTHISS-VARGTVG 403
Y+H+ +IHRD+K SN+L++ + ++ DFG++R E ++ VA T
Sbjct: 122 YIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA--TRW 176
Query: 404 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKPV 438
Y PE + T D++S G + E++ G++ +
Sbjct: 177 YRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 15/145 (10%)
Query: 307 ILVYEYMHNGTLRDRLHGSVNQKPLDW-LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS 365
+L+ +Y+ +G L D L + L + I + L LH IIH D+K
Sbjct: 85 VLIMDYIKDGDLFDLLK---KEGKLSEAEVKK-IIRQLVEALNDLH---KHNIIHNDIKL 137
Query: 366 SNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSF 424
N+L D R + D+GL + + S GT+ Y PE D ++
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAV 192
Query: 425 GVVLLELISGKKPVSVEDFGAELNI 449
GV+ EL++GK P ED EL++
Sbjct: 193 GVLTYELLTGKHPF-KEDEDEELDL 216
|
Length = 267 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 316 GTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 374
T RD L +N+ P L ++ + ++ A G+E+L + +HRD+ + N+L+
Sbjct: 223 RTRRDTL---INESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGK 276
Query: 375 RAKVSDFGLSRQAEEDLTHISSVARGT----VGYLDPEYYGNQQLTEKSDVYSFGVVLLE 430
K+ DFGL+R D +IS +G+ + ++ PE N T SDV+SFG++L E
Sbjct: 277 LVKICDFGLARDIMRDSNYIS---KGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 431 LIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQC 489
+ + G P EL + + IK+G + P + I E+ +C
Sbjct: 334 IFTLGGTPYP------ELPMNEQFYNAIKRG--YRMAKPAHASD-------EIYEIMQKC 378
Query: 490 VEQRGFSRPKMQEIVLAIQD 509
E++ RP ++V + D
Sbjct: 379 WEEKFEIRPDFSQLVHLVGD 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 36/108 (33%), Positives = 60/108 (55%), Gaps = 12/108 (11%)
Query: 331 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390
L L L + A+G+E+L + +HRD+ + N+LL K+ DFGL+R D
Sbjct: 234 LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLAR----D 286
Query: 391 LTHISS-VARGT----VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 433
+ H S+ V++G+ V ++ PE + T SDV+S+G++L E+ S
Sbjct: 287 IMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 1/94 (1%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS 104
LS +L GEIP + ++ L L L N TG +P ++ L L+++ L +N+ +G +P
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350
Query: 105 YMGSLPNLQELHIENNSFVGEIPPALLTGKVIFK 138
+G NL L + N+ GEIP L + +FK
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFK 384
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 4e-08
Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 1/90 (1%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 97
P + + LS L GEIP ++ + +L L L GN L G +P ++ L L + L +N+
Sbjct: 140 PNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQ 199
Query: 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIP 127
L G +P +G + +L+ +++ N+ GEIP
Sbjct: 200 LVGQIPRELGQMKSLKWIYLGYNNLSGEIP 229
|
Length = 968 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 5e-08
Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 39/206 (18%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE--VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-- 296
K + GS G V+ K G+ V +KI + + E LL ++H +++ +
Sbjct: 72 KTLTPGSEGRVFVAT-KPGQPDPVVLKIGQKGTT------LIEAMLLQNVNHPSVIRMKD 124
Query: 297 ------IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
I H +Y Y+ T R R PL L I +GL YL
Sbjct: 125 TLVSGAITCMVLPHYSSDLYTYL---TKRSR--------PLPIDQALIIEKQILEGLRYL 173
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDP 407
H IIHRDVK+ NI ++ + + D G ++ A L +A GTV P
Sbjct: 174 HA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL----GLA-GTVETNAP 225
Query: 408 EYYGNQQLTEKSDVYSFGVVLLELIS 433
E + K+D++S G+VL E+++
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 7e-08
Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 42/275 (15%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-IGY 299
K IG G FG VY + + + +A + + V E + + I+ + + L
Sbjct: 18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI 77
Query: 300 CEEEHQRILVY---------EYMHNGTLRDRLHGSVNQ---------KPLDWLTRLQIAH 341
+H I Y + L ++L + + K L I
Sbjct: 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKL----IKNIMK 133
Query: 342 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS------ 395
D LEY+H GI H D+K NI++D N R + D+G++ HI
Sbjct: 134 DMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQK 190
Query: 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 455
+ RGT+ Y + + +T + D+ S G +L+ + + FG N++H A
Sbjct: 191 DLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKW--AGIKLPWKGFGHNGNLIHAA-- 246
Query: 456 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV 490
K D I + G +KI++ + I+CV
Sbjct: 247 ---KCDFIKRLHE---GKIKIKNANKFIYDFIECV 275
|
Length = 294 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 28/212 (13%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKI----MADSCSHRTQQFVTEVALLSRIHHRN-LV 294
+KIG+G++G VY + K+ GK VA+K M + T + E++LL + +V
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIV 64
Query: 295 PLIG--YCEEEHQRI---LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 347
L+ + EE++ + LV+EY+ + L+ + +G +PL T + KG+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 348 EYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDL---THISSVARGTVG 403
+ H G++HRD+K N+L+D K++D GL R + TH T+
Sbjct: 124 AHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTLW 176
Query: 404 YLDPE-YYGNQQLTEKSDVYSFGVVLLELISG 434
Y PE G+ + D++S G + E+
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 1/92 (1%)
Query: 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNEL 98
R+ + LS G +P +L ++ L +L L N L+G +PD +S L + L +N+L
Sbjct: 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+G +P+ +P L +L + N GEIP L
Sbjct: 536 SGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567
|
Length = 968 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 32/215 (14%)
Query: 242 KIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHRTQQFVT--EVALLSRIH---HRN 292
+IG+G++G V+ K +D G+ VA+K + T EVA+L + H N
Sbjct: 8 EIGEGAYGKVF--KARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 293 LVPLIGYC-----EEEHQRILVYEYMHNG--TLRDRLH--GSVNQKPLDWLTRLQIAHDA 343
+V L C + E + LV+E++ T D++ G + D + +L
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL------ 119
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 403
+GL++LH+ ++HRD+K NIL+ + + K++DFGL+R + T+
Sbjct: 120 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS--FQMALTSVVVTLW 174
Query: 404 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 438
Y PE D++S G + E+ +KP+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 52/189 (27%), Positives = 89/189 (47%), Gaps = 30/189 (15%)
Query: 258 DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315
+G+E+ V + SHR F +L+S++ H +L + G C + I+V E++ +
Sbjct: 41 NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 316 GTL-----RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 370
G L +++ P+ W ++ +A A L YL + ++H +V + NILL
Sbjct: 101 GPLDVCLRKEKGR-----VPVAW--KITVAQQLASALSYLE---DKNLVHGNVCAKNILL 150
Query: 371 DINMRA-------KVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEKSDVY 422
A K+SD G+S A L+ V R + ++ PE G L+ +D +
Sbjct: 151 ARLGLAEGTSPFIKLSDPGVSFTA---LSREERVER--IPWIAPECVPGGNSLSTAADKW 205
Query: 423 SFGVVLLEL 431
SFG LLE+
Sbjct: 206 SFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 46 LSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP 103
LS N G IP + N+E L L N L+G +P D+ L+++ L N L G +P
Sbjct: 125 LSNNNFTGSIPRGSIPNLETLD---LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181
Query: 104 SYMGSLPNLQELHIENNSFVGEIPPAL 130
+ + +L +L+ L + +N VG+IP L
Sbjct: 182 NSLTNLTSLEFLTLASNQLVGQIPREL 208
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 34/105 (32%), Positives = 50/105 (47%)
Query: 36 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 95
T P + + +S NL+G I +M +L L L N G LPD L + L
Sbjct: 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSR 484
Query: 96 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYD 140
N+ +G++P +GSL L +L + N GEIP L + K + D
Sbjct: 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLD 529
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 34/87 (39%), Positives = 45/87 (51%), Gaps = 1/87 (1%)
Query: 41 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELT 99
+T + LS NL GEIP L + L +L L N L G +P + LR V L++N +
Sbjct: 358 LTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFS 417
Query: 100 GSLPSYMGSLPNLQELHIENNSFVGEI 126
G LPS LP + L I NN+ G I
Sbjct: 418 GELPSEFTKLPLVYFLDISNNNLQGRI 444
|
Length = 968 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 26/206 (12%)
Query: 243 IGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 301
IG GSFG VY D E VA+K + ++ + E+ ++ ++H N++ L Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHINIIFLKDYYY 129
Query: 302 EEHQRI--------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
E + +V E++ + H + N L ++ + L Y+H+
Sbjct: 130 TECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK 189
Query: 354 CNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE- 408
I HRD+K N+L+D N K+ DFG ++ + +++I S Y PE
Sbjct: 190 F---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPEL 241
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISG 434
G T D++S G ++ E+I G
Sbjct: 242 MLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 52/186 (27%), Positives = 81/186 (43%), Gaps = 23/186 (12%)
Query: 280 TEVALLSRIHHRNLVPLI-GYCEEEHQRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRL 337
E+ +L I HR ++ LI Y + +++ +Y + T DR PL +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS------GPLPLEQAI 188
Query: 338 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 397
I + L YLH GIIHRDVK+ NI LD A + DFG + + + H +
Sbjct: 189 TIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA---HPDTP 242
Query: 398 A----RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HW 452
GT+ PE K+D++S G+VL E+ + FG ++
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL----FGKQVKSSSSQ 298
Query: 453 ARSMIK 458
RS+I+
Sbjct: 299 LRSIIR 304
|
Length = 392 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 50/178 (28%), Positives = 78/178 (43%), Gaps = 22/178 (12%)
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
N+V L Y E LV ++ G L + P + + R A + L+ LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-SKFLNIPEECVKRW--AAEMVVALDALH 102
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE--DLTHISSVARGTVGYLDPEY 409
GI+ RD+ +NILLD +++ F + E+ D + ++ Y PE
Sbjct: 103 ---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCAPEV 153
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AELNIVHW----ARSMIKK 459
G + TE D +S G +L EL++GK V G LNI W ARS++++
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQ 211
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 61/245 (24%), Positives = 96/245 (39%), Gaps = 56/245 (22%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 296
K IG+G+FG V + KD G A+KI+ + +Q E +L +V +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66
Query: 297 IGYCEEEHQRILVYEYMHNGTL------RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
+++ L+ E++ G + +D L Q ++ +A DA L
Sbjct: 67 FYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQF---YIAETVLAIDAIHQL--- 120
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL--------------------------- 383
G IHRD+K N+LLD K+SDFGL
Sbjct: 121 ------GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 384 ----SRQAEEDLTHISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK 436
R+AE + +A TVG Y+ PE + + D +S GV++ E++ G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 437 PVSVE 441
P E
Sbjct: 235 PFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 42/166 (25%), Positives = 67/166 (40%), Gaps = 47/166 (28%)
Query: 334 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL---------- 383
L R IA + +E +H G IHRD+K NIL+D + K++DFGL
Sbjct: 102 LARFYIA-ELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 384 --------SRQ---------AEEDLTHISSVAR---------------GTVGYLDPEYYG 411
RQ +E D + + R GT Y+ PE
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKPVSVED-FGAELNIVHWARSM 456
T+ D +S GV+L E++ G+ P + +L +++W ++
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 8e-07
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 41/215 (19%)
Query: 243 IGKGSFGSVYYGKMKD-----------GKEVAVKIMADSCSHR--TQQFVTEVALLSRIH 289
+G+G+ +Y G + KE+ V + SHR + F +++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 290 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 349
H+++V L G C + + I+V E++ G L +H + W + ++A A L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 350 LHTGCNPGIIHRDVKSSNILL-------DINMRAKVSDFG-----LSRQAEEDLTHISSV 397
L + ++H +V + NILL + K+SD G LSRQ E + I +
Sbjct: 121 LE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ--ECVERIPWI 175
Query: 398 ARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLEL 431
A PE ++ L+ +D +SFG L E+
Sbjct: 176 A--------PECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 48/193 (24%), Positives = 91/193 (47%), Gaps = 22/193 (11%)
Query: 259 GKEVAVK-IMADSCSHRTQQFV-TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316
G+ V V+ I ++C++ F+ E+ + +H N+VP +++ +V +M G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 317 TLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 373
+ +D + +D ++ L IA+ K L+Y+H + G +HR VK+S+IL+ ++
Sbjct: 85 SAKDLICTHF----MDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVD 137
Query: 374 ----MRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGN--QQLTEKSDVYSF 424
+ S+ + + L + + +V +L PE Q KSD+YS
Sbjct: 138 GKVYLSGLRSNLSMINHGQR-LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 425 GVVLLELISGKKP 437
G+ EL +G P
Sbjct: 197 GITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 13/99 (13%)
Query: 36 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-------MSRLIDL 88
T+ PR+ + L GEIP L LT L L N LTG +P+ + +LI
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI-- 386
Query: 89 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 127
L +N L G +P +G+ +L+ + +++NSF GE+P
Sbjct: 387 ----LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421
|
Length = 968 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 63/258 (24%), Positives = 98/258 (37%), Gaps = 68/258 (26%)
Query: 241 KKIGKGSFGSV-YYGKMKDGKEVAVKIMADSCSHRTQQFV---TEVALLSRIHHRNLVPL 296
K IGKG+FG V K GK A+K + S + Q E +L+ +V L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW------LTRLQIAHDAAKGLEYL 350
++ L+ E++ G L L + + +TR +A + +E +
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMA-ECVLAIEAV 117
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS---------------RQAEEDLTHIS 395
H G IHRD+K NIL+D K+SDFGLS Q + + I
Sbjct: 118 H---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 396 S----------------------------VARGTVG---YLDPEYYGNQQLTEKSDVYSF 424
+ +A TVG Y+ PE + Q ++ D +S
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 425 GVVLLELISGKKPVSVED 442
G ++ E + G P E+
Sbjct: 235 GAIMFECLIGWPPFCSEN 252
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 44/239 (18%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 296
K IG+G+FG V + KD G A+KI+ + +Q E +L +V +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+++ L+ E++ G + L D LT + A+ + + +
Sbjct: 67 FYSFQDKLNLYLIMEFLPGGDMMTLLMKK------DTLTEEETQFYIAETVLAIDSIHQL 120
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGL-------------------------------SR 385
G IHRD+K N+LLD K+SDFGL R
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKR 180
Query: 386 QAEEDLTHISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 441
+AE + +A TVG Y+ PE + + D +S GV++ E++ G P E
Sbjct: 181 KAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 30/86 (34%), Positives = 47/86 (54%), Gaps = 1/86 (1%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 104
L N G+IP L ++ L L L N +G +P ++ + +L ++ L N LTG +P
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
Query: 105 YMGSLPNLQELHIENNSFVGEIPPAL 130
+ S NL +L + +NS GEIP +L
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSL 400
|
Length = 968 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 36/150 (24%), Positives = 61/150 (40%), Gaps = 53/150 (35%)
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGL--------------------------------- 383
G IHRD+K NIL+D++ K++DFGL
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 384 ----------------SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVV 427
++Q + L H S V GT Y+ PE + T+ D +S GV+
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAH-SLV--GTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 428 LLELISGKKP-VSVEDFGAELNIVHWARSM 456
L E++ G+ P ++ +L +++W ++
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 57/212 (26%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 242 KIGKG--SFGSVYYGK-MKDGKEVAVKIM-ADSCS-HRTQQFVTEVALLSRIHHRNLVPL 296
+IG+G + SVY + G V V+I ++C+ + EV L H N++
Sbjct: 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
++ +M G+ L + + L I A +GL YLH
Sbjct: 65 WTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIG-NILFGALRGLNYLHQN--- 120
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSR--------QAEEDLTHISSVARGTVGYLDPE 408
G IHR++K+S+IL I+ VS GLS Q + + + + +L PE
Sbjct: 121 GYIHRNIKASHIL--ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 409 YYGNQQL---TEKSDVYSFGVVLLELISGKKP 437
Q L KSD+YS G+ EL +G+ P
Sbjct: 179 LL-RQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 36/147 (24%), Positives = 58/147 (39%), Gaps = 47/147 (31%)
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLS------------------RQAEEDLT------ 392
G IHRD+K NIL+D + K++DFGL RQ D +
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 393 -------------------HISSVARGTVG---YLDPEYYGNQQLTEKSDVYSFGVVLLE 430
H +A VG Y+ PE T+ D +S GV+L E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 431 LISGKKP-VSVEDFGAELNIVHWARSM 456
++ G+ P ++ ++ +++W S+
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 26/99 (26%), Positives = 43/99 (43%), Gaps = 3/99 (3%)
Query: 337 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 396
L I + ++YLH IIHRD+K+ NI ++ + DFG + + +
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 397 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 435
GT+ PE D++S G+VL E+ +
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 32/149 (21%), Positives = 54/149 (36%), Gaps = 17/149 (11%)
Query: 240 CKKIGKGSFGSVYYGKMKDGKE-VAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VP-L 296
K + G VY + E +KI + EVA+L + + L VP +
Sbjct: 3 IKLLKGGLTNRVY--LLGTKDEDYVLKINPSR--EKGADREREVAILQLLARKGLPVPKV 58
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+ E + L+ E++ TL + + IA A+ L LH
Sbjct: 59 LASGESDGWSYLLMEWIEGETL----------DEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSR 385
+ H D+ NIL+D + D+ +
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 29/105 (27%), Positives = 48/105 (45%), Gaps = 8/105 (7%)
Query: 329 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388
+PL +A ++Y+H GIIHRD+K+ N+L++ + DFG + A
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311
Query: 389 EDLTHISSVARGTVGYLD---PEYYGNQQLTEKSDVYSFGVVLLE 430
+ + G G +D PE T D++S G+V+ E
Sbjct: 312 GSWS--TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 10/89 (11%)
Query: 239 FCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ--FVTEVALLSRI-H 289
F K +G G+FG V GK + VAVK M + +H ++ ++E+ +LS +
Sbjct: 42 FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVK-MLKASAHTDEREALMSELKILSHLGQ 100
Query: 290 HRNLVPLIGYCEEEHQRILVYEYMHNGTL 318
H+N+V L+G C +++ EY G L
Sbjct: 101 HKNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.002
Identities = 20/60 (33%), Positives = 30/60 (50%), Gaps = 3/60 (5%)
Query: 65 LTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 122
L L L N LT +PD + L +L+++ L N LT P LP+L+ L + N+
Sbjct: 2 LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 30/83 (36%), Positives = 46/83 (55%), Gaps = 2/83 (2%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 97
+ + LSG N ++PPE++ + AL EL L N + L +S L +L + L NN+
Sbjct: 185 LSNLNNLDLSG-NKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNK 243
Query: 98 LTGSLPSYMGSLPNLQELHIENN 120
L LP +G+L NL+ L + NN
Sbjct: 244 LE-DLPESIGNLSNLETLDLSNN 265
|
Length = 394 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 28/95 (29%), Positives = 46/95 (48%), Gaps = 9/95 (9%)
Query: 239 FCKKIGKGSFGSVY------YGKMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 290
K +G+G+FG V K + VAVK++ + + + +TE+ +L I HH
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHH 70
Query: 291 RNLVPLIGYCEEEHQRILV-YEYMHNGTLRDRLHG 324
N+V L+G C + ++V EY G L + L
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRS 105
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 557 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.35 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.34 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.19 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.17 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.15 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.13 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.1 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.02 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.02 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.97 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.96 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 98.96 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.96 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.93 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.9 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.89 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.87 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.86 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.84 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.74 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.72 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.72 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 98.72 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.7 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.68 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.66 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 98.64 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.63 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.63 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 98.59 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 98.58 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.55 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.51 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.51 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.48 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.4 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.4 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.38 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.32 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.3 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.29 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.29 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.27 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.25 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.24 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.22 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.22 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.19 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.17 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.16 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.16 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.16 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.11 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.1 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.08 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.06 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.96 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.92 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=500.07 Aligned_cols=445 Identities=27% Similarity=0.467 Sum_probs=291.7
Q ss_pred ceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
+|+.|+|++|.+++.+|..+.++++|+.|+|++|.+++.+| .|..+++|+.|+|++|+++|.+|..+.++++|+.|+++
T Consensus 500 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls 579 (968)
T PLN00113 500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579 (968)
T ss_pred ccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEecc
Confidence 45555555555555555555556666666666666666555 35556666666666666666666666666666666666
Q ss_pred cccCCCCCCcc-cccCceeeeecCCCcccccc-------ccc--ccceEEEeehhhHHHHHHHHHHHHHHHhhhhhhccc
Q 008707 119 NNSFVGEIPPA-LLTGKVIFKYDNNPKLHKES-------RRR--MRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKIS 188 (557)
Q Consensus 119 ~N~~~~~~p~~-~~~~~~~~~~~~n~~~~~~~-------~~~--~~~~~~i~~~i~~~~~l~~~~~~~~~~~~~~~~~~~ 188 (557)
+|++.|.+|.. .+.......+.+|+.+|+.. |.. ......+.++++++++++++++++.+++++++++.
T Consensus 580 ~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 658 (968)
T PLN00113 580 HNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNL- 658 (968)
T ss_pred CCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcc-
Confidence 66666666643 22223334567888888532 211 11111111221222222222222222222211111
Q ss_pred ccchhhhhccccccCCCCCCcceeccCCccccCCccccCChhHHHHHHHHhhcccCCCCceEEEEEEE-cCCcEEEEEEc
Q 008707 189 NQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIM 267 (557)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~ 267 (557)
..+..+... .. ... .+........+...++.. .+...+.||+|+||.||+|.. .+++.||+|.+
T Consensus 659 ~~~~~~~~~--------~~--~~~----~~~~~~~~~~~~~~~~~~-~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~ 723 (968)
T PLN00113 659 ELKRVENED--------GT--WEL----QFFDSKVSKSITINDILS-SLKEENVISRGKKGASYKGKSIKNGMQFVVKEI 723 (968)
T ss_pred ccccccccc--------cc--ccc----cccccccchhhhHHHHHh-hCCcccEEccCCCeeEEEEEECCCCcEEEEEEc
Confidence 111000000 00 000 000000111122333322 223456899999999999987 47899999988
Q ss_pred cCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHH
Q 008707 268 ADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 347 (557)
Q Consensus 268 ~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL 347 (557)
...... ..+|++++++++|||||++++++.+.+..++||||+++|+|.++++. ++|..+..++.|+++||
T Consensus 724 ~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L 793 (968)
T PLN00113 724 NDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKAL 793 (968)
T ss_pred cCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHH
Confidence 643221 23468899999999999999999999999999999999999999862 78999999999999999
Q ss_pred HHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHH
Q 008707 348 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVV 427 (557)
Q Consensus 348 ~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~l 427 (557)
+|||..+..+++||||||+||+++.++..++. ||.+...... ....+++.|+|||++.+..++.++|||||||+
T Consensus 794 ~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvv 867 (968)
T PLN00113 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLI 867 (968)
T ss_pred HHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHH
Confidence 99996445899999999999999998888775 5554432211 11247899999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 428 LLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN--VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 428 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+|||+||+.||.. .......+.+|+............+|+.+... ...++..++.+++.+||+.+|++||||+||++
T Consensus 868 l~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 868 LIELLTGKSPADA-EFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred HHHHHhCCCCCCc-ccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 9999999999963 33344567778777666666666677766443 34566778999999999999999999999999
Q ss_pred HHHhhhhhhcCC
Q 008707 506 AIQDSIKIEKGG 517 (557)
Q Consensus 506 ~L~~~~~~~~~~ 517 (557)
.|+++.+.....
T Consensus 947 ~L~~~~~~~~~~ 958 (968)
T PLN00113 947 TLESASRSSSSC 958 (968)
T ss_pred HHHHhhcccccc
Confidence 999987754433
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=416.64 Aligned_cols=288 Identities=49% Similarity=0.840 Sum_probs=251.8
Q ss_pred cccCChhHHHHHHHHhh--cccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEE
Q 008707 224 AYFIPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE 301 (557)
Q Consensus 224 ~~~~~~~~~~~~~~~~~--~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 301 (557)
...+++.++..+|.+|. ..||+|+||.||+|.+.+|..||||++........++|..|++++.+++|||+|+++|||.
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 44567999999999996 7999999999999999999999999887644321455999999999999999999999999
Q ss_pred ecC-eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEec
Q 008707 302 EEH-QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 380 (557)
Q Consensus 302 ~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 380 (557)
+.+ ..+|||||+++|+|.++++..... .++|.++++||.++|+||+|||+.+...|+|||||++|||+|+++++||+|
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 988 599999999999999999975433 899999999999999999999998777899999999999999999999999
Q ss_pred ccCccccCC-CCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc
Q 008707 381 FGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 459 (557)
Q Consensus 381 fgla~~~~~-~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 459 (557)
||+|+.... ........ .||.+|+|||++..+..+.|+||||||+++.|++||+.|.+.........+.+|+...+.+
T Consensus 221 FGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999966544 22111111 6999999999999999999999999999999999999998755444566799999999999
Q ss_pred CCcccccccccc-CCCCH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 460 GDVISIVDPVLI-GNVKI-ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 460 ~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
+...+++|+.+. ..+.. .+...+..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999987 66664 6788899999999999999999999999999665544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-47 Score=379.73 Aligned_cols=264 Identities=36% Similarity=0.538 Sum_probs=216.3
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccch--hHHHHHHHHHHHhhcCCCCccceeeEEEecC-eeEE
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRIL 308 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-~~~l 308 (557)
+......+.+.||+|+||+||+|.++....||||++...... ..+.|.+|+.+|.+++|||||+++|++.+.. ..++
T Consensus 38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 333444456779999999999999995555999999764322 2568999999999999999999999999887 7999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCC-eEeeccCCCCEEeCCCC-cEEEecccCccc
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSNILLDINM-RAKVSDFGLSRQ 386 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~-ivH~dlk~~NIll~~~~-~~kl~Dfgla~~ 386 (557)
||||+++|+|.++++.. ....+++..++.++.|||+||.|||+ .+ |+|||||++|||++.++ ++||+|||+++.
T Consensus 118 VtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred EEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 99999999999999864 36789999999999999999999998 77 99999999999999997 999999999987
Q ss_pred cCCCCccccccccCCCCccCCcccC--CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYG--NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~--~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
...... ......||+.|||||++. ...|+.|+||||||+++|||+||+.||.+... .+.+......+...
T Consensus 194 ~~~~~~-~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp- 265 (362)
T KOG0192|consen 194 KVISKT-SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRP- 265 (362)
T ss_pred eccccc-cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCC-
Confidence 654321 122256999999999999 56999999999999999999999999984332 22222233333222
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
..+...+..+..++.+||..||+.||++.||+..|+.+...-.
T Consensus 266 --------~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 266 --------PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred --------CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 2222355688999999999999999999999999999887443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=380.88 Aligned_cols=264 Identities=28% Similarity=0.467 Sum_probs=226.2
Q ss_pred hhHHHHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 229 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 229 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
..++.....++.+.||+|.||.||.|.++....||+|.++.. .-..+.|.+|+++|++|+|+|||+++|+|..++..+|
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 345667778899999999999999999998889999998764 3345778999999999999999999999999889999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
|||||+.|+|.++|+.. .+..+...+.+.++.|||+||+||++ +++|||||.++||||+++..+||+|||+|+...
T Consensus 279 VtE~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred EEEecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999863 46778999999999999999999999 999999999999999999999999999999776
Q ss_pred CCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
++.........-+..|.|||.+....++.||||||||++||||+| |+.||....- .+ +...+.+|....
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------~e-v~~~le~GyRlp--- 424 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------EE-VLELLERGYRLP--- 424 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH------HH-HHHHHhccCcCC---
Confidence 666655555567889999999999999999999999999999999 9999874332 22 233344443322
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
.+...+..+.+++..||..+|++|||++.+...|+++...
T Consensus 425 ------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 425 ------RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 2334566899999999999999999999999998887654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=360.05 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=211.1
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc-cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCe-eEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ-RILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~-~~lv~e~~ 313 (557)
.+..+.||+|..|+||++.++ +++.+|+|++... ....++++.+|+++++..+||+||.+||.|..++. ..++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 345688999999999999987 5889999998543 34567889999999999999999999999999884 99999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++|+|.+++.. .+.+++...-+++.+|++||.|||. .++|+||||||+||||+..|.|||||||.+....+.
T Consensus 161 DgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 161 DGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999984 4679999999999999999999995 399999999999999999999999999999887654
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
....+.||..|||||.+.+..|+.++||||||+.++|+.+|+.||... ........+.+.... .++...+.+.
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~-~~~~~~~~~Ll~~Iv-~~ppP~lP~~----- 305 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP-NPPYLDIFELLCAIV-DEPPPRLPEG----- 305 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc-CCCCCCHHHHHHHHh-cCCCCCCCcc-----
Confidence 345567999999999999999999999999999999999999999854 222233333333222 2332222221
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
....++.+++..|+++||.+|||++|+++.
T Consensus 306 ---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 306 ---EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ---cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 234579999999999999999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=362.92 Aligned_cols=255 Identities=28% Similarity=0.376 Sum_probs=207.2
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCccc-------hhHHHHHHHHHHHhhcCCCCccceeeEEEe
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCS-------HRTQQFVTEVALLSRIHHRNLVPLIGYCEE 302 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 302 (557)
+.....|-+++.||+|+||.|-+|.. ++|+.||||++.+... .....+.+|+++|++|+|||||+++++|+.
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 33455666789999999999999965 4799999999965321 122346799999999999999999999999
Q ss_pred cCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC---CcEEEe
Q 008707 303 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVS 379 (557)
Q Consensus 303 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~ 379 (557)
.+..||||||++||.|.+++-. .+.+.+..-..++.|++.|+.|||+ +||+||||||+|||+..+ -.+||+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred CCceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEec
Confidence 9999999999999999999974 4566777778899999999999998 999999999999999766 669999
Q ss_pred cccCccccCCCCccccccccCCCCccCCcccCCCCC---CcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 008707 380 DFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 456 (557)
Q Consensus 380 Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~---s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~ 456 (557)
|||+|+..+. .....+.+|||.|.|||++.+..+ ..++|+||+||+||-+++|.+||...... .. +.+.
T Consensus 322 DFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~s----l~eQ 393 (475)
T KOG0615|consen 322 DFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PS----LKEQ 393 (475)
T ss_pred ccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--cc----HHHH
Confidence 9999998863 344567889999999999976533 34889999999999999999999843221 11 2334
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 457 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 457 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+.+|.+.. .+....+...+..++|.+||..||++|||+.|+++
T Consensus 394 I~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 394 ILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 45555422 22233455568889999999999999999999986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=377.31 Aligned_cols=248 Identities=27% Similarity=0.447 Sum_probs=212.0
Q ss_pred HHHHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCc---cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
.+|...+.||+|+|+.||.++. ..|+.||+|++.+. ....++.+.+|++|.+.|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5566789999999999999987 78999999999763 2445678899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
|+|..++|..+++ ..+.+++..++.+++||+.||.|||+ ++|+|||||..|+|++++.++||+|||+|.....+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999988 36789999999999999999999998 99999999999999999999999999999988654
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
.. ...+.+|||.|+|||++.....+..+||||+||+||-|+.|++||+..+..+..+ .+...+..
T Consensus 172 ~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~-------~Ik~~~Y~------- 236 (592)
T KOG0575|consen 172 GE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN-------KIKLNEYS------- 236 (592)
T ss_pred cc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH-------HHHhcCcc-------
Confidence 33 3456789999999999999999999999999999999999999998544333221 22222110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.+.....+..+||.++|+.+|.+|||+++|+..
T Consensus 237 ---~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 237 ---MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---cccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 011223467799999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=346.48 Aligned_cols=263 Identities=28% Similarity=0.371 Sum_probs=216.9
Q ss_pred HHHHHHhhcccCCCCceEEEEEE-EcCCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceee-EEEecCe-eE
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIG-YCEEEHQ-RI 307 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~-~~~~~~~-~~ 307 (557)
.-+.|++.++||.|.||+||++. ..+|..||.|.++-. .....++...|+.+|++|+|||||++++ .|.+++. .+
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 34667888999999999999996 457999999988632 2345677899999999999999999999 5555554 88
Q ss_pred EEEEecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCC-CeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 308 LVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
+|||+|.+|+|.++++..+ ..+.+++..+++++.|++.||.++|+...+ -|+||||||.|||++.+|.+||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 9999999999999997654 456789999999999999999999974322 38899999999999999999999999999
Q ss_pred ccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 386 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 386 ~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
.......... ...|||.||+||.+.+..|+.|+||||+||++|||+..+.||.+. ++. .+...+.+|+...+
T Consensus 177 ~l~s~~tfA~-S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~-~L~~KI~qgd~~~~ 248 (375)
T KOG0591|consen 177 FLSSKTTFAH-SLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLL-SLCKKIEQGDYPPL 248 (375)
T ss_pred HhcchhHHHH-hhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHH-HHHHHHHcCCCCCC
Confidence 9876655444 345999999999999999999999999999999999999999854 222 24566777766554
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
.|. .....+..++..|+..||+.||+.-.+++.++...
T Consensus 249 p~~--------~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~l 286 (375)
T KOG0591|consen 249 PDE--------HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSEL 286 (375)
T ss_pred cHH--------HhhhHHHHHHHHHccCCcccCCCcchHHHHHHHHh
Confidence 432 23447889999999999999999766665555543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=353.57 Aligned_cols=197 Identities=33% Similarity=0.559 Sum_probs=177.0
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|.+.+.||+|+||+||+|+++ ++.+||||.+... ..+..+.+..|+.+|+.++|||||.+++++..++..++|||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 345677999999999999886 5789999998765 4555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC------CcEEEecccCcccc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN------MRAKVSDFGLSRQA 387 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~------~~~kl~Dfgla~~~ 387 (557)
.||+|.++++. .+.+++.++..++.|||.||++||+ ++|+||||||.|||++.. -.+||+|||+|+..
T Consensus 92 ~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 92 NGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred CCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999984 5689999999999999999999998 999999999999999764 45899999999998
Q ss_pred CCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCC
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVE 441 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~ 441 (557)
.... ...+.+|++-|||||++...+|+.|+|+||+|+++|+|++|+.||+..
T Consensus 166 ~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 166 QPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred Cchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 7543 345678999999999999999999999999999999999999999843
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=379.64 Aligned_cols=266 Identities=31% Similarity=0.499 Sum_probs=224.3
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccch-hHHHHHHHHHHHhhcCCCCccceeeEEEec
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEE 303 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 303 (557)
++......+.+.||+|+||+||+|... +...||||.++..... .+++|.+|++++..++|||||+++|+|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 455556667899999999999999754 3567999999887665 678999999999999999999999999999
Q ss_pred CeeEEEEEecCCCChhhhhhccC-------C----CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC
Q 008707 304 HQRILVYEYMHNGTLRDRLHGSV-------N----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 372 (557)
Q Consensus 304 ~~~~lv~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~ 372 (557)
+..+||+|||..|+|.++|.... . ...++..+.+.||.|||.||.||-+ +.+|||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhceecc
Confidence 99999999999999999997543 1 2238889999999999999999998 99999999999999999
Q ss_pred CCcEEEecccCccccCC-CCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHH
Q 008707 373 NMRAKVSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 450 (557)
Q Consensus 373 ~~~~kl~Dfgla~~~~~-~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~ 450 (557)
+..|||+|||+++.... ++.+......-+.+|||||.+..+.+|.+||||||||+|||+++ |+.||.+..-
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn------- 711 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN------- 711 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-------
Confidence 99999999999997543 33333323345789999999999999999999999999999999 9999864322
Q ss_pred HHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 451 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 451 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
+.+...+++|...+. +...|.++.+|+..||+.+|++||+++||-..|+......+
T Consensus 712 ~EVIe~i~~g~lL~~---------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 712 QEVIECIRAGQLLSC---------PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred HHHHHHHHcCCcccC---------CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 225566777776443 33566789999999999999999999999999999887533
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=325.64 Aligned_cols=262 Identities=23% Similarity=0.296 Sum_probs=203.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|+-..++|+|+||+||+++.+ +|+.||||++..... .-.+-.++|+++|++++|+|+|.++++|......++|+|||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 444578999999999999987 499999999875433 23456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
+..-| +-+.. ...+++...+.+++.|++.|+.|+|+ ++++||||||+||||+.+|.+||||||+|+....+..
T Consensus 84 dhTvL-~eLe~--~p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd- 156 (396)
T KOG0593|consen 84 DHTVL-HELER--YPNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD- 156 (396)
T ss_pred chHHH-HHHHh--ccCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCcc-
Confidence 76444 44444 35568889999999999999999998 9999999999999999999999999999998764322
Q ss_pred ccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHH--------HHHHhcCCccc
Q 008707 394 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA--------RSMIKKGDVIS 464 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 464 (557)
.......|.+|.|||.+.+ .+|...+||||+||++.||++|.+-|.+..+-+....+... .+.+...++..
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 2233457999999999987 69999999999999999999999999877655443322211 12222222221
Q ss_pred cc------cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 465 IV------DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 465 ~~------d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+ ++.-.....+....-+.+++..|+..||.+|++-+|++.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11 111111111223336789999999999999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=338.00 Aligned_cols=259 Identities=27% Similarity=0.387 Sum_probs=204.7
Q ss_pred HHHhhcccCCCCceEEEEEEEcC-CcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecC--eeEEEEEe
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYEY 312 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~~lv~e~ 312 (557)
.+...+.||+|+||+||++...+ |+..|||.+........+.+.+|+.+|.+++|||||+++|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 34567899999999999998764 8999999886543333677899999999999999999999754444 68899999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC-CCcEEEecccCccccCC--
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEE-- 389 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~-- 389 (557)
+++|+|.+++.+.. + .+++..+..+..||++||+|||+ +|++|+||||+|||++. ++.+||+|||++.....
T Consensus 98 ~~~GsL~~~~~~~g-~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 98 APGGSLSDLIKRYG-G-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred cCCCcHHHHHHHcC-C-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999998642 2 79999999999999999999998 99999999999999999 79999999999987663
Q ss_pred CCccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 390 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
..........||+.|||||++..+ ...+++||||+||++.||+||+.||... .....+.-.....+...
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P----- 242 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLP----- 242 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCC-----
Confidence 222233446799999999999953 3445999999999999999999999842 11122222222222111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
..+...+.+..+++.+|+..+|++||||+++++...-..+.
T Consensus 243 ----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 243 ----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred ----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 12222344778999999999999999999999875554443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=333.15 Aligned_cols=241 Identities=29% Similarity=0.378 Sum_probs=201.4
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
...++.+.||+|+||.||.++.+ +++.+|+|++++.. ..+.+...+|..+|.+++||.||.++-.|++.+..|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 34456899999999999999765 58899999997642 234677889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+.||.|..+|. .++.+++..+.-++..|+.||.|||+ +||+||||||+|||+|++|+++|+|||+++..-..
T Consensus 105 d~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 105 DYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred eccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 9999999999998 46789999999999999999999998 99999999999999999999999999999865433
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
. ..+.+.+||+.|||||++....|+..+|.||+|+++|||++|.+||...+... +. +.+.+++..
T Consensus 179 ~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~-~~I~~~k~~------- 243 (357)
T KOG0598|consen 179 G-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MY-DKILKGKLP------- 243 (357)
T ss_pred C-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HH-HHHhcCcCC-------
Confidence 2 23445789999999999999999999999999999999999999998654332 11 222223210
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRP 498 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RP 498 (557)
..+.....+..+++.+.++.||++|-
T Consensus 244 --~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 --LPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred --CCCccCCHHHHHHHHHHhccCHHHhc
Confidence 11111223677999999999999995
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=344.60 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=205.9
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv 309 (557)
..+.|++.||+|+|++|++|+.+ ++++||||++.+.. ....+.+..|-++|.+| .||.|++++-.|.++..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 45678999999999999999755 68999999986532 23345678899999999 799999999999999999999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
+||+++|+|.++++. -+.+++...+.++.+|+.||+|||+ +|||||||||+|||+|.|++++|+|||.|+....
T Consensus 153 Le~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999984 5789999999999999999999998 9999999999999999999999999999987643
Q ss_pred CCcc---------c---cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH
Q 008707 390 DLTH---------I---SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 457 (557)
Q Consensus 390 ~~~~---------~---~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 457 (557)
.... . ...+.||..|.+||++.....++.+|+|+|||++|+|+.|++||.+.. +....+.+...
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N---eyliFqkI~~l- 302 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN---EYLIFQKIQAL- 302 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc---HHHHHHHHHHh-
Confidence 2211 1 134679999999999999999999999999999999999999998432 22221111110
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 458 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 458 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
|= +++...+..+.+|+.+.|..||.+|+|.++|.+.
T Consensus 303 ---------~y----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 ---------DY----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---------cc----cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 00 1112223477899999999999999999998775
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=342.13 Aligned_cols=263 Identities=22% Similarity=0.296 Sum_probs=208.8
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcC-CCCccceeeEEEecC-eeEE
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH-QRIL 308 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~-~~~l 308 (557)
...+|...++||.|.||.||+|+.+ +|+.||||.+++... .+.-.-++|++.|++|+ ||||+++.+++.+.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4578889999999999999999754 689999999876432 33334568999999998 999999999998877 8999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
|||||+ .+|+++++.+ +..+++..+..|+.||++||+|+|. +|+.|||+||+|||+.....+||+|||+|+...
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 999995 6999999875 7789999999999999999999998 999999999999999999999999999999876
Q ss_pred CCCccccccccCCCCccCCccc-CCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc----
Q 008707 389 EDLTHISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI---- 463 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l-~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 463 (557)
...... ....|.+|.|||++ +...|+.+.||||+|||++|+++-++-|.+.+.-++...+ ...++.-...
T Consensus 162 SkpPYT--eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI---c~VLGtP~~~~~~e 236 (538)
T KOG0661|consen 162 SKPPYT--EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI---CEVLGTPDKDSWPE 236 (538)
T ss_pred cCCCcc--hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH---HHHhCCCccccchh
Confidence 543322 23479999999986 6778999999999999999999999999876643332211 1111111000
Q ss_pred -----cccc---c----cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 464 -----SIVD---P----VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 464 -----~~~d---~----~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
..++ | .-.++.-.....+..+++.+|+.+||.+||||+|.++.
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0000 0 00111122355678899999999999999999999986
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=348.55 Aligned_cols=266 Identities=32% Similarity=0.487 Sum_probs=216.2
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEcC--C--cE-EEEEEccC---ccchhHHHHHHHHHHHhhcCCCCccceeeEEEe
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMKD--G--KE-VAVKIMAD---SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 302 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 302 (557)
++......+.++||+|+||.||+|.++. + .. ||+|..+. .......+|++|.++|++++|||||++||++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 3444455567999999999999998763 2 23 89998875 235567889999999999999999999999999
Q ss_pred cCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEeccc
Q 008707 303 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 382 (557)
Q Consensus 303 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 382 (557)
...+++|||+|.||+|.++|+.. ...++..+...++.+.|.||+|||+ ++++||||.++|+|++.++.+||+|||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFG 307 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFG 307 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccc
Confidence 99999999999999999999863 3369999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHH-hcC
Q 008707 383 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI-KKG 460 (557)
Q Consensus 383 la~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~-~~~ 460 (557)
+++..... ........-+..|+|||.+....+++++|||||||++||+++ |..||.+... .+ +...+ ..+
T Consensus 308 Ls~~~~~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~------~~-v~~kI~~~~ 379 (474)
T KOG0194|consen 308 LSRAGSQY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN------YE-VKAKIVKNG 379 (474)
T ss_pred cccCCcce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH------HH-HHHHHHhcC
Confidence 98765411 111112235789999999999999999999999999999999 8889974432 22 22333 333
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCC
Q 008707 461 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGD 518 (557)
Q Consensus 461 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~ 518 (557)
-.... +...+..+..++.+||..+|++||+|.++.+.|+.+.......+
T Consensus 380 ~r~~~---------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~~ 428 (474)
T KOG0194|consen 380 YRMPI---------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAFD 428 (474)
T ss_pred ccCCC---------CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccccc
Confidence 22222 22445578899999999999999999999999999998766543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=334.19 Aligned_cols=268 Identities=23% Similarity=0.263 Sum_probs=205.0
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEec--Cee
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQR 306 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~ 306 (557)
.....|+-.++||+|.||.||+|+. .+|+.||+|++.-.. .....-..+|+.||++|.||||+++.+...+. ...
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 3455666678999999999999964 579999999986443 33445677899999999999999999998876 689
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
|||+|||+. +|.-++.. .+..+++.++..++.|++.||+|||+ +||+|||||.+|||||.+|.+||+|||+|++
T Consensus 194 YlVFeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEEEecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceee
Confidence 999999965 77777763 35679999999999999999999998 9999999999999999999999999999998
Q ss_pred cCCCCccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC--cc
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD--VI 463 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~ 463 (557)
+............-|.+|.|||++.+. .|+.+.|+||.||||.||++|++.|++.+..+....+--+........ ..
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 766554434444579999999998765 899999999999999999999999997664333222211110000000 00
Q ss_pred ccccccc-c--CCC-------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 464 SIVDPVL-I--GNV-------KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 464 ~~~d~~l-~--~~~-------~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+..... . ..+ ....+....+|+..+|..||.+|.|+.+.++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0110000 0 011 0111235679999999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=370.93 Aligned_cols=270 Identities=31% Similarity=0.494 Sum_probs=222.0
Q ss_pred hhHHHHHHHHhhcccCCCCceEEEEEEEcC--Cc----EEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEE
Q 008707 229 LPELEEATNNFCKKIGKGSFGSVYYGKMKD--GK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCE 301 (557)
Q Consensus 229 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 301 (557)
++++......+.+.||+|+||.||.|...+ |. .||+|.++... ..+..+|.+|..+|++++|||||+++|++-
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 556667777788999999999999998653 43 48999987754 455678999999999999999999999999
Q ss_pred ecCeeEEEEEecCCCChhhhhhccC----CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEE
Q 008707 302 EEHQRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 377 (557)
Q Consensus 302 ~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 377 (557)
+....++++|||++|+|..+|+... ....++....+.++.|||+|+.||++ +++|||||.++|+|+++...||
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VK 842 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVK 842 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEE
Confidence 9999999999999999999998753 24568899999999999999999998 9999999999999999999999
Q ss_pred EecccCccccCC-CCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 008707 378 VSDFGLSRQAEE-DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 455 (557)
Q Consensus 378 l~Dfgla~~~~~-~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~ 455 (557)
|+|||+|+...+ +.........-+..|||||.+..+.++.|+|||||||++||++| |..||...+- .+....
T Consensus 843 IaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n------~~v~~~ 916 (1025)
T KOG1095|consen 843 IADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN------FEVLLD 916 (1025)
T ss_pred EcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch------HHHHHH
Confidence 999999995433 33222222345679999999999999999999999999999999 9999973322 122222
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 008707 456 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 517 (557)
Q Consensus 456 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~ 517 (557)
..+.|++ +.+...+..+.+++.+||+.+|++||++..|++.+..+.......
T Consensus 917 ~~~ggRL----------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~ 968 (1025)
T KOG1095|consen 917 VLEGGRL----------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT 968 (1025)
T ss_pred HHhCCcc----------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence 3334422 234455668889999999999999999999999888888754443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=341.71 Aligned_cols=262 Identities=27% Similarity=0.435 Sum_probs=205.6
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEecC
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 304 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~ 304 (557)
....+++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.++..+ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3456778899999999999999742 35689999987543 23446789999999999 8999999999887644
Q ss_pred -eeEEEEEecCCCChhhhhhccCC--------------------------------------------------------
Q 008707 305 -QRILVYEYMHNGTLRDRLHGSVN-------------------------------------------------------- 327 (557)
Q Consensus 305 -~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 327 (557)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999998864211
Q ss_pred ---CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc-ccccccCCCC
Q 008707 328 ---QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVG 403 (557)
Q Consensus 328 ---~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~ 403 (557)
...+++..+..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++........ ......+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 1347788889999999999999998 99999999999999999999999999999865432221 1222345678
Q ss_pred ccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHH
Q 008707 404 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRI 482 (557)
Q Consensus 404 y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 482 (557)
|+|||.+.+..++.++||||||+++|||++ |..||....... .....+..+..... +...+..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTRMRA---------PENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCCCCC---------CCCCCHHH
Confidence 999999999899999999999999999997 999997543221 11122222222111 11223468
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 483 AEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 483 ~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
.+++.+||+.||++|||+.||++.|+++..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=338.92 Aligned_cols=246 Identities=27% Similarity=0.425 Sum_probs=207.4
Q ss_pred hhcccCCCCceEEEEEE-EcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCC
Q 008707 239 FCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 317 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gs 317 (557)
--++||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.+...+..++||||++||+
T Consensus 277 ~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggs 356 (550)
T KOG0578|consen 277 DFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGS 356 (550)
T ss_pred chhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCc
Confidence 34789999999999996 44688999999976666667789999999999999999999999988899999999999999
Q ss_pred hhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccccc
Q 008707 318 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 397 (557)
Q Consensus 318 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 397 (557)
|.|.+. ...+++.++..|+..+++||+|||. +||+|||||.+|||++.+|.+||+|||++..+...... ...
T Consensus 357 LTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K-R~T 428 (550)
T KOG0578|consen 357 LTDVVT----KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK-RST 428 (550)
T ss_pred hhhhhh----cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCc-ccc
Confidence 999996 4559999999999999999999998 99999999999999999999999999999988766543 344
Q ss_pred ccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHH
Q 008707 398 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 477 (557)
Q Consensus 398 ~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 477 (557)
..|||.|||||++....|.+|.||||||++++||+-|.+||-.++.- . +...+......++-. ...
T Consensus 429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl----r---AlyLIa~ng~P~lk~-------~~k 494 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----R---ALYLIATNGTPKLKN-------PEK 494 (550)
T ss_pred ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH----H---HHHHHhhcCCCCcCC-------ccc
Confidence 56999999999999999999999999999999999999999743221 1 122222222222211 122
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 478 SIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 478 ~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
....+.+++.+||..|+++||+++|+|+.
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 33478899999999999999999999974
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=336.32 Aligned_cols=272 Identities=26% Similarity=0.418 Sum_probs=220.7
Q ss_pred CChhHHHHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccch-hHHHHHHHHHHHhhcCCCCccceeeEEEecCe
Q 008707 227 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 305 (557)
Q Consensus 227 ~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 305 (557)
....|+......|.++||+|-||.|.++....+..||||+++..... .+.+|.+|+++|.+++||||+.++|+|..++.
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 34567788888899999999999999999998899999999876544 45889999999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
.++|+||+++|+|.+++..+.. ..+......+|+.||+.||+||.+ .++|||||.++|+|++.++++||+|||+++
T Consensus 610 icmI~EYmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCccccc
Confidence 9999999999999999987632 224455567899999999999999 999999999999999999999999999999
Q ss_pred ccCCC-CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh--CCCCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 386 QAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 386 ~~~~~-~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
..... .........-+.+|||+|.+..+.++.++|||+||+++||+++ ...||.... + ...++.....+..+..
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt--~-e~vven~~~~~~~~~~ 762 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT--D-EQVVENAGEFFRDQGR 762 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh--H-HHHHHhhhhhcCCCCc
Confidence 65433 3333344456789999999999999999999999999999876 778886222 1 1233333333332222
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 463 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 463 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
... ...+...+..+.+++.+||..|-++||++++|...|++..
T Consensus 763 ~~~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 763 QVV------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred cee------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 111 1123345668889999999999999999999999998754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=306.95 Aligned_cols=261 Identities=22% Similarity=0.272 Sum_probs=205.6
Q ss_pred HHHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 236 TNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+|...++||+|.||.||+|.+ .+|+.||||+++-... .-.....+|++.|+.++|+||+.+++.|...+...+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 455578999999999999975 4799999999875422 2235688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
++ .+|+..++. +...++...+..++.++++|++|||+ +.|+||||||.|+||+.+|.+||+|||+|+.+.....
T Consensus 83 m~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 95 599999986 36678999999999999999999998 9999999999999999999999999999999876554
Q ss_pred cccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc------cc
Q 008707 393 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI------SI 465 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------~~ 465 (557)
..... ..|.+|.|||.+.+ ..|+...||||.|||+.||+-|.+-|.+..+-+....+- +.+..-... .+
T Consensus 157 ~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If---~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 IQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIF---RALGTPTPDQWPEMTSL 232 (318)
T ss_pred ccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHH---HHcCCCCcccCcccccc
Confidence 33322 46899999998865 589999999999999999999998888665433322221 111111111 11
Q ss_pred cc-------c-cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 466 VD-------P-VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 466 ~d-------~-~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.| | ......-........+++.+|+..+|.+|+|++|.+++
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 0 00111222334466899999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=354.68 Aligned_cols=265 Identities=27% Similarity=0.474 Sum_probs=220.6
Q ss_pred hHHHHHHHHhhcccCCCCceEEEEEEEcC----CcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecC
Q 008707 230 PELEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 304 (557)
Q Consensus 230 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 304 (557)
.||......+.++||.|.||.||+|.++- ...||||.++.... ..+.+|+.|..||.+++||||+++.|+.....
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 35555555567889999999999998763 45799999987654 45678999999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCc
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 384 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 384 (557)
..++|+|||++|+|..+|+.. .+.+++.+...+++.||.||+||-. .++|||||.++||||+.+..+|++|||++
T Consensus 704 PvMIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999999874 5669999999999999999999997 99999999999999999999999999999
Q ss_pred cccCCCCcccccccc--CCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCC
Q 008707 385 RQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 461 (557)
Q Consensus 385 ~~~~~~~~~~~~~~~--g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 461 (557)
+...++......... -+.+|.|||.+....++.++||||||++|||.++ |.+||- ++.+. -+...+++|
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW--dmSNQ-----dVIkaIe~g- 850 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW--DMSNQ-----DVIKAIEQG- 850 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc--ccchH-----HHHHHHHhc-
Confidence 987665533322222 2568999999999999999999999999999887 999985 33221 122333333
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 462 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 462 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
.+--.+.+.+..|.+|+..||++|-.+||.+.+|+..|.+++....
T Consensus 851 --------yRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 851 --------YRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred --------cCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 1222244567789999999999999999999999999999987544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=338.27 Aligned_cols=247 Identities=27% Similarity=0.404 Sum_probs=203.0
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc----cc-hhHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS----CS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~ 307 (557)
..|.+.+.||+|.||+|+.|.+. +++.||+|++... .. ...+.+.+|+.+++.++ ||||+++++++......+
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 45667899999999999999765 6899999977553 11 23456778999999998 999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC-CcEEEecccCccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQ 386 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~ 386 (557)
+||||+.||+|.+++.. .+.+.+..+..++.|++.|++|||+ +||+||||||+|||++.+ +++||+|||++..
T Consensus 97 ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999999984 5678889999999999999999998 999999999999999999 9999999999988
Q ss_pred cCCCCccccccccCCCCccCCcccCCCC-CC-cccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGNQQ-LT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~~~-~s-~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
.. .......+.+|++.|+|||++.+.. |+ .++||||+|++||.|++|..||+..+. ... ...+..+...-
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l-~~ki~~~~~~~ 242 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNL-YRKIRKGEFKI 242 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHH-HHHHhcCCccC
Confidence 74 2223345678999999999999876 75 799999999999999999999985221 111 11133332210
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 504 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl 504 (557)
..... ..++..++.+|+..+|.+|+|+.||+
T Consensus 243 ------p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 243 ------PSYLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ------CCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 00110 44788999999999999999999999
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=336.33 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=212.2
Q ss_pred ccccCChhHHHHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEe
Q 008707 223 VAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 302 (557)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 302 (557)
..|.||+++|.+. +-||.|+.|.||+|++. ++.||||+++... ..+++-|++|+||||+.|.|+|..
T Consensus 117 e~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 117 ELWEIPFEEISEL-----EWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred hhccCCHHHhhhh-----hhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC
Confidence 3466777777654 56999999999999998 8999999876322 246778999999999999999999
Q ss_pred cCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEeccc
Q 008707 303 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 382 (557)
Q Consensus 303 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 382 (557)
...+|+|||||..|-|...|+ .+..+.......|..+||.||.|||. +.|+|||||.-||||+.+..|||+|||
T Consensus 184 sPcyCIiMEfCa~GqL~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred CceeEEeeeccccccHHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEecccc
Confidence 999999999999999999998 46778888899999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 383 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 383 la~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
-++...+..+ .-.+.||..|||||++++...+.|+||||||||||||+||..||.+.+.....
T Consensus 258 TS~e~~~~ST--kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII--------------- 320 (904)
T KOG4721|consen 258 TSKELSDKST--KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII--------------- 320 (904)
T ss_pred chHhhhhhhh--hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---------------
Confidence 9987765422 23456999999999999999999999999999999999999999854432110
Q ss_pred ccccc-ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 463 ISIVD-PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 463 ~~~~d-~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
-.+. ..+.--.+...++.+.-|+++||+-.|..||++.+|+..|+-...
T Consensus 321 -wGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 321 -WGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred -EeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 0000 111223355667789999999999999999999999999876654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=323.20 Aligned_cols=262 Identities=25% Similarity=0.343 Sum_probs=208.0
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccC-ccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD-SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
...|++.++||.|..++||+|+.. .++.||||++.- .+....+.+.+|+..|+.++||||++++..|..+..+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 356778899999999999999754 689999999853 344557889999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
||.+|++.++++... ...+++..+..|.+++++||.|||+ +|.+|||||+.||||+.+|.|||+|||.+....+..
T Consensus 105 fMa~GS~ldIik~~~-~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYY-PDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHc-cccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999998765 3459999999999999999999998 999999999999999999999999999876543322
Q ss_pred cc--cc-ccccCCCCccCCcccCC--CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 392 TH--IS-SVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 392 ~~--~~-~~~~g~~~y~aPE~l~~--~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
.. .. ....||+.|||||++.. ..|+.|+||||||++..||.+|..||..... .+.+...+. +......
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLq-n~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQ-NDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhc-CCCCCcc
Confidence 11 11 44579999999999644 4789999999999999999999999983221 111122222 2222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
-..+..+......+.+.+++..|+..||++|||++++++.
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1111111222334588999999999999999999999863
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=324.35 Aligned_cols=247 Identities=23% Similarity=0.344 Sum_probs=199.6
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCccchh---HHHHHHHHHHHhhcCCCCccceeeEEEe----cCeeEEEEEec
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVYEYM 313 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~~~~----~~~~~lv~e~~ 313 (557)
..||+|++|.||+|.+. |+.||||.+....... .+.+.+|++++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 56999999999999984 8999999987543222 4678899999999999999999999876 34678999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++|+|.+++.. ...+++.....++.|++.||+|||+ ..+++||||||+||++++++.+||+|||++........
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~- 178 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF- 178 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccc-
Confidence 99999999974 4568899999999999999999997 24889999999999999999999999999876543221
Q ss_pred ccccccCCCCccCCcccCC--CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 394 ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~--~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
...++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.. +........+....
T Consensus 179 ---~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~------- 242 (283)
T PHA02988 179 ---KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDLIINKNNSLK------- 242 (283)
T ss_pred ---cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCCCCC-------
Confidence 2347889999999976 68899999999999999999999999743321 11112222211111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
.+...+..+.+++.+||+.||++|||++||++.|++...
T Consensus 243 --~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 243 --LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred --CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 111234478899999999999999999999999988753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=331.89 Aligned_cols=245 Identities=29% Similarity=0.406 Sum_probs=206.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|.+.+.||+|.||+||+|+.+ +.+.||+|.+.+.. .++.+.+.+|++|++.++||||+.++++|+...+.++|+||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 445688999999999999766 57899999987643 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
.| +|..++. ..+.++++.+..++.|++.||.|||+ .+|.|||+||.|||++..+.+|+||||+|+..... ..
T Consensus 84 ~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~ 155 (808)
T KOG0597|consen 84 VG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TS 155 (808)
T ss_pred hh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC-ce
Confidence 76 9999998 46789999999999999999999998 99999999999999999999999999999987654 33
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
......|||-|||||++.+..|+..+|+||+||++||+++|++||-.. .+.+.++.... .+. .
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~-d~v-------~--- 218 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILK-DPV-------K--- 218 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhc-CCC-------C---
Confidence 334456999999999999999999999999999999999999999621 23333332222 111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.+......+.+++...+..||.+|-|..+++..
T Consensus 219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 122444578899999999999999999999875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=336.69 Aligned_cols=245 Identities=27% Similarity=0.399 Sum_probs=206.5
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+++++.||.|+-|.|-+|++. +|+.+|||++.+.. ......+.+|+-+|+.+.||||+++|+++++...+|+|.||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 346789999999999999865 79999999997652 22345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|-|.+++.. .+.+++..+..++.||+.|+.|+|. .+|+||||||+|+|+|..+++||+|||+|.....+.
T Consensus 94 v~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk- 166 (786)
T KOG0588|consen 94 VPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK- 166 (786)
T ss_pred cCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence 999999999984 5779999999999999999999998 999999999999999999999999999998765433
Q ss_pred cccccccCCCCccCCcccCCCCC-CcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 393 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~-s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.-.+.+|.|+|.|||++.+..| ..++||||.|||||.|+||+.||++.+ +.. +.-.+..|.++
T Consensus 167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~-LLlKV~~G~f~-------- 230 (786)
T KOG0588|consen 167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRV-LLLKVQRGVFE-------- 230 (786)
T ss_pred -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHH-HHHHHHcCccc--------
Confidence 2345689999999999999877 579999999999999999999998322 221 22233344331
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.+...+.+..+|+.+|+.+||+.|.|++||++.
T Consensus 231 --MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 231 --MPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --CCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 123344478899999999999999999999875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=323.72 Aligned_cols=257 Identities=22% Similarity=0.394 Sum_probs=205.7
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEc----CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
....+++.+.||+|+||.||+|.++ .+..||+|.++.... ...+.+.+|+.+++.++||||+++++++..++..+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 4456778899999999999999764 356899999876533 33467889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++++|||.+...
T Consensus 83 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999998743 3568999999999999999999998 99999999999999999999999999987654
Q ss_pred CCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
............++..|+|||.+.+..++.++|||||||++||+++ |+.||...... .. ...+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~----~~~~~~~~~~~-- 228 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DV----IKAVEDGFRLP-- 228 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HH----HHHHHCCCCCC--
Confidence 3322211222235678999999999999999999999999999875 99999743221 11 11222221111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
.+...+..+.+++.+||+.+|++||+++||.+.|...
T Consensus 229 -------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 -------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1122345788999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=334.07 Aligned_cols=263 Identities=28% Similarity=0.510 Sum_probs=208.9
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
++......+.+.||+|.||+||+|.|.+ .||||++... ..+..+.|+.|+.++++-+|.||+-++|+|..+.. .+
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 3333444567899999999999999873 5999998654 34466889999999999999999999999998876 99
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
|+.||+|-+|+.+++.. ...+...+.+.|++|||+||.|||+ ++|+|+|||..|||+.+++.|||+|||++..-.
T Consensus 465 iTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 99999999999999864 4678888999999999999999998 999999999999999999999999999987543
Q ss_pred CCC-ccccccccCCCCccCCcccCCC---CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 389 EDL-THISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 389 ~~~-~~~~~~~~g~~~y~aPE~l~~~---~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
... ........|...|||||+++.. .|++++||||||+++|||+||..||.....+...- .+..|-.
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif-------mVGrG~l-- 610 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF-------MVGRGYL-- 610 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE-------Eeccccc--
Confidence 221 1111222377889999999654 68999999999999999999999998333221110 1111211
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
..|. .......++++.+|+..||..++++||.+.+|+..|+.+...
T Consensus 611 ~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 611 MPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred Cccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1111 011234566899999999999999999999999999988874
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=326.75 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=202.8
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcC-----------------CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccc
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKD-----------------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVP 295 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~ 295 (557)
...|.+.+.||+|+||.||+|.+++ +..||+|.+.... ......+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3456678899999999999997542 3469999987643 334567999999999999999999
Q ss_pred eeeEEEecCeeEEEEEecCCCChhhhhhccC----------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeE
Q 008707 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV----------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359 (557)
Q Consensus 296 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~iv 359 (557)
+++++.+.+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ .+++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence 9999999999999999999999999886421 11346788899999999999999998 9999
Q ss_pred eeccCCCCEEeCCCCcEEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh--CCC
Q 008707 360 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKK 436 (557)
Q Consensus 360 H~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt--g~~ 436 (557)
||||||+|||++.++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999976533221 11222345788999999988899999999999999999987 556
Q ss_pred CCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 437 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 437 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
||...+. ......+............. ..+...+..+.+++.+||+.+|++|||+.||.+.|++
T Consensus 241 p~~~~~~---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTD---EQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCH---HHHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 7763322 12222222222221111100 0111233478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=315.25 Aligned_cols=248 Identities=23% Similarity=0.357 Sum_probs=212.1
Q ss_pred HHHHHHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCccchh---HHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
...+|++.+.||+|.||.|-+|.. ..|+.||||.+++....+ .-.+.+|++||..|+||||+++|.+|++.+..++
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 357888999999999999999964 689999999998754333 3457899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||..+|.|+|++.. .+.+++.....+++||..|+.|+|. ++++|||||.+|||+|+++++||+|||++..+.
T Consensus 131 vMEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence 9999999999999984 5779999999999999999999998 999999999999999999999999999998876
Q ss_pred CCCccccccccCCCCccCCcccCCCCC-CcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~~~~-s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
+.. .-++++|.|-|.+||++.+..| .+..|-||||++||-|+.|..||++.|... +.+.+..|.+.+
T Consensus 205 ~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-------lvrQIs~GaYrE--- 272 (668)
T KOG0611|consen 205 DKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-------LVRQISRGAYRE--- 272 (668)
T ss_pred ccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-------HHHHhhcccccC---
Confidence 543 3456889999999999999877 579999999999999999999999765432 223344444322
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
++.+....-+|.+|+..+|++|-|+.+|...
T Consensus 273 --------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 273 --------PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred --------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 1223355678999999999999999999764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=302.46 Aligned_cols=235 Identities=26% Similarity=0.367 Sum_probs=196.7
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
.+++.+.||.|+||+|.+++.+ +|..+|+|++.+..- .+.+...+|..+|+.+.||.++++++.+.+.+..+||||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 3456789999999999999877 478899999976432 334567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|++||.|..++++ .+.+++..++.++.||+.||+|||+ .+|++|||||+|||+|.+|.+||.|||+|+.....
T Consensus 125 yv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 125 YVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred ccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 9999999999984 5679999999999999999999998 99999999999999999999999999999987543
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
+.+.+|||.|+|||++....+..++|.||||+++|||+.|.+||-.... .... ..+-++++
T Consensus 198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY----~KI~~~~v--------- 258 (355)
T KOG0616|consen 198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIY----EKILEGKV--------- 258 (355)
T ss_pred ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHH----HHHHhCcc---------
Confidence 4567899999999999999999999999999999999999999974332 1111 11212221
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCC
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSR 497 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~R 497 (557)
.++..-...+.+++...++.|-.+|
T Consensus 259 -~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1111222367789999999998888
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=330.71 Aligned_cols=241 Identities=24% Similarity=0.350 Sum_probs=196.0
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
+.||+|+||.||++..+ +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999865 68999999987532 233456788999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccc
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 396 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 396 (557)
+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~ 153 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-ccc
Confidence 99998873 4578999999999999999999998 9999999999999999999999999999875422211 122
Q ss_pred cccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCH
Q 008707 397 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 476 (557)
Q Consensus 397 ~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 476 (557)
...||+.|+|||.+.+..++.++||||+||++|||++|+.||...+... .. ..+..+.. ..+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~----~~~~~~~~----------~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LF----ELILMEEI----------RFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HH----HHHHcCCC----------CCCC
Confidence 3458999999999999999999999999999999999999997433211 11 11111111 0111
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 008707 477 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 505 (557)
Q Consensus 477 ~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 505 (557)
.....+.+++.+||..||++|| +++++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 2234688999999999999999 7999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=338.26 Aligned_cols=259 Identities=29% Similarity=0.444 Sum_probs=203.9
Q ss_pred HHHHHhhcccCCCCceEEEEEEE------cCCcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCe
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 305 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~ 305 (557)
...+++.+.||+|+||.||+|.+ .++..||+|+++... ....+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45577889999999999999964 235689999986542 33456788999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhhhhhccC-----------------------------------------------------------
Q 008707 306 RILVYEYMHNGTLRDRLHGSV----------------------------------------------------------- 326 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 326 (557)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999886421
Q ss_pred -------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 327 -------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 327 -------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
....+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 01247888899999999999999998 99999999999999999999999999999865433221
Q ss_pred -ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 394 -ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 394 -~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..... .+..+....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~----~~~~~~~~~------- 337 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYK----MIKEGYRML------- 337 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHH----HHHhCccCC-------
Confidence 1122235668999999999999999999999999999998 88898643221 11111 222221110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
.+...+.++.+++.+||+.||++||+++||++.|++.
T Consensus 338 --~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 338 --SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0111234788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=317.26 Aligned_cols=257 Identities=26% Similarity=0.473 Sum_probs=207.8
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
+....+++.+.||+|++|.||+|.+.+++.||+|.++... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3345677789999999999999998888899999987543 235678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++++|.+++.... ...+++..+..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 82 LMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred cccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 999999999997542 4568999999999999999999998 999999999999999999999999999998765332
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
.........+..|+|||.+.+..++.++||||||+++|||+| |+.||...... .. ...+..+...
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~----~~~~~~~~~~------- 223 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EV----LQQVDQGYRM------- 223 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCCC-------
Confidence 222222223457999999999899999999999999999999 99999743211 11 1111111110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
......+..+.+++.+|++.+|++||++++|++.|++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 224 --PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0111233578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=317.63 Aligned_cols=255 Identities=30% Similarity=0.464 Sum_probs=206.2
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
..+.+.+.||+|+||.||+|.++ .++.||+|.+... ....+.+.+|+++++.++|+||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 44566789999999999999875 4889999988654 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++... ....+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999998653 24568999999999999999999998 99999999999999999999999999999876543322
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+ . ...+..+.. .
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~~---------~ 224 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V----YELLEKGYR---------M 224 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCCC---------C
Confidence 2222234668999999999899999999999999999998 999997443221 1 111222111 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
..+...+..+.+++.+|++.+|++||++.+++++|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11112245788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=337.46 Aligned_cols=262 Identities=30% Similarity=0.468 Sum_probs=205.3
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEec
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 303 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~ 303 (557)
+....+++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+++++.+ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 44566778999999999999998742 24579999987543 33446788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChhhhhhccC---------------------------------------------------------
Q 008707 304 HQRILVYEYMHNGTLRDRLHGSV--------------------------------------------------------- 326 (557)
Q Consensus 304 ~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------- 326 (557)
+..++||||+++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999885321
Q ss_pred ----------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc-cc
Q 008707 327 ----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-IS 395 (557)
Q Consensus 327 ----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~ 395 (557)
....+++..+++++.||++||+|||+ ++++||||||+||++++++.+||+|||++......... ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 01247888899999999999999998 99999999999999999999999999999765433221 11
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ... .....+.... .+
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~----~~~~~~~~~~--~~------ 337 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFY----KMVKRGYQMS--RP------ 337 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHH----HHHHcccCcc--CC------
Confidence 22235678999999998899999999999999999997 999997432211 111 1111111100 00
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
...+..+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 338 -~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 -DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 112347889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=317.77 Aligned_cols=255 Identities=26% Similarity=0.455 Sum_probs=206.7
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
...+++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 45566789999999999999998888899999876532 33567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999998754 34568888999999999999999998 99999999999999999999999999999876543322
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......++..|+|||.+.+..++.++||||||+++|+|+| |+.||....... .. ..+..+....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~~~-------- 224 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VM----SALQRGYRMP-------- 224 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HH----HHHHcCCCCC--------
Confidence 2222335678999999998889999999999999999998 999996332111 11 1122221110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
.....+..+.+++.+|+..+|++||++++|.++|++
T Consensus 225 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 225 -RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=316.42 Aligned_cols=251 Identities=32% Similarity=0.523 Sum_probs=202.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
..+++.+.||+|+||.||++.++++..+|+|.+.... ...+.+.+|+++++.++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3456678999999999999999888899999876432 234678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+|+|.+++... ...+++..+..++.|++.||+|||+ ++++|+||+|+||+++.++.++|+|||.+..........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999998743 2458899999999999999999998 999999999999999999999999999988654332222
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+. ..... .+..+... ..+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~----~i~~~~~~--~~~~---- 224 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVE----MISRGFRL--YRPK---- 224 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHH----HHHCCCCC--CCCC----
Confidence 222235668999999998889999999999999999999 8999974322 11111 12222111 1111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 507 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 507 (557)
..+..+.+++.+||+.+|++||+++|+++.|
T Consensus 225 ---~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 ---LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=321.65 Aligned_cols=250 Identities=24% Similarity=0.304 Sum_probs=198.7
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|+..+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+++++.++|+||+++++.+.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 345688999999999999764 68999999886432 12234578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+.+... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999998887643 23468899999999999999999998 9999999999999999999999999999987543222
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.... .+.+...+.....
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~---------- 222 (285)
T cd05631 158 --VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKEDQE---------- 222 (285)
T ss_pred --ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhcccc----------
Confidence 1233589999999999999999999999999999999999999985432211 1111111111110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 505 (557)
.+.......+.+++.+||+.||++||+ ++|+++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 111122346789999999999999997 788775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=316.16 Aligned_cols=255 Identities=27% Similarity=0.451 Sum_probs=210.0
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
...|++.+.||.|+||.||+|...+++.+++|.+..........+.+|+++++.++||||+++++++.+....++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45677889999999999999999889999999988765555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||.+.........
T Consensus 85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999999754 34568999999999999999999998 99999999999999999999999999999876443222
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.. ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+.. ..... +..+...
T Consensus 161 ~~-~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~----~~~~~~~--------- 223 (261)
T cd05148 161 SS-DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQ----ITAGYRM--------- 223 (261)
T ss_pred cc-CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHH----HHhCCcC---------
Confidence 22 2335678999999988889999999999999999998 89999743311 11111 1111110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
......+..+.+++.+|++.+|++|||+++|++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1112233468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=325.89 Aligned_cols=262 Identities=23% Similarity=0.302 Sum_probs=202.4
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
...|++.+.||+|+||.||++... ++..||+|.+.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 345566789999999999999876 58889999886542 2345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 9999999999874 4568899999999999999999997 2469999999999999999999999999987654322
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc--------
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI-------- 463 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------- 463 (557)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+..+ +..........+...
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence 223458999999999999999999999999999999999999997543221 111110000000000
Q ss_pred ----------------------ccccc---cccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 464 ----------------------SIVDP---VLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 464 ----------------------~~~d~---~l~~~~-~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
...+. ...... ......++.+++.+||+.||++|||++||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 000000 01123478899999999999999999999875
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=323.43 Aligned_cols=245 Identities=27% Similarity=0.376 Sum_probs=204.5
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+-.+.||+|.||.||+|... .++.||+|++.-.. ......+.+|+.++..++++||.++|+.+..+...+++||||.|
T Consensus 16 ~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~g 95 (467)
T KOG0201|consen 16 TKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGG 95 (467)
T ss_pred ccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcC
Confidence 33478999999999999765 68999999986433 34567788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|++.+.++. +..+.+..+.-+++++..|+.|||+ .+.+|||||+.|||+..+|.+||+|||.+..........
T Consensus 96 Gsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 96 GSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred cchhhhhcc---CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 999999973 4445777888899999999999998 999999999999999999999999999998877655444
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
.++.|||.|||||++....|+.|+||||||++.+||.+|.+|+......... -++-....+..+
T Consensus 169 ~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----------------flIpk~~PP~L~ 232 (467)
T KOG0201|consen 169 KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----------------FLIPKSAPPRLD 232 (467)
T ss_pred ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----------------EeccCCCCCccc
Confidence 6677999999999999989999999999999999999999999743321111 111111122222
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
......+.+++..|++.+|+.||+|+++++
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 344457899999999999999999999886
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=320.74 Aligned_cols=263 Identities=19% Similarity=0.204 Sum_probs=199.6
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 456789999999999999886 57899999986532 233466889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
+++.+..+.. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 83 EKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 9877765543 23568899999999999999999998 99999999999999999999999999999876443322
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHH---------HHHHHhcCCccc
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW---------ARSMIKKGDVIS 464 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~---------~~~~~~~~~~~~ 464 (557)
......|++.|+|||++.+..++.++||||+||++|||++|+.||...+..+....... ............
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 22334589999999999988899999999999999999999999985443211111100 000000000000
Q ss_pred cccccccC------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 465 IVDPVLIG------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 465 ~~d~~l~~------~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
...+.... .........+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 001112346899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=324.33 Aligned_cols=243 Identities=23% Similarity=0.297 Sum_probs=198.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 456789999999999999876 68999999986432 12345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 83 VPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 999999999873 4568899999999999999999998 999999999999999999999999999988654321
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.. ... ..+..+..
T Consensus 156 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~-~~i~~~~~---------- 215 (291)
T cd05612 156 ---WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIY-EKILAGKL---------- 215 (291)
T ss_pred ---ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHH-HHHHhCCc----------
Confidence 2235899999999999999999999999999999999999999743321 111 11112211
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 506 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~~ 506 (557)
..+......+.+++.+||+.||.+||+ ++|+++.
T Consensus 216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 011112336789999999999999995 8887753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=317.34 Aligned_cols=249 Identities=39% Similarity=0.607 Sum_probs=195.1
Q ss_pred hhcccCCCCceEEEEEEEc-----CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 239 FCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+.+.||+|.||.||+|.+. .+..|+||.+..... ...+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999887 257899999965433 3468899999999999999999999999988889999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC-C
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-L 391 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~-~ 391 (557)
+++|+|.+++... ....+++..+..|+.||++||+|||+ .+++|++|+++||+++.++.+||+|||++...... .
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999864 35678999999999999999999998 89999999999999999999999999999876322 1
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
............|+|||.+.+..++.++||||||+++|||++ |+.||...+ ..+.... +.++.....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~------~~~~~~~-~~~~~~~~~----- 226 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD------NEEIIEK-LKQGQRLPI----- 226 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC------HHHHHHH-HHTTEETTS-----
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccc-cccccccee-----
Confidence 222233446788999999998889999999999999999999 788886332 1222222 233322111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 507 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 507 (557)
+...+..+.+++.+||+.+|++|||+++|++.|
T Consensus 227 ----~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 ----PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111234688999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=324.70 Aligned_cols=239 Identities=25% Similarity=0.335 Sum_probs=192.9
Q ss_pred cCCCCceEEEEEEEc-CCcEEEEEEccCc---cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 243 IGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 243 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
||+|+||.||+|... +++.||+|++... .......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999876 5789999998643 223445678899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccccc
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 398 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 398 (557)
.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 153 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTF 153 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccc
Confidence 999874 4568899999999999999999998 9999999999999999999999999999875432221 22334
Q ss_pred cCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHH
Q 008707 399 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 478 (557)
Q Consensus 399 ~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 478 (557)
.||+.|+|||.+.+..++.++||||+||++|+|++|+.||...+. .+...... .+.. ..+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~-~~~~----------~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKIL-QEPL----------RFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHH-cCCC----------CCCCcC
Confidence 589999999999999999999999999999999999999974322 11122211 1111 011122
Q ss_pred HHHHHHHHHHccccCCCCCCC---HHHHHH
Q 008707 479 IWRIAEVAIQCVEQRGFSRPK---MQEIVL 505 (557)
Q Consensus 479 ~~~l~~li~~cl~~~P~~RPt---~~evl~ 505 (557)
...+.+++.+||+.||++||+ +.|+++
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 346789999999999999986 555554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=328.75 Aligned_cols=251 Identities=22% Similarity=0.318 Sum_probs=201.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++..++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 456789999999999999876 58899999986532 22345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 83 VPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999973 4568899999999999999999998 9999999999999999999999999999986543
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......|++.|+|||++.+..++.++|||||||++|||++|..||...+..+.. ..+... ... +......
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~---~~~---~~~~~~~ 223 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW---ENLKYW---KET---LQRPVYD 223 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH---HHHHhc---ccc---ccCCCCC
Confidence 122345899999999999999999999999999999999999999754332211 111100 000 0000000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.........+.+++.+|+..+|++||+++|+++.
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0011234478899999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=316.81 Aligned_cols=257 Identities=28% Similarity=0.477 Sum_probs=206.5
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcC------CcEEEEEEccCccch-hHHHHHHHHHHHhhcCCCCccceeeEEEecCee
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 306 (557)
..++.+.+.||+|+||.||+|...+ ++.||+|.+...... ..+.+.+|+++++.++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 4567788999999999999997643 478999998765443 457899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhccC-----------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc
Q 008707 307 ILVYEYMHNGTLRDRLHGSV-----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 375 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~ 375 (557)
++||||+++++|.+++.... ....+++..+..++.|++.|++|||+ ++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 99999999999999987532 23457888999999999999999998 89999999999999999999
Q ss_pred EEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 008707 376 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 453 (557)
Q Consensus 376 ~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~ 453 (557)
++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+... ..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~--- 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VI--- 234 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH---
Confidence 99999999876432221 11222335778999999999999999999999999999999 999986433211 11
Q ss_pred HHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 454 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 454 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
..+..+..... ....+..+.+++.+||+.+|++||+++||++.|++
T Consensus 235 -~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 235 -ECITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -HHHHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 12222222111 11233478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=328.15 Aligned_cols=245 Identities=23% Similarity=0.319 Sum_probs=199.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
..|++.+.||+|+||.||+|.++ +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 44667899999999999999876 58899999986432 223456889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+++|+|.+.+.. ...+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999874 4568888899999999999999998 99999999999999999999999999999876433
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
. ....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+. .+. ...+..+...
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~-~~~i~~~~~~------- 233 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRI-YEKILAGRLK------- 233 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHH-HHHHhcCCcC-------
Confidence 2 224589999999999999999999999999999999999999974321 111 1122222211
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVLA 506 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~~ 506 (557)
.+......+.+++.+||+.||++||+ ++++++.
T Consensus 234 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 234 ---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00111236789999999999999997 6777643
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=325.52 Aligned_cols=242 Identities=25% Similarity=0.351 Sum_probs=196.1
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
+.||+|+||.||++... +++.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999865 58999999987532 234457888999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccc
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 396 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 396 (557)
+|.+.+.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~ 153 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-TMK 153 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-ccc
Confidence 99988863 4568999999999999999999998 9999999999999999999999999999875432211 122
Q ss_pred cccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCH
Q 008707 397 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 476 (557)
Q Consensus 397 ~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 476 (557)
...|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+... ... .+..+.. . .+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~~-~~~~~~~------~----~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFE-LILMEDI------K----FPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HHH-HhccCCc------c----CCC
Confidence 3458999999999999899999999999999999999999997433211 111 1111111 0 111
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 008707 477 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 506 (557)
Q Consensus 477 ~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 506 (557)
.....+.+++.+||..||++|| +++|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2234678999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=320.82 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=201.3
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+++.+.||+|+||.||+|+-+ +|+.+|+|++++.. ..+.+.++.|-.+|....+|.||+++..|++...+||||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 345789999999999999755 69999999998753 34556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC--
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-- 390 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~-- 390 (557)
++||++..+|. ....+++..+..++.+++-|+.-+|+ .|++||||||+|+|||..|++||+|||++.-....
T Consensus 223 lPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 223 LPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred cCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999998 46789999999999999999999998 99999999999999999999999999998532110
Q ss_pred -------------------Cccc-----c--------------------ccccCCCCccCCcccCCCCCCcccceehhHH
Q 008707 391 -------------------LTHI-----S--------------------SVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 426 (557)
Q Consensus 391 -------------------~~~~-----~--------------------~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ 426 (557)
.... . ....|||.|+|||++.+..|+..+|.|||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 0000 0 0124999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCccc-cccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHH
Q 008707 427 VLLELISGKKPVSVEDFGA-ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQE 502 (557)
Q Consensus 427 ll~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~e 502 (557)
|+|||+.|.+||...+... ...+..|-........ .....+..++|.+|+. ||++|-- ++|
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~--------------~~~s~eA~DLI~rll~-d~~~RLG~~G~~E 441 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE--------------VDLSDEAKDLITRLLC-DPENRLGSKGAEE 441 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc--------------CcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence 9999999999998666543 3345555433221110 1111467799999999 9999986 555
Q ss_pred HHH
Q 008707 503 IVL 505 (557)
Q Consensus 503 vl~ 505 (557)
|.+
T Consensus 442 IK~ 444 (550)
T KOG0605|consen 442 IKK 444 (550)
T ss_pred Hhc
Confidence 543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=325.45 Aligned_cols=241 Identities=24% Similarity=0.349 Sum_probs=194.7
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
+.||+|+||.||++... +|+.||+|++.... ......+.+|+++++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46899999999999865 68999999986532 233456778999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccc
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 396 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 396 (557)
+|..++.. ...+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||++........ ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~ 153 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TMK 153 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-ccc
Confidence 99988863 4568999999999999999999998 9999999999999999999999999999875322211 122
Q ss_pred cccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCH
Q 008707 397 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 476 (557)
Q Consensus 397 ~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 476 (557)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||...+... . ... +..+.. . .+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~---~~~-~~~~~~------~----~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---L---FEL-ILMEEI------R----FPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHH-HhcCCC------C----CCC
Confidence 3458999999999999999999999999999999999999997433211 1 111 111111 0 111
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 008707 477 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 505 (557)
Q Consensus 477 ~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 505 (557)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 2234678999999999999998 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=323.11 Aligned_cols=203 Identities=27% Similarity=0.399 Sum_probs=175.1
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
+....|++.+.||+|+||.||++.+. ++..+|+|.+.... ......+.+|+++++.++||||+++++++.+++..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 34466778899999999999999876 57889999876542 23446788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ..+++|+||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 82 MEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred EecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 999999999999874 3458888999999999999999997 25799999999999999999999999999876533
Q ss_pred CCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCC
Q 008707 390 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~ 442 (557)
.. .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||....
T Consensus 157 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 157 SM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred hc---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 21 123358899999999999899999999999999999999999997443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=324.91 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=211.0
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCe-eEEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ-RILVY 310 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~-~~lv~ 310 (557)
..|...+.+|+|+||.++.++++ +++.+++|.+.-. ....++...+|+.++++++|||||.+.+.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 34667899999999999999876 4778999987533 23344578899999999999999999999999888 89999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
+||+||++.+.+.... +.-+++..+..|+.|++.|+.|||+ ++|+|||||+.|||++.++.|+|+|||+|+.....
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998763 6779999999999999999999998 99999999999999999999999999999998766
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
... .....||+.|+.||++.+..|..|+|||||||++|||++-+++|...++..- +.. +-++. ++|
T Consensus 160 ~~~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L------i~k-i~~~~----~~P-- 225 (426)
T KOG0589|consen 160 DSL-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL------ILK-INRGL----YSP-- 225 (426)
T ss_pred hhh-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH------HHH-Hhhcc----CCC--
Confidence 433 3445699999999999999999999999999999999999999986655321 111 11111 111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.+.....++..++..|+..+|+.||++.+++..
T Consensus 226 ---lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 ---LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 223344578899999999999999999999987
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=313.08 Aligned_cols=251 Identities=29% Similarity=0.489 Sum_probs=201.8
Q ss_pred HHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
..+++.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|+++++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 34567899999999999999988778899998864322 34568889999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++...+.....
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999998753 3468999999999999999999998 999999999999999999999999999987654332222
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+... .. ..+..+... .
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~----~~~~~~~~~---------~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VV----ESVSAGYRL---------Y 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HH----HHHHcCCcC---------C
Confidence 222224457999999999899999999999999999999 899997433211 11 111111100 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 507 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 507 (557)
.+...+..+.+++.+|+..+|++|||+.||++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1112344788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=329.74 Aligned_cols=242 Identities=24% Similarity=0.353 Sum_probs=202.5
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~l 308 (557)
....++.++||+|.||+|+++..+ +++.+|||++++.. ..+.+..+.|.+|+... +||.+++++..|.+.++.++
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 344567899999999999999887 47899999998753 45567788899998888 59999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||+.||++..+.+ ...+++..+.-++..|+.||+|||+ +||+|||||.+|||+|.+|.+||+|||+++..-
T Consensus 447 vmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccC
Confidence 999999999655554 4679999999999999999999998 999999999999999999999999999998753
Q ss_pred CCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
.. ...+.+.+|||.|+|||++.+..|+.++|.|||||+||||+.|..||.+.+.++..+ .+...
T Consensus 520 ~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd-------sI~~d-------- 583 (694)
T KOG0694|consen 520 GQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD-------SIVND-------- 583 (694)
T ss_pred CC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-------HHhcC--------
Confidence 22 224677899999999999999999999999999999999999999998655432111 11110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 500 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 500 (557)
..-|+.....+...++.+++..+|++|--+
T Consensus 584 --~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 --EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 112344455678899999999999999966
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=323.54 Aligned_cols=264 Identities=29% Similarity=0.455 Sum_probs=220.6
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEcC---C--cEEEEEEccCc-cchhHHHHHHHHHHHhhcCCCCccceeeEEEecC
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMKD---G--KEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 304 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 304 (557)
++........+.||+|-||.||+|.+.+ | -.||||.-+.. .....+.|+.|..+|++++||||++++|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 5556666678899999999999997542 3 36888987764 445678899999999999999999999999865
Q ss_pred eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCc
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 384 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 384 (557)
..++|||.++-|.|..+++. +...++..+...++.||+.||+|||+ ..+|||||.++|||+....-+||+|||++
T Consensus 464 P~WivmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchh
Confidence 57899999999999999986 35678889999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 385 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 385 ~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
+...++.....+...-+..|||||.+...+++.++|||-||+.+||++. |..||.+-.-.+.. ..+++|+..
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnGeRl 611 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENGERL 611 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCCCCC
Confidence 9987766555555556889999999999999999999999999999987 99999854433211 122333332
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 008707 464 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 516 (557)
Q Consensus 464 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 516 (557)
-.++.++..+..++.+||.+||.+||+++||...|.++...+..
T Consensus 612 ---------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~ 655 (974)
T KOG4257|consen 612 ---------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKI 655 (974)
T ss_pred ---------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhh
Confidence 23445666888999999999999999999999999998875443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.61 Aligned_cols=262 Identities=30% Similarity=0.447 Sum_probs=221.0
Q ss_pred hHHHHHHHHhhcccCCCCceEEEEEEEcC-CcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 230 PELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 230 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
.|++.....+.++||.|.||.||.|.|+. .-.||||.++.. ....++|++|..+|+.++|||+|+++|+|.....+|+
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYI 340 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYI 340 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEE
Confidence 35566666678999999999999999985 568999998754 3456889999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
|+|||..|+|.++|+.. +...++-...+.++.||+.||.||.. ++++||||.++|+||.++..+|++|||+++...
T Consensus 341 iTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 341 ITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 99999999999999875 44556667778999999999999998 999999999999999999999999999999886
Q ss_pred CCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
.+.........-++.|.|||.+....++.|+|||+||++|||+.| |-.||.+-+.... -..+++|-
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV-------Y~LLEkgy------ 483 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-------YGLLEKGY------ 483 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH-------HHHHhccc------
Confidence 665444444456889999999999999999999999999999999 8899986554322 22233322
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
+-+.+..++..+.+++..||+++|.+||++.||.+.++.+..
T Consensus 484 ---RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 484 ---RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ---cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 222344556689999999999999999999999999987764
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=312.21 Aligned_cols=255 Identities=27% Similarity=0.475 Sum_probs=204.2
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
....+++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++.. ...+++|||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEY 81 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEe
Confidence 3456778899999999999999988888999999875433 34678999999999999999999998854 567899999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++... ....+++.++..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 82 MSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999998753 23458999999999999999999998 9999999999999999999999999999977544322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.. ... ..+..+...
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~----~~~~~~~~~-------- 222 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVL----EQVERGYRM-------- 222 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHH----HHHHcCCCC--------
Confidence 22222235668999999988889999999999999999999 89999643211 111 112111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
..+...+..+.+++.+|+..+|++|||+.++.+.|++
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 -PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111223478899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=321.29 Aligned_cols=241 Identities=26% Similarity=0.360 Sum_probs=194.4
Q ss_pred cccCCCCceEEEEEEEc----CCcEEEEEEccCcc----chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 241 KKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+.||+|+||.||++... .++.||+|++.... ......+.+|+++++.++||||+++++.+..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999753 57899999986432 12335677899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++.. ...+.+..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999999873 4567888888999999999999998 9999999999999999999999999999875432222
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......|++.|+|||++.+..++.++||||||+++|||++|+.||...+.. .... .+..+...
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~-~~~~~~~~--------- 218 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTID-KILKGKLN--------- 218 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHH-HHHcCCCC---------
Confidence 122345899999999999988999999999999999999999999744321 1111 12122110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 505 (557)
.+......+.+++.+|++.+|++|| +++++++
T Consensus 219 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 -LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1111234678999999999999999 7888876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=311.76 Aligned_cols=257 Identities=26% Similarity=0.451 Sum_probs=207.2
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
++...++++.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..+++|
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 345677888999999999999999988899999999875432 3467889999999999999999999875 45689999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+.+++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 80 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 80 EYMENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EcCCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999988653 34568899999999999999999998 99999999999999999999999999999776533
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 469 (557)
.........++..|+|||.+....++.++||||||+++|||++ |+.||...+... ... .+..+....
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~~----- 223 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQ----NLERGYRMP----- 223 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHH----HHHcCCCCC-----
Confidence 2222222335678999999998889999999999999999999 999997433211 111 111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
.....+..+.+++.+|+..+|++||+++++.+.|+.
T Consensus 224 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 ----RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111123468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=325.10 Aligned_cols=247 Identities=23% Similarity=0.377 Sum_probs=192.7
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
..+++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34456789999999999999875 689999999865432 3346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+.. ...+..+..++.||+.||+|||+ .+++||||||+|||+++++.+||+|||++........
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986532 24567778899999999999998 9999999999999999999999999999987643322
Q ss_pred cccccccCCCCccCCcccCC-----CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 393 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~-----~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
. .....|+..|+|||.+.. ...+.++|||||||++|||++|+.||......+...+ ... +..+..
T Consensus 224 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~---~~~-~~~~~~----- 293 (353)
T PLN00034 224 P-CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL---MCA-ICMSQP----- 293 (353)
T ss_pred c-ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH---HHH-HhccCC-----
Confidence 1 223458999999998743 2345689999999999999999999973322221111 111 111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..........+.+++.+||+.+|++|||+.||++
T Consensus 294 ----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 ----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred ----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111123347889999999999999999999986
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=319.64 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=196.1
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
|.+.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 566789999999999999875 68899999886432 2234567789999999999999999999999999999999997
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
++|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 87 -~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~- 159 (288)
T cd07871 87 -SDLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT- 159 (288)
T ss_pred -cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcc-
Confidence 5898888642 3457888999999999999999998 99999999999999999999999999998765332211
Q ss_pred cccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC------------C
Q 008707 395 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG------------D 461 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------------~ 461 (557)
.....+++.|+|||.+.+ ..++.++||||+||++|+|+||+.||...+..+.... ........ .
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL---IFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHHhhccccchh
Confidence 223347899999998865 5688999999999999999999999975543222111 11111100 0
Q ss_pred ccccccccccCCC----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 462 VISIVDPVLIGNV----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 462 ~~~~~d~~l~~~~----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
......+...... ......+..+++.+|++.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000111100000 0011236789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=312.36 Aligned_cols=252 Identities=30% Similarity=0.487 Sum_probs=202.7
Q ss_pred HHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
..+++.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|+.+++.++||||+++++++......++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4456788999999999999998877789999887543 234678999999999999999999999998888999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+|+|.+++... ...+++..++.++.||+.||+|||+ .+++|+||||+||+++.++.+||+|||.+..........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999998753 3368999999999999999999998 999999999999999999999999999987654432222
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ... ..+.++.....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~----~~~~~~~~~~~-------- 222 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS---ETV----EKVSQGLRLYR-------- 222 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHH----HHHhcCCCCCC--------
Confidence 222235678999999998889999999999999999999 99998633211 111 11222211110
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
.......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 223 -~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 -PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0112347889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=315.31 Aligned_cols=255 Identities=30% Similarity=0.518 Sum_probs=204.5
Q ss_pred HHHhhcccCCCCceEEEEEEEcC------CcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
.+++.+.||+|+||.||+|.... ...||+|.+..... .....+.+|+++++.++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 45678999999999999997653 25799998865432 344678999999999999999999999999889999
Q ss_pred EEEecCCCChhhhhhccCC-------------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc
Q 008707 309 VYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 375 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~ 375 (557)
+|||+++++|.+++..... ...+++..++.++.|++.||+|||+ .+++|+||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCc
Confidence 9999999999999875321 1457888999999999999999998 99999999999999999999
Q ss_pred EEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 008707 376 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 453 (557)
Q Consensus 376 ~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~ 453 (557)
++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+ +
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~---- 235 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---V---- 235 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H----
Confidence 99999999876533221 11222346788999999998899999999999999999998 999997443211 1
Q ss_pred HHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 454 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 454 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
...+..+.... .....+..+.+++.+||+.+|++||+++||++.|+.
T Consensus 236 ~~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 IEMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 12222222211 122334578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=315.80 Aligned_cols=266 Identities=25% Similarity=0.390 Sum_probs=200.9
Q ss_pred HhhcccCCCCceEEEEEEE-----cCCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEec--CeeEEE
Q 008707 238 NFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILV 309 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~~lv 309 (557)
.+.+.||+|+||+||++.. .+++.||+|.+..... .....+.+|+++++.++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 5678999999999988653 3578899999875432 3456788999999999999999999987653 457899
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+++++|.+++.. ..+++..++.++.|++.||+|||+ ++++||||||+||++++++.++|+|||++.....
T Consensus 87 ~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999863 358999999999999999999998 9999999999999999999999999999987644
Q ss_pred CCcc--ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 390 DLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 390 ~~~~--~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
.... ......++..|+|||.+.+..++.++||||||+++|+|+||..||....... ....................+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhhh
Confidence 3221 1112235667999999998889999999999999999999999986432110 000000000000000111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
.......+...+..+.+++.+||+.+|++|||+++|++.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111112223457899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=310.84 Aligned_cols=255 Identities=27% Similarity=0.468 Sum_probs=204.7
Q ss_pred HHHHhhcccCCCCceEEEEEEEcC----CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
..+++.+.||+|+||.||+|.+.. ...||+|.+.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 446678999999999999998752 4579999887543 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+++++|.+++... ...+++..++.++.|++.||+|||+ ++++|+||||+||++++++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998753 3468999999999999999999998 9999999999999999999999999999987642
Q ss_pred CC-ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 390 DL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 390 ~~-~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
.. ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...... .. ...+..+....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~~--- 228 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DV----IKAVEDGYRLP--- 228 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HH----HHHHHcCCCCC---
Confidence 21 111222235678999999999899999999999999999998 99998632211 11 12222221110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
.....+..+.+++.+|++.+|++||+++||++.|+++
T Consensus 229 ------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 ------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0112234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=337.34 Aligned_cols=263 Identities=22% Similarity=0.277 Sum_probs=210.5
Q ss_pred HHHHhhcccCCCCceEEEEEEEcCC-cEEEEEEccCccchhHHHHHHHHHHHhhcC-CCCccceeeEE-Ee------cCe
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKDG-KEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYC-EE------EHQ 305 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~-~~------~~~ 305 (557)
...++.+.|.+|+|+.||.|....+ ..||+|++-.......+.+.+|+++|+.|+ |+|||.+++.. .. .-.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 3445678999999999999987765 999999987666777888999999999996 99999999932 11 135
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
.+|.||||.||.|-|++..+. ...|++.++++|+.|+++|+++||. +..+|+|||||.+||||+.+++.||||||.+.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rl-q~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRL-QTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHH-hccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 689999999999999998654 3449999999999999999999997 45679999999999999999999999999987
Q ss_pred ccCCCCccc--------cccccCCCCccCCccc---CCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 008707 386 QAEEDLTHI--------SSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 454 (557)
Q Consensus 386 ~~~~~~~~~--------~~~~~g~~~y~aPE~l---~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~ 454 (557)
..-...... .-....|+.|+|||.+ .+...++|+|||||||+||-|+....||+...
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------ 262 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------ 262 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------------
Confidence 543222111 1122479999999986 56788999999999999999999999998331
Q ss_pred HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCC
Q 008707 455 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGD 518 (557)
Q Consensus 455 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~ 518 (557)
...+++....--..+.....+.+||..||+.+|.+||++-+|+..+..+........
T Consensus 263 -------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 263 -------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP 319 (738)
T ss_pred -------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence 111122111111123556689999999999999999999999999999988655443
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=330.79 Aligned_cols=261 Identities=25% Similarity=0.402 Sum_probs=204.9
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcC-CCCccceeeEEEecCe
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ 305 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~ 305 (557)
...+.+.+.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+++++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 455667899999999999999753 134799999875433 34467899999999996 9999999999999999
Q ss_pred eEEEEEecCCCChhhhhhccCC----------------------------------------------------------
Q 008707 306 RILVYEYMHNGTLRDRLHGSVN---------------------------------------------------------- 327 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 327 (557)
.++||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999988864210
Q ss_pred -----------------------------------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC
Q 008707 328 -----------------------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 372 (557)
Q Consensus 328 -----------------------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~ 372 (557)
...+++..+..++.|+++||+|||+ .+++|+||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 1247788889999999999999998 99999999999999999
Q ss_pred CCcEEEecccCccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHH
Q 008707 373 NMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 450 (557)
Q Consensus 373 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~ 450 (557)
++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... .
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~-- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--T-- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--H--
Confidence 999999999999865432221 1222336778999999998899999999999999999997 999987432111 1
Q ss_pred HHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 451 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 451 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
....+..+.... .....+..+.+++.+||+.+|++||++.+|.++|+++.+
T Consensus 349 --~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 --FYNKIKSGYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHHHHhcCCCCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111122221110 112234578899999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=313.17 Aligned_cols=261 Identities=28% Similarity=0.450 Sum_probs=209.0
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
...+.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 445567889999999999999742 34568999887665555678999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccC----------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEE
Q 008707 308 LVYEYMHNGTLRDRLHGSV----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 377 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 377 (557)
+||||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 9999999999999986432 12358999999999999999999998 9999999999999999999999
Q ss_pred EecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 008707 378 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 455 (557)
Q Consensus 378 l~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~ 455 (557)
|+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIE 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence 999999876533221 11122335678999999999999999999999999999998 899986333211 112
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 456 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 456 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
.+..+...... . ..+..+.+++.+||+.+|.+|||++||.+.|+++.+.
T Consensus 234 ~i~~~~~~~~~-----~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 CITQGRVLQRP-----R----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHcCCcCCCC-----C----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 22333221111 1 1234689999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=325.84 Aligned_cols=246 Identities=24% Similarity=0.285 Sum_probs=199.8
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcC--CcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
...|++.+.||+|+||.||+|.++. +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3456778999999999999998653 3689999885431 2334568889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999974 4568899999999999999999998 999999999999999999999999999998654
Q ss_pred CCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ....+..+...
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-------~~~~i~~~~~~----- 246 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL-------IYQKILEGIIY----- 246 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCC-----
Confidence 32 123458999999999999889999999999999999999999997433211 11112222110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 506 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 506 (557)
.+......+.+++.+|++.+|++|+ +++|+++.
T Consensus 247 -----~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 247 -----FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1111223578999999999999995 89988764
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=310.13 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=204.1
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
...|++.++||+|+||.||+|.+.++..||+|++..... ..+.+.+|+++++.++||||+++++.+.. ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 355778899999999999999888777899999875322 34578899999999999999999998754 5578999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++|+|.+++... ....+++..+..++.|+++||+|||+ .+++|+||||+||++++++.++|+|||.+.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999999753 23457899999999999999999998 99999999999999999999999999999766443322
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......++..|+|||...+..++.++||||||+++|+|+| |..||....... ....+..+...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------~~~~~~~~~~~--------- 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRM--------- 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-------HHHHHhcCCCC---------
Confidence 2222335678999999988889999999999999999999 888886332111 11111111100
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
......+..+.+++.+|++.+|++||+++++++.|++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 11223445788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=320.47 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=196.7
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||.||++... +++.||+|+++... ....+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999875 58899999987532 22345678899999998 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD-TT 153 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC-cc
Confidence 999988863 4578999999999999999999998 9999999999999999999999999999875322111 12
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccc--cccHHHHHHHHHhcCCccccccccccCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--ELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+....+..+... +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~--- 224 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------I--- 224 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------C---
Confidence 23458999999999999999999999999999999999999997433221 122223333333332211 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPK------MQEIVL 505 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt------~~evl~ 505 (557)
+......+.+++.+|++.||.+||+ ++++++
T Consensus 225 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 225 -PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred -CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1112336789999999999999998 567654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=314.66 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=208.4
Q ss_pred HHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
.+.+.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++|+||+++++++......++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 3455788999999999999753 3557899988766555567799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccC-------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcE
Q 008707 310 YEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 376 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 376 (557)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+ ++++||||||+||+++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 99999999999986432 12348899999999999999999998 999999999999999999999
Q ss_pred EEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 008707 377 KVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 454 (557)
Q Consensus 377 kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~ 454 (557)
+|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||+| |+.||...+... . .
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~----~ 235 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---V----I 235 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H----H
Confidence 9999999976543221 11222346788999999999999999999999999999999 999986332211 1 1
Q ss_pred HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 455 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 455 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
..+..+..... ....+..+.+++.+||+.+|++|||+++|+++|+++.+.
T Consensus 236 ~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 ECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 12222222111 112345788999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=326.78 Aligned_cols=258 Identities=18% Similarity=0.182 Sum_probs=195.5
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
..|.+.+.||+|+||.||++... +++.||+|... .+.+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 34667889999999999999765 68899999643 245678999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
. ++|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 4 788888763 4568899999999999999999998 89999999999999999999999999999754332222
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccc-c---ccHHHHHHHHHhcCCc-------
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA-E---LNIVHWARSMIKKGDV------- 462 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~-~---~~~~~~~~~~~~~~~~------- 462 (557)
......||+.|+|||++.+..++.++|||||||++|||++|+.||-..+... . ......+......-+.
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 2334568999999999999999999999999999999999998875332111 0 0011111110000000
Q ss_pred ---cccc---------cccccCCC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 463 ---ISIV---------DPVLIGNV--KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 463 ---~~~~---------d~~l~~~~--~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
...+ .+...... ....+..+.+++.+||+.||++|||++|+++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 00000000 0123457889999999999999999999985
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=291.60 Aligned_cols=263 Identities=22% Similarity=0.324 Sum_probs=206.8
Q ss_pred HHHHHHhhcccCCCCceEEEEEE-EcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEe-----cCee
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQR 306 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-----~~~~ 306 (557)
...+|++.+.||+|+|+.||+++ ..+++.+|+|++.-...++.+..++|++..++++|||+++++++... ....
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34677888999999999999997 55789999998865556677889999999999999999999987643 3458
Q ss_pred EEEEEecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 307 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
|++++|...|+|.+.+.... ++..+++.+++.|+.+|++||++||+. ..++.||||||.|||+++++.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999997655 455799999999999999999999982 2349999999999999999999999999987
Q ss_pred ccCCCCcccc--------ccccCCCCccCCcccC---CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 008707 386 QAEEDLTHIS--------SVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 454 (557)
Q Consensus 386 ~~~~~~~~~~--------~~~~g~~~y~aPE~l~---~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~ 454 (557)
...-...... .....|..|.|||.+. +...+.++|||||||++|.|+.|..||+..
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~------------- 244 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI------------- 244 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH-------------
Confidence 6532221111 1123688999999985 456788999999999999999999999721
Q ss_pred HHHhcCCccc-cc-cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 455 SMIKKGDVIS-IV-DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 455 ~~~~~~~~~~-~~-d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
.++|.... .+ .+.+.---.......+.+++..|++.||.+||++.+++..+++..
T Consensus 245 --~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 245 --YQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --hhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 12232221 11 111110001124557899999999999999999999999887653
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=323.61 Aligned_cols=243 Identities=24% Similarity=0.347 Sum_probs=195.1
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
+.||+|+||.||++... +++.||+|++.... ......+..|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999864 68999999986532 223456778999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccc
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 396 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 396 (557)
+|.+++.. ...+++..+..++.||+.||+|||+ ..+++||||||+|||++.++.+||+|||++......... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~ 154 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT-MK 154 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc-cc
Confidence 99988863 4568999999999999999999996 269999999999999999999999999998754322211 22
Q ss_pred cccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCH
Q 008707 397 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 476 (557)
Q Consensus 397 ~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 476 (557)
...|++.|+|||++.+..++.++|||||||++|+|++|+.||...+... . ...+..+.. . .+.
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~----~~~i~~~~~------~----~p~ 217 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---L----FELILMEEI------R----FPR 217 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---H----HHHHhcCCC------C----CCC
Confidence 3458999999999999999999999999999999999999997443211 1 111111111 0 111
Q ss_pred HHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 008707 477 ESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 506 (557)
Q Consensus 477 ~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 506 (557)
.....+.+++.+||+.||++|+ +++++++.
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 1234678999999999999996 89999854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=308.63 Aligned_cols=248 Identities=28% Similarity=0.461 Sum_probs=197.4
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999875 68899999876543 33456789999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc-ccc
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-SSV 397 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~ 397 (557)
.+++... ...+++..++.++.|+++||+|||+ .+++||||+|+||+++.++.+||+|||++.......... ...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9998642 3468899999999999999999998 999999999999999999999999999987644321111 111
Q ss_pred ccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCH
Q 008707 398 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 476 (557)
Q Consensus 398 ~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 476 (557)
...+..|+|||.+.+..++.++||||||+++|||++ |..||....... ....+..+... ..+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGVRL---------PCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHHHcCCCC---------CCcc
Confidence 123457999999999889999999999999999998 888886322111 11112111111 1111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 477 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 477 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
..+..+.+++.+|++.+|++|||+.||+++|+.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 224478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=309.91 Aligned_cols=267 Identities=25% Similarity=0.384 Sum_probs=205.5
Q ss_pred HhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhc--CCCCccceeeEEEecC----eeEEEEE
Q 008707 238 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEEH----QRILVYE 311 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l--~h~nIv~~~~~~~~~~----~~~lv~e 311 (557)
++.+.+|+|+||.||+|.+. ++.||||++. ....+.|..|.+|++.. +|+||++|+++-.... .+.||++
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 45688999999999999998 6999999986 45567889999988765 7999999999876554 7899999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcC------CCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~------~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
|.+.|+|.++|+ ...++|....+|+..+++||+|||+. .+.+|+|||||.+||||.+|+++.|+|||+|.
T Consensus 289 fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 289 FHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999997 56799999999999999999999973 36789999999999999999999999999999
Q ss_pred ccCCCCcc-ccccccCCCCccCCcccCCCC-C-----CcccceehhHHHHHHHHhCCCCCCCCCccccc-----------
Q 008707 386 QAEEDLTH-ISSVARGTVGYLDPEYYGNQQ-L-----TEKSDVYSFGVVLLELISGKKPVSVEDFGAEL----------- 447 (557)
Q Consensus 386 ~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~-~-----s~~~DvwslG~ll~elltg~~pf~~~~~~~~~----------- 447 (557)
.+...... ..-...||.+|||||++.+.- . -.+.||||+|.|||||++....+......++.
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 87643321 122356999999999997642 1 13789999999999999977665421111111
Q ss_pred cHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 008707 448 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 516 (557)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 516 (557)
.+-+.-.-.+++.....+.|.-.. ...+..+.+.+..||+.||+.|-|+.=+.+.+.++....+.
T Consensus 445 t~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 445 TLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred CHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 111111111222222222221111 13345788999999999999999999999999999987665
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=319.02 Aligned_cols=261 Identities=28% Similarity=0.463 Sum_probs=204.7
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEe-cC
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE-EH 304 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~-~~ 304 (557)
...|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++.++ +|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 456788999999999999999642 25789999987543 23345688899999999 79999999998764 45
Q ss_pred eeEEEEEecCCCChhhhhhccCC---------------------------------------------------------
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVN--------------------------------------------------------- 327 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 327 (557)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999998864211
Q ss_pred -CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc-ccccccCCCCcc
Q 008707 328 -QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYL 405 (557)
Q Consensus 328 -~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~ 405 (557)
...+++..+..++.||+.||+|||+ .+|+||||||+||++++++.++|+|||++......... ......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 1267899999999999999999998 99999999999999999999999999999875433221 122234567899
Q ss_pred CCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHH
Q 008707 406 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 484 (557)
Q Consensus 406 aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 484 (557)
|||.+.+..++.++|||||||++|||++ |..||.+....+ . ....+..+.... .+......+.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~----~~~~~~~~~~~~---------~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--E----FCRRLKEGTRMR---------APEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--H----HHHHHhccCCCC---------CCccCCHHHHH
Confidence 9999999999999999999999999998 999997432211 1 111222221111 11122347889
Q ss_pred HHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 485 VAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 485 li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
++.+||+.+|++||++.||++.|+++.+
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=322.00 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=197.3
Q ss_pred HHhhcccCCCCceEEEEEEEc----CCcEEEEEEccCcc----chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~ 307 (557)
|++.+.||+|+||.||++... +++.||+|++.+.. ....+.+..|+++++.+ +||||+++++++..++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 456789999999999998753 57899999986432 22345678899999999 5999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++...
T Consensus 82 lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 82 LILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999873 4568899999999999999999998 99999999999999999999999999999865
Q ss_pred CCCCccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
............||+.|+|||.+.+. .++.++|||||||++|||+||+.||........ ... +...+...
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~-~~~~~~~~------ 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSE-VSRRILKC------ 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHH-HHHHHhcC------
Confidence 43333223344689999999999765 478899999999999999999999974332211 111 11111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 506 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 506 (557)
++.+ +......+.+++.+||+.||++|| +++++++.
T Consensus 227 ~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 DPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1111 112234678999999999999999 67787753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=316.54 Aligned_cols=261 Identities=22% Similarity=0.288 Sum_probs=195.0
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
.|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+++++.++||||+++++++.++...++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 4566799999999999999876 688999999864322 22346778999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
. ++|.+++... ...++...+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 86 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 86 H-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred C-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-
Confidence 5 6888777642 4568888999999999999999998 9999999999999999999999999999875432221
Q ss_pred ccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc--------c
Q 008707 394 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--------S 464 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~ 464 (557)
......+++.|+|||++.+ ..++.++||||+||++|+|++|+.||...... ................. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchhhcc
Confidence 1223457899999999865 46788999999999999999999999743221 11111111111100000 0
Q ss_pred ccccc-cc--CCCCH-------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 465 IVDPV-LI--GNVKI-------ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 465 ~~d~~-l~--~~~~~-------~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..++. .. ..... .....+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00 00000 01235779999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=303.19 Aligned_cols=267 Identities=22% Similarity=0.332 Sum_probs=202.5
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEe-----cCeeEEEEE
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRILVYE 311 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-----~~~~~lv~e 311 (557)
.+.||+|+||.|+.+..+ +|+.||||++... .....++..+|+++|+.++|+||+.+.+++.. -+..|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 578999999999999765 6899999998743 23456778899999999999999999998865 356899999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
+| +.+|.+.++ .+..++...+..++.|+++||+|+|+ .+|+||||||.|+|++.+..+||+|||+|+......
T Consensus 107 lM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 107 LM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred HH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 99 679999998 35569999999999999999999999 999999999999999999999999999999875431
Q ss_pred -ccccccccCCCCccCCcccC-CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHH--------HHHHhcCC
Q 008707 392 -THISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA--------RSMIKKGD 461 (557)
Q Consensus 392 -~~~~~~~~g~~~y~aPE~l~-~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~--------~~~~~~~~ 461 (557)
.........|.+|.|||++. ...|+.+.||||.|||+.||++|++-|.+.+......++..+ ...+....
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ 259 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK 259 (359)
T ss_pred cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence 11112344799999999875 468999999999999999999999999987754433332211 11111110
Q ss_pred cccccc------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhhhh
Q 008707 462 VISIVD------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKI 513 (557)
Q Consensus 462 ~~~~~d------~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~~~~ 513 (557)
....+. +.-....-+.......+++.+||..||.+|+|++|.++. |...-+.
T Consensus 260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 000000 000000011122367799999999999999999999875 4444443
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=318.66 Aligned_cols=260 Identities=24% Similarity=0.429 Sum_probs=205.0
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEc-CCc----EEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCe
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 305 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 305 (557)
+....++..+.||+|+||.||+|.+. +++ .||+|.+.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 34556677899999999999999864 333 48999986543 34456788999999999999999999998765 5
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
.++++||+++|+|.+++... ...+++..++.++.||+.||+|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 77999999999999998753 3458888999999999999999998 999999999999999999999999999998
Q ss_pred ccCCCCccc-cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 386 QAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 386 ~~~~~~~~~-~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+..... + ...+..+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~ 230 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SSILEKGERL 230 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHhCCCCC
Confidence 764332211 112224668999999999999999999999999999998 999997432211 1 1222222111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 464 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 464 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
. . +......+.+++.+||..+|++||++.+|++.|.++.+.
T Consensus 231 ~--~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 231 P--Q-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred C--C-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 1 0 111224688999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=318.95 Aligned_cols=241 Identities=27% Similarity=0.374 Sum_probs=190.8
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 57889999987532 22334556677777655 899999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 999998873 4568899999999999999999998 999999999999999999999999999997643322 122
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||.+.+... .... +.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~~~~-i~~~~----------~~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------LFDS-ILNDR----------PHFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHcCC----------CCCC
Confidence 33458999999999999899999999999999999999999997543211 1111 11110 0111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIVL 505 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~-evl~ 505 (557)
......+.+++.+||+.+|++||++. ++++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 12234678999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=304.88 Aligned_cols=247 Identities=30% Similarity=0.477 Sum_probs=199.8
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCChh
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 319 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL~ 319 (557)
+.||+|+||.||+|...++..+|+|.+..... .....+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 46899999999999988899999999875433 33456889999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccccccc
Q 008707 320 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 399 (557)
Q Consensus 320 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 399 (557)
+++... ...+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||++...............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 988643 3457899999999999999999998 99999999999999999999999999998765433222222223
Q ss_pred CCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHH
Q 008707 400 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 478 (557)
Q Consensus 400 g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 478 (557)
++..|+|||.+.+..++.++||||||+++|++++ |..||....... ....+..+.... .....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKGYRMS---------CPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcCCCCC---------CCCCC
Confidence 4678999999998889999999999999999998 999997432211 111222221111 11123
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 479 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 479 ~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
+..+.+++.+|+..+|++||++.|+++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 457889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=318.66 Aligned_cols=243 Identities=23% Similarity=0.353 Sum_probs=192.3
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 57899999987532 23345677899888877 799999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 999988863 4568999999999999999999998 9999999999999999999999999999875422211 12
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcc--ccccHHHHHHHHHhcCCccccccccccCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG--AELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .......++...+..+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---------- 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---------- 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC----------
Confidence 2345899999999999999999999999999999999999999632211 1112223333333222211
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKM 500 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~ 500 (557)
.+......+.+++.+||+.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111223467899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=297.69 Aligned_cols=260 Identities=20% Similarity=0.229 Sum_probs=198.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchh--HHHHHHHHHHHhhcCCCCccceeeEEEec--CeeEEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--TQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYE 311 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~~lv~e 311 (557)
|+....|++|.||.||+|+++ +++.||+|+++...... --.-++|+.+|.+.+|||||.+-.+.... +..|+|||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 445678999999999999876 68899999997543221 12457899999999999999999887653 46899999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
||+. +|...++.. ...+...++.-++.|+++|++|||. +.|+|||||++|+|+++.|.+||+|||+|+.++.+.
T Consensus 158 ~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 158 YVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 9965 899888754 3678888999999999999999998 999999999999999999999999999999998774
Q ss_pred ccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC--Ccccccc-
Q 008707 392 THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--DVISIVD- 467 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d- 467 (557)
...+ ....|.+|.|||++.+. .|+.+.|+||+|||+.||+++++-|.+...-+..+.+ -+.+... .+...++
T Consensus 232 k~~T-~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I---f~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 232 KPYT-PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI---FKLLGTPSEAIWPGYSE 307 (419)
T ss_pred ccCc-ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH---HHHhCCCccccCCCccc
Confidence 4333 33479999999998765 7999999999999999999999999866533322211 1111110 0000000
Q ss_pred --------------ccccCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 468 --------------PVLIGNVKIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 468 --------------~~l~~~~~~~-~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
..+++.+... ....-++++...+.+||.+|.|+.|-++.
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0111111111 12356799999999999999999998753
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=308.37 Aligned_cols=258 Identities=23% Similarity=0.316 Sum_probs=205.6
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc---cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+++++.++||||+++++++.+.+..++|+||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 456789999999999999865 6899999987542 223345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 313 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 313 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
+++++|.+++.... ....+++..+..++.|++.||+|||+ ++++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 99999998886432 23457888999999999999999998 999999999999999999999999999988764432
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.. .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ....+. ..+..+....
T Consensus 161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~----~~~~~~-~~~~~~~~~~------- 227 (267)
T cd08228 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLFSLC-QKIEQCDYPP------- 227 (267)
T ss_pred HH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc----cHHHHH-HHHhcCCCCC-------
Confidence 21 1223478899999999888899999999999999999999999863321 111211 1222211111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
.........+.+++.+||+.+|++||++.||++.++++.
T Consensus 228 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 228 -LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 111223457889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=290.18 Aligned_cols=247 Identities=26% Similarity=0.400 Sum_probs=205.5
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
..++++.||+|.||.||.|+.+ ++-.||+|++.+.. ....+++.+|++|-..|+||||+++|++|.+....|+++|
T Consensus 23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE 102 (281)
T KOG0580|consen 23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE 102 (281)
T ss_pred hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence 3456899999999999999866 56789999986542 2234678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|..+|.+...+... ....+++.....++.|+|.|+.|+|. ++|+||||||+|+|++..+.+||+|||.+....
T Consensus 103 ya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--- 175 (281)
T KOG0580|consen 103 YAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--- 175 (281)
T ss_pred ecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence 99999999999854 35668888889999999999999998 999999999999999999999999999987654
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||......+ .+ +.+.+- +..+|
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e--tY-----krI~k~---~~~~p--- 242 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE--TY-----KRIRKV---DLKFP--- 242 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH--HH-----HHHHHc---cccCC---
Confidence 334556789999999999999999999999999999999999999998443211 11 111111 11122
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
........++|.+|+..+|.+|.+..|+++.
T Consensus 243 ----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ----STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ----cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2334478899999999999999999999764
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=320.63 Aligned_cols=243 Identities=24% Similarity=0.331 Sum_probs=192.5
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHH---hhcCCCCccceeeEEEecCeeEEEE
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALL---SRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il---~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|.+++ +.++||||+++++++.+.+..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45688999999999999865 58999999987532 22335566776665 4567999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+++++|...+. ...+++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 82 E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 82 EYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred cCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999998875 3468999999999999999999998 99999999999999999999999999998754322
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
. .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+... .... +..+...
T Consensus 155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~~~-i~~~~~~------- 219 (324)
T cd05589 155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VFDS-IVNDEVR------- 219 (324)
T ss_pred C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhCCCC-------
Confidence 1 12233458999999999999999999999999999999999999997443211 1111 1111110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 505 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 505 (557)
.+...+..+.+++.+||+.||.+|| +++++++
T Consensus 220 ---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 220 ---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1112234678999999999999999 5666655
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=308.54 Aligned_cols=251 Identities=28% Similarity=0.390 Sum_probs=195.3
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--------------hhHHHHHHHHHHHhhcCCCCccceeeE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------------HRTQQFVTEVALLSRIHHRNLVPLIGY 299 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------~~~~~~~~E~~il~~l~h~nIv~~~~~ 299 (557)
..|++.+.||+|.||.|-+|+.. +++.||||++.+... ...+...+|+.+|++++|||||+++++
T Consensus 97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv 176 (576)
T KOG0585|consen 97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV 176 (576)
T ss_pred hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence 45667889999999999999765 689999999864211 112578899999999999999999999
Q ss_pred EEe--cCeeEEEEEecCCCChhhhhhccCCCCC-cCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcE
Q 008707 300 CEE--EHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 376 (557)
Q Consensus 300 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 376 (557)
..+ .+..|||+|||..|.+...-. .+. +.+.++++++++++.||+|||. +||+||||||+|+||+++|++
T Consensus 177 LDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 177 LDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred ecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcE
Confidence 876 457899999999988865433 333 8999999999999999999998 999999999999999999999
Q ss_pred EEecccCccccCCCCc----cccccccCCCCccCCcccCCC----CCCcccceehhHHHHHHHHhCCCCCCCCCcccccc
Q 008707 377 KVSDFGLSRQAEEDLT----HISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 448 (557)
Q Consensus 377 kl~Dfgla~~~~~~~~----~~~~~~~g~~~y~aPE~l~~~----~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~ 448 (557)
||+|||.+........ ..-....|||.|+|||...++ ..+.+.||||+||+||.|+.|+.||.+..
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~------ 323 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF------ 323 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch------
Confidence 9999999886622211 111235699999999998763 23568999999999999999999997321
Q ss_pred HHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 008707 449 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 507 (557)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 507 (557)
..+ +...+...++. .++. +++...+.++|.++|++||++|-+..+|....
T Consensus 324 ~~~-l~~KIvn~pL~-------fP~~-pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 324 ELE-LFDKIVNDPLE-------FPEN-PEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HHH-HHHHHhcCccc-------CCCc-ccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 111 11222222211 1111 13445788999999999999999999997653
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=323.42 Aligned_cols=238 Identities=26% Similarity=0.350 Sum_probs=192.4
Q ss_pred cccCCCCceEEEEEEE----cCCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 241 KKIGKGSFGSVYYGKM----KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
+.||+|+||.||++.. .+|+.||+|++..... .....+..|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999865 3578999999875322 233457789999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+|+|.+++.. ...+++..+..++.||++||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~- 154 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK- 154 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc-
Confidence 9999999863 4568999999999999999999998 99999999999999999999999999998765433221
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.. +.... +..+.. ..
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~-i~~~~~----------~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTM-ILKAKL----------GM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHH-HHcCCC----------CC
Confidence 22345899999999999888999999999999999999999999744321 11111 111111 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHH
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQE 502 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~e 502 (557)
+......+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1112346789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=316.01 Aligned_cols=261 Identities=29% Similarity=0.452 Sum_probs=201.0
Q ss_pred HHHhhcccCCCCceEEEEEEEc-----CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEe--cCeeEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRIL 308 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~l 308 (557)
.+++.+.||+|+||.||++..+ +++.||+|.+........+.+.+|+++++.++||||+++++++.. ....++
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred cceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 4566789999999999999753 578999999876655666789999999999999999999998754 346789
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||+++++|.+++... ...+++..+..++.|++.||+|||+ .|++||||||+||++++++.++|+|||++....
T Consensus 85 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 85 VMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 99999999999998643 3458999999999999999999998 999999999999999999999999999998764
Q ss_pred CCCccc--cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccc------c---ccHHHHHHHHH
Q 008707 389 EDLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA------E---LNIVHWARSMI 457 (557)
Q Consensus 389 ~~~~~~--~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~------~---~~~~~~~~~~~ 457 (557)
...... .....++..|+|||.+.+..++.++||||||+++|||++|..|+....... . ..........+
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 332211 111123456999999998889999999999999999999887764322110 0 00001111111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 458 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 458 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
..+... ......+..+.+++.+||+.+|++|||++||++.|+.+
T Consensus 240 ~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 240 KNNGRL---------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111100 01112234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=315.38 Aligned_cols=259 Identities=21% Similarity=0.278 Sum_probs=192.5
Q ss_pred HHhhcccCCCCceEEEEEEEc--CCcEEEEEEccCcc--chhHHHHHHHHHHHhhc---CCCCccceeeEEE-----ecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSC--SHRTQQFVTEVALLSRI---HHRNLVPLIGYCE-----EEH 304 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l---~h~nIv~~~~~~~-----~~~ 304 (557)
|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 566789999999999999863 46889999886432 22234566788777766 6999999999885 245
Q ss_pred eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCc
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 384 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 384 (557)
..++||||+. ++|.+++... ....+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 6899999995 6899888653 24458899999999999999999998 99999999999999999999999999999
Q ss_pred cccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---C
Q 008707 385 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---D 461 (557)
Q Consensus 385 ~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~ 461 (557)
....... ......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+. ...+....... .
T Consensus 158 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i~~~~~~~~~~~ 232 (290)
T cd07862 158 RIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGEED 232 (290)
T ss_pred EeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCChhh
Confidence 7654331 22334589999999999888999999999999999999999999985433211 11111111000 0
Q ss_pred cc-------cccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 462 VI-------SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 462 ~~-------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.. ..+.+... ..........+.+++.+|++.+|++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 00000000 0000112346789999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=312.37 Aligned_cols=256 Identities=27% Similarity=0.466 Sum_probs=202.3
Q ss_pred HHHHhhcccCCCCceEEEEEEE-----cCCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
..+++.+.||+|+||.||+|.+ .++..|++|.+.... ....+.+.+|+++++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4556789999999999999975 246789999987533 3344678899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccC--------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC
Q 008707 309 VYEYMHNGTLRDRLHGSV--------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 374 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~ 374 (557)
||||+++++|.+++.... ....+++..+..++.|++.||+|||+ ++++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 999999999999885321 12347888899999999999999998 9999999999999999999
Q ss_pred cEEEecccCccccCCCC-ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHH
Q 008707 375 RAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHW 452 (557)
Q Consensus 375 ~~kl~Dfgla~~~~~~~-~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~ 452 (557)
.+||+|||++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~---- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QE---- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HH----
Confidence 99999999998654322 111222335678999999988889999999999999999999 9999864321 11
Q ss_pred HHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 453 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 453 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
+...+..+..... +...+..+.+++.+|++.+|++||++.+|++.|..
T Consensus 235 ~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQLLPC---------SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1222222222111 11123468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=312.99 Aligned_cols=261 Identities=26% Similarity=0.442 Sum_probs=206.9
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEcC------CcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEec
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 303 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~ 303 (557)
+....+++.+.||+|+||.||++.+.. ...+|+|.+.... ......+.+|+++++.+ +|+||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 344556678899999999999998642 3679999887542 33445688999999999 799999999999999
Q ss_pred CeeEEEEEecCCCChhhhhhcc-------------CCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe
Q 008707 304 HQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 370 (557)
Q Consensus 304 ~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll 370 (557)
+..+++|||+++|+|.++++.. .....+++..++.++.|++.||+|||+ .+++||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEE
Confidence 9999999999999999998642 124568899999999999999999998 999999999999999
Q ss_pred CCCCcEEEecccCccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCcccccc
Q 008707 371 DINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 448 (557)
Q Consensus 371 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~ 448 (557)
++++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---
Confidence 99999999999999876443211 1122235678999999998899999999999999999998 999987433211
Q ss_pred HHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 449 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
..+.+..+... ..+......+.+++.+|+..+|++|||++||++.|++++
T Consensus 243 ----~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 ----LFKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ----HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11122222111 111122347889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=311.58 Aligned_cols=258 Identities=24% Similarity=0.418 Sum_probs=202.3
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCe
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 305 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 305 (557)
....+++.+.||+|+||.||+|.+. .+..||+|++.... ......+.+|+.+++.++||||+++++++...+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3455777899999999999999754 25679999886432 2344568899999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhccCC-------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEE
Q 008707 306 RILVYEYMHNGTLRDRLHGSVN-------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 378 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 378 (557)
.++||||+++++|.+++..... ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999865321 2346788889999999999999998 89999999999999999999999
Q ss_pred ecccCccccCCCCccc-cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 008707 379 SDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 456 (557)
Q Consensus 379 ~Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 456 (557)
+|||++.......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||...... +.. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~~~-~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------QVL-RF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHH-HH
Confidence 9999987654322211 112235778999999998889999999999999999999 78898643221 111 11
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 457 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 457 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
+..+..... +...+..+.+++.+|++.+|++|||+.|+++.|++
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 234 VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 222221111 11223478899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=318.99 Aligned_cols=242 Identities=24% Similarity=0.363 Sum_probs=193.8
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||.||+|... +++.||+|++.... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 47899999986532 23345677889998876 799999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+.+.. ...+++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++......... .
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~-~ 153 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT-T 153 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc-c
Confidence 999988873 4568899999999999999999998 99999999999999999999999999998764322211 2
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+... .... +..+... .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~~~~-i~~~~~~----------~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------LFES-ILHDDVL----------YP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------HHHH-HHcCCCC----------CC
Confidence 23458999999999999999999999999999999999999997443211 1111 1111110 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRP-------KMQEIVLA 506 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RP-------t~~evl~~ 506 (557)
......+.+++.+|++.+|++|| +++++++.
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11224678999999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=319.44 Aligned_cols=236 Identities=25% Similarity=0.371 Sum_probs=190.4
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||.||+|..+ +++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46899999999999876 58899999986532 23345677888888877 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++........ ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TT 153 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-cc
Confidence 999998873 4568899999999999999999998 9999999999999999999999999999875422211 12
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+... .. ..+..+... .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~-~~i~~~~~~----------~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD------LF-EAILNDEVV----------YP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HH-HHHhcCCCC----------CC
Confidence 23458999999999999999999999999999999999999997443211 11 112222110 01
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKM 500 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~ 500 (557)
......+.+++.+|++.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1123467899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=306.48 Aligned_cols=254 Identities=27% Similarity=0.443 Sum_probs=202.2
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
...+++.+.||+|++|.||+|.+..+..+|+|.+.... ...+.+.+|+++++.++|+|++++++++.. +..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 34567788999999999999998877789999876532 234678899999999999999999998754 5678999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
.+++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999999753 23457899999999999999999998 99999999999999999999999999999765433222
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......++..|+|||...+..++.++||||||+++|+|+| |+.||...... ...+ .+..+...
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~----~~~~~~~~--------- 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLE----QVERGYRM--------- 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH----HHHcCCCC---------
Confidence 2222235678999999998889999999999999999999 89999743211 1111 11111110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
......+..+.+++.+||..+|++||++++|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0112234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=311.27 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=203.1
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcC------CcEEEEEEccCccch-hHHHHHHHHHHHhhcCCCCccceeeEEEecCee
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 306 (557)
-..+++.+.||+|+||.||+|...+ +..||+|++...... ..+.+.+|+.++..++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 3457788999999999999997642 578999998754332 346688999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhccC-------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC
Q 008707 307 ILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 373 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~ 373 (557)
++++||+.+++|.+++.... ....+++..+..++.|++.||+|||+ ++++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCC
Confidence 99999999999999885321 12357888899999999999999998 999999999999999999
Q ss_pred CcEEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHH
Q 008707 374 MRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH 451 (557)
Q Consensus 374 ~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~ 451 (557)
+.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+... .+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~ 234 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QD 234 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH------HH
Confidence 9999999999876533221 11222335778999999988889999999999999999998 8888864322 11
Q ss_pred HHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 452 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 452 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
+ ...+..+..... ....+..+.+++.+|++.+|++||+++||++.|+.
T Consensus 235 ~-~~~i~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 V-IEMIRNRQVLPC---------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H-HHHHHcCCcCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 222222222111 11234468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=334.89 Aligned_cols=250 Identities=20% Similarity=0.307 Sum_probs=201.5
Q ss_pred HHhhcccCCCCceEEEEEEEc-C-CcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-D-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
|.+.+.||+|+||.||+|... + ++.||+|.+..........+.+|+++++.++||||+++++++...+..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 556789999999999999754 3 57788887755444455678889999999999999999999999999999999999
Q ss_pred CCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc-
Q 008707 315 NGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT- 392 (557)
Q Consensus 315 ~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~- 392 (557)
+|+|.+.+.... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 999998886432 34568899999999999999999998 9999999999999999999999999999987654322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+. .+.... +..+....
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~-~~~~~~~~-------- 290 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQ-VLYGKYDP-------- 290 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HHhCCCCC--------
Confidence 122344589999999999999999999999999999999999999974322 111111 11122111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+......+.+++.+||..+|++||++.++++
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 01112346889999999999999999999875
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=307.77 Aligned_cols=256 Identities=28% Similarity=0.485 Sum_probs=206.4
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
....+.+.+.||+|+||.||+|..++++.||+|.+.... ...+.+.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 345566789999999999999998888899999987543 3346788999999999999999999999988899999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++... ....+++..+..++.|++.|++|||+ ++++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999753 23568999999999999999999998 8999999999999999999999999999887654322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
........+..|+|||.+.+..++.++||||+|+++|+|++ |+.||....... ..+ .+..+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~----~~~~~~~~-------- 223 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLE----QVERGYRM-------- 223 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCCC--------
Confidence 22222234678999999998889999999999999999999 999996432111 111 11111100
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
..+...+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 224 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 -PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011124478899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=322.19 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=200.0
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
...|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 456677899999999999999876 58899999986421 22334577899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+++|+|.+++.. ..++...+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 122 ~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 122 MEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999863 347888888999999999999998 9999999999999999999999999999987644
Q ss_pred CCccccccccCCCCccCCcccCCC----CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 390 DLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~~----~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
..........||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+... ..............
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~~~~~ 268 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKNSLTF 268 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCCcCCC
Confidence 332223345689999999998653 47889999999999999999999997543211 11111111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 506 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~ 506 (557)
.+ .......+.+++.+|++.+|++ ||+++|+++.
T Consensus 269 ~~-------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 269 PD-------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CC-------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11 0112347789999999999988 9999999764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=322.92 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=200.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|++++..++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 456789999999999999876 68999999986532 23446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC-
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 391 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 391 (557)
+++++|.+++.. ...+++..+..++.||+.||+|||+ .|++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 83 MPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999974 3578999999999999999999998 999999999999999999999999999998754432
Q ss_pred ---------------------------ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcc
Q 008707 392 ---------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 444 (557)
Q Consensus 392 ---------------------------~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~ 444 (557)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11122345899999999999999999999999999999999999999744321
Q ss_pred ccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 008707 445 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVLA 506 (557)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-~~evl~~ 506 (557)
. .............. + . ....+..+.+++.+|+. +|.+||+ ++|+++.
T Consensus 237 ~------~~~~i~~~~~~~~~--p----~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 E------TYNKIINWKESLRF--P----P-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H------HHHHHhccCCcccC--C----C-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1 11111110000000 0 0 00124478899999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=314.03 Aligned_cols=264 Identities=30% Similarity=0.503 Sum_probs=205.3
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEc-CCc--EEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCe
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 305 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~ 305 (557)
.+....+++.+.||+|+||.||+|.++ ++. .+++|.+.... ....+.+.+|++++.++ +||||+++++++..++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 344566778899999999999999875 344 45777765432 33456788999999999 89999999999999999
Q ss_pred eEEEEEecCCCChhhhhhccC-------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC
Q 008707 306 RILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 372 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~ 372 (557)
.++||||+++++|.++++... ....+++.+++.++.|++.||+|||+ +|++||||||+||+++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~ 159 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGE 159 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecC
Confidence 999999999999999987432 12357899999999999999999998 99999999999999999
Q ss_pred CCcEEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHH
Q 008707 373 NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVH 451 (557)
Q Consensus 373 ~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~ 451 (557)
++.+||+|||++........ .....++..|+|||.+.+..++.++||||||+++|||+| |..||...+..+ .
T Consensus 160 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~-- 232 (303)
T cd05088 160 NYVAKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L-- 232 (303)
T ss_pred CCcEEeCccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---H--
Confidence 99999999999864321111 111224567999999988889999999999999999998 999996433211 1
Q ss_pred HHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 452 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 452 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
.. .+..+.... .....+..+.+++.+|++.+|++||+++++++.|+++...+.
T Consensus 233 -~~-~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 233 -YE-KLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred -HH-HHhcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 11 111111100 111123467899999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=307.97 Aligned_cols=248 Identities=21% Similarity=0.306 Sum_probs=194.4
Q ss_pred cCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 243 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 243 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
||+|+||.||++..+ +|+.||+|.+.... ....+.+..|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999865 58999999886422 12234566799999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccccc
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 398 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 398 (557)
.+.+... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQR 154 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eecc
Confidence 9888643 34458899999999999999999998 9999999999999999999999999999887644322 1223
Q ss_pred cCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHH
Q 008707 399 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 478 (557)
Q Consensus 399 ~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 478 (557)
.|++.|+|||++.+..++.++||||+||++|||++|+.||...... ....+...... .+.... . ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~-~~~~~~------~---~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTL-EDEVKF------E---HQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhh-cccccc------c---cccC
Confidence 5889999999999888999999999999999999999999743221 11111111111 111100 0 0112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 479 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 479 ~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
..++.+++.+||+.+|++||+++|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 346789999999999999999988764333
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=312.66 Aligned_cols=267 Identities=24% Similarity=0.443 Sum_probs=210.5
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEc--------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEE
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYC 300 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~ 300 (557)
++....+.+.+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 344566677899999999999999742 24579999886542 33456788999999999 899999999999
Q ss_pred EecCeeEEEEEecCCCChhhhhhccC-------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCC
Q 008707 301 EEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 367 (557)
Q Consensus 301 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~N 367 (557)
......++||||+++|+|.+++.... ....+++..+..++.||++||+|||+ +|++||||||+|
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~N 167 (304)
T cd05101 91 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARN 167 (304)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccce
Confidence 99999999999999999999987532 12357888899999999999999998 999999999999
Q ss_pred EEeCCCCcEEEecccCccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccc
Q 008707 368 ILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 445 (557)
Q Consensus 368 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~ 445 (557)
|+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~- 246 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE- 246 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-
Confidence 99999999999999999876433221 1222335678999999998889999999999999999998 78888643221
Q ss_pred cccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 008707 446 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 516 (557)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 516 (557)
+. ...+..+.... .....+..+.+++.+||..+|++|||+.||++.|+++......
T Consensus 247 -----~~-~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 247 -----EL-FKLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred -----HH-HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 11 11222221111 1112334788999999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=316.39 Aligned_cols=241 Identities=26% Similarity=0.395 Sum_probs=191.4
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||.||+|... +++.||+|+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999876 47899999987532 22345566788888765 899999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 999999873 3568889999999999999999998 9999999999999999999999999999875322211 12
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
....||+.|+|||.+.+..++.++||||+||++|||++|+.||...+... +.+ .+..+. +. .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~----~i~~~~------~~----~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQ----SIRMDN------PC----YP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhCC------CC----CC
Confidence 23458999999999999899999999999999999999999997443211 111 111111 00 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIVL 505 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~-evl~ 505 (557)
......+.+++.+||+.+|++||++. ++.+
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11223678999999999999999997 6644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=323.61 Aligned_cols=260 Identities=22% Similarity=0.319 Sum_probs=194.1
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEec-----CeeEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 308 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----~~~~l 308 (557)
|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 456789999999999999865 68999999886432 23345688999999999999999999987543 24799
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||+ +++|.+.+.. ...+++..+..++.||++||+|||+ .+++||||||+|||++.++.+||+|||++....
T Consensus 82 v~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 82 VFELM-ESDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEecC-CCCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 99999 4689888863 4568999999999999999999998 999999999999999999999999999997643
Q ss_pred CCCc--cccccccCCCCccCCcccCC--CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHH--------
Q 008707 389 EDLT--HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM-------- 456 (557)
Q Consensus 389 ~~~~--~~~~~~~g~~~y~aPE~l~~--~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~-------- 456 (557)
.... .......|++.|+|||++.+ ..++.++|||||||++|||+||+.||...+..... ..+...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~~ 231 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL---DLITDLLGTPSPET 231 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHHhCCCCHHH
Confidence 2211 11123458999999999876 67889999999999999999999999754422111 111110
Q ss_pred ---HhcCCcccccc---ccc---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 457 ---IKKGDVISIVD---PVL---IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 457 ---~~~~~~~~~~d---~~l---~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+........++ +.. ...........+.+++.+||+.+|++|||++|+++.
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 000 000000122467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=305.16 Aligned_cols=259 Identities=22% Similarity=0.328 Sum_probs=206.4
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
.|++.+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+++++.++||||+++++++..++..+++||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 4567789999999999999864 78999999875422 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 312 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
|+++++|.+++.... ....+++..++.++.||+.||+|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999999886422 24568999999999999999999998 99999999999999999999999999998766433
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ...... .+..... +..
T Consensus 160 ~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~-~~~~~~~-----~~~ 228 (267)
T cd08229 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-KIEQCDY-----PPL 228 (267)
T ss_pred Ccc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhh-hhhcCCC-----CCC
Confidence 221 12234788999999999888999999999999999999999999643221 111111 1111111 100
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
........+.+++.+|+..+|++|||+++|++.++++.
T Consensus 229 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 229 ---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11123447889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=305.58 Aligned_cols=245 Identities=28% Similarity=0.457 Sum_probs=195.8
Q ss_pred ccCCCCceEEEEEEEc---CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 242 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 242 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
.||+|+||.||+|.++ ++..+|+|++.... ....+.+.+|+.+++.++||||+++++++.. +..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 6899999999999753 57889999986433 2345678899999999999999999998864 4678999999999
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc--
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-- 394 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-- 394 (557)
+|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||.||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999863 3568899999999999999999998 999999999999999999999999999998764432211
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...... .. ...+.++.....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~----~~~i~~~~~~~~-------- 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EV----TQMIESGERMEC-------- 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHCCCCCCC--------
Confidence 112234578999999988889999999999999999998 99999743221 11 222333322111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
+...+..+.+++.+||+.+|++||++.+|.+.|+.
T Consensus 220 -~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 220 -PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=293.87 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=199.9
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccC--ccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
...|++.+.||+|.|+.||++... +|+.+|+|++.- ....+.+.+.+|++|.+.|+|||||++.+.+......|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 455677899999999999999654 688999998743 23446688999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC---CCcEEEecccCcccc
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA 387 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~ 387 (557)
|++.|++|..-+-. ....++..+--.++||++||.|+|. ++|||||+||+|+++-. ..-+||+|||+|...
T Consensus 90 e~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999998655442 2446677777899999999999998 99999999999999953 345999999999988
Q ss_pred CCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
++. .....+.|||+|||||+++...|+..+|||+.|++||-|+.|.+||.+++... +. +.+.+|... ++
T Consensus 164 ~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---ly----e~I~~g~yd--~~ 232 (355)
T KOG0033|consen 164 NDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LY----EQIKAGAYD--YP 232 (355)
T ss_pred CCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---HH----HHHhccccC--CC
Confidence 733 22334569999999999999999999999999999999999999998544321 22 223333321 11
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+...+ ....+..+++.+|+..||.+|.|+.|.++
T Consensus 233 ~~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEWD----TVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CcccC----cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11111 22336779999999999999999999864
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=298.02 Aligned_cols=265 Identities=21% Similarity=0.293 Sum_probs=200.1
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCC-ccceeeEEEecC-----
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEH----- 304 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~n-Iv~~~~~~~~~~----- 304 (557)
...+...++||+|+||+||+|+.+ +|+.||+|+++-... .......+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 344555678999999999999765 689999999865432 23345779999999999999 999999998877
Q ss_pred -eeEEEEEecCCCChhhhhhccCCC-CCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEeccc
Q 008707 305 -QRILVYEYMHNGTLRDRLHGSVNQ-KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 382 (557)
Q Consensus 305 -~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 382 (557)
..++|+||++ -+|.+++...... ..++...+..++.||+.||+|||+ ++|+||||||.||+|+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccc
Confidence 7899999994 5899998764321 457778899999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC
Q 008707 383 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 461 (557)
Q Consensus 383 la~~~~~~~~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 461 (557)
+|+...-+... .....+|.+|.|||++.+. .|+...||||+|||++||++++.-|.+....+. +.. +-+.++.-.
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q--l~~-If~~lGtP~ 241 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ--LFR-IFRLLGTPN 241 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH--HHH-HHHHcCCCC
Confidence 99976533222 2233479999999998876 899999999999999999999999985543111 111 111111110
Q ss_pred c------ccccc--ccccC-----CCCHHHH---HHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 462 V------ISIVD--PVLIG-----NVKIESI---WRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 462 ~------~~~~d--~~l~~-----~~~~~~~---~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
. ....+ ..... ......+ ....+++.+|++.+|.+|.|++..++.
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 0 00001 01100 0111111 267899999999999999999999875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=306.45 Aligned_cols=257 Identities=25% Similarity=0.299 Sum_probs=194.8
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecC-----eeEEEEEec
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILVYEYM 313 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-----~~~lv~e~~ 313 (557)
.+.+|.|+||.||+|... +++.||||++....+. -.+|+++|+.++|||||++.-+|.... ...+||||+
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym 104 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM 104 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc
Confidence 488999999999999866 4689999988654332 236999999999999999998886532 234899999
Q ss_pred CCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC-CcEEEecccCccccCCCC
Q 008707 314 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 314 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~~ 391 (557)
+ .+|.+.++... .+..++...+.-+..||++||+|||+ .+|+||||||.|+|+|.+ |.+||||||.|+....+.
T Consensus 105 P-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 105 P-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred h-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 6 48888887421 35667888888999999999999998 999999999999999976 889999999999876654
Q ss_pred ccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHH-----HHHhcC--Ccc
Q 008707 392 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR-----SMIKKG--DVI 463 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~-----~~~~~~--~~~ 463 (557)
...+. .-+..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.+..+....+--+- +.+..- ...
T Consensus 181 pniSY--icSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 181 PNISY--ICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred CceeE--EEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 44333 35788999998866 489999999999999999999999999765543322111110 111111 111
Q ss_pred ccccccccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 464 SIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 464 ~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+...+.+... .....+.++.+++.+++.++|.+|.++.|++..
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 2222222211 223445688999999999999999999999864
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.38 Aligned_cols=257 Identities=26% Similarity=0.445 Sum_probs=203.4
Q ss_pred HhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 238 NFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
++.+.||+|+||.||+|... ....+++|.+..... ...+.+.+|+.+++.++||||+++++.+..++..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 45688999999999999753 235789998865432 34567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccC---------------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEE
Q 008707 311 EYMHNGTLRDRLHGSV---------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 369 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIl 369 (557)
||+.+++|.+++.... ....+++.+++.++.|++.||+|||+ .+++||||||+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEE
Confidence 9999999999886421 12357889999999999999999998 99999999999999
Q ss_pred eCCCCcEEEecccCccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccc
Q 008707 370 LDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL 447 (557)
Q Consensus 370 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~ 447 (557)
+++++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||+| |..||......
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--- 236 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE--- 236 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence 999999999999999765332221 1122335678999999988889999999999999999999 99999743221
Q ss_pred cHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 448 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
.+.+ ....+... ..+......+.+++.+|++.+|++||+++||++.|+++...
T Consensus 237 ~~~~----~~~~~~~~---------~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 RLFN----LLKTGYRM---------ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHH----HHhCCCCC---------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1111 12211110 11112234788999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=316.71 Aligned_cols=240 Identities=26% Similarity=0.382 Sum_probs=191.0
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||.||+|.++ +|+.||+|+++... ....+.+..|..++... +||||+++++++.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999876 58899999987532 22345567788888765 899999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+++.. ...+++..+..++.|+++||+|||+ ++++||||||+||+++.++.++|+|||++....... ...
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 999998863 4568889999999999999999998 999999999999999999999999999987532211 112
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
....|++.|+|||++.+..++.++||||+||++|||++|+.||...+.. .+. ..+..+. +.+ +
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~----~~~~~~~------~~~----~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELF----ESIRVDT------PHY----P 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH----HHHHhCC------CCC----C
Confidence 3345899999999999999999999999999999999999999744321 111 1111111 011 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 504 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~-evl 504 (557)
.....++.+++.+||+.||++||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11233678999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=310.72 Aligned_cols=251 Identities=25% Similarity=0.304 Sum_probs=200.0
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|+..+.||+|+||.||++... +++.||+|++..... .....+.+|+++++.++||||+++++.+.+++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 456788999999999999865 688999999864321 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 82 MNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 9999999888643 23568999999999999999999998 9999999999999999999999999999877543222
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
. ....|++.|+|||.+.+..++.++||||+|+++|+|++|+.||...+... ..+.+...+..+. .
T Consensus 158 ~--~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~----------~ 222 (285)
T cd05605 158 I--RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKEDQ----------E 222 (285)
T ss_pred c--ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhcc----------c
Confidence 1 22358899999999998899999999999999999999999998543211 1111112222111 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 506 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 506 (557)
.+....+..+.+++.+|+..||++|| +++++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11222344688999999999999999 78888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=303.54 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=205.2
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
....+++.+.||+|+||.||++.+.++..+|+|.+... ....+.+.+|+++++.++|+||+++++++.. ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 34566778999999999999999888888999988653 2345678899999999999999999999887 778999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999999753 24567888999999999999999998 9999999999999999999999999999876543322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.......++..|+|||.+....++.++|+||||+++|+++| |+.||...+... .. ..+..+....
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~~~------- 223 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VI----RALERGYRMP------- 223 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HH----HHHhCCCCCC-------
Confidence 22222335678999999998889999999999999999999 999997432211 11 1222221111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
.....+..+.+++.+|+..+|++||++.++.+.|+.
T Consensus 224 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 --RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111233478899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=317.34 Aligned_cols=241 Identities=26% Similarity=0.357 Sum_probs=194.0
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||.||+|.+. +++.||+|++.... ......+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999876 47899999987532 23345677899999888 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........ ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence 999988873 4568999999999999999999998 9999999999999999999999999999875322211 12
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+... .. ..+..+.. ..+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~~-~~i~~~~~----------~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------LF-QSILEDEV----------RYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------HH-HHHHcCCC----------CCC
Confidence 23458999999999999999999999999999999999999997443211 11 11111111 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 505 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~-----~evl~ 505 (557)
......+.+++.+||..||.+||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1223468899999999999999999 77765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=315.62 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=194.3
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||.||+|... +++.||+|++.... ....+.+.+|..++.++ +||||+.+++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999875 57899999987532 22345678899999888 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+++.. ...+++..+..++.||+.||+|||+ ++++||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-TT 153 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-ce
Confidence 999988863 4568999999999999999999998 9999999999999999999999999999875322211 12
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
....||+.|+|||.+.+..++.++|||||||++|+|++|+.||............++..+.+...... .+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR----------IP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC----------CC
Confidence 23458999999999999999999999999999999999999997443332223333333333322211 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQ 501 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~ 501 (557)
......+.+++.+|+..||++||+++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 11223677999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=302.72 Aligned_cols=258 Identities=24% Similarity=0.340 Sum_probs=207.5
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc---cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+||+++++++..++..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 556789999999999999877 7899999987532 223356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 313 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 313 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
+++++|.+++.... ....+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 84 ADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 99999999886532 24558899999999999999999998 999999999999999999999999999987654332
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ...+.. ..+..+......
T Consensus 161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~-~~~~~~~~~~~~----- 229 (267)
T cd08224 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLC-KKIEKCDYPPLP----- 229 (267)
T ss_pred cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHH-hhhhcCCCCCCC-----
Confidence 11 1223478899999999988899999999999999999999999963321 122211 112222111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
.......+.+++.+|+..+|++|||+.+|+++|+++.
T Consensus 230 ---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 230 ---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred ---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1133457889999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=309.35 Aligned_cols=256 Identities=26% Similarity=0.416 Sum_probs=203.0
Q ss_pred HHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
..+.+.++||+|+||.||++... ++..+|+|.+........+.+.+|+++++.++|+||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 44556789999999999999642 356899998876666666789999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCC------------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcE
Q 008707 309 VYEYMHNGTLRDRLHGSVN------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA 376 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~ 376 (557)
+|||+++++|.+++..... ...+++..++.++.|++.|++|||+ .+++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999875321 1357889999999999999999998 999999999999999999999
Q ss_pred EEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 008707 377 KVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 454 (557)
Q Consensus 377 kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~ 454 (557)
+|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||....... . .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~---~- 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---A---I- 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---H---H-
Confidence 9999999875533221 11122235678999999999999999999999999999998 899986322111 1 1
Q ss_pred HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 455 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 455 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
..+..+..... +...+..+.+++.+||+.+|++||+++||++.|+.
T Consensus 235 ~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 235 ECITQGRELER---------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHcCccCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 11122211110 11223468899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=317.67 Aligned_cols=245 Identities=25% Similarity=0.344 Sum_probs=193.9
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCC-CCccceeeEEEecCeeEEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~~~~~lv~e 311 (557)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|.+++..++| ++|+.+++++.+.+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 456789999999999999876 47899999987532 2344567889999999976 568889999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 82 YVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999998873 4568889999999999999999998 999999999999999999999999999987532211
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
. ......||+.|+|||++.+..++.++||||+||++|+|+||+.||...+... .. ..+.....
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~----~~i~~~~~--------- 218 (324)
T cd05587 156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LF----QSIMEHNV--------- 218 (324)
T ss_pred C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HH----HHHHcCCC---------
Confidence 1 1223458999999999999999999999999999999999999997443211 11 11111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 505 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~-----~evl~ 505 (557)
..+......+.+++.+|+..+|++|++. +++++
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 219 -SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred -CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0111123367899999999999999976 55554
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=319.01 Aligned_cols=250 Identities=21% Similarity=0.272 Sum_probs=199.0
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 456789999999999999865 68899999987532 22345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 83 QPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 9999999999753 3568999999999999999999998 9999999999999999999999999999987654333
Q ss_pred cccccccCCCCccCCcccC------CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 393 HISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~------~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ................
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~~~ 231 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLKFP 231 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccCCC
Confidence 2233345899999999986 456788999999999999999999999743321 1112211111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+ .......+.+++.+|++ +|.+|||++++++
T Consensus 232 ~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 232 E-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1 01123467899999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=308.38 Aligned_cols=246 Identities=23% Similarity=0.298 Sum_probs=194.2
Q ss_pred cCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 243 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 243 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
||+|+||+||++... +++.||+|.+..... ...+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 688999999864322 2235677899999999999999999999999999999999999999
Q ss_pred hhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccccc
Q 008707 319 RDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 397 (557)
Q Consensus 319 ~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 397 (557)
.+.+.... ....+++..+..++.||+.||+|||+ .+++||||||+||+++.++.++|+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 88775322 34568999999999999999999998 99999999999999999999999999998765433221 223
Q ss_pred ccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHH
Q 008707 398 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 477 (557)
Q Consensus 398 ~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 477 (557)
..|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .... ....+..+.. ..+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~-~~~~~~~~~~----------~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKE-LKQRILNDSV----------TYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--hHHH-HHHhhcccCC----------CCccc
Confidence 458999999999999999999999999999999999999997433211 1111 1111111110 11122
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 008707 478 SIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 505 (557)
Q Consensus 478 ~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 505 (557)
.+..+.+++.+|++.+|++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 344688999999999999999 6677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=312.22 Aligned_cols=264 Identities=24% Similarity=0.429 Sum_probs=208.2
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEc--------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEE
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCE 301 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~ 301 (557)
+....|.+.+.||+|+||.||++... ++..+|+|.+.... ......+.+|+++++.+ +||||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 33456778899999999999999753 23579999987542 33456788899999999 7999999999999
Q ss_pred ecCeeEEEEEecCCCChhhhhhccCC-------------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCE
Q 008707 302 EEHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 368 (557)
Q Consensus 302 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NI 368 (557)
..+..++||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+ .+++||||||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Ni 171 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV 171 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHhe
Confidence 99999999999999999999975321 2358889999999999999999998 9999999999999
Q ss_pred EeCCCCcEEEecccCccccCCCCccc-cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCcccc
Q 008707 369 LLDINMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 446 (557)
Q Consensus 369 ll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~ 446 (557)
+++.++.++|+|||.+.......... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~-- 249 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 249 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--
Confidence 99999999999999987654321111 111224568999999998889999999999999999998 88898633221
Q ss_pred ccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 447 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
+ +...+..+.... .+......+.+++.+|+..+|++|||+.||++.|+++....
T Consensus 250 ----~-~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 250 ----E-LFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred ----H-HHHHHHcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1 112222222111 11123347889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=317.10 Aligned_cols=241 Identities=28% Similarity=0.392 Sum_probs=189.7
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHH-HHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||.||+|... +|+.||+|++.... ......+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999865 68999999986432 223344555654 46778999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|...+.. ...+++..+..++.||+.||+|||+ .|++||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TT 153 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Cc
Confidence 999988863 4568999999999999999999998 9999999999999999999999999999875322211 12
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.. +...... .+.. .+...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~-~~~~------~~~~~-- 218 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNIL-HKPL------VLRPG-- 218 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHH-cCCc------cCCCC--
Confidence 2345899999999999999999999999999999999999999744321 1111111 1111 01111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
....+.+++.+|+..+|.+||++++.++
T Consensus 219 --~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 219 --ASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred --CCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 2336779999999999999999864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=323.83 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=193.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 345688999999999999765 57899999986532 23345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 83 IPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999874 4568888899999999999999998 9999999999999999999999999999754311000
Q ss_pred ----------------------------------------------cccccccCCCCccCCcccCCCCCCcccceehhHH
Q 008707 393 ----------------------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 426 (557)
Q Consensus 393 ----------------------------------------------~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ 426 (557)
.......||+.|+|||.+.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0011235899999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHH--ccccCCCCCCCHHHHH
Q 008707 427 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQ--CVEQRGFSRPKMQEIV 504 (557)
Q Consensus 427 ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~~P~~RPt~~evl 504 (557)
++|||+||+.||...+.... ....+.......... ......++.+++.+ |+..+|..||+++||+
T Consensus 237 il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~~~-------~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTET------QLKVINWENTLHIPP-------QVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHH------HHHHHccccccCCCC-------CCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 99999999999974432111 111111000000000 00112356678877 5566667799999998
Q ss_pred HH
Q 008707 505 LA 506 (557)
Q Consensus 505 ~~ 506 (557)
+.
T Consensus 304 ~h 305 (381)
T cd05626 304 AH 305 (381)
T ss_pred cC
Confidence 74
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=305.57 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=205.4
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcC----CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
...+.+.+.||+|+||.||+|.+.+ ...|++|...... ....+.+.+|+.+++.++||||+++++++.+ ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4456678999999999999998653 2468999876554 3455678999999999999999999999876 45789
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999999743 3458999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
...........++..|+|||.+....++.++||||||+++||+++ |..||...+... ... .+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~----~~~~~~~~~~-- 229 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIG----RIENGERLPM-- 229 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH----HHHcCCcCCC--
Confidence 432222222234568999999988889999999999999999996 999997443221 111 1222221111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
....+..+.+++.+|+..+|++|||+.++++.|+++...+
T Consensus 230 -------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~~ 269 (270)
T cd05056 230 -------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEE 269 (270)
T ss_pred -------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1122347889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=307.80 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=206.7
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcC-----CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEe-cCee
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQR 306 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~ 306 (557)
...+.+.+.||+|+||.||+|.+.. +..|++|.+.... ....+.+.+|+.+++.++||||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4556678999999999999998775 6889999887543 3345678899999999999999999998765 4678
Q ss_pred EEEEEecCCCChhhhhhccCCC-----CCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 381 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 381 (557)
++++||+++++|.+++...... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998754322 568999999999999999999998 99999999999999999999999999
Q ss_pred cCccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhc
Q 008707 382 GLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKK 459 (557)
Q Consensus 382 gla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 459 (557)
|+++.+...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||...+. ..+.. .+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~----~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAA----YLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHH----HHHc
Confidence 999865332211 1122335678999999998889999999999999999999 9999974321 11222 1222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 460 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 460 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
+.... .....+..+.+++.+|+..+|++|||+.|+++.|+++..
T Consensus 235 ~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GYRLA---------QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCCCC---------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 21100 011123468899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=302.74 Aligned_cols=247 Identities=25% Similarity=0.445 Sum_probs=196.0
Q ss_pred ccCCCCceEEEEEEEc---CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCC
Q 008707 242 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 317 (557)
Q Consensus 242 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gs 317 (557)
.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 4899999999999764 355799999875433 334678899999999999999999998864 56899999999999
Q ss_pred hhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc--c
Q 008707 318 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI--S 395 (557)
Q Consensus 318 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~--~ 395 (557)
|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++.......... .
T Consensus 81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99998742 4568999999999999999999998 999999999999999999999999999997654332211 1
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
....++..|+|||.+.+..++.++||||||+++|++++ |..||......+ +...+.++.... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~---------~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRLD---------C 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCCCCC---------C
Confidence 11223578999999988889999999999999999996 999997432211 112222322111 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
+...+..+.+++.+||..+|++||++.+|.+.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 122345788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=303.54 Aligned_cols=250 Identities=30% Similarity=0.501 Sum_probs=204.7
Q ss_pred HHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
..+++.+.||.|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+....++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 45567899999999999999876 88999999876543 46778999999999999999999999998889999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||.+........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 84 KGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 99999998753 23368999999999999999999998 9999999999999999999999999999987643222
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
....+..|+|||.+....++.++||||||+++|+|++ |..||....... +...+..+....
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~--------- 219 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKGYRME--------- 219 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcCCCCC---------
Confidence 1224667999999988889999999999999999998 999997332211 111222221111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
.+...+..+.+++.+|+..+|++|||+.|++++|+.+
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1112245788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=321.86 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=196.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 445789999999999999876 58999999986432 23345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.++|+|||++........
T Consensus 83 ~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 83 LPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999874 4568999999999999999999998 9999999999999999999999999999875422110
Q ss_pred c-------------------------------------ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCC
Q 008707 393 H-------------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 435 (557)
Q Consensus 393 ~-------------------------------------~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~ 435 (557)
. ......||+.|+|||++....++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 001235899999999999999999999999999999999999
Q ss_pred CCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 008707 436 KPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVLA 506 (557)
Q Consensus 436 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~evl~~ 506 (557)
.||...+.. +...............+ . ......+.+++.+|+. +|.+|++ ++|+++.
T Consensus 237 ~Pf~~~~~~------~~~~~i~~~~~~~~~~~-----~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQ------ETYRKIINWKETLQFPD-----E--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHH------HHHHHHHcCCCccCCCC-----C--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999744321 11111111111001000 0 0122367789999996 9999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.34 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=197.2
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
..|++.+.||+|+||.||++... +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++.+.+++..++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 45667889999999999999876 57899999986421 223456788999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+++|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 123 Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~ 195 (370)
T cd05621 123 EYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 195 (370)
T ss_pred cCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence 99999999999863 357888899999999999999998 99999999999999999999999999999876543
Q ss_pred CccccccccCCCCccCCcccCCC----CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~----~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
.........||+.|+|||++.+. .++.++||||+||++|+|++|+.||...+.. ................
T Consensus 196 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~~p 269 (370)
T cd05621 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHKNSLNFP 269 (370)
T ss_pred CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCcccCCC
Confidence 33233345699999999998654 3788999999999999999999999744321 1111111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 506 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~ 506 (557)
+ .......+.+++.+|+..++.+ ||+++|+++.
T Consensus 270 ~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 270 E-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred C-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 1122346778899999755543 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=304.48 Aligned_cols=256 Identities=24% Similarity=0.381 Sum_probs=200.5
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCc----EEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
..+++.+.||+|+||.||+|.+. +++ .+++|.+..... .....+..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 34556789999999999999874 344 477787754322 233567788889999999999999998764 45788
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+ ++++|+||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999999742 4568999999999999999999998 999999999999999999999999999998654
Q ss_pred CCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 389 EDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 389 ~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
.... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+..... ....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~~~~- 232 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGERLAQ- 232 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCcCCC-
Confidence 3221 11223346778999999998899999999999999999998 999997432211 1222333332211
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
+.. ....+.+++.+|+..+|++|||+.|+++.|..+.+
T Consensus 233 -~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 233 -PQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -CCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 111 12357789999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=310.92 Aligned_cols=257 Identities=30% Similarity=0.495 Sum_probs=201.6
Q ss_pred HHhhcccCCCCceEEEEEEEcC-C--cEEEEEEccCc-cchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKD-G--KEVAVKIMADS-CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
+++.+.||+|+||.||+|..++ + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|||
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 4567899999999999998754 3 34788887643 233456788999999999 79999999999999999999999
Q ss_pred ecCCCChhhhhhccC-------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEE
Q 008707 312 YMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 378 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 378 (557)
|+++++|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEE
Confidence 999999999986432 11358889999999999999999998 99999999999999999999999
Q ss_pred ecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHH
Q 008707 379 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI 457 (557)
Q Consensus 379 ~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 457 (557)
+|||++........ ......+..|+|||.+.+..++.++|||||||++|||++ |..||....... . .. .+
T Consensus 161 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~---~~-~~ 231 (297)
T cd05089 161 ADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---L---YE-KL 231 (297)
T ss_pred CCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HH-HH
Confidence 99999864322111 111123557999999988889999999999999999998 999997433211 1 11 11
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 458 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 458 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
..+... ..+...+..+.+++.+|++.+|.+|||+.+|++.|+++....
T Consensus 232 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 232 PQGYRM---------EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred hcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111110 111122346889999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=308.58 Aligned_cols=265 Identities=23% Similarity=0.365 Sum_probs=201.1
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEcC---------------CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccce
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMKD---------------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPL 296 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~ 296 (557)
....|++.+.||+|+||.||++.... ...||+|.+.... ......+.+|++++++++|+||+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 34566778999999999999987542 2358999987543 3345678999999999999999999
Q ss_pred eeEEEecCeeEEEEEecCCCChhhhhhccC---------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCC
Q 008707 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSV---------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 367 (557)
Q Consensus 297 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~N 367 (557)
++++...+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++|+||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhh
Confidence 999999999999999999999999886431 11246888899999999999999998 999999999999
Q ss_pred EEeCCCCcEEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh--CCCCCCCCCcc
Q 008707 368 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 444 (557)
Q Consensus 368 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt--g~~pf~~~~~~ 444 (557)
|++++++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ +..||......
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~ 239 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE 239 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence 9999999999999999876533221 11122235678999999998889999999999999999998 56677632221
Q ss_pred ccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 445 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
.................. .......+..+.+++.+|++.+|++||++.+|++.|++
T Consensus 240 ---~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 ---QVIENTGEFFRNQGRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHHHHHhhhhcccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111111111110000 00111123478999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=318.93 Aligned_cols=263 Identities=26% Similarity=0.430 Sum_probs=205.5
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcC-CCCccceeeEEEe
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEE 302 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~ 302 (557)
++....+.+.+.||+|+||.||+|.+. .++.||+|++..... ...+.+.+|++++.++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 344555667899999999999999864 246899999975432 33457889999999997 9999999999999
Q ss_pred cCeeEEEEEecCCCChhhhhhccC--------------------------------------------------------
Q 008707 303 EHQRILVYEYMHNGTLRDRLHGSV-------------------------------------------------------- 326 (557)
Q Consensus 303 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------- 326 (557)
.+..++||||+.+|+|.++++...
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 899999999999999999986431
Q ss_pred ---------------------------------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCC
Q 008707 327 ---------------------------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 367 (557)
Q Consensus 327 ---------------------------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~N 367 (557)
....+++..++.++.|++.||+|||+ .+++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcce
Confidence 11236777888999999999999998 999999999999
Q ss_pred EEeCCCCcEEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccc
Q 008707 368 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGA 445 (557)
Q Consensus 368 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~ 445 (557)
||+++++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986533221 11122346788999999998889999999999999999998 889986332111
Q ss_pred cccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 446 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
.....+..+.... .+......+.+++.+||..+|++||+++||++.|+++.
T Consensus 350 ------~~~~~~~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 ------QFYNAIKRGYRMA---------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ------HHHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1112222221111 11112347889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=315.93 Aligned_cols=237 Identities=29% Similarity=0.386 Sum_probs=188.2
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHH-HHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||+||+|... +|+.||+|++.... ....+.+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999875 68999999986432 122334555554 56788999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+++.. ...+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||++........ ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TT 153 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC-cc
Confidence 999998873 4568899999999999999999998 9999999999999999999999999999875422211 22
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.. +...... .+.. .+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~-~~~~------~~~~--- 217 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNIL-NKPL------RLKP--- 217 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHH-cCCC------CCCC---
Confidence 2345899999999999999999999999999999999999999744321 1111111 1111 1111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQ 501 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~ 501 (557)
.....+.+++.+|++.+|++||++.
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 -NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1234688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=314.77 Aligned_cols=251 Identities=27% Similarity=0.387 Sum_probs=209.6
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcC-CcEEEEEEccCccch---hHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH---RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~l 308 (557)
...|++.+.||.|.||.||++..+. |+.+|+|.+.+.... ....+.+|+++|+++. |||||.+++.|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4456778999999999999998775 999999998764332 3468899999999998 9999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC----CcEEEecccCc
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLS 384 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla 384 (557)
|||++.||.|.+.+... .+++..+..++.|++.|++|||+ .|++||||||+|+|+... +.+|++|||++
T Consensus 114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 99999999999999754 38999999999999999999998 999999999999999643 47999999999
Q ss_pred cccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 385 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 385 ~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.+....... ..+..+..
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~-------~~i~~~~~-- 255 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF-------LAILRGDF-- 255 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH-------HHHHcCCC--
Confidence 98876 33345567999999999999999999999999999999999999999855432211 12333333
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.+...........+.+++.+|+..||..|+|+.++++.
T Consensus 256 ----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 ----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred ----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11222223334578899999999999999999999983
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=303.25 Aligned_cols=253 Identities=26% Similarity=0.438 Sum_probs=197.7
Q ss_pred hhcccCCCCceEEEEEEEcCC-c--EEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEec------CeeE
Q 008707 239 FCKKIGKGSFGSVYYGKMKDG-K--EVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRI 307 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~~~~-~--~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~------~~~~ 307 (557)
+.+.||+|+||.||+|.+... . .||+|.++.. .....+.+.+|+++++.++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 468899999999999987643 2 6899987653 234456788999999999999999999987432 2468
Q ss_pred EEEEecCCCChhhhhhccC---CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCc
Q 008707 308 LVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 384 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 384 (557)
++|||+++|+|.+++.... ....+++..+..++.|++.||+|||+ ++++||||||+||++++++.++|+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 9999999999998874321 23458899999999999999999998 99999999999999999999999999999
Q ss_pred cccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 385 RQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 385 ~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... + ....+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~-~~~~~~~~~~ 232 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------E-IYDYLRQGNR 232 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHHHcCCC
Confidence 876433221 1122335778999999999999999999999999999999 88999743221 1 1122333322
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 463 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 463 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
... ....+..+.+++.+||+.+|++|||+.||++.|+++
T Consensus 233 ~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 111234688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=311.25 Aligned_cols=266 Identities=25% Similarity=0.434 Sum_probs=207.9
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEc--------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEE
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCE 301 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~ 301 (557)
+....+.+.+.||+|+||.||+|... ....+|+|.+.... ......+.+|+++++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 33456667899999999999999752 24579999887543 33456788999999999 6999999999999
Q ss_pred ecCeeEEEEEecCCCChhhhhhccC-------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCE
Q 008707 302 EEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 368 (557)
Q Consensus 302 ~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NI 368 (557)
..+..+++|||+++|+|.+++.... ....+++.++..++.|++.||+|||+ +|++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeE
Confidence 9889999999999999999986532 12458889999999999999999998 9999999999999
Q ss_pred EeCCCCcEEEecccCccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCcccc
Q 008707 369 LLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 446 (557)
Q Consensus 369 ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~ 446 (557)
++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~- 244 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE- 244 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 9999999999999999865432211 1111224567999999998899999999999999999999 889986432211
Q ss_pred ccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 008707 447 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 516 (557)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 516 (557)
+...+..+.... .....+..+.+++.+|+..+|++|||+.|+++.|+++......
T Consensus 245 ------~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~ 299 (314)
T cd05099 245 ------LFKLLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE 299 (314)
T ss_pred ------HHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence 111222222111 1112234688999999999999999999999999998775543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=299.18 Aligned_cols=248 Identities=28% Similarity=0.401 Sum_probs=202.3
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|.+.+.||+|++|.||+|..+ +++.|++|.+... .....+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 345688999999999999875 5889999987542 2345667889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++... ....+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 82 ENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 999999999754 24578899999999999999999998 99999999999999999999999999998876543222
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.. . ....+..+....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----~~~~~~~~~~~~--------- 220 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---A----LILKIIRGVFPP--------- 220 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---H----HHHHHHcCCCCC---------
Confidence 22334788999999999988999999999999999999999999744311 1 111122221111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
........+.+++.+|++.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 11123447889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=304.70 Aligned_cols=255 Identities=28% Similarity=0.507 Sum_probs=203.0
Q ss_pred HHHHhhcccCCCCceEEEEEEEc----CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
..+++.+.||+|+||.||+|.+. .+..+|+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45667899999999999999764 23479999886543 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+++++|.+++... ...+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998753 3468899999999999999999998 9999999999999999999999999999987654
Q ss_pred CCccccc--cccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 390 DLTHISS--VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 390 ~~~~~~~--~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
....... ...++..|+|||.+.+..++.++|+||||+++||+++ |..||...+... .. ..+.++...
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~----~~~~~~~~~--- 228 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VI----KAIEEGYRL--- 228 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HH----HHHhCCCcC---
Confidence 3222111 1123567999999998899999999999999999887 999997432211 11 112222110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
+ .....+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 229 -~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -P-----APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -C-----CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 0112234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=307.71 Aligned_cols=259 Identities=25% Similarity=0.442 Sum_probs=205.3
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEcC------CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecC
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 304 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 304 (557)
+....+++.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 344566678999999999999997652 4689999986543 234567889999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhccC-------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEE
Q 008707 305 QRILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 377 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 377 (557)
..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEE
Confidence 9999999999999999986532 12347888999999999999999998 9999999999999999999999
Q ss_pred EecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 008707 378 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 455 (557)
Q Consensus 378 l~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~ 455 (557)
|+|||+++....... .......++..|+|||.+.+..++.++||||||+++||++| |..||...+... .. .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~----~ 232 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VL----K 232 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HH----H
Confidence 999999876543321 11223346788999999988889999999999999999998 999996432211 11 1
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 456 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 456 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
.+..+..... +...+..+.+++.+|++.+|++|||+.||++.|++
T Consensus 233 ~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 233 FVIDGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHhcCCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 2222221111 11124578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=307.24 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=200.2
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
...|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 456778899999999999999864 6889999998755444556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.++++. ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998863 4568899999999999999999998 9999999999999999999999999999986643221
Q ss_pred cccccccCCCCccCCcccC---CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccc
Q 008707 393 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~---~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 469 (557)
. .....+++.|+|||.+. ...++.++||||+|+++|||++|+.||...+...... .+..... ..+.
T Consensus 162 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~---~~~~ 230 (267)
T cd06646 162 K-RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSNF---QPPK 230 (267)
T ss_pred c-cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCCC---CCCC
Confidence 1 12234788999999874 3457789999999999999999999986332111000 0000000 0010
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.. ........+.+++.+||+.+|++|||+++|++.
T Consensus 231 ~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 231 LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 10 011233578899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=306.97 Aligned_cols=255 Identities=29% Similarity=0.467 Sum_probs=199.7
Q ss_pred HHHHhhcccCCCCceEEEEEEEcC------CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
..+.+.+.||+|+||.||+|.+.. +..|++|.+.... ......+.+|+.+++.++|+||+++++++.+.+..+
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 445567899999999999998753 5678999876443 233456899999999999999999999999888999
Q ss_pred EEEEecCCCChhhhhhccCC----CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC---cEEEec
Q 008707 308 LVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSD 380 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~D 380 (557)
+||||+++++|.+++..... ...+++..++.++.||+.||+|||+ ++++||||||+||+++.++ .+||+|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999875421 2358899999999999999999998 8999999999999998654 599999
Q ss_pred ccCccccCCCCccc-cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHh
Q 008707 381 FGLSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 458 (557)
Q Consensus 381 fgla~~~~~~~~~~-~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 458 (557)
||+++......... ......+..|+|||.+.+..++.++|||||||++|||++ |..||...+... +. ..+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~----~~~~ 235 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VM----EFVT 235 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHH
Confidence 99998763322111 111223568999999998899999999999999999997 999997433221 11 1111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 459 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 459 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
.+... ..+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus 236 ~~~~~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGRL---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11111 111222457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=299.26 Aligned_cols=248 Identities=29% Similarity=0.465 Sum_probs=197.5
Q ss_pred cccCCCCceEEEEEEEcC----CcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
++||+|+||.||+|.+.. +..+|+|.+..... ...+.+.+|+++++.+.||||+++++++.. +..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 479999999999997542 36899999875543 345678899999999999999999998764 467999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++...........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999974 3468999999999999999999998 9999999999999999999999999999986644332211
Q ss_pred --ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 396 --SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 396 --~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+. ..... .+..+.....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~----~~~~~~~~~~------- 219 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIA----MLESGERLPR------- 219 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHH----HHHcCCcCCC-------
Confidence 11223467999999999999999999999999999998 9999974322 11222 2222221111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
....+..+.+++.+|++.+|++||++.+|++.|+++.
T Consensus 220 --~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 --PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1112347889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=307.52 Aligned_cols=260 Identities=28% Similarity=0.436 Sum_probs=205.8
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEec
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 303 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~ 303 (557)
+....+.+.+.||+|+||.||++... .+..||+|+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 34456677899999999999999742 35579999887543 33456788999999999 799999999999999
Q ss_pred CeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccC
Q 008707 304 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 383 (557)
Q Consensus 304 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 383 (557)
+..++||||+++|+|.++++... ...+++.++..++.|++.||+|||+ ++++|+||||+||+++.++.++++|||+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999987532 3348999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCC
Q 008707 384 SRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 461 (557)
Q Consensus 384 a~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 461 (557)
+......... ......++..|+|||.+.+..++.++||||+|+++|+|++ |+.||....... . ....+..+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~----~~~~~~~~~ 261 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--K----FYKLIKEGY 261 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--H----HHHHHHcCC
Confidence 9865433221 1122235678999999999899999999999999999998 999987433211 1 111222221
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 462 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 462 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
... .....+..+.+++.+|+..+|++|||+.||++.|++.
T Consensus 262 ~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 RMA---------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred cCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 110 0111234788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=308.82 Aligned_cols=262 Identities=23% Similarity=0.410 Sum_probs=203.3
Q ss_pred HHHHHhhcccCCCCceEEEEEEE-----cCCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEec--Ce
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQ 305 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~ 305 (557)
..++.+.+.||+|+||.||++.+ .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 35567789999999999999974 247889999987543 33446789999999999999999999998775 56
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
.++||||+++++|.+++... ...+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++|+|||++.
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 88999999999999998643 3458999999999999999999998 999999999999999999999999999998
Q ss_pred ccCCCCcc--ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCc---------cccccHHHHHH
Q 008707 386 QAEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF---------GAELNIVHWAR 454 (557)
Q Consensus 386 ~~~~~~~~--~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~---------~~~~~~~~~~~ 454 (557)
........ ......++..|+|||.+.+..++.++||||||+++|+|+|+..|+..... ........ ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 236 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR-LV 236 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH-HH
Confidence 76433221 12233467789999999888899999999999999999998776532110 00111111 11
Q ss_pred HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 455 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 455 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
..+..+.... .....+..+.+++.+|++.+|++|||++++++.|+++
T Consensus 237 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1222221111 1112234789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.61 Aligned_cols=245 Identities=25% Similarity=0.350 Sum_probs=194.3
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+..|..++..+ +|++|+.+++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 346789999999999999876 47899999987532 22334567788888877 58999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++|+|.+.+.. ...+++..+..++.|++.||+|||+ .+++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 82 YVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred CCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999998863 4568899999999999999999998 999999999999999999999999999987543221
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||...+.. .+. . .+..+..
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~---~-~i~~~~~--------- 218 (323)
T cd05616 156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELF---Q-SIMEHNV--------- 218 (323)
T ss_pred C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHH---H-HHHhCCC---------
Confidence 1 122345899999999999999999999999999999999999999744321 111 1 1111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 505 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~-----~evl~ 505 (557)
.++.....++.+++.+|++.+|++|++. +++.+
T Consensus 219 -~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 219 -AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred -CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 0111223467899999999999999985 56543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=303.78 Aligned_cols=254 Identities=27% Similarity=0.439 Sum_probs=199.6
Q ss_pred HhhcccCCCCceEEEEEEEcC----CcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCe------
Q 008707 238 NFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------ 305 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~------ 305 (557)
.+.+.||+|+||.||+|.+.. +..||+|.++... ......+.+|+++++.++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 356889999999999998652 3679999987432 2334678999999999999999999998865544
Q ss_pred eEEEEEecCCCChhhhhhccC---CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEeccc
Q 008707 306 RILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 382 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 382 (557)
.+++|||+++|+|..++.... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCcc
Confidence 789999999999998885432 23468899999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCccc-cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcC
Q 008707 383 LSRQAEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 460 (557)
Q Consensus 383 la~~~~~~~~~~-~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 460 (557)
+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...... ... ..+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~----~~~~~~ 231 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIY----DYLRHG 231 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHH----HHHHcC
Confidence 998754332211 112235678999999988899999999999999999999 88998643211 111 122222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 461 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 461 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
..... +......+.+++.+|++.||++|||+.||++.|+++
T Consensus 232 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 NRLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 21111 112334788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=301.53 Aligned_cols=256 Identities=29% Similarity=0.479 Sum_probs=202.7
Q ss_pred HHHHhhcccCCCCceEEEEEEEcC-C---cEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
..++..+.||+|+||.||+|.... + ..+++|.+.... ....+.+..|+++++.++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 345567899999999999998752 3 379999886543 33456788999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+++++|.+++... ...+++..+..++.|++.|++|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999998642 3568999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcccc--ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 390 DLTHIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 390 ~~~~~~--~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
...... .....+..|+|||.+.+..++.++||||||+++|||++ |+.||...... +.. ..+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~-~~i~~~~~~~-- 230 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVM-KAINDGFRLP-- 230 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHH-HHHhcCCCCC--
Confidence 221111 11123457999999998889999999999999999998 99999633221 111 1122211100
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
.....+..+.+++.+|++.+|++||++.+|++.|++++
T Consensus 231 -------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 231 -------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 01122347889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=304.09 Aligned_cols=251 Identities=29% Similarity=0.514 Sum_probs=201.6
Q ss_pred HHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
.+++.+.||+|+||.||+|.+.+++.+|+|.+..... ....+.+|++++++++||||+++++++......++||||+++
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEH 83 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCC
Confidence 4556789999999999999887788999998865422 345788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
++|.+++... ...+++..+..++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||++...........
T Consensus 84 ~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 84 GCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 9999998742 3457899999999999999999998 8999999999999999999999999999876543322212
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
....++..|+|||.+.+..++.++||||||+++|||++ |..||...... .... .+..+. ....+..
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~-~~~~~~--~~~~~~~---- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVE-TINAGF--RLYKPRL---- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHH-HHhCCC--CCCCCCC----
Confidence 22234678999999998889999999999999999998 99999743221 1111 112111 1111111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
.+..+.+++.+||+.+|++|||++|+++.|.
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 2347889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=315.97 Aligned_cols=241 Identities=26% Similarity=0.356 Sum_probs=188.6
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHH-HHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEV-ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||.||+|... +++.||+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999876 57889999986432 12223444444 456788999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+++.. ...+.+..+..++.||++||+|||+ .||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~ 153 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TT 153 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cc
Confidence 999998873 4567888888999999999999998 9999999999999999999999999999875432211 12
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
....|++.|+|||++.+..++.++||||+||++|+|++|+.||...+.. +...... .+... ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~-~~~~~----------~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNIL-NKPLQ----------LK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHH-hCCcC----------CC
Confidence 3345899999999999999999999999999999999999999743321 1111111 11110 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
......+.+++.+|++.+|.+||++.+.+.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 122346789999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=312.44 Aligned_cols=237 Identities=27% Similarity=0.374 Sum_probs=187.1
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHH-HHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||.||+|... +++.||+|++.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999875 58899999986432 122334555554 67888999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+.+.. ...+++..+..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TT 153 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-cc
Confidence 999888863 4568888899999999999999998 9999999999999999999999999999875322211 12
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+.. +.... +..+.. ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~-i~~~~~----------~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYDN-ILHKPL----------QLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHHH-HhcCCC----------CCC
Confidence 3345899999999999989999999999999999999999999744321 11111 111111 011
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQ 501 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~ 501 (557)
......+.+++.+|++.+|.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12234678999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=302.29 Aligned_cols=249 Identities=29% Similarity=0.484 Sum_probs=199.9
Q ss_pred HHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEE-ecCeeEEEEEec
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVYEYM 313 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~~~~~~lv~e~~ 313 (557)
..+.+.+.||+|+||.||++... |+.||+|.+... ...+.+.+|+.+++.++|+|++++++++. .++..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 45667899999999999999876 888999988643 23467889999999999999999999754 456789999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++... ....+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999998753 23458899999999999999999998 999999999999999999999999999987643321
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
....++..|+|||++.+..++.++||||||+++|+|++ |+.||..... .+ +...+..+....
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~-~~~~~~~~~~~~-------- 219 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KD-VVPRVEKGYKMD-------- 219 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHhcCCCCC--------
Confidence 12234668999999999899999999999999999998 9999874322 11 112222221111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
.....+..+.+++.+|++.+|++|||+.++++.|+++
T Consensus 220 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 -APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1112345788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.26 Aligned_cols=261 Identities=25% Similarity=0.344 Sum_probs=195.7
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecC-----eeEEE
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILV 309 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-----~~~lv 309 (557)
++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+ ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 34688999999999999864 68999999986432 234467889999999999999999999998766 78999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+. ++|.+.+. ....+++..+..++.||+.||+|||+ .+++||||||+|||++.++.+||+|||++.....
T Consensus 83 ~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 83 TELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred eeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 99995 67877775 34578999999999999999999998 9999999999999999999999999999986543
Q ss_pred CCccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHH----------------H
Q 008707 390 DLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH----------------W 452 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~----------------~ 452 (557)
..........+++.|+|||.+.+. .++.++||||+||++|||++|+.||...+......... .
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 322222233478899999998774 57899999999999999999999998554321111100 0
Q ss_pred HHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 453 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 453 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
....+............+ ..........+.+++.+|++.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVL-YTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHh-cccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000110000000000000 00111123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=312.88 Aligned_cols=267 Identities=25% Similarity=0.445 Sum_probs=209.8
Q ss_pred hHHHHHHHHhhcccCCCCceEEEEEEEcC--------CcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeE
Q 008707 230 PELEEATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGY 299 (557)
Q Consensus 230 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~ 299 (557)
.++...++++.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+++++++ +||||++++++
T Consensus 7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 35556678889999999999999997531 2368999887543 33456789999999999 79999999999
Q ss_pred EEecCeeEEEEEecCCCChhhhhhccC-------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCC
Q 008707 300 CEEEHQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 366 (557)
Q Consensus 300 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~ 366 (557)
+...+..+++|||+++|+|.+++.... ....+++.++..++.|++.||+|||+ ++++||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccc
Confidence 999999999999999999999987431 12357888999999999999999998 99999999999
Q ss_pred CEEeCCCCcEEEecccCccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCcc
Q 008707 367 NILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG 444 (557)
Q Consensus 367 NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~ 444 (557)
||+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||...+..
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999998765432211 1112224567999999999999999999999999999998 88888643321
Q ss_pred ccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 445 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
+. ...+..+.... .....+..+.+++.+|+..+|++|||+.||++.|+.+.....
T Consensus 244 ------~~-~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 244 ------EL-FKLLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred ------HH-HHHHHcCCCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 11 11222221111 111223478899999999999999999999999999986544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=308.19 Aligned_cols=264 Identities=28% Similarity=0.443 Sum_probs=203.8
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcC-----------------CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccc
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKD-----------------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVP 295 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~ 295 (557)
...+++.+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3456778999999999999987642 2468999887543 334567889999999999999999
Q ss_pred eeeEEEecCeeEEEEEecCCCChhhhhhccC--------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCC
Q 008707 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 367 (557)
Q Consensus 296 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~N 367 (557)
+++++..+...+++||++++++|.+++.... ....+++..++.++.|++.||+|||+ .+++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 9999999999999999999999999987532 12268999999999999999999998 999999999999
Q ss_pred EEeCCCCcEEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh--CCCCCCCCCcc
Q 008707 368 ILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFG 444 (557)
Q Consensus 368 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt--g~~pf~~~~~~ 444 (557)
|+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999876533221 11223345778999999988889999999999999999998 6777753221
Q ss_pred ccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 445 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
......+......+...... ......+.++.+++.+|++.+|++|||+.||++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11122222211111111111 1111223578999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=302.72 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=195.6
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
+++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||++
T Consensus 3 ~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 3 IQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred chheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 356789999999999999764 68899999886542 3345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|..+. .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 83 GGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 99986542 36778888999999999999998 999999999999999999999999999987654322
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccc-cHHHHHHHHHhcCCccccccccccCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ...... ..+...... .+.
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~-- 221 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL-QCIVDEDPP-----VLP-- 221 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH-HHHhccCCC-----CCC--
Confidence 22345889999999999989999999999999999999999999743322111 111111 111111110 000
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.......+.+++.+|++.+|++||+++|+++.
T Consensus 222 -~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 222 -VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11123367899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=321.46 Aligned_cols=279 Identities=23% Similarity=0.272 Sum_probs=212.7
Q ss_pred cccCCccccCChhHHHHHHHHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCccchhHHHHHHHHHHHhhcC-C-----
Q 008707 218 FMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H----- 290 (557)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h----- 290 (557)
+.+++..+.+-..|....+|.+.+.||+|.||.|.+|.. ++++.||||++++.. ...++...|+.+|..|+ |
T Consensus 169 ~~~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~ 247 (586)
T KOG0667|consen 169 FDDEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDK 247 (586)
T ss_pred CCCCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCC
Confidence 334444444445555555778899999999999999965 469999999998653 33456678999999996 4
Q ss_pred CCccceeeEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe
Q 008707 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 370 (557)
Q Consensus 291 ~nIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll 370 (557)
-|+|+++++|...++.|||+|.+ .-+|+++++.. +..+++...++.|+.||+.||.+||+ .+|||+||||+|||+
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL 322 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILL 322 (586)
T ss_pred eeEEEeeeccccccceeeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheee
Confidence 48999999999999999999999 56999999976 45669999999999999999999998 999999999999999
Q ss_pred CCCC--cEEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcccccc
Q 008707 371 DINM--RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 448 (557)
Q Consensus 371 ~~~~--~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~ 448 (557)
.+.+ .+||+|||.++....... ....+..|.|||++.+..|+.+.||||||||++||++|.+-|.+.+..+...
T Consensus 323 ~~~~r~~vKVIDFGSSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~ 398 (586)
T KOG0667|consen 323 KDPKRSRIKVIDFGSSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLA 398 (586)
T ss_pred ccCCcCceeEEecccccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHH
Confidence 7543 599999999998765432 3345778999999999999999999999999999999999998665433322
Q ss_pred HHHHHH-----HHHhcCC-cccccc--------------------------------ccccC--------CCCHHHHHHH
Q 008707 449 IVHWAR-----SMIKKGD-VISIVD--------------------------------PVLIG--------NVKIESIWRI 482 (557)
Q Consensus 449 ~~~~~~-----~~~~~~~-~~~~~d--------------------------------~~l~~--------~~~~~~~~~l 482 (557)
.+..+. ..+..+. ....++ ....+ .........+
T Consensus 399 ~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F 478 (586)
T KOG0667|consen 399 RIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLF 478 (586)
T ss_pred HHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHH
Confidence 211110 0011100 000000 00001 0112344578
Q ss_pred HHHHHHccccCCCCCCCHHHHHHH
Q 008707 483 AEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 483 ~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.+++.+|+.+||.+|+|+.|.++.
T Consensus 479 ~dflk~~L~~dP~~R~tp~qal~H 502 (586)
T KOG0667|consen 479 IDFLKRCLEWDPAERITPAQALNH 502 (586)
T ss_pred HHHHHHHhccCchhcCCHHHHhcC
Confidence 999999999999999999999875
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=300.19 Aligned_cols=250 Identities=22% Similarity=0.353 Sum_probs=198.9
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 3667789999999999999876 477889998866555556778899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|..++.. ....+++..+..++.|+++||+|||+ .+++||||+|+||+++.++.++|+|||++........ .
T Consensus 86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~ 159 (282)
T cd06643 86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R 159 (282)
T ss_pred CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence 9999888764 24568999999999999999999998 9999999999999999999999999999876543221 1
Q ss_pred cccccCCCCccCCcccC-----CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccc
Q 008707 395 SSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~-----~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 469 (557)
.....+++.|+|||.+. +..++.++|||||||++|+|++|+.||...+.. +...... .+.......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~~-- 230 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIA-KSEPPTLAQ-- 230 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHh-hcCCCCCCC--
Confidence 22345789999999984 345778999999999999999999999743211 1111111 111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+...+..+.+++.+||+.+|++||++.++++
T Consensus 231 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 231 -----PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122347889999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=297.87 Aligned_cols=248 Identities=29% Similarity=0.433 Sum_probs=199.2
Q ss_pred cccCCCCceEEEEEEEcC--C--cEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMKD--G--KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 3 3699999877655 556789999999999999999999999988 889999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc--
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-- 393 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-- 393 (557)
++|.+.+..... ..+++..++.++.|++.||+|||+ ++++|+||+|+||+++.++.+||+|||++.........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999975422 568999999999999999999998 99999999999999999999999999999876442211
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... +........+....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~~~~-------- 221 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDKEGERLE-------- 221 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhcCCcCC--------
Confidence 1112346788999999999899999999999999999999 99999633221 11111111111110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
.....+..+.+++.+|++.+|++||++.||++.|.
T Consensus 222 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 -RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 11123457889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=301.99 Aligned_cols=250 Identities=30% Similarity=0.518 Sum_probs=196.1
Q ss_pred cccCCCCceEEEEEEEcC-Cc--EEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMKD-GK--EVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||.||+|.+++ +. .+++|.+.... ....+.+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998764 33 46888876533 34456788999999999 799999999999999999999999999
Q ss_pred CChhhhhhccC-------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEeccc
Q 008707 316 GTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 382 (557)
Q Consensus 316 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 382 (557)
|+|.+++.... ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 99999987432 12357899999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCC
Q 008707 383 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 461 (557)
Q Consensus 383 la~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 461 (557)
++........ ......+..|+|||.+.+..++.++||||||+++|||++ |..||...+... . .. .+..+.
T Consensus 158 l~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~---~~-~~~~~~ 228 (270)
T cd05047 158 LSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L---YE-KLPQGY 228 (270)
T ss_pred Cccccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---H---HH-HHhCCC
Confidence 9864321111 111224567999999988889999999999999999997 999996432211 1 11 111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 462 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 462 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
... ........+.+++.+|+..+|.+|||+.|+++.|+++.
T Consensus 229 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 RLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111 11122346889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=303.51 Aligned_cols=255 Identities=26% Similarity=0.476 Sum_probs=201.9
Q ss_pred HHHHhhcccCCCCceEEEEEEEcC-C---cEEEEEEccCc-cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
..+++.+.||+|+||.||+|.+.. + ..||+|.+... .....+.|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 345678999999999999998753 3 36999998754 234456899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999998753 3568899999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcccc--cccc--CCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 390 DLTHIS--SVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 390 ~~~~~~--~~~~--g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
...... .... .+..|+|||.+.+..++.++||||||+++|||++ |..||...+.. ....+ +..+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~----i~~~~~~- 230 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINA----IEQDYRL- 230 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHH----HHcCCcC-
Confidence 221111 1111 2357999999999999999999999999999887 99999633221 12221 1111100
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
......+..+.+++.+|+..+|++||++.+|++.|+.+
T Consensus 231 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 --------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00112234688999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=319.42 Aligned_cols=199 Identities=25% Similarity=0.396 Sum_probs=171.5
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+++.+.||+|+||+||++... +++.||+|++.... ......+.+|+.++..++|+||+++++.+.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 345789999999999999765 58899999986532 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 83 LPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999873 4578999999999999999999998 9999999999999999999999999999875432110
Q ss_pred ----------------------------------cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCC
Q 008707 393 ----------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 438 (557)
Q Consensus 393 ----------------------------------~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf 438 (557)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0011245899999999999999999999999999999999999999
Q ss_pred CCC
Q 008707 439 SVE 441 (557)
Q Consensus 439 ~~~ 441 (557)
...
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 744
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=306.24 Aligned_cols=263 Identities=24% Similarity=0.394 Sum_probs=201.0
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-----------------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccce
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-----------------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPL 296 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~ 296 (557)
..+++.+.||+|+||.||++... ++..||+|.+.... ....+.+.+|+++++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 45677899999999999998543 23468999987543 3345678999999999999999999
Q ss_pred eeEEEecCeeEEEEEecCCCChhhhhhccC--------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCE
Q 008707 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSV--------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 368 (557)
Q Consensus 297 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NI 368 (557)
++++..++..++||||+++++|.+++.... ....+++.++..++.|++.||+|||+ .+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 999999999999999999999999987532 12347788899999999999999998 9999999999999
Q ss_pred EeCCCCcEEEecccCccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh--CCCCCCCCCccc
Q 008707 369 LLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS--GKKPVSVEDFGA 445 (557)
Q Consensus 369 ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt--g~~pf~~~~~~~ 445 (557)
+++.++.++|+|||++......... ......+++.|++||...+..++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999998765332211 1122234678999999888889999999999999999998 778886332211
Q ss_pred cccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 446 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
................. .+ .....+..+.+++.+||+.+|++||++.||++.|++
T Consensus 242 ---~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 ---VIENTGEFFRDQGRQVY-LP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHhhcccccc-CC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111111110000 00 011223578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=306.39 Aligned_cols=261 Identities=25% Similarity=0.429 Sum_probs=203.7
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCe
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 305 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 305 (557)
....|++.+.||+|+||.||+|..+ .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3466778899999999999999754 245899998764432 234568889999999999999999999999899
Q ss_pred eEEEEEecCCCChhhhhhccCC-------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEE
Q 008707 306 RILVYEYMHNGTLRDRLHGSVN-------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 378 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 378 (557)
.++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999975321 2335677888999999999999998 99999999999999999999999
Q ss_pred ecccCccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 008707 379 SDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 456 (557)
Q Consensus 379 ~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 456 (557)
+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...+.. + ....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~-~~~~ 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------Q-VLKF 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHH
Confidence 999998765332211 1112234678999999998889999999999999999999 78898643221 1 1111
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 457 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 457 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
+..+..... ....+..+.+++.+|++.+|++|||+.++++.|++...
T Consensus 234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 234 VMDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred HHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 222211111 11223478999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=318.71 Aligned_cols=250 Identities=25% Similarity=0.326 Sum_probs=193.9
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 445789999999999999765 68999999886432 22345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 83 ~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 83 LPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999873 4568888999999999999999998 9999999999999999999999999999864321000
Q ss_pred -------------c---------------------------------ccccccCCCCccCCcccCCCCCCcccceehhHH
Q 008707 393 -------------H---------------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 426 (557)
Q Consensus 393 -------------~---------------------------------~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ 426 (557)
. ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001235899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHH
Q 008707 427 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR---PKMQEI 503 (557)
Q Consensus 427 ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~R---Pt~~ev 503 (557)
++|||++|..||...+.... ..............+. ......+.+++.+|+. +|.+| +++.|+
T Consensus 237 il~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~p~~-------~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 237 IMFECLIGWPPFCSENSHET------YRKIINWRETLYFPDD-------IHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHH------HHHHHccCCccCCCCC-------CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 99999999999974432111 1111111111111110 0122367899999997 66665 599998
Q ss_pred HHH
Q 008707 504 VLA 506 (557)
Q Consensus 504 l~~ 506 (557)
++.
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=311.92 Aligned_cols=264 Identities=27% Similarity=0.430 Sum_probs=204.0
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEE------cCCcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEec
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 303 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~ 303 (557)
+....+++.+.||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3456788899999999999999974 247889999987543 23446788999999999 689999999987654
Q ss_pred -CeeEEEEEecCCCChhhhhhccCC-------------------------------------------------------
Q 008707 304 -HQRILVYEYMHNGTLRDRLHGSVN------------------------------------------------------- 327 (557)
Q Consensus 304 -~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 327 (557)
...++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 467899999999999998864210
Q ss_pred ---------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc-cccc
Q 008707 328 ---------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-ISSV 397 (557)
Q Consensus 328 ---------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~ 397 (557)
...+++..+..++.|+++||+|||+ ++++||||||+||+++.++.+||+|||++......... ....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 1236788889999999999999998 99999999999999999999999999998765332221 1122
Q ss_pred ccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCH
Q 008707 398 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 476 (557)
Q Consensus 398 ~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 476 (557)
..++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .....+..+...... .
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~------~--- 305 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRMRAP------D--- 305 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCCCCC------C---
Confidence 335678999999988899999999999999999997 999987432211 111222222211110 0
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 477 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 477 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
.....+.+++.+||+.+|++|||+.||++.|+.+.+.
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 1123678999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=307.26 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=200.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
..|++.+.||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 34556788999999999999864 68899999887655555677889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++.. ..+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 99999999863 357888999999999999999998 99999999999999999999999999998765332211
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ... .....+ .... .
T Consensus 173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~--~~~----~~~~~~-~~~~-------~ 237 (296)
T cd06654 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR--ALY----LIATNG-TPEL-------Q 237 (296)
T ss_pred -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH--hHH----HHhcCC-CCCC-------C
Confidence 122347889999999998889999999999999999999999997432211 111 111111 0000 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
........+.+++.+||..+|++||++.||++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 11223346889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=299.00 Aligned_cols=249 Identities=33% Similarity=0.540 Sum_probs=202.6
Q ss_pred cccCCCCceEEEEEEEcC----CcEEEEEEccCccch-hHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||.||+|.... +..|++|.+...... ..+.+.+|+++++.++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998764 789999998765433 367889999999999999999999999999999999999999
Q ss_pred CChhhhhhccCC------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 316 GTLRDRLHGSVN------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 316 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
++|.+++..... ...+++..++.++.|++.||+|||+ ++++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999975321 3678999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 390 DLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 390 ~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
... .......++..|+|||.+....++.++||||+|+++|+|++ |..||...+.. .+ ...+..+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~----~~~~~~~~~~~--- 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EV----LEYLRKGYRLP--- 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HH----HHHHHcCCCCC---
Confidence 321 11223346889999999988889999999999999999999 69999744221 11 11222221111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
.....+..+.+++.+|++.+|++|||+.|+++.|+
T Consensus 228 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 ------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11122457889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=330.04 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=200.8
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEecC-------
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------- 304 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~------- 304 (557)
..|.+.+.||+|+||+||+|... +|+.||+|++... .......+.+|+.++..++|+||+++++.+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 35667899999999999999754 6899999998643 2334566888999999999999999988765322
Q ss_pred -eeEEEEEecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEeccc
Q 008707 305 -QRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 382 (557)
Q Consensus 305 -~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 382 (557)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 3679999999999999986432 34568999999999999999999998 999999999999999999999999999
Q ss_pred CccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC
Q 008707 383 LSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 461 (557)
Q Consensus 383 la~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 461 (557)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+. .+..... ..+.
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~-~~~~ 261 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKT-LAGR 261 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH-hcCC
Confidence 9987543221 122345689999999999999999999999999999999999999974432 1112211 1221
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 462 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 462 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
... .+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 262 ~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 262 YDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 111223478899999999999999999999864
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=301.21 Aligned_cols=239 Identities=23% Similarity=0.416 Sum_probs=188.8
Q ss_pred cccCCCCceEEEEEEEcC-------------CcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 241 KKIGKGSFGSVYYGKMKD-------------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
+.||+|+||.||+|.+.+ ...|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999997542 2358889877654555567888999999999999999999999988999
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc-------EEEec
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-------AKVSD 380 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~-------~kl~D 380 (557)
+||||+++|+|..++... ...+++..++.++.||++||+|||+ ++++||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 999999999999888642 3458899999999999999999998 99999999999999986654 89999
Q ss_pred ccCccccCCCCccccccccCCCCccCCcccC-CCCCCcccceehhHHHHHHHH-hCCCCCCCCCccccccHHHHHHHHHh
Q 008707 381 FGLSRQAEEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAELNIVHWARSMIK 458 (557)
Q Consensus 381 fgla~~~~~~~~~~~~~~~g~~~y~aPE~l~-~~~~s~~~DvwslG~ll~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~ 458 (557)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|..||......+. ....
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~- 222 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFY- 222 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHH-
Confidence 9998755322 1234678899999886 467889999999999999997 58888864322111 1111
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 008707 459 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 507 (557)
Q Consensus 459 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 507 (557)
.+.. .... .....+.+++.+||+.||++||++++|++.|
T Consensus 223 ~~~~-~~~~---------~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 EGQC-MLVT---------PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hcCc-cCCC---------CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1111 0000 1134688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=322.66 Aligned_cols=250 Identities=21% Similarity=0.271 Sum_probs=193.3
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 456789999999999999865 58899999986432 22345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC-
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 391 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 391 (557)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 83 IPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999974 4567888889999999999999998 999999999999999999999999999975321000
Q ss_pred -----------------------------------------ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHH
Q 008707 392 -----------------------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLE 430 (557)
Q Consensus 392 -----------------------------------------~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~e 430 (557)
........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000112358999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCC---CHHHHHHH
Q 008707 431 LISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP---KMQEIVLA 506 (557)
Q Consensus 431 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP---t~~evl~~ 506 (557)
|++|+.||...+..+. ............... .. .....+.+++.+|+ .+|.+|+ ++.|+++.
T Consensus 237 ll~G~~Pf~~~~~~~~------~~~i~~~~~~~~~~~---~~----~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 237 MLVGQPPFLADTPAET------QLKVINWETTLHIPS---QA----KLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhhCCCCCCCCCHHHH------HHHHhccCccccCCC---CC----CCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999999975432211 111111000000000 01 12235667787866 5999999 88998865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=315.47 Aligned_cols=254 Identities=23% Similarity=0.319 Sum_probs=197.9
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
....|++.+.||+|+||.||++..+ +++.||+|++.... ....+.+.+|+.+++.++||||+++++.+.+++..++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 3456777899999999999999876 57899999986421 2234557889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||+++|+|.+++.. ..++...+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 121 VMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 9999999999999863 347888889999999999999998 999999999999999999999999999998765
Q ss_pred CCCccccccccCCCCccCCcccCCC----CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGNQ----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~~----~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
...........||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.. ..............
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~~~ 267 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHKNSLT 267 (371)
T ss_pred cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCccc
Confidence 4333233345689999999998654 3788999999999999999999999744321 11122221111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 506 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~ 506 (557)
..+. ......+.+++.+|+...+.+ ||+++||++.
T Consensus 268 ~~~~-------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 268 FPDD-------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCc-------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1111 122346779999999844433 7799998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=321.24 Aligned_cols=249 Identities=21% Similarity=0.254 Sum_probs=191.3
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++.+.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 345789999999999999865 58899999986532 23345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC-
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 391 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 391 (557)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 83 IPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999874 3567888899999999999999998 999999999999999999999999999975321000
Q ss_pred ---------------------------------------------ccccccccCCCCccCCcccCCCCCCcccceehhHH
Q 008707 392 ---------------------------------------------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGV 426 (557)
Q Consensus 392 ---------------------------------------------~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ 426 (557)
........||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00011235899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHH
Q 008707 427 VLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEI 503 (557)
Q Consensus 427 ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~ev 503 (557)
++|||++|+.||...+... ................ .........+++.+++ .+|++|++ +.|+
T Consensus 237 il~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~p~-------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLE------TQMKVINWQTSLHIPP-------QAKLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHHhCCCCCCCCCHHH------HHHHHHccCCCcCCCC-------cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 9999999999997443211 1111111111000000 0111235667777765 59999997 8887
Q ss_pred HH
Q 008707 504 VL 505 (557)
Q Consensus 504 l~ 505 (557)
++
T Consensus 303 ~~ 304 (382)
T cd05625 303 KA 304 (382)
T ss_pred hc
Confidence 65
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=299.06 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=198.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-----chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
+...+.||+|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 445789999999999999764 58999999876432 122356888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+++++|.+.+.. ...++...+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 84 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 84 EYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999998874 3457888899999999999999998 99999999999999999999999999998765432
Q ss_pred Ccccc--ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 391 LTHIS--SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 391 ~~~~~--~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
..... ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ............
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~------ 225 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM------AAIFKIATQPTN------ 225 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH------HHHHHHhccCCC------
Confidence 21111 2334778999999999988999999999999999999999999633211 111111111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
...+......+.+++.+||..+|++|||+.|+++.
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11122233468899999999999999999999863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=297.36 Aligned_cols=247 Identities=33% Similarity=0.495 Sum_probs=198.9
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCccch-hHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCChh
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 319 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL~ 319 (557)
+.||+|+||.||++...+++.|++|.+...... ....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999988754333 4567899999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc-ccc
Q 008707 320 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS-SVA 398 (557)
Q Consensus 320 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~~ 398 (557)
+++... ...+++..+..++.|++.||+|||+ ++++||||+|+||+++.++.++|+|||++........... ...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 998643 3467888999999999999999998 9999999999999999999999999999876543221111 122
Q ss_pred cCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHH
Q 008707 399 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 477 (557)
Q Consensus 399 ~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 477 (557)
..+..|+|||.+.+..++.++|+||||+++|+|+| |..||....... . ...+..+... ..+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~----~~~~~~~~~~---------~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---T----RERIESGYRM---------PAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---H----HHHHhcCCCC---------CCCcc
Confidence 23567999999988889999999999999999999 888886432211 1 1111111100 01112
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 478 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 478 ~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
.+..+.+++.+|+..+|++|||+.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 3447889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=318.84 Aligned_cols=258 Identities=25% Similarity=0.408 Sum_probs=209.3
Q ss_pred ccccCChhHHHHHHHHhhcccCCCCceEEEEEEEcC--Cc--EEEEEEccCccch-hHHHHHHHHHHHhhcCCCCcccee
Q 008707 223 VAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD--GK--EVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLI 297 (557)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~ 297 (557)
..-.|+.+++ .+.++||+|.||+|++|.|+. |+ .||||+++..... ...+|.+|+.+|.+|+|+|++++|
T Consensus 103 lkclIpee~i-----~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLy 177 (1039)
T KOG0199|consen 103 LKCLIPEEQI-----KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLY 177 (1039)
T ss_pred cceeccHHHH-----HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEe
Confidence 3444555554 456899999999999998873 43 6899999876543 567899999999999999999999
Q ss_pred eEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEE
Q 008707 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 377 (557)
Q Consensus 298 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 377 (557)
|+.-+ ....||||.++.|+|.+.|+.. ....+.......++.|||.||.||.+ +++|||||.++|+|+-....||
T Consensus 178 GvVl~-qp~mMV~ELaplGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVK 252 (1039)
T KOG0199|consen 178 GVVLD-QPAMMVFELAPLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVK 252 (1039)
T ss_pred eeecc-chhhHHhhhcccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceee
Confidence 99987 6788999999999999999973 56678888899999999999999998 9999999999999999999999
Q ss_pred EecccCccccCCCCc--cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 008707 378 VSDFGLSRQAEEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 454 (557)
Q Consensus 378 l~Dfgla~~~~~~~~--~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~ 454 (557)
|+|||+.+-.+.... .......-+..|.|||.++...++.++|||+|||++|||+| |..||.+... ++.+
T Consensus 253 I~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------~qIL- 325 (1039)
T KOG0199|consen 253 ICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------IQIL- 325 (1039)
T ss_pred eecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------HHHH-
Confidence 999999988754332 22223335678999999999999999999999999999999 8899974432 1111
Q ss_pred HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 455 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 455 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
..+.+|. +-..+..++..+.+++.+||..+|++|||+..|.+.
T Consensus 326 ~~iD~~e---------rLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 326 KNIDAGE---------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred Hhccccc---------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 1122221 112244566789999999999999999999999743
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=298.26 Aligned_cols=253 Identities=27% Similarity=0.386 Sum_probs=191.7
Q ss_pred cccCCCCceEEEEEEEcC---CcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 241 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
+.||+|+||.||+|.+.+ +..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 45799998865432 33457888999999999999999999999988999999999999
Q ss_pred ChhhhhhccC--CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 317 TLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 317 sL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+|.+++.... .....++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999987532 22346677788899999999999998 999999999999999999999999999987543322211
Q ss_pred -cccccCCCCccCCcccCCC-------CCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 395 -SSVARGTVGYLDPEYYGNQ-------QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 395 -~~~~~g~~~y~aPE~l~~~-------~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||....... ... ....+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLT----YTVREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHH----HHhhcccCCC
Confidence 1223467889999998642 35789999999999999996 999997432211 111 1111111122
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
.++.+.. .....+.+++.+|+ .+|++|||++||++.|+
T Consensus 231 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222211 12235778999998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=303.23 Aligned_cols=258 Identities=25% Similarity=0.423 Sum_probs=202.2
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCc----EEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
...+++.+.||+|+||+||+|.+. +++ .||+|++.... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 345566799999999999999864 344 48999886543 33456788999999999999999999998754 577
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+++||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 999999999999998742 3468999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCccc-cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 388 EEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 388 ~~~~~~~-~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
....... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||...... .+. ..+..+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~~~~~ 232 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIP----DLLEKGERLPQ 232 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHHCCCcCCC
Confidence 4322211 111234678999999998899999999999999999998 89998743221 111 12222221111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
....+..+.+++.+||..||++||++.|+++.|+.+...
T Consensus 233 ---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 233 ---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 112234688999999999999999999999998877553
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=312.21 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=195.9
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
+|.+.+.||+|+||.||+|..+ +++.||+|.+.... ......+.+|+++++.++||||+++++++..++..++||||+
T Consensus 7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 3556789999999999999876 57889999886432 223346778999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++ +|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 87 ~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 87 DK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT 160 (309)
T ss_pred CC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCccc
Confidence 64 888877643 3457888999999999999999998 99999999999999999999999999998764332211
Q ss_pred ccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHH--------HHhcCCccc
Q 008707 394 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS--------MIKKGDVIS 464 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 464 (557)
.....+++.|+|||.+.+ ..++.++||||+|+++|+|+||+.||...+..+.......... .+.......
T Consensus 161 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 161 -YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred -cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 122347889999998865 4678999999999999999999999975544322111111000 000000000
Q ss_pred ccc-ccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 465 IVD-PVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 465 ~~d-~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..+ +.... ........++.+++.+|++.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000 00000 000112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=303.44 Aligned_cols=251 Identities=33% Similarity=0.544 Sum_probs=198.2
Q ss_pred HhhcccCCCCceEEEEEEEcC-CcEEEEEEccCccchhH--HHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
++.+.||+|+||+||++.... ++.||+|++........ ....+|+.+++.++||||+++++++.+....++|||+++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 467899999999999998774 66899999876543332 234569999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|.+++. ....+++..+..++.|+++||++||+ .+++|+||||+||++++++.++|+|||.+....... ..
T Consensus 82 ~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~-~~ 154 (260)
T PF00069_consen 82 GGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN-EN 154 (260)
T ss_dssp TEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT-SE
T ss_pred ccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc-cc
Confidence 999999997 35668999999999999999999999 999999999999999999999999999987642221 22
Q ss_pred cccccCCCCccCCcccC-CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 395 SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~-~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....++..|+|||.+. +..++.++||||+|+++|+|++|..||......+..... ....... ... .. .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~---~~~~~~~-~~~---~~---~ 224 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEII---EKILKRP-LPS---SS---Q 224 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHH---HHHHHTH-HHH---HT---T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhh---hhccccc-ccc---cc---c
Confidence 33445789999999998 888999999999999999999999999854211111111 1111100 000 00 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
........+.+++.+||+.+|++||++.++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001258899999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=286.04 Aligned_cols=253 Identities=26% Similarity=0.346 Sum_probs=204.2
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--------chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEE
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--------SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv 309 (557)
.+.||.|..++|-++.++ +|+++|+|++.... ..-.+.-.+|+.||+++ .||+|+++.++++.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 578999999999988665 68899999874321 11234566799999999 699999999999999999999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
+|.|+.|.|.|++. ...+++++...+|+.|+.+|+.|||. ++||||||||+|||++++.+++|+|||+++....
T Consensus 102 Fdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 102 FDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999998 46789999999999999999999998 9999999999999999999999999999998866
Q ss_pred CCccccccccCCCCccCCcccC------CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 390 DLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~------~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
... -...+|||+|+|||.+. ...|+...|+||+|+++|-|+.|.+||-.. ..-...+.+.+|...
T Consensus 176 Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR-------kQmlMLR~ImeGkyq 246 (411)
T KOG0599|consen 176 GEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR-------KQMLMLRMIMEGKYQ 246 (411)
T ss_pred chh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-------HHHHHHHHHHhcccc
Confidence 533 23467999999999884 457889999999999999999999999521 111223445555442
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhhhh
Q 008707 464 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKI 513 (557)
Q Consensus 464 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~~~~ 513 (557)
- ....-.+......++|.+|++.||.+|.|++|.++. +.++...
T Consensus 247 F------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 247 F------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred c------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 1 111122334467899999999999999999999864 4444443
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=299.25 Aligned_cols=249 Identities=25% Similarity=0.365 Sum_probs=200.6
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc-cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++|+||+++++.+.+++..++||||++
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred ceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 346789999999999999876 5889999987543 23345678889999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|.+++... ....++...+..++.|++.||.|||+ ++++|+||||+||++++++.++++|||.+.........
T Consensus 82 ~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 156 (255)
T cd08219 82 GGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY- 156 (255)
T ss_pred CCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc-
Confidence 99999988643 24557889999999999999999998 99999999999999999999999999998765433221
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.. .... .+..+.....
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~-~~~~~~~~~~--------- 220 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------NLIL-KVCQGSYKPL--------- 220 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------HHHH-HHhcCCCCCC---------
Confidence 22345788999999999988999999999999999999999999743221 1111 1222222111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+......+.+++.+||+.+|++||++.||+..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11223467899999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=304.00 Aligned_cols=256 Identities=29% Similarity=0.462 Sum_probs=202.4
Q ss_pred HHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
..+++.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+++++.++||||+++++++.++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMC 84 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccE
Confidence 44566789999999999999864 467899999875432 34467889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccC-------------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCE
Q 008707 308 LVYEYMHNGTLRDRLHGSV-------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 368 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NI 368 (557)
+||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ni 161 (288)
T cd05050 85 LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNC 161 (288)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhhe
Confidence 9999999999999986421 12347888899999999999999998 9999999999999
Q ss_pred EeCCCCcEEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCcccc
Q 008707 369 LLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAE 446 (557)
Q Consensus 369 ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~ 446 (557)
+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-- 239 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-- 239 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999876433211 11112234667999999998899999999999999999998 88888633221
Q ss_pred ccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 447 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
+.. ..+..+..... +...+..+.+++.+|++.+|++|||+.||++.|++
T Consensus 240 ----~~~-~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 ----EVI-YYVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----HHH-HHHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111 22333332211 11223478899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=299.88 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=199.5
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
...|.+.+.||+|+||.||+|... +++.||+|.++.........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 346778899999999999999765 5889999998765444556688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++.. ...+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence 999999999873 4568999999999999999999998 8999999999999999999999999999876543222
Q ss_pred cccccccCCCCccCCcccC---CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccc
Q 008707 393 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~---~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 469 (557)
......|+..|+|||.+. ...++.++|||||||++|+|++|+.||....... .... ....... .+.
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~-----~~~~~~~---~~~ 230 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFL-----MTKSNFQ---PPK 230 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHh-----hhccCCC---CCc
Confidence 122345889999999874 4567889999999999999999999986322111 0000 0111110 000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
... ....+..+.+++.+|+..+|++||++++|++
T Consensus 231 ~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000 0012236789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.14 Aligned_cols=263 Identities=22% Similarity=0.251 Sum_probs=191.8
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEec--------Cee
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--------HQR 306 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--------~~~ 306 (557)
.|++.+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++++++... ...
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 4667889999999999999875 58899999875432 2345799999999999999999876432 246
Q ss_pred EEEEEecCCCChhhhhhcc-CCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC-cEEEecccCc
Q 008707 307 ILVYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLS 384 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla 384 (557)
++||||++ ++|.+++... .....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||++
T Consensus 143 ~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 78999996 4676666432 235678999999999999999999998 9999999999999999665 6999999999
Q ss_pred cccCCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---
Q 008707 385 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--- 460 (557)
Q Consensus 385 ~~~~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--- 460 (557)
+....... .....|++.|+|||++.+ ..++.++|||||||++|||++|.+||.+....+. +... ...+...
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i-~~~~~~p~~~ 293 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRI-IQVLGTPTED 293 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHH-HHHhCCCCHH
Confidence 87643322 122357899999998865 4689999999999999999999999975443211 1111 1111000
Q ss_pred -------Ccccc-----ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhh
Q 008707 461 -------DVISI-----VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSI 511 (557)
Q Consensus 461 -------~~~~~-----~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~~ 511 (557)
..... ....+...++...+.++.+++.+||+.||.+|||+.|+++. ++.+.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 00000 00000011111233578899999999999999999999854 44443
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.33 Aligned_cols=253 Identities=25% Similarity=0.313 Sum_probs=195.1
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc---cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||++... +++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 456789999999999999875 5889999998642 122345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 83 YVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred CCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 9999999998642 4568899999999999999999998 9999999999999999999999999999876544333
Q ss_pred cccccccCCCCccCCcccCC-----CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 393 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~-----~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
.......||+.|+|||++.. ..++.++||||+||++|+|++|+.||..... .+................
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~~~ 231 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQFPP 231 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcccCCC
Confidence 22233458999999999863 4578899999999999999999999974332 111122221111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCC--CCCCCHHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRG--FSRPKMQEIVLA 506 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P--~~RPt~~evl~~ 506 (557)
.....+..+.+++.+|+..++ ..||+++++++.
T Consensus 232 ------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 232 ------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 001123467788888775533 347899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=311.98 Aligned_cols=240 Identities=25% Similarity=0.353 Sum_probs=191.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e 311 (557)
+++.+.||+|+||.||+|... +|+.||+|++.... ....+.+..|..++..+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 356789999999999999865 58899999986532 223456778899998885 5788889999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||++.......
T Consensus 82 y~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 82 YVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999998863 4568999999999999999999998 999999999999999999999999999987543221
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
. ......|++.|+|||++.+..++.++||||+||++|+|++|+.||...+.. .. ... +..+..
T Consensus 156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~---~~~-i~~~~~--------- 218 (323)
T cd05615 156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---EL---FQS-IMEHNV--------- 218 (323)
T ss_pred c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HH---HHH-HHhCCC---------
Confidence 1 122345899999999999989999999999999999999999999744321 11 111 111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKM 500 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 500 (557)
.++......+.+++.+|++.+|.+|++.
T Consensus 219 -~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 -SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0111123467899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=299.85 Aligned_cols=251 Identities=22% Similarity=0.358 Sum_probs=199.9
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
..|++.+.||+|+||.||+|... +++.|++|.+........+.+.+|+++++.++||||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45778899999999999999876 48899999987665566678889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|..++... ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++.........
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccccc
Confidence 999998877542 3568999999999999999999998 99999999999999999999999999988764332211
Q ss_pred ccccccCCCCccCCcccC-----CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 394 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~-----~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
.....+++.|+|||.+. ...++.++||||||+++|+|++|..||...+. ........ .........
T Consensus 167 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~-~~~~~~~~~- 237 (292)
T cd06644 167 -RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIA-KSEPPTLSQ- 237 (292)
T ss_pred -cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHh-cCCCccCCC-
Confidence 12234788999999984 34567899999999999999999999964321 11111111 111111100
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+......+.+++.+||+.+|++||++.||++
T Consensus 238 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 238 ------PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ------CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1122346889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=306.54 Aligned_cols=197 Identities=24% Similarity=0.383 Sum_probs=160.3
Q ss_pred hcccCCCCceEEEEEEEc---CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEe--cCeeEEEEEecC
Q 008707 240 CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEYMH 314 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~lv~e~~~ 314 (557)
.++||+|+||.||+|... +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 46789999886532 23457789999999999999999998854 456789999985
Q ss_pred CCChhhhhhccC------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe----CCCCcEEEecccCc
Q 008707 315 NGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLS 384 (557)
Q Consensus 315 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla 384 (557)
++|.+++.... ....+++..+..++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58887765321 12358889999999999999999998 999999999999999 45678999999999
Q ss_pred cccCCCCcc--ccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCC
Q 008707 385 RQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVED 442 (557)
Q Consensus 385 ~~~~~~~~~--~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~ 442 (557)
......... ......+|+.|+|||++.+ ..++.++||||+||++|+|++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876443221 1223458999999999876 468899999999999999999999997443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=301.14 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=206.2
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
+....+++.+.||+|+||+||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 34567788899999999999999865 58899999876432 33456789999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+ ..+++|+||+|+||++++++.++|+|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 999999999998874 3568999999999999999999996 26899999999999999999999999999865432
Q ss_pred CCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcc-----ccccHHHHHHHHHhcCCccc
Q 008707 390 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-----AELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 464 (557)
.. .....|+..|+|||.+.+..++.++|||||||++|+|+||..||...... ....+..+....+... .
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-- 230 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-P-- 230 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-C--
Confidence 21 12345889999999998889999999999999999999999999844332 1111222222222111 0
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 507 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 507 (557)
+.+. ....+..+.+++.+|++.+|++|||++|+++..
T Consensus 231 ---~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 ---PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0110 112345788999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=300.41 Aligned_cols=262 Identities=27% Similarity=0.462 Sum_probs=205.2
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-----CCcEEEEEEccCccch-hHHHHHHHHHHHhhcCCCCccceeeEEEe--cCee
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQR 306 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~ 306 (557)
..+++.+.||+|+||.||+|.+. +++.+|+|.+...... ..+.+.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 34566789999999999999864 3689999998765443 46789999999999999999999999877 5578
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999999753 3358999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCCcc--ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccc--------cHHHHHHHH
Q 008707 387 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--------NIVHWARSM 456 (557)
Q Consensus 387 ~~~~~~~--~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~--------~~~~~~~~~ 456 (557)
....... ......++..|++||.+.+..++.++||||||+++|||+||+.|+......... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532221 111223456799999998889999999999999999999999998643221100 011111122
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 457 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 457 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
+..+... ......+..+.+++.+|++.+|++|||+.||+++|+.+
T Consensus 239 ~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGERL---------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCCcC---------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2221111 11112235788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=300.76 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=200.1
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc-cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
.+++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|++++++++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 3567899999999999999876 6899999988653 2334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++........+++..+..++.|++.||.|||+ +.+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 158 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA- 158 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc-
Confidence 999999988754334478999999999999999999996 26999999999999999999999999999876533221
Q ss_pred ccccccCCCCccCCcccCCC------CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 394 ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~------~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||....... ...... .+..+...
T Consensus 159 --~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~-~~~~~~~~---- 228 (286)
T cd06622 159 --KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLS-AIVDGDPP---- 228 (286)
T ss_pred --ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHH-HHhhcCCC----
Confidence 223478899999998554 34789999999999999999999997432211 111111 11111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..+......+.+++.+|+..+|++||+++++++
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 229 -----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 112224457889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=302.65 Aligned_cols=250 Identities=24% Similarity=0.305 Sum_probs=197.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
++..+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.+++.++|++|+.+++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 345678999999999999765 588999998864321 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++... ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999988643 23468899999999999999999998 9999999999999999999999999999876543222
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
. ....|+..|+|||.+.+..++.++||||+|+++|+|++|+.||......... ........... .
T Consensus 158 ~--~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~~~------~---- 222 (285)
T cd05630 158 I--KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVQ------E---- 222 (285)
T ss_pred c--cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhhhh------h----
Confidence 1 2235899999999999999999999999999999999999999743221100 00111111000 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 505 (557)
.........+.+++.+||+.||++||| ++|+++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 011112336789999999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=301.51 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=200.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+.|...+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++..++..++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 45666788999999999999765 57889999886432 33456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++. ...+++..+..++.|+++|+.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999886 3458889999999999999999998 9999999999999999999999999999876543321
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......++..|+|||.+.+..++.++||||||+++|||++|+.||....... .. ..+..+.. +
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~----~~~~~~~~-----~---- 219 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VL----FLIPKNSP-----P---- 219 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HH----hhhhcCCC-----C----
Confidence 1122347889999999999899999999999999999999999986322111 11 11111111 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
......+..+.+++.+|++.+|++||++.||++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1112234578899999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=304.54 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=201.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
..|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 56667899999999999999864 68999999987654455567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 99999999863 457888999999999999999998 99999999999999999999999999998765433221
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+....... ....+ ... ..
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~~-~~~-------~~ 236 (297)
T cd06656 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG-TPE-------LQ 236 (297)
T ss_pred -cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccCC-CCC-------CC
Confidence 1223478899999999998899999999999999999999999974432111000 00000 000 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
........+.+++.+||..+|++||++++|++
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11223346789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=302.41 Aligned_cols=238 Identities=24% Similarity=0.379 Sum_probs=186.7
Q ss_pred ccCCCCceEEEEEEEcC-------------------------CcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccce
Q 008707 242 KIGKGSFGSVYYGKMKD-------------------------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 296 (557)
Q Consensus 242 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~ 296 (557)
.||+|+||.||+|.+.. ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13588998865544445678889999999999999999
Q ss_pred eeEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC--
Q 008707 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-- 374 (557)
Q Consensus 297 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~-- 374 (557)
++++......++||||+++|+|.+++.. ....+++..+..++.||++||+|||+ ++++||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998864 24568889999999999999999998 9999999999999997543
Q ss_pred -----cEEEecccCccccCCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHH-hCCCCCCCCCccccc
Q 008707 375 -----RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAEL 447 (557)
Q Consensus 375 -----~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~ell-tg~~pf~~~~~~~~~ 447 (557)
.++++|||++....... ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||.......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred cCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 38999999876543221 1236788999998865 56889999999999999985 6999997432211
Q ss_pred cHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 008707 448 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 507 (557)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 507 (557)
... ....... +.. .....+.+++.+||+.+|++|||+++|++.|
T Consensus 230 -~~~----~~~~~~~-------~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 -KER----FYEKKHR-------LPE----PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred -HHH----HHHhccC-------CCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111 1111100 000 1123688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=304.84 Aligned_cols=259 Identities=22% Similarity=0.318 Sum_probs=198.6
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
+++.+.||+|+||.||++.+. ++..+|+|.+.... .....++.+|++++++++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 456788999999999999866 57889999876542 2334568899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|.++++. ...+++..+..++.|+++||+|||+ ..+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 83 GGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999999974 3568889999999999999999996 2589999999999999999999999999987653321
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc-----------
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI----------- 463 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------- 463 (557)
.....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+... ...+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCCC
Confidence 123457899999999988889999999999999999999999997443211 111110000000000
Q ss_pred ---------ccccccc---cCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 464 ---------SIVDPVL---IGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 464 ---------~~~d~~l---~~~~~-~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+..+... ....+ ......+.+++.+|+..+|++|||++||++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000 00000 0123468899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=311.60 Aligned_cols=261 Identities=23% Similarity=0.285 Sum_probs=194.4
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecC------e
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------Q 305 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~------~ 305 (557)
..|++.+.||+|+||.||++... +|+.||+|++.... ......+.+|+.+++.++||||+++++++...+ .
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 100 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD 100 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence 45667899999999999999865 58999999986432 234466889999999999999999999886543 4
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
.++||||+.+ +|.+.+. ..++...+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 101 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 101 VYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred eEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 6899999964 6666654 237788889999999999999998 999999999999999999999999999997
Q ss_pred ccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcccccc------------H----
Q 008707 386 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN------------I---- 449 (557)
Q Consensus 386 ~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~------------~---- 449 (557)
....... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+... .
T Consensus 172 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 172 TACTNFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred ccccCcc--CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 6433221 223457899999999999999999999999999999999999998554321100 0
Q ss_pred HHHHHHHHhcCCccc------ccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 450 VHWARSMIKKGDVIS------IVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 450 ~~~~~~~~~~~~~~~------~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
...+........... ....... ..........+.+++.+||..||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000111111110000 0000000 00011123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.24 Aligned_cols=263 Identities=22% Similarity=0.245 Sum_probs=199.6
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEc---CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
+....|++.+.||+|+||.||++... .++.||+|.+... ....+|+++++.++||||+++++++......++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 33446778899999999999999754 3578999987643 234579999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
|||++. ++|.+++. ....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.++|+|||++....
T Consensus 164 v~e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~ 236 (392)
T PHA03207 164 VMPKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLD 236 (392)
T ss_pred EehhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence 999995 68888884 34678999999999999999999998 999999999999999999999999999997654
Q ss_pred CCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc--
Q 008707 389 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI-- 465 (557)
Q Consensus 389 ~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 465 (557)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............+...+...+....
T Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 43221 222345899999999999999999999999999999999999999755433211111111111111110000
Q ss_pred -----------ccccccCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 466 -----------VDPVLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 466 -----------~d~~l~~~~~-------~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+.......+. ......+.+++.+|+..||++|||+.|++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 0113467789999999999999999999864
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=297.07 Aligned_cols=251 Identities=30% Similarity=0.460 Sum_probs=193.3
Q ss_pred cccCCCCceEEEEEEEcC----CcEEEEEEccCc-cchhHHHHHHHHHHHhhcCCCCccceeeEEE-ecCeeEEEEEecC
Q 008707 241 KKIGKGSFGSVYYGKMKD----GKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVYEYMH 314 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~~~~~~lv~e~~~ 314 (557)
+.||+|+||.||+|.+.+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999997642 457999987543 2334567889999999999999999999775 4556889999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc-
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 393 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~- 393 (557)
+|+|.+++... ....++..+..++.|++.||+|||+ .+++||||||+||++++++.+||+|||++.........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998743 3346777888999999999999998 99999999999999999999999999998765332111
Q ss_pred --ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 394 --ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 394 --~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
......++..|+|||.+.+..++.++||||||+++|||++| ..||...+. ... .. .+..+.....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~---~~-~~~~~~~~~~----- 223 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDI---TV-YLLQGRRLLQ----- 223 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHH---HH-HHhcCCCCCC-----
Confidence 11122356789999999888999999999999999999995 556653211 111 11 1222211110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
+...+..+.+++.+||..+|++||++.||++.|+++..
T Consensus 224 ----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 224 ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 11123468899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=301.77 Aligned_cols=249 Identities=23% Similarity=0.290 Sum_probs=196.6
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
+..+.||+|+||+||+|.+. +++.||+|.+..... .....+.+|+++++.++|+||+.+++.+..++..++||||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 44578999999999999775 688999999865321 22345778999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+.+... ....+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 83 NGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred cCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 999999888643 23468999999999999999999998 9999999999999999999999999999876543221
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||........ . +.+...+..+.. .
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~-~~~~~~~~~~~~----------~ 223 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--R-EEVDRRVLETEE----------V 223 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHhhhcccc----------c
Confidence 1223589999999999988999999999999999999999999974322111 1 111111111110 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 505 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 505 (557)
+.......+.+++.+|++.+|++||+ +.++++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11122336789999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=297.38 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=202.3
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
..|+..+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 44566788999999999999875 58899999886432 34456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++.. ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999998863 457888999999999999999998 9999999999999999999999999999976543321
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
. .....++..|+|||.+.+..++.++|+||||+++|||+||+.||........ . ..+..+. ..
T Consensus 157 ~-~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~-~~~~~~~---------~~ 219 (277)
T cd06640 157 K-RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV------L-FLIPKNN---------PP 219 (277)
T ss_pred c-cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH------h-hhhhcCC---------CC
Confidence 1 2223478889999999888899999999999999999999999974322110 0 0111111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
......+..+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2233456688999999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=297.14 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=201.8
Q ss_pred HHHHhhcccCCCCceEEEEEEEcC-CcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
..|++.+.||+|+||.||+|.+.+ ++.+++|.+..... .+.+.+|+++++.++||||+++++.+.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 345677899999999999998875 78999999865422 678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 999999998642 4568999999999999999999998 8999999999999999999999999999887654322
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..... . .+..... +. ..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~-~~~~~~~-----~~--~~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------F-MIPNKPP-----PT--LS 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------h-hhccCCC-----CC--CC
Confidence 122234788999999999889999999999999999999999999743221100 0 0000000 00 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+......+.+++.+|++.+|++|||++||++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 11223347889999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=305.46 Aligned_cols=253 Identities=25% Similarity=0.323 Sum_probs=194.9
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||++..+ +++.+|+|++.+.. ....+.+.+|+.++..++|+||+++++.+.+.+..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 456789999999999999876 47789999986421 22334578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++... ...+++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 83 YVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 9999999999742 3568888999999999999999998 9999999999999999999999999999876543333
Q ss_pred cccccccCCCCccCCcccC-----CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 393 HISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~-----~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...+. .+..............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~~-- 229 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERFQF-- 229 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCccccC--
Confidence 2233446899999999986 34678899999999999999999999974332 1112222211111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGF--SRPKMQEIVLA 506 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~--~RPt~~evl~~ 506 (557)
+ .........+.+++.+|+..+++ .|++++|+++.
T Consensus 230 p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 00112234677888898865444 37899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=302.62 Aligned_cols=262 Identities=20% Similarity=0.243 Sum_probs=195.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|++|.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 345688999999999999875 68899999886432 223456888999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
. ++|.+++........+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 157 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRV 157 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccc
Confidence 6 6888888654444678999999999999999999998 99999999999999999999999999998765432211
Q ss_pred ccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC-----------C
Q 008707 394 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG-----------D 461 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-----------~ 461 (557)
.....+++.|+|||.+.+. .++.++||||||+++|+|+||+.||........ ............ .
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 158 -YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchhhHH
Confidence 1222468899999988654 578899999999999999999999974332110 000000000000 0
Q ss_pred cccccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 462 VISIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 462 ~~~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.......... .........++.+++.+||..||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0000112346779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=297.85 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=194.1
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
...||+|+||.||+|.+. ++..|++|.+........+.+.+|+++++.++|+||+++++++..++..++|+||+++++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 467999999999999865 5788999988766555667899999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC-CCcEEEecccCccccCCCCcccccc
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSV 397 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~ 397 (557)
.+++.........++..+..++.||+.||+|||+ .+++||||||+||+++. ++.++|+|||++........ ....
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 168 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTET 168 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cccc
Confidence 9998753211122778888999999999999998 99999999999999986 67899999999876543222 1222
Q ss_pred ccCCCCccCCcccCCC--CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 398 ARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 398 ~~g~~~y~aPE~l~~~--~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
..+++.|+|||.+... .++.++||||||+++|+|++|+.||....... ...+...... .....+
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~~-----------~~~~~~ 234 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMFK-----------IHPEIP 234 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhhc-----------cCCCCC
Confidence 3478899999998654 37889999999999999999999996322111 0111110000 011112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
......+.+++.+||+.+|++|||+.||++
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 223346889999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=306.64 Aligned_cols=260 Identities=22% Similarity=0.327 Sum_probs=195.6
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
.|.+.+.||+|+||.||+|..+ +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 3556789999999999999875 57899999886432 223346778999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
. ++|.+++... ...+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 87 ~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 160 (301)
T cd07873 87 D-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 160 (301)
T ss_pred c-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc
Confidence 6 5898888643 3467889999999999999999998 99999999999999999999999999998765332211
Q ss_pred ccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc---CCcccccc--
Q 008707 394 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK---GDVISIVD-- 467 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d-- 467 (557)
.....+++.|+|||.+.+ ..++.++||||||+++|+|+||+.||...+..+. .......... .......+
T Consensus 161 -~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 161 -YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred -ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhccc
Confidence 122346889999998865 4578899999999999999999999975443211 1111111100 00000000
Q ss_pred -------ccccCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 468 -------PVLIGN----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 468 -------~~l~~~----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+....+ ........+.+++.+|++.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 00112346789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=299.41 Aligned_cols=258 Identities=25% Similarity=0.427 Sum_probs=204.9
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEcC-Cc----EEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCee
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMKD-GK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 306 (557)
....+++.+.||+|+||.||+|.+++ |+ .+|+|.+..... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 83 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV 83 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence 34566778999999999999998653 33 589998765433 345678899999999999999999999987 788
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++||||+++|+|.+++... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||+++.
T Consensus 84 ~~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 84 QLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EEEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 9999999999999998753 3458999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCCccc-cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 387 AEEDLTHI-SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 387 ~~~~~~~~-~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
........ .....++..|+|||.+....++.++|+||||+++||+++ |+.||......+ ....+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~~~ 231 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGERLP 231 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCCCC
Confidence 64332211 111223568999999988889999999999999999999 999997433211 122222222111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
. +......+.+++.+||..+|++||++.++++.|.++.+
T Consensus 232 ~---------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 232 Q---------PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred C---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 11122367899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=319.73 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=212.2
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CC----cEEEEEEccCc-cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DG----KEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~----~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
+...+-.++||+|+||+||+|.|- .| -+||+|++... ..+...++++|+-+|.+++|||+++++|++.... ..
T Consensus 695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 334445789999999999999763 33 47899988654 3445678999999999999999999999998765 88
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
||++|++.|+|.|+++.. ...+.....+.|..|||+||.|||. ++++||||.++||||..-..+||.|||+++..
T Consensus 774 lvtq~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHHhcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 999999999999999864 5668888999999999999999998 99999999999999999999999999999987
Q ss_pred CCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 388 EEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 388 ~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
..+.. .......-.+.|||-|.+....|+.++|||||||++||++| |..|+++....+ +.+.++.|+..
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~geRL-- 919 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKGERL-- 919 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhccccC--
Confidence 55432 22223335778999999999999999999999999999999 999998654433 33444444431
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
..++....++..++.+||..|+..||+++++...+.+..+
T Consensus 920 -------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 920 -------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred -------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 1233455688899999999999999999999999888775
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=298.35 Aligned_cols=246 Identities=28% Similarity=0.417 Sum_probs=196.8
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccch---------hHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
.+.+.||+|++|.||+|... +++.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 45688999999999999764 5789999987543211 1246888999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||.+...
T Consensus 83 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~ 156 (267)
T cd06628 83 IFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156 (267)
T ss_pred EEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence 99999999999999974 3567888899999999999999998 99999999999999999999999999998876
Q ss_pred CCCCcc-----ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 388 EEDLTH-----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 388 ~~~~~~-----~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
...... ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...+.. ..... +...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~-- 227 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------QAIFK-IGEN-- 227 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------HHHHH-Hhcc--
Confidence 432111 112234788999999999888999999999999999999999999743211 10111 1111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 463 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 463 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.. ...+...+..+.+++.+||+.+|.+||++.||++
T Consensus 228 ---~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ---AS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---CC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 01 1112223457889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=295.36 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=189.3
Q ss_pred cccCCCCceEEEEEEEcC---CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 241 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
+.||+|+||.||+|.... ...+++|.+.... ......+.+|+++++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999997543 3468888775433 233457889999999999999999999999999999999999999
Q ss_pred ChhhhhhccCC--CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc-c
Q 008707 317 TLRDRLHGSVN--QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-H 393 (557)
Q Consensus 317 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~ 393 (557)
+|.+++..... ....++.....++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999975431 2334677788999999999999998 9999999999999999999999999999875432211 1
Q ss_pred ccccccCCCCccCCcccCC-------CCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 394 ISSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~-------~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
......+++.|+|||++.. ..++.++|||||||++|||++ |..||...... +.....+..+ ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhcc-CccC
Confidence 1122335678999998743 356789999999999999999 78888633211 1111222222 1122
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
.++.+. ......+.+++..|+ .||++|||++||++.|.
T Consensus 231 ~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222221 122345677888888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=303.64 Aligned_cols=259 Identities=25% Similarity=0.299 Sum_probs=191.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhc---CCCCccceeeEEEe-----cCe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEE-----EHQ 305 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~h~nIv~~~~~~~~-----~~~ 305 (557)
|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+++++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 456788999999999999876 588999998864321 2223556777777666 69999999998764 345
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
.++||||+. ++|.+++... ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred EEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence 789999996 5888888643 23458999999999999999999998 999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc--
Q 008707 386 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI-- 463 (557)
Q Consensus 386 ~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 463 (557)
....... .....++..|+|||.+.+..++.++||||+||++|+|++|++||......+. +.. ...........
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~-~~~~~~~~~~~~~ 231 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGK-IFDLIGLPPEDDW 231 (288)
T ss_pred cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHH-HHHHhCCCChhhC
Confidence 6643221 1223478899999999988999999999999999999999999974432211 111 11111000000
Q ss_pred --------cccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 464 --------SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 464 --------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..+.+... ..........+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000 0011122346789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=295.09 Aligned_cols=253 Identities=24% Similarity=0.370 Sum_probs=189.8
Q ss_pred cccCCCCceEEEEEEEcCC---cEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 241 KKIGKGSFGSVYYGKMKDG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
+.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975543 345667665432 234568999999999999999999999999999999999999999
Q ss_pred ChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC-Cccc
Q 008707 317 TLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHI 394 (557)
Q Consensus 317 sL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~-~~~~ 394 (557)
+|.+++.... .....+...+..++.||+.||+|||+ .+++||||||+||+++.++.++|+|||++...... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999987532 22346677788999999999999998 99999999999999999999999999988643221 1111
Q ss_pred cccccCCCCccCCcccCC-------CCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 395 SSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~-------~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..... .+.....+. +......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~-~~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIK-DQQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHh-hcccccC
Confidence 223447889999998753 245789999999999999997 5678753221 111222222 2223333
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
++.+...+. ..+.+++.+|| .+|++||+++||++.|.
T Consensus 231 ~~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 443332222 35778999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=331.92 Aligned_cols=261 Identities=22% Similarity=0.356 Sum_probs=203.1
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 456789999999999999875 58999999986532 22346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCC--------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCc
Q 008707 313 MHNGTLRDRLHGSVN--------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 384 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 384 (557)
++||+|.+++..... ....++..++.++.||++||+|||+ .|++||||||+||+++.++.++|+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999998864211 2345667788999999999999998 99999999999999999999999999999
Q ss_pred cccCCCCc-----------------cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccc
Q 008707 385 RQAEEDLT-----------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 447 (557)
Q Consensus 385 ~~~~~~~~-----------------~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~ 447 (557)
........ .......||+.|+|||.+.+..++.++|||||||++|||+||+.||...+....
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki- 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI- 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh-
Confidence 76521100 011123589999999999999999999999999999999999999974322110
Q ss_pred cHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhhhhh
Q 008707 448 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIE 514 (557)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-t~~evl~~L~~~~~~~ 514 (557)
.. ... . .++.... .....+..+.+++.+|+..||++|| +++++.+.|+......
T Consensus 240 --~~--~~~-----i---~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 240 --SY--RDV-----I---LSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred --hh--hhh-----c---cChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 00 000 0 0000000 0112334688999999999999996 7788888888877643
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=297.25 Aligned_cols=252 Identities=24% Similarity=0.356 Sum_probs=201.5
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
..|++.+.||+|+||.||+|.+. ++..+|+|.+........+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 45778899999999999999875 58899999987655556678899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 85 ~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 85 DGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred CCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence 999999998743 3568999999999999999999998 99999999999999999999999999988765432221
Q ss_pred ccccccCCCCccCCcccC-----CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 394 ISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~-----~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
.....+++.|+|||.+. ...++.++||||||+++|+|++|+.||...+.. +.... +..+......
T Consensus 160 -~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~-- 229 (280)
T cd06611 160 -RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLK-ILKSEPPTLD-- 229 (280)
T ss_pred -cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHH-HhcCCCCCcC--
Confidence 12234788999999875 345677999999999999999999999743211 11111 1112111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.+......+.+++.+||+.+|++||++.+|++.
T Consensus 230 -----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 230 -----QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -----CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 011223468899999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.36 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=200.2
Q ss_pred HHHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 345678899999999999975 4689999998865544556778899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|.+++.. ..+++.++..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++.........
T Consensus 100 ~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~- 171 (296)
T cd06655 100 GGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK- 171 (296)
T ss_pred CCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc-
Confidence 9999998863 358899999999999999999998 99999999999999999999999999998765433221
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.... ... +......... .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~-~~~~~~~~~~-------~ 237 (296)
T cd06655 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYL-IATNGTPELQ-------N 237 (296)
T ss_pred CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-HHhcCCcccC-------C
Confidence 2223578899999999988899999999999999999999999975432111 111 1111110000 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.......+.+++.+||..+|++||++.+|++
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 1122336789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=299.72 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=200.9
Q ss_pred HHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccch-hHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
..+...+.||+|+||.||+|..+ +.+.|++|.+...... ..+.+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 34456788999999999999864 2467999988654333 4567899999999999999999999999988999
Q ss_pred EEEEecCCCChhhhhhccCCC------CCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQ------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 381 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 381 (557)
+||||+++|+|.+++...... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999754321 268999999999999999999998 89999999999999999999999999
Q ss_pred cCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcC
Q 008707 382 GLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 460 (557)
Q Consensus 382 gla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 460 (557)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... .... ....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~----~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLN----RLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHH----HHHcC
Confidence 9987543222222222335778999999988888999999999999999999 88898632211 1111 11112
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 461 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 461 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
..... .....+..+.+++.+|++.+|++|||+.|+++.|.
T Consensus 235 ~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11110 01122347889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=295.20 Aligned_cols=249 Identities=33% Similarity=0.558 Sum_probs=200.7
Q ss_pred hhcccCCCCceEEEEEEEcC-----CcEEEEEEccCccch-hHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 239 FCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+.+.||.|+||.||++.+.+ +..||+|.+...... ..+.+..|+++++.++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 56889999999999998764 488999998765433 567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 83 MEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred cCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999987532 2228999999999999999999998 9999999999999999999999999999987654422
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.......+++.|+|||.+.+..++.++||||+|+++|+|++ |..||...+. ....+ .+..+.....
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~~~~------ 225 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLE----YLKKGYRLPK------ 225 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHhcCCCCCC------
Confidence 22212336789999999988889999999999999999998 7888864221 11111 1222221111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 507 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 507 (557)
....+..+.+++.+|++.+|++|||+.|+++.|
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 ---PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111344788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=307.75 Aligned_cols=253 Identities=24% Similarity=0.299 Sum_probs=195.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|..++..++|+||+++++++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456789999999999999876 57889999986421 22345578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 83 YVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred CCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 9999999999742 3568888999999999999999998 9999999999999999999999999999987654433
Q ss_pred cccccccCCCCccCCcccCC-----CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 393 HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~-----~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
.......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||...+.. +.............. .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~~-p 230 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERFQF-P 230 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCcccC-C
Confidence 33333468999999999875 46788999999999999999999999743321 111111111111100 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 506 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~ 506 (557)
+ .. ......+.+++.+|+...+++ |++++++++.
T Consensus 231 ~-~~----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 231 S-HI----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred C-cc----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 00 112346788999999866544 4688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=297.50 Aligned_cols=240 Identities=25% Similarity=0.430 Sum_probs=188.8
Q ss_pred cccCCCCceEEEEEEEcC--------CcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 241 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+.||+|+||.||+|.... ...|++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999997642 235888887655445557788999999999999999999999998899999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc--------EEEecccCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--------AKVSDFGLS 384 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~--------~kl~Dfgla 384 (557)
+++|+|.++++.. ...+++..++.++.||+.||+|||+ .+++||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999753 3468889999999999999999998 99999999999999987665 699999988
Q ss_pred cccCCCCccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCC-CCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 385 RQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 385 ~~~~~~~~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
...... ....+++.|+|||.+.+. .++.++||||||+++|+|++|. .||...+... .. ......
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~----~~~~~~-- 221 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KL----QFYEDR-- 221 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HH----HHHHcc--
Confidence 655332 223478889999999874 5789999999999999999985 5554221111 00 111110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 463 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 463 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
.. .+......+.+++.+||+.+|++|||+++|++.|+
T Consensus 222 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 HQ---------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cc---------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 11111236889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=294.56 Aligned_cols=238 Identities=26% Similarity=0.442 Sum_probs=188.8
Q ss_pred cccCCCCceEEEEEEEcCCc-----------EEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 241 KKIGKGSFGSVYYGKMKDGK-----------EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
+.||+|+||.||+|.+.+.. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999886433 5777876544332 5788899999999999999999999988 778999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC-------cEEEeccc
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-------RAKVSDFG 382 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~-------~~kl~Dfg 382 (557)
|||+++|+|.+++... ...+++..+..++.||+.||+|||+ .+++||||||+||+++.++ .++|+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999998753 2268899999999999999999998 9999999999999999887 79999999
Q ss_pred CccccCCCCccccccccCCCCccCCcccCCC--CCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhc
Q 008707 383 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKK 459 (557)
Q Consensus 383 la~~~~~~~~~~~~~~~g~~~y~aPE~l~~~--~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 459 (557)
++...... ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||...+... ...+ ...
T Consensus 154 ~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~----~~~ 221 (259)
T cd05037 154 IPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERF----YQD 221 (259)
T ss_pred cccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHH----Hhc
Confidence 98865431 123367789999999876 78999999999999999999 577776432111 1111 111
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 460 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 460 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
..... .+ ....+.+++.+||..+|.+|||+.||++.|+
T Consensus 222 ~~~~~--~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHRLP--MP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCCCC--CC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11100 00 0147889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=297.20 Aligned_cols=247 Identities=28% Similarity=0.392 Sum_probs=200.9
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
.|++.+.||.|++|.||+|... +++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 3567789999999999999876 58899999986543 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++.. ..+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 82 GGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccccc
Confidence 99999999873 378999999999999999999998 99999999999999999999999999999876543221
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....+++.|+|||.+.+..++.++||||||+++|+|+||+.||...+.. . ....+..+......+ .
T Consensus 155 -~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~-~~~~~~~~~~~~~~~-----~ 221 (274)
T cd06609 155 -RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------R-VLFLIPKNNPPSLEG-----N 221 (274)
T ss_pred -cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------H-HHHHhhhcCCCCCcc-----c
Confidence 22234788899999999988999999999999999999999999743311 1 111111221111111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..+..+.+++.+|+..+|++|||++++++
T Consensus 222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 02346889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=313.02 Aligned_cols=247 Identities=26% Similarity=0.436 Sum_probs=201.9
Q ss_pred ccCCCCceEEEEEEEcC-CcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCChhh
Q 008707 242 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 320 (557)
Q Consensus 242 ~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL~~ 320 (557)
+||+|.||+||.|++.+ ...+|||-+........+.+.+|+.+.++|+|.|||+++|.+..+++.-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 59999999999998764 56789999876666667789999999999999999999999999999999999999999999
Q ss_pred hhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC-CCCcEEEecccCccccCCCCcccccccc
Q 008707 321 RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVAR 399 (557)
Q Consensus 321 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 399 (557)
+++.....-.-.+.++-.+..||++||.|||. +.|||||||-+||||+ ..|.+||+|||-+++... ....+.++.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccccc
Confidence 99864322223777888899999999999998 9999999999999997 578899999999887643 234455677
Q ss_pred CCCCccCCcccCCC--CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHH
Q 008707 400 GTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 477 (557)
Q Consensus 400 g~~~y~aPE~l~~~--~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 477 (557)
||..|||||++..+ .|..++|||||||++.||.||++||.. .+.... ..++-|-+ ...+..+.+
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E--lgspqA------AMFkVGmy------KvHP~iPee 803 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE--LGSPQA------AMFKVGMY------KVHPPIPEE 803 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee--cCChhH------hhhhhcce------ecCCCCcHH
Confidence 99999999999765 688999999999999999999999961 111110 01111111 113445666
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 478 SIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 478 ~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
...+...+|.+|+.+||.+||+++++++-
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 77788999999999999999999999863
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=304.35 Aligned_cols=256 Identities=21% Similarity=0.303 Sum_probs=192.7
Q ss_pred hhcccCCC--CceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 239 FCKKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 239 ~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
+.++||+| +|++||++..+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 67899999765 68999999986532 233456778999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++|+|.+++.... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++++||+.+.........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999986432 3458899999999999999999998 99999999999999999999999999865433211100
Q ss_pred ------ccccccCCCCccCCcccCC--CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 394 ------ISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 394 ------~~~~~~g~~~y~aPE~l~~--~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..... ..+.....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~-----~~~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEK-----LNGTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHH-----hcCCcccc
Confidence 0112236678999999876 468899999999999999999999997432111 00000 00111000
Q ss_pred cc-------------------ccc-----------------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 466 VD-------------------PVL-----------------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 466 ~d-------------------~~l-----------------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+ ... ...........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 000 00011123347889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=297.98 Aligned_cols=250 Identities=28% Similarity=0.457 Sum_probs=196.9
Q ss_pred cccCCCCceEEEEEEEcC-------CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 241 KKIGKGSFGSVYYGKMKD-------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+++++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998653 2578999876543 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccC----CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC-----cEEEecccC
Q 008707 313 MHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-----RAKVSDFGL 383 (557)
Q Consensus 313 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~-----~~kl~Dfgl 383 (557)
+++++|.+++.... ....+++.+++.++.|++.||+|||+ .+++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999987532 22347889999999999999999998 8999999999999999877 899999999
Q ss_pred ccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCC
Q 008707 384 SRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD 461 (557)
Q Consensus 384 a~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 461 (557)
+........ .......++..|+|||.+.+..++.++||||||+++|+|+| |+.||...+.. .... .+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~----~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQ----HVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHH----HHhcCC
Confidence 876533221 11122235678999999999999999999999999999998 99999633211 1111 111111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 462 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 462 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
.. ......+..+.+++.+||..+|++||++++|++.|++
T Consensus 231 ~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 RL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 1112234578899999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=294.47 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=202.1
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.|++.+.||+|+||.||+|... +++.+++|.+........+.+.+|+++++.++||||+++++++.+....+++|||++
T Consensus 4 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred ceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 4556789999999999999875 578899999876555566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........ .
T Consensus 84 ~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~ 157 (262)
T cd06613 84 GGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K 157 (262)
T ss_pred CCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence 99999988742 3568899999999999999999998 9999999999999999999999999999876543221 1
Q ss_pred cccccCCCCccCCcccCCC---CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 395 SSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~---~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.....++..|+|||.+.+. .++.++||||||+++|+|+||+.||...+.... .. ........ .+.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~-----~~~~~~~~---~~~~- 226 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LF-----LISKSNFP---PPKL- 226 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HH-----HHHhccCC---Cccc-
Confidence 2233578899999999776 788999999999999999999999974332111 10 01111000 0000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
......+..+.+++.+|+..+|.+|||+.+|+.
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 -KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112234557899999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=294.84 Aligned_cols=247 Identities=30% Similarity=0.490 Sum_probs=198.3
Q ss_pred HHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
..+++.+.||+|+||.||++.. .++.||+|.+.... ..+.+.+|+.+++.++||||+++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4567789999999999999975 47889999886432 346788999999999999999999998764 4799999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-- 155 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-- 155 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccCC--
Confidence 99999998754 23458899999999999999999998 9999999999999999999999999999876433211
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
....+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+.. + ....+..+....
T Consensus 156 --~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~-~~~~~~~~~~~~--------- 217 (254)
T cd05083 156 --NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------E-VKECVEKGYRME--------- 217 (254)
T ss_pred --CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------H-HHHHHhCCCCCC---------
Confidence 1224568999999998899999999999999999998 99999743321 1 112222221111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
.....+..+.+++.+|++.+|++||++++|++.|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111223578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=311.01 Aligned_cols=261 Identities=22% Similarity=0.289 Sum_probs=195.2
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEec------Ce
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 305 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~------~~ 305 (557)
..|++.+.||+|+||.||++... .++.||+|++.... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 45666889999999999999765 58899999986532 23346678899999999999999999987643 35
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
.++||||+++ ++.+.+. ..+++..+..++.|+++||+|||+ +|++||||||+||+++.++.+||+|||+++
T Consensus 97 ~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred eEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccc
Confidence 6899999964 6766664 247888899999999999999998 999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccH-H--------------
Q 008707 386 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI-V-------------- 450 (557)
Q Consensus 386 ~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~-~-------------- 450 (557)
....... .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+....... .
T Consensus 168 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 168 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cCCCccc--cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 6543321 2234589999999999999999999999999999999999999985543211100 0
Q ss_pred -HHHHHHHhcCCcc-ccccccc-----c---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 451 -HWARSMIKKGDVI-SIVDPVL-----I---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 451 -~~~~~~~~~~~~~-~~~d~~l-----~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
..+.......... ....+.. . ..........+.+++.+|+..||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0011111111000 0000000 0 00111223467899999999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=290.25 Aligned_cols=258 Identities=24% Similarity=0.290 Sum_probs=207.1
Q ss_pred hHHHHHHHHhhcccCCCCceEEEEEEEcC-CcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCe
Q 008707 230 PELEEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ 305 (557)
Q Consensus 230 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 305 (557)
..+.-...++.+.||.|.-|+||++.+++ +..+|+|++.+.. .....++..|-+||+.++||.++.+|+.|+.++.
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 34445566778999999999999999875 5899999997643 2334567789999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
.|+|||||+||+|....+++ .++.+++..++.++..|+-||+|||- .|||+|||||+||||.++|++-|+||.++.
T Consensus 152 ~cl~meyCpGGdL~~LrqkQ-p~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQ-PGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred eEEEEecCCCccHHHHHhhC-CCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccc
Confidence 99999999999999888765 67789999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCC--------------------------------C-c----------------------cccccccCCCCccCCccc
Q 008707 386 QAEED--------------------------------L-T----------------------HISSVARGTVGYLDPEYY 410 (557)
Q Consensus 386 ~~~~~--------------------------------~-~----------------------~~~~~~~g~~~y~aPE~l 410 (557)
..... . . ..+....||-.|+|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 42110 0 0 001123489999999999
Q ss_pred CCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHcc
Q 008707 411 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV 490 (557)
Q Consensus 411 ~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl 490 (557)
.+...+.++|.|+|||++|||+.|..||.+.+.... +...+. +. ..+ ++. +.......+||.+.|
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l~NIv~----~~--l~F------p~~-~~vs~~akDLIr~LL 372 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--LRNIVG----QP--LKF------PEE-PEVSSAAKDLIRKLL 372 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh--HHHHhc----CC--CcC------CCC-CcchhHHHHHHHHHh
Confidence 999999999999999999999999999986654322 222111 10 001 111 134457889999999
Q ss_pred ccCCCCCCC----HHHHHHH
Q 008707 491 EQRGFSRPK----MQEIVLA 506 (557)
Q Consensus 491 ~~~P~~RPt----~~evl~~ 506 (557)
.+||++|-. +.||.+.
T Consensus 373 vKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 373 VKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred ccChhhhhccccchHHhhcC
Confidence 999999998 7887653
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=297.91 Aligned_cols=250 Identities=24% Similarity=0.401 Sum_probs=194.9
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEec------Cee
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE------HQR 306 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~------~~~ 306 (557)
..|++.+.||+|+||.||+|... +++.||+|++.... .....+..|+.++..+ +|+||+++++++... ...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL 84 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence 34566788999999999999865 58899999886543 3345788899999998 699999999998653 457
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++||||+.+++|.+++... ....+++..+..++.|++.||+|||+ ++++|+||+|+||++++++.++|+|||++..
T Consensus 85 ~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 85 WLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 8999999999999998753 24568899999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCccccccccCCCCccCCcccC-----CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 461 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~-----~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 461 (557)
...... ......|++.|+|||++. ...++.++|||||||++|||++|+.||...+... .. .......
T Consensus 161 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-----~~--~~~~~~~ 232 (272)
T cd06637 161 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----AL--FLIPRNP 232 (272)
T ss_pred cccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-----HH--HHHhcCC
Confidence 543221 223345889999999986 3457889999999999999999999996332111 00 0011111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 462 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 462 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..... ....+..+.+++.+||..+|.+|||+.||++
T Consensus 233 ~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 APRLK--------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCCC--------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11111 1122346889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=293.14 Aligned_cols=248 Identities=26% Similarity=0.399 Sum_probs=198.7
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEe-cCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~lv~e~ 312 (557)
|++.+.||+|++|.||++..+ +++.||+|.+.... ....+.+.+|++++++++|+|++++++.+.. +...+++|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 456789999999999999865 47889999886432 2345678899999999999999999998764 4467899999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++... ....+++.++..++.|++.|+++||+ .+++||||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 82 CEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred cCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 9999999998753 24568999999999999999999998 9999999999999999999999999999876643322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......+++.|+|||.+.+..++.++||||+|+++++|++|+.||...+.. ..... +..+...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~-~~~~~~~--------- 220 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYR-IIEGKLP--------- 220 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHH-HHhcCCC---------
Confidence 222345788999999999999999999999999999999999999743321 11111 1122211
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.........+.+++.+|++.+|++|||+.++++
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111223347889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=307.92 Aligned_cols=190 Identities=25% Similarity=0.341 Sum_probs=161.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
..|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++......++|||++
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence 34667899999999999999876 4678999975432 2346899999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
.++|.+++.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 140 -~~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~- 212 (357)
T PHA03209 140 -SSDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA- 212 (357)
T ss_pred -CCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCcc-
Confidence 4688888764 34568999999999999999999998 9999999999999999999999999999875432211
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 438 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf 438 (557)
.....||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 213 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 213 -FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 12345899999999999999999999999999999999865554
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=310.91 Aligned_cols=240 Identities=26% Similarity=0.303 Sum_probs=186.2
Q ss_pred cCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhhc---CCCCccceeeEEEecCeeEEEEEecCC
Q 008707 243 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI---HHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 243 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l---~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
||+|+||+||+|... +++.||+|++..... .....+..|..++... .||||+.+++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999875 589999999864321 1223455667777655 699999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+++.. ...+++..+..++.||++||+|||+ ++|+||||||+|||++.++.++|+|||++........ ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~ 153 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT 153 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence 999988873 4568999999999999999999998 9999999999999999999999999999875432221 12
Q ss_pred ccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 396 SVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...+.. + ....+..+... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~-~~~~i~~~~~~-~~~------- 218 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------Q-MYRNIAFGKVR-FPK------- 218 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------H-HHHHHHcCCCC-CCC-------
Confidence 334589999999998754 5789999999999999999999999743321 1 11122222110 000
Q ss_pred CHHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRP----KMQEIVL 505 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RP----t~~evl~ 505 (557)
......+.+++.+||..+|++|| ++.|+++
T Consensus 219 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 -NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 01223677999999999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=310.90 Aligned_cols=250 Identities=22% Similarity=0.344 Sum_probs=193.0
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|++++..++||||+++++.+.+.+..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 345688999999999999875 58899999986432 22345678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.++|+|||++........
T Consensus 83 ~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 83 LPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 999999999873 4568899999999999999999998 9999999999999999999999999999875422100
Q ss_pred ----------------------------------cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCC
Q 008707 393 ----------------------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 438 (557)
Q Consensus 393 ----------------------------------~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf 438 (557)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0011235899999999999999999999999999999999999999
Q ss_pred CCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 008707 439 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVLA 506 (557)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~evl~~ 506 (557)
...+... ............. +.+ .. .....+.+++.+++ .+|.+|++ +.|+++.
T Consensus 237 ~~~~~~~------~~~~i~~~~~~~~-~p~----~~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 237 CSETPQE------TYRKVMNWKETLV-FPP----EV--PISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCHHH------HHHHHHcCCCcee-cCC----CC--CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 7443211 1111111000000 000 00 11235677888876 49999995 5666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=294.94 Aligned_cols=250 Identities=25% Similarity=0.417 Sum_probs=198.4
Q ss_pred HhhcccCCCCceEEEEEEE-cCCcEEEEEEccCccc------hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 238 NFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
+..+.||+|++|.||+|.. .+++.||+|.+..... ...+.+.+|+++++.++|+||+++++++.+.+..++||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 3457899999999999976 4689999998864321 13467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC-cEEEecccCccccCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEE 389 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~ 389 (557)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 83 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 83 EWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred eccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999874 3568889999999999999999998 9999999999999998776 599999999877654
Q ss_pred CCcc---ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 390 DLTH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 390 ~~~~---~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
.... ......++..|+|||.+.+..++.++||||+|+++|+|++|..||...+..... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~------ 227 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIASAT------ 227 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhccC------
Confidence 3211 112234788999999998888999999999999999999999999744332211 1111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.....+......+.+++.+|+..+|++||++.|+++
T Consensus 228 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 ---TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011222334457889999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=292.95 Aligned_cols=248 Identities=25% Similarity=0.416 Sum_probs=196.8
Q ss_pred HhhcccCCCCceEEEEEEEcCCcEEEEEEccCcc------chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 238 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC------SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
...+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|+++++.++|+||+++++++.+.+..+++||
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 4568899999999999988889999999876422 1223568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 83 FVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999874 3457889999999999999999998 899999999999999999999999999987643211
Q ss_pred -----ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 392 -----THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 392 -----~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
........++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.... ... .....+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~~~---~~~~~~~~---- 227 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--MFY---IGAHRGLM---- 227 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--HHH---hhhccCCC----
Confidence 1111233478899999999998899999999999999999999999974321110 000 00000111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+.+ .......+.+++.+|++.+|++||++.|+++
T Consensus 228 -~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 228 -PRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 1122346789999999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=313.55 Aligned_cols=258 Identities=21% Similarity=0.239 Sum_probs=192.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
|.+.+.||+|+||.||+|.+. .++.||+|... ...+.+|++++++++|+||+++++++...+..++|||++ .
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~ 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-R 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-C
Confidence 455788999999999999876 47889999642 234568999999999999999999999999999999999 4
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc-cc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HI 394 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~ 394 (557)
++|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.++|+|||+++....... ..
T Consensus 244 ~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 244 SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 7888887642 3468999999999999999999998 9999999999999999999999999999976543221 11
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCC-ccccccHHHHHHHHHhcCCcc-----ccccc
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED-FGAELNIVHWARSMIKKGDVI-----SIVDP 468 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~-----~~~d~ 468 (557)
.....||+.|+|||++.+..++.++|||||||++|||++|..|+-... ..........+.+.+...... .....
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 223458999999999999999999999999999999999886643222 111111111111122211110 00000
Q ss_pred cc------------cCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 469 VL------------IGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 469 ~l------------~~~~~-------~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.+ ..... ......+.+++.+||+.||.+|||+.|+++.
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 00000 0112367899999999999999999999863
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=304.51 Aligned_cols=240 Identities=31% Similarity=0.424 Sum_probs=198.5
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCc---cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
.+.||.|+||.||.|+.. +.+.||||++.-. ..+..+++.+|+.+|++++|||++.+-|++-.+...++||||| -
T Consensus 31 LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-l 109 (948)
T KOG0577|consen 31 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-L 109 (948)
T ss_pred HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-h
Confidence 578999999999999754 6788999998643 3345678999999999999999999999999999999999999 5
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+-.|++.-. .+++.+..+..|..+.+.||+|||+ .+.+|||||+.|||+++.|.|||+|||.|.......
T Consensus 110 GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn---- 180 (948)
T KOG0577|consen 110 GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN---- 180 (948)
T ss_pred ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCchh----
Confidence 6888887653 5678899999999999999999999 999999999999999999999999999998765433
Q ss_pred ccccCCCCccCCcccC---CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 396 SVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~---~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.+.|||.|||||++. .+.|+-++||||||++..||.-.++|+-..+. ..+...+.+.+.. .+.
T Consensus 181 -sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-------MSALYHIAQNesP-----tLq- 246 (948)
T KOG0577|consen 181 -SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESP-----TLQ- 246 (948)
T ss_pred -cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-------HHHHHHHHhcCCC-----CCC-
Confidence 356999999999874 57899999999999999999999999752221 1122223333221 221
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..++...+.+++..|++.-|++|||..++++
T Consensus 247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 3466778999999999999999999988764
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=303.21 Aligned_cols=197 Identities=25% Similarity=0.388 Sum_probs=159.6
Q ss_pred hcccCCCCceEEEEEEEc---CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEe--cCeeEEEEEecC
Q 008707 240 CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEYMH 314 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~lv~e~~~ 314 (557)
..+||+|+||.||+|... ++..||+|.+.... ....+.+|+++++.++||||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 367999999999999865 35789999886532 23457789999999999999999998853 557789999985
Q ss_pred CCChhhhhhccC------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe----CCCCcEEEecccCc
Q 008707 315 NGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLS 384 (557)
Q Consensus 315 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla 384 (557)
++|.+++.... ....+++..+..++.||+.||+|||+ .+++||||||+||++ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 57777764221 22358889999999999999999998 999999999999999 45678999999999
Q ss_pred cccCCCCcc--ccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCC
Q 008707 385 RQAEEDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVED 442 (557)
Q Consensus 385 ~~~~~~~~~--~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~ 442 (557)
+........ ......+|+.|+|||.+.+ ..++.++|||||||++|||+||+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 876443221 1223457899999999876 457899999999999999999999997443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=301.52 Aligned_cols=257 Identities=27% Similarity=0.454 Sum_probs=200.4
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCc----EEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
..++..+.||+|+||.||+|.+. +|. .||+|.+..... .....+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 44455688999999999999864 343 578888765432 2344688999999999999999999998754 4679
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999998742 3458889999999999999999998 999999999999999999999999999998754
Q ss_pred CCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 389 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 389 ~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... . ...+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~~~~~- 232 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---I----PDLLEKGERLPQ- 232 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHCCCCCCC-
Confidence 32221 1112235678999999999999999999999999999998 999997432111 1 122222221110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
.......+.+++.+|+..+|++||+++++++.|.++...
T Consensus 233 --------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 233 --------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred --------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 011234688999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=292.12 Aligned_cols=246 Identities=28% Similarity=0.395 Sum_probs=197.5
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-----chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
|+..+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+++++.++|+||+++++++.++...++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 345688999999999999876 78999999875432 224467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 82 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 82 ELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999874 3458899999999999999999998 99999999999999999999999999998765433
Q ss_pred CccccccccCCCCccCCcccCCCC-CCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~-~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 469 (557)
. ......++..|++||.+.... ++.++|+||||+++|+|++|+.||..... ...............
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~----- 222 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPP----- 222 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCCC-----
Confidence 2 122344788999999987766 89999999999999999999999973321 111111111111111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+......+.+++.+|++.+|++||++.++++
T Consensus 223 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 ----IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11122346789999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=291.51 Aligned_cols=249 Identities=22% Similarity=0.356 Sum_probs=201.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||.||.+... +++.+++|.+... .....+.+.+|++++++++|+||+++++++.+.+..+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 456789999999999998754 5889999987543 2344567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 82 NGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred CCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999997542 4568899999999999999999998 8999999999999999999999999999887644332
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||...+. .+..... ..+.....
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~-~~~~~~~~-------- 221 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKI-VQGNYTPV-------- 221 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHH-HcCCCCCC--------
Confidence 12234478999999999988889999999999999999999999974321 1112221 12222111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
....+..+.+++.+|+..+|++||+++|+++.
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 11223468899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=300.48 Aligned_cols=245 Identities=25% Similarity=0.404 Sum_probs=197.2
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
...||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 457999999999999865 6899999998654444556788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccccc
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 398 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 398 (557)
.+++. ...+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++......... ....
T Consensus 106 ~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~ 177 (297)
T cd06659 106 TDIVS----QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSL 177 (297)
T ss_pred HHHHh----hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-ccce
Confidence 98875 3458899999999999999999998 99999999999999999999999999998755433221 2234
Q ss_pred cCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHH
Q 008707 399 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 478 (557)
Q Consensus 399 ~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 478 (557)
.++..|+|||.+.+..++.++||||||+++|||++|+.||...+... ... .+........ ......
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~----~~~~~~~~~~-------~~~~~~ 243 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMK----RLRDSPPPKL-------KNAHKI 243 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHhccCCCCc-------cccCCC
Confidence 57899999999998889999999999999999999999997432211 111 1111111000 001112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 479 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 479 ~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
...+.+++.+|++.+|++||+++||++.
T Consensus 244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 244 SPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 3367899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=292.15 Aligned_cols=254 Identities=22% Similarity=0.365 Sum_probs=199.8
Q ss_pred HHhhcccCCCCceEEEEEEEcC--CcEEEEEEccCc----------cchhHHHHHHHHHHHhh-cCCCCccceeeEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADS----------CSHRTQQFVTEVALLSR-IHHRNLVPLIGYCEEE 303 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~il~~-l~h~nIv~~~~~~~~~ 303 (557)
|.+.+.||+|+||.||+|.+.. ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++..+
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 4567889999999999998765 688999987532 12233457778888875 6999999999999999
Q ss_pred CeeEEEEEecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEeccc
Q 008707 304 HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 382 (557)
Q Consensus 304 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 382 (557)
+..+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEeccc
Confidence 99999999999999998875422 34568899999999999999999995 3689999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 383 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 383 la~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
++....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. .... .+..+..
T Consensus 160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~~~~-~~~~~~~ 230 (269)
T cd08528 160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------SLAT-KIVEAVY 230 (269)
T ss_pred ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------HHHH-HHhhccC
Confidence 998765432 223345788999999999888999999999999999999999999633211 1111 1111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 463 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 463 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
.... .......+.+++.+|++.+|++||++.|+..++++
T Consensus 231 ~~~~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 EPLP--------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CcCC--------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1110 11123478899999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=308.11 Aligned_cols=261 Identities=22% Similarity=0.284 Sum_probs=194.8
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEec------Ce
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 305 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~------~~ 305 (557)
..|.+.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++||||+++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 45667899999999999999865 58899999986532 23446688899999999999999999987543 35
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
.++||||++ ++|.+.+. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 104 VYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred EEEEEeCCC-CCHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 799999996 47777664 237788889999999999999998 999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHH---------HH----
Q 008707 386 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV---------HW---- 452 (557)
Q Consensus 386 ~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~---------~~---- 452 (557)
....... .....+++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+..... ++
T Consensus 175 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCCCCc--ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 6543321 22345899999999999999999999999999999999999999755432111000 00
Q ss_pred ---HHHHHhcCCccccc-----cccc-c---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 453 ---ARSMIKKGDVISIV-----DPVL-I---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 453 ---~~~~~~~~~~~~~~-----d~~l-~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+............. .+.. . ..........+.+++.+|++.||.+|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00001110000000 0000 0 00111123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=297.00 Aligned_cols=246 Identities=22% Similarity=0.353 Sum_probs=205.0
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
-|.+.+.||+|.|++|-+|++- +|+.||||++.+.. ......+.+|++.|+.++|||||++|++...+...|+|+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3556689999999999999754 79999999997643 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe-CCCCcEEEecccCccccCCCC
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll-~~~~~~kl~Dfgla~~~~~~~ 391 (557)
-.+|+|.|+|-.. ...+.+....+++.||+.|+.|+|+ ..+|||||||+||.+ ..-|-+||.|||++..+....
T Consensus 99 GD~GDl~DyImKH--e~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKH--EEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred cCCchHHHHHHhh--hccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999999764 5678999999999999999999998 999999999999877 456889999999998776543
Q ss_pred ccccccccCCCCccCCcccCCCCCC-cccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s-~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
. -.+.+|...|-|||++.+..|. ++.||||||+|||.|++|+.||+..++.+.... ++|...
T Consensus 174 k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImDCKY 236 (864)
T KOG4717|consen 174 K--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMDCKY 236 (864)
T ss_pred h--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhcccc
Confidence 3 3356799999999999998875 689999999999999999999985554433221 122111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..+.....+..++|..|+..||++|-+.+||..
T Consensus 237 --tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 --TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 123445568899999999999999999999864
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=329.63 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=195.5
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEe--cCeeEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRIL 308 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~l 308 (557)
...|.+.+.||+|+||+||+|.+. .+..||+|.+... .......+..|+.+++.++||||++++++|.+ ....++
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 345677899999999999999876 4678899987643 23345678899999999999999999998854 456899
Q ss_pred EEEecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCC----CCCeEeeccCCCCEEeCC-----------
Q 008707 309 VYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC----NPGIIHRDVKSSNILLDI----------- 372 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~----~~~ivH~dlk~~NIll~~----------- 372 (557)
||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+.. ..+|+||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 999999999999987532 2356899999999999999999999721 135999999999999964
Q ss_pred ------CCcEEEecccCccccCCCCccccccccCCCCccCCcccCC--CCCCcccceehhHHHHHHHHhCCCCCCCCCcc
Q 008707 373 ------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 444 (557)
Q Consensus 373 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~--~~~s~~~DvwslG~ll~elltg~~pf~~~~~~ 444 (557)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|+||+.||...+.
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~- 248 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN- 248 (1021)
T ss_pred ccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-
Confidence 23489999999986543221 223458999999999854 4578999999999999999999999973321
Q ss_pred ccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 445 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..+ +...+..+..... . ..+..+.++|.+||..+|.+||++.|+++
T Consensus 249 ----~~q-li~~lk~~p~lpi------~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 ----FSQ-LISELKRGPDLPI------K----GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred ----HHH-HHHHHhcCCCCCc------C----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 111 1122222211100 1 11346889999999999999999999984
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=291.86 Aligned_cols=248 Identities=27% Similarity=0.395 Sum_probs=200.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||.||++... +|+.||+|.+... .....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 456789999999999999765 6889999988642 2334467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
.+++|.+.+... ....+++..+..++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 157 (256)
T cd08218 82 EGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL 157 (256)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence 999999988743 23457889999999999999999998 99999999999999999999999999999766443221
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....|++.|+|||.+.+..++.++|+||||+++++|++|+.||...+. .+.+.... .+....
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-~~~~~~--------- 220 (256)
T cd08218 158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKII-RGSYPP--------- 220 (256)
T ss_pred -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHh-cCCCCC---------
Confidence 1223478899999999988899999999999999999999999974322 11222221 121111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
........+.+++.+|++.+|++||++.||++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11123447889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=297.72 Aligned_cols=245 Identities=27% Similarity=0.395 Sum_probs=197.0
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
...||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 467999999999999865 5889999998655455566788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccccc
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 398 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 398 (557)
.+++. ...+++..+..++.||+.||+|||+ .+++||||||+||++++++.++|+|||++......... ....
T Consensus 107 ~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~ 178 (292)
T cd06658 107 TDIVT----HTRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSL 178 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Ccee
Confidence 99885 2457889999999999999999998 89999999999999999999999999998765432221 1223
Q ss_pred cCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHH
Q 008707 399 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 478 (557)
Q Consensus 399 ~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 478 (557)
.++..|+|||.+.+..++.++||||||+++|||++|+.||...+... ... .+... +.+.+.. ....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~----~~~~~-----~~~~~~~--~~~~ 244 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMR----RIRDN-----LPPRVKD--SHKV 244 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhc-----CCCcccc--cccc
Confidence 47889999999988889999999999999999999999997432211 111 11111 0111110 1112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 479 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 479 ~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
...+.+++.+|+..+|++|||++|+++.
T Consensus 245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 245 SSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 3367899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=292.91 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=201.6
Q ss_pred HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhc--CCCCccceeeEEEec----CeeEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEE----HQRILVY 310 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l--~h~nIv~~~~~~~~~----~~~~lv~ 310 (557)
..+.+.||+|.||.||+|.|+ |+.||||++.. .+.+.+.+|.+|++.+ +|+||+.|++.-..+ ..++||+
T Consensus 213 I~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 213 IVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred eEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 345789999999999999998 99999999974 3456788899999876 999999999875433 2578999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHc-----CCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT-----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~-----~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
+|.+.|+|.|+|. ..+++....++++..+|.||+|||. .-+..|.|||||..||||..++.+.|+|+|+|.
T Consensus 289 dYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv 364 (513)
T KOG2052|consen 289 DYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 364 (513)
T ss_pred ecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence 9999999999996 4679999999999999999999995 235789999999999999999999999999998
Q ss_pred ccCCCC---ccccccccCCCCccCCcccCCCC------CCcccceehhHHHHHHHHhC----------CCCCCCCCcccc
Q 008707 386 QAEEDL---THISSVARGTVGYLDPEYYGNQQ------LTEKSDVYSFGVVLLELISG----------KKPVSVEDFGAE 446 (557)
Q Consensus 386 ~~~~~~---~~~~~~~~g~~~y~aPE~l~~~~------~s~~~DvwslG~ll~elltg----------~~pf~~~~~~~~ 446 (557)
...... ........||.+|||||++...- .-..+||||||.|+||+... +.||-+.-. ..
T Consensus 365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp-~D 443 (513)
T KOG2052|consen 365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP-SD 443 (513)
T ss_pred EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC-CC
Confidence 875542 22234567999999999996541 22378999999999999742 355532111 11
Q ss_pred ccHHHHHHHHHhcCCcccccccccc-CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 447 LNIVHWARSMIKKGDVISIVDPVLI-GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
.+..+ .++.+ -.+-+.|.+. .....+....+.+++..||..+|..|-|+--|.+.|.++.+.++
T Consensus 444 Ps~ee-MrkVV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 444 PSFEE-MRKVV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred CCHHH-Hhcce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 11111 11100 0011111111 12244667789999999999999999999999999998886433
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=290.72 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=202.1
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+..++..++|||+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 456789999999999999865 57899999986432 3356778999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc-
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 393 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~- 393 (557)
+++|.+++........+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999754333568999999999999999999998 99999999999999999999999999998776543222
Q ss_pred --ccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 394 --ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 394 --~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
......++..|+|||.+... .++.++|+||||+++|+|++|+.||....... .. ....... . +.+
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~----~~~~~~~-~-----~~~ 227 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VL----MLTLQND-P-----PSL 227 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hH----HHHhcCC-C-----CCc
Confidence 12334578899999998776 78999999999999999999999997432211 11 1111111 0 011
Q ss_pred cCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 471 IGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 471 ~~~~-~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.... ....+..+.+++.+|+..+|++||+++||++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1100 1123457889999999999999999999985
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=297.68 Aligned_cols=262 Identities=22% Similarity=0.285 Sum_probs=197.0
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 456788999999999999876 58999999886432 223356789999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
+++.|..+... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 83 DHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred CccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCccc
Confidence 99888877652 3468999999999999999999998 99999999999999999999999999999876443211
Q ss_pred ccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHH-HHHHH-------HHhcCCc-c
Q 008707 394 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-HWARS-------MIKKGDV-I 463 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~-~~~~~-------~~~~~~~-~ 463 (557)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+..... ..... ....... .
T Consensus 157 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 157 -YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred -ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 122346789999999876 56788999999999999999999999754432211100 00000 0000000 0
Q ss_pred ccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 464 SIVDPVLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 464 ~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
....+....... ......+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000000 112356889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=319.13 Aligned_cols=260 Identities=20% Similarity=0.308 Sum_probs=188.9
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCC------CCccceeeEEEec-Cee
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH------RNLVPLIGYCEEE-HQR 306 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h------~nIv~~~~~~~~~-~~~ 306 (557)
..|++.+.||+|+||+||+|... .++.||||+++... ...+.+..|+++++.++| .+++.+++++... ...
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 45667889999999999999865 57889999986432 223455668888777754 4588888888764 467
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC------------
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM------------ 374 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~------------ 374 (557)
++|||++ +++|.+++.. ...+++..+..++.||+.||+|||+ +.||+||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred EEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 8999988 7889888863 4568999999999999999999996 25999999999999998765
Q ss_pred ----cEEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHH
Q 008707 375 ----RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 450 (557)
Q Consensus 375 ----~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~ 450 (557)
.+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.....
T Consensus 282 ~~~~~vkl~DfG~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDERHS----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred CCCceEEECCCCccccCccc----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 4999999987643222 22345899999999999999999999999999999999999999855432211111
Q ss_pred H---------HHHH--------HHh-cCCcccccccccc----C-C--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 451 H---------WARS--------MIK-KGDVISIVDPVLI----G-N--VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 451 ~---------~~~~--------~~~-~~~~~~~~d~~l~----~-~--~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
. |... ... .+......++... . . ........+.+++.+||+.||++|||++|+++
T Consensus 358 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 358 EKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred HHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 1 0000 000 0000000010000 0 0 00011235779999999999999999999986
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=303.11 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=192.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEec------Ce
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 305 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~------~~ 305 (557)
..|.+.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 45677899999999999999764 678999999865322 2345677899999999999999999987543 34
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
.+++++++ +++|.+++. ...+++..+..++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 95 ~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~ 166 (343)
T cd07878 95 VYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 166 (343)
T ss_pred EEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccce
Confidence 68999988 789988775 3468999999999999999999998 999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc-----
Q 008707 386 QAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK----- 459 (557)
Q Consensus 386 ~~~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----- 459 (557)
...... ....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.... ..........
T Consensus 167 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 239 (343)
T cd07878 167 QADDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ---LKRIMEVVGTPSPEV 239 (343)
T ss_pred ecCCCc----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHHhCCCCHHH
Confidence 754332 22357899999999876 5788999999999999999999999975432111 0000000000
Q ss_pred ------CCccccccccccCCCCH--------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 460 ------GDVISIVDPVLIGNVKI--------ESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 460 ------~~~~~~~d~~l~~~~~~--------~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
........ .+ ..... .....+.+++.+|+..||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQ-SL-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhh-cc-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00 00000 012246799999999999999999999964
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=298.46 Aligned_cols=260 Identities=20% Similarity=0.246 Sum_probs=199.0
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||.||+|.++ +++.||+|.+.... ....+.+.+|+++++.++|+||+++++++..++..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 456789999999999999876 58899999886432 233467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
+++.+..+.. ....+++..+..++.||+.||+|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 83 ~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 83 ERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc
Confidence 8877766554 24558899999999999999999998 99999999999999999999999999998876554332
Q ss_pred ccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc------------C
Q 008707 394 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------------G 460 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------------~ 460 (557)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+. .......... .
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ---LYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHhhhcccCc
Confidence 22334578899999999887 889999999999999999999999974432111 1001110000 0
Q ss_pred Cc-----cccccccc-cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 461 DV-----ISIVDPVL-IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 461 ~~-----~~~~d~~l-~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.. ....++.. ...++...+..+.+++.+||..+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00000000 00111122567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=292.76 Aligned_cols=247 Identities=24% Similarity=0.377 Sum_probs=191.5
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-----chhHHHHHHHHHHHhhcCCCCccceeeEEEe--cCeeEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRIL 308 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~l 308 (557)
++..+.||+|+||.||+|... +++.|++|.+.... ......+.+|+++++.++||||+++++++.+ ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 345689999999999999865 58899999875321 1234568889999999999999999998865 356789
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
++||+++++|.+++.. ...+++.....++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++....
T Consensus 84 ~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 84 FMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999874 3457888899999999999999998 999999999999999999999999999987653
Q ss_pred CCCc--cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 389 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 389 ~~~~--~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
.... .......++..|+|||.+.+..++.++||||+|+++|||++|+.||...+. ............
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~----- 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT----- 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC-----
Confidence 2111 111223478899999999998899999999999999999999999973321 111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
. ...+......+.+++ +||..+|++||+++||++
T Consensus 227 ~----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 N----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred C----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1 111222233566666 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=292.07 Aligned_cols=253 Identities=28% Similarity=0.391 Sum_probs=200.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEe--cCeeEEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYE 311 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~lv~e 311 (557)
|++.+.||.|+||.||++... +++.||+|.+... .....+.+..|+++++.++||||+++++++.. ....+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 445688999999999999764 6789999988643 23345678899999999999999999998754 456789999
Q ss_pred ecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCC--CCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 312 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
|+++++|.+++.... ....+++..++.++.|++.||+|||... +.+++|+||+|+||++++++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 999999999986532 2457899999999999999999999211 2899999999999999999999999999998765
Q ss_pred CCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
..... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+. .. ..+.+..+...
T Consensus 162 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~----~~~~~~~~~~~----- 228 (265)
T cd08217 162 HDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQ----LASKIKEGKFR----- 228 (265)
T ss_pred CCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HH----HHHHHhcCCCC-----
Confidence 44321 1223478999999999998899999999999999999999999985431 11 11222222221
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
..+...+..+.+++.+|++.+|++||++++|++.
T Consensus 229 ----~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ----RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1222334578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=292.87 Aligned_cols=248 Identities=27% Similarity=0.395 Sum_probs=200.1
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
..+++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 45567789999999999999764 68899999876432 23446788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++.. ..+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 84 LGGGSALDLLEP----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999998863 458899999999999999999998 9999999999999999999999999999876543221
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ..... .+..+...
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~-~~~~~~~~--------- 219 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLF-LIPKNNPP--------- 219 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHH-HHhcCCCC---------
Confidence 12223478899999999888889999999999999999999999963221 11111 11111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
......+..+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1112234568899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=294.62 Aligned_cols=260 Identities=23% Similarity=0.312 Sum_probs=199.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||.||+|.+. +|+.||+|++.... ......+.+|+.+++.++||||+++++++..+...++||||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 456788999999999999875 68999999986543 233467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
+++|.+++... ...+++..++.++.||++||+|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 -~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 82 -PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred -CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 99999998753 3568999999999999999999998 99999999999999999999999999998876543322
Q ss_pred ccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc------cccc
Q 008707 394 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV------ISIV 466 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 466 (557)
......++..|+|||.+.+. .++.++||||+|+++|+|++|.+||....... ........+..... .+..
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcc
Confidence 22234578899999998654 46889999999999999999988886433211 11111111110000 0000
Q ss_pred c------ccc----cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 467 D------PVL----IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 467 d------~~l----~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+ +.. ..+........+.+++.+|+..+|++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 000 00001122367889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=290.40 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=202.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
+++.+.||+|++|.||++.++ +++.||+|.+.... ....+.+.+|+++++.++||||+++++.+...+..++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 456788999999999999876 58899999886543 3445678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|.+++... ...++...+..++.|++.||+|||+ ..+++|+||+|+||++++++.++|+|||.+.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 157 (265)
T cd06605 83 GGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK- 157 (265)
T ss_pred CCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-
Confidence 99999998753 2678889999999999999999996 379999999999999999999999999998765332211
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+. ......+.+..... +.... +..
T Consensus 158 --~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~-----~~~-- 226 (265)
T cd06605 158 --TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND-PPDGIFELLQYIVN-EPPPR-----LPS-- 226 (265)
T ss_pred --cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc-ccccHHHHHHHHhc-CCCCC-----CCh--
Confidence 14578899999999999999999999999999999999999974322 11222222222221 11111 100
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
......+.+++.+|+..+|++|||+.|++.
T Consensus 227 -~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 -GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 113446889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=298.21 Aligned_cols=262 Identities=23% Similarity=0.327 Sum_probs=196.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 456789999999999999886 589999998764322 23456888999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|..+... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 83 ~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 83 DHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred CccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccc
Confidence 99988887653 3458999999999999999999998 89999999999999999999999999998765433221
Q ss_pred ccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccc-cHHHHHH-------HHHhcCCcc-
Q 008707 394 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-NIVHWAR-------SMIKKGDVI- 463 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~-~~~~~~~-------~~~~~~~~~- 463 (557)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. .+..+.. .........
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 157 -YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred -cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 222347889999999865 45778999999999999999999999744321100 0000000 000000000
Q ss_pred ccccccccC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 464 SIVDPVLIG-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 464 ~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
....+.... ......+..+.+++.+||+.+|++||++++|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000 001123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=295.30 Aligned_cols=253 Identities=26% Similarity=0.368 Sum_probs=194.3
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEE-----ecCeeE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCE-----EEHQRI 307 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~-----~~~~~~ 307 (557)
..|++.+.||+|+||.||++... +++.+|+|++.... .....+.+|+.+++.+ +||||+++++++. .++..+
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 96 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLW 96 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEE
Confidence 34566789999999999999775 57899999876432 2335678899999999 6999999999874 345689
Q ss_pred EEEEecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 308 LVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
+||||+++++|.+++.... ....+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++|+|||++..
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~ 173 (286)
T cd06638 97 LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ 173 (286)
T ss_pred EEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceee
Confidence 9999999999999876422 34568888999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCccccccccCCCCccCCcccCC-----CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 461 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~-----~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 461 (557)
...... ......|++.|+|||.+.. ..++.++||||+||++|+|++|+.||....... . ... ...+.
T Consensus 174 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----~-~~~-~~~~~ 245 (286)
T cd06638 174 LTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----A-LFK-IPRNP 245 (286)
T ss_pred cccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----H-Hhh-ccccC
Confidence 543221 1223358899999999853 457889999999999999999999997432111 0 011 11111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 462 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 462 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.....++. .....+.+++.+||+.+|++|||+.||++.
T Consensus 246 ~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 PPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 11111111 112368899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=289.17 Aligned_cols=250 Identities=29% Similarity=0.430 Sum_probs=199.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|+..+.||+|+||.||+|... +++.|++|.+..... ...+.+.+|+++++.++|+||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 445688999999999999865 688999999875433 35678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 82 SGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999873 3457888899999999999999998 99999999999999999999999999998876543322
Q ss_pred ccc---cccCCCCccCCcccCCCC---CCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 394 ISS---VARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 394 ~~~---~~~g~~~y~aPE~l~~~~---~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
... ...+++.|+|||.+.+.. ++.++||||||+++|++++|+.||...+.. ..... .+..+......+
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~----~~~~~~~~~~~~ 229 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMF----HVGAGHKPPIPD 229 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHH----HHhcCCCCCCCc
Confidence 211 245788999999998766 889999999999999999999999743311 11111 111111111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.......+.+++.+|++.+|++|||+.|++.
T Consensus 230 -------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 -------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0112346779999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=308.24 Aligned_cols=242 Identities=27% Similarity=0.466 Sum_probs=195.1
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEcc--C--ccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCe--eEEEE
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA--D--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ--RILVY 310 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~--~--~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~--~~lv~ 310 (557)
+|..+||+|+|-+||+|.+. +|.+||--.++ . ......++|..|+.+|+.|+||||+++|.++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 35678999999999999765 47777754332 1 123445789999999999999999999999987655 67899
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC-CCcEEEecccCccccCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~ 389 (557)
|.+..|+|..++++ .+..+.+.+..|++||++||.|||+. +.+|+|||||.+||||+. .|.|||+|+|+|.....
T Consensus 123 EL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999985 46678889999999999999999984 689999999999999974 58899999999987754
Q ss_pred CCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC----cccc
Q 008707 390 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD----VISI 465 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~ 465 (557)
.... . ..|||.|||||.+. ..|...+||||||+.++||+|+.+||. +-.+.++.-+. +-.|- +..+
T Consensus 199 s~ak--s-vIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-----EC~n~AQIYKK-V~SGiKP~sl~kV 268 (632)
T KOG0584|consen 199 SHAK--S-VIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-----ECTNPAQIYKK-VTSGIKPAALSKV 268 (632)
T ss_pred cccc--e-eccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-----hhCCHHHHHHH-HHcCCCHHHhhcc
Confidence 4322 2 56999999999998 688999999999999999999999997 22333333222 22332 2222
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
-|| ++.++|.+|+.. ..+|||+.|+++-
T Consensus 269 ~dP------------evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 KDP------------EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred CCH------------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 233 688999999999 8999999999863
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=287.98 Aligned_cols=247 Identities=26% Similarity=0.369 Sum_probs=198.5
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+++++.++||||+++++.+..++..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 455788999999999999764 6889999988643 2334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC-cEEEecccCccccCCCCc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~ 392 (557)
++++|.+++... ....+++..+..++.|+++||+|||+ ++++|+||+|+||++++++ .++|+|||++........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 82 PGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 999999999753 24458899999999999999999998 9999999999999998654 589999999987654322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ..+.... .+......
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~-~~~~~~~~------ 222 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIM-SGTFAPIS------ 222 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHH-hcCCCCCC------
Confidence 12234788999999999888899999999999999999999999744321 1111111 11111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
......+.+++.+||+.+|++|||+.|+++
T Consensus 223 ---~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 ---DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ---CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 112346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=299.43 Aligned_cols=250 Identities=26% Similarity=0.333 Sum_probs=198.0
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++.+.+.+..++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 445688999999999999876 489999999865432 2445788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+.+++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++........
T Consensus 83 ~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 83 CPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred cCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999999998743 34568999999999999999999998 9999999999999999999999999999875432211
Q ss_pred c----------------------------ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcc
Q 008707 393 H----------------------------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG 444 (557)
Q Consensus 393 ~----------------------------~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~ 444 (557)
. ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 011234788999999999988999999999999999999999999744322
Q ss_pred ccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 008707 445 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK----MQEIVL 505 (557)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt----~~evl~ 505 (557)
.. . ..... .... . ......+..+.+++.+|+..+|++||+ ++|+++
T Consensus 239 ~~--~----~~~~~-~~~~------~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 ET--F----SNILK-KEVT------F--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HH--H----HHHhc-CCcc------C--CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 11 1 11111 1110 0 001113457899999999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=291.60 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=196.5
Q ss_pred HhhcccCCCCceEEEEEEEc----CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecC------e
Q 008707 238 NFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------Q 305 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~------~ 305 (557)
.+.+.||+|+||.||+|.+. +++.||+|++.... ....+++.+|+++++.++||||+++++++.... .
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 81 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPI 81 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccc
Confidence 35678999999999999764 36889999886542 334567889999999999999999999876532 2
Q ss_pred eEEEEEecCCCChhhhhhccC---CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEeccc
Q 008707 306 RILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 382 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 382 (557)
.++++||+.+|+|.+++.... ....+++.....++.|++.||+|||+ .+++||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 158 (273)
T cd05074 82 PMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFG 158 (273)
T ss_pred eEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECccc
Confidence 478899999999988775321 22357888999999999999999998 899999999999999999999999999
Q ss_pred CccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcC
Q 008707 383 LSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKG 460 (557)
Q Consensus 383 la~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 460 (557)
+++........ ......+++.|++||.+.+..++.++||||||+++|+|++ |+.||...+.. .... .+..+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~----~~~~~ 231 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYN----YLIKG 231 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHH----HHHcC
Confidence 98865432211 1122235678999999998889999999999999999999 88998733221 1111 11111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 461 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 461 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
.... .....+..+.+++.+|++.+|++||++.|+++.|+++
T Consensus 232 ~~~~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLK---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 0112234788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=286.73 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=208.2
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
....+.++||+|+||.||+|.++ .|+.+|+|.+.. ..+.+++.+|+.++++.+.|++|++||.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34556789999999999999876 599999998764 456788999999999999999999999888888899999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
..|++.|+++.. .+++.+..+..+++..+.||+|||- ..-+|||||+.|||++.+|.+||+|||.|....+....
T Consensus 111 GAGSiSDI~R~R--~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK 185 (502)
T KOG0574|consen 111 GAGSISDIMRAR--RKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK 185 (502)
T ss_pred CCCcHHHHHHHh--cCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh
Confidence 999999999863 6789999999999999999999997 88899999999999999999999999999887665444
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
. .+..|||.|||||++..-.|..++||||||+...||..|++||.+-..-.... . +....-|.+ .
T Consensus 186 R-NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF-------M-----IPT~PPPTF--~ 250 (502)
T KOG0574|consen 186 R-NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF-------M-----IPTKPPPTF--K 250 (502)
T ss_pred h-CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE-------e-----ccCCCCCCC--C
Confidence 3 34569999999999999999999999999999999999999997322100000 0 000011111 2
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.+..+..++-+++.+|+-..|++|-|+.++++.
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 345667789999999999999999999988763
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=295.42 Aligned_cols=242 Identities=26% Similarity=0.362 Sum_probs=197.9
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||++.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 456789999999999999876 58999999986432 23346688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++.. ...++...+..++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 83 VPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999874 3568999999999999999999998 99999999999999999999999999998876543
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...+.. . ....+..+...
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~--------- 216 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------Q-IYEKILEGKVR--------- 216 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHhcCCcc---------
Confidence 22335789999999998888899999999999999999999999744311 1 11111122110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 505 (557)
.+......+.+++.+||..+|.+|| +++|+++
T Consensus 217 -~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 -FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1111234788999999999999999 7777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=296.40 Aligned_cols=260 Identities=22% Similarity=0.281 Sum_probs=193.3
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+++++.++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 455688999999999999875 58899999886432 122356778999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
. ++|.+++... ...+++..++.++.||++||+|||+ .+++||||||+||+++.++.++|+|||++.........
T Consensus 82 ~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 155 (284)
T cd07839 82 D-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC 155 (284)
T ss_pred C-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC
Confidence 6 5787777542 4568999999999999999999998 99999999999999999999999999998765432221
Q ss_pred ccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC------ccccc
Q 008707 394 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD------VISIV 466 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 466 (557)
.....+++.|+|||.+.+. .++.++||||||+++|+|+||+.|+....... .............. .....
T Consensus 156 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 156 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred -cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhcc
Confidence 1223468899999998764 46889999999999999999999864222111 11111111110000 00000
Q ss_pred cccccC---------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 467 DPVLIG---------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 467 d~~l~~---------~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+..... .........+.+++.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 011122357789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=294.14 Aligned_cols=250 Identities=25% Similarity=0.377 Sum_probs=200.9
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
..|.+.+.||+|+||.||++... +++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 45667889999999999999754 68899999986544445567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++.. ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 99999999863 357888999999999999999998 99999999999999999999999999988765433221
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....+++.|+|||.+....++.++||||||+++|++++|+.||...+....... .. .+... .. .
T Consensus 172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~-~~~~~-----~~--~ 236 (293)
T cd06647 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IA-TNGTP-----EL--Q 236 (293)
T ss_pred -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hh-cCCCC-----CC--C
Confidence 1223478899999999888889999999999999999999999974432111100 00 00000 00 0
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
........+.+++.+||..+|++||++.++++.
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111233468899999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=291.24 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=194.9
Q ss_pred hhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc----------hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 239 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS----------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
..+.||+|+||.||+|... +|+.||+|.++.... ...+.+.+|+++++.++||||+++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 4578999999999999764 588999998753211 11246788999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+||||+++++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~ 158 (272)
T cd06629 85 IFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKS 158 (272)
T ss_pred EEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence 99999999999999874 3568888999999999999999998 89999999999999999999999999998765
Q ss_pred CCCCcc-ccccccCCCCccCCcccCCCC--CCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 388 EEDLTH-ISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 388 ~~~~~~-~~~~~~g~~~y~aPE~l~~~~--~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
...... ......++..|+|||.+.... ++.++|+||||+++|++++|..||...+.. .......... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~-~~~ 231 (272)
T cd06629 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AAMFKLGNKR-SAP 231 (272)
T ss_pred cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HHHHHhhccc-cCC
Confidence 432211 122334788999999987654 788999999999999999999999632211 1111111111 111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+.. ......+..+.+++.+|+..+|++|||+++|++
T Consensus 232 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 232 PIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111 111223457889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=292.52 Aligned_cols=250 Identities=25% Similarity=0.415 Sum_probs=193.8
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEe------cCee
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQR 306 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~------~~~~ 306 (557)
..|++.+.||+|+||.||+|... +++.+|+|++.... .....+..|+.+++++ +|+||+++++++.. ....
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 45667789999999999999874 58899999875432 3345688899999998 69999999998853 4578
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
+++|||+++|+|.+++.... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++..
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 99999999999999887532 3457888889999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCccccccccCCCCccCCcccC-----CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 461 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~-----~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 461 (557)
...... ......|++.|+|||.+. ...++.++||||||+++|+|++|+.||......... .. +....
T Consensus 171 ~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~------~~-~~~~~ 242 (282)
T cd06636 171 LDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL------FL-IPRNP 242 (282)
T ss_pred hhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh------hh-HhhCC
Confidence 532211 122344788999999885 346788999999999999999999999633211110 00 00000
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 462 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 462 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
. +.. .....+..+.+++.+||+.+|.+|||+.||++
T Consensus 243 ~-----~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 243 P-----PKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred C-----CCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000 01123347889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=288.88 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=192.5
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-----chhHHHHHHHHHHHhhcCCCCccceeeEEEec--CeeEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 308 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~~l 308 (557)
+++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 345689999999999999875 58999999875321 12345788899999999999999999988763 46789
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
+|||+++++|.+++.. ...+++.....++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 84 FMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 9999999999999873 3457888889999999999999998 999999999999999999999999999987653
Q ss_pred CCCc--cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 389 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 389 ~~~~--~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
.... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.. .. .........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~~~~----- 226 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-----AA-IFKIATQPT----- 226 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-----HH-HHHHhcCCC-----
Confidence 2211 1112234788999999998888999999999999999999999999733211 11 111111110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
....+......+.+++.+|+. +|++||+++||++
T Consensus 227 ----~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 ----NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ----CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 111223344567889999985 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=290.14 Aligned_cols=257 Identities=26% Similarity=0.324 Sum_probs=198.4
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEe--cCeeEEEEEec
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEYM 313 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~lv~e~~ 313 (557)
++.+.||.|++|.||++... +++.+|+|.+..... .....+.+|+++++.++||||+++++++.+ .+..++||||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 45688999999999999875 588999998865432 345678999999999999999999998865 34689999999
Q ss_pred CCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 314 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 314 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
++++|.+++.... ....++...+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 9999998875422 34567888999999999999999998 9999999999999999999999999999876543221
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... .....+.... +.........+. .
T Consensus 161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~-~-- 232 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP-PLGPIELLSY-IVNMPNPELKDE-P-- 232 (287)
T ss_pred ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC-CCChHHHHHH-HhcCCchhhccC-C--
Confidence 1234688999999999999999999999999999999999999854321 1111121111 111111111110 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.........+.+++.+|+..+|++|||+.||++
T Consensus 233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 001123457889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=294.94 Aligned_cols=259 Identities=20% Similarity=0.239 Sum_probs=196.5
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccch-----hHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
|++.+.||+|+||.||+|... +++.||+|.+...... ....+..|+++++.++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 345678999999999999875 5899999998654322 2345778999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+ +++|.+++... ...+++..+..++.||++||+|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 82 EFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred ccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 999 89999999743 2368999999999999999999998 99999999999999999999999999999876543
Q ss_pred CccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---------
Q 008707 391 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--------- 460 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------- 460 (557)
... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||......+. +.. ........
T Consensus 156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGK-IFEALGTPTEENWPGVT 231 (298)
T ss_pred Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHH-HHHHcCCCchhhhhhcc
Confidence 221 122235788999998854 4678899999999999999999888864432111 111 11110000
Q ss_pred CccccccccccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 461 DVISIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 461 ~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
............. ........+.+++.+||+.+|++|||++||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000000000001 11223457889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=293.50 Aligned_cols=253 Identities=23% Similarity=0.291 Sum_probs=197.3
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+++++.++||||+++++.+..++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 345688999999999999876 47899999886542 22345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||+++.......
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 83 VEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999974 3568899999999999999999998 9999999999999999999999999998864211100
Q ss_pred --------------cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh
Q 008707 393 --------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 458 (557)
Q Consensus 393 --------------~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 458 (557)
.......++..|+|||.+.+..++.++|+||||+++|||++|..||.+.+. .+.... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~------~~~~~~-~~ 229 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP------EELFGQ-VI 229 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-HH
Confidence 011123468889999999888899999999999999999999999974321 111111 11
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 008707 459 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509 (557)
Q Consensus 459 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~ 509 (557)
.+... .+.. ....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 230 ~~~~~---~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 230 SDDIE---WPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred hcccC---CCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11111 0100 01223468899999999999999997666665555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=289.64 Aligned_cols=246 Identities=26% Similarity=0.329 Sum_probs=200.0
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||.|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++.+.+....++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 456789999999999999876 58999999886432 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+.+++|.+++.. ...+++..+..++.|+++||.|||+ .+++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 82 LLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred CCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc
Confidence 999999999874 3578899999999999999999998 9999999999999999999999999999887644321
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+.. ...+........ ..
T Consensus 156 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~----------~~ 219 (258)
T cd05578 156 --TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQETA----------DV 219 (258)
T ss_pred --ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhccc----------cc
Confidence 22344788999999999888999999999999999999999999854432 111111111110 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKM--QEIV 504 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~--~evl 504 (557)
..+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1122234678899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=292.78 Aligned_cols=260 Identities=20% Similarity=0.232 Sum_probs=196.4
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEec--CeeEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 310 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~~lv~ 310 (557)
.|++.+.||+|+||.||+|.++ +++.+++|.++.... .....+.+|++++++++||||+++++++... ...++||
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 4667899999999999999876 588999998864322 2234567899999999999999999998877 8899999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+. ++|.+++... ...+++..+..++.||+.||+|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 86 e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 86 EYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred hhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 9996 5898888643 3468999999999999999999998 99999999999999999999999999998876543
Q ss_pred CccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh-----------
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK----------- 458 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~----------- 458 (557)
... .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||......... ..+.....
T Consensus 160 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 160 LKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL---NKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred ccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchHHHHHhh
Confidence 221 1223468889999998754 4688999999999999999999999754322111 00000000
Q ss_pred ------cCCccccccccccCCCCHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 459 ------KGDVISIVDPVLIGNVKIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 459 ------~~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
...........+...+... ....+.+++.+|++.+|++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000000111111111 2456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=294.29 Aligned_cols=261 Identities=22% Similarity=0.319 Sum_probs=193.2
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
.|++.+.||+|++|.||+|..+ +++.||+|.+..... .....+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus 6 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (291)
T cd07844 6 TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL 85 (291)
T ss_pred ceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecC
Confidence 3456789999999999999876 689999999864322 22345678999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
. ++|.+++... ...+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 86 ~-~~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 86 D-TDLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred C-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc
Confidence 7 5899888643 3468899999999999999999998 99999999999999999999999999998754322111
Q ss_pred ccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc----------
Q 008707 394 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV---------- 462 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---------- 462 (557)
.....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........ ..............
T Consensus 160 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 160 -YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred -ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhhcc
Confidence 112236788999998865 4578899999999999999999999974431110 00000010000000
Q ss_pred --cc----ccc-ccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 463 --IS----IVD-PVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 463 --~~----~~d-~~l~~~~-~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.. ... ..+.... .......+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 000 0000000 0011146789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=287.78 Aligned_cols=244 Identities=25% Similarity=0.374 Sum_probs=197.1
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
.+.||+|++|.||++... +++.+++|.+........+.+.+|+.+++.++||||+++++++...+..++++||+++++|
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L 103 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCH
Confidence 478999999999999864 6889999988654444556788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccccc
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 398 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 398 (557)
.+++.. ..+++..+..++.|++.||+|||+ ++++||||+|+||+++.++.++|+|||.+........ .....
T Consensus 104 ~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 175 (285)
T cd06648 104 TDIVTH----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSL 175 (285)
T ss_pred HHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccc
Confidence 999873 458889999999999999999998 9999999999999999999999999998875543221 12233
Q ss_pred cCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHH
Q 008707 399 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 478 (557)
Q Consensus 399 ~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 478 (557)
.|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+. ...... +..+....... ....
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~-~~~~~~~~~~~-------~~~~ 241 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKR-IRDNLPPKLKN-------LHKV 241 (285)
T ss_pred cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHH-HHhcCCCCCcc-------cccC
Confidence 478899999999888899999999999999999999999964321 111111 11111111100 1112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 479 IWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 479 ~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+..+.+++.+||+.+|++||++.++++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 347889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=289.08 Aligned_cols=246 Identities=27% Similarity=0.422 Sum_probs=197.0
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc-cchhHHHHHHHHHHHhhcC---CCCccceeeEEEecCeeEEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~---h~nIv~~~~~~~~~~~~~lv~e 311 (557)
|++.+.||+|+||.||+|.+. +++.||+|.+... .....+.+.+|+++++.++ |||++++++++..+...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 456788999999999999864 6899999988653 2344567889999999996 9999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++++|.+++.. ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 83 YAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred cCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 9999999998863 368899999999999999999998 999999999999999999999999999998765433
Q ss_pred ccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
.. .....|+..|+|||.+.+. .++.++|+||||+++|+|++|..||........ . ..+..... +.+
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~-~~~~~~~~-----~~~ 222 (277)
T cd06917 156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------M-MLIPKSKP-----PRL 222 (277)
T ss_pred cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------h-hccccCCC-----CCC
Confidence 22 2233588899999988654 568899999999999999999999974322111 0 01111101 111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..+ ..+..+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 13347889999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=289.10 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=200.9
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.|++.+.||+|++|.||+|.++ +++.|++|++..... ..+.+.+|+++++.++|+||+++++.+...+..++|+||++
T Consensus 20 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred cchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 3556688999999999999887 688999999875443 45678899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 99 ~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 172 (286)
T cd06614 99 GGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-K 172 (286)
T ss_pred CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-h
Confidence 999999998532 378999999999999999999998 9999999999999999999999999998876543221 1
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
.....++..|++||.+.+..++.++|+||||+++|+|++|+.||...+... ...... ........+
T Consensus 173 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~~~~~-~~~~~~~~~------- 238 (286)
T cd06614 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------ALFLIT-TKGIPPLKN------- 238 (286)
T ss_pred hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hcCCCCCcc-------
Confidence 122347889999999988889999999999999999999999997432211 111111 111111100
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
....+..+.+++.+|++.+|.+||++.+|++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1113457889999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=285.66 Aligned_cols=251 Identities=29% Similarity=0.403 Sum_probs=203.6
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
+++.+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++..++|+||+++++++...+..++||||++
T Consensus 3 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred ceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 345789999999999999877 489999999876543 446789999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|.+++.. ...+++..+..++.|+++|++|||+ ..+++|+||+|+||+++.++.++|+|||.+..........
T Consensus 83 ~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 157 (264)
T cd06623 83 GGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157 (264)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence 9999999974 3668999999999999999999995 2899999999999999999999999999988764433221
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
....++..|+|||.+.+..++.++|+||||+++|+|+||+.||....... ..+...... .+.... .
T Consensus 158 -~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~-~~~~~~---------~ 223 (264)
T cd06623 158 -NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFELMQAIC-DGPPPS---------L 223 (264)
T ss_pred -cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHHHHHHh-cCCCCC---------C
Confidence 22347889999999999999999999999999999999999997443211 112111111 111111 1
Q ss_pred CHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 475 KIE-SIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 475 ~~~-~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
... .+..+.+++.+|+..+|++||++.|+++.
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111 34578899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=292.42 Aligned_cols=258 Identities=21% Similarity=0.294 Sum_probs=193.4
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
+..+.||.|++|.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 45688999999999999875 58899999886432 2233568899999999999999999999999999999999995
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
++|.+++... ....+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 83 -~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 156 (284)
T cd07860 83 -QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT- 156 (284)
T ss_pred -cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccc-
Confidence 6888888643 34568999999999999999999998 99999999999999999999999999998765432211
Q ss_pred cccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC-------------
Q 008707 395 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG------------- 460 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------------- 460 (557)
.....+++.|+|||.+.+. .++.++||||||+++|+|+||+.||...+... ...+... .....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFR-TLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHH-HhCCCChhhhhhhhHHHH
Confidence 1222367889999988664 45889999999999999999999997443211 1111110 00000
Q ss_pred ---CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 461 ---DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 461 ---~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.........+ ..........+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 0000112235779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=285.24 Aligned_cols=242 Identities=25% Similarity=0.340 Sum_probs=195.3
Q ss_pred cCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 243 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 243 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
||.|++|.||++... +++.||+|++.... ....+.+.+|+++++.++||||+++++.+.++...+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999876 48899999986532 23346788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccccc
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 398 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 398 (557)
.+++.. ...++...+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 999974 3458899999999999999999998 999999999999999999999999999998765432 12223
Q ss_pred cCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHH
Q 008707 399 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 478 (557)
Q Consensus 399 ~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 478 (557)
.+++.|++||.+.+..++.++|+||+|+++|+|++|+.||...+.. .......... +.. ...++...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~-~~~--------~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILK-GNG--------KLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhc-cCC--------CCCCCccc
Confidence 4788999999998888999999999999999999999999744321 1111111111 110 01111122
Q ss_pred HHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 008707 479 IWRIAEVAIQCVEQRGFSRPK-----MQEIVL 505 (557)
Q Consensus 479 ~~~l~~li~~cl~~~P~~RPt-----~~evl~ 505 (557)
...+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 457899999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=283.03 Aligned_cols=247 Identities=30% Similarity=0.486 Sum_probs=201.8
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
...+.||+|++|.||++... +++.+++|++........+.+.+|+++++.++|+||+++++++..+...++++||++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 45688999999999999876 68899999987655445678999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccc
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 396 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 396 (557)
+|.+++... ...+++..+..++.|++.||++||+ .+++||||+|+||++++++.++|+|||.+........ ..
T Consensus 83 ~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 83 SLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred cHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 999998753 2578999999999999999999998 9999999999999999999999999999887654432 23
Q ss_pred cccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCH
Q 008707 397 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 476 (557)
Q Consensus 397 ~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 476 (557)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+... .... ..........++ .
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~~~~~-------~ 221 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK------ALFK-IATNGPPGLRNP-------E 221 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH------HHHH-HHhcCCCCcCcc-------c
Confidence 3457889999999988889999999999999999999999997432111 1111 111111111111 1
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 477 ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 477 ~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.....+.+++.+|++.+|++|||+.|+++
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11347889999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=288.51 Aligned_cols=252 Identities=28% Similarity=0.405 Sum_probs=196.8
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEecC------ee
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH------QR 306 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~------~~ 306 (557)
..|++.+.||+|++|.||+|..+ +++.+++|++..... ..+.+.+|+++++++ .|+||+++++++.... ..
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 45667899999999999999875 578899998865433 346788999999999 6999999999986544 48
Q ss_pred EEEEEecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 307 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
++||||+++++|.+++.... ....+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 99999999999999886532 24578999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCCccccccccCCCCccCCcccCC-----CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 008707 386 QAEEDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 460 (557)
Q Consensus 386 ~~~~~~~~~~~~~~g~~~y~aPE~l~~-----~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 460 (557)
........ .....++..|+|||.+.. ..++.++||||||+++|+|++|+.||...... ..+ .. +..+
T Consensus 162 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~----~~-~~~~ 233 (275)
T cd06608 162 QLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RAL----FK-IPRN 233 (275)
T ss_pred ecccchhh-hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHH----HH-hhcc
Confidence 65433221 223347889999998753 34678999999999999999999999632211 111 11 1111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 461 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 461 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
...... ........+.+++.+||..||++|||+.||++
T Consensus 234 ~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 PPPTLK-------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CCCCCC-------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111110 11223457889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=290.40 Aligned_cols=254 Identities=28% Similarity=0.366 Sum_probs=194.0
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
+.+.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~ 85 (288)
T cd06616 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELM 85 (288)
T ss_pred hHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecc
Confidence 445678999999999999865 58999999886432 334567889999999996 999999999999888999999998
Q ss_pred CCCChhhhhhcc--CCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 314 HNGTLRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 314 ~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
. +++.++.... .....+++..+..++.|++.||+|||+ +.+++||||||+||+++.++.++|+|||++.......
T Consensus 86 ~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 86 D-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred c-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 5 4555543211 124568999999999999999999997 2599999999999999999999999999997654332
Q ss_pred ccccccccCCCCccCCcccCCC---CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~---~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
.. ....|+..|+|||.+.+. .++.++||||||+++|+|++|+.||.... ...+....... +.. +
T Consensus 163 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~~-----~ 229 (288)
T cd06616 163 AK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GDP-----P 229 (288)
T ss_pred cc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CCC-----C
Confidence 21 222478899999998776 68899999999999999999999997332 11111111111 111 1
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.+........+..+.+++.+|++.+|++|||++||++.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111112234578899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=288.80 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=191.1
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHH-HhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVAL-LSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~i-l~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
+++.+.||+|+||.||+|.+. +|+.||+|.+.... ......+..|+.+ ++.++||||+++++++..++..+++|||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 445688999999999999876 58999999986543 2333455666665 56668999999999999999999999999
Q ss_pred CCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCC-CeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 314 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 314 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
+ |+|.+++.... ....+++..++.++.|++.||+|||+ + +++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 6 68888776432 34568999999999999999999998 5 99999999999999999999999999988654322
Q ss_pred ccccccccCCCCccCCcccCC----CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 392 THISSVARGTVGYLDPEYYGN----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~----~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... .+....... +.......
T Consensus 159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~-~~~~~~~~ 230 (283)
T cd06617 159 A--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQLKQVVE-EPSPQLPA 230 (283)
T ss_pred c--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHHHHHHHh-cCCCCCCc
Confidence 1 122347889999998865 45688999999999999999999999632211 111111111 11111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
...+..+.+++.+||..+|++||++++|++
T Consensus 231 --------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 231 --------EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112346889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=302.97 Aligned_cols=267 Identities=28% Similarity=0.426 Sum_probs=204.4
Q ss_pred hhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecC------eeEEEE
Q 008707 239 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QRILVY 310 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~------~~~lv~ 310 (557)
..+.||+|+||.||+|+.+ +|+.||||.+.... ....+...+|++++++++|+|||+++++-++.. ..++||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 3578999999999999955 69999999987643 345677889999999999999999999865543 568999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC--CCCc--EEEecccCccc
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMR--AKVSDFGLSRQ 386 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~--~~~~--~kl~Dfgla~~ 386 (557)
|||.||+|...+..-.+..++++...+.+..+++.||.|||+ +||+||||||.||++- ++|. .||+|||.|+.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 999999999999988888999999999999999999999998 9999999999999994 3344 79999999999
Q ss_pred cCCCCccccccccCCCCccCCcccC-CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC--cc
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD--VI 463 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~-~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~ 463 (557)
..++.. .....||..|.+||.+. ...|+..+|.|||||++|++.||..||........-....|. .+.+.+ ..
T Consensus 174 l~d~s~--~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~--~~tkkp~~v~ 249 (732)
T KOG4250|consen 174 LDDNSL--FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWH--IITKKPSGVA 249 (732)
T ss_pred CCCCCe--eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhh--hhccCCCcee
Confidence 877652 33456999999999998 588999999999999999999999999744332211111221 111111 11
Q ss_pred cccccccc------------CCCCHHHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHhhhh
Q 008707 464 SIVDPVLI------------GNVKIESIWRIAEVAIQCVEQRGFSRP--KMQEIVLAIQDSIK 512 (557)
Q Consensus 464 ~~~d~~l~------------~~~~~~~~~~l~~li~~cl~~~P~~RP--t~~evl~~L~~~~~ 512 (557)
...++... -.........+-..+..++..+|++|- ...+.-..+.++..
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 11111000 011223334566788888899999998 66666666666655
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=295.39 Aligned_cols=264 Identities=21% Similarity=0.274 Sum_probs=194.5
Q ss_pred HHhhcccCCCCceEEEEEEEcC---CcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEec--CeeEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 308 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~~l 308 (557)
|++.+.||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 4456889999999999998754 7899999987632 33346678899999999999999999999887 78999
Q ss_pred EEEecCCCChhhhhhccC--CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC----CCcEEEeccc
Q 008707 309 VYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFG 382 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~----~~~~kl~Dfg 382 (557)
||||++ +++.+.+.... ....++...+..++.|++.||+|||+ .+++||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 999996 46777664322 22368899999999999999999998 99999999999999999 8999999999
Q ss_pred CccccCCCCc--cccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccc-------cHHHH
Q 008707 383 LSRQAEEDLT--HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-------NIVHW 452 (557)
Q Consensus 383 la~~~~~~~~--~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~-------~~~~~ 452 (557)
++........ .......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||......... .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9887543322 112233478899999988664 5789999999999999999999999855433200 00000
Q ss_pred HHHHHhcC------------CccccccccccCCCC---H--------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 453 ARSMIKKG------------DVISIVDPVLIGNVK---I--------ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 453 ~~~~~~~~------------~~~~~~d~~l~~~~~---~--------~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+ ..+... ......+......+. . .....+.+++.+|++.+|++|||+.|+++
T Consensus 238 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 238 F-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred H-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 000000 000000000000000 0 12246889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=291.42 Aligned_cols=259 Identities=23% Similarity=0.260 Sum_probs=196.0
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEec--CeeEEEEEe
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYEY 312 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~~lv~e~ 312 (557)
++.+.||+|+||.||+|... +++.+|+|.+.... ....+.+.+|+++++.++|+|++++++++.+. +..++||||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 35688999999999999876 48899999987653 33345688999999999999999999999887 789999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
++ ++|.+++... ...+++..++.++.||++||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 82 MD-HDLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cc-ccHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 96 4888887642 2578999999999999999999998 8999999999999999999999999999987654432
Q ss_pred cccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC---ccc----
Q 008707 393 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VIS---- 464 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~---- 464 (557)
.......++..|+|||.+.+ ..++.++||||||+++|||+||+.||...+.... ..........-. ...
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhccccccc
Confidence 22222346788999998764 4678999999999999999999999975442211 111111110000 000
Q ss_pred ----------cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 465 ----------IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 465 ----------~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.....+........+..+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000001112457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=299.74 Aligned_cols=251 Identities=22% Similarity=0.368 Sum_probs=204.3
Q ss_pred HHHHhhcccCCCCceEEEEEEEcCCc-EEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
..+++...||.|+||.||+|..++.. ..|.|++........++++-|++||....||+||++++.|...+.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 44567788999999999999877544 45668777666777889999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
.||-+..++-. -+..+++.++.-++.|++.||.|||+ ++|+|||||+.|||++-+|.++|+|||.+........
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q- 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ- 185 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHHh-
Confidence 99998887754 36789999999999999999999998 9999999999999999999999999998865433222
Q ss_pred ccccccCCCCccCCccc-----CCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 394 ISSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l-----~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
....+.|||.|||||+. ....|+.++||||||++|.||..+.+|-. +.+....+.. +.+.....++.
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh------elnpMRVllK-iaKSePPTLlq- 257 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH------ELNPMRVLLK-IAKSEPPTLLQ- 257 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc------ccchHHHHHH-HhhcCCCcccC-
Confidence 23446699999999986 45688999999999999999999999975 2233332222 22222222222
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+..+...+.+++.+||..+|..||++.++++
T Consensus 258 ------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 258 ------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 2345568899999999999999999999875
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=287.06 Aligned_cols=245 Identities=28% Similarity=0.354 Sum_probs=195.2
Q ss_pred cCCCCceEEEEEEEcC-CcEEEEEEccCccc---hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 243 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 243 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
||+|+||.||++.... |+.+++|.+..... ...+.+.+|++++++++||||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999998874 89999999865432 3456788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc------
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT------ 392 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~------ 392 (557)
.+++... ..+++..+..++.|+++||+|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9999743 368999999999999999999998 9999999999999999999999999999876533211
Q ss_pred -cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 393 -HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 393 -~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.......++..|+|||......++.++||||||+++|++++|+.||...... ..... +..+......
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~----- 222 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQN-ILNGKIEWPE----- 222 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HhcCCcCCCc-----
Confidence 1122334778999999998888999999999999999999999999744321 11111 1111111000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
....+..+.+++.+|++.+|.+|||++++.+.|+
T Consensus 223 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 ---DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ---cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 0012457889999999999999999966655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=288.93 Aligned_cols=251 Identities=27% Similarity=0.377 Sum_probs=194.3
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEec-----CeeEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE-----HQRIL 308 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~-----~~~~l 308 (557)
.|.+.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++++ +|||++++++++... +..++
T Consensus 23 ~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l 101 (291)
T cd06639 23 TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101 (291)
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence 3456788999999999999875 68899999886432 2345677899999999 799999999998653 35899
Q ss_pred EEEecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 309 VYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
||||+++++|.++++... ....+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++...
T Consensus 102 v~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred EEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 999999999999886432 34568999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCccccccccCCCCccCCcccCCC-----CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQ-----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~-----~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
...... .....++..|+|||.+... .++.++||||||+++|||++|+.||...+... .+. . +..+..
T Consensus 179 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~~----~-~~~~~~ 250 (291)
T cd06639 179 TSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TLF----K-IPRNPP 250 (291)
T ss_pred cccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HHH----H-HhcCCC
Confidence 432211 1223478899999998653 36789999999999999999999997432111 111 1 111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 463 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 463 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
....+ .......+.+++.+|++.+|++||++.|+++
T Consensus 251 ~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 251 PTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11111 1122346889999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=290.04 Aligned_cols=263 Identities=21% Similarity=0.289 Sum_probs=196.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
|++.+.||+|++|.||+|... +|+.||+|.+..... ...+.+.+|+++++.++|+||+++++++.+.+..++||||++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred ceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 345688999999999999876 588999998865432 234567789999999999999999999999999999999997
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
++|.+++........+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||++.........
T Consensus 82 -~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 156 (284)
T cd07836 82 -KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT- 156 (284)
T ss_pred -ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc-
Confidence 4888887654334568999999999999999999998 89999999999999999999999999998765332211
Q ss_pred cccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCcccccc-HHHHH-------HHHHhcCC----
Q 008707 395 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN-IVHWA-------RSMIKKGD---- 461 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~-~~~~~-------~~~~~~~~---- 461 (557)
.....++..|++||.+.+ ..++.++||||||+++|+|++|+.||...+..+... ..+.. ...+....
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence 122346788999998865 456889999999999999999999998554322111 00000 00000000
Q ss_pred -ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 462 -VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 462 -~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.....+.. ...........+.+++.+|++.+|.+||+++||++
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 237 TFPRYPPQD-LQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccCCChHH-HHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 00011122456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=288.71 Aligned_cols=246 Identities=30% Similarity=0.404 Sum_probs=195.2
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
..|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 44677899999999999999875 58999999885332 233457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+. |++.+.+... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 5777766532 3468999999999999999999998 99999999999999999999999999998765432
Q ss_pred CccccccccCCCCccCCcccC---CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~---~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
. ...+++.|+|||.+. ...++.++||||||+++|||+||+.||...+... .... +..+....
T Consensus 169 ~-----~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~-~~~~~~~~--- 233 (307)
T cd06607 169 N-----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH-IAQNDSPT--- 233 (307)
T ss_pred C-----CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHH-HhcCCCCC---
Confidence 1 234788999999874 4567889999999999999999999997433211 0111 11111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+ ........+.+++.+||+.+|++||++.+|++.
T Consensus 234 --~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 --L---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred --C---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 112234578999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=291.77 Aligned_cols=261 Identities=19% Similarity=0.227 Sum_probs=185.8
Q ss_pred hhHHHHHHHHhhcccCCCCceEEEEEEEcC----CcEEEEEEccCccchh-H----------HHHHHHHHHHhhcCCCCc
Q 008707 229 LPELEEATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSCSHR-T----------QQFVTEVALLSRIHHRNL 293 (557)
Q Consensus 229 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~----------~~~~~E~~il~~l~h~nI 293 (557)
..++....|.+.+.||+|+||.||+|.+.+ +..+|+|+........ . .....+...+..+.|+||
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 344555667788999999999999998764 3456666533211110 0 112233445566789999
Q ss_pred cceeeEEEecC----eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEE
Q 008707 294 VPLIGYCEEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 369 (557)
Q Consensus 294 v~~~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIl 369 (557)
+++++.+.... ..++++|++. .++.+.+.. ....++..+..++.|++.||+|||+ .+++||||||+|||
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nil 158 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIM 158 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEE
Confidence 99998765433 3467888773 466666653 2335677889999999999999998 99999999999999
Q ss_pred eCCCCcEEEecccCccccCCCCc------cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCc
Q 008707 370 LDINMRAKVSDFGLSRQAEEDLT------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 443 (557)
Q Consensus 370 l~~~~~~kl~Dfgla~~~~~~~~------~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~ 443 (557)
++.++.++|+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~ 238 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGH 238 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcccc
Confidence 99999999999999986532211 111223589999999999999999999999999999999999999985432
Q ss_pred cccc-cH--HHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 444 GAEL-NI--VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 444 ~~~~-~~--~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
.... .. .++. ..+.++... ....+..+.+++..|++.+|++||++++|++.|+
T Consensus 239 ~~~~~~~~~~~~~-~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 239 NGNLIHAAKCDFI-KRLHEGKIK-----------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred chHHHHHhHHHHH-HHhhhhhhc-----------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 2111 00 1111 111111110 0112457889999999999999999999998763
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=282.86 Aligned_cols=248 Identities=28% Similarity=0.429 Sum_probs=198.5
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|.+.+.||+|+||.||+|..+ +|..+|+|.+.... ....+.+.+|+++++.++|+||+++++.+..+...++|+||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 345688999999999999876 58899999885431 234467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc-EEEecccCccccCCCCc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~-~kl~Dfgla~~~~~~~~ 392 (557)
++++|.+++... ....+++..+..++.|+++||+|||+ .+++|+||+|+||++++++. ++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 82 DGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 999999998753 23457899999999999999999998 99999999999999998764 69999999877654322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
. .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+ ..++...... +....
T Consensus 158 ~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-~~~~~-------- 221 (257)
T cd08225 158 L-AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQ-GYFAP-------- 221 (257)
T ss_pred c-ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc-ccCCC--------
Confidence 2 222347889999999988889999999999999999999999997332 2222222221 11111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
........+.+++.+|+..+|++|||++||++
T Consensus 222 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 222 -ISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11122346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=312.92 Aligned_cols=268 Identities=18% Similarity=0.237 Sum_probs=186.7
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcC--CcEEEEEE--------------ccC---ccchhHHHHHHHHHHHhhcCCCCcc
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKD--GKEVAVKI--------------MAD---SCSHRTQQFVTEVALLSRIHHRNLV 294 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~--------------~~~---~~~~~~~~~~~E~~il~~l~h~nIv 294 (557)
...|++.+.||+|+||.||++.++. +..++.|. +.+ ........+.+|++++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4567788999999999999987542 22222221 110 1122345688999999999999999
Q ss_pred ceeeEEEecCeeEEEEEecCCCChhhhhhccC--CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC
Q 008707 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 372 (557)
Q Consensus 295 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~ 372 (557)
++++++...+..++|+|++. ++|.+++.... .........+..++.||+.||+|||+ ++|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence 99999999999999999984 57777664321 11223455677899999999999998 99999999999999999
Q ss_pred CCcEEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCC-CCCCCccccccHHH
Q 008707 373 NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP-VSVEDFGAELNIVH 451 (557)
Q Consensus 373 ~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~p-f~~~~~~~~~~~~~ 451 (557)
++.+||+|||++...............|++.|+|||++.+..++.++|||||||++|||++|..+ |..........+.+
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 99999999999987654433333345689999999999999999999999999999999998754 43221111111111
Q ss_pred HHHHHHhc--CCcc-------ccccccccC----CCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 452 WARSMIKK--GDVI-------SIVDPVLIG----NVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 452 ~~~~~~~~--~~~~-------~~~d~~l~~----~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
... .+.. .... ..++..... ... ......+.+++.+||+.||++|||+.|+++.
T Consensus 383 ~~~-~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 383 IID-SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHH-hcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111 0000 0000 000000000 000 0112356788999999999999999999863
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=289.46 Aligned_cols=259 Identities=22% Similarity=0.291 Sum_probs=193.8
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
++.+.||.|++|.||+|... +|+.||+|++.... ......+.+|+++++.++|||++++++++.+.+..+++|||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 45688999999999999865 68999999886432 2233567889999999999999999999999999999999994
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
++|.+++.... ...+++..+..++.|+++||+|||+ ++++||||+|+||+++.++.++|+|||++..........
T Consensus 82 -~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~ 156 (283)
T cd07835 82 -LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156 (283)
T ss_pred -cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence 68999887432 2468999999999999999999998 899999999999999999999999999987654322111
Q ss_pred cccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC-------------
Q 008707 395 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG------------- 460 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------------- 460 (557)
....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...+.... +...........
T Consensus 157 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 157 -THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred -CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchhh
Confidence 112357889999987654 568899999999999999999999974432111 111111000000
Q ss_pred --CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 461 --DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 461 --~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.......... ..........+.+++.+|++.+|++|||++|+++
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000000 0011112246889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=285.63 Aligned_cols=244 Identities=26% Similarity=0.366 Sum_probs=196.3
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
...||+|+||.||++..+ +++.||+|.+..........+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 478999999999999875 6899999988654445566788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccccc
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 398 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 398 (557)
.+++. ...+++..+..++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||++........ .....
T Consensus 105 ~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 105 TDIVT----HTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 99875 3357889999999999999999998 8999999999999999999999999998876543221 12233
Q ss_pred cCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHH
Q 008707 399 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 478 (557)
Q Consensus 399 ~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 478 (557)
.+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...+... .... +..+.. +.+.. ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~~~~----~~~~~~-----~~~~~--~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKM----IRDNLP-----PKLKN--LHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HHhhCC-----cccCC--cccC
Confidence 47889999999988888999999999999999999999997432211 1111 111100 00000 0112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 479 IWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 479 ~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
...+.+++.+|++.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 346789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=292.85 Aligned_cols=266 Identities=21% Similarity=0.273 Sum_probs=194.4
Q ss_pred cccCCC--CceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
..||+| +||+||++.+. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 99999999875 68999999986432 23346788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc-
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI- 394 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~- 394 (557)
++|.+++.... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999887542 3458899999999999999999998 999999999999999999999999998654322111100
Q ss_pred -----cccccCCCCccCCcccCCC--CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHH-------------
Q 008707 395 -----SSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR------------- 454 (557)
Q Consensus 395 -----~~~~~g~~~y~aPE~l~~~--~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~------------- 454 (557)
.....++..|+|||.+.+. .++.++|||||||++|+|++|+.||...+... ...+...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccc
Confidence 1112245679999998763 47889999999999999999999997443211 0100000
Q ss_pred ---HHHhc----------------CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhhh
Q 008707 455 ---SMIKK----------------GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 512 (557)
Q Consensus 455 ---~~~~~----------------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~~~ 512 (557)
..... +......+..+...........+.+++.+||+.||++|||++|+++. +..+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 00000 00000011111111223345678999999999999999999999753 544444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=286.20 Aligned_cols=242 Identities=22% Similarity=0.280 Sum_probs=186.4
Q ss_pred ccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhh---cCCCCccceeeEEEecCeeEEEEEecC
Q 008707 242 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSR---IHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 242 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~---l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.||+|+||.||++... +++.+|+|.+..... .....+.+|..+++. .+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 588999998864321 222334455444443 469999999999999899999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 152 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence 9999998873 4568999999999999999999998 9999999999999999999999999999876543221
Q ss_pred cccccCCCCccCCcccC-CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 395 SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~-~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
....|++.|+|||.+. +..++.++||||+||++|+|++|..||.......... ....... .. ..
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~------~~----~~ 217 (279)
T cd05633 153 -HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------VN----VE 217 (279)
T ss_pred -cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhhc------CC----cC
Confidence 2235899999999986 4568899999999999999999999997433222111 1111100 01 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 506 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 506 (557)
.+...+..+.+++.+|+..+|++|| +++|+++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1222345788999999999999999 59888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=279.99 Aligned_cols=248 Identities=27% Similarity=0.410 Sum_probs=201.8
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEec--CeeEEEEEe
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYEY 312 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~~lv~e~ 312 (557)
...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++||||+++++.+... ...++++|+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 34578999999999999877 688999999865432 4467789999999999999999999999888 889999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 83 VSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999998743 378999999999999999999998 9999999999999999999999999999887655432
Q ss_pred c-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 393 H-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 393 ~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
. ......++..|+|||.+.....+.++||||||+++|+|++|..||...+ ............+..
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~--------- 222 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEP--------- 222 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCC---------
Confidence 1 1223447889999999988889999999999999999999999997544 111111111110111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
...+...+..+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1122223557899999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=286.21 Aligned_cols=244 Identities=23% Similarity=0.288 Sum_probs=191.6
Q ss_pred cCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 243 IGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 243 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
||+|+||+||++... +|+.||+|.+.... ......+..|+++++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999765 58899999886432 12334567899999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccccc
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 398 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 398 (557)
.+++.... ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||.+........ ....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~ 154 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGR 154 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc--cccc
Confidence 99987542 2468999999999999999999998 9999999999999999999999999999876543211 1223
Q ss_pred cCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHH
Q 008707 399 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 478 (557)
Q Consensus 399 ~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 478 (557)
.++..|+|||.+.+..++.++||||+|+++|+|++|+.||........ ... +....... ........
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~-~~~~~~~~----------~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KEE-LKRRTLEM----------AVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HHH-HHhccccc----------cccCCccC
Confidence 467899999999888899999999999999999999999974433111 111 11111000 00111122
Q ss_pred HHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 008707 479 IWRIAEVAIQCVEQRGFSRP-----KMQEIVL 505 (557)
Q Consensus 479 ~~~l~~li~~cl~~~P~~RP-----t~~evl~ 505 (557)
...+.+++.+||+.+|++|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 44788999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=286.76 Aligned_cols=256 Identities=23% Similarity=0.266 Sum_probs=192.1
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcC-CCCccceeeEEEec--CeeEEEEEe
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRILVYEY 312 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~--~~~~lv~e~ 312 (557)
++.+.||+|+||.||+|... +++.||+|.++... ........+|+.++.++. |+||+++++++.+. +..++||||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 45688999999999999865 58899999886542 222334557889999885 99999999999887 889999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
++ ++|.+.+... ...+++..+..++.|++.||+|||+ .+++||||+|+||+++. +.+||+|||++........
T Consensus 82 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 82 MD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred CC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 96 5888877642 3568999999999999999999998 99999999999999999 9999999999987643322
Q ss_pred cccccccCCCCccCCcccC-CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH-----------hcC
Q 008707 393 HISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI-----------KKG 460 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~-~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~-----------~~~ 460 (557)
. ....++..|+|||.+. +..++.++||||+||++|||++|+.||...+..+ ...+..... ...
T Consensus 155 ~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 155 Y--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred c--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhccc
Confidence 1 1234788999999764 4567889999999999999999999997544321 111111111 111
Q ss_pred CccccccccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 461 DVISIVDPVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 461 ~~~~~~d~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.......+.... ......+..+.+++.+||..+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 111110110000 001123568999999999999999999999985
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=287.40 Aligned_cols=260 Identities=22% Similarity=0.302 Sum_probs=191.3
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+++++.++|+||+++++++..++..++||||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 455789999999999999765 588999999864432 223467789999999999999999999999999999999995
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++.+.+... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 87 -~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~- 159 (291)
T cd07870 87 -TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT- 159 (291)
T ss_pred -CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-
Confidence 6777766532 3457788888999999999999998 89999999999999999999999999998764332211
Q ss_pred cccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC---------Cccc
Q 008707 395 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG---------DVIS 464 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~ 464 (557)
.....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...+.... .+.+ ....+... ....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEK-IWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHH-HHHHcCCCChhhhhhhhhccc
Confidence 1223468899999998754 578899999999999999999999974432111 0000 00000000 0000
Q ss_pred cccccc----cCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 465 IVDPVL----IGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 465 ~~d~~l----~~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
...... .... .......+.+++.+|+..||.+|||++|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 0000 0011346789999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=282.55 Aligned_cols=247 Identities=26% Similarity=0.380 Sum_probs=201.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||.||++... +++.+++|.+.... ......+.+|+++++.++|+||+++++++.+....++||||+
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 345688999999999999765 67899999886532 334567788999999999999999999999999999999999
Q ss_pred CCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 314 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 314 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
++++|.+++.... ....+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 9999999886532 23568899999999999999999998 999999999999999999999999999998765542
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.....+++.|++||.+.+..++.++|+||+|+++|+|++|+.||...+... ....+..+...
T Consensus 158 --~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~--------- 219 (256)
T cd08530 158 --AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGKYP--------- 219 (256)
T ss_pred --cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcCCCC---------
Confidence 222347889999999999899999999999999999999999997443211 11112222211
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.........+.+++.+|++.+|++||++.|+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 112234457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=289.66 Aligned_cols=264 Identities=23% Similarity=0.263 Sum_probs=195.7
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecC----
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH---- 304 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~---- 304 (557)
.....|++.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34456777899999999999999886 58899999986432 223356778999999999999999999887654
Q ss_pred ------eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEE
Q 008707 305 ------QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 378 (557)
Q Consensus 305 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 378 (557)
..++|+||+++ ++.+.+... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence 78999999975 777776542 3468999999999999999999998 99999999999999999999999
Q ss_pred ecccCccccCCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH
Q 008707 379 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 457 (557)
Q Consensus 379 ~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 457 (557)
+|||++...............++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... .....+....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Confidence 9999998764433222222235778999998865 45788999999999999999999999743221 1111111111
Q ss_pred hcCCc---ccc--------ccc------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 458 KKGDV---ISI--------VDP------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 458 ~~~~~---~~~--------~d~------~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..... ..+ .++ ..... ....+..+.+++.+||+.+|++||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11000 000 000 00000 0112457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=280.49 Aligned_cols=249 Identities=30% Similarity=0.462 Sum_probs=202.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|.+.+.||.|+||.||++... +++.|++|++..... ...+.+.+|+++++.++|||++++++.+......++|+|++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYA 81 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEec
Confidence 345688999999999999876 588999999865432 45567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 314 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 314 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
++++|.+++.... ....+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 158 (258)
T cd08215 82 DGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD 158 (258)
T ss_pred CCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCcc
Confidence 9999999987532 24678999999999999999999998 8999999999999999999999999999987654431
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||...+. ........ .+....
T Consensus 159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~-------- 222 (258)
T cd08215 159 -LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKIL-KGQYPP-------- 222 (258)
T ss_pred -eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHh-cCCCCC--------
Confidence 22334578899999999888899999999999999999999999974331 11111211 111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+......+.+++.+|+..+|++|||+.|+++
T Consensus 223 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 -IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11122347889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=297.40 Aligned_cols=264 Identities=19% Similarity=0.305 Sum_probs=195.3
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEe----cCeeEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRIL 308 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----~~~~~l 308 (557)
.|.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 85 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYV 85 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEE
Confidence 4556788999999999999865 58999999986532 2334667889999999999999999998753 346799
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||+. ++|.+++.. ...+++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 86 VMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 999995 689888863 4558999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCccc---cccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHH--------HHH
Q 008707 389 EDLTHI---SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA--------RSM 456 (557)
Q Consensus 389 ~~~~~~---~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~--------~~~ 456 (557)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+........... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 322111 122357889999999865 46889999999999999999999999754432111100000 000
Q ss_pred HhcCCcccccccc-ccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 457 IKKGDVISIVDPV-LIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 457 ~~~~~~~~~~d~~-l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
..........+.. .... .....+..+.+++.+|++.+|++||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000000 0000 011234578999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=277.80 Aligned_cols=246 Identities=26% Similarity=0.420 Sum_probs=200.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|.+.+.||+|++|.||++... +++.|++|.+..... ...+.+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 445789999999999999765 578999999876543 35567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++.. ...+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 82 ENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 99999999874 3568999999999999999999998 99999999999999999999999999999876544322
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....++..|+|||.+.+..++.++||||+|+++|+|++|..||...+. ... ..... ......
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~-~~~~~-~~~~~~--------- 218 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAA-LFRIV-QDDHPP--------- 218 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHH-HHHHh-ccCCCC---------
Confidence 2233578899999999888889999999999999999999999974321 110 01111 111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+......+.+++.+|+..+|++|||+.|++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11122347889999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=285.35 Aligned_cols=250 Identities=30% Similarity=0.399 Sum_probs=196.2
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
..+...+.||+|+||.||+|... ++..||+|.+.... ......+.+|+++++.++|||++++++++.+++..++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34566788999999999999865 58899999886432 233457889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+. |++.+.+... ...+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 105 e~~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 105 EYCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred eCCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 9996 5777776532 4558999999999999999999998 99999999999999999999999999988754332
Q ss_pred CccccccccCCCCccCCcccC---CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~---~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
....+++.|+|||.+. ...++.++||||||+++|+|++|+.||...+.. ........ +....
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~-~~~~~--- 243 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQ-NESPT--- 243 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHh-ccCCC---
Confidence 2234788999999973 456888999999999999999999998633211 11111111 11100
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
.........+.+++.+|++.+|++||++.+|++.+-..
T Consensus 244 -----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 244 -----LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred -----CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 01112334688999999999999999999999865443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=286.61 Aligned_cols=255 Identities=22% Similarity=0.305 Sum_probs=198.7
Q ss_pred HHhhcccCCCCceEEEEEEEc----CCcEEEEEEccCcc----chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~ 307 (557)
|++.+.||+|++|.||++... +++.||+|++.... ....+.+.+|++++.++ +||||+++++.+..+...+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 345688999999999999743 57889999886432 12335678899999999 5999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+||||+.+|+|.+++.. ...+++..+..++.|+++||+|||+ .+++||||+|+||+++.++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 82 LILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999998863 3568889999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCccccccccCCCCccCCcccCCCC--CCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~~--~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
............++..|+|||.+.+.. .+.++||||||+++|+|++|..||...... ..............
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~----- 228 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRILKSK----- 228 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHHccC-----
Confidence 443322223345788999999987654 788999999999999999999999633211 11112122211110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
+ ..+......+.+++.+||+.+|++|||++++.+.|+..
T Consensus 229 --~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 229 --P----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --C----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0 11111234678999999999999999999887766553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=282.34 Aligned_cols=244 Identities=27% Similarity=0.304 Sum_probs=188.8
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHh-hcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLS-RIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~-~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||.||+|... +++.||+|.+..... .....+..|..++. ..+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 588999999865321 12233445555444 44899999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||++..... .
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 999999873 3468889999999999999999998 9999999999999999999999999999876433 1
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
....++..|+|||.+.+..++.++||||+|+++|+|++|..||...+... . . ..+..+.... .....
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~---~-~~~~~~~~~~------~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---V---F-DNILSRRINW------PEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---H---H-HHHHhcccCC------CCccc
Confidence 22347889999999988888999999999999999999999997433211 1 1 1111111100 00111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
...+..+.+++.+||+.+|++||++.++.+.|.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 123457889999999999999998876655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=293.11 Aligned_cols=261 Identities=23% Similarity=0.294 Sum_probs=195.5
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEec------Ce
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQ 305 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~------~~ 305 (557)
..|+..+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 45666789999999999999865 6899999998643 223345677899999999999999999987643 35
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
.++||||+. ++|.+.+.. .++...+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++.
T Consensus 96 ~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 96 VYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred EEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 799999995 588887752 27888899999999999999998 999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcccccc------------HHHH-
Q 008707 386 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN------------IVHW- 452 (557)
Q Consensus 386 ~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~------------~~~~- 452 (557)
....... .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||...+...... +...
T Consensus 167 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 167 TAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 7644322 222347889999999999999999999999999999999999997544211100 0000
Q ss_pred ---HHHHHhcCCc------ccccccccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 453 ---ARSMIKKGDV------ISIVDPVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 453 ---~~~~~~~~~~------~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
......+... ......... .......+..+.+++.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0001111000 000000000 01111234568899999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=311.30 Aligned_cols=263 Identities=26% Similarity=0.414 Sum_probs=211.8
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEc----C----CcEEEEEEccCccc-hhHHHHHHHHHHHhhc-CCCCccceeeEE
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMK----D----GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYC 300 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~ 300 (557)
++......+.+.||+|.||.|++|... . ...||||.++.... .+.+.+..|+++|+.+ +|+||+.++|.|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 444455567779999999999999643 1 45799999876533 4567899999999999 699999999999
Q ss_pred EecCeeEEEEEecCCCChhhhhhccC-----CC--------CCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCC
Q 008707 301 EEEHQRILVYEYMHNGTLRDRLHGSV-----NQ--------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 367 (557)
Q Consensus 301 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~N 367 (557)
...+..++|+||+..|+|.++++... .. ..++....+.++.|||.|++||++ .+++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhh
Confidence 99999999999999999999998643 01 238889999999999999999998 999999999999
Q ss_pred EEeCCCCcEEEecccCccccCCCCcccccccc--CCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCcc
Q 008707 368 ILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG 444 (557)
Q Consensus 368 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~--g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~ 444 (557)
||++.+..+||+|||+|+.............. -+..|||||.+....|+.++||||||++|||++| |..||.+...
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~- 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP- 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence 99999999999999999975544333222111 3567999999999999999999999999999999 8899974211
Q ss_pred ccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 445 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
...+ ...+++|...+. +.....++.+++..||+.+|++||++.|+.+.|+...
T Consensus 528 -~~~l----~~~l~~G~r~~~---------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 528 -TEEL----LEFLKEGNRMEQ---------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred -HHHH----HHHHhcCCCCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 1112 224555554332 2223447889999999999999999999999999954
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=288.88 Aligned_cols=261 Identities=21% Similarity=0.266 Sum_probs=191.6
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcC-CCCccceeeEEEecCe-----eE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ-----RI 307 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~-----~~ 307 (557)
|++.+.||+|+||.||+|.+. +++.||+|.+..... .....+.+|+.+++.++ ||||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 445688999999999999875 589999998764322 23356888999999995 6999999999877665 79
Q ss_pred EEEEecCCCChhhhhhccCC--CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC-CCcEEEecccCc
Q 008707 308 LVYEYMHNGTLRDRLHGSVN--QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLS 384 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla 384 (557)
+||||+++ +|.+++..... ...+++..++.++.||+.||+|||+ ++++||||+|+||+++. ++.++|+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999975 88888765322 3468999999999999999999998 99999999999999998 889999999998
Q ss_pred cccCCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 385 RQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 385 ~~~~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||........ +.. +...+......
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~--~~~-~~~~~~~~~~~ 234 (295)
T cd07837 159 RAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ--LLH-IFKLLGTPTEQ 234 (295)
T ss_pred eecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH-HHHHhCCCChh
Confidence 765332211 111236788999998865 4578999999999999999999999974332111 111 00111100000
Q ss_pred cc------cc----cccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 464 SI------VD----PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 464 ~~------~d----~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.. .+ +... ..........+.+++.+||..+|++||+++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 00 0000 0001123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=286.20 Aligned_cols=261 Identities=21% Similarity=0.247 Sum_probs=193.0
Q ss_pred hhcccCCCCceEEEEEEEcCCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
+.+.+|.|+++.||++.. +++.||+|++... .....+.+.+|+++++.++|+||+++++++.+.+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 455666777777776665 5899999998654 3345567999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc----
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT---- 392 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~---- 392 (557)
+|.+++.... ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++|+|||.+........
T Consensus 85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 9999987542 3458888999999999999999998 9999999999999999999999999998865432211
Q ss_pred --cccccccCCCCccCCcccCC--CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHH----HhcC----
Q 008707 393 --HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM----IKKG---- 460 (557)
Q Consensus 393 --~~~~~~~g~~~y~aPE~l~~--~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~----~~~~---- 460 (557)
.......++..|+|||.+.. ..++.++||||||+++|||++|+.||...+... ...+..... +...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhh
Confidence 11122346778999999866 357889999999999999999999997432211 111100000 0000
Q ss_pred ---Cccc----ccccccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 461 ---DVIS----IVDPVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 461 ---~~~~----~~d~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.... ..++... ..........+.+++.+||..+|++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 0000000 01112233578899999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=297.83 Aligned_cols=260 Identities=23% Similarity=0.322 Sum_probs=193.0
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEec-----CeeEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 308 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----~~~~l 308 (557)
.|++.+.||+|+||.||+|... +|+.||+|.+.... ......+.+|+.+++.++||||+++++++... ...++
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 3556789999999999999765 68999999986432 23345678899999999999999999987644 35789
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
|+||+. ++|.+.+. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 86 v~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 86 VQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred Eehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999995 58877775 3568999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcc--ccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc--
Q 008707 389 EDLTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI-- 463 (557)
Q Consensus 389 ~~~~~--~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 463 (557)
..... ......|++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+... ........+......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHH
Confidence 32211 1122357889999998654 568899999999999999999999997543211 111111111110000
Q ss_pred -cccccc-------c--cCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 464 -SIVDPV-------L--IGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 464 -~~~d~~-------l--~~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
...+.. . .... .......+.+++.+||+.+|++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0 0000 01123468899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=291.16 Aligned_cols=260 Identities=23% Similarity=0.237 Sum_probs=192.7
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEec--CeeEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVY 310 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~~lv~ 310 (557)
.|++.+.||+|+||.||+|... +|+.||+|.++.... .....+.+|+.++++++|+||+++++++.+. +..++||
T Consensus 8 ~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred ceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 4556789999999999999875 589999998864322 1223466899999999999999999998765 4689999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+. ++|.+++... ...+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||++......
T Consensus 88 e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 88 EYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred ecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9996 5888887643 3568999999999999999999998 99999999999999999999999999999876543
Q ss_pred CccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC--Cc-----
Q 008707 391 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--DV----- 462 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~----- 462 (557)
... .....+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+.... ...+....... ..
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhchhhh
Confidence 211 122235778999999865 4678999999999999999999999974432211 11111111100 00
Q ss_pred ----ccccc--ccccCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 463 ----ISIVD--PVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 463 ----~~~~d--~~l~~~---~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
...+. ...... ........+.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 000000 00112446789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=288.78 Aligned_cols=253 Identities=24% Similarity=0.327 Sum_probs=198.0
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccC--ccchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEE
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMAD--SCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv 309 (557)
....|++.+.||.|+.+.||++...+.+.+|+|++.- .......-|..|+..|.+| .|.+|+++++|-..++..|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 4456778899999999999999988888888887643 2334457799999999999 499999999999999999999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
||+- ..+|..+|... ....+...++.+..|++.|+.++|+ .||||.||||.|+|+= .|.+||+|||.|.....
T Consensus 439 mE~G-d~DL~kiL~k~--~~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKK--KSIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 9986 46899999854 2333323677899999999999998 9999999999999986 58999999999998776
Q ss_pred CCccc-cccccCCCCccCCcccCCCC-----------CCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH
Q 008707 390 DLTHI-SSVARGTVGYLDPEYYGNQQ-----------LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 457 (557)
Q Consensus 390 ~~~~~-~~~~~g~~~y~aPE~l~~~~-----------~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 457 (557)
+.+.. .....||+.||+||.+.... .++++||||+|||||+|+-|+.||. ...+...-
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~-----~~~n~~aK----- 581 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG-----QIINQIAK----- 581 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH-----HHHHHHHH-----
Confidence 65443 33456999999999985432 5679999999999999999999997 12222221
Q ss_pred hcCCccccccccccCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 458 KKGDVISIVDPVLIGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 458 ~~~~~~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+..+.||.-.-+++ ....+++.+++..||..||.+||+..|+++.
T Consensus 582 ----l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 ----LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 22333332211221 1122348999999999999999999999864
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=293.03 Aligned_cols=265 Identities=25% Similarity=0.328 Sum_probs=195.2
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhc-CCCCccceeeEEEec--CeeE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE--HQRI 307 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~--~~~~ 307 (557)
...|.+.+.||+|+||.||+|... +++.+|+|++... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 356777899999999999999876 5889999987542 223345677899999999 999999999988653 3679
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+||||+. ++|.+++.. ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++...
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999996 589888863 267888899999999999999998 99999999999999999999999999999865
Q ss_pred CCCCcc----ccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHH--------
Q 008707 388 EEDLTH----ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR-------- 454 (557)
Q Consensus 388 ~~~~~~----~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~-------- 454 (557)
...... ......|+..|+|||.+.+ ..++.++||||||+++|+|+||+.||................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 433211 1222347889999998754 567889999999999999999999997543221110000000
Q ss_pred HHHhcCCcccccccccc------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 455 SMIKKGDVISIVDPVLI------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 455 ~~~~~~~~~~~~d~~l~------~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
..+.......+++.... .......+..+.+++.+|++.+|++|||+.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000100000 00011134578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=295.02 Aligned_cols=243 Identities=28% Similarity=0.413 Sum_probs=202.3
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|.+.+.||+|.|+.|.+|.+. ++..||+|.+.+..- ...+.+.+|+++|..++|||||+++.+......+|+||||+
T Consensus 58 y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya 137 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYA 137 (596)
T ss_pred eeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEec
Confidence 445789999999999999865 689999999976532 33456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
.+|.+.+++.. .....+..+..++.|+..|++|||+ +.|+|||||++|||++.+.++||+|||++..+... .
T Consensus 138 ~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~--~ 209 (596)
T KOG0586|consen 138 SGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG--L 209 (596)
T ss_pred cCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc--c
Confidence 99999999984 4556668888999999999999998 99999999999999999999999999999988643 3
Q ss_pred ccccccCCCCccCCcccCCCCC-CcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~-s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
..+..+|++.|.|||++.+..| .+++|+||+|+++|-|+.|..||++..... +-++.+.+
T Consensus 210 ~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~rvl~g 270 (596)
T KOG0586|consen 210 MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRPRVLRG 270 (596)
T ss_pred cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccchheee
Confidence 3456789999999999988765 579999999999999999999998554321 11111122
Q ss_pred CC--CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 473 NV--KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 473 ~~--~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.+ +.....+..+++.+++-.+|.+|+++++|.+.
T Consensus 271 k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 21 11122356699999999999999999999764
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=267.45 Aligned_cols=249 Identities=23% Similarity=0.377 Sum_probs=195.0
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecC
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
++...||.|..|.||+++.+ +|..+|||.+.... .+..++++..++++..- ..|+||+.+|+|..+....+.||.|
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM- 173 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM- 173 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence 35577999999999999876 48999999987653 44567788888877655 4899999999999999999999988
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
...+..++++. .+++++.-+-++...++.||.||.+ +++|+|||+||+|||+|+.|++|+||||++.+..+...+.
T Consensus 174 s~C~ekLlkri--k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAht 249 (391)
T KOG0983|consen 174 STCAEKLLKRI--KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHT 249 (391)
T ss_pred HHHHHHHHHHh--cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccccc
Confidence 34555555543 4568888888899999999999998 6999999999999999999999999999998876654433
Q ss_pred cccccCCCCccCCcccC---CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 395 SSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~---~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
...|.+.|||||.+. ...|+.++||||||+.++||.||+.||.+-+.+-+. +...+.+. . ..++...
T Consensus 250 --rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-----ltkvln~e-P-P~L~~~~- 319 (391)
T KOG0983|consen 250 --RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-----LTKVLNEE-P-PLLPGHM- 319 (391)
T ss_pred --cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-----HHHHHhcC-C-CCCCccc-
Confidence 335899999999985 457888999999999999999999999865443211 11112211 1 1122111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.....+.+++..||+.|+.+||.+.++++.
T Consensus 320 -----gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 320 -----GFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -----CcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 123478899999999999999999998763
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=284.38 Aligned_cols=250 Identities=26% Similarity=0.354 Sum_probs=195.0
Q ss_pred HHhhcccCCCCceEEEEEEE----cCCcEEEEEEccCcc----chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeE
Q 008707 237 NNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~ 307 (557)
|++.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+++++.+ +|+||+++++.+..+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 34568899999999999976 368899999986532 22346678899999999 5999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+||||+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++||||+|+||+++.++.++|+|||++...
T Consensus 82 lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 82 LILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999874 3567888999999999999999998 99999999999999999999999999998876
Q ss_pred CCCCccccccccCCCCccCCcccCCC--CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~--~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
............|+..|+|||.+... .++.++||||||+++|+|++|..||...... .............+.
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~---- 229 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP---- 229 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccCC----
Confidence 44322222234578899999998753 4678999999999999999999999632221 112222222211111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 505 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 505 (557)
.++......+.+++.+|++.+|++|| ++++++.
T Consensus 230 -------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 -------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01112234678999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=277.66 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=193.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc-----cchhHHHHHHHHHHHhhcCCCCccceeeEEEec--CeeEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRIL 308 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~~l 308 (557)
|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++|+||+++++++.+. +..++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 456789999999999999865 5899999987432 123345788999999999999999999998664 46789
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
++||+++++|.+++.. ...+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 84 FVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 9999999999999873 3457888999999999999999998 999999999999999999999999999998653
Q ss_pred CCCc--cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 389 EDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 389 ~~~~--~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
.... .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..... ...+.+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~---- 227 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA------MAAIFKIATQPTK---- 227 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH------HHHHHHHHcCCCC----
Confidence 2111 111223478899999999988899999999999999999999999973211 1111111111111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
...+......+.+++.+|+. +|..||++.+++.
T Consensus 228 -----~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 -----PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -----CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11122333478899999999 4799999998874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=289.50 Aligned_cols=264 Identities=20% Similarity=0.256 Sum_probs=190.9
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecC--------
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-------- 304 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-------- 304 (557)
.|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++....
T Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 4667889999999999999875 58899999875432 222345678999999999999999999986643
Q ss_pred eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCc
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 384 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 384 (557)
..++||||+. ++|.+.+... ...+++..+..++.|++.||+|||+ ++++|+||+|+||+++.++.+||+|||++
T Consensus 93 ~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 93 SFYLVFEFCE-HDLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred eEEEEEcCCC-cCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 3599999995 5888877642 3468999999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCcc---ccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 008707 385 RQAEEDLTH---ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 460 (557)
Q Consensus 385 ~~~~~~~~~---~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 460 (557)
......... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+..........+...+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 765432211 11223467889999988664 46889999999999999999999997543221111111110000000
Q ss_pred -----Ccccccccc-ccCCC---------CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 461 -----DVISIVDPV-LIGNV---------KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 461 -----~~~~~~d~~-l~~~~---------~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
......+.. ..... .......+.+++.+|+..+|++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000000000 00000 0001235679999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=279.29 Aligned_cols=239 Identities=23% Similarity=0.311 Sum_probs=185.1
Q ss_pred Hhhcc--cCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEec
Q 008707 238 NFCKK--IGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 238 ~~~~~--lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
.+.+. ||+|+||.||++..+ ++..+|+|.+....... .|......+ +||||+++++.+...+..++||||+
T Consensus 17 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~ 91 (267)
T PHA03390 17 EIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI 91 (267)
T ss_pred ccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence 34444 599999999999865 57889999876432111 122222223 6999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC-cEEEecccCccccCCCCc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~ 392 (557)
++++|.+++.. ...+++..+..++.|+++||+|||+ .+++||||+|+||+++.++ .++|+|||++.......
T Consensus 92 ~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~- 164 (267)
T PHA03390 92 KDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS- 164 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-
Confidence 99999999974 3478999999999999999999998 9999999999999999988 99999999987654322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
...++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... .......+.... .... .
T Consensus 165 ----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~--~~~~-~-------- 228 (267)
T PHA03390 165 ----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ--QKKL-P-------- 228 (267)
T ss_pred ----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh--cccC-C--------
Confidence 23478899999999998999999999999999999999999973322 222222222211 1100 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt-~~evl~ 505 (557)
........+.+++.+|++.+|++||+ ++|+++
T Consensus 229 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 229 -FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 01123347889999999999999995 688874
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=286.00 Aligned_cols=258 Identities=22% Similarity=0.289 Sum_probs=197.3
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
++.+.||+|++|.||+|... +++.+++|.+..... .....+.+|+++++.++|+||+++++++..+...++|+||++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 2 QKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred ccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 34578999999999999875 688999998865432 245678889999999999999999999999999999999996
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+ ++.+++... ...+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 82 ~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~ 154 (283)
T cd05118 82 T-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-P 154 (283)
T ss_pred C-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-c
Confidence 4 888887642 3578999999999999999999998 9999999999999999999999999999877654431 1
Q ss_pred cccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC---cccccc---
Q 008707 395 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---VISIVD--- 467 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d--- 467 (557)
.....++..|+|||.+.+. .++.++|+||+|+++|+|+||+.||...+..+.. ......+.... .....+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL---FKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCchHhcccchhhhh
Confidence 1223467889999998876 7889999999999999999999999744322111 11111110000 000000
Q ss_pred ---ccc-------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 468 ---PVL-------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 468 ---~~l-------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
... ...........+.+++.+||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000 00111233457899999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=295.44 Aligned_cols=263 Identities=22% Similarity=0.314 Sum_probs=196.3
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEec-----CeeEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 308 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----~~~~l 308 (557)
|.+.+.||+|+||+||+|... +++.||+|.+... .......+.+|+.+++.++|+||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 455788999999999999765 6899999988653 223345677899999999999999999987654 34799
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||+. ++|.+++.. ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 87 VYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 999995 688888863 4568999999999999999999998 999999999999999999999999999998764
Q ss_pred CCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc--------
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK-------- 459 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------- 459 (557)
..... .....++..|+|||.+.. ..++.++||||||+++|+|++|+.||...+....... .......
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~ 235 (337)
T cd07858 160 EKGDF-MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKL---ITELLGSPSEEDLGF 235 (337)
T ss_pred CCccc-ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHH---HHHHhCCCChHHhhh
Confidence 33211 222347889999998765 4688999999999999999999999975432211110 1110000
Q ss_pred ---CCcccc-------ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhh
Q 008707 460 ---GDVISI-------VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSI 511 (557)
Q Consensus 460 ---~~~~~~-------~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~~ 511 (557)
+..... .++... .........+.+++.+|++.+|++|||++|+++. ++...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred cCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000000 000000 0011234568899999999999999999999976 55443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=280.93 Aligned_cols=259 Identities=22% Similarity=0.275 Sum_probs=193.2
Q ss_pred HhhcccCCCCceEEEEEEEcC-CcEEEEEEccCccc--hhHHHHHHHHHHHhhc---CCCCccceeeEEEecCe-----e
Q 008707 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEEEHQ-----R 306 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~h~nIv~~~~~~~~~~~-----~ 306 (557)
++.+.||+|+||.||+|.++. ++.||+|.+..... .....+.+|+.+++++ +||||+++++++..... .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 356789999999999999874 89999999864322 2234566788877766 59999999999987766 8
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
+++|||+. ++|.+++.... ...+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||++..
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred EEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence 99999996 58988886532 3468999999999999999999998 8999999999999999999999999999877
Q ss_pred cCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc---
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--- 463 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 463 (557)
....... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+ .+..........+...
T Consensus 157 ~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhcCC
Confidence 6443221 12236888999999999899999999999999999999999997433211 1111111100000000
Q ss_pred ------cccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 464 ------SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 464 ------~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..+..... ..........+.+++.+||+.||++||+++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 1111233457789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=284.88 Aligned_cols=246 Identities=27% Similarity=0.390 Sum_probs=198.6
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc---cchhHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e 311 (557)
|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|++++++++ ||||+++++++.+++..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 456788999999999999875 6899999998652 2233467888999999998 9999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
++++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 83 YAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999974 3479999999999999999999998 999999999999999999999999999988654432
Q ss_pred c-------------------cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHH
Q 008707 392 T-------------------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 452 (557)
Q Consensus 392 ~-------------------~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~ 452 (557)
. .......++..|+|||......++.++||||||++++++++|..||...... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~--- 230 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LT--- 230 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HH---
Confidence 1 1122334688999999998888999999999999999999999999844311 11
Q ss_pred HHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 008707 453 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM----QEIVL 505 (557)
Q Consensus 453 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~----~evl~ 505 (557)
..... ... ...+...+..+.+++.+||+.+|++||++ +++++
T Consensus 231 ~~~~~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQKIL-KLE----------YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHH-hcC----------CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11111 100 01111224578899999999999999999 77754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=286.08 Aligned_cols=259 Identities=20% Similarity=0.274 Sum_probs=191.5
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|++|.||+|..+ +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.+....++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 456788999999999999876 688999998864322 23356888999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC-CCcEEEecccCccccCCCCc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~ 392 (557)
+ ++|.+.+... ....+++..+..++.||+.||+|||+ ++++|+||+|+||+++. ++.+||+|||++........
T Consensus 84 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 84 D-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred c-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 5 5787777543 23346788888999999999999998 89999999999999985 56799999999976543221
Q ss_pred cccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc-----
Q 008707 393 HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV----- 466 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 466 (557)
. .....+++.|+|||.+.+ ..++.++||||+|+++|+|+||+.||...+..+. +.. ........ .....
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~--~~~-~~~~~~~~-~~~~~~~~~~ 233 (294)
T PLN00009 159 T-FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE--LFK-IFRILGTP-NEETWPGVTS 233 (294)
T ss_pred c-cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCC-Chhhcccccc
Confidence 1 122346789999998866 4578899999999999999999999974332111 110 00000000 00000
Q ss_pred --c-----ccccC----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 467 --D-----PVLIG----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 467 --d-----~~l~~----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+ +.... .........+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 001112346789999999999999999999986
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=291.42 Aligned_cols=257 Identities=20% Similarity=0.209 Sum_probs=192.3
Q ss_pred hhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchh--------------HHHHHHHHHHHhhcCCCCccceeeEEEec
Q 008707 239 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR--------------TQQFVTEVALLSRIHHRNLVPLIGYCEEE 303 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 303 (557)
+.+.||+|+||.||+|... +++.||+|++....... ...+.+|+++++.++|+||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 4577999999999999865 68999999886432211 12477899999999999999999999999
Q ss_pred CeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccC
Q 008707 304 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 383 (557)
Q Consensus 304 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 383 (557)
+..++||||+. |+|.+++.. ...+++.....++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||+
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999996 689988863 4568899999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCC-------------ccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccH
Q 008707 384 SRQAEEDL-------------THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 449 (557)
Q Consensus 384 a~~~~~~~-------------~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~ 449 (557)
+....... ........+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+ .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~---~ 242 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID---Q 242 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 87654111 0111122367889999998764 46889999999999999999999997544221 1
Q ss_pred HHHHHHHHhcCCcccc-----------ccccccC---CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 450 VHWARSMIKKGDVISI-----------VDPVLIG---NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 450 ~~~~~~~~~~~~~~~~-----------~d~~l~~---~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
...+............ +...... .........+.+++.+|++.+|++|||++|++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 243 LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111111100000 0000000 001112346889999999999999999999985
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=279.65 Aligned_cols=241 Identities=22% Similarity=0.273 Sum_probs=186.0
Q ss_pred ccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHH---HhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 242 KIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVAL---LSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 242 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~i---l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.||+|+||.||+|... +++.||+|.+..... .....+..|..+ ++...||+|+.+++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999765 588999998865321 112223444443 444579999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+|+|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~-- 152 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-- 152 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence 9999988863 4568999999999999999999998 9999999999999999999999999999876543221
Q ss_pred cccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 395 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
....|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||........... ....... +..+
T Consensus 153 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~------~~~~--- 218 (278)
T cd05606 153 -HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTM------AVEL--- 218 (278)
T ss_pred -cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhcc------CCCC---
Confidence 223589999999998754 688999999999999999999999975432211111 1111100 1111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 505 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 505 (557)
+......+.+++.+|+..+|.+|| ++.|+++
T Consensus 219 -~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 -PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 111234788999999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=268.02 Aligned_cols=257 Identities=24% Similarity=0.376 Sum_probs=199.7
Q ss_pred HHh-hcccCCCCceEEEEEE-EcCCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNF-CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~-~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|.+ .+.||+|+|+.|--+. +.+|.++|||++.+.....+.++.+|++++.+. .|+||++++++|+++++.|+|||.|
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm 158 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKM 158 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecc
Confidence 444 6889999999998874 678999999999888777888999999999998 5999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc---EEEecccCccccC--
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAE-- 388 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfgla~~~~-- 388 (557)
.||+|..+|. +..-+++..+.++..+|+.||.|||. +||.||||||+|||-..... +|||||.+.....
T Consensus 159 ~GGplLshI~---~~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 159 RGGPLLSHIQ---KRKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred cCchHHHHHH---HhhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 9999999998 45678999999999999999999998 99999999999999976554 8999998876432
Q ss_pred CCCcccc----ccccCCCCccCCcccC-----CCCCCcccceehhHHHHHHHHhCCCCCCCCCcc----ccccH----HH
Q 008707 389 EDLTHIS----SVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AELNI----VH 451 (557)
Q Consensus 389 ~~~~~~~----~~~~g~~~y~aPE~l~-----~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~----~~~~~----~~ 451 (557)
.+..... .+..|+..|||||+.. ...|+.++|.||||+|+|-|++|.+||.+.-.. +.... .+
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN 312 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence 2211111 2335888999999863 346888999999999999999999999854322 11111 11
Q ss_pred HHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 452 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 452 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+-..+.+|.+. +.|. --.....+..+++...+..++.+|-++.++++
T Consensus 313 ~LFesIQEGkYe-FPdk-----dWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 313 KLFESIQEGKYE-FPDK-----DWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHhccCCc-CChh-----hhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 112233333321 1111 01122345678889999999999999999987
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=293.61 Aligned_cols=266 Identities=23% Similarity=0.324 Sum_probs=202.1
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecC-----eeEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRIL 308 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-----~~~l 308 (557)
|++.+.||.|++|.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 456789999999999999876 48999999987643 334567889999999999999999999987765 7899
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
+|||+. ++|.+.+.. ...+++..+..++.|++.||+|||+ .|++||||||.||+++.++.++|+|||++....
T Consensus 82 v~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 82 VTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred Eecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 999996 588888863 3478999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCc--cccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc------
Q 008707 389 EDLT--HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------ 459 (557)
Q Consensus 389 ~~~~--~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------ 459 (557)
.... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......... ..+......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~ 231 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL---NLIVEVLGTPSEEDL 231 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHhcCCCChhHh
Confidence 4421 111223478899999999887 8899999999999999999999999755432111 111110000
Q ss_pred -----CCccccccc-cc-----cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhhh
Q 008707 460 -----GDVISIVDP-VL-----IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 512 (557)
Q Consensus 460 -----~~~~~~~d~-~l-----~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~~~ 512 (557)
......+.. .. ........+..+.+++.+||+.+|++||++.++++. +++...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 000000000 00 000011134578899999999999999999999984 665544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=281.45 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=193.0
Q ss_pred HHHHhhcccCCCCceEEEEEEEcC-CcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
..+++.+.||+|+||.||+|.++. ++.||+|.+.... ......+..|+.++... .||||+++++++.+....+++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 345678999999999999999875 8999999986543 23345567788777766 49999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+. +++.+.+... ...+++..+..++.|++.||+|||+ ..+++||||+|+||++++++.++|+|||++.......
T Consensus 95 ~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 984 5777766542 3478899999999999999999996 2599999999999999999999999999987654332
Q ss_pred ccccccccCCCCccCCcccCCCC----CCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQ----LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~----~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
.. ....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... .+........ .......
T Consensus 170 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~-~~~~~~~ 241 (296)
T cd06618 170 AK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQE-EPPSLPP 241 (296)
T ss_pred cc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcC-CCCCCCC
Confidence 21 2224678999999987553 788999999999999999999999632111 1111111111 1111100
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.......+.+++.+||..+|++||++.++++.
T Consensus 242 -------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 -------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00123468899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=281.69 Aligned_cols=248 Identities=29% Similarity=0.403 Sum_probs=194.4
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc---cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
...++...+.||+|+||.||+|... +++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 3445666788999999999999875 5788999987532 22334568889999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||+. |++.+.+... ...+++..+..++.|++.|+.|||+ .+++||||+|+||+++.++.++|+|||++....
T Consensus 93 v~e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 93 VMEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EEEccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 999996 6887776532 3458899999999999999999998 999999999999999999999999999987654
Q ss_pred CCCccccccccCCCCccCCcccC---CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~---~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
.. ....+++.|+|||.+. ...++.++||||||+++|+|++|+.||...+.. ..... +..+.....
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~-~~~~~~~~~ 234 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYH-IAQNESPAL 234 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH------HHHHH-HhhcCCCCc
Confidence 32 1234788999999974 356788999999999999999999998633211 11111 111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
. .......+.+++.+||..+|++||+++++++.
T Consensus 235 -----~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 235 -----Q---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred -----C---cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 0 11233468899999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=280.15 Aligned_cols=261 Identities=23% Similarity=0.319 Sum_probs=194.7
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEEecC
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.+.+.||+|++|.||+|... +++.|++|.+..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 45688999999999999876 478999998865422 22334567999999998 999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+|+|.+.+.... ...+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (283)
T cd07830 81 EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY- 155 (283)
T ss_pred CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc-
Confidence 889998887532 3468999999999999999999998 99999999999999999999999999999866443221
Q ss_pred cccccCCCCccCCcccC-CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccH-H---------HHHHHHHhcCCcc
Q 008707 395 SSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI-V---------HWARSMIKKGDVI 463 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~-~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~-~---------~~~~~~~~~~~~~ 463 (557)
....++..|+|||.+. ...++.++|+||||+++++|++|+.||......+.... . .|...........
T Consensus 156 -~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 156 -TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred -CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 2234788999999874 45678999999999999999999999975432211100 0 0110000000000
Q ss_pred ccccccc---cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 464 SIVDPVL---IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 464 ~~~d~~l---~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..+.... ..+........+.+++.+|++.+|++|||++|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 00011112357889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=269.82 Aligned_cols=203 Identities=26% Similarity=0.385 Sum_probs=169.5
Q ss_pred HHHhhcccCCCCceEEEEEEEcC-----CcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEe-cCeeE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRI 307 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~ 307 (557)
.|+.+..||+|.||.||+|.-++ .+.+|+|.++.... .-.....+|+.+++.++||||+.+..+|-. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 45668899999999999995432 34799999875422 223567899999999999999999998876 77899
Q ss_pred EEEEecCCCChhhhhhccC--CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC----CcEEEecc
Q 008707 308 LVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSDF 381 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~----~~~kl~Df 381 (557)
+++||.+. +|.++++-.. ..+.++...+.+|+.||+.|+.|||+ +-|+||||||.||||..+ |.|||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999965 8888886433 44678999999999999999999998 899999999999999876 89999999
Q ss_pred cCccccCCCCccc--cccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCC
Q 008707 382 GLSRQAEEDLTHI--SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVED 442 (557)
Q Consensus 382 gla~~~~~~~~~~--~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~ 442 (557)
|+++.+.+..... ......|.+|.|||.+.+. .|+.+.||||+|||+.||+|.++-|.+..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 9999987654332 2344578999999998775 78999999999999999999998887544
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=278.95 Aligned_cols=244 Identities=30% Similarity=0.417 Sum_probs=191.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+...+.||+|+||.||+|... +++.|++|.+.... ....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 333577999999999999865 58899999886432 22345688899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+. |++.+.+... ...+++..+..++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-- 174 (313)
T cd06633 103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-- 174 (313)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence 95 5787777542 3568899999999999999999998 99999999999999999999999999988653221
Q ss_pred cccccccCCCCccCCcccC---CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccc
Q 008707 393 HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~---~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 469 (557)
....|+..|+|||.+. ...++.++||||||+++|+|++|..||...+... ....... +......
T Consensus 175 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~-~~~~~~~--- 241 (313)
T cd06633 175 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQ-NDSPTLQ--- 241 (313)
T ss_pred ---CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHh-cCCCCCC---
Confidence 2234788999999984 4568889999999999999999999986432211 1111111 1111111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.......+.+++.+|++.+|.+||++.++++.
T Consensus 242 -----~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 242 -----SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -----ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11123468899999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.55 Aligned_cols=245 Identities=28% Similarity=0.386 Sum_probs=196.4
Q ss_pred hcccCCCCceEEEEEE-EcCCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 240 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
+.+||.|.||.||-|. ..+|+-.|+|-++-. .....+.+.+|..++..++|||+|+++|+-..++..++.||||.+|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 3569999999999986 456889999977532 2333456889999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc---
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--- 393 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--- 393 (557)
+|.+.+.. ++..++.....+..|++.|++|||+ +|||||||||.||+++.+|.+|++|||.|.........
T Consensus 1320 sLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1320 SLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred cHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence 99999873 4456666667789999999999998 99999999999999999999999999999987655322
Q ss_pred ccccccCCCCccCCcccCCC---CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 394 ISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~---~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
.-....||+.|||||++.+. ....++||||+|||+.||+||+.||...+- +..+ ...+..|....+..
T Consensus 1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn--e~aI----My~V~~gh~Pq~P~--- 1464 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN--EWAI----MYHVAAGHKPQIPE--- 1464 (1509)
T ss_pred HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc--hhHH----HhHHhccCCCCCch---
Confidence 12335699999999999764 345699999999999999999999973332 2222 22333444433322
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
....+=.+++.+|+..||+.|.++.|+++
T Consensus 1465 ------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1465 ------RLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ------hhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 23345669999999999999999998875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=266.44 Aligned_cols=246 Identities=23% Similarity=0.328 Sum_probs=195.2
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEe----cCeeEEEEEec
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRILVYEYM 313 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~----~~~~~lv~e~~ 313 (557)
.++||-|-.|.|..+..+ +++.+|+|++... ....+|+++.-.. .|||||.+++++++ ...+.+|||.+
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 478999999999999776 6889999998643 3455788875544 69999999998754 44677999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC---CCcEEEecccCccccCCC
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~ 390 (557)
+||.|.+.+... ....+++.++..|+.||+.|+.|||+ .+|.||||||+|+|... +..+||+|||+|+.....
T Consensus 142 eGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~ 217 (400)
T KOG0604|consen 142 EGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP 217 (400)
T ss_pred cchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence 999999999865 45679999999999999999999998 99999999999999964 556999999999987653
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
... .+.+-||.|.|||++....|+..+|+||+|+++|-|++|.+||-... +..+.--.+..+..|.+. +.+
T Consensus 218 ~~L--~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~h---g~aispgMk~rI~~gqy~-FP~--- 288 (400)
T KOG0604|consen 218 GDL--MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---GLAISPGMKRRIRTGQYE-FPE--- 288 (400)
T ss_pred ccc--cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccC---CccCChhHHhHhhccCcc-CCC---
Confidence 332 23457999999999999999999999999999999999999995221 122222344455544431 111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..-........++|..+|..+|.+|-|+.|++.
T Consensus 289 --pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 289 --PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred --hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 111234457789999999999999999999975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=272.03 Aligned_cols=259 Identities=24% Similarity=0.370 Sum_probs=205.6
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEcC------CcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEe-cC
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EH 304 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~ 304 (557)
...+.+....+-+|.||.||.|.|.+ .+.|.+|.+++... -+...++.|.-.+..+.|||+.++.+++.+ ..
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 34444456679999999999997653 45678888775433 345678889999999999999999998754 55
Q ss_pred eeEEEEEecCCCChhhhhh-----ccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEe
Q 008707 305 QRILVYEYMHNGTLRDRLH-----GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 379 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 379 (557)
..++++.++.-|+|+.++. +......++..+...++.|++.|++|||. ++++|.||.++|++||+..++||+
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhheeEEec
Confidence 7889999999999999998 33345567788889999999999999998 999999999999999999999999
Q ss_pred cccCccccCCCC-ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHH
Q 008707 380 DFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI 457 (557)
Q Consensus 380 Dfgla~~~~~~~-~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 457 (557)
|=.+++..-... .........+..||+||.+.+..|+.++||||||++||||+| |+.||..-|. ... ...+
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP---fEm----~~yl 511 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP---FEM----EHYL 511 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH---HHH----HHHH
Confidence 999998754332 222333456889999999999999999999999999999999 9999973322 111 2223
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 458 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 458 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
.+|.. -..+.+.+++++.++.-||...|++||+++++..-|.+.
T Consensus 512 kdGyR---------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 512 KDGYR---------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred hccce---------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 33321 112345677999999999999999999999999877664
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=272.64 Aligned_cols=236 Identities=30% Similarity=0.386 Sum_probs=191.7
Q ss_pred cCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 243 IGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 243 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
||+|+||.||++... +++.+++|.+..... ...+.+..|+++++.++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999876 488999998865432 2345788999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccccc
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 398 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~ 398 (557)
.+++.. ...+++..+..++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTF 153 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-cccCC
Confidence 999974 3468999999999999999999998 9999999999999999999999999999887644321 12234
Q ss_pred cCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHH
Q 008707 399 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 478 (557)
Q Consensus 399 ~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 478 (557)
.++..|++||...+...+.++|+||||+++|++++|+.||...+. ........ .+.. ..+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~-~~~~----------~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKIL-KDPL----------RFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHh-cCCC----------CCCCCC
Confidence 478899999999888889999999999999999999999974432 11111111 1110 111112
Q ss_pred HHHHHHHHHHccccCCCCCCCHHH
Q 008707 479 IWRIAEVAIQCVEQRGFSRPKMQE 502 (557)
Q Consensus 479 ~~~l~~li~~cl~~~P~~RPt~~e 502 (557)
+..+.+++.+|+..+|++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 457889999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=275.78 Aligned_cols=248 Identities=26% Similarity=0.347 Sum_probs=193.1
Q ss_pred HHhhcccCCCCceEEEEEEEcC-CcEEEEEEccCc-----cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
|.+.+.||+|+||.||++.... +..+++|+++.. ......++..|+.+++.++||||+++++++.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 4567899999999999997653 445566655431 1223345778999999999999999999999888999999
Q ss_pred EecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 311 EYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
||+++++|.+.+.... ....+++..++.++.|++.||.|||+ .+++|+||+|+||++++ +.++|+|||.+.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecCC
Confidence 9999999998886422 34578999999999999999999998 99999999999999975 5699999999876543
Q ss_pred CCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccc
Q 008707 390 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 469 (557)
.... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ...... +..+...
T Consensus 158 ~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~-~~~~~~~------ 223 (260)
T cd08222 158 SCDL-ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLR-IVEGPTP------ 223 (260)
T ss_pred Cccc-ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHH-HHcCCCC------
Confidence 3221 2233478899999999888889999999999999999999999963321 111111 1112111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..+...+..+.+++.+|+..+|++||++.|+++
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 ---SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 112233457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=276.81 Aligned_cols=257 Identities=24% Similarity=0.317 Sum_probs=195.8
Q ss_pred hhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 239 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.+.||+|.+|.||+|... +++.||+|.+.... ....+.+..|+++++.++|+||+++++++.+....++||||+.
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 4578999999999999876 48999999987643 2334567889999999999999999999999999999999997
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
++|.+++... ...+++..+..++.|++.||+|||+ .+++||||+|+||++++++.++|+|||.+......... .
T Consensus 82 ~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (282)
T cd07829 82 MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-Y 155 (282)
T ss_pred cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc-c
Confidence 5899999753 2468999999999999999999998 89999999999999999999999999998776443221 1
Q ss_pred ccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc------cc--cc
Q 008707 396 SVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV------IS--IV 466 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~--~~ 466 (557)
....++..|+|||.+.+. .++.++||||||+++|||++|..||........ ............. .. ..
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhcccccc
Confidence 122356789999998766 789999999999999999999999975432111 1111111100000 00 00
Q ss_pred cccc-------cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 467 DPVL-------IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 467 d~~l-------~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+... ...........+.+++.+|+..+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000 00001112457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=282.38 Aligned_cols=262 Identities=22% Similarity=0.273 Sum_probs=190.0
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccch--hHHHHHHHHHHHhhcCCCCccceeeEEEecC-------
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH--RTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------- 304 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~------- 304 (557)
..|++.+.||+|+||.||+|..+ +++.+|+|++...... ....+.+|+++++.++||||+++++++....
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 34556789999999999999876 5889999987543221 2345678999999999999999999875433
Q ss_pred -eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccC
Q 008707 305 -QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 383 (557)
Q Consensus 305 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 383 (557)
..++|+||+. +++.+.+.. ....+++..+..++.|+++||+|||+ .+++|+||||+||++++++.++|+|||+
T Consensus 88 ~~~~lv~~~~~-~~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 88 GSVYMVTPYMD-HDLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred ceEEEEEecCC-cCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence 4689999996 467776653 24568999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCccc----------cccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHH
Q 008707 384 SRQAEEDLTHI----------SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 452 (557)
Q Consensus 384 a~~~~~~~~~~----------~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~ 452 (557)
+.......... .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~--- 238 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL--- 238 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---
Confidence 97654322111 112235788999998765 4578899999999999999999999975443211111
Q ss_pred HHHHHhc---------CCccccccccccCCCC-------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 453 ARSMIKK---------GDVISIVDPVLIGNVK-------IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 453 ~~~~~~~---------~~~~~~~d~~l~~~~~-------~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
....... .......+.......+ ......+.+++.+|+..+|++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1110000 0000000000000000 111246889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=279.72 Aligned_cols=243 Identities=24% Similarity=0.282 Sum_probs=196.0
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
-++||+|+||.||.++.+ +|+.+|.|.+.+... ......+.|..||.+++.+.||.+--.|++.+.+++|+..|+|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 578999999999999765 699999998865322 2334578899999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.-+|... ....+++..+..++.+|+.||+|||. .+||+|||||+|||+|+.|+++|+|+|+|..+........
T Consensus 270 GDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~ 345 (591)
T KOG0986|consen 270 GDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRG 345 (591)
T ss_pred CceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCcccc
Confidence 9999888754 34689999999999999999999998 9999999999999999999999999999998876544332
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
..||.+|||||++.+..|+...|.||+||++|||+.|+.||...... ...+.+.+.+...+ .+++
T Consensus 346 --rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK---vk~eEvdrr~~~~~----------~ey~ 410 (591)
T KOG0986|consen 346 --RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK---VKREEVDRRTLEDP----------EEYS 410 (591)
T ss_pred --ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh---hhHHHHHHHHhcch----------hhcc
Confidence 35999999999999999999999999999999999999999732211 01111222221111 1223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQ 501 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~ 501 (557)
..-..+..++....|+.||.+|-...
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCC
Confidence 33334677888889999999886443
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=290.39 Aligned_cols=256 Identities=21% Similarity=0.283 Sum_probs=189.5
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEec-----------
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE----------- 303 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~----------- 303 (557)
.|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+++++.++||||+++++.+...
T Consensus 6 ~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred ceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 4556789999999999999875 5889999988665555567788999999999999999999876543
Q ss_pred ---CeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC-CCcEEEe
Q 008707 304 ---HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVS 379 (557)
Q Consensus 304 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~ 379 (557)
...++||||+. ++|.+++. ...+++..+..++.||++||.|||+ .+++||||||+||+++. ++.++|+
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEEC
Confidence 35789999996 58888775 3458899999999999999999998 99999999999999974 5678999
Q ss_pred cccCccccCCCCccc--cccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 008707 380 DFGLSRQAEEDLTHI--SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 456 (557)
Q Consensus 380 Dfgla~~~~~~~~~~--~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~ 456 (557)
|||++.......... .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||......... ...
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~------~~~ 231 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM------QLI 231 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH
Confidence 999987653322111 122346889999998654 56788999999999999999999999744321110 000
Q ss_pred HhcCCc--------------cccccccccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 457 IKKGDV--------------ISIVDPVLIGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 457 ~~~~~~--------------~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+..... ............ ......++.+++.+|++.+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000 000000000000 0112346789999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=265.81 Aligned_cols=248 Identities=24% Similarity=0.337 Sum_probs=201.1
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
.....|.++||+|.||.|.+++.+ +++.+|+|++++... .....-+.|-++|+.-+||.+..+--.|+..++.|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 345567899999999999999766 689999999987532 3345567799999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||..||.|.-++.+ ...+++.....+...|+.||.|||+ ++||.||||.+|.|+|.+|++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HLsr---er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR---ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeehhh---hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999999988873 5678888888999999999999998 9999999999999999999999999999986422
Q ss_pred CCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccc
Q 008707 390 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 469 (557)
. .....+.+|||.|+|||++....|..+.|.|.+|+++|||++|+.||-..+.+.-..++- ...-.
T Consensus 321 ~-g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-----~ed~k-------- 386 (516)
T KOG0690|consen 321 Y-GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-----MEDLK-------- 386 (516)
T ss_pred c-cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-----hhhcc--------
Confidence 2 223567889999999999999999999999999999999999999997554432221111 00000
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 008707 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 505 (557)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 505 (557)
++.....+...++...+..||.+|- .++||.+
T Consensus 387 ----FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 387 ----FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ----CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 1112223567889999999999996 4566554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.25 Aligned_cols=246 Identities=28% Similarity=0.399 Sum_probs=183.4
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEe---------------
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------------- 302 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--------------- 302 (557)
.+.||+|+||.||+++.+ ||+.||||++.-.. ......+.+|+.++++|+|||||+++..+.+
T Consensus 484 L~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 484 LELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 578999999999999877 89999999986443 3344678899999999999999999621100
Q ss_pred --------------------------------------------------------------------------------
Q 008707 303 -------------------------------------------------------------------------------- 302 (557)
Q Consensus 303 -------------------------------------------------------------------------------- 302 (557)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred ----------------c--------CeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 008707 303 ----------------E--------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358 (557)
Q Consensus 303 ----------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 358 (557)
. ...|+=||||+...+.++++... ..-.....+.++++|++||+|+|+ +|+
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~--~~~~~d~~wrLFreIlEGLaYIH~---~gi 718 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH--FNSQRDEAWRLFREILEGLAYIHD---QGI 718 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc--cchhhHHHHHHHHHHHHHHHHHHh---Cce
Confidence 0 12578899999888888887532 111356678999999999999998 999
Q ss_pred EeeccCCCCEEeCCCCcEEEecccCccccC------C-----------CCccccccccCCCCccCCcccCCCC---CCcc
Q 008707 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAE------E-----------DLTHISSVARGTVGYLDPEYYGNQQ---LTEK 418 (557)
Q Consensus 359 vH~dlk~~NIll~~~~~~kl~Dfgla~~~~------~-----------~~~~~~~~~~g~~~y~aPE~l~~~~---~s~~ 418 (557)
+||||||.|||+++++.|||+|||+|.... + ..........||.-|+|||++.+.. |+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999998721 0 0011122345999999999997764 9999
Q ss_pred cceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCC
Q 008707 419 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP 498 (557)
Q Consensus 419 ~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP 498 (557)
+|+||+|+|++||+- ||... + +. ..+...++.|.+... .++.......=+.+|.++++.||.+||
T Consensus 799 iDmYSLGIVlFEM~y---PF~Ts-M-ER----a~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRP 863 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGTS-M-ER----ASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRP 863 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCch-H-HH----HHHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCC
Confidence 999999999999994 46511 1 11 112233445554433 112222333456899999999999999
Q ss_pred CHHHHHH
Q 008707 499 KMQEIVL 505 (557)
Q Consensus 499 t~~evl~ 505 (557)
||.|+++
T Consensus 864 tA~eLL~ 870 (1351)
T KOG1035|consen 864 TATELLN 870 (1351)
T ss_pred CHHHHhh
Confidence 9999975
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=285.37 Aligned_cols=260 Identities=21% Similarity=0.288 Sum_probs=189.7
Q ss_pred HHhhcccCCCCceEEEEEEEc-C--CcEEEEEEccCcc--chhHHHHHHHHHHHhhc-CCCCccceeeEEEec----Cee
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-D--GKEVAVKIMADSC--SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE----HQR 306 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~----~~~ 306 (557)
|++.+.||+|+||.||++... . +..||+|.+.... ....+.+.+|+++++++ .||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 445788999999999999875 3 6789999886432 22345678899999999 599999999875432 456
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++++|++. ++|.+.+. ....+++..+..++.||+.||+|||+ .+++||||||+||+++.++.++|+|||++..
T Consensus 82 ~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 82 YLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 78888885 68988886 34568999999999999999999998 9999999999999999999999999999986
Q ss_pred cCCCCcc---ccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh----
Q 008707 387 AEEDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---- 458 (557)
Q Consensus 387 ~~~~~~~---~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~---- 458 (557)
....... ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+.... .........
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 231 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ---LNQILQVLGTPDE 231 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH---HHHHHHHhCCCCH
Confidence 5432211 1122357899999998765 5688999999999999999999999975442211 000000000
Q ss_pred -------cCCcccc---cccc---ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 459 -------KGDVISI---VDPV---LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 459 -------~~~~~~~---~d~~---l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
....... .... ............+.+++.+|++.+|++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 0000 0000001123478899999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=279.97 Aligned_cols=259 Identities=23% Similarity=0.320 Sum_probs=192.0
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEe-cCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~lv~e 311 (557)
.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.. ....++++|
T Consensus 11 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e 90 (328)
T cd07856 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE 90 (328)
T ss_pred ceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEee
Confidence 3556789999999999999765 68999999875422 2234668889999999999999999998865 557889999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+ +++|.+++. ...++......++.|+++||+|||+ .+++||||+|+||++++++.++|+|||.+.......
T Consensus 91 ~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~ 162 (328)
T cd07856 91 LL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQM 162 (328)
T ss_pred hh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCCc
Confidence 98 678988875 3457888888999999999999998 999999999999999999999999999987543321
Q ss_pred ccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccH-HHHH-------HHHHhcCCc
Q 008707 392 THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI-VHWA-------RSMIKKGDV 462 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~-~~~~-------~~~~~~~~~ 462 (557)
....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........... .+.. ......+..
T Consensus 163 ----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 163 ----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred ----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 12346788999998765 5689999999999999999999999975432111100 0000 000000000
Q ss_pred ccccccc-ccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 463 ISIVDPV-LIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 463 ~~~~d~~-l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
...+... .....+ ......+.+++.+|++.+|++|||+.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000 000011 1123578899999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=281.06 Aligned_cols=263 Identities=23% Similarity=0.329 Sum_probs=194.3
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecC------ee
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 306 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~------~~ 306 (557)
.|.+.+.||+|+||.||+|... +++.||+|++.... ......+.+|+++++.++||||+++++++..+. ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDF 95 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceE
Confidence 4556789999999999999754 68999999885432 223456889999999999999999999887543 35
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++||||+ +++|.+++. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++..
T Consensus 96 ~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 96 YLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred EEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 8999999 789988875 3468899999999999999999998 9999999999999999999999999999886
Q ss_pred cCCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHH----------H
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR----------S 455 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~----------~ 455 (557)
..... ....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+.... ...... .
T Consensus 168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 168 TDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCHHHHH
Confidence 54322 22346889999999876 4578899999999999999999999974432110 000000 0
Q ss_pred HHhcCCcccccc--cccc----CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhhh
Q 008707 456 MIKKGDVISIVD--PVLI----GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDSIK 512 (557)
Q Consensus 456 ~~~~~~~~~~~d--~~l~----~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~~~ 512 (557)
.+.......... +... ..........+.+++.+|+..+|++|||+.++++ .++....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 000000000000 0000 0000112335789999999999999999999984 4555443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=286.98 Aligned_cols=264 Identities=23% Similarity=0.339 Sum_probs=192.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEec------CeeE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRI 307 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~------~~~~ 307 (557)
|...+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++++.++||||+++++++... ...+
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence 344688999999999999865 68999999886432 22335678999999999999999999988654 2468
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+|+||+. .+|.+.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 97 lv~e~~~-~~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 97 LVMPYMQ-TDLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred EEecccc-cCHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 9999995 4676654 2357889999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHH--------HHHHh
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA--------RSMIK 458 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~--------~~~~~ 458 (557)
.... ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+........... .....
T Consensus 168 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 168 DAEM----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred CCCC----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 3321 12346888999999876 46888999999999999999999999854322111000000 00000
Q ss_pred cCCcccccc--ccc-cCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhhhh
Q 008707 459 KGDVISIVD--PVL-IGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKI 513 (557)
Q Consensus 459 ~~~~~~~~d--~~l-~~~~---~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~~~~ 513 (557)
......... +.. .... .......+.+++.+|++.||++||+++|+++. ++...+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 000000000 000 0000 01123467899999999999999999999954 7776654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=272.85 Aligned_cols=267 Identities=20% Similarity=0.271 Sum_probs=205.8
Q ss_pred ChhHHHHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcC--CCC----ccceeeEE
Q 008707 228 PLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--HRN----LVPLIGYC 300 (557)
Q Consensus 228 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--h~n----Iv~~~~~~ 300 (557)
...|.....|.+...+|+|.||.|..+.+. .+..||+|+++.. ....+..+-|+++++++. .|+ +|++.++|
T Consensus 82 ~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 82 QVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred EeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 345666788888999999999999999655 4789999998754 344566778999999993 233 78888889
Q ss_pred EecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC--------
Q 008707 301 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------- 372 (557)
Q Consensus 301 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~-------- 372 (557)
.-.++.|+|+|.+ |-++.+++... +..+++...+..|+.|++++++|||+ .+++|.||||+|||+-+
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEec
Confidence 9999999999998 77999999865 46678999999999999999999998 99999999999999921
Q ss_pred ------------CCcEEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCC
Q 008707 373 ------------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSV 440 (557)
Q Consensus 373 ------------~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~ 440 (557)
+..++|+|||.|....... .....|..|.|||++.+..++..+||||+||||+|++||..-|+.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 3458999999998765443 334478999999999999999999999999999999999999986
Q ss_pred CCccccccHHHHH--------------HHHHhcCCccccccccccC----------------CCCHHHHHHHHHHHHHcc
Q 008707 441 EDFGAELNIVHWA--------------RSMIKKGDVISIVDPVLIG----------------NVKIESIWRIAEVAIQCV 490 (557)
Q Consensus 441 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~d~~l~~----------------~~~~~~~~~l~~li~~cl 490 (557)
.+..+.....+.+ ......|.+ +..+....+ .....+...|++|+.+||
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rl-dw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRL-DWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccc-cCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 6633222222211 111112211 111100000 112345568999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 008707 491 EQRGFSRPKMQEIVL 505 (557)
Q Consensus 491 ~~~P~~RPt~~evl~ 505 (557)
..||.+|+|+.|+++
T Consensus 391 ~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 391 EFDPARRITLREALS 405 (415)
T ss_pred ccCccccccHHHHhc
Confidence 999999999999985
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=265.41 Aligned_cols=252 Identities=25% Similarity=0.343 Sum_probs=196.0
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCccc-hhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
...||.|+||+|++-.++ .|+.+|||+++.... .+.++++.|.+...+- +.||||++||.+..++..++.||.|. .
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-I 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-h
Confidence 367999999999999876 599999999986544 5667888898876555 69999999999999999999999994 4
Q ss_pred Chhhhhhcc--CCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 317 TLRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 317 sL~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+|..+.+.. .....+++.-.-.|..-.+.||.||.+ +..|+|||+||+|||++..|.+||||||.+....+.....
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT 225 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKT 225 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhh
Confidence 654433221 135568888788888889999999998 5899999999999999999999999999998776543322
Q ss_pred cccccCCCCccCCcccCCC--CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 395 SSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~--~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.-.|...|||||.+... .|..++||||||++|||+.||+.||...+. +.+.+.+.+. |+...+..+
T Consensus 226 --~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~-gdpp~l~~~---- 293 (361)
T KOG1006|consen 226 --VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVI-GDPPILLFD---- 293 (361)
T ss_pred --hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHc-CCCCeecCc----
Confidence 23478899999999643 588899999999999999999999985433 3333333332 333222111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
....+....+..++.-|+..|-..||.++++.++
T Consensus 294 ~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 294 KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1112345578899999999999999999999865
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=299.03 Aligned_cols=253 Identities=26% Similarity=0.316 Sum_probs=205.3
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc---cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
....+.+.+.||+|+||.|..++++ +++.||+|++.++ .......|..|-.+|..-+.+-|++++-.|.++..+|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 3566778999999999999999886 5889999999874 23455679999999999899999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||++||+|..++... ..+++.-+..++..|+-||.-||+ .|+|||||||+|||+|.+|++||+|||.+....
T Consensus 153 VMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 99999999999999743 378999999999999999999998 999999999999999999999999999999888
Q ss_pred CCCccccccccCCCCccCCcccC----C-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYG----N-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~----~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
.+....+....|||.|++||++. + +.|++.+|.||+||++|||+.|..||-... +++.-.....-....
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~hk~~l 300 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMNHKESL 300 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhchhhhc
Confidence 77777777888999999999984 3 578999999999999999999999996332 222222222222222
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 008707 464 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK---MQEIVL 505 (557)
Q Consensus 464 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt---~~evl~ 505 (557)
.+.+. ........++|.+.+. +|+.|-. +.++..
T Consensus 301 ~FP~~-------~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 301 SFPDE-------TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred CCCcc-------cccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 22211 1133456677777665 5677777 777754
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=284.22 Aligned_cols=256 Identities=23% Similarity=0.305 Sum_probs=189.0
Q ss_pred HHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEec------CeeE
Q 008707 237 NNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRI 307 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~------~~~~ 307 (557)
|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (345)
T cd07877 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 98 (345)
T ss_pred eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEE
Confidence 44578899999999999975 468899999986532 22345678899999999999999999987543 3467
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
++++++ +++|.+++. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++...
T Consensus 99 lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 99 LVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred EEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 888877 789988875 2458899999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHH----------
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM---------- 456 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~---------- 456 (557)
... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.... +.......
T Consensus 171 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~ 244 (345)
T cd07877 171 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPGAELLKK 244 (345)
T ss_pred ccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHHHhh
Confidence 332 122347889999998866 4678899999999999999999999964332111 11000000
Q ss_pred HhcCCcc---cccccccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 457 IKKGDVI---SIVDPVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 457 ~~~~~~~---~~~d~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+...... ..+..... .+........+.+++.+|++.+|.+||++.++++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000 00000000 00000123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=282.34 Aligned_cols=255 Identities=21% Similarity=0.314 Sum_probs=192.0
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCe------e
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------R 306 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~------~ 306 (557)
.|++.+.||+|++|.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++...+. .
T Consensus 16 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 3456789999999999999876 57899999886432 2334567789999999999999999998766554 8
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .|++||||+|+||+++.++.++|+|||++..
T Consensus 96 ~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~ 167 (343)
T cd07851 96 YLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH 167 (343)
T ss_pred EEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccc
Confidence 9999998 6799998863 468999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc------
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------ 459 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------ 459 (557)
..... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ..........
T Consensus 168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~---~~~i~~~~~~~~~~~~ 240 (343)
T cd07851 168 TDDEM----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ---LKRIMNLVGTPDEELL 240 (343)
T ss_pred ccccc----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHhcCCCCHHHH
Confidence 64331 22346888999999865 4678899999999999999999999974432111 1100000000
Q ss_pred -----CCccccccc---cccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 460 -----GDVISIVDP---VLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 460 -----~~~~~~~d~---~l~~~~---~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
......+.. .....+ .......+.+++.+|++.+|++|||+.||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000 000000 0012457889999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=276.91 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=203.2
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
.++||.|.||+||-|.++ +|+.||||++.+. ......++.+|+.||+++.||.||.+...|+..++.++|||.+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 689999999999999865 6999999998653 23445778999999999999999999999999999999999995 5
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC---CcEEEecccCccccCCCCcc
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla~~~~~~~~~ 393 (557)
++.+++-.+ ..+.+++.....++.||+.||.|||- ++|+|+||||+|||+... -.+||||||+|+.+++..
T Consensus 648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 555555443 46678988888999999999999997 999999999999999643 469999999999987643
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
......|||.|+|||++++..|...-|+||.|+|+|.-++|..||+. +. ++ .+.+.+-.+ ++-+..+.
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE-dE----dI----ndQIQNAaF--MyPp~PW~- 789 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE-DE----DI----NDQIQNAAF--MYPPNPWS- 789 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC-cc----ch----hHHhhcccc--ccCCCchh-
Confidence 23445699999999999999999999999999999999999999972 11 11 112222211 12222222
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHH--------HHHHhhhhhhcCCCCccc
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV--------LAIQDSIKIEKGGDQKFS 522 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl--------~~L~~~~~~~~~~~~~~~ 522 (557)
+.....+++|...++..-.+|-+.+.-+ +...++...|...-+++=
T Consensus 790 ---eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~igeRyi 843 (888)
T KOG4236|consen 790 ---EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGERYI 843 (888)
T ss_pred ---hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCccee
Confidence 3334667888888999889998887654 234455555555544443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=283.26 Aligned_cols=238 Identities=25% Similarity=0.356 Sum_probs=192.2
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEe
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
..|.+...+|.|+|+.|-.+.+. +++..++|++.+. ..+..+|+.++... +||||+++.+.+.+....++|||.
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 45667778999999999888765 5888999998754 22234577676666 799999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe-CCCCcEEEecccCccccCCCC
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll-~~~~~~kl~Dfgla~~~~~~~ 391 (557)
+.|+-+.+.+... .... ..+..|+.+|+.|+.|||+ +|++||||||+|||+ ++.++++|+|||.++......
T Consensus 398 l~g~ell~ri~~~---~~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~ 470 (612)
T KOG0603|consen 398 LDGGELLRRIRSK---PEFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSC 470 (612)
T ss_pred ccccHHHHHHHhc---chhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchhh
Confidence 9999888877632 2222 6677899999999999998 999999999999999 689999999999998876551
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
...+-|..|.|||++....|++++|+||||++||+|++|+.||...... ..+...+..+...
T Consensus 471 ----~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s-------- 532 (612)
T KOG0603|consen 471 ----DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFS-------- 532 (612)
T ss_pred ----cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCccc--------
Confidence 1223588999999999999999999999999999999999999844433 1223334333332
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
........+++.+||+.||.+||+|.++..
T Consensus 533 ----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 533 ----ECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 233346789999999999999999999974
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=263.39 Aligned_cols=220 Identities=22% Similarity=0.209 Sum_probs=174.9
Q ss_pred CCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCChhhhhhc
Q 008707 246 GSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 324 (557)
Q Consensus 246 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 324 (557)
|.+|.||++... +++.||+|.+.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999765 68899999986542 223455555556799999999999999999999999999999999864
Q ss_pred cCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccccccCCCCc
Q 008707 325 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 404 (557)
Q Consensus 325 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y 404 (557)
...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++++|||.+....... ....++..|
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y 148 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY 148 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence 3458999999999999999999998 999999999999999999999999999876554321 122356789
Q ss_pred cCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHH
Q 008707 405 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 484 (557)
Q Consensus 405 ~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 484 (557)
+|||.+.+..++.++||||+|+++|||++|+.|+....... .... . ...+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~~--~-------~~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTHT--T-------LNIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cccc--c-------cCCcccCCHHHHH
Confidence 99999988888999999999999999999998875221100 0000 0 0011112346789
Q ss_pred HHHHccccCCCCCCCHH
Q 008707 485 VAIQCVEQRGFSRPKMQ 501 (557)
Q Consensus 485 li~~cl~~~P~~RPt~~ 501 (557)
++.+|++.||++||++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 99999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=295.93 Aligned_cols=143 Identities=32% Similarity=0.463 Sum_probs=127.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|.+.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++.+......++||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 456789999999999999876 68999999986432 22346788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
+.+++|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999874 3457888899999999999999998 899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-33 Score=277.12 Aligned_cols=237 Identities=23% Similarity=0.319 Sum_probs=198.6
Q ss_pred hcccCCCCceEEEEEEEcCCc-EEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 240 CKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
...||-|+||.|=++..+... .+|+|++++.. ..+.+.+..|-.+|...+.|.||++|..|.++...|++||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 456999999999999877544 48999887643 33445688899999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|.|+..++ +.+.++..+...++..+.+|++|||+ ++|++|||||+|.+++.+|-+||.|||+|+...... .+
T Consensus 505 GElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--KT 576 (732)
T KOG0614|consen 505 GELWTILR---DRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--KT 576 (732)
T ss_pred chhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccCC--ce
Confidence 99999998 46778888999999999999999998 999999999999999999999999999999886543 35
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
.+++|||.|.|||++.+...+.++|.||||+++|||++|.+||.+.+.-..++++- ..+ |.. +++
T Consensus 577 wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL---kGi---------d~i---~~P 641 (732)
T KOG0614|consen 577 WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL---KGI---------DKI---EFP 641 (732)
T ss_pred eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH---hhh---------hhh---hcc
Confidence 56889999999999999999999999999999999999999999776543333321 111 110 122
Q ss_pred HHHHHHHHHHHHHccccCCCCCCC
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPK 499 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt 499 (557)
....+...+++.+.+..+|.+|-.
T Consensus 642 r~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 642 RRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cccchhHHHHHHHHHhcCcHhhhc
Confidence 334446779999999999999986
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-33 Score=265.81 Aligned_cols=245 Identities=25% Similarity=0.333 Sum_probs=197.4
Q ss_pred hHHHHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhhc-CCCCccceeeEEEecC
Q 008707 230 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 304 (557)
Q Consensus 230 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~ 304 (557)
+.+.....+|..+||+|+||.|.+|..+ +.+.+|||++++... .+.+--+.|-++|... +-|.+++++..|+.-+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 3456677889999999999999999766 467899999987532 2333445677788766 5789999999999999
Q ss_pred eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCc
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 384 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 384 (557)
++|+||||+.||+|.-.++. -+.+.+..+..++..||-||-+||+ +||++||||.+||++|.+|++||+|||++
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred heeeEEEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccc
Confidence 99999999999999877763 4567778888999999999999998 99999999999999999999999999999
Q ss_pred cccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 385 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 385 ~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
+.---+ ...+.+.+|||.|+|||++....|+.++|.||||++||||+.|++||++++..+- .+ .+.+
T Consensus 498 KEni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el---F~----aI~e----- 564 (683)
T KOG0696|consen 498 KENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL---FQ----AIME----- 564 (683)
T ss_pred cccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HH----HHHH-----
Confidence 863222 2335678899999999999999999999999999999999999999997664321 11 1111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCC
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP 498 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP 498 (557)
.. -.++.....+...+....+...|.+|-
T Consensus 565 ---hn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 565 ---HN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ---cc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 00 123334445677888899999999885
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-32 Score=233.29 Aligned_cols=259 Identities=20% Similarity=0.285 Sum_probs=195.7
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
.++||+|.||+||+|+.. +++.||+|.++-.. +.-.....+|+-+++.++|.|||++++....++...+|+|||. .
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-q 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-Q 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-H
Confidence 478999999999999755 57889999886432 2233568899999999999999999999999999999999995 5
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccc
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 396 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 396 (557)
+|..+... -.+.++.....+++.|+++||.|+|+ +++.|||+||.|.+|+.+|.+|++|||+++-++-+... .+
T Consensus 86 dlkkyfds--lng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvrc-ys 159 (292)
T KOG0662|consen 86 DLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC-YS 159 (292)
T ss_pred HHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEe-ee
Confidence 78877764 35678889999999999999999999 99999999999999999999999999999987654322 22
Q ss_pred cccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCC---cccccccccc
Q 008707 397 VARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGD---VISIVDPVLI 471 (557)
Q Consensus 397 ~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d~~l~ 471 (557)
....|.+|.+|.++-+. -|+...|+||-||++.|+.. |.+-|.+.+..+...-+-|+.....+.. ...+.|-...
T Consensus 160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y 239 (292)
T KOG0662|consen 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY 239 (292)
T ss_pred ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence 33468999999998765 68889999999999999998 5555776655444332222221111111 1122222222
Q ss_pred CCCCHHH-----H----HHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 472 GNVKIES-----I----WRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 472 ~~~~~~~-----~----~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+-++... . ..=.+++++.+.-+|.+|.++++.++
T Consensus 240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 2222211 1 12357888888999999999998775
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=254.79 Aligned_cols=238 Identities=32% Similarity=0.443 Sum_probs=192.1
Q ss_pred CceEEEEEEEcC-CcEEEEEEccCccchh-HHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCChhhhhhc
Q 008707 247 SFGSVYYGKMKD-GKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 324 (557)
Q Consensus 247 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 324 (557)
+||.||+|.... ++.+++|++....... .+.+.+|++.+++++|+||+++++++......++++|++.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998874 8999999987654433 67899999999999999999999999999999999999999999999874
Q ss_pred cCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccccccCCCCc
Q 008707 325 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 404 (557)
Q Consensus 325 ~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y 404 (557)
. ..+++..+..++.+++.+++|||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++..|
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 2 238899999999999999999998 899999999999999999999999999998765432 12234478899
Q ss_pred cCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHH
Q 008707 405 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 484 (557)
Q Consensus 405 ~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 484 (557)
++||.+.+..++.++||||+|+++++|++|..||..... .....+ ....+..... ......+..+.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~----~~~~~~~~~~-------~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFK----KIGKPKPPFP-------PPEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHH----HHhccCCCCc-------cccccCCHHHHH
Confidence 999999888889999999999999999999999974211 111111 1211111100 000003347889
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 008707 485 VAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 485 li~~cl~~~P~~RPt~~evl~ 505 (557)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=276.74 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=202.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEE-----ecCeeEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCE-----EEHQRILV 309 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~-----~~~~~~lv 309 (557)
.+|.++||.|.+|.||+++.. +++.+|+|++..... ..+++..|+++++.+ .|||++.++|++. .++.++||
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLV 99 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLV 99 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEE
Confidence 446789999999999999754 688899998766533 346788899999998 6999999999875 35689999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
||||.+|+..|+++... +..+.|..+..|++.++.|+.|||. +.++|||||-.|||++.++.|||+|||.+.....
T Consensus 100 MEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 100 MEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred eeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 99999999999999775 7889999999999999999999997 9999999999999999999999999999988755
Q ss_pred CCccccccccCCCCccCCcccCC-----CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 390 DLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~-----~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
... ...+..|||.|||||++.- ..|+..+|+||||++..||.-|.+|+.+.... ..+ + .+..
T Consensus 176 T~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm--raL-------F---~IpR 242 (953)
T KOG0587|consen 176 TVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM--RAL-------F---LIPR 242 (953)
T ss_pred ccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh--hhh-------c---cCCC
Confidence 432 3345569999999999853 35677999999999999999999998633211 000 0 0011
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+|.....-+..+..++.++|..|+..|.++||++.++++.
T Consensus 243 --NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 243 --NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111222345677789999999999999999999988753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=283.80 Aligned_cols=258 Identities=20% Similarity=0.255 Sum_probs=165.5
Q ss_pred HHHhhcccCCCCceEEEEEEEcC-----CcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeE------EEecC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY------CEEEH 304 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~------~~~~~ 304 (557)
.|.+.+.||+|+||.||+|.+.+ +..||+|++...... +....| .+....+.++..++.. ...+.
T Consensus 133 ~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred CeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 45567899999999999998764 689999987643211 111111 1122222233322221 23456
Q ss_pred eeEEEEEecCCCChhhhhhccCCC-----------------CCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCC
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVNQ-----------------KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 367 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~N 367 (557)
..++||||+.+++|.+++...... .......+..++.|++.||+|||+ ++|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHH
Confidence 789999999999999988643100 011223456799999999999998 999999999999
Q ss_pred EEeCC-CCcEEEecccCccccCCCCccccccccCCCCccCCcccCCC----------------------CCCcccceehh
Q 008707 368 ILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ----------------------QLTEKSDVYSF 424 (557)
Q Consensus 368 Ill~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~----------------------~~s~~~Dvwsl 424 (557)
||+++ ++.+||+|||+++..............+++.|+|||.+... .+..++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 57899999999986544333333445689999999966322 23346799999
Q ss_pred HHHHHHHHhCCCCCCCCCcc-------ccccHHHHHHHHHhcCCccccccccccCCCC--HHHHHHHHHHHHHccccCCC
Q 008707 425 GVVLLELISGKKPVSVEDFG-------AELNIVHWARSMIKKGDVISIVDPVLIGNVK--IESIWRIAEVAIQCVEQRGF 495 (557)
Q Consensus 425 G~ll~elltg~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~l~~li~~cl~~~P~ 495 (557)
||++|||+++..|++..... .......|...... . ..+.+...+. ........+++.+|++.||+
T Consensus 366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-R-----ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc-c-----cchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 99999999977665421000 00111111111000 0 0000000000 00112345899999999999
Q ss_pred CCCCHHHHHHH
Q 008707 496 SRPKMQEIVLA 506 (557)
Q Consensus 496 ~RPt~~evl~~ 506 (557)
+|||++|+++.
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999874
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=259.65 Aligned_cols=259 Identities=25% Similarity=0.363 Sum_probs=194.0
Q ss_pred HHHHHHHhhcccCCCCceEEEEEE-EcCCcEEEEEEcc--Cccch-----hHHHHHHHHHHHhhcCCCCccceeeEEEe-
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMA--DSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEE- 302 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~--~~~~~-----~~~~~~~E~~il~~l~h~nIv~~~~~~~~- 302 (557)
....+|-+.+.||+|+|+.||+|. +...+.||+|+-. +...+ ..+...+|.+|.+.|.||.||++|++|.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 345566667889999999999996 4567889999743 22111 12457889999999999999999999875
Q ss_pred cCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC---CCCcEEEe
Q 008707 303 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVS 379 (557)
Q Consensus 303 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~ 379 (557)
.+.+|-|+|||+|.+|.-+++ ..+.++++.+..|++||+.||.||.+. +.+|+|-||||.|||+- ..|.+||.
T Consensus 540 tdsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred cccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence 456789999999999998887 456789999999999999999999973 57999999999999995 45789999
Q ss_pred cccCccccCCCCcc------ccccccCCCCccCCcccCC----CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccH
Q 008707 380 DFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGN----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 449 (557)
Q Consensus 380 Dfgla~~~~~~~~~------~~~~~~g~~~y~aPE~l~~----~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~ 449 (557)
|||+++...++... .++...||.+|++||.+.- ...+.|+||||+|+|+|+++-|+.||..... ..++
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHH
Confidence 99999987554322 2344569999999998743 3567899999999999999999999973221 1111
Q ss_pred HHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 450 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 450 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+ ...+...-.-.+. ..+....+...+|.+||.+.-++|....++..
T Consensus 694 Lq-------eNTIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 LQ-------ENTILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred Hh-------hhchhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11 1111111000000 01112235678999999999999988888764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=279.08 Aligned_cols=242 Identities=26% Similarity=0.405 Sum_probs=184.9
Q ss_pred hcccCCCCce-EEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecCCCC
Q 008707 240 CKKIGKGSFG-SVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGT 317 (557)
Q Consensus 240 ~~~lG~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~gs 317 (557)
.+.+|.|+.| .||+|... |++||||++-... .+-+.+|+..|+.- .|||||++++.-.++.+.|+..|.| ..+
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~s 588 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACS 588 (903)
T ss_pred HHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhh
Confidence 3678999998 56999987 8999999886432 34566899999988 5999999999999999999999999 469
Q ss_pred hhhhhhcc-CCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC---C--CcEEEecccCccccCCCC
Q 008707 318 LRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---N--MRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 318 L~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~---~--~~~kl~Dfgla~~~~~~~ 391 (557)
|.++++.. ...........+.+..|+++||+|||+ .+||||||||.||||+. + ..++|+|||+++....+.
T Consensus 589 L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 589 LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 99999863 111112224457889999999999998 99999999999999975 3 458999999999876554
Q ss_pred ccc--cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 392 THI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 392 ~~~--~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
... .....||-+|+|||.+.....+.++||||+||++|+.++| +.||... ...+.++. .|...- +
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~-~~R~~NIl--------~~~~~L--~- 733 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS-LERQANIL--------TGNYTL--V- 733 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch-HHhhhhhh--------cCccce--e-
Confidence 332 3345699999999999999888999999999999999985 9999722 11111111 111100 0
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+.... ++ +..++|.+|+.++|..||++.+|+.
T Consensus 734 ~L~~~~--d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 HLEPLP--DC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eeccCc--hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 011111 11 6779999999999999999999974
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=247.02 Aligned_cols=262 Identities=21% Similarity=0.310 Sum_probs=189.7
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccC-c-cchhHHHHHHHHHHHhhcCCCCccceeeEEEe--------cC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMAD-S-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------EH 304 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~-~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--------~~ 304 (557)
+|.-..+||+|.||.||+|+.+ +|+.||+|++.- + .........+|+++|+.|+|+|++.+++.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4444578999999999999866 477889886532 1 12223456789999999999999999988743 23
Q ss_pred eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCc
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 384 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 384 (557)
..|+||.+|+. +|.-++... ...++..++.+++.++..||.|+|. ..|+|||+||.|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~--~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR--KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc--cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 57999999964 777777632 3568889999999999999999998 99999999999999999999999999999
Q ss_pred cccCCCCcc---ccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 008707 385 RQAEEDLTH---ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 460 (557)
Q Consensus 385 ~~~~~~~~~---~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 460 (557)
+.+...... .......|.+|.+||.+.+ .+|+++.|||+-|||+.||+|+.+-+++....... +.+......-
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql---~~Is~LcGs~ 248 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQL---HLISQLCGSI 248 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHH---HHHHHHhccC
Confidence 765332211 1122345899999998765 58999999999999999999999999854322221 2222222111
Q ss_pred C-----------ccccc--cccccCCCC--HHHH------HHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 461 D-----------VISIV--DPVLIGNVK--IESI------WRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 461 ~-----------~~~~~--d~~l~~~~~--~~~~------~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
. +...+ .|...+.+. .+.. .+..+++.+++..||.+|+++++++..
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 0 00000 010011110 1111 156799999999999999999998753
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=267.46 Aligned_cols=257 Identities=22% Similarity=0.316 Sum_probs=175.5
Q ss_pred HHHhhcccCCCCceEEEEEEE-----------------cCCcEEEEEEccCccchhHHH--------------HHHHHHH
Q 008707 236 TNNFCKKIGKGSFGSVYYGKM-----------------KDGKEVAVKIMADSCSHRTQQ--------------FVTEVAL 284 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E~~i 284 (557)
.+.+.++||+|+||+||+|.+ ..++.||||.+........++ ...|+.+
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 455678999999999999964 235689999986433222222 3346777
Q ss_pred HhhcCCCCc-----cceeeEEEe--------cCeeEEEEEecCCCChhhhhhccCC---------------------CCC
Q 008707 285 LSRIHHRNL-----VPLIGYCEE--------EHQRILVYEYMHNGTLRDRLHGSVN---------------------QKP 330 (557)
Q Consensus 285 l~~l~h~nI-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~ 330 (557)
+.+++|.++ ++++++|.. .+..++||||+++++|.++++.... ...
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 777766554 677777653 3467999999999999998874211 123
Q ss_pred cCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccccccCCCCccCCccc
Q 008707 331 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410 (557)
Q Consensus 331 l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l 410 (557)
+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...............+++.|+|||.+
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 4667788999999999999998 8999999999999999999999999999976543322212222357899999987
Q ss_pred CCCCC----------------------CcccceehhHHHHHHHHhCCC-CCCCCCc-ccc-----ccHHHHHHHHHhcCC
Q 008707 411 GNQQL----------------------TEKSDVYSFGVVLLELISGKK-PVSVEDF-GAE-----LNIVHWARSMIKKGD 461 (557)
Q Consensus 411 ~~~~~----------------------s~~~DvwslG~ll~elltg~~-pf~~~~~-~~~-----~~~~~~~~~~~~~~~ 461 (557)
..... ..+.||||+||++|+|+++.. ||..... ... ..+..|.. .....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~~~ 460 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKGQK 460 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcccC
Confidence 54321 124799999999999999875 6652211 000 11111111 11111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 008707 462 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRG---FSRPKMQEIVL 505 (557)
Q Consensus 462 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P---~~RPt~~evl~ 505 (557)
. +-.. .........+++.+++..+| .+|+|++|+++
T Consensus 461 ~----~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 461 Y----DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred C----Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0 1000 11122356789999998766 68999999985
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=263.70 Aligned_cols=276 Identities=22% Similarity=0.256 Sum_probs=216.6
Q ss_pred CccccCChhHHHHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcC------CCCcc
Q 008707 222 GVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH------HRNLV 294 (557)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~------h~nIv 294 (557)
..+|.+.+.|+....|.+....|+|-||+|.+|... .|..||||++.++.. ..+.=++|++||++|. --|.+
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 456778899999999999999999999999999765 478999999987633 2344567999999995 34799
Q ss_pred ceeeEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC
Q 008707 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 374 (557)
Q Consensus 295 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~ 374 (557)
+++..|...+++|||+|-+ ..+|.+.|+......++....+..++.|+.-||.+|.. .||+|.||||+||||++..
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCc
Confidence 9999999999999999988 67999999987777889999999999999999999997 9999999999999999765
Q ss_pred -cEEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 008707 375 -RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA 453 (557)
Q Consensus 375 -~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~ 453 (557)
.+||||||.|......... ++..+..|.|||++.+..|+...|+||.||.||||+||+..|.+..-.....+..-+
T Consensus 574 ~iLKLCDfGSA~~~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~ 650 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL 650 (752)
T ss_pred ceeeeccCcccccccccccc---HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence 4799999999887655432 122356799999999999999999999999999999999999866543222222111
Q ss_pred -----HHHHhcCCcc---------------------------ccccc------cccC--CC---CHHHHHHHHHHHHHcc
Q 008707 454 -----RSMIKKGDVI---------------------------SIVDP------VLIG--NV---KIESIWRIAEVAIQCV 490 (557)
Q Consensus 454 -----~~~~~~~~~~---------------------------~~~d~------~l~~--~~---~~~~~~~l~~li~~cl 490 (557)
...+++|.+. ..+.| .+.. .+ .......+.+|+.+|+
T Consensus 651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml 730 (752)
T KOG0670|consen 651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML 730 (752)
T ss_pred cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence 1222222211 00111 1111 12 2334457889999999
Q ss_pred ccCCCCCCCHHHHHH
Q 008707 491 EQRGFSRPKMQEIVL 505 (557)
Q Consensus 491 ~~~P~~RPt~~evl~ 505 (557)
..||++|-|..+.++
T Consensus 731 ~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 731 ILDPEKRITVNQALK 745 (752)
T ss_pred ccChhhcCCHHHHhc
Confidence 999999999998875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=230.53 Aligned_cols=199 Identities=25% Similarity=0.379 Sum_probs=164.7
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhh-cCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSR-IHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~-l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
..-...||+|++|.|=+-++. +|...|+|.+.... .+..++.+.|+.+..+ ...|.+|.+||........++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 334578999999999887764 68999999987643 3445667788887554 47999999999988888999999999
Q ss_pred CCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 314 HNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 314 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
. .+|..+.+... .+..+++.-+-+|+..++.||.|||+ +..++|||+||+||||+.+|++|+||||.+....+...
T Consensus 128 ~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 D-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred h-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 4 57766554322 56788999999999999999999999 58999999999999999999999999999988766543
Q ss_pred cccccccCCCCccCCcccCC----CCCCcccceehhHHHHHHHHhCCCCCCC
Q 008707 393 HISSVARGTVGYLDPEYYGN----QQLTEKSDVYSFGVVLLELISGKKPVSV 440 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~----~~~s~~~DvwslG~ll~elltg~~pf~~ 440 (557)
.. ...|...|||||.+.. ..|+.++||||||+.+.||.+++.||+.
T Consensus 205 kt--~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 205 KT--MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred HH--HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 32 2347889999999853 4789999999999999999999999973
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=259.47 Aligned_cols=198 Identities=26% Similarity=0.392 Sum_probs=168.1
Q ss_pred hcccCCCCceEEEEEE-EcCCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 240 CKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
.+.||-|+||.|.++. .++...+|+|.+++.. ......++.|.+||..-..+-||++|-.|.+.+.+|+||+|++|
T Consensus 634 ik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 634 IKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred EeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 3679999999999995 4557789999987643 23445688899999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc--------
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-------- 387 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~-------- 387 (557)
|++..+|-+ -+-+++..++.++..+..|+++.|. .|++||||||+|||||.+|++||.|||++.-+
T Consensus 714 GDmMSLLIr---mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 714 GDMMSLLIR---MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred ccHHHHHHH---hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 999998873 4567888888899999999999997 99999999999999999999999999998532
Q ss_pred -CCCCcccc---------------------------------ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh
Q 008707 388 -EEDLTHIS---------------------------------SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 433 (557)
Q Consensus 388 -~~~~~~~~---------------------------------~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt 433 (557)
++. .+.. ....||+.|+|||++....|+..+|.||.|+|||||+.
T Consensus 788 Yq~g-dH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 788 YQEG-DHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred ccCC-CccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 110 0000 01249999999999999999999999999999999999
Q ss_pred CCCCCCCCCcc
Q 008707 434 GKKPVSVEDFG 444 (557)
Q Consensus 434 g~~pf~~~~~~ 444 (557)
|+.||......
T Consensus 867 g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 867 GQPPFLADTPG 877 (1034)
T ss_pred CCCCccCCCCC
Confidence 99999855543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-30 Score=241.37 Aligned_cols=245 Identities=22% Similarity=0.353 Sum_probs=194.2
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc---cchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEe
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
++.++||+|+|+.|..++++ +.+.+|+|++++. ..++.+-+..|-.++.+. +||.+|-++..|....++++|.||
T Consensus 253 ~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey 332 (593)
T KOG0695|consen 253 DLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY 332 (593)
T ss_pred eeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence 34688999999999999876 5778999998763 234445567788888777 699999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
++||+|.-... .+..++++.+..+...|+-||.|||+ +||+.||||.+|+|+|..|++||.|+|+++.--.+.
T Consensus 333 v~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~g- 405 (593)
T KOG0695|consen 333 VNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG- 405 (593)
T ss_pred ecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCCC-
Confidence 99999976665 46679999999999999999999998 999999999999999999999999999998743332
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcc-ccccHHHHHHHHHhcCCcccccccccc
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
..+++++|||.|.|||++++..|....|.|++|++++||+.|+.||+-..+. ...+-.+++-+.+-+..+.
T Consensus 406 d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-------- 477 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-------- 477 (593)
T ss_pred cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc--------
Confidence 2356788999999999999999999999999999999999999999843332 2233333333333222110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCC
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPK 499 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt 499 (557)
.+.........++..-+..||.+|-.
T Consensus 478 --iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 478 --IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 01111124557888889999998853
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-30 Score=229.31 Aligned_cols=256 Identities=20% Similarity=0.325 Sum_probs=193.5
Q ss_pred HHHHHhhcccCCCCceEEEEEE-EcCCcEEEEEEccCccchhHHHHHHHHHHHhhcC-CCCccceeeEEEec--CeeEEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEE--HQRILV 309 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~--~~~~lv 309 (557)
...|++.+++|+|.++.||.|. ..+++.++||++++ ...+.+.+|+.||+.|+ ||||+++++...+. ....+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4567888999999999999996 45688899999974 44567889999999996 99999999998764 467899
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC-CcEEEecccCccccC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAE 388 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~ 388 (557)
+||+++.+...+. .+++...+..++.+++.||.|+|+ .||.|||+||+|++||.. -.++|+|+|+|.++.
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999988877654 347778889999999999999999 999999999999999965 559999999999886
Q ss_pred CCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHH--------HHHhc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIKK 459 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~~ 459 (557)
...... ....+..|.-||.+.. ..|...-|+|||||++..|+..+.||-..... ...++..++ ..+.+
T Consensus 185 p~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN-~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC-HHHHHHHHHHhChHHHHHHHHH
Confidence 654432 2234667889998854 56788999999999999999999998633332 222322221 11111
Q ss_pred CCccccccccccC----------------CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 460 GDVISIVDPVLIG----------------NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 460 ~~~~~~~d~~l~~----------------~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
-.+ .+||.+.. +-..-...+..+++.+.+..|.++|||++|.+..
T Consensus 262 Y~i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQI--DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred Hcc--CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 111 12221110 0000112467899999999999999999998753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-31 Score=239.84 Aligned_cols=262 Identities=22% Similarity=0.283 Sum_probs=190.7
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecC-----eeEEEEE
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-----QRILVYE 311 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-----~~~lv~e 311 (557)
.+.||-|+||+||.+++. +|+.||+|++..... ...+.+.+|+++|..++|.|++..+++..-.. ..|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 478999999999999764 799999998865322 23467889999999999999999988765432 4678888
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
.+ ..+|..++- ....++...+.-+..||++||+|||+ .+|.||||||.|.|++.+..+||||||+++....+.
T Consensus 138 Lm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 88 457877775 45667888888899999999999999 999999999999999999999999999999765544
Q ss_pred ccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHH----------------H
Q 008707 392 THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA----------------R 454 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~----------------~ 454 (557)
.........|..|.|||++.+. .|+.+.||||.|||+.|++..+.-|+.........++..+ +
T Consensus 211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 3332233357889999999875 7899999999999999999999999854432222211100 0
Q ss_pred HHHhcCCccccccccccCCCC-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 455 SMIKKGDVISIVDPVLIGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 455 ~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
..+-.+....---+.+..-.. ...-.+-..+..+++..||..|.+..+.+..+.
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 111111100000011111011 111124568889999999999999988876543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-28 Score=229.78 Aligned_cols=210 Identities=38% Similarity=0.618 Sum_probs=182.4
Q ss_pred cCCCCceEEEEEEEcC-CcEEEEEEccCccch-hHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCChhh
Q 008707 243 IGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 320 (557)
Q Consensus 243 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL~~ 320 (557)
||+|.+|.||++.... ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998865 899999998755332 34678899999999999999999999999899999999999999999
Q ss_pred hhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC-CCcEEEecccCccccCCCCcccccccc
Q 008707 321 RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVAR 399 (557)
Q Consensus 321 ~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~ 399 (557)
++... ...+++..+..++.++++++++||+ .+++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKEN--EGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 98742 1468899999999999999999998 89999999999999999 89999999999987654321 122234
Q ss_pred CCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHH
Q 008707 400 GTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 478 (557)
Q Consensus 400 g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 478 (557)
+...|++||.+... .++.++|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 67889999999887 888999999999999999
Q ss_pred HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 479 IWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 479 ~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 267799999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=242.93 Aligned_cols=144 Identities=26% Similarity=0.421 Sum_probs=120.4
Q ss_pred CccccCChhHHHH-HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcC-----C---C
Q 008707 222 GVAYFIPLPELEE-ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----H---R 291 (557)
Q Consensus 222 ~~~~~~~~~~~~~-~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----h---~ 291 (557)
|.+..+.+.|.-. .+|-+.++||-|.|++||++.+. +.+.||+|+.+.. ....+..+.|+++|++++ | .
T Consensus 64 GGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~ 142 (590)
T KOG1290|consen 64 GGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKK 142 (590)
T ss_pred CCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCc
Confidence 3444455566655 77878899999999999999654 5778999998754 455677889999999994 2 3
Q ss_pred CccceeeEEEe----cCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCC
Q 008707 292 NLVPLIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 367 (557)
Q Consensus 292 nIv~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~N 367 (557)
+||++++.|.. +.+.|||+|++ |.+|..+|... +-+.++...+.+|++||+.||.|||. +.||+|.||||+|
T Consensus 143 ~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPEN 218 (590)
T KOG1290|consen 143 CVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPEN 218 (590)
T ss_pred eeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcce
Confidence 69999999864 45889999999 78898888866 56789999999999999999999998 5899999999999
Q ss_pred EEe
Q 008707 368 ILL 370 (557)
Q Consensus 368 Ill 370 (557)
||+
T Consensus 219 vLl 221 (590)
T KOG1290|consen 219 VLL 221 (590)
T ss_pred eee
Confidence 999
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-29 Score=227.24 Aligned_cols=252 Identities=18% Similarity=0.326 Sum_probs=189.3
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcC-CcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeE-EEecCeeEEEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY-CEEEHQRILVY 310 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~-~~~~~~~~lv~ 310 (557)
...|++.+.||+|.||.+-+++++. ...+++|.+... ....++|.+|..---.| .|.||+..|+. |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3567788999999999999999875 567888987654 34567899998766666 48999999874 67777888999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC--CCCcEEEecccCccccC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAE 388 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfgla~~~~ 388 (557)
||++.|+|.+-+. ..++.+.....++.|++.|+.|+|+ +++||||||.+||||- +...+||||||+++..+
T Consensus 102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999998886 3557788888999999999999999 9999999999999993 44579999999988765
Q ss_pred CCCccccccccCCCCccCCcccCC-----CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~-----~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
...... .-+..|.+||.... ....+.+|+|.||+++|.++||+.||+ .+......+.+|..-.-+. ..
T Consensus 175 ~tV~~~----~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~w~~rk--~~ 247 (378)
T KOG1345|consen 175 TTVKYL----EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQWLKRK--NP 247 (378)
T ss_pred ceehhh----hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHHHhccc--Cc
Confidence 432221 23557899997643 245678999999999999999999999 4444444555554332221 11
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 464 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 464 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
...+ .+. .-...+.++..+-+..+|++|--..++.++
T Consensus 248 ~~P~-----~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 248 ALPK-----KFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred cCch-----hhc-ccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 1111 110 112256788889999999999666665554
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-29 Score=247.27 Aligned_cols=193 Identities=25% Similarity=0.434 Sum_probs=164.2
Q ss_pred HHhhcccCCCCceEEEEEEEcC-CcEEEEEEccCccc--------hhHHHHHHHHHHHhhcC---CCCccceeeEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS--------HRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEH 304 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~---h~nIv~~~~~~~~~~ 304 (557)
|...+.+|+|+||.|+.|.++. ...|++|.+.+..- .+.-.+-.|++||..++ |+||++++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 4446789999999999998874 67899998865321 11123557999999996 999999999999999
Q ss_pred eeEEEEEec-CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccC
Q 008707 305 QRILVYEYM-HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 383 (557)
Q Consensus 305 ~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 383 (557)
.+|++||.. +|-+|.+++.. ...+++..+..|++||+.|++|||+ .||+|||||-+|+.++.+|-+||+|||.
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~---kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEF---KPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eeEEEecCCCCCcchhhhhhc---cCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccc
Confidence 999999975 56689999984 5678999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCccCCcccCCCCC-CcccceehhHHHHHHHHhCCCCC
Q 008707 384 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPV 438 (557)
Q Consensus 384 a~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~-s~~~DvwslG~ll~elltg~~pf 438 (557)
+...... .-..+.||..|.|||++.+..| ...-|||++|++||-++....||
T Consensus 717 aa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 717 AAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred hhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 8765433 2345679999999999999876 45679999999999999888887
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-27 Score=225.67 Aligned_cols=196 Identities=37% Similarity=0.618 Sum_probs=170.4
Q ss_pred HhhcccCCCCceEEEEEEEcC-CcEEEEEEccCccch-hHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.++.++|+|++++++++......++++|++++
T Consensus 2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 356789999999999998875 899999998765544 567889999999999999999999999998999999999999
Q ss_pred CChhhhhhccCCCCC-cCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 316 GTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 316 gsL~~~l~~~~~~~~-l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
++|.+++... .. +++..+..++.+++.++.+||+ .+++|+||+|.||+++.++.++|+|||.+..........
T Consensus 82 ~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 82 GDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999998743 23 7889999999999999999998 899999999999999999999999999988765442111
Q ss_pred cccccCCCCccCCccc-CCCCCCcccceehhHHHHHHHHhCCCCCC
Q 008707 395 SSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVS 439 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l-~~~~~s~~~DvwslG~ll~elltg~~pf~ 439 (557)
.....++..|++||.+ ....++.++|+|+||+++++|++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 2233467889999998 66777889999999999999999999996
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=227.31 Aligned_cols=255 Identities=24% Similarity=0.291 Sum_probs=191.0
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecC------eeEEEE
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QRILVY 310 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~------~~~lv~ 310 (557)
.+.+|.|.- .|..+.+. .+++||+|++.... ....++..+|..++..+.|+||++++.+|.-.. ..|+||
T Consensus 22 L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 22 LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred ecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence 356888887 56566433 58899999875431 233466778999999999999999999986543 468999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
|+| ..+|.+.+. -.++-.++..++.|++.|++|||+ .||+||||||+||++..+..+||.|||+|+..+..
T Consensus 101 e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 101 ELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred Hhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhcccCcc
Confidence 999 568888876 236677888999999999999998 99999999999999999999999999999876554
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcccccc----------------HHHHHH
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN----------------IVHWAR 454 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~----------------~~~~~~ 454 (557)
........+..|.|||++.+..+...+||||+||++.||++|+.-|.+.+.-+... +...++
T Consensus 172 --~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 --FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred --cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 23444557889999999999999999999999999999999999998766432211 111111
Q ss_pred HHHhcCC------ccc-cccccccCC--CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 455 SMIKKGD------VIS-IVDPVLIGN--VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 455 ~~~~~~~------~~~-~~d~~l~~~--~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
..++..+ ..+ +.|...... .+.-......+++.+||..+|++|-+++++++.
T Consensus 250 ~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 250 NYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1111111 111 112111111 122234467899999999999999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-28 Score=247.78 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=201.4
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.|+..+.+|.|.||.||+++.+ .++..|+|+++-....+..-+.+|+-+++.-+||||+.++|.+......++.||||.
T Consensus 16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred chhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 3556789999999999999765 689999999886656666777889999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+|+|++..+ -...+++.++..+++...+|++|||+ .|-+|||||-.||++++.|.+|++|||.+..+.....+
T Consensus 96 ggslQdiy~---~TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K- 168 (829)
T KOG0576|consen 96 GGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK- 168 (829)
T ss_pred CCcccceee---ecccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhhh-
Confidence 999999887 35778999999999999999999998 99999999999999999999999999999887655443
Q ss_pred cccccCCCCccCCccc---CCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 395 SSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l---~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
...+.||+.|||||+. +.+.|...+|||++|+...|+---+.|-. +... ..+..... .+.++|.-.
T Consensus 169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf--dlhp-----mr~l~LmT----kS~~qpp~l 237 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF--DLHP-----MRALFLMT----KSGFQPPTL 237 (829)
T ss_pred hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc--ccch-----HHHHHHhh----ccCCCCCcc
Confidence 3345699999999975 56688999999999999999998888753 1111 11111111 112222211
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+ .......+-++++.|+..+|.+||+++.+++
T Consensus 238 kD-k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 238 KD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11 1233446789999999999999999987754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=217.87 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=189.6
Q ss_pred HHhhcccCCCCceEEEEEEEc----CCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
+...++||+|.|++||++.+. .++.||+|.+.... ....+..|+++|..+ .+.||+++.+.+..++...+|+|
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 445789999999999999654 36789999886532 335688999999999 59999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC-CCcEEEecccCccccCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~ 390 (557)
|++.....++... ++...+..+++.+..||+++|+ +||+||||||.|+|.+. .+.-.|.|||+|..+...
T Consensus 116 ~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 116 YFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred ccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 9999988888753 5677888999999999999998 99999999999999984 567899999999721100
Q ss_pred C------c-------c------------------------------ccccccCCCCccCCcccCC-CCCCcccceehhHH
Q 008707 391 L------T-------H------------------------------ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGV 426 (557)
Q Consensus 391 ~------~-------~------------------------------~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ 426 (557)
. . . ......||++|.|||++.. ...++++||||.|+
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 0 0 0012349999999999865 46788999999999
Q ss_pred HHHHHHhCCCCCCCCCccccccHHHHHHHH----H-----hcCC--ccc------c---------cc-ccccC-C-----
Q 008707 427 VLLELISGKKPVSVEDFGAELNIVHWARSM----I-----KKGD--VIS------I---------VD-PVLIG-N----- 473 (557)
Q Consensus 427 ll~elltg~~pf~~~~~~~~~~~~~~~~~~----~-----~~~~--~~~------~---------~d-~~l~~-~----- 473 (557)
|+.-++++..||-...+ +...+.+.+.-+ + -.|. +.+ + ++ ..+.+ +
T Consensus 267 I~Lslls~~~PFf~a~d-d~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAKD-DADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred eeehhhccccccccCcc-ccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 99999999999863322 223333332110 0 0111 110 0 00 00000 0
Q ss_pred ---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 474 ---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 474 ---~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.....+..+.+++.+|+..+|.+|-|++|.++.
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 011112267899999999999999999998853
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=258.49 Aligned_cols=196 Identities=19% Similarity=0.275 Sum_probs=138.3
Q ss_pred hcCC-CCccceeeEE-------EecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 008707 287 RIHH-RNLVPLIGYC-------EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358 (557)
Q Consensus 287 ~l~h-~nIv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 358 (557)
.++| +||++++++| ......+.++|++ +++|.+++.. ....+++..++.++.||++||+|||+ +||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~---~gI 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHS---QGI 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 3455 5788888877 2233567788887 6799999974 24568999999999999999999998 999
Q ss_pred EeeccCCCCEEeCCC-------------------CcEEEecccCccccCCCC---------------ccccccccCCCCc
Q 008707 359 IHRDVKSSNILLDIN-------------------MRAKVSDFGLSRQAEEDL---------------THISSVARGTVGY 404 (557)
Q Consensus 359 vH~dlk~~NIll~~~-------------------~~~kl~Dfgla~~~~~~~---------------~~~~~~~~g~~~y 404 (557)
+||||||+||||+.. +.+|++|||+++...... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999643 445666666665321100 0001113478889
Q ss_pred cCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHH
Q 008707 405 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 484 (557)
Q Consensus 405 ~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 484 (557)
+|||++.+..++.++|||||||+||||++|..|+..... .. .. +... .+.+.. ........+
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~---~~-~~~~----~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TM---SS-LRHR----VLPPQI-----LLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HH---HH-HHHh----hcChhh-----hhcCHHHHH
Confidence 999999999999999999999999999999888752110 00 00 0000 001100 111224568
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 008707 485 VAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 485 li~~cl~~~P~~RPt~~evl~~ 506 (557)
++.+||..+|.+||++.||++.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8899999999999999999763
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.7e-25 Score=201.77 Aligned_cols=170 Identities=21% Similarity=0.190 Sum_probs=127.3
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.++++.. +..+++..++.++.|++.||+|||+ .+ ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc----
Confidence 6889988742 4569999999999999999999998 55 999999999999999 99987654422
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
..|++.|+|||++.+..++.++|||||||++|||+||+.||...... .............. ++... ...
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~---~~~~~-~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-----SAILEILLNGMPAD---DPRDR-SNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-----cHHHHHHHHHhccC---Ccccc-ccH
Confidence 14789999999999999999999999999999999999999633211 11111111110000 00000 011
Q ss_pred HHHH--HHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 476 IESI--WRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 476 ~~~~--~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
.... ..+.+++.+|+..+|.+||++.|+++.+......
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 1122 2589999999999999999999999988776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=216.73 Aligned_cols=262 Identities=23% Similarity=0.257 Sum_probs=198.7
Q ss_pred HHHhhcccCCCCceEEEEEEEcCC--cEEEEEEccCccchhHHHHHHHHHHHhhcCC----CCccceeeEE-EecCeeEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKDG--KEVAVKIMADSCSHRTQQFVTEVALLSRIHH----RNLVPLIGYC-EEEHQRIL 308 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~il~~l~h----~nIv~~~~~~-~~~~~~~l 308 (557)
.|.+.+.||+|+||.||.+..... ..+|+|............+..|..++..+.. .++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 566789999999999999987653 4789998765433322367789999998863 6899999988 47778899
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC-----CcEEEecccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-----MRAKVSDFGL 383 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~-----~~~kl~Dfgl 383 (557)
||+.+ |.+|.++..... ...++..++..++.|++.+|++||+ .|++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 889999876543 5789999999999999999999998 999999999999999865 4599999999
Q ss_pred cc--ccCCCCc----cc---cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHH
Q 008707 384 SR--QAEEDLT----HI---SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 454 (557)
Q Consensus 384 a~--~~~~~~~----~~---~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~ 454 (557)
++ .+..... .. ....+||..|.+++...+...+++.|+||+++++.+++.|..||........... +.
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~---~~ 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK---FE 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH---HH
Confidence 99 4322211 11 2235699999999999999999999999999999999999999974443322111 11
Q ss_pred HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 455 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 455 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
.......... .....+..+.++...+-..+..++|.+..+...|++.....
T Consensus 251 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDPRKLLTDR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhhhhcccc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111100000 11112235556666666789999999999999999888765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=202.80 Aligned_cols=263 Identities=20% Similarity=0.257 Sum_probs=205.2
Q ss_pred HHHhhcccCCCCceEEEEEE-EcCCcEEEEEEccCccchhHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEEec
Q 008707 236 TNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
-|+++++||+|.||.++.|. +-+++.||||.-.. ..+..++..|++.++.|. .++|..+|-|...+.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 34568999999999999996 45799999997543 234467888999999994 799999998888888889999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC-----CcEEEecccCccccC
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-----MRAKVSDFGLSRQAE 388 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~-----~~~kl~Dfgla~~~~ 388 (557)
|.+|+|+..- .+..++.+++..+|.|++.-++|+|+ +.+|.|||||+|+||... ..+.++|||+|+.+-
T Consensus 107 -GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 107 -GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred -CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 8899998864 57889999999999999999999998 999999999999999643 448999999999987
Q ss_pred CCCcccc------ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 389 EDLTHIS------SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 389 ~~~~~~~------~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
+..+... ....||.+||+-....+.+.+.+.|+-|+|-++++.+-|..||++-.....-.-.+ .| |+.
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYe----KI--Ge~ 254 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYE----KI--GET 254 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHH----Hh--ccc
Confidence 7655432 33459999999999999999999999999999999999999999655432111111 11 111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 463 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 463 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
...- -..+.-...+.++..-+...-..+-++-|+++-+...+.+..+...
T Consensus 255 Kr~T---~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 255 KRST---PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred cccC---CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 1000 0001111234466777777778888999999999998888876443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6e-25 Score=201.57 Aligned_cols=254 Identities=22% Similarity=0.370 Sum_probs=193.5
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccC--ccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMAD--SCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
.+.....++..+|.+...|..|+|+|+ |..+++|++.. ......++|..|...|+-+.||||+.++|.|.......+
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred CcchhhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 344456677888999999999999998 55667777643 223334679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEe--cccCccc
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS--DFGLSRQ 386 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~--Dfgla~~ 386 (557)
+..||+.|+|++.++.. .....+..++.+++.++|+|++|||+- +.-|..--|+.+.++||++.+++|. |--++..
T Consensus 265 isq~mp~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq 342 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ 342 (448)
T ss_pred eeeeccchHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee
Confidence 99999999999999965 345577788999999999999999982 3344455789999999999887764 4333222
Q ss_pred cCCCCccccccccCCCCccCCcccCCCCCC---cccceehhHHHHHHHHhCCCCCCCCCccc-cccHHHHHHHHHhcCCc
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGNQQLT---EKSDVYSFGVVLLELISGKKPVSVEDFGA-ELNIVHWARSMIKKGDV 462 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s---~~~DvwslG~ll~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~ 462 (557)
. ....-.|.|++||.+...+.+ .++|+|||++++||+.|...||..-..-+ +..++ -
T Consensus 343 e--------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia-------l---- 403 (448)
T KOG0195|consen 343 E--------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA-------L---- 403 (448)
T ss_pred c--------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-------h----
Confidence 1 112246889999999765443 48999999999999999999997332211 11110 0
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 463 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 463 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
..++...++.....+.+++.-|+..||.+||.++.|+-.|+.++
T Consensus 404 -----eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 -----EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -----ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 12223334444557889999999999999999999999998764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=208.87 Aligned_cols=172 Identities=19% Similarity=0.158 Sum_probs=129.9
Q ss_pred HHHHhhcccCCCCceEEEEEEEc--CCcEEEEEEccCc-----cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
..|.+.+.||+|+||+||+|.++ +++.||||++... .....+.+.+|++++++++|+|++..+.. .+..+
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~ 94 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG 94 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence 44667899999999999999875 4777899986532 12234568999999999999999853322 24579
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeecc-CCCCEEeCCCCcEEEecccCccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV-KSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dl-k~~NIll~~~~~~kl~Dfgla~~ 386 (557)
+||||++|++|... . ... ...++.|+++||+|||+ +||+|||| ||+|||++.++.++|+|||+|+.
T Consensus 95 LVmE~~~G~~L~~~-~---~~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 95 LVRGWTEGVPLHLA-R---PHG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred EEEEccCCCCHHHh-C---ccc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 99999999999632 1 111 14678999999999998 99999999 99999999999999999999987
Q ss_pred cCCCCcccc-------ccccCCCCccCCcccCCCC------CCccccee
Q 008707 387 AEEDLTHIS-------SVARGTVGYLDPEYYGNQQ------LTEKSDVY 422 (557)
Q Consensus 387 ~~~~~~~~~-------~~~~g~~~y~aPE~l~~~~------~s~~~Dvw 422 (557)
......... ....+++.|+|||.+...+ .+..+|-|
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 654332111 2345788899999986432 23346666
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=188.13 Aligned_cols=264 Identities=21% Similarity=0.291 Sum_probs=201.3
Q ss_pred HHHHHHhhcccCCCCceEEEEEE-EcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCC-CCccceeeEEEecCeeEEEE
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~~~~~lv~ 310 (557)
....|.+.++||.|+||.+|.|. ..+|++||||+-.+... ..++..|.+++..|++ ..|..+.-+..+...-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34556778999999999999996 55799999998654433 3467789999999974 67888888888888899999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC---CCcEEEecccCcccc
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA 387 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~ 387 (557)
+.+ |.+|+++..- ....++..+++-++-|++.-++|+|. ++++||||||+|+|..- ...+.++|||+|+.+
T Consensus 91 dLL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence 999 8899998864 46778999999999999999999998 99999999999999963 456999999999987
Q ss_pred CCCCccc------cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC
Q 008707 388 EEDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 461 (557)
Q Consensus 388 ~~~~~~~------~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 461 (557)
.+..+.. .....||..|.+-....+.+.+.+.|+-|+|.+|.++--|..||++-.........+- +.+..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk----I~EkK 240 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK----ISEKK 240 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH----HHHhh
Confidence 6543322 2234589999998888888889999999999999999999999996544322211111 11111
Q ss_pred ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 462 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 462 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
....+ ..+...+ |.++.-.+..|-...-++-|++.-+-+.+.-+-..
T Consensus 241 ~s~~i-e~LC~G~----P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 241 MSTPI-EVLCKGF----PAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred cCCCH-HHHhCCC----cHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 11000 1122222 33677778888888888899988888777766553
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.7e-21 Score=191.87 Aligned_cols=260 Identities=29% Similarity=0.432 Sum_probs=196.1
Q ss_pred HhhcccCCCCceEEEEEEEcCCcEEEEEEccCccch---hHHHHHHHHHHHhhcCCC-CccceeeEEEecCeeEEEEEec
Q 008707 238 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHR-NLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~-nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
.+.+.||.|.||.||++... ..+++|.+...... ....+.+|..+++.+.|+ +|+++++.+......+++++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 45678999999999999887 88999988754332 367799999999999988 7999999997777789999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC-cEEEecccCccccCCCCc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~ 392 (557)
.++++.+++........+.......++.|++.++.|+|+ .+++|||+||+||+++..+ .++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 999999777632111368888999999999999999998 8999999999999999988 799999999986544332
Q ss_pred c-----ccccccCCCCccCCcccCC---CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 393 H-----ISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 393 ~-----~~~~~~g~~~y~aPE~l~~---~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
. ......|+..|++||.+.+ ..++...|+||+|++++++++|..||...... .........+......
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~- 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP- 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc-
Confidence 1 2344568999999999987 57889999999999999999999997644321 0011111111111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.................+.+++..|+..+|..|.++.+....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223467899999999999999999987765
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-21 Score=211.99 Aligned_cols=173 Identities=28% Similarity=0.557 Sum_probs=138.4
Q ss_pred HHHHHHhhhhcCC---CCCCCCCCCCC--CCCeEEeeCCC---CCceEEEEecCCCccccCCccccCCCCCcEEECcCCC
Q 008707 3 LEALRSISDESER---TNDRGDPCVPV--PWEWVTCSTTT---PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF 74 (557)
Q Consensus 3 ~~~~~~~~~~~~~---~~~~~~~c~~~--~~~~v~c~~~~---p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~ 74 (557)
..||+.++.++.. .+|+||||.+. +|.||+|.... ...++.|+|++|+++|.+|..+..|++|+.|+|++|.
T Consensus 374 ~~aL~~~k~~~~~~~~~~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~ 453 (623)
T PLN03150 374 VSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNS 453 (623)
T ss_pred HHHHHHHHHhcCCcccCCCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCc
Confidence 3578888887743 48999999764 89999996422 1248999999999999999999999999999999999
Q ss_pred CCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccccccccCCCCCCccccc---CceeeeecCCCcccccc-
Q 008707 75 LTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKES- 149 (557)
Q Consensus 75 l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~~~~~- 149 (557)
|+|.+| .+..+++|+.|+|++|+|+|.+|..+++|++|+.|+|++|++.|.+|..+.. ....+.+.+|+.+|+..
T Consensus 454 l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 454 IRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred ccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCC
Confidence 999888 6999999999999999999999999999999999999999999999998754 23467889999999642
Q ss_pred ---ccc-ccceEEEeehhhHHHHHHHHHHH
Q 008707 150 ---RRR-MRFKLILGTSIGVLAILLVLFLC 175 (557)
Q Consensus 150 ---~~~-~~~~~~i~~~i~~~~~l~~~~~~ 175 (557)
|.. .....++++++++++++++++++
T Consensus 534 l~~C~~~~~~~~~i~~~~~~~~~~l~~~~~ 563 (623)
T PLN03150 534 LRACGPHLSVGAKIGIAFGVSVAFLFLVIC 563 (623)
T ss_pred CCCCcccCCCceEEEEEhHHHHHHHHHHHH
Confidence 221 22344555555544443333333
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-22 Score=215.66 Aligned_cols=252 Identities=21% Similarity=0.227 Sum_probs=183.3
Q ss_pred hhcccCCCCceEEEEEEEc-CCcEEEEEEcc----Ccc-c-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 239 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA----DSC-S-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~----~~~-~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
....+|.|++|.|+..... ..+..+.|... ... . .....+..|+-+-..++|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3578999999977776533 33334444332 111 1 111226667778888899999888887776666666699
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
||++ +|..++.. ...+....+..++.|+..|++|+|+ .|+.|||+|++|+++..+|.+||+|||.+.....+.
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 99999874 3467888889999999999999998 999999999999999999999999999987654433
Q ss_pred c---cccccccCCCCccCCcccCCCCCCc-ccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 392 T---HISSVARGTVGYLDPEYYGNQQLTE-KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 392 ~---~~~~~~~g~~~y~aPE~l~~~~~s~-~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
. .......|...|+|||.+.+.+|.+ ..||||.|+++..|.+|+.||......+... . .....+... +
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~----~~~~~~~~~---~ 546 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-K----TNNYSDQRN---I 546 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-h----hhccccccc---c
Confidence 2 4455667999999999999998876 6899999999999999999998554432211 0 000000000 0
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..-........+..-..++.+|++.+|.+|-|+++|++
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000011233446779999999999999999999986
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-21 Score=178.96 Aligned_cols=141 Identities=18% Similarity=0.186 Sum_probs=110.1
Q ss_pred hcccCCCCceEEEEEEEcCCcEEEEEEccCccch--h------------------------HHHHHHHHHHHhhcCCCCc
Q 008707 240 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--R------------------------TQQFVTEVALLSRIHHRNL 293 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~il~~l~h~nI 293 (557)
...||+|+||.||+|...+|+.||+|+++..... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999888999999998654211 0 0123459999999988877
Q ss_pred cceeeEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHH-HcCCCCCeEeeccCCCCEEeCC
Q 008707 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL-HTGCNPGIIHRDVKSSNILLDI 372 (557)
Q Consensus 294 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~ivH~dlk~~NIll~~ 372 (557)
.....+.. ...++||||++++++..... ....++......++.|++.+|.++ |+ .||+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-
Confidence 54443322 23489999998877655432 235688899999999999999999 67 8999999999999998
Q ss_pred CCcEEEecccCccccCC
Q 008707 373 NMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 373 ~~~~kl~Dfgla~~~~~ 389 (557)
++.++|+|||+|.....
T Consensus 153 ~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred CCcEEEEEccccccCCC
Confidence 47899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-21 Score=182.94 Aligned_cols=175 Identities=15% Similarity=0.181 Sum_probs=134.8
Q ss_pred hhHHHHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHH---------HHHHHHHHHhhcCCCCccceeeE
Q 008707 229 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ---------QFVTEVALLSRIHHRNLVPLIGY 299 (557)
Q Consensus 229 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---------~~~~E~~il~~l~h~nIv~~~~~ 299 (557)
.+++.+..|+..+.+|.|+||.||++.. ++..+|+|.+.+......+ .+.+|++.+.++.|++|..+.++
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 4556677778899999999999999766 5778999999754332222 26789999999999999999988
Q ss_pred EEec--------CeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC
Q 008707 300 CEEE--------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 371 (557)
Q Consensus 300 ~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~ 371 (557)
+... +..++||||++|.+|.+... ++. ....+++.+++.+|+ .|++|||++|.||+++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVS 169 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEe
Confidence 6543 35789999999999988632 222 245699999999998 9999999999999999
Q ss_pred CCCcEEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHH
Q 008707 372 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 432 (557)
Q Consensus 372 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ell 432 (557)
.++ ++|+|||............ .+.....+..++|+|+||+.+....
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence 888 9999999887653221110 1233444567899999999876554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=209.72 Aligned_cols=247 Identities=21% Similarity=0.297 Sum_probs=178.9
Q ss_pred HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCcc-chhHHHHHH---HHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC-SHRTQQFVT---EVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~---E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+.+.+.||.+.|=+|.+|+++.|. |+||++-+.. .-..+.|.+ |++ ...++|||.+++.-....+...|||-+|
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 345688999999999999999887 8889875433 223333433 444 4555899999998887777778889899
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc--CCC
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EED 390 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~--~~~ 390 (557)
+. .+|+|.+. .+..+...+...|+.|++.||..+|. .||+|||||.+||||+.-+=+.|+||..-+.. ..+
T Consensus 103 vk-hnLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VK-HNLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hh-hhhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 84 58999987 46667788888999999999999998 99999999999999998888999999754432 111
Q ss_pred C----ccccccccCCCCccCCcccCCC-----------CCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 008707 391 L----THISSVARGTVGYLDPEYYGNQ-----------QLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 454 (557)
Q Consensus 391 ~----~~~~~~~~g~~~y~aPE~l~~~-----------~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~ 454 (557)
. ...-.+.+.-..|.|||.+... ..+++-||||+||++.||++ |.+||. +.+...
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~---------LSQL~a 246 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT---------LSQLLA 246 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc---------HHHHHh
Confidence 1 1112233345689999987431 25678999999999999998 788886 333332
Q ss_pred HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 455 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 455 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
..-. . .......+.. -+-..+++++..|++.||++|-++++.++.-.
T Consensus 247 Yr~~--~-~~~~e~~Le~----Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 247 YRSG--N-ADDPEQLLEK----IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred Hhcc--C-ccCHHHHHHh----CcCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 2211 1 0000000000 00115789999999999999999999998733
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=9e-20 Score=169.60 Aligned_cols=141 Identities=21% Similarity=0.257 Sum_probs=111.4
Q ss_pred hcccCCCCceEEEEEEEcCCcEEEEEEccCccch--h------------------------HHHHHHHHHHHhhcCCCCc
Q 008707 240 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--R------------------------TQQFVTEVALLSRIHHRNL 293 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~il~~l~h~nI 293 (557)
...||+|++|.||+|...+|+.||||++...... . ...+..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3679999999999998878999999998754211 0 1224578999999999987
Q ss_pred cceeeEEEecCeeEEEEEecCCCChhhh-hhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC
Q 008707 294 VPLIGYCEEEHQRILVYEYMHNGTLRDR-LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 372 (557)
Q Consensus 294 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~ 372 (557)
.....+... ..++||||++|+++... +. ...++......++.|++.++.++|+ ..|++||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence 555444333 24899999988755433 32 3456778889999999999999996 37999999999999999
Q ss_pred CCcEEEecccCccccCC
Q 008707 373 NMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 373 ~~~~kl~Dfgla~~~~~ 389 (557)
++.++|+|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 88999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=186.33 Aligned_cols=219 Identities=28% Similarity=0.406 Sum_probs=164.1
Q ss_pred HhhcCCCCccceeeEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccC
Q 008707 285 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK 364 (557)
Q Consensus 285 l~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk 364 (557)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.|.+.. ....+++.-...++++|+.||+|+|.. .-.+|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeec
Confidence 4568899999999999999999999999999999999985 356788888999999999999999982 333999999
Q ss_pred CCCEEeCCCCcEEEecccCccccCCCC-ccccccccCCCCccCCcccCCC-------CCCcccceehhHHHHHHHHhCCC
Q 008707 365 SSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQ-------QLTEKSDVYSFGVVLLELISGKK 436 (557)
Q Consensus 365 ~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~g~~~y~aPE~l~~~-------~~s~~~DvwslG~ll~elltg~~ 436 (557)
..|++++....+||+|||+........ ........-..-|.|||.++.. ..+.++||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999987764211 1111111234579999999764 14678999999999999999999
Q ss_pred CCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 437 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 437 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
||......... .+.+.+ +.++ ....+-|.+.... +....+..++.+||..+|++||++++|-..++.+...
T Consensus 157 ~~~~~~~~~~~--~eii~~-~~~~-~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 157 PFDLRNLVEDP--DEIILR-VKKG-GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccccCCh--HHHHHH-HHhc-CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99854443222 122222 2221 1111122222111 3334788999999999999999999998888777664
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.1e-20 Score=176.38 Aligned_cols=229 Identities=21% Similarity=0.307 Sum_probs=147.7
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCc---cchhHHHHHHHHHHHhhcC----------CCCccceeeEEE----
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIH----------HRNLVPLIGYCE---- 301 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~----------h~nIv~~~~~~~---- 301 (557)
.+.||.|+++.||.+++. +++++|+|++... .....+++++|.-....+. |-.++-.++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 578999999999999887 4899999987432 2234466666665444432 222222232221
Q ss_pred -----ec---C-----eeEEEEEecCCCChhhhhhc---cC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccC
Q 008707 302 -----EE---H-----QRILVYEYMHNGTLRDRLHG---SV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK 364 (557)
Q Consensus 302 -----~~---~-----~~~lv~e~~~~gsL~~~l~~---~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk 364 (557)
.. . ..+++|+-+ .++|.+++.. .. ....+....++.+..|+++.+++||+ .|++|+||+
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~ 172 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIK 172 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-S
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEecccc
Confidence 11 1 236778877 5688877642 11 12234455667788999999999998 999999999
Q ss_pred CCCEEeCCCCcEEEecccCccccCCCCccccccccCCCCccCCcccCC--------CCCCcccceehhHHHHHHHHhCCC
Q 008707 365 SSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--------QQLTEKSDVYSFGVVLLELISGKK 436 (557)
Q Consensus 365 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~--------~~~s~~~DvwslG~ll~elltg~~ 436 (557)
|+|++++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|++|+++|.|.++..
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 99999999999999999988776553322 224678999997633 357889999999999999999999
Q ss_pred CCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCC
Q 008707 437 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 497 (557)
Q Consensus 437 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~R 497 (557)
||........... ...... +.+..+..+|..+|+.+|++|
T Consensus 249 Pf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 249 PFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9984433211100 122233 667789999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-19 Score=163.59 Aligned_cols=182 Identities=15% Similarity=0.139 Sum_probs=138.3
Q ss_pred hcccCCCCceEEEEEEEcCCcEEEEEEccCccch----hHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEEecC
Q 008707 240 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH----RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
...|+.|+||+||.+.. .+..++.+.+...... ....+.+|+++|++|. |+++++++++ +..+++|||+.
T Consensus 7 ~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~ 81 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA 81 (218)
T ss_pred ceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence 47899999999998766 5788887777544321 1235789999999995 5889999886 45799999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeecc-CCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV-KSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dl-k~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
|.+|.+.+.. . ...++.|++++|+++|+ .||+|||| ||.|||++.++.++|+|||++.........
T Consensus 82 G~~L~~~~~~----~------~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 82 GAAMYQRPPR----G------DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred CccHHhhhhh----h------hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 9998754321 1 13577899999999998 99999999 799999999999999999999865443211
Q ss_pred ----c--------cccccCCCCccCCcccCCC-CCC-cccceehhHHHHHHHHhCCCCCC
Q 008707 394 ----I--------SSVARGTVGYLDPEYYGNQ-QLT-EKSDVYSFGVVLLELISGKKPVS 439 (557)
Q Consensus 394 ----~--------~~~~~g~~~y~aPE~l~~~-~~s-~~~DvwslG~ll~elltg~~pf~ 439 (557)
. ......++.|++|+.-.-. ..+ ...+.++-|+-+|.++|+..+.-
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 1112357778888764332 333 56788999999999999988864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.4e-20 Score=186.66 Aligned_cols=232 Identities=25% Similarity=0.326 Sum_probs=182.4
Q ss_pred ccCCCCceEEEEEE----EcCCcEEEEEEccCccch--hHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEEecC
Q 008707 242 KIGKGSFGSVYYGK----MKDGKEVAVKIMADSCSH--RTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 242 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.+|+|.||.|+++. .+.|+-+|+|++++.... .+.....|..++...+ ||.++++.-.+..+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999763 345788999988654321 1224556888888886 9999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
||.|...+. +...+.......+...++-|++++|+ .+++|+|+|++||+++.+|++++.|||+++..-+....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999988876 45566777777888899999999998 99999999999999999999999999999876443222
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
+||..|||||++. ....+.|.||||++++||+||..||.. +......+. ....
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~-----------~~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA-----------ELEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh-----------ccCC
Confidence 6899999999998 457789999999999999999999984 111221111 1123
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH--HHHHHHH
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKM--QEIVLAI 507 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~--~evl~~L 507 (557)
+.+......+++.+++..+|..|--. ..+.+..
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 34445567789999999999999865 3444433
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-18 Score=161.02 Aligned_cols=133 Identities=16% Similarity=0.174 Sum_probs=103.9
Q ss_pred hcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhc-----CCCCccceeeEEEecC---eeE-EEE
Q 008707 240 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-----HHRNLVPLIGYCEEEH---QRI-LVY 310 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-----~h~nIv~~~~~~~~~~---~~~-lv~ 310 (557)
.+.||+|+||.||. +......+||++........+.+.+|+.+++.+ .||||++++|++.++. ..+ +|+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 36899999999996 443333478887654444557799999999999 5799999999998864 333 789
Q ss_pred Ee--cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHH-HHHHcCCCCCeEeeccCCCCEEeCC----CCcEEEecccC
Q 008707 311 EY--MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL-EYLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGL 383 (557)
Q Consensus 311 e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL-~~LH~~~~~~ivH~dlk~~NIll~~----~~~~kl~Dfgl 383 (557)
|| +.+|+|.+++.. ..+++. ..++.|++.++ +|||+ ++|+||||||+|||++. +..++|+||+.
T Consensus 85 e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred cCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 99 557999999963 235544 35677888777 99998 99999999999999974 34799999543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.8e-18 Score=161.40 Aligned_cols=142 Identities=20% Similarity=0.243 Sum_probs=109.5
Q ss_pred HHhhcccCCCCceEEEEEE--EcCCcEEEEEEccCccch------------------------hHHHHHHHHHHHhhcCC
Q 008707 237 NNFCKKIGKGSFGSVYYGK--MKDGKEVAVKIMADSCSH------------------------RTQQFVTEVALLSRIHH 290 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~il~~l~h 290 (557)
+.+.+.||+|+||.||+|. ..+|+.||+|++...... ....+..|++++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4567889999999999998 567999999998643210 01235689999999975
Q ss_pred CC--ccceeeEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCC-eEeeccCCCC
Q 008707 291 RN--LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-IIHRDVKSSN 367 (557)
Q Consensus 291 ~n--Iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~-ivH~dlk~~N 367 (557)
.+ +.+++++ ...++||||+++++|..... ....+.......++.|++.++++||+ .| ++||||||+|
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~N 179 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYN 179 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhh
Confidence 33 3444432 23589999999988876542 22345556678899999999999998 88 9999999999
Q ss_pred EEeCCCCcEEEecccCccccCC
Q 008707 368 ILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 368 Ill~~~~~~kl~Dfgla~~~~~ 389 (557)
|+++ ++.++|+|||.+.....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCC
Confidence 9999 88999999999876543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.1e-18 Score=185.15 Aligned_cols=246 Identities=22% Similarity=0.250 Sum_probs=175.6
Q ss_pred HHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcC---CCCccceeeEEEecCeeEEEEEe
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
.+.+.+.||+|+||.||+|...+|+.||+|+-++....+ |.--.+++.+|+ -+.|..+.......+..++|+||
T Consensus 699 ~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey 775 (974)
T KOG1166|consen 699 KFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEY 775 (974)
T ss_pred eEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeec
Confidence 344568899999999999998889999999977654432 111122333333 34566666666667788999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC-------CCCcEEEecccCcc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-------INMRAKVSDFGLSR 385 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~-------~~~~~kl~Dfgla~ 385 (557)
.+.|+|.+++. ..+.+++.-++.++.|++..+.+||. .+||||||||+|++|. +...++|+|||.+.
T Consensus 776 ~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 776 SPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred cccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 99999999998 56778999999999999999999998 9999999999999994 23459999999886
Q ss_pred ccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 386 QAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 386 ~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
...--.. ..-...++|-.+-.+|...+..+++++|.|.++-+++.|+.|++-- ...| ...
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------------~~~g-~~~ 910 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------------VKNG-SSW 910 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------------hcCC-cce
Confidence 5321111 1223345788899999999999999999999999999999987432 1111 111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
.++..+......+ .+-+++..+|..|-..=|...++...++....
T Consensus 911 ~~~~~~~Ry~~~~---~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 911 MVKTNFPRYWKRD---MWNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred eccccchhhhhHH---HHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 1222211111111 34466666666666666777777777766654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.7e-17 Score=155.89 Aligned_cols=134 Identities=25% Similarity=0.407 Sum_probs=112.9
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCccc--------hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+.||+|++|.||+|.+ .|..|++|+...... .....+.+|++++..+.|++|.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 577899997653221 1124577899999999999998888887777888999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++|++|.+.+... . . ....++.+++.+|+++|+ .+++|||++|.||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~---~---~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN---G---M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc---c---H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999988632 1 1 778899999999999998 9999999999999999 78899999998764
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-17 Score=159.83 Aligned_cols=197 Identities=19% Similarity=0.218 Sum_probs=138.7
Q ss_pred CCCCccceeeEEEe---------------------------cCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHH
Q 008707 289 HHRNLVPLIGYCEE---------------------------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH 341 (557)
Q Consensus 289 ~h~nIv~~~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 341 (557)
+|||||++.++|.+ ....|+||..++ .+|..++. ....+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~----~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLW----TRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHh----cCCCchHHHHHHHH
Confidence 59999999887643 335789998874 48888886 33456666778999
Q ss_pred HHHHHHHHHHcCCCCCeEeeccCCCCEEeC--CCC--cEEEecccCccccCC-----CCccccccccCCCCccCCcccCC
Q 008707 342 DAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INM--RAKVSDFGLSRQAEE-----DLTHISSVARGTVGYLDPEYYGN 412 (557)
Q Consensus 342 qia~aL~~LH~~~~~~ivH~dlk~~NIll~--~~~--~~kl~Dfgla~~~~~-----~~~~~~~~~~g~~~y~aPE~l~~ 412 (557)
|+++|+.|||. +||.|||+|.+|||+. +|+ .+.|+|||++--... +.....-...|....||||+...
T Consensus 349 QlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 99999999998 9999999999999994 333 378999998754322 11222223457888999999854
Q ss_pred CC------CCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHH
Q 008707 413 QQ------LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVA 486 (557)
Q Consensus 413 ~~------~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li 486 (557)
.. .-.|+|.|+.|-+.||+++...||-.. -+...+... .++..+. -.+...+..+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r-Gem~L~~r~-----Yqe~qLP---------alp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR-GEMLLDTRT-----YQESQLP---------ALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCccccc-chheechhh-----hhhhhCC---------CCcccCChHHHHHH
Confidence 32 124899999999999999999999521 000011110 1111111 12233445788999
Q ss_pred HHccccCCCCCCCHHHHHHHHH
Q 008707 487 IQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 487 ~~cl~~~P~~RPt~~evl~~L~ 508 (557)
...++.||.+||+..-....|+
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999999876665554
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.3e-17 Score=151.68 Aligned_cols=137 Identities=20% Similarity=0.214 Sum_probs=108.2
Q ss_pred HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccc----------------------hhHHHHHHHHHHHhhcCCCC--
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----------------------HRTQQFVTEVALLSRIHHRN-- 292 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~il~~l~h~n-- 292 (557)
+.+.+.||+|+||.||++...+|+.||||++..... .....+..|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 556789999999999999988899999998653210 01123667899999998774
Q ss_pred ccceeeEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC
Q 008707 293 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 372 (557)
Q Consensus 293 Iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~ 372 (557)
++..++ ....++||||++|++|.+.... .....++.+++.++.++|+ .+++||||+|.||++++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDD 160 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcC
Confidence 444443 2456899999999998765421 2346788999999999998 99999999999999999
Q ss_pred CCcEEEecccCccccCC
Q 008707 373 NMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 373 ~~~~kl~Dfgla~~~~~ 389 (557)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999866544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.7e-17 Score=152.15 Aligned_cols=130 Identities=25% Similarity=0.422 Sum_probs=106.7
Q ss_pred ccCCCCceEEEEEEEcCCcEEEEEEccCcc-c-------hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSC-S-------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 242 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~-------~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
.||+|+||.||+|.+. +..|++|...... . .....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999864 7889999854321 1 11356778999999999887766666666667789999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
+|++|.+.+... . . .++.+++.+|++||+ .+++|||++|.||+++ ++.+++.|||++..
T Consensus 80 ~g~~l~~~~~~~---~-~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEG---N-D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhc---H-H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999887531 1 1 789999999999998 9999999999999999 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.3e-18 Score=169.31 Aligned_cols=174 Identities=26% Similarity=0.362 Sum_probs=132.2
Q ss_pred eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCc
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 384 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 384 (557)
..++.|++|...+|.+++.+.......++.....++.|++.|+.| ++.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999876667778888899999999999999 58999999999999999999999999998
Q ss_pred cccCCCC-----ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHh
Q 008707 385 RQAEEDL-----THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIK 458 (557)
Q Consensus 385 ~~~~~~~-----~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 458 (557)
....... ........||..||+||.+.+..|+.|+||||||++|+|++. -..++.- .-...-++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhhhhhh
Confidence 8765443 112233459999999999999999999999999999999997 2222210 00111122
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 008707 459 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 503 (557)
Q Consensus 459 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev 503 (557)
.|.+ +|....+++. =..++.+++...|.+||++.++
T Consensus 474 ~g~i----p~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 474 DGII----PPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred cCCC----ChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence 2222 2222223332 2389999999999999955443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.8e-16 Score=170.85 Aligned_cols=133 Identities=24% Similarity=0.370 Sum_probs=108.7
Q ss_pred hhcccCCCCceEEEEEEEcCCcEEEEEE-ccCccc-------hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKI-MADSCS-------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~~~-------~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
..+.||+|+||.||+|.+.... +++|+ +.+... ...+.+.+|+++++.++|++++..+.++.+....++||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 415 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVM 415 (535)
T ss_pred ccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEE
Confidence 3688999999999999886443 44443 222111 12356889999999999999998888877777889999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
||+++++|.+++. ....++.|++++|.+||+ .+++||||||+||++ .++.++|+|||+++..
T Consensus 416 E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 416 EYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999998875 246789999999999998 999999999999999 6789999999998753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=4.8e-15 Score=131.90 Aligned_cols=135 Identities=22% Similarity=0.207 Sum_probs=113.1
Q ss_pred hcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCC--CCccceeeEEEecCeeEEEEEecCCCC
Q 008707 240 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEYMHNGT 317 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~~~~~~~~~~~~~lv~e~~~~gs 317 (557)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++++....+..+++|||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 3679999999999999864 7899998865433 4678899999999976 589999998888788999999998876
Q ss_pred hhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 318 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 318 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+... +......++.+++++++++|.....+++|+|++|+||+++..+.+++.|||.+...
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 6543 44566778999999999999733347999999999999999899999999988643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.9e-15 Score=139.00 Aligned_cols=138 Identities=22% Similarity=0.301 Sum_probs=99.1
Q ss_pred hcccCCCCceEEEEEEEcCCcEEEEEEccCccch--hHHH----------------------HHHHHHHHhhcCCCC--c
Q 008707 240 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQ----------------------FVTEVALLSRIHHRN--L 293 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~il~~l~h~n--I 293 (557)
.+.||+|+||.||+|...+++.||||++...... .... ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999987653211 1111 135666666664432 4
Q ss_pred cceeeEEEecCeeEEEEEecCCCChhhh-hhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC
Q 008707 294 VPLIGYCEEEHQRILVYEYMHNGTLRDR-LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 372 (557)
Q Consensus 294 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~ 372 (557)
.+.++. ...++||||++++.+... +... ... .....++.+++.++.++|+ ..+++|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~----~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV----RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh----hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence 444432 246899999998543221 1110 011 5567899999999999996 38999999999999999
Q ss_pred CCcEEEecccCccccCC
Q 008707 373 NMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 373 ~~~~kl~Dfgla~~~~~ 389 (557)
++.++++|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 89999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.7e-16 Score=168.09 Aligned_cols=204 Identities=25% Similarity=0.348 Sum_probs=138.4
Q ss_pred hhcccCCCCceEEEEEEEcC-CcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCC
Q 008707 239 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 317 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gs 317 (557)
.++.|..|+||.||.++++. .+.+|+|+-+++ -+.+- ++.....|.+| |+
T Consensus 87 ~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv---------------------gD 137 (1205)
T KOG0606|consen 87 TIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV---------------------GD 137 (1205)
T ss_pred eeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee---------------------ch
Confidence 46889999999999998874 567787542211 11110 12222222222 33
Q ss_pred hhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC------
Q 008707 318 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL------ 391 (557)
Q Consensus 318 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~------ 391 (557)
=...++ +-+.++.. ++.+++|||+ .||+|||+||+|.+|+.-|++|+.|||+++......
T Consensus 138 c~tllk---~~g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 138 CATLLK---NIGPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred hhhhcc---cCCCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 333333 22334332 2778999998 999999999999999999999999999886532111
Q ss_pred --------ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 392 --------THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 392 --------~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
.......+||+.|.|||++.-..|...+|.|++|+|+||.+.|+.||.+...++ .+.+.+...
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~visd~--- 274 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVISDD--- 274 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhhhhhh---
Confidence 111234579999999999999999999999999999999999999998553322 112222111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 008707 464 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPK 499 (557)
Q Consensus 464 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt 499 (557)
....+.+...+.+..+++.+.+..+|.+|--
T Consensus 275 -----i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 275 -----IEWPEEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred -----ccccccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 1122223344557889999999999999973
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-14 Score=139.81 Aligned_cols=136 Identities=18% Similarity=0.243 Sum_probs=105.5
Q ss_pred hcccC-CCCceEEEEEEEcCCcEEEEEEccCcc-------------chhHHHHHHHHHHHhhcCCCCc--cceeeEEEec
Q 008707 240 CKKIG-KGSFGSVYYGKMKDGKEVAVKIMADSC-------------SHRTQQFVTEVALLSRIHHRNL--VPLIGYCEEE 303 (557)
Q Consensus 240 ~~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~il~~l~h~nI--v~~~~~~~~~ 303 (557)
...|| .|+.|+||.+... +..+++|.+.... ......+.+|++++..|+|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45688 8999999999886 7788988774310 1223567889999999998775 6677764432
Q ss_pred C----eeEEEEEecCC-CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEE
Q 008707 304 H----QRILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 378 (557)
Q Consensus 304 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 378 (557)
. ..++|||+++| .+|.+++.. ..++.. .+.||+.++.+||+ .||+|+||||.|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 689888753 234433 36789999999998 99999999999999999899999
Q ss_pred ecccCcccc
Q 008707 379 SDFGLSRQA 387 (557)
Q Consensus 379 ~Dfgla~~~ 387 (557)
+|||.+...
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999988754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.6e-16 Score=167.28 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=185.3
Q ss_pred HHhhcccCCCCceEEEEEEEcC--CcEEEEEEccCcc--chhHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKD--GKEVAVKIMADSC--SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e 311 (557)
+++.+.||+|+|+.|-...... ...+|+|.+.... .........|..+-..+. |+|++.+++........+++++
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 3455779999999998776533 4456666554332 222344555777777776 9999999999999999999999
Q ss_pred ecCCCChhhhh-hccCCCCCcCHHHHHHHHHHHHHHHHHHH-cCCCCCeEeeccCCCCEEeCCCC-cEEEecccCccccC
Q 008707 312 YMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLH-TGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAE 388 (557)
Q Consensus 312 ~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~ 388 (557)
+..++++.+.+ +.. ....+......++.|+..++.|+| . .++.|+|+||+|.+++..+ ..+++|||+|..+.
T Consensus 102 ~s~g~~~f~~i~~~~--~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPD--STGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cccccccccccccCC--ccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999888 432 224556667789999999999999 6 9999999999999999999 99999999998876
Q ss_pred C--CCccccccccC-CCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 389 E--DLTHISSVARG-TVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 389 ~--~~~~~~~~~~g-~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
. ..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ....|.... +...
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~---~~~~- 251 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK---GRFT- 251 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc---cccc-
Confidence 5 33333444567 9999999999884 556789999999999999999999985544331 111111111 0000
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.... ........+++.+++..+|..|.+.+++..
T Consensus 252 ---~~~~----~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 252 ---QLPW----NSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ---cCcc----ccCChhhhhcccccccCCchhccccccccc
Confidence 0001 111224568888999999999999998753
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.2e-14 Score=133.55 Aligned_cols=199 Identities=25% Similarity=0.380 Sum_probs=141.6
Q ss_pred HhhcCCCCccceeeEEEec-----CeeEEEEEecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 008707 285 LSRIHHRNLVPLIGYCEEE-----HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358 (557)
Q Consensus 285 l~~l~h~nIv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 358 (557)
+-.+.|-|||+++.|+.+. .+..++.||+..|++.++|++.. ++..+......+|+.||..||.|||+ |+..+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCcc
Confidence 4445799999999998653 35689999999999999998754 56678888999999999999999998 67899
Q ss_pred EeeccCCCCEEeCCCCcEEEecccCcccc---CCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCC
Q 008707 359 IHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 435 (557)
Q Consensus 359 vH~dlk~~NIll~~~~~~kl~Dfgla~~~---~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~ 435 (557)
+|+++..+-|++..++-+|++--.-.... ............+-++|.+||.-.....+-++|||+||+...+|..+.
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE 279 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence 99999999999999998998532111110 001111222334678999999887777788999999999999998876
Q ss_pred CCCCCCCcc--ccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 436 KPVSVEDFG--AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 436 ~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.--...... .+.+... + +...-+. .=+..+.+|++.+|..||+|.+++.
T Consensus 280 iq~tnseS~~~~ee~ia~-~--------i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIAN-V--------IIGLENG------------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eccCCCcceeehhhhhhh-h--------eeeccCc------------cccCcCcccccCCCCCCcchhhhhc
Confidence 442211111 1111110 0 0000011 1126778999999999999998864
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.8e-13 Score=142.92 Aligned_cols=141 Identities=24% Similarity=0.305 Sum_probs=99.6
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCccchhHH----------------------------------------HHHH
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ----------------------------------------QFVT 280 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~ 280 (557)
+.||.|++|.||+|++++|+.||||+.++....... +|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 569999999999999999999999998654211100 1344
Q ss_pred HHHHHhhcC----CCCccceeeEE-EecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHH-HHHHHHcCC
Q 008707 281 EVALLSRIH----HRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-GLEYLHTGC 354 (557)
Q Consensus 281 E~~il~~l~----h~nIv~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-aL~~LH~~~ 354 (557)
|.+.+.+++ |.+-+.+-..+ ...+..++||||++|++|.+...... ... ....++.+++. .+..+|.
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~---~~~~ia~~~~~~~l~ql~~-- 275 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGL---DRKALAENLARSFLNQVLR-- 275 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCC---CHHHHHHHHHHHHHHHHHh--
Confidence 555444442 22222222222 22445799999999999988765321 112 23456666666 4678887
Q ss_pred CCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 355 ~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
.|++|+|++|.||+++.++.++++|||++.....
T Consensus 276 -~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 -DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred -CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.8e-12 Score=136.96 Aligned_cols=139 Identities=19% Similarity=0.257 Sum_probs=90.1
Q ss_pred cccCCCCceEEEEEEEcC-CcEEEEEEccCccchh----------------------------------HHH------HH
Q 008707 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHR----------------------------------TQQ------FV 279 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~~------~~ 279 (557)
+.||.|++|.||+|++++ |+.||||+.++..... .+. +.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 9999999997542110 111 23
Q ss_pred HHHHHHhhcC----CCCccceeeEEEe-cCeeEEEEEecCCCChhhhhhccCCCC---CcCHHHHHHHHHHHHHHHHHHH
Q 008707 280 TEVALLSRIH----HRNLVPLIGYCEE-EHQRILVYEYMHNGTLRDRLHGSVNQK---PLDWLTRLQIAHDAAKGLEYLH 351 (557)
Q Consensus 280 ~E~~il~~l~----h~nIv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~---~l~~~~~~~i~~qia~aL~~LH 351 (557)
+|...+.+++ +.+.+.+-.++.+ .+..++||||++|+.+.+.-.-...+. .+....+..++.|+ .
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f 277 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F 277 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H
Confidence 3333333332 3333333333322 456789999999999987422111111 12222233333333 3
Q ss_pred cCCCCCeEeeccCCCCEEeCCCC----cEEEecccCccccCC
Q 008707 352 TGCNPGIIHRDVKSSNILLDINM----RAKVSDFGLSRQAEE 389 (557)
Q Consensus 352 ~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla~~~~~ 389 (557)
. .|++|+|++|.||+++.++ .+++.|||++.....
T Consensus 278 ~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 R---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred h---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3 8999999999999999888 899999999987654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=5.2e-12 Score=115.08 Aligned_cols=127 Identities=18% Similarity=0.193 Sum_probs=95.4
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCcc-ceeeEEEecCeeEEEEEecCCCChh
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV-PLIGYCEEEHQRILVYEYMHNGTLR 319 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv-~~~~~~~~~~~~~lv~e~~~~gsL~ 319 (557)
+.++.|.++.||+++.. ++.|++|....... ....+.+|+++++.+.+.+++ +++.+. ....++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 56899999999999876 78899998764422 123467899999998655543 444443 23458999999998775
Q ss_pred hhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCC-----eEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 320 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-----IIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 320 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~-----ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
+. . . ....++.+++++|+.||+ .+ ++|||++|.||+++ ++.++++||+.+..
T Consensus 80 ~~-~-------~---~~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TE-D-------F---SDPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cc-c-------c---cCHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 43 0 0 112456799999999998 55 59999999999999 67899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.6e-11 Score=127.75 Aligned_cols=169 Identities=20% Similarity=0.211 Sum_probs=126.6
Q ss_pred EcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHH
Q 008707 256 MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 335 (557)
Q Consensus 256 ~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 335 (557)
..++.+|.|...+...........+-++-|+.++||||+++++.++..+..|+|+|-+. .|..+++. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34678888887765544444567778889999999999999999999999999999985 56666653 22455
Q ss_pred HHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccccccCCCCccCCcccCCCCC
Q 008707 336 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 415 (557)
Q Consensus 336 ~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~ 415 (557)
....+.||+.||.|||. +.+++|++|....|+|+..|..||++|.++........ .......--.|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 56679999999999996 58999999999999999999999999987765433221 111111223466666554332
Q ss_pred CcccceehhHHHHHHHHhCCCC
Q 008707 416 TEKSDVYSFGVVLLELISGKKP 437 (557)
Q Consensus 416 s~~~DvwslG~ll~elltg~~p 437 (557)
-..|.|.|||+++|++.|..+
T Consensus 182 -~s~D~~~Lg~li~el~ng~~~ 202 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGSLL 202 (690)
T ss_pred -cchhhhhHHHHHHHHhCcccC
Confidence 346999999999999999433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.9e-12 Score=148.90 Aligned_cols=136 Identities=32% Similarity=0.562 Sum_probs=91.0
Q ss_pred HHHHHhhhhcC-----CCCCCC-CCCCCCCCCeEEeeCCCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCC
Q 008707 4 EALRSISDESE-----RTNDRG-DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG 77 (557)
Q Consensus 4 ~~~~~~~~~~~-----~~~~~~-~~c~~~~~~~v~c~~~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 77 (557)
.||.+++++++ +.+|+. +.|| .|.||+|+.. .+++.|+|++|+++|.+|..+..+++|+.|+|++|++++
T Consensus 32 ~~l~~~~~~~~~~~~~~~~w~~~~~~c--~w~gv~c~~~--~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~ 107 (968)
T PLN00113 32 ELLLSFKSSINDPLKYLSNWNSSADVC--LWQGITCNNS--SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSG 107 (968)
T ss_pred HHHHHHHHhCCCCcccCCCCCCCCCCC--cCcceecCCC--CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCC
Confidence 57888888873 357953 4443 6999999853 478888888888888888888888888888888888887
Q ss_pred CCC-C-ccCCCCCcEEEecCccccCcC----------------------CCccCCCCcccccccccccCCCCCCccccc-
Q 008707 78 PLP-D-MSRLIDLRIVHLENNELTGSL----------------------PSYMGSLPNLQELHIENNSFVGEIPPALLT- 132 (557)
Q Consensus 78 ~~~-~-~~~l~~L~~L~l~~N~l~~~~----------------------p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~- 132 (557)
.+| + +..+++|++|+|++|+++|.+ |..++.+++|+.|++++|.+.+.+|..+..
T Consensus 108 ~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l 187 (968)
T PLN00113 108 PIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL 187 (968)
T ss_pred cCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhC
Confidence 666 3 446666666666666665544 444555555555555555555555554332
Q ss_pred -CceeeeecCCC
Q 008707 133 -GKVIFKYDNNP 143 (557)
Q Consensus 133 -~~~~~~~~~n~ 143 (557)
.+..+.+.+|.
T Consensus 188 ~~L~~L~L~~n~ 199 (968)
T PLN00113 188 TSLEFLTLASNQ 199 (968)
T ss_pred cCCCeeeccCCC
Confidence 33444555553
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-12 Score=134.72 Aligned_cols=254 Identities=22% Similarity=0.212 Sum_probs=183.6
Q ss_pred hHHHHHHHHhhcccCC--CCceEEEEEEE---cCCcEEEEEEccCccc--hhHHHHHHHHHHHhhc-CCCCccceeeEEE
Q 008707 230 PELEEATNNFCKKIGK--GSFGSVYYGKM---KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRI-HHRNLVPLIGYCE 301 (557)
Q Consensus 230 ~~~~~~~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l-~h~nIv~~~~~~~ 301 (557)
.+..+....+.+.+|. |.+|.||.+.. .++..+|+|.-+.... .....=.+|+.....+ .|+|.++.+..+.
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 3455566667889999 99999999976 3578899987432222 2223334577777777 4999999999999
Q ss_pred ecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHH----HHHHHHcCCCCCeEeeccCCCCEEeCCC-CcE
Q 008707 302 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK----GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRA 376 (557)
Q Consensus 302 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----aL~~LH~~~~~~ivH~dlk~~NIll~~~-~~~ 376 (557)
+.+..++-+|.+ +.+|..+.+.. ...++....+....+... |+.++|+ .+++|-|+||.||+...+ ...
T Consensus 189 ~~~~lfiqtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 189 GSGILFIQTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cCCcceeeeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCC---Ccccccccchhheeccccccee
Confidence 999999999998 57888877642 334677788888888888 9999998 999999999999999999 889
Q ss_pred EEecccCccccCCCCcc----ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHH
Q 008707 377 KVSDFGLSRQAEEDLTH----ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 452 (557)
Q Consensus 377 kl~Dfgla~~~~~~~~~----~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~ 452 (557)
+++|||+...+.+..-. ......|...|++||...+ .++.++|+|++|.++.+-.++..............
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~---- 337 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ---- 337 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCccc----
Confidence 99999998877654311 1122247888999998866 46789999999999999988877665331111000
Q ss_pred HHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 453 ARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 453 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
++++-+ ..++...-...+...+.+|++.+|-.|++.+++...
T Consensus 338 ----~r~~~i--------p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 338 ----LRQGYI--------PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ----cccccC--------chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 000000 011111111245568999999999999998887653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.2e-10 Score=107.19 Aligned_cols=137 Identities=15% Similarity=0.173 Sum_probs=99.2
Q ss_pred cccCCCCceEEEEEEEcC-------CcEEEEEEccCcc----------------------chhHHHH----HHHHHHHhh
Q 008707 241 KKIGKGSFGSVYYGKMKD-------GKEVAVKIMADSC----------------------SHRTQQF----VTEVALLSR 287 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~----~~E~~il~~ 287 (557)
..||.|--+.||.|...+ +..+|||+.+... ....+.+ .+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 4799999874210 0011223 389999999
Q ss_pred cCC--CCccceeeEEEecCeeEEEEEecCCCChh-hhhhccCCCCCcCHHHHHHHHHHHHHHHHHH-HcCCCCCeEeecc
Q 008707 288 IHH--RNLVPLIGYCEEEHQRILVYEYMHNGTLR-DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL-HTGCNPGIIHRDV 363 (557)
Q Consensus 288 l~h--~nIv~~~~~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~l~~~~~~~i~~qia~aL~~L-H~~~~~~ivH~dl 363 (557)
+.. -++..++++ ...++||||+.++.+. ..++ ...++......+..+++.+|..| |. .|++||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCC
Confidence 853 456666654 4678999999764332 1222 22344556677889999999999 76 89999999
Q ss_pred CCCCEEeCCCCcEEEecccCccccCC
Q 008707 364 KSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 364 k~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
++.||+++ ++.+.|+|||.+.....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999997 47899999998876644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.3e-10 Score=100.58 Aligned_cols=132 Identities=25% Similarity=0.402 Sum_probs=102.3
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEE-ccCccch-------hHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKI-MADSCSH-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~-------~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
..+++|+-+.+|.+.+. |.++++|. +++.... ....-.+|.+++.+++--.|...+=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999886 44566664 3332211 123566899999999876777777777777888999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
++|..|.+.+... ...++..+=.-+.-||. .||+||||.++||.+..++ +.++|||++...
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888743 14566777777889998 9999999999999998655 999999998743
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.4e-10 Score=107.78 Aligned_cols=142 Identities=21% Similarity=0.322 Sum_probs=109.3
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCC--CCccceeeEEEec---CeeEEEEEecC
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHH--RNLVPLIGYCEEE---HQRILVYEYMH 314 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h--~nIv~~~~~~~~~---~~~~lv~e~~~ 314 (557)
+.|+.|..+.||++...+|+.+++|....... .....+..|+++++.+.+ .++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999998764322 134568899999999965 3457777776553 25689999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcC-----------------------------------------
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG----------------------------------------- 353 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~----------------------------------------- 353 (557)
|.++.+.+. ...++......++.+++++|+.||+.
T Consensus 84 G~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLL----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCC----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 988877553 13466677778888888888888851
Q ss_pred ------------CCCCeEeeccCCCCEEeCC--CCcEEEecccCccc
Q 008707 354 ------------CNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQ 386 (557)
Q Consensus 354 ------------~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~ 386 (557)
....++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 1256799999999999998 56689999997754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.7e-10 Score=98.52 Aligned_cols=142 Identities=21% Similarity=0.272 Sum_probs=107.6
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEE-ccCccch-------hHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKI-MADSCSH-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~-------~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
..+-+|+-+.|+++.+. |+..+||. +.+.... ..++.++|.+.+.+++--.|.-..-++.+...-.++|||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 67889999999999997 77777774 3332221 235677899999998766776666677777888999999
Q ss_pred cCC-CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc---EEEecccCcccc
Q 008707 313 MHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQA 387 (557)
Q Consensus 313 ~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfgla~~~ 387 (557)
++| .++.+++..... ..........++.+|=+.+.-||. .+++||||..+||++..++. +.++|||++...
T Consensus 92 ~~g~~~vk~~i~~~~~-~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 92 IDGASTVKDFILSTME-DESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred ccchhHHHHHHHHHcc-CcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 976 478888865432 222333336789999999999998 99999999999999976544 589999997643
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.6e-12 Score=108.33 Aligned_cols=91 Identities=30% Similarity=0.501 Sum_probs=83.9
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
..++.|-|+||.++ .+|+.+.+|.+|+.|++++|+|...++++..|++|+.|+++-|++. .+|..|+.++.|+.||+.
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlt 110 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLT 110 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcc
Confidence 45788999999999 9999999999999999999999999999999999999999999999 999999999999999999
Q ss_pred cccCC-CCCCcccc
Q 008707 119 NNSFV-GEIPPALL 131 (557)
Q Consensus 119 ~N~~~-~~~p~~~~ 131 (557)
.|++. ..+|..+|
T Consensus 111 ynnl~e~~lpgnff 124 (264)
T KOG0617|consen 111 YNNLNENSLPGNFF 124 (264)
T ss_pred ccccccccCCcchh
Confidence 99987 23666655
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.5e-10 Score=126.55 Aligned_cols=122 Identities=26% Similarity=0.498 Sum_probs=95.9
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCC-Ccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSL-PNLQELH 116 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l-~~L~~l~ 116 (557)
++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+| .+++|++|+.|+|++|+|+|.+|..++.+ .++..++
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~ 521 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN 521 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEE
Confidence 689999999999999999999999999999999999999988 59999999999999999999999988764 4678899
Q ss_pred cccccCCCCCCcccccCceeeeecCCCcccccc-cccccceEEEeehhhHHHHHHHHHH
Q 008707 117 IENNSFVGEIPPALLTGKVIFKYDNNPKLHKES-RRRMRFKLILGTSIGVLAILLVLFL 174 (557)
Q Consensus 117 l~~N~~~~~~p~~~~~~~~~~~~~~n~~~~~~~-~~~~~~~~~i~~~i~~~~~l~~~~~ 174 (557)
+.+|.....+|. + ..|... .......++++++++++++++.+++
T Consensus 522 ~~~N~~lc~~p~-l-------------~~C~~~~~~~~~i~~~~~~~~~~l~~~~~~~~ 566 (623)
T PLN03150 522 FTDNAGLCGIPG-L-------------RACGPHLSVGAKIGIAFGVSVAFLFLVICAMC 566 (623)
T ss_pred ecCCccccCCCC-C-------------CCCcccCCCceEEEEEhHHHHHHHHHHHHHhh
Confidence 999975433432 1 123221 2344666777777665555554444
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.02 E-value=9e-09 Score=104.29 Aligned_cols=170 Identities=21% Similarity=0.297 Sum_probs=128.1
Q ss_pred CceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEE----ecCeeEEEEEecCC-CChhh
Q 008707 247 SFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE----EEHQRILVYEYMHN-GTLRD 320 (557)
Q Consensus 247 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~----~~~~~~lv~e~~~~-gsL~~ 320 (557)
.-.+.|++..+ +|..|++|+++............-+++++++.|+|||++.++|. .+...++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 33578899755 79999999995443322223335688999999999999999886 34568999999976 56766
Q ss_pred hhhccC------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 321 RLHGSV------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 321 ~l~~~~------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
..-... .+...++..+|.++.|++.||.++|+ .|+.-+-|.+++|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 543211 23457788999999999999999998 999999999999999998899999888765554
Q ss_pred CCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCC
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~p 437 (557)
.+.. |.+.+ -.+-|.-.||.+++.|.||..-
T Consensus 445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 3320 11111 2367899999999999999644
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.7e-10 Score=117.70 Aligned_cols=241 Identities=21% Similarity=0.209 Sum_probs=169.5
Q ss_pred hcccCCCCceEEEEEEEc--CCcEEEEEEccCccchhHH--HHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecC
Q 008707 240 CKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSCSHRTQ--QFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~--~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
...||.|.|+.|+....+ ++..+++|.+.+....... .-..|+.+...+ .|.+++.++..+......++--|||+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 577999999999988643 5788999987665433222 234577777776 58899998887777777789999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC-CcEEEecccCccccCCCCcc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++...+. ....+....++.+..|++.++.++|+ +.++|+|++|+||++..+ +..++.|||+.....-...
T Consensus 350 ~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~- 422 (524)
T KOG0601|consen 350 GGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG- 422 (524)
T ss_pred CcchhhhhH---HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccceecc-
Confidence 998876653 23446667788999999999999998 999999999999999876 7789999998865321111
Q ss_pred ccccccCCCCcc--CCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 394 ISSVARGTVGYL--DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 394 ~~~~~~g~~~y~--aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.....-++. +++......+..+.|++|||.-+.+..++..--.... +|. .+..|.....
T Consensus 423 ---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~--~i~~~~~p~~------ 483 (524)
T KOG0601|consen 423 ---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSL--TIRSGDTPNL------ 483 (524)
T ss_pred ---cccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cce--eeecccccCC------
Confidence 111223333 5555666778889999999999999998864432110 000 0111211111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
. .....+..+...+...++..||.+.++.....-.
T Consensus 484 ---~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 484 ---P-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ---C-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 1 1113566888899999999999999887654433
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.2e-08 Score=97.89 Aligned_cols=264 Identities=16% Similarity=0.139 Sum_probs=162.8
Q ss_pred hcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccc----eeeEEE--e-cCeeEEEEE
Q 008707 240 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVP----LIGYCE--E-EHQRILVYE 311 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~----~~~~~~--~-~~~~~lv~e 311 (557)
++.||+|+.+.+|-.-.- +. .+.|+.+........+ .+..|.+. .||-+-. ...... + +....+.|.
T Consensus 16 gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh-hc-hhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 578999999999965321 11 3446655433322222 23334444 4654322 222111 1 223678888
Q ss_pred ecCCC-Chhhhhhc---cCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 312 YMHNG-TLRDRLHG---SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 312 ~~~~g-sL~~~l~~---~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
.+.+. .+.+++.. ...-....|.-.+.+++.++.+.+-||. .|.+-||++++|+|+++++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeec
Confidence 88664 23333322 1123346788899999999999999998 99999999999999999999999875432222
Q ss_pred CCCCccccccccCCCCccCCcccC-----CCCCCcccceehhHHHHHHHHhC-CCCCCCCCcc-ccccHHHHHHHHHhcC
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFG-AELNIVHWARSMIKKG 460 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~-----~~~~s~~~DvwslG~ll~elltg-~~pf~~~~~~-~~~~~~~~~~~~~~~~ 460 (557)
.++..... ..|...|.+||.-. +..-+...|.|.+|+++++++.| ..||.+-... +..+-.+ ..+..|
T Consensus 168 ~ng~~~~c--pVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~g 242 (637)
T COG4248 168 ANGTLHLC--PVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAHG 242 (637)
T ss_pred cCCceEec--ccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhcc
Confidence 22222222 23788999999754 34556789999999999998885 9999865432 1111111 112223
Q ss_pred Ccccccccccc-----CCCC-HHHHHHHHHHHHHccccC--CCCCCCHHHHHHHHHhhhhhhcC
Q 008707 461 DVISIVDPVLI-----GNVK-IESIWRIAEVAIQCVEQR--GFSRPKMQEIVLAIQDSIKIEKG 516 (557)
Q Consensus 461 ~~~~~~d~~l~-----~~~~-~~~~~~l~~li~~cl~~~--P~~RPt~~evl~~L~~~~~~~~~ 516 (557)
.+....|.... ...+ ...+..+.-+..+|+... +.-|||++-.+..|..+.+...+
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 33222221110 0111 123346778889999654 56899999999998888775543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.3e-09 Score=95.43 Aligned_cols=127 Identities=25% Similarity=0.316 Sum_probs=83.3
Q ss_pred EEEEEEEcCCcEEEEEEccCcc--------------c------------hhHHHHHHHHHHHhhcCCC--CccceeeEEE
Q 008707 250 SVYYGKMKDGKEVAVKIMADSC--------------S------------HRTQQFVTEVALLSRIHHR--NLVPLIGYCE 301 (557)
Q Consensus 250 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~il~~l~h~--nIv~~~~~~~ 301 (557)
.||.|...+|..+|+|+.+... . .......+|++.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899999889999999874210 0 0113467899999999755 46666644
Q ss_pred ecCeeEEEEEecC--CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHH-HHcCCCCCeEeeccCCCCEEeCCCCcEEE
Q 008707 302 EEHQRILVYEYMH--NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY-LHTGCNPGIIHRDVKSSNILLDINMRAKV 378 (557)
Q Consensus 302 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~-LH~~~~~~ivH~dlk~~NIll~~~~~~kl 378 (557)
...++||||++ |..+..+... .++......++.+++..+.. +|. .|++||||.+.||+++++ .+.+
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEE
Confidence 24579999998 5445443321 11123345677888886665 566 999999999999999987 9999
Q ss_pred ecccCccccCC
Q 008707 379 SDFGLSRQAEE 389 (557)
Q Consensus 379 ~Dfgla~~~~~ 389 (557)
+|||.+.....
T Consensus 148 IDf~qav~~~~ 158 (188)
T PF01163_consen 148 IDFGQAVDSSH 158 (188)
T ss_dssp --GTTEEETTS
T ss_pred EecCcceecCC
Confidence 99998876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=1.9e-11 Score=105.90 Aligned_cols=106 Identities=33% Similarity=0.596 Sum_probs=65.8
Q ss_pred CceEEEEecCCCccc-cCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 39 PRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
|.|+.|||++|++.. .+|..|..++.|+.|+|++|.+.-++|++++|++|+.|.+..|.+- ++|..++.++.|+.|.+
T Consensus 102 p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhi 180 (264)
T KOG0617|consen 102 PALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHI 180 (264)
T ss_pred chhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhc
Confidence 344555555555542 2444454555555555555555555556777777777777777777 77777777777777777
Q ss_pred ccccCCCCCCccccc-----CceeeeecCCCccc
Q 008707 118 ENNSFVGEIPPALLT-----GKVIFKYDNNPKLH 146 (557)
Q Consensus 118 ~~N~~~~~~p~~~~~-----~~~~~~~~~n~~~~ 146 (557)
.+|+++ .+|+++.. .+....+.+|||..
T Consensus 181 qgnrl~-vlppel~~l~l~~~k~v~r~E~NPwv~ 213 (264)
T KOG0617|consen 181 QGNRLT-VLPPELANLDLVGNKQVMRMEENPWVN 213 (264)
T ss_pred ccceee-ecChhhhhhhhhhhHHHHhhhhCCCCC
Confidence 777777 77776654 23344566777764
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=8.4e-09 Score=97.17 Aligned_cols=137 Identities=23% Similarity=0.209 Sum_probs=99.7
Q ss_pred HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCcc----------------------chhHHHHHHHHHHHhhcCCC--C
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC----------------------SHRTQQFVTEVALLSRIHHR--N 292 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~il~~l~h~--n 292 (557)
+.++..||.|--|.||.|....|.++|||.=+-.. ...+....+|.++|+.|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 34678999999999999999999999999632110 01123467899999999644 6
Q ss_pred ccceeeEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC
Q 008707 293 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 372 (557)
Q Consensus 293 Iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~ 372 (557)
|...++ .++..+|||+++|-.|...- +.......++..|++-+..+-. .|++|||+++-||++++
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence 777776 46789999999886665432 1222333445555555554444 89999999999999999
Q ss_pred CCcEEEecccCccccC
Q 008707 373 NMRAKVSDFGLSRQAE 388 (557)
Q Consensus 373 ~~~~kl~Dfgla~~~~ 388 (557)
+|.+.++||--+....
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999997665443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.8e-08 Score=97.95 Aligned_cols=141 Identities=16% Similarity=0.170 Sum_probs=99.6
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCccch-----------hHHHHHHHHHHHhhcCCCCc--cceeeEEEe-----
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH-----------RTQQFVTEVALLSRIHHRNL--VPLIGYCEE----- 302 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~il~~l~h~nI--v~~~~~~~~----- 302 (557)
+.+-+-....|++..+. |+.+.||........ ....+.+|+..+..+...+| +.++++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 33443344457777664 788999976432211 11247789999988854333 344555543
Q ss_pred cCeeEEEEEecCCC-ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC-------CC
Q 008707 303 EHQRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-------NM 374 (557)
Q Consensus 303 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~-------~~ 374 (557)
....++|+|++++. +|.+++.... ....+......++.+++..++-||. .||+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCc
Confidence 23578999999875 7988875321 2334556677899999999999998 99999999999999975 46
Q ss_pred cEEEecccCccc
Q 008707 375 RAKVSDFGLSRQ 386 (557)
Q Consensus 375 ~~kl~Dfgla~~ 386 (557)
.+.++||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 799999997753
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.1e-10 Score=117.52 Aligned_cols=83 Identities=30% Similarity=0.379 Sum_probs=56.5
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
...|+.||||+|+++ .+|..+-.-+++-.|+||+|+|..+|.. |-+|+.|-+||||+|++. .+|..+.+|..|+.|.
T Consensus 102 l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~ 179 (1255)
T KOG0444|consen 102 LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLK 179 (1255)
T ss_pred cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhh
Confidence 344667777777777 6676666666777777777777766654 666777777777777777 6666666777777777
Q ss_pred cccccC
Q 008707 117 IENNSF 122 (557)
Q Consensus 117 l~~N~~ 122 (557)
|++|.+
T Consensus 180 Ls~NPL 185 (1255)
T KOG0444|consen 180 LSNNPL 185 (1255)
T ss_pred cCCChh
Confidence 777754
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.2e-09 Score=80.97 Aligned_cols=60 Identities=35% Similarity=0.482 Sum_probs=37.9
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNEL 98 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l 98 (557)
|+|+.|+|++|+|+...+..|.++++|++|+|++|+|+.+.+ .|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 356666677666663333456666666666666666666665 366666666666666654
|
... |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.6e-10 Score=110.19 Aligned_cols=94 Identities=28% Similarity=0.368 Sum_probs=77.6
Q ss_pred CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecC-ccccCcCCC-ccCCCCcc
Q 008707 36 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLEN-NELTGSLPS-YMGSLPNL 112 (557)
Q Consensus 36 ~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~-N~l~~~~p~-~~~~l~~L 112 (557)
..|+.++.|+|+.|+|+...|..|+.+++|+.||||+|.|+.+-| .|.+|++|..|-+-+ |+|+ .+|. .|++|.+|
T Consensus 64 ~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~sl 142 (498)
T KOG4237|consen 64 NLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSL 142 (498)
T ss_pred cCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHH
Confidence 458999999999999994445679999999999999999999988 699999977776655 9999 7775 57788888
Q ss_pred cccccccccCCCCCCcccc
Q 008707 113 QELHIENNSFVGEIPPALL 131 (557)
Q Consensus 113 ~~l~l~~N~~~~~~p~~~~ 131 (557)
+.|.+.-|++. .++...+
T Consensus 143 qrLllNan~i~-Cir~~al 160 (498)
T KOG4237|consen 143 QRLLLNANHIN-CIRQDAL 160 (498)
T ss_pred HHHhcChhhhc-chhHHHH
Confidence 88888887776 5555444
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.2e-09 Score=98.53 Aligned_cols=104 Identities=27% Similarity=0.451 Sum_probs=39.7
Q ss_pred CCCceEEEEecCCCccccCCcccc-CCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCcc-CCCCcccc
Q 008707 37 TPPRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQE 114 (557)
Q Consensus 37 ~p~~l~~L~L~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~ 114 (557)
.|-+++.|+|++|.|+ .+. .++ .|++|+.|||++|.|+.+ +.+..++.|+.|++++|+|+ .++..+ ..+++|+.
T Consensus 17 n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQE 92 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S-CHHHHHH-TT--E
T ss_pred cccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCE
Confidence 3557899999999999 665 465 589999999999999975 56888999999999999999 776555 36899999
Q ss_pred cccccccCCCCCCc----ccccCceeeeecCCCcc
Q 008707 115 LHIENNSFVGEIPP----ALLTGKVIFKYDNNPKL 145 (557)
Q Consensus 115 l~l~~N~~~~~~p~----~~~~~~~~~~~~~n~~~ 145 (557)
|++++|+|. .+.+ .-+..+..+.+.|||..
T Consensus 93 L~L~~N~I~-~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 93 LYLSNNKIS-DLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp EE-TTS----SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred EECcCCcCC-ChHHhHHHHcCCCcceeeccCCccc
Confidence 999999998 5543 12445677899999963
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.4e-09 Score=80.61 Aligned_cols=60 Identities=38% Similarity=0.504 Sum_probs=55.0
Q ss_pred CCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccccccccC
Q 008707 63 EALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 122 (557)
Q Consensus 63 ~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~ 122 (557)
++|++|+|++|+|+.+++ .|.++++|+.|++++|.++..-|..|.++++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 579999999999999988 599999999999999999966667899999999999999986
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=7.9e-10 Score=120.10 Aligned_cols=242 Identities=20% Similarity=0.220 Sum_probs=160.1
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCc---cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
.+.+-.|.++.++.+.-. .|...+.|+.... ...+.+....+-.++-..++|-++...-.+.-....+++++|..+
T Consensus 809 ~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~ 888 (1205)
T KOG0606|consen 809 TKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNG 888 (1205)
T ss_pred cccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhcc
Confidence 356788999998877533 2444444433211 111122222333333333456666555555556678999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC------
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE------ 389 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~------ 389 (557)
++|...++.. ...+..........+..+++|||+ ..+.|+|++|.|.++..++..++.|||.....+-
T Consensus 889 ~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 889 GDLPSKLHNS---GCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred CCchhhhhcC---CCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 9999998843 344555556677788899999997 6689999999999999999999999983322110
Q ss_pred ---------------CCc---------cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccc
Q 008707 390 ---------------DLT---------HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 445 (557)
Q Consensus 390 ---------------~~~---------~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~ 445 (557)
... .......+|+.|.+||.+.+......+|.|+.|++++|.++|..||.......
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 000 01123358999999999999999999999999999999999999998443221
Q ss_pred cccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHH
Q 008707 446 ELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ 501 (557)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ 501 (557)
.. +-+..+.. -..+..........+++.+.+..+|.+|-.|.
T Consensus 1043 ~f-------~ni~~~~~-------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 IF-------ENILNRDI-------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hh-------hccccCCC-------CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 11 01111111 01222333344666888888899999988777
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.5e-09 Score=112.05 Aligned_cols=151 Identities=18% Similarity=0.255 Sum_probs=107.0
Q ss_pred HHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc--------cccccCCCCccCCcccC
Q 008707 340 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI--------SSVARGTVGYLDPEYYG 411 (557)
Q Consensus 340 ~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~--------~~~~~g~~~y~aPE~l~ 411 (557)
+.+++.|+.|+|. ..++||++|.|++|.++..+..||+.|+.+.......... .....-...|.|||++.
T Consensus 105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455699999998 5899999999999999999999999999876544321111 11122456799999999
Q ss_pred CCCCCcccceehhHHHHHHHH-hCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHcc
Q 008707 412 NQQLTEKSDVYSFGVVLLELI-SGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCV 490 (557)
Q Consensus 412 ~~~~s~~~DvwslG~ll~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl 490 (557)
+...+.++|+||+|+++|.++ .|+.-+............. ..+..-...+..+.+.++.+-+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-------------~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-------------NLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-------------cccccccccccccCcHHHHHHHHHHh
Confidence 988899999999999999999 4555555332222111111 11111112233455668899999999
Q ss_pred ccCCCCCCCHHHHHH
Q 008707 491 EQRGFSRPKMQEIVL 505 (557)
Q Consensus 491 ~~~P~~RPt~~evl~ 505 (557)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998888754
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=9.7e-10 Score=112.08 Aligned_cols=107 Identities=21% Similarity=0.309 Sum_probs=62.3
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCC---ccCCCCcccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS---YMGSLPNLQE 114 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~---~~~~l~~L~~ 114 (557)
++|.+|+|++|+|+..-+.+|..|..|+.|+|++|+|+-+-. .|..+++|+.|||++|.|++.+-+ .|.+|++|+.
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 455666666666663334455555666666666666655544 356666666666666666655543 3456666677
Q ss_pred cccccccCCCCCCcccccCc---eeeeecCCCccc
Q 008707 115 LHIENNSFVGEIPPALLTGK---VIFKYDNNPKLH 146 (557)
Q Consensus 115 l~l~~N~~~~~~p~~~~~~~---~~~~~~~n~~~~ 146 (557)
|.+.+|++. .||...|.++ .-+.+.+|+...
T Consensus 397 L~l~gNqlk-~I~krAfsgl~~LE~LdL~~NaiaS 430 (873)
T KOG4194|consen 397 LRLTGNQLK-SIPKRAFSGLEALEHLDLGDNAIAS 430 (873)
T ss_pred eeecCceee-ecchhhhccCcccceecCCCCccee
Confidence 777777776 6666665543 334556665443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.6e-08 Score=102.98 Aligned_cols=145 Identities=24% Similarity=0.332 Sum_probs=93.2
Q ss_pred HHhh-cccCCCCceEEEEEEEcCCcEEEEEEccCccchhHH---------------------------------------
Q 008707 237 NNFC-KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQ--------------------------------------- 276 (557)
Q Consensus 237 ~~~~-~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~--------------------------------------- 276 (557)
.+|. +.|+.++-|.||+|++++|+.||||+.++......+
T Consensus 126 ~eF~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 126 SEFEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HHcCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 3443 568999999999999999999999998764322111
Q ss_pred -HHHHHHHHHhhcC-----CCCccceeeEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHH-HHH
Q 008707 277 -QFVTEVALLSRIH-----HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG-LEY 349 (557)
Q Consensus 277 -~~~~E~~il~~l~-----h~nIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~a-L~~ 349 (557)
++.+|..-+.+++ .+++.-.-=+.+-.+..+++|||++|-.+.+...-. ..+.+.. .++..++++ +..
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~~g~d~k---~ia~~~~~~f~~q 280 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--SAGIDRK---ELAELLVRAFLRQ 280 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH--hcCCCHH---HHHHHHHHHHHHH
Confidence 1223333333331 222221111223356779999999998888874321 2334422 233333332 222
Q ss_pred HHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 350 LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
+-. .|++|+|.+|.||+++.++.+.+.|||+.....+
T Consensus 281 ~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 281 LLR---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHh---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 222 7999999999999999999999999999877654
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.72 E-value=2.2e-09 Score=110.16 Aligned_cols=93 Identities=25% Similarity=0.407 Sum_probs=72.4
Q ss_pred CCCceEEEEecCCCcccc-CCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCcc-CCCCcccc
Q 008707 37 TPPRITKIALSGKNLKGE-IPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQE 114 (557)
Q Consensus 37 ~p~~l~~L~L~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~ 114 (557)
..|+|..+++.+|++... +|..+..|..|+.||||+|+|...|..+...+++-.|+||+|+|. +||..+ .+|+.|-+
T Consensus 76 ~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLf 154 (1255)
T KOG0444|consen 76 DLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLF 154 (1255)
T ss_pred cchhhHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhh
Confidence 346777888888888643 777888888888888888888877777888888888888888888 888764 47788888
Q ss_pred cccccccCCCCCCcccc
Q 008707 115 LHIENNSFVGEIPPALL 131 (557)
Q Consensus 115 l~l~~N~~~~~~p~~~~ 131 (557)
|||++|++. .+|+.+.
T Consensus 155 LDLS~NrLe-~LPPQ~R 170 (1255)
T KOG0444|consen 155 LDLSNNRLE-MLPPQIR 170 (1255)
T ss_pred hccccchhh-hcCHHHH
Confidence 888888887 7877654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.6e-09 Score=104.45 Aligned_cols=104 Identities=26% Similarity=0.343 Sum_probs=70.7
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCc-cCCCCccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELHI 117 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~l~l 117 (557)
++++.|+|++|-+. .+|.+++.+..|+.||+|+|+|...|..+..+..|+.+-.++|++. .+|.. +.+|.+|+.||+
T Consensus 435 ~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~-~vd~~~l~nm~nL~tLDL 512 (565)
T KOG0472|consen 435 QKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIG-SVDPSGLKNMRNLTTLDL 512 (565)
T ss_pred hcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhcccccc-ccChHHhhhhhhcceecc
Confidence 45566666666655 6666666666666666666655544434444445555555556665 55544 888999999999
Q ss_pred ccccCCCCCCccccc--CceeeeecCCCcc
Q 008707 118 ENNSFVGEIPPALLT--GKVIFKYDNNPKL 145 (557)
Q Consensus 118 ~~N~~~~~~p~~~~~--~~~~~~~~~n~~~ 145 (557)
.+|.+. .||+.+++ .+.-+.++|||+.
T Consensus 513 ~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 513 QNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred CCCchh-hCChhhccccceeEEEecCCccC
Confidence 999998 99998876 5567788999976
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.9e-09 Score=115.49 Aligned_cols=115 Identities=28% Similarity=0.423 Sum_probs=96.5
Q ss_pred CCCCCCCCCCeEEeeCCCCCceEEEEecCCCccccCCc-cccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccc
Q 008707 20 GDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98 (557)
Q Consensus 20 ~~~c~~~~~~~v~c~~~~p~~l~~L~L~~n~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l 98 (557)
+|.| |+.+.|- .+|+.|+|++|+|. ++|. .+.+|..|+.|+||+|+|+.++..+.++..|++|...+|+|
T Consensus 372 td~c----~p~l~~~----~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l 442 (1081)
T KOG0618|consen 372 TDSC----FPVLVNF----KHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQL 442 (1081)
T ss_pred cccc----hhhhccc----cceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCce
Confidence 4566 5555442 47999999999999 8885 58889999999999999998887899999999999999999
Q ss_pred cCcCCCccCCCCcccccccccccCC-CCCCcccc-cCceeeeecCCCcc
Q 008707 99 TGSLPSYMGSLPNLQELHIENNSFV-GEIPPALL-TGKVIFKYDNNPKL 145 (557)
Q Consensus 99 ~~~~p~~~~~l~~L~~l~l~~N~~~-~~~p~~~~-~~~~~~~~~~n~~~ 145 (557)
. .+| .+..++.|+.+|++.|+++ +.+|...- ..+..+.+.||++.
T Consensus 443 ~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 443 L-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred e-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 9 999 7889999999999999987 33566555 67788899999864
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.4e-07 Score=83.76 Aligned_cols=137 Identities=20% Similarity=0.233 Sum_probs=101.6
Q ss_pred CCCCceEEEEEEEcCCcEEEEEEccCcc------chhHHHHHHHHHHHhhcCCC--CccceeeEEEe-----cCeeEEEE
Q 008707 244 GKGSFGSVYYGKMKDGKEVAVKIMADSC------SHRTQQFVTEVALLSRIHHR--NLVPLIGYCEE-----EHQRILVY 310 (557)
Q Consensus 244 G~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~h~--nIv~~~~~~~~-----~~~~~lv~ 310 (557)
|.|+-+-|++.... |+.+-+|.-.+.. +.....|.+|+..++.|..- .+.+++ ++.. ....+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 56888999998876 4578888764211 23567899999999999532 244444 3321 22467999
Q ss_pred EecCC-CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc--EEEecccCccc
Q 008707 311 EYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQ 386 (557)
Q Consensus 311 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~~ 386 (557)
|-+.+ -+|.+++... .....+......+..+++.+++-||. .|+.|+|+.++||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98854 4788887543 22345667778899999999999998 99999999999999986667 99999986654
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=9.1e-09 Score=100.58 Aligned_cols=112 Identities=22% Similarity=0.321 Sum_probs=91.1
Q ss_pred EeeCCCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCC
Q 008707 32 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLP 110 (557)
Q Consensus 32 ~c~~~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 110 (557)
.|.|++-. =..++.++-+++ .+|..+. +.-..|+|..|+|+.++| .|..+++|+.||||+|+|+..-|+.|.++.
T Consensus 40 pC~Cs~~~-g~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~ 115 (498)
T KOG4237|consen 40 PCTCSDVE-GGIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLA 115 (498)
T ss_pred CcccCCCC-CceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhH
Confidence 35554322 467788888999 8997654 688999999999999999 599999999999999999988899999999
Q ss_pred ccccccccc-ccCCCCCCcccccCceee-eecCCCccccc
Q 008707 111 NLQELHIEN-NSFVGEIPPALLTGKVIF-KYDNNPKLHKE 148 (557)
Q Consensus 111 ~L~~l~l~~-N~~~~~~p~~~~~~~~~~-~~~~n~~~~~~ 148 (557)
+|..|-+.+ |+|+ .+|...|.++..+ .+..|++.|.+
T Consensus 116 ~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~i~C 154 (498)
T KOG4237|consen 116 SLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANHINC 154 (498)
T ss_pred hhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhhhcc
Confidence 987776665 9999 9999999887544 45667766654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.63 E-value=3.4e-07 Score=86.13 Aligned_cols=107 Identities=27% Similarity=0.305 Sum_probs=83.2
Q ss_pred HHHHHHHHHHHhhcCCC--CccceeeEEEec----CeeEEEEEecCCC-ChhhhhhccCCCCCcCHHHHHHHHHHHHHHH
Q 008707 275 TQQFVTEVALLSRIHHR--NLVPLIGYCEEE----HQRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 347 (557)
Q Consensus 275 ~~~~~~E~~il~~l~h~--nIv~~~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL 347 (557)
.....+|...+..+..- .+...+++.... ...++|+|++++. +|.+++... ...+......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence 34677888888888533 345566665542 2458999999874 799988742 2255666788999999999
Q ss_pred HHHHcCCCCCeEeeccCCCCEEeCCCC---cEEEecccCcccc
Q 008707 348 EYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQA 387 (557)
Q Consensus 348 ~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfgla~~~ 387 (557)
+-||. .||+|+|+++.|||++.++ .+.++||+-+...
T Consensus 132 ~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99998 9999999999999999887 7999999977654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.5e-08 Score=91.44 Aligned_cols=82 Identities=24% Similarity=0.392 Sum_probs=42.4
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCc-cCCCCCcEEEecCccccCcCCC--ccCCCCccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS--YMGSLPNLQEL 115 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l 115 (557)
.+++.|+|++|+|+ .++ .+..|+.|+.|+|++|+|+.+.+.+ ..+++|+.|+|++|+|. .+-. .+..+++|+.|
T Consensus 42 ~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~-~l~~l~~L~~l~~L~~L 118 (175)
T PF14580_consen 42 DKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKIS-DLNELEPLSSLPKLRVL 118 (175)
T ss_dssp TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS----SCCCCGGGGG-TT--EE
T ss_pred cCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCC-ChHHhHHHHcCCCccee
Confidence 47999999999999 665 4788999999999999999876555 46999999999999998 4443 56789999999
Q ss_pred ccccccCC
Q 008707 116 HIENNSFV 123 (557)
Q Consensus 116 ~l~~N~~~ 123 (557)
++.+|.++
T Consensus 119 ~L~~NPv~ 126 (175)
T PF14580_consen 119 SLEGNPVC 126 (175)
T ss_dssp E-TT-GGG
T ss_pred eccCCccc
Confidence 99999998
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.5e-08 Score=100.21 Aligned_cols=108 Identities=21% Similarity=0.197 Sum_probs=87.8
Q ss_pred CCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 37 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 37 ~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
.|+.+++|||++|.|+..-+..|.+|++|+.++|.+|.|+.+|-..+...+|+.|+|.+|.|+..-..++.-++.|+.||
T Consensus 76 lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslD 155 (873)
T KOG4194|consen 76 LPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLD 155 (873)
T ss_pred CccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhh
Confidence 37778999999999997788889999999999999999996544444455699999999999944455788899999999
Q ss_pred cccccCCCCCCcccccC---ceeeeecCCCcc
Q 008707 117 IENNSFVGEIPPALLTG---KVIFKYDNNPKL 145 (557)
Q Consensus 117 l~~N~~~~~~p~~~~~~---~~~~~~~~n~~~ 145 (557)
|+.|.|+ +||...|.. ...+.+.+|...
T Consensus 156 LSrN~is-~i~~~sfp~~~ni~~L~La~N~It 186 (873)
T KOG4194|consen 156 LSRNLIS-EIPKPSFPAKVNIKKLNLASNRIT 186 (873)
T ss_pred hhhchhh-cccCCCCCCCCCceEEeecccccc
Confidence 9999999 999877654 345567777543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.6e-09 Score=104.48 Aligned_cols=99 Identities=25% Similarity=0.417 Sum_probs=50.3
Q ss_pred eEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccC------------------------CCCCcEEEecCc
Q 008707 41 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSR------------------------LIDLRIVHLENN 96 (557)
Q Consensus 41 l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~------------------------l~~L~~L~l~~N 96 (557)
|++||+.+|-+. ++|++++.+.+|.-|||..|+|...| +|++ |.+|..|||..|
T Consensus 185 L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdN 262 (565)
T KOG0472|consen 185 LKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDN 262 (565)
T ss_pred HHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeecccc
Confidence 455555555555 55555555555555555555555333 4444 555555555555
Q ss_pred cccCcCCCccCCCCcccccccccccCCCCCCcccccC-ceeeeecCCC
Q 008707 97 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG-KVIFKYDNNP 143 (557)
Q Consensus 97 ~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~~-~~~~~~~~n~ 143 (557)
+++ +.|+.+--+.+|.+||+++|.|+ .+|..+++- +..+.+.|||
T Consensus 263 klk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNP 308 (565)
T KOG0472|consen 263 KLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNLHLKFLALEGNP 308 (565)
T ss_pred ccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccceeeehhhcCCc
Confidence 555 55555544555555555555555 455544432 2333444554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.4e-06 Score=82.96 Aligned_cols=138 Identities=13% Similarity=0.173 Sum_probs=85.2
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCC--ccceeeEEEecCeeEEEEEecCCCC-
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGYCEEEHQRILVYEYMHNGT- 317 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~~~~~~~~~~~~~lv~e~~~~gs- 317 (557)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 25568889876533 3345688999999986433 5777888877778889999998863
Q ss_pred hhhhh---------------------hccCCCCCcCHHHHH-HHHH----------HHHH-HHHHHHc-CCCCCeEeecc
Q 008707 318 LRDRL---------------------HGSVNQKPLDWLTRL-QIAH----------DAAK-GLEYLHT-GCNPGIIHRDV 363 (557)
Q Consensus 318 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------qia~-aL~~LH~-~~~~~ivH~dl 363 (557)
+...+ +.. ........... .+-. .+.+ ...+|.+ .....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~-~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHST-KCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCC-CCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 110 00011111000 0000 0001 1122221 11346789999
Q ss_pred CCCCEEeCCCCcEEEecccCcc
Q 008707 364 KSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 364 k~~NIll~~~~~~kl~Dfgla~ 385 (557)
.|.||++++++ +.++||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999998765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.4e-07 Score=104.23 Aligned_cols=98 Identities=24% Similarity=0.374 Sum_probs=70.5
Q ss_pred CCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 37 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 37 ~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
.|+.++.|+|++|+|+ .+|..+. ++|+.|+|++|+|+.++..+. .+|+.|+|++|+++ .+|..+. ++|+.|+
T Consensus 197 Ip~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~ 268 (754)
T PRK15370 197 IPEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLD 268 (754)
T ss_pred cccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEE
Confidence 4567888888888888 6776554 578888888888886654443 36777777777777 6776654 4677777
Q ss_pred cccccCCCCCCcccccCceeeeecCCC
Q 008707 117 IENNSFVGEIPPALLTGKVIFKYDNNP 143 (557)
Q Consensus 117 l~~N~~~~~~p~~~~~~~~~~~~~~n~ 143 (557)
+++|+|. .+|..+...+..+.+++|.
T Consensus 269 Ls~N~L~-~LP~~l~~sL~~L~Ls~N~ 294 (754)
T PRK15370 269 LFHNKIS-CLPENLPEELRYLSVYDNS 294 (754)
T ss_pred CcCCccC-ccccccCCCCcEEECCCCc
Confidence 7777777 6777766666666677664
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.7e-06 Score=81.00 Aligned_cols=138 Identities=24% Similarity=0.310 Sum_probs=95.8
Q ss_pred ccCCCCceEEEEEEEcCCcEEEEEEccCccchhH-------------------H-----HHHHHHHHHhhcC--CCCccc
Q 008707 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-------------------Q-----QFVTEVALLSRIH--HRNLVP 295 (557)
Q Consensus 242 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------~-----~~~~E~~il~~l~--h~nIv~ 295 (557)
.|.+|--+.||+|...++..+|+|+.+....... + -..+|+.-|.++. +=.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 5788999999999988899999999864321110 0 1345777777663 444555
Q ss_pred eeeEEEecCeeEEEEEecCCC-ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC
Q 008707 296 LIGYCEEEHQRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 374 (557)
Q Consensus 296 ~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~ 374 (557)
.+++. ...+||||+... .-.-.| +..++.......+..++++.+.-|-. ..++||+||+.-|||+. ++
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~L----kDv~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRL----KDVPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCc----ccCCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CC
Confidence 55543 347999999543 111112 22333343566778888888888775 48999999999999999 89
Q ss_pred cEEEecccCccccCCC
Q 008707 375 RAKVSDFGLSRQAEED 390 (557)
Q Consensus 375 ~~kl~Dfgla~~~~~~ 390 (557)
.+.|+|||-|....++
T Consensus 204 ~p~iID~~QaV~~~hp 219 (268)
T COG1718 204 EPYIIDVSQAVTIDHP 219 (268)
T ss_pred eEEEEECccccccCCC
Confidence 9999999988766543
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.2e-08 Score=85.53 Aligned_cols=107 Identities=25% Similarity=0.333 Sum_probs=89.7
Q ss_pred CceEEEEecCCCccccCCccccC-CCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKN-MEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
..|+.++|++|.|. .+|+.|.. ++.++.|+|++|+|+.+|.++..++.|+.|++++|.|. ..|.-+..|.+|..|+.
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds 130 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDS 130 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcC
Confidence 57899999999999 88887744 46899999999999998889999999999999999999 89998888999999999
Q ss_pred ccccCCCCCCcccccC--ceeeeecCCCccccc
Q 008707 118 ENNSFVGEIPPALLTG--KVIFKYDNNPKLHKE 148 (557)
Q Consensus 118 ~~N~~~~~~p~~~~~~--~~~~~~~~n~~~~~~ 148 (557)
.+|.+. +||-.++.. .....+.++|+...+
T Consensus 131 ~~na~~-eid~dl~~s~~~al~~lgnepl~~~~ 162 (177)
T KOG4579|consen 131 PENARA-EIDVDLFYSSLPALIKLGNEPLGDET 162 (177)
T ss_pred CCCccc-cCcHHHhccccHHHHHhcCCcccccC
Confidence 999998 999776542 233455566665443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=3.8e-07 Score=100.84 Aligned_cols=55 Identities=24% Similarity=0.366 Sum_probs=23.9
Q ss_pred CCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccccccCC
Q 008707 64 ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 123 (557)
Q Consensus 64 ~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~ 123 (557)
+|+.|+|++|+|+.++..+. .+|+.|+|++|+|+ .+|..+. ++|+.|++++|++.
T Consensus 263 ~L~~L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt 317 (754)
T PRK15370 263 ALQSLDLFHNKISCLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT 317 (754)
T ss_pred CCCEEECcCCccCccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc
Confidence 44555555555543322232 24555555555555 3443322 13344444444443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.9e-06 Score=78.74 Aligned_cols=137 Identities=18% Similarity=0.206 Sum_probs=87.0
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHH---------HHHHHHHHhhcCC---CCccceeeEE
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQ---------FVTEVALLSRIHH---RNLVPLIGYC 300 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~il~~l~h---~nIv~~~~~~ 300 (557)
....+...+.+-......|.+-..+ |+.+++|..+.......+. ..+++..+..++. .....++...
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 3334444555666666666666555 7889999876543322222 2234444444432 2233333222
Q ss_pred E-----ecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc
Q 008707 301 E-----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 375 (557)
Q Consensus 301 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~ 375 (557)
. .....+++|||++|..|.+... ++. .++..+++++.-+|+ .|++|||.+|.|++++++ .
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-c
Confidence 2 2334568999999988876532 221 245677888999998 999999999999999954 5
Q ss_pred EEEecccCcc
Q 008707 376 AKVSDFGLSR 385 (557)
Q Consensus 376 ~kl~Dfgla~ 385 (557)
+++.||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.38 E-value=4.5e-07 Score=99.87 Aligned_cols=34 Identities=21% Similarity=0.429 Sum_probs=18.0
Q ss_pred cccccccccccCCCCCCccccc--CceeeeecCCCcc
Q 008707 111 NLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPKL 145 (557)
Q Consensus 111 ~L~~l~l~~N~~~~~~p~~~~~--~~~~~~~~~n~~~ 145 (557)
+|+.|++++|+|+ .+|..++. .+..+.+++|+..
T Consensus 423 ~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls 458 (788)
T PRK15387 423 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS 458 (788)
T ss_pred hhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCC
Confidence 4455555555555 55554432 3345566666643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.32 E-value=7.8e-06 Score=78.23 Aligned_cols=142 Identities=20% Similarity=0.276 Sum_probs=84.1
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCC--CccceeeEEEe---cCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR--NLVPLIGYCEE---EHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~--nIv~~~~~~~~---~~~~~lv~e~~~~ 315 (557)
+.++.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++.+... ....+++|++++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568999999999999886 68999986543 4456778899999888532 35666664432 3356899999998
Q ss_pred CChhh----------------hh---hcc-CCCCCcCHHH---------HHHH------------HHHHHH-HHHHHHc-
Q 008707 316 GTLRD----------------RL---HGS-VNQKPLDWLT---------RLQI------------AHDAAK-GLEYLHT- 352 (557)
Q Consensus 316 gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~qia~-aL~~LH~- 352 (557)
..+.. .+ +.. .......... .... ...+.+ .++.+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87766 11 111 0111111110 0000 111222 2333332
Q ss_pred ---CCCCCeEeeccCCCCEEeC-CCCcEEEecccCcc
Q 008707 353 ---GCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSR 385 (557)
Q Consensus 353 ---~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~ 385 (557)
.....++|+|+.+.||+++ +++.+-|.||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1246799999999999999 56666799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.5e-06 Score=102.26 Aligned_cols=106 Identities=19% Similarity=0.325 Sum_probs=87.9
Q ss_pred CCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 37 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 37 ~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
.|.+|+.|+|.+|++. .+|..+..+++|+.|+|++|...+.+|.+..+++|+.|+|++|.....+|..++.+++|+.|+
T Consensus 609 ~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~ 687 (1153)
T PLN03210 609 RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLD 687 (1153)
T ss_pred CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEe
Confidence 4678999999999998 889889999999999999987767778899999999999999876669999999999999999
Q ss_pred cccccCCCCCCccc-ccCceeeeecCCC
Q 008707 117 IENNSFVGEIPPAL-LTGKVIFKYDNNP 143 (557)
Q Consensus 117 l~~N~~~~~~p~~~-~~~~~~~~~~~n~ 143 (557)
+++|...+.+|..+ ...+..+.+.+|.
T Consensus 688 L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~ 715 (1153)
T PLN03210 688 MSRCENLEILPTGINLKSLYRLNLSGCS 715 (1153)
T ss_pred CCCCCCcCccCCcCCCCCCCEEeCCCCC
Confidence 99875444888765 3345556666654
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.29 E-value=3.7e-07 Score=100.54 Aligned_cols=63 Identities=29% Similarity=0.283 Sum_probs=45.4
Q ss_pred CCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccccccCCCCCCccc
Q 008707 64 ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130 (557)
Q Consensus 64 ~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~ 130 (557)
+|+.|+|++|+|++++.. +.+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+
T Consensus 403 ~L~~LdLS~N~LssIP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 403 ELKELMVSGNRLTSLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred CCCEEEccCCcCCCCCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 344455555555443221 235777888888888 889889999999999999999998777655
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.4e-07 Score=89.22 Aligned_cols=82 Identities=23% Similarity=0.327 Sum_probs=67.4
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
..|++|||++|.|+ .+.+++.-+++++.|+||+|.|..+-. +..|++|+.||||+|.++ .+-++--.|-+.+.|.|+
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 56889999999999 899999888999999999999986555 788899999999999988 666555556666777777
Q ss_pred cccCC
Q 008707 119 NNSFV 123 (557)
Q Consensus 119 ~N~~~ 123 (557)
+|.|.
T Consensus 361 ~N~iE 365 (490)
T KOG1259|consen 361 QNKIE 365 (490)
T ss_pred hhhHh
Confidence 77665
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.27 E-value=9e-08 Score=97.84 Aligned_cols=101 Identities=22% Similarity=0.325 Sum_probs=59.6
Q ss_pred eEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccccc
Q 008707 41 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 120 (557)
Q Consensus 41 l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 120 (557)
|+.|-+++|+++ .+|.+++.+.+|..||.+.|+|..+++.++.|.+|+.|++..|++. .+|..+.. -.|..||+++|
T Consensus 145 Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~~-LpLi~lDfScN 221 (722)
T KOG0532|consen 145 LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LPLIRLDFSCN 221 (722)
T ss_pred ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-CceeeeecccC
Confidence 455555555555 5555555555556666666666555555555555555555555555 55555552 34566666666
Q ss_pred cCCCCCCccccc--CceeeeecCCCcc
Q 008707 121 SFVGEIPPALLT--GKVIFKYDNNPKL 145 (557)
Q Consensus 121 ~~~~~~p~~~~~--~~~~~~~~~n~~~ 145 (557)
++. .||..+.. -+..+.+++||..
T Consensus 222 kis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 222 KIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred cee-ecchhhhhhhhheeeeeccCCCC
Confidence 666 66666543 3456667777754
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.3e-05 Score=77.57 Aligned_cols=139 Identities=19% Similarity=0.168 Sum_probs=84.8
Q ss_pred cCCCCc-eEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEEecCCCChhh
Q 008707 243 IGKGSF-GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTLRD 320 (557)
Q Consensus 243 lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~gsL~~ 320 (557)
|..|.. ..||+.... +..+++|+..... ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 788999765 4788888875432 345678999998884 4446677877776667899999999877654
Q ss_pred hh-------------------hccCC-CCCcCH--HHHHHHHH--------------------HHHHHHHHHHc----CC
Q 008707 321 RL-------------------HGSVN-QKPLDW--LTRLQIAH--------------------DAAKGLEYLHT----GC 354 (557)
Q Consensus 321 ~l-------------------~~~~~-~~~l~~--~~~~~i~~--------------------qia~aL~~LH~----~~ 354 (557)
.. +.... ...+.. ........ .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 11000 001110 00000000 01111222211 11
Q ss_pred CCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 355 ~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
...++|+|+.|.||++++++.+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2568999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.2e-05 Score=84.72 Aligned_cols=144 Identities=19% Similarity=0.241 Sum_probs=91.6
Q ss_pred HHhh-cccCCCCceEEEEEEEcCCcEEEEEEccCccchhH-------------------------------H------HH
Q 008707 237 NNFC-KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT-------------------------------Q------QF 278 (557)
Q Consensus 237 ~~~~-~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------------------~------~~ 278 (557)
..|. +.||.-+.|.||+|++++|+.||||+-++..+... + +|
T Consensus 162 ~~f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF 241 (538)
T KOG1235|consen 162 SEFDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDF 241 (538)
T ss_pred HhcCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcch
Confidence 3443 67999999999999999999999999765432210 0 12
Q ss_pred HHHHHHHh----hcCCCC------ccceeeEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHH
Q 008707 279 VTEVALLS----RIHHRN------LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 348 (557)
Q Consensus 279 ~~E~~il~----~l~h~n------Iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~ 348 (557)
.+|.+-.. .+.|-+ |.+++- .-....+|+||||+|..+.|.-.- ....++... ++..+.++..
T Consensus 242 ~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~---i~~~l~~~~~ 314 (538)
T KOG1235|consen 242 TKEAKNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAI--DKRGISPHD---ILNKLVEAYL 314 (538)
T ss_pred HHHHHhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHH--HHcCCCHHH---HHHHHHHHHH
Confidence 33333222 223444 222222 123468999999999877665321 233455443 3444444322
Q ss_pred HHHcCCCCCeEeeccCCCCEEeCC----CCcEEEecccCccccCC
Q 008707 349 YLHTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 349 ~LH~~~~~~ivH~dlk~~NIll~~----~~~~kl~Dfgla~~~~~ 389 (557)
.+ ....|++|+|=+|.||+++. ++.+.+.|||+......
T Consensus 315 ~q--If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 315 EQ--IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HH--HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 21 11278999999999999984 67799999999876654
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.22 E-value=7.1e-07 Score=60.77 Aligned_cols=36 Identities=36% Similarity=0.506 Sum_probs=16.1
Q ss_pred CCcEEECcCCCCCCCCCCccCCCCCcEEEecCcccc
Q 008707 64 ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 99 (557)
Q Consensus 64 ~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~ 99 (557)
+|+.|+|++|+|+.+++.+.+|++|+.|++++|+|+
T Consensus 2 ~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCcccCchHhCCCCCCEEEecCCCCC
Confidence 444444444444443333444444444455554444
|
... |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.2e-07 Score=87.95 Aligned_cols=83 Identities=22% Similarity=0.383 Sum_probs=51.6
Q ss_pred CCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 37 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 37 ~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
..|.+..|+|++|+|. .+.. +..|.+|+.||||+|.++.+..--..|-+.+.|.|+.|.|+ .+.+ +..|-+|..||
T Consensus 305 L~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~N~iE-~LSG-L~KLYSLvnLD 380 (490)
T KOG1259|consen 305 LAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQNKIE-TLSG-LRKLYSLVNLD 380 (490)
T ss_pred hccceeEEecccccee-eehh-hhhcccceEeecccchhHhhhhhHhhhcCEeeeehhhhhHh-hhhh-hHhhhhheecc
Confidence 3588999999999999 6655 88899999999999998754332223334444444444444 2221 23333444444
Q ss_pred cccccCC
Q 008707 117 IENNSFV 123 (557)
Q Consensus 117 l~~N~~~ 123 (557)
+++|+|.
T Consensus 381 l~~N~Ie 387 (490)
T KOG1259|consen 381 LSSNQIE 387 (490)
T ss_pred ccccchh
Confidence 4444443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=6.4e-08 Score=101.38 Aligned_cols=125 Identities=23% Similarity=0.316 Sum_probs=95.0
Q ss_pred CCCCCCCCCCCe---EEeeCCC----------CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccC
Q 008707 19 RGDPCVPVPWEW---VTCSTTT----------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSR 84 (557)
Q Consensus 19 ~~~~c~~~~~~~---v~c~~~~----------p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~ 84 (557)
.||.|+.-.|.- ..|++.. .+.++.|||++|+++ .+. .+..|++|++|||++|+|..++- ....
T Consensus 154 ggd~~ns~~Wn~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~g 231 (1096)
T KOG1859|consen 154 GGDISNSPVWNKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLRHVPQLSMVG 231 (1096)
T ss_pred ccccccchhhhhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhccccccchhh
Confidence 356666656652 3455522 467899999999999 554 68889999999999999998776 5666
Q ss_pred CCCCcEEEecCccccCcCCCccCCCCcccccccccccCCCCC---CcccccCceeeeecCCCccccc
Q 008707 85 LIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEI---PPALLTGKVIFKYDNNPKLHKE 148 (557)
Q Consensus 85 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~---p~~~~~~~~~~~~~~n~~~~~~ 148 (557)
+. |+.|+|.||.++ ++-+ +.+|.+|+.||++.|-|.+.- |-.....+..+.+.|||--|..
T Consensus 232 c~-L~~L~lrnN~l~-tL~g-ie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 232 CK-LQLLNLRNNALT-TLRG-IENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hh-heeeeecccHHH-hhhh-HHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 65 999999999998 5554 678999999999999887432 2233445566789999988853
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=6.6e-07 Score=93.21 Aligned_cols=184 Identities=20% Similarity=0.218 Sum_probs=133.2
Q ss_pred hhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCC-ccceeeEEEecCeeEEEEEecCCC-
Q 008707 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEHQRILVYEYMHNG- 316 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~~~~~~~~~~~~~lv~e~~~~g- 316 (557)
+-+.+++|+++.+||.+-...+....+.+... ....-++++|.+++||| .+..++-++.+....++++++.++
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 34667889999999987554444445555432 33445889999999999 777777777777888999999776
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccc
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 396 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 396 (557)
+-...... ....+...+...+.+.-+++++++|+ ..-+|+| ||+..+ +..+..||+....+.... ...
T Consensus 321 s~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~ 388 (829)
T KOG0576|consen 321 SSALEMTV--SEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPR 388 (829)
T ss_pred cccccCCh--hhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--ccc
Confidence 22211111 22334445556667777889999997 4457888 777664 788999999887766543 234
Q ss_pred cccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCC
Q 008707 397 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 439 (557)
Q Consensus 397 ~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~ 439 (557)
...+++.|+|||+.....+..+.|+|+.|.-..++--|.+|-.
T Consensus 389 t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 4568999999999999999999999999987777777777754
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.4e-07 Score=94.89 Aligned_cols=101 Identities=27% Similarity=0.439 Sum_probs=85.0
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
..|+.|||+.|+++ .+|..+..| -|+.|-++||+++..+++++.+..|.+||.+.|++. .+|..++.+.+|+.|++.
T Consensus 121 ~~lt~l~ls~NqlS-~lp~~lC~l-pLkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vr 197 (722)
T KOG0532|consen 121 EALTFLDLSSNQLS-HLPDGLCDL-PLKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVR 197 (722)
T ss_pred hHHHHhhhccchhh-cCChhhhcC-cceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHh
Confidence 45788999999999 888888766 488888999999988888888889999999999999 899999999999999999
Q ss_pred cccCCCCCCccccc-CceeeeecCCC
Q 008707 119 NNSFVGEIPPALLT-GKVIFKYDNNP 143 (557)
Q Consensus 119 ~N~~~~~~p~~~~~-~~~~~~~~~n~ 143 (557)
.|++. .+|+++.. .+..+.|+.|.
T Consensus 198 Rn~l~-~lp~El~~LpLi~lDfScNk 222 (722)
T KOG0532|consen 198 RNHLE-DLPEELCSLPLIRLDFSCNK 222 (722)
T ss_pred hhhhh-hCCHHHhCCceeeeecccCc
Confidence 99998 89988873 23455666775
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.16 E-value=1e-06 Score=60.01 Aligned_cols=39 Identities=28% Similarity=0.532 Sum_probs=34.1
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCC
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP 78 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 78 (557)
++|+.|+|++|+|+ .+|+.+.+|++|+.|+|++|+|+..
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~~i 39 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPISDI 39 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCSBE
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCCCC
Confidence 47899999999999 8898899999999999999999953
|
... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.1e-05 Score=69.85 Aligned_cols=129 Identities=22% Similarity=0.312 Sum_probs=89.3
Q ss_pred HhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCcc-ceeeEEEecCeeEEEEEecCCC
Q 008707 238 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLV-PLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv-~~~~~~~~~~~~~lv~e~~~~g 316 (557)
+..+.||+|.+|.||+|.+. |..+|+|+-+.. ..+..+..|.+++..+.-.++. +++.|.. -++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 44688999999999999998 668999976543 3456788999999998765553 3343322 23459999887
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCC--CCEEeCCCCcEEEecccCcccc
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKS--SNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~--~NIll~~~~~~kl~Dfgla~~~ 387 (557)
.|.+.-... +.. -...++++---|.. .||-|+.|.- +||++. ++.+.|+||..|+.-
T Consensus 98 ~L~~~~~~~------~rk----~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~-~~~~~iIDFd~At~k 156 (201)
T COG2112 98 PLGKLEIGG------DRK----HLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVN-DRDVYIIDFDSATFK 156 (201)
T ss_pred chhhhhhcc------cHH----HHHHHHHHHHHHHH---hccchhhhcCCceeEEec-CCcEEEEEccchhhc
Confidence 887654321 222 23445555333444 8999999874 455555 459999999988743
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.11 E-value=5.9e-07 Score=96.91 Aligned_cols=89 Identities=28% Similarity=0.466 Sum_probs=84.1
Q ss_pred ceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccccc
Q 008707 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 119 (557)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 119 (557)
.|+.|||++|.+. .+|..+..+.+|+.|+++.|.|...+-+..++.+|++|+|.+|++. .+|.++..+.+|++|+++.
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 3899999999999 9999999999999999999999998888999999999999999999 9999999999999999999
Q ss_pred ccCCCCCCcccc
Q 008707 120 NSFVGEIPPALL 131 (557)
Q Consensus 120 N~~~~~~p~~~~ 131 (557)
|+|. .+|..+.
T Consensus 124 N~f~-~~Pl~i~ 134 (1081)
T KOG0618|consen 124 NHFG-PIPLVIE 134 (1081)
T ss_pred hccC-CCchhHH
Confidence 9998 8998664
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.7e-05 Score=73.13 Aligned_cols=104 Identities=25% Similarity=0.240 Sum_probs=82.3
Q ss_pred HHHHHHhhcCC-CCccceeeEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 008707 280 TEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358 (557)
Q Consensus 280 ~E~~il~~l~h-~nIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~i 358 (557)
.|.-+++.+++ +++++++|+|. .++|.||...+++...-.....-...+|..+.+||.++++.+.+++......+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888999975 69999999994 46799999877664321100012346899999999999999999997555568
Q ss_pred EeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 359 IHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 359 vH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
.-.|++++|+-+++++++|+.|...+...
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 88999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.08 E-value=5.6e-05 Score=86.01 Aligned_cols=79 Identities=13% Similarity=0.304 Sum_probs=57.4
Q ss_pred hcccCCCCceEEEEEEEcCC---cEEEEEEccCcc-chhHHHHHHHHHHHhhcC-CCCc--cceeeEEEec---CeeEEE
Q 008707 240 CKKIGKGSFGSVYYGKMKDG---KEVAVKIMADSC-SHRTQQFVTEVALLSRIH-HRNL--VPLIGYCEEE---HQRILV 309 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~nI--v~~~~~~~~~---~~~~lv 309 (557)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|+++++.+. |.++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 36688999999999887654 467777754322 123356889999999995 6665 7777777654 467899
Q ss_pred EEecCCCCh
Q 008707 310 YEYMHNGTL 318 (557)
Q Consensus 310 ~e~~~~gsL 318 (557)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987643
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.6e-06 Score=90.32 Aligned_cols=102 Identities=28% Similarity=0.506 Sum_probs=87.4
Q ss_pred CceEEEEecCCCccccCCccccCCC-CCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
..++.|++.+|.++ .+|+....++ +|+.|++++|++...+..+..+++|+.|++++|+++ .+|...+.+++|+.|++
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchhhhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 35889999999999 8888887775 999999999999987777899999999999999999 88887768889999999
Q ss_pred ccccCCCCCCcc--cccCceeeeecCCC
Q 008707 118 ENNSFVGEIPPA--LLTGKVIFKYDNNP 143 (557)
Q Consensus 118 ~~N~~~~~~p~~--~~~~~~~~~~~~n~ 143 (557)
++|++. .+|.. ....+..+.+.+|+
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 999998 89886 55567777777776
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.96 E-value=0.00019 Score=66.50 Aligned_cols=130 Identities=24% Similarity=0.300 Sum_probs=90.6
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCcc----------------chhHHHHHHHHHHHhhcC------CCCccceee
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC----------------SHRTQQFVTEVALLSRIH------HRNLVPLIG 298 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~il~~l~------h~nIv~~~~ 298 (557)
..||+|+.=.||.- ++.....||+..... ....++..+|+.-+..+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 56899999888864 344557788876544 122356667777666665 889999999
Q ss_pred EEEecCeeEEEEEecCC--C----ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC
Q 008707 299 YCEEEHQRILVYEYMHN--G----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 372 (557)
Q Consensus 299 ~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~ 372 (557)
+.+++....+|+|.+.+ | +|.+++. ...++. ...+. +-+-.+||-. .+|+.+|++|+||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~---L~~f~~~l~~---~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQA---LDEFKRYLLD---HHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHH---HHHHHHHHHH---cCCeecCCCcccEEEEe
Confidence 99999999999998754 2 5777774 333544 33333 3344556665 88999999999999953
Q ss_pred C--C--cEEEec-ccC
Q 008707 373 N--M--RAKVSD-FGL 383 (557)
Q Consensus 373 ~--~--~~kl~D-fgl 383 (557)
. + .+.|+| ||.
T Consensus 154 ~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGE 169 (199)
T ss_pred cCCCceEEEEEeCCCC
Confidence 2 2 477777 553
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.92 E-value=2e-07 Score=78.36 Aligned_cols=91 Identities=21% Similarity=0.282 Sum_probs=78.1
Q ss_pred CceEEEEecCCCccccCCcc---ccCCCCCcEEECcCCCCCCCCCCccC-CCCCcEEEecCccccCcCCCccCCCCcccc
Q 008707 39 PRITKIALSGKNLKGEIPPE---LKNMEALTELWLDGNFLTGPLPDMSR-LIDLRIVHLENNELTGSLPSYMGSLPNLQE 114 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~---~~~l~~L~~L~l~~N~l~~~~~~~~~-l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 114 (557)
..+..++|+++.|- .++.. +.....|...+|++|.+...++.|.. .+.++.|+|++|+|+ .+|..+..++.|+.
T Consensus 27 kE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 27 KELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred HHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 46788999999987 66665 44556778889999999999887655 568999999999999 99999999999999
Q ss_pred cccccccCCCCCCccccc
Q 008707 115 LHIENNSFVGEIPPALLT 132 (557)
Q Consensus 115 l~l~~N~~~~~~p~~~~~ 132 (557)
|+++.|.|. ..|..++.
T Consensus 105 lNl~~N~l~-~~p~vi~~ 121 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAP 121 (177)
T ss_pred cccccCccc-cchHHHHH
Confidence 999999999 88877766
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 557 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-59 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-58 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-55 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-37 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-35 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-34 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-26 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-25 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-24 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-24 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-24 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-24 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-24 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-24 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-23 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-23 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-23 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-23 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-23 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-23 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-23 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-23 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-23 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-23 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-23 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-23 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-23 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-23 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-23 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-23 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-23 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-23 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-23 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-23 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-23 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-23 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 8e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-23 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-23 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-23 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-22 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-22 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-22 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-22 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-22 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-22 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-22 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-22 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-22 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-22 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-22 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-22 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-22 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-22 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-22 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-22 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-22 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-22 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-22 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-22 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-22 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-22 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-22 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-22 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-21 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-21 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-21 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-21 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-21 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-20 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-20 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-20 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-20 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-20 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-19 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-19 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-19 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-19 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-19 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-19 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-19 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-19 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-19 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-19 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-19 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-19 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-19 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-19 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-19 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-19 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-19 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-18 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-18 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-18 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-18 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-18 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-18 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-17 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-17 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-17 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 6e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-17 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-17 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-17 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-17 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-17 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-16 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-16 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 8e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-15 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-15 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-15 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-15 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-15 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-15 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-15 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-15 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-15 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-14 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-14 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-14 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 9e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 9e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-13 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 4e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-13 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-13 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-13 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-13 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-13 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 7e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-12 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-12 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-12 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-12 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-12 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-11 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 7e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 9e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-10 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-10 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-10 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 8e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 9e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 9e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 5e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 8e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 9e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 7e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 3e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-06 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 454 bits (1170), Expect = e-158
Identities = 127/319 (39%), Positives = 193/319 (60%), Gaps = 7/319 (2%)
Query: 201 TSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKK--IGKGSFGSVYYGKMKD 258
+ + + + A ++ +Y +PL +LEEATNNF K IG G FG VY G ++D
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 259 GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 318
G +VA+K S ++F TE+ LS H +LV LIG+C+E ++ IL+Y+YM NG L
Sbjct: 63 GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122
Query: 319 RDRLHGSVNQK-PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 377
+ L+GS + W RL+I AA+GL YLHT IIHRDVKS NILLD N K
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179
Query: 378 VSDFGLSRQA-EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKK 436
++DFG+S++ E D TH+S+V +GT+GY+DPEY+ +LTEKSDVYSFGVVL E++ +
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 437 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFS 496
+ +N+ WA G + IVDP L ++ ES+ + + A++C+
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSED 299
Query: 497 RPKMQEIVLAIQDSIKIEK 515
RP M +++ ++ ++++++
Sbjct: 300 RPSMGDVLWKLEYALRLQE 318
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-130
Identities = 112/282 (39%), Positives = 173/282 (61%), Gaps = 6/282 (2%)
Query: 231 ELEEATNNFCK--KIGKGSFGSVYYGKMKDGKEVAVK-IMADSCSHRTQQFVTEVALLSR 287
EL+ A++NF +G+G FG VY G++ DG VAVK + + QF TEV ++S
Sbjct: 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISM 83
Query: 288 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-LDWLTRLQIAHDAAKG 346
HRNL+ L G+C +R+LVY YM NG++ L +P LDW R +IA +A+G
Sbjct: 84 AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARG 143
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 406
L YLH C+P IIHRDVK++NILLD A V DFGL++ + TH+++ RGT+G++
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIA 203
Query: 407 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--LNIVHWARSMIKKGDVIS 464
PEY + +EK+DV+ +GV+LLELI+G++ + + + ++ W + ++K+ + +
Sbjct: 204 PEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEA 263
Query: 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506
+VD L GN K E + ++ +VA+ C + RPKM E+V
Sbjct: 264 LVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 367 bits (945), Expect = e-125
Identities = 102/292 (34%), Positives = 153/292 (52%), Gaps = 26/292 (8%)
Query: 231 ELEEATNNF--------CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQ----F 278
EL+ TNNF K+G+G FG VY G + + VAVK +A T++ F
Sbjct: 19 ELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQF 77
Query: 279 VTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ 338
E+ ++++ H NLV L+G+ + LVY YM NG+L DRL PL W R +
Sbjct: 78 DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCK 137
Query: 339 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSV 397
IA AA G+ +LH IHRD+KS+NILLD AK+SDFGL+R + + T ++S
Sbjct: 138 IAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR 194
Query: 398 ARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG-AELNIVHWARS 455
GT Y+ PE G ++T KSD+YSFGVVLLE+I+G V D ++
Sbjct: 195 IVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAV---DEHREPQLLLDIKEE 249
Query: 456 MIK-KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506
+ + + +D + + S+ + VA QC+ ++ RP ++++
Sbjct: 250 IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 275 bits (704), Expect = 2e-88
Identities = 74/308 (24%), Positives = 118/308 (38%), Gaps = 31/308 (10%)
Query: 227 IPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 284
+ L + + +G FG V+ ++ + VAVKI ++ Q EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ-DKQSWQNEYEVYS 71
Query: 285 LSRIHHRNLVPLIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 340
L + H N++ IG + + L+ + G+L D L + W IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA----NVVSWNELCHIA 127
Query: 341 HDAAKGLEYLHT-------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393
A+GL YLH G P I HRD+KS N+LL N+ A ++DFGL+ + E +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 394 ISSVAR-GTVGYLDPEY-----YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 447
+ + GT Y+ PE + + D+Y+ G+VL EL S L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 448 NIVHWARSMIKKGDVISIV-----DPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQ 501
D+ +V PVL K + + E +C + +R
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 502 EIVLAIQD 509
+ I
Sbjct: 308 CVGERITQ 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 3e-75
Identities = 86/213 (40%), Positives = 123/213 (57%), Gaps = 10/213 (4%)
Query: 227 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 284
IP +L +KIG GSFG+V+ + G +VAVKI+ + H R +F+ EVA+
Sbjct: 34 IPWCDLN-----IKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 285 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 344
+ R+ H N+V +G + +V EY+ G+L LH S ++ LD RL +A+D A
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 345 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 404
KG+ YLH NP I+HR++KS N+L+D KV DFGLSR S A GT +
Sbjct: 148 KGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEW 205
Query: 405 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ PE ++ EKSDVYSFGV+L EL + ++P
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 4e-74
Identities = 84/328 (25%), Positives = 144/328 (43%), Gaps = 39/328 (11%)
Query: 225 YFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 284
+ I E+E + +G+G+FG V K + K+VA+K + + F+ E+
Sbjct: 3 HMIDYKEIE-----VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESE--RKAFIVELRQ 54
Query: 285 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 344
LSR++H N+V L G C LV EY G+L + LHG+ + +
Sbjct: 55 LSRVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 345 KGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGLSRQAEEDLTHISSVARGTVG 403
+G+ YLH+ +IHRD+K N+LL K+ DFG + + +T+ +G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN----NKGSAA 168
Query: 404 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG--- 460
++ PE + +EK DV+S+G++L E+I+ +KP ++ G + WA + G
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP--FDEIGGPAFRIMWA---VHNGTRP 223
Query: 461 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQK 520
+I + I + +C + RP M+EIV + ++ G D+
Sbjct: 224 PLIKNLPK------------PIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271
Query: 521 F----SSSSSKGQSSRKTLLTSFLEIES 544
S G+ R F E
Sbjct: 272 LQYPCQHSLPPGEDGRVEPYVDFAEFYR 299
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 3e-70
Identities = 75/240 (31%), Positives = 120/240 (50%), Gaps = 29/240 (12%)
Query: 213 ARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC 271
A GG + + E+E + K+IGKG FG V+ G++ D VA+K +
Sbjct: 2 AMGGSEFPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGD 56
Query: 272 SH-------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG 324
S + Q+F EV ++S ++H N+V L G +V E++ G L RL
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD 114
Query: 325 SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-----INMRAKVS 379
P+ W +L++ D A G+EY+ NP I+HRD++S NI L + AKV+
Sbjct: 115 --KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171
Query: 380 DFGLSRQAEEDLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
DFGLS+Q+ ++ G ++ PE + TEK+D YSF ++L +++G+ P
Sbjct: 172 DFGLSQQSVHSVSG----LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 2e-67
Identities = 75/223 (33%), Positives = 103/223 (46%), Gaps = 25/223 (11%)
Query: 227 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIM----ADSCSHRTQQFVTEV 282
I EL + IG G FG VY G EVAVK + S + E
Sbjct: 4 IDFAELT-----LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 283 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 342
L + + H N++ L G C +E LV E+ G L L G K + + A
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQ 113
Query: 343 AAKGLEYLHTGCNPGIIHRDVKSSNILLD--------INMRAKVSDFGLSRQAEEDLTHI 394
A+G+ YLH IIHRD+KSSNIL+ N K++DFGL+R E T
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTK 171
Query: 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
S A G ++ PE ++ SDV+S+GV+L EL++G+ P
Sbjct: 172 MSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 2e-67
Identities = 48/218 (22%), Positives = 97/218 (44%), Gaps = 21/218 (9%)
Query: 227 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 284
I +L F K+ + G ++ G+ + G ++ VK++ +++ F E
Sbjct: 7 IDFKQLN-----FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 285 LSRIHHRNLVPLIGYCEEEHQRIL--VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 342
L H N++P++G C+ + +M G+L + LH +D ++ A D
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-EGTNFVVDQSQAVKFALD 119
Query: 343 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV 402
A+G+ +LHT P I + S ++++D +M A++S + + S
Sbjct: 120 MARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAP 172
Query: 403 GYLDPEYYGNQQL---TEKSDVYSFGVVLLELISGKKP 437
++ PE + +D++SF V+L EL++ + P
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-66
Identities = 72/339 (21%), Positives = 128/339 (37%), Gaps = 48/339 (14%)
Query: 227 IPLPELEEATNNFC--KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTE--V 282
E +N + IG+G +G+VY G + D + VAVK+ + Q F+ E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNI 58
Query: 283 ALLSRIHHRNLVPLIGYCEE-----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRL 337
+ + H N+ I E + +LV EY NG+L L DW++
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS----LHTSDWVSSC 114
Query: 338 QIAHDAAKGLEYLHT------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR------ 385
++AH +GL YLHT P I HRD+ S N+L+ + +SDFGLS
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 386 -QAEEDLTHISSVARGTVGYLDPEY-------YGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ + + GT+ Y+ PE + ++ D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 438 VSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWR--------IAEVAI 487
+ + E + + + + V K W+ + E
Sbjct: 235 LFPGESVPEYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 488 QCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSSS 526
C +Q +R Q + + + I + ++
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 1e-64
Identities = 68/217 (31%), Positives = 113/217 (52%), Gaps = 19/217 (8%)
Query: 227 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSH--RTQQFVTEVAL 284
IP ++ ++IG GSFG+VY GK +VAVK++ + + Q F EV +
Sbjct: 21 IPDGQIT-----VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 285 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 344
L + H N++ +GY I V ++ +L LH ++ + + IA A
Sbjct: 74 LRKTRHVNILLFMGYSTAPQLAI-VTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTA 130
Query: 345 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVG 403
+G++YLH IIHRD+KS+NI L + K+ DFGL+ ++ +H G++
Sbjct: 131 RGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 404 YLDPE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
++ PE + + +SDVY+FG+VL EL++G+ P
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 1e-64
Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 227 IPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIM--ADSCSHRTQQFVTEVAL 284
IP +LE + IGKG FG VY+G+ EVA++++ + + F EV
Sbjct: 30 IPFEQLE-----IGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMA 82
Query: 285 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 344
+ H N+V +G C ++ TL + + LD QIA +
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIV 140
Query: 345 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR----QAEEDLTHISSVARG 400
KG+ YLH GI+H+D+KS N+ D N + ++DFGL + G
Sbjct: 141 KGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 401 TVGYLDPEYYGNQQL---------TEKSDVYSFGVVLLELISGKKP 437
+ +L PE ++ SDV++ G + EL + + P
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 1e-62
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 19/213 (8%)
Query: 239 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 297
+ +GKG FG ++ G+ + +K + + F+ EV ++ + H N++ I
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
G ++ + + EY+ GTLR + W R+ A D A G+ YLH +
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---SMN 128
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-------------GTVGY 404
IIHRD+ S N L+ N V+DFGL+R ++ T + G +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 405 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ PE + EK DV+SFG+VL E+I
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-61
Identities = 77/324 (23%), Positives = 130/324 (40%), Gaps = 44/324 (13%)
Query: 229 LPELEEATNN----FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 284
LP L + T K+IGKG +G V+ GK + G++VAVK+ + + TE+
Sbjct: 27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE-EASWFRETEIYQ 84
Query: 285 LSRIHHRNLVPLIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 340
+ H N++ I + L+ +Y NG+L D L LD + L++A
Sbjct: 85 TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK----STTLDAKSMLKLA 140
Query: 341 HDAAKGLEYLHT-----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395
+ + GL +LHT P I HRD+KS NIL+ N ++D GL+ + D +
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200
Query: 396 SVARGTVG---YLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 446
VG Y+ PE + Q +D+YSFG++L E+ E
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS----GGIVE 256
Query: 447 LNIVHWARSMIKKGDVISIVDPVLIGNV--KIESIWR-------IAEVAIQCVEQRGFSR 497
+ + + + + V I + + W + ++ +C SR
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316
Query: 498 PKMQEIVLAIQDSIKIEKGGDQKF 521
+ + K+ + D K
Sbjct: 317 LTALRVKKTLA---KMSESQDIKL 337
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 5e-59
Identities = 78/318 (24%), Positives = 136/318 (42%), Gaps = 40/318 (12%)
Query: 229 LPELEEATN----NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL 284
LP L + T + IGKG FG V+ GK + G+EVAVKI S R+ E+
Sbjct: 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQ 89
Query: 285 LSRIHHRNLVPLIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 340
+ H N++ I +++ LV +Y +G+L D L+ + + +++A
Sbjct: 90 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLA 145
Query: 341 HDAAKGLEYLH-----TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLT 392
A GL +LH T P I HRD+KS NIL+ N ++D GL+ A + +
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205
Query: 393 HISSVARGTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 446
+ GT Y+ PE + + +++D+Y+ G+V E+ + + +
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE-DYQ 264
Query: 447 LNIVHWARSMIKKGDVISIVD------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 500
L S ++ +V + E++ +A++ +C G +R
Sbjct: 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 501 QEIV-----LAIQDSIKI 513
I L+ Q+ IK+
Sbjct: 325 LRIKKTLSQLSQQEGIKM 342
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 7e-59
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 28/224 (12%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFV--TEVALLSRIHHRNLVPL 296
+ +GKG +G V+ G + G+ VAVKI + S + + TE+ + H N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQ-GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGF 67
Query: 297 IGYC----EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
I Q L+ Y G+L D L LD ++ L+I A GL +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 353 -----GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGY 404
P I HRD+KS NIL+ N + ++D GL+ Q+ L ++ GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 405 LDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
+ PE ++ D+++FG+VL E+ + +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-43
Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 297
+IG+GSF +VY G + EVA + D ++ Q+F E +L + H N+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 298 GY----CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
+ + +LV E M +GTL+ L + K L R QI KGL++LH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR-QIL----KGLQFLH 146
Query: 352 TGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410
T P IIHRD+K NI + K+ D GL+ + +V GT ++ PE Y
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAV-IGTPEFMAPEMY 202
Query: 411 GNQQLTEKSDVYSFGVVLLELISGKKP 437
++ E DVY+FG+ +LE+ + + P
Sbjct: 203 -EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPL 296
++IG+G+FG V+ G+++ VAVK ++ + F+ E +L + H N+V L
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
IG C ++ +V E + G L L T LQ+ DAA G+EYL +
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL-----DPEYYG 411
IHRD+ + N L+ K+SDFG+SR+ + A G + + PE
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG----VYAASGGLRQVPVKWTAPEALN 288
Query: 412 NQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ + +SDV+SFG++L E S G P
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASP 315
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-42
Identities = 64/200 (32%), Positives = 107/200 (53%), Gaps = 7/200 (3%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
K++G G FG V GK K +VAVK++ + +F E + ++ H LV G
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYG 70
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
C +E+ +V EY+ NG L + L + K L+ L++ +D +G+ +L +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLE---SHQF 125
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
IHRD+ + N L+D ++ KVSDFG++R +D S + V + PE + + + K
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 419 SDVYSFGVVLLELIS-GKKP 437
SDV++FG+++ E+ S GK P
Sbjct: 186 SDVWAFGILMWEVFSLGKMP 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
F ++IG G FG V+ G + +VA+K + + + F+ E ++ ++ H LV L G
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYG 70
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
C E+ LV E+M +G L D L + L L + D +G+ YL +
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL--LGMCLDVCEGMAYL---EEACV 125
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + + + K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 419 SDVYSFGVVLLELIS-GKKP 437
SDV+SFGV++ E+ S GK P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP 205
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
K+G+G FG V+ G VA+K + + F+ E ++ ++ H LV L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 246
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
EE I V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 247 VVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 419 SDVYSFGVVLLELIS-GKKP 437
SDV+SFG++L EL + G+ P
Sbjct: 362 SDVWSFGILLTELTTKGRVP 381
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 2e-42
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 7/201 (3%)
Query: 239 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 297
K+G G +G VY G K VAVK + + ++F+ E A++ I H NLV L+
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 282
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQISSAMEYLE---KKN 338
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
IHR++ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 418 KSDVYSFGVVLLELIS-GKKP 437
KSDV++FGV+L E+ + G P
Sbjct: 399 KSDVWAFGVLLWEIATYGMSP 419
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-42
Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 7/200 (3%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
F K++G G FG V YGK + +VA+K++ + +F+ E ++ + H LV L G
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYG 86
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
C ++ ++ EYM NG L + L + L++ D + +EYL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLE---SKQF 141
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
+HRD+ + N L++ KVSDFGLSR +D S ++ V + PE + + K
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 419 SDVYSFGVVLLELIS-GKKP 437
SD+++FGV++ E+ S GK P
Sbjct: 202 SDIWAFGVLMWEIYSLGKMP 221
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-42
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 7/200 (3%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
K+G+G FG V+ G VA+K + + F+ E ++ ++ H LV L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYA 329
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
EE I V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 330 VVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 384
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 419 SDVYSFGVVLLELIS-GKKP 437
SDV+SFG++L EL + G+ P
Sbjct: 445 SDVWSFGILLTELTTKGRVP 464
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 7e-42
Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 7/200 (3%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+++G G FG V+ G +VAVK + F+ E L+ ++ H+ LV L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYA 75
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
+E I + EYM NG+L D L + L L +A A+G+ ++
Sbjct: 76 VVTQEPIYI-ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 419 SDVYSFGVVLLELIS-GKKP 437
SDV+SFG++L E+++ G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 7/200 (3%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
KK+G G FG V+ +VAVK M + F+ E ++ + H LV L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHA 250
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
+E I + E+M G+L D L + + A+G+ ++
Sbjct: 251 VVTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIE---QRNY 305
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
IHRD++++NIL+ ++ K++DFGL+R E++ A+ + + PE T K
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 419 SDVYSFGVVLLELIS-GKKP 437
SDV+SFG++L+E+++ G+ P
Sbjct: 366 SDVWSFGILLMEIVTYGRIP 385
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 7/201 (3%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGK-EVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 297
K+G G +G VY G K VAVK + + ++F+ E A++ I H NLV L+
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLL 75
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 418 KSDVYSFGVVLLELIS-GKKP 437
KSDV++FGV+L E+ + G P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-41
Identities = 66/201 (32%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 197 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 253
Query: 299 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 309
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
+HRD+ + N+L+ + AKVSDFGL++ + + + V + PE ++ +
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 418 KSDVYSFGVVLLELIS-GKKP 437
KSDV+SFG++L E+ S G+ P
Sbjct: 366 KSDVWSFGILLWEIYSFGRVP 386
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-41
Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+ IG G FG V+ K + DGK +K + + ++ EV L+++ H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 300 CEEEHQRI----------------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 343
+ + E+ GTL + + LD + L++
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQI 131
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG 403
KG++Y+H + +I+RD+K SNI L + K+ DFGL + D S GT+
Sbjct: 132 TKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTLR 186
Query: 404 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
Y+ PE +Q ++ D+Y+ G++L EL+
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-41
Identities = 53/226 (23%), Positives = 109/226 (48%), Gaps = 19/226 (8%)
Query: 220 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHR 274
++ + + E + K +G G+FG+VY G E VA+K + ++ S +
Sbjct: 5 NQALLRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59
Query: 275 TQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW 333
+ + E +++ + + ++ L+G C L+ + M G L D + ++ +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGS 116
Query: 334 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLT 392
L AKG+ YL + ++HRD+ + N+L+ K++DFGL++ E+
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ + + + ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-40
Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 242 KIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLI 297
++G G+FGSV G + K+ VA+K++ + + E ++ ++ + +V LI
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
G C+ E +LV E G L L G ++ + ++ H + G++YL
Sbjct: 77 GVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQL 415
+HRD+ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 416 TEKSDVYSFGVVLLELIS-GKKP 437
+ +SDV+S+GV + E +S G+KP
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-40
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVP 295
+ IG+G FG V+ G + VA+K + S ++ F+ E + + H ++V
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
LIG E I + E G LR L + LD + + A+ + L YL +
Sbjct: 81 LIGVITENPVWI-IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLE---S 134
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 415
+HRD+ + N+L+ N K+ DFGLSR E+ + +S + + ++ PE ++
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 416 TEKSDVYSFGVVLLELIS-GKKP 437
T SDV+ FGV + E++ G KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-40
Identities = 60/209 (28%), Positives = 108/209 (51%), Gaps = 17/209 (8%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNL 293
K IG G G V YG+++ + VA+K + + R ++ F++E +++ + H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
+ L G ++V EYM NG+L L + + + + G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSD- 169
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPE--Y 409
G +HRD+ + N+L+D N+ KVSDFGLSR + + D + ++ + + + PE
Sbjct: 170 --LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 410 YGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ + SDV+SFGVV+ E+++ G++P
Sbjct: 228 FR--TFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 6e-40
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 12/213 (5%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALL 285
+ + +G+G FG VY G + K VAVK C+ ++ F++E ++
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM 67
Query: 286 SRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 345
+ H ++V LIG EEE I + E G L L N+ L LT + + K
Sbjct: 68 KNLDHPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICK 124
Query: 346 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 405
+ YL + +HRD+ NIL+ K+ DFGLSR E++ + +SV R + ++
Sbjct: 125 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM 181
Query: 406 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
PE ++ T SDV+ F V + E++S GK+P
Sbjct: 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 53/217 (24%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+ +G+G FG V+ K K D A+K + + ++ + EV L+++ H +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 299 YCEEEH---------QRILVY---EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 346
E++ ++ +Y + L+D ++G + + L I A+
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR------- 399
+E+LH + G++HRD+K SNI ++ KV DFGL ++D + +
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 400 ----GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELI 432
GT Y+ PE + K D++S G++L EL+
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-39
Identities = 70/296 (23%), Positives = 126/296 (42%), Gaps = 24/296 (8%)
Query: 160 GTSIGVLAILLVLFLC--------SLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYS 211
+I L+ C S I+ + + + + A++ + + + S
Sbjct: 303 SLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVS 362
Query: 212 IARG-GHFMDEGVAYFIPLP---ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VA 263
+DE Y +P E++ + IG+G FG V+ G + VA
Sbjct: 363 ETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVA 422
Query: 264 VKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL 322
+K + S ++ F+ E + + H ++V LIG E ++ E G LR L
Sbjct: 423 IKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL 481
Query: 323 HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 382
+ LD + + A+ + L YL + +HRD+ + N+L+ N K+ DFG
Sbjct: 482 QV--RKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 383 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
LSR E+ + +S + + ++ PE ++ T SDV+ FGV + E++ G KP
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 15/219 (6%)
Query: 229 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVA 283
+ +F + IG+G FG VY+G + D AVK + F+TE
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78
Query: 284 LLSRIHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 342
++ H N++ L+G C E ++V YM +G LR+ + +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQ 136
Query: 343 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED---LTHISSVAR 399
AKG++YL + +HRD+ + N +LD KV+DFGL+R + H + A+
Sbjct: 137 VAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 400 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
V ++ E Q+ T KSDV+SFGV+L EL++ G P
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-39
Identities = 66/228 (28%), Positives = 98/228 (42%), Gaps = 21/228 (9%)
Query: 220 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYG--KMKDGKE--VAVKIM-ADSCSHR 274
+ + I +L +K+G GSFG V G GK VAVK + D S
Sbjct: 8 LQSLTCLIGEKDLR-----LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQP 62
Query: 275 TQQ--FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD 332
F+ EV + + HRNL+ L G ++ V E G+L DRL L
Sbjct: 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLG 121
Query: 333 WLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEED 390
L + A A+G+ YL + IHRD+ + N+LL K+ DFGL R +D
Sbjct: 122 TL--SRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176
Query: 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ + + PE + + SD + FGV L E+ + G++P
Sbjct: 177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 20/214 (9%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+K+G+G F V + + DG A+K + ++ E + +H N++ L+ Y
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 300 CEEEHQR----ILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
C E L+ + GTL + + L L + +GLE +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--------GTVGYLD 406
G HRD+K +NILL + + D G QA + T+ Y
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 407 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
PE + + E++DV+S G VL ++ G+ P
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-39
Identities = 67/201 (33%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 25 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG 81
Query: 299 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 137
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
+HRD+ + N+L+ + AKVSDFGL+++A + V + PE ++ +
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----QDTGKLPVKWTAPEALREKKFST 193
Query: 418 KSDVYSFGVVLLELIS-GKKP 437
KSDV+SFG++L E+ S G+ P
Sbjct: 194 KSDVWSFGILLWEIYSFGRVP 214
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-39
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 241 KKIGKGSFGSVYYGKMKDGK---EVAVKIM-ADSCSHRTQQ-FVTEVALLSRIHHRNLVP 295
K++G G+FG+V G + K VAVKI+ ++ + + E ++ ++ + +V
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
+IG CE E + V E G L L + + +++ H + G++YL
Sbjct: 83 MIGICEAESWML-VMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---E 135
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQ 413
+HRD+ + N+LL AK+SDFGLS+ +A+E+ + + V + PE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 414 QLTEKSDVYSFGVVLLELIS-GKKP 437
+ + KSDV+SFGV++ E S G+KP
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-39
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALL 285
+ EE F +++GKG+FGSV + G+ VAVK + S + F E+ +L
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 286 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 343
+ H N+V G C +R L+ EY+ G+LRD L +++ +D + LQ
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 123
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 401
KG+EYL T IHRD+ + NIL++ R K+ DFGL++ +++ +
Sbjct: 124 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 402 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 433
+ + PE + + SDV+SFGVVL EL +
Sbjct: 181 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 9e-39
Identities = 53/226 (23%), Positives = 109/226 (48%), Gaps = 19/226 (8%)
Query: 220 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHR 274
++ + + E + K +G G+FG+VY G E VA+K + ++ S +
Sbjct: 5 NQALLRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59
Query: 275 TQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW 333
+ + E +++ + + ++ L+G C L+ + M G L D + ++ +
Sbjct: 60 ANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE--HKDNIGS 116
Query: 334 LTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLT 392
L AKG+ YL + ++HRD+ + N+L+ K++DFGL++ E+
Sbjct: 117 QYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 173
Query: 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ + + + ++ E ++ T +SDV+S+GV + EL++ G KP
Sbjct: 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-38
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 14/208 (6%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRN 292
K IG G FG VY G +K VA+K + + + + F+ E ++ + H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 293 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
++ L G + +++ EYM NG L L L + + A G++YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA- 164
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYY 410
N +HRD+ + NIL++ N+ KVSDFGLSR + + + T+ +S + + + PE
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 411 GNQQLTEKSDVYSFGVVLLELIS-GKKP 437
++ T SDV+SFG+V+ E+++ G++P
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-38
Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 13/204 (6%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPL 296
++G G+FGSV G + K+ VA+K++ + + E ++ ++ + +V L
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
IG C+ E +LV E G L L G ++ + ++ H + G++YL
Sbjct: 402 IGVCQAE-ALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEK 455
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYGNQQ 414
+HR++ + N+LL AK+SDFGLS+ A++ S + + + PE ++
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 415 LTEKSDVYSFGVVLLELIS-GKKP 437
+ +SDV+S+GV + E +S G+KP
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP 539
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 16/220 (7%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQ-FVTEVAL 284
E+ + +G+G FG V + G++VAVK + E+ +
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEI 76
Query: 285 LSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 342
L ++H N+V G C E+ L+ E++ +G+L++ L N+ ++ +L+ A
Sbjct: 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQ 134
Query: 343 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARG 400
KG++YL + +HRD+ + N+L++ + K+ DFGL++ + +++ +
Sbjct: 135 ICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 401 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 439
V + PE + SDV+SFGV L EL++ S
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS 231
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 54/229 (23%), Positives = 101/229 (44%), Gaps = 32/229 (13%)
Query: 229 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQFVT 280
++ F + +G+G+F ++ G ++ EV +K++ + + ++ F
Sbjct: 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61
Query: 281 EVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 340
+++S++ H++LV G C + ILV E++ G+L L + N + W L++A
Sbjct: 62 AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVA 119
Query: 341 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--------NMRAKVSDFGLSRQAEEDLT 392
A + +L +IH +V + NILL K+SD G+S
Sbjct: 120 KQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK-- 174
Query: 393 HISSVARGTVGYLDPE---YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ + + ++ PE N L +D +SFG L E+ S G KP
Sbjct: 175 ---DILQERIPWVPPECIENPKN--LNLATDKWSFGTTLWEICSGGDKP 218
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 15/219 (6%)
Query: 229 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVA 283
+ +F + IG+G FG VY+G + D AVK + QF+TE
Sbjct: 83 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 142
Query: 284 LLSRIHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 342
++ H N++ L+G C E ++V YM +G LR+ + +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQ 200
Query: 343 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVAR 399
AKG+++L + +HRD+ + N +LD KV+DFGL+R E D H + A+
Sbjct: 201 VAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257
Query: 400 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
V ++ E Q+ T KSDV+SFGV+L EL++ G P
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 15/217 (6%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYG-----KMKDGKEVAVKIMADSCSHRTQQFVTEVALL 285
EE + ++GKG+FGSV G VAVK + S + + F E+ +L
Sbjct: 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 286 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 343
+H +V G ++ LV EY+ +G LRD L ++ LD L +
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQI 136
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 401
KG+EYL + +HRD+ + NIL++ K++DFGL++ ++D + +
Sbjct: 137 CKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 402 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ + PE + + +SDV+SFGVVL EL + K
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-38
Identities = 59/207 (28%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNL 293
K +G G FG V G++K + VA+K + + + ++ F+ E +++ + H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
+ L G + ++V EYM NG+L L + + + + A G++YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSD- 165
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGTVGYLDPEYYG 411
G +HRD+ + NIL++ N+ KVSDFGL R + + + + + + + + PE
Sbjct: 166 --MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 412 NQQLTEKSDVYSFGVVLLELIS-GKKP 437
++ T SDV+S+G+VL E++S G++P
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYG-----KMKDGKEVAVKIMADSCSHRTQQFVTEVALL 285
+ EE F +++GKG+FGSV + G+ VAVK + S + F E+ +L
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 286 SRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 343
+ H N+V G C +R L+ EY+ G+LRD L +++ +D + LQ
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQI 154
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARGT 401
KG+EYL T IHRD+ + NIL++ R K+ DFGL++ +++ +
Sbjct: 155 CKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 402 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS 433
+ + PE + + SDV+SFGVVL EL +
Sbjct: 212 IFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 295
K+G G +VY + +VA+K + ++ + EV S++ H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
+I EE+ LV EY+ TL + + + PL T + + G+++ H +
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAH---D 129
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQQ 414
I+HRD+K NIL+D N K+ DFG+++ +E LT + V GTV Y PE +
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEA 188
Query: 415 LTEKSDVYSFGVVLLELISGKKP 437
E +D+YS G+VL E++ G+ P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-38
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLVP 295
+ IGKG FG VY+G+ D + A+K ++ + + F+ E L+ ++H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 296 LIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
LIG E ++ YM +G L + Q+ + A+G+EYL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLA--- 141
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT---VGYLDPEYYG 411
+HRD+ + N +LD + KV+DFGL+R + + R V + E
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 412 NQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ T KSDV+SFGV+L EL++ G P
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-38
Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLV 294
K +G G FG+V+ G E V +K++ D ++ Q + + + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
L+G C ++ V +Y+ G+L D + ++ L L AKG+ YL
Sbjct: 79 RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLE--- 132
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE-EDLTHISSVARGTVGYLDPEYYGNQ 413
G++HR++ + N+LL + +V+DFG++ +D + S A+ + ++ E
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 414 QLTEKSDVYSFGVVLLELIS-GKKP 437
+ T +SDV+S+GV + EL++ G +P
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-38
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT----QQFVTEVALLSRIHHRNLVP 295
+KIG+GSFG K DG++ +K + + S + ++ EVA+L+ + H N+V
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEI--NISRMSSKEREESRREVAVLANMKHPNIVQ 87
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQ-----KPLDWLTRLQIAHDAAKGLEYL 350
EE +V +Y G L R++ + LDW QI L+++
Sbjct: 88 YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICL----ALKHV 141
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410
H + I+HRD+KS NI L + ++ DFG++R + + GT YL PE
Sbjct: 142 H---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEIC 197
Query: 411 GNQQLTEKSDVYSFGVVLLELISGKKP 437
N+ KSD+++ G VL EL + K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-38
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 9/205 (4%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRT-QQFVTEVALLSRIHHRNLVPLI 297
IG GS+G + K DGK + K + S + Q V+EV LL + H N+V
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 298 GYCEEEHQRIL--VYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
+ L V EY G L + G+ ++ LD L++ L+ H
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 355 NPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
+ G ++HRD+K +N+ LD K+ DFGL+R D + + GT Y+ PE
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190
Query: 413 QQLTEKSDVYSFGVVLLELISGKKP 437
EKSD++S G +L EL + P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-38
Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 32/235 (13%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRT-QQFVTEVALLSRIHHRNLVPL 296
KKIG+G F VY DG VA+K + D + + E+ LL +++H N++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKP-------LDWLTRLQIAHDAAKGLEY 349
E+++ +V E G L + QK + Q+ LE+
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV--QLCS----ALEH 151
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLD 406
+H + ++HRD+K +N+ + K+ D GL R + ++ A VG Y+
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF----FSSKTTAAHSLVGTPYYMS 204
Query: 407 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 461
PE KSD++S G +L E+ + + P F + ++ I++ D
Sbjct: 205 PERIHENGYNFKSDIWSLGCLLYEMAALQSP-----FYGDKMNLYSLCKKIEQCD 254
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-37
Identities = 58/231 (25%), Positives = 96/231 (41%), Gaps = 48/231 (20%)
Query: 239 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 297
+G+G+FG V + D + A+K + + ++EV LL+ ++H+ +V
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 298 G-YCEEEHQRI------------LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHD 342
+ E + + EY NGTL D + Q+ W QI
Sbjct: 69 AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL-- 126
Query: 343 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--- 399
+ L Y+H + GIIHRD+K NI +D + K+ DFGL++ L + ++
Sbjct: 127 --EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 400 ----------GTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISG 434
GT Y+ E +Y EK D+YS G++ E+I
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYN-----EKIDMYSLGIIFFEMIYP 227
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 22/209 (10%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY 299
+G G+ G++ Y M D ++VAVK + C + EV LL H N++
Sbjct: 30 DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIRYFCT 86
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
++ + + E TL++ + L + + GL +LH + I+
Sbjct: 87 EKDRQFQYIAIELC-AATLQEYVEQ--KDFAHLGLEPITLLQQTTSGLAHLH---SLNIV 140
Query: 360 HRDVKSSNILL-----DINMRAKVSDFGLSRQAEED---LTHISSVARGTVGYLDPEYY- 410
HRD+K NIL+ ++A +SDFGL ++ + S V GT G++ PE
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GTEGWIAPEMLS 199
Query: 411 --GNQQLTEKSDVYSFGVVLLELISGKKP 437
+ T D++S G V +IS
Sbjct: 200 EDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 19/237 (8%)
Query: 217 HFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADS 270
+ + L E+ + +G G+FG VY G++ +VAVK + +
Sbjct: 12 YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71
Query: 271 CSHRTQQ-FVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGS 325
CS + + F+ E ++S+ +H+N+V IG + R ++ E M G LR+
Sbjct: 72 CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP 131
Query: 326 VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFG 382
L L L +A D A G +YL IHRD+ + N LL AK+ DFG
Sbjct: 132 SQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFG 188
Query: 383 LSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
++R A V ++ PE + T K+D +SFGV+L E+ S G P
Sbjct: 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 19/215 (8%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 291
+++G+GSFG VY G K + VA+K + ++ S R + F+ E +++ +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGSVNQKPLDWLTR---LQIAHDAA 344
++V L+G + +++ E M G LR N L + +Q+A + A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 345 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVG 403
G+ YL+ +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 404 YLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
++ PE + T SDV+SFGVVL E+ + ++P
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-37
Identities = 69/218 (31%), Positives = 104/218 (47%), Gaps = 24/218 (11%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKE---VAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNL 293
F IG+G+FG V ++K A+K M + S + F E+ +L ++ HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIA 340
+ L+G CE L EY +G L D L S L L A
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 341 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG 400
D A+G++YL IHRD+ + NIL+ N AK++DFGLSR +++ ++ R
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 203
Query: 401 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
V ++ E T SDV+S+GV+L E++S G P
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 19/279 (6%)
Query: 175 CSLIVLRKLRRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEE 234
I + S ++ + S ++T + + + L E+
Sbjct: 11 DYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPR 70
Query: 235 ATNNFCKKIGKGSFGSVYYGKMKDGK------EVAVKIMADSCSHRTQQ-FVTEVALLSR 287
+ +G G+FG VY G++ +VAVK + + CS + + F+ E ++S+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 288 IHHRNLVPLIGYCEEEHQRILVYEYMHNGT----LRDRLHGSVNQKPLDWLTRLQIAHDA 343
+H+N+V IG + R ++ E M G LR+ L L L +A D
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ-AEEDLTHISSVAR 399
A G +YL IHRD+ + N LL AK+ DFG++R A
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 400 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
V ++ PE + T K+D +SFGV+L E+ S G P
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 5e-37
Identities = 57/220 (25%), Positives = 94/220 (42%), Gaps = 18/220 (8%)
Query: 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQQ-FVTEVAL 284
+ + +G+G FG V + VAVK + + + + E+ +
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDI 86
Query: 285 LSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHD 342
L ++H +++ G CE+ LV EY+ G+LRD L + + L A
Sbjct: 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP----RHSIGLAQLLLFAQQ 142
Query: 343 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR--QAEEDLTHISSVARG 400
+G+ YLH IHRD+ + N+LLD + K+ DFGL++ + +
Sbjct: 143 ICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199
Query: 401 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVS 439
V + PE + SDV+SFGV L EL++ S
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQS 239
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-37
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 19/213 (8%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE----VAVKIM-ADSCSHRTQQ-FVTEVALLSRIHHRNLV 294
K +G+G FGSV G +K VAVK M D+ S R + F++E A + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 295 PLIGYCEEEHQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTR---LQIAHDAAKG 346
L+G C E + ++ +M G L L S + + L+ D A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYL 405
+EYL +HRD+ + N +L +M V+DFGLS++ D +A+ V ++
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 406 DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
E ++ T KSDV++FGV + E+ + G P
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 7e-37
Identities = 56/251 (22%), Positives = 97/251 (38%), Gaps = 46/251 (18%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIM-----------------ADSCSHRTQQFVTEVA 283
+ + +G F + + KD K A+K S + F E+
Sbjct: 37 RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 284 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQ--- 338
+++ I + + G + ++YEYM N ++ +++ ++
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 339 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 398
I Y+H I HRDVK SNIL+D N R K+SDFG S + S
Sbjct: 156 IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--- 210
Query: 399 RGTVGYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 451
RGT ++ PE Y G K D++S G+ L + P F ++++V
Sbjct: 211 RGTYEFMPPEFFSNESSYNG-----AKVDIWSLGICLYVMFYNVVP-----FSLKISLVE 260
Query: 452 WARSMIKKGDV 462
+ I+ ++
Sbjct: 261 -LFNNIRTKNI 270
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-37
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 295
+ +G+G G VY + + VA+K+M+++ S F T E R+ ++VP
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
+ + E + Q + ++ L L Q PL + I L+ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAA-- 153
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQQ 414
G HRDVK NIL+ + A + DFG++ +E LT + + GT+ Y+ PE +
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESH 211
Query: 415 LTEKSDVYSFGVVLLELISGKKP 437
T ++D+Y+ VL E ++G P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE----VAVKIM-ADSCSHR-TQQFVTEVALLSRIHHRNLV 294
+ +GKG FGSV ++K VAVK++ AD + ++F+ E A + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 295 PLIGYCEEEHQRI------LVYEYMHNGTLRDRLHGS---VNQKPLDWLTRLQIAHDAAK 345
L+G + ++ +M +G L L S N L T ++ D A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 346 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGY 404
G+EYL + IHRD+ + N +L +M V+DFGLSR+ D ++ V +
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 405 LDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
L E + T SDV++FGV + E+++ G+ P
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 60/201 (29%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHR---TQQFVTEVALLSRIHHRNLVPL 296
+ +GKG FG+VY + K +A+K++ + + Q EV + S + H N++ L
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
GY + + L+ EY GT+ L D + A L Y H +
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH---SK 128
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 416
+IHRD+K N+LL K++DFG S A GT+ YL PE +
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYLPPEMIEGRMHD 185
Query: 417 EKSDVYSFGVVLLELISGKKP 437
EK D++S GV+ E + GK P
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPP 206
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 51/220 (23%), Positives = 91/220 (41%), Gaps = 24/220 (10%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 298
+ + +G F VY + + G+E A+K + + + + + EV + ++ H N+V
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 299 YCEEEHQR-------ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
+ L+ + G L + L ++ PL T L+I + + ++++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA-----------RG 400
P IIHRD+K N+LL K+ DFG + + S
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 401 TVGYLDPE---YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
T Y PE Y N + EK D+++ G +L L + P
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 66/231 (28%), Positives = 107/231 (46%), Gaps = 27/231 (11%)
Query: 229 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQFVTEV 282
+ ++ ++G+G+FG V+ + + VAVK + ++ Q F E
Sbjct: 35 VHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREA 94
Query: 283 ALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG----------SVNQKP 330
LL+ + H+++V G C E ++V+EYM +G L R HG V P
Sbjct: 95 ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 331 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEE 389
L L +A A G+ YL +HRD+ + N L+ + K+ DFG+SR
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 390 DLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
D + + ++ PE Y + T +SDV+SFGVVL E+ + GK+P
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 15/202 (7%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 296
+ +GKG FG+VY + K +A+K++ S Q E+ + S + H N++ +
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGLEYLHTGCN 355
Y + + L+ E+ G L L D + + A L Y H
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSA-TFMEELADALHYCH---E 132
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL 415
+IHRD+K N+L+ K++DFG S A GT+ YL PE +
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTH 189
Query: 416 TEKSDVYSFGVVLLELISGKKP 437
EK D++ GV+ E + G P
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP 211
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-35
Identities = 59/238 (24%), Positives = 95/238 (39%), Gaps = 35/238 (14%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGY 299
K +G GS G+V + G+ VAVK M E+ LL+ H N++
Sbjct: 21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM---EIKLLTESDDHPNVIRYYCS 77
Query: 300 CEEEHQRILVYEYMHNGTLRDRL----HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
+ + E N L+D + N K + + A G+ +LH +
Sbjct: 78 ETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---S 133
Query: 356 PGIIHRDVKSSNILLDI-------------NMRAKVSDFGLSRQAEEDLTHISSVAR--- 399
IIHRD+K NIL+ N+R +SDFGL ++ + + +
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193
Query: 400 GTVGYLDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 450
GT G+ PE ++LT D++S G V ++S K + + E NI+
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 251
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 20/209 (9%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVT----EVALLSRIHHRNLVP 295
+ +G G V+ + ++D ++VAVK++ + R F E + ++H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 296 LIGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
+ E E +V EY+ TLRD +H + P+ +++ DA + L + H
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSH 133
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR---QAEEDLTHISSVARGTVGYLDPE 408
GIIHRDVK +NI++ KV DFG++R + +T ++V GT YL PE
Sbjct: 134 ---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPE 189
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ +SDVYS G VL E+++G+ P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 57/233 (24%), Positives = 108/233 (46%), Gaps = 29/233 (12%)
Query: 229 LPELEEATNNFCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTE 281
L E+ + F +++G+ FG VY G + VA+K + D ++ F E
Sbjct: 3 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 282 VALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG-----------SVNQ 328
L +R+ H N+V L+G ++ +++ Y +G L + + +
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 329 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-A 387
L+ + + A G+EYL + ++H+D+ + N+L+ + K+SD GL R+
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 388 EEDLTHISSVARGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
D + + + ++ PE YG + + SD++S+GVVL E+ S G +P
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 28/222 (12%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQFVTEVALLSRIHHRN 292
+++G+G+FG V+ + + VAVK + D + F E LL+ + H +
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 293 LVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHG-----------SVNQKPLDWLTRLQI 339
+V G C + I+V+EYM +G L R HG + L L I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 340 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE-DLTHISSVA 398
A A G+ YL + +HRD+ + N L+ N+ K+ DFG+SR D +
Sbjct: 139 ASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 399 RGTVGYLDPE--YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ ++ PE Y + T +SDV+SFGV+L E+ + GK+P
Sbjct: 196 MLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQP 235
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-35
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 28/224 (12%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 290
F K +G G+FG V + VAVK++ S ++ ++E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------HGSVNQKPLDWLT 335
N+V L+G C +++ EY G L + L ++ LD
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 336 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHI 394
L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
AR V ++ PE N T +SDV+S+G+ L EL S G P
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 33/243 (13%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRIHHRNL--VPL 296
K+IG G V+ + + A+K + + ++T + E+A L+++ + + L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
Y + +V E N L L +K +D R + + + +H
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 146
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 408
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V GTV Y+ PE
Sbjct: 147 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 203
Query: 409 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 258
Query: 463 ISI 465
I
Sbjct: 259 IEF 261
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 5e-35
Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPL 296
+GKGSF VY + + G EVA+K++ + Q+ EV + ++ H +++ L
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 352
Y E+ + LV E HNG + L KP R QI G+ YLH
Sbjct: 77 YNYFEDSNYVYLVLEMCHNGEMNRYLK--NRVKPFSENEARHFMHQII----TGMLYLH- 129
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPEY 409
+ GI+HRD+ SN+LL NM K++DFGL+ Q + GT Y+ PE
Sbjct: 130 --SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP----HEKHYTLCGTPNYISPEI 183
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKP 437
+SDV+S G + L+ G+ P
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 18/206 (8%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+GKG++G VY G+ +A+K + + S +Q E+AL + H+N+V +G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEYLHTGC 354
E + E + G+L L + + T+ QI GL+YLH
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-QILE----GLKYLH--- 139
Query: 355 NPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--YYG 411
+ I+HRD+K N+L++ + K+SDFG S++ + GT+ Y+ PE G
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKG 198
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKP 437
+ + +D++S G ++E+ +GK P
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 21/205 (10%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
++G+GSFG V+ K K G + AVK + E+ + + +VPL G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA 118
Query: 300 CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
E + E + G+L + G + + + Q +GLEYLH
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG-QAL----EGLEYLH---TRR 170
Query: 358 IIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDPEYYGN 412
I+H DVK+ N+LL + RA + DFG + + D S + GT ++ PE
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 413 QQLTEKSDVYSFGVVLLELISGKKP 437
+ K D++S ++L +++G P
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 7e-35
Identities = 71/285 (24%), Positives = 126/285 (44%), Gaps = 38/285 (13%)
Query: 184 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNN--FCK 241
R+ + +S +S + + S A P+ E + K
Sbjct: 28 RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGK 87
Query: 242 KIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HHR 291
+G+G FG V K K+ VAVK++ D + + V+E+ ++ I H+
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTRLQ 338
N++ L+G C ++ ++ EY G LR+ L V ++ + + +
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 339 IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 398
+ A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D+ +I
Sbjct: 208 CTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYK 260
Query: 399 RGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ T G L PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 64/228 (28%), Positives = 112/228 (49%), Gaps = 36/228 (15%)
Query: 239 FCKKIGKGSFGSVYYG--------KMKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI- 288
K +G+G+FG V K K+ VAVK++ D + + V+E+ ++ I
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 289 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLT 335
H+N++ L+G C ++ ++ EY G LR+ L V ++ + +
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 336 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395
+ + A+G+EYL + IHRD+ + N+L+ N K++DFGL+R D+ +I
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 396 SVARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ T G L PE ++ T +SDV+SFGV++ E+ + G P
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 70/278 (25%), Positives = 118/278 (42%), Gaps = 39/278 (14%)
Query: 190 QKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFG 249
Q YE + T S+ Y ++D + E F K +G G+FG
Sbjct: 6 QFRYESQLQMVQVTGSSDNEY------FYVDFREYEYDLKWEFPRENLEFGKVLGSGAFG 59
Query: 250 SVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HHRNLVPLIGYCE 301
V + VAVK++ + ++ ++E+ +++++ H N+V L+G C
Sbjct: 60 KVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119
Query: 302 EEHQRILVYEYMHNGTLRDRL-----------------HGSVNQKPLDWLTR---LQIAH 341
L++EY G L + L ++ L+ LT L A+
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179
Query: 342 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARG 400
AKG+E+L +HRD+ + N+L+ K+ DFGL+R + + AR
Sbjct: 180 QVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236
Query: 401 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
V ++ PE T KSDV+S+G++L E+ S G P
Sbjct: 237 PVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 1e-34
Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 41/233 (17%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 291
K +G+G FG V K VAVK++ ++ S + ++E +L +++H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------------HGSVNQKP 330
+++ L G C ++ +L+ EY G+LR L +++
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 331 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390
L + A ++G++YL ++HRD+ + NIL+ + K+SDFGLSR D
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSR----D 199
Query: 391 LTHISSVARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ S + + G + E + T +SDV+SFGV+L E+++ G P
Sbjct: 200 VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 63/227 (27%), Positives = 101/227 (44%), Gaps = 35/227 (15%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 290
K +G+G+FG V + VAVK++ + +H + ++E+ +L I HH
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 90
Query: 291 RNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTR 336
N+V L+G C + +++ E+ G L L + + L
Sbjct: 91 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150
Query: 337 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 396
+ + AKG+E+L + IHRD+ + NILL K+ DFGL+R D+
Sbjct: 151 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPD 203
Query: 397 VARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
R L PE ++ T +SDV+SFGV+L E+ S G P
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-34
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 296
+ +GKG F + + A KI+ S H+ ++ E+++ + H+++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 352
G+ E+ +V E +L + +K L R QI G +YLH
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIV----LGCQYLH- 132
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
+IHRD+K N+ L+ ++ K+ DFGL+ + E D V GT Y+ PE
Sbjct: 133 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK 189
Query: 413 QQLTEKSDVYSFGVVLLELISGKKP 437
+ + + DV+S G ++ L+ GK P
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 296
+ +GKG F + + A KI+ S H+ ++ E+++ + H+++V
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-WLTR---LQIAHDAAKGLEYLHT 352
G+ E+ +V E +L + +K L R QI G +YLH
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELH---KRRKALTEPEARYYLRQIV----LGCQYLH- 158
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
+IHRD+K N+ L+ ++ K+ DFGL+ + E D V GT Y+ PE
Sbjct: 159 --RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK 215
Query: 413 QQLTEKSDVYSFGVVLLELISGKKP 437
+ + + DV+S G ++ L+ GK P
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 295
+G+G+ +V+ G+ K G A+K+ S + E +L +++H+N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 296 LIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
L EE R +L+ E+ G+L L N L L + D G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 354 CNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
GI+HR++K NI+ D K++DFG +R+ E+D +S GT YL P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDM 186
Query: 410 Y--------GNQQLTEKSDVYSFGVVLLELISGKKP 437
Y ++ D++S GV +G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 59/243 (24%), Positives = 104/243 (42%), Gaps = 33/243 (13%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRI--HHRNLVPL 296
K+IG G V+ + + A+K + + ++T + E+A L+++ H ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
Y + +V E N L L +K +D R + + + +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 127
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 408
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V GTV Y+ PE
Sbjct: 128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GTVNYMPPEAIKDM 184
Query: 409 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 239
Query: 463 ISI 465
I
Sbjct: 240 IEF 242
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 56/201 (27%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+KIG+G+ G+VY G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 356
+ +V EY+ G+L D + + + QIA + + LE+LH+
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHSN--- 135
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 416
+IHRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYG 194
Query: 417 EKSDVYSFGVVLLELISGKKP 437
K D++S G++ +E+I G+ P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-34
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 290
F K +G G+FG V + VAVK++ + ++ ++E+ ++S + H
Sbjct: 50 FGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQH 109
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQ---------KPLDWLTRLQI 339
N+V L+G C +++ EY G L + R V + L
Sbjct: 110 ENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 340 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVA 398
+ A+G+ +L + IHRDV + N+LL AK+ DFGL+R + + A
Sbjct: 170 SSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNA 226
Query: 399 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
R V ++ PE + T +SDV+S+G++L E+ S G P
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 68/246 (27%), Positives = 101/246 (41%), Gaps = 67/246 (27%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKE------VAVKIMADSCSHRTQQ-FVTEVALLSRIHHR 291
+ + IG+G+FG V+ + VAVK++ + S Q F E AL++ +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL---------------------HGSVNQKP 330
N+V L+G C L++EYM G L + L S P
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 331 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390
L +L IA A G+ YL +HRD+ + N L+ NM K++DFGLSR
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 391 LTHISSVARGTVGYLDPEYY---GNQQL---------------TEKSDVYSFGVVLLELI 432
+YY GN + T +SDV+++GVVL E+
Sbjct: 228 -----------------DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
Query: 433 S-GKKP 437
S G +P
Sbjct: 271 SYGLQP 276
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-34
Identities = 67/252 (26%), Positives = 110/252 (43%), Gaps = 21/252 (8%)
Query: 239 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVT-EVALLSRIHHRNLVPL 296
+++G G FG V +D G++VA+K S + ++ E+ ++ +++H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 297 IGYCEEE------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
+ +L EY G LR L+ N L + D + L YL
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL 137
Query: 351 HTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 407
H IIHRD+K NI+L + K+ D G +++ ++ V GT+ YL P
Sbjct: 138 H---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTLQYLAP 192
Query: 408 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467
E ++ T D +SFG + E I+G +P F V W + +K + +V
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRP-----FLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 468 PVLIGNVKIESI 479
L G VK S+
Sbjct: 248 DDLTGAVKFSSV 259
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 33/243 (13%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMA-DSCSHRT-QQFVTEVALLSRIHHRNL--VPL 296
K+IG G V+ + + A+K + + ++T + E+A L+++ + + L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
Y + +V E N L L +K +D R + + + +H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH---QH 174
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPE----- 408
GI+H D+K +N L+ + K+ DFG++ Q + D T + S V G V Y+ PE
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQV--GAVNYMPPEAIKDM 231
Query: 409 ------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462
+++ KSDV+S G +L + GK P F +N + ++I
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP-----FQQIINQISKLHAIIDPNHE 286
Query: 463 ISI 465
I
Sbjct: 287 IEF 289
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 7e-34
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 21/216 (9%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 295
+G+G+ +V+ G+ K G A+K+ S + E +L +++H+N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 296 LIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
L EE R +L+ E+ G+L L N L L + D G+ +L
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-- 129
Query: 354 CNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
GI+HR++K NI+ D K++DFG +R+ E+D +S GT YL P+
Sbjct: 130 -ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDM 186
Query: 410 Y--------GNQQLTEKSDVYSFGVVLLELISGKKP 437
Y ++ D++S GV +G P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-34
Identities = 50/201 (24%), Positives = 76/201 (37%), Gaps = 13/201 (6%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRTQQFVTEVALLSRI-HHRNLVPL 296
++G GS+G V+ + K DG+ AVK + + EV ++ H V L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
EE L E +L+ L D L +LH +
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLH---SQ 176
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 416
G++H DVK +NI L R K+ DFGL + G Y+ PE
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPELL-QGSYG 233
Query: 417 EKSDVYSFGVVLLELISGKKP 437
+DV+S G+ +LE+ +
Sbjct: 234 TAADVFSLGLTILEVACNMEL 254
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 62/226 (27%), Positives = 109/226 (48%), Gaps = 36/226 (15%)
Query: 241 KKIGKGSFGSVYYGKMKDGK--------EVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 290
K +G+G+FG V + +VAVK++ + + ++E+ ++ I H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL-------------HGSVNQKPLDWLTRL 337
+N++ L+G C ++ ++ EY G LR+ L ++ L +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 338 QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 397
A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R D+ HI
Sbjct: 195 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 247
Query: 398 ARGTVGYL-----DPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
+ T G L PE ++ T +SDV+SFGV+L E+ + G P
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 15/201 (7%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
KIG+GS G V + K G++VAVK+M R + EV ++ H N+V +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 356
+ ++ E++ G L D + L QIA + L YLH
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQVR-------LNEEQIATVCEAVLQALAYLH---AQ 160
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 416
G+IHRD+KS +ILL ++ R K+SDFG Q +D+ S+ GT ++ PE
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYA 219
Query: 417 EKSDVYSFGVVLLELISGKKP 437
+ D++S G++++E++ G+ P
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPP 240
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-33
Identities = 43/204 (21%), Positives = 77/204 (37%), Gaps = 23/204 (11%)
Query: 242 KIGKGSFGSVYYGK--MKDGKEVAVKIMADSCSHRTQQ-FVTEVALLSRIHHRNLVPLIG 298
I G G +Y +G+ V +K + S Q + E L+ + H ++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 299 YCEEEHQRI-----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
+ E + +V EY+ +L+ L + + L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLH-- 199
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 413
+ G+++ D+K NI+L + K+ D G + + + GT G+ PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR----INSFGYLY-GTPGFQAPEIVRTG 252
Query: 414 QLTEKSDVYSFGVVLLELISGKKP 437
T +D+Y+ G L L
Sbjct: 253 P-TVATDIYTVGRTLAALTLDLPT 275
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 40/263 (15%), Positives = 82/263 (31%), Gaps = 28/263 (10%)
Query: 197 DSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFC--KKIGKGSFGSVYYG 254
L + ++Y + P E + + +G+G+F VY
Sbjct: 28 FKLLSGLSKPVSSYP---NTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEA 84
Query: 255 KMKD------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308
D ++ +K+ + + L + ++ +L
Sbjct: 85 TQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVL 144
Query: 309 VYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 366
V E GTL + + + + +K + + A +E +H IIH D+K
Sbjct: 145 VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPD 201
Query: 367 NILL-----------DINMRAKVSDFGLSRQAEEDLTHISSVAR-GTVGYLDPEYYGNQQ 414
N +L D++ + D G S + A+ T G+ E N+
Sbjct: 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP 261
Query: 415 LTEKSDVYSFGVVLLELISGKKP 437
+ D + + ++ G
Sbjct: 262 WNYQIDYFGVAATVYCMLFGTYM 284
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+KIGKGSFG V+ G K VA+KI+ + + E+ +LS+ + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCN 355
++ + ++ EY+ G+ D L L QIA + KGL+YLH +
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLH---S 137
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLDPEYYGN 412
IHRD+K++N+LL + K++DFG++ Q LT VG ++ PE
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQ----LTDTQIKRNTFVGTPFWMAPEVIKQ 193
Query: 413 QQLTEKSDVYSFGVVLLELISGKKP 437
K+D++S G+ +EL G+ P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+ IG G+ V ++VA+K + + C + + E+ +S+ HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDW--LTRLQIA---HDAAKGLEYLHTG 353
+ + LV + + G++ D + V + L IA + +GLEYLH
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-- 138
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT-VG---YLDPE- 408
G IHRDVK+ NILL + +++DFG+S + R T VG ++ PE
Sbjct: 139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 409 -----YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
Y K+D++SFG+ +EL +G P
Sbjct: 198 MEQVRGYD-----FKADIWSFGITAIELATGAAP 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-31
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 18/206 (8%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
++G G+FG VY K K+ G A K++ + ++ E+ +L+ H +V L+G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 356
+ + ++ E+ G + + LT QI + L +LH+
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRG-----LTEPQIQVVCRQMLEALNFLHSK--- 136
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 416
IIHRD+K+ N+L+ + +++DFG+S + + L S GT ++ PE + +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMK 195
Query: 417 E-----KSDVYSFGVVLLELISGKKP 437
+ K+D++S G+ L+E+ + P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+K+G+GS+GSVY K+ G+ VA+K + Q+ + E++++ + ++V G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTGCNP 356
+ +V EY G++ D + + K L +IA KGLEYLH
Sbjct: 93 YFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLT---EDEIATILQSTLKGLEYLHFM--- 144
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 416
IHRD+K+ NILL+ AK++DFG++ Q + + ++V GT ++ PE
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYN 203
Query: 417 EKSDVYSFGVVLLELISGKKP 437
+D++S G+ +E+ GK P
Sbjct: 204 CVADIWSLGITAIEMAEGKPP 224
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 6e-31
Identities = 24/232 (10%), Positives = 59/232 (25%), Gaps = 42/232 (18%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 296
+ + G V+ + + ++ A+K+ A++ ++ +R+ +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 297 IGYC--------------------------EEEHQRILVYEYMH--NGTLRDRLH-GSVN 327
+L+ L L V
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 328 QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387
+ L + + L + G++H N+ + + R + D +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 388 EEDLTHISSVARGTVGYLDPEYYG--NQQLTEKSDVYSFGVVLLELISGKKP 437
S V Y E+ T + + G+ + + P
Sbjct: 245 GTRGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-31
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 33/220 (15%)
Query: 239 FCKKIGKG--SFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNL 293
IGKG +V + K G+ V V+ + ++CS+ F+ E+ + +H N+
Sbjct: 29 LLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI 88
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYL 350
VP +++ +V +M G+ +D + + L IA K L+Y+
Sbjct: 89 VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG----MNELAIAYILQGVLKALDYI 144
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR------GTVGY 404
H + G +HR VK+S+IL+ ++ + +S + V + +
Sbjct: 145 H---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201
Query: 405 LDPE-------YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
L PE Y KSD+YS G+ EL +G P
Sbjct: 202 LSPEVLQQNLQGYD-----AKSDIYSVGITACELANGHVP 236
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 43/222 (19%), Positives = 79/222 (35%), Gaps = 33/222 (14%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKI--MADSCSHRTQQFVTEVALLSRI-HHRNLVPL 296
+KIG G FGSV+ + DG A+K + S Q + EV + + H ++V
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRL-HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
E+ ++ EY + G+L D + + +GL Y+H +
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---S 133
Query: 356 PGIIHRDVKSSNILLDIN-------------------MRAKVSDFGLSRQAEEDLTHISS 396
++H D+K SNI + + K+ D G +
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE-- 191
Query: 397 VARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
G +L E N K+D+++ + ++ +
Sbjct: 192 ---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 56/232 (24%), Positives = 104/232 (44%), Gaps = 23/232 (9%)
Query: 220 DEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRT 275
+ + + E+ ++G G+ G V+ K+ G +A K++ +
Sbjct: 23 QKQKVGELKDDDFEK-----ISELGAGNGGVVF--KVSHKPSGLVMARKLIHLEIKPAIR 75
Query: 276 QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 335
Q + E+ +L + +V G + + + E+M G+L D++ + P L
Sbjct: 76 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILG 134
Query: 336 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL--TH 393
+ ++ KGL YL I+HRDVK SNIL++ K+ DFG+S Q + + +
Sbjct: 135 K--VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 190
Query: 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 445
+ GT Y+ PE + +SD++S G+ L+E+ G+ P+ D
Sbjct: 191 V-----GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 237
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-30
Identities = 64/209 (30%), Positives = 98/209 (46%), Gaps = 20/209 (9%)
Query: 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMA---DSCSHRTQQFVTEVALLSRIHHRNL 293
+ +GKGSFG V K K G+E AVK+++ + + EV LL ++ H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
+ L + E++ LV E G L D + ++ + R Q+ G+ Y+H
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIR-QV----LSGITYMH 143
Query: 352 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 408
I+HRD+K N+LL + ++ DFGLS E + GT Y+ PE
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPE 198
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ EK DV+S GV+L L+SG P
Sbjct: 199 VL-HGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 31/216 (14%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 298
+ +G G++G VY G+ G+ A+K+M D ++ E+ +L + HHRN+ G
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 299 ------YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEY 349
+ Q LV E+ G++ D + + L IA + +GL +
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT----LKEEWIAYICREILRGLSH 144
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVG---YLD 406
LH +IHRD+K N+LL N K+ DFG+S Q L +G ++
Sbjct: 145 LH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ----LDRTVGRRNTFIGTPYWMA 197
Query: 407 PEYYGNQQLTE-----KSDVYSFGVVLLELISGKKP 437
PE + + KSD++S G+ +E+ G P
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 59/214 (27%), Positives = 101/214 (47%), Gaps = 31/214 (14%)
Query: 241 KKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRTQQFVTEVA-LLSRIHHRNLVP 295
++G+G++G V KM+ G+ +AVK + A S ++ + ++ + + V
Sbjct: 13 MELGRGAYGVVE--KMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT 70
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLH 351
G E + E M + +L D+ + V K P D L + IA K LE+LH
Sbjct: 71 FYGALFREGDVWICMELM-DTSL-DKFYKQVIDKGQTIPEDILGK--IAVSIVKALEHLH 126
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 407
+ +IHRDVK SN+L++ + K+ DFG+S + VA+ G Y+ P
Sbjct: 127 S--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL------VDDVAKDIDAGCKPYMAP 178
Query: 408 E----YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
E + + KSD++S G+ ++EL + P
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-30
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 239 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVP 295
KK+G G++G V + K E A+KI+ + + + + EVA+L + H N++
Sbjct: 41 RVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
L + E++ LV E G L D + N+ + + Q+ G+ YLH
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK-QV----LSGVTYLH-- 153
Query: 354 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410
I+HRD+K N+LL + + K+ DFGLS E + GT Y+ PE
Sbjct: 154 -KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEVL 210
Query: 411 GNQQLTEKSDVYSFGVVLLELISGKKP 437
++ EK DV+S GV+L L++G P
Sbjct: 211 -RKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 41/272 (15%), Positives = 88/272 (32%), Gaps = 61/272 (22%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH--- 290
+G+ + + G+ V + + + ++ V + LL I +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 291 -----RNLVPLIGYCEEEHQRI----------------LVYEYMH--NGTLRDRL-HGSV 326
R + P + + +++ +Y M T + L S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 327 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386
K L RLQ+ + L LH + G++H ++ +I+LD ++ F +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 387 AEEDLTHISSVARGTVGYLDPEY-----------YGNQQLTEKSDVYSFGVVLLELISGK 435
+ + + G+ PE +T D ++ G+V+ +
Sbjct: 256 DGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 436 KP--------VSVEDFGAELNIVHWARSMIKK 459
P S F + NI R++++
Sbjct: 311 LPITKDAALGGSEWIFRSCKNIPQPVRALLEG 342
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 296
F + +G G+F V+ K + GK A+K + S + R E+A+L +I H N+V L
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
E LV + + G L DR+ G +K + + Q+ ++YLH
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ-QV----LSAVKYLH--- 123
Query: 355 NPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 411
GI+HRD+K N+L + N + ++DFGLS+ + + +S+ GT GY+ PE
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGYVAPEVLA 180
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKP 437
+ ++ D +S GV+ L+ G P
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 60/249 (24%), Positives = 90/249 (36%), Gaps = 53/249 (21%)
Query: 239 FCKKIGKGSFGSVYYGKMKD-GKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRN 292
IG+GS+G V A+KI + ++ TEV L+ ++HH N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 293 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----------- 341
+ L E+E LV E H G L D+L+ ++ +
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 342 -------------------DAAK-------GLEYLHTGCNPGIIHRDVKSSNILL--DIN 373
+ L YLH N GI HRD+K N L + +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206
Query: 374 MRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE--YYGNQQLTEKSDVYSFGVVL 428
K+ DFGLS++ + GT ++ PE N+ K D +S GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 429 LELISGKKP 437
L+ G P
Sbjct: 267 HLLLMGAVP 275
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-29
Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 34/238 (14%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIHHR 291
K +G G+ G V + K+VA++I++ + TE+ +L +++H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 349
++ + + + E +V E M G L D++ + + + Q+ ++Y
Sbjct: 201 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QMLL----AVQY 254
Query: 350 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 406
LH GIIHRD+K N+LL + + K++DFG S+ E + GT YL
Sbjct: 255 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 309
Query: 407 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 461
PE G D +S GV+L +SG P S L + I G
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQITSGK 361
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 239 FCKKIGKGSFGSVYYGKMK-DGKEVAVKI-------------MADSCSHRTQQFVTEVAL 284
+K+G G++G V K K E A+K+ + ++ E++L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 285 LSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHD 342
L + H N++ L E++ LV E+ G L +++ ++ + + QI
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMK-QI--- 155
Query: 343 AAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVAR 399
G+ YLH I+HRD+K NILL + + K+ DFGLS +D +
Sbjct: 156 -LSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL-- 209
Query: 400 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
GT Y+ PE ++ EK DV+S GV++ L+ G P
Sbjct: 210 GTAYYIAPEVL-KKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-29
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---------ADSCSHRTQQFVTEVALLSRI-H 289
+ +G+G V K KE AVKI+ A+ + + EV +L ++
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 290 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 347
H N++ L E LV++ M G L D L ++++K + R + + +
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR-ALL----EVI 137
Query: 348 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 407
LH I+HRD+K NILLD +M K++DFG S Q + GT YL P
Sbjct: 138 CALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--GTPSYLAP 192
Query: 408 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
E + ++ D++S GV++ L++G P
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 68/207 (32%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 296
++IG GSFG+VY+ + + VA+K M + + Q + EV L ++ H N +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTG 353
G EH LV EY G+ D L V++KPL ++IA H A +GL YLH+
Sbjct: 120 RGCYLREHTAWLVMEYC-LGSASDLLE--VHKKPLQ---EVEIAAVTHGALQGLAYLHSH 173
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 413
+IHRDVK+ NILL K+ DFG + + + GT ++ PE
Sbjct: 174 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAM 225
Query: 414 QLTE---KSDVYSFGVVLLELISGKKP 437
+ K DV+S G+ +EL K P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 28/236 (11%), Positives = 66/236 (27%), Gaps = 42/236 (17%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHHRNL 293
+G+ + + G+ V + + + ++ V + LL I ++
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 294 ------------------VPLIGYCEEEHQRILVYEY--------MHNGTLRDRLHGSV- 326
+ + + + V + T + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 327 NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386
K L RLQ+ + L LH + G++H ++ +I+LD ++ F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 387 AEEDLTHISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ +T D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 241 KKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSCSHRTQQFVTEVA-LLSRIHHRNLVP 295
+IG+G++GSV KM G+ +AVK + + +Q + ++ ++ +V
Sbjct: 28 GEIGRGAYGSVN--KMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLH 351
G E + E M + + + P + L + I K L +L
Sbjct: 86 FYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKALNHLK 142
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----GTVGYLDP 407
N IIHRD+K SNILLD + K+ DFG+S Q + S+A+ G Y+ P
Sbjct: 143 E--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL------VDSIAKTRDAGCRPYMAP 194
Query: 408 E----YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
E Q +SDV+S G+ L EL +G+ P
Sbjct: 195 ERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLV 294
N +GKGSFG V K + +E AVK++ + + T + EV LL ++ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
L E+ +V E G L D + ++ + + Q+ G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-QV----FSGITYMH- 138
Query: 353 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
I+HRD+K NILL + + K+ DFGLS +++ + GT Y+ PE
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKP 437
EK DV+S GV+L L+SG P
Sbjct: 195 L-RGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-28
Identities = 48/210 (22%), Positives = 81/210 (38%), Gaps = 25/210 (11%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 296
IG+GS+G V K A K + +F E+ ++ + H N++ L
Sbjct: 12 TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
E+ LV E G L +R+ + + + + + Y H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMK-DV----LSAVAYCH--- 123
Query: 355 NPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--- 408
+ HRD+K N L + K+ DFGL+ + + + V GT Y+ P+
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQVLE 181
Query: 409 -YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
YG + D +S GV++ L+ G P
Sbjct: 182 GLYG-----PECDEWSAGVMMYVLLCGYPP 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 28/234 (11%)
Query: 216 GHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGKMKD---GKEVAVKIM-ADSC 271
G+ G Y + +LE ++G G+ G V+ KM+ G +AVK M
Sbjct: 11 GYLTIGGQRYQAEINDLEN-----LGEMGSGTCGQVW--KMRFRKTGHVIAVKQMRRSGN 63
Query: 272 SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQ 328
++ + ++ +L +V G + E M + R+ G + +
Sbjct: 64 KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE 123
Query: 329 KPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388
+ L ++ K L YL G+IHRDVK SNILLD + K+ DFG+S +
Sbjct: 124 RILG-----KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176
Query: 389 EDLTHISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+D S G Y+ PE ++DV+S G+ L+EL +G+ P
Sbjct: 177 DDKAKDRSA--GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 295
F +K+G G+FG V+ + + G E +K + D +Q E+ +L + H N++
Sbjct: 25 IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLE 348
+ E+ H +V E G L +R+ + + L+ A+ L
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARG--KALSE----GYVAELMKQMMNALA 138
Query: 349 YLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 405
Y H + ++H+D+K NIL + K+ DFGL+ + D ++ GT Y+
Sbjct: 139 YFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYM 193
Query: 406 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
PE + + +T K D++S GVV+ L++G P
Sbjct: 194 APEVF-KRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLV 294
N +GKGSFG V K + +E AVK++ + + T + EV LL ++ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
L E+ +V E G L D + ++ + + Q+ G+ Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIK-QV----FSGITYMH- 138
Query: 353 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE- 408
I+HRD+K NILL + + K+ DFGLS +++ + GT Y+ PE
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 409 ---YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
Y EK DV+S GV+L L+SG P
Sbjct: 195 LRGTYD-----EKCDVWSAGVILYILLSGTPP 221
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 30/217 (13%)
Query: 239 FCKKIGKGSFGSVYYGKMKD-GKEVAVKI-----MADSCSHRTQQFVTEVALLSRIHHRN 292
C+ IGKG F V ++ G++ AVKI S T+ E ++ + H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 293 LVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAK----- 345
+V L+ + +V+E+M L + + A+
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV----YSE----AVASHYMRQI 139
Query: 346 --GLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARG 400
L Y H + IIHRDVK +LL + + K+ FG++ Q E G
Sbjct: 140 LEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-G 195
Query: 401 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
T ++ PE + + DV+ GV+L L+SG P
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 59/228 (25%), Positives = 100/228 (43%), Gaps = 19/228 (8%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 298
K +G+GSF K + AVKI++ TQ+ E+ L H N+V L
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHE 73
Query: 299 YCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
++ LV E ++ G L +R+ ++ ++ R ++ + ++H +
Sbjct: 74 VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR-KL----VSAVSHMH---DV 125
Query: 357 GIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 413
G++HRD+K N+L + N+ K+ DFG +R D + + T+ Y PE
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQN 184
Query: 414 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 461
E D++S GV+L ++SG+ P D IKKGD
Sbjct: 185 GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 18/208 (8%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNLV 294
+ +++GKG+F V K G E A KI+ S R Q + E + ++ H N+V
Sbjct: 9 DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
L +EE LV++ + G L + + ++ + QI + + Y H
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI----LESIAYCH- 122
Query: 353 GCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
+ GI+HR++K N+LL K++DFGL+ + + GT GYL PE
Sbjct: 123 --SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEV 178
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKP 437
++ D+++ GV+L L+ G P
Sbjct: 179 LKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-27
Identities = 54/265 (20%), Positives = 106/265 (40%), Gaps = 21/265 (7%)
Query: 184 RRKISNQKSYEKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATN-----N 238
+K D + +++ + + P P + + +
Sbjct: 101 LIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYD 160
Query: 239 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 297
+++G G+FG V+ + G A K + + E+ +S + H LV L
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
E++++ +++YE+M G L +++ H +++ R Q+ KGL ++H
Sbjct: 221 DAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR-QV----CKGLCHMH--- 272
Query: 355 NPGIIHRDVKSSNILLDINMRA--KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
+H D+K NI+ K+ DFGL+ + V GT + PE
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAPEVAEG 330
Query: 413 QQLTEKSDVYSFGVVLLELISGKKP 437
+ + +D++S GV+ L+SG P
Sbjct: 331 KPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 60/215 (27%), Positives = 95/215 (44%), Gaps = 28/215 (13%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIH-H 290
IG+G V + G E AVKIM + + E +L ++ H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 348
+++ LI E LV++ M G L D L ++++K + R + + +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMR-SLL----EAVS 214
Query: 349 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 408
+LH I+HRD+K NILLD NM+ ++SDFG S E GT GYL PE
Sbjct: 215 FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--GTPGYLAPE 269
Query: 409 ------YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ ++ D+++ GV+L L++G P
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 48/206 (23%), Positives = 98/206 (47%), Gaps = 16/206 (7%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 296
+ +++G G+FG V+ K G+ K + E+++++++HH L+ L
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTG 353
E++++ +L+ E++ G L DR+ + ++ ++ + A +GL+++H
Sbjct: 114 HDAFEDKYEMVLILEFLSGGELFDRI---AAED--YKMSEAEVINYMRQACEGLKHMH-- 166
Query: 354 CNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 411
I+H D+K NI+ K+ DFGL+ + D I V T + PE
Sbjct: 167 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVD 223
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKP 437
+ + +D+++ GV+ L+SG P
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH 290
+ +++G G F V + K G E A K + A ++ EV++L ++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 348
N++ L E +L+ E + G L D L S++++ + QI G+
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QI----LDGVN 129
Query: 349 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 404
YLH I H D+K NI+L K+ DFGL+ + E+ GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEF 184
Query: 405 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ PE + L ++D++S GV+ L+SG P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-27
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 17/207 (8%)
Query: 239 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVP 295
+++GKG+F V G+E A I+ + Q+ E + + H N+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
L EE L+++ + G L + + ++ + QI + + + H
Sbjct: 75 LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ-QI----LEAVLHCH-- 127
Query: 354 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410
G++HR++K N+LL K++DFGL+ + E + A GT GYL PE
Sbjct: 128 -QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVL 185
Query: 411 GNQQLTEKSDVYSFGVVLLELISGKKP 437
+ D+++ GV+L L+ G P
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 298
+G+G+ V +E AVKI+ H + EV +L + HRN++ LI
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLH--GSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+ EEE + LV+E M G++ +H N+ + + + A L++LH N
Sbjct: 79 FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-DV----ASALDFLH---NK 130
Query: 357 GIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVAR------GTVGYLDP 407
GI HRD+K NIL + K+ DF L + + G+ Y+ P
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 408 E-----YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
E ++ D++S GV+L L+SG P
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 60/238 (25%), Positives = 99/238 (41%), Gaps = 34/238 (14%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIHHR 291
K +G G+ G V + K+VA+KI++ + TE+ +L +++H
Sbjct: 16 KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEY 349
++ + + + E +V E M G L D++ + + + Q+ ++Y
Sbjct: 76 CIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY-QML----LAVQY 129
Query: 350 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 406
LH GIIHRD+K N+LL + + K++DFG S+ E + GT YL
Sbjct: 130 LH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLA 184
Query: 407 PE---YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 461
PE G D +S GV+L +SG P S L + I G
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL------KDQITSGK 236
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHH 290
+++G G F V + K GKE A K + ++ EV +L I H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 348
N++ L E + +L+ E + G L D L S+ + + QI G+
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-QI----LDGVH 122
Query: 349 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 404
YLH + I H D+K NI+L N R K+ DFG++ + E + GT +
Sbjct: 123 YLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPEF 177
Query: 405 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ PE + L ++D++S GV+ L+SG P
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 58/234 (24%), Positives = 100/234 (42%), Gaps = 50/234 (21%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--------ADSCSHRTQQFVT----------- 280
+IGKGS+G V D A+K++ A +
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 281 -------EVALLSRIHHRNLVPLIGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPL 331
E+A+L ++ H N+V L+ ++ ++ +V+E ++ G + + KPL
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV----PTLKPL 134
Query: 332 DWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391
D KG+EYLH IIHRD+K SN+L+ + K++DFG+S + +
Sbjct: 135 SEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 392 THISSVARGTVGYLDPE--------YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+S+ GT ++ PE + G + DV++ GV L + G+ P
Sbjct: 192 ALLSNTV-GTPAFMAPESLSETRKIFSG-----KALDVWAMGVTLYCFVFGQCP 239
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 239 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA-DSCSHRTQQFV-TEVALLSRIHHRNLVP 295
+++GKG+F V K G E A KI+ S R Q + E + ++ H N+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
L +EE LV++ + G L + + ++ + QI + + Y H
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ-QI----LESIAYCH-- 145
Query: 354 CNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410
+ GI+HR++K N+LL K++DFGL+ + + GT GYL PE
Sbjct: 146 -SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTPGYLSPEVL 202
Query: 411 GNQQLTEKSDVYSFGVVLLELISGKKP 437
++ D+++ GV+L L+ G P
Sbjct: 203 KKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 23/213 (10%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMA------DSCSHRTQQFVTEVALLSRIHH 290
+ +++G G F V + K G + A K + + EV++L I H
Sbjct: 14 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 348
N++ L E + IL+ E + G L D L S+ ++ + QI G+
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-QI----LNGVY 128
Query: 349 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 404
YLH + I H D+K NI+L R K+ DFGL+ + + + GT +
Sbjct: 129 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEF 183
Query: 405 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ PE + L ++D++S GV+ L+SG P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 39/214 (18%), Positives = 77/214 (35%), Gaps = 17/214 (7%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMAD---SCSHRTQQFVTEVALLSRIHHRNLV 294
+ + + + D S ++ + +N V
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
+ + + + L+D ++ + + + L I A+ +E+LH
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH--- 181
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR-----------GTVG 403
+ G++HRD+K SNI ++ KV DFGL ++D + + GT
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 404 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
Y+ PE + K D++S G++L EL+
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST 275
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 18/77 (23%), Positives = 31/77 (40%), Gaps = 2/77 (2%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+ +G+G FG V+ K K D A+K I + ++ + EV L+++ H +V
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 299 YCEEEHQRILVYEYMHN 315
E E
Sbjct: 72 AWLETPPEKWQEEMDEI 88
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 56/213 (26%), Positives = 94/213 (44%), Gaps = 23/213 (10%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSRIHH 290
+ +++G G F V + K G E A K + A ++ EV++L ++ H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLE 348
N++ L E +L+ E + G L D L S++++ + QI G+
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QI----LDGVN 129
Query: 349 YLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 404
YLH I H D+K NI+L K+ DFGL+ + E+ GT +
Sbjct: 130 YLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIFGTPEF 184
Query: 405 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ PE + L ++D++S GV+ L+SG P
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 43/207 (20%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFV-TEVALLSRIHHRNLVP 295
+ +G+G FG V+ K K + Q V E+++L+ HRN++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIARHRNILH 65
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRL---HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
L E + ++++E++ + +R+ +N++ + Q+ + L++LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH-QV----CEALQFLH- 119
Query: 353 GCNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410
+ I H D++ NI+ + K+ +FG +RQ + + Y PE +
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRLLFTAPEYYAPEVH 175
Query: 411 GNQQLTEKSDVYSFGVVLLELISGKKP 437
+ ++ +D++S G ++ L+SG P
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 35/217 (16%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA----DSCSHRTQQFVTEVALLSRIHHRNLVP 295
+G+GS+G V + AVKI+ + E+ LL R+ H+N++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 296 L--IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------G 346
L + Y EE+ + +V EY G + SV +K R + A G
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEK------RFPV-CQAHGYFCQLIDG 121
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTV 402
LEYLH + GI+H+D+K N+LL K+S G++ A +D S G+
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ---GSP 175
Query: 403 GYLDPEYYGNQQLTE--KSDVYSFGVVLLELISGKKP 437
+ PE K D++S GV L + +G P
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 2e-25
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 40/216 (18%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+ +G+G++G V + VAVKI+ + E+ + ++H N+V G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLH 351
+ E + + L EY G L DR+ + DA + G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI---EPDIGMP-------EPDAQRFFHQLMAGVVYLH 122
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTVGYLDP 407
GI HRD+K N+LLD K+SDFGL+ E L + GT+ Y+ P
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAP 176
Query: 408 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
E ++ E DV+S G+VL +++G+ P
Sbjct: 177 ELLKRREFHA-----EPVDVWSCGIVLTAMLAGELP 207
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 54/218 (24%), Positives = 90/218 (41%), Gaps = 39/218 (17%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 291
+G G+FG V+ + KEV VK + + + E+A+LSR+ H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGT-LRDRL--HGSVNQKPLDWLTRL---QIAHDAAK 345
N++ ++ E + LV E +G L + H +++ L Q+
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----LASYIFRQLVS---- 141
Query: 346 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 405
+ YL IIHRD+K NI++ + K+ DFG + E + GT+ Y
Sbjct: 142 AVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYC 196
Query: 406 DPE------YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
PE Y G + +++S GV L L+ + P
Sbjct: 197 APEVLMGNPYRG-----PELEMWSLGVTLYTLVFEENP 229
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 36/222 (16%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQ----QFVTEVALLSRI-HHRNLV 294
K++G+G F V K G+E A K + R Q + + E+A+L ++
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFL--KKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GL 347
L E + IL+ EY G + + + ++ +D + G+
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSL----CLPELAEMVSE----NDVIRLIKQILEGV 144
Query: 348 EYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 404
YLH I+H D+K NILL K+ DFG+SR+ GT Y
Sbjct: 145 YYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA--CELREIMGTPEY 199
Query: 405 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 446
L PE +T +D+++ G++ L++ P F E
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTHTSP-----FVGE 236
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 26/208 (12%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLI 297
K IGKG+F V + + G+EVA+KI+ + Q+ EV ++ ++H N+V L
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
E E L+ EY G + D L HG + +K R QI ++Y H
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR-QIVS----AVQYCH---Q 132
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------Y 409
I+HRD+K+ N+LLD +M K++DFG S + G Y PE Y
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPELFQGKKY 190
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKP 437
G + DV+S GV+L L+SG P
Sbjct: 191 DG-----PEVDVWSLGVILYTLVSGSLP 213
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 16/203 (7%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+ +G G FG V+ + G ++A KI+ ++ E+++++++ H NL+ L
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH---DAAKGLEYLHTGCNP 356
E ++ +LV EY+ G L DR+ +++ LT L +G+ ++H
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRI---IDES--YNLTELDTILFMKQICEGIRHMH---QM 206
Query: 357 GIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 414
I+H D+K NIL + K+ DFGL+R+ + V GT +L PE
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--EKLKVNFGTPEFLAPEVVNYDF 264
Query: 415 LTEKSDVYSFGVVLLELISGKKP 437
++ +D++S GV+ L+SG P
Sbjct: 265 VSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 49/209 (23%), Positives = 93/209 (44%), Gaps = 27/209 (12%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 298
+ +G G G V + G++ A+K++ DS R EV + ++V ++
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCILD 89
Query: 299 YCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 351
E H ++ E M G L R+ ++ T + I D +++LH
Sbjct: 90 VYENMHHGKRCLLIIMECMEGGELFSRIQ----ERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 352 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 408
+ I HRDVK N+L + + K++DFG +++ ++ + + T Y+ PE
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPE 199
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
G ++ + D++S GV++ L+ G P
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 23/209 (11%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADS-CSHRTQQFVTEVALLSR-IHHRNLV 294
+ IG GS+ K E AVKI+ S E+ +L R H N++
Sbjct: 25 EVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-----EIEILLRYGQHPNII 79
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
L ++ +V E M G L D++ +++ + I K +EYLH
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLF-TI----TKTVEYLH- 133
Query: 353 GCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 408
G++HRD+K SNIL ++ DFG ++Q + + + T ++ PE
Sbjct: 134 --AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPE 190
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
Q D++S GV+L +++G P
Sbjct: 191 VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 60/216 (27%), Positives = 95/216 (43%), Gaps = 40/216 (18%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+ +G+G++G V + VAVKI+ + E+ + ++H N+V G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------GLEYLH 351
+ E + + L EY G L DR+ + DA + G+ YLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRI---EPDIGMP-------EPDAQRFFHQLMAGVVYLH 122
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS----RQAEEDLTHISSVARGTVGYLDP 407
GI HRD+K N+LLD K+SDFGL+ E L + GT+ Y+ P
Sbjct: 123 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC---GTLPYVAP 176
Query: 408 E------YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
E ++ E DV+S G+VL +++G+ P
Sbjct: 177 ELLKRREFHA-----EPVDVWSCGIVLTAMLAGELP 207
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 38/237 (16%)
Query: 239 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 297
++G+G+ VY K K K A+K++ + + TE+ +L R+ H N++ L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAK-------GLE 348
E + LV E + G L DR+ G +++ DAA +
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSER------------DAADAVKQILEAVA 162
Query: 349 YLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 405
YLH GI+HRD+K N+L + K++DFGLS+ E + + GT GY
Sbjct: 163 YLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGYC 217
Query: 406 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462
PE + D++S G++ L+ G +P E + I +
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF------RRILNCEY 268
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 23/214 (10%), Positives = 58/214 (27%), Gaps = 40/214 (18%)
Query: 242 KIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLVPLI 297
G + ++VA+ + Q+ ++ LSRI + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
++V E++ G+L++ + ++ A + H G
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA---G 149
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
+ S + + I+ ++ +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA-------NP 181
Query: 418 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 451
+ D+ G L L+ + P+ + L
Sbjct: 182 QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE 215
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 296
+G G+FG V G+ G +VAVKI+ + E+ L H +++ L
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
+V EY+ G L D + HG V + L + QI ++Y H
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ-QILS----AVDYCH--- 128
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------ 408
++HRD+K N+LLD +M AK++DFGLS + + G+ Y PE
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRL 186
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
Y G + D++S GV+L L+ G P
Sbjct: 187 YAG-----PEVDIWSCGVILYALLCGTLP 210
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 41/219 (18%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-----DSCSHRTQQFVT-EVALLSRIHHR-- 291
+G G FGSVY G + D VA+K + D V EV LL ++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 292 NLVPLIGYCEEEHQRILVYEYMHN-GTLRDRL--HGSVNQKPLDWLTRL---QIAHDAAK 345
++ L+ + E +L+ E L D + G++ ++ L R Q+
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE----LARSFFWQVLE---- 160
Query: 346 GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGY 404
+ + H N G++HRD+K NIL+D+N K+ DFG ++ + GT Y
Sbjct: 161 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVY 214
Query: 405 LDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
PE Y+G + V+S G++L +++ G P
Sbjct: 215 SPPEWIRYHRYHG-----RSAAVWSLGILLYDMVCGDIP 248
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 34/119 (28%), Positives = 58/119 (48%), Gaps = 6/119 (5%)
Query: 17 NDRGDPCVPVPWEWVTCSTTT-PPRITKIALSGKNLKGE--IPPELKNMEALTELWL-DG 72
D C W V C T T R+ + LSG NL IP L N+ L L++
Sbjct: 28 LPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI 86
Query: 73 NFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
N L GP+P +++L L +++ + ++G++P ++ + L L N+ G +PP++
Sbjct: 87 NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 2e-21
Identities = 28/106 (26%), Positives = 46/106 (43%), Gaps = 1/106 (0%)
Query: 41 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 100
+ + LS L+G+ + + ++ L N L L + +L + L NN + G
Sbjct: 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYG 258
Query: 101 SLPSYMGSLPNLQELHIENNSFVGEIPPAL-LTGKVIFKYDNNPKL 145
+LP + L L L++ N+ GEIP L + Y NN L
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 27/91 (29%), Positives = 40/91 (43%), Gaps = 3/91 (3%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEAL-TELWLDGNFLTGPLP-DMSRLIDLRIVHLENN 96
P + I G + G IP + L T + + N LTG +P + L +L V L N
Sbjct: 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRN 207
Query: 97 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP 127
L G GS N Q++H+ NS ++
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 7/93 (7%)
Query: 42 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD----MSRLIDLRIVHLENNE 97
+ S L G +PP + ++ L + DGN ++G +PD S+L + + N
Sbjct: 128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL--FTSMTISRNR 185
Query: 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
LTG +P +L NL + + N G+
Sbjct: 186 LTGKIPPTFANL-NLAFVDLSRNMLEGDASVLF 217
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 22/88 (25%), Positives = 39/88 (44%), Gaps = 3/88 (3%)
Query: 41 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT 99
KI L+ +L ++ ++ + L L L N + G LP +++L L +++ N L
Sbjct: 223 TQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 100 GSLPSYMGSLPNLQELHIENNSFVGEIP 127
G +P G+L NN + P
Sbjct: 282 GEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-06
Identities = 17/69 (24%), Positives = 27/69 (39%), Gaps = 2/69 (2%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE-NN 96
+ + L + G +P L ++ L L + N L G +P L + N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302
Query: 97 ELTGS-LPS 104
L GS LP+
Sbjct: 303 CLCGSPLPA 311
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 37/218 (16%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 293
F K +G+GSF +V + +E A+KI+ + + E ++SR+ H
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAK------- 345
V L +++ + Y NG L L ++ ++ +
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGEL------------LKYIRKIGSFDETCTRFYTAEIV 140
Query: 346 -GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR----- 399
LEYLH GIIHRD+K NILL+ +M +++DFG ++ + S AR
Sbjct: 141 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE----SKQARANSFV 193
Query: 400 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
GT Y+ PE + + SD+++ G ++ +L++G P
Sbjct: 194 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 59/258 (22%), Positives = 106/258 (41%), Gaps = 52/258 (20%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMA-----DSCSHRTQQFVT-EVALLSRIH---- 289
+GKG FG+V+ G + D +VA+K++ EVALL ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 290 HRNLVPLIGYCEEEHQRILVYEYMHNGT-LRDRL--HGSVNQKPLDWLTRL---QIAHDA 343
H ++ L+ + E + +LV E L D + G + + +R Q+
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG----PSRCFFGQVVA-- 150
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTHISSVARGTV 402
+++ H + G++HRD+K NIL+D+ AK+ DFG ++ GT
Sbjct: 151 --AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTR 202
Query: 403 GYLDPE------YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED--FGAELNIVHW-- 452
Y PE Y+ + V+S G++L +++ G P + AEL+
Sbjct: 203 VYSPPEWISRHQYHA-----LPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVS 257
Query: 453 --ARSMIKKGDVISIVDP 468
++I++ P
Sbjct: 258 PDCCALIRR---CLAPKP 272
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 26/209 (12%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 298
+ +G G G V K ++ A+K++ D R EV L R ++V ++
Sbjct: 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVD 122
Query: 299 YCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEYLH 351
E + +V E + G L R+ + T + I + ++YLH
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 352 TGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 408
+ I HRDVK N+L N K++DFG +++ + + T Y+ PE
Sbjct: 179 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPE 233
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
G ++ + D++S GV++ L+ G P
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 31/211 (14%)
Query: 240 CKKIGKGSFGSVYYGKMKDGKEVAVK-IMADSC-SHRTQQFVTEVALLSRIHHRNLVPLI 297
CK IG GSFG V+ K+ + EVA+K ++ D +R E+ ++ + H N+V L
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR------ELQIMRIVKHPNVVDLK 98
Query: 298 ------GYCEEEHQRILVYEYMHNGTLRD--RLHGSVNQKPLDWLTRL---QIAHDAAKG 346
G ++E LV EY+ T+ R + + Q L +L Q+ +
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQL----LRS 153
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGYL 405
L Y+H+ GI HRD+K N+LLD K+ DFG ++ ++S + + Y
Sbjct: 154 LAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYR 208
Query: 406 DPE-YYGNQQLTEKSDVYSFGVVLLELISGK 435
PE +G T D++S G V+ EL+ G+
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 61/212 (28%), Positives = 89/212 (41%), Gaps = 18/212 (8%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQ--QFVTEVALLSRIHHRNL 293
K IG+G+F V KMK +V A+KIM R + F E +L R +
Sbjct: 64 EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 294 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
L + ++ + LV EY G L L + P + R +A + ++ +H
Sbjct: 124 TQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFYLA-EIVMAIDSVH- 179
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
G +HRD+K NILLD +++DFG + D T S VA GT YL PE
Sbjct: 180 --RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 413 QQLTEKSDVY-------SFGVVLLELISGKKP 437
+ Y + GV E+ G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-23
Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVT--EVALLSRIHHRNL 293
+ +GKG FG V +++ ++ A K + R + + E +L +++ R +
Sbjct: 187 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV 246
Query: 294 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
V L Y E + LV M+ G L+ ++ + A GLE LH
Sbjct: 247 VSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLH- 303
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
I++RD+K NILLD + ++SD GL+ E T V GTVGY+ PE N
Sbjct: 304 --RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKN 359
Query: 413 QQLTEKSDVYSFGVVLLELISGKKPVSVED 442
++ T D ++ G +L E+I+G+ P
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIHHRNL 293
+ IGKGSFG V + D K++ A+K M C R + E+ ++ + H L
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77
Query: 294 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
V L Y ++ + + +V + + G LR L N + +L I + L+YL
Sbjct: 78 VNLW-YSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFIC-ELVMALDYLQ- 132
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
N IIHRD+K NILLD + ++DF ++ + +++A GT Y+ PE + +
Sbjct: 133 --NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI-TTMA-GTKPYMAPEMFSS 188
Query: 413 QQLTEKS---DVYSFGVVLLELISGKKP 437
++ S D +S GV EL+ G++P
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 61/239 (25%), Positives = 106/239 (44%), Gaps = 29/239 (12%)
Query: 215 GGHFMDEGVAYFIPLPELEEATN-NFCKKIGKGSFGSVYYGKMKD-GKEVAVK-IMAD-S 270
G M A +E + G+G+FG+V GK K G VA+K ++ D
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 271 CSHRTQQFVTEVALLSRIHHRNLVPLIGY----CEEEHQRI---LVYEYMHNGTLRD--R 321
+R Q + L+ +HH N+V L Y E + + I +V EY+ TL R
Sbjct: 62 FRNRELQ---IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCR 117
Query: 322 LHGSVNQKPLDWLTRL---QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAK 377
+ P L ++ Q+ + + LH + HRD+K N+L++ + K
Sbjct: 118 NYYRRQVAPPPILIKVFLFQLI----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLK 172
Query: 378 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 435
+ DFG +++ +++ + + Y PE +GNQ T D++S G + E++ G+
Sbjct: 173 LCDFGSAKKLSPSEPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVT--EVALLSRIHHRNL 293
+ +G+G FG V+ +MK ++ A K + R E +L+++H R +
Sbjct: 188 LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI 247
Query: 294 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-AHDAAKGLEYLH 351
V L Y E + LV M+ G +R ++ P R GLE+LH
Sbjct: 248 VSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 411
II+RD+K N+LLD + ++SD GL+ + + T A GT G++ PE
Sbjct: 307 ---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLL 362
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKP 437
++ D ++ GV L E+I+ + P
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 27/208 (12%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
K IG G+FG + + VAVK + + + + E+ + H N+V
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 300 CEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
++ EY G L +R+ G ++ + + Q+ G+ Y H +
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ-QLLS----GVSYCH---SMQ 136
Query: 358 IIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------Y 409
I HRD+K N LLD + R K+ DFG S+ + S+V GT Y+ PE Y
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLLRQEY 194
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKP 437
G + +DV+S GV L ++ G P
Sbjct: 195 DG-----KIADVWSCGVTLYVMLVGAYP 217
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 32/212 (15%)
Query: 240 CKKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSC-SHRTQQFVTEVALLSRIHHRNLVPL 296
K IG GSFG VY K+ D G+ VA+K ++ D +R E+ ++ ++ H N+V L
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRL 112
Query: 297 IGYCEEEHQRI------LVYEYMHNGTLRD--RLHGSVNQKPLDWLTRL---QIAHDAAK 345
+ ++ LV +Y+ T+ R + Q +L Q+ +
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF----R 167
Query: 346 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGY 404
L Y+H+ GI HRD+K N+LLD + K+ DFG ++Q ++S + + Y
Sbjct: 168 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYY 222
Query: 405 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 435
PE +G T DV+S G VL EL+ G+
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-22
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 296
+ +G+GSFG V K ++VA+K ++ S + E++ L + H +++ L
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
++V EY G L D + + + + QI +EY H
Sbjct: 75 YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQ-QIIC----AIEYCH--- 125
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------ 408
I+HRD+K N+LLD N+ K++DFGLS + + + G+ Y PE
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPEVINGKL 183
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
Y G + DV+S G+VL ++ G+ P
Sbjct: 184 YAG-----PEVDVWSCGIVLYVMLVGRLP 207
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 4e-22
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPL 296
+G G+FG V GK G +VAVKI+ + E+ L H +++ L
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
+V EY+ G L D + +G +++K L + QI G++Y H
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQ-QILS----GVDYCH--- 133
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE------ 408
++HRD+K N+LLD +M AK++DFGLS + + G+ Y PE
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPEVISGRL 191
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKP 437
Y G + D++S GV+L L+ G P
Sbjct: 192 YAG-----PEVDIWSSGVILYALLCGTLP 215
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIM--ADSCSHR-TQQFVTEVALLSRIHHRNL 293
K IG+G+FG V K+K+ +V A+KI+ + T F E +L + +
Sbjct: 77 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI 136
Query: 294 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
L Y ++ + LV +Y G L L ++ P + R +A + ++ +H
Sbjct: 137 TTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM-ARFYLA-EMVIAIDSVH- 192
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
+HRD+K NIL+D+N +++DFG + ED T SSVA GT Y+ PE
Sbjct: 193 --QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 413 QQLTEKS-----DVYSFGVVLLELISGKKP 437
+ + D +S GV + E++ G+ P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 50/214 (23%), Positives = 96/214 (44%), Gaps = 41/214 (19%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 297
+G G++GSV + G++VA+K ++ ++ E+ LL + H N++ L+
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 298 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRL---QIAHDAAKGLE 348
LV +M D L + K + + Q+ KGL+
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQT----D-LQKIMGLKFSEEKIQYLVYQML----KGLK 140
Query: 349 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE 408
Y+H+ G++HRD+K N+ ++ + K+ DFGL+R A+ ++T GY+
Sbjct: 141 YIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT----------GYVVTR 187
Query: 409 YY-------GNQQLTEKSDVYSFGVVLLELISGK 435
+Y + D++S G ++ E+++GK
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 2e-21
Identities = 64/268 (23%), Positives = 109/268 (40%), Gaps = 37/268 (13%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 297
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 298 ------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
EE LV E M + L V Q LD + + G+++LH
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELMDA----N-LC-QVIQMELDHERMSYLLYQMLCGIKHLH 181
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 411
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 182 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 236
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471
E D++S G ++ E++ K D+ + N +++ +
Sbjct: 237 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK---------------VIE--QL 279
Query: 472 GNVKIESIWRIAEVAIQCVEQRGFSRPK 499
G E + ++ VE R
Sbjct: 280 GTPCPEFMKKLQPTVRNYVENRPKYAGL 307
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-21
Identities = 41/107 (38%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 25 PVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MS 83
+P + S ++ + L L+GEIP EL ++ L L LD N LTG +P +S
Sbjct: 433 TIPSSLGSLS-----KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487
Query: 84 RLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+L + L NN LTG +P ++G L NL L + NNSF G IP L
Sbjct: 488 NCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAEL 534
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 7e-21
Identities = 39/150 (26%), Positives = 64/150 (42%), Gaps = 14/150 (9%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 97
+ + L +L GEIP L N L + L N LTG +P + RL +L I+ L NN
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL-----------LTGKVIFKYDNNPKLH 146
+G++P+ +G +L L + N F G IP A+ + GK N+
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKK 585
Query: 147 K--ESRRRMRFKLILGTSIGVLAILLVLFL 174
+ + + F+ I + L+ +
Sbjct: 586 ECHGAGNLLEFQGIRSEQLNRLSTRNPCNI 615
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-20
Identities = 26/119 (21%), Positives = 50/119 (42%), Gaps = 5/119 (4%)
Query: 25 PVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSR 84
WV + +A+SG + G++ + L L + N + +P +
Sbjct: 166 ANVVGWVLSDGCG--ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGD 221
Query: 85 LIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG-KVIFKYDNN 142
L+ + + N+L+G + + L+ L+I +N FVG IPP L + + +N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENK 280
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-20
Identities = 30/96 (31%), Positives = 45/96 (46%), Gaps = 1/96 (1%)
Query: 36 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLE 94
+ ++ L G+IPP L N L L L N+L+G +P + L LR + L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 95 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
N L G +P + + L+ L ++ N GEIP L
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGL 486
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 9e-19
Identities = 30/95 (31%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 96
+T + LSG + G +PP + L L L N +G LP + ++ L+++ L N
Sbjct: 294 DTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN 353
Query: 97 ELTGSLPSYMGSL-PNLQELHIENNSFVGEIPPAL 130
E +G LP + +L +L L + +N+F G I P L
Sbjct: 354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-18
Identities = 35/96 (36%), Positives = 49/96 (51%), Gaps = 3/96 (3%)
Query: 38 PPRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLE 94
+ + LS N G I P L L EL+L N TG +P +S +L +HL
Sbjct: 367 SASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLS 426
Query: 95 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
N L+G++PS +GSL L++L + N GEIP L
Sbjct: 427 FNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQEL 462
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-18
Identities = 26/120 (21%), Positives = 49/120 (40%), Gaps = 11/120 (9%)
Query: 17 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLK---GEIPPELKNMEALTELWLDGN 73
+ +PC ++ VTC ++T I LS K L + L ++ L L+L +
Sbjct: 34 SSNKNPCT---FDGVTCRDD---KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNS 87
Query: 74 FLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM--GSLPNLQELHIENNSFVGEIPPALL 131
+ G + L + L N L+G + + GS L+ L++ +N+ +
Sbjct: 88 HINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGG 147
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 7e-18
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 4/95 (4%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 96
+ + +S G IPP +++L L L N TG +PD L + L N
Sbjct: 247 TELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGN 304
Query: 97 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL 131
G++P + GS L+ L + +N+F GE+P L
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTL 339
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-17
Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 3/95 (3%)
Query: 39 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN 96
+ ++L+ GEIP L + LT L L GN G +P L + L +N
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSN 328
Query: 97 ELTGSLP-SYMGSLPNLQELHIENNSFVGEIPPAL 130
+G LP + + L+ L + N F GE+P +L
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESL 363
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 9e-17
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 95
+ +ALS N GE+P + L M L L L N +G LP+ + L + L +
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSS 377
Query: 96 NELTGSLPSYMG--SLPNLQELHIENNSFVGEIPPAL 130
N +G + + LQEL+++NN F G+IPP L
Sbjct: 378 NNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-16
Identities = 31/133 (23%), Positives = 56/133 (42%), Gaps = 26/133 (19%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 97
++ + G P N ++ L + N L+G +P + + L I++L +N+
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHND 667
Query: 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL---------------LTGKV----IFK 138
++GS+P +G L L L + +N G IP A+ L+G + F+
Sbjct: 668 ISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFE 727
Query: 139 ------YDNNPKL 145
+ NNP L
Sbjct: 728 TFPPAKFLNNPGL 740
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-15
Identities = 20/101 (19%), Positives = 37/101 (36%), Gaps = 7/101 (6%)
Query: 39 PRITKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTG--PLPDMSRLIDLRIVHLE 94
+T + LS +L G + L + L L + N L + +L L ++ L
Sbjct: 100 ASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLS 159
Query: 95 NNELTGSLPS---YMGSLPNLQELHIENNSFVGEIPPALLT 132
N ++G+ L+ L I N G++ +
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCV 200
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-14
Identities = 17/88 (19%), Positives = 33/88 (37%), Gaps = 1/88 (1%)
Query: 44 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSL 102
A + +G +L + + G + + + N L+G +
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648
Query: 103 PSYMGSLPNLQELHIENNSFVGEIPPAL 130
P +GS+P L L++ +N G IP +
Sbjct: 649 PKEIGSMPYLFILNLGHNDISGSIPDEV 676
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-13
Identities = 15/89 (16%), Positives = 30/89 (33%), Gaps = 3/89 (3%)
Query: 45 ALSGKNLKGEIPPELKNMEALTELWLDGNF--LTGPLP-DMSRLIDLRIVHLENNELTGS 101
++ + G+ +KN E GN G ++RL ++ + G
Sbjct: 564 KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGH 623
Query: 102 LPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+ ++ L + N G IP +
Sbjct: 624 TSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 4e-21
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIH---H 290
+ + IG+G FG VY + D ++ A+K + + + + E +LS +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 291 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRL--HGSVNQKPLDWLTRLQIAHDAAKGL 347
+V + Y ++ + + M+ G L L HG ++ R A + GL
Sbjct: 252 PFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAA-EIILGL 305
Query: 348 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 407
E++H N +++RD+K +NILLD + ++SD GL+ + H +SV GT GY+ P
Sbjct: 306 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-ASV--GTHGYMAP 359
Query: 408 EYYGNQQLTEKS-DVYSFGVVLLELISGKKP 437
E + S D +S G +L +L+ G P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-21
Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 37/268 (13%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 297
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 298 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
EE Q + +V E M + L V Q LD + + G+++LH
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELMDA----N-LC-QVIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 411
+ GIIHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 145 SA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVIL 199
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471
E D++S G ++ E+I G D + N +++ +
Sbjct: 200 GMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK---------------VIE--QL 242
Query: 472 GNVKIESIWRIAEVAIQCVEQRGFSRPK 499
G E + ++ VE R
Sbjct: 243 GTPCPEFMKKLQPTVRTYVENRPKYAGY 270
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 34/211 (16%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 297
+G G++GSV K G VAVK ++ ++ E+ LL + H N++ L+
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 298 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
EE + LV M G D L+ V + L + + +GL+Y+H
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLM--GA--D-LNNIVKCQKLTDDHVQFLIYQILRGLKYIH 149
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY- 410
+ IIHRD+K SN+ ++ + K+ DFGL+R +++T GY+ +Y
Sbjct: 150 SA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT----------GYVATRWYR 196
Query: 411 ------GNQQLTEKSDVYSFGVVLLELISGK 435
+ D++S G ++ EL++G+
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 6e-21
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 31/216 (14%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQ---FVTEVALLSRIHHRNL 293
K IG+G+FG V + K ++V A+K+++ + F E +++ + +
Sbjct: 72 EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV 131
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK-------- 345
V L +++ +V EYM G L ++ ++ + A+
Sbjct: 132 VQLFYAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPEKWARFYTAEVVL 179
Query: 346 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYL 405
L+ +H + G IHRDVK N+LLD + K++DFG + ++ A GT Y+
Sbjct: 180 ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 406 DPE---YYGNQQLTEKS-DVYSFGVVLLELISGKKP 437
PE G + D +S GV L E++ G P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 8e-21
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 22/205 (10%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 297
+ +G G++G+V + G +VA+K + ++ E+ LL + H N++ L+
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 298 -----GYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
++ LV +M D L + + L + + KGL Y+H
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFMGT----D-LGKLMKHEKLGEDRIQFLVYQMLKGLRYIH 145
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-Y 410
GIIHRD+K N+ ++ + K+ DFGL+RQA+ ++T V T Y PE
Sbjct: 146 AA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG--YVV--TRWYRAPEVIL 198
Query: 411 GNQQLTEKSDVYSFGVVLLELISGK 435
+ T+ D++S G ++ E+I+GK
Sbjct: 199 NWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 55/215 (25%), Positives = 89/215 (41%), Gaps = 31/215 (14%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT-----------EVALLSRIH 289
+ I GS+G+V G +G VA+K + ++ S + E+ LL+ H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 290 HRNLVPL----IGYCEEEHQRI-LVYEYMHNGTLRDRLHG--SVNQKPLDWLTRLQ-IAH 341
H N++ L + + E ++ LV E M D L + + +Q +
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT----D-LAQVIHDQRIVIS-PQHIQYFMY 141
Query: 342 DAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 401
GL LH G++HRD+ NILL N + DF L+R+ D V
Sbjct: 142 HILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--H 196
Query: 402 VGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 435
Y PE + T+ D++S G V+ E+ + K
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 12/210 (5%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHR--TQQFVTEVALLSRIHHRNL 293
+ K +GKG+FG V K K A+KI+ + + +TE +L H L
Sbjct: 151 EYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL 210
Query: 294 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
L Y + H R+ V EY + G L H S + + R A + L+YLH+
Sbjct: 211 TALK-YSFQTHDRLCFVMEYANGGELF--FHLSRERVFSEDRARFYGA-EIVSALDYLHS 266
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
+++RD+K N++LD + K++DFGL ++ +D + + GT YL PE +
Sbjct: 267 --EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLED 323
Query: 413 QQLTEKSDVYSFGVVLLELISGKKPVSVED 442
D + GVV+ E++ G+ P +D
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL-- 296
+K+G+G + V+ + + ++V VKI+ + ++ E+ +L + N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---EIKILENLRGGPNIITLAD 98
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA---HDAAKGLEYLHTG 353
I LV+E+++N + + LT I ++ K L+Y H+
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFK---------QLYQTLTDYDIRFYMYEILKALDYCHSM 149
Query: 354 CNPGIIHRDVKSSNILLDINMRA-KVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
GI+HRDVK N+++D R ++ D+GL+ + VA + + PE +
Sbjct: 150 ---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVD 204
Query: 413 QQLTEKS-DVYSFGVVLLELISGKKP 437
Q+ + S D++S G +L +I K+P
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 4e-19
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQF-----VT---EVALLSRIHHRN 292
+K+G+G++G VY K G+ VA+K + R T E++LL +HH N
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRI------RLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 293 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKG 346
+V LI E LV+E+M D L +++ Q+ +G
Sbjct: 81 IVSLIDVIHSERCLTLVFEFMEK----D-LKKVLDENKTGLQDSQIKIYLYQLL----RG 131
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 403
+ + H I+HRD+K N+L++ + K++DFGL+R TH V T+
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE--VV--TLW 184
Query: 404 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 435
Y P+ G+++ + D++S G + E+I+GK
Sbjct: 185 YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 242 KIGKGSFGSVYYGKMKD-GKEVAVKIM-------ADSCSHRTQQFVTEVALLSRIHHRNL 293
K+G G++ +VY G K G VA+K + S + R E++L+ + H N+
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR------EISLMKELKHENI 65
Query: 294 VPLIGYCEEEHQRILVYEYMHN--GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
V L E++ LV+E+M N D + L+ +GL + H
Sbjct: 66 VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 408
I+HRD+K N+L++ + K+ DFGL+R + V T+ Y P+
Sbjct: 126 EN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE--VV--TLWYRAPD 178
Query: 409 Y-YGNQQLTEKSDVYSFGVVLLELISGK 435
G++ + D++S G +L E+I+GK
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 87.7 bits (217), Expect = 5e-19
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 71/270 (26%)
Query: 239 FCKKIGKGSFGSVYYG------KMKDGKEVAVKIMADSCSHR-TQQFVTEVALLSRI-HH 290
K +G+G+FG V K + VAVK++ + +H + ++E+ +L I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 291 RNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQ--------------------- 328
N+V L+G C + +++ E+ G L L N+
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 329 -----KPLDWLTRLQIAHDAA----KGLEYLHTGCNPGIIHRDVKSSNILLDI------- 372
+ LD +T Q + + K L + P +++D + L+
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 373 -----------------------NMRAKVSDFGLSRQAEEDLTHI-SSVARGTVGYLDPE 408
K+ DFGL+R +D ++ AR + ++ PE
Sbjct: 206 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 409 YYGNQQLTEKSDVYSFGVVLLELIS-GKKP 437
++ T +SDV+SFGV+L E+ S G P
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 47/211 (22%), Positives = 80/211 (37%), Gaps = 47/211 (22%)
Query: 239 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL 296
+ +G G G V K ++ A+K++ D R EV L R ++V +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRI 76
Query: 297 IGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ---IAHDAAKGLEY 349
+ E + +V E + G L R+ + T + I + ++Y
Sbjct: 77 VDVYENLYAGRKCLLIVMECLDGGELFSRIQ----DRGDQAFTEREASEIMKSIGEAIQY 132
Query: 350 LHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLD 406
LH + I HRDVK N+L N K++DFG +++
Sbjct: 133 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE------------------TT 171
Query: 407 PEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
E Y + D++S GV++ L+ G P
Sbjct: 172 GEKYD-----KSCDMWSLGVIMYILLCGYPP 197
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 29/208 (13%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 291
KIG+GS+G V+ + +D G+ VA+K + R E+ +L ++ H
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR------EIRMLKQLKHP 62
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
NLV L+ + + LV+EY + T+ L Q+ + I + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 408
IHRDVK NIL+ + K+ DFG +R + VA T Y PE
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD--EVA--TRWYRSPE 172
Query: 409 Y-YGNQQLTEKSDVYSFGVVLLELISGK 435
G+ Q DV++ G V EL+SG
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 50/243 (20%), Positives = 91/243 (37%), Gaps = 62/243 (25%)
Query: 240 CKKIGKGSFGSVYYGKMKD-GKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPL- 296
K +G GSFG V + GK A+K ++ D + E+ ++ + H N++ L
Sbjct: 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNR---ELDIMKVLDHVNIIKLV 66
Query: 297 -IGYCEEEHQRI------------------------------------LVYEYMHNGTLR 319
Y + + ++ EY+ TL
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLH 125
Query: 320 D--RLHGSVNQKPLDWLTRL---QIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 374
+ + L + Q+ + + ++H+ GI HRD+K N+L++
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLF----RAVGFIHSL---GICHRDIKPQNLLVNSKD 178
Query: 375 -RAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE-YYGNQQLTEKSDVYSFGVVLLELI 432
K+ DFG +++ ++ + + Y PE G + T D++S G V ELI
Sbjct: 179 NTLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 433 SGK 435
GK
Sbjct: 237 LGK 239
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 31/216 (14%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI-- 297
K +G G G V+ K VA+K + + + + E+ ++ R+ H N+V +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 298 ------------GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 345
G E + +V EYM T D L + Q PL + +
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYM--ET--D-LANVLEQGPLLEEHARLFMYQLLR 131
Query: 346 GLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISS----VARG 400
GL+Y+H+ ++HRD+K +N+ ++ ++ K+ DFGL+R + +H +
Sbjct: 132 GLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-- 186
Query: 401 TVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGK 435
T Y P + T+ D+++ G + E+++GK
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 3e-18
Identities = 51/212 (24%), Positives = 97/212 (45%), Gaps = 40/212 (18%)
Query: 242 KIGKGSFGSVYYGKMKDGKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHRNL 293
KIG+G++G VY + G+ A+K + S + R E+++L + H N+
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR------EISILKELKHSNI 62
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKGL 347
V L + + +LV+E++ D L ++ + LQ+ G+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQ----D-LKKLLDVCEGGLESVTAKSFLLQLL----NGI 113
Query: 348 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGY 404
Y H ++HRD+K N+L++ K++DFGL+R TH + T+ Y
Sbjct: 114 AYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IV--TLWY 166
Query: 405 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 435
P+ G+++ + D++S G + E+++G
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHR 291
+G+GS+G V + KD G+ VA+K + R E+ LL ++ H
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR------EIKLLKQLRHE 84
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
NLV L+ C+++ + LV+E++ + T+ D L + LD+ + G+ + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLDPE 408
+ IIHRD+K NIL+ + K+ DFG +R E VA T Y PE
Sbjct: 142 SH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VA--TRWYRAPE 194
Query: 409 Y-YGNQQLTEKSDVYSFGVVLLELISGK 435
G+ + + DV++ G ++ E+ G+
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 4e-18
Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 41/215 (19%)
Query: 242 KIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQF-----VT---EVALLSRIHHRN 292
KIG+G++G+V+ K ++ + VA+K + R + E+ LL + H+N
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKHKN 62
Query: 293 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKG 346
+V L + + LV+E+ D L + D Q+ KG
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ----D-LKKYFDSCNGDLDPEIVKSFLFQLL----KG 113
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 403
L + H+ ++HRD+K N+L++ N K+++FGL+R + V T+
Sbjct: 114 LGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA--EVV--TLW 166
Query: 404 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGKKP 437
Y P+ +G + + D++S G + EL + +P
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 50/217 (23%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLI- 297
+G+G++G V G+ VA+K I + + E+ +L H N++ +
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76
Query: 298 ----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLE 348
E ++ ++ E M T D LH ++ + L + Q + ++
Sbjct: 77 IQRPDSFENFNEVYIIQELM--QT--D-LHRVISTQMLSDDHIQYFIY-QTL----RAVK 126
Query: 349 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTV---GYL 405
LH +IHRD+K SN+L++ N KV DFGL+R +E S ++
Sbjct: 127 VLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 406 DPEYY-------GNQQLTEKSDVYSFGVVLLELISGK 435
+Y + + + DV+S G +L EL +
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 28/210 (13%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMA-DSCSH--RTQQFVTEVALLSRIHHRNLVP 295
IG+G++G V + VA+K I + ++ RT + E+ +L R H N++
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT---LREIKILLRFRHENIIG 89
Query: 296 LI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
+ E+ +V + M T D L+ + + L + +GL+Y+
Sbjct: 90 INDIIRAPTIEQMKDVYIVQDLM--ET--D-LYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS----VARGTVGYLD 406
H+ ++HRD+K SN+LL+ K+ DFGL+R A+ D H VA T Y
Sbjct: 145 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA--TRWYRA 199
Query: 407 PEYYGN-QQLTEKSDVYSFGVVLLELISGK 435
PE N + T+ D++S G +L E++S +
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQF--VTEVALLSRIHHRNL 293
++ K +GKG+FG V + K A+KI+ + + + VTE +L H L
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 294 VPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK--- 345
L Y + H R+ V EY + G L L + A+
Sbjct: 68 TALK-YAFQTHDRLCFVMEYANGGEL---------------FFHLSRERVFTEERARFYG 111
Query: 346 -----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR- 399
LEYLH + +++RD+K N++LD + K++DFGL + E ++ + +
Sbjct: 112 AEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISD-GATMKT 164
Query: 400 --GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
GT YL PE + D + GVV+ E++ G+ P +D
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 7e-18
Identities = 63/227 (27%), Positives = 106/227 (46%), Gaps = 45/227 (19%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIH-HRNLVPL 296
KK+GKG++G V+ + G+ VAVK + D+ + T Q+ E+ +L+ + H N+V L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 297 --IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLD-----WLTRLQIAHDAAKGLEY 349
+ + + LV++YM T D LH + L+ ++ Q+ K ++Y
Sbjct: 75 LNVLRADNDRDVYLVFDYM--ET--D-LHAVIRANILEPVHKQYVVY-QLI----KVIKY 124
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
LH+G G++HRD+K SNILL+ KV+DFGLSR +++ +
Sbjct: 125 LHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 410 YGNQQLTE---------------------KSDVYSFGVVLLELISGK 435
LT+ D++S G +L E++ GK
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 7e-18
Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 293
+ +G GSFG V+ + + A+K++ R +Q E +LS + H +
Sbjct: 9 QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 68
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK---- 345
+ + G ++ Q ++ +Y+ G L + L+ + AK
Sbjct: 69 IRMWGTFQDAQQIFMIMDYIEGGEL---------------FSLLRKSQRFPNPVAKFYAA 113
Query: 346 ----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 401
LEYLH + II+RD+K NILLD N K++DFG ++ D+T+ GT
Sbjct: 114 EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY-VPDVTY---TLCGT 166
Query: 402 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
Y+ PE + + D +SFG+++ E+++G P
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 51/216 (23%), Positives = 91/216 (42%), Gaps = 38/216 (17%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMADSCSHRTQQF---VTEVALLSRIHHRNL 293
+ K +G GSFG V K K+ A+KI+ + +Q + E +L ++ L
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK---- 345
V L ++ +V EY+ G + + L+ A+
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEM---------------FSHLRRIGRFSEPHARFYAA 148
Query: 346 ----GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGT 401
EYLH + +I+RD+K N+L+D +V+DFG +++ + T GT
Sbjct: 149 QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRTW---TLCGT 201
Query: 402 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
L PE ++ + D ++ GV++ E+ +G P
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 27/212 (12%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 298
+KIG GSFG +Y G + G+EVA+K+ H Q E + + +P +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 72
Query: 299 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
E ++V E + G L + + K T L +A +EY+H
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLK-----TVLLLADQMISRIEYIH--- 122
Query: 355 NPGIIHRDVKSSNILLDINMRAK---VSDFGLSRQ--AEEDLTHISSVA----RGTVGYL 405
+ IHRDVK N L+ + + + DFGL+++ HI GT Y
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 406 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ + + + D+ S G VL+ G P
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 1e-17
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 242 KIGKGSFGSVYYGKMKD---GKEVAVK-IMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 297
K+G+G++G VY K KD K+ A+K I S E+ALL + H N++ L
Sbjct: 28 KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA---CREIALLRELKHPNVISLQ 84
Query: 298 GYCEEEHQRI--LVYEYMHN--GTLRDRLHGSVNQKPLDWLTRLQI---AHDAAKGLEYL 350
R L+++Y + + S K L R + + G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 351 HTGCNPGIIHRDVKSSNILLDI----NMRAKVSDFGLSRQ---AEEDLTHISSVARGTVG 403
H ++HRD+K +NIL+ R K++D G +R + L + V T
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200
Query: 404 YLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 435
Y PE G + T+ D+++ G + EL++ +
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 55/226 (24%), Positives = 97/226 (42%), Gaps = 55/226 (24%)
Query: 242 KIGKGSFGSVYYGKMKD-GKEVAVK------------IMADSCSHRTQQFVTEVALLSRI 288
KIG+G+FG V+ + + G++VA+K I A + E+ +L +
Sbjct: 24 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA----------LREIKILQLL 73
Query: 289 HHRNLVPLIGYCEEEHQRI--------LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 340
H N+V LI C + LV+++ + D L G ++ + T +I
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH----D-LAGLLSNVLVK-FTLSEIK 127
Query: 341 HDAA---KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR-------QAEED 390
GL Y+H I+HRD+K++N+L+ + K++DFGL+R
Sbjct: 128 RVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 391 LTHISSVARGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 435
T+ V T+ Y PE G + D++ G ++ E+ +
Sbjct: 185 YTNR--VV--TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 39/224 (17%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIM--ADSCSHRTQQFVTEVALLSRIHHR 291
K +G+GSFG V+ K G + A+K++ A + E +L ++H
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHP 86
Query: 292 NLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK- 345
+V L Y + ++ L+ +++ G L TRL + K
Sbjct: 87 FIVKLH-YAFQTEGKLYLILDFLRGGDL---------------FTRLSKEVMFTEEDVKF 130
Query: 346 -------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 398
L++LH + GII+RD+K NILLD K++DFGLS+++ + S
Sbjct: 131 YLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC 187
Query: 399 RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
GTV Y+ PE + T+ +D +SFGV++ E+++G P +D
Sbjct: 188 -GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 4e-17
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 38/214 (17%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQF-VT---EVALLSRIHHRNLV 294
+G+G F +VY + + VA+K I S T E+ LL + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 295 PLIGYCEEEHQRILVYEYMHN---GTLRDRLHGSVNQKPLD------WLTRLQIAHDAAK 345
L+ + LV+++M ++D N L ++ L +
Sbjct: 76 GLLDAFGHKSNISLVFDFMETDLEVIIKD------NSLVLTPSHIKAYM--LMTL----Q 123
Query: 346 GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTV 402
GLEYLH I+HRD+K +N+LLD N K++DFGL++ TH V T
Sbjct: 124 GLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ--VV--TR 176
Query: 403 GYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 435
Y PE +G + D+++ G +L EL+
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 4e-17
Identities = 52/243 (21%), Positives = 87/243 (35%), Gaps = 55/243 (22%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 297
IG+GS+G VY K VA+K + ++ + E+ +L+R+ ++ L
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 298 GYCEEEHQRI-----LVYEYMHNGTLRDRLHGSV--NQKPLDWLTRL-------QIAHDA 343
+ +V E + D L LT +
Sbjct: 92 DLIIPDDLLKFDELYIVLEIA--DS--D-LKKLFKTPIF----LTEEHIKTILYNLL--- 139
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THISSVARGTV 402
G ++H GIIHRD+K +N LL+ + KV DFGL+R + T+I +
Sbjct: 140 -LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 403 GYLDPEYYGNQQLTE--------------------KS-DVYSFGVVLLELISGKKPVSVE 441
+QLT KS D++S G + EL++ + +
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 442 DFG 444
Sbjct: 256 PTN 258
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 6e-17
Identities = 52/228 (22%), Positives = 97/228 (42%), Gaps = 45/228 (19%)
Query: 238 NFCKKIGKGSFGSVY---YGKMKDGKEV-AVKIMA-DSCSHRTQQFV---TEVALLSRIH 289
+ +GKG +G V+ + ++ A+K++ + E +L +
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 290 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAA 344
H +V LI Y + ++ L+ EY+ G L +L+ D A
Sbjct: 80 HPFIVDLI-YAFQTGGKLYLILEYLSGGEL---------------FMQLEREGIFMEDTA 123
Query: 345 K--------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA--EEDLTHI 394
L +LH GII+RD+K NI+L+ K++DFGL +++ + +TH
Sbjct: 124 CFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH- 179
Query: 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
+ GT+ Y+ PE D +S G ++ ++++G P + E+
Sbjct: 180 -TFC-GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 7e-17
Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 33/197 (16%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 297
IG GS+G V + + VA+K + ++ + E+A+L+R++H ++V ++
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 298 -----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH------DAAKG 346
E+ + +V E D K L H + G
Sbjct: 119 DIVIPKDVEKFDELYVVLEIAD----SD-FK-----KLFRTPVYLTELHIKTLLYNLLVG 168
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARG------ 400
++Y+H+ GI+HRD+K +N L++ + KV DFGL+R + S +
Sbjct: 169 VKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 401 TVGYLDPEYYGNQQLTE 417
+ +QLT
Sbjct: 226 NLVTFPHTKNLKRQLTG 242
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 61/226 (26%), Positives = 93/226 (41%), Gaps = 44/226 (19%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 292
+F K IGKGSFG V + K + AVK++ + + ++ LL + H
Sbjct: 41 HFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 293 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DAAK-- 345
LV L + + ++ V +Y++ G L LQ A+
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGEL---------------FYHLQRERCFLEPRARFY 144
Query: 346 ------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 399
L YLH + I++RD+K NILLD ++DFGL + E++ H +S
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEH-NSTTS 197
Query: 400 ---GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
GT YL PE Q D + G VL E++ G P +
Sbjct: 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 38/157 (24%), Positives = 63/157 (40%), Gaps = 23/157 (14%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 298
KKIG G+FG + GK + + VA+K+ Q E ++ + +P +
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYY 72
Query: 299 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
+ +V E + G L D + + K T L IA +EY+H
Sbjct: 73 FGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLK-----TVLMIAIQLISRMEYVH--- 122
Query: 355 NPGIIHRDVKSSNILLDINMRAKVS-----DFGLSRQ 386
+ +I+RDVK N L+ DF L+++
Sbjct: 123 SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 36/216 (16%)
Query: 237 NNFCK--KIGKGSFGSVYYGK-MKDGKEVAVKIM-------ADSCSHRTQQFVTEVALLS 286
+ K K+G+G++ +VY GK VA+K + A + R EV+LL
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR------EVSLLK 55
Query: 287 RIHHRNLVPLIGYCEEEHQRILVYEYMHN---GTLRDRLHGSVNQKPLDWLTRLQIAHDA 343
+ H N+V L E LV+EY+ L D ++
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC------GNIINMHNVKLFLFQL 109
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARG 400
+GL Y H ++HRD+K N+L++ K++DFGL+R + + V
Sbjct: 110 LRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE--VV-- 162
Query: 401 TVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 435
T+ Y P+ G+ + + D++ G + E+ +G+
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 43/214 (20%), Positives = 84/214 (39%), Gaps = 29/214 (13%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 298
++IG+GSFG ++ G + + ++VA+K Q E + +P +
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYY 73
Query: 299 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
+ +E +LV + + G L D + K T A ++ +H
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVK-----TVAMAAKQMLARVQSIH--- 123
Query: 355 NPGIIHRDVKSSNILLDINMRAK-----VSDFGLSRQAEEDLT--HISSVA----RGTVG 403
+++RD+K N L+ V DFG+ + + +T HI GT
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 404 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
Y+ + ++ + + D+ + G V + + G P
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 2e-16
Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 35/212 (16%)
Query: 242 KIGKGSFGSVYYGKMKD-GKEVAVKIM--------ADSCSHRTQQFVTEVALLSRIHHRN 292
K+G+G++G VY + VA+K + + R EV+LL + HRN
Sbjct: 41 KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR------EVSLLKELQHRN 94
Query: 293 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
++ L H+ L++EY N L+ + + + G+ + H+
Sbjct: 95 IIELKSVIHHNHRLHLIFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 353 GCNPGIIHRDVKSSNILLDINMRA-----KVSDFGLSRQ---AEEDLTHISSVARGTVGY 404
+HRD+K N+LL ++ + K+ DFGL+R TH + T+ Y
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHE--II--TLWY 203
Query: 405 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 435
PE G++ + D++S + E++
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 27/212 (12%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIG 298
+KIG GSFG +Y G ++ +EVA+K+ H Q + E + + +P +
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRW 70
Query: 299 YCEEEHQRILVYEYMHNG----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
+ E +LV + + G L + ++ K T L +A +E++H
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLK-----TVLMLADQMINRVEFVH--- 120
Query: 355 NPGIIHRDVKSSNILLDINMRAK---VSDFGLSRQAEEDLT--HISSVA----RGTVGYL 405
+ +HRD+K N L+ + RA + DFGL+++ + T HI GT Y
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 406 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ + + + D+ S G VL+ + G P
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 57/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 289
+ + IG+GS+ V ++K + A+K + D Q TE + + +
Sbjct: 12 DLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQASN 68
Query: 290 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGL 347
H LV L C + R+ V EY++ G L + Q+ L R A + + L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSA-EISLAL 123
Query: 348 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYL 405
YLH GII+RD+K N+LLD K++D+G+ ++ D T GT Y+
Sbjct: 124 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYI 177
Query: 406 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
PE + D ++ GV++ E+++G+ P
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 60/232 (25%), Positives = 101/232 (43%), Gaps = 49/232 (21%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV----AVKIMA-DSCSHRTQQFV---TEVALLSRI- 288
K +G G++G V+ + G + A+K++ + + + TE +L I
Sbjct: 57 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 116
Query: 289 HHRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAH----DA 343
LV L Y + ++ L+ +Y++ G L T L
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGEL---------------FTHLSQRERFTEHE 160
Query: 344 AK--------GLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395
+ LE+LH GII+RD+K NILLD N ++DFGLS+ E + +
Sbjct: 161 VQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFVADET 214
Query: 396 SVAR---GTVGYLDPE-YYGNQQLTEKS-DVYSFGVVLLELISGKKPVSVED 442
A GT+ Y+ P+ G +K+ D +S GV++ EL++G P +V+
Sbjct: 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 7e-16
Identities = 64/211 (30%), Positives = 96/211 (45%), Gaps = 14/211 (6%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 292
NF +GKGSFG V + K E+ AVKI+ D T V L
Sbjct: 344 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPF 403
Query: 293 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
L L C + R+ V EY++ G L H + + A + A GL +L
Sbjct: 404 LTQLH-SCFQTMDRLYFVMEYVNGGDLM--YHIQQVGRFKEPHAVFYAA-EIAIGLFFLQ 459
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 411
+ GII+RD+K N++LD K++DFG+ ++ D + GT Y+ PE
Sbjct: 460 ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIA 515
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
Q + D ++FGV+L E+++G+ P ED
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 37/220 (16%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---------- 289
+K+G G F +V+ K M + VA+KI+ + + E+ LL R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADNTKEDSM 83
Query: 290 -HRNLVPLIGY-----CEEEHQRILVYEYMHNGTLRDRLHGSVNQK-PLDWLTRLQIAHD 342
+++ L+ + H ++V+E + L + ++ PL + QI+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHV-VMVFEVLGE-NLLALIKKYEHRGIPLI-YVK-QISKQ 139
Query: 343 AAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRA------KVSDFGLSRQAEEDLT-HIS 395
GL+Y+H C IIH D+K N+L++I K++D G + +E T I
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 435
+ Y PE +D++S ++ ELI+G
Sbjct: 198 TRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 289
F + +GKGSFG V ++K+ ++ AVK I+ D T TE +LS +
Sbjct: 26 EFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM---TEKRILSLARN 82
Query: 290 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 348
H L L C + R+ V E+++ G L H +++ + R A + L
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLM--FHIQKSRRFDEARARFYAA-EIISALM 138
Query: 349 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYLD 406
+LH GII+RD+K N+LLD K++DFG+ ++ T ++ GT Y+
Sbjct: 139 FLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT--ATFC-GTPDYIA 192
Query: 407 PEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
PE D ++ GV+L E++ G P E+
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 289
+ + IG+GS+ V ++K + A++ + D Q TE + + +
Sbjct: 55 DLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ---TEKHVFEQASN 111
Query: 290 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLD-WLTRLQIAHDAAKGL 347
H LV L C + R+ V EY++ G L + Q+ L R A + + L
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSA-EISLAL 166
Query: 348 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ--AEEDLTHISSVARGTVGYL 405
YLH GII+RD+K N+LLD K++D+G+ ++ D T GT Y+
Sbjct: 167 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYI 220
Query: 406 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
PE + D ++ GV++ E+++G+ P
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 9e-16
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 242 KIGKGSFGSVYYGK-MKDGKEVAVK-IMADSCSHRTQQF-VT---EVALLSRIH---HRN 292
+IG G++G+VY + G VA+K + + ++ EVALL R+ H N
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 293 LVPLI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI---AHDAA 344
+V L+ + E + LV+E++ +D L +++ P L I
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVD----QD-LRTYLDKAPPPGLPAETIKDLMRQFL 130
Query: 345 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGY 404
+GL++LH I+HRD+K NIL+ K++DFGL+R + V T+ Y
Sbjct: 131 RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWY 185
Query: 405 LDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 435
PE + T D++S G + E+ K
Sbjct: 186 RAPEVLLQSTYATP-VDMWSVGCIFAEMFRRK 216
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVKIMA-DSCSHRTQQFVTEV---ALLSRIHHRN 292
K +GKGSFG V+ + K + A+K + D T V L H
Sbjct: 20 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 293 LVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
L + + + + V EY++ G L + K A + GL++LH
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAA-EIILGLQFLH 135
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE 408
+ GI++RD+K NILLD + K++DFG+ + E++ + GT Y+ PE
Sbjct: 136 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLG-DAKTNTFCGTPDYIAPE 188
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
Q+ D +SFGV+L E++ G+ P +D
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEV-AVK------IMADSCSHRTQQFVTEVALLSRI-H 289
NF +GKGSFG V + K E+ AVK ++ D T E +L+
Sbjct: 23 NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM---VEKRVLALPGK 79
Query: 290 HRNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLE 348
L L C + R+ V EY++ G L + V + A + A GL
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEPH-AVFYAA-EIAIGLF 135
Query: 349 YLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYL 405
+L + GII+RD+K N++LD K++DFG+ + E++ + GT Y+
Sbjct: 136 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWD-GVTTKTFCGTPDYI 188
Query: 406 DPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
PE Q + D ++FGV+L E+++G+ P ED
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 8e-15
Identities = 40/231 (17%), Positives = 80/231 (34%), Gaps = 45/231 (19%)
Query: 241 KKIGKGSFGSVYYGK---------MKDGKEVAVKI-MADSCSHRTQQF------VTEVAL 284
+ + G +Y ++ ++K+ D Q F +V
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 285 LSRIHHRNL--VPLIGYC--EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIA 340
+++ L +P ++ R LV + G + L + LQ+A
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVA 165
Query: 341 HDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV--SDFGLSRQAEEDLTHI---- 394
LE+LH +H +V + NI +D +++V + +G + + H+
Sbjct: 166 CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 395 --SSVARGTVGYLDPEY------YGNQQLTEKSDVYSFGVVLLELISGKKP 437
S G + E+ G + +SD+ S G +L+ + G P
Sbjct: 223 GSRSPHEGDL-----EFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLP 267
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 53/254 (20%), Positives = 92/254 (36%), Gaps = 60/254 (23%)
Query: 227 IPLPELEEATNNFC------KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFV 279
+P PE + + KKIG G FG +Y ++ A ++
Sbjct: 23 MPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVE-YQENGPLF 81
Query: 280 TEVALLSRIHHRNL--------------VPLIGYC-----EEEHQRILVYEYMHNGT-LR 319
+E+ R+ ++ +PL + R +V E + G L+
Sbjct: 82 SELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQ 139
Query: 320 D--RLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 377
+G+ + T LQ+ LEY+H +H D+K++N+LL +
Sbjct: 140 KISGQNGTFKKS-----TVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ 191
Query: 378 V--SDFGLSRQAEEDLTHISSVAR------GTVGYLDPEY------YGNQQLTEKSDVYS 423
V +D+GLS + + H GT+ E+ G + +SDV
Sbjct: 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTI-----EFTSLDAHKGVAL-SRRSDVEI 245
Query: 424 FGVVLLELISGKKP 437
G +L + GK P
Sbjct: 246 LGYCMLRWLCGKLP 259
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 20/136 (14%), Positives = 41/136 (30%), Gaps = 12/136 (8%)
Query: 17 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 76
N + + V+ ++ R+T ++L G G +P + + L L L +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNG--RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK 118
Query: 77 GP-----LPDMSRLIDLRIVHLENNELTGSLPSYMG--SLPNLQELHIENNSFVGEIPPA 129
+S + + Y +L + I ++ I +
Sbjct: 119 VNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS 178
Query: 130 ---LLTGKVIFKYDNN 142
L I + NN
Sbjct: 179 SRITLKDTQIGQLSNN 194
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 2/95 (2%)
Query: 41 ITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 99
I I + NLK + L+ M+ L L N L G LP I L ++L N++T
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQIT 366
Query: 100 GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGK 134
++ G ++ L +N IP
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKS 400
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 16/98 (16%), Positives = 36/98 (36%), Gaps = 10/98 (10%)
Query: 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP---------LPDMSRLIDLRI 90
+T + + ++P LK + + + + N L D ++I
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309
Query: 91 VHLENNEL-TGSLPSYMGSLPNLQELHIENNSFVGEIP 127
+++ N L T + + + + L L N G++P
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP 347
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 16/126 (12%), Positives = 38/126 (30%), Gaps = 22/126 (17%)
Query: 42 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--------------------D 81
T+I N+ + + + L + ++ +
Sbjct: 186 TQIGQLSNNI-TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK 244
Query: 82 MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDN 141
L DL V + N LP+++ +LP +Q +++ N + + +
Sbjct: 245 WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS-GEQLKDDWQALADAPV 303
Query: 142 NPKLHK 147
K+
Sbjct: 304 GEKIQI 309
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 15/110 (13%), Positives = 36/110 (32%), Gaps = 19/110 (17%)
Query: 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 99
+ K ++ + I + T++ N +T + RL LR ++ N+
Sbjct: 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFV 219
Query: 100 G-------------------SLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+ +L +L ++ + N + ++P L
Sbjct: 220 AENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFL 269
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 18/103 (17%), Positives = 33/103 (32%), Gaps = 12/103 (11%)
Query: 39 PRITKIALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPD----MSRLIDLRIVH 92
+T I L L + + + + L + L N + P S L I +
Sbjct: 488 YLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRN 545
Query: 93 ---LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 132
+ N P + P+L +L I +N + +
Sbjct: 546 QRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKITP 587
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 21/98 (21%), Positives = 32/98 (32%), Gaps = 10/98 (10%)
Query: 42 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--------PLPDMSRLIDLRIVHL 93
+ I LS + L+ + L GN LT + L + L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 94 ENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIPPAL 130
N+LT +LP L + + NSF + P
Sbjct: 496 RFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQP 532
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 20/116 (17%), Positives = 42/116 (36%), Gaps = 19/116 (16%)
Query: 35 TTTPPRI-------TKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTG-------P 78
T P ++ + LK IP + K++ ++ + N + P
Sbjct: 366 TEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
Query: 79 LP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
L + I++ ++L NN+++ + L +++ N EIP L
Sbjct: 425 LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML-TEIPKNSLKD 479
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 11/89 (12%), Positives = 31/89 (34%), Gaps = 4/89 (4%)
Query: 46 LSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRL-IDLRIVHLENNELTGSL 102
+ + + L + ++ + + SR+ + + +N +T +
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FV 198
Query: 103 PSYMGSLPNLQELHIENNSFVGEIPPALL 131
+ L L++ ++ N+ FV E
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENICEAW 227
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 11/95 (11%), Positives = 32/95 (33%), Gaps = 10/95 (10%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT----- 99
+ N++ LT++ + LP + L +++++++ N
Sbjct: 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL 291
Query: 100 ---GSLPSYMGSLPNLQELHIENNSF-VGEIPPAL 130
+ +Q ++I N+ + +L
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSL 326
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 17/99 (17%), Positives = 34/99 (34%), Gaps = 11/99 (11%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTEL------WLDGNFLTGPLPD-MSRLIDLRIV 91
P + I LS + P + N L GN P+ ++ L +
Sbjct: 513 PYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQL 571
Query: 92 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+ +N++ + PN+ L I++N + +
Sbjct: 572 QIGSNDIR-KVNE--KITPNISVLDIKDNPNISIDLSYV 607
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 10/75 (13%), Positives = 27/75 (36%), Gaps = 2/75 (2%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 105
G E P + +LT+L + N + + + ++ ++ +++N SY
Sbjct: 549 AQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNE-KITPNISVLDIKDNPNISIDLSY 606
Query: 106 MGSLPNLQELHIENN 120
+ + +
Sbjct: 607 VCPYIEAGMYMLFYD 621
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 3e-14
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 43/218 (19%)
Query: 242 KIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRTQQF-----VT---EVALL---S 286
+IG+G++G V+ K +D K VA+K + R Q ++ EVA+L
Sbjct: 18 EIGEGAYGKVF--KARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVLRHLE 69
Query: 287 RIHHRNLVPLI-----GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQI-- 339
H N+V L + E + LV+E++ +D L +++ P + I
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QD-LTTYLDKVPEPGVPTETIKD 124
Query: 340 -AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVA 398
+GL++LH+ ++HRD+K NIL+ + + K++DFGL+R + S V
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 399 RGTVGYLDPEY-YGNQQLTEKSDVYSFGVVLLELISGK 435
T+ Y PE + T D++S G + E+ K
Sbjct: 182 --TLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRK 216
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 48/253 (18%), Positives = 84/253 (33%), Gaps = 57/253 (22%)
Query: 228 PLPELEEATNNFC------KKIGKGSFGSVYYGKMKDGKEVAVKI--MADSCSHRTQQFV 279
E T+ IG+G FG +Y M + V +
Sbjct: 22 QFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF 81
Query: 280 TEVALLSRIHHRNL--------------VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGS 325
TE+ R VP + Y +M + DR
Sbjct: 82 TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFM----IMDRFGSD 137
Query: 326 VNQKPLDWLTR-------LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 378
+ QK + + LQ++ LEY+H +H D+K+SN+LL+ +V
Sbjct: 138 L-QKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV 193
Query: 379 --SDFGLSRQAEEDLTHISSVAR------GTVGYLDPEY------YGNQQLTEKSDVYSF 424
D+GL+ + + H + A GT+ E+ G + + D+
Sbjct: 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTI-----EFTSIDAHNGVAP-SRRGDLEIL 247
Query: 425 GVVLLELISGKKP 437
G +++ ++G P
Sbjct: 248 GYCMIQWLTGHLP 260
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NL 293
K IGKGSFG V K + VA+K++ + Q E+ +L + + N+
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-EIRILEHLRKQDKDNTMNV 161
Query: 294 VPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAK 345
+ ++ C + +E + L + + + + L ++ AH +
Sbjct: 162 IHMLENFTFRNHIC-------MTFELLSM-NLYELIKKN-KFQGFS-LPLVRKFAHSILQ 211
Query: 346 GLEYLHTGCNPGIIHRDVKSSNILLDINMRA--KVSDFGLSRQAEEDL-THISSVARGTV 402
L+ LH IIH D+K NILL R+ KV DFG S + + T+I S R
Sbjct: 212 CLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS--R--- 263
Query: 403 GYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK 435
Y PE + D++S G +L EL++G
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 19/96 (19%), Positives = 36/96 (37%), Gaps = 1/96 (1%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 97
P + + LS ++ +++ L+ L L GN + S L L+ +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
L +G L L+EL++ +N P +
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 17/87 (19%), Positives = 32/87 (36%), Gaps = 2/87 (2%)
Query: 46 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 103
++G + + P+ + LT L L L P + L L+++++ +N
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 104 SYMGSLPNLQELHIENNSFVGEIPPAL 130
L +LQ L N + L
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQEL 538
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 17/94 (18%), Positives = 36/94 (38%), Gaps = 2/94 (2%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 97
++ + L+G ++ + +L +L L L L+ +++ +N
Sbjct: 76 SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135
Query: 98 LTG-SLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+ LP Y +L NL+ L + +N L
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDL 169
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 16/97 (16%), Positives = 31/97 (31%), Gaps = 3/97 (3%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 96
+ + LS + + +E L L + L L +L + + +
Sbjct: 373 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 97 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
+ L +L+ L + NSF P + T
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 17/91 (18%), Positives = 32/91 (35%), Gaps = 2/91 (2%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 97
+T + LS L+ P ++ +L L + N L L+++ N
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 98 LTGSLPSYMGSLP-NLQELHIENNSFVGEIP 127
+ S + P +L L++ N F
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 16/82 (19%), Positives = 25/82 (30%), Gaps = 1/82 (1%)
Query: 50 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP-SYMGS 108
+ KG +L L L N + + L L + +++ L S S
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
Query: 109 LPNLQELHIENNSFVGEIPPAL 130
L NL L I +
Sbjct: 420 LRNLIYLDISHTHTRVAFNGIF 441
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 17/86 (19%), Positives = 26/86 (30%), Gaps = 4/86 (4%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 104
N +IP L + L L N L +L+++ L E+
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 105 YMGSLPNLQELHIENNSFVGEIPPAL 130
SL +L L + N A
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAF 96
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 19/98 (19%), Positives = 37/98 (37%), Gaps = 6/98 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDM-SRLIDLRIVHLENN 96
+ K+ NL + +++ L EL + N + LP+ S L +L + L +N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 97 ELTGSLPSYMGSLPNLQ----ELHIENNSFVGEIPPAL 130
++ + + L + L + N P A
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 12/96 (12%), Positives = 30/96 (31%), Gaps = 4/96 (4%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLI--DLRIVHLENN 96
+ + +S N K + +L L N + + L ++L N
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 97 ELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPAL 130
+ + ++ + + ++L +E P
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 16/94 (17%), Positives = 33/94 (35%), Gaps = 5/94 (5%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALT----ELWLDGNFLTGPLPDMSRLIDLRIVHLE 94
+ + LS ++ +L+ + + L L N + P + I L + L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLR 208
Query: 95 NNELTGSLPSY-MGSLPNLQELHIENNSFVGEIP 127
NN + ++ + L L+ + F E
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 15/114 (13%), Positives = 30/114 (26%), Gaps = 11/114 (9%)
Query: 40 RITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG----PLPDMSRLIDLRIVHLE 94
R+ K+ L + ++ + L L D S L L + +E
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 95 NNELT------GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 142
L + L N+ + + + + G + N
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNC 314
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 1e-12
Identities = 33/193 (17%), Positives = 57/193 (29%), Gaps = 54/193 (27%)
Query: 240 CKKIGKGSFGSVYYGKMKDGKEVAVKIMA--------DSCSHRTQQFVTEVALLSRIH-- 289
C+KIG+G FG V+ D VA+KI+A S ++ + E+ + +
Sbjct: 25 CEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLL 83
Query: 290 -------HRNLVPLIGYC------------------------------EEEHQRILVYEY 312
+ L ++ Q +V E+
Sbjct: 84 SGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEF 143
Query: 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 372
G +++ K T I H L + HRD+ N+LL
Sbjct: 144 EFGGIDLEQMR----TKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKK 197
Query: 373 NMRAKVSDFGLSR 385
K+ +
Sbjct: 198 TSLKKLHYTLNGK 210
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 54/258 (20%), Positives = 91/258 (35%), Gaps = 73/258 (28%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--------HR 291
+K+G G F +V+ ++ K VA+K++ S H T+ + E+ LL +
Sbjct: 43 RKLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 292 NLVPLIGY-----CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 346
+V L+ H +V+E + + L + S N + L +I +G
Sbjct: 102 MVVQLLDDFKISGVNGTHI-CMVFEVLGH-HLLKWIIKS-NYQGLPLPCVKKIIQQVLQG 158
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDIN--------------------------------- 373
L+YLHT C IIH D+K NILL +N
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 374 ----------------MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
++ K++D G + + T T Y E
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNT 272
Query: 418 KSDVYSFGVVLLELISGK 435
+D++S + EL +G
Sbjct: 273 PADIWSTACMAFELATGD 290
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 17/98 (17%), Positives = 34/98 (34%), Gaps = 6/98 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELK---NMEALTELWLDGNFLTGPLPDM---SRLIDLRIVH 92
R+ + L+ L + +L ++ L L + L+ + +L ++
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 93 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
L N L LP L+ +E N+ +L
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL 292
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 18/111 (16%), Positives = 33/111 (29%), Gaps = 9/111 (8%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM---SRLIDLRIVHLEN 95
+ + LS L +E L EL L N + + L+ + L +
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 96 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 146
N++ P ++ L L + N + L N +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL------CLELANTSIR 225
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 22/93 (23%), Positives = 33/93 (35%), Gaps = 1/93 (1%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 97
P + + L L LTEL L N + + + +L + L +N
Sbjct: 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNG 132
Query: 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
L+ + L NLQEL + NN L
Sbjct: 133 LSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 23/94 (24%), Positives = 41/94 (43%), Gaps = 1/94 (1%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 96
P IT + L+ L+ LT L + N ++ P++ +L L++++L++N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 97 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
EL+ NL ELH+ +NS
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 15/93 (16%), Positives = 31/93 (33%), Gaps = 1/93 (1%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 97
++T + + + P + + L L L N L+ + +L +HL +N
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+ + NL L + +N
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQ 141
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 18/89 (20%), Positives = 31/89 (34%), Gaps = 1/89 (1%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPS 104
L G LK + L L L+ N ++ L +L+I+ L N L S
Sbjct: 519 LWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 105 YMGSLPNLQELHIENNSFVGEIPPALLTG 133
+ +L+ L+++ N
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKKVFGPA 607
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 27/139 (19%), Positives = 44/139 (31%), Gaps = 4/139 (2%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG---PLPDMSRLIDLRIVHLEN 95
I +I LS + +L L L L L +L I+ L N
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 96 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRF 155
N + + L L+ L +++N+ + G I+ LH + F
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLA-RLWKHANPGGPIYFLKGLSHLHILNLESNGF 548
Query: 156 KLILGTSIGVLAILLVLFL 174
I L L ++ L
Sbjct: 549 DEIPVEVFKDLFELKIIDL 567
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 16/96 (16%), Positives = 37/96 (38%), Gaps = 3/96 (3%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 96
+T++ L +++ + L L L N L+ +L +L+ + L NN
Sbjct: 96 CTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155
Query: 97 ELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPAL 130
++ + + +L++L + +N P
Sbjct: 156 KIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCF 191
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 19/99 (19%), Positives = 36/99 (36%), Gaps = 6/99 (6%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM----SRLIDLRIVHL 93
+ K+ LS +K P + L L+L+ L L + +R + L
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSL 229
Query: 94 ENNELTGSLPSYMGSL--PNLQELHIENNSFVGEIPPAL 130
N++L+ + + L NL L + N+ +
Sbjct: 230 SNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF 268
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 16/103 (15%), Positives = 33/103 (32%), Gaps = 4/103 (3%)
Query: 32 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLR 89
T + + + L+ + + L L L N + L L ++
Sbjct: 374 TFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF 433
Query: 90 IVHLENNELTGSLPSYMGSLPNLQELHIENNSF--VGEIPPAL 130
++L N+ + +P+LQ L + + V P
Sbjct: 434 EIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPF 476
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 22/101 (21%), Positives = 36/101 (35%), Gaps = 9/101 (8%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT---------GPLPDMSRLIDLR 89
+T + LS N+ L+ +E L L L N L GP+ + L L
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539
Query: 90 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
I++LE+N L L+ + + N+
Sbjct: 540 ILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVF 580
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 6e-10
Identities = 15/100 (15%), Positives = 32/100 (32%), Gaps = 5/100 (5%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS-----RLIDLRIVHL 93
+ + + ++ G + L L L +F + L I++L
Sbjct: 329 KCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNL 388
Query: 94 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
N+++ L +L+ L + N E+ G
Sbjct: 389 TKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 19/90 (21%), Positives = 35/90 (38%), Gaps = 7/90 (7%)
Query: 46 LSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP 103
S L ++P +L N +T L L N L + +R L + + N ++ P
Sbjct: 11 CSHLKLT-QVPDDLPTN---ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEP 66
Query: 104 SYMGSLPNLQELHIENNSFVGEIPPALLTG 133
LP L+ L++++N +
Sbjct: 67 ELCQKLPMLKVLNLQHNELSQ-LSDKTFAF 95
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 26/146 (17%), Positives = 49/146 (33%), Gaps = 15/146 (10%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD----------MSRLIDL 88
P++ L N++ L + + L L +F + L L
Sbjct: 272 PQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCL 331
Query: 89 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKE 148
+++E+N++ G + L NL+ L + N+ F + LH
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNE-----TFVSLAHSPLHIL 386
Query: 149 SRRRMRFKLILGTSIGVLAILLVLFL 174
+ + + I + L L VL L
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEVLDL 412
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 18/110 (16%), Positives = 31/110 (28%), Gaps = 5/110 (4%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENN 96
+ I L NL N +L L L N +T + +L + + N
Sbjct: 560 FELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFN 619
Query: 97 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP---PALLTGKVIFKYDNNP 143
+ S + + E H P G + +D +
Sbjct: 620 PFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSS 669
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 10/81 (12%), Positives = 29/81 (35%), Gaps = 4/81 (4%)
Query: 50 NLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSL 109
N I ++ + L ++ + T +D + + + + +L
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNI----AVDWEDANSDYAKQYENEELSWSNL 490
Query: 110 PNLQELHIENNSFVGEIPPAL 130
+L ++ + N + ++P L
Sbjct: 491 KDLTDVELYNCPNMTQLPDFL 511
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 17/103 (16%), Positives = 31/103 (30%), Gaps = 13/103 (12%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP---------LPDM-SRLIDL 88
+T + L ++P L ++ L L + N L D +
Sbjct: 491 KDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550
Query: 89 RIVHLENNELTGSLPSY-MGSLPNLQELHIENNSFVGEIPPAL 130
+I ++ N L S + + L L +N A
Sbjct: 551 QIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAF 591
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 19/102 (18%), Positives = 39/102 (38%), Gaps = 11/102 (10%)
Query: 54 EIPPELK--NMEALTELWLDGNFLTGPLPD----MSRLIDLRIVH---LENNELTGSLPS 104
+ + + + L+ + + N + P S+L I H E N + P+
Sbjct: 742 SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800
Query: 105 YMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 146
+ + P+L +L I +N ++ L I +NP +
Sbjct: 801 GITTCPSLIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNIS 841
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 13/108 (12%), Positives = 32/108 (29%), Gaps = 4/108 (3%)
Query: 17 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 76
N + + V R+T ++L+G KG +P + + L L + T
Sbjct: 303 NFNKELDMWGDQPGVDLDNNG--RVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSET 360
Query: 77 GPLPDMSRL-IDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSF 122
+ + + + ++ L + ++
Sbjct: 361 VSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAI 408
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 9e-10
Identities = 22/100 (22%), Positives = 35/100 (35%), Gaps = 14/100 (14%)
Query: 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLENN 96
+T I +N KN LT + L N LT L D + L L + + N
Sbjct: 708 LMTSIP---ENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYN 763
Query: 97 ELTGSLPSYMGSLPNLQELHIE------NNSFVGEIPPAL 130
+ S P+ + L+ I N + + P +
Sbjct: 764 CFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 19/104 (18%), Positives = 36/104 (34%), Gaps = 10/104 (9%)
Query: 39 PRITKIALSGKNLKGEIPP--ELKNMEALTELWLDGNFLTGPLPDMS------RLIDLRI 90
++ + S LK IP K++ + + N + ++S + I+
Sbjct: 619 DQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677
Query: 91 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGK 134
V L NE+ + + + + NN IP L K
Sbjct: 678 VTLSYNEIQKFPTELFATGSPISTIILSNNLM-TSIPENSLKPK 720
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 20/99 (20%), Positives = 35/99 (35%), Gaps = 7/99 (7%)
Query: 39 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 96
P+I + NL+ E P L+ M L L N + L + L + L+ N
Sbjct: 548 PKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDYN 605
Query: 97 ELTGSLPSYMGS-LPNLQELHIENNSFVGEIPPALLTGK 134
++ +P + ++ L +N IP
Sbjct: 606 QIE-EIPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKS 642
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 5e-09
Identities = 20/118 (16%), Positives = 41/118 (34%), Gaps = 15/118 (12%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTEL------WLDGNFLTGPLPD-MSRLIDLRIV 91
P ++ + +S P + N L +GN + P ++ L +
Sbjct: 753 PYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811
Query: 92 HLENNELTGSLPSYMGSLPNLQELHIENNSF----VGEIPPALLTGKVIFKYDNNPKL 145
+ +N++ + + P L L I +N V + P + G + YD +
Sbjct: 812 QIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDI 866
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 11/94 (11%), Positives = 29/94 (30%), Gaps = 8/94 (8%)
Query: 46 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG---- 100
++ L + L L + + P+M + + L++ ++
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR-NPEMKPIKKDSRISLKDTQIGNLTNR 436
Query: 101 --SLPSYMGSLPNLQELHIENNSFVGEIPPALLT 132
+ + L LQ ++ N+ F +
Sbjct: 437 ITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWE 470
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 24/148 (16%), Positives = 43/148 (29%), Gaps = 8/148 (5%)
Query: 43 KIALSGKNLK-----GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 97
AL GKN + N EL + G+ L + R+ L L
Sbjct: 278 WEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGL---SLAGFG 334
Query: 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKL 157
G +P +G L L+ L +S + + ++M
Sbjct: 335 AKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDY 394
Query: 158 ILGTSIGVLAILLVLFLCSLIVLRKLRR 185
++ L + + ++K R
Sbjct: 395 DQRLNLSDLLQDAINRNPEMKPIKKDSR 422
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 27/95 (28%), Positives = 41/95 (43%), Gaps = 4/95 (4%)
Query: 37 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 95
T P + L L + P + + L + +D L LPD M + L + L
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLAR 136
Query: 96 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
N L +LP+ + SL L+EL I + E+P L
Sbjct: 137 NPLR-ALPASIASLNRLRELSIRACPELTELPEPL 170
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 19/106 (17%), Positives = 39/106 (36%), Gaps = 3/106 (2%)
Query: 42 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 101
+ L ++ +P + N++ L L + + L+ P + L L + L +
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRN 244
Query: 102 LPSYMGSLPNLQELHIENNSFVGEIPPAL--LTGKVIFKYDNNPKL 145
P G L+ L +++ S + +P + LT L
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 21/95 (22%), Positives = 41/95 (43%), Gaps = 12/95 (12%)
Query: 46 LSGKNLKGEIPPELKNMEA---------LTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 95
+ E+P L + +A L L L+ + LP ++ L +L+ + + N
Sbjct: 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRN 215
Query: 96 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+ L+ +L + LP L+EL + + + PP
Sbjct: 216 SPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIF 249
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 4/89 (4%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWL-DGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP 103
L G PP L L L D + L LP + RL L + L LP
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLP 294
Query: 104 SYMGSLPNLQELHIENNSFVGEIPPALLT 132
S + LP + + + ++
Sbjct: 295 SLIAQLPANCIILVPPH-LQAQLDQHRPV 322
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 26/100 (26%), Positives = 40/100 (40%), Gaps = 15/100 (15%)
Query: 42 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHL-ENNELT 99
+ + L E+P ++ L L L N L LP ++ L LR + + ELT
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELT 164
Query: 100 GSLPSYMGS---------LPNLQELHIENNSFVGEIPPAL 130
LP + S L NLQ L +E +P ++
Sbjct: 165 -ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASI 202
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 8e-05
Identities = 13/69 (18%), Positives = 27/69 (39%), Gaps = 4/69 (5%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN---ELTGS 101
L + +P ++ + L +L L G LP +++L I+ + + +L
Sbjct: 260 LKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319
Query: 102 LPSYMGSLP 110
P + P
Sbjct: 320 RPVARPAEP 328
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 11/107 (10%), Positives = 23/107 (21%), Gaps = 24/107 (22%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRL-------------------- 85
G L + + + +
Sbjct: 19 FQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDA 78
Query: 86 --IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+ L + L P L +LQ + I+ + E+P +
Sbjct: 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 14/97 (14%), Positives = 24/97 (24%), Gaps = 3/97 (3%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG--PLPDMSRLIDLRIVHLENN 96
+ + LS + +E L L + L L L + +
Sbjct: 376 NSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
Query: 97 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
L +L L + NSF +
Sbjct: 435 NTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 19/97 (19%), Positives = 38/97 (39%), Gaps = 3/97 (3%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 97
++ + L+G ++ P + +L L L +LI L+ +++ +N
Sbjct: 80 HHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF 139
Query: 98 LTG-SLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
+ LP+Y +L NL + + N I L
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSYNYIQT-ITVNDLQF 175
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 18/88 (20%), Positives = 30/88 (34%), Gaps = 3/88 (3%)
Query: 46 LSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLP 103
++G + K N LT L L L + L L+++++ +N L
Sbjct: 455 MAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDS 514
Query: 104 SYMGSLPNLQELHIENNSFVGEIPPALL 131
S+ L +L L N L
Sbjct: 515 SHYNQLYSLSTLDCSFNRIET-SKGILQ 541
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 19/96 (19%), Positives = 35/96 (36%), Gaps = 1/96 (1%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 97
+ + LS ++ + L+ L L GN + P S L L + +
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
L +G L L++L++ +N PA +
Sbjct: 116 LASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 15/89 (16%), Positives = 29/89 (32%), Gaps = 5/89 (5%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 104
+ L ++P ++ + + L N L S +L+ + L E+
Sbjct: 18 CMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDK 74
Query: 105 YMGSLPNLQELHIENNSFVGEIPPALLTG 133
L +L L + N P +G
Sbjct: 75 AWHGLHHLSNLILTGNPIQS-FSPGSFSG 102
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 18/94 (19%), Positives = 24/94 (25%), Gaps = 1/94 (1%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 96
P I LS LK N L L L + L L + L N
Sbjct: 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90
Query: 97 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+ P L +L+ L +
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPI 124
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 16/86 (18%), Positives = 28/86 (32%), Gaps = 1/86 (1%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 96
+T + LS L+ + L L + N L ++L L + N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531
Query: 97 ELTGSLPSYMGSLPNLQELHIENNSF 122
+ S +L ++ NNS
Sbjct: 532 RIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 18/101 (17%), Positives = 30/101 (29%), Gaps = 7/101 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPD-MSRLIDLRIVHLENN 96
+ + L + + L +L + NF+ LP S L +L V L N
Sbjct: 104 TSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163
Query: 97 ELTGSLPSYMGSLPNL----QELHIENNSFVGEIPPALLTG 133
+ + + L L + N I G
Sbjct: 164 YIQTITVNDLQFLRENPQVNLSLDMSLNPI-DFIQDQAFQG 203
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 16/85 (18%), Positives = 29/85 (34%), Gaps = 4/85 (4%)
Query: 52 KGEIPPELKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLENNELTGSLPSYMGS 108
KG I + + +L+ L L N L+ LR + L N + +
Sbjct: 339 KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMG 397
Query: 109 LPNLQELHIENNSFVGEIPPALLTG 133
L LQ L ++++ +
Sbjct: 398 LEELQHLDFQHSTLKRVTEFSAFLS 422
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 13/77 (16%), Positives = 30/77 (38%), Gaps = 4/77 (5%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 105
L+ N + + + ++ + L G + L D+ + + + + +L P+
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQLK-QFPT- 324
Query: 106 MGSLPNLQELHIENNSF 122
LP L+ L + N
Sbjct: 325 -LDLPFLKSLTLTMNKG 340
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 65/247 (26%), Positives = 101/247 (40%), Gaps = 25/247 (10%)
Query: 200 RTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYYGK-MKD 258
+S K Y+ + D+ Y + E IGKGSFG V +
Sbjct: 23 MSSHKKERKVYN----DGYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVE 78
Query: 259 GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NLVPLIGYCEEEHQRILVYEY 312
+ VA+KI+ + + Q EV LL ++ +V L + + LV+E
Sbjct: 79 QEWVAIKIIKNKKAFL-NQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEM 137
Query: 313 MHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 371
+ L D L + N + + L + A L +L T IIH D+K NILL
Sbjct: 138 LSY-NLYDLLRNT-NFRGVS-LNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLC 193
Query: 372 INMRA--KVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVL 428
R+ K+ DFG S Q + + +I S R Y PE D++S G +L
Sbjct: 194 NPKRSAIKIVDFGSSCQLGQRIYQYIQS--R---FYRSPEVLLGMPYDLAIDMWSLGCIL 248
Query: 429 LELISGK 435
+E+ +G+
Sbjct: 249 VEMHTGE 255
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 18/94 (19%), Positives = 29/94 (30%)
Query: 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 99
+ I L L EL L L+ + L L+ + L N+
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFE 314
Query: 100 GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
+ P+L L I+ N+ E+ L
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLEN 348
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 19/91 (20%), Positives = 30/91 (32%), Gaps = 2/91 (2%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENN 96
+ + LS K L L L L L L++++L ++
Sbjct: 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 97 ELTGSLPSYMGSLPNLQELHIENNSFVGEIP 127
L S LP LQ L+++ N F
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 19/99 (19%), Positives = 38/99 (38%), Gaps = 4/99 (4%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 94
P +T +++ G + E+ L+N+E L EL L + + ++ L L+ ++L
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 95 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
NE P L+ L + + +
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQN 423
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 16/97 (16%), Positives = 23/97 (23%), Gaps = 2/97 (2%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 96
P + S L + LT L L + D L + L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 97 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
L + + L+ L I L
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISS-IDFIPLHN 127
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 15/84 (17%), Positives = 35/84 (41%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
R+ + LS +L +++ + + L N LT + + ++L +N +
Sbjct: 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHI 535
Query: 99 TGSLPSYMGSLPNLQELHIENNSF 122
+ LPS + L + +++ N
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPL 559
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 14/96 (14%), Positives = 32/96 (33%), Gaps = 2/96 (2%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 97
R+ + L+ L L +AL L+ ++ L ++L +N
Sbjct: 81 HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNH 140
Query: 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
++ L+ L +NN+ + ++
Sbjct: 141 ISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSS 175
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 13/93 (13%), Positives = 29/93 (31%), Gaps = 1/93 (1%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 97
+T + L+ + ++ L L L N L S L+ +
Sbjct: 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG 116
Query: 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
++ + + L+ L++ +N P
Sbjct: 117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKG 149
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 5/89 (5%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS 104
L EIP L + L N L SRLI+L + L ++
Sbjct: 19 CENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED 75
Query: 105 YMGSLPNLQELHIENNSFVGEIPPALLTG 133
S L L + N + + L+G
Sbjct: 76 TFQSQHRLDTLVLTANPLIF-MAETALSG 103
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 17/99 (17%), Positives = 31/99 (31%), Gaps = 4/99 (4%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 96
P + + + L N + L L+L N ++ L+++ +NN
Sbjct: 104 PKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163
Query: 97 ELTGSLPSYMGSLPNLQ--ELHIENNSFVGEIPPALLTG 133
+ M SL L++ N I P
Sbjct: 164 AIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDS 201
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 18/97 (18%), Positives = 30/97 (30%), Gaps = 4/97 (4%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 93
+ + LS L + AL L L GN + + L I+ L
Sbjct: 424 LHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVL 483
Query: 94 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+L+ SL + + + +N AL
Sbjct: 484 SFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEAL 520
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 5/99 (5%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 96
+ K+ LS + N +LT L + GN L + L +LR + L ++
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360
Query: 97 ELTGSLPSYM--GSLPNLQELHIENNSFVGEIPPALLTG 133
++ S + +L +LQ L++ N + +
Sbjct: 361 DIETSDCCNLQLRNLSHLQSLNLSYNEPLS-LKTEAFKE 398
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 15/97 (15%), Positives = 30/97 (30%), Gaps = 6/97 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPDM---SRLIDLRIVHL 93
+ G I LKN +++L + P + + + ++L
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINL 261
Query: 94 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+ + + LQEL + E+P L
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGL 297
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 12/96 (12%), Positives = 31/96 (32%), Gaps = 6/96 (6%)
Query: 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM---SRLIDLRIVHLENN 96
+ L+G ++ I P + L G + S + L + E+
Sbjct: 180 TNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238
Query: 97 ELTGSLPSYMGSLP--NLQELHIENNSFVGEIPPAL 130
+ P+ L +++ ++++ + F
Sbjct: 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTF 274
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 17/99 (17%), Positives = 35/99 (35%), Gaps = 7/99 (7%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS---RLIDLRIVHLEN 95
+ + LS + + +E L L + L + + S L +L + + +
Sbjct: 78 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNLIYLDISH 135
Query: 96 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
+ + L +L+ L + NSF P + T
Sbjct: 136 THTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 173
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 38 PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTG---PLPDMSRLIDLRIVHL 93
P T++ L L+ +P + LT+L L N L+ L+ + L
Sbjct: 27 PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDL 85
Query: 94 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 128
N + ++ S L L+ L ++++ ++
Sbjct: 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSE 118
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 13/100 (13%), Positives = 31/100 (31%), Gaps = 8/100 (8%)
Query: 39 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLE 94
++ + NLK ++ ++ L L + + + L L ++ +
Sbjct: 101 EQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMA 158
Query: 95 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
N + + L NL L + ++ P
Sbjct: 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNS 197
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 14/80 (17%), Positives = 25/80 (31%), Gaps = 4/80 (5%)
Query: 56 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM--GSLPNLQ 113
+L L L N + + L L + +++ L + + SL NL
Sbjct: 71 SQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLI 129
Query: 114 ELHIENNSFVGEIPPALLTG 133
L I + + G
Sbjct: 130 YLDISHTHTR-VAFNGIFNG 148
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 18/88 (20%), Positives = 35/88 (39%), Gaps = 6/88 (6%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 95
+T + LS L+ ++ P ++ +L L + N L L L+++
Sbjct: 175 RNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDYSL 232
Query: 96 NELTGSLPSYMGSLP-NLQELHIENNSF 122
N + S + P +L L++ N F
Sbjct: 233 NHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 5e-10
Identities = 22/154 (14%), Positives = 46/154 (29%), Gaps = 6/154 (3%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
+ + L + ++ ++ L L L N L P+ + + L NN+L
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL 226
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKY---DNNPKLHKESRRRMRF 155
+ + NL+ + N F + + KL ++
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTV 285
Query: 156 KLILGTSIGVLAILLVLFLCSLIVLRKLRRKISN 189
+ L F LI L++ + +
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLS 319
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 24/95 (25%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
+ ++ LSG L +L L L L N L D+ L LR + L NN +
Sbjct: 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYV 92
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
L P+++ LH NN+ + + G
Sbjct: 93 Q-ELL----VGPSIETLHAANNNI-SRVSCSRGQG 121
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 3e-07
Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 4/91 (4%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 97
R ++ +LK + ++ + EL L GN L+ + L +++L +N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP 128
L + SL L+ L + NN E+
Sbjct: 70 LY-ETLD-LESLSTLRTLDLNNNYV-QELLV 97
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 16/76 (21%), Positives = 30/76 (39%), Gaps = 3/76 (3%)
Query: 58 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117
EL ++ L N ++ + SR + ++L NN++T G +Q L +
Sbjct: 94 ELLVGPSIETLHAANNNISR-VSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 118 ENNSFVGEIPPALLTG 133
+ N + A L
Sbjct: 152 KLNEID-TVNFAELAA 166
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 11/87 (12%), Positives = 29/87 (33%), Gaps = 5/87 (5%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDM-SRLIDLRIVHLENNELTGSLP 103
L+ + + + L L N + ++ + L ++L+ N + +
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVK 185
Query: 104 SYMGSLPNLQELHIENNSFVGEIPPAL 130
+ L+ L + +N + P
Sbjct: 186 GQV-VFAKLKTLDLSSNKLA-FMGPEF 210
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 9e-06
Identities = 10/69 (14%), Positives = 24/69 (34%), Gaps = 2/69 (2%)
Query: 61 NMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 119
N + + L L + +++ + L N L+ + + L+ L++ +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 120 NSFVGEIPP 128
N E
Sbjct: 68 NVLY-ETLD 75
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 5/105 (4%)
Query: 32 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS---RLIDL 88
+ S + + LS + + +E L L + L + + S L +L
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MSEFSVFLSLRNL 423
Query: 89 RIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
+ + + + L +L+ L + NSF P + T
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 19/99 (19%), Positives = 41/99 (41%), Gaps = 7/99 (7%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 95
++ + L+G ++ + + +L +L L L + + L L+ +++ +
Sbjct: 76 SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAH 133
Query: 96 NELT-GSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
N + LP Y +L NL+ L + +N I L
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 18/87 (20%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 96
+ + ++G + + P+ + LT L L L P + L L+++++ +N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504
Query: 97 ELTGSLPSYM-GSLPNLQELHIENNSF 122
+L S+P + L +LQ++ + N +
Sbjct: 505 QLK-SVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 17/89 (19%), Positives = 28/89 (31%), Gaps = 5/89 (5%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 104
N +IP L + L L N L +L+++ L E+
Sbjct: 14 CMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 105 YMGSLPNLQELHIENNSFVGEIPPALLTG 133
SL +L L + N + +G
Sbjct: 71 AYQSLSHLSTLILTGNPIQ-SLALGAFSG 98
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 16/99 (16%), Positives = 30/99 (30%), Gaps = 6/99 (6%)
Query: 38 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLE 94
P + LS L+ + + L L L + + D + L L + L
Sbjct: 27 PFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILT 84
Query: 95 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
N + L +LQ+L + + +
Sbjct: 85 GNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGH 122
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 19/101 (18%), Positives = 37/101 (36%), Gaps = 7/101 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-GPLPD-MSRLIDLRIVHLENN 96
+ K+ NL + +++ L EL + N + LP+ S L +L + L +N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 97 ELTGSLPSYMGSLPNLQ----ELHIENNSFVGEIPPALLTG 133
++ + + L + L + N I P
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKE 199
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 20/97 (20%), Positives = 37/97 (38%), Gaps = 3/97 (3%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 96
P + + LS ++ I +++ L+ L L GN + S L L+ +
Sbjct: 52 PELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVET 110
Query: 97 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
L +G L L+EL++ +N P +
Sbjct: 111 NLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 16/95 (16%), Positives = 37/95 (38%), Gaps = 7/95 (7%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 94
+ ++ + N G E+ ++ +L L L N L+ S L+ + L
Sbjct: 324 LKSLKRLTFTS-NKGGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 95 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA 129
N + ++ S L L+ L ++++ ++
Sbjct: 382 FNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEF 414
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 21/99 (21%), Positives = 33/99 (33%), Gaps = 6/99 (6%)
Query: 39 PRITKIALSGKNL--KGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 96
P + + LS L KG +L L L N + + L L + +++
Sbjct: 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHS 406
Query: 97 ELTGSLP--SYMGSLPNLQELHIENNSFVGEIPPALLTG 133
L + S SL NL L I + + G
Sbjct: 407 NLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNG 443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 16/65 (24%), Positives = 29/65 (44%), Gaps = 1/65 (1%)
Query: 56 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 115
+K++ L L + N ++ + ++ L L + L NN+L +G L NL L
Sbjct: 258 INAVKDLTKLKMLNVGSNQISD-ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316
Query: 116 HIENN 120
+ N
Sbjct: 317 FLSQN 321
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 1e-08
Identities = 16/83 (19%), Positives = 31/83 (37%), Gaps = 5/83 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNE 97
++ + + + L N+ L L+L+ N L ++ L +L + L N
Sbjct: 265 TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 98 LTGSLPSYMGSLPNLQELHIENN 120
+T P + SL + N
Sbjct: 323 ITDIRP--LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 55.6 bits (135), Expect = 1e-08
Identities = 18/92 (19%), Positives = 42/92 (45%), Gaps = 5/92 (5%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
R+ + + + + P L N+ LT L + N ++ + + L L+++++ +N++
Sbjct: 221 TRLNSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-INAVKDLTKLKMLNVGSNQI 277
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+ S + +L L L + NN E +
Sbjct: 278 SD--ISVLNNLSQLNSLFLNNNQLGNEDMEVI 307
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 14/64 (21%), Positives = 28/64 (43%), Gaps = 3/64 (4%)
Query: 57 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116
L ++ +L N +T + ++ + L + + NN++T P + +L L L
Sbjct: 193 SPLASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLE 249
Query: 117 IENN 120
I N
Sbjct: 250 IGTN 253
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 21/82 (25%), Positives = 45/82 (54%), Gaps = 5/82 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
ITK+ ++G+ + ++ + L L L+GN +T + +S L+ L +++ N++
Sbjct: 44 ESITKLVVAGEKVAS--IQGIEYLTNLEYLNLNGNQITD-ISPLSNLVKLTNLYIGTNKI 100
Query: 99 TGSLPSYMGSLPNLQELHIENN 120
T S + +L NL+EL++ +
Sbjct: 101 TD--ISALQNLTNLRELYLNED 120
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 1e-07
Identities = 14/82 (17%), Positives = 37/82 (45%), Gaps = 4/82 (4%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
++T + + + L+N+ L EL+L+ + ++ + ++ L + ++L N
Sbjct: 88 VKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD-ISPLANLTKMYSLNLGANHN 144
Query: 99 TGSLPSYMGSLPNLQELHIENN 120
S S + ++ L L + +
Sbjct: 145 L-SDLSPLSNMTGLNYLTVTES 165
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 2e-07
Identities = 19/94 (20%), Positives = 37/94 (39%), Gaps = 4/94 (4%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
+ ++ L+ N+ L N+ + L L N L +S + L + + +++
Sbjct: 110 TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV 167
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 132
P + +L +L L + N P A LT
Sbjct: 168 KDVTP--IANLTDLYSLSLNYNQIEDISPLASLT 199
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 18/76 (23%), Positives = 31/76 (40%), Gaps = 3/76 (3%)
Query: 57 PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116
+ N+ L L L+ N + + ++ L L N++T P + ++ L L
Sbjct: 171 TPIANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLK 227
Query: 117 IENNSFVGEIPPALLT 132
I NN P A L+
Sbjct: 228 IGNNKITDLSPLANLS 243
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.9 bits (115), Expect = 4e-06
Identities = 13/80 (16%), Positives = 29/80 (36%), Gaps = 4/80 (5%)
Query: 53 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 112
+I P ++ L +T + L + + + ++ S+ + L NL
Sbjct: 13 NQIFP-DADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVA-SIQG-IEYLTNL 68
Query: 113 QELHIENNSFVGEIPPALLT 132
+ L++ N P + L
Sbjct: 69 EYLNLNGNQITDISPLSNLV 88
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 4e-05
Identities = 11/61 (18%), Positives = 24/61 (39%), Gaps = 1/61 (1%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
++ + L+ L E + + LT L+L N +T + ++ L + N +
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLSKMDSADFANQVI 345
Query: 99 T 99
Sbjct: 346 K 346
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 15/104 (14%), Positives = 42/104 (40%), Gaps = 6/104 (5%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
+T + L N+ P + ++ L L+ N ++ + ++ L ++ + +N++
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQI 365
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 142
+ P + +L + +L + + ++ P I N
Sbjct: 366 SDLTP--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKN 406
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 22/89 (24%), Positives = 39/89 (43%), Gaps = 5/89 (5%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
+ +++L+G LK L ++ LT+L L N ++ L +S L L + L N++
Sbjct: 221 TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQI 277
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIP 127
+ P + L L L + N P
Sbjct: 278 SNISP--LAGLTALTNLELNENQLEDISP 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 24/94 (25%), Positives = 41/94 (43%), Gaps = 5/94 (5%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
+T + L+ + P L + LTEL L N ++ + ++ L L + L N+L
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLTALTNLELNENQL 299
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 132
S + +L NL L + N+ P + LT
Sbjct: 300 ED--ISPISNLKNLTYLTLYFNNISDISPVSSLT 331
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 2e-08
Identities = 24/82 (29%), Positives = 38/82 (46%), Gaps = 5/82 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
++T++ L + P L + ALT L L+ N L + +S L +L + L N +
Sbjct: 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFNNI 321
Query: 99 TGSLPSYMGSLPNLQELHIENN 120
+ P + SL LQ L NN
Sbjct: 322 SDISP--VSSLTKLQRLFFYNN 341
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 20/94 (21%), Positives = 37/94 (39%), Gaps = 5/94 (5%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
+ ++ +S + L + L L N ++ + + L +L + L N+L
Sbjct: 177 TTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQL 233
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 132
+ SL NL +L + NN P + LT
Sbjct: 234 KD--IGTLASLTNLTDLDLANNQISNLAPLSGLT 265
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 20/94 (21%), Positives = 39/94 (41%), Gaps = 5/94 (5%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
++T + +K ++ + LT++ N LT + + L L + + NN++
Sbjct: 46 DQVTTLQADRLGIK--SIDGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDILMNNNQI 102
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 132
+ + +L NL L + NN P LT
Sbjct: 103 AD--ITPLANLTNLTGLTLFNNQITDIDPLKNLT 134
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 21/89 (23%), Positives = 37/89 (41%), Gaps = 5/89 (5%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
+ + + + P L + L EL L+GN L + ++ L +L + L NN++
Sbjct: 199 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQI 255
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIP 127
+ P + L L EL + N P
Sbjct: 256 SNLAP--LSGLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 6e-07
Identities = 21/92 (22%), Positives = 39/92 (42%), Gaps = 5/92 (5%)
Query: 41 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 100
K L N+ + +++ +T L D + + + L +L ++ NN+LT
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTD 82
Query: 101 SLPSYMGSLPNLQELHIENNSFVGEIPPALLT 132
P + +L L ++ + NN P A LT
Sbjct: 83 ITP--LKNLTKLVDILMNNNQIADITPLANLT 112
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 8e-07
Identities = 23/81 (28%), Positives = 43/81 (53%), Gaps = 5/81 (6%)
Query: 41 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 100
+T+I S L I P LKN+ L ++ ++ N + + ++ L +L + L NN++T
Sbjct: 70 LTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITD 126
Query: 101 SLPSYMGSLPNLQELHIENNS 121
P + +L NL L + +N+
Sbjct: 127 IDP--LKNLTNLNRLELSSNT 145
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 19/94 (20%), Positives = 37/94 (39%), Gaps = 6/94 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
+ ++ LS + L + +L +L L ++ L L + + +N++
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQVTD--LKPLANLTTLERLDISSNKV 189
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 132
+ S + L NL+ L NN P +LT
Sbjct: 190 SD--ISVLAKLTNLESLIATNNQISDITPLGILT 221
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 22/80 (27%), Positives = 37/80 (46%), Gaps = 6/80 (7%)
Query: 41 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 100
+T + L + I P LKN+ L L L N ++ + +S L L+ + N +T
Sbjct: 114 LTGLTLFNNQITD-IDP-LKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSFGNQ-VTD 169
Query: 101 SLPSYMGSLPNLQELHIENN 120
P + +L L+ L I +N
Sbjct: 170 LKP--LANLTTLERLDISSN 187
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 14/107 (13%), Positives = 31/107 (28%), Gaps = 10/107 (9%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
I ++ + P L N+ +T+L L+ T + + +
Sbjct: 353 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGA 410
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 145
P+ + + E I N T +V + + +
Sbjct: 411 L-IAPATISDGGSYTEPDITWNL-------PSYTNEVSYTFSQPVTI 449
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 25/98 (25%), Positives = 41/98 (41%), Gaps = 7/98 (7%)
Query: 38 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 95
PP + L + EI KN++ L L L N ++ P + L+ L ++L
Sbjct: 51 PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109
Query: 96 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
N+L LP LQEL + N ++ ++ G
Sbjct: 110 NQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNG 143
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 23/112 (20%), Positives = 46/112 (41%), Gaps = 9/112 (8%)
Query: 37 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHL 93
PP +T++ L G + ++ LK + L +L L N ++ + + ++ LR +HL
Sbjct: 190 LPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISA-VDNGSLANTPHLRELHL 247
Query: 94 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 145
NN+L +P + +Q +++ NN+ I
Sbjct: 248 NNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYN--TKKASY 295
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 17/101 (16%), Positives = 41/101 (40%), Gaps = 9/101 (8%)
Query: 37 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT-GPLPDM--SRLIDLRIVH 92
P + ++ + + ++ + + + L N L + + + L +
Sbjct: 119 MPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 177
Query: 93 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
+ + +T ++P G P+L ELH++ N ++ A L G
Sbjct: 178 IADTNIT-TIPQ--GLPPSLTELHLDGNKI-TKVDAASLKG 214
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 12/91 (13%), Positives = 33/91 (36%), Gaps = 10/91 (10%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-------GPLPDMSRLIDLRIV 91
P + ++ L+ L ++P L + + + ++L N ++ P ++ V
Sbjct: 240 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 298
Query: 92 HLENNELT-GSLPSYM-GSLPNLQELHIENN 120
L +N + + + + + N
Sbjct: 299 SLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 21/103 (20%), Positives = 40/103 (38%), Gaps = 9/103 (8%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 97
+ K+ LS ++ + L N L EL L+ N L ++ +++V+L NN
Sbjct: 216 NNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274
Query: 98 LTG------SLPSYMGSLPNLQELHIENNSF-VGEIPPALLTG 133
++ P Y + + + +N EI P+
Sbjct: 275 ISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 97
PP + + +S L+ ++P EL+N L + +D N L LPD+ L + NN+
Sbjct: 130 PPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLKK-LPDL--PPSLEFIAAGNNQ 184
Query: 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
L LP + +LP L ++ +NNS ++P
Sbjct: 185 LE-ELPE-LQNLPFLTAIYADNNSLK-KLPDLP 214
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 29/99 (29%), Positives = 40/99 (40%), Gaps = 10/99 (10%)
Query: 35 TTTPPRI---TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIV 91
P I L E PEL+N+ LT ++ D N L LPD+ L +
Sbjct: 208 KKLPDLPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLKT-LPDL--PPSLEAL 262
Query: 92 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
++ +N LT LP SL L + E+PP L
Sbjct: 263 NVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-ELPPNL 299
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 22/96 (22%), Positives = 36/96 (37%), Gaps = 12/96 (12%)
Query: 35 TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE 94
+ PP + + S ++ + + L EL + N L LP + L +
Sbjct: 293 SELPPNLYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLIE-LPAL--PPRLERLIAS 345
Query: 95 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
N L +P NL++LH+E N E P
Sbjct: 346 FNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPDIP 376
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 26/110 (23%), Positives = 42/110 (38%), Gaps = 25/110 (22%)
Query: 37 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENN 96
PP + ++ +S L E+P L L N L +P++ +L+ +H+E N
Sbjct: 315 LPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPEL--PQNLKQLHVEYN 367
Query: 97 ELTGSLPSYMGSL----------------PNLQELHIENNSFVGEIPPAL 130
L P S+ NL++LH+E N E P
Sbjct: 368 PLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIP 415
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 26/99 (26%), Positives = 39/99 (39%), Gaps = 20/99 (20%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP---------DMSRLID-----LRIV 91
NL E+P E +N+++ TE + + P +SRL D +
Sbjct: 18 RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHEL 76
Query: 92 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
L N L+ SLP P+L+ L NS E+P
Sbjct: 77 ELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELP 110
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 21/105 (20%), Positives = 33/105 (31%), Gaps = 18/105 (17%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEA-------------LTELWLDGNFLTGPLPDMSRL 85
T+ + + PP EL L+ L+ LP+
Sbjct: 34 KSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPE--LP 90
Query: 86 IDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
L + N LT LP SL +L + + ++PP L
Sbjct: 91 PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL-SDLPPLL 133
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 14/87 (16%), Positives = 30/87 (34%), Gaps = 7/87 (8%)
Query: 35 TTTPPRITKI-ALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL 93
P + L + E+P +N L +L ++ N L + DLR +
Sbjct: 370 REFPDIPESVEDLRMNSHLAEVPELPQN---LKQLHVETNPLREFPDIPESVEDLR---M 423
Query: 94 ENNELTGSLPSYMGSLPNLQELHIENN 120
+ + + L++ E++
Sbjct: 424 NSERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 24/128 (18%), Positives = 47/128 (36%), Gaps = 26/128 (20%)
Query: 37 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRI------ 90
PPR+ ++ S +L E+P +N L +L ++ N L + DLR+
Sbjct: 335 LPPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLREFPDIPESVEDLRMNSHLAE 390
Query: 91 ----------VHLENNELTGSLPSYMGSLPNLQELHIENNSFVG--EIPPALLTGKVIFK 138
+H+E N L P ++++L + + V E
Sbjct: 391 VPELPQNLKQLHVETNPLR-EFPD---IPESVEDLRMNSERVVDPYEFAHETTDKLEDDV 446
Query: 139 YDNNPKLH 146
++++ H
Sbjct: 447 FEHHHHHH 454
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 22/98 (22%), Positives = 42/98 (42%), Gaps = 7/98 (7%)
Query: 38 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 95
P T + L ++ E+ + K ++ L L L N ++ S L L+ +++
Sbjct: 53 SPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111
Query: 96 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
N L +P +L EL I +N ++P + +G
Sbjct: 112 NHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSG 145
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 14/91 (15%), Positives = 32/91 (35%), Gaps = 10/91 (10%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-------GPLPDMSRLIDLRIV 91
P + ++ L L +P L +++ L ++L N +T P+ + +
Sbjct: 241 PTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGI 299
Query: 92 HLENNELT-GSLPSYM-GSLPNLQELHIENN 120
L NN + + + + + N
Sbjct: 300 SLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 28/87 (32%), Positives = 42/87 (48%), Gaps = 7/87 (8%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 104
+S L IP +L E L EL LD N + L D+ R L + L +N++ + +
Sbjct: 179 ISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIEN 234
Query: 105 YM-GSLPNLQELHIENNSFVGEIPPAL 130
LP L+ELH++NN +P L
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGL 260
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 16/98 (16%), Positives = 34/98 (34%), Gaps = 7/98 (7%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 97
+ + L N +I + + L +L++ N L +P L + + +N
Sbjct: 78 QHLYALVLVN-NKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNL-PSSLVELRIHDNR 134
Query: 98 LTGSLPSYM-GSLPNLQELHIENNSF-VGEIPPALLTG 133
+ +P + L N+ + + N P G
Sbjct: 135 IR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 6e-09
Identities = 34/111 (30%), Positives = 43/111 (38%), Gaps = 11/111 (9%)
Query: 31 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 82
V C T PP + T + LS L L LT+L LD LT L
Sbjct: 15 VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD 73
Query: 83 SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
L L + L +N+L SLP +LP L L + N +P L G
Sbjct: 74 GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRG 122
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 27/86 (31%), Positives = 41/86 (47%), Gaps = 7/86 (8%)
Query: 39 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 95
P +T + +S L +P + + L EL+L GN L LP ++ L + L N
Sbjct: 100 PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLAN 157
Query: 96 NELTGSLPSYM-GSLPNLQELHIENN 120
N LT LP+ + L NL L ++ N
Sbjct: 158 NNLT-ELPAGLLNGLENLDTLLLQEN 182
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 9e-09
Identities = 14/71 (19%), Positives = 35/71 (49%), Gaps = 1/71 (1%)
Query: 59 LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117
+ + L L + G +T +P++S L L ++ + ++ S+ + + +LP + + +
Sbjct: 84 ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL 143
Query: 118 ENNSFVGEIPP 128
N + +I P
Sbjct: 144 SYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-07
Identities = 15/90 (16%), Positives = 38/90 (42%), Gaps = 3/90 (3%)
Query: 41 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTG 100
+T I L+ N+ ++ ++ + +L ++ T +S L +L + + ++T
Sbjct: 46 LTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDVTS 102
Query: 101 SLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+ L +L L I +++ I +
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 10/82 (12%), Positives = 32/82 (39%), Gaps = 2/82 (2%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
+T + +S I ++ + + + L N + + L +L+ ++++ + +
Sbjct: 112 TSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGV 171
Query: 99 TGSLPSYMGSLPNLQELHIENN 120
+ P L +L+ +
Sbjct: 172 HDY--RGIEDFPKLNQLYAFSQ 191
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 21/86 (24%), Positives = 35/86 (40%), Gaps = 5/86 (5%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 97
P + + +S NL L L EL++ N L LPD S L ++ + N+
Sbjct: 430 PQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKLKT-LPDASLFPVLLVMKISRNQ 484
Query: 98 LTGSLPSYMGSLPNLQELHIENNSFV 123
L L +LQ++ + N +
Sbjct: 485 LKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 22/154 (14%), Positives = 47/154 (30%), Gaps = 4/154 (2%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENN 96
+ + + EI + +L EL + L + + D+ + L +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 97 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFK 156
E L + L +++ L + + + + L + F
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNL-ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241
Query: 157 LILGTSIGVLAILLVLFL-CSLIVLRKLRRKISN 189
+L +L + V F C+L L S+
Sbjct: 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 19/99 (19%), Positives = 36/99 (36%), Gaps = 5/99 (5%)
Query: 38 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLE 94
+ + LS + I L+ L L L + + + L L + L
Sbjct: 25 TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLS 82
Query: 95 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
+N L+ S+ G L +L+ L++ N + +L
Sbjct: 83 DNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 11/98 (11%), Positives = 29/98 (29%), Gaps = 4/98 (4%)
Query: 39 PRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLEN 95
+ + L G + + N+ L L + + D + L L + ++
Sbjct: 98 SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157
Query: 96 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
L + S+ ++ L + + +
Sbjct: 158 LSLRNYQSQSLKSIRDIHHLTLHLSES-AFLLEIFADI 194
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 15/93 (16%), Positives = 34/93 (36%), Gaps = 5/93 (5%)
Query: 32 TCSTTTPPRITKIALSGKNLK--GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 89
+ P + + LS +L+ + L ++ LT L + N +R
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMR 413
Query: 90 IVHLENNELTGSLPSYMGSLPNLQELHIENNSF 122
++L + + + + L+ L + NN+
Sbjct: 414 FLNLSSTGIR-VVKT--CIPQTLEVLDVSNNNL 443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 3e-05
Identities = 20/100 (20%), Positives = 39/100 (39%), Gaps = 11/100 (11%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 93
++ +I + + +P +++++L L L N + S L+ + L
Sbjct: 310 EKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVL 368
Query: 94 ENNELTGSLPSYMG---SLPNLQELHIENNSFVGEIPPAL 130
N L S+ +L NL L I N+F +P +
Sbjct: 369 SQNHLR-SMQKTGEILLTLKNLTSLDISRNTF-HPMPDSC 406
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 14/80 (17%), Positives = 27/80 (33%), Gaps = 2/80 (2%)
Query: 54 EIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 113
++ ++ L L L N L P+ + + L NN+L + + NL+
Sbjct: 183 DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 114 ELHIENNSFVGEIPPALLTG 133
+ N F +
Sbjct: 241 HFDLRGNGFHCGTLRDFFSK 260
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 21/91 (23%), Positives = 39/91 (42%), Gaps = 4/91 (4%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNE 97
R ++ +LK + ++ + EL L GN L+ D++ L +++L +N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIPP 128
L + SL L+ L + NN E+
Sbjct: 70 LY-ETLD-LESLSTLRTLDLNNNYV-QELLV 97
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 15/93 (16%), Positives = 35/93 (37%), Gaps = 8/93 (8%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENN 96
P I + + N+ + + ++L N +T L D ++ + L+ N
Sbjct: 99 PSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLN 154
Query: 97 ELTG-SLPSYMGSLPNLQELHIENNSFVGEIPP 128
E+ + S L+ L+++ N ++
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG 186
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 16/77 (20%), Positives = 30/77 (38%), Gaps = 3/77 (3%)
Query: 58 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117
EL ++ L N ++ + SR + ++L NN++T G +Q L +
Sbjct: 94 ELLVGPSIETLHAANNNISR-VSC-SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 118 ENNSFVGEIPPALLTGK 134
+ N + A L
Sbjct: 152 KLNEID-TVNFAELAAS 167
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 11/75 (14%), Positives = 26/75 (34%), Gaps = 2/75 (2%)
Query: 55 IPPELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQ 113
I +N + + L L + +++ + L N L+ + + L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 114 ELHIENNSFVGEIPP 128
L++ +N E
Sbjct: 62 LLNLSSNVLY-ETLD 75
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 17/97 (17%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 97
P + ++ L I + + L L L + +P+++ L+ L + + N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNH 229
Query: 98 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
+ L +L++L + N+ V I G
Sbjct: 230 FP-EIRPGSFHGLSSLKKLWVMNSQ-VSLIERNAFDG 264
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 23/98 (23%), Positives = 39/98 (39%), Gaps = 5/98 (5%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 96
+ + L +++ +I + +L L L N+LT L LR + L NN
Sbjct: 99 HHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNN 157
Query: 97 ELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
+ S+PSY +P+L L + + I G
Sbjct: 158 PIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEG 194
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 21/91 (23%), Positives = 43/91 (47%), Gaps = 11/91 (12%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHL 93
+ ++ +SG + EI P + +L +LW+ + ++ ++ L ++L
Sbjct: 218 VGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL---VELNL 273
Query: 94 ENNELTGSLPSYM-GSLPNLQELHIENNSFV 123
+N L+ SLP + L L ELH+ +N +
Sbjct: 274 AHNNLS-SLPHDLFTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 19/79 (24%), Positives = 35/79 (44%), Gaps = 4/79 (5%)
Query: 57 PELKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQE 114
P L + L EL + GN P L L+ + + N++++ + L +L E
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVE 270
Query: 115 LHIENNSFVGEIPPALLTG 133
L++ +N+ +P L T
Sbjct: 271 LNLAHNNLS-SLPHDLFTP 288
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 55.9 bits (134), Expect = 2e-08
Identities = 22/84 (26%), Positives = 37/84 (44%), Gaps = 5/84 (5%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
+T + LS L+ +PP L + L L N L + ++ L L+ + L NN L
Sbjct: 463 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRL 520
Query: 99 TGSLPS--YMGSLPNLQELHIENN 120
+ + S P L L+++ N
Sbjct: 521 Q-QSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 2e-07
Identities = 22/87 (25%), Positives = 40/87 (45%), Gaps = 4/87 (4%)
Query: 34 STTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL 93
+ + L+ K+L + L+ + +T L L N L P ++ L L ++
Sbjct: 436 LKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQA 493
Query: 94 ENNELTGSLPSYMGSLPNLQELHIENN 120
+N L ++ + +LP LQEL + NN
Sbjct: 494 SDNALE-NVDG-VANLPRLQELLLCNN 518
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 4e-04
Identities = 13/65 (20%), Positives = 24/65 (36%), Gaps = 7/65 (10%)
Query: 57 PELKNMEALTELWLDGNFLTGP--LPDMSRLIDLRIVHLENNELTGSLPSY----MGSLP 110
+ N+ L EL L N L + + L +++L+ N L LP
Sbjct: 502 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLP 560
Query: 111 NLQEL 115
++ +
Sbjct: 561 SVSSI 565
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 19/97 (19%), Positives = 36/97 (37%), Gaps = 5/97 (5%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 97
P + ++ L I + + L L L L +P+++ LI L + L N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNH 218
Query: 98 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
L+ ++ L +LQ+L + + I
Sbjct: 219 LS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDN 253
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 7/99 (7%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 95
+ + LS +++ I + L L L N LT +P+ L L+ + L N
Sbjct: 88 RHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTT-IPNGAFVYLSKLKELWLRN 145
Query: 96 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
N + S+PSY +P+L+ L + + I G
Sbjct: 146 NPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEG 183
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 21/88 (23%), Positives = 43/88 (48%), Gaps = 5/88 (5%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 96
++ ++ LSG +L I P + + L +LW+ + + + L L ++L +N
Sbjct: 207 IKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHN 265
Query: 97 ELTGSLPSYM-GSLPNLQELHIENNSFV 123
LT LP + L +L+ +H+ +N +
Sbjct: 266 NLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 24/94 (25%), Positives = 38/94 (40%), Gaps = 9/94 (9%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHL-E 94
+ + L L IP + L ELWL N + +P +R+ LR + L E
Sbjct: 112 ANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGE 169
Query: 95 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIP 127
L+ + L NL+ L++ + EIP
Sbjct: 170 LKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP 201
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 19/82 (23%), Positives = 35/82 (42%), Gaps = 10/82 (12%)
Query: 57 PELKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPN 111
P L + L EL L GN L+ G + L L + +++ + +L +
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKL---WMIQSQIQ-VIERNAFDNLQS 256
Query: 112 LQELHIENNSFVGEIPPALLTG 133
L E+++ +N+ +P L T
Sbjct: 257 LVEINLAHNNLT-LLPHDLFTP 277
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 19/110 (17%), Positives = 44/110 (40%), Gaps = 8/110 (7%)
Query: 34 STTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL 93
S +T + ++ ++ ++ + LT+L N +T D+S+ +L +
Sbjct: 37 SEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITT--LDLSQNTNLTYLAC 92
Query: 94 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 143
++N+LT +L + L L L+ + N ++ + N
Sbjct: 93 DSNKLT-NLD--VTPLTKLTYLNCDTNKL-TKLDVSQNPLLTYLNCARNT 138
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 24/107 (22%), Positives = 39/107 (36%), Gaps = 9/107 (8%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
+ ++ N+ ++ L LT L N LT D++ L L N L
Sbjct: 191 KLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE--IDVTPLTQLTYFDCSVNPL 245
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 145
T L + +L L LH + EI T + F+ + K+
Sbjct: 246 T-ELD--VSTLSKLTTLHCIQTDLL-EIDLTHNTQLIYFQAEGCRKI 288
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 15/82 (18%), Positives = 30/82 (36%), Gaps = 7/82 (8%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
++T++ ++ LT L N +T D+S+ L ++ + N +
Sbjct: 148 TQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITE--LDVSQNKLLNRLNCDTNNI 203
Query: 99 TGSLPSYMGSLPNLQELHIENN 120
T L + L L +N
Sbjct: 204 T-KLD--LNQNIQLTFLDCSSN 222
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 16/75 (21%), Positives = 28/75 (37%), Gaps = 5/75 (6%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY 105
+ + ++ + L L +T L D+S+ L ++L N ELT L
Sbjct: 280 FQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELT-ELD-- 334
Query: 106 MGSLPNLQELHIENN 120
+ L+ L N
Sbjct: 335 VSHNTKLKSLSCVNA 349
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 19/94 (20%), Positives = 34/94 (36%), Gaps = 8/94 (8%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
++ + + E+ L L L+L+ LT L D+S L+ + N +
Sbjct: 297 TQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-L-DVSHNTKLKSLSCVNAHI 351
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 132
S +G +P L + +P LT
Sbjct: 352 Q-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLT 382
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 19/97 (19%), Positives = 37/97 (38%), Gaps = 8/97 (8%)
Query: 36 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 95
+T ++T + +L EI L + L +G L D++ L ++ +
Sbjct: 251 STLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL-DVTHNTQLYLLDCQA 306
Query: 96 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 132
+T L + P L L++ N E+ + T
Sbjct: 307 AGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVSHNT 339
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 16/84 (19%), Positives = 26/84 (30%), Gaps = 7/84 (8%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
++T + L ++ + LT L N LT D+S L + N+
Sbjct: 106 TKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT--EIDVSHNTQLTELDCHLNKK 160
Query: 99 TGSLPSYMGSLPNLQELHIENNSF 122
L + L L N
Sbjct: 161 ITKLD--VTPQTQLTTLDCSFNKI 182
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 25/115 (21%), Positives = 39/115 (33%), Gaps = 10/115 (8%)
Query: 38 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLEN 95
+ + LS + I L+ L L L N + D S L L + L
Sbjct: 51 TEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSY 109
Query: 96 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPA----LLTGKVIFKYDNNPKL 145
N L+ +L S L +L L++ N + + LT I + N
Sbjct: 110 NYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTF 162
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 11/65 (16%), Positives = 27/65 (41%), Gaps = 2/65 (3%)
Query: 59 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHI 117
L + + L + ++++ L + N+L S+P + L +LQ++ +
Sbjct: 250 LIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWL 308
Query: 118 ENNSF 122
N +
Sbjct: 309 HTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 20/83 (24%), Positives = 31/83 (37%), Gaps = 5/83 (6%)
Query: 55 IPPEL-KNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLP 110
+ K + +LT L L GN G S L L+I+ + N + + L
Sbjct: 115 LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLT 174
Query: 111 NLQELHIENNSFVGEIPPALLTG 133
L+EL I+ + P L
Sbjct: 175 FLEELEIDASDLQ-SYEPKSLKS 196
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 8/99 (8%)
Query: 39 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 95
+TK+ +S + + + +++ L L + N L + S L L + LE
Sbjct: 104 SNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEK 161
Query: 96 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
LT S+P+ L L L + + + I
Sbjct: 162 CNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKR 198
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 22/100 (22%), Positives = 40/100 (40%), Gaps = 8/100 (8%)
Query: 38 PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLE 94
P + L +K + + + L EL L+ N ++ + + L +LR + L
Sbjct: 31 PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLR 88
Query: 95 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
+N L +P + L NL +L I N V + +
Sbjct: 89 SNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQD 126
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 18/97 (18%), Positives = 35/97 (36%), Gaps = 4/97 (4%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 96
+ ++ L NL IP E L ++ L L L + RL L+++ + +
Sbjct: 152 NSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHW 210
Query: 97 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
++ NL L I + + +P +
Sbjct: 211 PYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRH 246
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 20/91 (21%), Positives = 39/91 (42%), Gaps = 11/91 (12%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLT----GPLPDMSRLIDLRIVHL 93
+ + LS + I L + L E+ L G L ++ L R++++
Sbjct: 248 VYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL---RVLNV 303
Query: 94 ENNELTGSLPSYM-GSLPNLQELHIENNSFV 123
N+LT +L + S+ NL+ L +++N
Sbjct: 304 SGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 18/98 (18%), Positives = 41/98 (41%), Gaps = 6/98 (6%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 96
+T ++++ NL +P ++++ L L L N ++ M L+ L+ + L
Sbjct: 224 LNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGG 282
Query: 97 ELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
+L + Y L L+ L++ N + ++
Sbjct: 283 QLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHS 318
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 53.6 bits (128), Expect = 8e-08
Identities = 22/115 (19%), Positives = 39/115 (33%), Gaps = 13/115 (11%)
Query: 21 DPCVPVPWEWVTCS----TTTPPRI------TKIALSGKNLKGEIPPE-LKNMEALTELW 69
D C P + C+ + + T++ + + + L+ + L L
Sbjct: 3 DACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLT 62
Query: 70 LDGNFLTGPLPDM-SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 123
+ + L PD L ++L N L SL +LQEL + N
Sbjct: 63 IVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 1e-05
Identities = 18/95 (18%), Positives = 33/95 (34%), Gaps = 7/95 (7%)
Query: 54 EIPPELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMGS-LP 110
+ L E LTEL+++ L + L +LR + + + L + P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 111 NLQELHIENNSFVGEIPPALLTGK--VIFKYDNNP 143
L L++ N+ + + G NP
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNP 114
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 15/84 (17%), Positives = 36/84 (42%), Gaps = 4/84 (4%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
R+ ++ +S L + + + L L L N L + + L ++L++N +
Sbjct: 278 QRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSI 336
Query: 99 TGSLPSYMGSLPNLQELHIENNSF 122
+L + + L+ L + +N +
Sbjct: 337 V-TLK--LSTHHTLKNLTLSHNDW 357
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 22/99 (22%), Positives = 42/99 (42%), Gaps = 8/99 (8%)
Query: 39 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 95
I K+ + ++ +PP + +N+ LT L L+ N L+ LP L + + N
Sbjct: 99 HTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSN 156
Query: 96 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
N L + + +LQ L + +N + +L+
Sbjct: 157 NNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPS 193
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 14/100 (14%), Positives = 37/100 (37%), Gaps = 6/100 (6%)
Query: 37 TPPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLE 94
T + ++ ++P L + + L L+ + + ++ +++
Sbjct: 49 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 107
Query: 95 NNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
N + LP ++ ++P L L +E N +P +
Sbjct: 108 FNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 145
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 21/99 (21%), Positives = 41/99 (41%), Gaps = 8/99 (8%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 95
++ + L+ ++ EI + +L++ N + LP + L ++ LE
Sbjct: 75 RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLER 132
Query: 96 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
N+L+ SLP + + P L L + NN+ I
Sbjct: 133 NDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQA 169
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 21/94 (22%), Positives = 35/94 (37%), Gaps = 7/94 (7%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 97
P + ++ S ++ + + LT L L N LT + L V L NE
Sbjct: 210 PIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNE 265
Query: 98 LTGSLPSYM-GSLPNLQELHIENNSFVGEIPPAL 130
L + + + L+ L+I NN V +
Sbjct: 266 LE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYG 297
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 8/87 (9%)
Query: 39 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 95
P +T + L +L +P + N LT L + N L + D L+ + L +
Sbjct: 123 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 180
Query: 96 NELTGSLPSYMGSLPNLQELHIENNSF 122
N LT + +P+L ++ N
Sbjct: 181 NRLT-HVDL--SLIPSLFHANVSYNLL 204
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 36 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 95
+ P + +S L L A+ EL N + + ++L I+ L++
Sbjct: 189 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV-NVELTILKLQH 241
Query: 96 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
N LT + + P L E+ + N +I
Sbjct: 242 NNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVK 276
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 10/80 (12%), Positives = 31/80 (38%), Gaps = 6/80 (7%)
Query: 57 PELKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQ 113
E + + + + LP + + +++L + ++ + +Y +Q
Sbjct: 45 FEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQ 102
Query: 114 ELHIENNSFVGEIPPALLTG 133
+L++ N+ +PP +
Sbjct: 103 KLYMGFNAIR-YLPPHVFQN 121
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-07
Identities = 22/85 (25%), Positives = 36/85 (42%), Gaps = 2/85 (2%)
Query: 37 TPPRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 95
TP + ++ L K+ G+I L L L L + ++ +L L+ + L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSE 80
Query: 96 NELTGSLPSYMGSLPNLQELHIENN 120
N + G L LPNL L++ N
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGN 105
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 22/88 (25%), Positives = 35/88 (39%), Gaps = 8/88 (9%)
Query: 38 PPRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHL 93
P + LS NL + E + L L L N L + + +LR + L
Sbjct: 38 PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDL 95
Query: 94 ENNELTGSLPSYM-GSLPNLQELHIENN 120
+N L +L ++ L L+ L + NN
Sbjct: 96 SSNHLH-TLDEFLFSDLQALEVLLLYNN 122
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 34/173 (19%), Positives = 59/173 (34%), Gaps = 23/173 (13%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENN 96
+ + LS +L I E + L L L N L + S L L ++ L NN
Sbjct: 64 TNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNN 122
Query: 97 ELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRF 155
+ + + LQ+L++ N P L+ + PKL +
Sbjct: 123 HIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKD-----GNKLPKLMLLDLSSNKL 175
Query: 156 KLILGTSIGVLAILLVLFL----------CSLIVLRK--LRRKISNQKSYEKA 196
K + T + L + L C L L R++S+ +++
Sbjct: 176 KKLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQED 228
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 20/85 (23%), Positives = 39/85 (45%), Gaps = 2/85 (2%)
Query: 37 TPPRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 95
TP + ++ L ++ +G++ E L L LT + ++ +L L+ + L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSD 73
Query: 96 NELTGSLPSYMGSLPNLQELHIENN 120
N ++G L PNL L++ N
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGN 98
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 8e-04
Identities = 22/83 (26%), Positives = 37/83 (44%), Gaps = 7/83 (8%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP--LPDMSRLIDLRIVHLENN 96
++ K+ LS + G + + LT L L GN + + + +L +L+ + L N
Sbjct: 64 NKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
Query: 97 ELTGSLPSY----MGSLPNLQEL 115
E+T +L Y LP L L
Sbjct: 124 EVT-NLNDYRENVFKLLPQLTYL 145
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 13/99 (13%), Positives = 37/99 (37%), Gaps = 8/99 (8%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 95
+ ++ ++P L + + L L+ + + + ++ +++
Sbjct: 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGF 102
Query: 96 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
N + LP ++ ++P L L +E N +P +
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 139
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 21/83 (25%), Positives = 34/83 (40%), Gaps = 4/83 (4%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNE 97
+T + L NL L N L E+ L N L ++ L +++ NN
Sbjct: 226 VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283
Query: 98 LTGSLPSYMGSLPNLQELHIENN 120
L +L Y +P L+ L + +N
Sbjct: 284 LV-ALNLYGQPIPTLKVLDLSHN 305
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 20/87 (22%), Positives = 35/87 (40%), Gaps = 8/87 (9%)
Query: 39 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 95
P +T + L +L +P + N LT L + N L + D L+ + L +
Sbjct: 117 PLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSS 174
Query: 96 NELTGSLPSYMGSLPNLQELHIENNSF 122
N LT + +P+L ++ N
Sbjct: 175 NRLT-HVDL--SLIPSLFHANVSYNLL 198
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 19/98 (19%), Positives = 35/98 (35%), Gaps = 10/98 (10%)
Query: 36 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN 95
+ P + +S L L A+ EL N + + ++L I+ L++
Sbjct: 183 SLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV-NVELTILKLQH 235
Query: 96 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
N LT + + P L E+ + N +I
Sbjct: 236 NNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFVK 270
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 19/95 (20%), Positives = 37/95 (38%), Gaps = 5/95 (5%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
P + + LS +L + + L L+LD N + L +S L+ + L +N+
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDW 351
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
+ S N+ +++ +I L G
Sbjct: 352 DCN--SLRALFRNVARPAVDDADQHCKIDYQLEHG 384
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 8/99 (8%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 95
R+ + L L+ E+ P + + AL L+L N L LPD L +L + L
Sbjct: 105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHG 162
Query: 96 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
N ++ S+P L +L L + N + P
Sbjct: 163 NRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 21/84 (25%), Positives = 31/84 (36%), Gaps = 7/84 (8%)
Query: 54 EIPPE-LKNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSL 109
+ P + L L LD L L L L+ ++L++N L +LP L
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDL 152
Query: 110 PNLQELHIENNSFVGEIPPALLTG 133
NL L + N +P G
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRG 175
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 20/104 (19%), Positives = 41/104 (39%), Gaps = 9/104 (8%)
Query: 32 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRI 90
C + + L+ +P + A ++L GN ++ P +L I
Sbjct: 7 VCYNEPK---VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTI 60
Query: 91 VHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
+ L +N L + + L L++L + +N+ + + PA G
Sbjct: 61 LWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHG 103
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 21/89 (23%), Positives = 39/89 (43%), Gaps = 7/89 (7%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLEN 95
+T + L G + +P + + +L L L N + + L L ++L
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFA 210
Query: 96 NELTGSLPSY-MGSLPNLQELHIENNSFV 123
N L+ +LP+ + L LQ L + +N +V
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 28/108 (25%), Positives = 40/108 (37%), Gaps = 22/108 (20%)
Query: 32 TCSTTT---------------PPRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFL 75
TCS P IT+I L +K IPP + L + L N +
Sbjct: 10 TCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQI 68
Query: 76 TGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 120
+ L L L + L N++T LP + L +LQ L + N
Sbjct: 69 SE-LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNAN 114
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 20/84 (23%), Positives = 36/84 (42%), Gaps = 5/84 (5%)
Query: 42 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNEL 98
+ L G + E+P L + + +L L L+ N + L L +L ++ L +N+L
Sbjct: 83 NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKL 140
Query: 99 TGSLPSYMGSLPNLQELHIENNSF 122
L +Q +H+ N F
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 26/96 (27%), Positives = 38/96 (39%), Gaps = 12/96 (12%)
Query: 35 TTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLE 94
P + K+ + G L +P L EL + N L LP + +L +
Sbjct: 117 PALPSGLCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLAS-LPAL--PSELCKLWAY 169
Query: 95 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
NN+LT SLP LQEL + +N +P
Sbjct: 170 NNQLT-SLPM---LPSGLQELSVSDNQLA-SLPTLP 200
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 22/89 (24%), Positives = 32/89 (35%), Gaps = 8/89 (8%)
Query: 42 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGS 101
+ + L +P L +T L + N LT LP +LR + + N+LT S
Sbjct: 43 AVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLTS-LPA--LPPELRTLEVSGNQLT-S 95
Query: 102 LPSYMGSLPNLQELHIENNSFVGEIPPAL 130
LP L L +P L
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLP-ALPSGL 123
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 25/105 (23%), Positives = 38/105 (36%), Gaps = 24/105 (22%)
Query: 36 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVH-- 92
T P + K+ L +P L EL + GN LT LP S L +L +
Sbjct: 198 TLPSELYKLWAYNNRLT-SLPALPSG---LKELIVSGNRLTS-LPVLPSELKELMVSGNR 252
Query: 93 ---------------LENNELTGSLPSYMGSLPNLQELHIENNSF 122
+ N+LT LP + L + +++E N
Sbjct: 253 LTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPL 296
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 26/110 (23%), Positives = 41/110 (37%), Gaps = 26/110 (23%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNM-----------------EALTELWLDGNFLTGPLP 80
PP + + +SG L +P + L +LW+ GN LT LP
Sbjct: 80 PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTS-LP 137
Query: 81 DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
L+ + + +N+L SLP+ L +L NN +P
Sbjct: 138 V--LPPGLQELSVSDNQLA-SLPA---LPSELCKLWAYNNQLT-SLPMLP 180
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 8e-07
Identities = 15/87 (17%), Positives = 33/87 (37%), Gaps = 6/87 (6%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 95
+ T + +S + ++ ++ L L + N + L +L + L +
Sbjct: 20 SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQELEYLDLSH 78
Query: 96 NELTGSLPSYMGSLPNLQELHIENNSF 122
N+L + NL+ L + N+F
Sbjct: 79 NKLV-KISC--HPTVNLKHLDLSFNAF 102
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 6e-06
Identities = 15/100 (15%), Positives = 31/100 (31%), Gaps = 6/100 (6%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID----LRIVHL 93
+ S L + ++ L L L N L L ++ + L+ + +
Sbjct: 323 ISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDI 381
Query: 94 ENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLT 132
N ++ +L L++ +N I L
Sbjct: 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP 421
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 17/86 (19%), Positives = 37/86 (43%), Gaps = 4/86 (4%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 97
+ + +S L I L + L L N + + +L L+ +++ +N+
Sbjct: 398 TKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQ 455
Query: 98 LTGSLPSYM-GSLPNLQELHIENNSF 122
L S+P + L +LQ++ + N +
Sbjct: 456 LK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 27/142 (19%), Positives = 45/142 (31%), Gaps = 10/142 (7%)
Query: 65 LTELWLDGNFLTGPLPDM---SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 121
L L L N LP + L+ + L L S + L + L + +
Sbjct: 92 LKHLDLSFNAFDA-LPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 122 FVGEIPPALLTGKVIFKYDNNPKLHKESRRRMRFKLILGTSIGVLAILLVLFLCSLIVLR 181
+ + P L + N LH F IL S+ +A L + + ++
Sbjct: 151 YGEKEDPEGL------QDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204
Query: 182 KLRRKISNQKSYEKADSLRTST 203
K +S + L T
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLT 226
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 9e-07
Identities = 18/106 (16%), Positives = 37/106 (34%), Gaps = 16/106 (15%)
Query: 28 WEWVTCS----TTTPPRI----TKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTG 77
V CS P I ++ L+ + K + L ++ N +T
Sbjct: 13 GTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITD 71
Query: 78 PLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 120
+ + + + L +N L ++ M L +L+ L + +N
Sbjct: 72 -IEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSN 115
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 22/86 (25%), Positives = 43/86 (50%), Gaps = 9/86 (10%)
Query: 42 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNELT 99
+I L+ L+ + ++ K +E+L L L N +T D L +R++ L +N++T
Sbjct: 84 NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 100 GSLPSYMG---SLPNLQELHIENNSF 122
++ G +L +L L++ N F
Sbjct: 143 -TVAP--GAFDTLHSLSTLNLLANPF 165
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 47/236 (19%), Positives = 87/236 (36%), Gaps = 65/236 (27%)
Query: 241 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------N 292
+G+G+FG V + +VA+KI+ + +R + E+ +L +I +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFL 83
Query: 293 LVPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAA 344
V + + C + +E + + L + N +P L ++ +A+
Sbjct: 84 CVLMSDWFNFHGHMC-------IAFELLGK-NTFEFLKEN-NFQPYP-LPHVRHMAYQLC 133
Query: 345 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------KVSDFGLSR 385
L +LH + H D+K NIL + +V+DFG +
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 386 QAEEDL-THISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGK 435
E T +++ R Y PE + + DV+S G +L E G
Sbjct: 191 FDHEHHTTIVAT--R---HYRPPEVILELGWA-----QPCDVWSIGCILFEYYRGF 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 20/82 (24%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
++ ++L + +I L ++ L L+L N +T + +SRL L + LE+N++
Sbjct: 112 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 168
Query: 99 TGSLPSYMGSLPNLQELHIENN 120
+ + + L LQ L++ N
Sbjct: 169 S-DIVP-LAGLTKLQNLYLSKN 188
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 17/62 (27%), Positives = 33/62 (53%), Gaps = 3/62 (4%)
Query: 59 LKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118
LK+++ L L L+ N ++ + + L L ++L NN++T + + L L L +E
Sbjct: 108 LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLE 164
Query: 119 NN 120
+N
Sbjct: 165 DN 166
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 16/85 (18%), Positives = 37/85 (43%), Gaps = 3/85 (3%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
++ ++L + +I P L + L L+L N ++ L ++ L +L ++ L + E
Sbjct: 156 TKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQEC 212
Query: 99 TGSLPSYMGSLPNLQELHIENNSFV 123
++ +L + + S V
Sbjct: 213 LNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 21/82 (25%), Positives = 45/82 (54%), Gaps = 5/82 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
I +I + ++K + ++ + +T+L+L+GN LT + ++ L +L + L+ N++
Sbjct: 46 NSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTD-IKPLANLKNLGWLFLDENKV 102
Query: 99 TGSLPSYMGSLPNLQELHIENN 120
L S + L L+ L +E+N
Sbjct: 103 K-DLSS-LKDLKKLKSLSLEHN 122
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 27/82 (32%), Positives = 46/82 (56%), Gaps = 5/82 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
P +TK+ L+G L +I P L N++ L L+LD N + L + L L+ + LE+N +
Sbjct: 68 PNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGI 124
Query: 99 TGSLPSYMGSLPNLQELHIENN 120
+ + + LP L+ L++ NN
Sbjct: 125 S-DING-LVHLPQLESLYLGNN 144
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 23/105 (21%), Positives = 44/105 (41%), Gaps = 5/105 (4%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
+ + L + I P L + L L + ++ L ++ L L + ++N++
Sbjct: 129 SNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKI 185
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 143
+ + + SLPNL E+H++NN P A + I N
Sbjct: 186 S-DISP-LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQT 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 21/106 (19%), Positives = 46/106 (43%), Gaps = 6/106 (5%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
+ +++ + ++ P L N+ LT L D N ++ + ++ L +L VHL+NN++
Sbjct: 151 TNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQI 207
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNPK 144
+ + + + NL + + N + P V+ P
Sbjct: 208 S-DVSP-LANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPS 250
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 18/82 (21%), Positives = 39/82 (47%), Gaps = 5/82 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
I + L+ ++ P L + L L+LD N +T + ++ L +L+ + + N ++
Sbjct: 107 QSIKTLDLTS-TQITDVTP-LAGLSNLQVLYLDLNQITN-ISPLAGLTNLQYLSIGNAQV 163
Query: 99 TGSLPSYMGSLPNLQELHIENN 120
+ L + +L L L ++N
Sbjct: 164 S-DLTP-LANLSKLTTLKADDN 183
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 17/90 (18%), Positives = 39/90 (43%), Gaps = 6/90 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
IT ++ G + I ++ + L L L N +T L + L + + L N L
Sbjct: 41 DGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPL 97
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPP 128
++ + + L +++ L + + + ++ P
Sbjct: 98 K-NVSA-IAGLQSIKTLDLTSTQ-ITDVTP 124
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 21/82 (25%), Positives = 42/82 (51%), Gaps = 5/82 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
+ + L + ++ P LKN+ +TEL L GN L + ++ L ++ + L + ++
Sbjct: 63 NNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQI 119
Query: 99 TGSLPSYMGSLPNLQELHIENN 120
T + + L NLQ L+++ N
Sbjct: 120 TD--VTPLAGLSNLQVLYLDLN 139
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 18/82 (21%), Positives = 37/82 (45%), Gaps = 5/82 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
KIA N+ + +++ +T L G +T + + L +L + L++N++
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQI 75
Query: 99 TGSLPSYMGSLPNLQELHIENN 120
T L + +L + EL + N
Sbjct: 76 T-DLAP-LKNLTKITELELSGN 95
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 21/103 (20%), Positives = 43/103 (41%), Gaps = 6/103 (5%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
++T + + +I P L ++ L E+ L N ++ + ++ +L IV L N +
Sbjct: 173 SKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQTI 229
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDN 141
T + P + NL ++ I PA ++ + N
Sbjct: 230 T-NQPVFY--NNNLVVPNVVKGPSGAPIAPATISDNGTYASPN 269
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 17/90 (18%), Positives = 33/90 (36%), Gaps = 7/90 (7%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 104
NL ++P L L L N++ L L+++ L + ++
Sbjct: 11 YRFCNLT-QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 105 YM-GSLPNLQELHIENNSFVGEIPPALLTG 133
+LPNL+ L + ++ + P G
Sbjct: 67 EAFRNLPNLRILDLGSSKIY-FLHPDAFQG 95
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 27/112 (24%), Positives = 44/112 (39%), Gaps = 9/112 (8%)
Query: 38 PPRITKIALSGKNLKGEIPPEL-----KNMEALTELWLDGNFLTGPLPDM-SRLIDLRIV 91
P + ++ L L+ EL + + L L+L+ N+L P + S L LR +
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509
Query: 92 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 143
L +N LT L NL+ L I N + P + + +N
Sbjct: 510 SLNSNRLT-VLSHND-LPANLEILDISRNQLL-APNPDVFVSLSVLDITHNK 558
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 7/100 (7%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD---MSRLIDLRIVHLE 94
P + + L + + P+ + + L EL L L+ + L L + L
Sbjct: 73 PNLRILDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLS 131
Query: 95 NNELTG-SLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
N++ L G L +L+ + +N + L
Sbjct: 132 KNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEP 170
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 16/85 (18%), Positives = 34/85 (40%), Gaps = 5/85 (5%)
Query: 41 ITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDM-SRLIDLRIVHLENNEL 98
+ + LS + + + ++ L L L N + + L +L++++L N L
Sbjct: 268 VRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLL 326
Query: 99 TGSLPSYM-GSLPNLQELHIENNSF 122
L S LP + + ++ N
Sbjct: 327 G-ELYSSNFYGLPKVAYIDLQKNHI 350
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 18/103 (17%), Positives = 34/103 (33%), Gaps = 10/103 (9%)
Query: 39 PRITKIALSGKNLKGEIPPE--LKNMEALTELWLDGNFLTG------PLPDMSRLIDLRI 90
P + + L+ + +L +L+L N L L L++
Sbjct: 426 PHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQV 484
Query: 91 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG 133
++L +N L P L L+ L + +N + L
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPA 526
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 18/99 (18%), Positives = 34/99 (34%), Gaps = 6/99 (6%)
Query: 46 LSGKNLKGEIPPE--LKNMEALTELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGS 101
L L + + +N++ALT L L N + P +L L+ + +N++
Sbjct: 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163
Query: 102 LPSYMGSL--PNLQELHIENNSFVGEIPPALLTGKVIFK 138
+ L L + NS + F+
Sbjct: 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR 202
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 16/86 (18%), Positives = 31/86 (36%), Gaps = 3/86 (3%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENN 96
+ + L+ + +I E ++ L L L N L + L + + L+ N
Sbjct: 290 KDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKN 348
Query: 97 ELTGSLPSYMGSLPNLQELHIENNSF 122
+ L LQ L + +N+
Sbjct: 349 HIAIIQDQTFKFLEKLQTLDLRDNAL 374
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 21/82 (25%), Positives = 41/82 (50%), Gaps = 5/82 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
++ ++L + +I L ++ L L+L N +T + +SRL L + LE+N++
Sbjct: 109 KKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI 165
Query: 99 TGSLPSYMGSLPNLQELHIENN 120
+ + G L LQ L++ N
Sbjct: 166 S-DIVPLAG-LTKLQNLYLSKN 185
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 4e-05
Identities = 19/82 (23%), Positives = 40/82 (48%), Gaps = 5/82 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
+ + L +K ++ LK+++ L L L+ N ++ + + L L ++L NN++
Sbjct: 87 KNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISD-INGLVHLPQLESLYLGNNKI 143
Query: 99 TGSLPSYMGSLPNLQELHIENN 120
T + + L L L +E+N
Sbjct: 144 TD--ITVLSRLTKLDTLSLEDN 163
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 4e-05
Identities = 13/82 (15%), Positives = 35/82 (42%), Gaps = 5/82 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
K L K++ + + ++ ++ + + + + + L ++ + L N+L
Sbjct: 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKL 77
Query: 99 TGSLPSYMGSLPNLQELHIENN 120
T + + +L NL L ++ N
Sbjct: 78 T-DI-KPLTNLKNLGWLFLDEN 97
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 8e-05
Identities = 17/92 (18%), Positives = 39/92 (42%), Gaps = 5/92 (5%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
P++ + L + +I L + L L L+ N ++ + ++ L L+ ++L N +
Sbjct: 131 PQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHI 187
Query: 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+ L + L NL L + + + +
Sbjct: 188 S-DL-RALAGLKNLDVLELFSQECLNKPINHQ 217
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 27/82 (32%), Positives = 47/82 (57%), Gaps = 5/82 (6%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
P +TK+ L+G L +I P L N++ L L+LD N + L + L L+ + LE+N +
Sbjct: 65 PNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGI 121
Query: 99 TGSLPSYMGSLPNLQELHIENN 120
+ + + + LP L+ L++ NN
Sbjct: 122 S-DI-NGLVHLPQLESLYLGNN 141
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 15/84 (17%), Positives = 36/84 (42%), Gaps = 3/84 (3%)
Query: 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNEL 98
++ ++L + +I P L + L L+L N ++ L ++ L +L ++ L + E
Sbjct: 153 TKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQEC 209
Query: 99 TGSLPSYMGSLPNLQELHIENNSF 122
++ +L + + S
Sbjct: 210 LNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 18/92 (19%), Positives = 30/92 (32%), Gaps = 5/92 (5%)
Query: 34 STTTPPRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVH 92
++ + LS +L+ L L L L + L ++
Sbjct: 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPA--KLSVLD 280
Query: 93 LENNELTGSLPSYMGSLPNLQELHIENNSFVG 124
L N L PS LP + L ++ N F+
Sbjct: 281 LSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 6e-06
Identities = 15/99 (15%), Positives = 32/99 (32%), Gaps = 8/99 (8%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--------DMSRLIDLR 89
P + ++++ + +++ AL+ L L N G L L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 90 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 128
+ + +G + + LQ L + +NS
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 21/114 (18%), Positives = 39/114 (34%), Gaps = 4/114 (3%)
Query: 21 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP 80
+PC + P + E+ +++E L +D G
Sbjct: 4 EPCELDEESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRSLEYL-LKRVDTEADLGQFT 62
Query: 81 DMSRLIDLRIVHLENNELTGSLPSYM---GSLPNLQELHIENNSFVGEIPPALL 131
D+ + + L+ + + + + + LQEL +EN G PP LL
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 16/96 (16%), Positives = 30/96 (31%), Gaps = 7/96 (7%)
Query: 39 PRITKIALSGKNLKGEIPPELKN--MEALTELWLDGNFLTGPLPDMSRLID-----LRIV 91
+ ++ L + G PP L L L L ++ L L+++
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154
Query: 92 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 127
+ + P L L + +N +GE
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 20/115 (17%), Positives = 38/115 (33%), Gaps = 17/115 (14%)
Query: 21 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PL 79
DP CS + L ++P + + + L N +
Sbjct: 2 DPGTS------ECSVIG----YNAICINRGLH-QVPELPAH---VNYVDLSLNSIAELNE 47
Query: 80 PDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
SRL DL+ + +E + + L +L L ++ N F+ ++ G
Sbjct: 48 TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNG 101
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 20/86 (23%), Positives = 36/86 (41%), Gaps = 7/86 (8%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLEN 95
+ ++ L+ + +I + L +L L NFL + L L ++ L
Sbjct: 299 TDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSY 356
Query: 96 NELTGSLPSYM-GSLPNLQELHIENN 120
N + +L LPNL+EL ++ N
Sbjct: 357 NHIR-ALGDQSFLGLPNLKELALDTN 381
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 24/85 (28%), Positives = 42/85 (49%), Gaps = 7/85 (8%)
Query: 42 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLENNEL 98
K+ LS L I + +N++ L L L N + L D S L +L+ + L+ N+L
Sbjct: 326 LKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELALDTNQL 383
Query: 99 TGSLPSYM-GSLPNLQELHIENNSF 122
S+P + L +LQ++ + N +
Sbjct: 384 K-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 14/87 (16%), Positives = 27/87 (31%), Gaps = 6/87 (6%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTG-PLPDMS--RLIDLRIVHLE 94
+ + L ++ + L L L L G L L L ++ L
Sbjct: 79 SSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLR 137
Query: 95 NNELTGSLPSYM-GSLPNLQELHIENN 120
+N + P+ ++ L + N
Sbjct: 138 DNNIKKIQPASFFLNMRRFHVLDLTFN 164
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 2e-06
Identities = 50/319 (15%), Positives = 88/319 (27%), Gaps = 101/319 (31%)
Query: 266 IMADSCSHRTQQFVTEVA------LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 319
+ Q+FV EV L+S I P + Y R
Sbjct: 70 TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM--------YIEQ-----R 116
Query: 320 DRLHGSVNQKPLDWLTRLQIAHDAAKGLE--------YLH--TGCNPGIIHRDVKSS--- 366
DRL+ ++RLQ + L + G G K+
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS--G------KTWVAL 168
Query: 367 NILLDINMRAKVSD------FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSD 420
++ L ++ K+ E L + + +DP + T +SD
Sbjct: 169 DVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY----QIDPNW------TSRSD 218
Query: 421 VYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS--IVDPVLIGNVKIES 478
S + + AEL R + K ++ NV+
Sbjct: 219 -----------HSSNIKLRIHSIQAELR-----RLLKSKPYENCLLVLL-----NVQNAK 257
Query: 479 IWRIAEVAIQCVEQRGFSRPKMQEIVL----AIQDSIKIEKGGD---QKFSSSSSKGQSS 531
W + C K+ ++ + D + S + + +
Sbjct: 258 AWN--AFNLSC---------KI--LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV- 303
Query: 532 RKTLLTSFLEIESPDLSNE 550
K+LL +L+ DL E
Sbjct: 304 -KSLLLKYLDCRPQDLPRE 321
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 1e-05
Identities = 57/327 (17%), Positives = 98/327 (29%), Gaps = 81/327 (24%)
Query: 30 WVTCSTTT-PPRITKI---ALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRL 85
++ C P + LS I +++ A + W N ++ +
Sbjct: 310 YLDCRPQDLPREVLTTNPRRLSI------IAESIRDGLATWDNWKHVNC-----DKLTTI 358
Query: 86 IDLRIVHLENNELTGSLPSYMGSLPNLQELHI-ENNSFVGEIPPALLTGKVIFKYDNNP- 143
I+ + LE E L + ++ IP LL + +D
Sbjct: 359 IESSLNVLEPAEYR----------KMFDRLSVFPPSA---HIPTILL---SLIWFDVIKS 402
Query: 144 -------KLHKES---RRRMRFKLILGTSIGVLAILLVLFLCSLIVLRKLRRKISNQKSY 193
KLHK S ++ +I + +I L L L L R I + +
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKES------TISIPSIYLEL-KVKLENEYALHRSIVDHYNI 455
Query: 194 EKADSLRTSTKPSNTAYSIARGGHFMDEGVAYFIPLPELEEATNNFCKKIGKGSFGSVYY 253
K P Y + GH + E E F V+
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGHHLKNI--------EHPERMTLFRM---------VFL 498
Query: 254 GKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313
D + + KI DS + + L ++ + P I + +++R LV +
Sbjct: 499 ----DFRFLEQKIRHDSTAWNASGSILN--TLQQL--KFYKPYICDNDPKYER-LVNAIL 549
Query: 314 HNGTLRDRLHGSVNQKPLDWLTRLQIA 340
L + K D L+IA
Sbjct: 550 DF--LPKIEENLICSKYTDL---LRIA 571
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 52/241 (21%), Positives = 91/241 (37%), Gaps = 71/241 (29%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-----HHRNLV 294
+K+G G+FG V + + + K AVK++ + + + E +L +I ++ N+V
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT-RSAKIEADILKKIQNDDINNNNIV 99
Query: 295 PLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAAKG 346
G C L++E + +L + + + N + ++ + K
Sbjct: 100 KYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRN-NYNGFH-IEDIKLYCIEILKA 149
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------------KVSDF 381
L YL + H D+K NILLD K+ DF
Sbjct: 150 LNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 382 GLSRQAEEDL-THISSVARGTVGYLDPE------YYGNQQLTEKSDVYSFGVVLLELISG 434
G + + + I++ R Y PE + SD++SFG VL EL +G
Sbjct: 207 GCATFKSDYHGSIINT--R---QYRAPEVILNLGW------DVSSDMWSFGCVLAELYTG 255
Query: 435 K 435
Sbjct: 256 S 256
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 22/100 (22%), Positives = 39/100 (39%), Gaps = 6/100 (6%)
Query: 39 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGN-FLTGPLPDM-SRLIDLRIVHLEN 95
P I++I +S ++ N+ +T + + LT PD L L+ + + N
Sbjct: 55 PNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFN 114
Query: 96 NELTGSLP--SYMGSLPNLQELHIENNSFVGEIPPALLTG 133
L P + + S L I +N ++ IP G
Sbjct: 115 TGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 19/108 (17%), Positives = 37/108 (34%), Gaps = 19/108 (17%)
Query: 32 TCSTTTPPRITKIALSGKNLKG--EIPPELKNMEALTELWLDGNFLTGPLPDM--SRLID 87
C ++ K+++ +PP L L L +P S L +
Sbjct: 9 ECHQEE-----DFRVTCKDIQRIPSLPPST------QTLKLIETHLRT-IPSHAFSNLPN 56
Query: 88 LRIVHL-ENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
+ +++ + L L S+ +L + + I N + I P L
Sbjct: 57 ISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKE 103
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 21/101 (20%), Positives = 40/101 (39%), Gaps = 16/101 (15%)
Query: 35 TTTPPRI-----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 89
+ +++ L+ NL +P L +T L + N L LP++ L
Sbjct: 50 VSLLKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPEL--PASLE 103
Query: 90 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
+ +N L+ +LP +L+ L ++NN +P
Sbjct: 104 YLDACDNRLS-TLPE---LPASLKHLDVDNNQLT-MLPELP 139
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 23/104 (22%), Positives = 34/104 (32%), Gaps = 16/104 (15%)
Query: 35 TTTPPRI---TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIV 91
T P I L +P + L L + N LT LP++ L +
Sbjct: 133 TMLPELPALLEYINADNNQLT-MLPELPTS---LEVLSVRNNQLTF-LPEL--PESLEAL 185
Query: 92 HLENNELTGSLPSYMGSLPNLQE----LHIENNSFVGEIPPALL 131
+ N L SLP+ + +E N IP +L
Sbjct: 186 DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENIL 227
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 49/236 (20%), Positives = 90/236 (38%), Gaps = 65/236 (27%)
Query: 241 KKIGKGSFGSVY--YGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------N 292
+G+G+FG V G+ VAVKI+ + + + +E+ +L ++
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYC-EAARSEIQVLEHLNTTDPNSTFR 78
Query: 293 LVPLIGY-------CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQ-IAHDAA 344
V ++ + C +V+E + + D + + P L ++ +A+
Sbjct: 79 CVQMLEWFEHHGHIC-------IVFELLGL-STYDFIKEN-GFLPFR-LDHIRKMAYQIC 128
Query: 345 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRA-------------------KVSDFGLSR 385
K + +LH + + H D+K NIL + KV DFG +
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 386 QAEEDL-THISSVARGTVGYLDPE-----YYGNQQLTEKSDVYSFGVVLLELISGK 435
+E T +S+ R Y PE + + DV+S G +L+E G
Sbjct: 186 YDDEHHSTLVST--R---HYRAPEVILALGWS-----QPCDVWSIGCILIEYYLGF 231
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 9e-06
Identities = 24/83 (28%), Positives = 40/83 (48%), Gaps = 7/83 (8%)
Query: 42 TKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNEL 98
+ L+ L+ +P + K ++ L LW+ N L LP +L++L + L+ N+L
Sbjct: 64 RLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQL 121
Query: 99 TGSLPSYM-GSLPNLQELHIENN 120
SLP + SL L L + N
Sbjct: 122 K-SLPPRVFDSLTKLTYLSLGYN 143
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 29/102 (28%), Positives = 44/102 (43%), Gaps = 15/102 (14%)
Query: 31 VTCS----TTTPPRI----TKIALSGKNLKGEIPPE-LKNMEALTELWLDGNFLTGPLPD 81
V CS T P I K+ L L +P + + L L+L+ N L LP
Sbjct: 21 VDCSSKKLTAIPSNIPADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPA 78
Query: 82 M--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 120
L +L + + +N+L +LP + L NL EL ++ N
Sbjct: 79 GIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRN 119
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 27/108 (25%), Positives = 46/108 (42%), Gaps = 19/108 (17%)
Query: 32 TCSTTTPPRITKIALSGKNLK---GEIPPELKNMEALTELWLDGNFLTGPLPDM--SRLI 86
+C+ + S K L IP + +L L N L+ LP RL
Sbjct: 13 SCNNNK----NSVDCSSKKLTAIPSNIPADT------KKLDLQSNKLSS-LPSKAFHRLT 61
Query: 87 DLRIVHLENNELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
LR+++L +N+L +LP+ + L NL+ L + +N +P +
Sbjct: 62 KLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQ 107
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 18/100 (18%), Positives = 39/100 (39%), Gaps = 9/100 (9%)
Query: 39 PRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLPDM--SRLIDLRIVHLEN 95
++ + L+G ++ + + +L +L L L + L L+ +++ +
Sbjct: 76 SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAH 133
Query: 96 NELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPALLTG 133
N + S Y +L NL+ L + +N I L
Sbjct: 134 NLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 22/119 (18%), Positives = 33/119 (27%), Gaps = 28/119 (23%)
Query: 21 DPCVPVPWEWVTCSTTT---------------PPRITKIALSGKNLKGEIPPE-LKNMEA 64
+PCV T P + LS L+ + +
Sbjct: 1 EPCV------EVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLR-HLGSYSFFSFPE 53
Query: 65 LTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 120
L L L + + D L L + L N + SL L +LQ+L
Sbjct: 54 LQVLDLSRCEIQT-IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVET 110
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 29/103 (28%), Positives = 39/103 (37%), Gaps = 17/103 (16%)
Query: 31 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 81
V C + P I K+ L L + + LT L LD N L L
Sbjct: 19 VDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAG 77
Query: 82 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 120
L +L + L NN+L SLP G L L +L++ N
Sbjct: 78 VFDDLTELGTLGLANNQLA-SLPL--GVFDHLTQLDKLYLGGN 117
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 23/62 (37%), Positives = 31/62 (50%), Gaps = 9/62 (14%)
Query: 64 ALTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIE 118
L +L+L GN L LP RL L+ + L N+L S+P+ G L NLQ L +
Sbjct: 108 QLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPA--GAFDKLTNLQTLSLS 163
Query: 119 NN 120
N
Sbjct: 164 TN 165
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 17/56 (30%), Positives = 29/56 (51%), Gaps = 2/56 (3%)
Query: 66 TELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 120
TEL+LDGN T ++S L ++ L NN ++ +L + ++ L L + N
Sbjct: 34 TELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYN 88
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 27/101 (26%), Positives = 41/101 (40%), Gaps = 14/101 (13%)
Query: 31 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 81
V CS P I T++ L G +P EL N + LT + L N ++ L +
Sbjct: 15 VRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQ 72
Query: 82 -MSRLIDLRIVHLENNELTGSLPSYM-GSLPNLQELHIENN 120
S + L + L N L +P L +L+ L + N
Sbjct: 73 SFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGN 112
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 5e-05
Identities = 17/83 (20%), Positives = 31/83 (37%), Gaps = 2/83 (2%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 97
R ++ L G + I ++ + N + L L L+ + + NN
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNR 75
Query: 98 LTGSLPSYMGSLPNLQELHIENN 120
+ +LP+L EL + NN
Sbjct: 76 ICRIGEGLDQALPDLTELILTNN 98
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 19/88 (21%), Positives = 37/88 (42%), Gaps = 8/88 (9%)
Query: 38 PPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLPDMS--RLIDLRIVHLE 94
PPR ++LS ++ E+ ++ + L L L N + L DL + +
Sbjct: 51 PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVS 108
Query: 95 NNELTGSLPSYMGSLPNLQELHIENNSF 122
+N L ++ + +L+ L + N F
Sbjct: 109 HNRLQ-NISC--CPMASLRHLDLSFNDF 133
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 15/77 (19%), Positives = 24/77 (31%), Gaps = 2/77 (2%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 104
LS + + + T L N T S L L+ + L+ N L +
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394
Query: 105 YMGSLPNLQELHIENNS 121
N+ L + S
Sbjct: 395 VALMTKNMSSLETLDVS 411
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 20/91 (21%), Positives = 39/91 (42%), Gaps = 4/91 (4%)
Query: 33 CSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVH 92
+ I + LS L G + L + L L N + D++ L L+ ++
Sbjct: 422 RTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELN 479
Query: 93 LENNELTGSLP-SYMGSLPNLQELHIENNSF 122
+ +N+L S+P L +LQ + + +N +
Sbjct: 480 VASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 22/91 (24%), Positives = 39/91 (42%), Gaps = 11/91 (12%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTG-PLPDMSRLIDLRIVHLENNELTGSLPS 104
S +NL +P +L L L N ++ +PD+S L +LR++ L +N + SL
Sbjct: 38 YSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDF 93
Query: 105 YMG---SLPNLQELHIENNSFVGEIPPALLT 132
+L+ L + +N I +
Sbjct: 94 --HVFLFNQDLEYLDVSHNRLQ-NISCCPMA 121
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 32/103 (31%), Positives = 48/103 (46%), Gaps = 17/103 (16%)
Query: 31 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 81
V C T+ P I T + L +LK + +LT+L+L GN L LP+
Sbjct: 12 VECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNG 70
Query: 82 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 120
++L L ++L N+L SLP+ G L L+EL + N
Sbjct: 71 VFNKLTSLTYLNLSTNQLQ-SLPN--GVFDKLTQLKELALNTN 110
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 7e-05
Identities = 20/99 (20%), Positives = 37/99 (37%), Gaps = 5/99 (5%)
Query: 39 PRITKIALSGKNLKGEIPPE-LKNMEALTELWL-DGNFLTGPLPDM-SRLIDLRIVHLEN 95
+ KI +S ++ I + N+ L E+ + N L P+ L +L+ + + N
Sbjct: 54 GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 113
Query: 96 NELTGSLPSYM-GSLPNLQELHIENNSFVGEIPPALLTG 133
+ LP L I++N + I G
Sbjct: 114 TGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG 151
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 16/100 (16%), Positives = 38/100 (38%), Gaps = 13/100 (13%)
Query: 31 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 82
+T S P K L K++ + + + ++ ++ + + + + +
Sbjct: 3 ITVSTPIKQIFPDDAFAETIKANLKKKSVT-DAVTQ-NELNSIDQIIANNSDIKS-VQGI 59
Query: 83 SRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF 122
L ++R + L N+L + + L NL L + N
Sbjct: 60 QYLPNVRYLALGGNKLH-DISAL-KELTNLTYLILTGNQL 97
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 24/83 (28%), Positives = 37/83 (44%), Gaps = 7/83 (8%)
Query: 41 ITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELT 99
I +I + ++K L N + L L GN L + + L +L + L N+L
Sbjct: 43 IDQIIANNSDIKSVQGIQYLPN---VRYLALGGNKLH-DISALKELTNLTYLILTGNQLQ 98
Query: 100 GSLPS-YMGSLPNLQELHIENNS 121
SLP+ L NL+EL + N
Sbjct: 99 -SLPNGVFDKLTNLKELVLVENQ 120
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 24/61 (39%), Positives = 31/61 (50%), Gaps = 9/61 (14%)
Query: 65 LTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIEN 119
L EL L N L LPD +L +L ++L +N+L SLP G L NL EL +
Sbjct: 111 LKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQ-SLPK--GVFDKLTNLTELDLSY 166
Query: 120 N 120
N
Sbjct: 167 N 167
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 9/61 (14%)
Query: 65 LTELWLDGNFLTGPLPDM--SRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIEN 119
LT L L GN L LP+ +L +L+ + L N+L SLP G L NL L++ +
Sbjct: 87 LTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ-SLPD--GVFDKLTNLTYLNLAH 142
Query: 120 N 120
N
Sbjct: 143 N 143
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 28/103 (27%), Positives = 40/103 (38%), Gaps = 17/103 (16%)
Query: 31 VTCS----TTTPPRI----TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD- 81
V C + P I + L + P ++ L EL+L N L LP
Sbjct: 24 VDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVG 82
Query: 82 -MSRLIDLRIVHLENNELTGSLPSYMG---SLPNLQELHIENN 120
L L ++ L N+LT LPS L +L+EL + N
Sbjct: 83 VFDSLTQLTVLDLGTNQLT-VLPS--AVFDRLVHLKELFMCCN 122
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 21/58 (36%), Positives = 30/58 (51%), Gaps = 4/58 (6%)
Query: 65 LTELWLDGNFLTGPLPD--MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 120
LT L L N LT LP RL+ L+ + + N+LT LP + L +L L ++ N
Sbjct: 90 LTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 7e-04
Identities = 13/111 (11%), Positives = 35/111 (31%), Gaps = 9/111 (8%)
Query: 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP-LIGYC 300
K +G + Y + + + + +K+ T E ++ + + VP ++ +
Sbjct: 20 KDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE 79
Query: 301 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
+ L+ + D + +I A+ + H
Sbjct: 80 RHDGWSNLLMSEADGVLCSEE--------YEDEQSPEKIIELYAECIRLFH 122
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 557 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.69 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.68 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.63 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.62 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.61 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.57 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.56 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.51 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.5 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.46 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.45 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.45 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.43 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.43 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.38 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.38 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.37 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.37 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.36 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.36 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.35 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.35 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.34 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.34 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.34 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.32 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.32 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.32 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.31 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.3 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.3 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.29 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.28 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.27 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.26 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.26 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.26 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.26 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.25 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.25 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.25 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.25 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.24 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.22 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.22 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.21 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.21 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.2 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.19 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.19 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.19 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.19 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.18 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.18 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.18 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.18 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.18 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.17 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.16 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.16 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.16 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.15 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.15 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.14 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.14 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.14 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.13 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.13 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.12 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.12 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.12 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.11 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.11 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.11 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.1 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.08 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.08 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.07 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.07 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.07 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.07 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.06 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.06 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.05 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.05 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.03 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.01 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.0 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 98.99 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.99 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 98.98 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 98.98 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 98.91 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 98.9 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 98.88 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 98.88 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 98.87 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.87 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.87 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 98.86 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 98.85 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.84 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.82 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.82 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 98.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 98.8 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.77 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.73 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 98.72 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.72 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 98.71 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.67 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 98.66 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 98.64 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 98.64 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 98.64 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.62 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 98.62 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.55 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 98.52 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.52 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.52 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.45 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.43 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.38 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 98.34 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.28 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 98.26 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.25 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.24 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.21 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.08 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.04 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.02 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.02 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.85 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 97.82 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.76 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.62 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.57 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 97.54 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.49 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 97.44 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.36 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.3 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.26 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.24 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.2 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.16 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 97.15 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.05 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 97.03 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 96.88 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.88 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.84 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.81 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.81 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.77 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.77 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.65 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 96.51 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.48 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 96.47 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.13 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 94.91 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 94.14 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 93.81 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.66 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 93.6 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 92.69 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 92.58 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 91.59 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 90.6 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 88.32 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.95 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.22 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-54 Score=432.71 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=207.9
Q ss_pred HHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
+.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++||
T Consensus 43 ~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 122 (329)
T 4aoj_A 43 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVF 122 (329)
T ss_dssp EEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 345788999999999999875 47889999998766666788999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccC------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEE
Q 008707 311 EYMHNGTLRDRLHGSV------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 378 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 378 (557)
|||++|+|.++++... ....+++..++.|+.|||+||+|||+ ++|+||||||+|||+++++.+||
T Consensus 123 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki 199 (329)
T 4aoj_A 123 EYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKI 199 (329)
T ss_dssp ECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEE
T ss_pred EcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEE
Confidence 9999999999997542 13468999999999999999999998 99999999999999999999999
Q ss_pred ecccCccccCCCC-ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 008707 379 SDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 456 (557)
Q Consensus 379 ~Dfgla~~~~~~~-~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 456 (557)
+|||+++...... ........||+.|||||++.+..++.++|||||||++|||+| |+.||...... + +...
T Consensus 200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------~-~~~~ 272 (329)
T 4aoj_A 200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------E-AIDC 272 (329)
T ss_dssp CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------H-HHHH
T ss_pred cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------H-HHHH
Confidence 9999998764332 222334568999999999999999999999999999999999 89999743321 1 1222
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 457 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 457 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
+.++..... +...+..+.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 273 i~~g~~~~~---------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 273 ITQGRELER---------PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHTCCCCC---------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHcCCCCCC---------cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 333332211 122344788999999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=430.02 Aligned_cols=259 Identities=28% Similarity=0.453 Sum_probs=214.5
Q ss_pred HHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
.+.+.+.||+|+||.||+|.+. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..++|
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 3456789999999999999864 4778999999876666678899999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccC----------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEe
Q 008707 310 YEYMHNGTLRDRLHGSV----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 379 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 379 (557)
||||++|+|.++++... ....+++..++.++.|||+||+|||+ ++|+||||||+|||+++++.+||+
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEEC
Confidence 99999999999997531 24579999999999999999999998 999999999999999999999999
Q ss_pred cccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHH
Q 008707 380 DFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI 457 (557)
Q Consensus 380 Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 457 (557)
|||+|+....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||...+.. + +...+
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~-~~~~i 243 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------E-VIECI 243 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------H-HHHHH
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHHH
Confidence 9999987544322 22233458999999999999999999999999999999999 89999743321 1 22233
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 458 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 458 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
..+..... +...+.++.+++.+||+.||++|||++||.+.|+++.+.
T Consensus 244 ~~~~~~~~---------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 244 TQGRVLQR---------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 34433221 122345788999999999999999999999999988764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-54 Score=429.74 Aligned_cols=261 Identities=23% Similarity=0.399 Sum_probs=213.4
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecC
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 304 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 304 (557)
+...+++|.++||+|+||+||+|.+. +++.||||+++.... ...+.|.+|+.++++++|||||+++|+|.+++
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 33345568899999999999999873 467899999975433 34578999999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhccC-------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC
Q 008707 305 QRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 371 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~ 371 (557)
..++|||||++|+|.+++.... ....+++..++.|+.|||+||+|||+ ++|+||||||+||||+
T Consensus 103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVY 179 (308)
T ss_dssp SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEEC
Confidence 9999999999999999996432 12458999999999999999999999 9999999999999999
Q ss_pred CCCcEEEecccCccccCCCC-ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccH
Q 008707 372 INMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 449 (557)
Q Consensus 372 ~~~~~kl~Dfgla~~~~~~~-~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~ 449 (557)
+++.+||+|||+++...... ........||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+..
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~----- 254 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ----- 254 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-----
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-----
Confidence 99999999999998754332 222334568999999999999999999999999999999999 89999744321
Q ss_pred HHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 450 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 450 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
+ +...+..+..... +...+..+.+++.+||+.||++||||+||++.|+...
T Consensus 255 -~-~~~~i~~~~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 255 -D-VVEMIRNRQVLPC---------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp -H-HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -H-HHHHHHcCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 1 2233344433221 1223457889999999999999999999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=420.41 Aligned_cols=258 Identities=30% Similarity=0.491 Sum_probs=203.4
Q ss_pred HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
+.+.++||+|+||+||+|.+++ .||||+++.. .....+.|.+|++++++++|||||+++|++.+ +..++|||||+
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~ 114 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCE 114 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCS
T ss_pred eEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCC
Confidence 3578999999999999998763 5999998643 23455789999999999999999999998865 56899999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC-cc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-TH 393 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~ 393 (557)
+|+|.++++.. ...+++..+..|+.|||+||+|||+ ++|+||||||+|||+++++.+||+|||+|+...... ..
T Consensus 115 gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 115 GSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp SCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 99999999743 4569999999999999999999998 999999999999999999999999999998754322 22
Q ss_pred ccccccCCCCccCCcccCC---CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 394 ISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~---~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
......||+.|||||++.+ ..|+.++|||||||++|||+||+.||...+.. ..+...+..+... +.+
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~~----p~~ 259 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYAS----PDL 259 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCCC----CCS
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCC----CCc
Confidence 2344569999999999864 35899999999999999999999999743321 1122223332211 111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
.......+..+.+++.+||+.||++||||+||++.|+.+...
T Consensus 260 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 260 -SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp -TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred -ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 112223345788999999999999999999999999887654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=416.09 Aligned_cols=264 Identities=24% Similarity=0.269 Sum_probs=212.0
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+++.++||+|+||.||+|.++ +|+.||||+++.... ..+|+.+++.++|||||++++++.+++..|+|||||+|
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 345678999999999999876 589999999875322 24699999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC-cEEEecccCccccCCCCcc-
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEEDLTH- 393 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~~- 393 (557)
|+|.++++. ...+++..+..++.||+.||+|||+ ++|+||||||+||||+.++ .+||+|||+|+........
T Consensus 135 g~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 135 GSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp CBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999974 3569999999999999999999998 9999999999999999887 5999999999876543221
Q ss_pred ---ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 394 ---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 394 ---~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
......||+.|||||++.+..|+.++|||||||++|||+||+.||...+.... ... +..+...
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~-----i~~~~~~------- 274 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLK-----IASEPPP------- 274 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HHH-----HHHSCCG-------
T ss_pred ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHH-----HHcCCCC-------
Confidence 12335699999999999999999999999999999999999999975443221 111 1111110
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCCCccccCC
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFSSSS 525 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~~~~~~ 525 (557)
..+.+...+..+.+++.+||+.||++|||++||++.|.........-..+|-...
T Consensus 275 ~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 0011222334788999999999999999999999999998877666666665433
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-52 Score=417.64 Aligned_cols=249 Identities=26% Similarity=0.375 Sum_probs=201.5
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
.|++.+.||+|+||+||+|.+. +|+.||||++... .....+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 3667899999999999999875 6899999998653 234457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
|+||+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.......
T Consensus 105 ~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp CTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred CCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 9999999999753 34567899999999999999999998 9999999999999999999999999999987654322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+. .+.... +..+.... +..
T Consensus 181 -~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~-i~~~~~~~-----~~~ 247 (350)
T 4b9d_A 181 -LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLK-IISGSFPP-----VSL 247 (350)
T ss_dssp -HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHH-HHHTCCCC-----CCT
T ss_pred -cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHH-HHcCCCCC-----CCc
Confidence 12335699999999999999999999999999999999999999975432 222222 22232211 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..+.++.+++.+||+.||++|||++|+++
T Consensus 248 ----~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 ----HYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22346889999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-52 Score=415.63 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=205.9
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
|++.++||+|+||+||+|.++ +|+.||||++........+.+.+|+++|+.++|||||++++++.+++..|+|||||+|
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 455788999999999999876 6999999999755445556788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+++.. ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+........ .
T Consensus 156 g~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~ 227 (346)
T 4fih_A 156 GALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-R 227 (346)
T ss_dssp EEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-B
T ss_pred CcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCc-c
Confidence 999999973 458999999999999999999999 99999999999999999999999999999887554332 3
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
....||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+... .. ..+..+....... .
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~----~~i~~~~~~~~~~-------~ 293 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AM----KMIRDNLPPRLKN-------L 293 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HH----HHHHHSSCCCCSC-------G
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HH----HHHHcCCCCCCCc-------c
Confidence 34579999999999999999999999999999999999999997443211 11 1222221111111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
......+.+++.+||+.||++|||++|+++
T Consensus 294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122346889999999999999999999976
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=401.46 Aligned_cols=244 Identities=29% Similarity=0.429 Sum_probs=197.1
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEe----cCeeEEEE
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVY 310 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----~~~~~lv~ 310 (557)
++.++||+|+||+||+|.+. +++.||+|++... .....+.|.+|++++++++|||||++++++.+ ++..++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 35678999999999999876 5889999998643 23445679999999999999999999999865 34579999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCC--eEeeccCCCCEEeC-CCCcEEEecccCcccc
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLD-INMRAKVSDFGLSRQA 387 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~--ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~ 387 (557)
|||+||+|.+++.. ...+++..+..++.||+.||+|||+ ++ |+||||||+|||++ .++.+||+|||+|+..
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 99999999999974 4578999999999999999999998 66 99999999999997 4789999999999865
Q ss_pred CCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
.... .....||+.|||||++.+ .|+.++|||||||++|||+||+.||...... . .+...+..+.....++
T Consensus 183 ~~~~---~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-----~-~~~~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 183 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----A-QIYRRVTSGVKPASFD 252 (290)
T ss_dssp CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----H-HHHHHHTTTCCCGGGG
T ss_pred CCCc---cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-----H-HHHHHHHcCCCCCCCC
Confidence 4322 234579999999999876 5999999999999999999999999743221 1 1222333332221111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
. .. ..++.+++.+||+.||++|||++|+++
T Consensus 253 ~----~~----~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 253 K----VA----IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G----CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----cC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 11 236789999999999999999999975
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-52 Score=409.57 Aligned_cols=246 Identities=24% Similarity=0.368 Sum_probs=206.1
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
.|++.+.||+|+||+||+|... +|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 3677899999999999999875 68999999986432 2345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|++||+|.+++.. .+.+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 113 y~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 113 YAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred cCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999974 4579999999999999999999999 999999999999999999999999999999765432
Q ss_pred -ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 392 -THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 392 -~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
.......+||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+.. +. ...+..+... +
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~-~~~i~~~~~~------~ 253 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG------LI-FAKIIKLEYD------F 253 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHTCCC------C
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HH-HHHHHcCCCC------C
Confidence 22344567999999999999999999999999999999999999999754321 11 1222223221 1
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 504 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl 504 (557)
.... ..++.+++.+||+.||++|||++|++
T Consensus 254 p~~~----s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 254 PEKF----FPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CTTC----CHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred Cccc----CHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1112 23678999999999999999999874
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=417.14 Aligned_cols=247 Identities=24% Similarity=0.345 Sum_probs=206.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
|++.++||+|+||.||+|.+. +|+.||||++........+.+.+|+++|+.++|||||++++++.+++..|+|||||+|
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 556788999999999999876 6899999999765555566789999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.++++. ..+++..+..++.||+.||+|||+ ++|+||||||+||||+.+|.+||+|||+|+........ .
T Consensus 233 G~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~-~ 304 (423)
T 4fie_A 233 GALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-R 304 (423)
T ss_dssp EEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC-B
T ss_pred CcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcc-c
Confidence 999999973 458999999999999999999999 99999999999999999999999999999887554332 3
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
....||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+... . ...+..+....... .
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~----~~~i~~~~~~~~~~-------~ 370 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---A----MKMIRDNLPPRLKN-------L 370 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H----HHHHHHSCCCCCSC-------T
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---H----HHHHHcCCCCCCcc-------c
Confidence 34569999999999999999999999999999999999999997443211 1 12222221111111 1
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
......+.+++.+||..||++|||++|+++
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112346889999999999999999999976
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=417.27 Aligned_cols=266 Identities=26% Similarity=0.395 Sum_probs=215.7
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEcC------CcEEEEEEccCccc-hhHHHHHHHHHHHhhcCC-CCccceeeEEEec
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCS-HRTQQFVTEVALLSRIHH-RNLVPLIGYCEEE 303 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~ 303 (557)
+....+++.+.||+|+||.||+|.+.. ++.||||++..... ...+.|.+|+++|.+++| ||||+++|+|...
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 334456778999999999999998753 36899999876433 345679999999999965 8999999999764
Q ss_pred -CeeEEEEEecCCCChhhhhhccC-------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEE
Q 008707 304 -HQRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 369 (557)
Q Consensus 304 -~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIl 369 (557)
+..++|||||++|+|.++++... ....+++..+..++.|||+||+|||+ ++|+||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCcccee
Confidence 56899999999999999997532 13458999999999999999999999 99999999999999
Q ss_pred eCCCCcEEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccc
Q 008707 370 LDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL 447 (557)
Q Consensus 370 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~ 447 (557)
+++++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.....
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-- 295 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 295 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999987654332 23344568999999999999999999999999999999998 999997543221
Q ss_pred cHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 448 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
.+...+..|...... ...+.++.+++.+||+.||++|||++||++.|+++.+...
T Consensus 296 ----~~~~~i~~g~~~~~p---------~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 296 ----EFCRRLKEGTRMRAP---------DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp ----HHHHHHHHTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred ----HHHHHHHcCCCCCCC---------ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 123334444332221 1223478899999999999999999999999999887543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=409.72 Aligned_cols=266 Identities=26% Similarity=0.389 Sum_probs=200.4
Q ss_pred HhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecC----eeEEEEEec
Q 008707 238 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVYEYM 313 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~----~~~lv~e~~ 313 (557)
.+.+.||+|+||+||+|.++ |+.||||++.... .....+..|+..+.+++|||||++++++.+++ ..++||||+
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~ 83 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83 (303)
T ss_dssp EEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCC
Confidence 45688999999999999985 8999999986432 22223344666667889999999999998654 579999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCC-----CCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-----NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-----~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
++|+|.++++. ..+++..+.+++.|+++||+|||+.+ +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 84 EHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp TTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 99999999974 45899999999999999999999721 2399999999999999999999999999998764
Q ss_pred CCCcc---ccccccCCCCccCCcccCCC------CCCcccceehhHHHHHHHHhCCCCCCCCCccc---------cccHH
Q 008707 389 EDLTH---ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISGKKPVSVEDFGA---------ELNIV 450 (557)
Q Consensus 389 ~~~~~---~~~~~~g~~~y~aPE~l~~~------~~s~~~DvwslG~ll~elltg~~pf~~~~~~~---------~~~~~ 450 (557)
..... ......||+.|+|||++.+. .++.++|||||||++|||+||..||....... .....
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 43222 12234699999999999764 46789999999999999999988875332211 11122
Q ss_pred HHHHHHHhcCCccccccccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 451 HWARSMIKKGDVISIVDPVLIGN-VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 451 ~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
+ ....+..+. ++|.+... ...+.+..+.+++.+||+.||++||||+||++.|+++.+.+
T Consensus 240 ~-~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 240 E-MRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp H-HHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred H-HHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 2 222222211 12222111 12355668899999999999999999999999999987643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=395.16 Aligned_cols=244 Identities=25% Similarity=0.363 Sum_probs=190.4
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
.|++.+.||+|+||+||+|... +|+.||+|++.+.. ....+.+.+|+++++.++|||||++++++.+++..++|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3667899999999999999875 68999999986532 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+ +|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 94 y~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 94 YA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp CC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred CC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 99 7899999874 4679999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccccccccCCCCccCCcccCCCCC-CcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~-s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
. .....||+.|+|||++.+..+ +.++||||+||++|+|+||+.||...+.. +. ...+..+... +
T Consensus 167 ~--~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------~~-~~~i~~~~~~------~ 231 (275)
T 3hyh_A 167 F--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------VL-FKNISNGVYT------L 231 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHTCCC------C
T ss_pred c--cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------HH-HHHHHcCCCC------C
Confidence 2 234569999999999998876 57999999999999999999999754321 11 1222233221 1
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
... ....+.+++.+||+.||++|||++|+++
T Consensus 232 p~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 232 PKF----LSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp CTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCC----CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 2246789999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-51 Score=402.49 Aligned_cols=241 Identities=26% Similarity=0.331 Sum_probs=192.2
Q ss_pred HHHhhcccCCCCceEEEEEEEc----CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
.|++.+.||+|+||+||+|+.. +++.||+|++.... ......+.+|++++++++|||||++++++.+++..|+|
T Consensus 25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 4677899999999999999763 47889999986532 22334688899999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
||||+||+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 105 mEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp ECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999974 4579999999999999999999999 9999999999999999999999999999987543
Q ss_pred CCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccc
Q 008707 390 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 469 (557)
... ......||+.|||||++.+..|+.++||||+||++|||+||+.||.+.+.. +.. ..+.++...
T Consensus 179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~-~~i~~~~~~------ 244 (304)
T 3ubd_A 179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETM-TMILKAKLG------ 244 (304)
T ss_dssp --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCCCC------
T ss_pred CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHH-HHHHcCCCC------
Confidence 322 233456999999999999999999999999999999999999999854322 111 122222211
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 008707 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 500 (557)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 500 (557)
+ +...+.++.+++.+||+.||++|||+
T Consensus 245 ~----p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 245 M----PQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred C----CCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1 11123468899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=389.02 Aligned_cols=248 Identities=23% Similarity=0.358 Sum_probs=187.6
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecC----------
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH---------- 304 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~---------- 304 (557)
|++.+.||+|+||+||+|.++ +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 566899999999999999876 68999999986433 334567999999999999999999999987544
Q ss_pred --eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEeccc
Q 008707 305 --QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 382 (557)
Q Consensus 305 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 382 (557)
..|+|||||++|+|.+++.........++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccCc
Confidence 368999999999999999854333345667788999999999999999 999999999999999999999999999
Q ss_pred CccccCCCCcc-----------ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHH
Q 008707 383 LSRQAEEDLTH-----------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 451 (557)
Q Consensus 383 la~~~~~~~~~-----------~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~ 451 (557)
+|+........ ......||+.|||||++.+..|+.++|||||||++|||++ ||.... ....
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-----~~~~ 235 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-----ERVR 235 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH-----HHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc-----HHHH
Confidence 99876543221 1123469999999999999999999999999999999996 775211 1111
Q ss_pred HHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 452 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 452 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.. ..+........ .......+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~-~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TL-TDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-HHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 11222221111 1122235678999999999999999999976
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=373.65 Aligned_cols=276 Identities=41% Similarity=0.718 Sum_probs=242.1
Q ss_pred HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
|++.+.||+|+||.||+|.+++++.||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred cCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 34568899999999999998889999999987766666778999999999999999999999999999999999999999
Q ss_pred ChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC-ccc
Q 008707 317 TLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-THI 394 (557)
Q Consensus 317 sL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~ 394 (557)
+|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+|||++....... ...
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999997542 23468999999999999999999998 999999999999999999999999999998654322 222
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||.............|.......+.....+++.+....
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI 277 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCS
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcccc
Confidence 23345899999999998889999999999999999999999999866666667778887777777888888888887778
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
....+..+.+++.+||+.||++|||++||++.|+.+.+...
T Consensus 278 ~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred CHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 88889999999999999999999999999999999987543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=386.33 Aligned_cols=260 Identities=19% Similarity=0.318 Sum_probs=199.1
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEe------cCee
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQR 306 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~------~~~~ 306 (557)
.|++.+.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.. .+..
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 3567899999999999999875 69999999996542 2345678899999999999999999998764 3578
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
|+|||||+ |+|.+++. ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+.
T Consensus 135 ~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 99999995 68999987 35679999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCC---ccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 387 AEEDL---THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 387 ~~~~~---~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
..... ........||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+.. ..+......-..
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l---~~I~~~~g~p~~ 284 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL---QLIMMVLGTPSP 284 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH---HHHHHHHCCCCG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhcCCCCh
Confidence 64322 1223346799999999998775 5689999999999999999999999865432211 111111111000
Q ss_pred cccccc-----------ccc--CCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 463 ISIVDP-----------VLI--GNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 463 ~~~~d~-----------~l~--~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
..... .+. ...+ ......+.+++.+||..||++|||++|+++.
T Consensus 285 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 -AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp -GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 000 0000 0112367899999999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=373.23 Aligned_cols=287 Identities=39% Similarity=0.696 Sum_probs=240.1
Q ss_pred CChhHHHHHH--HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEec
Q 008707 227 IPLPELEEAT--NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEE 303 (557)
Q Consensus 227 ~~~~~~~~~~--~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 303 (557)
++..++.... |++.+.||+|+||.||+|...+++.||+|++..... .....+.+|+++++.++||||+++++++.+.
T Consensus 20 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTP 99 (326)
T ss_dssp CCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCS
T ss_pred ecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecC
Confidence 3445555443 344789999999999999988899999999875432 2234688999999999999999999999999
Q ss_pred CeeEEEEEecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEeccc
Q 008707 304 HQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFG 382 (557)
Q Consensus 304 ~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 382 (557)
+..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+..+++||||||+||+++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 99999999999999999998643 33458999999999999999999998212299999999999999999999999999
Q ss_pred CccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCc--cccccHHHHHHHHHhcC
Q 008707 383 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF--GAELNIVHWARSMIKKG 460 (557)
Q Consensus 383 la~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~--~~~~~~~~~~~~~~~~~ 460 (557)
++...............||+.|+|||.+.+..++.++||||||+++|+|++|+.||..... ........|+.......
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 3uim_A 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259 (326)
T ss_dssp SCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC
T ss_pred cccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch
Confidence 9987765544444555699999999999888899999999999999999999999963322 23455677777777777
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 461 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 461 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
......+..+........+..+.+++.+||+.||++|||++||++.|+...-.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp CSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred hhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 77788888888888889999999999999999999999999999999875443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=373.46 Aligned_cols=195 Identities=25% Similarity=0.413 Sum_probs=166.8
Q ss_pred HHHhhcccCCCCceEEEEEEEc----CCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
.|++.+.||+|+||+||+|..+ .++.||+|++.... ...++.+|+++++.+ +||||+++++++.+.+..++||
T Consensus 22 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvm 99 (361)
T 4f9c_A 22 VFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAM 99 (361)
T ss_dssp TCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEE
T ss_pred cEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEE
Confidence 3667889999999999999764 46789999886542 345678999999998 6999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC-CcEEEecccCccccCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEE 389 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~~~ 389 (557)
||+++|+|.+++. .+++..+..++.||+.||+|||+ +||+||||||+|||++.+ +.+||+|||+|+...+
T Consensus 100 E~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 100 PYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp ECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred eCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999999984 37899999999999999999999 999999999999999876 7999999999986543
Q ss_pred CCcc---------------------------ccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCC
Q 008707 390 DLTH---------------------------ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVE 441 (557)
Q Consensus 390 ~~~~---------------------------~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~ 441 (557)
.... ......||+.|+|||++.+. .|+.++||||+||++|||+||+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 2211 11234699999999999775 5899999999999999999999999643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=394.39 Aligned_cols=250 Identities=21% Similarity=0.332 Sum_probs=207.3
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.|++.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+++|+.++|||||+++++|.+++..++|||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 4667899999999999999876 689999999977656667789999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC--CcEEEecccCccccCCCCc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfgla~~~~~~~~ 392 (557)
||+|.+++.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 238 gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 238 GGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred CCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 9999999864 24569999999999999999999999 999999999999999854 8899999999998754432
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+... . ...+..+... +......
T Consensus 313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~------~-~~~i~~~~~~--~~~~~~~ 381 (573)
T 3uto_A 313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------T-LRNVKSCDWN--MDDSAFS 381 (573)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------H-HHHHHTTCCC--CCSGGGT
T ss_pred --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------H-HHHHHhCCCC--CCccccc
Confidence 234469999999999999999999999999999999999999998543321 1 1122222211 1111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.. ...+.+++.+||..||++|||++|+++
T Consensus 382 ~~----s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 382 GI----SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TS----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22 236789999999999999999999987
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=389.58 Aligned_cols=246 Identities=22% Similarity=0.274 Sum_probs=196.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHH---HHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTE---VALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E---~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
|++.+.||+|+||.||+|..+ +|+.||||++.+.. ......+.+| +.+++.++|||||+++++|.+.+..|+|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 445688999999999999876 58999999986431 1122233344 5666777899999999999999999999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||++||+|.+++.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++.+|.+||+|||+|+....
T Consensus 271 mEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp ECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 999999999999974 4569999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCccccccccCCCCccCCcccC-CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 390 DLTHISSVARGTVGYLDPEYYG-NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~-~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
.. ....+||+.|||||++. +..|+.++|+||+||++|||++|+.||.+....+.. + +...+......
T Consensus 345 ~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~-i~~~i~~~~~~----- 412 (689)
T 3v5w_A 345 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E-IDRMTLTMAVE----- 412 (689)
T ss_dssp CC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---H-HHHHHHHCCCC-----
T ss_pred CC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---H-HHHhhcCCCCC-----
Confidence 32 23457999999999996 457999999999999999999999999754332221 1 11122222110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 505 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 505 (557)
++.....++.+++.+||+.||.+|++ ++||++
T Consensus 413 -----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 413 -----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11112336789999999999999998 678765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=359.45 Aligned_cols=260 Identities=25% Similarity=0.386 Sum_probs=213.5
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
..|.+.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+++++.++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 34556789999999999999876 58999999987666667788999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++|+|.+++... ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 999999999753 4668999999999999999999998 99999999999999999999999999999876443221
Q ss_pred c-------------cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcccc---ccHHHHHHHHH
Q 008707 394 I-------------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE---LNIVHWARSMI 457 (557)
Q Consensus 394 ~-------------~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~---~~~~~~~~~~~ 457 (557)
. .....||+.|+|||.+.+..++.++||||||+++|||++|..||........ ..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~- 243 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY- 243 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT-
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc-
Confidence 1 1134689999999999999999999999999999999999999874433211 1111111110
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 008707 458 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 516 (557)
Q Consensus 458 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 516 (557)
. +...+..+.+++.+||+.||++|||++||++.|+++......
T Consensus 244 ------------~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 244 ------------C----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp ------------C----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred ------------C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 0 111123678999999999999999999999999999876543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=355.76 Aligned_cols=261 Identities=34% Similarity=0.508 Sum_probs=202.2
Q ss_pred HHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
..|++.+.||+|+||.||+|.+. |+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred hHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 44567899999999999999874 8899999986543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCC--eEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~--ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
+++|+|.+++........+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||++......
T Consensus 116 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 116 LSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 9999999999853222348999999999999999999998 88 999999999999999999999999999765433
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
.. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+... ............
T Consensus 193 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~~~~~~~~------- 258 (309)
T 3p86_A 193 FL-SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFKCKRL------- 258 (309)
T ss_dssp ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHHSCCCC-------
T ss_pred cc-ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcCCCC-------
Confidence 22 1233458999999999999999999999999999999999999997443211 111111111111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
..+...+..+.+++.+||+.+|++|||++||++.|+.+.+...
T Consensus 259 --~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 259 --EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred --CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 1111223468899999999999999999999999999987543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=361.56 Aligned_cols=263 Identities=24% Similarity=0.455 Sum_probs=213.4
Q ss_pred HHHHhhcccCCCCceEEEEEEEc--------CCcEEEEEEccCccc-hhHHHHHHHHHHHhhc-CCCCccceeeEEEecC
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 304 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~ 304 (557)
..|++.+.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+++++.+ +||||+++++++.+.+
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 160 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 160 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence 44567889999999999999863 355799999976533 3456799999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhccC-------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC
Q 008707 305 QRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 371 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~ 371 (557)
..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++
T Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~ 237 (370)
T 2psq_A 161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT 237 (370)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEEC
Confidence 9999999999999999997542 12458899999999999999999998 9999999999999999
Q ss_pred CCCcEEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccH
Q 008707 372 INMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 449 (557)
Q Consensus 372 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~ 449 (557)
.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||+| |..||....... +
T Consensus 238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~ 314 (370)
T 2psq_A 238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---L 314 (370)
T ss_dssp TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H
T ss_pred CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H
Confidence 999999999999987644322 12223346789999999999999999999999999999999 999997543322 1
Q ss_pred HHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 008707 450 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 516 (557)
Q Consensus 450 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 516 (557)
. ..+..+.... .+...+..+.+++.+||+.+|++|||+.||++.|+++......
T Consensus 315 ~----~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~ 368 (370)
T 2psq_A 315 F----KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368 (370)
T ss_dssp H----HHHHTTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred H----HHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence 1 1222222111 1122334788999999999999999999999999999886554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=347.65 Aligned_cols=248 Identities=24% Similarity=0.368 Sum_probs=204.3
Q ss_pred HHHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 345578999999999999986 4689999999876555556778999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+|+|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.........
T Consensus 101 ~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 172 (297)
T 3fxz_A 101 GGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 172 (297)
T ss_dssp TCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-
T ss_pred CCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-
Confidence 9999999974 358999999999999999999998 99999999999999999999999999999876544332
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
.....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+... ........+.. ... .
T Consensus 173 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~~-~~~-------~ 238 (297)
T 3fxz_A 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTP-ELQ-------N 238 (297)
T ss_dssp BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCSC-CCS-------C
T ss_pred cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCC-CCC-------C
Confidence 234468999999999999999999999999999999999999997443211 11111111111 110 0
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+......+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1122346889999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=355.58 Aligned_cols=266 Identities=25% Similarity=0.339 Sum_probs=207.6
Q ss_pred HHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecC----eeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~----~~~lv~e 311 (557)
.|++.+.||+|+||.||+|.+. ++.||||++... ......+.+|+.++++++||||+++++++.... ..++|||
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e 102 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITA 102 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred hchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEe
Confidence 4556789999999999999887 899999998654 233445667899999999999999999998744 4699999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCC----------CeEeeccCCCCEEeCCCCcEEEecc
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP----------GIIHRDVKSSNILLDINMRAKVSDF 381 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~----------~ivH~dlk~~NIll~~~~~~kl~Df 381 (557)
|+++|+|.++++. ..+++..++.++.|++.||+|||+ . +|+||||||+|||++.++.+||+||
T Consensus 103 ~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 103 FHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 9999999999974 348999999999999999999998 7 9999999999999999999999999
Q ss_pred cCccccCCCCcc-ccccccCCCCccCCcccCCC-----CCCcccceehhHHHHHHHHhCCCCCCCCCccccc--------
Q 008707 382 GLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQ-----QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL-------- 447 (557)
Q Consensus 382 gla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~-----~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~-------- 447 (557)
|++......... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.......
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999876543322 22334689999999999873 5567899999999999999999999865433211
Q ss_pred --cHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 448 --NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 448 --~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
....+... ...+.....+.... .....+..+.+++.+||+.||++|||++||++.|+++.+..
T Consensus 256 ~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 256 HPSLEDMQEV-VVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SCCHHHHHHH-HTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCchhhhhhh-hhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11111111 11111111111100 12244567999999999999999999999999999988753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=344.83 Aligned_cols=279 Identities=37% Similarity=0.588 Sum_probs=224.0
Q ss_pred cCChhHHHHHHHHhh--------cccCCCCceEEEEEEEcCCcEEEEEEccCcc----chhHHHHHHHHHHHhhcCCCCc
Q 008707 226 FIPLPELEEATNNFC--------KKIGKGSFGSVYYGKMKDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNL 293 (557)
Q Consensus 226 ~~~~~~~~~~~~~~~--------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~nI 293 (557)
.++..++...+.+|. +.||+|+||.||+|.. +++.||+|++.... ....+.+.+|+++++.++||||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 356778888887774 5699999999999987 48899999986432 2345779999999999999999
Q ss_pred cceeeEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC
Q 008707 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 373 (557)
Q Consensus 294 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~ 373 (557)
+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||+|||+ .+++||||||+||+++.+
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~~ 169 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEA 169 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTT
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcCC
Confidence 99999999999999999999999999999755445679999999999999999999998 999999999999999999
Q ss_pred CcEEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHH
Q 008707 374 MRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 452 (557)
Q Consensus 374 ~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~ 452 (557)
+.+||+|||++........ .......|++.|+|||.+.+ .++.++||||||+++|+|++|..||........ ...+
T Consensus 170 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~ 246 (307)
T 2nru_A 170 FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LLDI 246 (307)
T ss_dssp CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TTHH
T ss_pred CcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HHHH
Confidence 9999999999987654322 22233468999999998875 478999999999999999999999985443321 1122
Q ss_pred HHHHHhc-CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 453 ARSMIKK-GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 453 ~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
....... ......+++.+ .......+..+.+++.+||+.+|.+|||++||++.|+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 247 KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2221111 11223333332 34456777889999999999999999999999999998753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=357.38 Aligned_cols=263 Identities=26% Similarity=0.484 Sum_probs=211.3
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEc----CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCee
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 306 (557)
+....|++.+.||+|+||.||+|.+. .+..||||++.... ....+.+.+|+++++.++||||+++++++.+.+..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 125 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLA 125 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCcc
Confidence 33455667899999999999999875 34569999987643 34456799999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 126 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 126 MIVTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 9999999999999999642 4568999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCCcc--ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 387 AEEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 387 ~~~~~~~--~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....... +...+..+...
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~~~ 273 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEEGYRL 273 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCCC
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcCCCC
Confidence 6543221 1222335778999999998899999999999999999999 999997433211 11122222111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 464 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 464 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
. .+...+..+.+++.+||..||++|||++||++.|+.+.....
T Consensus 274 ~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 274 P---------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred C---------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 1 111233478899999999999999999999999999987544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=348.29 Aligned_cols=258 Identities=28% Similarity=0.456 Sum_probs=212.2
Q ss_pred HHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
..|++.+.||+|+||.||+|.++++..||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYIS 86 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccC
Confidence 44567899999999999999999888999999875432 34678999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++..........
T Consensus 87 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 87 NGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp TCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred CCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 99999999753 3468999999999999999999998 999999999999999999999999999998765554433
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....+++.|+|||.+.+..++.++||||||+++|+|+| |+.||....... ... .+..+... ..+
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~-~~~~~~~~--~~~----- 227 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVL-KVSQGHRL--YRP----- 227 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHH-HHHTTCCC--CCC-----
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHH-HHHcCCCC--CCC-----
Confidence 344456788999999998889999999999999999999 999997443221 111 12222111 111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
...+..+.+++.+||+.+|++|||++|+++.|+.+.+.+
T Consensus 228 --~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 228 --HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp --TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred --CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 111236889999999999999999999999999887653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=346.10 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=211.5
Q ss_pred HHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
.|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 89 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 89 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCC
Confidence 4556789999999999999998899999999875433 346789999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
++|.+++... ...+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 90 ~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 164 (269)
T 4hcu_A 90 GCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164 (269)
T ss_dssp CBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence 9999999742 4568999999999999999999998 9999999999999999999999999999987654433333
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
....+++.|+|||.+.+..++.++||||+|+++|+|++ |+.||...... +.. ..+..+... ..
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~-~~~~~~~~~--~~------- 228 (269)
T 4hcu_A 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVV-EDISTGFRL--YK------- 228 (269)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHH-HHHHTTCCC--CC-------
T ss_pred cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHH-HHHhcCccC--CC-------
Confidence 34456788999999998899999999999999999999 99999743321 111 112222110 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
+...+..+.+++.+||+.+|++|||++|+++.|+++.+.
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 111234688999999999999999999999999998763
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=345.89 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=210.5
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
...|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 345567899999999999999999888999999875433 3467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 999999999753 3568999999999999999999998 99999999999999999999999999999876544333
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||....... . ...+..+....
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~------~-~~~~~~~~~~~-------- 241 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------T-AEHIAQGLRLY-------- 241 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------H-HHHHHTTCCCC--------
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH------H-HHHHhcccCCC--------
Confidence 3333446788999999998889999999999999999998 999997443211 1 11122221110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
.+...+..+.+++.+||+.+|++|||++|+++.|+++.+.+
T Consensus 242 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 242 -RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp -CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 01111246889999999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=346.45 Aligned_cols=265 Identities=26% Similarity=0.409 Sum_probs=208.4
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc---cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
.|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 4566799999999999999865 6889999988543 22345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 92 YIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred CCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999974 3568999999999999999999998 999999999999999999999999999998765443
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
........||+.|+|||.+.+..++.++||||||+++|+|+||+.||...... ......+... .... .
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~-~~~~-----~ 233 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQDS-VPNV-----T 233 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSSC-CCCH-----H
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhcc-CCCc-----c
Confidence 33334456899999999999999999999999999999999999999744321 1111222111 1100 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhhhhhcCCC
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIEKGGD 518 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RP-t~~evl~~L~~~~~~~~~~~ 518 (557)
.......+..+.+++.+|++.||++|| +++++.+.|+.........+
T Consensus 234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~ 281 (294)
T 4eqm_A 234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANE 281 (294)
T ss_dssp HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTC
T ss_pred hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCc
Confidence 011122334788999999999999999 99999999998876544443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=352.72 Aligned_cols=245 Identities=26% Similarity=0.418 Sum_probs=203.0
Q ss_pred HHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||.||+|.+ .+|+.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 45678999999999999987 47999999998653 2334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~- 169 (328)
T 3fe3_A 97 SGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK- 169 (328)
T ss_dssp TTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG-
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc-
Confidence 99999999974 3568999999999999999999998 9999999999999999999999999999987654322
Q ss_pred ccccccCCCCccCCcccCCCCCC-cccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLT-EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s-~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.....||+.|+|||++.+..+. .++||||+||++|+|++|+.||.+.+.. + ....+..+...
T Consensus 170 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~-~~~~i~~~~~~--------- 232 (328)
T 3fe3_A 170 -LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------E-LRERVLRGKYR--------- 232 (328)
T ss_dssp -GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCC---------
T ss_pred -cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCCC---------
Confidence 3345699999999999887765 7999999999999999999999854322 1 11222222211
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.+......+.+++.+||..||.+|||++|+++.
T Consensus 233 -~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 233 -IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp -CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 011123467899999999999999999999863
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=344.25 Aligned_cols=245 Identities=25% Similarity=0.395 Sum_probs=203.2
Q ss_pred hhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCC
Q 008707 239 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 317 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gs 317 (557)
..+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 49 ~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 128 (321)
T 2c30_A 49 SYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128 (321)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred ccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCC
Confidence 3568999999999999886 699999999876655566788999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccccc
Q 008707 318 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 397 (557)
Q Consensus 318 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 397 (557)
|.+++. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......... ...
T Consensus 129 L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 200 (321)
T 2c30_A 129 LTDIVS----QVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKS 200 (321)
T ss_dssp HHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-BCC
T ss_pred HHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-ccc
Confidence 999986 3468999999999999999999998 99999999999999999999999999999876543322 233
Q ss_pred ccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHH
Q 008707 398 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 477 (557)
Q Consensus 398 ~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 477 (557)
..||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... +... .+..+....... ...
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------~~~~-~~~~~~~~~~~~-------~~~ 266 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------QAMK-RLRDSPPPKLKN-------SHK 266 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHH-HHHHSSCCCCTT-------GGG
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-HHhcCCCCCcCc-------ccc
Confidence 46899999999999999999999999999999999999999743221 1111 122221111110 111
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 478 SIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 478 ~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+..+.+++.+||+.||++|||++|+++
T Consensus 267 ~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 267 VSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 2346889999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=356.62 Aligned_cols=266 Identities=28% Similarity=0.449 Sum_probs=208.3
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-----CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEec--Cee
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQR 306 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~ 306 (557)
...|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+++++.++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 345667899999999999999852 5889999999876666677899999999999999999999998653 458
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999999753 3458999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCCc--cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcc---------ccccHHHHHHH
Q 008707 387 AEEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWARS 455 (557)
Q Consensus 387 ~~~~~~--~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~---------~~~~~~~~~~~ 455 (557)
...... .......++..|+|||.+.+..++.++||||||+++|+|+||..||...... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 644322 1222334677899999999999999999999999999999999998733211 00011111222
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 456 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 456 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
.+..+.... .+...+..+.+++.+||+.||++|||++||++.|+++.+.
T Consensus 244 ~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 244 LLKNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHTTCCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhccCcCC---------CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 222221111 1122345788999999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=359.36 Aligned_cols=271 Identities=24% Similarity=0.416 Sum_probs=217.1
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEc--------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEe
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE 302 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~ 302 (557)
....+.+.+.||+|+||.||+|.+. .+..||+|++.... ....+.+.+|+++++.+ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3445667899999999999999863 23579999987643 33457789999999999 89999999999999
Q ss_pred cCeeEEEEEecCCCChhhhhhccCC-------------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEE
Q 008707 303 EHQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNIL 369 (557)
Q Consensus 303 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIl 369 (557)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ .+|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence 9999999999999999999975421 2458999999999999999999998 99999999999999
Q ss_pred eCCCCcEEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccc
Q 008707 370 LDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAEL 447 (557)
Q Consensus 370 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~ 447 (557)
++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+...
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~-- 301 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 301 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999987654322 22233457889999999999999999999999999999999 999997443211
Q ss_pred cHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCCCccc
Q 008707 448 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQKFS 522 (557)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~~~ 522 (557)
+...+..+..... +...+..+.+++.+||+.+|++|||++||++.|+++............
T Consensus 302 -----~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 362 (382)
T 3tt0_A 302 -----LFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYY 362 (382)
T ss_dssp -----HHHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC----
T ss_pred -----HHHHHHcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCC
Confidence 1222333222111 112234788999999999999999999999999999987766655544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=342.16 Aligned_cols=271 Identities=21% Similarity=0.302 Sum_probs=213.5
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecC--eeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.... ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 456789999999999999876 48999999987543 234567889999999999999999999988755 77999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe----CCCCcEEEecccCccccC
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla~~~~ 388 (557)
+++++|.+++........+++..++.++.||+.||+|||+ .+|+||||||+||++ +.++.+||+|||++....
T Consensus 91 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp CTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 9999999999865444559999999999999999999998 999999999999999 778889999999998765
Q ss_pred CCCccccccccCCCCccCCcccC--------CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 008707 389 EDLTHISSVARGTVGYLDPEYYG--------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 460 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~--------~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 460 (557)
..... ....||+.|+|||++. +..++.++|||||||++|||++|+.||......... .+.........
T Consensus 168 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~ 243 (319)
T 4euu_A 168 DDEQF--VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITGK 243 (319)
T ss_dssp TTCCB--CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHHHHC
T ss_pred CCCce--eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHhcCC
Confidence 44322 2345899999999985 578899999999999999999999999744332211 11222222221
Q ss_pred Ccc---cc---------ccc--cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 461 DVI---SI---------VDP--VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 461 ~~~---~~---------~d~--~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
... .. ... .............+.+++.+||+.||++|||++|+++...+.....
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~ 311 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG 311 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC--
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcC
Confidence 110 00 000 1112345677788999999999999999999999999988776543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=361.43 Aligned_cols=258 Identities=29% Similarity=0.438 Sum_probs=210.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
..+.+.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 34556899999999999999986 689999999875432 3345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++... ...+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|||+++.......
T Consensus 194 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 194 VQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 9999999999743 3468999999999999999999998 9999999999999999999999999999986544322
Q ss_pred ccc-ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 393 HIS-SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 393 ~~~-~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
... ....+++.|+|||.+.+..++.++||||||+++|||+| |..||...... .+...+..+.....
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~----- 336 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKGGRLPC----- 336 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTTCCCCC-----
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCCCCC-----
Confidence 111 12235778999999998899999999999999999998 99999743321 12223333322111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
+...+..+.+++.+||+.||++|||+++|++.|+++.+.
T Consensus 337 ----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 337 ----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 112234788999999999999999999999999998764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=341.92 Aligned_cols=259 Identities=25% Similarity=0.380 Sum_probs=200.3
Q ss_pred HHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhh--cCCCCccceeeEEEe----cCeeEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR--IHHRNLVPLIGYCEE----EHQRILV 309 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~nIv~~~~~~~~----~~~~~lv 309 (557)
.|++.+.||+|+||.||+|.+ +++.||||++... ..+.+.+|.+++.. ++||||+++++++.. ....++|
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv 84 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLI 84 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred cEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEe
Confidence 455679999999999999988 5899999998643 34556667777776 789999999998654 3457899
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEeeccCCCCEEeCCCCcEEEecc
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH--------TGCNPGIIHRDVKSSNILLDINMRAKVSDF 381 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH--------~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 381 (557)
|||+++|+|.++++ ...+++..++.++.|++.||+||| + .+|+||||||+|||++.++.+||+||
T Consensus 85 ~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 85 THYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp ECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECCC
T ss_pred hhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEeeC
Confidence 99999999999995 356999999999999999999999 7 99999999999999999999999999
Q ss_pred cCccccCCCCccc---cccccCCCCccCCcccCCC------CCCcccceehhHHHHHHHHhC----------CCCCCCCC
Q 008707 382 GLSRQAEEDLTHI---SSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISG----------KKPVSVED 442 (557)
Q Consensus 382 gla~~~~~~~~~~---~~~~~g~~~y~aPE~l~~~------~~s~~~DvwslG~ll~elltg----------~~pf~~~~ 442 (557)
|++.......... .....||+.|+|||.+.+. .++.++||||||+++|||+|| +.||....
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~ 237 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence 9997654432221 2234689999999999876 455799999999999999999 88886332
Q ss_pred ccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 443 FGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
... .............+....... .......+..+.+++.+||+.||++|||++||++.|+++
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 238 PND-PSFEDMRKVVCVDQQRPNIPN----RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CSS-CCHHHHHHHHTTSCCCCCCCG----GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCC-cchhhhhHHHhccCCCCCCCh----hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 221 112211111111111111110 112234567899999999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=370.73 Aligned_cols=258 Identities=24% Similarity=0.423 Sum_probs=210.7
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
...+++.+.||+|+||.||+|.++++..||||+++... ...+.+.+|+++++.++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 34556789999999999999999889999999987643 34678999999999999999999999986 56789999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 265 ~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 265 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp TTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 999999999743 12357888999999999999999998 99999999999999999999999999999876543222
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......+++.|+|||.+....++.++||||||+++|||+| |+.||.+.+... + ...+..+....
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~----~~~i~~~~~~~-------- 405 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V----IRALERGYRMP-------- 405 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H----HHHHHHTCCCC--------
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHHcCCCCC--------
Confidence 2233346788999999998899999999999999999999 999997433211 1 12222221111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
.+...+..+.+++.+||+.||++|||+++|++.|+++...
T Consensus 406 -~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 406 -RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred -CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 1112344788999999999999999999999999988654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=337.67 Aligned_cols=263 Identities=16% Similarity=0.193 Sum_probs=211.3
Q ss_pred HHHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEec
Q 008707 236 TNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
.|++.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+++++.+ +|+|++++++++......++||||+
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 355678999999999999986 468999999886432 234578899999999 7999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc-----EEEecccCccccC
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-----AKVSDFGLSRQAE 388 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~-----~kl~Dfgla~~~~ 388 (557)
+++|.+++... ...+++..+..++.||+.||+|||+ ++++||||||+||+++.++. +||+|||++....
T Consensus 89 -~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 89 -GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp -CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred -CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999999753 4568999999999999999999998 99999999999999987766 9999999998765
Q ss_pred CCCcc------ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 389 EDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 389 ~~~~~------~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+..........+.........
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 43221 123456899999999999999999999999999999999999999865433322222222211111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 463 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 463 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
.. +... .+..+.+++.+||+.+|++|||+++|++.|+++.....
T Consensus 243 ~~-----~~~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 243 RE-----LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HH-----HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HH-----HHhh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 11 1111 23478899999999999999999999999999987544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=343.61 Aligned_cols=260 Identities=19% Similarity=0.226 Sum_probs=208.9
Q ss_pred HHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+++++.+ +||||+++++++...+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~- 87 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL- 87 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-
Confidence 44678999999999999986 4689999999865322 34578999999999 8999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc-----EEEecccCccccCC
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-----AKVSDFGLSRQAEE 389 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~-----~kl~Dfgla~~~~~ 389 (557)
+++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||++.....
T Consensus 88 ~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~ 162 (330)
T 2izr_A 88 GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID 162 (330)
T ss_dssp CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence 99999999753 4679999999999999999999998 99999999999999998887 99999999987644
Q ss_pred CCcc------ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 390 DLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 390 ~~~~------~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
.... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+..........
T Consensus 163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242 (330)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence 3221 1234569999999999999999999999999999999999999998654332222222211111110000
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 464 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 464 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
.+.. ..+ .+.+++.+|++.+|.+||++++|.+.|+++....
T Consensus 243 -----~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 243 -----VLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp -----HHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----HHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0000 112 7889999999999999999999999999888754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=355.95 Aligned_cols=260 Identities=27% Similarity=0.475 Sum_probs=200.2
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc----CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
...+++.+.||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 345566789999999999999875 57789999987543 3445679999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||+++|+|.+++... ...+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999742 4568999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCccc--cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 389 EDLTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 389 ~~~~~~--~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
...... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||....... +...+..+...
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~~~~i~~~~~~-- 269 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKAVDEGYRL-- 269 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------HHHHHHTTEEC--
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC--
Confidence 432211 112235678999999999999999999999999999998 999997433211 11222222111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
......+..+.+++.+||+.||++||++.||++.|+++....
T Consensus 270 -------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 270 -------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp -------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred -------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 111123457889999999999999999999999999998643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=371.31 Aligned_cols=258 Identities=29% Similarity=0.460 Sum_probs=213.6
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcC-CcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
...+++.+.||+|+||.||+|.++. +..||||++.... ...+.|.+|++++++++||||+++++++...+..++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3456678999999999999999875 8899999987543 3457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999999754 34568999999999999999999998 9999999999999999999999999999987654433
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.......+++.|+|||.+.+..++.++||||||+++|||+| |..||...+... +.+ .+..+...
T Consensus 374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~-------- 438 (495)
T 1opk_A 374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEKDYRM-------- 438 (495)
T ss_dssp ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHTTCCC--------
T ss_pred eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCCC--------
Confidence 33333446789999999998899999999999999999999 999997544322 222 22222111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
..+...+..+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 439 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 439 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred -CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 1112233478899999999999999999999999998754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=347.23 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=202.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|..+ +|+.||+|++.+.. ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence 456789999999999999876 58999999986532 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 87 ANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 999999999874 3568999999999999999999998 9999999999999999999999999999986433222
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...+.. +... .+..+... +
T Consensus 161 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~-~i~~~~~~------~-- 224 (337)
T 1o6l_A 161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFE-LILMEEIR------F-- 224 (337)
T ss_dssp -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH-HHHHCCCC------C--
T ss_pred -cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHH-HHHcCCCC------C--
Confidence 223456899999999999999999999999999999999999999744321 1111 11112110 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 506 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 506 (557)
+......+.+++.+||+.||++|| +++||++.
T Consensus 225 --p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 225 --PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 111234688999999999999999 89999764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=340.54 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=198.9
Q ss_pred HHHHhhcccCCCCceEEEEEEEcC----CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
..|++.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.+++.++||||+++++++. ++..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 455678999999999999998753 4579999987543 334567899999999999999999999985 4568999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 94 MELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCc
Confidence 9999999999999753 4568999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 390 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
..........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ ... .+..+....
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~----~i~~~~~~~---- 237 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIG----RIENGERLP---- 237 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----HHHTTCCCC----
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHH----HHHcCCCCC----
Confidence 43333333446789999999998899999999999999999997 999997543322 111 122222111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
.+...+..+.+++.+||+.||++|||+.||++.|+++.+.+.
T Consensus 238 -----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 238 -----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 111223478899999999999999999999999999987653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=343.70 Aligned_cols=259 Identities=22% Similarity=0.281 Sum_probs=199.3
Q ss_pred HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
|++.+.||+|+||+||+|.+.+|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence 456789999999999999998899999999864322 234678899999999999999999999999999999999997
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
++|.+.+.. ....+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 103 -~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~- 175 (311)
T 3niz_A 103 -KDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS- 175 (311)
T ss_dssp -EEHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred -CCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc-
Confidence 588887764 34568999999999999999999998 99999999999999999999999999999876543222
Q ss_pred cccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc--------
Q 008707 395 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI-------- 465 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 465 (557)
.....||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+....+. ...+............
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPKIFSILGTPNPREWPQVQELPL 252 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHHHHHHHCCCCTTTSGGGTTSHH
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHHCCCChHHhhhhhccch
Confidence 223458999999999876 5689999999999999999999999985543322 1112222211110000
Q ss_pred --------ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 466 --------VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 466 --------~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+.............++.+++.+||+.||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 253 WKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000000112246789999999999999999999985
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=346.46 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=203.1
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccch------hHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
.|++.+.||+|+||.||+|..+ +|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 3556789999999999999876 5899999998654321 34678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC----cEEEecccCc
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFGLS 384 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla 384 (557)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .||+||||||+||+++.++ .+||+|||++
T Consensus 93 v~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 93 ILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999973 4578999999999999999999998 9999999999999998776 7999999999
Q ss_pred cccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 385 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 385 ~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+... .. ..+..+...
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~-~~i~~~~~~- 236 (361)
T 2yab_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TL-ANITAVSYD- 236 (361)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH-HHHHTTCCC-
T ss_pred eEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhcCCC-
Confidence 87654322 233459999999999999999999999999999999999999997543211 11 112222110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+++..... ....+.+++.+||..||++|||+.|+++
T Consensus 237 -~~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 -FDEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp -CCHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -CCchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 01111111 1236889999999999999999999985
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=348.67 Aligned_cols=255 Identities=23% Similarity=0.317 Sum_probs=206.2
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
......|++.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 344567788999999999999999876 58999999986532 334567889999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC---CcEEEecccCc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLS 384 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla 384 (557)
+||||+++|+|.+.+.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+|||++
T Consensus 105 lv~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EEECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 99999999999998873 4568999999999999999999998 999999999999999865 45999999999
Q ss_pred cccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 385 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 385 ~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. . ....+..+....
T Consensus 179 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~-~~~~i~~~~~~~ 249 (362)
T 2bdw_A 179 IEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------R-LYAQIKAGAYDY 249 (362)
T ss_dssp BCCTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHTCCCC
T ss_pred eEecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHhCCCCC
Confidence 87654322 22346899999999999999999999999999999999999999744321 1 111222222110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
..+ .. ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 250 -~~~-~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 -PSP-EW----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -CTT-GG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -Ccc-cc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00 1123468899999999999999999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=359.57 Aligned_cols=252 Identities=30% Similarity=0.493 Sum_probs=207.0
Q ss_pred HHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecC-eeEEEEEecC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-QRILVYEYMH 314 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-~~~lv~e~~~ 314 (557)
.+++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|++++++++||||+++++++.... ..++||||++
T Consensus 194 ~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~ 270 (450)
T 1k9a_A 194 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270 (450)
T ss_dssp GEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCT
T ss_pred HeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecC
Confidence 4456789999999999999987 7899999997643 4577999999999999999999999987655 7899999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+|+|.+++... ....+++..++.++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++......
T Consensus 271 ~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 343 (450)
T 1k9a_A 271 KGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 343 (450)
T ss_dssp TCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence 99999999854 23447899999999999999999998 999999999999999999999999999998653321
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
....+++.|+|||.+.+..++.++||||||+++|||+| |+.||......+ .. ..+..+....
T Consensus 344 -~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~----~~i~~~~~~~--------- 406 (450)
T 1k9a_A 344 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGYKMD--------- 406 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HH----HHHHTTCCCC---------
T ss_pred -cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCCC---------
Confidence 12246889999999999999999999999999999999 999997543322 11 2222332111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
.+...+..+.+++.+||+.||++|||+.||++.|+++...+
T Consensus 407 ~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 407 APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 11223457889999999999999999999999999987653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=337.16 Aligned_cols=255 Identities=28% Similarity=0.449 Sum_probs=210.3
Q ss_pred HHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
.|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEH 87 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTT
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCC
Confidence 3456789999999999999998889999999876433 346789999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 88 ~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (267)
T 3t9t_A 88 GCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162 (267)
T ss_dssp CBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred CcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence 9999999753 4568999999999999999999998 9999999999999999999999999999987644322222
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+.. +.. ..+..+.... .
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~-~~i~~~~~~~--~------- 226 (267)
T 3t9t_A 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVV-EDISTGFRLY--K------- 226 (267)
T ss_dssp TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHH-HHHHTTCCCC--C-------
T ss_pred ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHH-HHHhcCCcCC--C-------
Confidence 33446788999999998889999999999999999999 89999743321 111 1222221110 0
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
+...+..+.+++.+||+.+|++|||++|+++.|+++.+
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11123468899999999999999999999999999876
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=345.49 Aligned_cols=260 Identities=26% Similarity=0.429 Sum_probs=211.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
..|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 102 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLL 102 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceE
Confidence 44566899999999999999862 35789999987543 344577899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCC---------------------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCC
Q 008707 308 LVYEYMHNGTLRDRLHGSVN---------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 366 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~ 366 (557)
+||||+++++|.+++..... ...+++..++.++.||++||+|||+ ++++||||||+
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~ 179 (314)
T 2ivs_A 103 LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAAR 179 (314)
T ss_dssp EEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGG
T ss_pred EEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchh
Confidence 99999999999999975432 2348999999999999999999998 99999999999
Q ss_pred CEEeCCCCcEEEecccCccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCcc
Q 008707 367 NILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG 444 (557)
Q Consensus 367 NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~ 444 (557)
||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876443322 2233446788999999998889999999999999999999 99999754432
Q ss_pred ccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 445 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
. +. ..+..+.... .+...+..+.+++.+||+.||++|||+.||++.|+++...
T Consensus 260 ~---~~----~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 260 R---LF----NLLKTGHRME---------RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp G---HH----HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred H---HH----HHhhcCCcCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 2 11 1222222111 1112234788999999999999999999999999998764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=342.12 Aligned_cols=261 Identities=29% Similarity=0.462 Sum_probs=215.9
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEcC-CcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
....+++.+.||+|+||.||+|.+.. +..||+|++... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 34456678999999999999998874 889999998754 3345778999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999999754 34568999999999999999999998 999999999999999999999999999998776554
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+... ..+ .+..+...
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~----~~~~~~~~------- 231 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE----LLEKDYRM------- 231 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HHHTTCCC-------
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHhccCCC-------
Confidence 444444457889999999998899999999999999999999 999997544322 111 11111111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
..+...+..+.+++.+|+..||++|||++||++.|+.+....
T Consensus 232 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 232 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111122347889999999999999999999999999987743
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=356.56 Aligned_cols=265 Identities=27% Similarity=0.437 Sum_probs=211.3
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecC
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 304 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 304 (557)
+....+++.+.||+|+||.||+|.+. +++.||||++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 147 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 147 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 33455667899999999999999853 46789999987543 344567889999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhccC----CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC---cEE
Q 008707 305 QRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAK 377 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~---~~k 377 (557)
..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++ .+|
T Consensus 148 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 148 PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEE
Confidence 9999999999999999997642 22468999999999999999999998 9999999999999999555 599
Q ss_pred EecccCccccCCCC-ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 008707 378 VSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 455 (557)
Q Consensus 378 l~Dfgla~~~~~~~-~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~ 455 (557)
|+|||+++...... ........+|+.|+|||.+.+..++.++|||||||++|||++ |..||...... + +..
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~-~~~ 297 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------E-VLE 297 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------H-HHH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHH
Confidence 99999997542221 112223457899999999998899999999999999999998 99999744321 1 112
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 456 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 456 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
.+..+.... .....+..+.+++.+||+.+|++|||+.||++.|+.+.....
T Consensus 298 ~i~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 298 FVTSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHHcCCCCC---------CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 222222111 111223468899999999999999999999999999887543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=340.13 Aligned_cols=259 Identities=25% Similarity=0.430 Sum_probs=210.5
Q ss_pred HHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
..|++.+.||+|+||.||+|...++..||+|++.... ...+.+.+|+++++.++||||+++++++.+ +..++||||++
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~ 90 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCC
Confidence 4566789999999999999999888899999987543 335678999999999999999999999874 56899999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++..........
T Consensus 91 ~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 99999998742 12358999999999999999999998 999999999999999999999999999998776544333
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....... . ...+..+....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~~~~~--------- 230 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---V----IQNLERGYRMV--------- 230 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H----HHHHHTTCCCC---------
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---H----HHHHhcccCCC---------
Confidence 334457889999999988889999999999999999999 999997433211 1 11222221111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
.+...+..+.+++.+|++.+|++|||+++|++.|+++.....
T Consensus 231 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 111223478899999999999999999999999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=366.52 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=205.7
Q ss_pred HHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
..+++.+.||+|+||.||+|.++++..||||+++... ...+.+.+|++++++++||||+++++++.+ +..++||||++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 4456788999999999999999988889999987543 235679999999999999999999999876 67899999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+|+|.+++... ....+++..+..++.||+.||+|||+ ++++||||||+|||++.++.+||+|||+++.........
T Consensus 262 ~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 262 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 99999999743 23458899999999999999999998 999999999999999999999999999998765433222
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....+++.|+|||.+.+..++.++||||||+++|||+| |+.||.+.... + +...+..+....
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~-~~~~i~~~~~~~--------- 401 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------E-VLDQVERGYRMP--------- 401 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCCCC---------
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCC---------
Confidence 333446789999999998899999999999999999999 99999743321 1 112222322111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
.+...+..+.+++.+||+.+|++|||+++|++.|+++.....
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 112234478899999999999999999999999998875433
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=343.51 Aligned_cols=251 Identities=23% Similarity=0.299 Sum_probs=203.9
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc------hhHHHHHHHHHHHhhcCCCCccceeeEEEecCee
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 306 (557)
...|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 355777899999999999999876 589999999865322 1356789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC----cEEEeccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 382 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg 382 (557)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+++||||||+||+++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999973 4568999999999999999999998 9999999999999999877 79999999
Q ss_pred CccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 383 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 383 la~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||....... .... +.....
T Consensus 164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~-~~~~~~ 234 (326)
T 2y0a_A 164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLAN-VSAVNY 234 (326)
T ss_dssp TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHH-HHHTCC
T ss_pred CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------HHHH-HHhcCC
Confidence 9987653322 223458999999999999999999999999999999999999997443211 1111 111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 463 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 463 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
. ........ .+..+.+++.+||+.||++|||+.|+++
T Consensus 235 ~--~~~~~~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 E--FEDEYFSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C--CCHHHHTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C--cCcccccc----CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00000111 1236789999999999999999999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=353.93 Aligned_cols=253 Identities=22% Similarity=0.294 Sum_probs=204.0
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
...|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 456777899999999999999865 68999999986543 234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC---CCCcEEEecccCcccc
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQA 387 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~ 387 (557)
||+++|+|.+.+.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++ .++.+||+|||++...
T Consensus 90 E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 90 DLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp CCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999874 4568999999999999999999998 9999999999999998 4678999999999876
Q ss_pred CCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
...... .....||+.|+|||++.+..++.++||||+||++|+|++|..||...+... ....+..+.... ..
T Consensus 164 ~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~~-~~ 234 (444)
T 3soa_A 164 EGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-------LYQQIKAGAYDF-PS 234 (444)
T ss_dssp CTTCCB-CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHTCCCC-CT
T ss_pred cCCCce-eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHHhCCCCC-Cc
Confidence 543322 223469999999999999999999999999999999999999997443211 112222222211 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+ ... ..+..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~-~~~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 235 P-EWD----TVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp T-TTT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred c-ccc----cCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 011 123468899999999999999999999873
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=339.70 Aligned_cols=264 Identities=23% Similarity=0.393 Sum_probs=207.3
Q ss_pred HHHHHhhcccCCCCceEEEEEEE-----cCCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEec--Ce
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQ 305 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~ 305 (557)
...|++.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+++++.++||||+++++++... ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 34456789999999999999984 358899999987543 23457789999999999999999999999876 66
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccc
Confidence 89999999999999999643 4568999999999999999999998 999999999999999999999999999998
Q ss_pred ccCCCCc--cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcc--------ccccHHHHHHH
Q 008707 386 QAEEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG--------AELNIVHWARS 455 (557)
Q Consensus 386 ~~~~~~~--~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~--------~~~~~~~~~~~ 455 (557)
....... .......+|..|+|||.+.+..++.++||||||+++|+|+||..|+...... ...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 7654432 2233445788899999999989999999999999999999999987522100 01111111222
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 456 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 456 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
.+..+.... .+...+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus 255 ~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 255 TLKEGKRLP---------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHTTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhccCCCC---------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 222222111 11223347889999999999999999999999999875
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=343.92 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=181.4
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
+.||+|+||.||+|.+. +++.||+|++... ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 77999999999999876 5899999998643 3456778999999996 99999999999999999999999999999
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC---cEEEecccCccccCCCCcccc
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~Dfgla~~~~~~~~~~~ 395 (557)
.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++ .+||+|||++......... .
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-~ 166 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-L 166 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc-c
Confidence 999974 4679999999999999999999998 9999999999999998665 7999999999865443222 2
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..............+..+.... . ....
T Consensus 167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~--~----~~~~ 240 (325)
T 3kn6_A 167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF--E----GEAW 240 (325)
T ss_dssp -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC--C----SHHH
T ss_pred cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC--C----cccc
Confidence 234579999999999999999999999999999999999999985544322111222233333332211 0 0000
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
......+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 112347889999999999999999999874
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=347.98 Aligned_cols=255 Identities=23% Similarity=0.282 Sum_probs=204.3
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-----chhHHHHHHHHHHHhhcCCCCccceeeEEEecCee
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 306 (557)
....|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4567788999999999999999875 68999999985321 12356789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc---EEEeccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFG 382 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfg 382 (557)
++||||+++++|.+.+.... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999988776432 34468999999999999999999998 99999999999999986654 9999999
Q ss_pred CccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 383 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 383 la~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
++......... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... + ....+..+..
T Consensus 179 ~a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~-~~~~i~~~~~ 249 (351)
T 3c0i_A 179 VAIQLGESGLV-AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------R-LFEGIIKGKY 249 (351)
T ss_dssp TCEECCTTSCB-CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------H-HHHHHHHTCC
T ss_pred ceeEecCCCee-ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------H-HHHHHHcCCC
Confidence 99876543322 2334589999999999999999999999999999999999999974311 1 1111222221
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 463 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 463 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
. .++..... .+..+.+++.+||+.||++|||+.|+++
T Consensus 250 ~--~~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 K--MNPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp C--CCHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C--CCcccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1 01101111 1246889999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=340.32 Aligned_cols=262 Identities=28% Similarity=0.480 Sum_probs=202.9
Q ss_pred HHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
.+++.+.||+|+||.||+|.+. ++.||+|++... ...+.+.+|++++++++||||+++++++.+ ..++||||+++
T Consensus 9 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~ 83 (307)
T 2eva_A 9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEG 83 (307)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTT
T ss_pred HeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCC
Confidence 3456789999999999999986 789999998643 345778999999999999999999998864 47899999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc-EEEecccCccccCCCCccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR-AKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~-~kl~Dfgla~~~~~~~~~~ 394 (557)
|+|.+++........+++..++.++.|+++||+|||+...++++||||||+||+++.++. +||+|||++.......
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~--- 160 (307)
T 2eva_A 84 GSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--- 160 (307)
T ss_dssp CBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------
T ss_pred CCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc---
Confidence 999999985433335788999999999999999999733368999999999999998886 7999999997654322
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .... .....+..... ...
T Consensus 161 -~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~-~~~~~~~~~~~-----~~~- 228 (307)
T 2eva_A 161 -TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIM-WAVHNGTRPPL-----IKN- 228 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHH-HHHHTTCCCCC-----BTT-
T ss_pred -ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHH-HHHhcCCCCCc-----ccc-
Confidence 22348999999999999999999999999999999999999997432211 1111 11122221111 111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCCCCc
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGGDQK 520 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~~~~ 520 (557)
.+..+.+++.+||+.||++|||++||++.|+.+.........+
T Consensus 229 ---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 271 (307)
T 2eva_A 229 ---LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271 (307)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred ---cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence 2346889999999999999999999999999998766554443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=348.31 Aligned_cols=262 Identities=26% Similarity=0.434 Sum_probs=210.5
Q ss_pred HHHHhhcccCCCCceEEEEEEEcC------CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
..|++.+.||+|+||.||+|.+.+ ++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 126 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 126 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceE
Confidence 345567899999999999998753 4789999997643 334567999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCC---------------------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCC
Q 008707 308 LVYEYMHNGTLRDRLHGSVN---------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 366 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~ 366 (557)
+||||+++|+|.+++..... ...+++..++.++.||++||+|||+ ++|+||||||+
T Consensus 127 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~ 203 (343)
T 1luf_A 127 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATR 203 (343)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred EEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcc
Confidence 99999999999999975321 2568999999999999999999998 99999999999
Q ss_pred CEEeCCCCcEEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCcc
Q 008707 367 NILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG 444 (557)
Q Consensus 367 NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~ 444 (557)
||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|+| |..||......
T Consensus 204 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 283 (343)
T 1luf_A 204 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283 (343)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred eEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChH
Confidence 99999999999999999986543221 22233457889999999998889999999999999999999 99999743321
Q ss_pred ccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 445 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
. ....+..+..... +...+..+.+++.+||+.||++|||+.||++.|+++.....
T Consensus 284 ~-------~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 284 E-------VIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp H-------HHHHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred H-------HHHHHhCCCcCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 1 1222333332211 11223478899999999999999999999999999876443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=343.39 Aligned_cols=250 Identities=25% Similarity=0.382 Sum_probs=199.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 456789999999999999876 689999999864322 234568899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC-cc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-TH 393 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~ 393 (557)
+|+|.+++. ....+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++....... ..
T Consensus 89 ~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 89 GGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp TEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 999999987 35679999999999999999999998 999999999999999999999999999998654322 12
Q ss_pred ccccccCCCCccCCcccCCCCC-CcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~-s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....... .....+ ........ +
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~----~~~~~~~~---~---- 230 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW----KEKKTYLN---P---- 230 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHH----HTTCTTST---T----
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHH----hcccccCC---c----
Confidence 2234568999999999987765 779999999999999999999997543321 111111 11111100 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.......+.+++.+||+.||++|||++|+++.
T Consensus 231 --~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 231 --WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 01123367899999999999999999999763
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=343.80 Aligned_cols=249 Identities=19% Similarity=0.289 Sum_probs=202.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
|++.+.||+|+||.||+|... +++.||+|.+... ......+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g 85 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCC
Confidence 456789999999999999876 5889999998644 34456788999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC--CCcEEEecccCccccCCCCcc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~ 393 (557)
|+|.+++... ...+++..++.++.|++.||+|||+ .|++||||||+|||++. ++.+||+|||++........
T Consensus 86 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~- 159 (321)
T 1tki_A 86 LDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc-
Confidence 9999999742 3568999999999999999999998 99999999999999987 78999999999987654332
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....||+.|+|||++.+..++.++||||||+++|+|++|..||...... +.... +..+... ++......
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~-i~~~~~~--~~~~~~~~ 229 (321)
T 1tki_A 160 -FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIEN-IMNAEYT--FDEEAFKE 229 (321)
T ss_dssp -EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH-HHHTCCC--CCHHHHTT
T ss_pred -cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHH-HHcCCCC--CChhhhcc
Confidence 22345899999999999988999999999999999999999999744321 11111 1112111 00000111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.+..+.+++.+||..||++|||+.|+++.
T Consensus 230 ----~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 230 ----ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 23468899999999999999999999984
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=344.85 Aligned_cols=263 Identities=26% Similarity=0.417 Sum_probs=196.5
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcCC----cEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCee-
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKDG----KEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR- 306 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~- 306 (557)
...|++.+.||+|+||.||+|.+... ..||+|++... .....+.+.+|+++++.++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 34567789999999999999987643 27999998754 334567899999999999999999999999876655
Q ss_pred -----EEEEEecCCCChhhhhhccC---CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEE
Q 008707 307 -----ILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 378 (557)
Q Consensus 307 -----~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl 378 (557)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEE
Confidence 89999999999999986432 22368999999999999999999998 99999999999999999999999
Q ss_pred ecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHH
Q 008707 379 SDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSM 456 (557)
Q Consensus 379 ~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 456 (557)
+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ... .
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~----~ 251 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IYN----Y 251 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH----H
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HHH----H
Confidence 99999987644322 11223346788999999999999999999999999999999 999997543322 111 1
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 457 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 457 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
+..+.... .....+..+.+++.+||+.||++|||+.|+++.|+++.....
T Consensus 252 ~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 252 LIGGNRLK---------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HHTTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HhcCCCCC---------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 11111111 111223478899999999999999999999999999987543
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=349.64 Aligned_cols=262 Identities=27% Similarity=0.426 Sum_probs=209.1
Q ss_pred HHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccc-hhHHHHHHHHHHHhhc-CCCCccceeeEEEecC-e
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH-Q 305 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~-~ 305 (557)
..|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++.++ +||||+++++++.+.+ .
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 44566899999999999999743 357899999976433 3456799999999999 7999999999988755 4
Q ss_pred eEEEEEecCCCChhhhhhccCC----------------------------------------------------------
Q 008707 306 RILVYEYMHNGTLRDRLHGSVN---------------------------------------------------------- 327 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 327 (557)
.++||||+++|+|.+++.....
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 8999999999999999975421
Q ss_pred -----CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc-cccccccCC
Q 008707 328 -----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGT 401 (557)
Q Consensus 328 -----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~ 401 (557)
...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++........ .......||
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 1228999999999999999999999 9999999999999999999999999999987643322 223344578
Q ss_pred CCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHH
Q 008707 402 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIW 480 (557)
Q Consensus 402 ~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 480 (557)
+.|+|||++.+..++.++||||||+++|||+| |+.||........ +...+..+..... +.....
T Consensus 259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~~~---------~~~~~~ 323 (359)
T 3vhe_A 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMRA---------PDYTTP 323 (359)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH------HHHHHHHTCCCCC---------CTTCCH
T ss_pred ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH------HHHHHHcCCCCCC---------CCCCCH
Confidence 89999999999999999999999999999998 9999975443221 1122222221111 111234
Q ss_pred HHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 481 RIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 481 ~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
.+.+++.+||+.||++|||++||++.|+++....
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 6889999999999999999999999999988653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=340.96 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=197.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecC--------
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH-------- 304 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~-------- 304 (557)
..|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 34566899999999999999986 79999999986433 335578999999999999999999999986543
Q ss_pred -------------------------------------------------eeEEEEEecCCCChhhhhhccCCCCCcCHHH
Q 008707 305 -------------------------------------------------QRILVYEYMHNGTLRDRLHGSVNQKPLDWLT 335 (557)
Q Consensus 305 -------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 335 (557)
..++||||+++++|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 2789999999999999998655445567777
Q ss_pred HHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc-----------cccccccCCCCc
Q 008707 336 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT-----------HISSVARGTVGY 404 (557)
Q Consensus 336 ~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~g~~~y 404 (557)
++.++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++........ .......||+.|
T Consensus 166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 242 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242 (332)
T ss_dssp HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence 89999999999999998 9999999999999999999999999999987654421 112234589999
Q ss_pred cCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHH
Q 008707 405 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAE 484 (557)
Q Consensus 405 ~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 484 (557)
+|||.+.+..++.++||||||+++|||++|..|+.. ... .......+.... ........+.+
T Consensus 243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~-~~~~~~~~~~~~---------~~~~~~~~~~~ 304 (332)
T 3qd2_B 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVR-IITDVRNLKFPL---------LFTQKYPQEHM 304 (332)
T ss_dssp SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHH-HHHHHHTTCCCH---------HHHHHCHHHHH
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHH-HHHHhhccCCCc---------ccccCChhHHH
Confidence 999999999999999999999999999998776531 111 111111111110 11223346789
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 008707 485 VAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 485 li~~cl~~~P~~RPt~~evl~ 505 (557)
++.+||+.||++|||++|+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCcCCCHHHHhh
Confidence 999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=345.93 Aligned_cols=262 Identities=24% Similarity=0.398 Sum_probs=208.6
Q ss_pred HhhcccCCCCceEEEEEEEc-----CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEec--CeeEEE
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-----DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILV 309 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~~lv 309 (557)
++.+.||+|+||.||++.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 56789999999999998653 58899999987643 34456799999999999999999999999874 578999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+++|+|.+++.. ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 114 ~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp ECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999974 348999999999999999999998 9999999999999999999999999999987654
Q ss_pred CCc--cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccc--------cccHHHHHHHHHhc
Q 008707 390 DLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--------ELNIVHWARSMIKK 459 (557)
Q Consensus 390 ~~~--~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~--------~~~~~~~~~~~~~~ 459 (557)
... .......+++.|+|||.+.+..++.++||||||+++|+|+||..||....... ...........+..
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 332 12233457888999999999899999999999999999999999997432110 00001111222222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 460 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 460 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
+... ......+..+.+++.+||+.||++|||++||++.|+.+.+.-.
T Consensus 267 ~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 267 GERL---------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp TCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ccCC---------CCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 2111 1122233478899999999999999999999999999887544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=335.06 Aligned_cols=259 Identities=19% Similarity=0.278 Sum_probs=197.7
Q ss_pred HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
|++.+.||+|+||.||+|...+|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 446789999999999999998899999999865432 234678899999999999999999999999999999999997
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+ +|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 156 (288)
T 1ob3_A 84 Q-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK- 156 (288)
T ss_dssp E-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred C-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccccc-
Confidence 5 898888743 4568999999999999999999998 99999999999999999999999999999876433221
Q ss_pred cccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc--------cc
Q 008707 395 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--------SI 465 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 465 (557)
.....||+.|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+..+ ............... ..
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhcccc
Confidence 223357999999999876 458999999999999999999999997543221 111111111111100 00
Q ss_pred cccccc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 466 VDPVLI-------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 466 ~d~~l~-------~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+++... ..........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 111110 0011122346789999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=345.29 Aligned_cols=265 Identities=24% Similarity=0.438 Sum_probs=212.1
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc--------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEec
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE 303 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~ 303 (557)
...|++.+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+++++.+ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 345667899999999999999863 46789999987543 33456789999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChhhhhhccCC-------------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe
Q 008707 304 HQRILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 370 (557)
Q Consensus 304 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll 370 (557)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ .+++||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence 999999999999999999975421 2348899999999999999999998 999999999999999
Q ss_pred CCCCcEEEecccCccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCcccccc
Q 008707 371 DINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELN 448 (557)
Q Consensus 371 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~ 448 (557)
+.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence 99999999999999876543221 1223346788999999988889999999999999999999 999997443211
Q ss_pred HHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 008707 449 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 517 (557)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~ 517 (557)
....+..+.... .....+..+.+++.+||+.+|.+|||+.||++.|+++.......
T Consensus 268 ----~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~~ 323 (334)
T 2pvf_A 268 ----LFKLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTNE 323 (334)
T ss_dssp ----HHHHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred ----HHHHHhcCCCCC---------CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccccC
Confidence 112222222111 11122347889999999999999999999999999999876544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=349.38 Aligned_cols=248 Identities=22% Similarity=0.345 Sum_probs=197.8
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
.+++.+.||+|+||.||+|..+ +++.||+|++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++||
T Consensus 53 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 3456789999999999999876 57899999987542 22334578899999887 8999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 133 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 133 EYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999874 3568999999999999999999998 99999999999999999999999999999863322
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccc--cccHHHHHHHHHhcCCccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA--ELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .......+...+..+...
T Consensus 207 ~~-~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----- 280 (396)
T 4dc2_A 207 GD-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----- 280 (396)
T ss_dssp TC-CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC-----
T ss_pred CC-ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC-----
Confidence 22 2344569999999999999999999999999999999999999997443221 111122222333322211
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 500 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 500 (557)
.+......+.+++.+||+.||++||++
T Consensus 281 -----~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 -----IPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----CCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 111123468899999999999999996
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=333.44 Aligned_cols=252 Identities=31% Similarity=0.519 Sum_probs=200.5
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchh-------HHHHHHHHHHHhhcCCCCccceeeEEEecCee
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR-------TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 306 (557)
..|++.+.||+|+||.||+|.+. +++.||+|++....... .+.+.+|+++++.++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 44566789999999999999875 68999999986432211 167889999999999999999999987654
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCC--eEeeccCCCCEEeCCCCc-----EEEe
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMR-----AKVS 379 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~--ivH~dlk~~NIll~~~~~-----~kl~ 379 (557)
++||||+++|+|.+.+.. ....+++..++.++.|++.||+|||+ .+ ++||||||+||+++.++. +||+
T Consensus 97 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 699999999999998864 34578999999999999999999998 88 999999999999988776 9999
Q ss_pred cccCccccCCCCccccccccCCCCccCCccc--CCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH
Q 008707 380 DFGLSRQAEEDLTHISSVARGTVGYLDPEYY--GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 457 (557)
Q Consensus 380 Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l--~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 457 (557)
|||++...... .....||+.|+|||.+ ....++.++||||||+++|+|++|+.||........ .......
T Consensus 172 Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~ 243 (287)
T 4f0f_A 172 DFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINMIR 243 (287)
T ss_dssp CCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHHHH
T ss_pred CCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHHHh
Confidence 99999765432 2334589999999998 445678899999999999999999999974433221 1111111
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 458 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 458 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
..+.. + ..+...+..+.+++.+||+.||++|||++||++.|+++
T Consensus 244 ~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EEGLR-----P----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSCCC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred ccCCC-----C----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11111 1 11122234788999999999999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=333.85 Aligned_cols=246 Identities=28% Similarity=0.395 Sum_probs=193.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--------------------------hhHHHHHHHHHHHhhcC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------------------------HRTQQFVTEVALLSRIH 289 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~il~~l~ 289 (557)
|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 456789999999999999875 588999999864321 11246889999999999
Q ss_pred CCCccceeeEEEe--cCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCC
Q 008707 290 HRNLVPLIGYCEE--EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSN 367 (557)
Q Consensus 290 h~nIv~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~N 367 (557)
||||+++++++.+ .+..++||||+++++|.+++. ...+++..+..++.||++||+|||+ .+++||||||+|
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~N 167 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSN 167 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGG
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHH
Confidence 9999999999986 567899999999999988654 4578999999999999999999998 999999999999
Q ss_pred EEeCCCCcEEEecccCccccCCCCccccccccCCCCccCCcccCCCC---CCcccceehhHHHHHHHHhCCCCCCCCCcc
Q 008707 368 ILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFG 444 (557)
Q Consensus 368 Ill~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~---~s~~~DvwslG~ll~elltg~~pf~~~~~~ 444 (557)
|+++.++.+||+|||++......... .....||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~- 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDAL-LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI- 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCE-ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH-
T ss_pred EEECCCCCEEEecCCCcccccccccc-ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH-
Confidence 99999999999999999876543322 23345899999999998765 47889999999999999999999974322
Q ss_pred ccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 445 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
... ...+..+.... .+ ... .+..+.+++.+||+.||++|||++|+++
T Consensus 246 -----~~~-~~~~~~~~~~~-~~---~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 -----MCL-HSKIKSQALEF-PD---QPD----IAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -----HHH-HHHHHHCCCCC-CS---SSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -----HHH-HHHHhcccCCC-CC---ccc----cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 111 11222221110 00 111 2236889999999999999999999975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=344.55 Aligned_cols=268 Identities=17% Similarity=0.233 Sum_probs=204.7
Q ss_pred HHHhhcccCCCCceEEEEEEEcC------CcEEEEEEccCccchh-----------HHHHHHHHHHHhhcCCCCccceee
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSCSHR-----------TQQFVTEVALLSRIHHRNLVPLIG 298 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~il~~l~h~nIv~~~~ 298 (557)
.|++.+.||+|+||.||+|.+.. ++.||+|++....... ...+..|+..+..++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 45567999999999999998764 4789999986543211 112445666777788999999999
Q ss_pred EEEec----CeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC--C
Q 008707 299 YCEEE----HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--I 372 (557)
Q Consensus 299 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~--~ 372 (557)
++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||+ .+|+||||||+|||++ .
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSC
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCC
Confidence 98764 4589999999 9999999975 34679999999999999999999999 9999999999999999 8
Q ss_pred CCcEEEecccCccccCCCCccc------cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcccc
Q 008707 373 NMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 446 (557)
Q Consensus 373 ~~~~kl~Dfgla~~~~~~~~~~------~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~ 446 (557)
++.+||+|||+++......... .....||+.|+|||.+.+..++.++|||||||++|||+||+.||......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~-- 267 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD-- 267 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC--
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC--
Confidence 8999999999998764432211 12344899999999999999999999999999999999999999843322
Q ss_pred ccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 447 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
............ ......+++.+... ..+..+.+++.+||+.+|++||++++|++.|+++.....
T Consensus 268 ~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 268 PKYVRDSKIRYR-ENIASLMDKCFPAA---NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp HHHHHHHHHHHH-HCHHHHHHHHSCTT---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHhh-hhHHHHHHHhcccc---cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 112221221111 12222222222111 123478899999999999999999999999999987544
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=347.60 Aligned_cols=250 Identities=21% Similarity=0.344 Sum_probs=204.7
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 4566789999999999999876 688999999876655566788999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC--CCcEEEecccCccccCCCCc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~ 392 (557)
+|+|.+++.. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||++........
T Consensus 132 gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 132 GGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999999874 24568999999999999999999998 99999999999999974 47799999999987654322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. +.... +..+... .++....
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~-i~~~~~~--~~~~~~~ 275 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQN-VKRCDWE--FDEDAFS 275 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHH-HHHCCCC--CCSSTTT
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCCC--CCccccc
Confidence 22335899999999999999999999999999999999999999754321 11111 1111110 1111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..+..+.+++.+||+.||++|||+.|+++
T Consensus 276 ----~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 276 ----SVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp ----TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ----cCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 22346889999999999999999999986
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=343.06 Aligned_cols=262 Identities=29% Similarity=0.449 Sum_probs=212.0
Q ss_pred HHHHhhcccCCCCceEEEEEEE------cCCcEEEEEEccCccc-hhHHHHHHHHHHHhhc-CCCCccceeeEEEecCee
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKM------KDGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~ 306 (557)
..|++.+.||+|+||.||+|.+ .+++.||+|++..... ...+.+.+|+++++++ +||||+++++++.+.+..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 102 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCc
Confidence 4456789999999999999985 2467899999875433 3457799999999999 899999999999999999
Q ss_pred EEEEEecCCCChhhhhhccCC---------------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC
Q 008707 307 ILVYEYMHNGTLRDRLHGSVN---------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 371 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~ 371 (557)
++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+ .+++||||||+||+++
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~ 179 (313)
T 1t46_A 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (313)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEc
Confidence 999999999999999975421 2258999999999999999999998 9999999999999999
Q ss_pred CCCcEEEecccCccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccH
Q 008707 372 INMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 449 (557)
Q Consensus 372 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~ 449 (557)
.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|+| |..||....... ..
T Consensus 180 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~ 257 (313)
T 1t46_A 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--KF 257 (313)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--HH
T ss_pred CCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--HH
Confidence 9999999999999876544322 2233446789999999988899999999999999999999 999997543321 11
Q ss_pred HHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 450 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 450 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
. ..+..+... ......+..+.+++.+||+.||.+|||+.||++.|+++....
T Consensus 258 ~----~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 258 Y----KMIKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp H----HHHHHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred H----HHhccCCCC---------CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1 112221110 011122347889999999999999999999999999988753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=337.10 Aligned_cols=268 Identities=25% Similarity=0.373 Sum_probs=204.3
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhc--CCCCccceeeEEEec----C
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI--HHRNLVPLIGYCEEE----H 304 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l--~h~nIv~~~~~~~~~----~ 304 (557)
+.....|++.+.||+|+||.||+|.+. ++.||||++... ....+.+|.+++..+ +||||+++++++... .
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 444567788999999999999999987 899999998643 234455566666655 899999999999876 6
Q ss_pred eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCC--------CeEeeccCCCCEEeCCCCcE
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP--------GIIHRDVKSSNILLDINMRA 376 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~--------~ivH~dlk~~NIll~~~~~~ 376 (557)
..++||||+++|+|.++++. ..+++..++.++.|++.||+|||+ . +++||||||+||+++.++.+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 181 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNGTC 181 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred ceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCCCE
Confidence 88999999999999999963 358999999999999999999998 6 99999999999999999999
Q ss_pred EEecccCccccCCCCccc---cccccCCCCccCCcccCCCCCCcc------cceehhHHHHHHHHhC----------CCC
Q 008707 377 KVSDFGLSRQAEEDLTHI---SSVARGTVGYLDPEYYGNQQLTEK------SDVYSFGVVLLELISG----------KKP 437 (557)
Q Consensus 377 kl~Dfgla~~~~~~~~~~---~~~~~g~~~y~aPE~l~~~~~s~~------~DvwslG~ll~elltg----------~~p 437 (557)
||+|||++.......... .....||+.|+|||.+.+...+.+ +|||||||++|||+|| +.|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999997664432221 123468999999999988766655 9999999999999999 666
Q ss_pred CCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 438 VSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 438 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
|....... ..... .............+... ......+..+.+++.+||+.||++|||++||++.|+++.+..
T Consensus 262 ~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 262 YHDLVPSD-PSYED-MREIVCIKKLRPSFPNR---WSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp TTTTSCSS-CCHHH-HHHHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HhhhcCCC-Cchhh-hHHHHhhhccCcccccc---chhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 65322221 11111 12222111111111100 011256678999999999999999999999999999988754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=339.07 Aligned_cols=254 Identities=24% Similarity=0.407 Sum_probs=201.9
Q ss_pred HHHHhhcccCCCCceEEEEEEEcC-C-------cEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCee
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKD-G-------KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 306 (557)
..|.+.+.||+|+||.||+|.+.. + ..||+|++........+.+.+|+++++.++||||+++++++.+.+..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 445678899999999999997653 3 57999998766666678899999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc--------EEE
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--------AKV 378 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~--------~kl 378 (557)
++||||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++++||||||+|||++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence 9999999999999999753 3448999999999999999999998 99999999999999998877 999
Q ss_pred ecccCccccCCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCC-CCCCCCccccccHHHHHHHH
Q 008707 379 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKK-PVSVEDFGAELNIVHWARSM 456 (557)
Q Consensus 379 ~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~-pf~~~~~~~~~~~~~~~~~~ 456 (557)
+|||++...... ....+++.|+|||.+.+ ..++.++||||||+++|||++|.. ||...+.. ......
T Consensus 163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~------~~~~~~ 231 (289)
T 4fvq_A 163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ------RKLQFY 231 (289)
T ss_dssp CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHH
T ss_pred ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH------HHHHHh
Confidence 999998765432 12347889999999987 678999999999999999999554 44422111 111111
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 008707 457 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 516 (557)
Q Consensus 457 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 516 (557)
......... .+..+.+++.+||+.||++|||++|+++.|+++......
T Consensus 232 ~~~~~~~~~------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 232 EDRHQLPAP------------KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp HTTCCCCCC------------SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred hccCCCCCC------------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 111111111 122577999999999999999999999999998875443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=347.43 Aligned_cols=266 Identities=26% Similarity=0.409 Sum_probs=208.2
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEecC
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 304 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~ 304 (557)
....|++.+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3455667899999999999999862 45689999987542 33456789999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhccCC--------------------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccC
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVN--------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVK 364 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk 364 (557)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+ .||+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence 99999999999999999975421 1347899999999999999999998 999999999
Q ss_pred CCCEEeCCCCcEEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCC
Q 008707 365 SSNILLDINMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVED 442 (557)
Q Consensus 365 ~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~ 442 (557)
|+||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987644322 12233457889999999988899999999999999999998 999997543
Q ss_pred ccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 008707 443 FGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 516 (557)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 516 (557)
... . ....+..+... ..+...+..+.+++.+||+.||.+|||+.||++.|+.+......
T Consensus 280 ~~~--~----~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 280 VDA--N----FYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp CSH--H----HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred cHH--H----HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 321 1 11222222111 11112234788999999999999999999999999998775443
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=349.35 Aligned_cols=247 Identities=24% Similarity=0.354 Sum_probs=198.5
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv 309 (557)
..|++.+.||+|+||.||+|..+ +++.||+|++.+.. ....+.+.+|.++++.+ +||||+++++++.+.+..++|
T Consensus 23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv 102 (353)
T 3txo_A 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV 102 (353)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence 34566899999999999999876 58999999987532 23446688899999988 699999999999999999999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 103 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 103 MEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999974 3568999999999999999999998 9999999999999999999999999999986433
Q ss_pred CCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccc
Q 008707 390 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 469 (557)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .. ..+..+...
T Consensus 177 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~-~~i~~~~~~------ 242 (353)
T 3txo_A 177 NGV-TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LF-EAILNDEVV------ 242 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHCCCC------
T ss_pred CCc-cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HH-HHHHcCCCC------
Confidence 222 2334569999999999998889999999999999999999999997543221 11 112222211
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 008707 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKM------QEIVL 505 (557)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~------~evl~ 505 (557)
++......+.+++.+||+.||++||++ +||++
T Consensus 243 ----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 243 ----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111123367899999999999999998 67765
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=334.65 Aligned_cols=258 Identities=28% Similarity=0.460 Sum_probs=205.2
Q ss_pred HHHhhcccCCCCceEEEEEEEcC----CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
.|.+.+.||+|+||.||+|.+.. +..||+|.+.... ....+.+.+|+++++.++||||+++++++.++ ..++||
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~ 91 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIM 91 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEE
Confidence 45567899999999999998653 3369999987643 34567799999999999999999999998754 568999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+++++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 92 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 166 (281)
T 3cc6_A 92 ELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166 (281)
T ss_dssp ECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC---
T ss_pred ecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccccc
Confidence 999999999999753 4568999999999999999999998 99999999999999999999999999999876554
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 469 (557)
.........+++.|+|||.+.+..++.++||||||+++|+|+| |+.||....... ... .+..+.....
T Consensus 167 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~----~~~~~~~~~~---- 235 (281)
T 3cc6_A 167 DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIG----VLEKGDRLPK---- 235 (281)
T ss_dssp ------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHH----HHHHTCCCCC----
T ss_pred cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHH----HHhcCCCCCC----
Confidence 3333334457889999999998899999999999999999998 999997443322 211 1222211111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
+...+..+.+++.+||+.+|++|||+.||++.|+++.+.+.
T Consensus 236 -----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 236 -----PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 11123468899999999999999999999999999987654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=330.42 Aligned_cols=249 Identities=31% Similarity=0.425 Sum_probs=192.3
Q ss_pred HHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccc----hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
.|++.+.||+|+||.||+|.+. ++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred heeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 3456789999999999999986 89999999865322 224678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCC---eEeeccCCCCEEeCC--------CCcEEEec
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG---IIHRDVKSSNILLDI--------NMRAKVSD 380 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~---ivH~dlk~~NIll~~--------~~~~kl~D 380 (557)
|+++++|.+++. ...+++..++.++.|++.||+|||+ .+ ++||||||+||+++. ++.+||+|
T Consensus 87 ~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 87 FARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred cCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999985 4568999999999999999999998 77 999999999999986 67899999
Q ss_pred ccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 008707 381 FGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 460 (557)
Q Consensus 381 fgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 460 (557)
||++........ ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+... ...... .+
T Consensus 160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~-~~ 229 (271)
T 3dtc_A 160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGVA-MN 229 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHH-TS
T ss_pred CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhhh-cC
Confidence 999986644322 23358999999999998899999999999999999999999997433211 111111 11
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 461 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 461 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
... ...+...+..+.+++.+||+.+|++|||++|+++.|+++
T Consensus 230 ~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 KLA--------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCC--------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111 011112234788999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=345.48 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=201.5
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 4566799999999999999876 58899999986432 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+.+|+|.+++.. ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++.......
T Consensus 96 ~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 96 LLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 9999999999973 5679999999999999999999998 999999999999999999999999999998765432
Q ss_pred ccccccccCCCCccCCcccCC---CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~---~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||............. . +.....
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~-~~~~~~------ 237 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---T-FETTVV------ 237 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH---H-HHHCCC------
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH---H-Hhhccc------
Confidence 2234569999999999964 458999999999999999999999997544332222211 1 111111
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-MQEIVL 505 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-~~evl~ 505 (557)
.++......+.+++.+||+.||.+||+ +++|++
T Consensus 238 ----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 ----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111122347889999999999999998 777654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=346.61 Aligned_cols=270 Identities=19% Similarity=0.269 Sum_probs=203.0
Q ss_pred HHHhhcccCCC--CceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 236 TNNFCKKIGKG--SFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 236 ~~~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
.|++.+.||+| +||.||+|... +++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 35567999999 99999999886 68999999986542 334567888999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+++|+|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+......
T Consensus 106 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 106 SFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp ECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 999999999999754 23568999999999999999999998 99999999999999999999999999988654222
Q ss_pred Cc------cccccccCCCCccCCcccCC--CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh----
Q 008707 391 LT------HISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK---- 458 (557)
Q Consensus 391 ~~------~~~~~~~g~~~y~aPE~l~~--~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~---- 458 (557)
.. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+.... +.........
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 182 GQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLD 259 (389)
T ss_dssp TEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH--HHHC----------
T ss_pred cccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHhcCCCCcccc
Confidence 11 11122358899999999987 6789999999999999999999999975443211 1110000000
Q ss_pred c------------------CCccccc---ccc------ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHh
Q 008707 459 K------------------GDVISIV---DPV------LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQD 509 (557)
Q Consensus 459 ~------------------~~~~~~~---d~~------l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~ 509 (557)
. ....... .+. ............+.+++.+||+.||++|||++|+++. +++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 0 0000000 000 0000111223468899999999999999999999864 444
Q ss_pred hh
Q 008707 510 SI 511 (557)
Q Consensus 510 ~~ 511 (557)
+.
T Consensus 340 ~~ 341 (389)
T 3gni_B 340 IK 341 (389)
T ss_dssp C-
T ss_pred Hh
Confidence 43
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=342.60 Aligned_cols=257 Identities=23% Similarity=0.413 Sum_probs=201.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCc----EEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
..|++.+.||+|+||.||+|.+. +++ .||+|.+.... ....+.+.+|++++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 44566799999999999999865 344 36888875432 344577999999999999999999999998754 789
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
|+|++.+|+|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 99999999999999753 4568999999999999999999998 999999999999999999999999999998764
Q ss_pred CCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 389 EDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 389 ~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
..... ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||....... +. ..+..+....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~----~~~~~~~~~~-- 239 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGERLP-- 239 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCCCC--
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HH----HHHHcCCCCC--
Confidence 43222 2223346889999999999999999999999999999999 999998544322 11 1222222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
.+...+..+.+++.+||+.+|++|||++||++.|+.+...
T Consensus 240 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 240 -------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred -------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1112234788999999999999999999999999988763
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=345.27 Aligned_cols=244 Identities=24% Similarity=0.330 Sum_probs=199.1
Q ss_pred HHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|.+.+.||+|+||.||+|.+ .+++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 45678999999999999987 468999999986432 12235788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+ +|+|.+++.. ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++........
T Consensus 91 ~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~ 163 (336)
T 3h4j_B 91 A-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163 (336)
T ss_dssp C-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred C-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence 9 7899998874 3568999999999999999999998 9999999999999999999999999999987654322
Q ss_pred cccccccCCCCccCCcccCCCCC-CcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 393 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~-s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||........... +..+ .
T Consensus 164 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-------i~~~----------~ 224 (336)
T 3h4j_B 164 --LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-------VNSC----------V 224 (336)
T ss_dssp --TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-------CCSS----------C
T ss_pred --cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-------HHcC----------C
Confidence 233468999999999988776 6899999999999999999999985433221100 0000 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
...+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 01111223468899999999999999999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=331.02 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=208.4
Q ss_pred cccCCCCceEEEEEEEc---CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 241 KKIGKGSFGSVYYGKMK---DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+++++.++||||+++++++ ..+..++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 48999999999999764 57889999997643 34567799999999999999999999999 456689999999999
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc--c
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--I 394 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--~ 394 (557)
+|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......... .
T Consensus 95 ~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 169 (287)
T 1u59_A 95 PLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 169 (287)
T ss_dssp EHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECC
T ss_pred CHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeec
Confidence 99999864 34568999999999999999999998 99999999999999999999999999999876543322 1
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||....... . ...+..+....
T Consensus 170 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~----~~~i~~~~~~~--------- 233 (287)
T 1u59_A 170 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V----MAFIEQGKRME--------- 233 (287)
T ss_dssp CCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---H----HHHHHTTCCCC---------
T ss_pred cccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---H----HHHHhcCCcCC---------
Confidence 223346889999999988889999999999999999999 999997443211 1 12222222111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 517 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~ 517 (557)
.+...+..+.+++.+||+.+|++||++.||++.|+.+.......
T Consensus 234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 234 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 11223347889999999999999999999999999998876554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=338.21 Aligned_cols=242 Identities=22% Similarity=0.360 Sum_probs=201.1
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|..+++.++||||+++++++.+.+..++||||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 456789999999999999876 68999999986532 12346788899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 88 ~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 88 IEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp CCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 999999999974 4568999999999999999999998 99999999999999999999999999999876432
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ........ +.. .+
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~-~~~------~~-- 222 (318)
T 1fot_A 160 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILN-AEL------RF-- 222 (318)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH-CCC------CC--
T ss_pred --cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCC------CC--
Confidence 23356899999999999999999999999999999999999999743321 11122221 211 01
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 505 (557)
+......+.+++.+|+..||++|| +++||++
T Consensus 223 --p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 223 --PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 111223688999999999999999 8899875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=328.93 Aligned_cols=251 Identities=21% Similarity=0.364 Sum_probs=203.4
Q ss_pred HHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEec--CeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE--HQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~--~~~~lv~e 311 (557)
.|++.+.||+|+||.||+|.++ ++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. +..++|||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITH 89 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEE
T ss_pred HhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeec
Confidence 4556789999999999999986 8999999987542 34456799999999999999999999999876 77899999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCC--eEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~--ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|+++|+|.+++... ....+++..++.++.|++.||+|||+ .+ ++||||||+||+++.++.++|+|||++.....
T Consensus 90 ~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 90 WMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp CCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 99999999999853 23368999999999999999999998 78 99999999999999999999999988754332
Q ss_pred CCccccccccCCCCccCCcccCCCCCCc---ccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 390 DLTHISSVARGTVGYLDPEYYGNQQLTE---KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~~~~s~---~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
. ...||+.|+|||.+.+..++. ++||||||+++|||++|+.||..... ..........+....
T Consensus 166 ~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~-- 231 (271)
T 3kmu_A 166 P------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGLRPT-- 231 (271)
T ss_dssp T------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCCCCC--
T ss_pred c------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCCCCC--
Confidence 2 234799999999998765544 79999999999999999999974332 111222222221111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
.+...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 232 -------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 232 -------IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111223478899999999999999999999999998754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=334.86 Aligned_cols=260 Identities=21% Similarity=0.270 Sum_probs=197.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||+||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 456789999999999999876 58999999986432 233467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
.+ ++.+.+.. ....+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 84 DQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp SE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSC
T ss_pred CC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccc
Confidence 75 56555543 34679999999999999999999999 99999999999999999999999999999876543222
Q ss_pred ccccccCCCCccCCcccCCCC-CCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc------c
Q 008707 394 ISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI------V 466 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~-~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 466 (557)
.....||+.|+|||.+.+.. ++.++||||+|+++|+|++|..||...... ......+............ .
T Consensus 158 -~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhhcccc
Confidence 23345899999999997765 799999999999999999988886422211 1111111111111100000 0
Q ss_pred c---------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 467 D---------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 467 d---------~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+ ..............+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 00000111223447889999999999999999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=345.45 Aligned_cols=251 Identities=23% Similarity=0.320 Sum_probs=199.5
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
.+.||+|+||.||+|... +|+.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 467999999999999875 6899999999876556667899999999999999999999999999999999999999999
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe--CCCCcEEEecccCccccCCCCccccc
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISS 396 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll--~~~~~~kl~Dfgla~~~~~~~~~~~~ 396 (557)
.+++.. ....+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++........ ..
T Consensus 174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~ 246 (373)
T 2x4f_A 174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK 246 (373)
T ss_dssp HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence 998864 24568999999999999999999998 999999999999999 5678899999999987654332 22
Q ss_pred cccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCH
Q 008707 397 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 476 (557)
Q Consensus 397 ~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 476 (557)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +........... . .......
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~~--~-~~~~~~~--- 314 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRWD--L-EDEEFQD--- 314 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC--S-CSGGGTT---
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccCC--C-Chhhhcc---
Confidence 345899999999999999999999999999999999999999754322 111222211110 0 0011111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHhh
Q 008707 477 ESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDS 510 (557)
Q Consensus 477 ~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~ 510 (557)
....+.+++.+||+.||++|||++|+++ .+++.
T Consensus 315 -~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 315 -ISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp -SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred -CCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 2347889999999999999999999997 45544
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=341.08 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=198.0
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
|++.+.||+|+||.||+|..+ +++.||+|++.... ....+.+.+|..++.++ +||||+++++++.+.+..++|||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 456789999999999999876 58899999987542 23446688999999988 89999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 91 YVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 9999999999874 3568999999999999999999998 999999999999999999999999999998643222
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcccc--ccHHHHHHHHHhcCCcccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--LNIVHWARSMIKKGDVISIVDPV 469 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~ 469 (557)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..........+..+...
T Consensus 165 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------ 237 (345)
T 3a8x_A 165 D-TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------ 237 (345)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC------
T ss_pred C-cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC------
Confidence 2 23345699999999999999999999999999999999999999974322111 11112222222222211
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 008707 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 500 (557)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 500 (557)
.+......+.+++.+||+.||++||++
T Consensus 238 ----~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 238 ----IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 111123468899999999999999996
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=337.84 Aligned_cols=268 Identities=25% Similarity=0.403 Sum_probs=211.3
Q ss_pred hHHHHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhh--cCCCCccceeeEEEecC---
Q 008707 230 PELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSR--IHHRNLVPLIGYCEEEH--- 304 (557)
Q Consensus 230 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~nIv~~~~~~~~~~--- 304 (557)
.+.....|++.+.||+|+||.||+|.+. ++.||+|++... ..+.+.+|.+++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 4455667778999999999999999985 899999998643 34567789999887 68999999999998775
Q ss_pred -eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHH--------cCCCCCeEeeccCCCCEEeCCCCc
Q 008707 305 -QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH--------TGCNPGIIHRDVKSSNILLDINMR 375 (557)
Q Consensus 305 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH--------~~~~~~ivH~dlk~~NIll~~~~~ 375 (557)
..++||||+++|+|.+++.. ..+++..++.++.|++.||+||| + .+++||||||+||+++.++.
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSC
T ss_pred ceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCC
Confidence 78999999999999999974 35899999999999999999999 6 89999999999999999999
Q ss_pred EEEecccCccccCCCCcc---ccccccCCCCccCCcccCCC------CCCcccceehhHHHHHHHHhC----------CC
Q 008707 376 AKVSDFGLSRQAEEDLTH---ISSVARGTVGYLDPEYYGNQ------QLTEKSDVYSFGVVLLELISG----------KK 436 (557)
Q Consensus 376 ~kl~Dfgla~~~~~~~~~---~~~~~~g~~~y~aPE~l~~~------~~s~~~DvwslG~ll~elltg----------~~ 436 (557)
+||+|||++......... ......||+.|+|||.+.+. .++.++||||||+++|||+|| ..
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999999876443321 12334589999999999775 334789999999999999999 77
Q ss_pred CCCCCCccccccHHHHHHHHHhcCCccccccccccCC-CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 437 PVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN-VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 437 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
||...... ......+... +..+.. .+.+... .....+..+.+++.+||+.||++|||++||++.|+++.+.+
T Consensus 266 p~~~~~~~-~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 266 PYYDLVPS-DPSVEEMRKV-VCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp TTTTTSCS-SCCHHHHHHH-HTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CccccCcC-cccHHHHHHH-HHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 88643322 1122222222 211111 1111111 12356678999999999999999999999999999998754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=329.82 Aligned_cols=264 Identities=22% Similarity=0.308 Sum_probs=207.2
Q ss_pred HHHHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEE-EecCeeEEEEEe
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVYEY 312 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-~~~~~~~lv~e~ 312 (557)
..|++.+.||+|+||.||+|.. .+++.||+|++.... ..+.+.+|+++++.++|++++..++.+ ...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 4566789999999999999986 468899999865432 223577899999999988877777665 566778999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe---CCCCcEEEecccCccccCC
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~ 389 (557)
+ +++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||++ +.++.+||+|||++.....
T Consensus 87 ~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 87 L-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp C-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred c-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 9 99999998743 4568999999999999999999998 999999999999999 7889999999999987654
Q ss_pred CCcc------ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 390 DLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 390 ~~~~------~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
.... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.........................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 3221 1234468999999999999999999999999999999999999998655443333332222211111110
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 464 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 464 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
. ....+ +..+.+++.+||+.+|++|||++||++.|+++.....
T Consensus 241 ~-----~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 241 V-----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp H-----HTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred h-----hhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 0 01111 2478899999999999999999999999999988654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=347.61 Aligned_cols=267 Identities=25% Similarity=0.380 Sum_probs=210.7
Q ss_pred HHHHhhcccCCCCceEEEEEEE-----cCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEE--ecCeeE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRI 307 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~--~~~~~~ 307 (557)
..|++.+.||+|+||.||+|.+ .+++.||+|++........+.+.+|+++++.++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 4456789999999999999984 358899999998766666778999999999999999999999886 456688
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999999753 3458999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCcc--ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcc--------ccccHHHHHHHHH
Q 008707 388 EEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG--------AELNIVHWARSMI 457 (557)
Q Consensus 388 ~~~~~~--~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~--------~~~~~~~~~~~~~ 457 (557)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ............+
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 543321 223345788899999999888999999999999999999999998633221 0011111122222
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 458 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 458 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
..+... ..+...+..+.+++.+||+.||++|||++||++.|+.+.....
T Consensus 258 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 258 EEGQRL---------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred hcccCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 222111 1122234578899999999999999999999999999876443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=345.49 Aligned_cols=245 Identities=24% Similarity=0.365 Sum_probs=200.1
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
.|++.+.||+|+||.||+|..+ +|+.||+|+++... ....+.+..|.+++..+ +||||+++++++.+.+..++||
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 3456789999999999999886 58899999987532 23346678899999887 8999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++.....
T Consensus 98 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 98 EYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999974 3568999999999999999999998 99999999999999999999999999999864322
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+... + . ..+..+.. .+
T Consensus 172 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~---~-~~i~~~~~------~~ 237 (345)
T 1xjd_A 172 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---L---F-HSIRMDNP------FY 237 (345)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---H-HHHHHCCC------CC
T ss_pred CC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---H---H-HHHHhCCC------CC
Confidence 22 2334569999999999999999999999999999999999999997543211 1 1 11222211 11
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQ-EIV 504 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~-evl 504 (557)
+......+.+++.+||..||++||++. ||+
T Consensus 238 ----p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 ----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 111234688999999999999999998 665
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=352.57 Aligned_cols=253 Identities=24% Similarity=0.324 Sum_probs=202.0
Q ss_pred HHhhcccCCCCceEEEEEEEcC-CcEEEEEEccCccc---hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|.++. ++.||+|++.+... ...+.+.+|..++..++||||+++++++.+.+..++||||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4457899999999999999874 78999999864321 1223488999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++... ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 156 ~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 230 (437)
T 4aw2_A 156 YVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 230 (437)
T ss_dssp CTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC
Confidence 9999999999742 4669999999999999999999998 9999999999999999999999999999987655544
Q ss_pred cccccccCCCCccCCcccC-----CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 393 HISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~-----~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+. ....+........
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~~-- 302 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKERFQF-- 302 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTHHHHCCC--
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH------HHhhhhccccccC--
Confidence 4444567999999999986 56789999999999999999999999975432211 1111111000000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 506 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~ 506 (557)
+..... ....+.+++.+|+..+|++ ||+++|+++.
T Consensus 303 p~~~~~----~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 303 PTQVTD----VSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp CSSCCC----SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred Cccccc----CCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 111111 2236789999999888888 9999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=340.30 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=192.2
Q ss_pred HHHHhhcccCCCCceEEEEEEE----cCCcEEEEEEccCcc----chhHHHHHHHHHHHhhcCCCCccceeeEEEecCee
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 306 (557)
..|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+++++.++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 3456789999999999999987 468999999987542 22345678899999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++||||+++++|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 97 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999974 3568899999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+.. ....... .+..
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~-~~~~---- 238 (327)
T 3a62_A 171 SIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKIL-KCKL---- 238 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHH-HTCC----
T ss_pred cccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-hCCC----
Confidence 433222 123346899999999999999999999999999999999999999754321 1111111 1111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 505 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 505 (557)
..+......+.+++.+||+.||++|| ++.|+++
T Consensus 239 ------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 239 ------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 01111234788999999999999999 7778776
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=332.82 Aligned_cols=260 Identities=22% Similarity=0.330 Sum_probs=198.7
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
.|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 3556789999999999999876 688999999875422 234678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 115 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 115 LINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp CCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred ecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999974 3568999999999999999999998 999999999999999999999999999998765443
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
........|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.. .....+...... +
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~----~--- 254 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIPR----P--- 254 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCCC----G---
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCCC----c---
Confidence 33333445899999999999999999999999999999999999999743221 112222221110 0
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhhhhhc
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RP-t~~evl~~L~~~~~~~~ 515 (557)
.......+..+.+++.+||+.||++|| +++++++.|+.......
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 001112233688999999999999999 99999999998876543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=336.62 Aligned_cols=263 Identities=30% Similarity=0.536 Sum_probs=197.7
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
|+....|++.+.||+|+||.||+|.+.. .||+|++.... ....+.+.+|+++++.++||||+++++++ .....++
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~l 96 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAI 96 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEE
Confidence 4444556778999999999999998753 59999986543 33457799999999999999999999965 4556899
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||+++++|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 97 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 97 VTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999999998643 4668999999999999999999998 999999999999999999999999999997654
Q ss_pred CCC-ccccccccCCCCccCCcccC---CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 389 EDL-THISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 389 ~~~-~~~~~~~~g~~~y~aPE~l~---~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
... ........||+.|+|||.+. +..++.++||||||+++|+|++|+.||....... .+...+..+....
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~ 245 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSP 245 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCc
Confidence 321 12223345899999999986 5678889999999999999999999997433211 1222222332221
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
.+. ......+..+.+++.+||+.+|++|||++||++.|+++.+
T Consensus 246 ~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 DLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred chh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 111 1112234578899999999999999999999999998754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=329.73 Aligned_cols=256 Identities=24% Similarity=0.367 Sum_probs=206.4
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEe-------
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------- 302 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~------- 302 (557)
......|++.+.||+|+||.||+|.+. +++.||+|++.... +.+.+|+++++.++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 444566777899999999999999886 78999999986543 346689999999999999999998854
Q ss_pred ---------cCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC
Q 008707 303 ---------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN 373 (557)
Q Consensus 303 ---------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~ 373 (557)
....++||||+++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.+
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEET
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCC
Confidence 44579999999999999999754 24568999999999999999999998 999999999999999999
Q ss_pred CcEEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHH
Q 008707 374 MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA 453 (557)
Q Consensus 374 ~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~ 453 (557)
+.+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|+|++|..|+... .. .
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~-~ 227 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SK-F 227 (284)
T ss_dssp TEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HH-H
T ss_pred CCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HH-H
Confidence 9999999999987654322 22345899999999999999999999999999999999999887411 11 1
Q ss_pred HHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 008707 454 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 517 (557)
Q Consensus 454 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~ 517 (557)
...+..+.... .+ +..+.+++.+||+.||++|||+.|+++.|+.+.+.....
T Consensus 228 ~~~~~~~~~~~--------~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 228 FTDLRDGIISD--------IF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp HHHHHTTCCCT--------TS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-----
T ss_pred HHHhhcccccc--------cC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCcc
Confidence 11122222211 11 235789999999999999999999999999887754433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=351.32 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=200.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|..+ +++.||+|++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 445789999999999999886 58899999986421 12234578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
++||+|.+++.. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 151 ~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~ 223 (410)
T 3v8s_A 151 MPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223 (410)
T ss_dssp CTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSE
T ss_pred CCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCc
Confidence 999999999873 358899999999999999999998 9999999999999999999999999999987765443
Q ss_pred cccccccCCCCccCCcccCCCC----CCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 393 HISSVARGTVGYLDPEYYGNQQ----LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~----~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
.......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+... ...............+.
T Consensus 224 ~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~~~~~~~~p~~ 297 (410)
T 3v8s_A 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMNHKNSLTFPDD 297 (410)
T ss_dssp EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHTHHHHCCCCTT
T ss_pred ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh------HHHHHHhccccccCCCc
Confidence 3344567999999999997655 7899999999999999999999997543221 11111111000011000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFS--RPKMQEIVLA 506 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~--RPt~~evl~~ 506 (557)
.. ....+.+++.+||+.+|.+ ||+++||++.
T Consensus 298 ---~~----~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 298 ---ND----ISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp ---CC----CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred ---cc----ccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 01 1236889999999999988 9999999864
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=331.92 Aligned_cols=264 Identities=21% Similarity=0.308 Sum_probs=201.4
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc---cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
.|++.+.||+|+||.||+|... +|+.||+|++... .....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 4567899999999999999874 6899999998642 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 312 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
|+++++|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 999999999886432 34568999999999999999999998 99999999999999999999999999998876443
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ..... ..+..+.......
T Consensus 190 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~~~~~~~--- 260 (310)
T 2wqm_A 190 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KKIEQCDYPPLPS--- 260 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHH-HHHHTTCSCCCCT---
T ss_pred Ccc-ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHH-HHhhcccCCCCcc---
Confidence 221 22345899999999999999999999999999999999999999743221 11211 2222222211111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 516 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 516 (557)
. ..+..+.+++.+||+.||++|||++||++.|+++......
T Consensus 261 -~----~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 261 -D----HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp -T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -c----ccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 1 1233688999999999999999999999999999876543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=346.25 Aligned_cols=271 Identities=22% Similarity=0.303 Sum_probs=213.7
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecC--eeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~~lv~e~ 312 (557)
|.+.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|++++++++||||+++++++...+ ..++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 456789999999999999876 48999999987543 234567889999999999999999999998755 67999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe----CCCCcEEEecccCccccC
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla~~~~ 388 (557)
+++|+|.+++........+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++....
T Consensus 91 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp CTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred CCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 9999999999865444559999999999999999999998 999999999999999 777889999999998765
Q ss_pred CCCccccccccCCCCccCCcccCC--------CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGN--------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 460 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~--------~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 460 (557)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.....+...
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~~ 243 (396)
T 4eut_A 168 DDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKIITGK 243 (396)
T ss_dssp CGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHHHSC
T ss_pred CCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHhcCC
Confidence 4322 223458999999999864 4677899999999999999999999974433221 112222222221
Q ss_pred Ccccc------------c--cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 461 DVISI------------V--DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 461 ~~~~~------------~--d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
+.... . +..............+.+++.+||+.||++||+++|+++.++++....
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 11000 0 001112334677788999999999999999999999999999988743
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=336.28 Aligned_cols=250 Identities=22% Similarity=0.274 Sum_probs=196.9
Q ss_pred hhHHHHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhc-CCCCccceeeEEEecC
Q 008707 229 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 304 (557)
Q Consensus 229 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~ 304 (557)
..++....|++.+.||+|+||+||+|.+. +|+.||||++..... .....+..|+..+..+ +||||+++++++.+.+
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 44566677888999999999999999887 699999998765322 2334555666666665 8999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCc
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 384 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 384 (557)
..++||||+ +++|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a 204 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLL 204 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred EEEEEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceee
Confidence 999999999 77999888753 4569999999999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 385 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 385 ~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
........ .....||+.|+|||++.+ .++.++||||||+++|||++|..|+..... ...+..+....
T Consensus 205 ~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~~ 271 (311)
T 3p1a_A 205 VELGTAGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPP 271 (311)
T ss_dssp EECC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCCH
T ss_pred eecccCCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCCc
Confidence 87654322 233458999999999886 689999999999999999999776642211 11112221111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+.. .....+.+++.+||+.||++|||++|+++
T Consensus 272 ----~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 ----EFTA----GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ----HHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----cccc----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 1111 12347889999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=326.31 Aligned_cols=263 Identities=23% Similarity=0.305 Sum_probs=207.7
Q ss_pred HHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEE-EecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC-EEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~-~~~~~~~lv~e~~~ 314 (557)
|++.+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+++++.++|++++..+.++ ...+..++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~- 87 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-
Confidence 45678999999999999987 5689999999865432 34688999999999988877776665 5567789999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC---CCCcEEEecccCccccCCCC
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~~~ 391 (557)
+++|.+++... ...+++..++.++.|++.||+|||+ ++++||||||+||+++ .++.+||+|||++.......
T Consensus 88 ~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 88 GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999999743 4568999999999999999999998 9999999999999994 78899999999998765433
Q ss_pred cc------ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 392 TH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 392 ~~------~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
.. ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..............+..........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 240 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-- 240 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH--
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH--
Confidence 21 1234468999999999999999999999999999999999999998654433333332222211111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 516 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 516 (557)
.+...+ +..+.+++.+||+.||++|||++||++.|+++......
T Consensus 241 ---~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 241 ---VLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ---HHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred ---HHHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 011111 24688999999999999999999999999999876543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=333.84 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=190.2
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
.|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 4667899999999999999875 58999999986543 223467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccC---CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 314 HNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 314 ~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
+ |+|.+++.... ....+++..+..++.||+.||+|||+ .||+||||||+||+++.++.+||+|||++......
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 7 69998886432 23458999999999999999999998 99999999999999999999999999999876533
Q ss_pred CccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc------
Q 008707 391 LTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI------ 463 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 463 (557)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.... ...+..........
T Consensus 162 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 162 VNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp CCC-CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGGGG
T ss_pred ccc-CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhhhh
Confidence 222 223458999999999976 4689999999999999999999999985443221 11111111110000
Q ss_pred --cccccccc------------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 464 --SIVDPVLI------------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 464 --~~~d~~l~------------~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..+.+.+. ..........+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000000 0000112346889999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=368.98 Aligned_cols=258 Identities=27% Similarity=0.432 Sum_probs=210.5
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
...+++.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 34456788999999999999999988899999987543 235679999999999999999999999876 6789999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 344 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 344 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp TTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred cCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 999999999743 23458899999999999999999998 99999999999999999999999999999876543222
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......++..|+|||.+.+..++.++||||||+++|||+| |+.||.+.... + +...+..+....
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~-~~~~i~~~~~~~-------- 484 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------E-VLDQVERGYRMP-------- 484 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------H-HHHHHHTTCCCC--------
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCC--------
Confidence 2233446788999999998899999999999999999999 99999743321 1 122223332111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
.+...+..+.+++.+||+.||++|||+++|++.|+++...
T Consensus 485 -~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 485 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 1112234788999999999999999999999999987654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=327.29 Aligned_cols=249 Identities=20% Similarity=0.267 Sum_probs=203.2
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
..|++.+.||+|+||.||+|... ++..||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 45677899999999999999876 47789999987665556778999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe---CCCCcEEEecccCccccCCC
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~ 390 (557)
++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||++ +.++.++|+|||++......
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 89 TGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999998874 3568999999999999999999998 999999999999999 78899999999999876543
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
.. .....||+.|+|||.+.+. ++.++||||||+++|+|++|+.||....... ....+..+..... ...
T Consensus 163 ~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~--~~~ 230 (277)
T 3f3z_A 163 KM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGTFTFP--EKD 230 (277)
T ss_dssp SC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCCC--HHH
T ss_pred cc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCCCC--chh
Confidence 32 2334589999999998765 8999999999999999999999997543211 1111222211100 000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.. ..+..+.+++.+|++.||++|||+.|+++
T Consensus 231 ~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 WL----NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 12347889999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=339.95 Aligned_cols=258 Identities=21% Similarity=0.276 Sum_probs=191.5
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcC-CCCccceeeEEE--------ecC
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCE--------EEH 304 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~--------~~~ 304 (557)
..|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 35567899999999999999875 68999999987665666678999999999996 999999999984 344
Q ss_pred eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCC--eEeeccCCCCEEeCCCCcEEEeccc
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLDINMRAKVSDFG 382 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~--ivH~dlk~~NIll~~~~~~kl~Dfg 382 (557)
..++||||+. |+|.+++........+++..++.++.||+.||+|||+ .+ ++||||||+|||++.++.+||+|||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecCc
Confidence 5789999995 7999988764455679999999999999999999998 78 9999999999999999999999999
Q ss_pred CccccCCCCccc-----------cccccCCCCccCCccc---CCCCCCcccceehhHHHHHHHHhCCCCCCCCCcccccc
Q 008707 383 LSRQAEEDLTHI-----------SSVARGTVGYLDPEYY---GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 448 (557)
Q Consensus 383 la~~~~~~~~~~-----------~~~~~g~~~y~aPE~l---~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~ 448 (557)
++.......... .....||+.|+|||.+ .+..++.++||||||+++|+|++|+.||.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--- 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--- 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence 998765432211 1133589999999998 56678999999999999999999999997432211
Q ss_pred HHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 449 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
... +..... ........+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 261 ---~~~-----~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 261 ---IVN-----GKYSIP--------PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -------------CCCC--------TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred ---hhc-----CcccCC--------cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 000 000000 000111247799999999999999999999999999987544
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=336.99 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=204.6
Q ss_pred HHHHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEE----ecCeeEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE----EEHQRILV 309 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~----~~~~~~lv 309 (557)
..|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+++++.++||||+++++++. .....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 3456689999999999999987 468999999987655566778999999999999999999999986 34478899
Q ss_pred EEecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 310 YEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
|||+++|+|.+++.... ....+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 99999999999887532 34678999999999999999999998 899999999999999999999999999987653
Q ss_pred CCCccc--------cccccCCCCccCCcccCCCC---CCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH
Q 008707 389 EDLTHI--------SSVARGTVGYLDPEYYGNQQ---LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 457 (557)
Q Consensus 389 ~~~~~~--------~~~~~g~~~y~aPE~l~~~~---~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 457 (557)
...... .....|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||....... ...... .
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~----~ 260 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVALA----V 260 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHHH----H
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhHH----h
Confidence 221110 11234799999999987654 6889999999999999999999996321111 111111 1
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 458 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 458 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
... . .. ......+..+.+++.+||+.||.+|||++||++.|+.+....
T Consensus 261 ~~~-~-~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 261 QNQ-L-SI-------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp HCC----C-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred hcc-C-CC-------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 110 0 00 001112347889999999999999999999999999876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=339.00 Aligned_cols=256 Identities=24% Similarity=0.408 Sum_probs=201.5
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcE----EEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKE----VAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
.|++.+.||+|+||.||+|.+. +++. ||+|.+.... ....+.+.+|+.+++.++||||+++++++. ++..++|
T Consensus 14 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp TEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred HceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 3456789999999999999875 3443 7888775432 223356778999999999999999999986 4568899
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+.+|+|.+++... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 9999999999999743 3568888999999999999999998 9999999999999999999999999999987654
Q ss_pred CCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 390 DLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 390 ~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
... .......+++.|+|||.+.+..++.++||||||+++|+|+| |+.||....... . ...+..+.......
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~----~~~~~~~~~~~~~~ 240 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE---V----PDLLEKGERLAQPQ 240 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH---H----HHHHHTTCBCCCCT
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH---H----HHHHHcCCCCCCCC
Confidence 332 22234457889999999998899999999999999999999 999998543322 1 12222222111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
..+..+.+++.+||+.||++|||++||++.|+.+...
T Consensus 241 ---------~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 241 ---------ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp ---------TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred ---------cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1122567999999999999999999999999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=332.21 Aligned_cols=259 Identities=30% Similarity=0.459 Sum_probs=202.9
Q ss_pred HHhhcccCCCCceEEEEEEEcC----CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEE-ecCeeEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCE-EEHQRILVY 310 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-~~~~~~lv~ 310 (557)
|++.+.||+|+||.||+|.+.+ ...||+|.+.... ....+.+.+|+.++++++||||+++++++. .++..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 4457899999999999998653 2368999887543 334577899999999999999999999864 556789999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+++|+|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 107 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 107 PYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp ECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 99999999999974 34568899999999999999999998 99999999999999999999999999999876443
Q ss_pred Cc---cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 391 LT---HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 391 ~~---~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
.. .......+|+.|+|||.+.+..++.++||||||+++|+|++ +.+||....... ... .+..+....
T Consensus 182 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~----~~~~~~~~~-- 252 (298)
T 3f66_A 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV----YLLQGRRLL-- 252 (298)
T ss_dssp GGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHH----HHHTTCCCC--
T ss_pred chhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHH----HHhcCCCCC--
Confidence 21 11223447788999999999899999999999999999999 556665332221 111 111121110
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 516 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 516 (557)
. +...+..+.+++.+||+.+|++|||++|+++.|+++......
T Consensus 253 ~-------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 253 Q-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred C-------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 0 111234688999999999999999999999999999875443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=339.53 Aligned_cols=257 Identities=23% Similarity=0.406 Sum_probs=199.8
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcE----EEEEEccCc-cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKE----VAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
..|++.+.||+|+||.||+|.+. +++. ||+|.+... .....+.+.+|+.+++.++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 34556799999999999999865 3443 577776543 2345678999999999999999999999998765 789
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
|+|++.+|+|.+++... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++....
T Consensus 94 v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 99999999999999753 4568999999999999999999998 999999999999999999999999999998764
Q ss_pred CCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 389 EDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 389 ~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
.... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....... +. ..+..+....
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~----~~~~~~~~~~-- 239 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGERLP-- 239 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCCCC--
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCCCCC--
Confidence 4322 12223346788999999999999999999999999999999 999998544332 11 1222222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
.+...+..+.+++.+||+.||++|||++||++.|+.+...
T Consensus 240 -------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 240 -------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp -------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred -------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1112234688999999999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=344.75 Aligned_cols=260 Identities=29% Similarity=0.455 Sum_probs=197.9
Q ss_pred HHhhcccCCCCceEEEEEEEcC--C--cEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEe-cCeeEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKD--G--KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVY 310 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~lv~ 310 (557)
+++.+.||+|+||.||+|.+.+ + ..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 3456889999999999998642 2 368999886543 3456789999999999999999999998654 56789999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+++|+|.+++.. ....+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 171 e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 171 PYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp ECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred ECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999974 34568899999999999999999998 99999999999999999999999999999865432
Q ss_pred Ccc---ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 391 LTH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 391 ~~~---~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
... ......+++.|+|||.+.+..++.++||||||+++|||+| |.+||......+ ... .+..+....
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~----~~~~~~~~~-- 316 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV----YLLQGRRLL-- 316 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHH----HHHTTCCCC--
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHH----HHHcCCCCC--
Confidence 211 1223346788999999999999999999999999999999 677886433222 221 122222111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 517 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~ 517 (557)
. +...+..+.+++.+||+.+|++|||++||++.|+++......+
T Consensus 317 ~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 317 Q-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp C-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 1 1112346889999999999999999999999999998765544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=339.30 Aligned_cols=265 Identities=19% Similarity=0.200 Sum_probs=198.1
Q ss_pred HHHHhhcccCCCCceEEEEEEEc----CCcEEEEEEccCccch-----------hHHHHHHHHHHHhhcCCCCccceeeE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSH-----------RTQQFVTEVALLSRIHHRNLVPLIGY 299 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~il~~l~h~nIv~~~~~ 299 (557)
..|++.+.||+|+||.||+|.+. ++..||+|++...... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 44567899999999999999876 5788999998654321 11346678899999999999999999
Q ss_pred EEe----cCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC-
Q 008707 300 CEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM- 374 (557)
Q Consensus 300 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~- 374 (557)
+.. ....++||||+ +++|.+++... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSST
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCC
Confidence 987 67889999999 99999999743 378999999999999999999998 9999999999999998877
Q ss_pred -cEEEecccCccccCCCCcc------ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccc
Q 008707 375 -RAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL 447 (557)
Q Consensus 375 -~~kl~Dfgla~~~~~~~~~------~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~ 447 (557)
.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ..
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~ 268 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD-PV 268 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC-HH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc-cH
Confidence 9999999999876432211 113446899999999999999999999999999999999999999632221 11
Q ss_pred cHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 448 NIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 448 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
... ......... ....+..... ....+..+.+++.+||+.||++|||+++|++.|++...
T Consensus 269 ~~~-~~~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQ-TAKTNLLDE-LPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHH-HHHHHHHHT-TTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHH-HHHHhhccc-ccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111 111111111 1000000000 00123478899999999999999999999999988654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=330.05 Aligned_cols=259 Identities=27% Similarity=0.401 Sum_probs=205.0
Q ss_pred hhcccCCCCceEEEEEEEcC-C---cEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCee-EEEEEe
Q 008707 239 FCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR-ILVYEY 312 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~-~lv~e~ 312 (557)
..+.||+|+||.||+|.+.+ + ..||+|++..... ...+.+.+|+++++.++||||+++++++.+.+.. ++||||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 35889999999999998643 2 3799999875433 3457789999999999999999999999876655 999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+.+|+|.+++.. ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 105 ~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 105 MCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp CTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred ccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 999999999975 34668999999999999999999998 9999999999999999999999999999986543221
Q ss_pred ---cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccc
Q 008707 393 ---HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469 (557)
Q Consensus 393 ---~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 469 (557)
.......+++.|+|||.+.+..++.++||||||+++|+|++|..|+..... ...... .+..+....
T Consensus 180 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~~~----~~~~~~~~~----- 248 (298)
T 3pls_A 180 YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDLTH----FLAQGRRLP----- 248 (298)
T ss_dssp GCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGHHH----HHHTTCCCC-----
T ss_pred cccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHHHH----HhhcCCCCC-----
Confidence 122234578899999999999999999999999999999996555432221 112222 122222111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcCC
Q 008707 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKGG 517 (557)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~~ 517 (557)
.+...+..+.+++.+||+.+|++|||++|+++.|+++.......
T Consensus 249 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 249 ----QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred ----CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 11112346889999999999999999999999999998865544
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=340.88 Aligned_cols=242 Identities=23% Similarity=0.291 Sum_probs=201.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 122 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 455789999999999999876 68999999986432 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 123 ~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-- 194 (350)
T 1rdq_E 123 VAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp CTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred CCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC--
Confidence 999999999974 3468999999999999999999998 99999999999999999999999999999876543
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +.. ..+..+... +
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~-~~i~~~~~~------~-- 257 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIY-EKIVSGKVR------F-- 257 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCCCC------C--
T ss_pred --cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHH-HHHHcCCCC------C--
Confidence 22346899999999999999999999999999999999999999744321 111 122222211 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 505 (557)
+......+.+++.+||+.||++||+ ++||++
T Consensus 258 --p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 258 --PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 1112346889999999999999998 888875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=336.17 Aligned_cols=262 Identities=23% Similarity=0.307 Sum_probs=196.9
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 445789999999999999886 489999998865432 23467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++. ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 85 DHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp SEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred CCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 9999998876 34568999999999999999999998 99999999999999999999999999999876543222
Q ss_pred ccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHH--------HHHHhcCCccc
Q 008707 394 ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWA--------RSMIKKGDVIS 464 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 464 (557)
.....||+.|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+..+........ ...........
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 159 -YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred -cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 223458999999999876 67899999999999999999999999855433221111100 00011110000
Q ss_pred ---cccccccCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 465 ---IVDPVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 465 ---~~d~~l~~~---~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..++..... ........+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 001000000 00122346889999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=341.70 Aligned_cols=251 Identities=24% Similarity=0.297 Sum_probs=192.1
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.|++.+.||+|+||.||++... +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 4567899999999999999876 689999999875432 23568899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc--EEEecccCccccCCCCc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~~~~~~~~ 392 (557)
+|+|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++. +||+|||+++.......
T Consensus 100 ~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~ 173 (361)
T 3uc3_A 100 GGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 173 (361)
T ss_dssp SCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCC
Confidence 9999999874 3568999999999999999999998 99999999999999987765 99999999875432211
Q ss_pred cccccccCCCCccCCcccCCCCCCcc-cceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEK-SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~-~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... ........... .... ..+
T Consensus 174 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~-~~~~-~~~---- 243 (361)
T 3uc3_A 174 --PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILS-VKYS-IPD---- 243 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHT-TCCC-CCT----
T ss_pred --CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhc-CCCC-CCC----
Confidence 223458999999999988777655 899999999999999999997543322 22222222221 1110 000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.......+.+++.+||+.||++|||+.|+++.
T Consensus 244 ---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 ---DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp ---TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ---cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00112367899999999999999999999874
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=348.52 Aligned_cols=252 Identities=24% Similarity=0.272 Sum_probs=200.1
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|..+ +|+.||+|++.+.. ....+.+.+|..++..++||||+++++++.+.+..++||||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 445788999999999999886 68999999986532 12234588899999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++... +..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 143 ~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~ 217 (412)
T 2vd5_A 143 YVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217 (412)
T ss_dssp CCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCCc
Confidence 9999999999753 3468999999999999999999998 9999999999999999999999999999987755444
Q ss_pred cccccccCCCCccCCcccC-------CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 393 HISSVARGTVGYLDPEYYG-------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~-------~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...+.... ............
T Consensus 218 ~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~~~~- 290 (412)
T 2vd5_A 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------YGKIVHYKEHLS- 290 (412)
T ss_dssp EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTHHHHCC-
T ss_pred cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------HHHHHhcccCcC-
Confidence 3344457999999999987 45789999999999999999999999975432211 111111000000
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR---PKMQEIVLA 506 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~R---Pt~~evl~~ 506 (557)
-+.. ....+..+.+++.+||. +|++| |+++||++.
T Consensus 291 -~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 291 -LPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp -CC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred -CCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0100 11123478899999999 99998 589998763
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=335.86 Aligned_cols=266 Identities=23% Similarity=0.271 Sum_probs=197.9
Q ss_pred hHHHHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-----chhHHHHHHHHHHHhhcC---CCCccceeeEE
Q 008707 230 PELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-----SHRTQQFVTEVALLSRIH---HRNLVPLIGYC 300 (557)
Q Consensus 230 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~---h~nIv~~~~~~ 300 (557)
.++....|++.+.||+|+||+||+|.+. +++.||+|++.... ......+.+|+++++.++ ||||+++++++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 3445566778899999999999999864 68999999986322 112345677888877775 99999999999
Q ss_pred EecC-----eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc
Q 008707 301 EEEH-----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 375 (557)
Q Consensus 301 ~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~ 375 (557)
.... ..++|||++. ++|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp EECCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSC
T ss_pred eccCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCC
Confidence 7755 4789999996 6999998754 23448999999999999999999998 99999999999999999999
Q ss_pred EEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 008707 376 AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 455 (557)
Q Consensus 376 ~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~ 455 (557)
+||+|||++........ .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+... ....+..
T Consensus 159 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~ 233 (308)
T 3g33_A 159 VKLADFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFD 233 (308)
T ss_dssp EEECSCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHH
T ss_pred EEEeeCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHH
Confidence 99999999987644322 233458999999999999999999999999999999999999997543322 1111112
Q ss_pred HHhcCCcccccc------ccccC--C-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 456 MIKKGDVISIVD------PVLIG--N-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 456 ~~~~~~~~~~~d------~~l~~--~-----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
............ ..+.. . ........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 111111000000 00000 0 00112347889999999999999999999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=336.71 Aligned_cols=260 Identities=29% Similarity=0.476 Sum_probs=203.3
Q ss_pred HHHHhhcccCCCCceEEEEEEEcC-----CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKD-----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
..+++.+.||+|+||.||+|.+.. +..||+|++.... ......+.+|+++++.++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 344456889999999999998753 2369999987543 3345678999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 99999999999999753 4568999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCcc--ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 389 EDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 389 ~~~~~--~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
..... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... + +...+..+....
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~-~~~~~~~~~~~~- 270 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------E-VMKAINDGFRLP- 270 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHTTCCCC-
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------H-HHHHHHCCCcCC-
Confidence 43221 1122335778999999999999999999999999999999 99999743221 1 112222221111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
.....+..+.+++.+||+.+|++||++.||++.|+++.....
T Consensus 271 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 271 --------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp --------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred --------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 111223478899999999999999999999999999887433
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=331.49 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=204.5
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccch------hHHHHHHHHHHHhhcCCCCccceeeEEEecCee
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 306 (557)
...|++.+.||+|+||.||+|... +|+.||+|++...... ..+.+.+|+++++.++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456778899999999999999876 5899999998653221 356789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC----cEEEeccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 382 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg 382 (557)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999973 4568999999999999999999998 9999999999999999887 79999999
Q ss_pred CccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 383 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 383 la~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
++........ .....||+.|+|||.+.+..++.++||||||+++|+|++|..||....... ... .+..+..
T Consensus 165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~-~i~~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLA-NITSVSY 235 (321)
T ss_dssp TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHH-HHHTTCC
T ss_pred cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------HHH-HHHhccc
Confidence 9987654322 223458999999999999999999999999999999999999997443211 111 1111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 463 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 463 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..++..... .+..+.+++.+||+.||++|||+.|+++
T Consensus 236 --~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 --DFDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CCCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --ccChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 011111111 1236889999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=335.57 Aligned_cols=262 Identities=26% Similarity=0.421 Sum_probs=199.0
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcC----CcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecC---
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--- 304 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--- 304 (557)
...|.+.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|++++++++||||+++++++.+..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 3455668899999999999997652 4589999986542 334567899999999999999999999987654
Q ss_pred --eeEEEEEecCCCChhhhhhccC---CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEe
Q 008707 305 --QRILVYEYMHNGTLRDRLHGSV---NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 379 (557)
Q Consensus 305 --~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 379 (557)
..++||||+++|+|.+++.... ....+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEe
Confidence 3599999999999999985321 34568999999999999999999998 999999999999999999999999
Q ss_pred cccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHH
Q 008707 380 DFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI 457 (557)
Q Consensus 380 Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 457 (557)
|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||....... ... .+
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~----~~ 262 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYD----YL 262 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----HH
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH----HH
Confidence 9999987644321 12223447889999999999999999999999999999999 889997543322 111 11
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 458 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 458 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
..+..... +...+..+.+++.+||+.+|++|||+.+|++.|+++....
T Consensus 263 ~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 263 LHGHRLKQ---------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HTTCCCCC---------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HcCCCCCC---------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 12211111 1122347889999999999999999999999999988753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=341.18 Aligned_cols=246 Identities=26% Similarity=0.333 Sum_probs=200.3
Q ss_pred HHHhhcccCCCCceEEEEEEEcC-CcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
.|++.+.||+|+||.||+|..+. ++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..++||
T Consensus 21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 100 (353)
T 2i0e_A 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100 (353)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence 45567899999999999998874 7899999987532 23346688899999988 7999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||++||+|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||++......
T Consensus 101 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 101 EYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999974 3468999999999999999999998 99999999999999999999999999999864322
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. +.... +..+...
T Consensus 175 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~-i~~~~~~------- 239 (353)
T 2i0e_A 175 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQS-IMEHNVA------- 239 (353)
T ss_dssp TC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHCCCC-------
T ss_pred Cc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHH-HHhCCCC-------
Confidence 22 233456999999999999999999999999999999999999999754321 11111 2222111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 505 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 505 (557)
++......+.+++.+||+.||++||+ ++||++
T Consensus 240 ---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 240 ---YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11122347889999999999999995 466664
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=350.78 Aligned_cols=244 Identities=25% Similarity=0.373 Sum_probs=201.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 456789999999999999876 69999999986432 12346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 98 ~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 98 VSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp CSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 999999999973 4569999999999999999999998 9999999999999999999999999999987654322
Q ss_pred cccccccCCCCccCCcccCCCCC-CcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 393 HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~-s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...+... + ...+..+...
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~----~~~i~~~~~~-------- 234 (476)
T 2y94_A 172 --LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---L----FKKICDGIFY-------- 234 (476)
T ss_dssp --BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---H----HHHHHTTCCC--------
T ss_pred --ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---H----HHHHhcCCcC--------
Confidence 234468999999999988765 689999999999999999999997443221 1 1122222211
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+......+.+++.+||+.||++|||++||++
T Consensus 235 --~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 235 --TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 01111236889999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=338.00 Aligned_cols=275 Identities=24% Similarity=0.388 Sum_probs=197.7
Q ss_pred HHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHH--HhhcCCCCccceeeEEEe-----cCeeEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVAL--LSRIHHRNLVPLIGYCEE-----EHQRIL 308 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~i--l~~l~h~nIv~~~~~~~~-----~~~~~l 308 (557)
.|++.+.||+|+||.||+|.. +++.||||++... ....+..|.++ +..++||||+++++.+.. ....++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 14 NLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp SEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred HhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 345678999999999999987 4899999998643 23344445554 445799999999986542 335689
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCC---------CeEeeccCCCCEEeCCCCcEEEe
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP---------GIIHRDVKSSNILLDINMRAKVS 379 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~---------~ivH~dlk~~NIll~~~~~~kl~ 379 (557)
||||+++|+|.+++.. ...++..+..++.||++||+|||+ . +|+||||||+|||++.++.+||+
T Consensus 90 v~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEe
Confidence 9999999999999974 345888999999999999999998 7 99999999999999999999999
Q ss_pred cccCccccCCCCc-------cccccccCCCCccCCcccCC-------CCCCcccceehhHHHHHHHHhCCCCCCCCCccc
Q 008707 380 DFGLSRQAEEDLT-------HISSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGA 445 (557)
Q Consensus 380 Dfgla~~~~~~~~-------~~~~~~~g~~~y~aPE~l~~-------~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~ 445 (557)
|||++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987643221 11223458999999999987 456679999999999999999977764332211
Q ss_pred c-ccH----------HHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 446 E-LNI----------VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 446 ~-~~~----------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
. ... ................+.... ......+..+.+++.+||+.||++|||++|+++.|+++...-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 1 100 011111111111111111000 112245667999999999999999999999999999999876
Q ss_pred cCCCCcccc
Q 008707 515 KGGDQKFSS 523 (557)
Q Consensus 515 ~~~~~~~~~ 523 (557)
.....+.+.
T Consensus 321 ~~~~~~~~~ 329 (336)
T 3g2f_A 321 ERNKSVSPT 329 (336)
T ss_dssp CC-------
T ss_pred HhcccCCCc
Confidence 666544443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=335.95 Aligned_cols=256 Identities=25% Similarity=0.294 Sum_probs=197.6
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc-----cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-----CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
...|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 355667899999999999999875 5889999998643 2344578999999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccC-------------------------------------CCCCcCHHHHHHHHHHHHHHHHHH
Q 008707 308 LVYEYMHNGTLRDRLHGSV-------------------------------------NQKPLDWLTRLQIAHDAAKGLEYL 350 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qia~aL~~L 350 (557)
+||||+++|+|.+++.... ....+++..++.++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 9999999999999885211 012345677889999999999999
Q ss_pred HcCCCCCeEeeccCCCCEEeCCCC--cEEEecccCccccCCCC---ccccccccCCCCccCCcccCC--CCCCcccceeh
Q 008707 351 HTGCNPGIIHRDVKSSNILLDINM--RAKVSDFGLSRQAEEDL---THISSVARGTVGYLDPEYYGN--QQLTEKSDVYS 423 (557)
Q Consensus 351 H~~~~~~ivH~dlk~~NIll~~~~--~~kl~Dfgla~~~~~~~---~~~~~~~~g~~~y~aPE~l~~--~~~s~~~Dvws 423 (557)
|+ .+|+||||||+||+++.++ .+||+|||++....... ........||+.|+|||.+.+ ..++.++||||
T Consensus 185 H~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 98 8999999999999998776 89999999998653321 112234458999999999975 67889999999
Q ss_pred hHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 008707 424 FGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEI 503 (557)
Q Consensus 424 lG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~ev 503 (557)
||+++|||++|+.||...... +............. .+. . ......+.+++.+||+.+|.+|||+.|+
T Consensus 262 lG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~~~~--~~~-~----~~~~~~~~~li~~~l~~~p~~Rps~~~~ 328 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKLCFE--NPN-Y----NVLSPLARDLLSNLLNRNVDERFDAMRA 328 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCCTT--SGG-G----GGSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred HHHHHHHHHHCCCCCCCCChH------HHHHHHHhcccccC--Ccc-c----ccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 999999999999999744322 11222222211110 000 0 1123468899999999999999999999
Q ss_pred HH
Q 008707 504 VL 505 (557)
Q Consensus 504 l~ 505 (557)
++
T Consensus 329 l~ 330 (345)
T 3hko_A 329 LQ 330 (345)
T ss_dssp HH
T ss_pred hc
Confidence 87
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=339.88 Aligned_cols=261 Identities=24% Similarity=0.417 Sum_probs=210.3
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCee
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 306 (557)
...|++.+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+++++.++||||+++++++.+.+..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 345667899999999999999765 367899999875433 3456789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhccC-------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEe
Q 008707 307 ILVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 379 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 379 (557)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+||+
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~ 180 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 180 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEEC
Confidence 99999999999999987532 12457899999999999999999998 999999999999999999999999
Q ss_pred cccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHH
Q 008707 380 DFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMI 457 (557)
Q Consensus 380 Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 457 (557)
|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+.. + ....+
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~-~~~~~ 253 (322)
T 1p4o_A 181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------Q-VLRFV 253 (322)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------H-HHHHH
T ss_pred cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH------H-HHHHH
Confidence 9999986543322 11223346889999999998889999999999999999999 89999743321 1 11222
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 458 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 458 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
..+..... ....+..+.+++.+||+.+|++|||+.|+++.|++....
T Consensus 254 ~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~ 300 (322)
T 1p4o_A 254 MEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300 (322)
T ss_dssp HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence 22222111 112234688999999999999999999999999988664
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=334.61 Aligned_cols=265 Identities=28% Similarity=0.442 Sum_probs=210.5
Q ss_pred HHHHhhcccCCCCceEEEEEEE-----cCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecC--eeE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKM-----KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH--QRI 307 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--~~~ 307 (557)
..+++.+.||+|+||.||+|.+ .+++.||+|++........+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 3455678999999999999984 358899999998766666778999999999999999999999986644 689
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+||||+++++|.+++... ...+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 121 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 999999999999999753 3568999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCcc--ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcc---------ccccHHHHHHHH
Q 008707 388 EEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG---------AELNIVHWARSM 456 (557)
Q Consensus 388 ~~~~~~--~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~---------~~~~~~~~~~~~ 456 (557)
...... ......++..|+|||.+.+..++.++||||||+++|+|+||..||...... ........+...
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 544321 122334677899999999888999999999999999999999998632110 000111112222
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 457 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 457 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
+..+.... .+...+..+.+++.+||+.+|++|||+.||++.|+++.+.
T Consensus 276 ~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 276 LKNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHTTCCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhcCCCCC---------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 22221111 1112234788999999999999999999999999998764
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=336.68 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=193.6
Q ss_pred HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCC--CCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h--~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||++...+++.||+|++.... ....+.+.+|+++++.++| |||+++++++.+++..++|||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 89 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 89 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-
Confidence 45678999999999999999889999999986432 3345678999999999976 999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+.+++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||++........
T Consensus 90 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 90 CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 558899999984 4568999999999999999999998 9999999999999997 67899999999987654332
Q ss_pred c-ccccccCCCCccCCcccCC-----------CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 008707 393 H-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 460 (557)
Q Consensus 393 ~-~~~~~~g~~~y~aPE~l~~-----------~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 460 (557)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ........+...
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~ 237 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPN 237 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHCTT
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHhcCC
Confidence 2 2234468999999999854 6788999999999999999999999973211 111122222111
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 461 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 461 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.. ...+......+.+++.+||+.||.+|||+.|+++.
T Consensus 238 ~~---------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 238 HE---------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp SC---------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc---------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11 11111122468899999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=339.27 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=186.8
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.|++.+.||+|+||.||+|... +++.||+|++.... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 4556789999999999999887 47899999987542 34568899999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC---CCcEEEecccCccccCCCC
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~ 391 (557)
+|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||++.......
T Consensus 132 ~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 132 GGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp SCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 9999999873 4568999999999999999999998 99999999999999975 8899999999998764332
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+..+... ...
T Consensus 206 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~i~~~~~~-~~~---- 272 (349)
T 2w4o_A 206 L--MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMFRRILNCEYY-FIS---- 272 (349)
T ss_dssp ---------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHHHHHHTTCCC-CCT----
T ss_pred c--cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHHHHHHhCCCc-cCC----
Confidence 1 223458999999999999999999999999999999999999997433211 111112222111 000
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 273 -~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 273 -PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011122347889999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=334.38 Aligned_cols=263 Identities=27% Similarity=0.424 Sum_probs=210.1
Q ss_pred HHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccc-hhHHHHHHHHHHHhhc-CCCCccceeeEEEecC-e
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH-Q 305 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~-~ 305 (557)
..|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|++++.++ +||||+++++++...+ .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 44567899999999999999752 468899999876433 3456789999999999 7999999999987754 5
Q ss_pred eEEEEEecCCCChhhhhhccCC-------------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC
Q 008707 306 RILVYEYMHNGTLRDRLHGSVN-------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 372 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~ 372 (557)
.++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+ .+++||||||+||+++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 183 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECC
Confidence 8999999999999999975421 1238899999999999999999998 99999999999999999
Q ss_pred CCcEEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHH
Q 008707 373 NMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 450 (557)
Q Consensus 373 ~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~ 450 (557)
++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|+| |..||........
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---- 259 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 259 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH----
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH----
Confidence 99999999999987644322 22233457889999999998899999999999999999998 9999975433211
Q ss_pred HHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 451 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 451 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
....+..+..... +...+..+.+++.+||+.||.+|||+.||++.|+.+.+...
T Consensus 260 --~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 260 --FCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp --HHHHHHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred --HHHHhccCccCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 1122222221111 11123468899999999999999999999999999987654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=339.42 Aligned_cols=262 Identities=24% Similarity=0.282 Sum_probs=202.4
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcC-----CCCccceeeEEEecC
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----HRNLVPLIGYCEEEH 304 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----h~nIv~~~~~~~~~~ 304 (557)
++....|++.+.||+|+||.||+|.+. +++.||||++... ....+.+..|+++++.++ ||||+++++++...+
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 333456677899999999999999874 6889999998743 334566788999999996 999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC------------
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI------------ 372 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~------------ 372 (557)
..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~ 184 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRR 184 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEEC
T ss_pred eeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhc
Confidence 999999999 99999999754 23468999999999999999999998 99999999999999975
Q ss_pred -------------CCcEEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCC
Q 008707 373 -------------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 439 (557)
Q Consensus 373 -------------~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~ 439 (557)
++.+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 185 ~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 185 VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp TTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 7889999999998654322 23458999999999999999999999999999999999999998
Q ss_pred CCCccccccHHHHHHHHHhc-----------CCcccccccc-cc---C-C-CCHH---------------HHHHHHHHHH
Q 008707 440 VEDFGAELNIVHWARSMIKK-----------GDVISIVDPV-LI---G-N-VKIE---------------SIWRIAEVAI 487 (557)
Q Consensus 440 ~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~d~~-l~---~-~-~~~~---------------~~~~l~~li~ 487 (557)
..+..+.... +...... ......++.. .. + . .... ....+.+++.
T Consensus 261 ~~~~~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 337 (360)
T 3llt_A 261 THEHMEHLAM---MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLY 337 (360)
T ss_dssp CSSHHHHHHH---HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHH
T ss_pred CCcHHHHHHH---HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHH
Confidence 5443221111 1111100 0000000000 00 0 0 0000 1146779999
Q ss_pred HccccCCCCCCCHHHHHH
Q 008707 488 QCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 488 ~cl~~~P~~RPt~~evl~ 505 (557)
+||+.||++|||++|+++
T Consensus 338 ~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 338 SILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHCCSSGGGSCCHHHHTT
T ss_pred HHhcCChhhCCCHHHHhc
Confidence 999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=360.93 Aligned_cols=252 Identities=25% Similarity=0.418 Sum_probs=203.3
Q ss_pred ccCCCCceEEEEEEEc---CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCC
Q 008707 242 KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 317 (557)
Q Consensus 242 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gs 317 (557)
.||+|+||.||+|.+. ++..||||+++... ....+.+.+|+++++.++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 46679999997643 3356789999999999999999999999976 56899999999999
Q ss_pred hhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc--cc
Q 008707 318 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--IS 395 (557)
Q Consensus 318 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--~~ 395 (557)
|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........ ..
T Consensus 422 L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 496 (613)
T 2ozo_A 422 LHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496 (613)
T ss_dssp HHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred HHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence 99999742 4568999999999999999999998 99999999999999999999999999999876433221 11
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
....+++.|+|||++.+..++.++|||||||++|||+| |+.||...+..+ +...+..+.... .
T Consensus 497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~---------~ 560 (613)
T 2ozo_A 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRME---------C 560 (613)
T ss_dssp -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTTCCCC---------C
T ss_pred cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCCCCC---------C
Confidence 22235689999999998899999999999999999998 999998543221 122333333211 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
+...+..+.+++.+||+.+|++||++.+|++.|+.+.....
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 12234578899999999999999999999999999876543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=328.38 Aligned_cols=246 Identities=27% Similarity=0.419 Sum_probs=180.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 456789999999999999874 689999999864321 2246788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++... ...+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 93 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 167 (278)
T 3cok_A 93 CHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167 (278)
T ss_dssp CTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred CCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence 9999999998742 3568999999999999999999998 9999999999999999999999999999987653322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||......... .. +... +..
T Consensus 168 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~-~~~~------~~~--- 230 (278)
T 3cok_A 168 K-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------NK-VVLA------DYE--- 230 (278)
T ss_dssp -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSS------CCC---
T ss_pred c-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------HH-Hhhc------ccC---
Confidence 1 22345899999999999989999999999999999999999999754432111 00 0000 000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+......+.+++.+||+.||++|||++|+++
T Consensus 231 -~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 -MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 11122346889999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=328.49 Aligned_cols=244 Identities=26% Similarity=0.416 Sum_probs=197.6
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 456789999999999999876 47789999986432 12245688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 91 ~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~- 163 (279)
T 3fdn_A 91 APLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 163 (279)
T ss_dssp CTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc-
Confidence 999999999874 3568999999999999999999998 999999999999999999999999999986554322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.... . ..+.....
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~-~~~~~~~~---------- 224 (279)
T 3fdn_A 164 --RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------Y-KRISRVEF---------- 224 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H-HHHHHTCC----------
T ss_pred --ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH------H-HHHHhCCC----------
Confidence 2234589999999999999999999999999999999999999974432211 1 11111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
..+...+..+.+++.+||+.||++|||++||++.
T Consensus 225 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0111123467899999999999999999999974
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=334.01 Aligned_cols=260 Identities=25% Similarity=0.376 Sum_probs=196.1
Q ss_pred HHHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCccc---hhHHHHHHHHHHHhhcCCCCccceeeEEEecCe----eE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ----RI 307 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~----~~ 307 (557)
.|++.+.||+|+||.||+|.+ .+++.||+|++..... .....+.+|+++++.++||||+++++++..... .+
T Consensus 13 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 455679999999999999987 4689999999875422 334578899999999999999999999876543 49
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+||||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 93 lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred EEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 99999999999999974 3568999999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCc--cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 388 EEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 388 ~~~~~--~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
..... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...............
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~ 240 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPPS 240 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCHH
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCCcc
Confidence 44322 1222345899999999999999999999999999999999999999744321 111222222111100
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHH-HHHHHHhhhhhh
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQE-IVLAIQDSIKIE 514 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e-vl~~L~~~~~~~ 514 (557)
.... ..+..+.+++.+||+.||++||++.+ +...+.+....+
T Consensus 241 ---~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 283 (311)
T 3ork_A 241 ---ARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGE 283 (311)
T ss_dssp ---HHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTC
T ss_pred ---cccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCC
Confidence 0001 12346889999999999999996555 555566655443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=322.87 Aligned_cols=251 Identities=24% Similarity=0.367 Sum_probs=202.3
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
..|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45667899999999999999876 68999999986432 33457789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999987 34678999999999999999999998 9999999999999999999999999999986543221
Q ss_pred -cccccccCCCCccCCcccCCCCC-CcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 393 -HISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 393 -~~~~~~~g~~~y~aPE~l~~~~~-s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
.......|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||....... .....+ ....... .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~----~~~~~~~---~--- 229 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW----KEKKTYL---N--- 229 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHH----HTTCTTS---T---
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHh----hhccccc---C---
Confidence 12233458999999999987765 779999999999999999999997543321 111111 1111100 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.....+..+.+++.+||+.||++|||++|+++
T Consensus 230 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 ---PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00112336789999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=337.68 Aligned_cols=264 Identities=16% Similarity=0.198 Sum_probs=205.3
Q ss_pred HHHhhcccCCCCceEEEEEEEcC---------CcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccc-----------
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKD---------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVP----------- 295 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~----------- 295 (557)
.|++.+.||+|+||.||+|.... ++.||+|++... +.+.+|++++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 34567899999999999998764 789999998643 45778999999999999988
Q ss_pred ----eeeEEEe-cCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe
Q 008707 296 ----LIGYCEE-EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL 370 (557)
Q Consensus 296 ----~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll 370 (557)
+++++.. ++..++||||+ +++|.+++... ....+++..++.++.||+.||+|||+ .+|+||||||+||++
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFV 192 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEE
Confidence 5667765 67889999999 99999999853 23679999999999999999999999 999999999999999
Q ss_pred CCCC--cEEEecccCccccCCCCcc------ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCC
Q 008707 371 DINM--RAKVSDFGLSRQAEEDLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442 (557)
Q Consensus 371 ~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~ 442 (557)
+.++ .+||+|||++......... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9988 8999999999876543221 1123468999999999999999999999999999999999999998543
Q ss_pred ccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 443 FGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 443 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
... ..+........ . ......+..... ...+..+.+++.+||+.||++|||++||++.|+++.....
T Consensus 273 ~~~-~~~~~~~~~~~-~-~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 273 PNT-EDIMKQKQKFV-D-KPGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TCH-HHHHHHHHHHH-H-SCCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCH-HHHHHHHHhcc-C-Chhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 221 11222221111 1 111111111000 0112478899999999999999999999999999987654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=330.69 Aligned_cols=257 Identities=26% Similarity=0.426 Sum_probs=205.2
Q ss_pred HHhhc-ccCCCCceEEEEEEEc---CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 237 NNFCK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 237 ~~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
|.+.+ .||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++ ..+..++||
T Consensus 18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~ 96 (291)
T 1xbb_A 18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVM 96 (291)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEE
T ss_pred hhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEE
Confidence 34445 8999999999999653 46889999987543 23356799999999999999999999999 566789999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 97 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (291)
T 1xbb_A 97 EMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170 (291)
T ss_dssp ECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence 99999999999974 4568999999999999999999998 99999999999999999999999999999876543
Q ss_pred Cccc--cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 391 LTHI--SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 391 ~~~~--~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
.... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+... +...+..+....
T Consensus 171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~~--- 240 (291)
T 1xbb_A 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMG--- 240 (291)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCC---
T ss_pred CCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCCC---
Confidence 3221 122336788999999988889999999999999999999 999997443211 122222322211
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhcC
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEKG 516 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~~ 516 (557)
.+...+..+.+++.+||+.||++||++.||++.|+++......
T Consensus 241 ------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 283 (291)
T 1xbb_A 241 ------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283 (291)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhh
Confidence 1112234788999999999999999999999999998876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=324.68 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=196.8
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
..|.+.+.||+|+||.||++... ++..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56777899999999999999875 58899999986543 33457889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe---CCCCcEEEecccCccccC
Q 008707 313 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 313 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~ 388 (557)
+++|+|.+.+.... ....+++..+..++.|++.||+|||+ .+++||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999886432 34678999999999999999999998 999999999999999 456789999999998754
Q ss_pred CCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
.... .....|++.|+|||.+. ..++.++||||||+++|+|++|+.||....... .. .............
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~-~~~~~~~~~~~~~- 247 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQ-QKATYKEPNYAVE- 247 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHHCCCCCCC--
T ss_pred Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HH-hhhccCCcccccc-
Confidence 4322 23345899999999986 468899999999999999999999997543221 11 1111111100000
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
... ....+.+++.+||+.||++|||++||++
T Consensus 248 --~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 --CRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --cCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001 1236789999999999999999999985
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=337.11 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=200.1
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
...|++.+.||+|+||.||+|..+ +++.||+|++..... ...+|++++.++ +||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 345677899999999999999876 588999999865432 234688888888 79999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC----CcEEEecccCcccc
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQA 387 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~~~ 387 (557)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ .||+||||||+|||+.++ +.+||+|||++...
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999873 4568999999999999999999998 999999999999998543 34999999999876
Q ss_pred CCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... +...+..+....
T Consensus 171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~~~~i~~~~~~~--- 242 (342)
T 2qr7_A 171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE----ILARIGSGKFSL--- 242 (342)
T ss_dssp BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH----HHHHHHHCCCCC---
T ss_pred cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH----HHHHHccCCccc---
Confidence 44322 2233468999999999988888999999999999999999999997533222111 222233333211
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
...........+.+++.+||..||++|||+.|+++.
T Consensus 243 ---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 243 ---SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111111223468899999999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=330.72 Aligned_cols=253 Identities=30% Similarity=0.488 Sum_probs=199.4
Q ss_pred HHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEec-CeeEEEEEec
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-HQRILVYEYM 313 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-~~~~lv~e~~ 313 (557)
..|++.+.||+|+||.||+|.+. |+.||+|++.... ..+.+.+|+++++.++||||+++++++.+. +..++||||+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 97 (278)
T 1byg_A 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 97 (278)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred hhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence 34567899999999999999886 8899999987542 456789999999999999999999987554 4789999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++++|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 98 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 999999999743 12237888999999999999999998 999999999999999999999999999987654332
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
....+++.|+|||.+.+..++.++||||||+++|+|+| |+.||....... .. ..+..+...
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~----~~~~~~~~~--------- 233 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGYKM--------- 233 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----HHHTTTCCC---------
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHhcCCCC---------
Confidence 12347889999999998899999999999999999998 999997543321 11 122222111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
......+..+.+++.+||+.||++|||+.|+++.|+++...+
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 111122347889999999999999999999999999987654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=339.50 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=194.6
Q ss_pred HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCc--cchhHHHHHHHHHHHhhcC--CCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~--h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|...+++.||||++... .....+.+.+|+++++.++ ||||+++++++...+..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 5567899999999999999888999999998643 2334577899999999996 5999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+.+++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++ ++.+||+|||++........
T Consensus 137 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 137 CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 568899999984 3478888999999999999999998 9999999999999996 58899999999987654322
Q ss_pred c-ccccccCCCCccCCcccCC-----------CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 008707 393 H-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 460 (557)
Q Consensus 393 ~-~~~~~~g~~~y~aPE~l~~-----------~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 460 (557)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ........+...
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~~~~ 284 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIIDPN 284 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHCTT
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHhCcc
Confidence 1 2234569999999999865 3688999999999999999999999973221 111122222211
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 461 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 461 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.... .+......+.+++.+||+.||++|||+.|+++.
T Consensus 285 ~~~~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 285 HEIE---------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp SCCC---------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCC---------CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 1111 111113468899999999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=328.83 Aligned_cols=250 Identities=26% Similarity=0.400 Sum_probs=201.4
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
...|.+.+.||+|+||.||++... +|+.||+|++........+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 356677899999999999999876 6899999999765444556788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe---CCCCcEEEecccCccccCC
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~ 389 (557)
+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||++ +.++.++|+|||++.....
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999998874 3468999999999999999999998 999999999999999 7789999999999876543
Q ss_pred CCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccc
Q 008707 390 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 469 (557)
.. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... + ...+..+... ....
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~----~~~i~~~~~~--~~~~ 229 (304)
T 2jam_A 162 GI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---L----FEKIKEGYYE--FESP 229 (304)
T ss_dssp BT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H----HHHHHHCCCC--CCTT
T ss_pred Cc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---H----HHHHHcCCCC--CCcc
Confidence 21 122348999999999999999999999999999999999999997433211 1 1122222211 0011
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
. ....+..+.+++.+||+.||++|||++|+++
T Consensus 230 ~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 230 F----WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp T----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred c----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1 1122347889999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=338.84 Aligned_cols=261 Identities=30% Similarity=0.495 Sum_probs=206.2
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcE--EEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKE--VAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~l 308 (557)
...|++.+.||+|+||.||+|.+. ++.. +|+|.+.... ....+.+.+|+++++++ +||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 345667899999999999999865 4554 4899886532 33446788999999999 89999999999999999999
Q ss_pred EEEecCCCChhhhhhccC-------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc
Q 008707 309 VYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 375 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~ 375 (557)
||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ .+++||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 999999999999997531 13468999999999999999999998 99999999999999999999
Q ss_pred EEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHH
Q 008707 376 AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWAR 454 (557)
Q Consensus 376 ~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~ 454 (557)
+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|+|+| |+.||...... + ..
T Consensus 181 ~kL~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~-~~ 251 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------E-LY 251 (327)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HH
T ss_pred EEEcccCcCcccccccc--ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------H-HH
Confidence 99999999875432211 122346889999999988889999999999999999998 99999744321 1 11
Q ss_pred HHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 455 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 455 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
..+..+... ..+...+..+.+++.+||+.+|++|||++|+++.|+++.....
T Consensus 252 ~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 252 EKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HHGGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHhhcCCCC---------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 222222111 1111223478899999999999999999999999999987543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=322.95 Aligned_cols=259 Identities=24% Similarity=0.303 Sum_probs=205.0
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc------hhHHHHHHHHHHHhhcCCCCccceeeEEEecCee
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 306 (557)
...|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 345677899999999999999887 689999999864321 1357789999999999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC----cEEEeccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFG 382 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfg 382 (557)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999974 3568999999999999999999998 9999999999999998877 79999999
Q ss_pred CccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 383 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 383 la~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
++........ .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .. ..+.....
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TL-TNISAVNY 228 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHTTCC
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HH-HHhHhccc
Confidence 9987644322 123358999999999999999999999999999999999999997543211 11 11111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhhhh
Q 008707 463 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDSIKI 513 (557)
Q Consensus 463 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~~~~ 513 (557)
. .++..... .+..+.+++.+||+.||++|||+.|+++ .++.+...
T Consensus 229 ~--~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 229 D--FDEEYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp C--CCHHHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred C--Ccchhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 0 00001111 1236889999999999999999999997 45555443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=340.43 Aligned_cols=263 Identities=26% Similarity=0.421 Sum_probs=209.9
Q ss_pred HHHHhhcccCCCCceEEEEEEEcC------CcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCee
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKD------GKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~ 306 (557)
..|++.+.||+|+||.||+|.+.. ...||+|.+.... ....+.+.+|+++++.+ +||||+++++++.+.+..
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 125 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCce
Confidence 445668999999999999998753 2479999987643 33456789999999999 899999999999999999
Q ss_pred EEEEEecCCCChhhhhhccC-----------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc
Q 008707 307 ILVYEYMHNGTLRDRLHGSV-----------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR 375 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~ 375 (557)
++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.
T Consensus 126 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~ 202 (333)
T 2i1m_A 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHV 202 (333)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGE
T ss_pred EEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCe
Confidence 99999999999999987532 13457899999999999999999998 99999999999999999999
Q ss_pred EEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHH
Q 008707 376 AKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWA 453 (557)
Q Consensus 376 ~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~ 453 (557)
+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|+| |..||........ ..
T Consensus 203 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~--- 277 (333)
T 2i1m_A 203 AKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--FY--- 277 (333)
T ss_dssp EEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--HH---
T ss_pred EEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--HH---
Confidence 99999999986543322 12223446789999999988899999999999999999999 9999975433211 11
Q ss_pred HHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 454 RSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 454 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
.....+.... .+...+..+.+++.+||+.||.+|||++||++.|+++.....
T Consensus 278 -~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 278 -KLVKDGYQMA---------QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp -HHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred -HHHhcCCCCC---------CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 1222221110 011123478899999999999999999999999999876543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=334.37 Aligned_cols=242 Identities=23% Similarity=0.308 Sum_probs=199.2
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--------hhHHHHHHHHHHHhhcCCCCccceeeEEEecC
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 304 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 304 (557)
...|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 355667899999999999999865 688999999865421 12345778999999999999999999999999
Q ss_pred eeEEEEEecCCC-ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccC
Q 008707 305 QRILVYEYMHNG-TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 383 (557)
Q Consensus 305 ~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 383 (557)
..++||||+.+| +|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeeccc
Confidence 999999999776 99999873 4569999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCccCCcccCCCCC-CcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 384 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 384 a~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~-s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
+........ .....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||......
T Consensus 177 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------------ 236 (335)
T 3dls_A 177 AAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------------ 236 (335)
T ss_dssp CEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------------
T ss_pred ceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------------
Confidence 987654332 223458999999999988776 88999999999999999999999732110
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 463 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 463 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
...... .+......+.+++.+||+.||++|||++|+++.
T Consensus 237 ---~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ---VEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---HhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 000123368899999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=332.82 Aligned_cols=246 Identities=29% Similarity=0.424 Sum_probs=198.6
Q ss_pred HHHHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
..|+..+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4456678999999999999986 468999999986432 233467889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+. |+|.+.+... ...+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9996 6888877643 4568999999999999999999998 89999999999999999999999999999876432
Q ss_pred CccccccccCCCCccCCcccC---CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~---~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
....||+.|+|||++. ...++.++||||||+++|||++|+.||...+. ......... +.......
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~-~~~~~~~~ 275 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ-NESPALQS 275 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHH-SCCCCCCC
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHh-cCCCCCCC
Confidence 2345899999999984 56789999999999999999999999974332 111122222 21111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
. ..+..+.+++.+||+.||++|||++|+++.
T Consensus 276 ----~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 276 ----G----HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----C----CCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 123468899999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=342.42 Aligned_cols=249 Identities=26% Similarity=0.343 Sum_probs=192.4
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHH-HhhcCCCCccceeeEEEecCeeEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVAL-LSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~i-l~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
..|++.+.||+|+||.||+|+.+ +++.||+|++.+... ...+.+.+|..+ ++.++||||+++++++.+.+..++|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 34567899999999999999886 478999999865432 233456677776 5678999999999999999999999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||++||+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 118 ~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 118 LDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999974 3568899999999999999999998 9999999999999999999999999999986433
Q ss_pred CCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccc
Q 008707 390 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 469 (557)
... ......||+.|+|||++.+..++.++|||||||++|||++|..||...+.. +.... +..+...
T Consensus 192 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~-i~~~~~~------ 257 (373)
T 2r5t_A 192 HNS-TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDN-ILNKPLQ------ 257 (373)
T ss_dssp CCC-CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHH-HHHSCCC------
T ss_pred CCC-ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHH-HHhcccC------
Confidence 221 233456999999999999999999999999999999999999999744321 11111 1122111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 008707 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 507 (557)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 507 (557)
+... ....+.+++.+||+.||.+||++.+.++.+
T Consensus 258 ~~~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i 291 (373)
T 2r5t_A 258 LKPN----ITNSARHLLEGLLQKDRTKRLGAKDDFMEI 291 (373)
T ss_dssp CCSS----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHH
T ss_pred CCCC----CCHHHHHHHHHHcccCHHhCCCCCCCHHHH
Confidence 1111 223688999999999999999986444333
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=353.30 Aligned_cols=247 Identities=24% Similarity=0.336 Sum_probs=192.4
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc---cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
.|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 4566889999999999999875 6899999998643 22334567889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ ..||+||||||+|||++.++.+||+|||++.......
T Consensus 229 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 229 YANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp CCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred eCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 9999999999874 3568999999999999999999995 2799999999999999999999999999998643332
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... + ... +..+...
T Consensus 304 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~---~~~-i~~~~~~-------- 367 (446)
T 4ejn_A 304 AT-MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---L---FEL-ILMEEIR-------- 367 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHH-HHHCCCC--------
T ss_pred cc-cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---H---HHH-HHhCCCC--------
Confidence 22 234569999999999999999999999999999999999999997443221 1 111 1111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 505 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 505 (557)
.+......+.+++.+||+.||++|| +++|+++
T Consensus 368 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 368 --FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1111234688999999999999999 9999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=327.73 Aligned_cols=246 Identities=24% Similarity=0.351 Sum_probs=201.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 445789999999999999876 47899999986432 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 97 ~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 170 (294)
T 2rku_A 97 CRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170 (294)
T ss_dssp CTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCcc
Confidence 999999998874 3568999999999999999999998 9999999999999999999999999999987643322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ... .+..+.. .+..
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~-~~~~~~~------~~~~ 236 (294)
T 2rku_A 171 R-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYL-RIKKNEY------SIPK 236 (294)
T ss_dssp C-BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH-HHHTTCC------CCCT
T ss_pred c-cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH-HHhhccC------CCcc
Confidence 2 233458999999999999899999999999999999999999997443221 111 1111111 0111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.....+.+++.+||+.||++|||++|+++.
T Consensus 237 ----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 237 ----HINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 122368899999999999999999999863
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=337.39 Aligned_cols=265 Identities=27% Similarity=0.442 Sum_probs=207.1
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecC
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH 304 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 304 (557)
+....|++.+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 34456677899999999999999742 47789999986543 344567899999999999999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhccCC----CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC---CCcEE
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVN----QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAK 377 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~---~~~~k 377 (557)
..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+ .+++||||||+||+++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEE
Confidence 99999999999999999976431 2458999999999999999999998 99999999999999984 44699
Q ss_pred EecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHH
Q 008707 378 VSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARS 455 (557)
Q Consensus 378 l~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~ 455 (557)
|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|+| |..||...... + ...
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~-~~~ 256 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------E-VLE 256 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------H-HHH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH------H-HHH
Confidence 999999875433221 12223447889999999988889999999999999999998 99999743321 1 112
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 456 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 456 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
.+..+.... .....+..+.+++.+||+.||.+|||+.||++.|+.+.....
T Consensus 257 ~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 257 FVTSGGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp HHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHhcCCCCC---------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 222222111 111223478899999999999999999999999999887544
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=362.75 Aligned_cols=249 Identities=27% Similarity=0.460 Sum_probs=200.6
Q ss_pred cccCCCCceEEEEEEEc---CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+.||+|+||.||+|.+. .++.||||+++.... ...+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999664 467899999875432 335789999999999999999999999965 458899999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc--c
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT--H 393 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~--~ 393 (557)
|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 999999973 4568999999999999999999998 9999999999999999999999999999987654322 1
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+... +...+..+.....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~------- 593 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERMGC------- 593 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCCCC-------
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC-------
Confidence 2222346788999999999999999999999999999998 999997543221 2223333322211
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
+...+..+.+++.+||+.||++|||+++|++.|+++..
T Consensus 594 --p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 594 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11234578899999999999999999999999998754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=329.45 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=195.1
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecCCCC
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGT 317 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~gs 317 (557)
.+.||+|+||.||+|... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 367999999999999865 6899999999766555567889999999985 79999999999999999999999999999
Q ss_pred hhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc---EEEecccCccccCCCCc--
Q 008707 318 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEEDLT-- 392 (557)
Q Consensus 318 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfgla~~~~~~~~-- 392 (557)
|.+++.. ...+++..+..++.||+.||+|||+ .+++||||||+||+++.++. +||+|||++........
T Consensus 98 L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 171 (316)
T 2ac3_A 98 ILSHIHK---RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171 (316)
T ss_dssp HHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---------
T ss_pred HHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccc
Confidence 9999974 3568999999999999999999998 89999999999999998776 99999999876532211
Q ss_pred ----cccccccCCCCccCCcccCC-----CCCCcccceehhHHHHHHHHhCCCCCCCCCccccc--------cHHHHHHH
Q 008707 393 ----HISSVARGTVGYLDPEYYGN-----QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--------NIVHWARS 455 (557)
Q Consensus 393 ----~~~~~~~g~~~y~aPE~l~~-----~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~--------~~~~~~~~ 455 (557)
.......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+.. ........
T Consensus 172 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (316)
T 2ac3_A 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251 (316)
T ss_dssp ----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHH
T ss_pred cccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHH
Confidence 11123358999999999875 45788999999999999999999999854432100 00111122
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 456 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 456 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+..+... ..+. .... .+..+.+++.+||+.||++|||++|+++
T Consensus 252 ~i~~~~~~-~~~~-~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 252 SIQEGKYE-FPDK-DWAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHCCCC-CCHH-HHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhccCcc-cCch-hccc----CCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 22222211 0000 0011 2346889999999999999999999986
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=323.81 Aligned_cols=247 Identities=24% Similarity=0.365 Sum_probs=196.1
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCChh
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLR 319 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL~ 319 (557)
..||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 57999999999999875 58899999987665556678999999999999999999999999999999999999999999
Q ss_pred hhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC-CCcEEEecccCccccCCCCccccccc
Q 008707 320 DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVA 398 (557)
Q Consensus 320 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~ 398 (557)
+++........+++..+..++.|++.||+|||+ .+++|+||||+||+++. ++.+||+|||++........ .....
T Consensus 108 ~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~ 183 (295)
T 2clq_A 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTETF 183 (295)
T ss_dssp HHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CCC
T ss_pred HHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-ccccc
Confidence 999865444567788999999999999999998 99999999999999987 89999999999987644322 12334
Q ss_pred cCCCCccCCcccCCC--CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCH
Q 008707 399 RGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 476 (557)
Q Consensus 399 ~g~~~y~aPE~l~~~--~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 476 (557)
.|++.|+|||.+.+. .++.++||||||+++|+|++|+.||........ ........ . ..+.+ +.
T Consensus 184 ~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~-~-----~~~~~----~~ 249 (295)
T 2clq_A 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----AMFKVGMF-K-----VHPEI----PE 249 (295)
T ss_dssp CCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----HHHHHHHH-C-----CCCCC----CT
T ss_pred CCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----HHHhhccc-c-----ccccc----cc
Confidence 589999999998764 378999999999999999999999973322111 00011010 0 01111 11
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 477 ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 477 ~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..+..+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22347889999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=325.15 Aligned_cols=248 Identities=24% Similarity=0.347 Sum_probs=200.7
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 87 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 87 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence 456789999999999999876 58899999986432 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc---EEEecccCccccCCC
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGLSRQAEED 390 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfgla~~~~~~ 390 (557)
++++|.+.+.. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++. +||+|||++......
T Consensus 88 ~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 88 TGGELFEDIVA---REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp CSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 99999988874 3568999999999999999999998 99999999999999986655 999999999876543
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
.. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+... . ...+..+.... ..+ .
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~----~~~~~~~~~~~-~~~-~ 230 (284)
T 3kk8_A 162 EA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L----YAQIKAGAYDY-PSP-E 230 (284)
T ss_dssp CB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHHTCCCC-CTT-T
T ss_pred cc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---H----HHHHHhccccC-Cch-h
Confidence 32 223458999999999999999999999999999999999999997433211 1 11122221110 000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.. ..+..+.+++.+||+.||++|||++|+++
T Consensus 231 ~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 231 WD----TVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TT----TSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hc----ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01 12346889999999999999999999987
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=327.14 Aligned_cols=244 Identities=24% Similarity=0.360 Sum_probs=200.8
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 4556789999999999999876 57889999986432 1224678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 95 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 95 FAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred eCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999874 3468999999999999999999998 999999999999999999999999999987654322
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ... .+..... .
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~-~~~~~~~------~-- 230 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------THR-RIVNVDL------K-- 230 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHH-HHHTTCC------C--
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HHH-HHhcccc------C--
Confidence 223458999999999999999999999999999999999999997443211 111 1111111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+......+.+++.+|++.||.+|||++|+++
T Consensus 231 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 --FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 11112346889999999999999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=338.93 Aligned_cols=254 Identities=22% Similarity=0.317 Sum_probs=201.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
..|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 34556789999999999999876 68999999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCC-CeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
+++++|.+++.. ...+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||++.......
T Consensus 113 ~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 186 (360)
T 3eqc_A 113 MDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 186 (360)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc
Confidence 999999999974 3468899999999999999999997 5 89999999999999999999999999987653221
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHH---------------------
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV--------------------- 450 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~--------------------- 450 (557)
.....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+........
T Consensus 187 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 187 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp -------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred ---ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 22345899999999999999999999999999999999999999754432110000
Q ss_pred ---------------HHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 451 ---------------HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 451 ---------------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
... ..+..+..... ........+.+++.+||+.||++|||++|+++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELL-DYIVNEPPPKL--------PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----------CCCHHHHH-HHHHHSCCCCC--------CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccccCCCCcccchhhh-hHHhccCCCCC--------CcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000 00000000000 001123468899999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=338.83 Aligned_cols=252 Identities=26% Similarity=0.345 Sum_probs=201.4
Q ss_pred HHHhhcccCCCCceEEEEEEE----cCCcEEEEEEccCcc----chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCee
Q 008707 236 TNNFCKKIGKGSFGSVYYGKM----KDGKEVAVKIMADSC----SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~ 306 (557)
.|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+++++.+ +||||+++++++...+..
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 134 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 134 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence 456789999999999999987 368999999986432 12345577899999999 699999999999999999
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 135 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999974 3468999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCccCCcccCC--CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~--~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..............
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~--- 283 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSEP--- 283 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHCCC---
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhccCC---
Confidence 65443333444569999999999986 357889999999999999999999997443322 22222222221110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 506 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 506 (557)
..+......+.+++.+||..||++|| +++|+++.
T Consensus 284 --------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 284 --------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp --------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --------CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11112234678999999999999999 99999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=352.11 Aligned_cols=251 Identities=25% Similarity=0.314 Sum_probs=203.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
+++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 344688999999999999876 68999999986432 22345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
++||+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++........
T Consensus 266 ~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~ 341 (576)
T 2acx_A 266 MNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 341 (576)
T ss_dssp CCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred CCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCcc
Confidence 9999999998753 23458999999999999999999998 9999999999999999999999999999987654322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... +...+.....
T Consensus 342 --~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~-i~~~i~~~~~---------- 406 (576)
T 2acx_A 342 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REE-VERLVKEVPE---------- 406 (576)
T ss_dssp --EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHH-HHHHHHHCCC----------
T ss_pred --ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHH-HHHHhhcccc----------
Confidence 2234699999999999999999999999999999999999999985433211 111 1122222111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 506 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 506 (557)
.++......+.+++.+||+.||++|| +++||++.
T Consensus 407 ~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 11111234788999999999999999 78888753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=333.91 Aligned_cols=246 Identities=24% Similarity=0.354 Sum_probs=202.1
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
.|.+.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 121 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence 3456789999999999999876 47899999986432 2345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++++|.+++.. ...+++..++.++.||++||+|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 122 ~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 122 LCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp CCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999998874 3568999999999999999999998 999999999999999999999999999998764332
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... .... +..+.. .+.
T Consensus 196 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~-~~~~~~------~~~ 261 (335)
T 2owb_A 196 ER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------TYLR-IKKNEY------SIP 261 (335)
T ss_dssp CC-BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH-HHHTCC------CCC
T ss_pred cc-ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------HHHH-HhcCCC------CCC
Confidence 22 233458999999999999899999999999999999999999997443211 1111 111111 011
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.. ....+.+++.+||+.||++|||++|+++
T Consensus 262 ~~----~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 262 KH----INPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp TT----SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 1236789999999999999999999986
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=335.93 Aligned_cols=245 Identities=22% Similarity=0.319 Sum_probs=188.6
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEe----cCeeEEEEEecC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRILVYEYMH 314 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~----~~~~~lv~e~~~ 314 (557)
+.||+|+||.||+|.+. +++.||||++... ..+.+|++++.++ +||||+++++++.. ....++||||++
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~ 142 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 142 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCC
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCC
Confidence 68999999999999876 5889999998632 4566888887554 89999999999875 567899999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC---CCcEEEecccCccccCCCC
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~ 391 (557)
+|+|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 143 gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 143 GGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp SEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 99999999753 23468999999999999999999998 99999999999999997 7889999999998764332
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcccc-ccHHHHHHHHHhcCCccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE-LNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ..... .+..+.... ..+ .
T Consensus 219 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~i~~~~~~~-~~~-~ 290 (400)
T 1nxk_A 219 S--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQYEF-PNP-E 290 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH----HHHHTCCCC-CTT-T
T ss_pred c--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH----HHHcCcccC-CCc-c
Confidence 2 2234589999999999999999999999999999999999999975443221 11111 122222110 000 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.. .....+.+++.+||+.||++|||+.||++.
T Consensus 291 ~~----~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 291 WS----EVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01 123468899999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=335.46 Aligned_cols=262 Identities=23% Similarity=0.339 Sum_probs=197.6
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
.|++.+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 3556789999999999999876 489999998864432 3345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++. ....+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 106 ~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 106 VDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp CSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred CCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence 99999988765 34568999999999999999999998 9999999999999999999999999999987544322
Q ss_pred cccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHH----------HHHhcCC
Q 008707 393 HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR----------SMIKKGD 461 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~----------~~~~~~~ 461 (557)
. .....|++.|+|||.+.+. .++.++||||||+++|+|++|+.||........ +..... .......
T Consensus 180 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 180 V-YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHHCG
T ss_pred c-cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhhHhhhcc
Confidence 2 2234589999999999775 789999999999999999999999985443211 111110 0011111
Q ss_pred c-cccccccccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 462 V-ISIVDPVLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 462 ~-~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
. .....+.+..... ...+..+.+++.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0 0001111111111 1224578899999999999999999999863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-40 Score=345.49 Aligned_cols=260 Identities=22% Similarity=0.278 Sum_probs=193.2
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEec------Cee
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 306 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~------~~~ 306 (557)
.|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 3556789999999999999865 5889999998754 233456788999999999999999999999654 357
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++.
T Consensus 143 ~lv~E~~~~-~l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEECCSE-EHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred EEEEeCCCC-CHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 999999965 5666664 238899999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHH-H--------------
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV-H-------------- 451 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~-~-------------- 451 (557)
...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+ +
T Consensus 214 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---CCC--C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCCcc--cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 654322 23346899999999999999999999999999999999999999865532211100 0
Q ss_pred -HHHHHHhcCCc------cccccccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 452 -WARSMIKKGDV------ISIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 452 -~~~~~~~~~~~------~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.....+..... ...+...+.... .......+.+++.+||..||++|||++|+++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00011111000 000000000000 11224578999999999999999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=338.52 Aligned_cols=262 Identities=25% Similarity=0.338 Sum_probs=189.5
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcC-CCCccceeeEEEecC--eeE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEH--QRI 307 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~--~~~ 307 (557)
...|++.+.||+|+||.||+|.+. +|+.||+|++... .....+.+.+|+.+++.+. ||||+++++++...+ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 345667899999999999999875 6899999998643 2344567889999999997 999999999997544 689
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+||||++ ++|.+++.. ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++..
T Consensus 88 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 159 (388)
T 3oz6_A 88 LVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF 159 (388)
T ss_dssp EEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred EEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence 9999996 689988873 468899999999999999999999 99999999999999999999999999999865
Q ss_pred CCCC--------------------ccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCcccc
Q 008707 388 EEDL--------------------THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 446 (557)
Q Consensus 388 ~~~~--------------------~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~ 446 (557)
.... ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 239 (388)
T 3oz6_A 160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ 239 (388)
T ss_dssp SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 3211 111223468999999999976 6789999999999999999999999986543221
Q ss_pred ccHHHHHHHHHhcCCcccc---cc-----------------ccccCCCC-------------HHHHHHHHHHHHHccccC
Q 008707 447 LNIVHWARSMIKKGDVISI---VD-----------------PVLIGNVK-------------IESIWRIAEVAIQCVEQR 493 (557)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~---~d-----------------~~l~~~~~-------------~~~~~~l~~li~~cl~~~ 493 (557)
. ..+...+..-..... .. ........ ......+.+++.+||+.|
T Consensus 240 ~---~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 240 L---ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp H---HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred H---HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 1 111111110000000 00 00000000 011236889999999999
Q ss_pred CCCCCCHHHHHHH
Q 008707 494 GFSRPKMQEIVLA 506 (557)
Q Consensus 494 P~~RPt~~evl~~ 506 (557)
|++|||++|+++.
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999875
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=321.12 Aligned_cols=244 Identities=29% Similarity=0.434 Sum_probs=195.0
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEe----cCeeEEEE
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVY 310 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----~~~~~lv~ 310 (557)
++.+.||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.+++.++||||+++++++.. ....++||
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence 45678999999999999875 5788999988643 23455778999999999999999999998865 35689999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCC--eEeeccCCCCEEeC-CCCcEEEecccCcccc
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLD-INMRAKVSDFGLSRQA 387 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~--ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~ 387 (557)
||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+ ++||||||+||+++ .++.+||+|||++...
T Consensus 109 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 99999999999974 3568899999999999999999998 77 99999999999998 7899999999999765
Q ss_pred CCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
.... .....|++.|+|||.+.+ .++.++||||||+++|+|++|+.||...... ... ...+..+......+
T Consensus 183 ~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~-~~~~~~~~~~~~~~ 252 (290)
T 1t4h_A 183 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQI-YRRVTSGVKPASFD 252 (290)
T ss_dssp CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHH-HHHHTTTCCCGGGG
T ss_pred cccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHH-HHHHhccCCccccC
Confidence 4332 223458999999998875 5899999999999999999999999743221 111 11222222111111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
. . ....+.+++.+||+.||.+|||++|+++
T Consensus 253 ~----~----~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 253 K----V----AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp G----C----CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C----C----CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 1 1236889999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=337.35 Aligned_cols=259 Identities=21% Similarity=0.317 Sum_probs=192.7
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccch-hHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 445789999999999999876 6899999998643222 12245579999999999999999999999999999999996
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
|+|.+++... ...+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++.........
T Consensus 84 -~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~- 156 (324)
T 3mtl_A 84 -KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 156 (324)
T ss_dssp -EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred -cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCccc-
Confidence 5898888753 4568999999999999999999998 99999999999999999999999999999865433222
Q ss_pred cccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc---cccc---
Q 008707 395 SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI---SIVD--- 467 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~d--- 467 (557)
.....||+.|+|||.+.+ ..++.++||||+|+++|+|++|+.||.+.+..+ ....+.......... ....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcchh
Confidence 223357999999999876 578999999999999999999999998544322 122222222111100 0000
Q ss_pred ------ccccCC----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 468 ------PVLIGN----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 468 ------~~l~~~----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+..... ........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000 00112346789999999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=335.32 Aligned_cols=259 Identities=19% Similarity=0.253 Sum_probs=190.5
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
.|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 35 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 4566899999999999999865 688999999865432 2245678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC-----CCCcEEEecccCcccc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-----INMRAKVSDFGLSRQA 387 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~-----~~~~~kl~Dfgla~~~ 387 (557)
++ |+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||++...
T Consensus 115 ~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 115 AE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp CS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred CC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 97 599999874 4568999999999999999999999 9999999999999994 4556999999999876
Q ss_pred CCCCccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
...... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+. +.. ..............
T Consensus 188 ~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~-~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 188 GIPIRQ-FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFK-IFEVLGLPDDTTWP 263 (329)
T ss_dssp C------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCCTTTST
T ss_pred CCcccc-cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHH-HHHHhCCCchhhhh
Confidence 533222 2233479999999999874 589999999999999999999999975432211 111 11111110000000
Q ss_pred -----------cccccCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 467 -----------DPVLIGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 467 -----------d~~l~~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+...... .......+.+++.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000000 0012346789999999999999999999985
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=330.96 Aligned_cols=256 Identities=22% Similarity=0.276 Sum_probs=200.9
Q ss_pred HHHHHHHHhh-cccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCe
Q 008707 231 ELEEATNNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 305 (557)
Q Consensus 231 ~~~~~~~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~ 305 (557)
+.....|.+. +.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.+ .||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3344455554 88999999999999876 58999999987543 23356788999999999 57999999999999999
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC---CCcEEEeccc
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFG 382 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfg 382 (557)
.++||||+++|+|.+++... ....+++..++.++.|++.||+|||+ .|++||||||+||+++. ++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 99999999999999998643 34678999999999999999999998 99999999999999987 7899999999
Q ss_pred CccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 383 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 383 la~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
++........ .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.... ... +.....
T Consensus 180 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~-i~~~~~ 250 (327)
T 3lm5_A 180 MSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET------YLN-ISQVNV 250 (327)
T ss_dssp GCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHH-HHHTCC
T ss_pred cccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH------HHH-HHhccc
Confidence 9987654322 2234589999999999999999999999999999999999999975432211 111 111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 463 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 463 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
. ............+.+++.+||+.||++|||++|+++
T Consensus 251 ~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 251 D------YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp C------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c------cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 0 001111122346889999999999999999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=326.37 Aligned_cols=246 Identities=28% Similarity=0.420 Sum_probs=203.0
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 456789999999999999865 68899999986543 3445789999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|.+++. ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.........
T Consensus 104 ~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 175 (303)
T 3a7i_A 104 GGSALDLLE----PGPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK- 175 (303)
T ss_dssp TEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC-
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccccc-
Confidence 999999986 3568999999999999999999998 99999999999999999999999999999876543222
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... . ...+..+... .+...+
T Consensus 176 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~----~~~~~~~~~~-----~~~~~~ 243 (303)
T 3a7i_A 176 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---V----LFLIPKNNPP-----TLEGNY 243 (303)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H----HHHHHHSCCC-----CCCSSC
T ss_pred cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---H----HHHhhcCCCC-----CCcccc
Confidence 233458999999999999999999999999999999999999997432211 1 1112222211 111222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+..+.+++.+||+.+|++|||+.||++.
T Consensus 244 ----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 244 ----SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 2368899999999999999999999874
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=332.30 Aligned_cols=253 Identities=16% Similarity=0.162 Sum_probs=203.6
Q ss_pred HHHHhhcccCCCCceEEEEEE------EcCCcEEEEEEccCccchhHHHHHHHHHHHhhcC---CCCccceeeEEEecCe
Q 008707 235 ATNNFCKKIGKGSFGSVYYGK------MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQ 305 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~~~~~~~~~~~ 305 (557)
..|.+.+.||+|+||.||+|. ..+++.||+|++.... ...+..|+++++.++ |+||+.+++++...+.
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~ 141 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG 141 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSC
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCC
Confidence 345567899999999999994 4468899999987543 446777888888886 9999999999999999
Q ss_pred eEEEEEecCCCChhhhhhccC--CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC-----------
Q 008707 306 RILVYEYMHNGTLRDRLHGSV--NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI----------- 372 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~----------- 372 (557)
.++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ .+|+||||||+|||++.
T Consensus 142 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~ 218 (365)
T 3e7e_A 142 SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDL 218 (365)
T ss_dssp EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------
T ss_pred cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccc
Confidence 999999999999999997432 35679999999999999999999998 99999999999999998
Q ss_pred CCcEEEecccCccccCCC-CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHH
Q 008707 373 NMRAKVSDFGLSRQAEED-LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 451 (557)
Q Consensus 373 ~~~~kl~Dfgla~~~~~~-~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~ 451 (557)
++.+||+|||+++..... .........||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 219 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----- 293 (365)
T 3e7e_A 219 SAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----- 293 (365)
T ss_dssp CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-----
T ss_pred cCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-----
Confidence 899999999999764321 12223345699999999999999999999999999999999999999963322110
Q ss_pred HHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHhhhhhh
Q 008707 452 WARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR-PKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 452 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~R-Pt~~evl~~L~~~~~~~ 514 (557)
.+...+.... ....+.+++.+|++.+|.+| |+++++.+.|++.....
T Consensus 294 -------------~~~~~~~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 294 -------------KPEGLFRRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -------------EECSCCTTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------------eechhccccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0111111111 13467799999999999998 58999999999888754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=340.30 Aligned_cols=261 Identities=21% Similarity=0.295 Sum_probs=205.8
Q ss_pred HHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCccchhHHHHHHHHHHHhhcCC-CCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
|++.+.||+|+||.||+|.+ .+++.||||++..... .+.+.+|+++++.++| ++|..+..++...+..++||||+
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~- 85 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL- 85 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-
Confidence 45678999999999999986 4689999998764322 2357889999999976 55666666677788889999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe---CCCCcEEEecccCccccCCCC
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~~~~~~~ 391 (557)
+++|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||| +.++.+||+|||+++......
T Consensus 86 g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 86 GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 99999999743 4569999999999999999999998 999999999999999 588999999999998765433
Q ss_pred cc------ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 392 TH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 392 ~~------~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+...........+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 21 122456899999999999999999999999999999999999999865443322222222211111111111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
...+ +.++.+++.+||+.+|++||++++|+++|+++....
T Consensus 241 -----~~~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 241 -----CRGY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp -----HTTS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -----hcCC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 1111 347889999999999999999999999999987644
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=324.14 Aligned_cols=245 Identities=21% Similarity=0.291 Sum_probs=198.1
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv 309 (557)
...|++.+.||+|+||.||+|... +++.||+|++... .......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 355667899999999999999886 6899999998753 233456788999999999 899999999999999999999
Q ss_pred EEecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC---------------
Q 008707 310 YEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN--------------- 373 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~--------------- 373 (557)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+ ++++||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997532 12568999999999999999999998 999999999999999844
Q ss_pred ----CcEEEecccCccccCCCCccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCcccccc
Q 008707 374 ----MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 448 (557)
Q Consensus 374 ----~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~ 448 (557)
..+||+|||.+....... ...||+.|+|||.+.+. .++.++||||||+++|+|++|..|+...+
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 479999999998765432 23489999999999776 66789999999999999999998775221
Q ss_pred HHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 449 IVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 449 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
. ...+..+..... ... .+..+.+++.+||+.||++|||+.|+++
T Consensus 236 ~----~~~~~~~~~~~~-----~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 Q----WHEIRQGRLPRI-----PQV----LSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp H----HHHHHTTCCCCC-----SSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H----HHHHHcCCCCCC-----Ccc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1 111222222111 111 2346889999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=324.03 Aligned_cols=259 Identities=27% Similarity=0.402 Sum_probs=196.9
Q ss_pred HHHHhhcccCCCCceEEEEEEEc--CCc--EEEEEEccCc---cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK--DGK--EVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
..|++.+.||+|+||.||+|.+. +++ .||+|++... .....+.+.+|+++++.++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 34567899999999999999864 233 6899988653 2344577899999999999999999999998765 88
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+||||+++++|.+++... ...+++..+..++.|+++||+|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 97 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 999999999999998753 3568899999999999999999998 99999999999999999999999999999876
Q ss_pred CCCCcc--ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 388 EEDLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 388 ~~~~~~--~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+.. +........+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~~~ 245 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERLP 245 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCCCCC
Confidence 543321 1223347788999999988889999999999999999999 99999744321 11222222111111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
.....+..+.+++.+||+.+|++|||+.++++.|+++....
T Consensus 246 ---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 286 (291)
T 1u46_A 246 ---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286 (291)
T ss_dssp ---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ---------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence 11122347889999999999999999999999999887643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=325.65 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=200.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEe--cCeeEEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYE 311 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~lv~e 311 (557)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+ ....++|||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence 456789999999999999876 68999999986532 3445678999999999999999999998754 568899999
Q ss_pred ecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCC-----eEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 312 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG-----IIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~-----ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
|+++++|.+++.... ....+++..++.++.|++.||+|||+ .+ ++||||||+||+++.++.+||+|||++.
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp CCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred CCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999987532 34458999999999999999999998 77 9999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 386 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 386 ~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
........ .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.. + ....+..+.....
T Consensus 165 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~i~~~~~~~~ 236 (279)
T 2w5a_A 165 ILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------E-LAGKIREGKFRRI 236 (279)
T ss_dssp HC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHTCCCCC
T ss_pred eecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------H-HHHHHhhcccccC
Confidence 76543221 22335899999999999989999999999999999999999999744321 1 1222333332211
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAI 507 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L 507 (557)
+...+..+.+++.+||+.+|++|||++||++.+
T Consensus 237 ---------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 237 ---------PYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp ---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred ---------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 112234788999999999999999999998754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=341.48 Aligned_cols=253 Identities=25% Similarity=0.353 Sum_probs=191.5
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--------hhHHHHHHHHHHHhhcCCCCccceeeEEEe
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEE 302 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 302 (557)
.....|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 33456677899999999999999875 579999999864311 112347899999999999999999999864
Q ss_pred cCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC---cEEEe
Q 008707 303 EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAKVS 379 (557)
Q Consensus 303 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~---~~kl~ 379 (557)
+..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred -CceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEe
Confidence 457999999999999998873 4678999999999999999999998 9999999999999997544 59999
Q ss_pred cccCccccCCCCccccccccCCCCccCCcccCC---CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 008707 380 DFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 456 (557)
Q Consensus 380 Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~---~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~ 456 (557)
|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...... ..+.. .
T Consensus 285 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~----~ 356 (419)
T 3i6u_A 285 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKD----Q 356 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHH----H
T ss_pred ecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHH----H
Confidence 999998765432 2234568999999999853 57788999999999999999999999743322 12221 2
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 457 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 457 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+..+..... +..... ....+.+++.+||+.||++|||++|+++
T Consensus 357 i~~~~~~~~--~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYNFI--PEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCCCC--HHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCCC--chhhcc----cCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 222221110 000111 2346889999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.57 Aligned_cols=261 Identities=19% Similarity=0.252 Sum_probs=196.7
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEe--------cC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------EH 304 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--------~~ 304 (557)
.|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+++++.++||||+++++++.. .+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 97 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 97 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------C
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCc
Confidence 4566799999999999999874 689999998854322 234578899999999999999999999877 44
Q ss_pred eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCc
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 384 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 384 (557)
..++||||+++ +|.+.+... ...+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++
T Consensus 98 ~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 98 SIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp EEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 68999999974 777777643 3568999999999999999999998 99999999999999999999999999999
Q ss_pred cccCCCC---ccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 008707 385 RQAEEDL---THISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 460 (557)
Q Consensus 385 ~~~~~~~---~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 460 (557)
....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+......-
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~ 248 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCGSI 248 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCC
Confidence 8764322 112233458999999999876 4679999999999999999999999985443221 11112211111
Q ss_pred Cccc---c-----ccc---cccCCCCH-H------HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 461 DVIS---I-----VDP---VLIGNVKI-E------SIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 461 ~~~~---~-----~d~---~l~~~~~~-~------~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.... . .+. ........ . ....+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 0000 0 000 00000011 1 1235789999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=321.79 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=193.5
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
.|.+.+.||+|+||.||+|.+. +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 3456789999999999999886 68999999986432 1234578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 92 YVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp CCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred ccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999974 3468999999999999999999998 999999999999999999999999999998765432
Q ss_pred ccccccccCCCCccCCcccCCCCC-CcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~-s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
. .....+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...... . ....+..+... +
T Consensus 166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~------~ 230 (276)
T 2h6d_A 166 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------T-LFKKIRGGVFY------I 230 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCC------C
T ss_pred c--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------H-HHHHhhcCccc------C
Confidence 2 223358999999999988765 68999999999999999999999743321 1 11122222110 0
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+......+.+++.+||+.||++|||+.|+++.
T Consensus 231 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 231 ----PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11122368899999999999999999999873
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=347.88 Aligned_cols=255 Identities=27% Similarity=0.396 Sum_probs=200.7
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
...|++.+.||+|+||.||+|... ++..||+|++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456778999999999999999876 68899999987542 233567889999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC---CcEEEecccCcccc
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLSRQA 387 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla~~~ 387 (557)
||+++|+|.+.+.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.. +.+||+|||++...
T Consensus 116 e~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999998874 3568999999999999999999998 999999999999999764 45999999999876
Q ss_pred CCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
..... .....||+.|+|||++.+ .++.++||||+||++|+|++|..||....... +...+..+.... +
T Consensus 190 ~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~--~ 257 (494)
T 3lij_A 190 ENQKK--MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVEKGKYTF--D 257 (494)
T ss_dssp BTTBC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC--C
T ss_pred CCCcc--ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC--C
Confidence 54322 233458999999999874 68999999999999999999999997543221 112222222211 1
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhh
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDS 510 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~ 510 (557)
...... .+..+.+++.+||+.+|++|||+.|+++. +++.
T Consensus 258 ~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 258 SPEWKN----VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp SGGGTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred chhccc----CCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 111111 22368899999999999999999999864 4443
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=330.82 Aligned_cols=262 Identities=20% Similarity=0.213 Sum_probs=196.7
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccch-----hHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
..|++.+.||+|+||.||+|.+. +|+.||+|++...... ..+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 45677899999999999999876 5899999998643221 12467899999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||+++ +|.+++.. ....+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 90 v~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp EEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred EEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 9999975 88888864 24568888999999999999999998 999999999999999999999999999998765
Q ss_pred CCCccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
..... .....||+.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+.... +.. +.............+
T Consensus 164 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~-i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 164 SPNRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTR-IFETLGTPTEEQWPD 239 (346)
T ss_dssp SCCCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCCTTTSSS
T ss_pred CCccc-CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHHcCCCChhhhhh
Confidence 43222 2234589999999998664 588999999999999999999999975432211 111 111111111000000
Q ss_pred ------c---cccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 468 ------P---VLIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 468 ------~---~l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
. ......+ ......+.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 0000001 1123578899999999999999999999874
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=345.85 Aligned_cols=249 Identities=23% Similarity=0.317 Sum_probs=200.8
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
.+.||+|+||.||+|..+ +|+.||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++||||++|
T Consensus 190 ~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~g 269 (543)
T 3c4z_A 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269 (543)
T ss_dssp EEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred EEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccC
Confidence 467999999999999886 58999999986532 12346788999999999999999999999999999999999999
Q ss_pred CChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 316 GTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 316 gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
|+|.+++.... ....+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++.........
T Consensus 270 g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~- 345 (543)
T 3c4z_A 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK- 345 (543)
T ss_dssp CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC-
T ss_pred CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc-
Confidence 99999987542 24569999999999999999999998 99999999999999999999999999999876543322
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+.... +..+.. .+
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~~~-i~~~~~----------~~ 412 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQR-VLEQAV----------TY 412 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHHHH-HHHCCC----------CC
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHHHH-Hhhccc----------CC
Confidence 233469999999999999999999999999999999999999997543221 11222222 212111 01
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 505 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~-----~evl~ 505 (557)
+...+..+.+++.+||+.||++||++ +||++
T Consensus 413 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 413 PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 11223478899999999999999975 56653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.51 Aligned_cols=250 Identities=20% Similarity=0.353 Sum_probs=196.4
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+++++.++||||+++++++...+..++||||++
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 3556789999999999999886 588999999876655566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+++|.+++... ...+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........ .
T Consensus 100 ~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 173 (302)
T 2j7t_A 100 GGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ-K 173 (302)
T ss_dssp TEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH-C
T ss_pred CCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc-c
Confidence 99999988643 4568999999999999999999998 9999999999999999999999999998764322111 1
Q ss_pred cccccCCCCccCCccc-----CCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccc
Q 008707 395 SSVARGTVGYLDPEYY-----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l-----~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 469 (557)
.....|++.|+|||.+ .+..++.++||||||+++|+|++|+.||...+.. ....... .+.......
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~~~~~-- 244 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIA-KSDPPTLLT-- 244 (302)
T ss_dssp -----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHH-HSCCCCCSS--
T ss_pred cccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHh-ccCCcccCC--
Confidence 1223589999999998 4667889999999999999999999999743321 1111111 121111111
Q ss_pred ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 470 l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+...+..+.+++.+||+.||++|||+.|+++
T Consensus 245 -----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 -----PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -----GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -----ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1112346889999999999999999999974
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=322.87 Aligned_cols=250 Identities=26% Similarity=0.360 Sum_probs=198.7
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
...|++.+.||+|+||.||+|... +|+.||+|++.... ..+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 344566789999999999999876 58999999986532 346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++++|.+++... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 106 ~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 106 CGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 9999999998642 4568999999999999999999998 9999999999999999999999999999987654322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....... ... .+..+.......
T Consensus 181 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~-~~~~~~~~~~~~----- 247 (314)
T 3com_A 181 K-RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIF-MIPTNPPPTFRK----- 247 (314)
T ss_dssp C-BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH-HHHHSCCCCCSS-----
T ss_pred c-cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHH-HHhcCCCcccCC-----
Confidence 2 223458999999999999999999999999999999999999997433211 111 111111111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
....+..+.+++.+||..||++|||+.|+++
T Consensus 248 --~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 248 --PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp --GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1112347889999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=343.06 Aligned_cols=251 Identities=26% Similarity=0.347 Sum_probs=201.9
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
...|++.+.||+|+||+||+|... +++.||+|++.... ......+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 466788999999999999999876 68999999985432 234567899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC---CCCcEEEecccCcccc
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQA 387 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~ 387 (557)
||+.+|+|.+.+.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||++...
T Consensus 101 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999998874 3568999999999999999999998 9999999999999995 4567999999999876
Q ss_pred CCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
..... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+..... . ...+..+.......
T Consensus 175 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~-~~~i~~~~~~~~~~ 244 (486)
T 3mwu_A 175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------I-LKRVETGKYAFDLP 244 (486)
T ss_dssp CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-HHHHHHTCCCSCSG
T ss_pred CCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H-HHHHHhCCCCCCCc
Confidence 54322 223458999999999976 58999999999999999999999997543211 1 12222222211000
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.. ......+.+++.+||+.+|++|||+.|+++.
T Consensus 245 --~~----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 245 --QW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp --GG----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred --cc----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 1123468899999999999999999999874
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=322.39 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=195.5
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc----chhHHHHHHHHHHHhhcCCCCccceeeEEE--ecCeeEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHHRNLVPLIGYCE--EEHQRILV 309 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~nIv~~~~~~~--~~~~~~lv 309 (557)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++. +....++|
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 456789999999999999875 58899999986532 234567899999999999999999999984 45578999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+.++ |.+.+... ....+++..+..++.||+.||+|||+ ++++||||||+||+++.++.+||+|||++.....
T Consensus 87 ~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred ehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 9999876 77777644 35678999999999999999999998 9999999999999999999999999999987643
Q ss_pred CC-ccccccccCCCCccCCcccCCCC--CCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 390 DL-THISSVARGTVGYLDPEYYGNQQ--LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 390 ~~-~~~~~~~~g~~~y~aPE~l~~~~--~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
.. ........|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+.. .. ...+..+...
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~-~~~i~~~~~~--- 231 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KL-FENIGKGSYA--- 231 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HH-HHHHHHCCCC---
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HH-HHHHhcCCCC---
Confidence 22 22223445899999999997654 377999999999999999999999744321 11 1222222211
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+... ....+.+++.+||+.||++|||++|+++.
T Consensus 232 ---~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 232 ---IPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---CCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---CCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111 23367899999999999999999999964
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=330.80 Aligned_cols=249 Identities=26% Similarity=0.366 Sum_probs=199.0
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--------hhHHHHHHHHHHHhhc-CCCCccceeeEEEecCe
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQ 305 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~ 305 (557)
.|++.+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 174 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence 3445689999999999999986 699999999865321 1245678999999999 79999999999999999
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+ .|++|+||||+||+++.++.+||+|||++.
T Consensus 175 ~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 175 MFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp EEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 9999999999999999874 3568999999999999999999998 999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCccCCcccC------CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc
Q 008707 386 QAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 459 (557)
Q Consensus 386 ~~~~~~~~~~~~~~g~~~y~aPE~l~------~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 459 (557)
....... .....||+.|+|||++. ...++.++||||||+++|+|++|..||....... . ...+..
T Consensus 249 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~----~~~i~~ 319 (365)
T 2y7j_A 249 HLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---M----LRMIME 319 (365)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---H----HHHHHH
T ss_pred ccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---H----HHHHHh
Confidence 7654322 22345899999999985 3367889999999999999999999997432211 1 111222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 460 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 460 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+..... .+ .... .+..+.+++.+||+.||++|||+.|+++
T Consensus 320 ~~~~~~-~~-~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 320 GQYQFS-SP-EWDD----RSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp TCCCCC-HH-HHSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCC-Cc-cccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 211100 00 0011 1236889999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.78 Aligned_cols=191 Identities=26% Similarity=0.389 Sum_probs=152.1
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEe-----cCeeE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-----EHQRI 307 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-----~~~~~ 307 (557)
.|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++.++||||+++++++.. ....+
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 4567899999999999999866 68999999986532 3345678999999999999999999999843 35689
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+|||++ +++|.+++. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 134 lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 999998 579999887 34679999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcc--------------------------ccccccCCCCccCCccc-CCCCCCcccceehhHHHHHHHHh
Q 008707 388 EEDLTH--------------------------ISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELIS 433 (557)
Q Consensus 388 ~~~~~~--------------------------~~~~~~g~~~y~aPE~l-~~~~~s~~~DvwslG~ll~ellt 433 (557)
...... ......||+.|+|||++ ....++.++|||||||++|||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 432110 12234579999999976 56679999999999999999999
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=335.31 Aligned_cols=268 Identities=22% Similarity=0.274 Sum_probs=205.0
Q ss_pred ChhHHHHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcC--------CCCccceee
Q 008707 228 PLPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--------HRNLVPLIG 298 (557)
Q Consensus 228 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--------h~nIv~~~~ 298 (557)
...++....|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+++++.++ |+||+++++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~ 108 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD 108 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEE
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeec
Confidence 334444456778899999999999999865 5889999998754 344567889999999996 788999999
Q ss_pred EEE----ecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCC-CeEeeccCCCCEEeCCC
Q 008707 299 YCE----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDIN 373 (557)
Q Consensus 299 ~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~ivH~dlk~~NIll~~~ 373 (557)
++. +....++||||+ +++|.+.+... ....+++..++.++.||+.||+|||+ + ||+||||||+|||++.+
T Consensus 109 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~ 183 (397)
T 1wak_A 109 DFKISGVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVN 183 (397)
T ss_dssp EEEEEETTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCC
T ss_pred ceeecCCCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEecc
Confidence 987 556789999999 66776666543 23568999999999999999999998 7 99999999999999977
Q ss_pred C-------------------------------------------------cEEEecccCccccCCCCccccccccCCCCc
Q 008707 374 M-------------------------------------------------RAKVSDFGLSRQAEEDLTHISSVARGTVGY 404 (557)
Q Consensus 374 ~-------------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y 404 (557)
+ .+||+|||++....... ....||+.|
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----~~~~gt~~y 259 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----TEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----CSCCSCGGG
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----ccCCCCCcc
Confidence 5 79999999998765432 223589999
Q ss_pred cCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcccccc---HHHHHHHHHhc--------CCcc-cccccc---
Q 008707 405 LDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN---IVHWARSMIKK--------GDVI-SIVDPV--- 469 (557)
Q Consensus 405 ~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~---~~~~~~~~~~~--------~~~~-~~~d~~--- 469 (557)
+|||++.+..++.++|||||||++|||+||+.||...+...... ........... +... ..+...
T Consensus 260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 339 (397)
T 1wak_A 260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL 339 (397)
T ss_dssp CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence 99999999999999999999999999999999998554432221 11111111111 1000 000000
Q ss_pred --------------c--cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 470 --------------L--IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 470 --------------l--~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+ ...........+.+++.+||+.||++|||++|+++
T Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 01234566778999999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.72 Aligned_cols=261 Identities=22% Similarity=0.296 Sum_probs=194.5
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecC------ee
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 306 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~------~~ 306 (557)
.|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++.... ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 3556789999999999999875 68999999985432 234567889999999999999999999997653 45
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++||||+ +++|.+++.. ..+++..+..++.||+.||+|||+ .||+||||||+||+++.++.+||+|||+++.
T Consensus 106 ~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp EEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 9999999 8899999874 458899999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC----
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD---- 461 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---- 461 (557)
..... ....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+... .+......-.
T Consensus 178 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~---~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 178 ADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK---EIMKVTGTPPAEFV 250 (367)
T ss_dssp CCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCHHHH
T ss_pred ccccc----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCCHHHH
Confidence 65432 23458999999999877 688999999999999999999999998654322111 1111100000
Q ss_pred --------------ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhhh
Q 008707 462 --------------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 512 (557)
Q Consensus 462 --------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~~~ 512 (557)
........+ ..........+.+++.+||..||++|||++|+++. +++...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 000000000 01111223468899999999999999999999883 544433
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=344.44 Aligned_cols=252 Identities=27% Similarity=0.359 Sum_probs=205.1
Q ss_pred HHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 233 EEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 233 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
....|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4567788899999999999999876 68999999985432 3346779999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe---CCCCcEEEecccCcc
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL---DINMRAKVSDFGLSR 385 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll---~~~~~~kl~Dfgla~ 385 (557)
||||+.+|+|.+.+.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||+ +.++.+||+|||++.
T Consensus 104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 9999999999998873 4668999999999999999999998 999999999999999 567889999999998
Q ss_pred ccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 386 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 386 ~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
....... .....||+.|+|||++.+ .++.++||||+||++|+|++|..||...+... ....+..+.....
T Consensus 178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKYTFE 247 (484)
T ss_dssp HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCCC
T ss_pred Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCCCC
Confidence 7654332 223458999999999876 68999999999999999999999997543211 1122223322110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.. ... ..+..+.+++.+||+.+|++|||+.|+++.
T Consensus 248 ~~--~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 LP--QWK----KVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp SG--GGG----GSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Cc--ccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 00 001 123468899999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=326.29 Aligned_cols=256 Identities=20% Similarity=0.293 Sum_probs=196.7
Q ss_pred HHHHhhcccCCCCceEEEEEEE-cCCcEEEEEEccCccchhHHHHHHHHHHHhhcC-CCCccceeeEEEe--cCeeEEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKM-KDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEE--EHQRILVY 310 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~--~~~~~lv~ 310 (557)
..|++.+.||+|+||.||+|.. .+++.||+|++... ..+.+.+|+++++.++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 3456789999999999999986 46899999998743 3467889999999997 9999999999987 66789999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC-cEEEecccCccccCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEE 389 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~ 389 (557)
||+.+++|.+++. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||++.....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999875 27888999999999999999998 9999999999999999776 899999999987654
Q ss_pred CCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHH--------HHHhcC
Q 008707 390 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR--------SMIKKG 460 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~~~ 460 (557)
... .....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ..+..... ..+...
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHHHHHHHhcCCchhhhHHHHh
Confidence 332 223458999999999877 678999999999999999999999995332211 11111100 111111
Q ss_pred Ccc--------------ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 461 DVI--------------SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 461 ~~~--------------~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
... ..................+.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 000000011111113457889999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=336.68 Aligned_cols=197 Identities=25% Similarity=0.352 Sum_probs=164.5
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEec-----CeeE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRI 307 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----~~~~ 307 (557)
.|++.+.||+|+||.||+|.+. +++.||||++.... ....+.+.+|+++++.++||||+++++++... ...+
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 4556799999999999999876 57899999987532 33456789999999999999999999998765 5689
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+||||+. ++|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 107 lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 9999985 699999873 4669999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCcc---------------------ccccccCCCCccCCccc-CCCCCCcccceehhHHHHHHHHhCCCCCC
Q 008707 388 EEDLTH---------------------ISSVARGTVGYLDPEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVS 439 (557)
Q Consensus 388 ~~~~~~---------------------~~~~~~g~~~y~aPE~l-~~~~~s~~~DvwslG~ll~elltg~~pf~ 439 (557)
...... ......||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 433211 12345689999999986 56679999999999999999998655554
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-41 Score=344.10 Aligned_cols=246 Identities=15% Similarity=0.147 Sum_probs=188.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc---cchhHHHHHHHHHH---HhhcCCCCcccee-------eEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS---CSHRTQQFVTEVAL---LSRIHHRNLVPLI-------GYCEE 302 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~i---l~~l~h~nIv~~~-------~~~~~ 302 (557)
|++.+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+++ ++.++||||++++ +++.+
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 345789999999999999864 6899999998632 33455788999954 5555799999998 66655
Q ss_pred cC-----------------eeEEEEEecCCCChhhhhhccC----CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEee
Q 008707 303 EH-----------------QRILVYEYMHNGTLRDRLHGSV----NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHR 361 (557)
Q Consensus 303 ~~-----------------~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~ 361 (557)
.+ ..++||||+ +|+|.+++.... ....+++..++.++.||+.||+|||+ .+|+||
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHr 230 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHT 230 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECS
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence 43 278999999 689999997531 12234468888999999999999999 999999
Q ss_pred ccCCCCEEeCCCCcEEEecccCccccCCCCccccccccCCCCccCCcccCCC-----------CCCcccceehhHHHHHH
Q 008707 362 DVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-----------QLTEKSDVYSFGVVLLE 430 (557)
Q Consensus 362 dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~-----------~~s~~~DvwslG~ll~e 430 (557)
||||+|||++.++.+||+|||+++..... .....| +.|+|||++.+. .++.++|||||||++||
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e 305 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGAR----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTCE----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCCc----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence 99999999999999999999999864331 223457 999999999877 89999999999999999
Q ss_pred HHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHH
Q 008707 431 LISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQ 508 (557)
Q Consensus 431 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~ 508 (557)
|++|+.||.......... .... ..... +..+.+++.+||+.||++|||+.|+++ .++
T Consensus 306 lltg~~Pf~~~~~~~~~~---------------~~~~--~~~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 364 (377)
T 3byv_A 306 IWCADLPITKDAALGGSE---------------WIFR--SCKNI----PQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364 (377)
T ss_dssp HHHSSCCC------CCSG---------------GGGS--SCCCC----CHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred HHHCCCCCcccccccchh---------------hhhh--hccCC----CHHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence 999999997433221110 0000 00112 246889999999999999999999996 455
Q ss_pred hhhh
Q 008707 509 DSIK 512 (557)
Q Consensus 509 ~~~~ 512 (557)
++..
T Consensus 365 ~~~~ 368 (377)
T 3byv_A 365 QLRT 368 (377)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=327.01 Aligned_cols=256 Identities=24% Similarity=0.337 Sum_probs=183.4
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||+
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 95 (303)
T 2vwi_A 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 95 (303)
T ss_dssp CCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence 4456789999999999999864 68999999886432 234567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcc-----CCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 314 HNGTLRDRLHGS-----VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 314 ~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
++++|.+++... .....+++..++.++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 999999988642 124568999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCc----cccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 389 EDLT----HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 389 ~~~~----~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
.... .......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ . ..... +...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~---~~~~~-~~~~ 245 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---L---MLTLQ-NDPP 245 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H---HHHHT-SSCC
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---H---HHHhc-cCCC
Confidence 3211 11223458999999999865 4688999999999999999999999975433221 1 11111 1111
Q ss_pred cc----ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 464 SI----VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 464 ~~----~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.. .++.....+ +..+.+++.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11 111111222 346889999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=356.46 Aligned_cols=246 Identities=25% Similarity=0.330 Sum_probs=201.3
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
.|++.+.||+|+||.||+|... +++.||||++.+.. ....+.+..|..++..+ +||+|+.+++++.+.+..++||
T Consensus 342 ~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp TEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred ceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 3556789999999999999876 57889999987531 23446788899999988 7999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 422 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred eCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999984 3568999999999999999999998 99999999999999999999999999999864332
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||.+.+.. +... .+..+..
T Consensus 496 ~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~-~i~~~~~-------- 559 (674)
T 3pfq_A 496 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQ-SIMEHNV-------- 559 (674)
T ss_dssp TC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH-HHHSSCC--------
T ss_pred Cc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHH-HHHhCCC--------
Confidence 22 234456999999999999999999999999999999999999999854321 1111 2222211
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKM-----QEIVL 505 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~-----~evl~ 505 (557)
.++.....++.+++.+||+.||++||++ +||++
T Consensus 560 --~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 560 --AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1111223478899999999999999998 66654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=356.22 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=206.1
Q ss_pred HHHHHhhcccCCCCceEEEEEEEcC----CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
...+++.+.||+|+||.||+|.+.. +..||+|.+.... ....+.+.+|+.+++.++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 3456678899999999999998753 4579999987543 334567999999999999999999999985 456899
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 468 v~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 99999999999999753 4568999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
...........+++.|+|||.+.+..++.++||||||+++|||++ |..||.+....+ . ...+..+....
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~----~~~i~~~~~~~--- 612 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---V----IGRIENGERLP--- 612 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H----HHHHHHTCCCC---
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---H----HHHHHcCCCCC---
Confidence 443333333446789999999998899999999999999999997 999997443221 1 11222222111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
.+...+..+.+++.+||+.||++|||+.||++.|+++.+.+
T Consensus 613 ------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 613 ------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 11122347889999999999999999999999999987654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=325.31 Aligned_cols=254 Identities=25% Similarity=0.334 Sum_probs=197.6
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--------hhHHHHHHHHHHHhhcCCCCccceeeEEE
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCE 301 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 301 (557)
......|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+++++.++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 344567788999999999999999876 578999999864321 12245889999999999999999999987
Q ss_pred ecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc---EEE
Q 008707 302 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKV 378 (557)
Q Consensus 302 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl 378 (557)
... .++||||+++++|.+++. ....+++..+..++.||+.||+|||+ ++++||||||+||+++.++. +||
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred CCc-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEE
Confidence 655 899999999999999887 34678999999999999999999998 99999999999999987654 999
Q ss_pred ecccCccccCCCCccccccccCCCCccCCcccC---CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 008707 379 SDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 455 (557)
Q Consensus 379 ~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~---~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~ 455 (557)
+|||++........ .....|++.|+|||.+. ...++.++||||||+++|+|++|..||....... .+..
T Consensus 159 ~Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~---- 230 (322)
T 2ycf_A 159 TDFGHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKD---- 230 (322)
T ss_dssp CCCTTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHH----
T ss_pred ccCccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHH----
Confidence 99999987654321 22345899999999973 5678899999999999999999999997443221 2222
Q ss_pred HHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 456 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 456 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+..+.... .+..... .+..+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~--~~~~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 231 QITSGKYNF--IPEVWAE----VSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHTCCCC--CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhCcccc--Cchhhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 122222110 0011111 2347889999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=321.27 Aligned_cols=250 Identities=21% Similarity=0.308 Sum_probs=184.6
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc-h-hHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-H-RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~-~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
.|++.+.||+|+||.||+|... +|+.||+|++..... . ..+.+.++...++.++||||+++++++.+.+..++||||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 87 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence 4556789999999999999874 689999999875422 2 223444555568888999999999999999999999999
Q ss_pred cCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCCCC-CeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 313 MHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 313 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
++ |+|.+++.... ....+++..++.++.|++.||+|||+ + +++||||||+||+++.++.+||+|||++......
T Consensus 88 ~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 88 MD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp CS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred hc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 96 58877765421 35679999999999999999999998 7 9999999999999999999999999999876543
Q ss_pred CccccccccCCCCccCCccc----CCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 391 LTHISSVARGTVGYLDPEYY----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l----~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
.. .....||+.|+|||.+ .+..++.++||||+|+++|+|++|+.||...... .............. ..
T Consensus 164 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~-~~ 235 (290)
T 3fme_A 164 VA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPSPQ-LP 235 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCCCC-CC
T ss_pred cc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCCCC-cc
Confidence 22 2223589999999996 5667899999999999999999999999743221 11122222221111 10
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
....+..+.+++.+||+.||++|||++|+++
T Consensus 236 --------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 236 --------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp --------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 0112346889999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.04 Aligned_cols=259 Identities=23% Similarity=0.283 Sum_probs=192.0
Q ss_pred HHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCe------eEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------RILV 309 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~------~~lv 309 (557)
.|++.+.||+|+||.||+|.+..+..||+|++..... ...+|+++++.++||||+++++++...+. .++|
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv 116 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV 116 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence 3556799999999999999998777799998764322 12369999999999999999999865433 7899
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC-CCCcEEEecccCccccC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAE 388 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~ 388 (557)
|||++++.+............+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++...
T Consensus 117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~ 193 (394)
T 4e7w_A 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193 (394)
T ss_dssp EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence 9999765444333222235678999999999999999999998 9999999999999999 79999999999998764
Q ss_pred CCCccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC-------
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG------- 460 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------- 460 (557)
..... ....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+. +..... .....
T Consensus 194 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~-~~g~p~~~~~~~ 268 (394)
T 4e7w_A 194 AGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIK-VLGTPSREQIKT 268 (394)
T ss_dssp TTCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHH-HHCCCCHHHHHH
T ss_pred CCCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH-HhCCCCHHHHHh
Confidence 43222 234579999999998765 589999999999999999999999985543221 111111 11000
Q ss_pred ---CccccccccccC-----CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 461 ---DVISIVDPVLIG-----NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 461 ---~~~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
......-+.... .........+.+++.+||+.||++|||+.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000000000000 0111233478899999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.88 Aligned_cols=250 Identities=27% Similarity=0.364 Sum_probs=199.1
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc-------------hhHHHHHHHHHHHhhcCCCCccceeeEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 300 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~il~~l~h~nIv~~~~~~ 300 (557)
..|.+.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 44667899999999999999876 578999999865321 2346788999999999999999999999
Q ss_pred EecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC---cEE
Q 008707 301 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM---RAK 377 (557)
Q Consensus 301 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~---~~k 377 (557)
.+....++||||+++|+|.+.+.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+|
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEE
T ss_pred EcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999998874 3568999999999999999999998 9999999999999998776 699
Q ss_pred EecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH
Q 008707 378 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 457 (557)
Q Consensus 378 l~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 457 (557)
|+|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+... ....+
T Consensus 190 l~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i 259 (504)
T 3q5i_A 190 IVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------IIKKV 259 (504)
T ss_dssp ECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHH
T ss_pred EEECCCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHH
Confidence 999999987654322 233458999999999875 68999999999999999999999998543221 11222
Q ss_pred hcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 458 KKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 458 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
..+.... +...... .+..+.+++.+||+.||.+|||++|+++.
T Consensus 260 ~~~~~~~--~~~~~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 260 EKGKYYF--DFNDWKN----ISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHCCCCC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HcCCCCC--CccccCC----CCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2232211 0000011 12468899999999999999999999863
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=334.90 Aligned_cols=199 Identities=26% Similarity=0.324 Sum_probs=171.4
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhc------CCCCccceeeEEEecCeeE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI------HHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l------~h~nIv~~~~~~~~~~~~~ 307 (557)
..|++.+.||+|+||.||+|... +++.||||++... ....+.+.+|+++++.+ .|+||+++++++...+..+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 34667899999999999999776 5889999998754 33346677899888887 4679999999999999999
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc--EEEecccCcc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR--AKVSDFGLSR 385 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~ 385 (557)
+||||+. ++|.+++... ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++. +||+|||++.
T Consensus 176 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9999995 6999988754 23458999999999999999999998 89999999999999999887 9999999997
Q ss_pred ccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCc
Q 008707 386 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDF 443 (557)
Q Consensus 386 ~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~ 443 (557)
...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+.
T Consensus 251 ~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 251 YEHQRV----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp ETTCCC----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ecCCcc----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 654332 234589999999999999999999999999999999999999986543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=325.43 Aligned_cols=259 Identities=22% Similarity=0.297 Sum_probs=201.8
Q ss_pred HHHHHhhcccCCCCceEEEEEEE-c-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCC------CccceeeEEEecCe
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKM-K-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR------NLVPLIGYCEEEHQ 305 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~------nIv~~~~~~~~~~~ 305 (557)
...|++.+.||+|+||.||+|.. . +++.||+|++... ....+.+.+|+++++.++|+ +++++++++...+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 34566789999999999999986 3 5889999998754 33456788999999998765 49999999999999
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC-------------
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI------------- 372 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~------------- 372 (557)
.++||||+ +++|.+++... ....+++..+..++.|++.||+|||+ ++++||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 89999998754 23468899999999999999999998 99999999999999987
Q ss_pred ------CCcEEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcccc
Q 008707 373 ------NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 446 (557)
Q Consensus 373 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~ 446 (557)
++.+||+|||++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEHH----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSCC----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCcccc----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 6679999999998654332 234589999999999999999999999999999999999999985543221
Q ss_pred ccHHHHHHHHHhc--------CCccccc---------------------ccc-ccCCCCHHHHHHHHHHHHHccccCCCC
Q 008707 447 LNIVHWARSMIKK--------GDVISIV---------------------DPV-LIGNVKIESIWRIAEVAIQCVEQRGFS 496 (557)
Q Consensus 447 ~~~~~~~~~~~~~--------~~~~~~~---------------------d~~-l~~~~~~~~~~~l~~li~~cl~~~P~~ 496 (557)
... ....... ....... .+. -...........+.+++.+||+.||++
T Consensus 243 ~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 243 LAM---MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHH---HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHH---HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 111 1111110 0000000 000 001112345668999999999999999
Q ss_pred CCCHHHHHH
Q 008707 497 RPKMQEIVL 505 (557)
Q Consensus 497 RPt~~evl~ 505 (557)
|||++|+++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999985
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=333.29 Aligned_cols=261 Identities=20% Similarity=0.265 Sum_probs=180.6
Q ss_pred hcccCCCCceEEEEEEEc---CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEe--cCeeEEEEEecC
Q 008707 240 CKKIGKGSFGSVYYGKMK---DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYEYMH 314 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~lv~e~~~ 314 (557)
.++||+|+||.||+|.++ +++.||+|++.... ....+.+|+++++.++||||+++++++.. ....++||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 568999999999999876 57899999987542 23467899999999999999999999954 678899999996
Q ss_pred CCChhhhhhccC------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe----CCCCcEEEecccCc
Q 008707 315 NGTLRDRLHGSV------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL----DINMRAKVSDFGLS 384 (557)
Q Consensus 315 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll----~~~~~~kl~Dfgla 384 (557)
|+|.+++.... ....+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||++
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 58887775321 22358999999999999999999998 999999999999999 67789999999999
Q ss_pred cccCCCCc--cccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccc----c--ccHHHHHHH
Q 008707 385 RQAEEDLT--HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGA----E--LNIVHWARS 455 (557)
Q Consensus 385 ~~~~~~~~--~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~----~--~~~~~~~~~ 455 (557)
........ .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... . ......+..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~ 259 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 259 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHH
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHH
Confidence 87654321 122345689999999999874 58999999999999999999999997544320 0 011111111
Q ss_pred HHhcCCcccccc---------------ccccCCCCH---------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 456 MIKKGDVISIVD---------------PVLIGNVKI---------ESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 456 ~~~~~~~~~~~d---------------~~l~~~~~~---------~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.+..-......+ ......... .....+.+++.+||+.||++|||++|+++.
T Consensus 260 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 260 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111100000000 000000000 002367899999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=327.76 Aligned_cols=260 Identities=23% Similarity=0.284 Sum_probs=190.3
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecC------ee
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 306 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~------~~ 306 (557)
.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 3556789999999999999865 58899999986532 334567889999999999999999999997654 68
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++||||+. ++|.+.+. ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++..
T Consensus 106 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 106 YIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred EEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 99999996 57888775 247889999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHH----------------
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV---------------- 450 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~---------------- 450 (557)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+........
T Consensus 177 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 177 AGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred cccccc--cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 643321 22345899999999999999999999999999999999999999855432110000
Q ss_pred HHHHHHHhcCCcc------ccccccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 451 HWARSMIKKGDVI------SIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 451 ~~~~~~~~~~~~~------~~~d~~l~~~~---~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
............. ..+.....+.. .......+.+++.+||..||++|||++|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000111110000 00000000111 12235678999999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=328.66 Aligned_cols=257 Identities=22% Similarity=0.310 Sum_probs=201.9
Q ss_pred HHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchh-----------------HHHHHHHHHHHhhcCCCCccceee
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHR-----------------TQQFVTEVALLSRIHHRNLVPLIG 298 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~il~~l~h~nIv~~~~ 298 (557)
.|++.+.||+|+||.||+|.. +++.||+|++....... .+.+.+|+++++.++||||+++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 455678999999999999998 89999999986432111 178999999999999999999999
Q ss_pred EEEecCeeEEEEEecCCCChhhh------hhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC
Q 008707 299 YCEEEHQRILVYEYMHNGTLRDR------LHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 372 (557)
Q Consensus 299 ~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~ 372 (557)
++.+.+..++||||+++|+|.++ +... ....+++..++.++.|++.||+|||+ +.|++||||||+||+++.
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKN-YTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDK 187 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSS-SCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECT
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc-cccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcC
Confidence 99999999999999999999998 5432 25679999999999999999999996 389999999999999999
Q ss_pred CCcEEEecccCccccCCCCccccccccCCCCccCCcccCCC-CCCc-ccceehhHHHHHHHHhCCCCCCCCCccccccHH
Q 008707 373 NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTE-KSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 450 (557)
Q Consensus 373 ~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~-~~s~-~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~ 450 (557)
++.+||+|||++...... ......|++.|+|||.+.+. .++. ++||||||+++|+|++|+.||....... ..
T Consensus 188 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~- 261 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--EL- 261 (348)
T ss_dssp TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--HH-
T ss_pred CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HH-
Confidence 999999999999876443 22334589999999999887 6666 9999999999999999999998543311 11
Q ss_pred HHHHHHHhcCCcccccc------cccc---CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 451 HWARSMIKKGDVISIVD------PVLI---GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 451 ~~~~~~~~~~~~~~~~d------~~l~---~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
...+..+......+ +... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 262 ---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 ---FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ---HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12222222111100 0000 0001223457889999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=325.44 Aligned_cols=260 Identities=21% Similarity=0.294 Sum_probs=198.2
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEec-----CeeEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRIL 308 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----~~~~l 308 (557)
.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 3556789999999999999876 68899999987543 33446789999999999999999999998754 36899
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
|||++. |+|.+++.. ..+++..+..++.|++.||+|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 108 v~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 999996 599998863 458999999999999999999998 999999999999999999999999999998765
Q ss_pred CCCccc--cccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc--
Q 008707 389 EDLTHI--SSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI-- 463 (557)
Q Consensus 389 ~~~~~~--~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 463 (557)
...... .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+.. ..+..........
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQEDL 256 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHH---HHHHHHHCSCCHHHH
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHH---HHHHHHhCCCCHHHH
Confidence 432221 233468999999998654 45899999999999999999999999855433221 1111111110000
Q ss_pred -------------cccccccc--CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 464 -------------SIVDPVLI--GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 464 -------------~~~d~~l~--~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
....+... ..........+.+++.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00001123468899999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=336.44 Aligned_cols=251 Identities=10% Similarity=0.035 Sum_probs=178.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhhc--CCCCcccee-------eEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRI--HHRNLVPLI-------GYCEEE 303 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l--~h~nIv~~~-------~~~~~~ 303 (557)
|.+.+.||+|+||.||+|.+. +|+.||+|++..... ...+.+.+|+++++.+ +||||++++ +++...
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~ 143 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQ 143 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEET
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecC
Confidence 446789999999999999876 689999999976432 3445677886655555 599987755 444332
Q ss_pred -----------------CeeEEEEEecCCCChhhhhhccCCCCCcCHHHH------HHHHHHHHHHHHHHHcCCCCCeEe
Q 008707 304 -----------------HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTR------LQIAHDAAKGLEYLHTGCNPGIIH 360 (557)
Q Consensus 304 -----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~aL~~LH~~~~~~ivH 360 (557)
...++||||++ |+|.+++... ...+++..+ ..++.||+.||+|||+ ++|+|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivH 217 (371)
T 3q60_A 144 SQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVH 217 (371)
T ss_dssp TSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred CCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCcc
Confidence 34799999998 8999999753 223344445 6778999999999998 99999
Q ss_pred eccCCCCEEeCCCCcEEEecccCccccCCCCccccccccCCCCccCCcccCC--CCCCcccceehhHHHHHHHHhCCCCC
Q 008707 361 RDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPV 438 (557)
Q Consensus 361 ~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~--~~~s~~~DvwslG~ll~elltg~~pf 438 (557)
|||||+|||++.++.+||+|||+++....... ...+|+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp TTCSGGGEEECTTSCEEECCGGGEEETTCEEE----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred CcCCHHHEEECCCCCEEEEecceeeecCCCcc----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999987643221 2346799999999987 68899999999999999999999999
Q ss_pred CCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 439 SVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 439 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
........... .....................+..+.+++.+||+.||++|||+.|+++
T Consensus 294 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 294 GLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 85532211000 000000000000000001123447889999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=335.18 Aligned_cols=263 Identities=21% Similarity=0.229 Sum_probs=194.5
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEec-----------
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE----------- 303 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~----------- 303 (557)
.|++.+.||+|+||.||+|... +|+.||+|++..... ...+|+++++.++||||+++++++...
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 4556799999999999999864 689999998865422 233799999999999999999998443
Q ss_pred ---------------------------CeeEEEEEecCCCChhhhhhcc-CCCCCcCHHHHHHHHHHHHHHHHHHHcCCC
Q 008707 304 ---------------------------HQRILVYEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355 (557)
Q Consensus 304 ---------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~ 355 (557)
...++||||++ |+|.+.+... .....+++..+..++.||++||+|||+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--- 159 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS--- 159 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---
Confidence 34789999997 5877776532 145679999999999999999999998
Q ss_pred CCeEeeccCCCCEEeC-CCCcEEEecccCccccCCCCccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHh
Q 008707 356 PGIIHRDVKSSNILLD-INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELIS 433 (557)
Q Consensus 356 ~~ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~ellt 433 (557)
.||+||||||+||+++ .++.+||+|||++........ .....+|+.|+|||.+.+. .++.++||||+||++|||++
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 9999999999999997 688999999999987644332 2234579999999998765 58999999999999999999
Q ss_pred CCCCCCCCCccccccHHHHHHHHHhcC----------CccccccccccC-----CCCHHHHHHHHHHHHHccccCCCCCC
Q 008707 434 GKKPVSVEDFGAELNIVHWARSMIKKG----------DVISIVDPVLIG-----NVKIESIWRIAEVAIQCVEQRGFSRP 498 (557)
Q Consensus 434 g~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~d~~l~~-----~~~~~~~~~l~~li~~cl~~~P~~RP 498 (557)
|+.||.+.+..+. +...+ ...... ......-+.... ..+...+..+.+++.+||+.||++||
T Consensus 238 g~~pf~~~~~~~~--~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (383)
T 3eb0_A 238 GKPLFSGETSIDQ--LVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI 314 (383)
T ss_dssp SSCSSCCSSHHHH--HHHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred CCCCCCCCChHHH--HHHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCC
Confidence 9999985443221 11111 111100 000000000000 01112334688999999999999999
Q ss_pred CHHHHHHH--HHhhh
Q 008707 499 KMQEIVLA--IQDSI 511 (557)
Q Consensus 499 t~~evl~~--L~~~~ 511 (557)
|+.|+++. ++++.
T Consensus 315 t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 315 NPYEAMAHPFFDHLR 329 (383)
T ss_dssp CHHHHHTSGGGHHHH
T ss_pred CHHHHhcCHHHHHHH
Confidence 99999853 44443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=322.34 Aligned_cols=248 Identities=24% Similarity=0.406 Sum_probs=192.1
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEe------cCeeEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE------EHQRIL 308 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~------~~~~~l 308 (557)
|++.+.||+|+||.||+|.+. +++.||+|++.... ...+.+.+|+.+++++ +||||+++++++.. .+..++
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred EEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 456789999999999999874 68999999986442 3446788999999999 79999999999976 467899
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||+++|+|.+++... ....+++..++.++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 105 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred EEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 99999999999999754 23568899999999999999999998 999999999999999999999999999988764
Q ss_pred CCCccccccccCCCCccCCcccC-----CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~-----~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
..... .....|++.|+|||.+. +..++.++||||||+++|+|++|+.||....... ... .+..+...
T Consensus 181 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~-~~~~~~~~ 252 (326)
T 2x7f_A 181 RTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ALF-LIPRNPAP 252 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH-HHHHSCCC
T ss_pred cCccc-cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HHH-HhhcCccc
Confidence 33221 22345899999999987 5678899999999999999999999997433211 111 11112111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 464 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 464 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.... .. .+..+.+++.+||..||++|||+.|+++
T Consensus 253 ~~~~----~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 253 RLKS----KK----WSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp CCSC----SC----SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCCc----cc----cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111 11 1347889999999999999999999987
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=319.36 Aligned_cols=248 Identities=26% Similarity=0.306 Sum_probs=199.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---------chhHHHHHHHHHHHhhcC-CCCccceeeEEEecCe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---------SHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ 305 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~ 305 (557)
|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++++. ||||+++++++...+.
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence 445789999999999999886 58899999986432 122456889999999995 9999999999999999
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
.++||||+++++|.+++.. ...+++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 99 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 99 FFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 9999999999999999974 3568999999999999999999998 999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCccCCcccC------CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc
Q 008707 386 QAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 459 (557)
Q Consensus 386 ~~~~~~~~~~~~~~g~~~y~aPE~l~------~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 459 (557)
....... .....|++.|+|||.+. ...++.++||||||+++|+|++|..||...... .. ...+..
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~-~~~~~~ 243 (298)
T 1phk_A 173 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LM-LRMIMS 243 (298)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHH
T ss_pred hcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------HH-HHHHhc
Confidence 7654322 22345899999999984 456889999999999999999999999743321 11 112222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 460 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 460 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+..... .+ .....+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~-~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 244 GNYQFG-SP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp TCCCCC-TT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCcccC-cc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 221100 00 01122347889999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=333.21 Aligned_cols=260 Identities=22% Similarity=0.275 Sum_probs=190.6
Q ss_pred HHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccc-----------hhHHHHHHHHHHHhhcCCCCccceeeEEEe--
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS-----------HRTQQFVTEVALLSRIHHRNLVPLIGYCEE-- 302 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-- 302 (557)
.|++.+.||+|+||.||+|...+|+.||||++..... ...+.+.+|+++++.++||||+++++++..
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 102 (362)
T 3pg1_A 23 PYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE 102 (362)
T ss_dssp SCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC
T ss_pred ceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc
Confidence 3455789999999999999988899999999854321 123678999999999999999999999854
Q ss_pred ---cCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEe
Q 008707 303 ---EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVS 379 (557)
Q Consensus 303 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~ 379 (557)
....++||||+. |+|.+.+.. ....+++..+..++.||+.||+|||+ .+++||||||+||+++.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 103 EPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp TTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEEE
Confidence 336799999997 688888874 34578999999999999999999999 999999999999999999999999
Q ss_pred cccCccccCCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh
Q 008707 380 DFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 458 (557)
Q Consensus 380 Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 458 (557)
|||++........ .....|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ...+.....
T Consensus 177 Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~ 251 (362)
T 3pg1_A 177 DFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQ---LNKIVEVVG 251 (362)
T ss_dssp CTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred ecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcC
Confidence 9999975443322 223458899999999877 6789999999999999999999999985443211 111111111
Q ss_pred cCCccc-----------ccccccc-------CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 459 KGDVIS-----------IVDPVLI-------GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 459 ~~~~~~-----------~~d~~l~-------~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
...... .+..... ..........+.+++.+||+.||++|||++|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 252 TPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp CCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 100000 0000000 00011123468899999999999999999999863
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=330.18 Aligned_cols=255 Identities=21% Similarity=0.310 Sum_probs=181.0
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEec------Cee
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQR 306 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~------~~~ 306 (557)
.|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+++++.++||||+++++++... ...
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 4556789999999999999864 68999999986532 33456788999999999999999999998654 567
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+ .||+||||||+||+++.++.+||+|||+++.
T Consensus 110 ~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp EEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred EEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 9999999 7899988863 568999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
.... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..... ..+...+.... .+.
T Consensus 182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~p~-~~~ 253 (367)
T 2fst_X 182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRLVGTPG-AEL 253 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCC-HHH
T ss_pred cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCC-HHH
Confidence 5433 223458999999999877 68899999999999999999999999855432211 11111111100 000
Q ss_pred ccc-----------cc--cCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 466 VDP-----------VL--IGNVKI-----ESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 466 ~d~-----------~l--~~~~~~-----~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+.. .+ ...... .....+.+++.+||..||++|||++|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 00 000000 112467899999999999999999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=324.53 Aligned_cols=256 Identities=25% Similarity=0.375 Sum_probs=196.6
Q ss_pred HHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
.|++.+.||+|+||.||+|.++. .||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 34 ~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 34 QLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp CEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred HeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence 34567999999999999998863 49999886432 223356778999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC--
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-- 391 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-- 391 (557)
++++|.+++... ...+++..++.++.||+.||+|||+ .+++||||||+||+++ ++.+||+|||++.......
T Consensus 112 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~ 185 (319)
T 2y4i_B 112 KGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG 185 (319)
T ss_dssp CSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred cCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence 999999999752 4468899999999999999999998 9999999999999998 6899999999987643211
Q ss_pred --ccccccccCCCCccCCcccCC---------CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 008707 392 --THISSVARGTVGYLDPEYYGN---------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 460 (557)
Q Consensus 392 --~~~~~~~~g~~~y~aPE~l~~---------~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 460 (557)
........|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||....... ....+..+
T Consensus 186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~ 258 (319)
T 2y4i_B 186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-------IIWQMGTG 258 (319)
T ss_dssp --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-------HHHHHHTT
T ss_pred ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHhccC
Confidence 111223458899999999864 457889999999999999999999997433211 11122222
Q ss_pred CccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 461 DVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 461 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
........ ..+..+.+++.+||+.+|++|||++||++.|+++....
T Consensus 259 ~~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 259 MKPNLSQI--------GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CCCCCCCS--------SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CCCCCCcC--------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 22111111 11235789999999999999999999999999988754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=315.05 Aligned_cols=250 Identities=24% Similarity=0.392 Sum_probs=191.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEe-----------
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----------- 302 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----------- 302 (557)
..|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|+++++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV 84 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence 34567899999999999999875 6899999998643 3445778899999999999999999998754
Q ss_pred --cCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEec
Q 008707 303 --EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 380 (557)
Q Consensus 303 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 380 (557)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 85 KKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp -CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred ccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence 45689999999999999999752 4567888999999999999999998 9999999999999999999999999
Q ss_pred ccCccccCCCC-------------ccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCcccc
Q 008707 381 FGLSRQAEEDL-------------THISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 446 (557)
Q Consensus 381 fgla~~~~~~~-------------~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~ 446 (557)
||++....... ........|++.|+|||.+.+. .++.++||||||+++|+|++ ||....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~---- 232 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM---- 232 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH----
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch----
Confidence 99998754321 1112234589999999999764 68999999999999999998 554111
Q ss_pred ccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 447 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
...... ..+..... .+........+..+.+++.+||+.||++|||+.|+++
T Consensus 233 -~~~~~~-~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 -ERVNIL-KKLRSVSI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp -HHHHHH-HHHHSTTC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hHHHHH-Hhcccccc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 111111 11221111 1112222333456889999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=323.76 Aligned_cols=261 Identities=20% Similarity=0.304 Sum_probs=198.4
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcC-----------CCCccceeeEEEe
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----------HRNLVPLIGYCEE 302 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------h~nIv~~~~~~~~ 302 (557)
..|++.+.||+|+||.||+|... +++.||+|++... ....+.+.+|++++++++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 45667899999999999999874 6899999998753 334567888999999886 8999999999876
Q ss_pred cC----eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCC-CeEeeccCCCCEEeC------
Q 008707 303 EH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLD------ 371 (557)
Q Consensus 303 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~ivH~dlk~~NIll~------ 371 (557)
.+ ..++|||++ +++|.+++... ....+++..+..++.||+.||+|||+ + +|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCc
Confidence 54 789999999 89999999754 24558999999999999999999998 7 999999999999994
Q ss_pred CCCcEEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHH
Q 008707 372 INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVH 451 (557)
Q Consensus 372 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~ 451 (557)
..+.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||+||+.||.............
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCCC----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 44579999999998765432 22358999999999999999999999999999999999999998554322111111
Q ss_pred HH---HHHHhc--------CCc----------cccccc--------c--ccCCCCHHHHHHHHHHHHHccccCCCCCCCH
Q 008707 452 WA---RSMIKK--------GDV----------ISIVDP--------V--LIGNVKIESIWRIAEVAIQCVEQRGFSRPKM 500 (557)
Q Consensus 452 ~~---~~~~~~--------~~~----------~~~~d~--------~--l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~ 500 (557)
.+ ...+.. +.. ...+.. . -....+......+.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 328 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 328 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence 11 111110 000 000000 0 0112345677889999999999999999999
Q ss_pred HHHHH
Q 008707 501 QEIVL 505 (557)
Q Consensus 501 ~evl~ 505 (557)
+|+++
T Consensus 329 ~ell~ 333 (373)
T 1q8y_A 329 GGLVN 333 (373)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=316.80 Aligned_cols=250 Identities=23% Similarity=0.335 Sum_probs=193.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCc--cchhHHHHHHHHHHHhhcC--CCCccceeeEEEecCeeEEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~--h~nIv~~~~~~~~~~~~~lv~ 310 (557)
..|++.+.||+|+||.||++...+++.||+|++... .....+.+.+|++++++++ ||||+++++++.+.+..++||
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 107 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 107 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEE
Confidence 345567899999999999999988999999998643 2334577899999999997 599999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
| +.+++|.+++.. ...+++..+..++.|+++||+|||+ .+++||||||+||+++ ++.+||+|||++......
T Consensus 108 e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 108 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp C-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----
T ss_pred e-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEE-CCeEEEeeccccccccCc
Confidence 9 568899999974 4568999999999999999999998 9999999999999996 489999999999876443
Q ss_pred Ccc-ccccccCCCCccCCcccCC-----------CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHh
Q 008707 391 LTH-ISSVARGTVGYLDPEYYGN-----------QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 458 (557)
Q Consensus 391 ~~~-~~~~~~g~~~y~aPE~l~~-----------~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 458 (557)
... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||..... ..........
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~~~ 254 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIID 254 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHHHh
Confidence 221 1223458999999999875 4678899999999999999999999973221 1111222222
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 459 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 459 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
..... ..+......+.+++.+||+.||++|||++|+++.
T Consensus 255 ~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 255 PNHEI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TTSCC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccc---------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11111 1111113468899999999999999999999863
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.33 Aligned_cols=257 Identities=24% Similarity=0.267 Sum_probs=190.4
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEec------CeeEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRILV 309 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~------~~~~lv 309 (557)
|++.+.||+|+||.||+|.+. +|+.||||++..... ...+|+++++.++||||+++++++... ...++|
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 456789999999999999986 589999999865322 234699999999999999999988542 236799
Q ss_pred EEecCCCChhhhhhcc-CCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC-CcEEEecccCcccc
Q 008707 310 YEYMHNGTLRDRLHGS-VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQA 387 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~-~~~kl~Dfgla~~~ 387 (557)
|||+++ ++.+.+... .....+++..+..++.||++||+|||+ .+|+||||||+|||++.+ +.+||+|||+++..
T Consensus 132 ~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred hhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 999975 666655421 235679999999999999999999998 999999999999999965 56899999999876
Q ss_pred CCCCccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHH-------HHh-
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS-------MIK- 458 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~-------~~~- 458 (557)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+ .+.+.+.. .+.
T Consensus 208 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 208 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp CTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHH
T ss_pred ccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHh
Confidence 44322 2234589999999998765 78999999999999999999999998544221 11111110 000
Q ss_pred -cCCccccccccccCC-----CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 459 -KGDVISIVDPVLIGN-----VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 459 -~~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.........+.+... +....+..+.+++.+||..||++|||+.|+++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000111111111000 11122357889999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=318.56 Aligned_cols=255 Identities=21% Similarity=0.286 Sum_probs=189.6
Q ss_pred HHhhcccCCCCceEEEEEEEcC-CcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEE--------------
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCE-------------- 301 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-------------- 301 (557)
|++.+.||+|+||.||+|.... ++.||+|++........+.+.+|+++++.++||||+++++++.
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 92 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92 (320)
T ss_dssp EEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence 4567899999999999998874 8999999987665566678999999999999999999999873
Q ss_pred ecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC-CCCcEEEec
Q 008707 302 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSD 380 (557)
Q Consensus 302 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~D 380 (557)
+....++||||+. |+|.+++. ...+++..++.++.|++.||+|||+ .+++||||||+||+++ +++.+||+|
T Consensus 93 ~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 93 ELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp SCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3467899999997 69999886 3568899999999999999999998 9999999999999997 567999999
Q ss_pred ccCccccCCCCc--cccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHH
Q 008707 381 FGLSRQAEEDLT--HISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMI 457 (557)
Q Consensus 381 fgla~~~~~~~~--~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~ 457 (557)
||++........ .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+.... .....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~------~~~~~ 238 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ------MQLIL 238 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH------HHHHH
Confidence 999987643221 11223347899999998865 6789999999999999999999999985443211 11111
Q ss_pred hcCCc-------------ccccccccc-CCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 458 KKGDV-------------ISIVDPVLI-GNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 458 ~~~~~-------------~~~~d~~l~-~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
..... ......... ... ....+..+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 10000 000000000 000 0112347889999999999999999999986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=324.29 Aligned_cols=200 Identities=28% Similarity=0.317 Sum_probs=169.3
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcC-CC-----CccceeeEEEecCeeE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HR-----NLVPLIGYCEEEHQRI 307 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~-----nIv~~~~~~~~~~~~~ 307 (557)
..|++.+.||+|+||.||+|... +++.||||++... ......+..|+++++.++ |+ +|+++++++...+..+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 45567899999999999999876 5789999998753 233466778999998885 55 4999999999999999
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC--CCCcEEEecccCcc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSR 385 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfgla~ 385 (557)
+||||+. ++|.+++... ....+++..+..++.|++.||+|||+. +.+|+||||||+|||++ .++.+||+|||++.
T Consensus 133 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCce
Confidence 9999995 5999998754 235689999999999999999999951 27999999999999995 47789999999998
Q ss_pred ccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCC
Q 008707 386 QAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442 (557)
Q Consensus 386 ~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~ 442 (557)
...... ....||+.|+|||++.+..++.++|||||||++|||+||+.||...+
T Consensus 210 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 210 QLGQRI----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ETTCCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccccc----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 765432 23458999999999999999999999999999999999999998554
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=311.23 Aligned_cols=253 Identities=26% Similarity=0.338 Sum_probs=202.3
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
+.....|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 344567778899999999999999876 68999999986432 234577899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC---CcEEEecccCc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN---MRAKVSDFGLS 384 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~---~~~kl~Dfgla 384 (557)
+||||+++++|.+.+.. ...+++..++.++.|++.||+|||+ .+++||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 99999999999998864 3468999999999999999999998 999999999999999754 46999999999
Q ss_pred cccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 385 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 385 ~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
......... ....+++.|+|||.+.+. ++.++||||||+++|+|++|+.||...+.. +. ...+..+....
T Consensus 172 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~-~~~~~~~~~~~ 241 (287)
T 2wei_A 172 TCFQQNTKM--KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY------DI-LKRVETGKYAF 241 (287)
T ss_dssp GTBCCCSSC--SCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HHHHHHCCCCC
T ss_pred eeecCCCcc--ccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HH-HHHHHcCCCCC
Confidence 876443221 223478899999998764 889999999999999999999999744321 11 12222222211
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.. ..... .+..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~--~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DL--PQWRT----ISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CS--GGGTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cc--hhhhh----cCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 00111 2346889999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=318.97 Aligned_cols=260 Identities=21% Similarity=0.274 Sum_probs=197.2
Q ss_pred HHHhhcccCCCCceEEEEEEE--cCCcEEEEEEccCccc--hhHHHHHHHHHHHhhc---CCCCccceeeEEE-----ec
Q 008707 236 TNNFCKKIGKGSFGSVYYGKM--KDGKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCE-----EE 303 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~h~nIv~~~~~~~-----~~ 303 (557)
.|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++. ..
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~ 91 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 91 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCC
Confidence 355678999999999999987 3588999999864322 1223566788877776 7999999999987 55
Q ss_pred CeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccC
Q 008707 304 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 383 (557)
Q Consensus 304 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 383 (557)
...++||||+. |+|.+++... ....+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~ 166 (326)
T 1blx_A 92 TKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 166 (326)
T ss_dssp EEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcc
Confidence 67899999997 6999998754 24458999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 384 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 384 a~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
+....... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+... ....+..........
T Consensus 167 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 167 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEE 241 (326)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCGG
T ss_pred cccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCcc
Confidence 98764332 2233458999999999999999999999999999999999999998543221 111111111110000
Q ss_pred ccc----------c---ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 464 SIV----------D---PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 464 ~~~----------d---~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
... . ...........+..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0 00000111123346889999999999999999999985
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=324.70 Aligned_cols=262 Identities=19% Similarity=0.241 Sum_probs=184.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCe-------e
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ-------R 306 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~-------~ 306 (557)
..|++.+.||+|+||.||+|.+. +|+.||||++.... .......+|++.+..++||||+++++++...+. .
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 34556889999999999999875 68999999886532 223456678888899999999999999876433 7
Q ss_pred EEEEEecCCCChhhhhhc-cCCCCCcCHHHHHHHHHHHHHHHHHHH--cCCCCCeEeeccCCCCEEeCC-CCcEEEeccc
Q 008707 307 ILVYEYMHNGTLRDRLHG-SVNQKPLDWLTRLQIAHDAAKGLEYLH--TGCNPGIIHRDVKSSNILLDI-NMRAKVSDFG 382 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~aL~~LH--~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfg 382 (557)
++||||+++ +|.+.+.. ......+++..+..++.|++.||+||| + .+|+||||||+|||++. ++.+||+|||
T Consensus 102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 899999976 55443332 224567889999999999999999999 7 99999999999999996 8999999999
Q ss_pred CccccCCCCccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC-
Q 008707 383 LSRQAEEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG- 460 (557)
Q Consensus 383 la~~~~~~~~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~- 460 (557)
++........ .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||...+.... +.. +.......
T Consensus 178 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~-~~~~~~~~~ 252 (360)
T 3e3p_A 178 SAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHE-IVRVLGCPS 252 (360)
T ss_dssp TCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCC
T ss_pred CceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHH-HHHHcCCCC
Confidence 9987654332 2234589999999998665 489999999999999999999999985443221 111 11111000
Q ss_pred -----------Cccccccc------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 461 -----------DVISIVDP------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 461 -----------~~~~~~d~------~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
......+. ....+........+.+++.+||+.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000 00111122245678999999999999999999999863
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=323.27 Aligned_cols=254 Identities=21% Similarity=0.307 Sum_probs=192.5
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCee------
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQR------ 306 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~------ 306 (557)
.|.+.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 4556789999999999999875 58999999987542 23356788999999999999999999999876654
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++||||+. ++|.+.+. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 123 ~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp EEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999996 68888774 348999999999999999999998 9999999999999999999999999999986
Q ss_pred cCCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
.... .....||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+. +.. ........ ....
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~-i~~~~~~~-~~~~ 265 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQ-ILKVTGVP-GTEF 265 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCC-CHHH
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCC-cHHH
Confidence 5433 223458999999999887 6889999999999999999999999985443211 111 11100000 0000
Q ss_pred c---------------cccccCC---CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 466 V---------------DPVLIGN---VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 466 ~---------------d~~l~~~---~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
. ....... ........+.+++.+||+.||++|||++|+++.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0 0000000 001123478899999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=321.70 Aligned_cols=259 Identities=19% Similarity=0.255 Sum_probs=199.1
Q ss_pred HHHHHhhcccCCCCceEEEEEEEc-CC-cEEEEEEccCccchhHHHHHHHHHHHhhcCCCC------ccceeeEEEecCe
Q 008707 234 EATNNFCKKIGKGSFGSVYYGKMK-DG-KEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN------LVPLIGYCEEEHQ 305 (557)
Q Consensus 234 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n------Iv~~~~~~~~~~~ 305 (557)
...|++.+.||+|+||.||+|... ++ +.||+|++... ....+.+.+|+++++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 455677899999999999999875 34 68999998753 334567888999999997665 8999999999999
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEe---------------
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILL--------------- 370 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll--------------- 370 (557)
.++||||+ ++++.+.+... ....+++..+..++.||+.||+|||+ .+|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence 99999999 66777777643 23568999999999999999999998 999999999999999
Q ss_pred ----CCCCcEEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCcccc
Q 008707 371 ----DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAE 446 (557)
Q Consensus 371 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~ 446 (557)
+.++.+||+|||++....... ....||+.|+|||++.+..++.++||||||+++|||++|+.||...+....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 567889999999998654332 234589999999999999999999999999999999999999985443221
Q ss_pred ccHHHHHHHHHhc--------CCccccc-ccc---------------------ccCCCCHHHHHHHHHHHHHccccCCCC
Q 008707 447 LNIVHWARSMIKK--------GDVISIV-DPV---------------------LIGNVKIESIWRIAEVAIQCVEQRGFS 496 (557)
Q Consensus 447 ~~~~~~~~~~~~~--------~~~~~~~-d~~---------------------l~~~~~~~~~~~l~~li~~cl~~~P~~ 496 (557)
. ..+...... ....... ... ............+.+++.+||+.||++
T Consensus 248 ~---~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 248 L---VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp H---HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred H---HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 1 111111110 0000000 000 000112234567899999999999999
Q ss_pred CCCHHHHHH
Q 008707 497 RPKMQEIVL 505 (557)
Q Consensus 497 RPt~~evl~ 505 (557)
|||+.|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=326.00 Aligned_cols=258 Identities=21% Similarity=0.250 Sum_probs=194.9
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEec-----CeeEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRILV 309 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----~~~~lv 309 (557)
|++.+.||+|+||.||+|.+. +|+.||||++.... ......+.+|+++++.++||||+++++++... ...++|
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 456789999999999999876 68899999986533 33456788999999999999999999987654 678999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+. ++|.+++.. ..+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 93 QELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp ECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 99996 689998863 468999999999999999999998 9999999999999999999999999999987643
Q ss_pred CCcc---------ccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc
Q 008707 390 DLTH---------ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 459 (557)
Q Consensus 390 ~~~~---------~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 459 (557)
.... ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..... .........
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~ 241 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL---LLIFGIIGT 241 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHHHhCC
Confidence 2211 1122358999999998754 77899999999999999999999999855432111 111111110
Q ss_pred CCcccccc----c-------cc--cCCC-----CHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 460 GDVISIVD----P-------VL--IGNV-----KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 460 ~~~~~~~d----~-------~l--~~~~-----~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
........ + .+ .... ....+..+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000 0 00 0000 0122346889999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=321.79 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=192.6
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCe------eE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ------RI 307 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~------~~ 307 (557)
|.+.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++..... .+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 445688999999999999875 68999999986532 2335678899999999999999999999987654 49
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+||||+. ++|.+++. ..+++..+..++.||+.||+|||+ +|++||||||+||+++.++.+||+|||++...
T Consensus 106 lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp EEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred EEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 9999996 68888764 348999999999999999999998 99999999999999999999999999999865
Q ss_pred CCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCC-----
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD----- 461 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----- 461 (557)
... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+. ...+........
T Consensus 177 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~ 249 (353)
T 3coi_A 177 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGTEFVQ 249 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCCHHHHT
T ss_pred CCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHHH
Confidence 432 223458999999999877 6789999999999999999999999985543211 111111110000
Q ss_pred -------------ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 462 -------------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 462 -------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
......+.+ ..........+.+++.+||+.||++|||++|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 250 KLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp TCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000000 01112234578899999999999999999999863
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=317.52 Aligned_cols=253 Identities=26% Similarity=0.336 Sum_probs=175.9
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHH-HHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVA-LLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||.||+|... +|+.||+|++.... ......+..|+. +++.++||||+++++++...+..++||||+
T Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~ 103 (327)
T 3aln_A 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM 103 (327)
T ss_dssp EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence 345688999999999999885 68999999987543 233445566665 677789999999999999999999999999
Q ss_pred CCCChhhhhhcc--CCCCCcCHHHHHHHHHHHHHHHHHHHcCCCC-CeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 314 HNGTLRDRLHGS--VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 314 ~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
.+ +|.+++... .....+++..+..++.|++.||.|||+ . +++||||||+||+++.++.+||+|||++......
T Consensus 104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 75 787776531 125678999999999999999999998 7 9999999999999999999999999999876443
Q ss_pred CccccccccCCCCccCCccc----CCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 391 LTHISSVARGTVGYLDPEYY----GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l----~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
.. .....|++.|+|||.+ .+..++.++||||||+++|+|++|+.||....... +.... +..+..
T Consensus 180 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~-~~~~~~---- 247 (327)
T 3aln_A 180 IA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQLTQ-VVKGDP---- 247 (327)
T ss_dssp ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC-CCCSCC----
T ss_pred cc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HHHHH-HhcCCC----
Confidence 22 1223589999999998 45678999999999999999999999997432110 00000 001111
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+.+...........+.+++.+||+.||++|||+.||++.
T Consensus 248 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 248 -PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 111111111223478899999999999999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=327.44 Aligned_cols=247 Identities=24% Similarity=0.343 Sum_probs=184.8
Q ss_pred hcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 240 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +||||+++++++.+.+..++||||+. |+|
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL 95 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNL 95 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCH
Confidence 4789999999998776677999999998643 235678899999987 89999999999999999999999995 699
Q ss_pred hhhhhccCCCC----CcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC-------------CcEEEecc
Q 008707 319 RDRLHGSVNQK----PLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN-------------MRAKVSDF 381 (557)
Q Consensus 319 ~~~l~~~~~~~----~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~-------------~~~kl~Df 381 (557)
.+++....... ..++..++.++.||+.||+|||+ .+|+||||||+|||++.+ +.+||+||
T Consensus 96 ~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DF 172 (434)
T 2rio_A 96 QDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172 (434)
T ss_dssp HHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCC
T ss_pred HHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEccc
Confidence 99997532111 11333457899999999999998 999999999999999754 47999999
Q ss_pred cCccccCCCCcc---ccccccCCCCccCCcccCC-------CCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHH
Q 008707 382 GLSRQAEEDLTH---ISSVARGTVGYLDPEYYGN-------QQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIV 450 (557)
Q Consensus 382 gla~~~~~~~~~---~~~~~~g~~~y~aPE~l~~-------~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~ 450 (557)
|++......... ......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||....... .
T Consensus 173 G~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~ 248 (434)
T 2rio_A 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE----S 248 (434)
T ss_dssp TTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----H
T ss_pred ccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----H
Confidence 999876543221 1223468999999999976 578999999999999999999 999997432211 1
Q ss_pred HHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 451 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 451 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.. + .+... . +.............+.+++.+||+.||++|||+.||++
T Consensus 249 ~i----~-~~~~~-~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NI----I-RGIFS-L--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH----H-HTCCC-C--CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH----h-cCCCC-c--ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 11 1 11110 0 01111123455678999999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=315.25 Aligned_cols=249 Identities=20% Similarity=0.275 Sum_probs=169.1
Q ss_pred HHh-hcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEe----cCeeEEEE
Q 008707 237 NNF-CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVY 310 (557)
Q Consensus 237 ~~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----~~~~~lv~ 310 (557)
|.+ .+.||+|+||.||+|.+. +++.||+|++.... ....+....++.++||||+++++++.. ....++||
T Consensus 30 y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~ 105 (336)
T 3fhr_A 30 YQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIM 105 (336)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEE
Confidence 444 356999999999999887 68999999986531 112222334566799999999999876 45589999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC---CCcEEEecccCcccc
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQA 387 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~ 387 (557)
||+++|+|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++. ++.+||+|||++...
T Consensus 106 e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 106 ECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp ECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred eccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 999999999999854 23569999999999999999999998 99999999999999976 455999999999865
Q ss_pred CCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
.... .....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......... ......+..+.. ..
T Consensus 182 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~-~~-- 252 (336)
T 3fhr_A 182 TQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS---PGMKRRIRLGQY-GF-- 252 (336)
T ss_dssp -------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------CC--
T ss_pred cccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh---hhHHHhhhcccc-cc--
Confidence 4332 22345799999999999989999999999999999999999999744322110 000111111110 00
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
........+..+.+++.+||+.||++|||++|+++
T Consensus 253 ---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 253 ---PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp ---CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00001122346889999999999999999999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=340.05 Aligned_cols=268 Identities=23% Similarity=0.323 Sum_probs=203.9
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc-cchhHHHHHHHHHHHhhcCCCCccceeeEEEe------cCee
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQR 306 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~------~~~~ 306 (557)
..|++.+.||+|+||.||+|.+. +|+.||+|++... .....+.+.+|+++++.++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 56788999999999999999875 5899999998754 33445678999999999999999999998755 6678
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc---EEEecccC
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR---AKVSDFGL 383 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~---~kl~Dfgl 383 (557)
++||||+++|+|.+++........+++..++.++.|++.||+|||+ .||+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 9999999999999999865555578899999999999999999998 99999999999999997665 99999999
Q ss_pred ccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 384 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 384 a~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
+........ .....||+.|+|||.+.+..++.++||||||+++|+|++|..||...... ..|.......+...
T Consensus 171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC------
T ss_pred ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccchh
Confidence 987654332 23345899999999999999999999999999999999999999743211 11111000000000
Q ss_pred cccc----------cc--ccCCCCHHHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHhhhh
Q 008707 464 SIVD----------PV--LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQE-----IVLAIQDSIK 512 (557)
Q Consensus 464 ~~~d----------~~--l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~e-----vl~~L~~~~~ 512 (557)
.... .. .........+..+.+++.+||..||++|||+.| ..+.++++..
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000 00 011233445678999999999999999999988 4455555554
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=309.82 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=177.7
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc-hh-HHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-HR-TQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~-~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||.||+|.+. +|+.||+|++..... .. .+.+.++..+++.++||||+++++++.+.+..++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (318)
T 2dyl_A 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM 106 (318)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence 456789999999999999886 689999999875432 22 234445556788889999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCC-CeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP-GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~-~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
++.+..+... ....+++..+..++.|+++||+|||+ . +++||||||+||+++.++.+||+|||++........
T Consensus 107 -~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 107 -GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp -SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred -CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence 5566555543 24568999999999999999999997 5 999999999999999999999999999976544322
Q ss_pred cccccccCCCCccCCcccC-----CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 393 HISSVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~-----~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
.....|++.|+|||.+. ...++.++||||||+++|+|++|+.||...... .+....... +.......
T Consensus 181 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~-~~~~~~~~ 252 (318)
T 2dyl_A 181 --KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQ-EEPPLLPG 252 (318)
T ss_dssp --------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHH-SCCCCCCS
T ss_pred --ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhc-cCCCCCCc
Confidence 22335899999999984 557888999999999999999999999742211 111222222 11111110
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.. ..+..+.+++.+||+.||.+|||++||++.
T Consensus 253 ---~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 253 ---HM----GFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ---SS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ---cC----CCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 01 122368899999999999999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=316.72 Aligned_cols=243 Identities=26% Similarity=0.414 Sum_probs=189.2
Q ss_pred HHHHHHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccch------hHHHHHHHHHHHhhc----CCCCccceeeE
Q 008707 231 ELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRI----HHRNLVPLIGY 299 (557)
Q Consensus 231 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l----~h~nIv~~~~~ 299 (557)
+.....|++.+.||+|+||.||+|... +++.||+|++...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 344566778899999999999999874 6889999998654221 223456799999998 89999999999
Q ss_pred EEecCeeEEEEEe-cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC-CCCcEE
Q 008707 300 CEEEHQRILVYEY-MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAK 377 (557)
Q Consensus 300 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~-~~~~~k 377 (557)
+...+..++|||+ +.+++|.+++.. ...+++..++.++.||++||+|||+ .+++||||||+||+++ .++.+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEE
Confidence 9999999999999 789999999974 3468999999999999999999998 8999999999999999 889999
Q ss_pred EecccCccccCCCCccccccccCCCCccCCcccCCCCC-CcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHH
Q 008707 378 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 456 (557)
Q Consensus 378 l~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~-s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~ 456 (557)
|+|||++....... .....|++.|+|||.+.+..+ +.++||||||+++|+|++|+.||.... +
T Consensus 181 l~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~----- 244 (312)
T 2iwi_A 181 LIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------E----- 244 (312)
T ss_dssp ECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H-----
T ss_pred EEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------H-----
Confidence 99999998765432 223458999999999876665 458999999999999999999997321 0
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 457 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 457 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+..... .+.. .....+.+++.+||+.+|++|||++|+++
T Consensus 245 ~~~~~~------~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 245 ILEAEL------HFPA----HVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHTCC------CCCT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred Hhhhcc------CCcc----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001110 0111 12346889999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=314.54 Aligned_cols=239 Identities=24% Similarity=0.374 Sum_probs=194.4
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccch------hHHHHHHHHHHHhhcC--CCCccceeeEEEecCe
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH------RTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQ 305 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~--h~nIv~~~~~~~~~~~ 305 (557)
..|++.+.||+|+||.||+|... +++.||+|++...... ..+.+.+|+.+++.++ |+||+++++++...+.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 34566899999999999999864 6889999998653211 2245678999999996 5999999999999999
Q ss_pred eEEEEEecCC-CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC-CCCcEEEecccC
Q 008707 306 RILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD-INMRAKVSDFGL 383 (557)
Q Consensus 306 ~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~-~~~~~kl~Dfgl 383 (557)
.++|||++.+ ++|.+++.. ...+++..++.++.||++||+|||+ .+|+||||||+||+++ +++.+||+|||+
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~ 196 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGS 196 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence 9999999976 899999874 3568999999999999999999998 9999999999999999 789999999999
Q ss_pred ccccCCCCccccccccCCCCccCCcccCCCCC-CcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc
Q 008707 384 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462 (557)
Q Consensus 384 a~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~-s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 462 (557)
+....... .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.... . +..+..
T Consensus 197 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~-~~~~~~ 260 (320)
T 3a99_A 197 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------E-IIRGQV 260 (320)
T ss_dssp CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------H-HHHCCC
T ss_pred cccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------h-hhcccc
Confidence 98765432 223458999999999876655 688999999999999999999997321 0 111111
Q ss_pred cccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 463 ISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 463 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
. .... .+..+.+++.+||+.||++|||++||++
T Consensus 261 ~------~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 F------FRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp C------CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c------cccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 1111 2236889999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=322.64 Aligned_cols=246 Identities=24% Similarity=0.338 Sum_probs=183.1
Q ss_pred HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEEEecCC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
+++.+.||+|+||+||.....+++.||||++..... ..+.+|+++++.+ +||||+++++++.+....++||||+.
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~- 101 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA- 101 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence 344688999999997666566799999999865332 2355799999999 79999999999999999999999995
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC-----CCcEEEecccCccccCCC
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfgla~~~~~~ 390 (557)
|+|.+++... ........++.++.||+.||+|||+ .+|+||||||+|||++. ...+||+|||++......
T Consensus 102 g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 102 ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 6999999753 2334445667899999999999999 99999999999999953 235889999999876533
Q ss_pred Cc--cccccccCCCCccCCcccC---CCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 391 LT--HISSVARGTVGYLDPEYYG---NQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 391 ~~--~~~~~~~g~~~y~aPE~l~---~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
.. .......||+.|+|||++. ...++.++|||||||++|||+| |..||....... ........ ...
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~-~~~ 248 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGAC-SLD 248 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCC-CCT
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccC-Ccc
Confidence 21 1223456999999999997 4567889999999999999999 999996322110 11111111 111
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
... ........+.+++.+||+.||++|||++||++
T Consensus 249 ~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 249 CLH------PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TSC------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccC------ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111 11233446789999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=297.03 Aligned_cols=234 Identities=14% Similarity=0.189 Sum_probs=182.4
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
..|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+.++..++||||+++++++.+++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 44667799999999999999886 489999999975432 33467899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||++|++|.+++.. . .....+..++.|++.||+|||+ +||+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999853 2 3556788899999999999998 999999999999999999999998543
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
|++ .++.++||||||+++|||+||+.||...+......... ... .+.. ..+
T Consensus 175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~-~~~~---~~~-- 225 (286)
T 3uqc_A 175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDT-AGQP---IEP-- 225 (286)
T ss_dssp -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCT-TSCB---CCH--
T ss_pred -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHh-ccCC---CCh--
Confidence 333 25889999999999999999999998554322110000 000 0000 000
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
.......+..+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus 226 -~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 226 -ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp -HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred -hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 00011223468899999999999999 99999999999886543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=335.52 Aligned_cols=240 Identities=18% Similarity=0.286 Sum_probs=193.1
Q ss_pred HHHHhhcccCCCCceEEEEEEEc--CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCe-----e
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK--DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQ-----R 306 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~-----~ 306 (557)
..|++.+.||+|+||.||+|.+. +|+.||||++.... ....+.+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 45667899999999999999876 58999999986543 3445678899999999999999999999987665 6
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++||||+++++|.+++. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.+ .+||+|||++..
T Consensus 160 ~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 99999999999988765 268999999999999999999998 999999999999999975 899999999987
Q ss_pred cCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
.... ....||+.|+|||++.+.. +.++||||||+++|+|++|..||.........
T Consensus 231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------- 285 (681)
T 2pzi_A 231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------- 285 (681)
T ss_dssp TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-------------------
T ss_pred cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc-------------------
Confidence 6543 2345899999999987654 88999999999999999999888632211000
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhhh
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSIK 512 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-t~~evl~~L~~~~~ 512 (557)
...........+.+++.+||+.||++|| +++++.+.|.....
T Consensus 286 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 ----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp ----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0000112234688999999999999999 57777777776543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=306.27 Aligned_cols=243 Identities=18% Similarity=0.232 Sum_probs=183.7
Q ss_pred HHHHHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCcc--------chhHHHHHHHHHHHhhcC---------CCCcc
Q 008707 232 LEEATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--------SHRTQQFVTEVALLSRIH---------HRNLV 294 (557)
Q Consensus 232 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~il~~l~---------h~nIv 294 (557)
+....|++.+.||+|+||.||+|.+ +|+.||||++.... ....+.+.+|+++++.++ ||||+
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred cccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 3356788899999999999999988 58999999986542 223367889999999886 65655
Q ss_pred ceeeE-----------------EEe-------------cCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHH
Q 008707 295 PLIGY-----------------CEE-------------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAA 344 (557)
Q Consensus 295 ~~~~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia 344 (557)
++.+. +.+ .+..++||||+++|++.+.+. ...+++..+..++.||+
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLT 171 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHH
Confidence 55554 333 678999999999997766664 25589999999999999
Q ss_pred HHHHHHH-cCCCCCeEeeccCCCCEEeCCCC--------------------cEEEecccCccccCCCCccccccccCCCC
Q 008707 345 KGLEYLH-TGCNPGIIHRDVKSSNILLDINM--------------------RAKVSDFGLSRQAEEDLTHISSVARGTVG 403 (557)
Q Consensus 345 ~aL~~LH-~~~~~~ivH~dlk~~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~g~~~ 403 (557)
.||+||| + .+|+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 8 9999999999999999887 8999999999876532 2358999
Q ss_pred ccCCcccCCCCCCcccceehhHHH-HHHHHhCCCCCCCCCccccccHHHHHHHHHh-cCCccccccccccCCCCHHHHHH
Q 008707 404 YLDPEYYGNQQLTEKSDVYSFGVV-LLELISGKKPVSVEDFGAELNIVHWARSMIK-KGDVISIVDPVLIGNVKIESIWR 481 (557)
Q Consensus 404 y~aPE~l~~~~~s~~~DvwslG~l-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~ 481 (557)
|+|||++.+.. +.++||||++++ .+++++|..||... .........+. ..... ..............
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~ 311 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRK 311 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhccC----cccchhhhhhcCHH
Confidence 99999998766 889999998777 77888999998521 00011111111 11110 00011112345678
Q ss_pred HHHHHHHccccCCCCCCCHHHHH
Q 008707 482 IAEVAIQCVEQRGFSRPKMQEIV 504 (557)
Q Consensus 482 l~~li~~cl~~~P~~RPt~~evl 504 (557)
+.+++.+||+.| |++|++
T Consensus 312 ~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 312 IQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHhccC-----CHHHHH
Confidence 999999999976 899987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=291.61 Aligned_cols=221 Identities=22% Similarity=0.301 Sum_probs=173.6
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHH-hhcCCCCccceeeEEEe----cCeeEEEEEecC
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALL-SRIHHRNLVPLIGYCEE----EHQRILVYEYMH 314 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il-~~l~h~nIv~~~~~~~~----~~~~~lv~e~~~ 314 (557)
+.||+|+||.||+|... +++.||+|++... ..+.+|++++ +.++||||+++++++.. ....++||||++
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 98 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLD 98 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecC
Confidence 77999999999999874 6899999998642 4566888888 55589999999999877 677899999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC---CCcEEEecccCccccCCCC
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~ 391 (557)
+|+|.+++... ....+++..++.++.|++.||+|||+ .+++||||||+||+++. ++.+||+|||++.....
T Consensus 99 ~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~-- 172 (299)
T 3m2w_A 99 GGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG-- 172 (299)
T ss_dssp SCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT--
T ss_pred CCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccccccc--
Confidence 99999999864 34568999999999999999999998 99999999999999998 78899999999865432
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
..++.++||||||+++|+|++|+.||........ ........... .
T Consensus 173 ---------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~~~~~~~--~ 218 (299)
T 3m2w_A 173 ---------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMKTRIRMG--Q 218 (299)
T ss_dssp ---------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSCCSSCTT--C
T ss_pred ---------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHHHHHhhc--c
Confidence 3457899999999999999999999974322110 00000000000 0
Q ss_pred CCCC----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 472 GNVK----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 472 ~~~~----~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
...+ ...+..+.+++.+||+.||++|||+.|+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0011 1123478899999999999999999999873
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=307.54 Aligned_cols=237 Identities=16% Similarity=0.126 Sum_probs=177.0
Q ss_pred hhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc---hhHHHHHHHHHHHhhcCC-CCcccee----------------
Q 008707 239 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---HRTQQFVTEVALLSRIHH-RNLVPLI---------------- 297 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h-~nIv~~~---------------- 297 (557)
..+.||+|+||.||+|.+. +|+.||||++..... ...+.+.+|+.+++.++| +|.....
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 4578999999999999865 689999999874322 235678999999999977 3221111
Q ss_pred -----eEEEe-----cCeeEEEEEecCCCChhhhhhcc----CCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeecc
Q 008707 298 -----GYCEE-----EHQRILVYEYMHNGTLRDRLHGS----VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDV 363 (557)
Q Consensus 298 -----~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~----~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dl 363 (557)
.++.. ....+++|+.+ +++|.+++... .....+++..++.++.||++||+|||+ ++|+||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCc
Confidence 11111 12346667765 78999888421 124567888999999999999999998 99999999
Q ss_pred CCCCEEeCCCCcEEEecccCccccCCCCccccccccCCCCccCCccc----------CCCCCCcccceehhHHHHHHHHh
Q 008707 364 KSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY----------GNQQLTEKSDVYSFGVVLLELIS 433 (557)
Q Consensus 364 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l----------~~~~~s~~~DvwslG~ll~ellt 433 (557)
||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|||+|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt 312 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence 999999999999999999998875543 233457 999999999 66678899999999999999999
Q ss_pred CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 434 GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 434 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
|+.||.......... ..+.. .... +..+.+++.+||+.||++||++.|+++
T Consensus 313 g~~Pf~~~~~~~~~~---------------~~~~~--~~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 313 ADLPNTDDAALGGSE---------------WIFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp SSCCCCTTGGGSCSG---------------GGGSS--CCCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcchhhhHH---------------HHHhh--cccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999997443221110 00100 0112 246889999999999999999877754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-30 Score=275.92 Aligned_cols=186 Identities=17% Similarity=0.144 Sum_probs=130.1
Q ss_pred cccCCCCceEEEEEE-EcCCcEEEEEEccCcc----------chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEE
Q 008707 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSC----------SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~l 308 (557)
...+.|++|.+..++ .-.|+.+++|++.... ....++|.+|+++|+++ .|+||+++++++++++..||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 456777777776653 3358899999986431 12335699999999999 69999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||||++|++|.++|.. ...++.. +|+.||+.||+|+|+ +||+||||||+|||++.++.+||+|||+|+...
T Consensus 320 VMEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EEECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EEecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 9999999999999984 4556553 589999999999999 999999999999999999999999999998765
Q ss_pred CCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCC
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~p 437 (557)
..... .....||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 391 ~~~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDCSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCcc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 44332 233459999999999976 456789999999998877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-26 Score=245.51 Aligned_cols=183 Identities=17% Similarity=0.204 Sum_probs=145.5
Q ss_pred hcccCCCCceEEEEEEEcCCcEEEEEEccCccc--------hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 240 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
.+.||+|+||.||+|... ++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++|||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 578999999999999554 78889987543211 123458999999999999999977777667778899999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++++|.+++.. +..++.|+++||+|||+ ++|+||||||+|||++. .+||+|||+++......
T Consensus 420 ~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 420 YINGKLAKDVIED-----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp CCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred CCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 9999999999873 45899999999999998 99999999999999998 99999999999875532
Q ss_pred ccc------cccccCCCCccCCcccCC--CCCCcccceehhHHHHHHHHhCCCCCC
Q 008707 392 THI------SSVARGTVGYLDPEYYGN--QQLTEKSDVYSFGVVLLELISGKKPVS 439 (557)
Q Consensus 392 ~~~------~~~~~g~~~y~aPE~l~~--~~~s~~~DvwslG~ll~elltg~~pf~ 439 (557)
... .....||+.|+|||++.. ..|+...|+|+..+-..+-+.++.+|.
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 221 234568999999999987 567888999999888888887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2e-23 Score=205.46 Aligned_cols=140 Identities=15% Similarity=0.112 Sum_probs=114.9
Q ss_pred hcccCCCCceEEEEEEEcCCcEEEEEEccCccc------------------hhHHHHHHHHHHHhhcCCCCccceeeEEE
Q 008707 240 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS------------------HRTQQFVTEVALLSRIHHRNLVPLIGYCE 301 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 301 (557)
.+.||+|+||.||+|.+.+|+.||+|+++.... .....+.+|+++++.++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 488999999999999987799999999864321 13456889999999999 5 67777654
Q ss_pred ecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecc
Q 008707 302 EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDF 381 (557)
Q Consensus 302 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Df 381 (557)
. +..++||||++|++|.+ +.. .....++.|++.||+|||+ .||+||||||+|||++ ++.+||+||
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred c-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 4 56799999999999988 431 1244799999999999998 9999999999999999 999999999
Q ss_pred cCccccCCCCccccccccCCCCccCCcccC
Q 008707 382 GLSRQAEEDLTHISSVARGTVGYLDPEYYG 411 (557)
Q Consensus 382 gla~~~~~~~~~~~~~~~g~~~y~aPE~l~ 411 (557)
|+++. +..+.|||.+.
T Consensus 237 G~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TTCEE--------------TTSTTHHHHHH
T ss_pred CCCeE--------------CCCCCHHHHHH
Confidence 99863 34567888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.9e-19 Score=174.68 Aligned_cols=135 Identities=23% Similarity=0.247 Sum_probs=104.4
Q ss_pred hhcccCCCCceEEEEEEE-cCCcE--EEEEEccCccch------------------------hHHHHHHHHHHHhhcCCC
Q 008707 239 FCKKIGKGSFGSVYYGKM-KDGKE--VAVKIMADSCSH------------------------RTQQFVTEVALLSRIHHR 291 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~il~~l~h~ 291 (557)
+.+.||+|+||.||+|.+ .+|+. ||||+++..... ....+.+|++++..+.|+
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 130 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA 130 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHT
T ss_pred hCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhC
Confidence 457899999999999988 67888 999986542111 113678899999999888
Q ss_pred Cc--cceeeEEEecCeeEEEEEecCC-C----ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHH-cCCCCCeEeecc
Q 008707 292 NL--VPLIGYCEEEHQRILVYEYMHN-G----TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH-TGCNPGIIHRDV 363 (557)
Q Consensus 292 nI--v~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH-~~~~~~ivH~dl 363 (557)
++ +.+++. +..++||||+.+ | +|.+.... .++..+..++.|++.||.||| + .||+||||
T Consensus 131 ~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~---~givHrDl 197 (258)
T 1zth_A 131 GVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQE---AELVHADL 197 (258)
T ss_dssp TCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSC
T ss_pred CCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCC
Confidence 64 333332 357899999942 4 66665432 223456789999999999999 7 99999999
Q ss_pred CCCCEEeCCCCcEEEecccCccccC
Q 008707 364 KSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 364 k~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
||.|||++. .++|+|||+|....
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEETT
T ss_pred CHHHEEEcC--cEEEEECcccccCC
Confidence 999999998 99999999997653
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.69 E-value=2.9e-17 Score=164.15 Aligned_cols=141 Identities=28% Similarity=0.535 Sum_probs=121.4
Q ss_pred HHHHHhhhhcC----CCCCCC-CCCCCCCCCeEEeeCC-CCCceEEEEecCCCccc--cCCccccCCCCCcEEECcC-CC
Q 008707 4 EALRSISDESE----RTNDRG-DPCVPVPWEWVTCSTT-TPPRITKIALSGKNLKG--EIPPELKNMEALTELWLDG-NF 74 (557)
Q Consensus 4 ~~~~~~~~~~~----~~~~~~-~~c~~~~~~~v~c~~~-~p~~l~~L~L~~n~l~~--~~p~~~~~l~~L~~L~l~~-N~ 74 (557)
.||.++|+++. +.+|+. ++||.+.|.||+|... ...+++.|+|++|+++| .+|..+.++++|+.|+|++ |.
T Consensus 9 ~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~ 88 (313)
T 1ogq_A 9 QALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88 (313)
T ss_dssp HHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETT
T ss_pred HHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCc
Confidence 57888888873 458963 3455567999999763 23689999999999999 8999999999999999995 99
Q ss_pred CCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccccccccCCCCCCcccc--cCceeeeecCCCc
Q 008707 75 LTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL--TGKVIFKYDNNPK 144 (557)
Q Consensus 75 l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~--~~~~~~~~~~n~~ 144 (557)
+.+.+| .|.++++|++|+|++|++++.+|..+..+++|++|++++|++.+.+|..+. ..+..+.+++|..
T Consensus 89 l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 161 (313)
T 1ogq_A 89 LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred ccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcc
Confidence 999888 699999999999999999999999999999999999999999988998764 3567778888864
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=9e-17 Score=148.64 Aligned_cols=122 Identities=23% Similarity=0.299 Sum_probs=109.3
Q ss_pred CCCCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecC
Q 008707 25 PVPWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLEN 95 (557)
Q Consensus 25 ~~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~ 95 (557)
.|.|..|.|+. ..|++|+.|+|++|.|+ .+|..|.++++|+.|+|++|+|+++++ .|.++++|+.|+|++
T Consensus 9 ~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 9 TCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 56788899976 34678999999999999 899999999999999999999999988 599999999999999
Q ss_pred ccccCcCCCccCCCCcccccccccccCCCCCCccccc---CceeeeecCCCccccc
Q 008707 96 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 96 N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~~~~ 148 (557)
|+|++..|..|..+++|+.|++++|+|+ .+|...+. .+..+.+.+||+.|++
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~C~c 142 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGANPLYCDC 142 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCC-BCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCC-eeChhhhhcCccccEEEeCCCCeecCC
Confidence 9999777778999999999999999999 78887554 5577899999999975
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.6e-16 Score=158.94 Aligned_cols=138 Identities=16% Similarity=0.152 Sum_probs=99.4
Q ss_pred HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccc--------------hhHH--------HHHHHHHHHhhcCCCCcc
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS--------------HRTQ--------QFVTEVALLSRIHHRNLV 294 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~il~~l~h~nIv 294 (557)
|++...||+|+||.||+|...+|+.||||+++.... .... ...+|+..|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 345678999999999999999999999998753210 0001 123566677777544432
Q ss_pred ceeeEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC
Q 008707 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM 374 (557)
Q Consensus 295 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~ 374 (557)
...-+.. ...++||||++|++|.+.... .....++.|++.+|.+||+ .|||||||||.|||+++++
T Consensus 177 vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 177 VPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEK 242 (397)
T ss_dssp CCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEE
T ss_pred CCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCC
Confidence 2221211 234799999999888765431 1235688999999999998 9999999999999998776
Q ss_pred ----------cEEEecccCccccC
Q 008707 375 ----------RAKVSDFGLSRQAE 388 (557)
Q Consensus 375 ----------~~kl~Dfgla~~~~ 388 (557)
.+.|+||+-+....
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETT
T ss_pred CcccccccccceEEEEeCCcccCC
Confidence 38999999776543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.63 E-value=9.6e-16 Score=145.81 Aligned_cols=104 Identities=23% Similarity=0.329 Sum_probs=83.3
Q ss_pred CCCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCc
Q 008707 26 VPWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENN 96 (557)
Q Consensus 26 ~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N 96 (557)
|+|++|.|+. +.|++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+.+++. |..+++|+.|+|++|
T Consensus 19 Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 19 CSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp EETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred EeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 3799999987 3467899999999999977788888889999999999998877774 788888888888888
Q ss_pred cccCcCCCccCCCCcccccccccccCCCCCCccc
Q 008707 97 ELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130 (557)
Q Consensus 97 ~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~ 130 (557)
+|++..+..|..+++|+.|++++|+|. .+|..+
T Consensus 99 ~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~ 131 (229)
T 3e6j_A 99 QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGI 131 (229)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTG
T ss_pred cCCccChhHhCcchhhCeEeccCCccc-ccCccc
Confidence 888544555677777777777777777 676654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.63 E-value=6e-16 Score=142.97 Aligned_cols=126 Identities=19% Similarity=0.233 Sum_probs=108.6
Q ss_pred CCCCCCCCeEEeeCC--------CCCceEEEEecCCCccccCCc-cccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEE
Q 008707 22 PCVPVPWEWVTCSTT--------TPPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIV 91 (557)
Q Consensus 22 ~c~~~~~~~v~c~~~--------~p~~l~~L~L~~n~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L 91 (557)
.| .|.|+.+.|+.. .|.+++.|+|++|+|++..+. .|..+++|+.|+|++|+|++.+| .|.++++|+.|
T Consensus 5 ~C-~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 83 (192)
T 1w8a_A 5 MC-HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL 83 (192)
T ss_dssp TS-EEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CC-EECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEE
Confidence 35 578999999872 456899999999999955554 38999999999999999999988 59999999999
Q ss_pred EecCccccCcCCCccCCCCcccccccccccCCCCCCcccc--cCceeeeecCCCccccc
Q 008707 92 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL--TGKVIFKYDNNPKLHKE 148 (557)
Q Consensus 92 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~--~~~~~~~~~~n~~~~~~ 148 (557)
+|++|+|++..|..|..+++|+.|++++|+|++.+|..+. ..+..+.+++|++.|+.
T Consensus 84 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 84 QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred ECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 9999999977788899999999999999999966666553 35678899999999874
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.9e-15 Score=137.61 Aligned_cols=125 Identities=20% Similarity=0.307 Sum_probs=107.7
Q ss_pred CCCCCCCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEE
Q 008707 22 PCVPVPWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVH 92 (557)
Q Consensus 22 ~c~~~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~ 92 (557)
.| .|.|++|.|+. ..+++|+.|+|++|++++..+..|.++++|+.|+|++|+|++.++. |..+++|+.|+
T Consensus 4 ~C-~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (177)
T 2o6r_A 4 RC-SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILY 82 (177)
T ss_dssp TC-EEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CC-EeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEE
Confidence 46 57899999987 2367899999999999966666789999999999999999998885 89999999999
Q ss_pred ecCccccCcCCCccCCCCcccccccccccCCCCCCccccc---CceeeeecCCCccccc
Q 008707 93 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 93 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~~~~ 148 (557)
|++|+|++..+..+..+++|+.|++++|+++ .+|...+. .+..+.+.+|++.|..
T Consensus 83 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 83 LHENKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCCCCccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeeccC
Confidence 9999999666666889999999999999999 78877643 5677889999998853
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.61 E-value=6.6e-16 Score=173.26 Aligned_cols=139 Identities=20% Similarity=0.281 Sum_probs=118.5
Q ss_pred HHHHHHhhhhcCCCCCCCCC------CCCCCC------------CeEEeeCCCCCceEEEEecCCCccccCCccccCCCC
Q 008707 3 LEALRSISDESERTNDRGDP------CVPVPW------------EWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEA 64 (557)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~------c~~~~~------------~~v~c~~~~p~~l~~L~L~~n~l~~~~p~~~~~l~~ 64 (557)
..||+++++++.-.+|+.+. |++|.| .||+|++. .+++.|+|++|+++|.+|++|++|++
T Consensus 271 ~~ALl~~k~~l~~~~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~--~~V~~L~Ls~~~L~G~ip~~l~~L~~ 348 (876)
T 4ecn_A 271 YKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNN--GRVTGLSLAGFGAKGRVPDAIGQLTE 348 (876)
T ss_dssp HHHHHHHHHHTTGGGCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTT--SCEEEEECTTTCCEEEECGGGGGCTT
T ss_pred HHHHHHHHHHcCCCCCCcCCCcccccCCccccccccccccccCcCceEecCC--CCEEEEECccCCCCCcCchHHhcccc
Confidence 36899999998666895322 335789 99999873 68999999999999999999999999
Q ss_pred CcEEEC-cCCCCCCC-----------------------------------------------------------------
Q 008707 65 LTELWL-DGNFLTGP----------------------------------------------------------------- 78 (557)
Q Consensus 65 L~~L~l-~~N~l~~~----------------------------------------------------------------- 78 (557)
|+.|+| ++|.++|.
T Consensus 349 L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l 428 (876)
T 4ecn_A 349 LKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428 (876)
T ss_dssp CCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTT
T ss_pred ceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccccchhhc
Confidence 999999 77765443
Q ss_pred -----------CC-CccCCCCCcEEEecCccccC-----------------cCCCccC--CCCcccccccccccCCCCCC
Q 008707 79 -----------LP-DMSRLIDLRIVHLENNELTG-----------------SLPSYMG--SLPNLQELHIENNSFVGEIP 127 (557)
Q Consensus 79 -----------~~-~~~~l~~L~~L~l~~N~l~~-----------------~~p~~~~--~l~~L~~l~l~~N~~~~~~p 127 (557)
+| .|+++++|+.|+|++|+|+| .+|..++ ++++|+.|++++|++.|.+|
T Consensus 429 ~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP 508 (876)
T 4ecn_A 429 QIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLP 508 (876)
T ss_dssp TTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCC
T ss_pred eeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccCh
Confidence 55 68999999999999999997 3999988 99999999999999999999
Q ss_pred ccccc--CceeeeecCCC
Q 008707 128 PALLT--GKVIFKYDNNP 143 (557)
Q Consensus 128 ~~~~~--~~~~~~~~~n~ 143 (557)
..+.. .+..+.+++|.
T Consensus 509 ~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 509 DFLYDLPELQSLNIACNR 526 (876)
T ss_dssp GGGGGCSSCCEEECTTCT
T ss_pred HHHhCCCCCCEEECcCCC
Confidence 87754 56778888887
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.57 E-value=6.2e-15 Score=139.22 Aligned_cols=100 Identities=26% Similarity=0.358 Sum_probs=57.9
Q ss_pred CCCCCCCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEE
Q 008707 22 PCVPVPWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVH 92 (557)
Q Consensus 22 ~c~~~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~ 92 (557)
.| .|.|..|.|+. ..|++++.|+|++|+|++..+..|.++++|+.|+|++|+|+++.| .|.++++|+.|+
T Consensus 8 ~C-~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~ 86 (220)
T 2v9t_B 8 AC-TCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLV 86 (220)
T ss_dssp TS-EEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEE
T ss_pred CC-EECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEE
Confidence 35 56888999976 234566677777776664444456666666666666666666554 355555555555
Q ss_pred ecCccccCcCCC-ccCCCCcccccccccccCC
Q 008707 93 LENNELTGSLPS-YMGSLPNLQELHIENNSFV 123 (557)
Q Consensus 93 l~~N~l~~~~p~-~~~~l~~L~~l~l~~N~~~ 123 (557)
|++|+|+ .+|. .|..+++|+.|++++|+|.
T Consensus 87 Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~ 117 (220)
T 2v9t_B 87 LYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN 117 (220)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCCcCC-ccCHhHccCCCCCCEEECCCCCCC
Confidence 5555555 3332 2344444444444444444
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.56 E-value=4e-15 Score=163.12 Aligned_cols=135 Identities=21% Similarity=0.263 Sum_probs=114.5
Q ss_pred HHHHHhhhhcCCC-------------CCCC-CCCCCCCC---CeEEeeCCCCCceEEEEecCCCccccCCccccCCCCCc
Q 008707 4 EALRSISDESERT-------------NDRG-DPCVPVPW---EWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALT 66 (557)
Q Consensus 4 ~~~~~~~~~~~~~-------------~~~~-~~c~~~~~---~~v~c~~~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~ 66 (557)
.||+++++++... +|+. .+| |.| .||+|+.. .+++.|+|++|+++|.+|++|++|++|+
T Consensus 33 ~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~--c~w~~~~GV~C~~~--~~V~~L~L~~~~l~g~lp~~l~~L~~L~ 108 (636)
T 4eco_A 33 LALKEIWDALNGKNWSQQGFGTQPGANWNFNKEL--DMWGAQPGVSLNSN--GRVTGLSLEGFGASGRVPDAIGQLTELE 108 (636)
T ss_dssp HHHHHHHHHTTGGGCCCCC------CCCCCSSCG--GGTTCCTTEEECTT--CCEEEEECTTSCCEEEECGGGGGCTTCC
T ss_pred HHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCc--ccccCCCCeEEcCC--CCEEEEEecCcccCCcCChHHhcCccce
Confidence 5788888877432 5753 223 369 99999875 5899999999999999999999999999
Q ss_pred EEECcCCC------------------------------------------------------------------------
Q 008707 67 ELWLDGNF------------------------------------------------------------------------ 74 (557)
Q Consensus 67 ~L~l~~N~------------------------------------------------------------------------ 74 (557)
.|+|++|.
T Consensus 109 ~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l 188 (636)
T 4eco_A 109 VLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188 (636)
T ss_dssp EEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTT
T ss_pred EEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhhh
Confidence 99999984
Q ss_pred ------CCCCCC-CccCCCCCcEEEecCccccCc-----------------CCCccC--CCCcccccccccccCCCCCCc
Q 008707 75 ------LTGPLP-DMSRLIDLRIVHLENNELTGS-----------------LPSYMG--SLPNLQELHIENNSFVGEIPP 128 (557)
Q Consensus 75 ------l~~~~~-~~~~l~~L~~L~l~~N~l~~~-----------------~p~~~~--~l~~L~~l~l~~N~~~~~~p~ 128 (557)
|++ +| .|+++++|+.|+|++|+|+|. +|..++ ++++|++|++++|++.|.+|.
T Consensus 189 ~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~ 267 (636)
T 4eco_A 189 GQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267 (636)
T ss_dssp TCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCT
T ss_pred ccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChH
Confidence 445 45 699999999999999999975 999999 999999999999999999998
Q ss_pred cccc--CceeeeecCCC
Q 008707 129 ALLT--GKVIFKYDNNP 143 (557)
Q Consensus 129 ~~~~--~~~~~~~~~n~ 143 (557)
.+.. .+..+.+++|.
T Consensus 268 ~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 268 FLKALPEMQLINVACNR 284 (636)
T ss_dssp TTTTCSSCCEEECTTCT
T ss_pred HHhcCCCCCEEECcCCC
Confidence 7754 56777888887
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=5.8e-15 Score=165.51 Aligned_cols=110 Identities=32% Similarity=0.451 Sum_probs=102.5
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
++|+.|+|++|+++|.+|.+++++++|+.|+|++|+|+|.+| .|+++++|+.|||++|+++|.+|..+..+++|+.|++
T Consensus 632 ~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~l 711 (768)
T 3rgz_A 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDL 711 (768)
T ss_dssp BCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEEC
T ss_pred ccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEEC
Confidence 578999999999999999999999999999999999999999 6999999999999999999999999999999999999
Q ss_pred ccccCCCCCCcc-cccCceeeeecCCCccccc
Q 008707 118 ENNSFVGEIPPA-LLTGKVIFKYDNNPKLHKE 148 (557)
Q Consensus 118 ~~N~~~~~~p~~-~~~~~~~~~~~~n~~~~~~ 148 (557)
++|+++|.||.. .+.......+.|||++|+.
T Consensus 712 s~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 712 SNNNLSGPIPEMGQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp CSSEEEEECCSSSSGGGSCGGGGCSCTEEEST
T ss_pred cCCcccccCCCchhhccCCHHHhcCCchhcCC
Confidence 999999999975 4555666789999999974
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=2.8e-14 Score=128.96 Aligned_cols=103 Identities=27% Similarity=0.340 Sum_probs=81.8
Q ss_pred EEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccccccc
Q 008707 42 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 120 (557)
Q Consensus 42 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 120 (557)
+.|++++|+|+ .+|..+. ++|+.|+|++|+|++++| .|.++++|+.|+|++|+|++..|..|..+++|+.|++++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 57888888888 6887663 788889999999988877 4888888999999999888555555678888999999999
Q ss_pred cCCCCCCccccc---CceeeeecCCCccccc
Q 008707 121 SFVGEIPPALLT---GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 121 ~~~~~~p~~~~~---~~~~~~~~~n~~~~~~ 148 (557)
+|+ .+|+..+. .+..+.+++|++.|.+
T Consensus 89 ~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 89 QLK-SIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred ccC-EeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 888 67765443 4567788889888864
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.51 E-value=5.4e-14 Score=131.44 Aligned_cols=121 Identities=23% Similarity=0.354 Sum_probs=97.2
Q ss_pred CCCCCCCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEE
Q 008707 22 PCVPVPWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVH 92 (557)
Q Consensus 22 ~c~~~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~ 92 (557)
.| .|.|++|.|+. ..+++++.|+|++|++++..+..|.++++|+.|+|++|+|++.++. |..+++|+.|+
T Consensus 4 ~C-~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 82 (208)
T 2o6s_A 4 RC-SCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN 82 (208)
T ss_dssp TC-EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CC-EECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEE
Confidence 45 57999999987 2367899999999999965556688999999999999999988775 78899999999
Q ss_pred ecCccccCcCCCccCCCCcccccccccccCCCCCCcccc---cCceeeeecCCCc
Q 008707 93 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPK 144 (557)
Q Consensus 93 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~---~~~~~~~~~~n~~ 144 (557)
|++|+|++..+..+..+++|+.|++++|++. .+|+..+ ..+..+.+.+|..
T Consensus 83 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l 136 (208)
T 2o6s_A 83 LSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCcCCccCHhHhcCccCCCEEEcCCCcCc-ccCHhHhccCCcCCEEECCCCcc
Confidence 9999999555556788999999999999998 6666543 3455667777754
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.50 E-value=4.7e-14 Score=133.17 Aligned_cols=124 Identities=17% Similarity=0.165 Sum_probs=65.4
Q ss_pred CCCCCeEEeeCC--------CCCceEEEEecCCCccccCC-------------------------ccccCCCCCcEEECc
Q 008707 25 PVPWEWVTCSTT--------TPPRITKIALSGKNLKGEIP-------------------------PELKNMEALTELWLD 71 (557)
Q Consensus 25 ~~~~~~v~c~~~--------~p~~l~~L~L~~n~l~~~~p-------------------------~~~~~l~~L~~L~l~ 71 (557)
.|.|+.+.|+.. .|+.++.|+|++|+|++..| ..|.++++|+.|+|+
T Consensus 10 ~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 10 RCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred EECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 467888888662 23345556666665554333 334444444444444
Q ss_pred CCCCCCCCCC-ccCCCCCcEEEecCccccCcCCCccCCCCcccccccccccCCCCCCcccc--cCceeeeecCCCccccc
Q 008707 72 GNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL--TGKVIFKYDNNPKLHKE 148 (557)
Q Consensus 72 ~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~--~~~~~~~~~~n~~~~~~ 148 (557)
+|+|++.++. |..+++|+.|+|++|+|++..|..|..+++|+.|++++|+|++..|..+. ..+..+.+.+|++.|++
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 169 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNC 169 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSG
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCC
Confidence 4444444442 44555555555555555544455555555555555555555522233322 23445666777777653
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=1.3e-13 Score=124.46 Aligned_cols=101 Identities=23% Similarity=0.268 Sum_probs=90.6
Q ss_pred CCCCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecC
Q 008707 25 PVPWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 95 (557)
Q Consensus 25 ~~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~ 95 (557)
.|.|+.+.|+. ..+++++.|+|++|+|++..|..|.++++|+.|+|++|+|+++++. |..+++|+.|+|++
T Consensus 8 ~C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 8 SCSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 57899999987 2367899999999999977788899999999999999999999885 89999999999999
Q ss_pred ccccCcCCCccCCCCcccccccccccCCCC
Q 008707 96 NELTGSLPSYMGSLPNLQELHIENNSFVGE 125 (557)
Q Consensus 96 N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~ 125 (557)
|+|++..|..|..+++|+.|++++|.+...
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 999955556789999999999999999843
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.1e-14 Score=146.18 Aligned_cols=139 Identities=19% Similarity=0.238 Sum_probs=113.0
Q ss_pred HHHHHHhhhhc--C----CCCC----CCCCCCCCCCCeEEeeC-------CCCCceEEEEecCCCccccCCccccCCCCC
Q 008707 3 LEALRSISDES--E----RTND----RGDPCVPVPWEWVTCST-------TTPPRITKIALSGKNLKGEIPPELKNMEAL 65 (557)
Q Consensus 3 ~~~~~~~~~~~--~----~~~~----~~~~c~~~~~~~v~c~~-------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L 65 (557)
-.||.+++..+ + ..+| ++++ ..|.|.|++|.. ...++++.|+|++|+++ .+|..++++++|
T Consensus 29 ~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~-~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~l~~L 106 (328)
T 4fcg_A 29 HDVLSQWQRHYNADRNRWHSAWRQANSNNP-QIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHL 106 (328)
T ss_dssp HHHHHHHHHHHHHCCTTHHHHHHHHTTTCT-TSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGGGTTC
T ss_pred HHHHHHHHHhccCCchhhhhhhcccccccc-cccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhhCCCC
Confidence 46788888765 2 2457 2222 123699999963 23468999999999999 999999999999
Q ss_pred cEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccccccCCCCCCccc-----------ccCc
Q 008707 66 TELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL-----------LTGK 134 (557)
Q Consensus 66 ~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~-----------~~~~ 134 (557)
+.|+|++|.|+.++..|..+++|+.|+|++|+++ .+|..+..+++|+.|++++|++.+.+|..+ ...+
T Consensus 107 ~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L 185 (328)
T 4fcg_A 107 QHMTIDAAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185 (328)
T ss_dssp SEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTC
T ss_pred CEEECCCCCccchhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCC
Confidence 9999999999955557999999999999999999 999999999999999999999888999877 3455
Q ss_pred eeeeecCCCc
Q 008707 135 VIFKYDNNPK 144 (557)
Q Consensus 135 ~~~~~~~n~~ 144 (557)
..+.+++|..
T Consensus 186 ~~L~L~~n~l 195 (328)
T 4fcg_A 186 QSLRLEWTGI 195 (328)
T ss_dssp CEEEEEEECC
T ss_pred CEEECcCCCc
Confidence 6666766653
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.1e-13 Score=123.61 Aligned_cols=103 Identities=22% Similarity=0.345 Sum_probs=88.3
Q ss_pred EEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccccccc
Q 008707 42 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 120 (557)
Q Consensus 42 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 120 (557)
+.|++++|+++ .+|..+. ++|+.|+|++|+|++.+| .|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 68999999998 8898775 899999999999999988 5999999999999999999544445689999999999999
Q ss_pred cCCCCCCccccc---CceeeeecCCCccccc
Q 008707 121 SFVGEIPPALLT---GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 121 ~~~~~~p~~~~~---~~~~~~~~~n~~~~~~ 148 (557)
+|. .+|+..+. .+..+.+.+|++.|..
T Consensus 92 ~l~-~l~~~~~~~l~~L~~L~L~~N~~~c~~ 121 (174)
T 2r9u_A 92 HLK-SIPRGAFDNLKSLTHIYLYNNPWDCEC 121 (174)
T ss_dssp CCC-CCCTTTTTTCTTCSEEECCSSCBCTTB
T ss_pred ccc-eeCHHHhccccCCCEEEeCCCCccccc
Confidence 999 78876443 5667889999999865
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.45 E-value=1.5e-13 Score=129.65 Aligned_cols=105 Identities=19% Similarity=0.294 Sum_probs=75.1
Q ss_pred eeCCCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-C-ccCCCCCcEEEecCccccCcCCCccCCCC
Q 008707 33 CSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-D-MSRLIDLRIVHLENNELTGSLPSYMGSLP 110 (557)
Q Consensus 33 c~~~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~ 110 (557)
|.|.. +.|++++|.++ .+|..+. ..++.|+|++|+|++.++ . |..+++|+.|+|++|+|++..|..|..++
T Consensus 9 C~C~~----~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~ 81 (220)
T 2v70_A 9 CRCEG----TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGAS 81 (220)
T ss_dssp CEEET----TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred CEECC----CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCC
Confidence 66642 48999999999 7887664 456788888888888755 3 77788888888888888855555777788
Q ss_pred cccccccccccCCCCCCccccc---CceeeeecCCCcc
Q 008707 111 NLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKL 145 (557)
Q Consensus 111 ~L~~l~l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~ 145 (557)
+|+.|++++|++. .+|...+. .+..+.+++|...
T Consensus 82 ~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~ 118 (220)
T 2v70_A 82 GVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT 118 (220)
T ss_dssp TCCEEECCSSCCC-CCCGGGGTTCSSCCEEECTTSCCC
T ss_pred CCCEEECCCCccC-ccCHhHhcCCcCCCEEECCCCcCC
Confidence 8888888888887 55554332 3455566666543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.45 E-value=2.7e-13 Score=122.89 Aligned_cols=104 Identities=18% Similarity=0.269 Sum_probs=90.2
Q ss_pred CCCCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecC
Q 008707 25 PVPWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 95 (557)
Q Consensus 25 ~~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~ 95 (557)
.|...-+.|+. ..|++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+++++. |.++++|+.|+|++
T Consensus 11 ~C~~~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 11 SCDQTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp EECSSEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred EECCcEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 45667788876 2467899999999999987888999999999999999999999885 78999999999999
Q ss_pred ccccCcCCCccCCCCcccccccccccCCCCCCcc
Q 008707 96 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPA 129 (557)
Q Consensus 96 N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~ 129 (557)
|+|++..+..|..+++|+.|++++|.+. ..+..
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~-c~~~~ 123 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD-CECRD 123 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBC-TTBGG
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcc-ccccc
Confidence 9999544445899999999999999998 55543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=1.1e-13 Score=155.03 Aligned_cols=121 Identities=22% Similarity=0.320 Sum_probs=77.1
Q ss_pred HHHHHhhhhcC----CCCCC-CCCCCCCCCCeEEeeCCCCCceEEEEecCCCcccc---CCccccCCCCCcEEECcCCCC
Q 008707 4 EALRSISDESE----RTNDR-GDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGE---IPPELKNMEALTELWLDGNFL 75 (557)
Q Consensus 4 ~~~~~~~~~~~----~~~~~-~~~c~~~~~~~v~c~~~~p~~l~~L~L~~n~l~~~---~p~~~~~l~~L~~L~l~~N~l 75 (557)
.||.++|+.+. +++|+ ++.| |.|+||+|+ ..+++.|+|+++.+.|. +|+.+.+|+.|+.++++.|.+
T Consensus 15 ~all~~k~~~~~~~~l~~W~~~~~~--C~w~gv~C~---~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l~~~~~~~ 89 (768)
T 3rgz_A 15 HQLISFKDVLPDKNLLPDWSSNKNP--CTFDGVTCR---DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHI 89 (768)
T ss_dssp HHHHHHHTTCSCTTSSTTCCTTSCG--GGSTTEEEE---TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEEECTTSCE
T ss_pred HHHHHHHhhCCCcccccCCCCCCCC--cCCcceEEC---CCcEEEEECCCCCcCCccCccChhHhccCcccccCCcCCCc
Confidence 58999998873 56896 4444 369999998 26899999999999987 666555555555555555554
Q ss_pred CCCCCCccCCCCCcEEEecCccccCcCCC--ccCCCCcccccccccccCCCCCCcc
Q 008707 76 TGPLPDMSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQELHIENNSFVGEIPPA 129 (557)
Q Consensus 76 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~~~~~~p~~ 129 (557)
...++.|+++++|++|+|++|.++|.+|. .++.+++|++|++++|.+.+.+|..
T Consensus 90 ~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~ 145 (768)
T 3rgz_A 90 NGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVS 145 (768)
T ss_dssp EECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCC
T ss_pred CCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHH
Confidence 43333455555555555555555555554 5555555555555555555444443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.43 E-value=3.7e-13 Score=132.64 Aligned_cols=108 Identities=30% Similarity=0.407 Sum_probs=75.6
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCC-ccCCCCcccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELH 116 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~l~ 116 (557)
++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|+|+ .+|. .+..+++|+.|+
T Consensus 100 ~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~ 178 (290)
T 1p9a_G 100 PALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLL 178 (290)
T ss_dssp TTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS-CCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCC-ccCHHHhcCcCCCCEEE
Confidence 4667777777777744445677777777777777777776664 667777777777777777 4443 456677777777
Q ss_pred cccccCCCCCCcccccC--ceeeeecCCCccccc
Q 008707 117 IENNSFVGEIPPALLTG--KVIFKYDNNPKLHKE 148 (557)
Q Consensus 117 l~~N~~~~~~p~~~~~~--~~~~~~~~n~~~~~~ 148 (557)
+++|+++ .+|..++.. +..+.+.+||+.|++
T Consensus 179 L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 7777777 777776653 456778899998875
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.38 E-value=4.5e-13 Score=135.56 Aligned_cols=102 Identities=21% Similarity=0.246 Sum_probs=89.3
Q ss_pred EEecCC-CccccCCccccCCCCCcEEECcC-CCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccccccc
Q 008707 44 IALSGK-NLKGEIPPELKNMEALTELWLDG-NFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 120 (557)
Q Consensus 44 L~L~~n-~l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 120 (557)
++++++ +|+ .+|. |..+++|+.|+|++ |+|+++++ .|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455666 788 6888 99999999999996 99999987 5999999999999999999888888999999999999999
Q ss_pred cCCCCCCcccccC--ceeeeecCCCccccc
Q 008707 121 SFVGEIPPALLTG--KVIFKYDNNPKLHKE 148 (557)
Q Consensus 121 ~~~~~~p~~~~~~--~~~~~~~~n~~~~~~ 148 (557)
+|+ .+|+.++.. +..+.+.+|++.|++
T Consensus 91 ~l~-~~~~~~~~~~~L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 91 ALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (347)
T ss_dssp CCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred ccc-eeCHHHcccCCceEEEeeCCCccCCC
Confidence 999 788877654 567788999999875
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.38 E-value=1.5e-12 Score=125.50 Aligned_cols=117 Identities=22% Similarity=0.274 Sum_probs=95.8
Q ss_pred CCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCcc
Q 008707 27 PWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNE 97 (557)
Q Consensus 27 ~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~ 97 (557)
.|+.|.|+. ..|++++.|+|++|++++..|..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|+
T Consensus 15 ~~~~l~~~~~~l~~~p~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 94 (251)
T 3m19_A 15 GKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94 (251)
T ss_dssp GGTEEECTTCCCSSCCSCCCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred CCeEEecCCCCccccCCCCCCCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCc
Confidence 345677765 3467899999999999977777899999999999999999998884 8999999999999999
Q ss_pred ccCcCCCccCCCCcccccccccccCCCCCCcccc---cCceeeeecCCCc
Q 008707 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPK 144 (557)
Q Consensus 98 l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~---~~~~~~~~~~n~~ 144 (557)
|++..|..|..+++|+.|++++|+|+ .+|...+ ..+..+.+++|..
T Consensus 95 l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l 143 (251)
T 3m19_A 95 LASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143 (251)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred ccccChhHhcccCCCCEEEcCCCcCC-CcChhHhccCCcccEEECcCCcC
Confidence 99666667888999999999999998 7777654 3456667777753
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.37 E-value=1.6e-12 Score=125.25 Aligned_cols=108 Identities=20% Similarity=0.276 Sum_probs=70.5
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++..|..|..+++|+.|++
T Consensus 83 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 162 (251)
T 3m19_A 83 TELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSL 162 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEEC
Confidence 4566666666666644445566667777777777777766664 566777777777777777444445667777777777
Q ss_pred ccccCCCCCCcccc---cCceeeeecCCCcccc
Q 008707 118 ENNSFVGEIPPALL---TGKVIFKYDNNPKLHK 147 (557)
Q Consensus 118 ~~N~~~~~~p~~~~---~~~~~~~~~~n~~~~~ 147 (557)
++|++. .+|+..+ ..+..+.+.+|++.|.
T Consensus 163 ~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 163 STNQLQ-SVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CSSCCS-CCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCcCC-ccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 777777 4554333 2445667777777765
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.2e-12 Score=127.62 Aligned_cols=127 Identities=22% Similarity=0.340 Sum_probs=96.3
Q ss_pred CCCCCCCCC-CCCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCC
Q 008707 17 NDRGDPCVP-VPWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLI 86 (557)
Q Consensus 17 ~~~~~~c~~-~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~ 86 (557)
.|.|..|.. ..|+.|.|+. ..|++++.|+|++|++++..+..|.++++|+.|+|++|+|+.+++. |..++
T Consensus 6 ~~~~~~C~c~~~~~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~ 85 (270)
T 2o6q_A 6 KKDGGVCSCNNNKNSVDCSSKKLTAIPSNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELK 85 (270)
T ss_dssp GGGTCSBEEETTTTEEECTTSCCSSCCSCCCTTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCT
T ss_pred CCCCCCCEeCCCCCEEEccCCCCCccCCCCCCCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCC
Confidence 355555532 1355666655 2356789999999999955556889999999999999999988775 78899
Q ss_pred CCcEEEecCccccCcCCCccCCCCcccccccccccCCCCCCcccc---cCceeeeecCCCc
Q 008707 87 DLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPK 144 (557)
Q Consensus 87 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~---~~~~~~~~~~n~~ 144 (557)
+|+.|+|++|++++..+..+..+++|+.|++++|++. .+|...+ ..+..+.+++|..
T Consensus 86 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l 145 (270)
T 2o6q_A 86 NLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145 (270)
T ss_dssp TCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccC-eeCHHHhCcCcCCCEEECCCCcC
Confidence 9999999999999555556788999999999999998 6665543 3456677777753
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.6e-12 Score=119.87 Aligned_cols=110 Identities=21% Similarity=0.274 Sum_probs=94.9
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
.++|+.|+|++|++++..+..|.++++|++|+|++|+|++.++. |..+++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 130 (208)
T 2o6s_A 51 LTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLR 130 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEE
Confidence 46899999999999955555678999999999999999998885 89999999999999999965566688999999999
Q ss_pred cccccCCCCCCcccc---cCceeeeecCCCccccc
Q 008707 117 IENNSFVGEIPPALL---TGKVIFKYDNNPKLHKE 148 (557)
Q Consensus 117 l~~N~~~~~~p~~~~---~~~~~~~~~~n~~~~~~ 148 (557)
+++|+++ .+|...+ ..+..+.+.+|++.|..
T Consensus 131 l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~ 164 (208)
T 2o6s_A 131 LYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTC 164 (208)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSCCBCCCT
T ss_pred CCCCccc-eeCHHHhccCCCccEEEecCCCeecCC
Confidence 9999999 6777644 35677889999988754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.36 E-value=1.3e-12 Score=133.04 Aligned_cols=121 Identities=20% Similarity=0.171 Sum_probs=95.5
Q ss_pred CCCCCCeEEeeC--------CCCCceEEEEecCCCccccCCcccc-CCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEe
Q 008707 24 VPVPWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHL 93 (557)
Q Consensus 24 ~~~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l 93 (557)
|.|.+..|.|+. ..|+.++.|+|++|+|++..+..+. ++++|+.|+|++|+|+++++ .|.++++|+.|+|
T Consensus 16 C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L 95 (361)
T 2xot_A 16 CLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDL 95 (361)
T ss_dssp CEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEEC
Confidence 456778889977 3466789999999999966666676 89999999999999999887 4899999999999
Q ss_pred cCccccCcCCCccCCCCcccccccccccCCCCCCccccc---CceeeeecCCCcc
Q 008707 94 ENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKL 145 (557)
Q Consensus 94 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~ 145 (557)
++|+|++..+..|..+++|+.|+|++|+|. .+++..+. .+..+.+++|...
T Consensus 96 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~ 149 (361)
T 2xot_A 96 SSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS 149 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCC
T ss_pred CCCcCCcCCHHHhCCCcCCCEEECCCCccc-EECHHHhCCcccCCEEECCCCcCC
Confidence 999999555567888999999999999988 55444333 4556677777543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.35 E-value=3.2e-13 Score=134.68 Aligned_cols=108 Identities=26% Similarity=0.309 Sum_probs=92.0
Q ss_pred eEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccccc
Q 008707 41 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 120 (557)
Q Consensus 41 l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 120 (557)
|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|.+..+++|+.|+|++|+|++.+|..+..+++|+.|++++|
T Consensus 199 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N 278 (313)
T 1ogq_A 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278 (313)
T ss_dssp CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCC
Confidence 77788888888877777888888899999999999888888888899999999999999899999999999999999999
Q ss_pred cCCCCCCccc-ccCceeeeecCCCccccc
Q 008707 121 SFVGEIPPAL-LTGKVIFKYDNNPKLHKE 148 (557)
Q Consensus 121 ~~~~~~p~~~-~~~~~~~~~~~n~~~~~~ 148 (557)
+++|.+|... +..+..+.+.+|+++|+.
T Consensus 279 ~l~~~ip~~~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 279 NLCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp EEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred cccccCCCCccccccChHHhcCCCCccCC
Confidence 9998888752 334567789999999874
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=1.1e-12 Score=143.36 Aligned_cols=108 Identities=15% Similarity=0.057 Sum_probs=93.1
Q ss_pred CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccc
Q 008707 36 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 114 (557)
Q Consensus 36 ~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 114 (557)
+.|++++.|||++|+|++..|..|.+|++|++|+|++|+|+++++ .|.++++|++|+|++|+|++..|..|.++++|+.
T Consensus 49 ~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~ 128 (635)
T 4g8a_A 49 NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQK 128 (635)
T ss_dssp SSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCE
T ss_pred CCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCE
Confidence 357789999999999996666789999999999999999999988 5999999999999999999555567899999999
Q ss_pred cccccccCCCCCCccccc---CceeeeecCCCc
Q 008707 115 LHIENNSFVGEIPPALLT---GKVIFKYDNNPK 144 (557)
Q Consensus 115 l~l~~N~~~~~~p~~~~~---~~~~~~~~~n~~ 144 (557)
|++++|+++ .+|+..+. .+..+.+.+|..
T Consensus 129 L~Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l 160 (635)
T 4g8a_A 129 LVAVETNLA-SLENFPIGHLKTLKELNVAHNLI 160 (635)
T ss_dssp EECTTSCCC-CSTTCCCTTCTTCCEEECCSSCC
T ss_pred EECCCCcCC-CCChhhhhcCcccCeeccccCcc
Confidence 999999999 78776543 456677777754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.34 E-value=3.4e-13 Score=142.90 Aligned_cols=29 Identities=10% Similarity=0.015 Sum_probs=25.0
Q ss_pred HHHHHHHHHHHhhcCCCCccceeeEEEec
Q 008707 275 TQQFVTEVALLSRIHHRNLVPLIGYCEEE 303 (557)
Q Consensus 275 ~~~~~~E~~il~~l~h~nIv~~~~~~~~~ 303 (557)
.++|..|++.+.+++|+|+|+++|||...
T Consensus 323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~ 351 (487)
T 3oja_A 323 SETERLECERENQARQREIDALKEQYRTV 351 (487)
T ss_dssp --CHHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred HHHHHHHHHHHhcccccchhhHHHHhcCh
Confidence 46799999999999999999999998764
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.34 E-value=3.4e-12 Score=124.33 Aligned_cols=109 Identities=22% Similarity=0.292 Sum_probs=82.9
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
++|+.|+|++|.+++..|..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|++++..|..|..+++|+.|++
T Consensus 109 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 188 (270)
T 2o6q_A 109 VNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKL 188 (270)
T ss_dssp SSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEEC
Confidence 5677777777777755556677788888888888888877764 778888888888888888554556778888888888
Q ss_pred ccccCCCCCCccccc---CceeeeecCCCccccc
Q 008707 118 ENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 118 ~~N~~~~~~p~~~~~---~~~~~~~~~n~~~~~~ 148 (557)
++|+++ .+|...+. .+..+.+.+||+.|++
T Consensus 189 ~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 189 DNNQLK-RVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp CSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred CCCcCC-cCCHHHhccccCCCEEEecCCCeeCCC
Confidence 888888 67765443 4567788999988875
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.3e-12 Score=120.53 Aligned_cols=91 Identities=22% Similarity=0.341 Sum_probs=85.1
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
.++|+.|+|++|.|++..|..|.++++|+.|+|++|+|++.++. |.++++|+.|+|++|+|++..|..+..+++|+.|+
T Consensus 53 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 132 (192)
T 1w8a_A 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEE
Confidence 46899999999999988899999999999999999999999985 99999999999999999988899999999999999
Q ss_pred cccccCCCCCCc
Q 008707 117 IENNSFVGEIPP 128 (557)
Q Consensus 117 l~~N~~~~~~p~ 128 (557)
+++|.+.+..+-
T Consensus 133 L~~N~l~c~c~l 144 (192)
T 1w8a_A 133 LASNPFNCNCHL 144 (192)
T ss_dssp CTTCCBCCSGGG
T ss_pred eCCCCccCcCcc
Confidence 999999976654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.32 E-value=3.5e-12 Score=120.21 Aligned_cols=110 Identities=20% Similarity=0.286 Sum_probs=99.3
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
.++|+.|+|++|.|++..|..|.++++|+.|+|++|+|+.+++. |..+++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 55 l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 134 (220)
T 2v9t_B 55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS 134 (220)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEE
Confidence 36899999999999988899999999999999999999998885 89999999999999999987788999999999999
Q ss_pred cccccCCCCCCccccc---CceeeeecCCCccccc
Q 008707 117 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 117 l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~~~~ 148 (557)
+++|+|+ .+|...+. .+..+.+.+|++.|++
T Consensus 135 L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~~~c~c 168 (220)
T 2v9t_B 135 LYDNKLQ-TIAKGTFSPLRAIQTMHLAQNPFICDC 168 (220)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred CCCCcCC-EECHHHHhCCCCCCEEEeCCCCcCCCC
Confidence 9999999 67765443 4567899999999975
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.6e-12 Score=132.31 Aligned_cols=93 Identities=22% Similarity=0.200 Sum_probs=69.6
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
.++|+.|+|++|+|++..|..|.++++|+.|+|++|+|+++++ .|.++++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 63 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 142 (361)
T 2xot_A 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY 142 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEE
Confidence 3567888888888886555667778888888888888877776 377788888888888887766667777777777777
Q ss_pred cccccCCCCCCcccc
Q 008707 117 IENNSFVGEIPPALL 131 (557)
Q Consensus 117 l~~N~~~~~~p~~~~ 131 (557)
|++|+|. .+|..++
T Consensus 143 L~~N~l~-~l~~~~~ 156 (361)
T 2xot_A 143 LSQNQIS-RFPVELI 156 (361)
T ss_dssp CCSSCCC-SCCGGGT
T ss_pred CCCCcCC-eeCHHHh
Confidence 7777777 6766553
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=2.2e-12 Score=141.08 Aligned_cols=111 Identities=16% Similarity=0.178 Sum_probs=97.5
Q ss_pred CCceEEEEecCCCcc-ccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCccccc
Q 008707 38 PPRITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 115 (557)
Q Consensus 38 p~~l~~L~L~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l 115 (557)
.+.++.|+|++|.+. +.+|..|..+++|+.|+|++|+|++++| .|.++++|+.|+|++|+|++..|..|..+++|+.|
T Consensus 468 ~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L 547 (635)
T 4g8a_A 468 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 547 (635)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEE
T ss_pred chhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEE
Confidence 578999999999854 4578889999999999999999999988 59999999999999999997777789999999999
Q ss_pred ccccccCCCCCCcccc---cCceeeeecCCCccccc
Q 008707 116 HIENNSFVGEIPPALL---TGKVIFKYDNNPKLHKE 148 (557)
Q Consensus 116 ~l~~N~~~~~~p~~~~---~~~~~~~~~~n~~~~~~ 148 (557)
++++|+|++..|..+. ..+..+.+++||+.|++
T Consensus 548 ~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 548 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp ECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred ECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 9999999955555543 35677899999999986
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.31 E-value=6.5e-12 Score=122.46 Aligned_cols=108 Identities=19% Similarity=0.253 Sum_probs=58.8
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
++|+.|+|++|++++..|..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|++++..|..+..+++|+.|++
T Consensus 109 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 188 (272)
T 3rfs_A 109 TNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRL 188 (272)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEEC
Confidence 4455555555555544444455555555555555555555553 455556666666666665444444555566666666
Q ss_pred ccccCCCCCCcccc---cCceeeeecCCCcccc
Q 008707 118 ENNSFVGEIPPALL---TGKVIFKYDNNPKLHK 147 (557)
Q Consensus 118 ~~N~~~~~~p~~~~---~~~~~~~~~~n~~~~~ 147 (557)
++|++. .+|+..+ ..+..+.+.+|++.|.
T Consensus 189 ~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~ 220 (272)
T 3rfs_A 189 YQNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCT 220 (272)
T ss_dssp CSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCcCC-ccCHHHHhCCcCCCEEEccCCCcccc
Confidence 666665 3333322 2345556666666654
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.30 E-value=1.9e-12 Score=116.51 Aligned_cols=107 Identities=22% Similarity=0.269 Sum_probs=89.9
Q ss_pred CCCCceEEEEecCCCcc-ccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccc
Q 008707 36 TTPPRITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 114 (557)
Q Consensus 36 ~~p~~l~~L~L~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 114 (557)
..|++|+.|+|++|+++ +.+|..+..+++|+.|+|++|.|++. +.|..+++|+.|+|++|++++.+|..+..+++|+.
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 45688999999999998 78898889999999999999999988 77999999999999999999768877778999999
Q ss_pred cccccccCCCCCC--cccc--cCceeeeecCCCc
Q 008707 115 LHIENNSFVGEIP--PALL--TGKVIFKYDNNPK 144 (557)
Q Consensus 115 l~l~~N~~~~~~p--~~~~--~~~~~~~~~~n~~ 144 (557)
|++++|++. .+| ..+. ..+..+.+.+|+.
T Consensus 100 L~Ls~N~l~-~~~~~~~l~~l~~L~~L~l~~N~l 132 (168)
T 2ell_A 100 LNLSGNKLK-DISTLEPLKKLECLKSLDLFNCEV 132 (168)
T ss_dssp EECBSSSCC-SSGGGGGGSSCSCCCEEECCSSGG
T ss_pred EeccCCccC-cchhHHHHhcCCCCCEEEeeCCcC
Confidence 999999998 665 3332 3456677788764
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.30 E-value=1.7e-12 Score=114.32 Aligned_cols=106 Identities=21% Similarity=0.286 Sum_probs=87.2
Q ss_pred CCCceEEEEecCCCcc-ccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccc
Q 008707 37 TPPRITKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 115 (557)
Q Consensus 37 ~p~~l~~L~L~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l 115 (557)
.|++++.|+|++|+++ +.+|..+..+++|+.|+|++|.|++. +.+..+++|+.|+|++|++++.+|..+..+++|+.|
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 4578999999999998 78888888999999999999999888 778889999999999999996688877788999999
Q ss_pred ccccccCCCCCC--cccc--cCceeeeecCCCc
Q 008707 116 HIENNSFVGEIP--PALL--TGKVIFKYDNNPK 144 (557)
Q Consensus 116 ~l~~N~~~~~~p--~~~~--~~~~~~~~~~n~~ 144 (557)
++++|+++ .+| ..+. ..+..+.+.+|+.
T Consensus 94 ~ls~N~i~-~~~~~~~~~~l~~L~~L~l~~N~l 125 (149)
T 2je0_A 94 NLSGNKIK-DLSTIEPLKKLENLKSLDLFNCEV 125 (149)
T ss_dssp ECTTSCCC-SHHHHGGGGGCTTCCEEECTTCGG
T ss_pred ECCCCcCC-ChHHHHHHhhCCCCCEEeCcCCcc
Confidence 99999998 544 4332 3456677788764
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=3.4e-12 Score=137.33 Aligned_cols=118 Identities=18% Similarity=0.198 Sum_probs=98.8
Q ss_pred CCCCCeEEeeCC----------CCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEe
Q 008707 25 PVPWEWVTCSTT----------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHL 93 (557)
Q Consensus 25 ~~~~~~v~c~~~----------~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l 93 (557)
.|+|.|+ |++. .+++|+.|+|++|++++..|..|.++++|++|+|++|+|++.+| .|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 3589998 8763 35689999999999998888899999999999999999999988 5999999999999
Q ss_pred cCccccCcCCCccCCCCcccccccccccCCC-CCCcccc--cCceeeeecCCC
Q 008707 94 ENNELTGSLPSYMGSLPNLQELHIENNSFVG-EIPPALL--TGKVIFKYDNNP 143 (557)
Q Consensus 94 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~-~~p~~~~--~~~~~~~~~~n~ 143 (557)
++|++++..|..|+.+++|++|++++|++.+ .+|..+. ..+..+.+.+|.
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 134 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESS
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCc
Confidence 9999996666679999999999999999984 2454443 345566677665
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.28 E-value=6e-12 Score=127.26 Aligned_cols=99 Identities=23% Similarity=0.290 Sum_probs=84.7
Q ss_pred CCCCCCCeEEeeCC--------CC--CceEEEEecC-CCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcE
Q 008707 23 CVPVPWEWVTCSTT--------TP--PRITKIALSG-KNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 90 (557)
Q Consensus 23 c~~~~~~~v~c~~~--------~p--~~l~~L~L~~-n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~ 90 (557)
|..|.|..|.|+.. .+ .+|+.|+|++ |.|++..|..|.+|++|+.|+|++|+|++++| .|.+|++|+.
T Consensus 5 c~~C~~~~v~~~~~n~l~~ip~l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 84 (347)
T 2ifg_A 5 CCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSR 84 (347)
T ss_dssp SCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCE
T ss_pred CccccCCEEEcCCCCCCCccCCCCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCE
Confidence 53578999999875 12 3589999996 99997777889999999999999999999999 5899999999
Q ss_pred EEecCccccCcCCC-ccCCCCcccccccccccCC
Q 008707 91 VHLENNELTGSLPS-YMGSLPNLQELHIENNSFV 123 (557)
Q Consensus 91 L~l~~N~l~~~~p~-~~~~l~~L~~l~l~~N~~~ 123 (557)
|+|++|+|+ .+|. .+..++ |+.|+|.+|.+.
T Consensus 85 L~l~~N~l~-~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 85 LNLSFNALE-SLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp EECCSSCCS-CCCSTTTCSCC-CCEEECCSSCCC
T ss_pred EeCCCCccc-eeCHHHcccCC-ceEEEeeCCCcc
Confidence 999999999 5555 455554 999999999998
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.27 E-value=5.3e-12 Score=128.02 Aligned_cols=116 Identities=21% Similarity=0.256 Sum_probs=97.9
Q ss_pred CCCCCeEEeeCC----------CCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEe
Q 008707 25 PVPWEWVTCSTT----------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHL 93 (557)
Q Consensus 25 ~~~~~~v~c~~~----------~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l 93 (557)
.|+|.++ |.+. .+++|+.|+|++|++++..+..|.++++|+.|+|++|+|++.++ .|.++++|+.|+|
T Consensus 29 ~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 29 SCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp EECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 5689987 7762 35689999999999996666689999999999999999999888 5999999999999
Q ss_pred cCccccCcCCC-ccCCCCcccccccccccCCCCCCc-ccc---cCceeeeecCCC
Q 008707 94 ENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIPP-ALL---TGKVIFKYDNNP 143 (557)
Q Consensus 94 ~~N~l~~~~p~-~~~~l~~L~~l~l~~N~~~~~~p~-~~~---~~~~~~~~~~n~ 143 (557)
++|+++ .+|. .+..+++|+.|++++|++. .+|. ..+ ..+..+.+.+|.
T Consensus 108 s~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~ 160 (353)
T 2z80_A 108 SYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160 (353)
T ss_dssp CSSCCS-SCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESS
T ss_pred CCCcCC-cCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCc
Confidence 999999 5555 4889999999999999999 7887 443 355667777774
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.2e-11 Score=119.69 Aligned_cols=139 Identities=14% Similarity=0.075 Sum_probs=108.0
Q ss_pred HhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEEecCCC
Q 008707 238 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
++...++.|+.+.||++... ++.+++|+...........+.+|+++++.+. +..+.++++++.+.+..++||||++|.
T Consensus 17 ~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 95 (263)
T 3tm0_A 17 RCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGV 95 (263)
T ss_dssp EEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSE
T ss_pred eeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCe
Confidence 34566888888999999865 6899999986432223346889999999994 677889999999888999999999999
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcC-------------------------------------------
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------------------------------------------- 353 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~------------------------------------------- 353 (557)
+|.+.+.. ......++.+++++|+.||+.
T Consensus 96 ~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 96 LCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp EHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred ehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 98876321 112346889999999999971
Q ss_pred -------------CCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 354 -------------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 354 -------------~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
....++|||+++.||+++++..+.|+||+.+.
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01458999999999999876556799998764
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=7.2e-12 Score=131.04 Aligned_cols=108 Identities=24% Similarity=0.335 Sum_probs=94.7
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
.++|+.|+|++|+++ .+| .+..+++|+.|+|++|+|++..| .|.++++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 184 l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 261 (440)
T 3zyj_A 184 LSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261 (440)
T ss_dssp CSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEE
T ss_pred ccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEE
Confidence 467889999999998 676 47888999999999999999887 599999999999999999977788899999999999
Q ss_pred cccccCCCCCCccccc---CceeeeecCCCccccc
Q 008707 117 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 117 l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~~~~ 148 (557)
|++|+++ .+|...+. .+..+.+++||+.|++
T Consensus 262 L~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 262 LAHNNLT-LLPHDLFTPLHHLERIHLHHNPWNCNC 295 (440)
T ss_dssp CTTSCCC-CCCTTTTSSCTTCCEEECCSSCEECSS
T ss_pred CCCCCCC-ccChhHhccccCCCEEEcCCCCccCCC
Confidence 9999999 78876654 4567899999999986
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=7e-12 Score=131.56 Aligned_cols=110 Identities=19% Similarity=0.229 Sum_probs=95.8
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
.++|+.|+|++|.+++..|..|.++++|+.|+|++|+|++.+| .|..+++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 298 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 377 (455)
T 3v47_A 298 FTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELA 377 (455)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEE
Confidence 3678999999999997788889999999999999999988877 588999999999999999977788899999999999
Q ss_pred cccccCCCCCCccccc---CceeeeecCCCccccc
Q 008707 117 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 117 l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~~~~ 148 (557)
+++|+++ .+|...+. .+..+.+++|++.|++
T Consensus 378 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~ 411 (455)
T 3v47_A 378 LDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 411 (455)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCCCccc-cCCHhHhccCCcccEEEccCCCcccCC
Confidence 9999999 67776543 5677889999998875
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.1e-11 Score=120.91 Aligned_cols=124 Identities=18% Similarity=0.142 Sum_probs=99.9
Q ss_pred CCCCCC-CCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcE
Q 008707 21 DPCVPV-PWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 90 (557)
Q Consensus 21 ~~c~~~-~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~ 90 (557)
|||... ....+.|.. ..|++++.|+|++|++++..+..|.++++|+.|+|++|+|++.++ .|.++++|+.
T Consensus 1 ~~C~~~~~~~~~~c~~~~l~~ip~~l~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 80 (276)
T 2z62_A 1 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLST 80 (276)
T ss_dssp CCSEEEETTTEEECTTSCCSSCCSSSCTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCceeccCCceEEecCCCccccCCCCCCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCE
Confidence 567432 222466665 246789999999999996666789999999999999999999888 5999999999
Q ss_pred EEecCccccCcCCCccCCCCcccccccccccCCCCCCcccc---cCceeeeecCCCcc
Q 008707 91 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPKL 145 (557)
Q Consensus 91 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~---~~~~~~~~~~n~~~ 145 (557)
|+|++|++++..|..+..+++|+.|++++|++. .++...+ ..+..+.+.+|...
T Consensus 81 L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~ 137 (276)
T 2z62_A 81 LILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137 (276)
T ss_dssp EECTTCCCCEECTTTTTTCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCC
T ss_pred EECCCCccCccChhhhcCCccccEEECCCCCcc-ccCchhcccCCCCCEEECcCCccc
Confidence 999999999777788999999999999999998 5555332 35566777877643
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.26 E-value=6.5e-12 Score=126.00 Aligned_cols=107 Identities=16% Similarity=0.239 Sum_probs=82.1
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
.++|+.|+|++|+|+ .+|..+.++++|+.|+|++|++++.++.+..+++|+.|+|++|++.+.+|..++.+++|+.|++
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L 260 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEEC
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEEC
Confidence 356778888888887 7777788888888888888888876667888888888888888887788888888888888888
Q ss_pred ccccCCCCCCccccc--CceeeeecCCCcc
Q 008707 118 ENNSFVGEIPPALLT--GKVIFKYDNNPKL 145 (557)
Q Consensus 118 ~~N~~~~~~p~~~~~--~~~~~~~~~n~~~ 145 (557)
++|++.+.+|..+.. .+..+.+.+|+..
T Consensus 261 ~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~ 290 (328)
T 4fcg_A 261 KDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290 (328)
T ss_dssp TTCTTCCBCCTTGGGCTTCCEEECTTCTTC
T ss_pred CCCCchhhcchhhhcCCCCCEEeCCCCCch
Confidence 888777778776543 4566677777644
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=7.1e-12 Score=122.99 Aligned_cols=109 Identities=19% Similarity=0.286 Sum_probs=65.0
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
++|+.|+|++|.+++..+..|.++++|+.|+|++|+|++.++. |..+++|+.|+|++|++++..|..+..+++|+.|++
T Consensus 129 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 208 (285)
T 1ozn_A 129 AALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208 (285)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeC
Confidence 4556666666666633334455566666666666666655553 566666666666666666555666666666666666
Q ss_pred ccccCCCCCCcccc---cCceeeeecCCCccccc
Q 008707 118 ENNSFVGEIPPALL---TGKVIFKYDNNPKLHKE 148 (557)
Q Consensus 118 ~~N~~~~~~p~~~~---~~~~~~~~~~n~~~~~~ 148 (557)
++|++. .+|...+ ..+..+.+.+|++.|++
T Consensus 209 ~~n~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~~ 241 (285)
T 1ozn_A 209 FANNLS-ALPTEALAPLRALQYLRLNDNPWVCDC 241 (285)
T ss_dssp CSSCCS-CCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred CCCcCC-cCCHHHcccCcccCEEeccCCCccCCC
Confidence 666666 4444322 24456677777777754
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.25 E-value=9e-12 Score=123.58 Aligned_cols=111 Identities=16% Similarity=0.169 Sum_probs=86.5
Q ss_pred CCceEEEEecCCCccc-cCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCccccc
Q 008707 38 PPRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 115 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l 115 (557)
.++|+.|+|++|.+++ .+|..+..+++|+.|+|++|+|++.+| .|..+++|+.|+|++|++++..+..+..+++|+.|
T Consensus 149 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 228 (306)
T 2z66_A 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVL 228 (306)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEE
T ss_pred CcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEe
Confidence 3678888888888876 577788888888888888888888776 58888888888888888885555567788888888
Q ss_pred ccccccCCCCCCccccc---CceeeeecCCCccccc
Q 008707 116 HIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 116 ~l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~~~~ 148 (557)
++++|++.+..|..+.. .+..+.+++|++.|++
T Consensus 229 ~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 229 DYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp ECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred ECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 88888888666665543 4567788888888764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.25 E-value=1.7e-11 Score=128.73 Aligned_cols=115 Identities=20% Similarity=0.235 Sum_probs=98.1
Q ss_pred CCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccc
Q 008707 28 WEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNEL 98 (557)
Q Consensus 28 ~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l 98 (557)
|..|.|+. +.|++++.|+|++|+|++..|..|.++++|+.|+|++|+|++.++ .|.++++|+.|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 46788876 346789999999999998888999999999999999999999987 599999999999999999
Q ss_pred cCcCCCccCCCCcccccccccccCCCCCCccccc---CceeeeecCCC
Q 008707 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNP 143 (557)
Q Consensus 99 ~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~---~~~~~~~~~n~ 143 (557)
++..+..|..+++|+.|++++|++. .+|...+. .+..+.+.+|.
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~ 182 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK 182 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCT
T ss_pred CccChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCC
Confidence 9555566889999999999999998 78876554 34556666644
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.25 E-value=1.9e-11 Score=120.37 Aligned_cols=107 Identities=28% Similarity=0.348 Sum_probs=92.3
Q ss_pred CCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCccccc
Q 008707 37 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 115 (557)
Q Consensus 37 ~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l 115 (557)
..++|+.|+|++|.|+ .+|..+.++++|+.|+|++|+|++.++ .|.++++|+.|+|++|+|++..|..|..+++|+.|
T Consensus 75 ~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 153 (290)
T 1p9a_G 75 TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153 (290)
T ss_dssp CCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEE
Confidence 4578999999999999 889889999999999999999999988 49999999999999999995555667889999999
Q ss_pred ccccccCCCCCCccccc---CceeeeecCCCcc
Q 008707 116 HIENNSFVGEIPPALLT---GKVIFKYDNNPKL 145 (557)
Q Consensus 116 ~l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~ 145 (557)
++++|+|+ .+|..++. .+..+.+++|...
T Consensus 154 ~L~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~ 185 (290)
T 1p9a_G 154 SLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185 (290)
T ss_dssp ECTTSCCS-CCCTTTTTTCTTCCEEECCSSCCC
T ss_pred ECCCCcCC-ccCHHHhcCcCCCCEEECCCCcCC
Confidence 99999999 88887754 4567788888654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=5.8e-12 Score=132.18 Aligned_cols=118 Identities=16% Similarity=0.179 Sum_probs=98.2
Q ss_pred CCeEEeeCC-------CCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC--CccCCCCCcEEEecCccc
Q 008707 28 WEWVTCSTT-------TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLENNEL 98 (557)
Q Consensus 28 ~~~v~c~~~-------~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~l~~L~~L~l~~N~l 98 (557)
++.|.|+.. .|++|+.|+|++|.+++..|..|.++++|++|+|++|.+.+.++ .|.++++|++|+|++|++
T Consensus 12 ~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l 91 (455)
T 3v47_A 12 GYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91 (455)
T ss_dssp TTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTT
T ss_pred ccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCcc
Confidence 334777762 46789999999999998889999999999999999999987654 499999999999999999
Q ss_pred cCcCCCccCCCCcccccccccccCCCCCCcc--c--ccCceeeeecCCCcc
Q 008707 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPA--L--LTGKVIFKYDNNPKL 145 (557)
Q Consensus 99 ~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~--~--~~~~~~~~~~~n~~~ 145 (557)
++..|..|+++++|+.|++++|++.+.+|.. + ...+..+.+++|...
T Consensus 92 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~ 142 (455)
T 3v47_A 92 LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142 (455)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCC
T ss_pred CccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccC
Confidence 9788999999999999999999998655543 2 235567778887643
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.22 E-value=1.3e-11 Score=129.58 Aligned_cols=108 Identities=23% Similarity=0.316 Sum_probs=94.8
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
.++|+.|+|++|+++ .+| .+..+++|+.|+|++|+|++.+| .|.++++|+.|+|++|++++..|..|..+++|+.|+
T Consensus 195 l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 272 (452)
T 3zyi_A 195 LFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELN 272 (452)
T ss_dssp CTTCCEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEE
Confidence 467899999999998 555 58889999999999999999888 599999999999999999988888899999999999
Q ss_pred cccccCCCCCCccccc---CceeeeecCCCccccc
Q 008707 117 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 117 l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~~~~ 148 (557)
+++|+++ .+|...+. .+..+.+++||+.|++
T Consensus 273 L~~N~l~-~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 273 LAHNNLS-SLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp CCSSCCS-CCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred CCCCcCC-ccChHHhccccCCCEEEccCCCcCCCC
Confidence 9999999 78876654 4567899999999986
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=1e-11 Score=135.30 Aligned_cols=110 Identities=19% Similarity=0.136 Sum_probs=95.7
Q ss_pred CCceEEEEecCCCccc-cCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCccccc
Q 008707 38 PPRITKIALSGKNLKG-EIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 115 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l 115 (557)
.++|+.|+|++|.+++ .+|..+..+++|+.|+|++|++++.+| .|.++++|+.|+|++|++++..|..+..+++|+.|
T Consensus 447 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 526 (606)
T 3vq2_A 447 LTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTL 526 (606)
T ss_dssp CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEE
T ss_pred CCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEE
Confidence 3678999999999987 478889999999999999999999888 48999999999999999998889999999999999
Q ss_pred ccccccCCCCCCccccc---CceeeeecCCCccccc
Q 008707 116 HIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 116 ~l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~~~~ 148 (557)
++++|+++ .+|..+.. .+..+.+.+||+.|++
T Consensus 527 ~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c 561 (606)
T 3vq2_A 527 DCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACIC 561 (606)
T ss_dssp ECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSS
T ss_pred ECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCC
Confidence 99999998 88887543 3677899999999976
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=2.4e-11 Score=132.31 Aligned_cols=123 Identities=20% Similarity=0.177 Sum_probs=97.1
Q ss_pred CCCCCC-CCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcE
Q 008707 21 DPCVPV-PWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 90 (557)
Q Consensus 21 ~~c~~~-~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~ 90 (557)
+||... .-..|.|+. ..|++++.|+|++|.+++..|..|.++++|+.|+|++|+|++.+| .|.++++|++
T Consensus 5 ~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~ 84 (606)
T 3vq2_A 5 NPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSN 84 (606)
T ss_dssp -CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred CCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCE
Confidence 466431 223577765 346789999999999997777789999999999999999999888 5899999999
Q ss_pred EEecCccccCcCCCccCCCCcccccccccccCCCCCCc-ccc--cCceeeeecCCCc
Q 008707 91 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP-ALL--TGKVIFKYDNNPK 144 (557)
Q Consensus 91 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~-~~~--~~~~~~~~~~n~~ 144 (557)
|+|++|++++..|..|+++++|++|++++|++. .+|+ .+. ..+..+.+.+|..
T Consensus 85 L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l 140 (606)
T 3vq2_A 85 LILTGNPIQSFSPGSFSGLTSLENLVAVETKLA-SLESFPIGQLITLKKLNVAHNFI 140 (606)
T ss_dssp EECTTCCCCCCCTTSSTTCTTCCEEECTTSCCC-CSSSSCCTTCTTCCEEECCSSCC
T ss_pred eECCCCcccccChhhcCCcccCCEEEccCCccc-cccccccCCCCCCCEEeCCCCcc
Confidence 999999999777889999999999999999998 5553 332 2445666677654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.21 E-value=2.7e-11 Score=121.69 Aligned_cols=117 Identities=21% Similarity=0.325 Sum_probs=100.0
Q ss_pred CCCCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecC
Q 008707 25 PVPWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLEN 95 (557)
Q Consensus 25 ~~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~ 95 (557)
.|.|+.+.|+. ..+++++.|+|++|++++..|..|.++++|+.|+|++|+|++..| .|.++++|+.|+|++
T Consensus 32 ~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 32 HCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred cccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 56899999986 235689999999999997777889999999999999999999877 599999999999999
Q ss_pred ccccCcCCCccCCCCcccccccccccCCCCCCccccc---CceeeeecCCCcc
Q 008707 96 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKL 145 (557)
Q Consensus 96 N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~ 145 (557)
|+++ .+|..+. ++|+.|++++|++. .+|...+. .+..+.+.+|...
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~ 160 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCB
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccc
Confidence 9999 8888766 79999999999998 77776543 4566778887653
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.7e-11 Score=114.86 Aligned_cols=109 Identities=23% Similarity=0.227 Sum_probs=96.7
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
.++|+.|+|++|+|++..+..|.++++|+.|+|++|+|+++++. |..+++|+.|+|++|+|+ .+|..+..+++|+.|+
T Consensus 63 l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~ 141 (229)
T 3e6j_A 63 LINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLA 141 (229)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEE
T ss_pred ccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEE
Confidence 46899999999999844445679999999999999999999885 899999999999999999 9999999999999999
Q ss_pred cccccCCCCCCccccc---CceeeeecCCCccccc
Q 008707 117 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 117 l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~~~~ 148 (557)
+++|+|. .+|...+. .+..+.+.+||+.|++
T Consensus 142 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~c~c 175 (229)
T 3e6j_A 142 LDQNQLK-SIPHGAFDRLSSLTHAYLFGNPWDCEC 175 (229)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECTTSCBCTTB
T ss_pred CCCCcCC-ccCHHHHhCCCCCCEEEeeCCCccCCc
Confidence 9999999 77766543 5677899999999875
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=2.4e-11 Score=111.98 Aligned_cols=86 Identities=26% Similarity=0.292 Sum_probs=78.2
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
++|+.|+|++|.|++..|..|.++++|+.|+|++|+|+++++ .|..+++|+.|+|++|+|++..+..|..+++|+.|++
T Consensus 54 ~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 133 (193)
T 2wfh_A 54 KHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAI 133 (193)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred cCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEe
Confidence 679999999999997777789999999999999999999998 5999999999999999999444456889999999999
Q ss_pred ccccCCC
Q 008707 118 ENNSFVG 124 (557)
Q Consensus 118 ~~N~~~~ 124 (557)
++|.+..
T Consensus 134 ~~N~~~C 140 (193)
T 2wfh_A 134 GANPLYC 140 (193)
T ss_dssp CSSCEEC
T ss_pred CCCCeec
Confidence 9999873
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.19 E-value=1.3e-11 Score=117.72 Aligned_cols=121 Identities=21% Similarity=0.319 Sum_probs=96.0
Q ss_pred CCCCCCCCCeEE--eeC-----CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCC-CCCCCC-CccCCCCCcEE
Q 008707 21 DPCVPVPWEWVT--CST-----TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF-LTGPLP-DMSRLIDLRIV 91 (557)
Q Consensus 21 ~~c~~~~~~~v~--c~~-----~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~-~~~~l~~L~~L 91 (557)
++|....|.++. |.. ..|++++.|+|++|++++..+..|.++++|+.|+|++|+ ++++++ .|.++++|+.|
T Consensus 6 ~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L 85 (239)
T 2xwt_C 6 PPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHI 85 (239)
T ss_dssp SSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEE
T ss_pred CCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEE
Confidence 356432335544 643 146789999999999996666689999999999999997 988888 69999999999
Q ss_pred EecC-ccccCcCCCccCCCCcccccccccccCCCCCCcccc--cCce---eeeecCCC
Q 008707 92 HLEN-NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL--TGKV---IFKYDNNP 143 (557)
Q Consensus 92 ~l~~-N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~--~~~~---~~~~~~n~ 143 (557)
+|++ |++++..|..|..+++|+.|++++|++. .+|. +. ..+. .+.+++|+
T Consensus 86 ~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~~L~l~~N~ 141 (239)
T 2xwt_C 86 EIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD-LTKVYSTDIFFILEITDNP 141 (239)
T ss_dssp EEEEETTCCEECTTSEECCTTCCEEEEEEECCC-SCCC-CTTCCBCCSEEEEEEESCT
T ss_pred ECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCc-cccc-cccccccccccEEECCCCc
Confidence 9999 9999555567889999999999999999 6887 22 2333 67778883
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.19 E-value=3.1e-11 Score=131.50 Aligned_cols=127 Identities=15% Similarity=0.056 Sum_probs=102.0
Q ss_pred CCCCCCCCC-CCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCC
Q 008707 18 DRGDPCVPV-PWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLID 87 (557)
Q Consensus 18 ~~~~~c~~~-~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~ 87 (557)
|.+.+|... .+.-+.|+. ..|+.++.|+|++|.|++..|..|.++++|++|+|++|+|++..| .|.++++
T Consensus 3 ~~~~~C~~~~~~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 82 (606)
T 3t6q_A 3 SSDQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHR 82 (606)
T ss_dssp ---CCCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTT
T ss_pred cccCceecccCCceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccc
Confidence 555566432 245677866 357889999999999998888899999999999999999999888 5999999
Q ss_pred CcEEEecCccccCcCCCccCCCCcccccccccccCCCCCC-ccc--ccCceeeeecCCCcc
Q 008707 88 LRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP-PAL--LTGKVIFKYDNNPKL 145 (557)
Q Consensus 88 L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p-~~~--~~~~~~~~~~~n~~~ 145 (557)
|+.|+|++|++++..|..|+.+++|+.|++++|++. .++ ..+ ...+..+.+++|...
T Consensus 83 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~-~l~~~~~~~l~~L~~L~L~~n~l~ 142 (606)
T 3t6q_A 83 LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGIS-SIDFIPLHNQKTLESLYLGSNHIS 142 (606)
T ss_dssp CCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCS-CGGGSCCTTCTTCCEEECCSSCCC
T ss_pred cCeeeCCCCcccccChhhhcccccccEeeccccCcc-cCCcchhccCCcccEEECCCCccc
Confidence 999999999999888999999999999999999998 553 333 234566677777543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=3.6e-11 Score=126.97 Aligned_cols=118 Identities=22% Similarity=0.245 Sum_probs=98.5
Q ss_pred CCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCcc
Q 008707 27 PWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE 97 (557)
Q Consensus 27 ~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~ 97 (557)
.|..|.|+. ..|++++.|+|++|+|++..|..|.++++|+.|+|++|.|++..| .|.++++|+.|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 467888876 347789999999999998778899999999999999999999987 69999999999999999
Q ss_pred ccCcCCCccCCCCcccccccccccCCCCCCcccc--cCceeeeecCCCc
Q 008707 98 LTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL--TGKVIFKYDNNPK 144 (557)
Q Consensus 98 l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~--~~~~~~~~~~n~~ 144 (557)
+++..+..|.++++|+.|++++|++.+..|..+. ..+..+.+.+|..
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l 140 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDL 140 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTC
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCcc
Confidence 9944445678999999999999999944444443 3456677788764
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=6e-11 Score=116.31 Aligned_cols=115 Identities=21% Similarity=0.299 Sum_probs=94.3
Q ss_pred eEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCcc-cc
Q 008707 30 WVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE-LT 99 (557)
Q Consensus 30 ~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~-l~ 99 (557)
-|.|+. ..|++++.|+|++|++++..+..|.++++|+.|+|++|.|++..| .|..+++|+.|+|++|. ++
T Consensus 15 ~~~c~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~ 94 (285)
T 1ozn_A 15 TTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 94 (285)
T ss_dssp EEECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCC
T ss_pred EEEcCcCCcccCCcCCCCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCcc
Confidence 466765 347789999999999997666789999999999999999999877 69999999999999997 88
Q ss_pred CcCCCccCCCCcccccccccccCCCCCCcccc--cCceeeeecCCCc
Q 008707 100 GSLPSYMGSLPNLQELHIENNSFVGEIPPALL--TGKVIFKYDNNPK 144 (557)
Q Consensus 100 ~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~--~~~~~~~~~~n~~ 144 (557)
...|..+..+++|+.|++++|++.+..|..+. ..+..+.+.+|..
T Consensus 95 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l 141 (285)
T 1ozn_A 95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141 (285)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred ccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcc
Confidence 55578899999999999999999943343332 3556677777764
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.18 E-value=3.2e-11 Score=109.36 Aligned_cols=90 Identities=22% Similarity=0.338 Sum_probs=79.0
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
.++|+.|+|++|+|++..+..+.++++|+.|+|++|+|++.++. |..+++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~ 130 (177)
T 2o6r_A 51 LTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIW 130 (177)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred cccccEEECCCCcceEeChhHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEE
Confidence 36899999999999955556689999999999999999999885 89999999999999999954444568899999999
Q ss_pred cccccCCCCCC
Q 008707 117 IENNSFVGEIP 127 (557)
Q Consensus 117 l~~N~~~~~~p 127 (557)
+++|++.+..|
T Consensus 131 l~~N~~~~~~~ 141 (177)
T 2o6r_A 131 LHTNPWDCSCP 141 (177)
T ss_dssp CCSSCBCCCHH
T ss_pred ecCCCeeccCc
Confidence 99999996665
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.18 E-value=6.5e-11 Score=115.32 Aligned_cols=106 Identities=23% Similarity=0.299 Sum_probs=73.8
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
.++|+.|+|++|.+++..|..+.++++|+.|+|++|+|++.++. |..+++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 35677777777777755555567777777777777777777764 67777777788877777755555567777778888
Q ss_pred cccccCCCCCCcccc---cCceeeeecCCCc
Q 008707 117 IENNSFVGEIPPALL---TGKVIFKYDNNPK 144 (557)
Q Consensus 117 l~~N~~~~~~p~~~~---~~~~~~~~~~n~~ 144 (557)
+++|+++ .+|+..+ ..+..+.+.+|..
T Consensus 164 l~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l 193 (272)
T 3rfs_A 164 LSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193 (272)
T ss_dssp CCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred CCCCCcC-ccCHHHhcCCccCCEEECCCCcC
Confidence 8888777 5555432 3455666666654
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.2e-11 Score=127.27 Aligned_cols=107 Identities=18% Similarity=0.210 Sum_probs=67.1
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
++|+.|+|++|.+++..|..|.++++|+.|+|++|+|++.+..+..+++|+.|+|++|+++ .+|..+..+++|+.|+++
T Consensus 248 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~ 326 (390)
T 3o6n_A 248 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 326 (390)
T ss_dssp TTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECC
T ss_pred CCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECC
Confidence 4566666666666655566666666666666666666665545556666666666666666 555556666666666666
Q ss_pred cccCCCCCCcccccCceeeeecCCCcccc
Q 008707 119 NNSFVGEIPPALLTGKVIFKYDNNPKLHK 147 (557)
Q Consensus 119 ~N~~~~~~p~~~~~~~~~~~~~~n~~~~~ 147 (557)
+|++. .+|...+..+..+.+++|++.|+
T Consensus 327 ~N~i~-~~~~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 327 HNSIV-TLKLSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp SSCCC-CCCCCTTCCCSEEECCSSCEEHH
T ss_pred CCccc-eeCchhhccCCEEEcCCCCccch
Confidence 66666 55555555666667777776664
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=4.6e-11 Score=119.83 Aligned_cols=107 Identities=23% Similarity=0.304 Sum_probs=93.9
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
+++|+.|+|++|.+++..|..+.++++|+.|+|++|+|++.++ .|..+++|+.|+|++|+++ .+|..+..+++|+.|+
T Consensus 191 ~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~ 269 (330)
T 1xku_A 191 PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVY 269 (330)
T ss_dssp CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEE
T ss_pred cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEE
Confidence 4689999999999998888899999999999999999999888 5999999999999999999 9999999999999999
Q ss_pred cccccCCCCCCccccc---------CceeeeecCCCccc
Q 008707 117 IENNSFVGEIPPALLT---------GKVIFKYDNNPKLH 146 (557)
Q Consensus 117 l~~N~~~~~~p~~~~~---------~~~~~~~~~n~~~~ 146 (557)
+++|+++ .+|...+. ....+.+.+||..+
T Consensus 270 l~~N~i~-~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 270 LHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp CCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCG
T ss_pred CCCCcCC-ccChhhcCCcccccccccccceEeecCcccc
Confidence 9999999 77776553 23456788998764
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.17 E-value=4.3e-11 Score=131.11 Aligned_cols=106 Identities=16% Similarity=0.223 Sum_probs=97.0
Q ss_pred ceEEEEecCCCccccCCcccc--CCCCCcEEECcCCCCCCCCCCccCCCCCcEEEe------cCccccCcCCCccCCCCc
Q 008707 40 RITKIALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHL------ENNELTGSLPSYMGSLPN 111 (557)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~~~--~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l------~~N~l~~~~p~~~~~l~~ 111 (557)
+|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++++..+.++++|+.|+| ++|++.+.+|..+..+++
T Consensus 489 ~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~ 567 (636)
T 4eco_A 489 LLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPS 567 (636)
T ss_dssp GCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSS
T ss_pred CccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCCcChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCC
Confidence 8999999999999 8999887 999999999999999995557999999999999 568888899999999999
Q ss_pred ccccccccccCCCCCCcccccCceeeeecCCCcccc
Q 008707 112 LQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHK 147 (557)
Q Consensus 112 L~~l~l~~N~~~~~~p~~~~~~~~~~~~~~n~~~~~ 147 (557)
|+.|++++|++. .+|..++..+..+.+++|+..|.
T Consensus 568 L~~L~Ls~N~l~-~ip~~~~~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 568 LTQLQIGSNDIR-KVNEKITPNISVLDIKDNPNISI 602 (636)
T ss_dssp CCEEECCSSCCC-BCCSCCCTTCCEEECCSCTTCEE
T ss_pred CCEEECCCCcCC-ccCHhHhCcCCEEECcCCCCccc
Confidence 999999999994 99999988889999999998873
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.16 E-value=6e-11 Score=124.00 Aligned_cols=115 Identities=19% Similarity=0.199 Sum_probs=97.3
Q ss_pred CCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccc
Q 008707 28 WEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNEL 98 (557)
Q Consensus 28 ~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l 98 (557)
|..|.|.. ..|++++.|+|++|+|++..+..|.++++|+.|+|++|+|+++.+ .|.++++|+.|+|++|+|
T Consensus 45 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l 124 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124 (440)
T ss_dssp SCEEECCSCCCSSCCSCCCTTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCC
T ss_pred CCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcC
Confidence 56788876 346789999999999997788899999999999999999999887 599999999999999999
Q ss_pred cCcCCCccCCCCcccccccccccCCCCCCccccc---CceeeeecCCC
Q 008707 99 TGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNP 143 (557)
Q Consensus 99 ~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~---~~~~~~~~~n~ 143 (557)
+...+..|..+++|+.|++++|++. .+|...+. .+..+.+.+|.
T Consensus 125 ~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~~~ 171 (440)
T 3zyj_A 125 TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK 171 (440)
T ss_dssp SSCCTTTSCSCSSCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCT
T ss_pred CeeCHhHhhccccCceeeCCCCccc-ccCHHHhhhCcccCEeCCCCCC
Confidence 9555557899999999999999998 77776554 44556666654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.16 E-value=3.6e-11 Score=108.99 Aligned_cols=103 Identities=22% Similarity=0.255 Sum_probs=83.5
Q ss_pred CCceEEEEecCCCccccCCccccCCC-CCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCc-cCCCCccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNME-ALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQEL 115 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~l 115 (557)
+.+|+.|+|++|+++ .+|. +..+. +|+.|+|++|.|++. +.|..+++|+.|+|++|+|+ .+|.. +..+++|+.|
T Consensus 18 ~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L 93 (176)
T 1a9n_A 18 AVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTEL 93 (176)
T ss_dssp TTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEE
T ss_pred cCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCccc-ccCcchhhcCCCCCEE
Confidence 467999999999999 6664 55554 999999999999987 77999999999999999999 55644 4889999999
Q ss_pred ccccccCCCCCCc--ccc--cCceeeeecCCCcc
Q 008707 116 HIENNSFVGEIPP--ALL--TGKVIFKYDNNPKL 145 (557)
Q Consensus 116 ~l~~N~~~~~~p~--~~~--~~~~~~~~~~n~~~ 145 (557)
++++|++. .+|. .+. ..+..+.+++|+..
T Consensus 94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 99999997 7886 332 34567788888754
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.16 E-value=5.7e-11 Score=119.13 Aligned_cols=116 Identities=24% Similarity=0.409 Sum_probs=97.1
Q ss_pred CCCCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecC
Q 008707 25 PVPWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLEN 95 (557)
Q Consensus 25 ~~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~ 95 (557)
.|.|+.+.|+. ..|+.++.|+|++|++++..+..|.++++|++|+|++|+|++..| .|..+++|+.|+|++
T Consensus 30 ~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 30 QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred cCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCC
Confidence 56899999975 246789999999999996666689999999999999999999977 699999999999999
Q ss_pred ccccCcCCCccCCCCcccccccccccCCCCCCcccc---cCceeeeecCCCc
Q 008707 96 NELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPK 144 (557)
Q Consensus 96 N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~---~~~~~~~~~~n~~ 144 (557)
|+++ .+|..+. ++|+.|++++|++. .++...+ ..+..+.+.+|..
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l 157 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPL 157 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCC
T ss_pred CcCC-ccChhhc--ccccEEECCCCccc-ccCHhHhcCCccccEEECCCCcC
Confidence 9999 8888765 79999999999998 6665443 3456667777764
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.6e-11 Score=133.51 Aligned_cols=107 Identities=18% Similarity=0.210 Sum_probs=67.1
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
++|+.|+|++|.+++.+|..|.++++|+.|+|++|+|+++++.+..+++|+.|+|++|.++ .+|..+..+++|+.|+++
T Consensus 254 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~ 332 (597)
T 3oja_B 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 332 (597)
T ss_dssp TTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECC
T ss_pred CCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCCCCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECC
Confidence 4556666666666655566666666666666666666665445555666666666666666 566556666666666666
Q ss_pred cccCCCCCCcccccCceeeeecCCCcccc
Q 008707 119 NNSFVGEIPPALLTGKVIFKYDNNPKLHK 147 (557)
Q Consensus 119 ~N~~~~~~p~~~~~~~~~~~~~~n~~~~~ 147 (557)
+|++. .+|...+..+..+.+++|++.|.
T Consensus 333 ~N~l~-~~~~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 333 HNSIV-TLKLSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp SSCCC-CCCCCTTCCCSEEECCSSCEEHH
T ss_pred CCCCC-CcChhhcCCCCEEEeeCCCCCCh
Confidence 66665 55555555666667777776664
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.15 E-value=1.6e-11 Score=121.70 Aligned_cols=118 Identities=17% Similarity=0.311 Sum_probs=96.6
Q ss_pred CCCCCCCCeEEeeC--------CCCCceEEEEecCCCccccCCc-cccCCCCCcEEECcCCCCCCC---CCCccCCCCCc
Q 008707 22 PCVPVPWEWVTCST--------TTPPRITKIALSGKNLKGEIPP-ELKNMEALTELWLDGNFLTGP---LPDMSRLIDLR 89 (557)
Q Consensus 22 ~c~~~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~---~~~~~~l~~L~ 89 (557)
+| .|.|++|+|+. ..|++++.|+|++|+++ .+|. .|.++++|+.|+|++|+|+.. ++.+..+++|+
T Consensus 4 ~C-~C~~~~l~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~ 81 (306)
T 2z66_A 4 RC-SCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLK 81 (306)
T ss_dssp TC-EEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCC
T ss_pred CC-eeCCCEEEcCCCCcccCCCCCCCCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccC
Confidence 45 57899999987 24678999999999999 6665 478999999999999999865 23577899999
Q ss_pred EEEecCccccCcCCCccCCCCcccccccccccCCCCCCc-ccc---cCceeeeecCCC
Q 008707 90 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP-ALL---TGKVIFKYDNNP 143 (557)
Q Consensus 90 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~-~~~---~~~~~~~~~~n~ 143 (557)
.|+|++|.++ .+|..+..+++|+.|++++|++. .+|. ..+ ..+..+.+++|.
T Consensus 82 ~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~~l~~L~~L~l~~n~ 137 (306)
T 2z66_A 82 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTH 137 (306)
T ss_dssp EEECCSCSEE-EEEEEEETCTTCCEEECTTSEEE-SSTTTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCccc-cChhhcCCCCCCCEEECCCCccc-ccccchhhhhccCCCEEECCCCc
Confidence 9999999999 78888889999999999999998 5554 332 345666777775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.15 E-value=1.1e-10 Score=112.66 Aligned_cols=131 Identities=17% Similarity=0.086 Sum_probs=98.1
Q ss_pred ccC-CCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCC--ccceeeEEEecCeeEEEEEecCCCCh
Q 008707 242 KIG-KGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 242 ~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
.++ .|..+.||++...+|+.+++|+.... ....+.+|+++++.+.+.+ +.+++++...++..++||||++|.++
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l 102 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 102 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc
Confidence 344 56669999998777888999987643 2245778999999996444 56688888887889999999999888
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------------
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-------------------------------------------- 354 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------------------------------------- 354 (557)
. ... .. ...++.++++.|+.||+..
T Consensus 103 ~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T 1nd4_A 103 L--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 171 (264)
T ss_dssp T--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred C--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence 4 221 11 2357788888888888621
Q ss_pred -----------CCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 355 -----------NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 355 -----------~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
...++|||++|.||++++++.+.|+||+.+..
T Consensus 172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01299999999999998766667999998653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.15 E-value=3.2e-11 Score=133.79 Aligned_cols=104 Identities=27% Similarity=0.366 Sum_probs=91.4
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
+.|+.|+|++|.+. .+|..+.+|++|+.|+|++|.|+.+++.|.+|++|+.|+|++|+|+ .+|..|+.|++|+.|+|+
T Consensus 224 ~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~ 301 (727)
T 4b8c_D 224 QLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFF 301 (727)
T ss_dssp CCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCSCCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECC
T ss_pred CCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCcccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECC
Confidence 56889999999999 8998888999999999999999955557999999999999999999 889999999999999999
Q ss_pred cccCCCCCCccccc--CceeeeecCCCcc
Q 008707 119 NNSFVGEIPPALLT--GKVIFKYDNNPKL 145 (557)
Q Consensus 119 ~N~~~~~~p~~~~~--~~~~~~~~~n~~~ 145 (557)
+|.|. .||..+.. .+..+.+++|+..
T Consensus 302 ~N~l~-~lp~~~~~l~~L~~L~L~~N~l~ 329 (727)
T 4b8c_D 302 DNMVT-TLPWEFGNLCNLQFLGVEGNPLE 329 (727)
T ss_dssp SSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred CCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence 99998 89987643 5667788888754
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.14 E-value=5e-11 Score=110.15 Aligned_cols=83 Identities=19% Similarity=0.359 Sum_probs=39.5
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCcc-ccCcCCCccCCCCcccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNE-LTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~l~ 116 (557)
++|+.|+|++|.+++..|..+..+++|+.|+|++|++++..+ .+..+++|+.|+|++|. ++ .+| .+..+++|+.|+
T Consensus 88 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~ 165 (197)
T 4ezg_A 88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLN 165 (197)
T ss_dssp TTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEE
T ss_pred CCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEE
Confidence 344455555555544444444445555555555555544333 34444555555555554 33 343 344444555555
Q ss_pred cccccCC
Q 008707 117 IENNSFV 123 (557)
Q Consensus 117 l~~N~~~ 123 (557)
+++|+++
T Consensus 166 l~~n~i~ 172 (197)
T 4ezg_A 166 IQFDGVH 172 (197)
T ss_dssp CTTBCCC
T ss_pred CCCCCCc
Confidence 5555544
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.14 E-value=6.7e-11 Score=119.74 Aligned_cols=107 Identities=20% Similarity=0.201 Sum_probs=90.2
Q ss_pred CCCCCCCeEEeeC--------CCCCceEEEEecCCCccccCC-ccccCCCCCcEEECcCCCCCCCCC--CccCCCCCcE-
Q 008707 23 CVPVPWEWVTCST--------TTPPRITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRI- 90 (557)
Q Consensus 23 c~~~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~--~~~~l~~L~~- 90 (557)
.|.|.|+.|.|+. +.|++++.|+|++|+|+ .+| ..|.+|++|+.|+|++|++.+.+| .|.++++|+.
T Consensus 6 ~C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~ 84 (350)
T 4ay9_X 6 ICHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEI 84 (350)
T ss_dssp SSEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEE
T ss_pred ccEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhh
Confidence 3568899999986 34678999999999999 565 579999999999999999988766 4899998775
Q ss_pred EEecCccccCcCCCccCCCCcccccccccccCCCCCCcccc
Q 008707 91 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL 131 (557)
Q Consensus 91 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~ 131 (557)
+.+++|+|+...|..|..+++|+.|++++|++. .+|+..+
T Consensus 85 l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~-~~~~~~~ 124 (350)
T 4ay9_X 85 RIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHK 124 (350)
T ss_dssp EEEEETTCCEECTTSBCCCTTCCEEEEEEECCS-SCCCCTT
T ss_pred hcccCCcccccCchhhhhccccccccccccccc-cCCchhh
Confidence 677789999666778999999999999999998 6776543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.14 E-value=4.5e-11 Score=128.57 Aligned_cols=101 Identities=25% Similarity=0.321 Sum_probs=68.5
Q ss_pred ceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccccc
Q 008707 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 119 (557)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 119 (557)
.|+.|+|++|+|+ .+|. +++|++|+.|+|++|+|+.+++.|+++++|+.|+|++|+|+ .+| .++.+++|+.|++++
T Consensus 442 ~L~~L~Ls~n~l~-~lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~-~lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 442 DVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCN 517 (567)
T ss_dssp TCSEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCS
T ss_pred CceEEEecCCCCC-CCcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCC-CCc-ccCCCCCCcEEECCC
Confidence 4667777777777 4665 77777777777777777754446777777777777777777 366 677777777777777
Q ss_pred ccCCCCC-Ccccc--cCceeeeecCCCc
Q 008707 120 NSFVGEI-PPALL--TGKVIFKYDNNPK 144 (557)
Q Consensus 120 N~~~~~~-p~~~~--~~~~~~~~~~n~~ 144 (557)
|+|++.. |..+. ..+..+.+++|+.
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l 545 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSL 545 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcC
Confidence 7777433 55543 3455666677664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.13 E-value=8.2e-11 Score=132.06 Aligned_cols=105 Identities=17% Similarity=0.282 Sum_probs=94.8
Q ss_pred ceEEEEecCCCccccCCcccc--CCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecC------ccccCcCCCccCCCCc
Q 008707 40 RITKIALSGKNLKGEIPPELK--NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLEN------NELTGSLPSYMGSLPN 111 (557)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~~~--~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~------N~l~~~~p~~~~~l~~ 111 (557)
+|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++++..+.++++|+.|+|++ |++.+.+|..+..+++
T Consensus 729 ~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~ 807 (876)
T 4ecn_A 729 LLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPS 807 (876)
T ss_dssp GCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSCCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSS
T ss_pred CccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCccchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCC
Confidence 7999999999999 8998887 89999999999999999655799999999999976 8888899999999999
Q ss_pred ccccccccccCCCCCCcccccCceeeeecCCCccc
Q 008707 112 LQELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 146 (557)
Q Consensus 112 L~~l~l~~N~~~~~~p~~~~~~~~~~~~~~n~~~~ 146 (557)
|+.|++++|++ +.+|..++..+..+.+++|+...
T Consensus 808 L~~L~Ls~N~L-~~Ip~~l~~~L~~LdLs~N~l~~ 841 (876)
T 4ecn_A 808 LIQLQIGSNDI-RKVDEKLTPQLYILDIADNPNIS 841 (876)
T ss_dssp CCEEECCSSCC-CBCCSCCCSSSCEEECCSCTTCE
T ss_pred CCEEECCCCCC-CccCHhhcCCCCEEECCCCCCCc
Confidence 99999999999 59999988888889999998664
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=5e-11 Score=125.90 Aligned_cols=108 Identities=19% Similarity=0.241 Sum_probs=96.5
Q ss_pred CceEEEEecCCCccccCC-ccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 39 PRITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
.+|+.|+|++|+++ .+| ..+.++++|+.|+|++|+|++.++ .|..+++|+.|+|++|++++..|..|..+++|+.|+
T Consensus 224 ~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 302 (477)
T 2id5_A 224 LNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLN 302 (477)
T ss_dssp CCCSEEEEESSCCC-SCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEE
T ss_pred ccccEEECcCCccc-ccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEE
Confidence 37899999999999 566 578999999999999999999888 599999999999999999988899999999999999
Q ss_pred cccccCCCCCCccccc---CceeeeecCCCccccc
Q 008707 117 IENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 117 l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~~~~ 148 (557)
+++|+++ .+|...+. .+..+.+++|++.|++
T Consensus 303 L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 303 VSGNQLT-TLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp CCSSCCS-CCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred CCCCcCc-eeCHhHcCCCcccCEEEccCCCccCcc
Confidence 9999999 78877654 4567899999999975
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.12 E-value=3e-11 Score=109.54 Aligned_cols=88 Identities=22% Similarity=0.190 Sum_probs=79.9
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCC--ccCCCCcccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQE 114 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~ 114 (557)
.++|+.|+|++|.|++. ..+..+++|+.|+|++|+|++.++. |..+++|+.|+|++|+|+ .+|. .+..+++|+.
T Consensus 41 ~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~ 117 (176)
T 1a9n_A 41 LDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTY 117 (176)
T ss_dssp TTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCE
T ss_pred CCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCE
Confidence 35899999999999954 6799999999999999999998776 599999999999999997 7887 7889999999
Q ss_pred cccccccCCCCCCcc
Q 008707 115 LHIENNSFVGEIPPA 129 (557)
Q Consensus 115 l~l~~N~~~~~~p~~ 129 (557)
|++++|.+. .+|..
T Consensus 118 L~l~~N~i~-~~~~~ 131 (176)
T 1a9n_A 118 LCILRNPVT-NKKHY 131 (176)
T ss_dssp EECCSSGGG-GSTTH
T ss_pred EEecCCCCC-CcHhH
Confidence 999999998 78874
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.12 E-value=5.4e-11 Score=106.87 Aligned_cols=102 Identities=18% Similarity=0.222 Sum_probs=82.5
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCC--CccCCCCccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLP--SYMGSLPNLQEL 115 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~l 115 (557)
++|+.|+|++|.+++. ..+..+++|+.|+|++|+|++.+|. +..+++|+.|+|++|+|+ .+| ..+..+++|+.|
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~l~~l~~L~~L 125 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK-DISTLEPLKKLECLKSL 125 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCC-SSGGGGGGSSCSCCCEE
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccC-cchhHHHHhcCCCCCEE
Confidence 6799999999999954 7788999999999999999997775 667999999999999999 554 678899999999
Q ss_pred ccccccCCCCCCc---ccc---cCceeeeecCCCc
Q 008707 116 HIENNSFVGEIPP---ALL---TGKVIFKYDNNPK 144 (557)
Q Consensus 116 ~l~~N~~~~~~p~---~~~---~~~~~~~~~~n~~ 144 (557)
++++|++. .+|. ..+ ..+..+.+.+|+.
T Consensus 126 ~l~~N~l~-~~~~~~~~~~~~l~~L~~L~l~~n~~ 159 (168)
T 2ell_A 126 DLFNCEVT-NLNDYRESVFKLLPQLTYLDGYDRED 159 (168)
T ss_dssp ECCSSGGG-TSTTHHHHHHTTCSSCCEETTEETTS
T ss_pred EeeCCcCc-chHHHHHHHHHhCccCcEecCCCCCh
Confidence 99999998 6665 222 2344555555543
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.1e-10 Score=126.02 Aligned_cols=119 Identities=18% Similarity=0.199 Sum_probs=94.5
Q ss_pred CCCCC-CCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEE
Q 008707 22 PCVPV-PWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIV 91 (557)
Q Consensus 22 ~c~~~-~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L 91 (557)
+|+.| ..+.+.|+. ..|++++.|+|++|.+++..|..|.++++|+.|+|++|+|++..| .|.++++|++|
T Consensus 26 ~~~~~~~~~~l~ls~~~L~~ip~~~~~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 105 (562)
T 3a79_B 26 TPFSNELESMVDYSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYL 105 (562)
T ss_dssp -------CCEEECTTSCCCSCCTTSCTTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEE
T ss_pred cccccCCCcEEEcCCCCCccCCCCCCCCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEE
Confidence 34444 234677765 246789999999999997677899999999999999999999988 59999999999
Q ss_pred EecCccccCcCCCccCCCCcccccccccccCCCCCC--cccc--cCceeeeecCCCc
Q 008707 92 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP--PALL--TGKVIFKYDNNPK 144 (557)
Q Consensus 92 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p--~~~~--~~~~~~~~~~n~~ 144 (557)
+|++|+|+ .+|.. .+++|+.|++++|++. .+| ..+. ..+..+.+++|..
T Consensus 106 ~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l~-~l~~p~~~~~l~~L~~L~L~~n~l 158 (562)
T 3a79_B 106 DVSHNRLQ-NISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF 158 (562)
T ss_dssp ECTTSCCC-EECSC--CCTTCSEEECCSSCCS-BCCCCGGGGGCTTCCEEEEECSBC
T ss_pred ECCCCcCC-ccCcc--ccccCCEEECCCCCcc-ccCchHhhcccCcccEEecCCCcc
Confidence 99999999 88887 8999999999999998 544 4443 3556677777764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.11 E-value=4.2e-11 Score=135.57 Aligned_cols=107 Identities=22% Similarity=0.315 Sum_probs=83.6
Q ss_pred CceEEEEecCCCcc-----ccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCCccCCCCcc
Q 008707 39 PRITKIALSGKNLK-----GEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNL 112 (557)
Q Consensus 39 ~~l~~L~L~~n~l~-----~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 112 (557)
++|+.|+|++|.++ +..|..|.++++|+.|+|++|+|++.+|. |..+++|+.|+|++|+|++..|..+. ++|
T Consensus 451 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L 528 (844)
T 3j0a_A 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANL 528 (844)
T ss_dssp TTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCC
T ss_pred CccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccc
Confidence 45666666666665 33345577888999999999999988884 88999999999999999955555554 789
Q ss_pred cccccccccCCCCCCcccccCceeeeecCCCccccc
Q 008707 113 QELHIENNSFVGEIPPALLTGKVIFKYDNNPKLHKE 148 (557)
Q Consensus 113 ~~l~l~~N~~~~~~p~~~~~~~~~~~~~~n~~~~~~ 148 (557)
+.|++++|++++..| ..+..+..+.+.+||+.|++
T Consensus 529 ~~L~Ls~N~l~~~~~-~~~~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 529 EILDISRNQLLAPNP-DVFVSLSVLDITHNKFICEC 563 (844)
T ss_dssp CEEEEEEECCCCCCS-CCCSSCCEEEEEEECCCCSS
T ss_pred cEEECCCCcCCCCCh-hHhCCcCEEEecCCCccccc
Confidence 999999999995555 44567788899999999854
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.11 E-value=6.2e-11 Score=118.98 Aligned_cols=107 Identities=22% Similarity=0.227 Sum_probs=93.4
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
+++|+.|+|++|.+++..|..+.++++|+.|+|++|+|++.++ .|..+++|+.|+|++|+++ .+|..+..+++|+.|+
T Consensus 192 ~~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~ 270 (332)
T 2ft3_A 192 PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVY 270 (332)
T ss_dssp CSSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEE
T ss_pred cCCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEE
Confidence 3689999999999997777889999999999999999999988 5999999999999999999 9999999999999999
Q ss_pred cccccCCCCCCcccccC---------ceeeeecCCCccc
Q 008707 117 IENNSFVGEIPPALLTG---------KVIFKYDNNPKLH 146 (557)
Q Consensus 117 l~~N~~~~~~p~~~~~~---------~~~~~~~~n~~~~ 146 (557)
+++|+++ .+|...+.. +..+.+.+||..+
T Consensus 271 l~~N~l~-~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~ 308 (332)
T 2ft3_A 271 LHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPY 308 (332)
T ss_dssp CCSSCCC-BCCTTSSSCSSCCSSSCCBSEEECCSSSSCG
T ss_pred CCCCCCC-ccChhHccccccccccccccceEeecCcccc
Confidence 9999998 777655432 3467888998764
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.11 E-value=8.8e-11 Score=132.94 Aligned_cols=119 Identities=15% Similarity=0.120 Sum_probs=91.9
Q ss_pred CCCCCCCeEEeeCCCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCC-C-CccCCCCCcEEEecCccccC
Q 008707 23 CVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPL-P-DMSRLIDLRIVHLENNELTG 100 (557)
Q Consensus 23 c~~~~~~~v~c~~~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-~-~~~~l~~L~~L~l~~N~l~~ 100 (557)
|..+.|+.|.+ .|++++.|+|++|.|++..|..|.++++|+.|+|++|.+.+.+ | .|.++++|+.|+|++|+|++
T Consensus 11 cs~~~L~~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~ 87 (844)
T 3j0a_A 11 YRFCNLTQVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYF 87 (844)
T ss_dssp ESCCCSSCCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCE
T ss_pred ccCCCCCCCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcc
Confidence 33444555543 6789999999999999888888999999999999999666654 4 58889999999999999987
Q ss_pred cCCCccCCCCcccccccccccCCCCCCcc-cc---cCceeeeecCCCc
Q 008707 101 SLPSYMGSLPNLQELHIENNSFVGEIPPA-LL---TGKVIFKYDNNPK 144 (557)
Q Consensus 101 ~~p~~~~~l~~L~~l~l~~N~~~~~~p~~-~~---~~~~~~~~~~n~~ 144 (557)
..|..|..+++|+.|++++|++.+.+|.. .+ ..+..+.+++|..
T Consensus 88 ~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l 135 (844)
T 3j0a_A 88 LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135 (844)
T ss_dssp ECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCC
T ss_pred cCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcc
Confidence 77888888999999999999888666654 22 2445666777654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.11 E-value=1.1e-10 Score=128.83 Aligned_cols=117 Identities=26% Similarity=0.362 Sum_probs=87.4
Q ss_pred CCCCCeEEeeC--------CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecC
Q 008707 25 PVPWEWVTCST--------TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLEN 95 (557)
Q Consensus 25 ~~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~ 95 (557)
.|.++.+.|+. ..|++++.|+|++|.+++..+..|.++++|+.|+|++|.+++.+|. |.++++|+.|+|++
T Consensus 3 ~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 82 (680)
T 1ziw_A 3 TVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82 (680)
T ss_dssp -CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred eeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence 35567778876 3467889999999999966666788888999999998888888774 78888888888888
Q ss_pred ccccCcCCC-ccCCCCcccccccccccCCCCCCcccc---cCceeeeecCCC
Q 008707 96 NELTGSLPS-YMGSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNP 143 (557)
Q Consensus 96 N~l~~~~p~-~~~~l~~L~~l~l~~N~~~~~~p~~~~---~~~~~~~~~~n~ 143 (557)
|+++ .+|. .|+.+++|++|++++|++. .+|+..+ ..+..+.+.+|.
T Consensus 83 n~l~-~l~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~ 132 (680)
T 1ziw_A 83 NELS-QLSDKTFAFCTNLTELHLMSNSIQ-KIKNNPFVKQKNLITLDLSHNG 132 (680)
T ss_dssp SCCC-CCCTTTTTTCTTCSEEECCSSCCC-CCCSCTTTTCTTCCEEECCSSC
T ss_pred CccC-ccChhhhccCCCCCEEECCCCccC-ccChhHccccCCCCEEECCCCc
Confidence 8888 4554 6888888888888888887 5554332 234555666654
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.10 E-value=8.4e-11 Score=126.46 Aligned_cols=89 Identities=27% Similarity=0.308 Sum_probs=82.0
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcC-CCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL-PSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~l~~L~~l~ 116 (557)
.++|+.|+|++|.|+ .+|..|++|++|+.|+|++|+|+++ |.|+.+++|+.|+|++|+|++.. |..++.+++|+.|+
T Consensus 462 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~l-p~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~ 539 (567)
T 1dce_A 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLN 539 (567)
T ss_dssp GTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEE
T ss_pred cccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCCC-cccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEE
Confidence 358999999999999 9999999999999999999999995 49999999999999999999766 99999999999999
Q ss_pred cccccCCCCCCcc
Q 008707 117 IENNSFVGEIPPA 129 (557)
Q Consensus 117 l~~N~~~~~~p~~ 129 (557)
+++|+++ .+|+.
T Consensus 540 L~~N~l~-~~~~~ 551 (567)
T 1dce_A 540 LQGNSLC-QEEGI 551 (567)
T ss_dssp CTTSGGG-GSSSC
T ss_pred ecCCcCC-CCccH
Confidence 9999999 45543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.08 E-value=2.3e-10 Score=111.60 Aligned_cols=108 Identities=19% Similarity=0.217 Sum_probs=91.2
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
-++|+.|+|++|.+++..+..|.++++|+.|+|++|+|++.++ .|.++++|+.|++++|++++..+..+..+++|+.|+
T Consensus 51 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 130 (276)
T 2z62_A 51 FPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130 (276)
T ss_dssp CTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred ccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEE
Confidence 3689999999999997677789999999999999999999887 599999999999999999966666789999999999
Q ss_pred cccccCCC-CCCcccc--cCceeeeecCCCcc
Q 008707 117 IENNSFVG-EIPPALL--TGKVIFKYDNNPKL 145 (557)
Q Consensus 117 l~~N~~~~-~~p~~~~--~~~~~~~~~~n~~~ 145 (557)
+++|++.+ .+|..+. ..+..+.+++|...
T Consensus 131 l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~ 162 (276)
T 2z62_A 131 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162 (276)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCC
T ss_pred CcCCccceecCchhhccCCCCCEEECCCCCCC
Confidence 99999984 2676654 35667778887643
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.08 E-value=4.5e-11 Score=118.94 Aligned_cols=86 Identities=17% Similarity=0.243 Sum_probs=48.0
Q ss_pred CceEEEEecCCCccccCCccc--cCCCCCcEEECcCCCCCCCCCCccCC-----CCCcEEEecCccccCcCCCccCCCCc
Q 008707 39 PRITKIALSGKNLKGEIPPEL--KNMEALTELWLDGNFLTGPLPDMSRL-----IDLRIVHLENNELTGSLPSYMGSLPN 111 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~--~~l~~L~~L~l~~N~l~~~~~~~~~l-----~~L~~L~l~~N~l~~~~p~~~~~l~~ 111 (557)
++|+.|+|++|++++.+|..+ ..+++|+.|+|++|+|++.++.+..+ ++|++|+|++|++++..|..|+.+++
T Consensus 95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSSSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcchhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 345556666666655555554 55556666666666665552234444 55666666666665444455555566
Q ss_pred ccccccccccCCC
Q 008707 112 LQELHIENNSFVG 124 (557)
Q Consensus 112 L~~l~l~~N~~~~ 124 (557)
|+.|++++|++.|
T Consensus 175 L~~L~Ls~N~l~~ 187 (312)
T 1wwl_A 175 LSTLDLSDNPELG 187 (312)
T ss_dssp CCEEECCSCTTCH
T ss_pred CCEEECCCCCcCc
Confidence 6666666665543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.07 E-value=2.8e-10 Score=123.74 Aligned_cols=106 Identities=18% Similarity=0.232 Sum_probs=89.6
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCC-ccCCCCcccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELH 116 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~l~ 116 (557)
++|+.|+|++|.|++..|..|.++++|+.|+|++|.|++.+|. |+++++|+.|+|++|.|+ .+|. .|..+++|+.|+
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEE
Confidence 5799999999999987788999999999999999999999885 899999999999999999 5555 468999999999
Q ss_pred cccccCCCCCCcccc--cCceeeeecCCCcc
Q 008707 117 IENNSFVGEIPPALL--TGKVIFKYDNNPKL 145 (557)
Q Consensus 117 l~~N~~~~~~p~~~~--~~~~~~~~~~n~~~ 145 (557)
+++|.+.+..|..+. ..+..+.+++|...
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 184 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLT 184 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCS
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCC
Confidence 999999954444443 35567778888644
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.07 E-value=4e-11 Score=132.99 Aligned_cols=93 Identities=31% Similarity=0.399 Sum_probs=85.4
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
.++|+.|+|++|.|+ .+|..|++|++|+.|+|++|+|+.++..|++|++|+.|+|++|.|+ .+|..|+.|++|+.|+|
T Consensus 246 l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L 323 (727)
T 4b8c_D 246 YDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGV 323 (727)
T ss_dssp CCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEEC
T ss_pred CCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeC
Confidence 367999999999999 9999999999999999999999966557999999999999999998 99999999999999999
Q ss_pred ccccCCCCCCccccc
Q 008707 118 ENNSFVGEIPPALLT 132 (557)
Q Consensus 118 ~~N~~~~~~p~~~~~ 132 (557)
++|+|.+.+|..+..
T Consensus 324 ~~N~l~~~~p~~~~~ 338 (727)
T 4b8c_D 324 EGNPLEKQFLKILTE 338 (727)
T ss_dssp TTSCCCSHHHHHHHH
T ss_pred CCCccCCCChHHHhh
Confidence 999999777776643
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.07 E-value=1.6e-10 Score=124.75 Aligned_cols=109 Identities=20% Similarity=0.276 Sum_probs=88.2
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCC-CCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-GPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
++|+.|+|++|.+++..|..+.++++|+.|+|++|+++ +.+| .|..+++|+.|+|++|++++..|..+..+++|+.|+
T Consensus 421 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 500 (570)
T 2z63_A 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500 (570)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred CCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEe
Confidence 57888888888888778888888888888888888887 4555 588888999999999999877788888899999999
Q ss_pred cccccCCCCCCcccc---cCceeeeecCCCccccc
Q 008707 117 IENNSFVGEIPPALL---TGKVIFKYDNNPKLHKE 148 (557)
Q Consensus 117 l~~N~~~~~~p~~~~---~~~~~~~~~~n~~~~~~ 148 (557)
+++|+++ .+|+..+ ..+..+.+++|++.|.+
T Consensus 501 l~~n~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~ 534 (570)
T 2z63_A 501 MASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 534 (570)
T ss_dssp CCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred CCCCcCC-CCCHHHhhcccCCcEEEecCCcccCCC
Confidence 9999998 4554433 35567788999988864
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.07 E-value=1e-10 Score=116.64 Aligned_cols=106 Identities=21% Similarity=0.203 Sum_probs=63.0
Q ss_pred CceEEEEecCCCccccCCcccc-CCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELK-NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
++|+.|+|++|.+++..|..+. .+++|+.|+|++|+|++.+ ....+++|+.|+|++|+|+ .+|..+..+++|+.|++
T Consensus 144 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L 221 (317)
T 3o53_A 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISL 221 (317)
T ss_dssp SSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE-CCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEEC
T ss_pred CCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccc-cccccccCCEEECCCCcCC-cchhhhcccCcccEEEC
Confidence 3455555555555544444442 4556666666666655542 2223666666666777666 45555666777777777
Q ss_pred ccccCCCCCCcccc--cCceeeeecCCCcccc
Q 008707 118 ENNSFVGEIPPALL--TGKVIFKYDNNPKLHK 147 (557)
Q Consensus 118 ~~N~~~~~~p~~~~--~~~~~~~~~~n~~~~~ 147 (557)
++|+++ .+|..+. ..+..+.+++|++.|+
T Consensus 222 ~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~ 252 (317)
T 3o53_A 222 RNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG 252 (317)
T ss_dssp TTSCCC-EECTTCCCCTTCCEEECTTCCCBHH
T ss_pred cCCccc-chhhHhhcCCCCCEEEccCCCccCc
Confidence 777776 5666543 2455667777777654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=1.5e-10 Score=125.94 Aligned_cols=109 Identities=21% Similarity=0.232 Sum_probs=63.2
Q ss_pred CceEEEEecCCCcccc---CCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccc
Q 008707 39 PRITKIALSGKNLKGE---IPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQE 114 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~---~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 114 (557)
++|+.|+|++|.+++. .+..+..+++|+.|+|++|++++.+| .|..+++|+.|+|++|++++..|..+..+++| .
T Consensus 449 ~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~ 527 (606)
T 3t6q_A 449 PALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-Y 527 (606)
T ss_dssp TTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-E
T ss_pred CCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-E
Confidence 4555555555555541 12345555566666666666665555 36666666666666666665566666666666 6
Q ss_pred cccccccCCCCCCccc--ccCceeeeecCCCccccc
Q 008707 115 LHIENNSFVGEIPPAL--LTGKVIFKYDNNPKLHKE 148 (557)
Q Consensus 115 l~l~~N~~~~~~p~~~--~~~~~~~~~~~n~~~~~~ 148 (557)
|++++|++++..|..+ ...+..+.+.+||+.|++
T Consensus 528 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 528 LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp EECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred EECcCCcccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 6666666663222222 224566778888888764
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=2.7e-10 Score=125.86 Aligned_cols=90 Identities=20% Similarity=0.211 Sum_probs=56.9
Q ss_pred ccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccccccccCCCCCCccc----ccC
Q 008707 59 LKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL----LTG 133 (557)
Q Consensus 59 ~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~----~~~ 133 (557)
+.++++|+.|+|++|+|+.+++ .|.++++|+.|+|++|+|++..+..|..+++|+.|++++|+++ .+|+.. +..
T Consensus 532 ~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~~~~~ 610 (680)
T 1ziw_A 532 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLIT-SVEKKVFGPAFRN 610 (680)
T ss_dssp TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCC-BCCHHHHHHHHTT
T ss_pred hcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCC-ccChhHhcccccc
Confidence 4555555566666666665554 3666666777777777766333334556677777777777776 444432 345
Q ss_pred ceeeeecCCCcccccc
Q 008707 134 KVIFKYDNNPKLHKES 149 (557)
Q Consensus 134 ~~~~~~~~n~~~~~~~ 149 (557)
+..+.+.+||+.|++.
T Consensus 611 L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 611 LTELDMRFNPFDCTCE 626 (680)
T ss_dssp CSEEECTTCCCCBCCC
T ss_pred cCEEEccCCCcccCCc
Confidence 6678899999999865
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.05 E-value=2.8e-10 Score=122.84 Aligned_cols=108 Identities=23% Similarity=0.328 Sum_probs=74.5
Q ss_pred CceEEEEecCCCccc--cCCccccCCCCCcEEECcCCCCCC-CCCC-ccCC----------------------CCCcEEE
Q 008707 39 PRITKIALSGKNLKG--EIPPELKNMEALTELWLDGNFLTG-PLPD-MSRL----------------------IDLRIVH 92 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~--~~p~~~~~l~~L~~L~l~~N~l~~-~~~~-~~~l----------------------~~L~~L~ 92 (557)
++|+.|+|++|++++ .+|..+.++++|+.|+|++|++++ .++. +..+ ++|+.|+
T Consensus 377 ~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~~L~~L~ 456 (562)
T 3a79_B 377 KRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLD 456 (562)
T ss_dssp SSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCCTTCSEEE
T ss_pred CCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhcCcCCEEE
Confidence 567777777777774 233456777777777777777776 3332 4433 4666666
Q ss_pred ecCccccCcCCCccCCCCcccccccccccCCCCCCccccc---CceeeeecCCCccccc
Q 008707 93 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 93 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~~~~ 148 (557)
|++|+|+ .+|..+..+++|+.|++++|+++ .+|...+. .+..+.+++||+.|++
T Consensus 457 L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c 513 (562)
T 3a79_B 457 LHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTC 513 (562)
T ss_dssp CCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCH
T ss_pred CCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCc
Confidence 6666666 67777778888888888888888 78876332 4556788899988874
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.05 E-value=4.5e-10 Score=115.29 Aligned_cols=105 Identities=19% Similarity=0.257 Sum_probs=89.2
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCCc-cCCCCcccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQELH 116 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~l~ 116 (557)
++|+.|+|++|.+++..|..|.++++|+.|+|++|.+++.+|. |.++++|+.|+|++|+++ .+|.. |..+++|+.|+
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEE
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEE
Confidence 6799999999999977777899999999999999999999885 899999999999999999 66665 58999999999
Q ss_pred cccccCCCCCCcccc---cCceeeeecCCCcc
Q 008707 117 IENNSFVGEIPPALL---TGKVIFKYDNNPKL 145 (557)
Q Consensus 117 l~~N~~~~~~p~~~~---~~~~~~~~~~n~~~ 145 (557)
+++|++. .+++..+ ..+..+.+.+|...
T Consensus 148 L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~ 178 (390)
T 3o6n_A 148 MSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 178 (390)
T ss_dssp CCSSCCC-BCCTTTTSSCTTCCEEECCSSCCS
T ss_pred CCCCccC-ccChhhccCCCCCCEEECCCCcCC
Confidence 9999998 5554433 35567778887644
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.05 E-value=7.9e-11 Score=103.46 Aligned_cols=88 Identities=18% Similarity=0.214 Sum_probs=77.8
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCc-CCCccCCCCccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGS-LPSYMGSLPNLQEL 115 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~l 115 (557)
-++|+.|+|++|.+++. ..+.++++|+.|+|++|+|++.+|. +..+++|+.|++++|++++. .|..+..+++|+.|
T Consensus 41 l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L 118 (149)
T 2je0_A 41 FEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSL 118 (149)
T ss_dssp CTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEE
T ss_pred cCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEE
Confidence 36899999999999955 7799999999999999999997774 77799999999999999952 34789999999999
Q ss_pred ccccccCCCCCCc
Q 008707 116 HIENNSFVGEIPP 128 (557)
Q Consensus 116 ~l~~N~~~~~~p~ 128 (557)
++++|+++ .+|.
T Consensus 119 ~l~~N~l~-~~~~ 130 (149)
T 2je0_A 119 DLFNCEVT-NLND 130 (149)
T ss_dssp ECTTCGGG-GSTT
T ss_pred eCcCCccc-chHH
Confidence 99999998 5655
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.03 E-value=4.2e-10 Score=121.45 Aligned_cols=107 Identities=15% Similarity=0.060 Sum_probs=86.1
Q ss_pred CCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCccccc
Q 008707 37 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 115 (557)
Q Consensus 37 ~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l 115 (557)
.|++++.|+|++|++++..+..|.++++|+.|+|++|+|++.++ .|.++++|++|+|++|++++..|..|.++++|+.|
T Consensus 26 l~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (570)
T 2z63_A 26 LPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKL 105 (570)
T ss_dssp SCSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEE
T ss_pred ccccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccc
Confidence 46788999999999997777788999999999999999998877 48889999999999999986666788888889999
Q ss_pred ccccccCCCCCCcccc---cCceeeeecCCCc
Q 008707 116 HIENNSFVGEIPPALL---TGKVIFKYDNNPK 144 (557)
Q Consensus 116 ~l~~N~~~~~~p~~~~---~~~~~~~~~~n~~ 144 (557)
++++|++. .+|...+ ..+..+.+++|..
T Consensus 106 ~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l 136 (570)
T 2z63_A 106 VAVETNLA-SLENFPIGHLKTLKELNVAHNLI 136 (570)
T ss_dssp ECTTSCCC-CSTTCSCTTCTTCCEEECCSSCC
T ss_pred cccccccc-cCCCccccccccccEEecCCCcc
Confidence 99988888 6665322 3455666777653
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.01 E-value=3.7e-10 Score=120.54 Aligned_cols=108 Identities=21% Similarity=0.290 Sum_probs=70.5
Q ss_pred CceEEEEecCCCccc--cCCccccCCCCCcEEECcCCCCCCCCC-C-ccCCC----------------------CCcEEE
Q 008707 39 PRITKIALSGKNLKG--EIPPELKNMEALTELWLDGNFLTGPLP-D-MSRLI----------------------DLRIVH 92 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~~-~-~~~l~----------------------~L~~L~ 92 (557)
++|+.|+|++|++++ .+|..+.++++|+.|+|++|++++.+| . +..++ +|+.|+
T Consensus 348 ~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~L~~L~ 427 (520)
T 2z7x_B 348 TELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLD 427 (520)
T ss_dssp SSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCCTTCCEEE
T ss_pred CCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhcccCCEEE
Confidence 467777777777775 455566777777777777777776333 2 44444 555555
Q ss_pred ecCccccCcCCCccCCCCcccccccccccCCCCCCcccc---cCceeeeecCCCccccc
Q 008707 93 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALL---TGKVIFKYDNNPKLHKE 148 (557)
Q Consensus 93 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~---~~~~~~~~~~n~~~~~~ 148 (557)
|++|+|+ .+|..+..+++|+.|++++|+++ .+|...+ ..+..+.+++|++.|++
T Consensus 428 Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 428 LHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp CCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccC
Confidence 5556655 56666667777777777777777 6776633 24556677888877763
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.1e-09 Score=111.00 Aligned_cols=140 Identities=16% Similarity=0.232 Sum_probs=105.7
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEcc--Ccc-chhHHHHHHHHHHHhhcC--CCCccceeeEEEec---CeeEEEEEe
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMA--DSC-SHRTQQFVTEVALLSRIH--HRNLVPLIGYCEEE---HQRILVYEY 312 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~il~~l~--h~nIv~~~~~~~~~---~~~~lv~e~ 312 (557)
+.++.|.++.||+.... +..+++|+.. ... ......+.+|+++++.+. +..+++++.++.+. +..++||||
T Consensus 44 ~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~ 122 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEF 122 (359)
T ss_dssp EECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEEC
T ss_pred EEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEe
Confidence 56899999999999876 4678888765 322 122356788999999996 45678888888776 458999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-------------------------------------- 354 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~-------------------------------------- 354 (557)
++|..+.+.. ...++......++.+++++|+.||+..
T Consensus 123 v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 123 VSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred cCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 9988775422 233677788889999999999999720
Q ss_pred -----------------CCCeEeeccCCCCEEeCCCCc--EEEecccCccc
Q 008707 355 -----------------NPGIIHRDVKSSNILLDINMR--AKVSDFGLSRQ 386 (557)
Q Consensus 355 -----------------~~~ivH~dlk~~NIll~~~~~--~kl~Dfgla~~ 386 (557)
...++|||+++.||+++.++. +.|.||+.+..
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998864
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=6.9e-10 Score=119.22 Aligned_cols=107 Identities=19% Similarity=0.164 Sum_probs=67.3
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCc------------------cCCCCCcEEEecCccccC
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM------------------SRLIDLRIVHLENNELTG 100 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~------------------~~l~~L~~L~l~~N~l~~ 100 (557)
++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+..+..+ ..+++|+.|+|++|+|+
T Consensus 387 ~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~- 464 (549)
T 2z81_A 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLK- 464 (549)
T ss_dssp TTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCS-
T ss_pred CCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccC-
Confidence 45666666666666 56666666666666666666665433221 25667777777777777
Q ss_pred cCCCccCCCCcccccccccccCCCCCCccc--ccCceeeeecCCCccccc
Q 008707 101 SLPSYMGSLPNLQELHIENNSFVGEIPPAL--LTGKVIFKYDNNPKLHKE 148 (557)
Q Consensus 101 ~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~--~~~~~~~~~~~n~~~~~~ 148 (557)
.+|. ...+++|+.|++++|++++..|..+ ...+..+.+++|++.|++
T Consensus 465 ~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 465 TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCC
Confidence 6665 3567777777777777774333323 234567788888887763
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.00 E-value=3.1e-10 Score=104.81 Aligned_cols=101 Identities=16% Similarity=0.206 Sum_probs=56.7
Q ss_pred ceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccccc
Q 008707 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 119 (557)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 119 (557)
+|+.|+|++|+++ .+| .+..+++|+.|+|++|.++.. +.+..+++|+.|+|++|++++..|..+..+++|+.|++++
T Consensus 45 ~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~ 121 (197)
T 4ezg_A 45 SLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHATNY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121 (197)
T ss_dssp TCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCSCC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCS
T ss_pred CccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCCcc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecC
Confidence 4566666666666 555 455666666666666654432 3455566666666666666655555566666666666666
Q ss_pred ccCCCCCCcccc--cCceeeeecCCC
Q 008707 120 NSFVGEIPPALL--TGKVIFKYDNNP 143 (557)
Q Consensus 120 N~~~~~~p~~~~--~~~~~~~~~~n~ 143 (557)
|++++..|..+. ..+..+.+++|.
T Consensus 122 n~i~~~~~~~l~~l~~L~~L~L~~n~ 147 (197)
T 4ezg_A 122 SAHDDSILTKINTLPKVNSIDLSYNG 147 (197)
T ss_dssp SBCBGGGHHHHTTCSSCCEEECCSCT
T ss_pred CccCcHhHHHHhhCCCCCEEEccCCC
Confidence 666543444332 233444555554
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=98.99 E-value=3.3e-10 Score=107.95 Aligned_cols=105 Identities=22% Similarity=0.244 Sum_probs=85.3
Q ss_pred CCceEEEEecCCC-ccccCCccccCCCCCcEEECcC-CCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCccc-
Q 008707 38 PPRITKIALSGKN-LKGEIPPELKNMEALTELWLDG-NFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQ- 113 (557)
Q Consensus 38 p~~l~~L~L~~n~-l~~~~p~~~~~l~~L~~L~l~~-N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~- 113 (557)
.++|+.|+|++|+ +++..+..|.++++|+.|+|++ |+|++.++ .|.++++|+.|+|++|+++ .+|. +..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~-~lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCC-SCCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCc-cccc-ccccccccc
Confidence 4679999999997 8855555789999999999998 99998887 5889999999999999999 5887 78888887
Q ss_pred --ccccccc-cCCCCCCccccc---Cce-eeeecCCCcc
Q 008707 114 --ELHIENN-SFVGEIPPALLT---GKV-IFKYDNNPKL 145 (557)
Q Consensus 114 --~l~l~~N-~~~~~~p~~~~~---~~~-~~~~~~n~~~ 145 (557)
.|++++| ++. .+|+..+. .+. .+.+++|...
T Consensus 132 L~~L~l~~N~~l~-~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 132 FFILEITDNPYMT-SIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp EEEEEEESCTTCC-EECTTTTTTTBSSEEEEECCSCCCC
T ss_pred ccEEECCCCcchh-hcCcccccchhcceeEEEcCCCCCc
Confidence 9999999 888 77776554 344 6677777643
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.4e-10 Score=115.22 Aligned_cols=105 Identities=15% Similarity=0.221 Sum_probs=64.8
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCC---CCCC--ccCC---------------------------
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTG---PLPD--MSRL--------------------------- 85 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~---~~~~--~~~l--------------------------- 85 (557)
.++|+.|+|++|.+++..|..+.++++|+.|+|++|++.+ .++. +..+
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l 223 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAG 223 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHT
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcC
Confidence 4578888888888886666778888888888888887654 2111 2334
Q ss_pred CCCcEEEecCccccCcCCCccCCC---CcccccccccccCCCCCCcccccCceeeeecCCC
Q 008707 86 IDLRIVHLENNELTGSLPSYMGSL---PNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 143 (557)
Q Consensus 86 ~~L~~L~l~~N~l~~~~p~~~~~l---~~L~~l~l~~N~~~~~~p~~~~~~~~~~~~~~n~ 143 (557)
++|+.|+|++|+|++..|..+..+ ++|+.|++++|+|+ .+|..++..+..+.+++|.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~ 283 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNR 283 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCc
Confidence 455555555555554445555444 45666666666665 5555555555555555554
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.98 E-value=3.8e-10 Score=120.51 Aligned_cols=109 Identities=14% Similarity=0.124 Sum_probs=86.5
Q ss_pred CCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCC--CC-CccCCCCCcEEEecCccccCcCCCc-cCCCCcc
Q 008707 37 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP--LP-DMSRLIDLRIVHLENNELTGSLPSY-MGSLPNL 112 (557)
Q Consensus 37 ~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~~-~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L 112 (557)
..++|+.|+|++|.+++.+|..+.++++|+.|+|++|+|++. +| .+..+++|+.|+|++|++++.+|.. +..+++|
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 346788899999999887888888888999999999998873 34 4888889999999999988657764 6778888
Q ss_pred cccccccccCCCCCCcccccCceeeeecCCCcc
Q 008707 113 QELHIENNSFVGEIPPALLTGKVIFKYDNNPKL 145 (557)
Q Consensus 113 ~~l~l~~N~~~~~~p~~~~~~~~~~~~~~n~~~ 145 (557)
+.|++++|++++.+|..+...+..+.+++|...
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l~ 434 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIK 434 (520)
T ss_dssp CEEECCSSCCCGGGGGSCCTTCCEEECCSSCCC
T ss_pred CEEECcCCCCCcchhhhhcccCCEEECCCCccc
Confidence 888888888877777776666677777777543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=98.98 E-value=2.2e-10 Score=113.90 Aligned_cols=86 Identities=19% Similarity=0.250 Sum_probs=48.8
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCC---CCCc--cCCCCCcEEEecCccccC--cCCC-ccCCCC
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP---LPDM--SRLIDLRIVHLENNELTG--SLPS-YMGSLP 110 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~---~~~~--~~l~~L~~L~l~~N~l~~--~~p~-~~~~l~ 110 (557)
++|++|+|++|++++..|..|.++++|+.|+|++|++.+. ++.+ ..+++|+.|+|++|+|++ .++. .+..++
T Consensus 149 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~ 228 (312)
T 1wwl_A 149 PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV 228 (312)
T ss_dssp TTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTC
T ss_pred CCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCC
Confidence 5777777777777766666777777777777777776553 2222 555555555555555551 1111 122344
Q ss_pred cccccccccccCCC
Q 008707 111 NLQELHIENNSFVG 124 (557)
Q Consensus 111 ~L~~l~l~~N~~~~ 124 (557)
+|+.|++++|++.+
T Consensus 229 ~L~~L~Ls~N~l~~ 242 (312)
T 1wwl_A 229 QLQGLDLSHNSLRD 242 (312)
T ss_dssp CCSEEECTTSCCCS
T ss_pred CCCEEECCCCcCCc
Confidence 44555555555443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.91 E-value=1.4e-09 Score=110.12 Aligned_cols=105 Identities=18% Similarity=0.216 Sum_probs=89.0
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCC--ccCCCCcccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQE 114 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~ 114 (557)
.++|+.|+|++|++++..|..|.++++|++|+|++|+|++.++. |.++++|+.|+|++|+++ .+|. .+..+++|+.
T Consensus 75 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~ 153 (353)
T 2z80_A 75 CVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQI 153 (353)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCE
T ss_pred CCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcE
Confidence 46899999999999977788899999999999999999988875 999999999999999999 6776 7889999999
Q ss_pred ccccccc-CCCCCCccccc---CceeeeecCCCc
Q 008707 115 LHIENNS-FVGEIPPALLT---GKVIFKYDNNPK 144 (557)
Q Consensus 115 l~l~~N~-~~~~~p~~~~~---~~~~~~~~~n~~ 144 (557)
|++++|+ +. .++...+. .+..+.+++|..
T Consensus 154 L~l~~n~~~~-~~~~~~~~~l~~L~~L~l~~n~l 186 (353)
T 2z80_A 154 LRVGNMDTFT-KIQRKDFAGLTFLEELEIDASDL 186 (353)
T ss_dssp EEEEESSSCC-EECTTTTTTCCEEEEEEEEETTC
T ss_pred EECCCCcccc-ccCHHHccCCCCCCEEECCCCCc
Confidence 9999995 55 66654443 345567777754
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.90 E-value=6.2e-10 Score=117.74 Aligned_cols=101 Identities=27% Similarity=0.307 Sum_probs=85.8
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
+++|+.|+|++|.+++..|..|.++++|+.|+|++|.|++.+| |..+++|+.|+|++|.|+ .+|. .++|+.|++
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~l~-~l~~----~~~L~~L~L 106 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQ-ELLV----GPSIETLHA 106 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE-CTTCTTCCEEECCSSEEE-EEEE----CTTCCEEEC
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc-cccCCCCCEEEecCCcCC-CCCC----CCCcCEEEC
Confidence 4589999999999997777899999999999999999998777 999999999999999999 4442 378889999
Q ss_pred ccccCCCCCCcccccCceeeeecCCCcc
Q 008707 118 ENNSFVGEIPPALLTGKVIFKYDNNPKL 145 (557)
Q Consensus 118 ~~N~~~~~~p~~~~~~~~~~~~~~n~~~ 145 (557)
++|++. .+|...+..+..+.+++|...
T Consensus 107 ~~N~l~-~~~~~~l~~L~~L~L~~N~l~ 133 (487)
T 3oja_A 107 ANNNIS-RVSCSRGQGKKNIYLANNKIT 133 (487)
T ss_dssp CSSCCC-CEEECCCSSCEEEECCSSCCC
T ss_pred cCCcCC-CCCccccCCCCEEECCCCCCC
Confidence 999988 566666677778888887644
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.89 E-value=3.4e-09 Score=102.58 Aligned_cols=100 Identities=26% Similarity=0.348 Sum_probs=71.5
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
++|+.|+|++|.|+ .+|. +.++++|+.|+|++|+|++.++ +.. ++|+.|+|++|+++ .+| .+..+++|+.|+++
T Consensus 63 ~~L~~L~L~~N~i~-~~~~-l~~l~~L~~L~L~~N~l~~l~~-~~~-~~L~~L~L~~N~l~-~~~-~l~~l~~L~~L~Ls 136 (263)
T 1xeu_A 63 TNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNG-IPS-ACLSRLFLDNNELR-DTD-SLIHLKNLEILSIR 136 (263)
T ss_dssp TTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCSCCTT-CCC-SSCCEEECCSSCCS-BSG-GGTTCTTCCEEECT
T ss_pred CCCCEEECCCCccC-CChh-hccCCCCCEEECCCCccCCcCc-ccc-CcccEEEccCCccC-CCh-hhcCcccccEEECC
Confidence 57888888888888 4444 8888888888888888887544 222 77888888888887 444 47788888888888
Q ss_pred cccCCCCCCc-ccccCceeeeecCCCcc
Q 008707 119 NNSFVGEIPP-ALLTGKVIFKYDNNPKL 145 (557)
Q Consensus 119 ~N~~~~~~p~-~~~~~~~~~~~~~n~~~ 145 (557)
+|+++ .+|. .-...+..+.+++|...
T Consensus 137 ~N~i~-~~~~l~~l~~L~~L~L~~N~i~ 163 (263)
T 1xeu_A 137 NNKLK-SIVMLGFLSKLEVLDLHGNEIT 163 (263)
T ss_dssp TSCCC-BCGGGGGCTTCCEEECTTSCCC
T ss_pred CCcCC-CChHHccCCCCCEEECCCCcCc
Confidence 88887 4552 12334566677777644
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.89 E-value=1.5e-09 Score=107.74 Aligned_cols=102 Identities=25% Similarity=0.439 Sum_probs=75.7
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
.++|+.|+|++|++++ +|. +..+++|+.|+|++|++++.++ +..+++|+.|+|++|+++ .+|. +..+++|+.|++
T Consensus 106 l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~l 180 (308)
T 1h6u_A 106 LQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKA 180 (308)
T ss_dssp CTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEEC
T ss_pred CCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc-ccCCCCccEEEccCCcCC-CChh-hcCCCCCCEEEC
Confidence 4678888888888884 543 8888888888888888887665 778888888888888888 4544 778888888888
Q ss_pred ccccCCCCCCc-ccccCceeeeecCCCcc
Q 008707 118 ENNSFVGEIPP-ALLTGKVIFKYDNNPKL 145 (557)
Q Consensus 118 ~~N~~~~~~p~-~~~~~~~~~~~~~n~~~ 145 (557)
++|++. .+|. .-...+..+.+++|...
T Consensus 181 ~~n~l~-~~~~l~~l~~L~~L~L~~N~l~ 208 (308)
T 1h6u_A 181 DDNKIS-DISPLASLPNLIEVHLKNNQIS 208 (308)
T ss_dssp CSSCCC-CCGGGGGCTTCCEEECTTSCCC
T ss_pred CCCccC-cChhhcCCCCCCEEEccCCccC
Confidence 888887 4543 22334556667777543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=98.88 E-value=2.8e-09 Score=105.65 Aligned_cols=102 Identities=27% Similarity=0.433 Sum_probs=84.0
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
.++|+.|+|++|.++ .+| .+..+++|+.|+|++|+|++.+ .+..+++|+.|+|++|+++ .+|. +..+++|+.|++
T Consensus 84 l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~l~~n~l~~~~-~l~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~l 158 (308)
T 1h6u_A 84 LTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVT-PLAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSI 158 (308)
T ss_dssp CCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCG-GGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEEC
T ss_pred CCCCCEEEccCCcCC-Cch-hhcCCCCCCEEECCCCCCCCch-hhcCCCCCCEEECCCCccC-cCcc-ccCCCCccEEEc
Confidence 468999999999999 454 6899999999999999999864 4999999999999999999 4554 889999999999
Q ss_pred ccccCCCCCCc-ccccCceeeeecCCCcc
Q 008707 118 ENNSFVGEIPP-ALLTGKVIFKYDNNPKL 145 (557)
Q Consensus 118 ~~N~~~~~~p~-~~~~~~~~~~~~~n~~~ 145 (557)
++|++. .+|. .-...+..+.+++|...
T Consensus 159 ~~n~l~-~~~~l~~l~~L~~L~l~~n~l~ 186 (308)
T 1h6u_A 159 GNAQVS-DLTPLANLSKLTTLKADDNKIS 186 (308)
T ss_dssp CSSCCC-CCGGGTTCTTCCEEECCSSCCC
T ss_pred cCCcCC-CChhhcCCCCCCEEECCCCccC
Confidence 999998 5665 22345567778887643
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.88 E-value=1.8e-09 Score=107.09 Aligned_cols=105 Identities=18% Similarity=0.215 Sum_probs=86.1
Q ss_pred CceEEEEecCCCccccCCccc--cCCCCCcEEECcCCCCCCCCCC-----ccCCCCCcEEEecCccccCcCCCccCCCCc
Q 008707 39 PRITKIALSGKNLKGEIPPEL--KNMEALTELWLDGNFLTGPLPD-----MSRLIDLRIVHLENNELTGSLPSYMGSLPN 111 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~--~~l~~L~~L~l~~N~l~~~~~~-----~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 111 (557)
++|+.|+|++|.+++..|..+ ..+++|++|+|++|++++..+. +..+++|+.|+|++|++++..|..+..+++
T Consensus 91 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~ 170 (310)
T 4glp_A 91 SRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPA 170 (310)
T ss_dssp SCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTT
T ss_pred CceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCC
Confidence 348999999999999999888 8999999999999999986552 457999999999999999777788999999
Q ss_pred ccccccccccCCCC--CCccc----ccCceeeeecCCC
Q 008707 112 LQELHIENNSFVGE--IPPAL----LTGKVIFKYDNNP 143 (557)
Q Consensus 112 L~~l~l~~N~~~~~--~p~~~----~~~~~~~~~~~n~ 143 (557)
|+.|++++|++.+. ++... +..+..+.+++|.
T Consensus 171 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~ 208 (310)
T 4glp_A 171 LTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTG 208 (310)
T ss_dssp CCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSC
T ss_pred CCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCC
Confidence 99999999998642 33222 3345666777775
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.87 E-value=3.9e-09 Score=102.13 Aligned_cols=100 Identities=20% Similarity=0.292 Sum_probs=84.4
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
++|+.|+|++|+++ .+| .+..+++|+.|+|++|+|++.++ +..+++|+.|+|++|+++ .+|.... ++|+.|+++
T Consensus 41 ~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~L~L~~N~l~-~l~~~~~--~~L~~L~L~ 114 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEELSVNRNRLK-NLNGIPS--ACLSRLFLD 114 (263)
T ss_dssp TTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCEEECCSSCCS-CCTTCCC--SSCCEEECC
T ss_pred CcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh-hccCCCCCEEECCCCccC-CcCcccc--CcccEEEcc
Confidence 67999999999999 777 78999999999999999999888 999999999999999999 5776433 899999999
Q ss_pred cccCCCCCCc-ccccCceeeeecCCCcc
Q 008707 119 NNSFVGEIPP-ALLTGKVIFKYDNNPKL 145 (557)
Q Consensus 119 ~N~~~~~~p~-~~~~~~~~~~~~~n~~~ 145 (557)
+|+++ .+|. .-...+..+.+++|...
T Consensus 115 ~N~l~-~~~~l~~l~~L~~L~Ls~N~i~ 141 (263)
T 1xeu_A 115 NNELR-DTDSLIHLKNLEILSIRNNKLK 141 (263)
T ss_dssp SSCCS-BSGGGTTCTTCCEEECTTSCCC
T ss_pred CCccC-CChhhcCcccccEEECCCCcCC
Confidence 99999 5653 12345667788888643
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.87 E-value=2.8e-09 Score=104.77 Aligned_cols=99 Identities=30% Similarity=0.479 Sum_probs=58.8
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
++|+.|+|++|++++ ++. +.++++|+.|+|++|+|++. +.+..+++|+.|+|++|+++ .++ .+..+++|+.|+++
T Consensus 68 ~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~L~~n~i~-~~~-~l~~l~~L~~L~l~ 142 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVKDL-SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLG 142 (291)
T ss_dssp TTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCG-GGGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEECC
T ss_pred CCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCCCC-hhhccCCCCCEEECCCCcCC-CCh-hhcCCCCCCEEEcc
Confidence 567777777777773 333 66677777777777776653 34666666777777777666 333 35566666666666
Q ss_pred cccCCCCCCc-ccccCceeeeecCCC
Q 008707 119 NNSFVGEIPP-ALLTGKVIFKYDNNP 143 (557)
Q Consensus 119 ~N~~~~~~p~-~~~~~~~~~~~~~n~ 143 (557)
+|++. .++. .-...+..+.+++|.
T Consensus 143 ~n~l~-~~~~l~~l~~L~~L~L~~N~ 167 (291)
T 1h6t_A 143 NNKIT-DITVLSRLTKLDTLSLEDNQ 167 (291)
T ss_dssp SSCCC-CCGGGGGCTTCSEEECCSSC
T ss_pred CCcCC-cchhhccCCCCCEEEccCCc
Confidence 66666 3321 112234444555553
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.87 E-value=1.6e-09 Score=109.18 Aligned_cols=104 Identities=18% Similarity=0.326 Sum_probs=67.6
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
.++|+.|+|++|.++ .+|. +..+++|+.|+|++|.+++. +.+..+++|+.|++++|+++ .+| .+..+++|+.|++
T Consensus 220 ~~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~-~~~-~~~~l~~L~~L~L 294 (347)
T 4fmz_A 220 MTRLNSLKIGNNKIT-DLSP-LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQIS-DIS-VLNNLSQLNSLFL 294 (347)
T ss_dssp CTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC-CCG-GGGGCTTCSEEEC
T ss_pred CCcCCEEEccCCccC-CCcc-hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCccC-CCh-hhcCCCCCCEEEC
Confidence 356777777777777 3443 67777777777777777764 45677777777777777777 343 3666777777777
Q ss_pred ccccCCCCCCcccc--cCceeeeecCCCccc
Q 008707 118 ENNSFVGEIPPALL--TGKVIFKYDNNPKLH 146 (557)
Q Consensus 118 ~~N~~~~~~p~~~~--~~~~~~~~~~n~~~~ 146 (557)
++|++.+..|..+. ..+..+.+++|+...
T Consensus 295 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 325 (347)
T 4fmz_A 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325 (347)
T ss_dssp CSSCCCGGGHHHHHTCTTCSEEECCSSSCCC
T ss_pred cCCcCCCcChhHhhccccCCEEEccCCcccc
Confidence 77777644443332 344556666666443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=98.86 E-value=6.3e-10 Score=110.88 Aligned_cols=101 Identities=27% Similarity=0.307 Sum_probs=85.7
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
+++|+.|+|++|.+++..|..|.++++|+.|+|++|++++.++ |..+++|+.|+|++|+|+ .+| .+++|+.|++
T Consensus 33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~Ls~n~l~-~l~----~~~~L~~L~l 106 (317)
T 3o53_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHA 106 (317)
T ss_dssp GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE-ETTCTTCCEEECCSSEEE-EEE----ECTTCCEEEC
T ss_pred CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh-hhhcCCCCEEECcCCccc-ccc----CCCCcCEEEC
Confidence 4689999999999997667889999999999999999998776 999999999999999999 444 3478999999
Q ss_pred ccccCCCCCCcccccCceeeeecCCCcc
Q 008707 118 ENNSFVGEIPPALLTGKVIFKYDNNPKL 145 (557)
Q Consensus 118 ~~N~~~~~~p~~~~~~~~~~~~~~n~~~ 145 (557)
++|++. .++...+..+..+.+++|...
T Consensus 107 ~~n~l~-~~~~~~~~~L~~L~l~~N~l~ 133 (317)
T 3o53_A 107 ANNNIS-RVSCSRGQGKKNIYLANNKIT 133 (317)
T ss_dssp CSSCCS-EEEECCCSSCEEEECCSSCCC
T ss_pred CCCccC-CcCccccCCCCEEECCCCCCC
Confidence 999998 666666777888888888654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=98.85 E-value=2.8e-09 Score=104.74 Aligned_cols=101 Identities=25% Similarity=0.334 Sum_probs=70.0
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
.++|+.|+|++|.+++ +| .+..+++|+.|+|++|+|++. +.+..+++|+.|+|++|++++ + ..+..+++|+.|++
T Consensus 89 l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L 163 (291)
T 1h6t_A 89 LKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSL 163 (291)
T ss_dssp CTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCCC-GGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCCCEEECCCCcCCC-Ch-hhccCCCCCEEECCCCcCCCC-hhhcCCCCCCEEEccCCcCCc-c-hhhccCCCCCEEEc
Confidence 3677888888888873 44 377788888888888888774 567777888888888888773 4 45677777888888
Q ss_pred ccccCCCCCCc-ccccCceeeeecCCCc
Q 008707 118 ENNSFVGEIPP-ALLTGKVIFKYDNNPK 144 (557)
Q Consensus 118 ~~N~~~~~~p~-~~~~~~~~~~~~~n~~ 144 (557)
++|++. .+++ .-...+..+.+++|..
T Consensus 164 ~~N~l~-~~~~l~~l~~L~~L~L~~N~i 190 (291)
T 1h6t_A 164 EDNQIS-DIVPLAGLTKLQNLYLSKNHI 190 (291)
T ss_dssp CSSCCC-CCGGGTTCTTCCEEECCSSCC
T ss_pred cCCccc-cchhhcCCCccCEEECCCCcC
Confidence 888777 3433 2223445566666643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.84 E-value=8.1e-10 Score=109.36 Aligned_cols=183 Identities=22% Similarity=0.243 Sum_probs=119.8
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcC-CCC--ccceeeEEEecC---eeEEEEEecC
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRN--LVPLIGYCEEEH---QRILVYEYMH 314 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~n--Iv~~~~~~~~~~---~~~lv~e~~~ 314 (557)
+.++.|....||+.. ..+++|+.... .....+.+|.++++.+. +.. +..++......+ ..++||++++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 458899999999874 56889985432 34567889999999883 333 344444433333 3478999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcC-----------------------------------------
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG----------------------------------------- 353 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~----------------------------------------- 353 (557)
|.++.+... ..++..+...++.++++.++.||+.
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988765332 2356667778888888888888851
Q ss_pred --------------CCCCeEeeccCCCCEEeCC--CCcEEEecccCccccCCCCccccccccCCCCc---cCCcccCC--
Q 008707 354 --------------CNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGY---LDPEYYGN-- 412 (557)
Q Consensus 354 --------------~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y---~aPE~l~~-- 412 (557)
....++|+|+++.||++++ +..+.|+||+.+........... ...+ ..|+....
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~-----~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS-----LMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT-----TCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH-----HHhhccccCHHHHHHHH
Confidence 0135899999999999998 45678999998765422111100 0000 12221100
Q ss_pred ---CCC---------CcccceehhHHHHHHHHhCCCCCC
Q 008707 413 ---QQL---------TEKSDVYSFGVVLLELISGKKPVS 439 (557)
Q Consensus 413 ---~~~---------s~~~DvwslG~ll~elltg~~pf~ 439 (557)
+.. ....+.|+++.++|.+.+|..+|-
T Consensus 250 ~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 250 NHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 000 113589999999999999987763
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.82 E-value=4.3e-11 Score=110.69 Aligned_cols=103 Identities=25% Similarity=0.237 Sum_probs=79.7
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
++|+.|+|++|.+++ +| .+.++++|+.|+|++|+|+.+++.+..+++|+.|+|++|+++ .+| .+..+++|+.|+++
T Consensus 48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~l~ 123 (198)
T 1ds9_A 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMS 123 (198)
T ss_dssp TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECC-CHH-HHHHHHHSSEEEES
T ss_pred CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEEECcCCcCC-cCC-ccccCCCCCEEECC
Confidence 578899999999884 77 888888999999999998865545777788999999999988 466 57788889999999
Q ss_pred cccCCCCCCc--cc--ccCceeeeecCCCccc
Q 008707 119 NNSFVGEIPP--AL--LTGKVIFKYDNNPKLH 146 (557)
Q Consensus 119 ~N~~~~~~p~--~~--~~~~~~~~~~~n~~~~ 146 (557)
+|++. .+|. .+ ...+..+.+.+|+..+
T Consensus 124 ~N~i~-~~~~~~~l~~l~~L~~L~l~~N~l~~ 154 (198)
T 1ds9_A 124 NNKIT-NWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp EEECC-CHHHHHHHTTTTTCSEEEECSCHHHH
T ss_pred CCcCC-chhHHHHHhcCCCCCEEEecCCcccc
Confidence 99888 5554 22 3345667778887543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.82 E-value=7.4e-09 Score=110.96 Aligned_cols=93 Identities=22% Similarity=0.323 Sum_probs=61.7
Q ss_pred ceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccccc
Q 008707 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 119 (557)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 119 (557)
+|+.|+|++|.|++ +|. .+++|+.|+|++|+|+++++ .+++|+.|+|++|+|+ .+|. |. ++|+.|++++
T Consensus 121 ~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~-~lp~-l~--~~L~~L~Ls~ 189 (571)
T 3cvr_A 121 SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLT-FLPE-LP--ESLEALDVST 189 (571)
T ss_dssp TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCS-CCCC-CC--TTCCEEECCS
T ss_pred CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCC-Ccch-hh--CCCCEEECcC
Confidence 45555555555553 444 45667777777777776443 5678888888888888 4777 55 7888888888
Q ss_pred ccCCCCCCcccccCc-------eeeeecCCCcc
Q 008707 120 NSFVGEIPPALLTGK-------VIFKYDNNPKL 145 (557)
Q Consensus 120 N~~~~~~p~~~~~~~-------~~~~~~~n~~~ 145 (557)
|+|+ .+|. +...+ ..+.+++|...
T Consensus 190 N~L~-~lp~-~~~~L~~~~~~L~~L~Ls~N~l~ 220 (571)
T 3cvr_A 190 NLLE-SLPA-VPVRNHHSEETEIFFRCRENRIT 220 (571)
T ss_dssp SCCS-SCCC-CC--------CCEEEECCSSCCC
T ss_pred CCCC-chhh-HHHhhhcccccceEEecCCCcce
Confidence 8887 7877 55555 66677777544
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=98.81 E-value=8.8e-09 Score=110.35 Aligned_cols=93 Identities=27% Similarity=0.370 Sum_probs=69.3
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
+++|+.|+|++|+|+ .+| ..+++|+.|+|++|+|+++++ |.+ +|+.|+|++|+|++ +|. .+++|+.|++
T Consensus 79 ~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 147 (571)
T 3cvr_A 79 PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLSTLPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINA 147 (571)
T ss_dssp CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCCCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCCcch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeC
Confidence 457899999999999 788 457889999999999888555 554 78888888888884 666 4677777777
Q ss_pred ccccCCCCCCcccccCceeeeecCCC
Q 008707 118 ENNSFVGEIPPALLTGKVIFKYDNNP 143 (557)
Q Consensus 118 ~~N~~~~~~p~~~~~~~~~~~~~~n~ 143 (557)
++|+|+ .+|. ....+..+.+++|.
T Consensus 148 s~N~l~-~lp~-~l~~L~~L~Ls~N~ 171 (571)
T 3cvr_A 148 DNNQLT-MLPE-LPTSLEVLSVRNNQ 171 (571)
T ss_dssp CSSCCS-CCCC-CCTTCCEEECCSSC
T ss_pred CCCccC-cCCC-cCCCcCEEECCCCC
Confidence 777777 4666 44455566666664
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.80 E-value=7.1e-09 Score=112.19 Aligned_cols=80 Identities=31% Similarity=0.505 Sum_probs=45.6
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
++|+.|+|++|.|++..| +..|++|+.|+|++|+|+++ |.+..+++|+.|+|++|+|+ .+| .+..|++|+.|+|+
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~-~l~-~l~~l~~L~~L~Ls 139 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL-SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLG 139 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC-TTSTTCTTCCEEECTTSCCC-CCG-GGGGCTTCSEEECC
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC-hhhccCCCCCEEEecCCCCC-CCc-cccCCCccCEEECC
Confidence 456666666666663322 55666666666666666552 35555666666666666655 233 25555555555555
Q ss_pred cccCC
Q 008707 119 NNSFV 123 (557)
Q Consensus 119 ~N~~~ 123 (557)
+|++.
T Consensus 140 ~N~l~ 144 (605)
T 1m9s_A 140 NNKIT 144 (605)
T ss_dssp SSCCC
T ss_pred CCccC
Confidence 55555
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=98.80 E-value=7.7e-09 Score=111.91 Aligned_cols=100 Identities=24% Similarity=0.341 Sum_probs=61.7
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
++|+.|+|++|.|+ .+| .+..|++|+.|+|++|+|+++ +.+..+++|+.|+|++|+|++ + ..+..|++|+.|+|+
T Consensus 87 ~~L~~L~Ls~N~l~-~l~-~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls 161 (605)
T 1m9s_A 87 KNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLE 161 (605)
T ss_dssp TTCCEEECCSSCCC-CCT-TSTTCTTCCEEECTTSCCCCC-GGGGGCTTCSEEECCSSCCCC-C-GGGGSCTTCSEEECC
T ss_pred CCCCEEECcCCCCC-CCh-hhccCCCCCEEEecCCCCCCC-ccccCCCccCEEECCCCccCC-c-hhhcccCCCCEEECc
Confidence 56777777777776 344 566677777777777777653 456666777777777777663 3 346666667777777
Q ss_pred cccCCCCCCcccccCceeeeecCCC
Q 008707 119 NNSFVGEIPPALLTGKVIFKYDNNP 143 (557)
Q Consensus 119 ~N~~~~~~p~~~~~~~~~~~~~~n~ 143 (557)
+|+|.+..|-.-+..+..+.+++|.
T Consensus 162 ~N~l~~~~~l~~l~~L~~L~Ls~N~ 186 (605)
T 1m9s_A 162 DNQISDIVPLAGLTKLQNLYLSKNH 186 (605)
T ss_dssp SSCCCCCGGGTTCTTCCEEECCSSC
T ss_pred CCcCCCchhhccCCCCCEEECcCCC
Confidence 7766643332223344455555554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.77 E-value=1.4e-08 Score=106.31 Aligned_cols=95 Identities=26% Similarity=0.265 Sum_probs=47.0
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
++|+.|+|++|+|++ +| ++.+++|+.|+|++|+|++.. ++++++|+.|+|++|++++ +| ++.+++|+.|+++
T Consensus 64 ~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~ 135 (457)
T 3bz5_A 64 TGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNLD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCA 135 (457)
T ss_dssp TTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECT
T ss_pred CCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCceee--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECC
Confidence 345555555555553 33 455555555555555555531 5555555555555555552 33 4555555555555
Q ss_pred cccCCCCCCcccccCceeeeecCC
Q 008707 119 NNSFVGEIPPALLTGKVIFKYDNN 142 (557)
Q Consensus 119 ~N~~~~~~p~~~~~~~~~~~~~~n 142 (557)
+|+++ .+|-.-...+..+.+++|
T Consensus 136 ~N~l~-~l~l~~l~~L~~L~l~~n 158 (457)
T 3bz5_A 136 RNTLT-EIDVSHNTQLTELDCHLN 158 (457)
T ss_dssp TSCCS-CCCCTTCTTCCEEECTTC
T ss_pred CCccc-eeccccCCcCCEEECCCC
Confidence 55555 244333333444444444
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.73 E-value=9.7e-09 Score=107.99 Aligned_cols=80 Identities=33% Similarity=0.472 Sum_probs=49.6
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
++|+.|+|++|.+++ +|. +..+++|+.|+|++|++++.++ +..+++|+.|+|++|++++..| +..+++|+.|+++
T Consensus 265 ~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~ 339 (466)
T 1o6v_A 265 TKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY 339 (466)
T ss_dssp TTCSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECC
T ss_pred CCCCEEECCCCccCc-ccc-ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECC
Confidence 566777777777763 332 6666666666666666666544 5566666666666666664444 4555666666666
Q ss_pred cccCC
Q 008707 119 NNSFV 123 (557)
Q Consensus 119 ~N~~~ 123 (557)
+|++.
T Consensus 340 ~n~l~ 344 (466)
T 1o6v_A 340 NNKVS 344 (466)
T ss_dssp SSCCC
T ss_pred CCccC
Confidence 66655
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=98.72 E-value=1.5e-08 Score=106.52 Aligned_cols=99 Identities=27% Similarity=0.363 Sum_probs=44.0
Q ss_pred ceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccccc
Q 008707 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 119 (557)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 119 (557)
+|+.|+|++|.+++..| +..+++|+.|+|++|++++.++ +..+++|+.|+|++|++++..| +..+++|+.|++++
T Consensus 244 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~ 318 (466)
T 1o6v_A 244 NLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYF 318 (466)
T ss_dssp TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCS
T ss_pred CCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcC
Confidence 34444444444442222 4444444444444444444333 4444455555555555543222 44455555555555
Q ss_pred ccCCCCCCcccccCceeeeecCCC
Q 008707 120 NSFVGEIPPALLTGKVIFKYDNNP 143 (557)
Q Consensus 120 N~~~~~~p~~~~~~~~~~~~~~n~ 143 (557)
|++.+..|-..+..+..+.+.+|+
T Consensus 319 n~l~~~~~~~~l~~L~~L~l~~n~ 342 (466)
T 1o6v_A 319 NNISDISPVSSLTKLQRLFFYNNK 342 (466)
T ss_dssp SCCSCCGGGGGCTTCCEEECCSSC
T ss_pred CcCCCchhhccCccCCEeECCCCc
Confidence 555533332223334444444443
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.72 E-value=2.9e-08 Score=103.86 Aligned_cols=96 Identities=27% Similarity=0.324 Sum_probs=55.5
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
++|+.|+|++|.+++ +| +++++++|+.|++++|++++.+..+ .+|+.|++++|++++ +| .++.+++|+.|+++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~ 203 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKKLPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYAD 203 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcccCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECC
Confidence 456666666666663 55 4666666666666666666533222 366666666666663 55 46666666666666
Q ss_pred cccCCCCCCcccccCceeeeecCCC
Q 008707 119 NNSFVGEIPPALLTGKVIFKYDNNP 143 (557)
Q Consensus 119 ~N~~~~~~p~~~~~~~~~~~~~~n~ 143 (557)
+|++. .+|... ..+..+.+.+|.
T Consensus 204 ~N~l~-~l~~~~-~~L~~L~l~~n~ 226 (454)
T 1jl5_A 204 NNSLK-KLPDLP-LSLESIVAGNNI 226 (454)
T ss_dssp SSCCS-SCCCCC-TTCCEEECCSSC
T ss_pred CCcCC-cCCCCc-CcccEEECcCCc
Confidence 66666 355432 344455555553
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=98.71 E-value=3e-08 Score=103.87 Aligned_cols=98 Identities=17% Similarity=0.239 Sum_probs=76.9
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
++|+.|+|++|.+++ +| .+..+++|+.|+|++|+|++.+ +..+++|+.|+|++|+|++ +| ++.+++|+.|+++
T Consensus 42 ~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~ 114 (457)
T 3bz5_A 42 ATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITTLD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCD 114 (457)
T ss_dssp TTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECC
T ss_pred CCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCeEc--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECC
Confidence 578888888888884 45 6888888888888888888863 8888888888888888884 44 7888888888888
Q ss_pred cccCCCCCCcccccCceeeeecCCCc
Q 008707 119 NNSFVGEIPPALLTGKVIFKYDNNPK 144 (557)
Q Consensus 119 ~N~~~~~~p~~~~~~~~~~~~~~n~~ 144 (557)
+|+++ .+|-.-...+..+.+++|..
T Consensus 115 ~N~l~-~l~~~~l~~L~~L~l~~N~l 139 (457)
T 3bz5_A 115 TNKLT-KLDVSQNPLLTYLNCARNTL 139 (457)
T ss_dssp SSCCS-CCCCTTCTTCCEEECTTSCC
T ss_pred CCcCC-eecCCCCCcCCEEECCCCcc
Confidence 88888 57644445566677777754
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.67 E-value=3.4e-08 Score=107.10 Aligned_cols=93 Identities=27% Similarity=0.312 Sum_probs=47.3
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
|++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+++++ .+++|+.|+|++|+|+ .+|. .+++|+.|++
T Consensus 60 ~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~l~-~l~~---~l~~L~~L~L 128 (622)
T 3g06_A 60 PAHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTSLPV---LPPGLLELSIFSNPLT-HLPA---LPSGLCKLWI 128 (622)
T ss_dssp CTTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSCCCC---CCTTCCEEEECSCCCC-CCCC---CCTTCCEEEC
T ss_pred CCCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCcCCC---CCCCCCEEECcCCcCC-CCCC---CCCCcCEEEC
Confidence 345555555555555 4443 34555555555555554433 4455555555555555 3443 2345555555
Q ss_pred ccccCCCCCCcccccCceeeeecCCC
Q 008707 118 ENNSFVGEIPPALLTGKVIFKYDNNP 143 (557)
Q Consensus 118 ~~N~~~~~~p~~~~~~~~~~~~~~n~ 143 (557)
++|+++ .+|..+ ..+..+.+++|.
T Consensus 129 ~~N~l~-~lp~~l-~~L~~L~Ls~N~ 152 (622)
T 3g06_A 129 FGNQLT-SLPVLP-PGLQELSVSDNQ 152 (622)
T ss_dssp CSSCCS-CCCCCC-TTCCEEECCSSC
T ss_pred CCCCCC-cCCCCC-CCCCEEECcCCc
Confidence 555555 455432 334444455443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=98.66 E-value=4.8e-10 Score=103.59 Aligned_cols=103 Identities=22% Similarity=0.301 Sum_probs=86.6
Q ss_pred CceEEEEecCCCccccCCc------cccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcc
Q 008707 39 PRITKIALSGKNLKGEIPP------ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 112 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~------~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L 112 (557)
..++.++|+.|.++|.+|. .+..+++|+.|+|++|+|++++ .+..+++|+.|+|++|+|+ .+|..+..+++|
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCCC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcccc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 3577788888888888887 8999999999999999999954 9999999999999999999 899888888999
Q ss_pred cccccccccCCCCCCcccc--cCceeeeecCCCcc
Q 008707 113 QELHIENNSFVGEIPPALL--TGKVIFKYDNNPKL 145 (557)
Q Consensus 113 ~~l~l~~N~~~~~~p~~~~--~~~~~~~~~~n~~~ 145 (557)
+.|++++|++. .+| .+. ..+..+.+.+|...
T Consensus 96 ~~L~L~~N~l~-~l~-~~~~l~~L~~L~l~~N~i~ 128 (198)
T 1ds9_A 96 EELWISYNQIA-SLS-GIEKLVNLRVLYMSNNKIT 128 (198)
T ss_dssp SEEEEEEEECC-CHH-HHHHHHHSSEEEESEEECC
T ss_pred CEEECcCCcCC-cCC-ccccCCCCCEEECCCCcCC
Confidence 99999999999 576 332 24556677777543
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=98.64 E-value=1.6e-08 Score=109.62 Aligned_cols=76 Identities=28% Similarity=0.386 Sum_probs=61.4
Q ss_pred CCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccccccCCCCCCccccc--Cceeeeec
Q 008707 63 EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYD 140 (557)
Q Consensus 63 ~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~--~~~~~~~~ 140 (557)
++|+.|+|++|+|++++ ..+++|+.|+|++|+|+ .+|. .+++|+.|++++|+|+ .+|..+.. .+..+.+.
T Consensus 221 ~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~ 292 (622)
T 3g06_A 221 SGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 292 (622)
T ss_dssp TTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECC
T ss_pred CCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEec
Confidence 67888899999888855 45688999999999999 7887 5678999999999998 89887643 45677888
Q ss_pred CCCccc
Q 008707 141 NNPKLH 146 (557)
Q Consensus 141 ~n~~~~ 146 (557)
+|+...
T Consensus 293 ~N~l~~ 298 (622)
T 3g06_A 293 GNPLSE 298 (622)
T ss_dssp SCCCCH
T ss_pred CCCCCC
Confidence 888653
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=98.64 E-value=2.7e-08 Score=104.16 Aligned_cols=82 Identities=24% Similarity=0.353 Sum_probs=56.2
Q ss_pred CCceEEEEecCCCccccCCccccCC-CCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNM-EALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
|++|+.|+|++|.+++ ++ .+ ++|+.|+|++|+++++++. +++|+.|++++|+++ .+|. .+++|+.|+
T Consensus 296 ~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~ 363 (454)
T 1jl5_A 296 PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIELPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLH 363 (454)
T ss_dssp CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEE
T ss_pred CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccccccc---CCcCCEEECCCCccc-cccc---hhhhccEEE
Confidence 3455555555555552 22 23 5788888888888874433 477888888888888 6776 367888888
Q ss_pred cccccCCC--CCCcccc
Q 008707 117 IENNSFVG--EIPPALL 131 (557)
Q Consensus 117 l~~N~~~~--~~p~~~~ 131 (557)
+++|++.+ .+|..+.
T Consensus 364 L~~N~l~~l~~ip~~l~ 380 (454)
T 1jl5_A 364 VEYNPLREFPDIPESVE 380 (454)
T ss_dssp CCSSCCSSCCCCCTTCC
T ss_pred CCCCCCCcCCCChHHHH
Confidence 88888886 5666553
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=98.64 E-value=5.2e-08 Score=97.98 Aligned_cols=99 Identities=28% Similarity=0.451 Sum_probs=57.9
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
++++.|++++|.+. .+|. +..+++|+.|+|++|++++.++ +..+++|+.|+|++|.++ .+| .+..+++|+.|+++
T Consensus 44 ~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~-~~~-~~~~l~~L~~L~l~ 118 (347)
T 4fmz_A 44 ESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKIT-DIS-ALQNLTNLRELYLN 118 (347)
T ss_dssp TTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECT
T ss_pred ccccEEEEeCCccc-cchh-hhhcCCccEEEccCCccccchh-hhcCCcCCEEEccCCccc-Cch-HHcCCCcCCEEECc
Confidence 45666666666666 4443 5666666666666666665544 666666666666666666 344 35666666666666
Q ss_pred cccCCCCCCc-ccccCceeeeecCCC
Q 008707 119 NNSFVGEIPP-ALLTGKVIFKYDNNP 143 (557)
Q Consensus 119 ~N~~~~~~p~-~~~~~~~~~~~~~n~ 143 (557)
+|++. .+|. .-...+..+.+.+|+
T Consensus 119 ~n~i~-~~~~~~~l~~L~~L~l~~n~ 143 (347)
T 4fmz_A 119 EDNIS-DISPLANLTKMYSLNLGANH 143 (347)
T ss_dssp TSCCC-CCGGGTTCTTCCEEECTTCT
T ss_pred CCccc-CchhhccCCceeEEECCCCC
Confidence 66666 4443 112234445555553
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=98.62 E-value=2.4e-08 Score=100.81 Aligned_cols=104 Identities=19% Similarity=0.247 Sum_probs=84.3
Q ss_pred eeCCCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCC-ccCCCC
Q 008707 33 CSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS-YMGSLP 110 (557)
Q Consensus 33 c~~~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~ 110 (557)
|.|+. ++++.++|+++ .+|..+ .++|+.|+|++|+|+.+++ .|.++++|+.|+|++|++.+.+|. .|.+++
T Consensus 7 C~C~~----~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~ 79 (350)
T 4ay9_X 7 CHCSN----RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79 (350)
T ss_dssp SEEET----TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCT
T ss_pred cEeeC----CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcch
Confidence 66643 46899999999 899877 3789999999999999888 599999999999999999767875 577898
Q ss_pred cccc-cccccccCCCCCCccccc---CceeeeecCCCc
Q 008707 111 NLQE-LHIENNSFVGEIPPALLT---GKVIFKYDNNPK 144 (557)
Q Consensus 111 ~L~~-l~l~~N~~~~~~p~~~~~---~~~~~~~~~n~~ 144 (557)
+|.. +.+.+|++. .+|+..+. .+..+.+++|..
T Consensus 80 ~l~~~l~~~~N~l~-~l~~~~f~~l~~L~~L~l~~n~l 116 (350)
T 4ay9_X 80 KLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGI 116 (350)
T ss_dssp TCCEEEEEEETTCC-EECTTSBCCCTTCCEEEEEEECC
T ss_pred hhhhhhcccCCccc-ccCchhhhhcccccccccccccc
Confidence 8765 667789998 78776654 345667777754
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.55 E-value=4.9e-09 Score=107.39 Aligned_cols=85 Identities=22% Similarity=0.377 Sum_probs=45.2
Q ss_pred CceEEEEecCCCcc-ccCC---ccccCCCCCcEEECcCCCCC--C---CCC-CccCCCCCcEEEecCcccc----CcCCC
Q 008707 39 PRITKIALSGKNLK-GEIP---PELKNMEALTELWLDGNFLT--G---PLP-DMSRLIDLRIVHLENNELT----GSLPS 104 (557)
Q Consensus 39 ~~l~~L~L~~n~l~-~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~~-~~~~l~~L~~L~l~~N~l~----~~~p~ 104 (557)
++|++|+|++|+++ +.+| ..+..+++|+.|+|++|+|+ | ..+ .+..+++|+.|+|++|+|+ +.+|.
T Consensus 159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~ 238 (386)
T 2ca6_A 159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI 238 (386)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence 35555555555554 2333 23445555555555555555 2 233 4555555666666666553 34555
Q ss_pred ccCCCCcccccccccccCC
Q 008707 105 YMGSLPNLQELHIENNSFV 123 (557)
Q Consensus 105 ~~~~l~~L~~l~l~~N~~~ 123 (557)
.+..+++|+.|++++|+++
T Consensus 239 ~l~~~~~L~~L~L~~n~i~ 257 (386)
T 2ca6_A 239 ALKSWPNLRELGLNDCLLS 257 (386)
T ss_dssp HGGGCTTCCEEECTTCCCC
T ss_pred HHccCCCcCEEECCCCCCc
Confidence 5555555666666665555
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=98.52 E-value=5.9e-09 Score=106.78 Aligned_cols=108 Identities=16% Similarity=0.202 Sum_probs=90.2
Q ss_pred CceEEEEecCCCcc--c---cCCccccCCCCCcEEECcCCCCC----CCCC-CccCCCCCcEEEecCccccCc----CCC
Q 008707 39 PRITKIALSGKNLK--G---EIPPELKNMEALTELWLDGNFLT----GPLP-DMSRLIDLRIVHLENNELTGS----LPS 104 (557)
Q Consensus 39 ~~l~~L~L~~n~l~--~---~~p~~~~~l~~L~~L~l~~N~l~----~~~~-~~~~l~~L~~L~l~~N~l~~~----~p~ 104 (557)
++|+.|+|++|+|+ | .+|..+..+++|+.|+|++|.|+ +.+| .+..+++|+.|+|++|+|++. +|.
T Consensus 187 ~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~ 266 (386)
T 2ca6_A 187 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 266 (386)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred CCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHH
Confidence 58999999999998 3 35557889999999999999996 5555 589999999999999999865 567
Q ss_pred cc--CCCCcccccccccccCCC----CCCccc---ccCceeeeecCCCccc
Q 008707 105 YM--GSLPNLQELHIENNSFVG----EIPPAL---LTGKVIFKYDNNPKLH 146 (557)
Q Consensus 105 ~~--~~l~~L~~l~l~~N~~~~----~~p~~~---~~~~~~~~~~~n~~~~ 146 (557)
.+ +.+++|+.|++++|++++ .+|..+ +..+..+.+.+|+...
T Consensus 267 ~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 267 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 66 448999999999999995 388876 4567788899998653
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.52 E-value=1.1e-08 Score=103.84 Aligned_cols=109 Identities=18% Similarity=0.183 Sum_probs=81.0
Q ss_pred CCCceEEEEecCCCccccCC----ccccCCC-CCcEEECcCCCCCCCCC-CccCC-----CCCcEEEecCccccCcCCCc
Q 008707 37 TPPRITKIALSGKNLKGEIP----PELKNME-ALTELWLDGNFLTGPLP-DMSRL-----IDLRIVHLENNELTGSLPSY 105 (557)
Q Consensus 37 ~p~~l~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~l~~N~l~~~~~-~~~~l-----~~L~~L~l~~N~l~~~~p~~ 105 (557)
.|.+|+.|+|++|.+++..+ ..+.+++ +|+.|+|++|+|++..+ .+..+ ++|+.|+|++|++++..+..
T Consensus 20 ~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~ 99 (362)
T 3goz_A 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDE 99 (362)
T ss_dssp SCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHH
T ss_pred CCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHH
Confidence 45679999999999985555 6678888 89999999999988766 46554 88999999999998666654
Q ss_pred cCC----C-CcccccccccccCCCCCCccc-------ccCceeeeecCCCcc
Q 008707 106 MGS----L-PNLQELHIENNSFVGEIPPAL-------LTGKVIFKYDNNPKL 145 (557)
Q Consensus 106 ~~~----l-~~L~~l~l~~N~~~~~~p~~~-------~~~~~~~~~~~n~~~ 145 (557)
+.. + ++|+.|++++|++++..+..+ ...+..+.+++|...
T Consensus 100 l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 151 (362)
T 3goz_A 100 LVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151 (362)
T ss_dssp HHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred HHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence 433 3 789999999999884333322 135667778877643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=7.4e-07 Score=86.20 Aligned_cols=135 Identities=17% Similarity=0.111 Sum_probs=97.6
Q ss_pred ccCCCCce-EEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 242 KIGKGSFG-SVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 242 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
.+..|..| .||+.... ++..+++|+-.. .....+.+|..+|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455555 68988765 466789997653 23456788999999884 33477888999988999999999999887
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcC---------------------------------------------
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG--------------------------------------------- 353 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~--------------------------------------------- 353 (557)
.+..... ......+..++++.|+-||+.
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7654321 122345667777777777741
Q ss_pred ----------CCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 354 ----------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 354 ----------~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
....++|||+.+.||++++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112489999999999999877677999997753
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.50 E-value=4.1e-08 Score=94.29 Aligned_cols=87 Identities=22% Similarity=0.297 Sum_probs=61.1
Q ss_pred CceEE--EEecCCCccccCCc----cccCCCCCcEEECcCCCCCCCC--CC-ccCCCCCcEEEecCccccCcCCCccCCC
Q 008707 39 PRITK--IALSGKNLKGEIPP----ELKNMEALTELWLDGNFLTGPL--PD-MSRLIDLRIVHLENNELTGSLPSYMGSL 109 (557)
Q Consensus 39 ~~l~~--L~L~~n~l~~~~p~----~~~~l~~L~~L~l~~N~l~~~~--~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l 109 (557)
+.|.. ++++.|... .++. ...++++|+.|+|++|+|+++. |. +..+++|+.|+|++|+|++. ..+..+
T Consensus 141 p~L~~~~l~l~~N~~~-~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l 217 (267)
T 3rw6_A 141 PDLVAQNIDVVLNRRS-CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKI 217 (267)
T ss_dssp HHHHHTTCCCCTTSHH-HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGG
T ss_pred cchhhcCccccCCHHH-HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhc
Confidence 34554 777888543 3332 2256788888899999888854 33 67788888999998888843 224444
Q ss_pred C--cccccccccccCCCCCCc
Q 008707 110 P--NLQELHIENNSFVGEIPP 128 (557)
Q Consensus 110 ~--~L~~l~l~~N~~~~~~p~ 128 (557)
. +|+.|+|++|.+++.+|+
T Consensus 218 ~~l~L~~L~L~~Npl~~~~~~ 238 (267)
T 3rw6_A 218 KGLKLEELWLDGNSLCDTFRD 238 (267)
T ss_dssp TTSCCSEEECTTSTTGGGCSS
T ss_pred ccCCcceEEccCCcCccccCc
Confidence 4 888888888888877773
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.3e-06 Score=86.29 Aligned_cols=135 Identities=15% Similarity=0.187 Sum_probs=92.9
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCC---CccceeeEEE-ecCeeEEEEEecCCC
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR---NLVPLIGYCE-EEHQRILVYEYMHNG 316 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~---nIv~~~~~~~-~~~~~~lv~e~~~~g 316 (557)
+.++.|....||+. |..+++|+... ......+.+|.++++.+.+. .+.+++.+.. ..+..++|||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 45788888899988 56788887432 23456788999999999642 3566666664 445678999999998
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcC-------------------------------------------
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------------------------------------------- 353 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~------------------------------------------- 353 (557)
.+.+... ..++......++.++++.|+.||+.
T Consensus 99 ~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 8765321 1123444445555555555555531
Q ss_pred --------------CCCCeEeeccCCCCEEeCC---CCc-EEEecccCccc
Q 008707 354 --------------CNPGIIHRDVKSSNILLDI---NMR-AKVSDFGLSRQ 386 (557)
Q Consensus 354 --------------~~~~ivH~dlk~~NIll~~---~~~-~kl~Dfgla~~ 386 (557)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1245799999999999987 455 48999997754
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.38 E-value=5.6e-08 Score=97.25 Aligned_cols=126 Identities=10% Similarity=0.046 Sum_probs=87.6
Q ss_pred CCCCCCCCCCCCCeEEeeCCC----------CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCC-CC-CccC
Q 008707 17 NDRGDPCVPVPWEWVTCSTTT----------PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGP-LP-DMSR 84 (557)
Q Consensus 17 ~~~~~~c~~~~~~~v~c~~~~----------p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~-~~~~ 84 (557)
.|.+--|.+..|+-+..+... .++++.|+|++|.+.+..+. +..+++|+.|+|++|.+++. ++ .+..
T Consensus 38 ~W~~~~~~~~~~~~l~l~~~~~~~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~ 116 (336)
T 2ast_B 38 RWYRLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQ 116 (336)
T ss_dssp HHHHHHTCSTTSSEEECTTCBCCHHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTT
T ss_pred HHHHHhcCchhheeeccccccCCHHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhh
Confidence 354322333357766655421 15788888888888855554 56788888888888888764 55 4788
Q ss_pred CCCCcEEEecCccccCcCCCccCCCCcccccccccc-cCCCC-CCccc--ccCceeeeecCCC
Q 008707 85 LIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN-SFVGE-IPPAL--LTGKVIFKYDNNP 143 (557)
Q Consensus 85 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N-~~~~~-~p~~~--~~~~~~~~~~~n~ 143 (557)
+++|+.|+|++|++++..|..++.+++|+.|++++| .+++. +|..+ ...+..+.+.+|+
T Consensus 117 ~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~ 179 (336)
T 2ast_B 117 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCF 179 (336)
T ss_dssp BCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCT
T ss_pred CCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCC
Confidence 888888888888888777888888888888888888 56642 44422 3345666777763
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=98.34 E-value=9.9e-09 Score=102.80 Aligned_cols=134 Identities=19% Similarity=0.234 Sum_probs=102.1
Q ss_pred HHHHHHHhhhhcCCCCC--CCCCCCCCCCCeEEeeCCCCCceEEEEecCCCccccCCccccCC--CCCcEEECcCCCCCC
Q 008707 2 VLEALRSISDESERTND--RGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNM--EALTELWLDGNFLTG 77 (557)
Q Consensus 2 ~~~~~~~~~~~~~~~~~--~~~~c~~~~~~~v~c~~~~p~~l~~L~L~~n~l~~~~p~~~~~l--~~L~~L~l~~N~l~~ 77 (557)
|-+.|..|-+-++..+. -+--|. .|..+.|. |..++.|+|++|.+. |..+..+ ++|+.|++++|.+++
T Consensus 13 P~eil~~If~~L~~~d~~~~~~vc~--~W~~~~~~---~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~ 84 (336)
T 2ast_B 13 PDELLLGIFSCLCLPELLKVSGVCK--RWYRLASD---ESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQ 84 (336)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSSCH--HHHHHHTC---STTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECS
T ss_pred CHHHHHHHHHhCCHHHHHHHHHHHH--HHHHHhcC---chhheeeccccccCC---HHHHHhhhhccceEEEcCCccccc
Confidence 34455555444433221 122343 58776553 456899999999988 4556777 899999999999999
Q ss_pred CCCCccCCCCCcEEEecCccccCc-CCCccCCCCcccccccccccCCCCCCcccc--cCceeeeecCCC
Q 008707 78 PLPDMSRLIDLRIVHLENNELTGS-LPSYMGSLPNLQELHIENNSFVGEIPPALL--TGKVIFKYDNNP 143 (557)
Q Consensus 78 ~~~~~~~l~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~--~~~~~~~~~~n~ 143 (557)
.++.+..+++|+.|+|++|.+++. +|..+..+++|+.|++++|++.+.+|..+. ..+..+.+.+|.
T Consensus 85 ~~~~~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~ 153 (336)
T 2ast_B 85 PLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 153 (336)
T ss_dssp CCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCB
T ss_pred cchhhccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCC
Confidence 999888999999999999999866 888899999999999999999866666553 356677788874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=2.1e-06 Score=86.70 Aligned_cols=80 Identities=5% Similarity=0.037 Sum_probs=56.2
Q ss_pred ccc-CCCCceEEEEEEEc-------CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcC-C--CCccceeeEEEec---
Q 008707 241 KKI-GKGSFGSVYYGKMK-------DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIH-H--RNLVPLIGYCEEE--- 303 (557)
Q Consensus 241 ~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h--~nIv~~~~~~~~~--- 303 (557)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+.+++.+. + -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88999999998764 26788999765432 001245678999998884 3 3567788877655
Q ss_pred CeeEEEEEecCCCChhh
Q 008707 304 HQRILVYEYMHNGTLRD 320 (557)
Q Consensus 304 ~~~~lv~e~~~~gsL~~ 320 (557)
+..++|||+++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999876653
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=98.26 E-value=1e-07 Score=96.61 Aligned_cols=102 Identities=14% Similarity=0.039 Sum_probs=84.2
Q ss_pred EEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-----CccCCC-CCcEEEecCccccCcCCCccCCC-----Cc
Q 008707 43 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-----DMSRLI-DLRIVHLENNELTGSLPSYMGSL-----PN 111 (557)
Q Consensus 43 ~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-----~~~~l~-~L~~L~l~~N~l~~~~p~~~~~l-----~~ 111 (557)
.++|++|+++|.+|..+...++|+.|+|++|.|++..+ .|..++ +|+.|+|++|+|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 57899999999998887777789999999999999875 377888 89999999999997777777765 89
Q ss_pred ccccccccccCCCCCCcccc-------cCceeeeecCCCc
Q 008707 112 LQELHIENNSFVGEIPPALL-------TGKVIFKYDNNPK 144 (557)
Q Consensus 112 L~~l~l~~N~~~~~~p~~~~-------~~~~~~~~~~n~~ 144 (557)
|+.|++++|++++..+..+. ..+..+.+++|..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l 121 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCG
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcC
Confidence 99999999999855554332 3566778888874
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.24 E-value=1.5e-07 Score=90.24 Aligned_cols=77 Identities=23% Similarity=0.356 Sum_probs=44.8
Q ss_pred CceEEEEecCCCccc--cCCccccCCCCCcEEECcCCCCCCCCC--CccCCCCCcEEEecCccccCcCCC-------ccC
Q 008707 39 PRITKIALSGKNLKG--EIPPELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHLENNELTGSLPS-------YMG 107 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~~--~~~~l~~L~~L~l~~N~l~~~~p~-------~~~ 107 (557)
++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++... .+..+ +|+.|+|++|.+++.+|+ .+.
T Consensus 170 ~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~~l~~l-~L~~L~L~~Npl~~~~~~~~~y~~~il~ 248 (267)
T 3rw6_A 170 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL-KLEELWLDGNSLCDTFRDQSTYISAIRE 248 (267)
T ss_dssp TTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGGGGTTS-CCSEEECTTSTTGGGCSSHHHHHHHHHH
T ss_pred CCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhhhcccC-CcceEEccCCcCccccCcchhHHHHHHH
Confidence 456666666666665 344555566666666666666666521 23333 666666666666655552 234
Q ss_pred CCCcccccc
Q 008707 108 SLPNLQELH 116 (557)
Q Consensus 108 ~l~~L~~l~ 116 (557)
.+++|+.||
T Consensus 249 ~~P~L~~LD 257 (267)
T 3rw6_A 249 RFPKLLRLD 257 (267)
T ss_dssp HCTTCCEES
T ss_pred HCcccCeEC
Confidence 555665554
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.21 E-value=1.4e-06 Score=86.85 Aligned_cols=94 Identities=15% Similarity=0.071 Sum_probs=80.2
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCc-EEEecCccccCcCCCccCCCCccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLR-IVHLENNELTGSLPSYMGSLPNLQEL 115 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~l 115 (557)
.++|+.|+|++|+++..-+..|.++++|+.|+|++| ++.+.+ .|.++.+|+ .|++++ +++..-+..|.+|++|+.+
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 468999999999999444457999999999999999 777777 599999999 999999 7873445678999999999
Q ss_pred ccccccCCCCCCcccccCc
Q 008707 116 HIENNSFVGEIPPALLTGK 134 (557)
Q Consensus 116 ~l~~N~~~~~~p~~~~~~~ 134 (557)
++++|++. .|+...|.+.
T Consensus 303 ~l~~n~i~-~I~~~aF~~~ 320 (329)
T 3sb4_A 303 LATGDKIT-TLGDELFGNG 320 (329)
T ss_dssp EECSSCCC-EECTTTTCTT
T ss_pred EeCCCccC-ccchhhhcCC
Confidence 99999999 8998887644
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.08 E-value=1.7e-05 Score=79.15 Aligned_cols=140 Identities=16% Similarity=0.228 Sum_probs=80.3
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcC--CCCccceee------EEEecCeeEEEEEe
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH--HRNLVPLIG------YCEEEHQRILVYEY 312 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--h~nIv~~~~------~~~~~~~~~lv~e~ 312 (557)
+.|+.|..+.||+....+| .+++|+.... ...+..|+.+++.|. .-.+.+++. +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4466677899999987654 5889988652 233445666666663 112344443 12345678999999
Q ss_pred cCCCChh--------------hhhhccCC----C-------CCcCHHHH-------------------------------
Q 008707 313 MHNGTLR--------------DRLHGSVN----Q-------KPLDWLTR------------------------------- 336 (557)
Q Consensus 313 ~~~gsL~--------------~~l~~~~~----~-------~~l~~~~~------------------------------- 336 (557)
++|..+. ..++.... . ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11111100 0 00122110
Q ss_pred HHHHHHHHHHHHHHHc----------CCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 337 LQIAHDAAKGLEYLHT----------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 337 ~~i~~qia~aL~~LH~----------~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
..+..++..++++|++ .....++|||+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111223445666652 013789999999999999888889999999764
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.04 E-value=2.3e-07 Score=97.03 Aligned_cols=107 Identities=17% Similarity=0.153 Sum_probs=79.8
Q ss_pred CceEEEEecCCCccccCCccccC-----CCCCcEEECcCCCCCCC----CC-CccCCCCCcEEEecCccccCcCCCccCC
Q 008707 39 PRITKIALSGKNLKGEIPPELKN-----MEALTELWLDGNFLTGP----LP-DMSRLIDLRIVHLENNELTGSLPSYMGS 108 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~~----~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 108 (557)
++|+.|+|++|.+++..+..+.. .++|+.|+|++|.+++. ++ .+..+++|+.|+|++|++++..+..+..
T Consensus 284 ~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 363 (461)
T 1z7x_W 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQ 363 (461)
T ss_dssp TTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHH
T ss_pred CCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHH
Confidence 67999999999997554444332 36999999999999875 33 4677899999999999988554443432
Q ss_pred -----CCcccccccccccCCC----CCCccc--ccCceeeeecCCCcc
Q 008707 109 -----LPNLQELHIENNSFVG----EIPPAL--LTGKVIFKYDNNPKL 145 (557)
Q Consensus 109 -----l~~L~~l~l~~N~~~~----~~p~~~--~~~~~~~~~~~n~~~ 145 (557)
+++|+.|++++|++++ .+|..+ ...+..+.+++|+..
T Consensus 364 ~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~ 411 (461)
T 1z7x_W 364 GLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred HHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence 6789999999999885 566654 345667788888744
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=1.8e-05 Score=80.94 Aligned_cols=74 Identities=14% Similarity=0.138 Sum_probs=49.0
Q ss_pred cccCCCCceEEEEEEEc-CCcEEEEEEccCccc-------hhHHHHHHHHHHHhhcCC--CC-ccceeeEEEecCeeEEE
Q 008707 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS-------HRTQQFVTEVALLSRIHH--RN-LVPLIGYCEEEHQRILV 309 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~h--~n-Iv~~~~~~~~~~~~~lv 309 (557)
+.+|.|..+.||++... +++.+++|....... ...+.+..|.++++.+.. +. +.+++.+ +.+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence 57999999999999754 468899997653221 123456779999988842 33 3455543 34456899
Q ss_pred EEecCCC
Q 008707 310 YEYMHNG 316 (557)
Q Consensus 310 ~e~~~~g 316 (557)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.02 E-value=1.1e-07 Score=99.41 Aligned_cols=85 Identities=22% Similarity=0.246 Sum_probs=43.9
Q ss_pred CceEEEEecCCCccccC-----CccccCCCCCcEEECcCCCCCCC----CC-CccCCCCCcEEEecCccccCcCCCccC-
Q 008707 39 PRITKIALSGKNLKGEI-----PPELKNMEALTELWLDGNFLTGP----LP-DMSRLIDLRIVHLENNELTGSLPSYMG- 107 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~-----p~~~~~l~~L~~L~l~~N~l~~~----~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~- 107 (557)
++|+.|+|++|.+++.- +..+..+++|+.|+|++|+|+.. ++ .+..+++|+.|+|++|.+++..+..+.
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 45666666666665321 11122456666666666666652 22 355566666666666665532222221
Q ss_pred ----CCCcccccccccccCC
Q 008707 108 ----SLPNLQELHIENNSFV 123 (557)
Q Consensus 108 ----~l~~L~~l~l~~N~~~ 123 (557)
..++|+.|++++|.++
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~ 326 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFT 326 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCB
T ss_pred HhccCCccceeeEcCCCCCc
Confidence 1245556666666555
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=0.00012 Score=72.13 Aligned_cols=137 Identities=18% Similarity=0.215 Sum_probs=90.9
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcC---CCCccceeeEEEecCeeEEEEEecCCCC
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGYCEEEHQRILVYEYMHNGT 317 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~~~~~~~~~~~~~lv~e~~~~gs 317 (557)
+.|+.|....+|+.... +..+++|+.... ....+..|.+.|+.|. ...+++++.+....+..++||||+++..
T Consensus 42 ~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~ 117 (312)
T 3jr1_A 42 EKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSK 117 (312)
T ss_dssp EEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCC
T ss_pred EEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCC
Confidence 46899999999999864 678889986532 3567889999999884 3568888888888888999999999876
Q ss_pred hhh-----------hhhccCC-------------------CCCcCHHHHH---HHH----------------HHHHHHH-
Q 008707 318 LRD-----------RLHGSVN-------------------QKPLDWLTRL---QIA----------------HDAAKGL- 347 (557)
Q Consensus 318 L~~-----------~l~~~~~-------------------~~~l~~~~~~---~i~----------------~qia~aL- 347 (557)
+.. .++.... .-.-+|.... ++. .++++.+
T Consensus 118 ~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~ 197 (312)
T 3jr1_A 118 NKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVA 197 (312)
T ss_dssp CCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHH
Confidence 421 1222111 0011343321 111 1122222
Q ss_pred HHHHc-CCCCCeEeeccCCCCEEeCCCCcEEEeccc
Q 008707 348 EYLHT-GCNPGIIHRDVKSSNILLDINMRAKVSDFG 382 (557)
Q Consensus 348 ~~LH~-~~~~~ivH~dlk~~NIll~~~~~~kl~Dfg 382 (557)
..|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus 198 ~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 198 DTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 1246899999999999999887 8899974
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.85 E-value=1.1e-06 Score=89.37 Aligned_cols=107 Identities=21% Similarity=0.176 Sum_probs=77.2
Q ss_pred CceEEEEecCCCccccCCccc-----cCCCCCcEEECcCCCCCCC----CC-CccCCCCCcEEEecCccccC----cCCC
Q 008707 39 PRITKIALSGKNLKGEIPPEL-----KNMEALTELWLDGNFLTGP----LP-DMSRLIDLRIVHLENNELTG----SLPS 104 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~-----~~l~~L~~L~l~~N~l~~~----~~-~~~~l~~L~~L~l~~N~l~~----~~p~ 104 (557)
++|+.|+|++|.|+..-...+ ...++|+.|+|++|.|+.. ++ .+..+++|+.|+|++|+|+. .++.
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~ 205 (372)
T 3un9_A 126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAA 205 (372)
T ss_dssp HTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHH
T ss_pred HhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHH
Confidence 468999999999975433333 3468899999999998753 22 35778899999999999873 2355
Q ss_pred ccCCCCcccccccccccCCCC----CCccc--ccCceeeeecCCCcc
Q 008707 105 YMGSLPNLQELHIENNSFVGE----IPPAL--LTGKVIFKYDNNPKL 145 (557)
Q Consensus 105 ~~~~l~~L~~l~l~~N~~~~~----~p~~~--~~~~~~~~~~~n~~~ 145 (557)
.+..+++|+.|++++|+|+.. ++..+ ...+..+.+++|+..
T Consensus 206 ~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~ 252 (372)
T 3un9_A 206 QLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS 252 (372)
T ss_dssp HGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred HHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence 667778999999999998732 11111 235677788888743
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.82 E-value=1.3e-06 Score=88.63 Aligned_cols=107 Identities=17% Similarity=0.112 Sum_probs=75.9
Q ss_pred CCceEEEEecCCCccccCCccc-cCCCCCcEEECcCCCCCCCCC-Cc-----cCCCCCcEEEecCccccC----cCCCcc
Q 008707 38 PPRITKIALSGKNLKGEIPPEL-KNMEALTELWLDGNFLTGPLP-DM-----SRLIDLRIVHLENNELTG----SLPSYM 106 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~~-~~-----~~l~~L~~L~l~~N~l~~----~~p~~~ 106 (557)
+.+|+.|+|++|.|+..-...+ ..+++|+.|+|++|.|+.... .+ ...++|+.|+|++|.|+. .++..+
T Consensus 100 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L 179 (372)
T 3un9_A 100 RHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGL 179 (372)
T ss_dssp SSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHH
T ss_pred CCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHH
Confidence 4689999999999975433333 345789999999999976533 23 346789999999999873 245556
Q ss_pred CCCCcccccccccccCCCC----CCccc--ccCceeeeecCCCc
Q 008707 107 GSLPNLQELHIENNSFVGE----IPPAL--LTGKVIFKYDNNPK 144 (557)
Q Consensus 107 ~~l~~L~~l~l~~N~~~~~----~p~~~--~~~~~~~~~~~n~~ 144 (557)
..+++|+.|+|++|+|... ++..+ ...+..+.+++|..
T Consensus 180 ~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i 223 (372)
T 3un9_A 180 AGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGA 223 (372)
T ss_dssp HTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCC
T ss_pred hcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCC
Confidence 6788999999999998731 12222 12566777888764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00011 Score=71.51 Aligned_cols=73 Identities=19% Similarity=0.288 Sum_probs=54.0
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcC-CC--CccceeeEEEecCeeEEEEEecCCCC
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HR--NLVPLIGYCEEEHQRILVYEYMHNGT 317 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~--nIv~~~~~~~~~~~~~lv~e~~~~gs 317 (557)
+.+|.|..+.||+.+..+|+.|++|+...........|..|++.|+.|. .. -+.+++++ + ..++||||++++.
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~ 96 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERP 96 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccC
Confidence 5689999999999999999999999865543333456788999999884 21 24444443 2 3478999998765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00031 Score=72.36 Aligned_cols=79 Identities=11% Similarity=0.108 Sum_probs=46.9
Q ss_pred CCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccccccCCCCccCCcccCCC---CCCcccceehhHHHHHHHH
Q 008707 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELI 432 (557)
Q Consensus 356 ~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~---~~s~~~DvwslG~ll~ell 432 (557)
..++|||+++.||+++.++ +.++||+.+...........-...-...|.+|+..... ......++.+....+|+.+
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 310 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF 310 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence 7899999999999998776 99999998875432211110000001234555544311 1122345557777777777
Q ss_pred hCC
Q 008707 433 SGK 435 (557)
Q Consensus 433 tg~ 435 (557)
++.
T Consensus 311 ~~~ 313 (420)
T 2pyw_A 311 NKR 313 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 653
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.57 E-value=7.9e-06 Score=74.13 Aligned_cols=86 Identities=22% Similarity=0.291 Sum_probs=68.7
Q ss_pred CCceEEEEecCC-Ccccc----CCccccCCCCCcEEECcCCCCCCC----CC-CccCCCCCcEEEecCccccCc----CC
Q 008707 38 PPRITKIALSGK-NLKGE----IPPELKNMEALTELWLDGNFLTGP----LP-DMSRLIDLRIVHLENNELTGS----LP 103 (557)
Q Consensus 38 p~~l~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~~-~~~~l~~L~~L~l~~N~l~~~----~p 103 (557)
.+.|++|+|++| .|... +...+...++|++|+|++|.|... +. .+...++|+.|+|++|.|... +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 368999999999 88632 455677789999999999999753 12 355668899999999999842 45
Q ss_pred CccCCCCccccccc--ccccCC
Q 008707 104 SYMGSLPNLQELHI--ENNSFV 123 (557)
Q Consensus 104 ~~~~~l~~L~~l~l--~~N~~~ 123 (557)
..+...++|+.|++ ++|.|.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~ 136 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLG 136 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHhCCCceEEEecCCCCCCC
Confidence 66777889999999 889987
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00015 Score=71.97 Aligned_cols=45 Identities=13% Similarity=0.308 Sum_probs=27.1
Q ss_pred CCCCcEEEecCccccCcCCC-ccCCCCcccccccccccCCCCCCccccc
Q 008707 85 LIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIPPALLT 132 (557)
Q Consensus 85 l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~l~l~~N~~~~~~p~~~~~ 132 (557)
+++|+.|+|++|+++ .+|. .|.+|++|+.+++.+| +. .|++..|.
T Consensus 225 ~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~-~I~~~aF~ 270 (329)
T 3sb4_A 225 MPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LK-TIGQRVFS 270 (329)
T ss_dssp CTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CC-EECTTTTT
T ss_pred cCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cc-eehHHHhh
Confidence 456666666666666 4443 4556666666666666 55 56665554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00011 Score=62.23 Aligned_cols=56 Identities=32% Similarity=0.415 Sum_probs=46.5
Q ss_pred EEEEecCCCcc-ccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCcccc
Q 008707 42 TKIALSGKNLK-GEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELT 99 (557)
Q Consensus 42 ~~L~L~~n~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~ 99 (557)
..++.++++|+ ..+|..+. ++|+.|+|++|+|+.++++ |..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 48999999997 56775543 5799999999999998884 888999999999999764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.44 E-value=8.4e-06 Score=73.98 Aligned_cols=85 Identities=15% Similarity=0.251 Sum_probs=67.9
Q ss_pred CceEEEEecCCCcccc----CCccccCCCCCcEEECcCCCCCCC----C-CCccCCCCCcEEEe--cCccccCc----CC
Q 008707 39 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGP----L-PDMSRLIDLRIVHL--ENNELTGS----LP 103 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~----~-~~~~~l~~L~~L~l--~~N~l~~~----~p 103 (557)
++|++|+|++|.|... +...+...++|+.|+|++|.|+.. + ..+...++|+.|+| ++|.|+.. +.
T Consensus 65 ~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~ 144 (185)
T 1io0_A 65 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 144 (185)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHH
Confidence 6799999999999742 445566678999999999999863 2 24777889999999 88999743 34
Q ss_pred CccCCCCcccccccccccCC
Q 008707 104 SYMGSLPNLQELHIENNSFV 123 (557)
Q Consensus 104 ~~~~~l~~L~~l~l~~N~~~ 123 (557)
..+...++|+.|++++|.+.
T Consensus 145 ~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 145 NMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCcCEEeccCCCCC
Confidence 45556689999999999886
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.41 E-value=1.4e-05 Score=86.36 Aligned_cols=106 Identities=15% Similarity=0.075 Sum_probs=70.2
Q ss_pred CCceEEEEec----CCCcccc-----CCccccCCCCCcEEECcCC--CCCCCCC-Cc-cCCCCCcEEEecCccccC-cCC
Q 008707 38 PPRITKIALS----GKNLKGE-----IPPELKNMEALTELWLDGN--FLTGPLP-DM-SRLIDLRIVHLENNELTG-SLP 103 (557)
Q Consensus 38 p~~l~~L~L~----~n~l~~~-----~p~~~~~l~~L~~L~l~~N--~l~~~~~-~~-~~l~~L~~L~l~~N~l~~-~~p 103 (557)
.++|+.|+|+ .|.+++. ++..+.++++|+.|+|++| .+++... .+ ..+++|+.|+|++|++++ .++
T Consensus 402 ~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~ 481 (592)
T 3ogk_B 402 LKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLM 481 (592)
T ss_dssp CCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHH
T ss_pred CCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHH
Confidence 4678888885 6777742 3334666888888888743 3555433 33 347788888888888875 345
Q ss_pred CccCCCCcccccccccccCCCCCCccc---ccCceeeeecCCC
Q 008707 104 SYMGSLPNLQELHIENNSFVGEIPPAL---LTGKVIFKYDNNP 143 (557)
Q Consensus 104 ~~~~~l~~L~~l~l~~N~~~~~~p~~~---~~~~~~~~~~~n~ 143 (557)
..+..+++|+.|++++|.+++.....+ +..+..+.+++|+
T Consensus 482 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 482 EFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp HHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred HHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 555677888888888888764322222 3456677777777
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00072 Score=66.69 Aligned_cols=142 Identities=14% Similarity=0.207 Sum_probs=79.6
Q ss_pred cccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCC--ccceeeE------EEecCeeEEEEEe
Q 008707 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIGY------CEEEHQRILVYEY 312 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~~~~~------~~~~~~~~lv~e~ 312 (557)
+.|+.|....+|+....+| .+++|+.... .....+..|+.+++.+...+ +.+++.. ....+..+++|+|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4577788899999987655 6888987652 12234567888888774212 3333321 1234567899999
Q ss_pred cCCCChhh--------------hhhccC---CCC-----C-cCHHHHHH------------HHHHHHHHHHHHHc----C
Q 008707 313 MHNGTLRD--------------RLHGSV---NQK-----P-LDWLTRLQ------------IAHDAAKGLEYLHT----G 353 (557)
Q Consensus 313 ~~~gsL~~--------------~l~~~~---~~~-----~-l~~~~~~~------------i~~qia~aL~~LH~----~ 353 (557)
++|..+.. .++... ... . ..|..... +...+.+.++++++ .
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 98865321 111110 000 0 11221100 01113444555542 1
Q ss_pred CCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 354 ~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
...+++|+|+++.||+++.+..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13579999999999999877656899998765
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0008 Score=67.98 Aligned_cols=140 Identities=17% Similarity=0.205 Sum_probs=82.6
Q ss_pred cccCCCCceEEEEEEEc--------CCcEEEEEEccCccchhHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEE
Q 008707 241 KKIGKGSFGSVYYGKMK--------DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e 311 (557)
+.+..|....+|+.... +++.+++|+.... ......+.+|.++++.|. +.-..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45777888889998875 2478999986332 223455668999999884 4334666766543 28999
Q ss_pred ecCCCChhhh-----------------hhccC--CCCCcC--HHHHHHHHHHHHH-------------------HHHHHH
Q 008707 312 YMHNGTLRDR-----------------LHGSV--NQKPLD--WLTRLQIAHDAAK-------------------GLEYLH 351 (557)
Q Consensus 312 ~~~~gsL~~~-----------------l~~~~--~~~~l~--~~~~~~i~~qia~-------------------aL~~LH 351 (557)
|++|.+|..- ++... -..... +.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9988554311 11110 011122 3444545444322 123332
Q ss_pred ----c-CCCCCeEeeccCCCCEEeCCC----CcEEEecccCcc
Q 008707 352 ----T-GCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSR 385 (557)
Q Consensus 352 ----~-~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~ 385 (557)
. .....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 1 123579999999999999876 789999998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00077 Score=69.53 Aligned_cols=72 Identities=14% Similarity=0.240 Sum_probs=49.4
Q ss_pred cccCCCCceEEEEEEEcC--------CcEEEEEEccCccchhHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEE
Q 008707 241 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e 311 (557)
+.|+.|....||++...+ ++.+++|+..... ....+.+|..+++.+. +.-..++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 567888889999998753 5789999874321 1145557999999885 3333666765542 38999
Q ss_pred ecCCCCh
Q 008707 312 YMHNGTL 318 (557)
Q Consensus 312 ~~~~gsL 318 (557)
|++|.++
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00073 Score=66.08 Aligned_cols=71 Identities=10% Similarity=0.091 Sum_probs=44.1
Q ss_pred hcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCc-cceeeEEEecCeeEEEEEec-CCCC
Q 008707 240 CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYEYM-HNGT 317 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~~~~~~~~~~~~~lv~e~~-~~gs 317 (557)
.+.|+.|....+|+. ..+++|+....... .-...+|+.+++.+...++ .+++++. .+.-++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 367888999999999 56888887543211 1123468888887743223 4555543 33457899999 6544
Q ss_pred h
Q 008707 318 L 318 (557)
Q Consensus 318 L 318 (557)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0034 Score=61.96 Aligned_cols=141 Identities=13% Similarity=0.170 Sum_probs=81.3
Q ss_pred ccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCC--CccceeeE-----EEecCeeEEEEEecC
Q 008707 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR--NLVPLIGY-----CEEEHQRILVYEYMH 314 (557)
Q Consensus 242 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~--nIv~~~~~-----~~~~~~~~lv~e~~~ 314 (557)
.++ |....||+....+|+.+++|...... .....+..|..+++.+... .+++++.. ....+..+++|++++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 466 77789999887778789999876331 2345667788888888421 24444443 223456688999998
Q ss_pred CCChhh--------------hhhccC------CCCCcCHHHH----------------------HHHHHHHHHHHHHHHc
Q 008707 315 NGTLRD--------------RLHGSV------NQKPLDWLTR----------------------LQIAHDAAKGLEYLHT 352 (557)
Q Consensus 315 ~gsL~~--------------~l~~~~------~~~~l~~~~~----------------------~~i~~qia~aL~~LH~ 352 (557)
|..+.. .++... ......+... ...+.+++..+.-+-.
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 744310 011100 0111222111 1111122222222211
Q ss_pred -CCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 353 -GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 353 -~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
.....++|||+++.||+++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1236789999999999999 4 899999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0023 Score=63.48 Aligned_cols=142 Identities=12% Similarity=0.065 Sum_probs=73.2
Q ss_pred cccCCCCceE-EEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcC-C-CCccceeeEEEecCeeEEEEEecCCCC
Q 008707 241 KKIGKGSFGS-VYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-H-RNLVPLIGYCEEEHQRILVYEYMHNGT 317 (557)
Q Consensus 241 ~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h-~nIv~~~~~~~~~~~~~lv~e~~~~gs 317 (557)
+.|+.|.... +|+....+++.+++|....... ..+..|+.+++.+. + -.+.+++.+....+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3455555444 6677654467788876543211 23445777777774 2 23556666533333 78999997666
Q ss_pred hhhhhhcc---------------------CC--CCCcCHHHHH-------H-H------------HHHHHHHHHHHH---
Q 008707 318 LRDRLHGS---------------------VN--QKPLDWLTRL-------Q-I------------AHDAAKGLEYLH--- 351 (557)
Q Consensus 318 L~~~l~~~---------------------~~--~~~l~~~~~~-------~-i------------~~qia~aL~~LH--- 351 (557)
+.+.+... .. ...+...... . + ...+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 65433211 00 0111111100 0 0 001112222221
Q ss_pred cCCCCCeEeeccCCCCEEeCCC----CcEEEecccCcccc
Q 008707 352 TGCNPGIIHRDVKSSNILLDIN----MRAKVSDFGLSRQA 387 (557)
Q Consensus 352 ~~~~~~ivH~dlk~~NIll~~~----~~~kl~Dfgla~~~ 387 (557)
......++|||+.+.||+++.+ +.+.|+||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123689999999999999875 67999999987653
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00014 Score=78.30 Aligned_cols=80 Identities=13% Similarity=0.096 Sum_probs=59.6
Q ss_pred CceEEEEecCCCcccc----CCccccCCCCCcEEECcCCCCCCCC----C-CccCCCCCcEEEecCccccCcCCCccCCC
Q 008707 39 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPL----P-DMSRLIDLRIVHLENNELTGSLPSYMGSL 109 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~----~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 109 (557)
++|++|+|++|.+++. ++..+.++++|+.|+|++|.+++.. + .+.++++|+.|+|++|.+. .+|..+..+
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~-~l~~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL-ELVGFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGG-GGHHHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHH-HHHHHHhhh
Confidence 6789999999988755 4444567888999999999887443 2 2567888999999998887 466666667
Q ss_pred Cccccccccc
Q 008707 110 PNLQELHIEN 119 (557)
Q Consensus 110 ~~L~~l~l~~ 119 (557)
++|+.|++++
T Consensus 243 ~~L~~L~l~~ 252 (592)
T 3ogk_B 243 ANLEEFCGGS 252 (592)
T ss_dssp TTCCEEEECB
T ss_pred hHHHhhcccc
Confidence 7777777764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0001 Score=65.61 Aligned_cols=83 Identities=12% Similarity=0.103 Sum_probs=63.1
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCC-CCCC-CCCccCC----CCCcEEEecCcc-ccCcCCCccCCCCc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF-LTGP-LPDMSRL----IDLRIVHLENNE-LTGSLPSYMGSLPN 111 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~-~~~~~~l----~~L~~L~l~~N~-l~~~~p~~~~~l~~ 111 (557)
..|+.|||+++.++..=-..+.++++|+.|+|+++. |+.. +..+..+ ++|+.|+|++|. ++..-=..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 469999999999885434567899999999999995 6542 2235554 479999999985 76322234678899
Q ss_pred cccccccccc
Q 008707 112 LQELHIENNS 121 (557)
Q Consensus 112 L~~l~l~~N~ 121 (557)
|+.|++++..
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 9999999875
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=97.03 E-value=6.5e-05 Score=80.97 Aligned_cols=82 Identities=12% Similarity=0.176 Sum_probs=44.7
Q ss_pred ceEEEEecCCCccccCCcccc-CCCCCcEEECcCC-CCCCC-CCC-ccCCCCCcEEEecCccccCcCCCcc----CCCCc
Q 008707 40 RITKIALSGKNLKGEIPPELK-NMEALTELWLDGN-FLTGP-LPD-MSRLIDLRIVHLENNELTGSLPSYM----GSLPN 111 (557)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~~~-~l~~L~~L~l~~N-~l~~~-~~~-~~~l~~L~~L~l~~N~l~~~~p~~~----~~l~~ 111 (557)
+|+.|+|++|.+++..+..+. .+++|+.|+|++| .++.. ++. +.++++|+.|+|++|.+++..+..+ ..+++
T Consensus 106 ~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~ 185 (594)
T 2p1m_B 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTS 185 (594)
T ss_dssp TCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCC
T ss_pred CCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCc
Confidence 566666666666655554443 4566666666666 33331 222 3356666666666666554333222 24456
Q ss_pred cccccccccc
Q 008707 112 LQELHIENNS 121 (557)
Q Consensus 112 L~~l~l~~N~ 121 (557)
|+.|++++|.
T Consensus 186 L~~L~l~~~~ 195 (594)
T 2p1m_B 186 LVSLNISCLA 195 (594)
T ss_dssp CCEEECTTCC
T ss_pred CcEEEecccC
Confidence 6666666665
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=96.88 E-value=6e-05 Score=81.27 Aligned_cols=105 Identities=16% Similarity=0.149 Sum_probs=76.3
Q ss_pred CCceEEEEec--C----CCccccCC------ccccCCCCCcEEECcCCCCCCCCC-CccC-CCCCcEEEecCccccCcCC
Q 008707 38 PPRITKIALS--G----KNLKGEIP------PELKNMEALTELWLDGNFLTGPLP-DMSR-LIDLRIVHLENNELTGSLP 103 (557)
Q Consensus 38 p~~l~~L~L~--~----n~l~~~~p------~~~~~l~~L~~L~l~~N~l~~~~~-~~~~-l~~L~~L~l~~N~l~~~~p 103 (557)
.++|+.|+|+ + |.++ ..| ..+.++++|+.|+|++ .++.... .+.. +++|+.|+|++|.+++..+
T Consensus 396 ~~~L~~L~L~~~~~~~~~~l~-~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~ 473 (594)
T 2p1m_B 396 RPNMTRFRLCIIEPKAPDYLT-LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGM 473 (594)
T ss_dssp CTTCCEEEEEESSTTCCCTTT-CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHH
T ss_pred CCCcceeEeecccCCCccccc-CCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHH
Confidence 4789999999 4 5666 222 2367789999999987 6665433 4554 8899999999999976555
Q ss_pred Ccc-CCCCcccccccccccCCCCCCccc---ccCceeeeecCCCc
Q 008707 104 SYM-GSLPNLQELHIENNSFVGEIPPAL---LTGKVIFKYDNNPK 144 (557)
Q Consensus 104 ~~~-~~l~~L~~l~l~~N~~~~~~p~~~---~~~~~~~~~~~n~~ 144 (557)
..+ ..+++|+.|++++|.+++.....+ +..+..+.+.+|+.
T Consensus 474 ~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 474 HHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp HHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred HHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 555 568999999999999964333322 24566778888874
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0052 Score=61.09 Aligned_cols=68 Identities=13% Similarity=0.244 Sum_probs=44.7
Q ss_pred CCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcC---CCCccceeeE------EEecCeeEEEEEecC
Q 008707 244 GKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH---HRNLVPLIGY------CEEEHQRILVYEYMH 314 (557)
Q Consensus 244 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~nIv~~~~~------~~~~~~~~lv~e~~~ 314 (557)
|.|....||+....+| .+++|+...... ..|+.+++.|. -|.+++++.. ....+..+++|+|++
T Consensus 32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444679999987767 899998765331 35666666663 2324555532 234567899999998
Q ss_pred CCCh
Q 008707 315 NGTL 318 (557)
Q Consensus 315 ~gsL 318 (557)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 8655
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0031 Score=63.55 Aligned_cols=72 Identities=13% Similarity=0.173 Sum_probs=44.1
Q ss_pred cccCCCCceEEEEEEEcC---------CcEEEEEEccCccchhHHHHHHHHHHHhhcCCCC-ccceeeEEEecCeeEEEE
Q 008707 241 KKIGKGSFGSVYYGKMKD---------GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN-LVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-Iv~~~~~~~~~~~~~lv~ 310 (557)
+.++.|....+|+....+ ++.+++|+....... ......|.++++.+...+ +.++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 567888888999998754 268889986543221 112357888888885333 44666544 2 36899
Q ss_pred EecCCCC
Q 008707 311 EYMHNGT 317 (557)
Q Consensus 311 e~~~~gs 317 (557)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0015 Score=55.13 Aligned_cols=57 Identities=25% Similarity=0.255 Sum_probs=34.7
Q ss_pred EEECcCCCCC--CCCCCccCCCCCcEEEecCccccCcCCC-ccCCCCcccccccccccCCCCCCcccccCceeeeecCCC
Q 008707 67 ELWLDGNFLT--GPLPDMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNNP 143 (557)
Q Consensus 67 ~L~l~~N~l~--~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~l~l~~N~~~~~~p~~~~~~~~~~~~~~n~ 143 (557)
.++.+++.|+ .++..+. .+|+.|+|++|+|+ .+|. .|..+++|+. +.+.+||
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~----------------------L~L~~NP 66 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLT-ALPPGLLDALPALRT----------------------AHLGANP 66 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCS-SCCTTTGGGCTTCCE----------------------EECCSSC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCC-ccChhhhhhccccCE----------------------EEecCCC
Confidence 6777777776 4443332 34677777777777 4444 3445555544 4566778
Q ss_pred ccccc
Q 008707 144 KLHKE 148 (557)
Q Consensus 144 ~~~~~ 148 (557)
|.|++
T Consensus 67 ~~CdC 71 (130)
T 3rfe_A 67 WRCDC 71 (130)
T ss_dssp CBCSG
T ss_pred eeccC
Confidence 88875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0064 Score=62.98 Aligned_cols=73 Identities=11% Similarity=0.087 Sum_probs=47.2
Q ss_pred cccCCCCceEEEEEEEcC-CcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCc-cceeeEEEecCeeEEEEEecCCCCh
Q 008707 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL-VPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI-v~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
+.|+.|....+|+....+ +..+++|+......... ...+|..+++.|...++ .++++.+. + .+||||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 568889899999998875 47888998643221111 12478999999864444 56676663 2 359999987443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.00017 Score=72.59 Aligned_cols=105 Identities=14% Similarity=0.222 Sum_probs=70.9
Q ss_pred CceEEEEecCCCccccCCcccc--CCCCCcEEECcC--CCCCCC------CCCc--cCCCCCcEEEecCccccCcCCCcc
Q 008707 39 PRITKIALSGKNLKGEIPPELK--NMEALTELWLDG--NFLTGP------LPDM--SRLIDLRIVHLENNELTGSLPSYM 106 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~--~l~~L~~L~l~~--N~l~~~------~~~~--~~l~~L~~L~l~~N~l~~~~p~~~ 106 (557)
++|+.|+|..|.+....-..+. .+++|+.|+|+. |...+. -+.+ ..+++|+.|+|.+|.+.+..+..+
T Consensus 193 ~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~l 272 (362)
T 2ra8_A 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMF 272 (362)
T ss_dssp TTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHH
T ss_pred CCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHH
Confidence 6899999999988754444444 789999999863 332221 1222 357899999999999875443323
Q ss_pred ---CCCCcccccccccccCCCC----CCccc--ccCceeeeecCCC
Q 008707 107 ---GSLPNLQELHIENNSFVGE----IPPAL--LTGKVIFKYDNNP 143 (557)
Q Consensus 107 ---~~l~~L~~l~l~~N~~~~~----~p~~~--~~~~~~~~~~~n~ 143 (557)
..+++|+.|+|+.|.+.+. ++..+ +..+..+.+.+|.
T Consensus 273 a~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~ 318 (362)
T 2ra8_A 273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNY 318 (362)
T ss_dssp HHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBB
T ss_pred HhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCc
Confidence 3578999999999998743 23221 2345666777664
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0022 Score=65.47 Aligned_cols=100 Identities=15% Similarity=0.153 Sum_probs=73.9
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCC-----CCCC-CccCCCCCcEEEecCccccCcCC-CccCCCCc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT-----GPLP-DMSRLIDLRIVHLENNELTGSLP-SYMGSLPN 111 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~-----~~~~-~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~ 111 (557)
.+|+.|.| .|+++..-+..|.++++|+.++|.+|.+. .+.+ .|.++++|+.++|++ .++ .++ ..|.+|++
T Consensus 248 ~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~-~I~~~aF~~c~~ 324 (401)
T 4fdw_A 248 SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIR-ILGQGLLGGNRK 324 (401)
T ss_dssp CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCC-EECTTTTTTCCS
T ss_pred CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceE-EEhhhhhcCCCC
Confidence 46888888 55677344567889999999999998876 3444 589999999999994 477 555 46778899
Q ss_pred ccccccccccCCCCCCcccccC--ceeeeecCCC
Q 008707 112 LQELHIENNSFVGEIPPALLTG--KVIFKYDNNP 143 (557)
Q Consensus 112 L~~l~l~~N~~~~~~p~~~~~~--~~~~~~~~n~ 143 (557)
|+.+.+..| ++ .|+...|.+ +..+.+.+|.
T Consensus 325 L~~l~lp~~-l~-~I~~~aF~~~~L~~l~l~~n~ 356 (401)
T 4fdw_A 325 VTQLTIPAN-VT-QINFSAFNNTGIKEVKVEGTT 356 (401)
T ss_dssp CCEEEECTT-CC-EECTTSSSSSCCCEEEECCSS
T ss_pred ccEEEECcc-cc-EEcHHhCCCCCCCEEEEcCCC
Confidence 999999555 66 777766653 4555676664
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.65 E-value=0.01 Score=54.09 Aligned_cols=103 Identities=12% Similarity=0.062 Sum_probs=68.3
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccc
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 396 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 396 (557)
+|.++|... +.++++.++|.++.|.+.+|.-+-.. ..-..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 34 SL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence 788988764 67899999999999999998876210 1112334567899999999988764 1110
Q ss_pred cccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCC
Q 008707 397 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPV 438 (557)
Q Consensus 397 ~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf 438 (557)
.....+.+||... ...+.+.=|||+|+++|.-+--..|-
T Consensus 98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e 136 (229)
T 2yle_A 98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE 136 (229)
T ss_dssp -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc
Confidence 0133567888763 34567888999999999998755553
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0029 Score=64.51 Aligned_cols=89 Identities=18% Similarity=0.224 Sum_probs=62.0
Q ss_pred CceEEEEecCCCccccCC-ccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCcccc-----CcCCCccCCCCc
Q 008707 39 PRITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELT-----GSLPSYMGSLPN 111 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~-----~~~p~~~~~l~~ 111 (557)
++|+.|+|..| ++ .++ ..|.+ .+|+.++| .|.++.+.+ .|.++++|+.+++.+|.+. ..-+..|.+|++
T Consensus 226 ~~L~~l~l~~~-l~-~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~ 301 (401)
T 4fdw_A 226 SQLKTIEIPEN-VS-TIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPK 301 (401)
T ss_dssp TTCCCEECCTT-CC-EECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTT
T ss_pred CCCCEEecCCC-cc-Ccccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCcc
Confidence 46778888764 55 444 44555 78888888 455666655 5888888888888887764 133446778888
Q ss_pred ccccccccccCCCCCCcccccC
Q 008707 112 LQELHIENNSFVGEIPPALLTG 133 (557)
Q Consensus 112 L~~l~l~~N~~~~~~p~~~~~~ 133 (557)
|+.+.+. |.+. .|+...|.+
T Consensus 302 L~~l~l~-~~i~-~I~~~aF~~ 321 (401)
T 4fdw_A 302 LARFEIP-ESIR-ILGQGLLGG 321 (401)
T ss_dssp CCEECCC-TTCC-EECTTTTTT
T ss_pred CCeEEeC-CceE-EEhhhhhcC
Confidence 8888888 4576 777777654
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.00026 Score=71.22 Aligned_cols=105 Identities=17% Similarity=0.149 Sum_probs=69.3
Q ss_pred CCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-Cc--cCCCCCcEEEecC--ccccCc-----CCCcc
Q 008707 37 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DM--SRLIDLRIVHLEN--NELTGS-----LPSYM 106 (557)
Q Consensus 37 ~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~--~~l~~L~~L~l~~--N~l~~~-----~p~~~ 106 (557)
.+|+|+.|+|++|.-. .++. +. +++|+.|+|..|.++...- .+ ..+++|+.|+|+. |...|. +...+
T Consensus 170 ~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l 246 (362)
T 2ra8_A 170 AMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLF 246 (362)
T ss_dssp TCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGS
T ss_pred cCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHH
Confidence 3579999999988422 3444 43 8999999999988764322 23 3789999999964 332211 11122
Q ss_pred --CCCCcccccccccccCCCCCCccc-----ccCceeeeecCCCc
Q 008707 107 --GSLPNLQELHIENNSFVGEIPPAL-----LTGKVIFKYDNNPK 144 (557)
Q Consensus 107 --~~l~~L~~l~l~~N~~~~~~p~~~-----~~~~~~~~~~~n~~ 144 (557)
..+++|+.|++.+|.+....+..+ ...+..+.++.|..
T Consensus 247 ~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L 291 (362)
T 2ra8_A 247 SKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVL 291 (362)
T ss_dssp CTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCC
T ss_pred hcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCC
Confidence 357899999999999874333222 33566677777753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.13 E-value=0.06 Score=55.00 Aligned_cols=73 Identities=11% Similarity=0.124 Sum_probs=48.0
Q ss_pred cccCCCCceEEEEEEEcC--------CcEEEEEEccCccchhHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEE
Q 008707 241 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e 311 (557)
+.+..|....+|+....+ ++.+++|+....... .-...+|.++++.+. +.-..++++.+. -++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 567778888999998763 578999986543211 112347888888884 333455565332 268999
Q ss_pred ecCCCCh
Q 008707 312 YMHNGTL 318 (557)
Q Consensus 312 ~~~~gsL 318 (557)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9988653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=94.91 E-value=0.005 Score=55.66 Aligned_cols=85 Identities=13% Similarity=0.155 Sum_probs=60.8
Q ss_pred CCceEEEEecCC-Cccc----cCCccccCCCCCcEEECcCCCCCCC--CC---CccCCCCCcEEEecCccccCc----CC
Q 008707 38 PPRITKIALSGK-NLKG----EIPPELKNMEALTELWLDGNFLTGP--LP---DMSRLIDLRIVHLENNELTGS----LP 103 (557)
Q Consensus 38 p~~l~~L~L~~n-~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~--~~---~~~~l~~L~~L~l~~N~l~~~----~p 103 (557)
.+.|++|+|++| .|.. .+-+.+..-+.|+.|+|++|+|... .. .+..-+.|+.|+|++|+|... +-
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala 119 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 119 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHH
Confidence 367899999986 6652 2445566678999999999999743 11 244567899999999999732 33
Q ss_pred CccCCCCcccccccccccC
Q 008707 104 SYMGSLPNLQELHIENNSF 122 (557)
Q Consensus 104 ~~~~~l~~L~~l~l~~N~~ 122 (557)
..+..-+.|+.|+|++|..
T Consensus 120 ~aL~~N~tL~~L~L~n~~~ 138 (197)
T 1pgv_A 120 RSTLVTQSIVEFKADNQRQ 138 (197)
T ss_dssp HHTTTTCCCSEEECCCCSS
T ss_pred HHHhhCCceeEEECCCCcC
Confidence 4455556799999987643
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=94.14 E-value=0.076 Score=53.26 Aligned_cols=87 Identities=16% Similarity=0.121 Sum_probs=43.0
Q ss_pred ceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCC-CccCCCCccccccc
Q 008707 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELHI 117 (557)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~l~l 117 (557)
.|+.+.+..+ ++..-...|.++.+|+.+.+..+ +..+.. .|.++.+|+.+.+.+|.++ .++ ..|.+|.+|+.+.+
T Consensus 241 ~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~-~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 241 ALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIE-TLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp SCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCC-EECTTTTTTCTTCCEEEC
T ss_pred cceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccc-eehhhhhcCCCCCCEEEc
Confidence 4555555543 33222234555555666655433 333333 3555566666666555555 333 34555556665555
Q ss_pred ccccCCCCCCcccc
Q 008707 118 ENNSFVGEIPPALL 131 (557)
Q Consensus 118 ~~N~~~~~~p~~~~ 131 (557)
..| ++ .|....|
T Consensus 318 p~~-l~-~I~~~aF 329 (379)
T 4h09_A 318 PTA-LK-TIQVYAF 329 (379)
T ss_dssp CTT-CC-EECTTTT
T ss_pred Ccc-cc-EEHHHHh
Confidence 433 43 4544443
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=93.81 E-value=0.14 Score=51.70 Aligned_cols=96 Identities=13% Similarity=0.226 Sum_probs=55.2
Q ss_pred eEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCC-CccCCCCcccccccc
Q 008707 41 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELHIE 118 (557)
Q Consensus 41 l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~l~l~ 118 (557)
|+.+.+.++-.+ .-...|.++++|+.+.+. +.++.+.. .|.++.+|+.++|..| ++ .+. ..|.+|.+|+.+.+.
T Consensus 267 L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~C~~L~~i~ip 342 (394)
T 4gt6_A 267 LASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-IT-QILDDAFAGCEQLERIAIP 342 (394)
T ss_dssp CCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEC
T ss_pred ccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-cc-EehHhHhhCCCCCCEEEEC
Confidence 444555443332 333456666777777775 44554544 4777777777777654 55 443 456677777777775
Q ss_pred cccCCCCCCccccc---CceeeeecCC
Q 008707 119 NNSFVGEIPPALLT---GKVIFKYDNN 142 (557)
Q Consensus 119 ~N~~~~~~p~~~~~---~~~~~~~~~n 142 (557)
.+ ++ .|....|. .+..+.+.+|
T Consensus 343 ~s-v~-~I~~~aF~~C~~L~~i~~~~~ 367 (394)
T 4gt6_A 343 SS-VT-KIPESAFSNCTALNNIEYSGS 367 (394)
T ss_dssp TT-CC-BCCGGGGTTCTTCCEEEESSC
T ss_pred cc-cC-EEhHhHhhCCCCCCEEEECCc
Confidence 43 55 66666554 2344455444
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.66 E-value=0.2 Score=50.71 Aligned_cols=30 Identities=30% Similarity=0.383 Sum_probs=24.9
Q ss_pred CeEeeccCCCCEEe------CCCCcEEEecccCccc
Q 008707 357 GIIHRDVKSSNILL------DINMRAKVSDFGLSRQ 386 (557)
Q Consensus 357 ~ivH~dlk~~NIll------~~~~~~kl~Dfgla~~ 386 (557)
.++|+|+.+.||++ +++..+.++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999987753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=93.60 E-value=0.073 Score=53.82 Aligned_cols=70 Identities=11% Similarity=0.074 Sum_probs=41.2
Q ss_pred cccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCC-CccCCCCcccccccccccCCCCCCccccc
Q 008707 58 ELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELHIENNSFVGEIPPALLT 132 (557)
Q Consensus 58 ~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~~~~~~p~~~~~ 132 (557)
.+.++.+|+.+.+.+| ++.+.. .|.++.+|+.++|.++ ++ .++ ..|.+|++|+.+.+..| ++ .|++..|.
T Consensus 292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~-~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~ 363 (394)
T 4fs7_A 292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VE-EIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQ 363 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCEECCCTT-CC-EECTTTBT
T ss_pred cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-cc-EEhHHhccCCCCCCEEEECcc-cc-EehHHHhh
Confidence 3556666777766554 444444 4666677777777543 55 443 35666677777666655 54 56655554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=92.69 E-value=0.18 Score=50.53 Aligned_cols=88 Identities=16% Similarity=0.269 Sum_probs=51.8
Q ss_pred ceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCC-ccCCCCccccccc
Q 008707 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHI 117 (557)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~l~l 117 (557)
.++.+.+..+ +...-...+.++..|+.+.+..+ ++.+.. .|.++.+|+.+.+..+ ++ .++. .|.++++|+.+.+
T Consensus 218 ~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~-~i~~~aF~~c~~L~~i~l 293 (379)
T 4h09_A 218 NLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VK-TVPYLLCSGCSNLTKVVM 293 (379)
T ss_dssp SCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CS-EECTTTTTTCTTCCEEEE
T ss_pred ccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ce-eccccccccccccccccc
Confidence 3555555433 33233345666677777777655 444444 4666777777777544 44 3433 4566777777777
Q ss_pred ccccCCCCCCccccc
Q 008707 118 ENNSFVGEIPPALLT 132 (557)
Q Consensus 118 ~~N~~~~~~p~~~~~ 132 (557)
.+|.+. .|++..|.
T Consensus 294 ~~~~i~-~I~~~aF~ 307 (379)
T 4h09_A 294 DNSAIE-TLEPRVFM 307 (379)
T ss_dssp CCTTCC-EECTTTTT
T ss_pred cccccc-eehhhhhc
Confidence 777666 66666554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=92.58 E-value=0.17 Score=51.08 Aligned_cols=80 Identities=14% Similarity=0.213 Sum_probs=63.0
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCC-CccCCCCcccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELH 116 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~l~ 116 (557)
..|+.+.+. +.++..-...|.++++|+.++|..| ++.+.. .|.++.+|+.+.|..+ ++ .+. ..|.+|++|+.++
T Consensus 288 ~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~ 363 (394)
T 4gt6_A 288 PALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIE 363 (394)
T ss_dssp TTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEE
T ss_pred cccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEE
Confidence 467888885 5676333457899999999999875 665555 5999999999999765 77 565 4688999999999
Q ss_pred cccccC
Q 008707 117 IENNSF 122 (557)
Q Consensus 117 l~~N~~ 122 (557)
+.+|..
T Consensus 364 ~~~~~~ 369 (394)
T 4gt6_A 364 YSGSRS 369 (394)
T ss_dssp ESSCHH
T ss_pred ECCcee
Confidence 988764
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=91.59 E-value=0.039 Score=48.80 Aligned_cols=93 Identities=10% Similarity=0.105 Sum_probs=58.1
Q ss_pred cCCccccCCCCCcEEECcCCCCCCC-CCCccCCCCCcEEEecCcc-ccCcCCCccCCC----Cccccccccccc-CCCC-
Q 008707 54 EIPPELKNMEALTELWLDGNFLTGP-LPDMSRLIDLRIVHLENNE-LTGSLPSYMGSL----PNLQELHIENNS-FVGE- 125 (557)
Q Consensus 54 ~~p~~~~~l~~L~~L~l~~N~l~~~-~~~~~~l~~L~~L~l~~N~-l~~~~p~~~~~l----~~L~~l~l~~N~-~~~~- 125 (557)
.+|.....--+|+.|||+++.|+.. +..+.++++|+.|+|++|. |+..-=..+..+ ++|+.|+++++. ++..
T Consensus 52 ~LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~G 131 (176)
T 3e4g_A 52 HLPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKG 131 (176)
T ss_dssp GSCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHH
T ss_pred cCCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHH
Confidence 3454332234799999999998764 3357889999999999996 663222234443 479999999975 5511
Q ss_pred CC-cccccCceeeeecCCCccc
Q 008707 126 IP-PALLTGKVIFKYDNNPKLH 146 (557)
Q Consensus 126 ~p-~~~~~~~~~~~~~~n~~~~ 146 (557)
+. -.-+..+..+.+.+.+...
T Consensus 132 l~~L~~~~~L~~L~L~~c~~It 153 (176)
T 3e4g_A 132 IIALHHFRNLKYLFLSDLPGVK 153 (176)
T ss_dssp HHHGGGCTTCCEEEEESCTTCC
T ss_pred HHHHhcCCCCCEEECCCCCCCC
Confidence 00 0112345566666655443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=90.60 E-value=0.2 Score=50.57 Aligned_cols=78 Identities=12% Similarity=0.086 Sum_probs=62.7
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCC-CccCCCCcccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLP-SYMGSLPNLQELH 116 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~l~ 116 (557)
.+|+.+.+.++ ++..-...|.++++|+.++|.++ ++.+.. .|.++.+|+.++|+.| ++ .++ ..|.+|++|+.+.
T Consensus 297 ~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~C~~L~~i~ 372 (394)
T 4fs7_A 297 SSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LR-KIGANAFQGCINLKKVE 372 (394)
T ss_dssp TTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTBTTCTTCCEEE
T ss_pred ccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-cc-EehHHHhhCCCCCCEEE
Confidence 57889999765 66334457999999999999865 776666 5999999999999887 77 554 5788999999999
Q ss_pred cccc
Q 008707 117 IENN 120 (557)
Q Consensus 117 l~~N 120 (557)
+..|
T Consensus 373 lp~~ 376 (394)
T 4fs7_A 373 LPKR 376 (394)
T ss_dssp EEGG
T ss_pred ECCC
Confidence 8765
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=88.32 E-value=0.085 Score=47.55 Aligned_cols=69 Identities=19% Similarity=0.235 Sum_probs=51.0
Q ss_pred CCccccCCCCCcEEECcCC-CCCCC----CC-CccCCCCCcEEEecCccccCc----CCCccCCCCcccccccccccCC
Q 008707 55 IPPELKNMEALTELWLDGN-FLTGP----LP-DMSRLIDLRIVHLENNELTGS----LPSYMGSLPNLQELHIENNSFV 123 (557)
Q Consensus 55 ~p~~~~~l~~L~~L~l~~N-~l~~~----~~-~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~~~ 123 (557)
+...+.+-+.|+.|+|++| +|... +- .+..-+.|+.|+|++|+|... +...+..-+.|+.|+|++|+|.
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 3334556689999999996 77642 11 356667899999999999732 3344455678999999999997
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.95 E-value=2.2 Score=38.69 Aligned_cols=116 Identities=11% Similarity=0.074 Sum_probs=77.1
Q ss_pred CCCCccceeeEEEecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCE
Q 008707 289 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 368 (557)
Q Consensus 289 ~h~nIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NI 368 (557)
.||+++.. .+-.+++...+.++.-. +...+-. -...+...+++++.+|+....++++ -+|--|+|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 58888866 45555565555555433 2222221 2346788899999999998866653 47889999999
Q ss_pred EeCCCCcEEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCC
Q 008707 369 LLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVS 439 (557)
Q Consensus 369 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~ 439 (557)
+++.++.+++.=.|+-... +|. ..+...=.-.+=+++..+++++..|.
T Consensus 111 ~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999876653222 111 11222223456678899999999886
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.22 E-value=0.21 Score=51.68 Aligned_cols=60 Identities=8% Similarity=0.087 Sum_probs=17.9
Q ss_pred hcccCCCCceEEEEEEEcC-CcEEEE------EEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEe
Q 008707 240 CKKIGKGSFGSVYYGKMKD-GKEVAV------KIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE 302 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 302 (557)
.+.|| ||.||+|.+.. ..+||+ |..+... .+....+.+|..+++.++|||+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 46677 99999998864 357888 6654321 2233568889999999999999999987643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 557 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-65 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-58 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-57 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-56 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-51 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-40 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-09 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-04 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.002 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.003 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-04 | |
| d1j7la_ | 263 | d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos | 0.001 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (555), Expect = 1e-67
Identities = 78/276 (28%), Positives = 137/276 (49%), Gaps = 25/276 (9%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPL 296
++IG GSFG+VY GK +VAVK++ + + Q F EV +L + H N++
Sbjct: 12 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+GY +V ++ +L LH + + + + IA A+G++YLH
Sbjct: 70 MGYSTAPQ-LAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH---AK 123
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQ- 414
IIHRD+KS+NI L ++ K+ DFGL+ + +H G++ ++ PE Q
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 415 --LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472
+ +SDVY+FG+VL EL++G+ P S +N M+ +G + P L
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRG----YLSPDL-S 232
Query: 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508
V+ + + +C++++ RP +I+ +I+
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 4e-65
Identities = 67/271 (24%), Positives = 122/271 (45%), Gaps = 21/271 (7%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+++G G FG V+ G +VAVK + S F+ E L+ ++ H+ LV L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
+E ++ EYM NG+L D L + L L +A A+G+ ++
Sbjct: 76 VVTQEP-IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
IHRD++++NIL+ + K++DFGL+R E++ A+ + + PE T K
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 419 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 478
SDV+SFG++L E+++ + E+ +++G + D
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPDNCP-------- 236
Query: 479 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509
+ ++ C ++R RP + ++D
Sbjct: 237 -EELYQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 4e-64
Identities = 72/272 (26%), Positives = 124/272 (45%), Gaps = 21/272 (7%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 297
F ++IG G FG V+ G + +VA+K + + + F+ E ++ ++ H LV L
Sbjct: 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLY 66
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
G C E+ LV+E+M +G L D + + T L + D +G+ YL
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYL---EEAC 121
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
+IHRD+ + N L+ N KVSDFG++R +D S+ + V + PE + + +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 418 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 477
KSDV+SFGV++ E+ S K +E+ I G + P L
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTG--FRLYKPRLAST---- 229
Query: 478 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509
+ ++ C ++R RP ++ + +
Sbjct: 230 ---HVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 1e-63
Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 21/272 (7%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLI 297
F K++G G FG V YGK + +VA+K++ + S +F+ E ++ + H LV L
Sbjct: 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
G C ++ ++ EYM NG L + L + L++ D + +EYL +
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLE---SKQ 120
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
+HRD+ + N L++ KVSDFGLSR +D S ++ V + PE + +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 418 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 477
KSD+++FGV++ E+ S K +E I +G + + P L
Sbjct: 181 KSDIWAFGVLMWEIYSLGKMPYERFTNSET------AEHIAQG--LRLYRPHLASE---- 228
Query: 478 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509
++ + C ++ RP + ++ I D
Sbjct: 229 ---KVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-63
Identities = 74/301 (24%), Positives = 132/301 (43%), Gaps = 34/301 (11%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYC 300
+ IGKG FG V+ GK + G+EVAVKI S R+ E+ + H N++ I
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 301 EEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC-- 354
+++ Q LV +Y +G+L D L+ + + +++A A GL +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 355 ---NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR---GTVGYLDPE 408
P I HRD+KS NIL+ N ++D GL+ + + I GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 409 YY------GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFG----AELNIVHWARSMIK 458
+ + +++D+Y+ G+V E+ + + +L + ++
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 459 KGDVISIVDPVLIGNVK-IESIWRIAEVAIQCVEQRGFSRPKMQEIV-----LAIQDSIK 512
K + P + + E++ +A++ +C G +R I L+ Q+ IK
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302
Query: 513 I 513
+
Sbjct: 303 M 303
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 3e-63
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 12/215 (5%)
Query: 232 LEEATNNF--CKKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLSR 287
+E ++F ++G G+ G V+ K G +A K++ + Q + E+ +L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 288 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 347
+ +V G + + + E+M G+L L + +++ KGL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGL 117
Query: 348 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 407
YL I+HRDVK SNIL++ K+ DFG+S Q + + + GT Y+ P
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSP 172
Query: 408 EYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVED 442
E + +SD++S G+ L+E+ G+ P+ D
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-60
Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 27/272 (9%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
+ IGKG FG V G + G +VAVK + + + Q F+ E ++++++ H NLV L+G
Sbjct: 11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLG 67
Query: 299 YCEEEHQRI-LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
EE + +V EYM G+L D L + L L+ + D + +EYL
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE---GNN 123
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
+HRD+ + N+L+ + AKVSDFGL+++A + V + PE ++ +
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFST 179
Query: 418 KSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIE 477
KSDV+SFG++L E+ S + ++ ++KG + D
Sbjct: 180 KSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCP------- 226
Query: 478 SIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509
+ EV C RP ++ ++
Sbjct: 227 --PAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 5e-60
Identities = 69/274 (25%), Positives = 120/274 (43%), Gaps = 21/274 (7%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
K+G+G FG V+ G VA+K + + + F+ E ++ ++ H LV L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYA 79
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
EE +V EYM G+L D L G K L + +A A G+ Y+
Sbjct: 80 VVSEEP-IYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVE---RMNY 134
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
+HRD++++NIL+ N+ KV+DFGL+R E++ A+ + + PE + T K
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194
Query: 419 SDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIES 478
SDV+SFG++L EL + + E+ +++G +
Sbjct: 195 SDVWSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPCPPECPE------- 241
Query: 479 IWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512
+ ++ QC + RP + + ++D
Sbjct: 242 --SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (499), Expect = 4e-59
Identities = 77/311 (24%), Positives = 123/311 (39%), Gaps = 49/311 (15%)
Query: 229 LPELEEATNNF--CKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQ-QFV 279
L LE NN + IG+G+FG V+ + VAVK++ + S Q F
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 280 TEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG--------------- 324
E AL++ + N+V L+G C L++EYM G L + L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 325 ------SVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKV 378
S PL +L IA A G+ YL +HRD+ + N L+ NM K+
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181
Query: 379 SDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
+DFGLSR D + ++ PE + T +SDV+++GVVL E+ S
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 438 VSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSR 497
E+ ++ G++++ + + + + C + R
Sbjct: 242 PYYGMAHEEV------IYYVRDGNILACPENCPL---------ELYNLMRLCWSKLPADR 286
Query: 498 PKMQEIVLAIQ 508
P I +Q
Sbjct: 287 PSFCSIHRILQ 297
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 7e-59
Identities = 75/274 (27%), Positives = 116/274 (42%), Gaps = 30/274 (10%)
Query: 239 FCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 295
F +IG+GSF +VY G + EVA + D ++ Q+F E +L + H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 296 LIGYCEE----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
E + +LV E M +GTL+ L K + KGL++LH
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 352 TGCNPGIIHRDVKSSNILL-DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410
T P IIHRD+K NI + K+ D GL+ GT ++ PE Y
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMY 185
Query: 411 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470
++ E DVY+FG+ +LE+ + + P S E + G + D V
Sbjct: 186 -EEKYDESVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 504
I VK E+ C+ Q R +++++
Sbjct: 239 IPEVK--------EIIEGCIRQNKDERYSIKDLL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-58
Identities = 67/276 (24%), Positives = 124/276 (44%), Gaps = 29/276 (10%)
Query: 241 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVP 295
K++G G+FG+V G + K VAVKI+ + + + + E ++ ++ + +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
+IG CE E +LV E G L L + + +++ H + G++YL
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLE---E 125
Query: 356 PGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS--VARGTVGYLDPEYYGNQ 413
+HRD+ + N+LL AK+SDFGLS+ D + + + V + PE
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 414 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473
+ + KSDV+SFGV++ E S + G+E+ +M++KG+ +
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV------TAMLEKGERMGCPAGCP--- 236
Query: 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509
+ ++ C +RP + L +++
Sbjct: 237 ------REMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (494), Expect = 2e-58
Identities = 73/276 (26%), Positives = 118/276 (42%), Gaps = 21/276 (7%)
Query: 238 NFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL 296
K+G G +G VY G K VAVK + + + ++F+ E A++ I H NLV L
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQL 78
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+G C E ++ E+M G L D L N++ + + L +A + +EYL
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE---KK 134
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 416
IHRD+ + N L+ N KV+DFGLSR D + A+ + + PE + +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 417 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 476
KSDV++FGV+L E+ + I V +++
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQVYELLEKDYRMERPE 239
Query: 477 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512
++ E+ C + RP EI A + +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 194 bits (493), Expect = 3e-58
Identities = 72/303 (23%), Positives = 136/303 (44%), Gaps = 42/303 (13%)
Query: 231 ELEEATNNFC-----------KKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT 275
+ EA F + IG G FG V G +K + VA+K + + +
Sbjct: 11 DPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ 70
Query: 276 -QQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWL 334
+ F++E +++ + H N++ L G + +++ E+M NG+L L N +
Sbjct: 71 RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQFTVI 128
Query: 335 TRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394
+ + A G++YL + +HRD+ + NIL++ N+ KVSDFGLSR E+D +
Sbjct: 129 QLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 395 SSVA----RGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 449
+ + + + + PE ++ T SDV+S+G+V+ E++S G++P +N
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245
Query: 450 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509
+ + D S + ++ + C ++ RPK +IV +
Sbjct: 246 IEQDYRLPPPMDCPS----------------ALHQLMLDCWQKDRNHRPKFGQIVNTLDK 289
Query: 510 SIK 512
I+
Sbjct: 290 MIR 292
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 7e-58
Identities = 63/288 (21%), Positives = 123/288 (42%), Gaps = 30/288 (10%)
Query: 231 ELEEATNNFC---KKIGKGSFGSVYYGKMK---DGKEVAVKIM-ADSCSHRTQQFVTEVA 283
+L +N ++G G+FGSV G + +VA+K++ + T++ + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 284 LLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDA 343
++ ++ + +V LIG C+ +LV E G L L G ++ + ++ H
Sbjct: 62 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQV 118
Query: 344 AKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGT 401
+ G++YL +HRD+ + N+LL AK+SDFGLS+ D S +
Sbjct: 119 SMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 402 VGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 461
+ + PE ++ + +SDV+S+GV + E +S + + G E+ + I++G
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAFIEQGK 229
Query: 462 VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509
+ + + C + RP + ++
Sbjct: 230 RMECPPECP---------PELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-57
Identities = 68/275 (24%), Positives = 110/275 (40%), Gaps = 25/275 (9%)
Query: 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLV 294
IG GS+G + K DGK + K + Q V+EV LL + H N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 295 PLIGYCEEEHQRIL--VYEYMHNGTLRDRLH-GSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
+ L V EY G L + G+ ++ LD L++ L+ H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 352 --TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
+ ++HRD+K +N+ LD K+ DFGL+R D + + GT Y+ PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF-VGTPYYMSPEQ 185
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469
EKSD++S G +L EL + P + I++G I
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-------KIREGKFRRIPYRY 238
Query: 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 504
+ E+ + + + + RP ++EI+
Sbjct: 239 SD---------ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (487), Expect = 3e-57
Identities = 68/271 (25%), Positives = 113/271 (41%), Gaps = 33/271 (12%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLVPL 296
++IG GSFG+VY+ + + + VA+K M + + Q + EV L ++ H N +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
G EH LV EY ++KPL + + H A +GL YLH +
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLH---SH 134
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY---GNQ 413
+IHRDVK+ NILL K+ DFG + + + GT ++ PE
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEG 189
Query: 414 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473
Q K DV+S G+ +EL K P+ + + L I + + ++
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------HIAQNESPALQSGHWSEY 242
Query: 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 504
+ C+++ RP + ++
Sbjct: 243 FR--------NFVDSCLQKIPQDRPTSEVLL 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 5e-57
Identities = 75/286 (26%), Positives = 121/286 (42%), Gaps = 29/286 (10%)
Query: 233 EEATNNFCKKIGKGSFGSVYYGKMKDGK----EVAVKIM-ADSCSHRTQQFVTEVALLSR 287
+F + IG+G FG VY+G + D AVK + + QF+TE ++
Sbjct: 25 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKD 84
Query: 288 IHHRNLVPLIGYC-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 346
H N++ L+G C E ++V YM +G LR+ + AKG
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKG 142
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA---EEDLTHISSVARGTVG 403
+ + +HRD+ + N +LD KV+DFGL+R E D H + A+ V
Sbjct: 143 M---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 404 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 463
++ E Q+ T KSDV+SFGV+L EL++ P ++N + +G +
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITV-YLLQGRRL 253
Query: 464 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQD 509
+ + EV ++C + RP E+V I
Sbjct: 254 LQPE---------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 6e-57
Identities = 58/269 (21%), Positives = 114/269 (42%), Gaps = 26/269 (9%)
Query: 241 KKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
++G G+FG VY + K+ A K++ + ++ E+ +L+ H N+V L+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
E+ ++ E+ G + + ++PL + L YLH + II
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLH---DNKII 132
Query: 360 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY-----YGNQQ 414
HRD+K+ NIL ++ K++DFG+S + + S GT ++ PE ++
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPYWMAPEVVMCETSKDRP 191
Query: 415 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474
K+DV+S G+ L+E+ + P + L I K + ++ P +
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-------KIAKSEPPTLAQPSRWSS- 243
Query: 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEI 503
+ +C+E+ +R ++
Sbjct: 244 ------NFKDFLKKCLEKNVDARWTTSQL 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-56
Identities = 67/268 (25%), Positives = 109/268 (40%), Gaps = 30/268 (11%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHRNLVPL 296
+ +GKG FG+VY + K +A+K++ + + Q EV + S + H N++ L
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
GY + + L+ EY GT+ L D + A L Y H +
Sbjct: 72 YGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCH---SK 125
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 416
+IHRD+K N+LL K++DFG S A GT+ YL PE +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL---CGTLDYLPPEMIEGRMHD 182
Query: 417 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 476
EK D++S GV+ E + GK P F A + R + V
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPP-----FEANTYQETYKRISRVEFTFPDFVTEGAR----- 232
Query: 477 ESIWRIAEVAIQCVEQRGFSRPKMQEIV 504
++ + ++ RP ++E++
Sbjct: 233 -------DLISRLLKHNPSQRPMLREVL 253
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 7e-56
Identities = 75/280 (26%), Positives = 129/280 (46%), Gaps = 28/280 (10%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRTQ-QFVTEVALLSRIHHRNLV 294
K IG G FG VY G +K VA+K + + + + F+ E ++ + H N++
Sbjct: 13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
L G + +++ EYM NG L L L + + A G++YL
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLA--- 127
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED--LTHISSVARGTVGYLDPEYYGN 412
N +HRD+ + NIL++ N+ KVSDFGLSR E+D T+ +S + + + PE
Sbjct: 128 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 187
Query: 413 QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472
++ T SDV+SFG+V+ E+++ + E +V+ ++
Sbjct: 188 RKFTSASDVWSFGIVMWEVMTYGERPYWEL---------------SNHEVMKAINDGFRL 232
Query: 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512
++ I ++ +QC +Q RPK +IV + I+
Sbjct: 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-55
Identities = 74/298 (24%), Positives = 124/298 (41%), Gaps = 41/298 (13%)
Query: 239 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 290
F K +G G+FG V VAVK++ + + ++E+ +LS + +H
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 86
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG---------------SVNQKPLDWLT 335
N+V L+G C +++ EY G L + L ++ LD
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 336 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-I 394
L ++ AKG+ +L + IHRD+ + NILL K+ DFGL+R + D + +
Sbjct: 147 LLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 454
AR V ++ PE N T +SDV+S+G+ L EL S + +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----PYPGMPVDSKFY 258
Query: 455 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512
MIK+G + + + ++ C + RP ++IV I+ I
Sbjct: 259 KMIKEGFRMLSPEHAP---------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 3e-55
Identities = 54/198 (27%), Positives = 102/198 (51%), Gaps = 9/198 (4%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+KIG+G+ G+VY G+EVA++ M + + + E+ ++ + N+V +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
+ +V EY+ G+L D + + +D + + + LE+LH + +I
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 360 HRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKS 419
HRD+KS NILL ++ K++DFG Q + + S++ GT ++ PE + K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 420 DVYSFGVVLLELISGKKP 437
D++S G++ +E+I G+ P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 1e-54
Identities = 77/296 (26%), Positives = 128/296 (43%), Gaps = 38/296 (12%)
Query: 238 NFCKKIGKGSFGSVYYGKMKDG---KEVAVKIMADSCSHR-TQQFVTEVALLSRI-HHRN 292
F IG+G+FG V ++K + A+K M + S + F E+ +L ++ HH N
Sbjct: 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 293 LVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTRLQI 339
++ L+G CE L EY +G L D L + L L
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 132
Query: 340 AHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR 399
A D A+G++YL IHRD+ + NIL+ N AK++DFGLSR E + ++ R
Sbjct: 133 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGR 187
Query: 400 GTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 459
V ++ E T SDV+S+GV+L E++S AEL + +
Sbjct: 188 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKLPQ 241
Query: 460 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515
G + + ++ QC ++ + RP +I++++ ++ K
Sbjct: 242 GYRLEKPLNCD---------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 8e-54
Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 46/295 (15%)
Query: 239 FCKKIGKGSFGSVYYGKMKD------GKEVAVKIM-ADSCSHRTQQFVTEVALLSRI-HH 290
F K +G G+FG V +VAVK++ + S + ++E+ +++++ H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 291 RNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHG--------------------SVNQKP 330
N+V L+G C L++EY G L + L +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 331 LDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390
L + L A+ AKG+E+L +HRD+ + N+L+ K+ DFGL+R D
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 391 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNI 449
+ + AR V ++ PE T KSDV+S+G++L E+ S
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------------ 265
Query: 450 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 504
+ + ++ + + I + C RP +
Sbjct: 266 --PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 4e-53
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 12/211 (5%)
Query: 229 LPELEEATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLS 286
+P +E+ + +G+G++G V + + VAVKI+ + E+ +
Sbjct: 1 VPFVEDWD--LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINK 58
Query: 287 RIHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 346
++H N+V G+ E + + L EY G L DR+ + + H G
Sbjct: 59 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAG 115
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED-LTHISSVARGTVGYL 405
+ YLH GI HRD+K N+LLD K+SDFGL+ + + + GT+ Y+
Sbjct: 116 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 406 DPEYYGNQQL-TEKSDVYSFGVVLLELISGK 435
PE ++ E DV+S G+VL +++G+
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGE 203
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 5e-53
Identities = 68/281 (24%), Positives = 112/281 (39%), Gaps = 29/281 (10%)
Query: 239 FCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSCSHRTQ---QFVTEVALLSRIHHR 291
+K+G GSFG V G+ VAVK + + + F+ EV + + HR
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
NL+ L G ++ V E G+L DRL +Q T + A A+G+ YL
Sbjct: 72 NLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH--ISSVARGTVGYLDPEY 409
+ IHRD+ + N+LL K+ DFGL R ++ H + + + PE
Sbjct: 129 ---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469
+ + SD + FGV L E+ + + LN + K+G+ + +
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510
I V +QC + RP + + ++
Sbjct: 241 ---------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 2e-52
Identities = 63/282 (22%), Positives = 117/282 (41%), Gaps = 26/282 (9%)
Query: 239 FCKKIGKGSFGSVYYGKMKDGKE----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNL 293
+ IG+G FG V+ G + VA+K + S ++F+ E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
V LIG E ++ E G LR V + LD + + A+ + L YL
Sbjct: 71 VKLIGVITENP-VWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLE-- 125
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 413
+ +HRD+ + N+L+ N K+ DFGLSR E+ + +S + + ++ PE +
Sbjct: 126 -SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 414 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473
+ T SDV+ FGV + E++ ++ I+ G+ + +
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLPMPPNCPP-- 236
Query: 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515
+ + +C RP+ E+ + ++ EK
Sbjct: 237 -------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-51
Identities = 65/289 (22%), Positives = 123/289 (42%), Gaps = 33/289 (11%)
Query: 239 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHR-TQQFVTEVALLSRIHHR 291
+++G+GSFG VY G K VA+K + ++ S R +F+ E +++ +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------GSVNQKPLDWLTRLQIAHDAA 344
++V L+G + +++ E M G L+ L + P +Q+A + A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 345 KGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA-EEDLTHISSVARGTVG 403
G+ YL +HRD+ + N ++ + K+ DFG++R E D V
Sbjct: 144 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 404 YLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 463
++ PE + T SDV+SFGVVL E+ + + ++ + +G ++
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFVMEGGLL 254
Query: 464 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512
D + E+ C + RP EI+ +I++ ++
Sbjct: 255 DKPDNCP---------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (447), Expect = 6e-51
Identities = 45/200 (22%), Positives = 92/200 (46%), Gaps = 10/200 (5%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+++G G+FG V+ G+ K + E+++++++HH L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
E++++ +L+ E++ G L DR+ + + A +GL+++H I+
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH---EHSIV 149
Query: 360 HRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
H D+K NI+ + K+ DFGL+ + D + T + PE + +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGF 207
Query: 418 KSDVYSFGVVLLELISGKKP 437
+D+++ GV+ L+SG P
Sbjct: 208 YTDMWAIGVLGYVLLSGLSP 227
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 176 bits (446), Expect = 8e-51
Identities = 46/200 (23%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+++G G+FG V+ + G A K + + E+ +S + H LV L
Sbjct: 32 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
E++++ +++YE+M G L +++ + ++ KGL ++H +
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 146
Query: 360 HRDVKSSNILL--DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
H D+K NI+ + K+ DFGL+ + + + GT + PE + +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGY 204
Query: 418 KSDVYSFGVVLLELISGKKP 437
+D++S GV+ L+SG P
Sbjct: 205 YTDMWSVGVLSYILLSGLSP 224
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 8e-50
Identities = 60/271 (22%), Positives = 127/271 (46%), Gaps = 28/271 (10%)
Query: 241 KKIGKGSFGSVYYGKMKDGKE-----VAVKIMADSCSHRT-QQFVTEVALLSRIHHRNLV 294
K +G G+FG+VY G E VA+K + ++ S + ++ + E +++ + + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
L+G C + L+ + M G L D + ++ + L AKG+ YL
Sbjct: 75 RLLGICLTSTVQ-LITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---E 128
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ-AEEDLTHISSVARGTVGYLDPEYYGNQ 413
+ ++HRD+ + N+L+ K++DFGL++ E+ + + + + ++ E ++
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 188
Query: 414 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473
T +SDV+S+GV + EL++ +E+ S+++KG+ + I
Sbjct: 189 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEKGERLPQPPICTI-- 240
Query: 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 504
+ + ++C SRPK +E++
Sbjct: 241 -------DVYMIMVKCWMIDADSRPKFRELI 264
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 4e-49
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 239 FCKKIGKGSFGSVYYGK-MKDGKEVAVKIM---ADSCSHRTQQFVTEVALLSRIHHRNLV 294
F K +G+GSF +V + + +E A+KI+ ++ E ++SR+ H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
L +++ + Y NG L + D + LEYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH--- 125
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR-QAEEDLTHISSVARGTVGYLDPEYYGNQ 413
GIIHRD+K NILL+ +M +++DFG ++ + E ++ GT Y+ PE +
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 414 QLTEKSDVYSFGVVLLELISGKKP 437
+ SD+++ G ++ +L++G P
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-48
Identities = 70/297 (23%), Positives = 125/297 (42%), Gaps = 40/297 (13%)
Query: 239 FCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCSHRTQQ-FVTEVALLSRI-HH 290
K +G+G+FG V + VAVK++ + +H + ++E+ +L I HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 291 RNLVPLIGYCEEEHQRI-LVYEYMHNGTLRDRLHG-------------SVNQKPLDWLTR 336
N+V L+G C + + ++ E+ G L L + + L
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 337 LQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI-S 395
+ + AKG+E+L + IHRD+ + NILL K+ DFGL+R +D ++
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 455
AR + ++ PE ++ T +SDV+SFGV+L E+ S + I
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEEFCR 248
Query: 456 MIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512
+K+G + D + + + C RP E+V + + ++
Sbjct: 249 RLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-47
Identities = 64/294 (21%), Positives = 123/294 (41%), Gaps = 42/294 (14%)
Query: 239 FCKKIGKGSFGSVYYGKMK--------DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRI- 288
K +G+G+FG V + +VAVK++ +D+ ++E+ ++ I
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 289 HHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLH-------------GSVNQKPLDWLT 335
H+N++ L+G C ++ ++ EY G LR+ L ++ L
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 336 RLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395
+ A+ A+G+EYL + IHRD+ + N+L+ + K++DFGL+R +
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 396 S-VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 454
+ R V ++ PE ++ T +SDV+SFGV+L E+ + V
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY------PGVPVEELF 247
Query: 455 SMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508
++K+G + + + C RP +++V +
Sbjct: 248 KLLKEGHRMDKPSNCT---------NELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 3e-47
Identities = 41/200 (20%), Positives = 90/200 (45%), Gaps = 11/200 (5%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+ +G+G FG V+ K K + + + E+++L+ HRN++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHES 69
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
E + ++++E++ + +R++ + L+ + H + L++LH + I
Sbjct: 70 FESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 360 HRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
H D++ NI+ + K+ +FG +RQ + Y PE + + ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182
Query: 418 KSDVYSFGVVLLELISGKKP 437
+D++S G ++ L+SG P
Sbjct: 183 ATDMWSLGTLVYVLLSGINP 202
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (410), Expect = 2e-46
Identities = 59/207 (28%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT---QQFVTEVALLSRIHHRNLVPL 296
+ +G G V+ + ++ ++VAVK++ + +F E + ++H +V +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 297 IGYCEEEHQRI----LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
E E +V EY+ TLRD +H + P+ +++ DA + L +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFS-- 127
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYY 410
GIIHRDVK +NI++ KV DFG++R + ++ A GT YL PE
Sbjct: 128 -HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 411 GNQQLTEKSDVYSFGVVLLELISGKKP 437
+ +SDVYS G VL E+++G+ P
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPP 213
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 160 bits (406), Expect = 7e-46
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIM---------ADSCSHRTQQFVTEVALLSRIH- 289
+ +G+G V K KE AVKI+ A+ + + EV +L ++
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 290 HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 349
H N++ L E LV++ M G L D L + L +I + +
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICA 125
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
LH I+HRD+K NILLD +M K++DFG S Q + GT YL PE
Sbjct: 126 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYLAPEI 180
Query: 410 Y------GNQQLTEKSDVYSFGVVLLELISGKKP 437
+ ++ D++S GV++ L++G P
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (407), Expect = 9e-46
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 13/205 (6%)
Query: 238 NFCKKIGKGSFGSVYYGK-MKDGKEVAVKIMA-DSCSHRTQQFVTEVALLSRIHHRNLVP 295
+F +G G+F V + + K VA+K +A + + E+A+L +I H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 296 LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCN 355
L E L+ + + G L DR+ + ++ ++YLH
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG- 127
Query: 356 PGIIHRDVKSSNILL---DINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
I+HRD+K N+L D + + +SDFGLS+ + ++ GT GY+ PE
Sbjct: 128 --IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC--GTPGYVAPEVLAQ 183
Query: 413 QQLTEKSDVYSFGVVLLELISGKKP 437
+ ++ D +S GV+ L+ G P
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 162 bits (411), Expect = 1e-45
Identities = 56/230 (24%), Positives = 92/230 (40%), Gaps = 19/230 (8%)
Query: 237 NNF--CKKIGKGSFGSVYYGKMKD-GKEVAVKIM------ADSCSHRTQQFVTEVALLSR 287
N+F + IG+G FG VY + D GK A+K + ++L+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 288 IHHRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 347
+V + + + + M+ G L L A + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 348 EYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDP 407
E++H N +++RD+K +NILLD + ++SD GL+ + H S GT GY+ P
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174
Query: 408 EYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSM 456
E +D +S G +L +L+ G P + I +M
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 224
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-45
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 12/227 (5%)
Query: 239 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHR---TQQFVTEVALLSR-IHHRNL 293
K +GKGSFG V+ + K + A+K + + + E +LS H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
+ + + V EY++ G L + + D A + GL++L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFL--- 119
Query: 354 CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQ 413
+ GI++RD+K NILLD + K++DFG+ ++ ++ GT Y+ PE Q
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178
Query: 414 QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 460
+ D +SFGV+L E++ G+ P +D + + +
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 225
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (404), Expect = 3e-45
Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 14/201 (6%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 296
+ +G GSFG V+ + + +G+ A+K++ R +Q E +LS + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
G ++ Q ++ +Y+ G L L + A + LEYLH +
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLH---SK 123
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 416
II+RD+K NILLD N K++DFG ++ + + GT Y+ PE +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL----CGTPDYIAPEVVSTKPYN 179
Query: 417 EKSDVYSFGVVLLELISGKKP 437
+ D +SFG+++ E+++G P
Sbjct: 180 KSIDWWSFGILIYEMLAGYTP 200
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 2e-44
Identities = 61/283 (21%), Positives = 97/283 (34%), Gaps = 28/283 (9%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+KIG GSFG +Y G + G+EVA+K+ H Q E + + +P I +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRW 70
Query: 300 C-EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
C E ++V E + + T L +A +EY+H +
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIH---SKNF 124
Query: 359 IHRDVKSSNIL---LDINMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPEY 409
IHRDVK N L + DFGL+++ + TH + GT Y
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPV 469
+ + + + D+ S G VL+ G P + +S V
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----MSTPIEV 239
Query: 470 LIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512
L E A C R +P + ++
Sbjct: 240 LCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 156 bits (394), Expect = 4e-44
Identities = 42/199 (21%), Positives = 89/199 (44%), Gaps = 8/199 (4%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLIG 298
+KIG+G++G VY + G+ A+K + + E+++L + H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
+ + +LV+E++ + + L+ +T G+ Y H + +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEK 418
+HRD+K N+L++ K++DFGL+R + + G+++ +
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTT 181
Query: 419 SDVYSFGVVLLELISGKKP 437
D++S G + E+++G
Sbjct: 182 IDIWSVGCIFAEMVNGTPL 200
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 153 bits (387), Expect = 5e-43
Identities = 42/284 (14%), Positives = 91/284 (32%), Gaps = 28/284 (9%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
++IG+GSFG ++ G + + ++VA+K Q E + +P + Y
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 300 CEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGII 359
+E ++ + +L D L + + T A ++ +H ++
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLD--LCGRKFSVKTVAMAAKQMLARVQSIH---EKSLV 123
Query: 360 HRDVKSSNILLD-----INMRAKVSDFGLSRQAEEDLTHI------SSVARGTVGYLDPE 408
+RD+K N L+ V DFG+ + + +T GT Y+
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 409 YYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468
+ ++ + + D+ + G V + + G P + +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL-----R 238
Query: 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512
L E + + P + ++
Sbjct: 239 ELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 8e-43
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 233 EEATNNFCKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSCSHRTQQFVTEVALLSRIHHR 291
+E + K IG GSFG VY K+ D G+ VA+K + + E+ ++ ++ H
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHC 73
Query: 292 NLVPLIGYCEEEHQR------ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAK 345
N+V L + ++ LV +Y+ R H S ++ L + + +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 346 GLEYLHTGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGY 404
L Y+H + GI HRD+K N+LLD + K+ DFG ++Q ++S + Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--YY 188
Query: 405 LDP-EYYGNQQLTEKSDVYSFGVVLLELISGKKP 437
P +G T DV+S G VL EL+ G+
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-42
Identities = 43/200 (21%), Positives = 88/200 (44%), Gaps = 8/200 (4%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 297
+KIG+G++G VY + K G+ VA+K + + E++LL ++H N+V L+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
E++ LV+E++H + + +GL + +
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFC---HSHR 122
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
++HRD+K N+L++ K++DFGL+R + + G + +
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 182
Query: 418 KSDVYSFGVVLLELISGKKP 437
D++S G + E+++ +
Sbjct: 183 AVDIWSLGCIFAEMVTRRAL 202
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 1e-41
Identities = 49/231 (21%), Positives = 90/231 (38%), Gaps = 15/231 (6%)
Query: 241 KKIGKGSFGSVYYGKMK--DGKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNL 293
+IG+G++G V+ + G+ VA+K + + T + V + L H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLR---DRLHGSVNQKPLDWLTRLQIAHDAAKGLEYL 350
V L C + + V + + T + +GL++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 351 HTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410
H + ++HRD+K NIL+ + + K++DFGL+R + S V T+ Y PE
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYRAPEVL 187
Query: 411 GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGD 461
D++S G + E+ K +L + + + D
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-41
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 14/204 (6%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-----ADSCSHRTQQFVTEVALLSRIHHRNLV 294
+G+G F +VY + K + VA+K + +++ + + E+ LL + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
L+ + LV+++M N L +GLEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLH--- 117
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GNQ 413
I+HRD+K +N+LLD N K++DFGL++ + T Y PE G +
Sbjct: 118 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 414 QLTEKSDVYSFGVVLLELISGKKP 437
D+++ G +L EL+
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-41
Identities = 54/232 (23%), Positives = 103/232 (44%), Gaps = 8/232 (3%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIM-ADSCSHRTQQFVTEVALLSRIHHRNLVPLIG 298
IG+G++G V + VA+K + Q+ + E+ +L R H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 299 YCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGI 358
+ Y+ + L+ + + L + +GL+Y+H + +
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANV 130
Query: 359 IHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVAR--GTVGYLDPEYYGNQQL- 415
+HRD+K SN+LL+ K+ DFGL+R A+ D H + T Y PE N +
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 416 TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467
T+ D++S G +L E++S + + + +LN + + D+ I++
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-41
Identities = 52/231 (22%), Positives = 94/231 (40%), Gaps = 23/231 (9%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIG 298
+ +G G G V K ++ A+K++ D + EV L R ++V ++
Sbjct: 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVD 72
Query: 299 YCE----EEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
E ++V E + G L R+ + +I + ++YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 355 NPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 411
+ I HRDVK N+L N K++DFG +++ + + T Y+ PE G
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAPEVLG 186
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV 462
++ + D++S GV++ L+ G P L I ++ I+ G
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---GLAISPGMKTRIRMGQY 234
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-40
Identities = 54/216 (25%), Positives = 91/216 (42%), Gaps = 11/216 (5%)
Query: 239 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH---RTQQFVTEVALLSRIHHRNLV 294
+ K +GKG+FG V + K G+ A+KI+ VTE +L H L
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 295 PLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
L + + V EY + G L L T + A+ + L
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRE------RVFTEERARFYGAEIVSALEYLH 122
Query: 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQ 414
+ +++RD+K N++LD + K++DFGL ++ D + + GT YL PE +
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDND 181
Query: 415 LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 450
D + GVV+ E++ G+ P +D ++
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-40
Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 19/208 (9%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT------QQFVTEVALLSRIHHRNL 293
+++G G F V + K G + A K + + + + EV++L I H N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 294 VPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG 353
+ L E + IL+ E + G L D L ++ L + G+ YLH
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLH-- 130
Query: 354 CNPGIIHRDVKSSNILLD----INMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEY 409
+ I H D+K NI+L R K+ DFGL+ + + + GT ++ PE
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--GTPEFVAPEI 187
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKP 437
+ L ++D++S GV+ L+SG P
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-40
Identities = 47/200 (23%), Positives = 89/200 (44%), Gaps = 9/200 (4%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 297
+KIG+G++G+V+ K + + VA+K + D + E+ LL + H+N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG 357
+ + LV+E+ + LD KGL + H +
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH---SRN 121
Query: 358 IIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTE 417
++HRD+K N+L++ N K+++FGL+R + S+ +G + +
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 418 KSDVYSFGVVLLELISGKKP 437
D++S G + EL + +P
Sbjct: 182 SIDMWSAGCIFAELANAGRP 201
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (363), Expect = 4e-39
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 14/218 (6%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQ---FVTEVALLSRIHHRNLVPL 296
K +G GSFG V K K G A+KI+ + +Q + E +L ++ LV L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 297 IGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
++ +V EY+ G + L A EYLH +
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLH---SL 160
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 416
+I+RD+K N+L+D +V+DFG +++ + + GT L PE ++
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL----CGTPEALAPEIILSKGYN 216
Query: 417 EKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR 454
+ D ++ GV++ E+ +G P + + +
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK 254
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 6e-39
Identities = 49/223 (21%), Positives = 87/223 (39%), Gaps = 24/223 (10%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIM------ADSCSHRTQQFVTEVALLSRIH--HR 291
+G G FGSVY G + D VA+K + + EV LL ++
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
++ L+ + E +L+ E + L + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHC- 126
Query: 352 TGCNPGIIHRDVKSSNILLDIN-MRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY 410
N G++HRD+K NIL+D+N K+ DFG ++ + GT Y PE+
Sbjct: 127 --HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVYSPPEWI 181
Query: 411 -GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW 452
++ + V+S G++L +++ G P F + I+
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDEEIIRG 219
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-38
Identities = 50/225 (22%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIM--ADSCSHRTQQFVTEVALLSRIHHRNLVPLI 297
KIG+G+FG V+ + K G++VA+K + + + E+ +L + H N+V LI
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 298 GYCEE--------EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEY 349
C + LV+++ + + L T +I L
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN------VLVKFTLSEIKRVMQMLLNG 129
Query: 350 LHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ---AEEDLTHISSVARGTVGYLD 406
L+ I+HRD+K++N+L+ + K++DFGL+R A+ + + T+ Y
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 407 PEYY-GNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV 450
PE G + D++ G ++ E+ + + +L ++
Sbjct: 190 PELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 10/201 (4%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 297
+ +G G++G+V + G +VA+K + ++ E+ LL + H N++ L+
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 298 GYCEEEHQRILVYEYMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGCNP 356
+ ++ G + + L + + KGL Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AA 140
Query: 357 GIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLT 416
GIIHRD+K N+ ++ + K+ DFGL+RQA+ ++T + T
Sbjct: 141 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT---GYVVTRWYRAPEVILNWMRYT 197
Query: 417 EKSDVYSFGVVLLELISGKKP 437
+ D++S G ++ E+I+GK
Sbjct: 198 QTVDIWSVGCIMAEMITGKTL 218
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (335), Expect = 2e-35
Identities = 45/205 (21%), Positives = 92/205 (44%), Gaps = 20/205 (9%)
Query: 239 FCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPL 296
+K+G+G + V+ + ++V VKI+ + ++ E+ +L + N++ L
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITL 95
Query: 297 IGYCEEEHQR--ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGC 354
++ R LV+E+++N + + L ++ K L+Y H
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCH--- 146
Query: 355 NPGIIHRDVKSSNILLDI-NMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYY-GN 412
+ GI+HRDVK N+++D + + ++ D+GL+ + V + + PE
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDY 204
Query: 413 QQLTEKSDVYSFGVVLLELISGKKP 437
Q D++S G +L +I K+P
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 7e-35
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 241 KKIGKGSFGSVYYGK----MKDGKEVAVKIM----ADSCSHRTQQFVTEVALLSRI-HHR 291
K +G G++G V+ + GK A+K++ + T+ TE +L I
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 292 NLVPLIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
LV L + E + L+ +Y++ G L L + T ++ + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR------ERFTEHEVQIYVGEIVLALE 143
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPE--Y 409
GII+RD+K NILLD N ++DFGLS++ D T + GT+ Y+ P+
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203
Query: 410 YGNQQLTEKSDVYSFGVVLLELISGKKP 437
G+ + D +S GV++ EL++G P
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 2e-31
Identities = 44/205 (21%), Positives = 87/205 (42%), Gaps = 18/205 (8%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 297
+G G++GSV K G VAVK ++ ++ E+ LL + H N++ L+
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 298 GYCEE-----EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT 352
E + + ++ L + + + L + + +GL+Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIH- 138
Query: 353 GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGN 412
+ IIHRD+K SN+ ++ + K+ DFGL+R + ++
Sbjct: 139 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNW 193
Query: 413 QQLTEKSDVYSFGVVLLELISGKKP 437
+ D++S G ++ EL++G+
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 4e-31
Identities = 55/217 (25%), Positives = 93/217 (42%), Gaps = 20/217 (9%)
Query: 241 KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRT--QQFVTEVALLSRIHHRNLVPLI 297
K IG G+ G V + VA+K ++ ++T ++ E+ L+ ++H+N++ L+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 298 GYC------EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLH 351
EE LV E M + Q LD + + G+++LH
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLH 136
Query: 352 TGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYG 411
+ IHRD+K SNI++ + K+ DFGL+R A V T Y PE
Sbjct: 137 SAGI---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV--VTRYYRAPEVIL 191
Query: 412 NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELN 448
E D++S G ++ E++ K D+ + N
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (302), Expect = 1e-30
Identities = 50/238 (21%), Positives = 94/238 (39%), Gaps = 27/238 (11%)
Query: 241 KKIGKGSFGSVYYGK-MKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGY 299
+K+G G F +V+ K M + VA+KI+ T+ E+ LL R++ +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 300 CEEEHQRILVY-------------EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 346
++L + + G L + + + QI+ G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDIN------MRAKVSDFGLSRQAEEDLTHISSVARG 400
L+Y+H GIIH D+K N+L++I ++ K++D G + +E T+
Sbjct: 138 LDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----IQ 191
Query: 401 TVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIK 458
T Y PE +D++S ++ ELI+G ++ + +I+
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.8 bits (222), Expect = 2e-21
Identities = 24/163 (14%), Positives = 49/163 (30%), Gaps = 28/163 (17%)
Query: 241 KKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS----------HRTQQFVTEVALLSRIHH 290
K +G+G +V+ + E VK + + F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 291 RNLVPLIGYCEEEH----QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKG 346
R L L G + ++ E + + ++ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEE 115
Query: 347 LEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389
+ + + GI+H D+ N+L+ + DF S + E
Sbjct: 116 VAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.8 bits (159), Expect = 3e-12
Identities = 12/93 (12%), Positives = 37/93 (39%), Gaps = 5/93 (5%)
Query: 28 WEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLID 87
+ +T + L N+ P + ++ L L+ N ++ ++ L +
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV-SSLANLTN 352
Query: 88 LRIVHLENNELTGSLPSYMGSLPNLQELHIENN 120
+ + +N+++ P + +L + +L + +
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 55.4 bits (132), Expect = 8e-09
Identities = 21/72 (29%), Positives = 35/72 (48%), Gaps = 3/72 (4%)
Query: 61 NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 120
N++ LT L L N ++ P +S L L+ + NN+++ S + +L N+ L +N
Sbjct: 305 NLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 121 SFVGEIPPALLT 132
P A LT
Sbjct: 362 QISDLTPLANLT 373
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 15/74 (20%), Positives = 32/74 (43%), Gaps = 5/74 (6%)
Query: 43 KIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSL 102
K L N+ + +++ +T L D + + + L +L ++ NN+LT
Sbjct: 26 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDIT 82
Query: 103 PSYMGSLPNLQELH 116
P + +L L ++
Sbjct: 83 P--LKNLTKLVDIL 94
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 12/73 (16%), Positives = 26/73 (35%), Gaps = 3/73 (4%)
Query: 60 KNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 119
+ + L +T + + L + + + + S+ + L NL +++ N
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQ-TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75
Query: 120 NSFVGEIPPALLT 132
N P LT
Sbjct: 76 NQLTDITPLKNLT 88
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 28/125 (22%), Positives = 49/125 (39%), Gaps = 23/125 (18%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNE 97
+ +++L+G LK L ++ LT+L L N ++ L +S L L + L N+
Sbjct: 218 LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQ 274
Query: 98 LTGSLP--------------------SYMGSLPNLQELHIENNSFVGEIPPALLTGKVIF 137
++ P S + +L NL L + N+ P + LT
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRL 334
Query: 138 KYDNN 142
+ NN
Sbjct: 335 FFANN 339
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 16/67 (23%), Positives = 25/67 (37%), Gaps = 3/67 (4%)
Query: 61 NMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 120
+ L L N ++ P +L + L N+L + SL NL +L + NN
Sbjct: 195 KLTNLESLIATNNQISDITPLGIL-TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 121 SFVGEIP 127
P
Sbjct: 252 QISNLAP 258
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.5 bits (145), Expect = 1e-10
Identities = 18/84 (21%), Positives = 29/84 (34%), Gaps = 2/84 (2%)
Query: 23 CVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDM 82
+ + + L + G +P L ++ L L + N L G +P
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
Query: 83 SRLIDLRIVHLENN-ELTGS-LPS 104
L + NN L GS LP+
Sbjct: 288 GNLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.1 bits (136), Expect = 2e-09
Identities = 31/119 (26%), Positives = 55/119 (46%), Gaps = 6/119 (5%)
Query: 17 NDRGDPCVPVPWEWVTCS-TTTPPRITKIALSGKNLKG--EIPPELKNMEALTELWLDG- 72
D C W V C T R+ + LSG NL IP L N+ L L++ G
Sbjct: 28 LPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI 86
Query: 73 -NFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPAL 130
N + P +++L L +++ + ++G++P ++ + L L N+ G +PP++
Sbjct: 87 NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 3e-09
Identities = 19/55 (34%), Positives = 26/55 (47%), Gaps = 1/55 (1%)
Query: 92 HLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP-ALLTGKVIFKYDNNPKL 145
L NN + G+LP + L L L++ N+ GEIP L + Y NN L
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.9 bits (133), Expect = 4e-09
Identities = 16/60 (26%), Positives = 26/60 (43%), Gaps = 2/60 (3%)
Query: 69 WLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIP 127
L N + G LP +++L L +++ N L G +P G+L NN + P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 51.6 bits (122), Expect = 8e-08
Identities = 23/112 (20%), Positives = 40/112 (35%), Gaps = 11/112 (9%)
Query: 32 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRI 90
C + S L+ ++P +L L L N +T D L +L
Sbjct: 9 QCHLRV------VQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHT 59
Query: 91 VHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTGKVIFKYDNN 142
+ L NN+++ P L L+ L++ N E+P + + N
Sbjct: 60 LILINNKISKISPGAFAPLVKLERLYLSKNQL-KELPEKMPKTLQELRVHEN 110
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 39.6 bits (91), Expect = 6e-04
Identities = 22/124 (17%), Positives = 41/124 (33%), Gaps = 31/124 (25%)
Query: 37 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNF---------------------- 74
PP +T++ L G + LK + L +L L N
Sbjct: 169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN 228
Query: 75 --LTGPLPDMSRLIDLRIVHLENNELTG------SLPSYMGSLPNLQELHIENNSF-VGE 125
L ++ +++V+L NN ++ P Y + + + +N E
Sbjct: 229 NKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288
Query: 126 IPPA 129
I P+
Sbjct: 289 IQPS 292
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.6 bits (119), Expect = 3e-07
Identities = 19/84 (22%), Positives = 36/84 (42%), Gaps = 8/84 (9%)
Query: 30 WVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLR 89
+ PP + ++ +S L E+P L L N L +P++ + +L+
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPELPQ--NLK 327
Query: 90 IVHLENNELTGSLPSYMGSLPNLQ 113
+H+E N L P S+ +L+
Sbjct: 328 QLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 6e-06
Identities = 22/116 (18%), Positives = 37/116 (31%), Gaps = 9/116 (7%)
Query: 17 NDRGDPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLT 76
+ P + + + EI +L EL + N L
Sbjct: 238 DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 297
Query: 77 GPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSF--VGEIPPAL 130
LP + L + N L +P NL++LH+E N +IP ++
Sbjct: 298 E-LPAL--PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESV 346
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 37.5 bits (85), Expect = 0.003
Identities = 15/53 (28%), Positives = 26/53 (49%), Gaps = 4/53 (7%)
Query: 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRI 90
PPR+ ++ S +L E+P +N L +L ++ N L + DLR+
Sbjct: 303 PPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 7e-07
Identities = 23/103 (22%), Positives = 38/103 (36%), Gaps = 25/103 (24%)
Query: 46 LSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDL----------------- 88
L+ K+L + L+ + +T L L N L P ++ L L
Sbjct: 5 LAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVA 62
Query: 89 -----RIVHLENNELTG-SLPSYMGSLPNLQELHIENNSFVGE 125
+ + L NN L + + S P L L+++ NS E
Sbjct: 63 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 2e-06
Identities = 18/64 (28%), Positives = 33/64 (51%), Gaps = 3/64 (4%)
Query: 56 PPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 115
L N+ LT L D N ++ + ++ L +L VHL+NN+++ P + + NL +
Sbjct: 166 LTPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 116 HIEN 119
+ N
Sbjct: 223 TLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 15/53 (28%), Positives = 28/53 (52%), Gaps = 2/53 (3%)
Query: 80 PDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT 132
++ L L + ++N+++ P + SLPNL E+H++NN P A +
Sbjct: 167 TPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTS 217
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.2 bits (102), Expect = 3e-05
Identities = 15/75 (20%), Positives = 30/75 (40%), Gaps = 6/75 (8%)
Query: 65 LTELWLDGNFLT-GPLPDM-SRLIDLRIVHLENNELTG----SLPSYMGSLPNLQELHIE 118
+ L + L+ ++ L ++V L++ LT + S + P L EL++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 119 NNSFVGEIPPALLTG 133
+N +L G
Sbjct: 64 SNELGDVGVHCVLQG 78
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 4e-04
Identities = 15/94 (15%), Positives = 29/94 (30%), Gaps = 4/94 (4%)
Query: 53 GEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNL 112
+I + L +T + + L + + N+++ + LPN+
Sbjct: 15 KQIFS-DDAFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQG--IQYLPNV 70
Query: 113 QELHIENNSFVGEIPPALLTGKVIFKYDNNPKLH 146
+L + N P A L D N
Sbjct: 71 TKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKD 104
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (89), Expect = 4e-04
Identities = 23/127 (18%), Positives = 39/127 (30%), Gaps = 19/127 (14%)
Query: 21 DPCVPVPWEWVTCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP 80
D C P + C+ + L E LTEL+++ L
Sbjct: 3 DACCPHGSSGLRCT-------------RDGAL-DSLHHLPGAENLTELYIENQQHLQHLE 48
Query: 81 D--MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLTG--KVI 136
+ L +LR + + + L P P L L++ N+ + + G
Sbjct: 49 LRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQE 107
Query: 137 FKYDNNP 143
NP
Sbjct: 108 LVLSGNP 114
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.3 bits (90), Expect = 6e-04
Identities = 16/75 (21%), Positives = 29/75 (38%), Gaps = 2/75 (2%)
Query: 58 ELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117
E+ + + E+ D LT PD+ + D I+HL N L + + L +L++
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 118 ENNSFVGEIPPALLT 132
+ L
Sbjct: 63 DRAELTKLQVDGTLP 77
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Score = 38.8 bits (89), Expect = 0.001
Identities = 17/135 (12%), Positives = 45/135 (33%), Gaps = 10/135 (7%)
Query: 230 PELEEATNNF-CKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRI 288
PEL++ + C K +G + Y + + + + +K+ T E ++ +
Sbjct: 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWL 66
Query: 289 HHRNLVP-LIGYCEEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGL 347
+ VP ++ + + L+ + D + +I A+ +
Sbjct: 67 EGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE--------YEDEQSPEKIIELYAECI 118
Query: 348 EYLHTGCNPGIIHRD 362
H+ + +
Sbjct: 119 RLFHSIDISDCPYTN 133
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 557 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.72 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.64 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.41 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.39 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.31 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.28 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.27 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.26 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.26 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.23 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.17 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.15 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.09 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.08 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 98.82 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.82 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.78 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.75 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.62 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.61 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.6 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 98.58 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.56 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 98.56 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.46 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 98.44 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 98.38 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.35 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.18 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.17 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.12 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.07 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 97.71 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.64 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.39 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.34 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 96.92 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 96.77 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.72 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 96.71 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 96.66 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.64 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.51 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.25 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 95.34 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 92.48 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 90.18 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-52 Score=403.57 Aligned_cols=254 Identities=29% Similarity=0.471 Sum_probs=199.7
Q ss_pred HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNG 316 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g 316 (557)
+++.+.||+|+||+||+|.+.+++.||||++.... ...++|.+|++++++++|||||+++|++..++..++||||+++|
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g 85 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG 85 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTC
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCC
Confidence 34678999999999999999988999999987543 34567999999999999999999999999999999999999999
Q ss_pred ChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccccc
Q 008707 317 TLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISS 396 (557)
Q Consensus 317 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~ 396 (557)
+|.+++... ...+++..++.++.|||+||+|||+ ++|+||||||+|||+++++.+||+|||+++...........
T Consensus 86 ~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 86 CLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp BHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred cHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 999998753 4668899999999999999999998 99999999999999999999999999999877554444444
Q ss_pred cccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhC-CCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 397 VARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 397 ~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
...||+.|+|||++.+..++.++|||||||++|||+|+ .+||..... ..+. ..+..+.... .+
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~----~~i~~~~~~~--~p------- 224 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVV----EDISTGFRLY--KP------- 224 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHH----HHHHHTCCCC--CC-------
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH---HHHH----HHHHhcCCCC--Cc-------
Confidence 45689999999999999999999999999999999995 555542211 1111 2222222111 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
...+..+.+++.+||+.||++||||+||++.|+++.+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1123478899999999999999999999999999865
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=401.27 Aligned_cols=258 Identities=29% Similarity=0.500 Sum_probs=202.6
Q ss_pred HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
+++.+.||+|+||+||+|+++ ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +..++||||++
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~ 86 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE 86 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCC
Confidence 456789999999999999875 35999998643 34456789999999999999999999998754 56899999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC-cc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-TH 393 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~ 393 (557)
+|+|.+++... ...+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 87 ~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 87 GSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 99999999743 4569999999999999999999999 999999999999999999999999999998764432 22
Q ss_pred ccccccCCCCccCCcccCCC---CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 394 ISSVARGTVGYLDPEYYGNQ---QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~---~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
......||+.|+|||++.+. .++.++|||||||++|||+||+.||...+... .+...+..+.....+
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~~p~~---- 231 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSPDL---- 231 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSCCCCG----
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCCCcc----
Confidence 23345689999999998643 57899999999999999999999997433211 122222222211111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
.......+..+.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 232 -~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 232 -SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp -GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 111222345788999999999999999999999999988764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.2e-52 Score=407.38 Aligned_cols=258 Identities=28% Similarity=0.413 Sum_probs=213.2
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
..+++.+.||+|+||+||+|.++ +++.||||+++... ...++|.+|++++++++|||||++++++.+++..++||||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence 44567899999999999999886 58899999987543 34567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
++|+|.+++... ....+++..+..++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+........
T Consensus 96 ~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~ 171 (287)
T d1opja_ 96 TYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 171 (287)
T ss_dssp TTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred cCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence 999999998754 35678999999999999999999998 99999999999999999999999999999987655444
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
......|++.|+|||++.+..++.++|||||||++|||++|..||..... ..+ +...+..+....
T Consensus 172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~~~-~~~~i~~~~~~~--------- 236 (287)
T d1opja_ 172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQ-VYELLEKDYRME--------- 236 (287)
T ss_dssp EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHH-HHHHHHTTCCCC---------
T ss_pred eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----HHH-HHHHHhcCCCCC---------
Confidence 44445588999999999999999999999999999999997777642221 111 122233332111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
.+...+..+.+++.+||+.||++|||++||++.|+.+.+
T Consensus 237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112233478899999999999999999999999987654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-50 Score=396.01 Aligned_cols=247 Identities=24% Similarity=0.368 Sum_probs=205.3
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
|++.+.||+|+||+||+|... +|+.||||++........+.+.+|+++++.++|||||++++++.+++..++||||++|
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 556789999999999999865 6999999998765555567899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+++.. ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+........ .
T Consensus 102 g~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~-~ 173 (293)
T d1yhwa1 102 GSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 173 (293)
T ss_dssp CBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-B
T ss_pred CcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccccc-c
Confidence 999998763 458999999999999999999998 99999999999999999999999999999876543322 2
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVK 475 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 475 (557)
....||+.|+|||++.+..++.++||||+||++|+|+||+.||.+.+.. +........+.. ... .+
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~-~~~-------~~ 239 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-ELQ-------NP 239 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-CCS-------SG
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCC-CCC-------Cc
Confidence 3446999999999999999999999999999999999999999744321 112222222211 110 11
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 476 IESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 476 ~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
......+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122347889999999999999999999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=398.83 Aligned_cols=256 Identities=25% Similarity=0.401 Sum_probs=208.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
..+++.+.||+|+||.||+|.+++++.||||++.... ...+.|.+|++++++++|||||+++|++.+ +..++||||++
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~ 90 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME 90 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence 4566789999999999999999988999999987543 345679999999999999999999998765 56799999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+|+|.+++... ....+++..++.++.||++||+|||+ ++|+||||||+||||++++.+||+|||+|+.........
T Consensus 91 ~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 99999987643 23458999999999999999999998 999999999999999999999999999999876554444
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
.....||+.|+|||++.+..++.++|||||||++|||+||..|+..... ..+ +...+..+.....
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-----~~~-~~~~i~~~~~~~~--------- 231 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NPE-VIQNLERGYRMVR--------- 231 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHH-HHHHHHTTCCCCC---------
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-----HHH-HHHHHHhcCCCCC---------
Confidence 4455689999999999988999999999999999999996655532211 111 1222333322111
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
+...+..+.+++.+||+.||++||||+||++.|++.-
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 1122346889999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-50 Score=400.47 Aligned_cols=255 Identities=27% Similarity=0.467 Sum_probs=198.5
Q ss_pred HhhcccCCCCceEEEEEEEcC-C---cEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 238 NFCKKIGKGSFGSVYYGKMKD-G---KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
++.+.||+|+||+||+|.++. + ..||||.+.... ....+.|.+|+++|++++|||||+++|++.+++..++||||
T Consensus 29 ~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey 108 (299)
T d1jpaa_ 29 KIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEF 108 (299)
T ss_dssp EEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred EEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEe
Confidence 345789999999999998753 2 358999886543 34556799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++.. ....+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 109 ~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 183 (299)
T d1jpaa_ 109 MENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183 (299)
T ss_dssp CTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred cCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence 999999998874 34569999999999999999999998 9999999999999999999999999999987654322
Q ss_pred cc----cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 393 HI----SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 393 ~~----~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
.. .....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... + +...+..+....
T Consensus 184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------~-~~~~i~~~~~~~--- 253 (299)
T d1jpaa_ 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------D-VINAIEQDYRLP--- 253 (299)
T ss_dssp ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHTTCCCC---
T ss_pred cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH------H-HHHHHHcCCCCC---
Confidence 11 112347899999999999999999999999999999998 89999743321 1 112233322111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
.+...+..+.+++.+||+.||++||||+||++.|+++.+.
T Consensus 254 ------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 254 ------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1222345788999999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=391.98 Aligned_cols=251 Identities=28% Similarity=0.483 Sum_probs=210.9
Q ss_pred HhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCCCC
Q 008707 238 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHNGT 317 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~gs 317 (557)
++.+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++||||++++|++.+++..++||||+++|+
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~ 85 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEE
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCc
Confidence 4678999999999999999988899999987643 345689999999999999999999999999999999999999999
Q ss_pred hhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccccc
Q 008707 318 LRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHISSV 397 (557)
Q Consensus 318 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~ 397 (557)
|.+++... ...+++..++.++.|+++||+|||+ .||+||||||+||++++++.+||+|||+++............
T Consensus 86 l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 86 LLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp HHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred HHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 99987653 4568899999999999999999998 999999999999999999999999999998765544433444
Q ss_pred ccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCCCH
Q 008707 398 ARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNVKI 476 (557)
Q Consensus 398 ~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 476 (557)
..||+.|+|||.+.+..++.++||||||+++|||+| |+.||......+ +...+.++.... .| .
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~~~~~~--~p-------~ 224 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQGLRLY--RP-------H 224 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTTCCCC--CC-------T
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHHHHhCCCCC--Cc-------c
Confidence 568999999999999999999999999999999998 899997443211 222333332211 11 1
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 477 ESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 477 ~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
..+..+.+++.+||+.||++|||++||++.|.++
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 2234788999999999999999999999998753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=392.73 Aligned_cols=249 Identities=24% Similarity=0.351 Sum_probs=199.9
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
|++.+.||+|+||+||+|.++ +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 556799999999999999875 68999999986543 2334568999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC-cc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL-TH 393 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~ 393 (557)
+|+|.+++. ....+++..+..++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+...... ..
T Consensus 87 gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 87 GGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp TEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred CCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 999999997 35679999999999999999999998 999999999999999999999999999998764332 22
Q ss_pred ccccccCCCCccCCcccCCCCC-CcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~-s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......||+.|+|||++.+..+ +.++||||+||++|||+||+.||........ ... ...........
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~----~~~~~~~~~~~------- 228 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYS----DWKEKKTYLNP------- 228 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHH----HHHTTCTTSTT-------
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH-HHH----HHhcCCCCCCc-------
Confidence 2344569999999999988776 6789999999999999999999974432211 111 11111111000
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.......+.+++.+||+.||++|||++|+++
T Consensus 229 --~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 --WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0111236779999999999999999999964
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=392.49 Aligned_cols=243 Identities=26% Similarity=0.425 Sum_probs=203.7
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||+||+|.++ +++.||+|++.+.. ....+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 567899999999999999886 58899999986432 23356788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++.. ...+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+|.......
T Consensus 88 ~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 88 APLGTVYRELQK---LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred cCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 999999999974 4568999999999999999999998 999999999999999999999999999998765432
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+... ....+.++... +
T Consensus 161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-------~~~~i~~~~~~------~-- 223 (263)
T d2j4za1 161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEFT------F-- 223 (263)
T ss_dssp --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-------HHHHHHTTCCC------C--
T ss_pred --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCCCC------C--
Confidence 223469999999999999999999999999999999999999997543211 11222222211 1
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+...+.++.+++.+||+.||++|||++|+++
T Consensus 224 --p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 224 --PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1112346889999999999999999999986
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-50 Score=393.38 Aligned_cols=249 Identities=22% Similarity=0.362 Sum_probs=204.3
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
|++.+.||+|+||.||+|.+. +++.||||++........+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 556789999999999999875 6889999999776666667899999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+++... ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|........ ..
T Consensus 94 g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~ 167 (288)
T d2jfla1 94 GAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RR 167 (288)
T ss_dssp EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HH
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc-cc
Confidence 9999987643 4569999999999999999999998 9999999999999999999999999999976543221 22
Q ss_pred ccccCCCCccCCcccC-----CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 396 SVARGTVGYLDPEYYG-----NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~-----~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
....||+.|+|||++. +..|+.++|||||||++|||+||+.||...+... .. . .+..+.......
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~~---~-~i~~~~~~~~~~--- 237 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---VL---L-KIAKSEPPTLAQ--- 237 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HH---H-HHHHSCCCCCSS---
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---HH---H-HHHcCCCCCCCc---
Confidence 3456999999999984 4567899999999999999999999997543222 11 1 112222211111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+...+..+.+++.+||+.||++|||++|+++
T Consensus 238 ----~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 ----PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122347889999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=390.55 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=192.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEe--cCeeEEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--EHQRILVYE 311 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--~~~~~lv~e 311 (557)
|++.+.||+|+||+||+|..+ +|+.||+|++.... ....+.+.+|++++++++|||||++++++.+ ++..++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 556799999999999999875 68999999986542 3345678999999999999999999999865 456899999
Q ss_pred ecCCCChhhhhhccC-CCCCcCHHHHHHHHHHHHHHHHHHHcCC--CCCeEeeccCCCCEEeCCCCcEEEecccCccccC
Q 008707 312 YMHNGTLRDRLHGSV-NQKPLDWLTRLQIAHDAAKGLEYLHTGC--NPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAE 388 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~~LH~~~--~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~ 388 (557)
|+++|+|.+++.... ....+++..++.++.||+.||+|||+.. ..+|+||||||+|||++.++.+||+|||+|+...
T Consensus 86 y~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 165 (269)
T d2java1 86 YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN 165 (269)
T ss_dssp CCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-
T ss_pred cCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecc
Confidence 999999999986432 3567999999999999999999999710 1249999999999999999999999999998875
Q ss_pred CCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 389 EDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 389 ~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||...+.. + +...+..+.....
T Consensus 166 ~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~-~~~~i~~~~~~~~--- 234 (269)
T d2java1 166 HDTSF-AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------E-LAGKIREGKFRRI--- 234 (269)
T ss_dssp -----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-HHHHHHHTCCCCC---
T ss_pred cCCCc-cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------H-HHHHHHcCCCCCC---
Confidence 43322 23456899999999999999999999999999999999999999744321 1 2222333333221
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
... .+.++.+++.+||+.||++|||++||++
T Consensus 235 --~~~----~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 --PYR----YSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --Ccc----cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 2336889999999999999999999975
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=388.02 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=206.6
Q ss_pred hc-ccCCCCceEEEEEEEc---CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 240 CK-KIGKGSFGSVYYGKMK---DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 240 ~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.+ +||+|+||+||+|.++ ++..||||+++... ....+.|.+|++++++++|||||+++|++.+ +..++||||++
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~ 91 (285)
T d1u59a_ 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG 91 (285)
T ss_dssp EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCC
Confidence 44 4999999999999764 35579999987543 3456789999999999999999999999875 46899999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc-
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH- 393 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~- 393 (557)
+|+|.+++.. ....+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 92 ~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 166 (285)
T d1u59a_ 92 GGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166 (285)
T ss_dssp TEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhccccccccc
Confidence 9999998764 24579999999999999999999999 99999999999999999999999999999876543322
Q ss_pred -ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 394 -ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 394 -~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ +...+..|.....
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~~~~~~------ 233 (285)
T d1u59a_ 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMEC------ 233 (285)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTTCCCCC------
T ss_pred ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCCCC------
Confidence 2233458899999999999999999999999999999998 899997443221 2233444433222
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
+...+.++.+++.+||+.+|++|||+.+|.+.|+.....
T Consensus 234 ---p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 234 ---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 122335788999999999999999999999999877653
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=383.76 Aligned_cols=244 Identities=29% Similarity=0.434 Sum_probs=196.1
Q ss_pred HhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEe----cCeeEEEE
Q 008707 238 NFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE----EHQRILVY 310 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~----~~~~~lv~ 310 (557)
++.++||+|+||+||+|.+. +++.||+|++... .....+.+.+|++++++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 35578999999999999876 5889999998653 23445679999999999999999999999865 34578999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCC--eEeeccCCCCEEeC-CCCcEEEecccCcccc
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPG--IIHRDVKSSNILLD-INMRAKVSDFGLSRQA 387 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~--ivH~dlk~~NIll~-~~~~~kl~Dfgla~~~ 387 (557)
||+++|+|.+++.. ...+++..+..++.||++||+|||+ ++ |+||||||+|||++ +++.+||+|||+|+..
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 99999999999974 3568999999999999999999998 66 99999999999996 5789999999999865
Q ss_pred CCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
.... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .. +...+..+.....++
T Consensus 166 ~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~-~~~~i~~~~~~~~~~ 235 (270)
T d1t4ha_ 166 RASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQ-IYRRVTSGVKPASFD 235 (270)
T ss_dssp CTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HH-HHHHHTTTCCCGGGG
T ss_pred cCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HH-HHHHHHcCCCCcccC
Confidence 4332 234569999999999876 5899999999999999999999999733211 11 222333332221111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
. .. ..++.+++.+||+.||++|||++|+++
T Consensus 236 ~----~~----~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 236 K----VA----IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp G----CC----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----cC----CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1 11 235789999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=389.49 Aligned_cols=248 Identities=27% Similarity=0.460 Sum_probs=201.2
Q ss_pred cccCCCCceEEEEEEEcC---CcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 241 KKIGKGSFGSVYYGKMKD---GKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
++||+|+||+||+|.+++ ++.||||+++... ....+.|.+|++++++++|||||++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998753 4689999986532 3345679999999999999999999999965 457899999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc--
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH-- 393 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-- 393 (557)
|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 999999874 4669999999999999999999998 99999999999999999999999999999876543322
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+.. + +...+.++.....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~------~-~~~~i~~~~~~~~------- 231 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------E-VTAMLEKGERMGC------- 231 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCCCCC-------
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH------H-HHHHHHcCCCCCC-------
Confidence 2233458999999999999999999999999999999998 89999843321 1 2233444432221
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
+...+..+.+++.+||+.||++|||++||++.|+..-
T Consensus 232 --p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 232 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 1223357889999999999999999999999887753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=394.68 Aligned_cols=257 Identities=29% Similarity=0.453 Sum_probs=201.5
Q ss_pred HHhhcccCCCCceEEEEEEEcCC-----cEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDG-----KEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
+++.+.||+|+||.||+|.++.+ ..||||++.... ......|.+|++++++++|||||+++|++.+.+..++||
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEE
Confidence 34568899999999999987642 379999986543 334567999999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
||+.+|++.+.+.. ....+++..+..++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.....
T Consensus 89 e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 89 EYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp ECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 99999999988764 34679999999999999999999998 99999999999999999999999999999876443
Q ss_pred Cc--cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 391 LT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 391 ~~--~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
.. .......||+.|+|||++.+..++.++|||||||++|||+++..|+...... .+ +...+..+...
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~~-~~~~i~~~~~~----- 232 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HE-VMKAINDGFRL----- 232 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HH-HHHHHHTTCCC-----
T ss_pred CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----HH-HHHHHhccCCC-----
Confidence 22 2223345899999999999999999999999999999999976665422211 11 12223333221
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
..+...+..+.+++.+||+.||++||||+||++.|+++.+.
T Consensus 233 ----~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 233 ----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 11222345788999999999999999999999999988874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=390.32 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=203.3
Q ss_pred HHHHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
..+++.+.||+|+||.||+|.+++++.||||++.... ...+.|.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 3467889999999999999999988899999987543 345779999999999999999999999855 56789999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
+|+|.+++... ....+++..++.++.||+.||+|||+ ++|+||||||+||||+.++.+||+|||+++.........
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 99999888754 23468999999999999999999998 999999999999999999999999999998765444433
Q ss_pred cccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 395 SSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
.....||+.|+|||++....++.++|||||||++|||+||..|+..... ..+.. ..+..+.... .
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-----~~~~~-~~i~~~~~~~---------~ 235 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREVL-DQVERGYRMP---------C 235 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHHHH-HHHHTTCCCC---------C
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-----HHHHH-HHHHhcCCCC---------C
Confidence 4445689999999999999999999999999999999997666542221 11111 2222222111 1
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
+...+..+.+++.+||+.||++||||++|+++|+.....
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 122334788999999999999999999999999886643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=400.41 Aligned_cols=268 Identities=22% Similarity=0.321 Sum_probs=204.2
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
..|++.+.||+|+||+||+|.+. +|+.||+|+++... ....+.+.+|+.++++++|||||+++++|.+.+..++||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 34566789999999999999875 68999999986543 33456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ .++|+||||||+|||++.++.+||+|||+|....+..
T Consensus 86 ~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 159 (322)
T d1s9ja_ 86 MDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 159 (322)
T ss_dssp CTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred CCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence 999999999974 3568999999999999999999996 1489999999999999999999999999998764322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHH-HHHH--------HhcCCc-
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHW-ARSM--------IKKGDV- 462 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~-~~~~--------~~~~~~- 462 (557)
.....||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+.......... .... ...+..
T Consensus 160 --~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (322)
T d1s9ja_ 160 --ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 237 (322)
T ss_dssp --C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------------
T ss_pred --cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccc
Confidence 2235699999999999999999999999999999999999999986543211000000 0000 000000
Q ss_pred -------------ccccccccc---CCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHhh
Q 008707 463 -------------ISIVDPVLI---GNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDS 510 (557)
Q Consensus 463 -------------~~~~d~~l~---~~~-~~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~ 510 (557)
....+.... ... ......++.+++.+||..||++|||++|+++ .+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 238 SSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp --------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred cccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 000000000 000 0011236889999999999999999999987 35543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=391.26 Aligned_cols=246 Identities=23% Similarity=0.344 Sum_probs=201.7
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 667899999999999999875 68999999986432 23346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC-
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL- 391 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~- 391 (557)
+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+......
T Consensus 90 ~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 90 AKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999998874 4579999999999999999999999 999999999999999999999999999998765432
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
........||+.|+|||++.+..++.++||||+||++|||+||+.||...+.. + +...+..+... +.
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~-~~~~i~~~~~~------~p 230 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------L-IFQKIIKLEYD------FP 230 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHTTCCC------CC
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------H-HHHHHHcCCCC------CC
Confidence 22233456999999999999999999999999999999999999999854321 1 11222222211 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.. ...++.+++.+||+.||++|||++|+++
T Consensus 231 ~~----~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 231 EK----FFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp TT----CCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred cc----CCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 11 2336889999999999999999999754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=397.61 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=204.6
Q ss_pred HHHHhhcccCCCCceEEEEEEEcC-C-----cEEEEEEccCc-cchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCee
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKD-G-----KEVAVKIMADS-CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~ 306 (557)
..+++.+.||+|+||+||+|.+.. + ..||+|.+... .......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 345678999999999999998753 2 36999988653 233456789999999998 899999999999999999
Q ss_pred EEEEEecCCCChhhhhhccCC--------------------CCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCC
Q 008707 307 ILVYEYMHNGTLRDRLHGSVN--------------------QKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSS 366 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~ 366 (557)
++||||+++|+|.++++.... ...+++..++.++.||++||+|||+ ++|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence 999999999999999975421 2358899999999999999999999 99999999999
Q ss_pred CEEeCCCCcEEEecccCccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCcc
Q 008707 367 NILLDINMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFG 444 (557)
Q Consensus 367 NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~ 444 (557)
|||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876543322 2234457999999999999999999999999999999998 89999754332
Q ss_pred ccccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 008707 445 AELNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQ 508 (557)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~ 508 (557)
. .+ ...+..+... ..+...+..+.+++.+||+.||++|||++||++.|.
T Consensus 274 ~--~~----~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 A--NF----YKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp H--HH----HHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H--HH----HHHHhcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 11 2223333211 112223347889999999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.3e-49 Score=388.41 Aligned_cols=249 Identities=25% Similarity=0.364 Sum_probs=188.9
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
.|++.+.||+|+||+||+|.++ +|+.||||++.... ....+.+.+|+++++.++|||||++++++.+++..++||||+
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 3667899999999999999876 68999999986543 233456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC---CCCcEEEecccCccccCCC
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD---INMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~---~~~~~kl~Dfgla~~~~~~ 390 (557)
+||+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+||++. +++.+||+|||+++.....
T Consensus 90 ~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 90 SGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred CCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 99999999973 5679999999999999999999998 9999999999999995 5788999999999876443
Q ss_pred CccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVL 470 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 470 (557)
.. .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... . ...+..+... +....
T Consensus 164 ~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~----~~~i~~~~~~--~~~~~ 232 (307)
T d1a06a_ 164 SV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---L----FEQILKAEYE--FDSPY 232 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H----HHHHHTTCCC--CCTTT
T ss_pred Ce--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---H----HHHHhccCCC--CCCcc
Confidence 22 233569999999999999999999999999999999999999997433211 1 1122222211 01111
Q ss_pred cCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 471 IGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 471 ~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.. ..+..+.+++.+||+.||++|||++|+++
T Consensus 233 ~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 233 WD----DISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cc----CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11 22346889999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-48 Score=386.18 Aligned_cols=245 Identities=28% Similarity=0.389 Sum_probs=200.3
Q ss_pred HHHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
..|+..+.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 44666899999999999999875 68899999986543 233467899999999999999999999999999999999
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
|||.+|+|..++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|......
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 99999999776653 4679999999999999999999998 99999999999999999999999999999875442
Q ss_pred CccccccccCCCCccCCcccCC---CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccc
Q 008707 391 LTHISSVARGTVGYLDPEYYGN---QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVD 467 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~---~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 467 (557)
....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||..... .+...... .+.......
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~-~~~~~~~~~ 236 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIA-QNESPALQS 236 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHH-HSCCCCCSC
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-hCCCCCCCC
Confidence 23459999999999864 4588999999999999999999999974322 11112222 222211111
Q ss_pred ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 468 PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 468 ~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.. .+..+.+++.+||+.||++|||++|+++
T Consensus 237 ----~~----~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 237 ----GH----WSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----TT----SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CC----CCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11 2346889999999999999999999976
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=385.21 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=200.4
Q ss_pred HHHHhhcccCCCCceEEEEEEEcC----CcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKD----GKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
..|++.+.||+|+||.||+|.+.. +..||||.++... ....+.+.+|++++++++||||+++++++. ++..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 346678999999999999998753 3568999886543 334567999999999999999999999996 4678999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+++|+|.+++.. ....+++..++.++.||++||+|||+ ++++||||||+||+++.++.+||+|||+|+....
T Consensus 86 ~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999998764 35678999999999999999999999 9999999999999999999999999999987655
Q ss_pred CCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 390 DLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
..........||+.|+|||.+.+..++.++|||||||++|||+| |.+||......+ +. ..+..+.....
T Consensus 161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~----~~i~~~~~~~~--- 230 (273)
T d1mp8a_ 161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI----GRIENGERLPM--- 230 (273)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTCCCCC---
T ss_pred CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HH----HHHHcCCCCCC---
Confidence 44444444568999999999999999999999999999999998 899997544322 22 22333332211
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
+...+..+.+++.+||+.||++|||++||++.|+.+.+.+.
T Consensus 231 ------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 231 ------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp ------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 11233478899999999999999999999999999876543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-48 Score=393.13 Aligned_cols=251 Identities=21% Similarity=0.334 Sum_probs=207.0
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
.|++.+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+++..++||||++
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4667899999999999999875 689999999977666667789999999999999999999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC--CCcEEEecccCccccCCCCc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI--NMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~ 392 (557)
||+|.+++.. ....+++..+..++.||+.||+|||+ +||+||||||+|||++. ++.+||+|||+++.......
T Consensus 107 gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 107 GGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp SCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 9999999864 24569999999999999999999999 99999999999999964 67899999999987754432
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+.. +.... +..+... ++.....
T Consensus 182 --~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~-i~~~~~~--~~~~~~~ 250 (350)
T d1koaa2 182 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRN-VKSCDWN--MDDSAFS 250 (350)
T ss_dssp --EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHTCCC--SCCGGGG
T ss_pred --cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCCC--CCccccc
Confidence 23346899999999999999999999999999999999999999754321 11111 2222110 0111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
.....+.+++.+||+.||++|||++|+++.
T Consensus 251 ----~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 251 ----GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ----GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 123468899999999999999999999873
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3e-48 Score=391.68 Aligned_cols=249 Identities=21% Similarity=0.340 Sum_probs=206.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
|++.+.||+|+||.||+|... +|+.||||++........+.+.+|++++++++|||||++++++.+++..++|||||+|
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 567899999999999999875 6999999999776555667889999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC--CCCcEEEecccCccccCCCCcc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD--INMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~--~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
|+|.+.+.. ....+++..++.++.||+.||+|||+ +||+||||||+|||++ .++.+||+|||+|........
T Consensus 111 g~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~- 184 (352)
T d1koba_ 111 GELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 184 (352)
T ss_dssp CBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred ChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCc-
Confidence 999988764 34569999999999999999999998 9999999999999998 578999999999988765432
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....||+.|+|||++.+..++.++||||+||++|+|+||+.||.+.+... .. ..+..+... +.. .
T Consensus 185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~-~~i~~~~~~--~~~----~ 250 (352)
T d1koba_ 185 -VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TL-QNVKRCDWE--FDE----D 250 (352)
T ss_dssp -EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HH-HHHHHCCCC--CCS----S
T ss_pred -eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhCCCC--CCc----c
Confidence 233458999999999999999999999999999999999999997543221 11 122222211 011 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.....+..+.+++.+||+.||.+|||++|+++
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122346789999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-49 Score=383.57 Aligned_cols=250 Identities=30% Similarity=0.483 Sum_probs=198.7
Q ss_pred HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEe-cCeeEEEEEecCC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYEYMHN 315 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~lv~e~~~~ 315 (557)
+++.+.||+|+||.||+|.++ |+.||||+++.. ...+.+.+|++++++++||||++++|++.+ .+..++||||+++
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~ 85 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 85 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTT
T ss_pred eEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCC
Confidence 457789999999999999986 789999999753 345679999999999999999999999854 4568999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcccc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHIS 395 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~ 395 (557)
|+|.+++... ....+++..++.++.||+.||+|||+ .+++||||||+|||++.++.+||+|||+++......
T Consensus 86 g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~---- 157 (262)
T d1byga_ 86 GSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 157 (262)
T ss_dssp EEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC----
Confidence 9999999743 23358999999999999999999998 999999999999999999999999999998754332
Q ss_pred ccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCCC
Q 008707 396 SVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGNV 474 (557)
Q Consensus 396 ~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 474 (557)
....+++.|+|||.+.+..++.++|||||||++|||+| |+.||...+.. .+... +.++.....
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~----i~~~~~~~~--------- 221 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR----VEKGYKMDA--------- 221 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHH----HTTTCCCCC---------
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHcCCCCCC---------
Confidence 22347889999999998999999999999999999998 68887644332 22222 233322221
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 475 KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 475 ~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
+...+..+.+++.+||+.||++||||+||++.|++++.-
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 222234788999999999999999999999999998654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=381.50 Aligned_cols=249 Identities=22% Similarity=0.288 Sum_probs=203.1
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc------chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC------SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 308 (557)
.|++.+.||+|+||+||+|.++ +|+.||||++.... ....+.+.+|++++++++|||||++++++.+.+..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4667899999999999999875 68999999986432 1235779999999999999999999999999999999
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC----cEEEecccCc
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM----RAKVSDFGLS 384 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~----~~kl~Dfgla 384 (557)
||||+++|+|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++ .+||+|||++
T Consensus 91 v~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 91 ILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999974 3579999999999999999999998 9999999999999998776 4999999999
Q ss_pred cccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccc
Q 008707 385 RQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVIS 464 (557)
Q Consensus 385 ~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 464 (557)
........ .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+... .. ..+..+....
T Consensus 165 ~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~-~~i~~~~~~~ 235 (293)
T d1jksa_ 165 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TL-ANVSAVNYEF 235 (293)
T ss_dssp EECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HH-HHHHTTCCCC
T ss_pred hhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------HH-HHHHhcCCCC
Confidence 87654332 233458999999999999999999999999999999999999997543211 11 1122221110
Q ss_pred cccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 465 IVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 465 ~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+.... ..+..+.+++.+||+.||++|||++|+++
T Consensus 236 --~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 236 --EDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp --CHHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CchhcC----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001 12336789999999999999999999976
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-48 Score=382.43 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=207.6
Q ss_pred HHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCccc-hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSCS-HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
+++.+.||+|+||+||+|+++ +++.||||++..... ...++|.+|++++++++||||+++++++...+..++|
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 456899999999999999875 357899999875433 3456799999999999999999999999999999999
Q ss_pred EEecCCCChhhhhhccC---------------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCE
Q 008707 310 YEYMHNGTLRDRLHGSV---------------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNI 368 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NI 368 (557)
|||+++|+|.+++.... ....+++..++.++.|++.||+|||+ ++++||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccce
Confidence 99999999999986421 12358899999999999999999998 9999999999999
Q ss_pred EeCCCCcEEEecccCccccCCCC-ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCC-CCCCCCCcccc
Q 008707 369 LLDINMRAKVSDFGLSRQAEEDL-THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAE 446 (557)
Q Consensus 369 ll~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~-~pf~~~~~~~~ 446 (557)
|++.++.+||+|||+|+...... ........|++.|+|||.+.+..++.++|||||||++|||++|. .||...+..
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~-- 249 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-- 249 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH--
Confidence 99999999999999998654432 22233456889999999999999999999999999999999986 567633221
Q ss_pred ccHHHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 008707 447 LNIVHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSI 511 (557)
Q Consensus 447 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~ 511 (557)
+ +...+..+...... ...+.++.+++.+||+.+|++||||.||+++|+++.
T Consensus 250 ----e-~~~~v~~~~~~~~p---------~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 250 ----E-VIYYVRDGNILACP---------ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ----H-HHHHHHTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----H-HHHHHHcCCCCCCC---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1 12234444432221 122347889999999999999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=383.51 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=204.0
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||.||+|..+ +|+.||||++.+.. ....+.+.+|+.+|+.++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 556899999999999999875 69999999986532 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
++||+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||+|+.......
T Consensus 87 ~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 87 ANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp CTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred cCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 999999999884 4568999999999999999999999 9999999999999999999999999999987644322
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+... +...+..+... +..
T Consensus 161 -~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-------~~~~i~~~~~~------~p~ 226 (337)
T d1o6la_ 161 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-------LFELILMEEIR------FPR 226 (337)
T ss_dssp -CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC------CCT
T ss_pred -ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-------HHHHHhcCCCC------CCc
Confidence 2334569999999999999999999999999999999999999998554321 11222222211 111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 505 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 505 (557)
. ...++.+++.+||+.||++||+ ++|+++
T Consensus 227 ~----~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 227 T----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp T----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred c----CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 1 2236789999999999999995 788876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-47 Score=372.29 Aligned_cols=253 Identities=27% Similarity=0.405 Sum_probs=196.2
Q ss_pred HHhhcccCCCCceEEEEEEEcC--C--cEEEEEEccCc---cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKD--G--KEVAVKIMADS---CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
+++.+.||+|+||.||+|++.. + ..||||++... .....+.|.+|++++++++||||++++|++.+ +..++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 5678899999999999998653 2 37899988653 23345679999999999999999999999976 467899
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||+++|++.+.+... ...+++..++.++.||+.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 9999999999887653 4569999999999999999999998 9999999999999999999999999999998654
Q ss_pred CCcc--ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 390 DLTH--ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 390 ~~~~--~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
.... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||.+.+.. +........+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~~~~~-- 235 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGERLP-- 235 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCCCCC--
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCCCCCC--
Confidence 4322 2233457889999999999999999999999999999998 89999744322 22222223322211
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDS 510 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~ 510 (557)
.....+..+.+++.+||+.||++||||+||.+.|++.
T Consensus 236 -------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 -------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1112234788999999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-47 Score=379.45 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=200.0
Q ss_pred HHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEec-Ce
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEE-HQ 305 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~-~~ 305 (557)
..|++.+.||+|+||.||+|.+. +++.||||+++... ....+.+.+|..++.++ +|+||+.+++++... ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 44667899999999999999864 24689999987543 34456788888888887 689999999988654 46
Q ss_pred eEEEEEecCCCChhhhhhccC-------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC
Q 008707 306 RILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI 372 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~ 372 (557)
.++||||+++|+|.++++... ....+++..+..++.||++||+|||+ ++|+||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECC
Confidence 899999999999999997532 13458999999999999999999998 99999999999999999
Q ss_pred CCcEEEecccCccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhC-CCCCCCCCccccccHH
Q 008707 373 NMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISG-KKPVSVEDFGAELNIV 450 (557)
Q Consensus 373 ~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg-~~pf~~~~~~~~~~~~ 450 (557)
++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+|| ..||.......
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~----- 244 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----- 244 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-----
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 999999999999876443322 23345689999999999999999999999999999999996 45776433221
Q ss_pred HHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 451 HWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 451 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
.+...+..+......+ ..+..+.+++.+||+.||++|||++||++.|+++++.
T Consensus 245 -~~~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 245 -EFCRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp -HHHHHHHHTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHhcCCCCCCCc---------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1223333443322211 1234688999999999999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-47 Score=378.09 Aligned_cols=243 Identities=22% Similarity=0.343 Sum_probs=202.9
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEY 312 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~ 312 (557)
|++.+.||+|+||+||+|.++ +|+.||||+++... ....+.+.+|+.+++.++|||||++++++.+++..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 556799999999999999875 68999999986432 23456789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCc
Q 008707 313 MHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLT 392 (557)
Q Consensus 313 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~ 392 (557)
++||+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~- 158 (316)
T d1fota_ 86 IEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT- 158 (316)
T ss_dssp CCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB-
T ss_pred cCCccccccccc---cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEecccc-
Confidence 999999998874 5667888899999999999999998 999999999999999999999999999998765432
Q ss_pred cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccC
Q 008707 393 HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIG 472 (557)
Q Consensus 393 ~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 472 (557)
....||+.|+|||++.+..++.++||||+||++|||+||+.||...+.. +.. ..+..+...
T Consensus 159 ---~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~-~~i~~~~~~--------- 219 (316)
T d1fota_ 159 ---YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTY-EKILNAELR--------- 219 (316)
T ss_dssp ---CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH-HHHHHCCCC---------
T ss_pred ---ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHH-HHHHcCCCC---------
Confidence 2356999999999999999999999999999999999999999754321 111 122222211
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 008707 473 NVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVLA 506 (557)
Q Consensus 473 ~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~~ 506 (557)
.+...+..+.+++.+||..||.+|| |++|+++.
T Consensus 220 -~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 -FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 1111223688999999999999996 89999863
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=380.14 Aligned_cols=254 Identities=24% Similarity=0.426 Sum_probs=202.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCc----EEEEEEccCc-cchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGK----EVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
|++.+.||+|+||+||+|.+. +|+ .||+|.+... .....+.|.+|++++++++|||||+++|++.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 566799999999999999875 343 5889988653 234567899999999999999999999999865 567889
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
|++.+|+|.+.+.. ....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 90 e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 90 QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp ECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 99999999998875 35678999999999999999999998 99999999999999999999999999999876543
Q ss_pred Ccc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 391 LTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 391 ~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
... ......||+.|+|||.+.+..++.++|||||||++|||+| |..||.+.+... +. ..+..+....
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~----~~i~~~~~~~---- 233 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SILEKGERLP---- 233 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HH----HHHHHTCCCC----
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHcCCCCC----
Confidence 322 2233458999999999999999999999999999999999 889997544322 22 2223332211
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhh
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIK 512 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~ 512 (557)
.+...+..+.+++.+||+.||++|||++||++.|+.+.+
T Consensus 234 -----~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 234 -----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 112233478899999999999999999999999988764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=375.92 Aligned_cols=256 Identities=29% Similarity=0.461 Sum_probs=204.8
Q ss_pred HhhcccCCCCceEEEEEEEcCC----cEEEEEEccCc-cchhHHHHHHHHHHHhhcCCCCccceeeEEEe-cCeeEEEEE
Q 008707 238 NFCKKIGKGSFGSVYYGKMKDG----KEVAVKIMADS-CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE-EHQRILVYE 311 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~lv~e 311 (557)
+|.++||+|+||+||+|.+.++ ..||||++... .....++|.+|++++++++||||++++|++.. ++..++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 3467899999999999987542 36899998753 34456789999999999999999999999865 567899999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++|+|.+++... ...+++..++.++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 110 ~~~~g~l~~~~~~~--~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CCTTCBHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EeecCchhhhhccc--cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999998753 4567788899999999999999998 999999999999999999999999999998764432
Q ss_pred cc---ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 392 TH---ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 392 ~~---~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
.. ......||+.|+|||.+....++.++||||||+++|||+||+.||...... ..+. ..+..|.... .+
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~----~~i~~g~~~~--~p 256 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDIT----VYLLQGRRLL--QP 256 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CH----HHHHTTCCCC--CC
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHH----HHHHcCCCCC--Cc
Confidence 22 222345899999999999999999999999999999999988887632211 1111 2223332211 11
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
...+..+.+++.+||+.||++||+|+||++.|+++...
T Consensus 257 -------~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 257 -------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 12234788999999999999999999999999999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-46 Score=367.55 Aligned_cols=257 Identities=25% Similarity=0.373 Sum_probs=201.3
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecC----eeE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRI 307 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~----~~~ 307 (557)
.|++.+.||+|+||.||+|.+. +|+.||||+++... ....+.+.+|+++++.++||||+++++++...+ ..+
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 3567799999999999999875 68999999987543 233467899999999999999999999987654 378
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+||||++|++|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++..+++|||.+...
T Consensus 88 lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhh
Confidence 99999999999998874 4578999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCc--cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 388 EEDLT--HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 388 ~~~~~--~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||...+. .+.....+..+.....
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~~~ 235 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIPPS 235 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCCGG
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCCCc
Confidence 33221 223345699999999999999999999999999999999999999974332 2223333333322110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhh
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-KMQEIVLAIQDSI 511 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-t~~evl~~L~~~~ 511 (557)
..... .+..+.+++.+||+.||++|| |++++++.|.++.
T Consensus 236 ---~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 236 ---ARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ---GTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---hhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 11111 234788999999999999999 8999999888764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-47 Score=376.29 Aligned_cols=266 Identities=26% Similarity=0.379 Sum_probs=200.4
Q ss_pred HhhcccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHH--HHHHHhhcCCCCccceeeEEEecC----eeEEEEE
Q 008707 238 NFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVT--EVALLSRIHHRNLVPLIGYCEEEH----QRILVYE 311 (557)
Q Consensus 238 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~il~~l~h~nIv~~~~~~~~~~----~~~lv~e 311 (557)
.+.+.||+|+||.||+|+++ |+.||||++... ..+.+.+ |+..+..++||||+++++++.+.+ ..++|||
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 34688999999999999975 899999998643 2233344 445556789999999999997654 5789999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcC-----CCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG-----CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~-----~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
|+++|+|.++++. ..+++..++.++.|+|.||+|||+. .+++|+||||||+||||+.++.+||+|||+++.
T Consensus 82 y~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 82 YHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp CCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 9999999999974 3589999999999999999999962 126999999999999999999999999999987
Q ss_pred cCCCCcc---ccccccCCCCccCCcccCCCC------CCcccceehhHHHHHHHHhCCCCCCCCCcccc--------ccH
Q 008707 387 AEEDLTH---ISSVARGTVGYLDPEYYGNQQ------LTEKSDVYSFGVVLLELISGKKPVSVEDFGAE--------LNI 449 (557)
Q Consensus 387 ~~~~~~~---~~~~~~g~~~y~aPE~l~~~~------~s~~~DvwslG~ll~elltg~~pf~~~~~~~~--------~~~ 449 (557)
....... ......||+.|+|||++.+.. ++.++|||||||++|||+||..||........ ...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 6443321 223456999999999987643 56799999999999999999988753322110 011
Q ss_pred HHHHHHHHhcCCccccccccccCCC-CHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhhc
Q 008707 450 VHWARSMIKKGDVISIVDPVLIGNV-KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIEK 515 (557)
Q Consensus 450 ~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~~ 515 (557)
..........+. .+|.+.... ..+.+..+.+++.+||+.||++|||+.||++.|+++.+.+.
T Consensus 238 ~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 238 VEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp HHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence 122222222211 112221111 23455678999999999999999999999999999987654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=380.32 Aligned_cols=257 Identities=29% Similarity=0.487 Sum_probs=204.5
Q ss_pred HHHhhcccCCCCceEEEEEEEcC-Cc--EEEEEEccCc-cchhHHHHHHHHHHHhhc-CCCCccceeeEEEecCeeEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMKD-GK--EVAVKIMADS-CSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQRILVY 310 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~~lv~ 310 (557)
.+++.+.||+|+||.||+|.+++ |. .||||.+... .....+.+.+|+++|+++ +|||||++++++.+.+..++||
T Consensus 11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ 90 (309)
T d1fvra_ 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 90 (309)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEE
Confidence 34567899999999999998764 43 5788887543 233456799999999999 7999999999999999999999
Q ss_pred EecCCCChhhhhhcc-------------CCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEE
Q 008707 311 EYMHNGTLRDRLHGS-------------VNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAK 377 (557)
Q Consensus 311 e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~k 377 (557)
||+++|+|.++++.. .....+++..+..++.||++||.|||+ ++++||||||+|||++.++.+|
T Consensus 91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceE
Confidence 999999999999743 134678999999999999999999999 9999999999999999999999
Q ss_pred EecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCC-CCCCCCCccccccHHHHHHHH
Q 008707 378 VSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWARSM 456 (557)
Q Consensus 378 l~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~-~pf~~~~~~~~~~~~~~~~~~ 456 (557)
|+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|. .||...+. .+ +...
T Consensus 168 l~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~------~~-~~~~ 238 (309)
T d1fvra_ 168 IADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AE-LYEK 238 (309)
T ss_dssp ECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HH-HHHH
T ss_pred Ecccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH------HH-HHHH
Confidence 999999986543322 22345899999999999999999999999999999999976 56753321 11 1222
Q ss_pred HhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 457 IKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 457 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
+.++.... .+...+..+.+++.+||+.||++||||+||++.|+++.+.
T Consensus 239 i~~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 239 LPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 33332211 1122334788999999999999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=375.14 Aligned_cols=260 Identities=25% Similarity=0.421 Sum_probs=207.5
Q ss_pred HHHHhhcccCCCCceEEEEEEEcC--------CcEEEEEEccCccc-hhHHHHHHHHHHHhhc-CCCCccceeeEEEecC
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCS-HRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEH 304 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~ 304 (557)
..|++.+.||+|+||.||+|+... +..||||+++.... .....+.+|...+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 355678999999999999997642 24799999976543 3457788999999888 7999999999999999
Q ss_pred eeEEEEEecCCCChhhhhhccC-------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC
Q 008707 305 QRILVYEYMHNGTLRDRLHGSV-------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 371 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~ 371 (557)
..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+ .+|+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence 9999999999999999997542 13468999999999999999999999 9999999999999999
Q ss_pred CCCcEEEecccCccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccH
Q 008707 372 INMRAKVSDFGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 449 (557)
Q Consensus 372 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~ 449 (557)
.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~----- 244 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE----- 244 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH-----
Confidence 9999999999999876543322 2334568999999999999999999999999999999998 68888643321
Q ss_pred HHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 450 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 450 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
.+...+..+...... ...+..+.+++.+||+.||++|||+.||++.|+++...
T Consensus 245 --~~~~~i~~~~~~~~p---------~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 245 --ELFKLLKEGHRMDKP---------SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp --HHHHHHHTTCCCCCC---------SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHcCCCCCCC---------ccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence 122334444322221 11234688999999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-47 Score=379.00 Aligned_cols=261 Identities=30% Similarity=0.442 Sum_probs=210.9
Q ss_pred HHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhc-CCCCccceeeEEEecCee
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRI-HHRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~~~~ 306 (557)
..+++.+.||+|+||.||+|++. +++.||||+++... ......+.+|+.+++++ +|||||++++++.+....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 45667899999999999999863 45789999997643 33456789999999999 699999999999999999
Q ss_pred EEEEEecCCCChhhhhhccC---------------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeC
Q 008707 307 ILVYEYMHNGTLRDRLHGSV---------------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLD 371 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~ 371 (557)
++||||+++|+|.++++... ....+++..+..++.||++||+|||+ ++++||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence 99999999999999987542 23358899999999999999999998 9999999999999999
Q ss_pred CCCcEEEecccCccccCCCCc-cccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHh-CCCCCCCCCccccccH
Q 008707 372 INMRAKVSDFGLSRQAEEDLT-HISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELIS-GKKPVSVEDFGAELNI 449 (557)
Q Consensus 372 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~ellt-g~~pf~~~~~~~~~~~ 449 (557)
.++.+|++|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+| |.+||....... .
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~--~- 256 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K- 256 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H-
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH--H-
Confidence 999999999999987654432 22334568999999999999999999999999999999999 555565332221 1
Q ss_pred HHHHHHHHhcCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 450 VHWARSMIKKGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 450 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
+...+..+.... .+...+..+.+++.+||+.||++||||+||+++|++++..
T Consensus 257 ---~~~~i~~~~~~~---------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 ---FYKMIKEGFRML---------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp ---HHHHHHHTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHhcCCCCC---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 122223322111 1112234788999999999999999999999999987654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.1e-46 Score=365.87 Aligned_cols=248 Identities=25% Similarity=0.296 Sum_probs=201.0
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc---------hhHHHHHHHHHHHhhcC-CCCccceeeEEEecCe
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS---------HRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQ 305 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~ 305 (557)
|++.+.||+|+||+||+|+.. +|+.||||++..... ...+.+.+|+.++++++ ||||+++++++.+++.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 456789999999999999874 689999999864321 12346889999999997 9999999999999999
Q ss_pred eEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 306 RILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 306 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
.++||||+++|+|.++++. ...+++..++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 85 ~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999974 4579999999999999999999998 999999999999999999999999999998
Q ss_pred ccCCCCccccccccCCCCccCCcccC------CCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc
Q 008707 386 QAEEDLTHISSVARGTVGYLDPEYYG------NQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK 459 (557)
Q Consensus 386 ~~~~~~~~~~~~~~g~~~y~aPE~l~------~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 459 (557)
....... .....||+.|+|||.+. ...++.++||||+||++|||+||+.||...+... ....+..
T Consensus 159 ~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~i~~ 229 (277)
T d1phka_ 159 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIMS 229 (277)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHH
T ss_pred EccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHHHHh
Confidence 8755332 23356899999999985 3457889999999999999999999998543211 1122222
Q ss_pred CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 460 GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 460 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+.... ........+.++.+++.+||+.||++|||++||++
T Consensus 230 ~~~~~------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 230 GNYQF------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp TCCCC------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCC------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 32210 00011122347889999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=371.83 Aligned_cols=248 Identities=19% Similarity=0.294 Sum_probs=202.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecCC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMHN 315 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~ 315 (557)
|++.+.||+|+||+||+|.+. +++.||||+++... .....+.+|+++|+.++|||||++++++.+++..|+|||||+|
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~g 85 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCC
Confidence 556789999999999999876 68899999987543 3445688999999999999999999999999999999999999
Q ss_pred CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCC--CcEEEecccCccccCCCCcc
Q 008707 316 GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDIN--MRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 316 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~--~~~kl~Dfgla~~~~~~~~~ 393 (557)
|+|.+++... ...+++..+..++.||+.||+|||+ +||+||||||+|||++.+ ..+||+|||++........
T Consensus 86 g~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~- 159 (321)
T d1tkia_ 86 LDIFERINTS--AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE-
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCc-
Confidence 9999999742 3468999999999999999999998 999999999999999854 5799999999987654322
Q ss_pred ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccccccCC
Q 008707 394 ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLIGN 473 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 473 (557)
.....+++.|+|||.+.+..++.++||||+||++|+|++|+.||...+.. +.... +..+... ++......
T Consensus 160 -~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~-i~~~~~~--~~~~~~~~ 229 (321)
T d1tkia_ 160 -FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIEN-IMNAEYT--FDEEAFKE 229 (321)
T ss_dssp -EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH-HHHTCCC--CCHHHHTT
T ss_pred -ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCCCC--CChhhccC
Confidence 22345899999999999999999999999999999999999999754321 11111 2222110 01111111
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 474 VKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 474 ~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
. ..++.+++.+||..||++|||++|+++
T Consensus 230 ~----s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 230 I----SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp S----CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 236789999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-46 Score=377.89 Aligned_cols=243 Identities=23% Similarity=0.288 Sum_probs=202.7
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
.|++.+.||+|+||.||+|.++ +|+.||||++.... ....+.+.+|+++++.++|||||++++++.+....++|||
T Consensus 42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 3556789999999999999875 69999999986432 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+.+|+|.+++.. ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+......
T Consensus 122 ~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 122 YVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp CCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred cccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence 9999999999874 3568999999999999999999998 999999999999999999999999999998775432
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
....||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+.. . ....+..+... .
T Consensus 196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~-~~~~i~~~~~~------~- 257 (350)
T d1rdqe_ 196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------Q-IYEKIVSGKVR------F- 257 (350)
T ss_dssp ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCC------C-
T ss_pred ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------H-HHHHHhcCCCC------C-
Confidence 2346999999999999999999999999999999999999999744321 1 11222222211 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 505 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 505 (557)
+.....++.+++.+||..||.+|+ |++||++
T Consensus 258 ---p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 258 ---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 111234688999999999999994 8999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=371.11 Aligned_cols=256 Identities=21% Similarity=0.207 Sum_probs=195.3
Q ss_pred hcccCCCCceEEEEEEEc-CCcEEEEEEccCccch-----hHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 240 CKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSH-----RTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
.+.||+|+||+||+|.++ +|+.||||++...... ..+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 368999999999999875 5899999998643221 1246889999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
.++++..+.. ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++.........
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 8887776665 35668888999999999999999998 99999999999999999999999999999876554322
Q ss_pred ccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc----
Q 008707 394 ISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP---- 468 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~---- 468 (557)
.....||+.|+|||++... .++.++||||+||++|||+||+.||.+....+ ....+.............+.
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSST
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhccc
Confidence 2234589999999998654 67999999999999999999999997543322 11111121111111000000
Q ss_pred --c---ccCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 469 --V---LIGNVKI-----ESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 469 --~---l~~~~~~-----~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
. .....+. .....+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 0001111 12346889999999999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-47 Score=376.08 Aligned_cols=245 Identities=24% Similarity=0.362 Sum_probs=200.3
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHHHHHHHh-hcCCCCccceeeEEEecCeeEEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVTEVALLS-RIHHRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~-~l~h~nIv~~~~~~~~~~~~~lv~e 311 (557)
|++.+.||+|+||+||+|.+. +|+.||||++++.. ....+.+..|..++. .++|||||++++++.+++..++|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 456899999999999999876 68999999986432 233456667777765 6799999999999999999999999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~ 391 (557)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 84 YLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred ecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999999974 4568899999999999999999999 999999999999999999999999999998765433
Q ss_pred ccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccccccccc
Q 008707 392 THISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDPVLI 471 (557)
Q Consensus 392 ~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 471 (557)
.. .....||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+... +...+..+... +
T Consensus 158 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~~------~- 222 (320)
T d1xjda_ 158 AK-TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPF------Y- 222 (320)
T ss_dssp CC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCC------C-
T ss_pred cc-ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCCC------C-
Confidence 22 233569999999999999999999999999999999999999998543221 12222222211 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 008707 472 GNVKIESIWRIAEVAIQCVEQRGFSRPKMQ-EIVL 505 (557)
Q Consensus 472 ~~~~~~~~~~l~~li~~cl~~~P~~RPt~~-evl~ 505 (557)
+...+..+.+++.+||+.||++|||+. ||++
T Consensus 223 ---p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 223 ---PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111234688999999999999999996 7764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6e-46 Score=376.74 Aligned_cols=246 Identities=22% Similarity=0.274 Sum_probs=195.5
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc---chhHHHHHH---HHHHHhhcCCCCccceeeEEEecCeeEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC---SHRTQQFVT---EVALLSRIHHRNLVPLIGYCEEEHQRILV 309 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~---E~~il~~l~h~nIv~~~~~~~~~~~~~lv 309 (557)
|++.+.||+|+||.||+|... +|+.||||++.... ......+.+ |+++++.++|||||++++++.+.+..++|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 456789999999999999876 68999999985421 112223444 46677777899999999999999999999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCC
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~ 389 (557)
|||++||+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 mE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp ECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999974 4568899999999999999999998 9999999999999999999999999999987654
Q ss_pred CCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccccc
Q 008707 390 DLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIVDP 468 (557)
Q Consensus 390 ~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 468 (557)
.. .....||+.|+|||++.. ..++.++|||||||++|||+||+.||......... . +.........
T Consensus 160 ~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~-~~~~~~~~~~------ 226 (364)
T d1omwa3 160 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---E-IDRMTLTMAV------ 226 (364)
T ss_dssp SC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH---H-HHHHSSSCCC------
T ss_pred Cc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH---H-HHHhcccCCC------
Confidence 32 233469999999999864 56899999999999999999999999854433211 1 1111111110
Q ss_pred cccCCCCHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 008707 469 VLIGNVKIESIWRIAEVAIQCVEQRGFSRPK-----MQEIVL 505 (557)
Q Consensus 469 ~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt-----~~evl~ 505 (557)
..... ....+.+++.+||+.||++||| ++|+++
T Consensus 227 ~~~~~----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 227 ELPDS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCSS----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCC----CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11111 2336889999999999999999 688875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=370.27 Aligned_cols=260 Identities=24% Similarity=0.397 Sum_probs=210.3
Q ss_pred HHHHhhcccCCCCceEEEEEEEc------CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeE
Q 008707 235 ATNNFCKKIGKGSFGSVYYGKMK------DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 235 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 307 (557)
..+++.+.||+|+||.||+|.+. +++.||||+++... ......|.+|++++++++||||+++++++..++..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 34567899999999999999874 25789999997543 334457899999999999999999999999999999
Q ss_pred EEEEecCCCChhhhhhccC-------CCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEec
Q 008707 308 LVYEYMHNGTLRDRLHGSV-------NQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 380 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 380 (557)
+||||+++|+|.+++.... ....+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence 9999999999999886431 23457889999999999999999998 8999999999999999999999999
Q ss_pred ccCccccCCCCcc-ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCC-CCCCCCCccccccHHHHHHHHHh
Q 008707 381 FGLSRQAEEDLTH-ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGK-KPVSVEDFGAELNIVHWARSMIK 458 (557)
Q Consensus 381 fgla~~~~~~~~~-~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~-~pf~~~~~~~~~~~~~~~~~~~~ 458 (557)
||+++........ ......||+.|+|||.+.+..++.++||||||+++|||+||. .||.+.. ..+.. ..+.
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~------~~~~~-~~i~ 249 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVL-RFVM 249 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHHH-HHHH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC------HHHHH-HHHH
Confidence 9999876443322 223345899999999999999999999999999999999985 6776332 22222 2233
Q ss_pred cCCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhh
Q 008707 459 KGDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKI 513 (557)
Q Consensus 459 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~ 513 (557)
++...... ...+..+.+++.+||+.+|++|||++||++.|++..+.
T Consensus 250 ~~~~~~~p---------~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 250 EGGLLDKP---------DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp TTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred hCCCCCCc---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 33332211 12234788999999999999999999999999887653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=370.27 Aligned_cols=249 Identities=22% Similarity=0.300 Sum_probs=194.8
Q ss_pred HHhh-cccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhc-CCCCccceeeEEEe----cCeeEEE
Q 008707 237 NNFC-KKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRI-HHRNLVPLIGYCEE----EHQRILV 309 (557)
Q Consensus 237 ~~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~----~~~~~lv 309 (557)
|++. +.||+|+||+||+|.+. +++.||||+++.. ..+.+|++++.++ +|||||++++++.+ +...++|
T Consensus 13 y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 13 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 4443 56999999999999874 6899999998642 4567899987655 89999999999875 4668999
Q ss_pred EEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC---CCcEEEecccCccc
Q 008707 310 YEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQ 386 (557)
Q Consensus 310 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~ 386 (557)
||||+||+|.+++... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++. ++.+||+|||+|+.
T Consensus 88 mEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~ 163 (335)
T d2ozaa1 88 MECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163 (335)
T ss_dssp EECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeee
Confidence 9999999999999753 24579999999999999999999998 99999999999999985 46799999999987
Q ss_pred cCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCccccc
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISIV 466 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 466 (557)
...... .....||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+...... .......+..+...
T Consensus 164 ~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~~~--- 235 (335)
T d2ozaa1 164 TTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQYE--- 235 (335)
T ss_dssp CCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSSS---
T ss_pred ccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCCCC---
Confidence 654332 2344699999999999999999999999999999999999999975432211 11111111111100
Q ss_pred cccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 467 DPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 467 d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+..........++.+++.+||+.||++|||+.|+++
T Consensus 236 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 236 ---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ---CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000001123457889999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-45 Score=362.47 Aligned_cols=259 Identities=18% Similarity=0.261 Sum_probs=197.6
Q ss_pred HHhhcccCCCCceEEEEEEEcCCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
|++.++||+|+||+||+|.+++|+.||||++.... ....+.+.+|+.++++++||||+++++++.+++..+++||++.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 44578999999999999999999999999986542 2235789999999999999999999999999999999999998
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCccc
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTHI 394 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~ 394 (557)
++.+..+.. ....+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||.+.........
T Consensus 84 ~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~- 156 (286)
T d1ob3a_ 84 QDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK- 156 (286)
T ss_dssp EEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred hhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCccc-
Confidence 776666654 35779999999999999999999998 99999999999999999999999999999876543322
Q ss_pred cccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc--------
Q 008707 395 SSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI-------- 465 (557)
Q Consensus 395 ~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 465 (557)
.....+++.|+|||.+.+. .++.++||||+||++|||++|+.||...+..+. +.+ .............
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~-i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMR-IFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCTTTSTTGGGSTT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHH-HHHhhCCCChhhccchhhhhh
Confidence 2333589999999998754 568999999999999999999999975432211 111 1111111000000
Q ss_pred cc-------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 466 VD-------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 466 ~d-------~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+ +.............+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00000111122346889999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-45 Score=362.30 Aligned_cols=261 Identities=21% Similarity=0.308 Sum_probs=196.3
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc--hhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS--HRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||+||+|.+. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 445789999999999999874 689999999864322 23567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
.+ ++.+.+... ....+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+........
T Consensus 84 ~~-~~~~~~~~~-~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~ 158 (298)
T d1gz8a_ 84 HQ-DLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158 (298)
T ss_dssp SE-EHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred CC-chhhhhhhh-cccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence 65 444444332 35679999999999999999999998 99999999999999999999999999999876544332
Q ss_pred ccccccCCCCccCCcccCCCC-CCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc------cccc
Q 008707 394 ISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV------ISIV 466 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~-~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 466 (557)
.....||+.|+|||.+.... ++.++||||+||++|+|++|+.||.+.+..+. +.. .......... ....
T Consensus 159 -~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~-i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 159 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFR-IFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp -TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCTTTSTTGGGST
T ss_pred -ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHH-HHHhcCCCchhhcccccccc
Confidence 33345899999999877655 57899999999999999999999975432211 111 1111111000 0000
Q ss_pred c--ccc--cCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 467 D--PVL--IGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 467 d--~~l--~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
+ ... ..... ......+.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 000 00000 1112467899999999999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=358.72 Aligned_cols=238 Identities=24% Similarity=0.383 Sum_probs=193.1
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccc------hhHHHHHHHHHHHhhcC--CCCccceeeEEEecCee
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCS------HRTQQFVTEVALLSRIH--HRNLVPLIGYCEEEHQR 306 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~--h~nIv~~~~~~~~~~~~ 306 (557)
.|++.+.||+|+||+||+|... +|+.||||++..... ....++.+|+.++++++ |||||++++++.+++..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 3567799999999999999875 689999999864321 11234678999999996 89999999999999999
Q ss_pred EEEEEecCC-CChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC-CCcEEEecccCc
Q 008707 307 ILVYEYMHN-GTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-NMRAKVSDFGLS 384 (557)
Q Consensus 307 ~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~-~~~~kl~Dfgla 384 (557)
++|||++.+ +++.+++.. ...+++..++.++.||++||+|||+ ++|+||||||+|||++. ++.+||+|||+|
T Consensus 85 ~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence 999999976 578887763 4578999999999999999999998 99999999999999985 478999999999
Q ss_pred cccCCCCccccccccCCCCccCCcccCCCCC-CcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 385 RQAEEDLTHISSVARGTVGYLDPEYYGNQQL-TEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 385 ~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~-s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
....... .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||...+ .+..+..
T Consensus 159 ~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~~- 221 (273)
T d1xwsa_ 159 ALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQV- 221 (273)
T ss_dssp EECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCCC-
T ss_pred eeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HHhhccc-
Confidence 8754432 234569999999999987655 678999999999999999999997321 0111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 464 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 464 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
.+.... +.++.+++.+||+.||++|||++|+++
T Consensus 222 -----~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 -----FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -----CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 011122 246889999999999999999999986
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=358.79 Aligned_cols=260 Identities=20% Similarity=0.256 Sum_probs=194.0
Q ss_pred HHHhhcccCCCCceEEEEEEEc-C-CcEEEEEEccCccc--hhHHHHHHHHHHHhhc---CCCCccceeeEEEe-----c
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-D-GKEVAVKIMADSCS--HRTQQFVTEVALLSRI---HHRNLVPLIGYCEE-----E 303 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~h~nIv~~~~~~~~-----~ 303 (557)
.|++.+.||+|+||+||+|.+. + ++.||||+++.... .....+.+|+.+++.| +||||++++++|.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 4566789999999999999874 4 56799999864322 2233566788887776 79999999999853 3
Q ss_pred CeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccC
Q 008707 304 HQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGL 383 (557)
Q Consensus 304 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgl 383 (557)
...+++||++.++.+...... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred ceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhh
Confidence 467899999988776544432 45678999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 384 SRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 384 a~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
+....... ......||+.|+|||++.+..++.++||||+||++|||+||+.||.+.+..+. +.. ...........
T Consensus 163 ~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~-i~~~~~~~~~~ 237 (305)
T d1blxa_ 163 ARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGK-ILDVIGLPGEE 237 (305)
T ss_dssp CCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHCCCCGG
T ss_pred hhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHhhCCCchh
Confidence 87654332 23345699999999999999999999999999999999999999985543221 111 11111110000
Q ss_pred ccc------c-------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 464 SIV------D-------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 464 ~~~------d-------~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
... . ..............+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 0 00000111122346789999999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.7e-43 Score=345.71 Aligned_cols=261 Identities=16% Similarity=0.195 Sum_probs=207.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCC-CCccceeeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~~~~~lv~e~~~ 314 (557)
|++.+.||+|+||+||+|++. +|+.||||++.... ....+.+|+++++.++| +|++.+++++..+...++|||++
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~- 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL- 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-
Confidence 556789999999999999876 68999999875432 23456789999999965 89999999999999999999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC-----CCcEEEecccCccccCC
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI-----NMRAKVSDFGLSRQAEE 389 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~-----~~~~kl~Dfgla~~~~~ 389 (557)
+++|.+++.. ....++..++..++.|++.||+|||+ +||+||||||+|||++. ++.+||+|||+|+....
T Consensus 84 ~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~ 158 (293)
T d1csna_ 84 GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 158 (293)
T ss_dssp CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence 7899998865 34568999999999999999999998 99999999999999974 57799999999987644
Q ss_pred CCcc------ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc
Q 008707 390 DLTH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI 463 (557)
Q Consensus 390 ~~~~------~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 463 (557)
.... ......||+.|+|||.+.+..++.++|||||||++|||+||+.||.+............+..........
T Consensus 159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (293)
T d1csna_ 159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238 (293)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence 3221 1234569999999999999999999999999999999999999998655443322222222211111111
Q ss_pred ccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 464 SIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 464 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
+ +.... +.++.+++..|+..+|++||+++.+.+.|+++.+..
T Consensus 239 ~-----l~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 239 E-----LCAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp H-----HTTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred H-----hcCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 1 11122 346889999999999999999999999999987644
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=358.00 Aligned_cols=265 Identities=23% Similarity=0.245 Sum_probs=194.7
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccceeeEEEec------CeeEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE------HQRIL 308 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~------~~~~l 308 (557)
+|+..++||+|+||+||+|++. +|+.||||++..... .+.+|++++++++||||++++++|... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 3445688999999999999876 689999999865432 234799999999999999999998542 34689
Q ss_pred EEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC-cEEEecccCcccc
Q 008707 309 VYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQA 387 (557)
Q Consensus 309 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~ 387 (557)
||||++++.+............+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999766544443333356679999999999999999999998 9999999999999999775 8999999999876
Q ss_pred CCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhc-------
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKK------- 459 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~------- 459 (557)
..... .....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+. +.... .....
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~-~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEII-KVLGTPTREQIR 248 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHH-HHHCCCCHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHH-HHhCCChHHhhh
Confidence 54332 223458999999998765 5789999999999999999999999975443221 11111 00000
Q ss_pred --------CCccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhhh
Q 008707 460 --------GDVISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIK 512 (557)
Q Consensus 460 --------~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~~~ 512 (557)
......................+.+++.+||+.||++|||++|+++. ++++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 00000000000001111223468899999999999999999999863 555443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.2e-43 Score=345.92 Aligned_cols=261 Identities=22% Similarity=0.284 Sum_probs=198.0
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCccce-eeEEEecCeeEEEEEecC
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNLVPL-IGYCEEEHQRILVYEYMH 314 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~-~~~~~~~~~~~lv~e~~~ 314 (557)
|++.+.||+|+||.||+|.+. +|+.||||++.... ..+++..|+++++.++|+|++.. .+++.+.+..++||||+
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~- 85 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 85 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-
Confidence 567799999999999999875 68999999876532 23457889999999987665554 55567778889999999
Q ss_pred CCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCC---CCcEEEecccCccccCCCC
Q 008707 315 NGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDI---NMRAKVSDFGLSRQAEEDL 391 (557)
Q Consensus 315 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~---~~~~kl~Dfgla~~~~~~~ 391 (557)
++++.+.+.. ....+++..+..++.|++.||+|||+ ++|+||||||+|||++. +..++|+|||+|+......
T Consensus 86 ~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 86 GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 5677666653 35679999999999999999999999 99999999999999864 4569999999998765433
Q ss_pred cc------ccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 392 TH------ISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 392 ~~------~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
.. ......||+.|+|||.+.+..++.++|||||||++|||+||+.||......................+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-- 238 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-- 238 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH--
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh--
Confidence 21 2234569999999999999999999999999999999999999998554433222221111111111110
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhhhh
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLAIQDSIKIE 514 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~L~~~~~~~ 514 (557)
.+... .+.++.+++.+||+.+|++||++++|.+.|++.....
T Consensus 239 ---~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 239 ---VLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ---HHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---HhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 11111 2246889999999999999999999999999876543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=353.02 Aligned_cols=261 Identities=20% Similarity=0.230 Sum_probs=193.0
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCc--cchhHHHHHHHHHHHhhcCCCCccceeeEEEe--------cC
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADS--CSHRTQQFVTEVALLSRIHHRNLVPLIGYCEE--------EH 304 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~--------~~ 304 (557)
.|++.++||+|+||+||+|.+. +|+.||||++... .....+++.+|+++|++++||||+++++++.. .+
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 4556789999999999999875 7999999998543 22344678899999999999999999998855 34
Q ss_pred eeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCc
Q 008707 305 QRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLS 384 (557)
Q Consensus 305 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla 384 (557)
..++|||++.++.+..... ....++...+..++.|+++||+|||+ +||+||||||+|||++.++.+||+|||++
T Consensus 91 ~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred eEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeeccee
Confidence 5789999998776665443 35678899999999999999999998 99999999999999999999999999999
Q ss_pred cccCCCCc---cccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcC
Q 008707 385 RQAEEDLT---HISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKG 460 (557)
Q Consensus 385 ~~~~~~~~---~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 460 (557)
........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..... .........-
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~---~~i~~~~~~~ 241 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLCGSI 241 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCC
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH---HHHHHhcCCC
Confidence 76643221 122334689999999998765 6899999999999999999999999754332211 1111111110
Q ss_pred Ccc--cccc-c--------cccCCCCHH-------HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 461 DVI--SIVD-P--------VLIGNVKIE-------SIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 461 ~~~--~~~d-~--------~l~~~~~~~-------~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
... ...+ . ......... ....+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 000 0000 0 000001111 1235678999999999999999999985
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-42 Score=350.58 Aligned_cols=259 Identities=21% Similarity=0.306 Sum_probs=192.8
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc-chhHHHHHHHHHHHhhcCCCCccceeeEEEecC----eeEEEE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC-SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH----QRILVY 310 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~----~~~lv~ 310 (557)
|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+++|+.++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 556799999999999999864 79999999987543 344567899999999999999999999987643 235556
Q ss_pred EecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCC
Q 008707 311 EYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEED 390 (557)
Q Consensus 311 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~ 390 (557)
+++.+|+|.+++.. ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 90 THLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 66779999999963 358999999999999999999998 99999999999999999999999999999875443
Q ss_pred Ccc--ccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc----
Q 008707 391 LTH--ISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI---- 463 (557)
Q Consensus 391 ~~~--~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---- 463 (557)
... ......||+.|+|||++.. ..++.++||||+||++|+|++|+.||...+..+...... .........
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPSQEDLNC 239 (345)
T ss_dssp GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCSCCHHHHHT
T ss_pred CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHh---hhccCCChhhhhh
Confidence 221 2334568999999999854 567889999999999999999999997554322111110 000000000
Q ss_pred -------c--cccccccCCCCH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 464 -------S--IVDPVLIGNVKI-----ESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 464 -------~--~~d~~l~~~~~~-----~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
. ...+. ....+. .....+.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPH-KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCC-CCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhcccccCCc-cCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00000 000000 111367899999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=349.17 Aligned_cols=265 Identities=22% Similarity=0.307 Sum_probs=193.6
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecC------ee
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEH------QR 306 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~------~~ 306 (557)
.|++.+.||+|+||+||+|.+. +|+.||||+++... ....+.+.+|+++|+.++|||||+++++|...+ ..
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 4556789999999999999875 69999999997532 234567899999999999999999999997654 46
Q ss_pred EEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 307 ILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 307 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
++||||+ +.+|..+.+ ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+|++|||+|+.
T Consensus 99 ~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp EEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceec
Confidence 9999999 667877765 3469999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCCccccccccCCCCccCCcccCC-CCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHH-----HHHhcC
Q 008707 387 AEEDLTHISSVARGTVGYLDPEYYGN-QQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWAR-----SMIKKG 460 (557)
Q Consensus 387 ~~~~~~~~~~~~~g~~~y~aPE~l~~-~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~-----~~~~~~ 460 (557)
..... ....||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+............ ......
T Consensus 171 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 65433 23458999999999876 456899999999999999999999998554322111100000 000000
Q ss_pred C----------ccccccccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhhhh
Q 008707 461 D----------VISIVDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA--IQDSIKI 513 (557)
Q Consensus 461 ~----------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~--L~~~~~~ 513 (557)
. ........+ ..........+.+++.+||..||++|||++|+++. |+.+.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp SCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred cchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 0 000000000 00111122367899999999999999999999984 6655443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=351.07 Aligned_cols=250 Identities=26% Similarity=0.347 Sum_probs=200.4
Q ss_pred HHhhcccCCCCceEEEEEEEc----CCcEEEEEEccCcc----chhHHHHHHHHHHHhhcCC-CCccceeeEEEecCeeE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK----DGKEVAVKIMADSC----SHRTQQFVTEVALLSRIHH-RNLVPLIGYCEEEHQRI 307 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~~~~~ 307 (557)
|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 667899999999999999753 47899999986432 2234668899999999976 89999999999999999
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
++|||+.+|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 106 ~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999974 3457788899999999999999998 99999999999999999999999999999877
Q ss_pred CCCCccccccccCCCCccCCcccCCC--CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcccc
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQ--QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVISI 465 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~--~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 465 (557)
............|++.|+|||.+.+. .++.++||||+||++|+|+||+.||........ .......... ...
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~--~~~i~~~~~~-~~~--- 253 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILK-SEP--- 253 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHH-CCC---
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhccc-CCC---
Confidence 55544444556699999999999754 467899999999999999999999985543322 1121122111 111
Q ss_pred ccccccCCCCHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 008707 466 VDPVLIGNVKIESIWRIAEVAIQCVEQRGFSRP-----KMQEIVL 505 (557)
Q Consensus 466 ~d~~l~~~~~~~~~~~l~~li~~cl~~~P~~RP-----t~~evl~ 505 (557)
..+......+.+++.+||+.||++|| |++|+++
T Consensus 254 -------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 -------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11112234788999999999999999 4788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=339.73 Aligned_cols=260 Identities=20% Similarity=0.250 Sum_probs=200.2
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEecCeeEEEEEec
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEEHQRILVYEYM 313 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~ 313 (557)
|++.+.||+|+||+||+|++. +++.||||+++... .....++.+|+.+++.++||||+++++++.+....++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 456789999999999999875 68899999986432 334578899999999999999999999999999999999999
Q ss_pred CCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCccccCCCCcc
Q 008707 314 HNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQAEEDLTH 393 (557)
Q Consensus 314 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~ 393 (557)
.++++..++. ..+.+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||.+.........
T Consensus 84 ~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 84 DQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp SEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred cccccccccc---cccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 9998888776 45678899999999999999999998 99999999999999999999999999999877554332
Q ss_pred ccccccCCCCccCCcccCCCC-CCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCc------cccc
Q 008707 394 ISSVARGTVGYLDPEYYGNQQ-LTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDV------ISIV 466 (557)
Q Consensus 394 ~~~~~~g~~~y~aPE~l~~~~-~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 466 (557)
.....+++.|+|||.+.... ++.++||||+||++|||++|+.||...... ......+......... ....
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH--HHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 22334788899999987664 689999999999999999999997532211 1111111111111000 0000
Q ss_pred cc---------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 467 DP---------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 467 d~---------~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
+. .-...........+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000111122346789999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.8e-42 Score=343.41 Aligned_cols=256 Identities=20% Similarity=0.288 Sum_probs=193.8
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcC-CCCccceeeEEEe--cCeeEEEEE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEE--EHQRILVYE 311 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~--~~~~~lv~e 311 (557)
.|++.+.||+|+||+||+|+.. +|+.||||+++.. ..+.+.+|+++|++++ ||||+++++++.. ....++|||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 4667899999999999999875 6899999998753 3467889999999995 9999999999874 356899999
Q ss_pred ecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCC-cEEEecccCccccCCC
Q 008707 312 YMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINM-RAKVSDFGLSRQAEED 390 (557)
Q Consensus 312 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~-~~kl~Dfgla~~~~~~ 390 (557)
|+.+++|.++. ..+++..+..++.||+.||+|||+ +||+||||||+|||++.++ .+||+|||+|......
T Consensus 113 ~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 113 HVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp CCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred ecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99999997764 358999999999999999999998 9999999999999998655 6999999999876543
Q ss_pred CccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccc--cHHHH-----HHHHHhcCCc
Q 008707 391 LTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAEL--NIVHW-----ARSMIKKGDV 462 (557)
Q Consensus 391 ~~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~--~~~~~-----~~~~~~~~~~ 462 (557)
.. .....+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||......... ..... ..........
T Consensus 184 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 184 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred Cc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 22 2334589999999998765 5799999999999999999999999754432111 00000 0001111000
Q ss_pred c------cccc--------ccccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 008707 463 I------SIVD--------PVLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIVL 505 (557)
Q Consensus 463 ~------~~~d--------~~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl~ 505 (557)
. .... .............++.+++.+||..||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000 00000011122346789999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-41 Score=339.86 Aligned_cols=259 Identities=22% Similarity=0.265 Sum_probs=187.9
Q ss_pred HHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEe------cCeeE
Q 008707 237 NNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEE------EHQRI 307 (557)
Q Consensus 237 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~------~~~~~ 307 (557)
|++.++||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+.++++++||||++++++|.. ....|
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 556789999999999999876 69999999987542 3344678899999999999999999999863 36789
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
+||||+.++.+ +.+. ..+++..++.++.||+.||+|||+ +||+||||||+|||++.++.++++|||+++..
T Consensus 99 iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 99 LVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhcc
Confidence 99999976544 4443 347899999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHH----------------H
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIV----------------H 451 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~----------------~ 451 (557)
..... .....+|+.|+|||.+.+..+++++||||+||++|+|++|+.||.+.+........ .
T Consensus 170 ~~~~~--~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 170 GTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ccccc--cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 44322 23345899999999999999999999999999999999999999755422111000 0
Q ss_pred HHHHHHhcCCc------cccccccccCCC---CHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 008707 452 WARSMIKKGDV------ISIVDPVLIGNV---KIESIWRIAEVAIQCVEQRGFSRPKMQEIVLA 506 (557)
Q Consensus 452 ~~~~~~~~~~~------~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~~P~~RPt~~evl~~ 506 (557)
........... ............ .......+.+++.+||..||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00111111100 000001111111 12345578899999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-41 Score=339.63 Aligned_cols=262 Identities=19% Similarity=0.286 Sum_probs=194.2
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCcc--chhHHHHHHHHHHHhhcCCCCccceeeEEEec-----CeeE
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSC--SHRTQQFVTEVALLSRIHHRNLVPLIGYCEEE-----HQRI 307 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----~~~~ 307 (557)
.|++.+.||+|+||+||+|... +|+.||||++.... ....+.+.+|+++++.++|||||++++++... ...+
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 3566799999999999999865 69999999997543 23456788999999999999999999998642 3456
Q ss_pred EEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEecccCcccc
Q 008707 308 LVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQA 387 (557)
Q Consensus 308 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~~ 387 (557)
++++++.+|+|.+++. ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+|++|||++...
T Consensus 99 ~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp EEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhccc
Confidence 6778888999999986 3469999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCCccccccccCCCCccCCcccCCC-CCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHHHHhcCCcc--c
Q 008707 388 EEDLTHISSVARGTVGYLDPEYYGNQ-QLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARSMIKKGDVI--S 464 (557)
Q Consensus 388 ~~~~~~~~~~~~g~~~y~aPE~l~~~-~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~ 464 (557)
... .....|++.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+...... .+.......... .
T Consensus 172 ~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~---~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 172 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLVGTPGAELLK 244 (348)
T ss_dssp TGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCHHHHT
T ss_pred Ccc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCChHHhh
Confidence 433 2334588999999987665 56889999999999999999999998554321111 111110000000 0
Q ss_pred ---------ccccc-ccCCCC-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH--HHHhhh
Q 008707 465 ---------IVDPV-LIGNVK-----IESIWRIAEVAIQCVEQRGFSRPKMQEIVL--AIQDSI 511 (557)
Q Consensus 465 ---------~~d~~-l~~~~~-----~~~~~~l~~li~~cl~~~P~~RPt~~evl~--~L~~~~ 511 (557)
..... -..... ......+.+++.+||..||++|||++|+++ .+++..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 00000 000000 011236789999999999999999999997 355443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.8e-37 Score=313.10 Aligned_cols=270 Identities=20% Similarity=0.264 Sum_probs=193.7
Q ss_pred HHHhhcccCCCCceEEEEEEEc-CCcEEEEEEccCccchhHHHHHHHHHHHhhcC-----------CCCccceeeEEEe-
Q 008707 236 TNNFCKKIGKGSFGSVYYGKMK-DGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-----------HRNLVPLIGYCEE- 302 (557)
Q Consensus 236 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------h~nIv~~~~~~~~- 302 (557)
+|++.++||+|+||+||+|+.. +|+.||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 4677899999999999999875 69999999997542 23456788999888875 5789999988754
Q ss_pred -cCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCc------
Q 008707 303 -EHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMR------ 375 (557)
Q Consensus 303 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~------ 375 (557)
....+++++++..+..............+++..+..++.||+.||+|||+ ..||+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence 34566777776555433333333356778999999999999999999997 489999999999999986543
Q ss_pred EEEecccCccccCCCCccccccccCCCCccCCcccCCCCCCcccceehhHHHHHHHHhCCCCCCCCCccccccHHHHHHH
Q 008707 376 AKVSDFGLSRQAEEDLTHISSVARGTVGYLDPEYYGNQQLTEKSDVYSFGVVLLELISGKKPVSVEDFGAELNIVHWARS 455 (557)
Q Consensus 376 ~kl~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~l~~~~~s~~~DvwslG~ll~elltg~~pf~~~~~~~~~~~~~~~~~ 455 (557)
++++|||.+....... ....||+.|+|||++.+..++.++||||+||++++|++|+.||.................
T Consensus 171 ~kl~dfg~s~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEHY----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBCC----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeeccccccccccc----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 9999999998654332 334589999999999999999999999999999999999999985543322111111111
Q ss_pred ---HHh--------cCCc-ccccc---------c----------cccCCCCHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 008707 456 ---MIK--------KGDV-ISIVD---------P----------VLIGNVKIESIWRIAEVAIQCVEQRGFSRPKMQEIV 504 (557)
Q Consensus 456 ---~~~--------~~~~-~~~~d---------~----------~l~~~~~~~~~~~l~~li~~cl~~~P~~RPt~~evl 504 (557)
.+. .+.. ....+ . .............+.+++.+||..||++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 110 0000 00000 0 001123456677899999999999999999999998
Q ss_pred HH--HHhhhh
Q 008707 505 LA--IQDSIK 512 (557)
Q Consensus 505 ~~--L~~~~~ 512 (557)
+. +++...
T Consensus 327 ~Hp~f~~~~~ 336 (362)
T d1q8ya_ 327 NHPWLKDTLG 336 (362)
T ss_dssp TCGGGTTCTT
T ss_pred cCcccCCCCC
Confidence 74 554443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=2.5e-23 Score=190.40 Aligned_cols=161 Identities=16% Similarity=0.164 Sum_probs=118.3
Q ss_pred hhcccCCCCceEEEEEEEcCCcEEEEEEccCccc------------------hhHHHHHHHHHHHhhcCCCCccceeeEE
Q 008707 239 FCKKIGKGSFGSVYYGKMKDGKEVAVKIMADSCS------------------HRTQQFVTEVALLSRIHHRNLVPLIGYC 300 (557)
Q Consensus 239 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~il~~l~h~nIv~~~~~~ 300 (557)
+.+.||+|+||+||+|...+|+.||||+++.... .....+.+|+..+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 4689999999999999988899999998753210 0123355788899999999999887653
Q ss_pred EecCeeEEEEEecCCCChhhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHcCCCCCeEeeccCCCCEEeCCCCcEEEec
Q 008707 301 EEEHQRILVYEYMHNGTLRDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHTGCNPGIIHRDVKSSNILLDINMRAKVSD 380 (557)
Q Consensus 301 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~~~~~ivH~dlk~~NIll~~~~~~kl~D 380 (557)
..+++||++++..+.+ ++......++.|++++++|||+ .||+||||||+|||++++ .++|+|
T Consensus 84 ----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECC
T ss_pred ----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEE
Confidence 2479999998765543 2233456789999999999998 999999999999999964 589999
Q ss_pred ccCccccCCCCccccccccCCCCccCC------cccCCCCCCcccceehhHHH
Q 008707 381 FGLSRQAEEDLTHISSVARGTVGYLDP------EYYGNQQLTEKSDVYSFGVV 427 (557)
Q Consensus 381 fgla~~~~~~~~~~~~~~~g~~~y~aP------E~l~~~~~s~~~DvwslG~l 427 (557)
||+|.....+.... |... +.+ ...|+.++|+||+.--
T Consensus 146 FG~a~~~~~~~~~~---------~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 146 FPQSVEVGEEGWRE---------ILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CTTCEETTSTTHHH---------HHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred CCCcccCCCCCcHH---------HHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 99997765432110 1100 111 2456788999996543
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.72 E-value=3.9e-18 Score=168.04 Aligned_cols=141 Identities=28% Similarity=0.540 Sum_probs=119.6
Q ss_pred HHHHHhhhhcC----CCCCC-CCCCCCCCCCeEEeeCC-CCCceEEEEecCCCccc--cCCccccCCCCCcEEECcC-CC
Q 008707 4 EALRSISDESE----RTNDR-GDPCVPVPWEWVTCSTT-TPPRITKIALSGKNLKG--EIPPELKNMEALTELWLDG-NF 74 (557)
Q Consensus 4 ~~~~~~~~~~~----~~~~~-~~~c~~~~~~~v~c~~~-~p~~l~~L~L~~n~l~~--~~p~~~~~l~~L~~L~l~~-N~ 74 (557)
.||.++|+.+. +.+|. ++.||.+.|.||+|+.. ...+++.|+|++|+++| .+|.++++|++|++|+|++ |+
T Consensus 9 ~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~ 88 (313)
T d1ogqa_ 9 QALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88 (313)
T ss_dssp HHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETT
T ss_pred HHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccc
Confidence 68888888773 46895 44455678999999874 34579999999999998 5899999999999999996 89
Q ss_pred CCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccccccccCCCCCCccccc--CceeeeecCCCc
Q 008707 75 LTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT--GKVIFKYDNNPK 144 (557)
Q Consensus 75 l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~--~~~~~~~~~n~~ 144 (557)
++|.+| +|++|++|++|+|++|+|.+..|..+..+..|+.+++++|++.+.+|..+.. .+..+.+++|..
T Consensus 89 l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l 161 (313)
T d1ogqa_ 89 LVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred cccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccc
Confidence 998887 6999999999999999999888888999999999999999999889987754 345567777754
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.64 E-value=1.9e-16 Score=144.18 Aligned_cols=123 Identities=19% Similarity=0.213 Sum_probs=107.3
Q ss_pred CCCCCeEEeeC--------CCCCceEEEEecCCCccccCC-ccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEec
Q 008707 25 PVPWEWVTCST--------TTPPRITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLE 94 (557)
Q Consensus 25 ~~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~ 94 (557)
.|.|..|.|+. +.|+++++|+|++|.|++.++ ..|.++++|+.|+|++|.+.+.++ .|..+++|+.|+|+
T Consensus 7 ~C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 7 HCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp EEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred EEcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 46789999985 356789999999999986564 567899999999999999999988 59999999999999
Q ss_pred CccccCcCCCccCCCCcccccccccccCCCCCCccccc---CceeeeecCCCccccc
Q 008707 95 NNELTGSLPSYMGSLPNLQELHIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 95 ~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~~~~ 148 (557)
+|+|++..|..|.++++|+.|+|++|+|+ .+|++.|. .+..+.+.+|++.|+.
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~-~i~~~~f~~l~~L~~l~L~~N~~~~~~ 142 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred cccccccCHHHHhCCCcccccccCCcccc-ccCHHHhcCCccccccccccccccccc
Confidence 99999666678899999999999999999 88887765 4567789999998864
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=2.5e-13 Score=118.48 Aligned_cols=105 Identities=19% Similarity=0.209 Sum_probs=90.1
Q ss_pred EEEEecCCCccccCCccccCCCCCcEEECcCC-CCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCccccccccc
Q 008707 42 TKIALSGKNLKGEIPPELKNMEALTELWLDGN-FLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 119 (557)
Q Consensus 42 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 119 (557)
..+++++++++ .+|..+..+++|+.|+|++| .|+.+.+ .|.++++|+.|+|++|+|+..-|..|..+++|+.|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 34677778888 78888999999999999866 5888777 599999999999999999955567789999999999999
Q ss_pred ccCCCCCCcccccC--ceeeeecCCCccccc
Q 008707 120 NSFVGEIPPALLTG--KVIFKYDNNPKLHKE 148 (557)
Q Consensus 120 N~~~~~~p~~~~~~--~~~~~~~~n~~~~~~ 148 (557)
|+|+ .+|.+.+.. +..+.+++||+.|++
T Consensus 90 N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 90 NALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119 (156)
T ss_dssp SCCS-CCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred CCCc-ccChhhhccccccccccCCCcccCCc
Confidence 9999 999988764 457789999999875
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.39 E-value=2.7e-13 Score=113.32 Aligned_cols=100 Identities=25% Similarity=0.350 Sum_probs=81.1
Q ss_pred EEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccccccc
Q 008707 42 TKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENNS 121 (557)
Q Consensus 42 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~ 121 (557)
+.|+|++|+|+ .+| .+..+++|++|+|++|+|+.++++|..+++|+.|++++|+|+ .+|. +..+++|+.|++++|+
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc-ccCc-cccccccCeEECCCCc
Confidence 36899999998 776 488899999999999999987667889999999999999999 6764 8889999999999999
Q ss_pred CCCCCCc--ccc--cCceeeeecCCCccc
Q 008707 122 FVGEIPP--ALL--TGKVIFKYDNNPKLH 146 (557)
Q Consensus 122 ~~~~~p~--~~~--~~~~~~~~~~n~~~~ 146 (557)
|. .+|. .+. ..+..+.+.+|+...
T Consensus 77 i~-~~~~~~~l~~~~~L~~L~l~~N~i~~ 104 (124)
T d1dcea3 77 LQ-QSAAIQPLVSCPRLVLLNLQGNSLCQ 104 (124)
T ss_dssp CC-SSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred cC-CCCCchhhcCCCCCCEEECCCCcCCc
Confidence 98 6664 222 345677888888543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=2.7e-12 Score=122.47 Aligned_cols=108 Identities=27% Similarity=0.315 Sum_probs=79.9
Q ss_pred ceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
+|+.|+|++|.+.+..+..+..+.+|+.|++++|.++.+++. +..+++|+.|++++|+|++..|..|..+++|+.|+|+
T Consensus 101 ~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls 180 (266)
T d1p9ag_ 101 ALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180 (266)
T ss_dssp TCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECC
T ss_pred ccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecc
Confidence 344444444444433333444455555555556666666664 6778899999999999996667778999999999999
Q ss_pred cccCCCCCCccccc--CceeeeecCCCccccc
Q 008707 119 NNSFVGEIPPALLT--GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 119 ~N~~~~~~p~~~~~--~~~~~~~~~n~~~~~~ 148 (557)
+|+|+ .||++++. .+..+.++||||.|++
T Consensus 181 ~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp SSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 99999 99998875 4567899999999986
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.28 E-value=2.3e-12 Score=107.54 Aligned_cols=85 Identities=27% Similarity=0.345 Sum_probs=76.8
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCC--CccCCCCcccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP--SYMGSLPNLQELH 116 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~l~ 116 (557)
++|++|+|++|.|+ .+|+.++.+++|+.|++++|+|+.. |++..+++|+.|++++|+|+ .+| ..+..+++|+.|+
T Consensus 20 ~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~L~ 96 (124)
T d1dcea3 20 LLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLN 96 (124)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCEEE
T ss_pred CCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-CccccccccCeEECCCCccC-CCCCchhhcCCCCCCEEE
Confidence 57999999999999 8898999999999999999999976 56999999999999999999 555 4688999999999
Q ss_pred cccccCCCCCC
Q 008707 117 IENNSFVGEIP 127 (557)
Q Consensus 117 l~~N~~~~~~p 127 (557)
+++|+++ .++
T Consensus 97 l~~N~i~-~~~ 106 (124)
T d1dcea3 97 LQGNSLC-QEE 106 (124)
T ss_dssp CTTSGGG-GSS
T ss_pred CCCCcCC-cCc
Confidence 9999997 444
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=2.4e-12 Score=112.80 Aligned_cols=105 Identities=21% Similarity=0.244 Sum_probs=88.6
Q ss_pred CCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCc-cCCCCccccc
Q 008707 37 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSY-MGSLPNLQEL 115 (557)
Q Consensus 37 ~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~l 115 (557)
.+.++++|+|++|+|+ .+|..+..+++|+.|+|++|+|+.+ +.|..+++|+.|+|++|+++ .+|.. +..+++|+.|
T Consensus 16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhccccccc-CCCccccccccccccc
Confidence 3467999999999999 7787778899999999999999965 67999999999999999999 66654 5679999999
Q ss_pred ccccccCCCCCCc-cc---ccCceeeeecCCCcc
Q 008707 116 HIENNSFVGEIPP-AL---LTGKVIFKYDNNPKL 145 (557)
Q Consensus 116 ~l~~N~~~~~~p~-~~---~~~~~~~~~~~n~~~ 145 (557)
++++|++. .+++ .. +..+..+.+.+|+..
T Consensus 93 ~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 93 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred eecccccc-ccccccccccccccchhhcCCCccc
Confidence 99999998 7765 22 245677889999854
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.26 E-value=3.2e-12 Score=115.56 Aligned_cols=88 Identities=23% Similarity=0.356 Sum_probs=80.8
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
.++|+.|+|++|.+.+..+..+..+++|+.|+|++|+|+.+++ .|.++++|+.|+|++|+|++..|+.|..+++|+.|+
T Consensus 53 l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~ 132 (192)
T d1w8aa_ 53 LPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132 (192)
T ss_dssp CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEE
T ss_pred CceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccc
Confidence 3689999999999998888899999999999999999999988 499999999999999999966677889999999999
Q ss_pred cccccCCCC
Q 008707 117 IENNSFVGE 125 (557)
Q Consensus 117 l~~N~~~~~ 125 (557)
+++|.+...
T Consensus 133 L~~N~~~~~ 141 (192)
T d1w8aa_ 133 LASNPFNCN 141 (192)
T ss_dssp CTTCCBCCS
T ss_pred ccccccccc
Confidence 999998743
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.26 E-value=9.9e-13 Score=128.66 Aligned_cols=108 Identities=26% Similarity=0.309 Sum_probs=97.4
Q ss_pred eEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccccc
Q 008707 41 ITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIENN 120 (557)
Q Consensus 41 l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 120 (557)
...+++++|.+.|.+|..+..+++|+.|++++|.+++.+|.+..+++|+.|+|++|+|+|.+|..|+++++|+.|+|++|
T Consensus 199 ~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N 278 (313)
T d1ogqa_ 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278 (313)
T ss_dssp CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCC
Confidence 35688889999988999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCccc-ccCceeeeecCCCccccc
Q 008707 121 SFVGEIPPAL-LTGKVIFKYDNNPKLHKE 148 (557)
Q Consensus 121 ~~~~~~p~~~-~~~~~~~~~~~n~~~~~~ 148 (557)
+|+|.+|... ...+..+.+.+|+.+|+.
T Consensus 279 ~l~g~iP~~~~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 279 NLCGEIPQGGNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp EEEEECCCSTTGGGSCGGGTCSSSEEEST
T ss_pred cccccCCCcccCCCCCHHHhCCCccccCC
Confidence 9999999642 345667789999988864
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.23 E-value=5.4e-12 Score=121.52 Aligned_cols=111 Identities=19% Similarity=0.273 Sum_probs=96.5
Q ss_pred CCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCccccc
Q 008707 37 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 115 (557)
Q Consensus 37 ~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l 115 (557)
.+.+|+.|++++|.|++..+..|..+++|+.|+|++|+|+++++ .|.++++|+.|++++|++++..|..|..+++|+.|
T Consensus 127 ~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L 206 (284)
T d1ozna_ 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206 (284)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred hhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccc
Confidence 35679999999999995556778899999999999999999888 58999999999999999998889999999999999
Q ss_pred ccccccCCCCCCccccc---CceeeeecCCCccccc
Q 008707 116 HIENNSFVGEIPPALLT---GKVIFKYDNNPKLHKE 148 (557)
Q Consensus 116 ~l~~N~~~~~~p~~~~~---~~~~~~~~~n~~~~~~ 148 (557)
++++|++. .+|...+. .+..+.+++||+.|++
T Consensus 207 ~l~~N~i~-~~~~~~~~~~~~L~~L~l~~N~l~C~C 241 (284)
T d1ozna_ 207 YLFANNLS-ALPTEALAPLRALQYLRLNDNPWVCDC 241 (284)
T ss_dssp ECCSSCCS-CCCHHHHTTCTTCCEEECCSSCEECSG
T ss_pred cccccccc-cccccccccccccCEEEecCCCCCCCc
Confidence 99999999 56654443 4577889999999975
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.17 E-value=2.2e-11 Score=115.97 Aligned_cols=105 Identities=29% Similarity=0.254 Sum_probs=86.8
Q ss_pred CCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccc
Q 008707 36 TTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 115 (557)
Q Consensus 36 ~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l 115 (557)
+.|++++.|+|++|+|++..+..|.++++|+.|+|++|+|+.+ |.+..+++|+.|+|++|+++ .+|..+..+++|+.|
T Consensus 28 ~lp~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L 105 (266)
T d1p9ag_ 28 DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVL 105 (266)
T ss_dssp CCCTTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-ECCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEE
T ss_pred CcCcCCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-cccccccccccccccccccc-ccccccccccccccc
Confidence 3467899999999999955557799999999999999999864 45778999999999999999 678888999999999
Q ss_pred ccccccCCCCCCcccccC---ceeeeecCCC
Q 008707 116 HIENNSFVGEIPPALLTG---KVIFKYDNNP 143 (557)
Q Consensus 116 ~l~~N~~~~~~p~~~~~~---~~~~~~~~n~ 143 (557)
++++|.+. .++...+.. ...+.+.+|.
T Consensus 106 ~l~~~~~~-~~~~~~~~~l~~l~~L~l~~n~ 135 (266)
T d1p9ag_ 106 DVSFNRLT-SLPLGALRGLGELQELYLKGNE 135 (266)
T ss_dssp ECCSSCCC-CCCSSTTTTCTTCCEEECTTSC
T ss_pred cccccccc-eeeccccccccccccccccccc
Confidence 99999998 677665543 3455666664
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.15 E-value=3.4e-11 Score=116.97 Aligned_cols=109 Identities=23% Similarity=0.284 Sum_probs=97.7
Q ss_pred CCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCccccc
Q 008707 37 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQEL 115 (557)
Q Consensus 37 ~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l 115 (557)
.+++++.|++++|.+++..+..+.+++.++.|++++|.+++..+ .|.++++|+.|+|++|+|+ .+|..|..+++|+.|
T Consensus 169 ~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L 247 (305)
T d1xkua_ 169 LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 247 (305)
T ss_dssp CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEE
T ss_pred cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEE
Confidence 46789999999999998899999999999999999999999988 5899999999999999999 889999999999999
Q ss_pred ccccccCCCCCCccccc---------CceeeeecCCCcccc
Q 008707 116 HIENNSFVGEIPPALLT---------GKVIFKYDNNPKLHK 147 (557)
Q Consensus 116 ~l~~N~~~~~~p~~~~~---------~~~~~~~~~n~~~~~ 147 (557)
++++|+|+ .|+...|. .+..+.+++||+.+.
T Consensus 248 ~Ls~N~i~-~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 248 YLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp ECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred ECCCCccC-ccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 99999999 88876553 345678999998754
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.09 E-value=6.5e-11 Score=102.78 Aligned_cols=101 Identities=21% Similarity=0.220 Sum_probs=85.5
Q ss_pred CCCCCCCCeEEeeCC----C------CCceEEEEecCCC-ccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCc
Q 008707 22 PCVPVPWEWVTCSTT----T------PPRITKIALSGKN-LKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLR 89 (557)
Q Consensus 22 ~c~~~~~~~v~c~~~----~------p~~l~~L~L~~n~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~ 89 (557)
.|+.+.+++|+|+.. . .++++.|+|++|+ |+..-+..|.++++|+.|+|++|+|+.+.+ .|..+++|+
T Consensus 4 ~C~c~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~ 83 (156)
T d2ifga3 4 ACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83 (156)
T ss_dssp SSCCSSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCC
T ss_pred CCCcCCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccc
Confidence 577777899999871 1 2578999998765 884445679999999999999999999988 499999999
Q ss_pred EEEecCccccCcCCCccCCCCcccccccccccCC
Q 008707 90 IVHLENNELTGSLPSYMGSLPNLQELHIENNSFV 123 (557)
Q Consensus 90 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~ 123 (557)
.|+|++|+|+ .+|..+....+|+.|+|++|.+.
T Consensus 84 ~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 84 RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp EEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred ceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 9999999999 88877666668999999999985
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.08 E-value=1.4e-10 Score=112.51 Aligned_cols=100 Identities=29% Similarity=0.488 Sum_probs=84.8
Q ss_pred CCCCCCCeEEeeC--------CCCCceEEEEecCCCccccCC-ccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEE
Q 008707 23 CVPVPWEWVTCST--------TTPPRITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVH 92 (557)
Q Consensus 23 c~~~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~ 92 (557)
| .|.|+.|+|+. +.|++++.|+|++|+|+ .+| ..|.++++|++|++++|.+..+.| .|.++++|+.|+
T Consensus 8 c-~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~ 85 (305)
T d1xkua_ 8 C-QCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 85 (305)
T ss_dssp C-EEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred C-EecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEec
Confidence 5 47899999987 34688999999999999 665 479999999999999999999988 599999999999
Q ss_pred ecCccccCcCCCccCCCCcccccccccccCCCCCCc
Q 008707 93 LENNELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 128 (557)
Q Consensus 93 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~ 128 (557)
+++|+|+ .+|..+. ..|..|++.+|.+. .++.
T Consensus 86 l~~n~l~-~l~~~~~--~~l~~L~~~~n~l~-~l~~ 117 (305)
T d1xkua_ 86 LSKNQLK-ELPEKMP--KTLQELRVHENEIT-KVRK 117 (305)
T ss_dssp CCSSCCS-BCCSSCC--TTCCEEECCSSCCC-BBCH
T ss_pred ccCCccC-cCccchh--hhhhhhhccccchh-hhhh
Confidence 9999999 7886543 46777888888887 5554
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.00 E-value=9.5e-11 Score=102.41 Aligned_cols=86 Identities=22% Similarity=0.242 Sum_probs=76.8
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCC-ccCCCCCcEEEecCccccCcCCC--ccCCCCccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPD-MSRLIDLRIVHLENNELTGSLPS--YMGSLPNLQEL 115 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l 115 (557)
+.|+.|+|++|.|+ .++ .|..+++|+.|+|++|+|+.+++. +..+++|+.|+|++|+|+ .+++ .+..+++|+.|
T Consensus 41 ~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L 117 (162)
T d1a9na_ 41 DQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 117 (162)
T ss_dssp TCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred ccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccceecccccc-ccccccccccccccchh
Confidence 57999999999999 665 588999999999999999998886 678999999999999999 6664 67889999999
Q ss_pred ccccccCCCCCCc
Q 008707 116 HIENNSFVGEIPP 128 (557)
Q Consensus 116 ~l~~N~~~~~~p~ 128 (557)
++++|.++ .+|.
T Consensus 118 ~l~~N~i~-~~~~ 129 (162)
T d1a9na_ 118 CILRNPVT-NKKH 129 (162)
T ss_dssp ECCSSGGG-GSTT
T ss_pred hcCCCccc-cccc
Confidence 99999998 6764
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.82 E-value=4.4e-09 Score=100.59 Aligned_cols=107 Identities=20% Similarity=0.195 Sum_probs=87.2
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
++|++|+|++|.+....+..+..+++|+.+++++|+|+++++ .|..+++|+.|+|++|+|++..|..|.++++|+.+++
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l 184 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhh
Confidence 679999999999986666678888999999999999998887 4888999999999999999666777889999999999
Q ss_pred ccccCCCCCCcccc--cCceeeeecCCCcc
Q 008707 118 ENNSFVGEIPPALL--TGKVIFKYDNNPKL 145 (557)
Q Consensus 118 ~~N~~~~~~p~~~~--~~~~~~~~~~n~~~ 145 (557)
++|++.+..|..+. ..+..+.+++|...
T Consensus 185 ~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~ 214 (284)
T d1ozna_ 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCS
T ss_pred hhccccccChhHhhhhhhcccccccccccc
Confidence 99999854455543 24566777777644
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.82 E-value=2.9e-09 Score=99.16 Aligned_cols=102 Identities=22% Similarity=0.282 Sum_probs=85.4
Q ss_pred CCCCCeEEeeC--------CCCCceEEEEecCCCccccCC-ccccCCCCCcEEECcCCCCCCCCC--CccCCCCCcEEEe
Q 008707 25 PVPWEWVTCST--------TTPPRITKIALSGKNLKGEIP-PELKNMEALTELWLDGNFLTGPLP--DMSRLIDLRIVHL 93 (557)
Q Consensus 25 ~~~~~~v~c~~--------~~p~~l~~L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~--~~~~l~~L~~L~l 93 (557)
.|..+.|.|+. ..|.+++.|+|++|.|+ .+| ..|.++++|++|+|++|.+...++ .|.++++++.|++
T Consensus 7 ~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~ 85 (242)
T d1xwdc1 7 HCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85 (242)
T ss_dssp EECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred CCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence 56778899986 23568999999999999 555 568999999999999999988655 4899999999998
Q ss_pred cC-ccccCcCCCccCCCCcccccccccccCCCCCCc
Q 008707 94 EN-NELTGSLPSYMGSLPNLQELHIENNSFVGEIPP 128 (557)
Q Consensus 94 ~~-N~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~ 128 (557)
.+ |++....+..|..+++|+.+++++|++. .+|.
T Consensus 86 ~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~-~~~~ 120 (242)
T d1xwdc1 86 EKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPD 120 (242)
T ss_dssp ECCTTCCEECTTSEECCTTCCEEEEESCCCC-SCCC
T ss_pred cccccccccccccccccccccccccchhhhc-cccc
Confidence 65 6788666777899999999999999998 5554
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.78 E-value=4.9e-11 Score=107.99 Aligned_cols=103 Identities=25% Similarity=0.233 Sum_probs=84.7
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
.++|++|+|++|+|+ .++ .+.+|++|+.|+|++|+|+.+++.+..+++|+.|++++|+|+ .++ .+..+++|+.|++
T Consensus 47 L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L 122 (198)
T d1m9la_ 47 LKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEE
T ss_pred ccccceeECcccCCC-Ccc-cccCCccccChhhccccccccccccccccccccccccccccc-ccc-ccccccccccccc
Confidence 467999999999999 676 588999999999999999876554556778999999999999 565 3778999999999
Q ss_pred ccccCCCCCCc--cc--ccCceeeeecCCCcc
Q 008707 118 ENNSFVGEIPP--AL--LTGKVIFKYDNNPKL 145 (557)
Q Consensus 118 ~~N~~~~~~p~--~~--~~~~~~~~~~~n~~~ 145 (557)
++|+|+ .+++ .+ +..+..+.+.+||..
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccchhc-cccccccccCCCccceeecCCCccc
Confidence 999998 6664 22 345677889999843
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.75 E-value=8.3e-09 Score=93.06 Aligned_cols=99 Identities=24% Similarity=0.383 Sum_probs=62.3
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
++++.|+|++|+++ .++ .+..|++|++|+|++|+|++..+ +.++++|+.|++++|.+. .+|. +.+++.|+.|+++
T Consensus 40 ~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~-l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~ 114 (199)
T d2omxa2 40 DQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLF 114 (199)
T ss_dssp TTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECC
T ss_pred cCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc-ccCCcccccccccccccc-cccc-ccccccccccccc
Confidence 45677777777776 443 36667777777777777776544 667777777777777766 4543 6667777777777
Q ss_pred cccCCCCCCc-ccccCceeeeecCCC
Q 008707 119 NNSFVGEIPP-ALLTGKVIFKYDNNP 143 (557)
Q Consensus 119 ~N~~~~~~p~-~~~~~~~~~~~~~n~ 143 (557)
+|.+. .++. .-+..+..+.+++|.
T Consensus 115 ~~~~~-~~~~~~~l~~L~~L~l~~n~ 139 (199)
T d2omxa2 115 NNQIT-DIDPLKNLTNLNRLELSSNT 139 (199)
T ss_dssp SSCCC-CCGGGTTCTTCSEEECCSSC
T ss_pred ccccc-cccccchhhhhHHhhhhhhh
Confidence 77666 3322 223344555555554
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.62 E-value=1.3e-08 Score=101.35 Aligned_cols=98 Identities=23% Similarity=0.340 Sum_probs=76.3
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIE 118 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 118 (557)
+.+..+++++|.+++ + ..+..+++++.|+|++|+|++.. .+..+++|+.|+|++|+|+ .+| .+.++++|+.|+++
T Consensus 285 ~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~ 359 (384)
T d2omza2 285 TALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISDIS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAG 359 (384)
T ss_dssp TTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSCCG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECC
T ss_pred ccccccccccccccc-c-cccchhcccCeEECCCCCCCCCc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECC
Confidence 567889999999884 3 34778889999999999998864 4888899999999999998 566 58889999999999
Q ss_pred cccCCCCCCc-ccccCceeeeecCC
Q 008707 119 NNSFVGEIPP-ALLTGKVIFKYDNN 142 (557)
Q Consensus 119 ~N~~~~~~p~-~~~~~~~~~~~~~n 142 (557)
+|+++ .+++ .-+..+..+.+++|
T Consensus 360 ~N~l~-~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 360 HNQIS-DLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp SSCCC-BCGGGTTCTTCSEEECCCE
T ss_pred CCcCC-CChhhccCCCCCEeeCCCC
Confidence 99998 4443 22345566666665
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.61 E-value=3.6e-08 Score=89.54 Aligned_cols=82 Identities=26% Similarity=0.464 Sum_probs=60.2
Q ss_pred ceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccccc
Q 008707 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 119 (557)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 119 (557)
+++.|++++|.++ .++ .+..+++|+.|+|++|+|++.. .+..+++|+.|++++|+|+ .+| .+..+++|+.|++++
T Consensus 47 ~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~ 121 (210)
T d1h6ta2 47 SIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEH 121 (210)
T ss_dssp TCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTT
T ss_pred CccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCccccCcc-ccccCcccccccccccccc-ccc-ccccccccccccccc
Confidence 5777888888877 444 3677788888888888887744 4667788888888888887 566 367778888888888
Q ss_pred ccCCCCCC
Q 008707 120 NSFVGEIP 127 (557)
Q Consensus 120 N~~~~~~p 127 (557)
|.+. .++
T Consensus 122 ~~~~-~~~ 128 (210)
T d1h6ta2 122 NGIS-DIN 128 (210)
T ss_dssp SCCC-CCG
T ss_pred cccc-ccc
Confidence 8776 554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.60 E-value=3.9e-08 Score=89.29 Aligned_cols=101 Identities=28% Similarity=0.395 Sum_probs=76.1
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
.++|++|+|++|.|++ ++ .++++++|+.|++++|+|+++ +.+..+++|+.|++++|.+. .++ .+..++.|+.+++
T Consensus 67 l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 67 LPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKDL-SSLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYL 141 (210)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCG-GGGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEEC
T ss_pred CCCCCEEeCCCccccC-cc-ccccCcccccccccccccccc-cccccccccccccccccccc-ccc-ccccccccccccc
Confidence 4689999999999994 55 378899999999999999874 46888999999999999887 554 4667777888888
Q ss_pred ccccCCCCCCcccccCceeeeecCCC
Q 008707 118 ENNSFVGEIPPALLTGKVIFKYDNNP 143 (557)
Q Consensus 118 ~~N~~~~~~p~~~~~~~~~~~~~~n~ 143 (557)
++|.+.+.-+...+..+..+.+++|.
T Consensus 142 ~~n~l~~~~~~~~l~~L~~l~l~~n~ 167 (210)
T d1h6ta2 142 GNNKITDITVLSRLTKLDTLSLEDNQ 167 (210)
T ss_dssp CSSCCCCCGGGGGCTTCSEEECCSSC
T ss_pred cccccccccccccccccccccccccc
Confidence 88877632222233445556666664
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=98.58 E-value=5.4e-08 Score=87.54 Aligned_cols=100 Identities=26% Similarity=0.433 Sum_probs=76.9
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
-++|++|+|++|.+++ +++ +.++++|+.|++++|.+.... .+.++++|+.|++++|.+. .++ .+..+++|+.|++
T Consensus 61 l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~l~~~~~~-~~~-~~~~l~~L~~L~l 135 (199)
T d2omxa2 61 LNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIADIT-PLANLTNLTGLTLFNNQIT-DID-PLKNLTNLNRLEL 135 (199)
T ss_dssp CTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred CCCcCcCccccccccC-ccc-ccCCccccccccccccccccc-ccccccccccccccccccc-ccc-ccchhhhhHHhhh
Confidence 3689999999999994 443 899999999999999988654 5888999999999999887 343 3778889999999
Q ss_pred ccccCCCCCCc-ccccCceeeeecCCC
Q 008707 118 ENNSFVGEIPP-ALLTGKVIFKYDNNP 143 (557)
Q Consensus 118 ~~N~~~~~~p~-~~~~~~~~~~~~~n~ 143 (557)
++|++. .+|. .....+..+.+.+|.
T Consensus 136 ~~n~l~-~~~~l~~~~~L~~L~l~~n~ 161 (199)
T d2omxa2 136 SSNTIS-DISALSGLTSLQQLNFSSNQ 161 (199)
T ss_dssp CSSCCC-CCGGGTTCTTCSEEECCSSC
T ss_pred hhhhhc-cccccccccccccccccccc
Confidence 999887 5653 122344555666654
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.56 E-value=2.8e-08 Score=91.49 Aligned_cols=85 Identities=21% Similarity=0.415 Sum_probs=66.4
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
.+.+..+.++++.+....+ +.++++|+.|++++|.++... .+.++++|+.|+|++|+++ .+|. +.++++|+.|++
T Consensus 128 ~~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~n~~~~~~-~l~~l~~L~~L~Ls~n~l~-~l~~-l~~l~~L~~L~L 202 (227)
T d1h6ua2 128 LSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLT-PLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHL 202 (227)
T ss_dssp CTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEEC
T ss_pred ccchhhhhchhhhhchhhh--hccccccccccccccccccch-hhcccccceecccCCCccC-CChh-hcCCCCCCEEEC
Confidence 4677888888888874333 667788899999988887544 4788888999999999888 5554 778888999999
Q ss_pred ccccCCCCCCc
Q 008707 118 ENNSFVGEIPP 128 (557)
Q Consensus 118 ~~N~~~~~~p~ 128 (557)
++|+++ .+|+
T Consensus 203 s~N~lt-~i~~ 212 (227)
T d1h6ua2 203 KNNQIS-DVSP 212 (227)
T ss_dssp TTSCCC-BCGG
T ss_pred cCCcCC-CCcc
Confidence 999888 6664
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=98.56 E-value=3.7e-08 Score=97.85 Aligned_cols=101 Identities=25% Similarity=0.330 Sum_probs=73.6
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
.++|+.|++++|.+++. + .+..++.++.+++++|++++. +.+..+++|+.|++++|++++ ++. +..+++|+.|++
T Consensus 262 ~~~L~~L~l~~~~l~~~-~-~~~~~~~l~~l~~~~n~l~~~-~~~~~~~~l~~L~ls~n~l~~-l~~-l~~l~~L~~L~L 336 (384)
T d2omza2 262 LTKLTELKLGANQISNI-S-PLAGLTALTNLELNENQLEDI-SPISNLKNLTYLTLYFNNISD-ISP-VSSLTKLQRLFF 336 (384)
T ss_dssp CTTCSEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCSCC-GGGGGCTTCSEEECCSSCCSC-CGG-GGGCTTCCEEEC
T ss_pred cccCCEeeccCcccCCC-C-ccccccccccccccccccccc-cccchhcccCeEECCCCCCCC-Ccc-cccCCCCCEEEC
Confidence 35788888888888843 3 367788888888888888863 457778888888888888884 432 777888888888
Q ss_pred ccccCCCCCCcccc--cCceeeeecCCCcc
Q 008707 118 ENNSFVGEIPPALL--TGKVIFKYDNNPKL 145 (557)
Q Consensus 118 ~~N~~~~~~p~~~~--~~~~~~~~~~n~~~ 145 (557)
++|+++ .+|. +. ..+..+.+++|+..
T Consensus 337 ~~n~l~-~l~~-l~~l~~L~~L~l~~N~l~ 364 (384)
T d2omza2 337 ANNKVS-DVSS-LANLTNINWLSAGHNQIS 364 (384)
T ss_dssp CSSCCC-CCGG-GGGCTTCCEEECCSSCCC
T ss_pred CCCCCC-CChh-HcCCCCCCEEECCCCcCC
Confidence 888887 5652 32 34566777777643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.46 E-value=2.5e-07 Score=86.72 Aligned_cols=134 Identities=13% Similarity=0.087 Sum_probs=93.6
Q ss_pred CCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEEecCCCChhhhh
Q 008707 244 GKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYEYMHNGTLRDRL 322 (557)
Q Consensus 244 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~gsL~~~l 322 (557)
+.++.+.||+.... +..+++|+...........+.+|..+++.+. +--+.+++.+..+++..++||++++|.++.+..
T Consensus 23 ~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~ 101 (263)
T d1j7la_ 23 EGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY 101 (263)
T ss_dssp CCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHT
T ss_pred CCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccc
Confidence 33444689998654 6667888876544444445778999888874 434677888888888999999999998876544
Q ss_pred hccCCCCCcCHHHHHHHHHHHHHHHHHHHcC-------------------------------------------------
Q 008707 323 HGSVNQKPLDWLTRLQIAHDAAKGLEYLHTG------------------------------------------------- 353 (557)
Q Consensus 323 ~~~~~~~~l~~~~~~~i~~qia~aL~~LH~~------------------------------------------------- 353 (557)
... .....++.++++.++.||+.
T Consensus 102 ~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (263)
T d1j7la_ 102 EDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF 173 (263)
T ss_dssp TTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHH
T ss_pred ccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHH
Confidence 311 11233556666667777741
Q ss_pred -------CCCCeEeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 354 -------CNPGIIHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 354 -------~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
....++|+|+.|.||++++++..-|.||+.+..
T Consensus 174 l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 123489999999999999776667999987653
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=98.44 E-value=1.3e-09 Score=98.41 Aligned_cols=82 Identities=22% Similarity=0.424 Sum_probs=72.5
Q ss_pred CceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCC--CccCCCCcccccc
Q 008707 39 PRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLP--SYMGSLPNLQELH 116 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p--~~~~~l~~L~~l~ 116 (557)
++|+.|+|++|.|+ .+|.....+++|+.|++++|+|+.+ +.+..+++|+.|+|++|+|+ .++ ..+..+++|+.|+
T Consensus 70 ~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~ 146 (198)
T d1m9la_ 70 ENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL-SGIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLL 146 (198)
T ss_dssp TTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH-HHHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEE
T ss_pred ccccChhhcccccc-ccccccccccccccccccccccccc-ccccccccccccccccchhc-cccccccccCCCccceee
Confidence 57999999999999 7887666668899999999999975 56888999999999999999 665 4688999999999
Q ss_pred cccccCC
Q 008707 117 IENNSFV 123 (557)
Q Consensus 117 l~~N~~~ 123 (557)
+++|++.
T Consensus 147 L~~N~l~ 153 (198)
T d1m9la_ 147 LAGNPLY 153 (198)
T ss_dssp ECSSHHH
T ss_pred cCCCccc
Confidence 9999987
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=98.38 E-value=2.1e-07 Score=85.42 Aligned_cols=100 Identities=23% Similarity=0.388 Sum_probs=57.6
Q ss_pred CCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccc
Q 008707 38 PPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHI 117 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 117 (557)
.++|+.|+++++...+.. .+...+.++.++++++.+.... .+..+++|+.|++++|.++ ..+. ++++++|+.|++
T Consensus 106 l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~L 180 (227)
T d1h6ua2 106 LQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS-PLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKA 180 (227)
T ss_dssp CTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEEC
T ss_pred cccccccccccccccccc--hhccccchhhhhchhhhhchhh-hhccccccccccccccccc-cchh-hcccccceeccc
Confidence 355666666666665322 2445566666666666665432 3555666677777766666 2222 566666777777
Q ss_pred ccccCCCCCCc-ccccCceeeeecCCC
Q 008707 118 ENNSFVGEIPP-ALLTGKVIFKYDNNP 143 (557)
Q Consensus 118 ~~N~~~~~~p~-~~~~~~~~~~~~~n~ 143 (557)
++|+++ .+|+ .-+..+..+.+++|+
T Consensus 181 s~n~l~-~l~~l~~l~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 181 DDNKIS-DISPLASLPNLIEVHLKNNQ 206 (227)
T ss_dssp CSSCCC-CCGGGGGCTTCCEEECTTSC
T ss_pred CCCccC-CChhhcCCCCCCEEECcCCc
Confidence 777666 4543 122344555666664
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.35 E-value=1.9e-07 Score=86.42 Aligned_cols=104 Identities=21% Similarity=0.315 Sum_probs=83.0
Q ss_pred EeeCCCCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCC-ccCCC
Q 008707 32 TCSTTTPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPS-YMGSL 109 (557)
Q Consensus 32 ~c~~~~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l 109 (557)
.|+|.. ..+++++++++ .+|..+. ++++.|+|++|+|+.+++ .|.++++|++|+|++|.+...+|. .|..+
T Consensus 5 ~C~C~~----~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l 77 (242)
T d1xwdc1 5 ICHCSN----RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL 77 (242)
T ss_dssp SEEECS----SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESC
T ss_pred cCCCcC----CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccc
Confidence 488863 68999999999 9998764 689999999999998887 599999999999999999866654 57789
Q ss_pred Cccccccccc-ccCCCCCCccccc---CceeeeecCCC
Q 008707 110 PNLQELHIEN-NSFVGEIPPALLT---GKVIFKYDNNP 143 (557)
Q Consensus 110 ~~L~~l~l~~-N~~~~~~p~~~~~---~~~~~~~~~n~ 143 (557)
++++.+.+.. |++. .++...+. .+..+.+.+|.
T Consensus 78 ~~l~~l~~~~~n~l~-~~~~~~~~~l~~L~~l~l~~~~ 114 (242)
T d1xwdc1 78 PKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTG 114 (242)
T ss_dssp TTCCEEEEECCTTCC-EECTTSEECCTTCCEEEEESCC
T ss_pred ccccccccccccccc-ccccccccccccccccccchhh
Confidence 9999998764 6777 66665543 44556666664
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.18 E-value=1.9e-06 Score=83.68 Aligned_cols=92 Identities=25% Similarity=0.274 Sum_probs=54.5
Q ss_pred ceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCccccccccc
Q 008707 40 RITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELHIEN 119 (557)
Q Consensus 40 ~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 119 (557)
+++.|||++|+++ .+|.. +++|++|+|++|+|+.++.. +.+|+.|++++|+++ .++... +.|++|++++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLK-ALSDLP---PLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCS-CCCSCC---TTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcccccc---hhhhhhhhhhhcccc-hhhhhc---cccccccccc
Confidence 4667777777777 66642 35677777777777754333 346677777777776 554311 2467777777
Q ss_pred ccCCCCCCccc-ccCceeeeecCCC
Q 008707 120 NSFVGEIPPAL-LTGKVIFKYDNNP 143 (557)
Q Consensus 120 N~~~~~~p~~~-~~~~~~~~~~~n~ 143 (557)
|.+. .+|... ...+..+.+.+|.
T Consensus 108 n~l~-~lp~~~~l~~L~~L~l~~~~ 131 (353)
T d1jl5a_ 108 NQLE-KLPELQNSSFLKIIDVDNNS 131 (353)
T ss_dssp SCCS-SCCCCTTCTTCCEEECCSSC
T ss_pred cccc-cccchhhhccceeecccccc
Confidence 7776 666432 2234444444443
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.17 E-value=2.6e-06 Score=79.09 Aligned_cols=130 Identities=18% Similarity=0.127 Sum_probs=87.0
Q ss_pred ccCCCCc-eEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCC--CCccceeeEEEecCeeEEEEEecCCCCh
Q 008707 242 KIGKGSF-GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHH--RNLVPLIGYCEEEHQRILVYEYMHNGTL 318 (557)
Q Consensus 242 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--~nIv~~~~~~~~~~~~~lv~e~~~~gsL 318 (557)
.+..|.. +.||+...+++..+++|...... ...+..|...++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455553 68999998888889999865432 2346678888887742 3367778888888889999999988655
Q ss_pred hhhhhccCCCCCcCHHHHHHHHHHHHHHHHHHHc----------------------------------------------
Q 008707 319 RDRLHGSVNQKPLDWLTRLQIAHDAAKGLEYLHT---------------------------------------------- 352 (557)
Q Consensus 319 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~~LH~---------------------------------------------- 352 (557)
.+.. ... ...+.++++.|+-||+
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3311 111 1122334444444442
Q ss_pred ---------CCCCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 353 ---------GCNPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 353 ---------~~~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
.....++|+|+.|.||+++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 012348999999999999987667899998764
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.12 E-value=2.5e-06 Score=82.92 Aligned_cols=83 Identities=28% Similarity=0.446 Sum_probs=69.4
Q ss_pred CCCceEEEEecCCCccccCCccccCCCCCcEEECcCCCCCCCCCCccCCCCCcEEEecCccccCcCCCccCCCCcccccc
Q 008707 37 TPPRITKIALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLPDMSRLIDLRIVHLENNELTGSLPSYMGSLPNLQELH 116 (557)
Q Consensus 37 ~p~~l~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 116 (557)
.|++|++|+|++|+|+ .+|..+ .+|+.|++++|+++.+. .+ .+.|++|++++|.++ .+|. ++.+++|+.|+
T Consensus 56 ~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l~-~l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~ 126 (353)
T d1jl5a_ 56 LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKALS-DL--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIID 126 (353)
T ss_dssp CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCCC-SC--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred CCCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchhh-hh--ccccccccccccccc-cccc-hhhhccceeec
Confidence 4678999999999999 888654 68999999999998653 22 246999999999999 8886 67899999999
Q ss_pred cccccCCCCCCcc
Q 008707 117 IENNSFVGEIPPA 129 (557)
Q Consensus 117 l~~N~~~~~~p~~ 129 (557)
+++|.+. ..|..
T Consensus 127 l~~~~~~-~~~~~ 138 (353)
T d1jl5a_ 127 VDNNSLK-KLPDL 138 (353)
T ss_dssp CCSSCCS-CCCCC
T ss_pred ccccccc-ccccc
Confidence 9999998 55544
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.07 E-value=1.6e-07 Score=81.39 Aligned_cols=82 Identities=22% Similarity=0.178 Sum_probs=56.8
Q ss_pred EEecCCCccccCCccccCCCCCcEEECcCCCCCCCCC--C-ccCCCCCcEEEecCccccCcCCC-ccCCCCccccccccc
Q 008707 44 IALSGKNLKGEIPPELKNMEALTELWLDGNFLTGPLP--D-MSRLIDLRIVHLENNELTGSLPS-YMGSLPNLQELHIEN 119 (557)
Q Consensus 44 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~--~-~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~l~l~~ 119 (557)
+++.+|... .++....++++|++|+|++|+|+.+.+ . +..+++|+.|+|++|+|+ .++. ......+|+.|++++
T Consensus 47 l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~ 124 (162)
T d1koha1 47 LNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDG 124 (162)
T ss_dssp TTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTT
T ss_pred cchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCC
Confidence 334444333 455445678888899999998887643 3 677888999999999888 6654 223445788888999
Q ss_pred ccCCCCCC
Q 008707 120 NSFVGEIP 127 (557)
Q Consensus 120 N~~~~~~p 127 (557)
|.+.....
T Consensus 125 Npl~~~~~ 132 (162)
T d1koha1 125 NSLSDTFR 132 (162)
T ss_dssp STTSSSSS
T ss_pred CCcCcCcc
Confidence 98874433
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.71 E-value=2.7e-06 Score=73.35 Aligned_cols=78 Identities=23% Similarity=0.318 Sum_probs=53.1
Q ss_pred CceEEEEecCCCcccc--CCccccCCCCCcEEECcCCCCCCCCC-CccCCCCCcEEEecCccccCcCCCc-------cCC
Q 008707 39 PRITKIALSGKNLKGE--IPPELKNMEALTELWLDGNFLTGPLP-DMSRLIDLRIVHLENNELTGSLPSY-------MGS 108 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~-------~~~ 108 (557)
+.|++|+|++|+|+.. ++..+..+++|+.|+|++|+|+...+ .+....+|+.|++++|.++...... +..
T Consensus 65 ~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~ 144 (162)
T d1koha1 65 PELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRER 144 (162)
T ss_dssp TTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTT
T ss_pred CCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHH
Confidence 5688888888888732 22345667888888888888887665 3444556888888888887544421 445
Q ss_pred CCcccccc
Q 008707 109 LPNLQELH 116 (557)
Q Consensus 109 l~~L~~l~ 116 (557)
+|+|+.||
T Consensus 145 ~P~L~~LD 152 (162)
T d1koha1 145 FPKLLRLD 152 (162)
T ss_dssp STTCCEET
T ss_pred CCCCCEEC
Confidence 77777665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.64 E-value=8.3e-05 Score=73.44 Aligned_cols=76 Identities=16% Similarity=0.209 Sum_probs=48.9
Q ss_pred hcccCCCCceEEEEEEEcC-CcEEEEEEccCcc-------chhHHHHHHHHHHHhhcC-C--CCccceeeEEEecCeeEE
Q 008707 240 CKKIGKGSFGSVYYGKMKD-GKEVAVKIMADSC-------SHRTQQFVTEVALLSRIH-H--RNLVPLIGYCEEEHQRIL 308 (557)
Q Consensus 240 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~E~~il~~l~-h--~nIv~~~~~~~~~~~~~l 308 (557)
.+.||.|....||+....+ ++.+++|.-.... .....+...|++.|+.+. + ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3679999999999998654 6789999643211 112234557888888773 3 235555544 4456689
Q ss_pred EEEecCCCC
Q 008707 309 VYEYMHNGT 317 (557)
Q Consensus 309 v~e~~~~gs 317 (557)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.39 E-value=0.0002 Score=68.60 Aligned_cols=135 Identities=13% Similarity=0.180 Sum_probs=78.7
Q ss_pred eEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCCc--ccee-----eEEEecCeeEEEEEecCCCChh--
Q 008707 249 GSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRNL--VPLI-----GYCEEEHQRILVYEYMHNGTLR-- 319 (557)
Q Consensus 249 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~nI--v~~~-----~~~~~~~~~~lv~e~~~~gsL~-- 319 (557)
-.||++...+|..|++|+.++. ....+++..|...+..|....+ +..+ ..+...+..+.+++++.|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999987654 2345678889999988853222 2121 1234566788999999764321
Q ss_pred ---h---------hhhc----cC--CCCCcCHH----------------------HHHHHHHHHHHHHHHH-HcCCCCCe
Q 008707 320 ---D---------RLHG----SV--NQKPLDWL----------------------TRLQIAHDAAKGLEYL-HTGCNPGI 358 (557)
Q Consensus 320 ---~---------~l~~----~~--~~~~l~~~----------------------~~~~i~~qia~aL~~L-H~~~~~~i 358 (557)
. .++. .. .....+.. .....+.++...+.-. .+....++
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 0000 00 01111111 1122233333333222 12224689
Q ss_pred EeeccCCCCEEeCCCCcEEEecccCccc
Q 008707 359 IHRDVKSSNILLDINMRAKVSDFGLSRQ 386 (557)
Q Consensus 359 vH~dlk~~NIll~~~~~~kl~Dfgla~~ 386 (557)
+|+|+.+.|||++++ ..+.||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 45899997764
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.34 E-value=1.6e-05 Score=79.72 Aligned_cols=84 Identities=18% Similarity=0.192 Sum_probs=43.7
Q ss_pred ceEEEEecCCCcccc-CCccccCCCCCcEEECcCCCCCCC----CC-CccCCCCCcEEEecCccccC----cCCCccC-C
Q 008707 40 RITKIALSGKNLKGE-IPPELKNMEALTELWLDGNFLTGP----LP-DMSRLIDLRIVHLENNELTG----SLPSYMG-S 108 (557)
Q Consensus 40 ~l~~L~L~~n~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~----~~-~~~~l~~L~~L~l~~N~l~~----~~p~~~~-~ 108 (557)
+|+.|||++|++++. +..-+..+++|++|+|++|.|+.. +. .+..+++|+.|||++|.|+. .+...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 466666666666532 122244456666666666665521 11 24556666666666666541 1222222 1
Q ss_pred CCcccccccccccCC
Q 008707 109 LPNLQELHIENNSFV 123 (557)
Q Consensus 109 l~~L~~l~l~~N~~~ 123 (557)
..+|+.|++++|+++
T Consensus 83 ~~~L~~L~L~~n~it 97 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLT 97 (460)
T ss_dssp TCCCCEEECTTSCCB
T ss_pred CCCCCEEECCCCCcc
Confidence 235666666666664
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.92 E-value=2.9e-05 Score=77.80 Aligned_cols=85 Identities=31% Similarity=0.392 Sum_probs=67.5
Q ss_pred CceEEEEecCCCccc----cCCccccCCCCCcEEECcCCCCCCC----CC-Ccc-CCCCCcEEEecCccccCc----CCC
Q 008707 39 PRITKIALSGKNLKG----EIPPELKNMEALTELWLDGNFLTGP----LP-DMS-RLIDLRIVHLENNELTGS----LPS 104 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~~-~~~-~l~~L~~L~l~~N~l~~~----~p~ 104 (557)
+++++|+|++|+|+. .++..+..+++|+.|||++|+|+.. +. .+. ...+|+.|+|++|+++.. ++.
T Consensus 27 ~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~ 106 (460)
T d1z7xw1 27 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS 106 (460)
T ss_dssp TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHH
T ss_pred CCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccc
Confidence 468999999999872 3455678899999999999998632 11 232 345799999999999743 566
Q ss_pred ccCCCCcccccccccccCC
Q 008707 105 YMGSLPNLQELHIENNSFV 123 (557)
Q Consensus 105 ~~~~l~~L~~l~l~~N~~~ 123 (557)
.+..+++|+.|++++|++.
T Consensus 107 ~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 107 TLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp HTTSCTTCCEEECCSSBCH
T ss_pred hhhccccccccccccccch
Confidence 7888999999999999987
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=96.77 E-value=8.7e-05 Score=71.81 Aligned_cols=86 Identities=21% Similarity=0.313 Sum_probs=62.0
Q ss_pred CCceEEEEecCCCccc----cCCccccCCCCCcEEECcCCCCCCC-----C-CCccCCCCCcEEEecCccccCc----CC
Q 008707 38 PPRITKIALSGKNLKG----EIPPELKNMEALTELWLDGNFLTGP-----L-PDMSRLIDLRIVHLENNELTGS----LP 103 (557)
Q Consensus 38 p~~l~~L~L~~n~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~-----~-~~~~~l~~L~~L~l~~N~l~~~----~p 103 (557)
.+.++.|++++|.+.. .+...+..++.|+.|+|++|+|+.. + ..+..+++|+.|+|++|.|+.. +.
T Consensus 157 ~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~ 236 (344)
T d2ca6a1 157 APPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236 (344)
T ss_dssp CCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHH
T ss_pred Ccccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccc
Confidence 4678888888888762 2333456678888888888888642 2 2466788888888888887522 44
Q ss_pred CccCCCCcccccccccccCC
Q 008707 104 SYMGSLPNLQELHIENNSFV 123 (557)
Q Consensus 104 ~~~~~l~~L~~l~l~~N~~~ 123 (557)
..+..+++|+.|++++|.|.
T Consensus 237 ~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 237 IALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp HHGGGCTTCCEEECTTCCCC
T ss_pred ccccccccchhhhhhcCccC
Confidence 55667788888888888876
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.72 E-value=0.00041 Score=64.96 Aligned_cols=83 Identities=22% Similarity=0.298 Sum_probs=63.9
Q ss_pred CCceEEEEecCC--Ccccc-CCccccCCCCCcEEECcCC-CCCCCCC-CccCCCCCcEEEecCc-cccCcCCCccCCCCc
Q 008707 38 PPRITKIALSGK--NLKGE-IPPELKNMEALTELWLDGN-FLTGPLP-DMSRLIDLRIVHLENN-ELTGSLPSYMGSLPN 111 (557)
Q Consensus 38 p~~l~~L~L~~n--~l~~~-~p~~~~~l~~L~~L~l~~N-~l~~~~~-~~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~~ 111 (557)
++.|+.|+|+++ .++.. +..-..++++|+.|+|++| .++.... .+.++++|++|+|+++ .+++.....++.+++
T Consensus 147 ~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~ 226 (284)
T d2astb2 147 SETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226 (284)
T ss_dssp CTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTT
T ss_pred ccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCC
Confidence 468999999875 34422 3333466899999999986 4765444 6888999999999994 687666677888999
Q ss_pred ccccccccc
Q 008707 112 LQELHIENN 120 (557)
Q Consensus 112 L~~l~l~~N 120 (557)
|+.|+++++
T Consensus 227 L~~L~l~~~ 235 (284)
T d2astb2 227 LKTLQVFGI 235 (284)
T ss_dssp CCEEECTTS
T ss_pred CCEEeeeCC
Confidence 999999877
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.71 E-value=0.00026 Score=66.41 Aligned_cols=104 Identities=19% Similarity=0.176 Sum_probs=70.2
Q ss_pred CceEEEEecCC-Ccccc-CCccccC-CCCCcEEECcCC--CCCCC-CCC-ccCCCCCcEEEecCc-cccCcCCCccCCCC
Q 008707 39 PRITKIALSGK-NLKGE-IPPELKN-MEALTELWLDGN--FLTGP-LPD-MSRLIDLRIVHLENN-ELTGSLPSYMGSLP 110 (557)
Q Consensus 39 ~~l~~L~L~~n-~l~~~-~p~~~~~-l~~L~~L~l~~N--~l~~~-~~~-~~~l~~L~~L~l~~N-~l~~~~p~~~~~l~ 110 (557)
++|++|+|+++ +++.. ++..+.. .++|+.|+++++ .++.. +.. +.++++|+.|+|++| .+++..+..+.+++
T Consensus 121 ~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred HhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 68999999996 45422 3333434 478999999975 34432 223 456899999999986 48877788899999
Q ss_pred cccccccccc-cCCCCCCccccc--CceeeeecCC
Q 008707 111 NLQELHIENN-SFVGEIPPALLT--GKVIFKYDNN 142 (557)
Q Consensus 111 ~L~~l~l~~N-~~~~~~p~~~~~--~~~~~~~~~n 142 (557)
+|+.|+++++ .++......+.. .+..+.+.++
T Consensus 201 ~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 9999999994 565433333322 3344455443
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=96.66 E-value=0.00013 Score=70.50 Aligned_cols=106 Identities=17% Similarity=0.162 Sum_probs=71.0
Q ss_pred CceEEEEecCCCcc----ccC---------CccccCCCCCcEEECcCCCCCCCC----C-CccCCCCCcEEEecCccccC
Q 008707 39 PRITKIALSGKNLK----GEI---------PPELKNMEALTELWLDGNFLTGPL----P-DMSRLIDLRIVHLENNELTG 100 (557)
Q Consensus 39 ~~l~~L~L~~n~l~----~~~---------p~~~~~l~~L~~L~l~~N~l~~~~----~-~~~~l~~L~~L~l~~N~l~~ 100 (557)
++|+.|+|++|.+. ..+ .......+.|+.|++++|+++..- . .+...+.|+.|+|++|+|+.
T Consensus 121 ~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 200 (344)
T d2ca6a1 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 200 (344)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred ccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhhhcccccccccccc
Confidence 57999999999752 011 112245678999999999887421 1 25567889999999999863
Q ss_pred -----cCCCccCCCCcccccccccccCCCC----CCccc--ccCceeeeecCCCc
Q 008707 101 -----SLPSYMGSLPNLQELHIENNSFVGE----IPPAL--LTGKVIFKYDNNPK 144 (557)
Q Consensus 101 -----~~p~~~~~l~~L~~l~l~~N~~~~~----~p~~~--~~~~~~~~~~~n~~ 144 (557)
.+...+..+++|+.|++++|.+... +...+ ...+..+.+++|..
T Consensus 201 ~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i 255 (344)
T d2ca6a1 201 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 255 (344)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred cccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCcc
Confidence 1345567788999999999988622 11111 22445667777753
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.64 E-value=0.0029 Score=61.91 Aligned_cols=72 Identities=14% Similarity=0.254 Sum_probs=49.1
Q ss_pred cccCCCCceEEEEEEEcC--------CcEEEEEEccCccchhHHHHHHHHHHHhhcC-CCCccceeeEEEecCeeEEEEE
Q 008707 241 KKIGKGSFGSVYYGKMKD--------GKEVAVKIMADSCSHRTQQFVTEVALLSRIH-HRNLVPLIGYCEEEHQRILVYE 311 (557)
Q Consensus 241 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e 311 (557)
+.|+.|-.-.+|++...+ .+.|++++.... .. .-...+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 568888888999998754 346777776532 22 234557999999884 5444577777643 58999
Q ss_pred ecCCCCh
Q 008707 312 YMHNGTL 318 (557)
Q Consensus 312 ~~~~gsL 318 (557)
|++|..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.51 E-value=0.00027 Score=60.57 Aligned_cols=86 Identities=14% Similarity=0.162 Sum_probs=64.5
Q ss_pred CCceEEEEecCC-Ccccc----CCccccCCCCCcEEECcCCCCCCC--CC---CccCCCCCcEEEecCccccCc----CC
Q 008707 38 PPRITKIALSGK-NLKGE----IPPELKNMEALTELWLDGNFLTGP--LP---DMSRLIDLRIVHLENNELTGS----LP 103 (557)
Q Consensus 38 p~~l~~L~L~~n-~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~--~~---~~~~l~~L~~L~l~~N~l~~~----~p 103 (557)
.++|++|+|+++ .++.. +-..+...++|+.|+|++|.|... .. .+...+.|+.|+|++|.|+.. +-
T Consensus 14 ~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~ 93 (167)
T d1pgva_ 14 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLL 93 (167)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHH
T ss_pred CCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHH
Confidence 368999999974 46532 334577778999999999998742 22 255678899999999998732 23
Q ss_pred CccCCCCcccccccccccCC
Q 008707 104 SYMGSLPNLQELHIENNSFV 123 (557)
Q Consensus 104 ~~~~~l~~L~~l~l~~N~~~ 123 (557)
..+...++|+.|++++|.+.
T Consensus 94 ~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 94 RSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHTTTTCCCSEEECCCCSSC
T ss_pred HHHHhCCcCCEEECCCCcCC
Confidence 35667788999999999876
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.25 E-value=0.0065 Score=57.20 Aligned_cols=141 Identities=11% Similarity=0.095 Sum_probs=74.5
Q ss_pred ccCCCCceEEEEEEEcCCcEEEEEEccCccchhHHHHHHHHHHHhhcCCCC--ccceee------EEEecCeeEEEEEec
Q 008707 242 KIGKGSFGSVYYGKMKDGKEVAVKIMADSCSHRTQQFVTEVALLSRIHHRN--LVPLIG------YCEEEHQRILVYEYM 313 (557)
Q Consensus 242 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--Iv~~~~------~~~~~~~~~lv~e~~ 313 (557)
.|..|.--+.|+....+|+ +++|+..... ..+.+..|++++..|...+ +...+. +.........++.++
T Consensus 25 ~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~ 101 (316)
T d2ppqa1 25 GIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFL 101 (316)
T ss_dssp EECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECC
T ss_pred cCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeec
Confidence 4566777788999877654 8999876432 2344556777888774322 222211 122345567777777
Q ss_pred CCCChhh--------------hhhcc---CC-C--CC------------------cCHHHHHHHHHHHHHHHHHHHc-CC
Q 008707 314 HNGTLRD--------------RLHGS---VN-Q--KP------------------LDWLTRLQIAHDAAKGLEYLHT-GC 354 (557)
Q Consensus 314 ~~gsL~~--------------~l~~~---~~-~--~~------------------l~~~~~~~i~~qia~aL~~LH~-~~ 354 (557)
.+..... .++.. .. . .. .........+..+...+...+. ..
T Consensus 102 ~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L 181 (316)
T d2ppqa1 102 EGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDL 181 (316)
T ss_dssp CCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSS
T ss_pred ccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcccc
Confidence 6643211 00000 00 0 00 0000111222222222333221 23
Q ss_pred CCCeEeeccCCCCEEeCCCCcEEEecccCcc
Q 008707 355 NPGIIHRDVKSSNILLDINMRAKVSDFGLSR 385 (557)
Q Consensus 355 ~~~ivH~dlk~~NIll~~~~~~kl~Dfgla~ 385 (557)
..|++|+|+.++||+++.+...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4789999999999999988777899999775
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=95.34 E-value=0.00096 Score=56.93 Aligned_cols=82 Identities=16% Similarity=0.151 Sum_probs=58.1
Q ss_pred CceEEEEecCCCcccc----CCccccCCCCCcEEECcCCCCCCCC-----CCccCCCCCcEEEecCccccCc-------C
Q 008707 39 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPL-----PDMSRLIDLRIVHLENNELTGS-------L 102 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~-----~~~~~l~~L~~L~l~~N~l~~~-------~ 102 (557)
+.|+.|+|++|.+... +...+...+.|+.|+|++|.|+..- ..+..-++|+.|+|++|.+... +
T Consensus 44 ~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l 123 (167)
T d1pgva_ 44 KHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDM 123 (167)
T ss_dssp SCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHH
T ss_pred CccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHH
Confidence 5799999999999743 2234556789999999999998631 1366778899999999976621 2
Q ss_pred CCccCCCCcccccccccc
Q 008707 103 PSYMGSLPNLQELHIENN 120 (557)
Q Consensus 103 p~~~~~l~~L~~l~l~~N 120 (557)
...+...++|+.|+++.+
T Consensus 124 ~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 124 MMAIEENESLLRVGISFA 141 (167)
T ss_dssp HHHHHHCSSCCEEECCCC
T ss_pred HHHHHhCCCccEeeCcCC
Confidence 233344566666666544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=92.48 E-value=0.0083 Score=50.64 Aligned_cols=85 Identities=21% Similarity=0.292 Sum_probs=59.0
Q ss_pred CceEEEEecC-CCcccc----CCccccCCCCCcEEECcCCCCCCCCC-----CccCCCCCcEEEecCccccCc----CCC
Q 008707 39 PRITKIALSG-KNLKGE----IPPELKNMEALTELWLDGNFLTGPLP-----DMSRLIDLRIVHLENNELTGS----LPS 104 (557)
Q Consensus 39 ~~l~~L~L~~-n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~-----~~~~l~~L~~L~l~~N~l~~~----~p~ 104 (557)
+.|+.|+|++ +.++.. +-..+...++|+.|+|++|.++..-- .+...++|+.|++++|.++.. +-.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 5899999997 556532 33446678899999999998875321 255678899999999988632 234
Q ss_pred ccCCCCccccccc--ccccCC
Q 008707 105 YMGSLPNLQELHI--ENNSFV 123 (557)
Q Consensus 105 ~~~~l~~L~~l~l--~~N~~~ 123 (557)
.+...++|+.++| ++|.+.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCC
T ss_pred HHHhCccccEEeeccCCCcCc
Confidence 5666778876444 566664
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=90.18 E-value=0.0075 Score=50.93 Aligned_cols=84 Identities=14% Similarity=0.231 Sum_probs=61.0
Q ss_pred CceEEEEecCCCcccc----CCccccCCCCCcEEECcCCCCCCCC-----CCccCCCCCcEEEe--cCccccC----cCC
Q 008707 39 PRITKIALSGKNLKGE----IPPELKNMEALTELWLDGNFLTGPL-----PDMSRLIDLRIVHL--ENNELTG----SLP 103 (557)
Q Consensus 39 ~~l~~L~L~~n~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~-----~~~~~l~~L~~L~l--~~N~l~~----~~p 103 (557)
+.|+.|+|++|.++.. +-..+...+.|+.|++++|.++..- ..+...++|+.++| ++|.+.. .+.
T Consensus 46 ~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La 125 (166)
T d1io0a_ 46 TYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIA 125 (166)
T ss_dssp CSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHH
T ss_pred CccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHH
Confidence 5799999999998743 2234666799999999999987531 24677888987666 5667752 244
Q ss_pred CccCCCCcccccccccccC
Q 008707 104 SYMGSLPNLQELHIENNSF 122 (557)
Q Consensus 104 ~~~~~l~~L~~l~l~~N~~ 122 (557)
..+...++|+.|+++.|+.
T Consensus 126 ~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 126 NMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCCCcCEEeCcCCCC
Confidence 5566778888888876654
|